data_1r2n_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1r2n _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 N--CA 1.476 0.87 0 CA-C-O 115.807 -2.044 . . . . 10.0 105.858 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 23.41 91.8 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 129.598 3.159 . . . . 10.0 117.253 160.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 28.67 65.06 0.11 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 128.291 2.636 . . . . 10.0 114.474 155.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 86.7 mt -56.46 137.93 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 126.387 1.875 . . . . 10.0 113.376 -158.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.6 t -136.7 -165.22 1.7 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 126.324 1.85 . . . . 10.0 114.052 -174.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 70.01 2.83 41.23 Favored Glycine 0 C--N 1.34 0.786 0 C-N-CA 127.471 2.463 . . . . 10.0 111.485 168.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -158.56 -51.35 0.01 OUTLIER Pre-proline 0 N--CA 1.443 -0.823 0 CA-C-O 114.274 -2.774 . . . . 10.0 116.642 -168.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -63.95 -60.69 0.14 Allowed 'Trans proline' 0 N--CA 1.465 -0.202 0 CA-C-N 123.509 2.289 . . . . 10.0 113.21 -175.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 7.9 pm0 -67.16 4.35 0.94 Allowed 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 127.836 2.454 . . . . 10.0 115.764 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.421 ' CG ' ' N ' ' A' ' 11' ' ' ILE . 11.1 p-90 -51.37 -43.14 61.78 Favored 'General case' 0 C--O 1.222 -0.361 0 O-C-N 121.516 -0.74 . . . . 10.0 112.564 176.439 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.421 ' N ' ' CG ' ' A' ' 10' ' ' TRP . 8.9 tt -60.87 -49.63 83.82 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.361 0 C-N-CA 123.926 0.89 . . . . 10.0 109.306 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 2.6 m95 -55.38 -52.62 62.93 Favored 'General case' 0 C--O 1.224 -0.259 0 C-N-CA 123.433 0.693 . . . . 10.0 111.912 175.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.6 mt -57.38 -53.61 56.24 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.112 0.565 . . . . 10.0 112.222 177.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.84 -46.79 51.67 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.391 1.476 . . . . 10.0 113.33 173.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 13.3 tp -65.62 -45.02 84.7 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 125.336 1.455 . . . . 10.0 113.047 179.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.45 -56.86 10.1 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 124.621 1.105 . . . . 10.0 111.407 165.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.2 m -49.51 -52.49 29.15 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.995 1.318 . . . . 10.0 112.242 174.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.41 -58.86 5.79 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.143 0.977 . . . . 10.0 112.176 177.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 95.3 mt -57.97 -49.34 77.16 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.678 0.791 . . . . 10.0 112.544 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 23.5 mmt -55.23 -51.04 67.86 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.587 0.755 . . . . 10.0 111.026 175.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -56.33 -58.53 13.82 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 124.441 1.019 . . . . 10.0 113.738 176.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 80.8 mt -56.21 -45.41 79.89 Favored 'General case' 0 C--O 1.221 -0.397 0 CA-C-N 118.593 1.196 . . . . 10.0 112.113 176.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.83 -42.05 77.8 Favored Glycine 0 CA--C 1.534 1.24 0 C-N-CA 124.814 1.197 . . . . 10.0 113.46 172.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 15.4 m -59.38 -61.61 2.5 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.457 1.103 . . . . 10.0 110.723 171.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -52.24 -40.96 62.37 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.039 0.936 . . . . 10.0 110.976 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -55.77 -58.08 9.32 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.611 1.165 . . . . 10.0 112.986 172.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -59.65 -38.61 81.89 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 113.255 0.835 . . . . 10.0 113.255 178.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.469 ' C ' ' H ' ' A' ' 30' ' ' LYS . 11.8 mt -56.19 -67.44 0.3 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.627 1.171 . . . . 10.0 113.597 169.118 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 t -76.37 40.98 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 CA-C-O 123.749 1.738 . . . . 10.0 110.879 179.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.469 ' H ' ' C ' ' A' ' 28' ' ' LEU . 42.9 tttm -140.87 -44.88 0.39 Allowed 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 127.87 2.468 . . . . 10.0 109.336 171.204 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.96 23.15 0.87 Allowed Glycine 0 CA--C 1.529 0.925 0 N-CA-C 115.629 1.012 . . . . 10.0 115.629 173.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 37.3 mmm -59.54 -44.97 93.06 Favored 'General case' 0 C--O 1.225 -0.235 0 C-N-CA 127.13 2.172 . . . . 10.0 113.63 -179.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.62 -84.43 1.18 Allowed Glycine 0 CA--C 1.531 1.045 0 C-N-CA 123.764 0.697 . . . . 10.0 112.508 -170.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.8 t 33.02 88.81 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.242 0.682 0 C-N-CA 128.358 2.663 . . . . 10.0 116.942 166.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.7 m -79.68 -50.85 10.01 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.167 -1.379 . . . . 10.0 113.877 174.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -48.91 117.47 6.37 Favored Pre-proline 0 CA--C 1.536 0.416 0 O-C-N 124.764 1.29 . . . . 10.0 110.949 -172.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -58.57 -29.65 89.61 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 123.726 2.951 . . . . 10.0 113.682 179.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.29 -60.64 2.3 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 123.107 0.563 . . . . 10.0 111.48 176.15 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.21 -40.02 23.0 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 125.097 1.359 . . . . 10.0 113.559 171.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.5 tttp -46.57 -47.44 19.76 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 125.243 1.417 . . . . 10.0 113.403 172.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -57.72 -53.08 62.26 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.473 0.709 . . . . 10.0 111.009 176.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -56.95 -50.24 73.24 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 123.089 0.555 . . . . 10.0 112.34 -179.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -54.44 -51.25 65.55 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 118.916 -0.564 . . . . 10.0 112.342 173.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.38 -61.98 1.93 Allowed 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 113.399 0.888 . . . . 10.0 113.399 177.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.5 mt -48.86 -56.06 2.81 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 C-N-CA 124.912 1.285 . . . . 10.0 110.832 178.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.5 m -69.49 -20.34 63.73 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.861 1.264 . . . . 10.0 113.432 -172.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 28.1 m -84.4 -38.82 19.78 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.404 1.081 . . . . 10.0 112.28 174.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 19.1 mt -59.33 -41.4 89.06 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 117.873 -1.061 . . . . 10.0 112.803 174.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . 0.405 33.0 m -58.49 -49.56 92.85 Favored Pre-proline 0 N--CA 1.486 1.36 0 CA-C-N 121.082 1.765 . . . . 10.0 114.707 -178.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -49.82 -45.32 32.66 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 123.587 2.858 . . . . 10.0 115.107 162.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.6 -46.79 84.2 Favored 'General case' 0 CA--C 1.548 0.892 0 CA-C-N 119.82 1.191 . . . . 10.0 113.704 -179.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 30.9 mm -53.22 -55.48 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 124.989 1.316 . . . . 10.0 109.595 169.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.65 -44.85 77.56 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.124 0.969 . . . . 10.0 113.567 177.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 50.2 t80 -52.59 -56.78 12.92 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.28 1.432 . . . . 10.0 111.871 172.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 14.4 m -49.92 -52.58 32.12 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.304 1.441 . . . . 10.0 110.658 177.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 32.6 mmt -69.23 -48.13 62.77 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 123.965 0.906 . . . . 10.0 113.05 -176.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -54.69 -42.55 71.55 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 120.17 1.35 . . . . 10.0 113.213 172.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.7 tp -53.33 -54.54 35.03 Favored 'General case' 0 C--O 1.224 -0.272 0 CA-C-N 119.406 1.003 . . . . 10.0 111.292 171.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 23.9 p -51.6 -41.08 60.95 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 115.239 1.57 . . . . 10.0 115.239 178.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 58.4 mtm -66.86 -50.88 61.09 Favored 'General case' 0 C--N 1.334 -0.09 0 C-N-CA 123.597 0.759 . . . . 10.0 110.477 176.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.5 tp -48.58 -52.65 21.79 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.859 0.863 . . . . 10.0 112.95 172.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.5 mt -76.94 -5.58 49.12 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.318 1.047 . . . . 10.0 113.805 -177.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.28 -34.7 5.56 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 115.504 0.962 . . . . 10.0 115.504 174.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -49.27 -43.04 42.75 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 115.278 1.584 . . . . 10.0 115.278 -176.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.05 3.52 61.2 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 115.388 0.915 . . . . 10.0 115.388 -179.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.23 143.4 26.45 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 127.016 2.126 . . . . 10.0 109.02 171.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 t -145.51 171.16 15.06 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 123.995 0.918 . . . . 10.0 111.013 166.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.02 136.05 53.39 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 123.897 0.879 . . . . 10.0 109.675 179.627 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 58.7 t -129.56 129.61 23.19 Favored Pre-proline 0 C--N 1.329 -0.295 0 C-N-CA 125.069 1.348 . . . . 10.0 110.969 -176.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -80.81 116.23 3.15 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 N-CA-C 109.367 -1.051 . . . . 10.0 109.367 -178.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -156.68 164.37 38.22 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 112.862 0.69 . . . . 10.0 112.862 172.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.36 -81.95 0.14 Allowed Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.68 -0.968 . . . . 10.0 110.68 175.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.76 -3.31 0.7 Allowed Glycine 0 CA--C 1.527 0.822 0 N-CA-C 118.684 2.234 . . . . 10.0 118.684 170.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -151.64 -171.89 4.06 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 119.327 1.564 . . . . 10.0 112.221 -165.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -91.89 93.95 9.06 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 125.456 1.502 . . . . 10.0 111.091 -175.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 60.2 m-80 -89.5 120.74 69.63 Favored Pre-proline 0 N--CA 1.45 -0.429 0 N-CA-C 112.953 0.723 . . . . 10.0 112.953 -165.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -61.47 131.93 38.36 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 124.171 3.247 . . . . 10.0 112.159 171.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.4 mm -140.16 126.3 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 C-N-CA 125.99 1.716 . . . . 10.0 111.701 -179.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -93.58 85.0 4.76 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 122.967 1.365 . . . . 10.0 113.08 174.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 63.7 p-90 -59.33 -28.28 66.68 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 120.858 -1.151 . . . . 10.0 113.96 174.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -54.14 -27.48 33.77 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 124.273 1.029 . . . . 10.0 112.2 178.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 21.4 mtt-85 -54.62 -50.21 68.65 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.92 1.288 . . . . 10.0 112.78 168.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -67.44 -39.86 85.42 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 121.409 -0.807 . . . . 10.0 112.114 178.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -52.54 -50.65 62.45 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 123.787 0.835 . . . . 10.0 112.135 170.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 54.0 t0 -52.54 -69.12 0.12 Allowed 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 126.079 1.751 . . . . 10.0 111.325 170.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 50.4 m0 -55.48 -35.23 65.3 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 125.821 1.648 . . . . 10.0 113.004 -171.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 25.5 tp -49.58 -43.41 46.17 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 126.408 1.883 . . . . 10.0 112.174 177.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -101.27 -38.5 8.05 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.833 0.853 . . . . 10.0 112.281 179.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 1.6 m -51.15 -55.02 20.0 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.88 1.272 . . . . 10.0 113.468 175.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . 0.263 44.9 p -68.12 -40.58 22.39 Favored Pre-proline 0 N--CA 1.476 0.855 0 N-CA-C 114.63 1.344 . . . . 10.0 114.63 -171.161 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -56.75 -43.04 58.45 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 123.935 3.09 . . . . 10.0 115.522 168.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 53.2 mt -60.39 -47.06 87.72 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 121.395 -0.816 . . . . 10.0 111.394 176.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 6.0 tt -50.89 -48.01 60.53 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.628 1.571 . . . . 10.0 111.596 171.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.5 mp -58.83 -46.76 86.92 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.61 1.164 . . . . 10.0 113.365 170.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.79 -38.34 78.33 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 123.824 0.849 . . . . 10.0 112.868 177.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 -52.24 -54.1 35.4 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 119.317 0.962 . . . . 10.0 111.13 169.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.31 -42.08 88.77 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.651 0.78 . . . . 10.0 112.152 -178.509 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.66 -54.73 37.84 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.962 0.905 . . . . 10.0 112.056 173.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.33 -41.15 79.44 Favored 'General case' 0 C--O 1.224 -0.237 0 C-N-CA 123.767 0.827 . . . . 10.0 112.667 174.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.9 tp -63.8 -38.51 91.38 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 114.461 1.282 . . . . 10.0 114.461 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.2 t -94.85 1.45 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 125.022 1.329 . . . . 10.0 112.316 179.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.2 t70 48.57 53.51 12.02 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.866 1.666 . . . . 10.0 112.095 -174.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.27 145.9 47.58 Favored 'General case' 0 CA--C 1.534 0.339 0 O-C-N 119.977 -1.702 . . . . 10.0 112.459 -174.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.47 135.95 54.17 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 112.715 0.635 . . . . 10.0 112.715 175.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -42.89 -39.74 2.66 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 125.906 1.682 . . . . 10.0 113.41 175.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -47.32 -60.21 5.32 Favored Glycine 0 CA--C 1.525 0.691 0 C-N-CA 125.12 1.343 . . . . 10.0 115.222 169.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.6 p -62.05 -46.8 87.54 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 117.147 -1.406 . . . . 10.0 111.321 178.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 66.9 mt -48.39 -52.92 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 125.001 1.321 . . . . 10.0 111.147 178.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.2 tp -62.64 -51.27 67.93 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 112.548 0.573 . . . . 10.0 112.548 179.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.15 -44.9 43.13 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.506 0.722 . . . . 10.0 110.905 174.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.52 -59.94 4.65 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 127.431 2.292 . . . . 10.0 114.8 174.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.5 t -61.03 -46.33 96.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 123.697 0.799 . . . . 10.0 111.388 -178.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -56.62 -50.35 63.76 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 123.695 0.664 . . . . 10.0 112.619 174.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -54.7 -46.85 74.2 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 113.275 0.843 . . . . 10.0 113.275 173.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -57.45 -45.39 84.78 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.804 0.842 . . . . 10.0 112.135 174.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -43.98 -55.65 5.53 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 125.385 1.469 . . . . 10.0 113.131 167.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 80.1 mt -55.73 -54.11 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 CA-C-O 118.03 -0.986 . . . . 10.0 110.464 173.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 63.4 ttp -46.36 -55.64 7.02 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 120.091 1.314 . . . . 10.0 112.978 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 1.7 mp . . . . . 0 N--CA 1.474 0.754 0 O-C-N 121.543 -0.723 . . . . 10.0 111.591 179.273 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 63.3 t . . . . . 0 N--CA 1.475 0.823 0 N-CA-C 110.128 -0.323 . . . . 10.0 110.128 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -50.08 -61.18 5.97 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 125.923 1.725 . . . . 10.0 112.709 171.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -46.99 -38.84 11.4 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 127.191 2.196 . . . . 10.0 113.638 178.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 48.2 mt -99.62 -6.87 26.58 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 115.347 1.61 . . . . 10.0 115.347 -178.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 17.0 m -69.67 116.74 10.41 Favored 'General case' 0 N--CA 1.464 0.256 0 O-C-N 120.162 -1.586 . . . . 10.0 110.378 -178.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.552 ' HD3' ' H ' ' A' ' 129' ' ' LYS . 0.1 OUTLIER -55.44 -49.65 71.9 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 128.195 2.598 . . . . 10.0 113.3 177.711 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 61.3 t -69.67 106.32 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 C-N-CA 123.773 0.829 . . . . 10.0 110.121 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -46.89 -59.51 3.04 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 124.769 1.228 . . . . 10.0 114.067 -173.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 m -46.46 -42.1 14.9 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.467 1.507 . . . . 10.0 113.497 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -70.18 -24.59 63.16 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 114.917 1.451 . . . . 10.0 114.917 -178.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 68.8 mtp85 -54.01 -41.65 68.21 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 118.862 0.755 . . . . 10.0 110.864 176.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -69.59 -32.07 70.59 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.755 1.222 . . . . 10.0 114.202 176.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.9 t -54.88 -52.23 45.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-N 119.063 0.847 . . . . 10.0 109.615 168.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 64.2 m95 -61.08 -44.23 97.69 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 114.238 1.199 . . . . 10.0 114.238 174.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 90.4 t90 -53.36 -48.4 68.59 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 119.284 0.947 . . . . 10.0 112.959 172.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.603 0 C-N-CA 124.013 0.925 . . . . 10.0 111.607 177.073 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.819 0 N-CA-C 112.235 0.457 . . . . 10.0 112.235 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 41.4 ttp -55.47 -57.92 9.92 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.218 1.007 . . . . 10.0 112.776 174.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.3 pp -61.61 -35.84 79.04 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 118.309 -0.853 . . . . 10.0 112.147 -176.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 75.3 t80 -54.1 -55.27 29.19 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 119.312 0.96 . . . . 10.0 111.95 167.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 54.7 mt -53.59 -55.27 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 123.807 0.843 . . . . 10.0 110.741 177.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 9.9 mp -56.24 -37.06 69.23 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.23 1.012 . . . . 10.0 112.678 178.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -57.27 -58.19 9.31 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 124.057 0.943 . . . . 10.0 112.999 173.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.47 -40.91 85.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 CA-C-O 118.338 -0.839 . . . . 10.0 111.442 177.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 47.1 mt -56.72 -49.48 75.07 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 119.875 1.216 . . . . 10.0 112.098 171.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.424 ' HA ' ' HD2' ' A' ' 175' ' ' ARG . 11.8 t80 -77.01 -70.25 0.47 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 120.087 -1.633 . . . . 10.0 112.877 -175.186 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -73.76 -21.91 60.03 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.587 1.155 . . . . 10.0 113.439 -174.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -87.84 -79.02 1.26 Allowed Glycine 0 CA--C 1.526 0.761 0 C-N-CA 123.599 0.619 . . . . 10.0 113.539 171.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -53.68 -32.42 51.63 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 126.275 1.83 . . . . 10.0 113.024 -166.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.3 m -52.1 -56.46 14.28 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 114.01 1.115 . . . . 10.0 114.01 172.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.7 p -53.63 -50.55 65.48 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 122.081 0.944 . . . . 10.0 112.307 -177.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 47.7 tttm -57.14 -46.07 83.0 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.165 0.986 . . . . 10.0 112.086 173.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.81 -47.48 80.18 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 114.504 1.298 . . . . 10.0 114.504 174.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -56.42 -11.33 1.2 Allowed 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 126.095 1.758 . . . . 10.0 114.223 177.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.1 m -107.11 6.64 29.06 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.408 1.883 . . . . 10.0 114.869 -179.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 93.2 mmm -91.92 -92.68 0.15 Allowed 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 123.48 1.609 . . . . 10.0 114.139 -170.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -138.69 153.93 72.67 Favored Pre-proline 0 C--O 1.236 0.352 0 C-N-CA 129.823 3.249 . . . . 10.0 105.57 170.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -52.8 -46.25 34.99 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.296 1.998 . . . . 10.0 113.102 179.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . 0.462 ' CD ' ' HD3' ' A' ' 227' ' ' ARG . 0.1 OUTLIER -53.02 -45.99 68.21 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 128.972 2.909 . . . . 10.0 113.285 173.619 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 91.7 t -69.24 -53.01 27.74 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.237 0 C-N-CA 124.031 0.933 . . . . 10.0 109.81 -178.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.13 -46.8 75.66 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.287 0.635 . . . . 10.0 111.933 177.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 60.2 p -59.99 -56.23 24.31 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.972 0.909 . . . . 10.0 112.687 174.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 61.3 m -57.19 -53.21 60.73 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.189 0.995 . . . . 10.0 113.036 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -49.57 -49.49 46.26 Favored 'General case' 0 C--O 1.221 -0.438 0 C-N-CA 123.258 0.623 . . . . 10.0 111.098 174.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -57.19 -48.43 78.78 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 114.664 1.357 . . . . 10.0 114.664 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 40.4 t -55.91 -49.66 73.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 CA-C-N 118.802 0.728 . . . . 10.0 110.477 176.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 94.2 mt -58.54 -51.69 68.82 Favored 'General case' 0 C--O 1.222 -0.389 0 N-CA-C 113.168 0.803 . . . . 10.0 113.168 175.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . 0.424 ' HD2' ' HA ' ' A' ' 153' ' ' PHE . 35.5 ttp180 -47.76 -47.76 30.38 Favored 'General case' 0 C--O 1.225 -0.222 0 C-N-CA 126.816 2.046 . . . . 10.0 111.087 174.446 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 63.5 m-20 -58.47 -58.36 8.89 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 122.819 0.448 . . . . 10.0 111.282 174.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 54.2 t -51.92 -52.29 23.84 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 C-N-CA 124.033 0.933 . . . . 10.0 111.875 179.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 64.1 m -54.59 -61.07 2.55 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 127.408 2.283 . . . . 10.0 113.178 175.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 51.6 t -51.58 -50.13 31.28 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 CA-C-N 120.26 1.391 . . . . 10.0 110.805 -178.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 79.1 t -58.99 -61.0 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 124.211 1.004 . . . . 10.0 112.268 176.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 78.5 mt -57.47 -51.46 69.36 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 118.623 0.647 . . . . 10.0 112.403 -177.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 10.8 m95 . . . . . 0 N--CA 1.466 0.374 0 C-N-CA 123.66 0.784 . . . . 10.0 111.521 179.172 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 16.4 m . . . . . 0 N--CA 1.475 0.785 0 CA-C-O 118.898 -0.572 . . . . 10.0 112.439 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 62.2 t90 -57.75 -57.59 12.09 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.344 1.457 . . . . 10.0 112.304 167.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 9.3 tt -58.24 -40.45 81.75 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.802 0.841 . . . . 10.0 112.574 -175.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 14.7 pt -82.67 -5.65 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 N-CA-C 115.195 1.554 . . . . 10.0 115.195 178.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.3 -169.26 33.11 Favored Glycine 0 N--CA 1.45 -0.404 0 CA-C-O 122.551 1.084 . . . . 10.0 113.921 -168.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 23.3 t -53.17 -39.96 63.98 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 114.166 -1.017 . . . . 10.0 111.879 177.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -68.48 -14.9 63.32 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 125.744 1.618 . . . . 10.0 115.171 -174.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -136.27 -104.81 0.75 Allowed Glycine 0 CA--C 1.541 1.662 0 C-N-CA 125.21 1.386 . . . . 10.0 114.951 -174.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -89.43 127.17 35.81 Favored 'General case' 0 C--N 1.328 -0.352 0 O-C-N 120.697 -1.473 . . . . 10.0 109.357 168.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -72.51 65.38 1.37 Allowed Glycine 0 CA--C 1.532 1.127 0 N-CA-C 113.915 0.326 . . . . 10.0 113.915 173.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 60.7 mt -79.61 -42.72 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 126.08 1.752 . . . . 10.0 108.725 166.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 79.4 t -126.34 133.38 24.91 Favored Pre-proline 0 N--CA 1.454 -0.264 0 C-N-CA 126.502 1.921 . . . . 10.0 109.417 -174.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -68.74 153.76 72.54 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 123.811 3.007 . . . . 10.0 111.476 -176.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 12.2 tp -43.13 -39.77 2.95 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.381 1.072 . . . . 10.0 112.214 171.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -48.39 -52.35 22.26 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 114.702 1.371 . . . . 10.0 114.702 176.055 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 14.0 mm -75.96 -40.44 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 124.378 1.071 . . . . 10.0 109.666 177.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -49.29 -49.8 42.08 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 118.592 0.633 . . . . 10.0 111.946 173.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 16.3 m -57.74 -47.08 83.47 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 126.045 1.738 . . . . 10.0 112.953 174.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -63.25 -52.36 62.45 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.985 0.914 . . . . 10.0 112.131 179.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 93.2 mt -52.55 -59.22 4.72 Favored 'General case' 0 C--O 1.228 -0.041 0 C-N-CA 124.278 1.031 . . . . 10.0 109.973 176.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -52.52 -46.16 66.59 Favored 'General case' 0 C--O 1.221 -0.427 0 CA-C-O 117.821 -1.085 . . . . 10.0 112.37 176.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 4.6 tmm? -52.42 -51.82 57.12 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 120.62 1.555 . . . . 10.0 113.023 175.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 79.5 t -60.9 -50.35 80.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 124.418 1.087 . . . . 10.0 111.419 178.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 4.6 mp -55.81 -52.01 65.46 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.77 1.628 . . . . 10.0 111.979 175.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -55.12 -61.85 2.05 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 126.449 1.9 . . . . 10.0 110.471 178.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 98.1 t . . . . . 0 N--CA 1.478 0.962 0 CA-C-N 119.529 1.059 . . . . 10.0 111.597 -178.496 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.316 0 CA-C-O 121.091 0.273 . . . . 10.0 112.753 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -44.32 -57.96 3.2 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 127.106 2.163 . . . . 10.0 112.316 166.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -55.82 -39.88 78.84 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 124.188 0.899 . . . . 10.0 114.032 177.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 24.4 mt -70.43 -27.53 64.34 Favored 'General case' 0 CA--C 1.511 -0.535 0 N-CA-C 115.52 1.674 . . . . 10.0 115.52 177.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 74.2 mt -63.27 -57.55 11.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 108.642 -0.873 . . . . 10.0 108.642 165.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 32.0 tp -58.79 -64.72 0.83 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.92 0.888 . . . . 10.0 113.184 -172.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 84.0 mt -71.52 5.19 2.5 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 115.332 1.604 . . . . 10.0 115.332 -171.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.6 mtp-105 -112.32 0.38 15.68 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.188 0.995 . . . . 10.0 113.316 172.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 8.8 t -108.03 177.96 4.65 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 124.046 0.938 . . . . 10.0 111.0 174.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 227' ' ' ARG . . . . . 0.462 ' HD3' ' CD ' ' A' ' 166' ' ' GLU . 41.7 ttt180 -71.62 98.13 1.84 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.786 0.835 . . . . 10.0 110.96 170.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -80.87 76.96 7.79 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.828 0.851 . . . . 10.0 112.116 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 40.19 102.25 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 128.857 2.863 . . . . 10.0 116.497 177.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . 0.482 0.3 OUTLIER 71.83 -55.44 0.66 Allowed 'General case' 0 C--O 1.242 0.677 0 C-N-CA 124.769 1.227 . . . . 10.0 110.637 -175.273 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -68.25 169.47 39.89 Favored Glycine 0 C--O 1.239 0.429 0 C-N-CA 129.735 3.541 . . . . 10.0 119.701 171.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.461 0 C-N-CA 128.498 2.719 . . . . 10.0 113.46 166.616 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 N--CA 1.477 0.918 0 CA-C-O 115.804 -2.046 . . . . 10.0 105.785 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 23.4 91.84 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 129.58 3.152 . . . . 10.0 117.236 160.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 28.63 65.11 0.11 Allowed 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 128.306 2.643 . . . . 10.0 114.458 155.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 86.7 mt -56.51 137.99 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 126.358 1.863 . . . . 10.0 113.372 -158.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.6 t -136.76 -165.26 1.7 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 126.329 1.852 . . . . 10.0 113.97 -174.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 70.05 2.8 41.33 Favored Glycine 0 C--N 1.34 0.768 0 C-N-CA 127.477 2.465 . . . . 10.0 111.487 168.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.8 tpp180 -158.58 -51.34 0.01 OUTLIER Pre-proline 0 N--CA 1.444 -0.772 0 CA-C-O 114.206 -2.806 . . . . 10.0 116.623 -168.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_exo -63.99 -60.6 0.15 Allowed 'Trans proline' 0 CA--C 1.528 0.185 0 CA-C-N 123.517 2.292 . . . . 10.0 113.242 -175.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 7.9 pm0 -67.19 4.22 0.99 Allowed 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 127.855 2.462 . . . . 10.0 115.735 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.422 ' CG ' ' N ' ' A' ' 11' ' ' ILE . 11.0 p-90 -51.32 -43.1 61.64 Favored 'General case' 0 C--O 1.222 -0.361 0 O-C-N 121.496 -0.752 . . . . 10.0 112.669 176.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.422 ' N ' ' CG ' ' A' ' 10' ' ' TRP . 8.9 tt -60.85 -49.65 83.74 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.319 0 C-N-CA 123.936 0.894 . . . . 10.0 109.298 179.359 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 2.6 m95 -55.34 -52.63 62.86 Favored 'General case' 0 C--O 1.224 -0.261 0 C-N-CA 123.384 0.674 . . . . 10.0 111.93 175.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.8 mt -57.36 -53.63 55.96 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 123.193 0.597 . . . . 10.0 112.186 177.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.87 -46.79 51.93 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.41 1.484 . . . . 10.0 113.326 173.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 13.2 tp -65.7 -44.9 84.71 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.302 1.441 . . . . 10.0 113.027 179.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.97 -55.89 13.69 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 124.544 1.069 . . . . 10.0 111.759 166.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 22.5 m -49.76 -52.62 30.4 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.001 1.32 . . . . 10.0 112.43 174.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.38 -58.88 5.71 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.133 0.973 . . . . 10.0 112.173 177.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 95.2 mt -57.55 -48.51 79.14 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.593 0.757 . . . . 10.0 112.816 -179.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 57.6 mtt -57.41 -49.5 76.03 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.089 0.956 . . . . 10.0 111.534 176.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -56.63 -58.85 12.35 Favored Glycine 0 CA--C 1.528 0.844 0 CA-C-O 118.873 -0.959 . . . . 10.0 113.673 174.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 81.1 mt -56.16 -46.08 79.43 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-N 118.82 1.31 . . . . 10.0 112.13 176.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.62 -41.6 74.44 Favored Glycine 0 CA--C 1.535 1.294 0 C-N-CA 124.742 1.163 . . . . 10.0 113.254 173.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 27.9 m -62.46 -58.71 6.62 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.097 0.959 . . . . 10.0 111.316 172.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -52.27 -40.96 62.44 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.001 0.92 . . . . 10.0 110.949 177.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.4 t80 -55.82 -58.02 9.59 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.583 1.153 . . . . 10.0 112.968 172.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.1 m-30 -59.64 -38.69 82.07 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 113.225 0.824 . . . . 10.0 113.225 178.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.467 ' C ' ' H ' ' A' ' 30' ' ' LYS . 11.8 mt -56.1 -67.41 0.3 Allowed 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.625 1.17 . . . . 10.0 113.628 169.104 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 t -76.41 40.95 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 CA-C-O 123.756 1.741 . . . . 10.0 110.91 179.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.467 ' H ' ' C ' ' A' ' 28' ' ' LEU . 42.8 tttm -140.84 -44.84 0.39 Allowed 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 127.872 2.469 . . . . 10.0 109.354 171.153 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.96 23.15 0.87 Allowed Glycine 0 CA--C 1.529 0.945 0 N-CA-C 115.624 1.01 . . . . 10.0 115.624 173.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 37.3 mmm -59.59 -45.01 93.16 Favored 'General case' 0 C--O 1.224 -0.272 0 C-N-CA 127.161 2.184 . . . . 10.0 113.529 -178.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.62 -84.43 1.18 Allowed Glycine 0 CA--C 1.53 1.018 0 C-N-CA 123.766 0.698 . . . . 10.0 112.47 -170.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.7 t 33.01 88.79 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.243 0.753 0 C-N-CA 128.405 2.682 . . . . 10.0 116.975 166.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.7 m -79.7 -50.83 10.03 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.193 -1.367 . . . . 10.0 113.855 174.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -48.92 117.51 6.42 Favored Pre-proline 0 CA--C 1.537 0.443 0 O-C-N 124.76 1.288 . . . . 10.0 110.983 -172.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -58.57 -29.68 89.71 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 123.713 2.942 . . . . 10.0 113.688 179.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.29 -60.63 2.31 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.122 0.569 . . . . 10.0 111.429 176.215 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.19 -40.04 22.86 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 125.072 1.349 . . . . 10.0 113.583 171.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.5 tttp -46.58 -47.42 19.79 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.275 1.43 . . . . 10.0 113.397 172.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -57.76 -53.07 62.36 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.487 0.715 . . . . 10.0 110.978 176.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 44.2 m-85 -56.96 -50.23 73.28 Favored 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 123.075 0.55 . . . . 10.0 112.345 -179.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -54.4 -51.24 65.5 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 118.926 -0.559 . . . . 10.0 112.376 173.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.41 -62.01 1.91 Allowed 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 113.374 0.879 . . . . 10.0 113.374 177.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.3 mt -48.48 -56.78 1.88 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 124.863 1.265 . . . . 10.0 110.889 178.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.8 m -68.46 -21.67 64.61 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.871 1.268 . . . . 10.0 113.413 -172.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 27.5 m -83.37 -40.05 19.9 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.423 1.089 . . . . 10.0 112.33 175.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 16.8 mt -59.14 -44.19 92.06 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 113.147 0.795 . . . . 10.0 113.147 174.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 31.9 t -43.26 -64.51 0.74 Allowed Pre-proline 0 CA--C 1.549 0.911 0 C-N-CA 124.978 1.311 . . . . 10.0 113.119 177.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -67.88 -24.64 39.8 Favored 'Trans proline' 0 CA--C 1.543 0.975 0 C-N-CA 122.383 2.056 . . . . 10.0 113.767 177.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -67.27 -48.73 66.82 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 120.316 1.416 . . . . 10.0 113.154 175.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 27.6 mt -66.12 -42.65 91.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 O-C-N 120.568 -1.333 . . . . 10.0 109.443 174.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.32 -45.56 72.64 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 113.261 0.837 . . . . 10.0 113.261 171.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 45.0 t80 -49.81 -54.96 16.03 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 125.704 1.602 . . . . 10.0 111.681 169.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 14.7 m -48.92 -53.35 20.03 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.386 1.475 . . . . 10.0 111.0 176.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 32.2 mmt -67.99 -48.62 65.27 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 124.122 0.969 . . . . 10.0 113.062 -177.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -56.83 -40.44 76.07 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 120.182 1.355 . . . . 10.0 113.322 173.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.8 tp -53.31 -54.54 34.93 Favored 'General case' 0 C--O 1.225 -0.223 0 CA-C-N 119.795 1.18 . . . . 10.0 111.272 170.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 24.0 p -51.69 -41.04 61.14 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 115.217 1.562 . . . . 10.0 115.217 179.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 59.0 mtm -66.86 -50.89 61.07 Favored 'General case' 0 C--N 1.334 -0.085 0 C-N-CA 123.571 0.748 . . . . 10.0 110.435 176.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.3 tp -48.57 -52.65 21.71 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.889 0.875 . . . . 10.0 112.939 172.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.5 mt -76.98 -5.5 48.91 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.325 1.05 . . . . 10.0 113.793 -177.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.25 -34.7 5.56 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 115.522 0.969 . . . . 10.0 115.522 174.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -49.3 -43.06 43.01 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 115.277 1.584 . . . . 10.0 115.277 -176.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.07 3.57 61.13 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 115.379 0.912 . . . . 10.0 115.379 -179.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.25 143.42 26.43 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 127.021 2.129 . . . . 10.0 109.015 171.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 t -145.51 171.11 15.13 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 124.081 0.952 . . . . 10.0 111.041 166.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.04 136.05 53.39 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 123.89 0.876 . . . . 10.0 109.706 179.633 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 58.6 t -129.58 129.55 23.18 Favored Pre-proline 0 C--N 1.33 -0.281 0 C-N-CA 125.074 1.35 . . . . 10.0 110.949 -176.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -80.7 116.27 3.18 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 N-CA-C 109.4 -1.038 . . . . 10.0 109.4 -178.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -156.74 164.41 38.15 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 112.824 0.676 . . . . 10.0 112.824 172.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.37 -81.96 0.14 Allowed Glycine 0 CA--C 1.526 0.764 0 N-CA-C 110.684 -0.966 . . . . 10.0 110.684 175.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.74 -3.39 0.7 Allowed Glycine 0 CA--C 1.527 0.808 0 N-CA-C 118.662 2.225 . . . . 10.0 118.662 170.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -151.59 -171.89 4.06 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 119.406 1.603 . . . . 10.0 112.218 -165.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -91.88 93.86 9.03 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 125.525 1.53 . . . . 10.0 111.111 -175.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 60.3 m-80 -89.41 120.79 69.69 Favored Pre-proline 0 N--CA 1.45 -0.425 0 N-CA-C 112.941 0.719 . . . . 10.0 112.941 -165.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -61.54 131.87 37.92 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 124.181 3.254 . . . . 10.0 112.201 171.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.4 mm -140.07 126.3 22.07 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 C-N-CA 126.055 1.742 . . . . 10.0 111.75 -179.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -93.6 85.02 4.76 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 123.012 1.387 . . . . 10.0 113.065 174.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 63.8 p-90 -59.36 -28.25 66.69 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 120.865 -1.147 . . . . 10.0 113.931 174.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -55.07 -28.47 52.62 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.239 1.015 . . . . 10.0 113.152 178.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.0 mtt-85 -49.88 -58.04 6.21 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.447 1.099 . . . . 10.0 111.292 168.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -62.6 -40.64 97.58 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 126.076 1.75 . . . . 10.0 112.437 -179.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -52.24 -48.92 64.92 Favored 'General case' 0 CA--C 1.568 1.647 0 CA-C-N 119.597 1.09 . . . . 10.0 111.15 168.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -59.19 -64.38 0.96 Allowed 'General case' 0 N--CA 1.494 1.753 0 CA-C-N 121.212 1.824 . . . . 10.0 110.792 169.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 48.1 m0 -50.65 -35.51 31.01 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.94 1.296 . . . . 10.0 111.865 -170.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 26.4 tp -51.29 -42.59 61.26 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.39 1.876 . . . . 10.0 113.335 176.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -101.45 -52.54 3.21 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.213 1.005 . . . . 10.0 112.645 -175.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 1.1 m -46.15 -51.01 14.85 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 125.64 1.576 . . . . 10.0 112.829 175.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.7 m -64.58 -45.89 76.75 Favored Pre-proline 0 CA--C 1.547 0.837 0 O-C-N 121.343 -0.848 . . . . 10.0 112.661 -169.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -51.29 -44.83 40.74 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 124.053 3.169 . . . . 10.0 116.749 162.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 59.4 mt -59.3 -46.67 87.93 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 119.134 0.879 . . . . 10.0 111.358 175.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.5 tp -50.31 -47.74 55.52 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.341 1.856 . . . . 10.0 111.892 172.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.9 mp -60.87 -46.5 90.36 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.414 1.486 . . . . 10.0 113.032 170.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.9 -38.22 78.37 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.82 0.848 . . . . 10.0 112.854 178.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -52.3 -54.05 36.4 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 119.269 0.94 . . . . 10.0 111.166 169.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.3 -42.11 88.79 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.621 0.768 . . . . 10.0 112.131 -178.507 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.66 -54.77 37.27 Favored 'General case' 0 C--O 1.225 -0.186 0 C-N-CA 123.995 0.918 . . . . 10.0 112.011 173.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.28 -41.18 79.23 Favored 'General case' 0 C--O 1.224 -0.239 0 C-N-CA 123.719 0.808 . . . . 10.0 112.725 174.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.9 tp -63.77 -38.56 91.54 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 114.45 1.278 . . . . 10.0 114.45 -179.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.2 t -94.82 1.47 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 125.008 1.323 . . . . 10.0 112.313 179.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.2 t70 48.61 53.4 12.25 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.829 1.652 . . . . 10.0 112.1 -174.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.17 145.88 47.77 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 119.916 -1.74 . . . . 10.0 112.474 -174.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.54 135.9 54.45 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 112.697 0.628 . . . . 10.0 112.697 175.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -42.83 -39.71 2.61 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.894 1.678 . . . . 10.0 113.456 175.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -47.32 -60.22 5.32 Favored Glycine 0 CA--C 1.526 0.731 0 C-N-CA 125.109 1.338 . . . . 10.0 115.252 169.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.4 p -62.06 -46.75 87.75 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 117.057 -1.449 . . . . 10.0 111.335 178.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 66.9 mt -48.45 -52.93 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 124.995 1.318 . . . . 10.0 111.128 178.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.1 tp -62.55 -51.35 67.74 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 112.554 0.576 . . . . 10.0 112.554 179.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.13 -44.9 42.86 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.424 0.689 . . . . 10.0 110.97 174.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.58 -59.89 4.73 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 127.363 2.265 . . . . 10.0 114.787 174.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.6 t -61.04 -46.29 96.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 123.685 0.794 . . . . 10.0 111.41 -178.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -56.64 -50.36 63.75 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 123.674 0.654 . . . . 10.0 112.642 174.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -54.21 -46.74 72.56 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.571 0.748 . . . . 10.0 112.94 173.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -60.89 -41.77 96.67 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 112.707 0.632 . . . . 10.0 112.707 176.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -43.85 -56.94 4.89 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 125.43 1.491 . . . . 10.0 113.078 164.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 85.4 mt -56.84 -50.49 75.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 CA-C-N 117.776 0.788 . . . . 10.0 111.668 175.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 47.9 ttp -48.66 -58.4 4.8 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.295 1.438 . . . . 10.0 112.056 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 36.8 mm . . . . . 0 N--CA 1.471 0.602 0 O-C-N 121.959 -0.463 . . . . 10.0 112.03 178.736 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 68.5 t . . . . . 0 N--CA 1.475 0.794 0 N-CA-C 110.371 -0.233 . . . . 10.0 110.371 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -49.22 -60.92 5.8 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 125.871 1.7 . . . . 10.0 112.275 171.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -48.85 -37.71 20.29 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 126.576 1.95 . . . . 10.0 113.76 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 49.7 mt -99.31 -6.57 27.69 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 115.22 1.563 . . . . 10.0 115.22 -178.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 16.8 m -69.74 116.73 10.48 Favored 'General case' 0 N--CA 1.464 0.266 0 O-C-N 120.165 -1.584 . . . . 10.0 110.345 -178.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.553 ' HD3' ' H ' ' A' ' 129' ' ' LYS . 0.2 OUTLIER -55.45 -49.61 72.0 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 128.205 2.602 . . . . 10.0 113.305 177.728 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 60.9 t -69.64 106.35 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 123.788 0.835 . . . . 10.0 110.089 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -46.88 -59.55 3.01 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 124.809 1.244 . . . . 10.0 114.038 -173.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 m -46.47 -42.11 14.97 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.501 1.521 . . . . 10.0 113.496 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -70.2 -24.54 63.14 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 114.918 1.451 . . . . 10.0 114.918 -178.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 69.3 mtp85 -53.66 -42.18 67.6 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-N 118.923 0.783 . . . . 10.0 110.701 176.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -69.57 -31.65 69.94 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.826 1.25 . . . . 10.0 114.322 176.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.8 t -55.31 -51.74 53.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-N 119.064 0.847 . . . . 10.0 109.582 168.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 66.8 m95 -62.08 -42.77 99.54 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 114.335 1.235 . . . . 10.0 114.335 174.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 92.8 t90 -53.92 -48.63 70.0 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.265 1.026 . . . . 10.0 112.618 172.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.573 0 C-N-CA 123.71 0.804 . . . . 10.0 111.639 176.603 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.747 0 N-CA-C 112.234 0.457 . . . . 10.0 112.234 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 9.6 tmm? -51.67 -52.94 44.13 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.919 1.688 . . . . 10.0 111.858 173.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 7.8 tt -53.59 -52.05 61.03 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.856 1.662 . . . . 10.0 112.392 175.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 72.9 t80 -49.47 -53.91 20.58 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.225 1.01 . . . . 10.0 112.098 173.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 36.9 mm -52.81 -56.09 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 CA-C-N 118.818 0.736 . . . . 10.0 110.387 177.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 18.5 mt -58.71 -34.48 71.37 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 117.979 -1.01 . . . . 10.0 112.037 -178.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -57.26 -58.18 9.36 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 119.513 1.052 . . . . 10.0 113.076 173.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.4 -40.91 85.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 CA-C-O 118.32 -0.847 . . . . 10.0 111.438 177.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 44.1 mt -56.76 -49.42 75.3 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 119.919 1.236 . . . . 10.0 112.12 171.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.424 ' HA ' ' HD2' ' A' ' 175' ' ' ARG . 12.0 t80 -77.02 -70.31 0.47 Allowed 'General case' 0 C--N 1.326 -0.435 0 O-C-N 120.049 -1.657 . . . . 10.0 112.857 -175.216 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -73.7 -21.98 60.06 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.665 1.186 . . . . 10.0 113.411 -174.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -87.77 -79.17 1.26 Allowed Glycine 0 CA--C 1.527 0.806 0 C-N-CA 123.639 0.637 . . . . 10.0 113.49 171.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -53.52 -32.47 50.65 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 126.295 1.838 . . . . 10.0 113.067 -166.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.2 m -52.13 -56.42 14.65 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 114.018 1.118 . . . . 10.0 114.018 172.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.3 p -53.69 -50.57 65.57 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 122.079 0.942 . . . . 10.0 112.271 -177.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 47.6 tttm -57.09 -46.02 82.9 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.168 0.987 . . . . 10.0 112.16 173.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.84 -47.48 80.25 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 114.475 1.287 . . . . 10.0 114.475 174.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -56.53 -11.25 1.21 Allowed 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.034 1.734 . . . . 10.0 114.249 177.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.1 m -107.05 6.62 29.16 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.411 1.884 . . . . 10.0 114.846 -179.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 93.2 mmm -91.9 -92.67 0.15 Allowed 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 123.523 1.63 . . . . 10.0 114.146 -170.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -138.72 153.95 72.63 Favored Pre-proline 0 C--O 1.235 0.308 0 C-N-CA 129.756 3.223 . . . . 10.0 105.552 170.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -52.85 -46.19 35.46 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 122.285 1.99 . . . . 10.0 113.088 179.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . 0.462 ' CD ' ' HD3' ' A' ' 227' ' ' ARG . 0.1 OUTLIER -53.02 -46.04 68.22 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 129.049 2.94 . . . . 10.0 113.259 173.571 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 92.2 t -69.25 -53.0 27.75 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.253 0 C-N-CA 124.06 0.944 . . . . 10.0 109.771 -178.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.12 -46.86 75.63 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.284 0.634 . . . . 10.0 111.915 177.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 60.5 p -59.99 -56.15 25.28 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.908 0.883 . . . . 10.0 112.741 174.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 61.8 m -57.24 -53.18 60.97 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.13 0.972 . . . . 10.0 113.006 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -49.6 -49.51 46.42 Favored 'General case' 0 C--O 1.222 -0.375 0 C-N-CA 123.311 0.644 . . . . 10.0 111.086 174.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -57.16 -48.37 78.87 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 114.678 1.362 . . . . 10.0 114.678 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 40.3 t -56.01 -49.59 74.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 CA-C-N 118.794 0.725 . . . . 10.0 110.507 176.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 94.1 mt -58.58 -51.57 69.35 Favored 'General case' 0 C--O 1.222 -0.394 0 N-CA-C 113.197 0.814 . . . . 10.0 113.197 175.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . 0.424 ' HD2' ' HA ' ' A' ' 153' ' ' PHE . 35.5 ttp180 -47.87 -47.75 31.57 Favored 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 126.82 2.048 . . . . 10.0 111.017 174.463 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 63.6 m-20 -58.54 -58.29 9.19 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 122.809 0.444 . . . . 10.0 111.283 174.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 59.8 t -51.67 -48.86 36.55 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 124.074 0.949 . . . . 10.0 111.678 179.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 19.8 m -58.76 -62.08 2.13 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 127.267 2.227 . . . . 10.0 112.009 178.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 54.5 t -50.69 -49.44 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 C-N-CA 124.599 1.159 . . . . 10.0 110.998 -179.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 74.2 t -59.65 -62.6 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 123.883 0.873 . . . . 10.0 112.55 177.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -57.97 -45.95 85.9 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 118.669 0.668 . . . . 10.0 112.108 -175.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 9.5 m0 . . . . . 0 N--CA 1.466 0.333 0 C-N-CA 123.652 0.781 . . . . 10.0 113.0 176.163 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 98.2 t . . . . . 0 N--CA 1.479 0.993 0 CA-C-O 119.381 -0.342 . . . . 10.0 111.418 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 28.1 t90 -54.63 -53.91 48.53 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.657 1.183 . . . . 10.0 112.493 174.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 10.0 tt -55.52 -44.95 77.15 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 124.187 0.995 . . . . 10.0 112.625 -178.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 15.0 pt -84.93 -5.52 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 N-CA-C 115.118 1.525 . . . . 10.0 115.118 -178.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.29 -169.27 33.13 Favored Glycine 0 N--CA 1.45 -0.397 0 CA-C-O 122.604 1.113 . . . . 10.0 113.925 -168.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 23.3 t -53.18 -41.0 64.82 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 114.156 -1.022 . . . . 10.0 111.871 177.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -54.17 -32.16 54.67 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 128.621 2.768 . . . . 10.0 115.266 179.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -131.25 -103.86 0.97 Allowed Glycine 0 CA--C 1.528 0.879 0 CA-C-N 119.346 0.976 . . . . 10.0 113.566 -167.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -89.47 127.17 35.82 Favored 'General case' 0 C--N 1.328 -0.328 0 O-C-N 120.657 -1.496 . . . . 10.0 109.32 169.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -72.42 65.31 1.35 Allowed Glycine 0 CA--C 1.532 1.138 0 N-CA-C 113.914 0.326 . . . . 10.0 113.914 173.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 60.7 mt -79.57 -42.76 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 C-N-CA 126.096 1.759 . . . . 10.0 108.766 166.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 79.2 t -126.29 133.41 24.93 Favored Pre-proline 0 N--CA 1.454 -0.25 0 C-N-CA 126.496 1.918 . . . . 10.0 109.372 -174.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -68.76 153.76 72.49 Favored 'Trans proline' 0 N--CA 1.461 -0.441 0 C-N-CA 123.834 3.023 . . . . 10.0 111.459 -176.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 12.2 tp -43.17 -39.78 3.02 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.312 1.045 . . . . 10.0 112.202 171.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -48.33 -52.37 21.86 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 114.715 1.376 . . . . 10.0 114.715 176.012 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 14.0 mm -75.93 -40.47 38.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 C-N-CA 124.39 1.076 . . . . 10.0 109.681 177.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -49.31 -49.78 42.39 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 118.546 0.612 . . . . 10.0 111.981 173.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 16.1 m -57.67 -47.07 83.35 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 126.013 1.725 . . . . 10.0 112.991 174.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -63.31 -52.38 62.16 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.024 0.93 . . . . 10.0 112.06 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 93.2 mt -52.51 -59.96 3.81 Favored 'General case' 0 C--N 1.335 -0.053 0 C-N-CA 124.363 1.065 . . . . 10.0 109.953 176.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -52.92 -45.12 67.47 Favored 'General case' 0 C--O 1.216 -0.667 0 CA-C-O 116.773 -1.584 . . . . 10.0 112.086 176.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 4.6 tmm? -52.65 -53.04 52.59 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 121.719 2.054 . . . . 10.0 113.114 174.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 81.8 t -59.96 -47.03 93.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 125.129 1.371 . . . . 10.0 111.158 178.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 4.2 mp -59.81 -50.16 74.89 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.677 1.591 . . . . 10.0 112.298 174.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 32.6 m-20 -55.57 -59.72 4.44 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 127.458 2.303 . . . . 10.0 111.069 177.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 25.4 m . . . . . 0 N--CA 1.479 0.98 0 O-C-N 121.086 -1.009 . . . . 10.0 112.56 -177.812 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.327 0 CA-C-O 120.895 0.164 . . . . 10.0 113.157 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -44.9 -56.17 4.79 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 126.522 1.929 . . . . 10.0 112.007 166.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -55.67 -39.28 75.34 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 124.554 1.073 . . . . 10.0 114.003 177.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 24.9 mt -69.66 -27.81 65.35 Favored 'General case' 0 CA--C 1.512 -0.481 0 N-CA-C 115.687 1.736 . . . . 10.0 115.687 176.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 74.6 mt -63.45 -57.5 11.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 108.545 -0.909 . . . . 10.0 108.545 165.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 32.1 tp -58.81 -64.65 0.86 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.948 0.899 . . . . 10.0 113.193 -172.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 84.1 mt -71.51 5.14 2.52 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 115.347 1.61 . . . . 10.0 115.347 -171.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.6 mtp-105 -112.33 0.4 15.67 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 124.214 1.006 . . . . 10.0 113.304 172.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 8.8 t -108.06 177.98 4.65 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 124.089 0.956 . . . . 10.0 111.03 174.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 227' ' ' ARG . . . . . 0.462 ' HD3' ' CD ' ' A' ' 166' ' ' GLU . 41.8 ttt180 -71.65 98.16 1.86 Allowed 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.824 0.85 . . . . 10.0 110.893 170.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -80.92 77.03 7.84 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.861 0.864 . . . . 10.0 112.1 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 40.1 102.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 128.901 2.88 . . . . 10.0 116.444 177.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . 0.481 0.3 OUTLIER 71.86 -55.42 0.66 Allowed 'General case' 0 C--O 1.242 0.691 0 C-N-CA 124.749 1.22 . . . . 10.0 110.644 -175.334 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -68.32 169.48 40.13 Favored Glycine 0 C--O 1.239 0.422 0 C-N-CA 129.727 3.537 . . . . 10.0 119.655 171.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.459 0 C-N-CA 128.477 2.711 . . . . 10.0 113.438 166.655 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 N--CA 1.477 0.913 0 CA-C-O 115.813 -2.041 . . . . 10.0 105.805 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 23.35 91.93 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 129.568 3.147 . . . . 10.0 117.213 160.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 28.57 65.08 0.1 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 128.307 2.643 . . . . 10.0 114.514 155.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 86.8 mt -56.52 137.98 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 126.379 1.872 . . . . 10.0 113.336 -158.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.6 t -136.71 -165.19 1.69 Allowed 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 126.331 1.852 . . . . 10.0 114.05 -174.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 69.95 2.83 40.72 Favored Glycine 0 C--N 1.34 0.768 0 C-N-CA 127.503 2.477 . . . . 10.0 111.511 168.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.8 tpp180 -158.51 -51.39 0.01 OUTLIER Pre-proline 0 N--CA 1.443 -0.783 0 CA-C-O 114.309 -2.758 . . . . 10.0 116.665 -168.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_exo -64.0 -60.58 0.15 Allowed 'Trans proline' 0 N--CA 1.464 -0.218 0 CA-C-N 123.524 2.294 . . . . 10.0 113.215 -175.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 7.9 pm0 -67.24 4.34 0.97 Allowed 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 127.831 2.452 . . . . 10.0 115.764 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.422 ' CG ' ' N ' ' A' ' 11' ' ' ILE . 11.0 p-90 -51.43 -43.06 61.91 Favored 'General case' 0 C--O 1.223 -0.34 0 O-C-N 121.509 -0.744 . . . . 10.0 112.641 176.453 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.422 ' N ' ' CG ' ' A' ' 10' ' ' TRP . 8.9 tt -60.91 -49.61 83.94 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.34 0 C-N-CA 123.862 0.865 . . . . 10.0 109.316 179.4 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 2.6 m95 -55.35 -52.67 62.76 Favored 'General case' 0 C--O 1.224 -0.259 0 C-N-CA 123.4 0.68 . . . . 10.0 111.871 175.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.3 mt -57.3 -53.65 55.69 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 123.21 0.604 . . . . 10.0 112.227 177.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.86 -46.8 51.83 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.413 1.485 . . . . 10.0 113.324 173.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 13.4 tp -65.64 -44.96 84.8 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 125.298 1.439 . . . . 10.0 113.03 179.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -50.02 -57.15 10.35 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 124.045 0.831 . . . . 10.0 111.264 166.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 22.6 m -48.43 -52.62 21.22 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.602 1.161 . . . . 10.0 112.364 174.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.39 -58.86 5.81 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.139 0.976 . . . . 10.0 112.188 177.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 94.2 mt -57.61 -50.43 73.17 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.762 0.825 . . . . 10.0 112.578 -179.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -54.14 -50.31 67.23 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.464 1.106 . . . . 10.0 111.346 175.343 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -58.07 -57.99 16.92 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 124.271 0.939 . . . . 10.0 113.666 176.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 80.8 mt -56.24 -45.77 79.86 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-N 118.434 1.117 . . . . 10.0 112.103 176.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.28 -42.75 74.52 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 125.03 1.3 . . . . 10.0 113.167 172.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 24.1 m -60.79 -59.64 5.06 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 124.038 0.935 . . . . 10.0 111.303 171.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -52.28 -41.02 62.52 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.061 0.944 . . . . 10.0 110.974 178.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -55.75 -58.03 9.55 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.561 1.144 . . . . 10.0 113.006 172.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -59.63 -38.7 82.06 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 113.226 0.825 . . . . 10.0 113.226 178.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.468 ' C ' ' H ' ' A' ' 30' ' ' LYS . 11.8 mt -56.16 -67.47 0.29 Allowed 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.572 1.149 . . . . 10.0 113.576 169.154 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 t -76.36 41.02 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 CA-C-O 123.802 1.763 . . . . 10.0 110.891 179.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.468 ' H ' ' C ' ' A' ' 28' ' ' LEU . 43.0 tttm -140.89 -44.91 0.39 Allowed 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 127.905 2.482 . . . . 10.0 109.303 171.199 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.9 23.07 0.86 Allowed Glycine 0 CA--C 1.529 0.956 0 N-CA-C 115.644 1.017 . . . . 10.0 115.644 173.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 37.3 mmm -59.52 -44.96 93.02 Favored 'General case' 0 C--O 1.224 -0.253 0 C-N-CA 127.17 2.188 . . . . 10.0 113.578 -178.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.66 -84.45 1.18 Allowed Glycine 0 CA--C 1.531 1.045 0 C-N-CA 123.741 0.686 . . . . 10.0 112.477 -170.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.7 t 33.09 88.75 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.242 0.682 0 C-N-CA 128.36 2.664 . . . . 10.0 116.941 166.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.8 m -79.67 -50.89 9.96 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.187 -1.37 . . . . 10.0 113.832 174.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -48.86 117.47 6.33 Favored Pre-proline 0 CA--C 1.536 0.428 0 O-C-N 124.794 1.309 . . . . 10.0 110.983 -172.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -58.53 -29.66 89.51 Favored 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 123.792 2.995 . . . . 10.0 113.698 179.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.35 -60.65 2.3 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.058 0.543 . . . . 10.0 111.455 176.183 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.08 -40.15 22.33 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 125.14 1.376 . . . . 10.0 113.554 171.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -46.53 -47.4 19.57 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 125.261 1.424 . . . . 10.0 113.463 172.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -57.77 -53.01 62.99 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.425 0.69 . . . . 10.0 111.009 176.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -57.04 -50.21 73.44 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 123.049 0.54 . . . . 10.0 112.323 -179.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -54.37 -51.28 65.31 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 118.935 -0.555 . . . . 10.0 112.379 173.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.36 -62.0 1.92 Allowed 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 113.404 0.89 . . . . 10.0 113.404 177.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.5 mt -48.88 -56.35 2.51 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 C-N-CA 124.829 1.251 . . . . 10.0 110.496 178.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.5 m -70.07 -16.91 63.2 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.109 1.364 . . . . 10.0 113.688 -172.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 27.5 m -87.92 -37.72 16.2 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.134 0.973 . . . . 10.0 112.152 174.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 20.4 mt -60.88 -39.36 88.94 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-O 118.406 -0.807 . . . . 10.0 113.091 173.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . 0.35 33.3 m -55.16 -54.11 54.07 Favored Pre-proline 0 N--CA 1.485 1.278 0 N-CA-C 114.579 1.326 . . . . 10.0 114.579 179.318 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -67.61 -26.44 39.71 Favored 'Trans proline' 0 CA--C 1.545 1.055 0 CA-C-N 123.137 2.156 . . . . 10.0 113.099 173.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.44 -47.7 75.27 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-N 120.181 1.355 . . . . 10.0 113.324 175.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 19.3 tt -65.51 -41.03 89.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 O-C-N 120.431 -1.418 . . . . 10.0 111.419 171.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -49.89 -49.93 47.79 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 118.732 0.696 . . . . 10.0 112.156 170.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 53.2 t80 -51.85 -57.93 7.92 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 125.711 1.604 . . . . 10.0 112.473 173.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.5 m -49.2 -52.72 25.07 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 125.094 1.358 . . . . 10.0 110.856 178.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' MET . . . . . 0.435 ' HG3' ' CB ' ' A' ' 85' ' ' ASP . 32.9 mmt -70.02 -47.95 60.02 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 124.21 1.004 . . . . 10.0 112.618 -175.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -56.14 -41.07 74.79 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 120.328 1.422 . . . . 10.0 113.206 172.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.8 tp -53.3 -54.57 34.54 Favored 'General case' 0 C--O 1.224 -0.272 0 CA-C-N 120.024 1.284 . . . . 10.0 111.275 170.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 23.9 p -51.6 -41.16 61.02 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 115.203 1.557 . . . . 10.0 115.203 178.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 57.6 mtm -66.84 -50.81 61.37 Favored 'General case' 0 C--N 1.333 -0.113 0 C-N-CA 123.54 0.736 . . . . 10.0 110.481 176.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.2 tp -48.64 -52.66 22.06 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.882 0.873 . . . . 10.0 112.894 172.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.4 mt -76.9 -5.61 49.15 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.383 1.073 . . . . 10.0 113.786 -177.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.26 -34.66 5.59 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 115.53 0.972 . . . . 10.0 115.53 174.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 75.3 t80 -49.32 -43.13 43.26 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 115.206 1.558 . . . . 10.0 115.206 -176.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.02 3.54 61.06 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 115.313 0.885 . . . . 10.0 115.313 -179.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.25 143.41 26.44 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 127.035 2.134 . . . . 10.0 109.011 172.023 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 t -145.5 171.07 15.19 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 124.064 0.946 . . . . 10.0 111.019 166.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.97 136.08 53.37 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 123.947 0.899 . . . . 10.0 109.73 179.554 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 58.7 t -129.59 129.56 23.17 Favored Pre-proline 0 C--N 1.329 -0.295 0 C-N-CA 125.098 1.359 . . . . 10.0 110.966 -176.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -80.77 116.24 3.16 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 N-CA-C 109.41 -1.035 . . . . 10.0 109.41 -178.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -156.71 164.41 38.16 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 112.845 0.683 . . . . 10.0 112.845 172.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.37 -81.93 0.14 Allowed Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.681 -0.967 . . . . 10.0 110.681 175.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.8 -3.34 0.69 Allowed Glycine 0 CA--C 1.526 0.762 0 N-CA-C 118.677 2.231 . . . . 10.0 118.677 170.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -151.61 -171.89 4.06 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 119.379 1.589 . . . . 10.0 112.224 -165.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -91.84 93.88 9.05 Favored 'General case' 0 CA--C 1.519 -0.23 0 C-N-CA 125.547 1.539 . . . . 10.0 111.146 -175.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 60.5 m-80 -89.52 120.79 69.62 Favored Pre-proline 0 N--CA 1.45 -0.43 0 N-CA-C 112.933 0.716 . . . . 10.0 112.933 -165.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -61.53 131.92 38.19 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 124.208 3.272 . . . . 10.0 112.158 171.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.5 mm -140.12 126.34 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 C-N-CA 126.0 1.72 . . . . 10.0 111.71 -179.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -93.65 85.07 4.76 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 122.701 1.238 . . . . 10.0 113.055 174.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 63.8 p-90 -59.45 -28.2 66.75 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 113.921 1.082 . . . . 10.0 113.921 174.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -54.58 -28.53 46.8 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 113.809 1.04 . . . . 10.0 113.809 178.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 77.7 mtt-85 -52.15 -58.63 6.0 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 119.318 0.963 . . . . 10.0 111.263 169.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -58.67 -40.06 82.43 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 125.697 1.599 . . . . 10.0 111.967 -179.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -52.18 -50.95 60.83 Favored 'General case' 0 CA--C 1.552 1.05 0 CA-C-N 119.368 0.986 . . . . 10.0 112.133 168.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.435 ' CB ' ' HG3' ' A' ' 56' ' ' MET . 0.0 OUTLIER -60.34 -59.82 4.8 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.961 1.304 . . . . 10.0 112.388 173.18 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 52.3 m0 -54.19 -37.8 64.92 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 126.88 2.072 . . . . 10.0 112.714 -176.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 32.5 tp -50.39 -45.16 55.26 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 126.207 1.803 . . . . 10.0 111.845 178.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -97.79 -43.35 7.18 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 123.961 0.905 . . . . 10.0 112.671 -178.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -58.26 -44.09 88.2 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 113.105 0.779 . . . . 10.0 113.105 -176.446 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.5 m -68.58 -45.21 35.08 Favored Pre-proline 0 CA--C 1.544 0.735 0 O-C-N 121.302 -0.874 . . . . 10.0 112.386 -172.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -52.34 -44.43 46.68 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 123.672 2.914 . . . . 10.0 115.865 165.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 52.8 mt -59.09 -46.63 87.81 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 118.815 0.734 . . . . 10.0 111.426 175.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.2 tp -50.47 -48.73 56.51 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.65 1.58 . . . . 10.0 112.235 172.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.0 mp -59.09 -46.99 86.88 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.192 1.397 . . . . 10.0 112.714 170.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.88 -38.25 78.4 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.866 0.866 . . . . 10.0 112.837 178.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -52.24 -54.09 35.53 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 119.34 0.973 . . . . 10.0 111.187 169.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.35 -42.1 88.58 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.635 0.774 . . . . 10.0 112.113 -178.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.64 -54.79 36.95 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 124.006 0.923 . . . . 10.0 112.014 173.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.25 -41.15 79.05 Favored 'General case' 0 C--O 1.224 -0.237 0 C-N-CA 123.715 0.806 . . . . 10.0 112.764 174.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.8 tp -63.8 -38.54 91.46 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 114.436 1.273 . . . . 10.0 114.436 -179.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.2 t -94.83 1.39 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 125.069 1.347 . . . . 10.0 112.316 179.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.2 t70 48.63 53.49 12.13 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.864 1.666 . . . . 10.0 112.079 -174.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.27 145.93 47.56 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 119.988 -1.695 . . . . 10.0 112.469 -174.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.56 135.91 54.51 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 112.723 0.638 . . . . 10.0 112.723 175.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -42.87 -39.63 2.6 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.83 1.652 . . . . 10.0 113.508 175.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -47.34 -60.19 5.35 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 125.147 1.356 . . . . 10.0 115.264 169.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.6 p -62.09 -46.77 87.6 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 117.1 -1.428 . . . . 10.0 111.309 178.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 66.9 mt -48.41 -52.94 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 125.038 1.335 . . . . 10.0 111.117 178.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.2 tp -62.59 -51.31 67.84 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 112.528 0.566 . . . . 10.0 112.528 179.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.28 -44.81 44.25 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.437 0.695 . . . . 10.0 110.935 174.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.56 -59.9 4.71 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 127.393 2.277 . . . . 10.0 114.831 174.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.6 t -61.01 -46.38 96.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 123.705 0.802 . . . . 10.0 111.37 -178.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -56.6 -50.36 63.61 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 123.686 0.66 . . . . 10.0 112.631 174.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -54.64 -46.67 73.99 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 113.215 0.82 . . . . 10.0 113.215 173.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -57.74 -45.75 85.39 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.218 0.607 . . . . 10.0 111.938 174.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -43.22 -56.09 4.79 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 125.196 1.379 . . . . 10.0 113.002 167.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 88.9 mt -56.76 -52.58 52.76 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 123.518 0.727 . . . . 10.0 111.372 174.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 6.1 tmm? -51.58 -56.72 11.9 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.786 1.234 . . . . 10.0 112.566 -176.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 44.5 mm . . . . . 0 N--CA 1.472 0.666 0 C-N-CA 123.068 0.547 . . . . 10.0 112.075 177.119 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 67.9 t . . . . . 0 N--CA 1.476 0.873 0 N-CA-C 110.36 -0.237 . . . . 10.0 110.36 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -49.77 -60.7 6.24 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 125.937 1.732 . . . . 10.0 112.191 172.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -49.11 -37.49 21.9 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.558 1.943 . . . . 10.0 113.732 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 48.8 mt -99.07 -6.71 27.93 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 115.315 1.598 . . . . 10.0 115.315 -179.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 16.9 m -69.66 116.75 10.42 Favored 'General case' 0 N--CA 1.464 0.229 0 O-C-N 120.15 -1.594 . . . . 10.0 110.386 -178.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.553 ' HD3' ' H ' ' A' ' 129' ' ' LYS . 0.1 OUTLIER -55.5 -49.63 72.06 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 128.23 2.612 . . . . 10.0 113.252 177.765 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 60.3 t -69.61 106.33 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 123.819 0.848 . . . . 10.0 110.071 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -46.92 -59.56 3.01 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 124.787 1.235 . . . . 10.0 114.048 -173.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 m -46.41 -42.13 14.7 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.474 1.51 . . . . 10.0 113.513 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -70.15 -24.63 63.19 Favored 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 114.95 1.463 . . . . 10.0 114.95 -178.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 69.3 mtp85 -53.78 -41.82 67.65 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 118.857 0.753 . . . . 10.0 110.881 176.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -69.42 -32.44 71.43 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.815 1.246 . . . . 10.0 114.216 176.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 49.0 t -55.12 -52.11 47.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 CA-C-N 119.033 0.833 . . . . 10.0 109.965 169.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 69.7 m95 -59.39 -51.5 69.63 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 113.47 0.915 . . . . 10.0 113.47 174.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 85.3 t90 -47.98 -47.23 33.07 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.268 1.027 . . . . 10.0 113.304 174.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.559 0 C-N-CA 124.058 0.943 . . . . 10.0 111.768 176.665 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.547 0.86 0 N-CA-C 112.922 0.712 . . . . 10.0 112.922 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 39.4 ttp -58.13 -51.41 69.83 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.19 0.996 . . . . 10.0 112.18 172.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 5.6 mp -51.65 -48.55 63.33 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 126.596 1.959 . . . . 10.0 112.042 175.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 77.9 t80 -54.07 -54.26 41.87 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.664 0.785 . . . . 10.0 113.06 172.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 49.4 mt -54.32 -55.35 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 123.566 0.746 . . . . 10.0 110.8 178.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . 0.289 3.9 pp -60.63 -31.26 70.46 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 116.833 -1.556 . . . . 10.0 113.371 179.055 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -57.26 -58.2 9.28 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 120.554 1.524 . . . . 10.0 113.064 170.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.39 -40.88 85.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-O 118.321 -0.847 . . . . 10.0 111.469 177.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 46.9 mt -56.83 -49.34 75.7 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 119.84 1.2 . . . . 10.0 112.164 171.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.423 ' HA ' ' HD2' ' A' ' 175' ' ' ARG . 11.8 t80 -76.97 -70.34 0.47 Allowed 'General case' 0 C--N 1.326 -0.447 0 O-C-N 120.056 -1.653 . . . . 10.0 112.887 -175.288 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -73.71 -21.99 60.05 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.596 1.158 . . . . 10.0 113.439 -174.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -87.78 -79.08 1.26 Allowed Glycine 0 CA--C 1.526 0.77 0 C-N-CA 123.602 0.62 . . . . 10.0 113.545 171.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 5.4 m-30 -53.61 -32.46 51.25 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 126.271 1.828 . . . . 10.0 113.019 -166.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.3 m -52.08 -56.44 14.4 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 113.991 1.108 . . . . 10.0 113.991 172.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.6 p -53.68 -50.58 65.52 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 122.121 0.962 . . . . 10.0 112.282 -177.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 47.7 tttm -57.15 -46.01 83.09 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.194 0.998 . . . . 10.0 112.11 173.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.82 -47.46 80.24 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 114.545 1.313 . . . . 10.0 114.545 174.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -56.49 -11.28 1.21 Allowed 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 126.068 1.747 . . . . 10.0 114.258 177.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.1 m -107.08 6.57 29.04 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.467 1.907 . . . . 10.0 114.881 -179.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 93.2 mmm -91.89 -92.67 0.15 Allowed 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 123.506 1.622 . . . . 10.0 114.164 -170.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -138.69 153.97 72.71 Favored Pre-proline 0 C--O 1.236 0.349 0 C-N-CA 129.848 3.259 . . . . 10.0 105.548 170.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -52.88 -46.21 35.38 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.261 1.974 . . . . 10.0 113.074 179.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . 0.462 ' CD ' ' HD3' ' A' ' 227' ' ' ARG . 0.1 OUTLIER -52.95 -46.08 68.02 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 129.022 2.929 . . . . 10.0 113.242 173.569 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 92.2 t -69.18 -52.99 28.02 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 C-N-CA 124.085 0.954 . . . . 10.0 109.85 -178.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.2 -46.8 75.89 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.238 0.615 . . . . 10.0 111.933 177.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 60.1 p -59.95 -56.25 24.06 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.972 0.909 . . . . 10.0 112.68 174.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 62.0 m -57.22 -53.19 60.94 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.202 1.001 . . . . 10.0 113.004 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -49.61 -49.49 46.65 Favored 'General case' 0 C--O 1.222 -0.375 0 C-N-CA 123.239 0.616 . . . . 10.0 111.102 174.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -57.11 -48.46 78.57 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 114.629 1.344 . . . . 10.0 114.629 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 40.4 t -55.95 -49.63 74.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 CA-C-N 118.794 0.725 . . . . 10.0 110.476 176.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 94.2 mt -58.57 -51.63 69.09 Favored 'General case' 0 C--O 1.222 -0.389 0 N-CA-C 113.201 0.815 . . . . 10.0 113.201 175.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . 0.423 ' HD2' ' HA ' ' A' ' 153' ' ' PHE . 35.5 ttp180 -47.71 -47.77 29.85 Favored 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 126.85 2.06 . . . . 10.0 111.092 174.395 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 63.4 m-20 -58.55 -58.29 9.22 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 122.799 0.44 . . . . 10.0 111.255 174.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 54.2 t -51.93 -47.61 41.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 C-N-CA 124.082 0.953 . . . . 10.0 112.143 179.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 25.0 m -59.39 -63.02 1.45 Allowed 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 127.507 2.323 . . . . 10.0 111.755 178.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 55.8 t -50.12 -49.9 21.21 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 C-N-CA 124.799 1.24 . . . . 10.0 110.975 -179.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 70.8 t -59.13 -61.65 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 123.912 0.885 . . . . 10.0 112.616 178.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 91.5 mt -58.36 -46.99 85.23 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 118.19 0.45 . . . . 10.0 111.871 -176.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 9.0 m0 . . . . . 0 N--CA 1.465 0.295 0 C-N-CA 124.121 0.968 . . . . 10.0 112.217 174.67 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 90.4 t . . . . . 0 N--CA 1.479 0.991 0 CA-C-O 119.499 -0.286 . . . . 10.0 111.657 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 34.7 t90 -55.79 -55.82 27.88 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.844 1.258 . . . . 10.0 112.288 174.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 9.8 tt -55.9 -44.23 78.03 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 124.289 1.036 . . . . 10.0 112.639 -177.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 14.7 pt -82.79 -5.68 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 N-CA-C 114.989 1.477 . . . . 10.0 114.989 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.58 -169.35 32.75 Favored Glycine 0 N--CA 1.45 -0.379 0 CA-C-O 122.545 1.08 . . . . 10.0 113.855 -168.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 23.2 t -53.15 -39.55 63.63 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 114.217 -0.992 . . . . 10.0 111.847 177.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -56.86 -32.39 65.76 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 128.439 2.695 . . . . 10.0 115.286 -179.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -129.61 -104.41 1.11 Allowed Glycine 0 CA--C 1.524 0.628 0 CA-C-O 122.169 0.872 . . . . 10.0 112.738 -167.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -89.39 127.17 35.79 Favored 'General case' 0 C--N 1.328 -0.352 0 O-C-N 120.64 -1.506 . . . . 10.0 109.3 170.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -72.5 65.38 1.37 Allowed Glycine 0 CA--C 1.532 1.124 0 N-CA-C 113.879 0.312 . . . . 10.0 113.879 173.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 60.6 mt -79.67 -42.69 22.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 126.083 1.753 . . . . 10.0 108.725 166.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 79.8 t -126.31 133.4 24.93 Favored Pre-proline 0 N--CA 1.454 -0.264 0 C-N-CA 126.47 1.908 . . . . 10.0 109.364 -174.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -68.73 153.75 72.57 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 123.822 3.015 . . . . 10.0 111.456 -176.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 12.2 tp -43.1 -39.87 2.96 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.358 1.063 . . . . 10.0 112.199 171.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -48.28 -52.44 21.34 Favored 'General case' 0 CA--C 1.539 0.519 0 N-CA-C 114.673 1.361 . . . . 10.0 114.673 176.052 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 14.0 mm -75.88 -40.53 38.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 124.434 1.094 . . . . 10.0 109.625 177.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.29 -49.79 42.08 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 118.61 0.641 . . . . 10.0 111.974 173.639 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 15.9 m -57.69 -47.08 83.35 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 126.046 1.738 . . . . 10.0 112.964 174.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -63.27 -52.33 62.48 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.958 0.903 . . . . 10.0 112.114 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 93.3 mt -52.58 -58.95 5.16 Favored 'General case' 0 C--O 1.227 -0.087 0 C-N-CA 124.293 1.037 . . . . 10.0 110.021 176.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -54.8 -43.73 73.17 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 117.766 -1.111 . . . . 10.0 112.912 177.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 4.6 tmm? -52.31 -53.2 47.4 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 120.277 1.399 . . . . 10.0 112.252 174.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 77.1 t -60.81 -48.13 90.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 124.525 1.13 . . . . 10.0 111.754 178.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 5.1 mp -56.74 -53.45 57.65 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.148 1.379 . . . . 10.0 111.712 175.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -55.68 -52.76 62.77 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.127 1.771 . . . . 10.0 111.594 178.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 46.0 t . . . . . 0 N--CA 1.479 1.012 0 C-N-CA 124.618 1.167 . . . . 10.0 110.705 173.788 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.338 0 CA-C-O 120.932 0.185 . . . . 10.0 112.929 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 35.6 t80 -43.94 -56.31 4.02 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.513 1.925 . . . . 10.0 112.723 168.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -58.98 -39.16 93.86 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 124.576 1.084 . . . . 10.0 113.114 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 24.7 mt -69.5 -27.92 65.61 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 115.792 1.775 . . . . 10.0 115.792 175.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 74.3 mt -63.35 -57.61 11.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 119.22 0.918 . . . . 10.0 108.634 165.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 32.2 tp -58.87 -64.66 0.86 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.924 0.89 . . . . 10.0 113.165 -172.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 84.2 mt -71.55 5.22 2.5 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 115.323 1.601 . . . . 10.0 115.323 -171.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.6 mtp-105 -112.36 0.38 15.64 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.199 1.0 . . . . 10.0 113.272 172.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 8.8 t -108.03 177.97 4.65 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 124.026 0.93 . . . . 10.0 111.015 174.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 227' ' ' ARG . . . . . 0.462 ' HD3' ' CD ' ' A' ' 166' ' ' GLU . 41.8 ttt180 -71.65 98.22 1.87 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.752 0.821 . . . . 10.0 110.91 170.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -80.96 77.03 7.89 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.814 0.846 . . . . 10.0 112.123 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 40.09 102.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 128.857 2.863 . . . . 10.0 116.481 177.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . 0.482 0.3 OUTLIER 71.87 -55.46 0.66 Allowed 'General case' 0 C--O 1.242 0.699 0 C-N-CA 124.711 1.205 . . . . 10.0 110.591 -175.331 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -68.28 169.47 40.01 Favored Glycine 0 C--O 1.239 0.417 0 C-N-CA 129.757 3.551 . . . . 10.0 119.653 171.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.474 0 C-N-CA 128.458 2.703 . . . . 10.0 113.43 166.573 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 N--CA 1.476 0.87 0 CA-C-O 115.817 -2.039 . . . . 10.0 105.775 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 23.44 91.84 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 129.532 3.133 . . . . 10.0 117.276 160.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 28.6 65.05 0.11 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 128.301 2.641 . . . . 10.0 114.514 155.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 86.6 mt -56.44 137.98 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 126.396 1.878 . . . . 10.0 113.338 -158.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.6 t -136.8 -165.22 1.7 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 126.286 1.834 . . . . 10.0 114.021 -174.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 70.06 2.79 41.4 Favored Glycine 0 C--N 1.34 0.786 0 C-N-CA 127.443 2.449 . . . . 10.0 111.451 168.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -158.57 -51.32 0.01 OUTLIER Pre-proline 0 N--CA 1.443 -0.783 0 CA-C-O 114.263 -2.78 . . . . 10.0 116.649 -168.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -64.03 -60.6 0.15 Allowed 'Trans proline' 0 CA--C 1.528 0.185 0 CA-C-N 123.538 2.299 . . . . 10.0 113.205 -175.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 7.9 pm0 -67.21 4.3 0.97 Allowed 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 127.886 2.475 . . . . 10.0 115.732 179.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.421 ' CG ' ' N ' ' A' ' 11' ' ' ILE . 11.1 p-90 -51.39 -43.07 61.8 Favored 'General case' 0 C--O 1.222 -0.361 0 O-C-N 121.455 -0.778 . . . . 10.0 112.617 176.43 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.421 ' N ' ' CG ' ' A' ' 10' ' ' TRP . 8.9 tt -60.83 -49.65 83.73 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.34 0 C-N-CA 123.926 0.89 . . . . 10.0 109.339 179.37 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 2.6 m95 -55.4 -52.67 62.81 Favored 'General case' 0 C--O 1.224 -0.259 0 C-N-CA 123.407 0.683 . . . . 10.0 111.871 175.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.5 mt -57.34 -53.62 56.04 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 123.175 0.59 . . . . 10.0 112.198 177.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.86 -46.82 51.89 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.427 1.491 . . . . 10.0 113.268 173.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 13.3 tp -65.68 -44.92 84.76 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 125.274 1.43 . . . . 10.0 113.012 179.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.49 -56.79 10.34 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 124.568 1.08 . . . . 10.0 111.588 166.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 22.3 m -49.22 -52.68 25.41 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.987 1.315 . . . . 10.0 112.373 174.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.42 -58.85 5.84 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.151 0.98 . . . . 10.0 112.19 177.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 93.0 mt -57.26 -49.03 77.35 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.686 0.794 . . . . 10.0 112.736 -179.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 52.8 mtt -58.83 -47.87 83.33 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.121 0.968 . . . . 10.0 111.101 177.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -57.13 -58.6 13.72 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 124.333 0.968 . . . . 10.0 113.99 173.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 80.8 mt -56.24 -45.52 79.96 Favored 'General case' 0 C--O 1.221 -0.426 0 CA-C-N 118.646 1.223 . . . . 10.0 112.112 176.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.08 -41.04 84.7 Favored Glycine 0 CA--C 1.531 1.093 0 O-C-N 120.929 -1.107 . . . . 10.0 113.652 173.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 22.1 m -60.06 -60.43 3.84 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.793 0.837 . . . . 10.0 110.831 171.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -52.22 -41.02 62.38 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.073 0.949 . . . . 10.0 110.958 179.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -55.8 -58.01 9.63 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.557 1.143 . . . . 10.0 112.991 172.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -59.65 -38.72 82.16 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 113.201 0.815 . . . . 10.0 113.201 178.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.468 ' C ' ' H ' ' A' ' 30' ' ' LYS . 11.8 mt -56.11 -67.42 0.3 Allowed 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.58 1.152 . . . . 10.0 113.627 169.131 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 t -76.37 40.93 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-O 123.77 1.747 . . . . 10.0 110.891 179.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.468 ' H ' ' C ' ' A' ' 28' ' ' LEU . 42.9 tttm -140.82 -44.82 0.39 Allowed 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 127.884 2.474 . . . . 10.0 109.35 171.187 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -73.02 23.15 0.88 Allowed Glycine 0 CA--C 1.529 0.928 0 N-CA-C 115.634 1.014 . . . . 10.0 115.634 173.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 37.3 mmm -59.54 -44.96 93.07 Favored 'General case' 0 C--O 1.223 -0.296 0 C-N-CA 127.136 2.174 . . . . 10.0 113.578 -179.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.72 -84.4 1.19 Allowed Glycine 0 CA--C 1.53 1.007 0 C-N-CA 123.718 0.675 . . . . 10.0 112.452 -170.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.8 t 33.04 88.79 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.242 0.682 0 C-N-CA 128.4 2.68 . . . . 10.0 116.961 166.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.7 m -79.62 -50.93 9.93 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.187 -1.37 . . . . 10.0 113.866 174.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -48.93 117.51 6.43 Favored Pre-proline 0 CA--C 1.537 0.454 0 O-C-N 124.719 1.262 . . . . 10.0 110.937 -172.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -58.57 -29.7 89.77 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 123.746 2.964 . . . . 10.0 113.669 179.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.26 -60.68 2.28 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.111 0.565 . . . . 10.0 111.441 176.192 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.16 -40.07 22.71 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 125.097 1.359 . . . . 10.0 113.565 171.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -46.53 -47.45 19.55 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 125.221 1.408 . . . . 10.0 113.463 172.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -57.74 -53.06 62.47 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.431 0.693 . . . . 10.0 110.99 176.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 44.2 m-85 -56.95 -50.22 73.28 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 123.09 0.556 . . . . 10.0 112.339 -179.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -54.33 -51.32 65.08 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 118.962 -0.542 . . . . 10.0 112.369 173.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.42 -62.02 1.91 Allowed 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 113.34 0.867 . . . . 10.0 113.34 177.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.6 mt -48.8 -56.98 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 124.842 1.257 . . . . 10.0 110.396 178.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.2 m -69.76 -16.45 63.31 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.085 1.354 . . . . 10.0 113.605 -172.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 30.1 m -87.0 -43.28 12.47 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 119.735 1.152 . . . . 10.0 111.842 174.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 20.1 mt -56.84 -40.94 76.98 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 112.937 0.718 . . . . 10.0 112.937 173.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 44.4 t -49.43 -62.05 2.85 Favored Pre-proline 0 CA--C 1.552 1.047 0 C-N-CA 124.473 1.109 . . . . 10.0 112.494 178.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -48.72 -46.92 22.62 Favored 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 124.593 3.529 . . . . 10.0 116.236 164.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.64 -45.7 93.07 Favored 'General case' 0 CA--C 1.548 0.901 0 CA-C-N 119.904 1.229 . . . . 10.0 113.875 -176.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 52.9 mt -57.58 -51.69 66.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 124.536 1.134 . . . . 10.0 109.376 172.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.5 -45.85 73.37 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.31 1.044 . . . . 10.0 113.056 176.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -50.52 -56.7 10.47 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 125.283 1.433 . . . . 10.0 112.228 171.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 13.2 m -49.72 -52.73 29.24 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 125.283 1.433 . . . . 10.0 110.674 177.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 32.4 mmt -68.67 -48.34 64.2 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 124.001 0.92 . . . . 10.0 113.025 -176.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -57.01 -40.16 76.11 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-O 117.083 -1.437 . . . . 10.0 113.214 173.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.8 tp -53.3 -54.54 34.82 Favored 'General case' 0 C--O 1.224 -0.272 0 CA-C-N 120.118 1.327 . . . . 10.0 111.334 170.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 24.0 p -51.64 -41.1 61.06 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 115.221 1.563 . . . . 10.0 115.221 178.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 57.9 mtm -66.86 -50.85 61.19 Favored 'General case' 0 C--N 1.334 -0.09 0 C-N-CA 123.597 0.759 . . . . 10.0 110.477 176.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.4 tp -48.58 -52.67 21.69 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.88 0.872 . . . . 10.0 112.926 172.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.5 mt -76.98 -5.53 49.01 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.358 1.063 . . . . 10.0 113.781 -177.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.29 -34.72 5.54 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 115.47 0.948 . . . . 10.0 115.47 174.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -49.29 -43.13 42.99 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 115.206 1.558 . . . . 10.0 115.206 -175.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.03 3.56 61.03 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 115.35 0.9 . . . . 10.0 115.35 -179.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.2 143.36 26.5 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 127.056 2.142 . . . . 10.0 109.038 171.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 t -145.47 171.13 15.09 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 124.023 0.929 . . . . 10.0 111.077 166.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.02 136.04 53.4 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 123.932 0.893 . . . . 10.0 109.711 179.583 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 58.9 t -129.52 129.61 23.21 Favored Pre-proline 0 C--N 1.329 -0.299 0 C-N-CA 125.109 1.364 . . . . 10.0 110.999 -176.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -80.76 116.22 3.16 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 N-CA-C 109.417 -1.032 . . . . 10.0 109.417 -178.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -156.75 164.4 38.16 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.824 0.676 . . . . 10.0 112.824 172.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.35 -81.96 0.14 Allowed Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.696 -0.961 . . . . 10.0 110.696 175.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.72 -3.4 0.7 Allowed Glycine 0 CA--C 1.527 0.836 0 N-CA-C 118.637 2.215 . . . . 10.0 118.637 170.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -151.56 -171.85 4.05 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 119.339 1.569 . . . . 10.0 112.257 -165.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -91.92 93.91 9.03 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 125.504 1.522 . . . . 10.0 111.088 -175.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 60.5 m-80 -89.51 120.82 69.62 Favored Pre-proline 0 N--CA 1.45 -0.431 0 N-CA-C 112.963 0.727 . . . . 10.0 112.963 -165.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -61.49 131.89 38.14 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 124.183 3.255 . . . . 10.0 112.199 171.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.6 mm -140.14 126.36 21.92 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 C-N-CA 125.999 1.72 . . . . 10.0 111.704 -179.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -93.66 85.04 4.74 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 122.812 1.291 . . . . 10.0 113.046 174.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 63.7 p-90 -59.35 -28.24 66.66 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 113.905 1.076 . . . . 10.0 113.905 174.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -55.39 -32.05 62.32 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.296 1.038 . . . . 10.0 111.811 178.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.437 HH11 ' HG3' ' A' ' 82' ' ' ARG . 23.4 ttm-85 -47.78 -40.63 21.38 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 126.888 2.075 . . . . 10.0 113.493 170.032 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 62.2 m-85 -86.47 -39.57 16.18 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.418 1.887 . . . . 10.0 111.755 -177.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -49.07 -47.85 44.62 Favored 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 124.555 1.142 . . . . 10.0 111.013 166.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -52.03 -71.97 0.06 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 126.471 1.908 . . . . 10.0 111.809 167.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 52.7 m0 -55.09 -33.77 63.08 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 124.095 0.958 . . . . 10.0 113.582 -170.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 24.3 tp -49.68 -40.44 40.05 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 126.285 1.834 . . . . 10.0 111.994 177.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -105.02 -40.37 5.92 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.378 0.671 . . . . 10.0 112.377 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 76.0 p -62.29 -42.16 99.12 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 120.664 1.575 . . . . 10.0 114.022 -179.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . 0.291 69.5 p -69.44 -41.32 16.85 Favored Pre-proline 0 CA--C 1.547 0.854 0 N-CA-C 114.959 1.466 . . . . 10.0 114.959 -176.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -55.11 -42.92 64.22 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 123.328 2.685 . . . . 10.0 115.137 166.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 55.0 mt -60.33 -47.39 86.22 Favored 'General case' 0 CA--C 1.544 0.724 0 O-C-N 121.507 -0.745 . . . . 10.0 111.677 176.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 6.1 tt -50.19 -49.37 52.72 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.723 1.609 . . . . 10.0 111.522 171.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.6 mp -57.26 -47.34 81.66 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.274 1.03 . . . . 10.0 113.135 170.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.86 -38.21 78.26 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 123.844 0.857 . . . . 10.0 112.9 178.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -52.32 -54.02 36.9 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 119.299 0.954 . . . . 10.0 111.21 169.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.33 -42.11 88.67 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 123.64 0.776 . . . . 10.0 112.144 -178.558 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.7 -54.68 38.59 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.98 0.912 . . . . 10.0 112.041 173.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.29 -41.18 79.32 Favored 'General case' 0 C--O 1.224 -0.24 0 C-N-CA 123.677 0.791 . . . . 10.0 112.714 174.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 32.2 tp -63.8 -38.56 91.55 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 114.436 1.273 . . . . 10.0 114.436 -179.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.2 t -94.79 1.41 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 125.005 1.322 . . . . 10.0 112.298 179.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.2 t70 48.6 53.5 12.08 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.864 1.666 . . . . 10.0 112.101 -174.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.28 145.88 47.59 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 119.951 -1.718 . . . . 10.0 112.47 -174.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.47 135.93 54.16 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 112.711 0.634 . . . . 10.0 112.711 175.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -42.89 -39.64 2.63 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.854 1.661 . . . . 10.0 113.471 175.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -47.33 -60.22 5.33 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 125.205 1.383 . . . . 10.0 115.213 169.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.5 p -62.1 -46.75 87.7 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 117.053 -1.451 . . . . 10.0 111.321 178.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 66.9 mt -48.48 -52.89 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 124.998 1.319 . . . . 10.0 111.11 178.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.1 tp -62.58 -51.37 67.62 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 112.528 0.566 . . . . 10.0 112.528 179.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.11 -44.86 42.66 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.47 0.708 . . . . 10.0 110.959 174.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.62 -59.89 4.72 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 127.404 2.281 . . . . 10.0 114.79 174.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.8 t -61.04 -46.32 96.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 123.705 0.802 . . . . 10.0 111.411 -178.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -56.62 -50.35 63.7 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 123.674 0.655 . . . . 10.0 112.642 174.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -54.93 -46.62 74.97 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 113.696 0.998 . . . . 10.0 113.696 173.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -55.02 -49.27 71.94 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.48 0.712 . . . . 10.0 111.166 173.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -42.87 -54.57 5.05 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 125.06 1.314 . . . . 10.0 113.059 170.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 86.9 mt -56.11 -54.43 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 CA-C-O 118.281 -0.866 . . . . 10.0 111.327 173.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 1.7 ptt? -56.8 -45.29 82.32 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 119.692 1.133 . . . . 10.0 113.038 -174.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 1.7 mp . . . . . 0 N--CA 1.479 1.001 0 CA-C-N 119.051 0.841 . . . . 10.0 111.047 174.732 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 60.8 t . . . . . 0 N--CA 1.478 0.935 0 N-CA-C 110.14 -0.319 . . . . 10.0 110.14 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -50.79 -61.14 6.31 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 126.305 1.907 . . . . 10.0 112.646 171.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -42.83 -42.26 3.56 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 127.772 2.429 . . . . 10.0 113.208 176.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 47.7 mt -100.84 -6.81 24.27 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 115.531 1.678 . . . . 10.0 115.531 -175.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 17.0 m -69.65 116.71 10.36 Favored 'General case' 0 N--CA 1.465 0.294 0 O-C-N 120.14 -1.6 . . . . 10.0 110.398 -178.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.553 ' HD3' ' H ' ' A' ' 129' ' ' LYS . 0.2 OUTLIER -55.45 -49.6 72.05 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 128.2 2.6 . . . . 10.0 113.25 177.75 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 60.8 t -69.69 106.33 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 123.797 0.839 . . . . 10.0 110.103 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -46.87 -59.54 3.01 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 124.774 1.229 . . . . 10.0 114.089 -173.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 m -46.52 -42.05 15.1 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.488 1.515 . . . . 10.0 113.495 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -70.16 -24.61 63.18 Favored 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 114.958 1.466 . . . . 10.0 114.958 -178.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 69.0 mtp85 -54.12 -41.43 68.33 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 118.845 0.748 . . . . 10.0 110.839 176.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -69.73 -32.18 70.59 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.842 1.257 . . . . 10.0 114.217 176.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.8 t -54.84 -52.23 44.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 CA-C-N 119.013 0.824 . . . . 10.0 109.83 168.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 65.6 m95 -59.66 -49.87 76.06 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 113.458 0.911 . . . . 10.0 113.458 173.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 89.8 t90 -48.35 -48.59 36.36 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 119.504 1.047 . . . . 10.0 113.214 173.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.637 0 C-N-CA 124.203 1.001 . . . . 10.0 111.976 176.241 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.547 0.854 0 N-CA-C 112.971 0.73 . . . . 10.0 112.971 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 38.2 ttp -57.49 -53.7 55.2 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.275 1.03 . . . . 10.0 112.005 171.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 62.7 tp -53.51 -47.0 70.28 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.191 1.396 . . . . 10.0 111.852 178.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -50.53 -54.84 19.33 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.003 0.921 . . . . 10.0 112.407 170.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 54.5 mt -53.62 -55.05 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 123.762 0.825 . . . . 10.0 110.805 177.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 38.8 mt -57.16 -35.98 70.2 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 118.365 -0.826 . . . . 10.0 112.997 178.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -57.24 -58.26 9.02 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 124.068 0.947 . . . . 10.0 113.006 173.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.34 -40.89 85.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 CA-C-O 118.343 -0.837 . . . . 10.0 111.492 177.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 45.4 mt -56.83 -49.4 75.53 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 119.845 1.202 . . . . 10.0 112.14 171.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.423 ' HA ' ' HD2' ' A' ' 175' ' ' ARG . 11.9 t80 -76.97 -70.34 0.47 Allowed 'General case' 0 C--N 1.326 -0.447 0 O-C-N 120.022 -1.674 . . . . 10.0 112.887 -175.264 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -73.74 -21.87 60.07 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.567 1.147 . . . . 10.0 113.448 -174.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -87.8 -79.16 1.26 Allowed Glycine 0 CA--C 1.527 0.783 0 C-N-CA 123.666 0.651 . . . . 10.0 113.496 171.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -53.63 -32.4 51.15 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 126.299 1.839 . . . . 10.0 113.046 -166.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.2 m -52.08 -56.5 13.99 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 114.012 1.116 . . . . 10.0 114.012 172.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.4 p -53.67 -50.53 65.61 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 122.057 0.932 . . . . 10.0 112.281 -177.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 47.6 tttm -57.13 -46.05 83.0 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.197 0.999 . . . . 10.0 112.117 173.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.82 -47.46 80.24 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 114.545 1.313 . . . . 10.0 114.545 174.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -56.5 -11.29 1.22 Allowed 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 126.089 1.755 . . . . 10.0 114.228 177.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.2 m -107.1 6.64 29.08 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.416 1.886 . . . . 10.0 114.877 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 93.2 mmm -91.88 -92.63 0.15 Allowed 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 123.521 1.629 . . . . 10.0 114.191 -170.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -138.74 153.98 72.62 Favored Pre-proline 0 C--O 1.236 0.359 0 C-N-CA 129.802 3.241 . . . . 10.0 105.548 170.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -52.86 -46.22 35.24 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 122.3 2.0 . . . . 10.0 113.088 179.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . 0.462 ' CD ' ' HD3' ' A' ' 227' ' ' ARG . 0.1 OUTLIER -52.97 -46.03 68.04 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 129.022 2.929 . . . . 10.0 113.276 173.578 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 91.7 t -69.26 -53.03 27.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 C-N-CA 124.02 0.928 . . . . 10.0 109.782 -178.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.09 -46.85 75.53 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.282 0.633 . . . . 10.0 111.923 177.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 60.5 p -60.02 -56.19 24.74 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.953 0.901 . . . . 10.0 112.67 174.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 62.0 m -57.22 -53.19 60.94 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.202 1.001 . . . . 10.0 113.004 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -49.59 -49.54 46.26 Favored 'General case' 0 C--O 1.221 -0.425 0 C-N-CA 123.289 0.636 . . . . 10.0 111.067 174.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -57.12 -48.41 78.72 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 114.671 1.36 . . . . 10.0 114.671 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 40.4 t -55.95 -49.63 74.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 CA-C-N 118.832 0.742 . . . . 10.0 110.476 176.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 94.1 mt -58.54 -51.65 68.99 Favored 'General case' 0 C--O 1.222 -0.392 0 N-CA-C 113.168 0.803 . . . . 10.0 113.168 175.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . 0.423 ' HD2' ' HA ' ' A' ' 153' ' ' PHE . 35.5 ttp180 -47.79 -47.76 30.7 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 126.824 2.05 . . . . 10.0 111.059 174.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 63.7 m-20 -58.53 -58.32 9.06 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 122.771 0.428 . . . . 10.0 111.286 174.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 59.5 t -51.85 -49.48 36.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 124.048 0.939 . . . . 10.0 111.449 179.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 35.3 m -55.74 -64.09 0.96 Allowed 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 128.428 2.691 . . . . 10.0 111.939 177.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 55.7 t -51.05 -49.56 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 124.541 1.136 . . . . 10.0 111.317 -179.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 79.6 t -59.76 -61.64 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 124.209 1.004 . . . . 10.0 112.198 177.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -57.86 -47.72 81.91 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 118.873 0.761 . . . . 10.0 112.287 -176.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 10.7 m95 . . . . . 0 N--CA 1.469 0.498 0 C-N-CA 123.878 0.871 . . . . 10.0 111.71 175.584 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 93.2 t . . . . . 0 N--CA 1.479 1.007 0 CA-C-O 119.252 -0.404 . . . . 10.0 111.442 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 52.1 t90 -55.46 -51.58 66.48 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.317 1.047 . . . . 10.0 112.498 174.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 34.4 tp -54.29 -45.63 72.56 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.878 1.271 . . . . 10.0 112.362 -178.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 15.4 pt -87.41 -5.05 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 115.17 1.544 . . . . 10.0 115.17 -177.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.49 -169.22 32.84 Favored Glycine 0 N--CA 1.451 -0.353 0 CA-C-O 122.545 1.08 . . . . 10.0 113.882 -168.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 23.2 t -53.21 -41.44 65.34 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 114.243 -0.979 . . . . 10.0 111.818 177.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -67.2 -17.05 64.66 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 115.659 1.726 . . . . 10.0 115.659 -175.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -130.99 -105.97 1.09 Allowed Glycine 0 CA--C 1.532 1.1 0 CA-C-N 120.381 1.446 . . . . 10.0 113.82 -172.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -89.42 127.15 35.8 Favored 'General case' 0 C--N 1.328 -0.352 0 O-C-N 120.64 -1.506 . . . . 10.0 109.349 168.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -72.46 65.36 1.36 Allowed Glycine 0 CA--C 1.532 1.124 0 N-CA-C 113.873 0.309 . . . . 10.0 113.873 173.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 60.7 mt -79.63 -42.74 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 126.083 1.753 . . . . 10.0 108.721 166.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 79.8 t -126.29 133.4 24.93 Favored Pre-proline 0 N--CA 1.454 -0.264 0 C-N-CA 126.502 1.921 . . . . 10.0 109.364 -174.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -68.78 153.82 72.33 Favored 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 123.751 2.967 . . . . 10.0 111.425 -176.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 12.2 tp -43.18 -39.75 3.03 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.281 1.033 . . . . 10.0 112.223 171.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -48.34 -52.39 21.82 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 114.705 1.372 . . . . 10.0 114.705 176.053 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 14.0 mm -75.91 -40.48 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 124.378 1.071 . . . . 10.0 109.674 177.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -49.29 -49.85 41.84 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 118.553 0.615 . . . . 10.0 111.946 173.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 15.9 m -57.69 -47.08 83.36 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 126.046 1.738 . . . . 10.0 112.964 174.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -63.28 -52.33 62.45 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.977 0.911 . . . . 10.0 112.101 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 93.3 mt -52.58 -59.34 4.57 Favored 'General case' 0 C--N 1.335 -0.044 0 C-N-CA 124.265 1.026 . . . . 10.0 109.989 176.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -52.75 -47.35 67.51 Favored 'General case' 0 C--O 1.219 -0.53 0 CA-C-O 117.286 -1.34 . . . . 10.0 112.102 176.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 4.6 tmm? -50.84 -52.5 40.91 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 120.976 1.716 . . . . 10.0 112.974 174.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 80.4 t -60.86 -46.93 95.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 124.798 1.239 . . . . 10.0 111.524 178.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 4.1 mp -59.45 -51.57 69.32 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.496 1.518 . . . . 10.0 112.261 175.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -55.08 -55.97 25.06 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 127.245 2.218 . . . . 10.0 110.281 175.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 38.1 t . . . . . 0 N--CA 1.476 0.842 0 C-N-CA 124.529 1.131 . . . . 10.0 111.488 173.709 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.236 0 N-CA-C 111.731 -0.547 . . . . 10.0 111.731 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -44.03 -58.81 2.61 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 127.2 2.2 . . . . 10.0 112.357 166.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -55.41 -41.7 81.17 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 123.991 0.805 . . . . 10.0 114.319 179.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 23.8 mt -70.63 -26.73 63.61 Favored 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 115.505 1.668 . . . . 10.0 115.505 178.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 74.0 mt -63.2 -57.56 11.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 108.741 -0.837 . . . . 10.0 108.741 165.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 32.1 tp -58.77 -64.68 0.85 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.901 0.88 . . . . 10.0 113.183 -172.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 84.0 mt -71.53 5.19 2.51 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 115.315 1.598 . . . . 10.0 115.315 -171.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.6 mtp-105 -112.31 0.33 15.67 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.231 1.012 . . . . 10.0 113.324 172.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 8.8 t -108.04 177.99 4.65 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 124.014 0.926 . . . . 10.0 111.013 174.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 227' ' ' ARG . . . . . 0.462 ' HD3' ' CD ' ' A' ' 166' ' ' GLU . 41.8 ttt180 -71.64 98.19 1.86 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.773 0.829 . . . . 10.0 110.924 170.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -80.96 77.07 7.89 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.836 0.854 . . . . 10.0 112.073 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 40.15 102.25 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 128.893 2.877 . . . . 10.0 116.436 177.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . 0.483 0.3 OUTLIER 71.88 -55.47 0.66 Allowed 'General case' 0 C--O 1.242 0.67 0 C-N-CA 124.692 1.197 . . . . 10.0 110.644 -175.355 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -68.25 169.43 39.98 Favored Glycine 0 C--O 1.239 0.417 0 C-N-CA 129.784 3.564 . . . . 10.0 119.629 171.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.461 0 C-N-CA 128.443 2.697 . . . . 10.0 113.409 166.61 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 N--CA 1.477 0.876 0 CA-C-O 115.801 -2.047 . . . . 10.0 105.812 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 23.38 91.92 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 129.647 3.179 . . . . 10.0 117.197 160.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 28.55 65.1 0.1 Allowed 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 128.302 2.641 . . . . 10.0 114.496 155.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 86.5 mt -56.48 137.98 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 126.379 1.872 . . . . 10.0 113.343 -158.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.6 t -136.76 -165.16 1.69 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 126.312 1.845 . . . . 10.0 114.025 -174.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 69.98 2.81 40.78 Favored Glycine 0 C--N 1.34 0.792 0 C-N-CA 127.477 2.465 . . . . 10.0 111.526 168.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -158.56 -51.4 0.01 OUTLIER Pre-proline 0 N--CA 1.443 -0.783 0 CA-C-O 114.284 -2.77 . . . . 10.0 116.665 -168.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_exo -63.91 -60.73 0.14 Allowed 'Trans proline' 0 N--CA 1.465 -0.185 0 CA-C-N 123.533 2.297 . . . . 10.0 113.201 -175.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 7.9 pm0 -67.13 4.26 0.96 Allowed 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 127.865 2.466 . . . . 10.0 115.746 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.422 ' CG ' ' N ' ' A' ' 11' ' ' ILE . 11.1 p-90 -51.35 -43.15 61.72 Favored 'General case' 0 C--O 1.223 -0.34 0 O-C-N 121.487 -0.758 . . . . 10.0 112.585 176.475 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.422 ' N ' ' CG ' ' A' ' 10' ' ' TRP . 8.9 tt -60.83 -49.64 83.78 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.338 0 C-N-CA 123.883 0.873 . . . . 10.0 109.287 179.447 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 2.6 m95 -55.38 -52.65 62.85 Favored 'General case' 0 C--O 1.224 -0.261 0 C-N-CA 123.402 0.681 . . . . 10.0 111.84 175.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 91.0 mt -57.35 -53.65 55.69 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 123.19 0.596 . . . . 10.0 112.178 177.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.88 -46.79 52.02 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.387 1.475 . . . . 10.0 113.295 173.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 13.3 tp -65.64 -44.96 84.79 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 125.282 1.433 . . . . 10.0 112.999 179.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -50.82 -54.7 20.98 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 124.297 0.951 . . . . 10.0 112.016 166.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 22.3 m -50.06 -52.67 32.59 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.961 1.304 . . . . 10.0 112.481 173.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.44 -58.82 5.97 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.181 0.992 . . . . 10.0 112.159 177.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 94.1 mt -57.39 -51.31 69.93 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.716 0.806 . . . . 10.0 112.695 -179.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.9 mpp? -57.8 -44.95 86.67 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 119.073 0.851 . . . . 10.0 111.967 176.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -58.5 -58.47 14.42 Favored Glycine 0 CA--C 1.53 1.03 0 CA-C-O 119.267 -0.741 . . . . 10.0 113.474 174.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 80.7 mt -56.24 -46.01 79.77 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-N 118.37 1.085 . . . . 10.0 112.089 175.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.38 -42.48 74.74 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 124.942 1.258 . . . . 10.0 113.179 173.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 28.6 m -61.95 -58.6 7.29 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.86 0.864 . . . . 10.0 111.373 171.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -52.3 -40.94 62.48 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.017 0.927 . . . . 10.0 110.976 177.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -55.76 -58.11 9.22 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.617 1.167 . . . . 10.0 112.943 172.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.1 m-30 -59.63 -38.61 81.84 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 113.245 0.831 . . . . 10.0 113.245 178.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.468 ' C ' ' H ' ' A' ' 30' ' ' LYS . 11.8 mt -56.23 -67.37 0.3 Allowed 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.58 1.152 . . . . 10.0 113.614 169.119 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 t -76.37 40.92 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 CA-C-O 123.745 1.736 . . . . 10.0 110.862 179.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.468 ' H ' ' C ' ' A' ' 28' ' ' LEU . 42.9 tttm -140.85 -44.8 0.39 Allowed 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 127.862 2.465 . . . . 10.0 109.317 171.164 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -73.01 23.15 0.88 Allowed Glycine 0 CA--C 1.529 0.958 0 N-CA-C 115.626 1.01 . . . . 10.0 115.626 173.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 37.3 mmm -59.53 -44.94 93.04 Favored 'General case' 0 C--O 1.224 -0.277 0 C-N-CA 127.101 2.161 . . . . 10.0 113.594 -179.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.68 -84.4 1.19 Allowed Glycine 0 CA--C 1.53 1.007 0 C-N-CA 123.709 0.671 . . . . 10.0 112.507 -170.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.8 t 33.03 88.78 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.242 0.706 0 C-N-CA 128.395 2.678 . . . . 10.0 116.956 166.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.0 m -79.63 -50.82 10.09 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.184 -1.371 . . . . 10.0 113.94 174.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -49.0 117.55 6.54 Favored Pre-proline 0 CA--C 1.536 0.418 0 O-C-N 124.753 1.283 . . . . 10.0 110.902 -172.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -58.56 -29.64 89.54 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 123.757 2.971 . . . . 10.0 113.701 179.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.38 -60.64 2.29 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.089 0.556 . . . . 10.0 111.402 176.231 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.13 -40.13 22.74 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 125.085 1.354 . . . . 10.0 113.54 171.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -46.48 -47.44 19.28 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.208 1.403 . . . . 10.0 113.468 172.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -57.75 -53.07 62.35 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.495 0.718 . . . . 10.0 110.94 176.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -56.98 -50.22 73.33 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 123.102 0.561 . . . . 10.0 112.321 -179.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -54.39 -51.27 65.36 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 118.962 -0.542 . . . . 10.0 112.369 173.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.42 -61.98 1.93 Allowed 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 113.419 0.896 . . . . 10.0 113.419 177.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.5 mt -48.65 -57.48 1.54 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 C-N-CA 124.869 1.268 . . . . 10.0 110.349 178.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.5 m -68.56 -17.87 64.23 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.109 1.364 . . . . 10.0 113.672 -172.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 27.4 m -87.14 -40.48 14.59 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.436 1.095 . . . . 10.0 112.123 174.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 23.7 mt -59.45 -42.0 90.94 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 121.321 -0.862 . . . . 10.0 112.573 171.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 24.7 t -43.24 -61.16 1.95 Allowed Pre-proline 0 N--CA 1.48 1.047 0 C-N-CA 125.57 1.548 . . . . 10.0 113.625 176.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -70.95 -28.71 19.18 Favored 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 123.135 2.557 . . . . 10.0 114.205 174.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.45 -46.24 87.17 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-N 120.709 1.595 . . . . 10.0 113.363 177.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 56.3 mt -56.14 -51.7 59.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 124.414 1.085 . . . . 10.0 109.248 171.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.65 -43.5 76.33 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 113.484 0.92 . . . . 10.0 113.484 175.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -50.96 -55.89 15.06 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 120.853 1.661 . . . . 10.0 111.818 171.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 10.6 m -49.74 -52.79 29.03 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.359 1.464 . . . . 10.0 110.877 177.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 32.6 mmt -68.88 -48.11 64.2 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 123.964 0.906 . . . . 10.0 112.938 -176.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -55.58 -41.97 74.11 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 120.342 1.428 . . . . 10.0 112.974 172.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.8 tp -53.25 -54.59 34.01 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-N 119.697 1.135 . . . . 10.0 111.281 171.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 24.0 p -51.67 -41.06 61.12 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 115.191 1.552 . . . . 10.0 115.191 179.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 55.6 mtm -66.86 -50.83 61.25 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 123.562 0.745 . . . . 10.0 110.479 176.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.5 tp -48.55 -52.7 21.4 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.846 0.858 . . . . 10.0 112.952 172.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.5 mt -76.97 -5.52 48.95 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.331 1.053 . . . . 10.0 113.799 -177.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.28 -34.77 5.5 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 115.55 0.98 . . . . 10.0 115.55 174.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 75.3 t80 -49.22 -43.09 42.22 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 115.258 1.577 . . . . 10.0 115.258 -176.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.1 3.59 61.18 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 115.348 0.899 . . . . 10.0 115.348 -179.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.25 143.43 26.42 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 127.035 2.134 . . . . 10.0 109.011 171.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 t -145.55 171.1 15.17 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 124.012 0.925 . . . . 10.0 111.045 166.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.0 136.08 53.37 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 123.853 0.861 . . . . 10.0 109.698 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 59.0 t -129.54 129.56 23.19 Favored Pre-proline 0 C--N 1.329 -0.317 0 C-N-CA 125.068 1.347 . . . . 10.0 110.988 -176.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -80.76 116.25 3.16 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 N-CA-C 109.411 -1.034 . . . . 10.0 109.411 -178.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -156.71 164.38 38.2 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 112.818 0.673 . . . . 10.0 112.818 172.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.43 -81.99 0.15 Allowed Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.644 -0.983 . . . . 10.0 110.644 175.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.76 -3.42 0.69 Allowed Glycine 0 CA--C 1.526 0.776 0 N-CA-C 118.673 2.229 . . . . 10.0 118.673 170.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -151.58 -171.89 4.06 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 119.343 1.571 . . . . 10.0 112.25 -165.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -91.86 93.91 9.06 Favored 'General case' 0 CA--C 1.519 -0.237 0 C-N-CA 125.514 1.526 . . . . 10.0 111.061 -175.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 60.4 m-80 -89.49 120.81 69.64 Favored Pre-proline 0 N--CA 1.45 -0.465 0 N-CA-C 112.982 0.734 . . . . 10.0 112.982 -165.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -61.52 131.88 38.02 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 124.205 3.27 . . . . 10.0 112.199 171.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.5 mm -140.09 126.33 22.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 C-N-CA 126.059 1.744 . . . . 10.0 111.716 -179.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -93.64 85.01 4.75 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 122.628 1.204 . . . . 10.0 113.053 174.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 63.8 p-90 -59.4 -28.25 66.74 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 113.896 1.072 . . . . 10.0 113.896 174.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -55.28 -26.02 37.67 Favored 'General case' 0 CA--C 1.562 1.415 0 C-N-CA 124.277 1.031 . . . . 10.0 111.773 178.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -45.42 -64.86 0.63 Allowed 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 125.297 1.439 . . . . 10.0 110.618 166.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 36.1 m-85 -62.67 -38.55 90.77 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 126.563 1.945 . . . . 10.0 110.936 -174.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -52.7 -49.86 64.48 Favored 'General case' 0 CA--C 1.555 1.159 0 CA-C-N 119.334 0.97 . . . . 10.0 112.048 168.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -60.06 -62.78 1.62 Allowed 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.476 1.111 . . . . 10.0 111.696 171.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 54.5 m0 -53.38 -37.06 62.09 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 125.821 1.648 . . . . 10.0 112.693 -174.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 28.2 tp -50.23 -41.44 50.05 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 126.275 1.83 . . . . 10.0 111.864 177.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -103.02 -40.7 6.38 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.883 0.873 . . . . 10.0 112.546 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 79.3 p -61.55 -42.45 98.86 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-N 120.553 1.524 . . . . 10.0 113.763 -179.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . 0.322 75.5 p -65.77 -47.69 65.05 Favored Pre-proline 0 N--CA 1.477 0.913 0 CA-C-O 117.586 -1.197 . . . . 10.0 114.22 -178.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -53.0 -42.68 62.75 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 123.232 2.621 . . . . 10.0 115.442 169.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 51.3 mt -59.75 -48.04 83.26 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 121.314 -0.866 . . . . 10.0 111.935 176.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.81 -37.49 84.61 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 119.586 1.085 . . . . 10.0 112.416 175.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.4 mp -56.39 -48.99 75.76 Favored 'General case' 0 CA--C 1.545 0.782 0 O-C-N 121.009 -1.057 . . . . 10.0 111.828 165.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.81 -38.24 78.17 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 119.164 0.893 . . . . 10.0 112.863 178.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -52.33 -54.06 36.45 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 119.322 0.965 . . . . 10.0 111.163 169.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.27 -42.07 88.97 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.63 0.772 . . . . 10.0 112.172 -178.569 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.76 -54.63 39.48 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 123.917 0.887 . . . . 10.0 112.066 173.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.38 -41.16 79.69 Favored 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 123.687 0.795 . . . . 10.0 112.681 174.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.8 tp -63.73 -38.54 91.5 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 114.485 1.291 . . . . 10.0 114.485 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.1 t -94.83 1.42 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 125.035 1.334 . . . . 10.0 112.308 179.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.2 t70 48.62 53.45 12.18 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.834 1.654 . . . . 10.0 112.1 -174.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.27 145.85 47.62 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 119.969 -1.707 . . . . 10.0 112.464 -174.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.42 135.93 53.96 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 112.697 0.629 . . . . 10.0 112.697 175.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -42.89 -39.68 2.64 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.877 1.671 . . . . 10.0 113.499 175.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -47.28 -60.22 5.29 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 125.103 1.335 . . . . 10.0 115.309 169.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.5 p -62.05 -46.82 87.46 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 117.098 -1.429 . . . . 10.0 111.332 178.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 67.0 mt -48.38 -52.92 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 125.038 1.335 . . . . 10.0 111.124 178.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.4 tp -62.67 -51.25 67.97 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 112.544 0.572 . . . . 10.0 112.544 179.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.2 -44.86 43.55 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.479 0.712 . . . . 10.0 110.912 174.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.59 -59.86 4.77 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 127.385 2.274 . . . . 10.0 114.8 174.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.1 t -61.09 -46.36 96.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 123.668 0.787 . . . . 10.0 111.362 -178.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -56.56 -50.41 63.19 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 123.68 0.657 . . . . 10.0 112.602 174.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -54.85 -46.54 74.66 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 113.278 0.844 . . . . 10.0 113.278 173.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -55.22 -48.64 73.6 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.315 1.046 . . . . 10.0 111.202 173.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -42.99 -55.33 4.9 Favored Glycine 0 CA--C 1.534 1.223 0 C-N-CA 125.1 1.333 . . . . 10.0 113.18 169.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 85.1 mt -56.91 -52.22 58.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 123.555 0.742 . . . . 10.0 111.974 174.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 54.0 ttp -48.68 -58.03 5.37 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.821 1.249 . . . . 10.0 112.226 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 40.2 mm . . . . . 0 N--CA 1.473 0.716 0 O-C-N 121.566 -0.709 . . . . 10.0 111.891 179.548 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 67.8 t . . . . . 0 N--CA 1.476 0.849 0 N-CA-C 110.377 -0.231 . . . . 10.0 110.377 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -49.15 -60.53 6.08 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 125.871 1.7 . . . . 10.0 112.212 171.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -49.57 -37.47 27.46 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.497 1.919 . . . . 10.0 113.635 -179.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 50.1 mt -99.37 -6.49 27.72 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 115.207 1.558 . . . . 10.0 115.207 -178.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 16.9 m -69.64 116.73 10.37 Favored 'General case' 0 N--CA 1.465 0.275 0 O-C-N 120.228 -1.545 . . . . 10.0 110.389 -178.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.552 ' HD3' ' H ' ' A' ' 129' ' ' LYS . 0.1 OUTLIER -55.52 -49.59 72.21 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 128.222 2.609 . . . . 10.0 113.268 177.731 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 60.6 t -69.65 106.32 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 123.791 0.836 . . . . 10.0 110.085 179.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -46.87 -59.55 3.01 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 124.807 1.243 . . . . 10.0 114.048 -173.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 m -46.5 -42.1 15.1 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.5 1.52 . . . . 10.0 113.484 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -70.18 -24.53 63.15 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 114.952 1.464 . . . . 10.0 114.952 -178.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 69.4 mtp85 -53.81 -42.02 67.94 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 118.887 0.767 . . . . 10.0 110.682 176.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -69.47 -32.03 70.68 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.805 1.242 . . . . 10.0 114.27 176.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.8 t -55.11 -52.09 48.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-N 119.055 0.843 . . . . 10.0 109.7 168.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 67.8 m95 -61.38 -44.11 97.72 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 114.287 1.217 . . . . 10.0 114.287 174.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 88.0 t90 -53.34 -48.15 68.74 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 124.254 1.022 . . . . 10.0 112.704 172.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.557 0 C-N-CA 123.984 0.914 . . . . 10.0 111.602 177.071 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.792 0 N-CA-C 112.633 0.605 . . . . 10.0 112.633 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 10.3 tmm? -52.24 -54.76 27.14 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.96 1.704 . . . . 10.0 111.903 172.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 61.4 tp -56.89 -48.94 77.0 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.994 1.718 . . . . 10.0 112.808 178.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 70.2 t80 -49.35 -53.79 20.53 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.131 0.972 . . . . 10.0 111.631 171.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 52.2 mt -54.05 -55.14 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 123.824 0.85 . . . . 10.0 110.774 177.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 19.4 mt -57.24 -35.37 69.62 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 118.055 -0.974 . . . . 10.0 113.461 177.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -57.26 -58.21 9.22 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 119.398 0.999 . . . . 10.0 113.036 172.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.42 -40.91 85.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-O 118.263 -0.875 . . . . 10.0 111.408 177.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 44.9 mt -56.8 -49.39 75.51 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 119.907 1.231 . . . . 10.0 112.148 171.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.423 ' HA ' ' HD2' ' A' ' 175' ' ' ARG . 11.9 t80 -76.95 -70.33 0.47 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 120.092 -1.63 . . . . 10.0 112.869 -175.248 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -73.78 -21.87 60.03 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.596 1.158 . . . . 10.0 113.454 -174.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -87.88 -79.07 1.26 Allowed Glycine 0 CA--C 1.527 0.784 0 C-N-CA 123.6 0.619 . . . . 10.0 113.532 171.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -53.59 -32.4 50.92 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 126.266 1.826 . . . . 10.0 113.08 -166.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.2 m -52.15 -56.44 14.54 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 113.996 1.109 . . . . 10.0 113.996 172.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.6 p -53.65 -50.57 65.47 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 122.126 0.965 . . . . 10.0 112.325 -177.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 47.6 tttm -57.11 -46.06 82.92 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.165 0.986 . . . . 10.0 112.118 173.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.86 -47.49 80.27 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 114.465 1.283 . . . . 10.0 114.465 174.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -56.41 -11.34 1.21 Allowed 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.097 1.759 . . . . 10.0 114.249 177.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.1 m -107.07 6.64 29.13 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.396 1.878 . . . . 10.0 114.891 -179.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 93.3 mmm -91.89 -92.69 0.15 Allowed 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 123.499 1.619 . . . . 10.0 114.132 -170.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -138.67 153.96 72.72 Favored Pre-proline 0 C--O 1.236 0.349 0 C-N-CA 129.807 3.243 . . . . 10.0 105.529 170.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -52.83 -46.22 35.19 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.305 2.003 . . . . 10.0 113.064 179.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . 0.461 ' CD ' ' HD3' ' A' ' 227' ' ' ARG . 0.1 OUTLIER -53.02 -46.04 68.24 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 129.006 2.922 . . . . 10.0 113.27 173.635 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 92.5 t -69.16 -53.09 27.51 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.215 0 C-N-CA 124.1 0.96 . . . . 10.0 109.798 -178.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.1 -46.89 75.56 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.273 0.629 . . . . 10.0 111.902 177.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 60.2 p -59.94 -56.21 24.54 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.932 0.893 . . . . 10.0 112.68 174.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 61.8 m -57.23 -53.16 61.22 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.169 0.988 . . . . 10.0 113.059 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -49.55 -49.47 46.13 Favored 'General case' 0 C--O 1.221 -0.438 0 C-N-CA 123.312 0.645 . . . . 10.0 111.132 174.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -57.19 -48.4 78.84 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 114.618 1.34 . . . . 10.0 114.618 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 40.5 t -56.03 -49.58 74.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-N 118.808 0.731 . . . . 10.0 110.462 176.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 93.9 mt -58.58 -51.6 69.21 Favored 'General case' 0 C--O 1.222 -0.394 0 N-CA-C 113.218 0.821 . . . . 10.0 113.218 175.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . 0.423 ' HD2' ' HA ' ' A' ' 153' ' ' PHE . 35.5 ttp180 -47.76 -47.79 30.38 Favored 'General case' 0 C--O 1.224 -0.265 0 C-N-CA 126.807 2.043 . . . . 10.0 111.078 174.411 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 63.7 m-20 -58.48 -58.35 8.94 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 122.794 0.438 . . . . 10.0 111.274 174.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 59.7 t -51.95 -48.81 39.82 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 C-N-CA 124.082 0.953 . . . . 10.0 111.457 179.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 28.8 m -57.25 -62.81 1.5 Allowed 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 128.129 2.572 . . . . 10.0 111.976 178.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 55.5 t -51.32 -50.17 28.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 C-N-CA 124.572 1.149 . . . . 10.0 111.079 -179.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 75.6 t -58.85 -60.6 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 124.053 0.941 . . . . 10.0 112.212 177.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -58.34 -48.47 80.45 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 118.663 0.665 . . . . 10.0 112.085 -177.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 9.0 m95 . . . . . 0 N--CA 1.468 0.458 0 C-N-CA 124.04 0.936 . . . . 10.0 112.759 177.302 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 86.9 t . . . . . 0 N--CA 1.478 0.947 0 CA-C-O 119.561 -0.257 . . . . 10.0 111.587 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 25.9 t90 -55.44 -53.22 58.96 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.895 1.278 . . . . 10.0 112.466 175.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 9.7 tt -56.45 -44.2 80.25 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.897 0.879 . . . . 10.0 112.675 -178.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 14.7 pt -84.61 -5.78 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 N-CA-C 115.069 1.507 . . . . 10.0 115.069 -178.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.32 -169.25 33.08 Favored Glycine 0 N--CA 1.45 -0.374 0 CA-C-O 122.522 1.068 . . . . 10.0 113.978 -168.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 23.2 t -53.2 -40.92 64.79 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 114.236 -0.982 . . . . 10.0 111.821 177.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -54.78 -31.64 59.08 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 128.472 2.709 . . . . 10.0 115.209 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -131.3 -103.89 0.97 Allowed Glycine 0 CA--C 1.529 0.943 0 CA-C-N 119.441 1.019 . . . . 10.0 113.58 -167.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -89.46 127.14 35.81 Favored 'General case' 0 C--N 1.329 -0.323 0 O-C-N 120.666 -1.491 . . . . 10.0 109.3 169.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -72.43 65.3 1.35 Allowed Glycine 0 CA--C 1.533 1.165 0 N-CA-C 113.91 0.324 . . . . 10.0 113.91 173.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 60.8 mt -79.58 -42.69 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 C-N-CA 126.031 1.732 . . . . 10.0 108.748 166.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 79.4 t -126.31 133.41 24.94 Favored Pre-proline 0 N--CA 1.455 -0.22 0 C-N-CA 126.413 1.885 . . . . 10.0 109.353 -174.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -68.72 153.83 72.46 Favored 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 123.791 2.994 . . . . 10.0 111.444 -176.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 12.2 tp -43.24 -39.73 3.12 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.399 1.08 . . . . 10.0 112.142 171.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -48.43 -52.32 22.63 Favored 'General case' 0 CA--C 1.539 0.519 0 N-CA-C 114.669 1.359 . . . . 10.0 114.669 176.08 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 14.0 mm -75.93 -40.55 38.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 124.422 1.089 . . . . 10.0 109.625 177.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -49.27 -49.84 41.68 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-O 121.446 0.641 . . . . 10.0 111.921 173.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 16.2 m -57.7 -47.0 83.61 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 126.047 1.739 . . . . 10.0 112.991 174.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -63.38 -52.33 62.12 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.966 0.906 . . . . 10.0 112.094 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 93.4 mt -52.54 -59.06 4.9 Favored 'General case' 0 C--O 1.228 -0.07 0 C-N-CA 124.321 1.048 . . . . 10.0 109.944 176.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -54.02 -41.84 68.46 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 117.938 -1.029 . . . . 10.0 113.235 176.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 4.6 tmm? -55.66 -53.05 61.27 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 120.265 1.393 . . . . 10.0 112.086 173.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 79.9 t -60.95 -45.6 98.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 124.783 1.233 . . . . 10.0 111.603 178.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 4.2 mp -59.58 -51.42 69.92 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.314 1.446 . . . . 10.0 112.003 175.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -57.75 -52.72 64.31 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.04 1.336 . . . . 10.0 111.431 176.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 39.2 t . . . . . 0 N--CA 1.479 0.992 0 C-N-CA 124.601 1.16 . . . . 10.0 111.553 172.965 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.287 0 CA-C-O 120.903 0.168 . . . . 10.0 112.96 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -45.6 -57.76 3.94 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 126.624 1.97 . . . . 10.0 112.539 170.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -56.99 -40.81 91.81 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 124.057 0.837 . . . . 10.0 113.857 178.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 24.4 mt -70.41 -27.12 64.04 Favored 'General case' 0 CA--C 1.513 -0.464 0 N-CA-C 115.649 1.722 . . . . 10.0 115.649 177.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 74.0 mt -63.34 -57.54 11.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 108.687 -0.857 . . . . 10.0 108.687 165.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 32.0 tp -58.77 -64.71 0.84 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.905 0.882 . . . . 10.0 113.187 -172.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 84.4 mt -71.53 5.16 2.52 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 115.27 1.582 . . . . 10.0 115.27 -171.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.6 mtp-105 -112.31 0.33 15.67 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.228 1.011 . . . . 10.0 113.242 172.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 8.8 t -108.06 177.98 4.65 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 124.038 0.935 . . . . 10.0 111.026 174.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 227' ' ' ARG . . . . . 0.461 ' HD3' ' CD ' ' A' ' 166' ' ' GLU . 41.8 ttt180 -71.65 98.19 1.86 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.732 0.813 . . . . 10.0 110.935 170.694 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -80.86 76.97 7.77 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.896 0.878 . . . . 10.0 112.128 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 40.12 102.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 128.857 2.863 . . . . 10.0 116.464 177.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . 0.483 0.3 OUTLIER 71.86 -55.51 0.66 Allowed 'General case' 0 C--O 1.242 0.662 0 C-N-CA 124.705 1.202 . . . . 10.0 110.631 -175.331 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -68.24 169.5 39.8 Favored Glycine 0 C--O 1.239 0.429 0 C-N-CA 129.757 3.551 . . . . 10.0 119.645 171.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.474 0 C-N-CA 128.49 2.716 . . . . 10.0 113.429 166.585 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 N--CA 1.476 0.87 0 CA-C-O 115.799 -2.048 . . . . 10.0 105.83 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 23.39 91.88 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 129.588 3.155 . . . . 10.0 117.203 160.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 28.63 65.04 0.11 Allowed 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 128.322 2.649 . . . . 10.0 114.48 155.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 86.6 mt -56.48 137.97 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 126.396 1.878 . . . . 10.0 113.315 -158.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.6 t -136.75 -165.26 1.71 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 126.327 1.851 . . . . 10.0 114.015 -174.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 70.06 2.78 41.34 Favored Glycine 0 C--N 1.34 0.762 0 C-N-CA 127.464 2.459 . . . . 10.0 111.485 168.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -158.52 -51.37 0.01 OUTLIER Pre-proline 0 N--CA 1.443 -0.783 0 CA-C-O 114.26 -2.781 . . . . 10.0 116.619 -168.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -63.94 -60.61 0.15 Allowed 'Trans proline' 0 N--CA 1.465 -0.202 0 CA-C-N 123.55 2.303 . . . . 10.0 113.25 -175.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 7.9 pm0 -67.25 4.3 0.99 Allowed 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 127.839 2.456 . . . . 10.0 115.755 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.422 ' CG ' ' N ' ' A' ' 11' ' ' ILE . 11.1 p-90 -51.36 -43.1 61.74 Favored 'General case' 0 C--O 1.222 -0.361 0 O-C-N 121.5 -0.75 . . . . 10.0 112.621 176.427 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.422 ' N ' ' CG ' ' A' ' 10' ' ' TRP . 8.9 tt -60.88 -49.56 84.14 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.34 0 C-N-CA 123.878 0.871 . . . . 10.0 109.336 179.407 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 2.6 m95 -55.44 -52.61 63.02 Favored 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 123.387 0.675 . . . . 10.0 111.887 175.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.6 mt -57.39 -53.53 57.06 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 123.153 0.581 . . . . 10.0 112.231 177.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.96 -46.75 52.69 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.378 1.471 . . . . 10.0 113.31 173.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 13.3 tp -65.6 -44.95 84.99 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 125.345 1.458 . . . . 10.0 113.029 179.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.54 -56.72 10.57 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 124.508 1.051 . . . . 10.0 111.441 166.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.5 m -49.6 -52.46 30.2 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.877 1.271 . . . . 10.0 112.186 174.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.43 -58.83 5.94 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.174 0.99 . . . . 10.0 112.198 177.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 93.5 mt -57.28 -49.06 77.29 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.686 0.794 . . . . 10.0 112.695 -179.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 45.6 mtt -59.02 -46.62 87.75 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.418 1.087 . . . . 10.0 111.388 177.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -58.35 -58.58 13.82 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 124.394 0.997 . . . . 10.0 113.98 173.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 80.7 mt -56.21 -45.87 79.71 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-N 118.596 1.198 . . . . 10.0 112.113 176.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.15 -40.66 84.21 Favored Glycine 0 CA--C 1.532 1.122 0 O-C-N 120.931 -1.106 . . . . 10.0 113.598 173.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 28.1 m -61.61 -58.92 6.2 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.486 0.714 . . . . 10.0 111.19 171.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -52.24 -41.01 62.42 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.073 0.949 . . . . 10.0 110.95 178.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -55.77 -58.05 9.45 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 124.599 1.159 . . . . 10.0 112.973 172.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.1 m-30 -59.62 -38.69 81.99 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 113.223 0.823 . . . . 10.0 113.223 178.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.468 ' C ' ' H ' ' A' ' 30' ' ' LYS . 11.8 mt -56.1 -67.43 0.3 Allowed 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.627 1.171 . . . . 10.0 113.637 169.099 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 t -76.37 40.92 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 CA-C-O 123.708 1.718 . . . . 10.0 110.852 179.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.468 ' H ' ' C ' ' A' ' 28' ' ' LEU . 42.9 tttm -140.84 -44.84 0.39 Allowed 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 127.883 2.473 . . . . 10.0 109.331 171.18 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.96 23.11 0.87 Allowed Glycine 0 CA--C 1.529 0.925 0 N-CA-C 115.629 1.012 . . . . 10.0 115.629 173.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 37.3 mmm -59.51 -45.0 92.98 Favored 'General case' 0 C--O 1.225 -0.235 0 C-N-CA 127.163 2.185 . . . . 10.0 113.596 -179.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.69 -84.42 1.19 Allowed Glycine 0 CA--C 1.53 1.007 0 C-N-CA 123.741 0.686 . . . . 10.0 112.483 -170.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.8 t 33.11 88.75 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.242 0.682 0 C-N-CA 128.399 2.68 . . . . 10.0 116.937 166.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.2 m -79.62 -50.91 9.96 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.152 -1.385 . . . . 10.0 113.855 174.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -48.87 117.51 6.37 Favored Pre-proline 0 CA--C 1.536 0.415 0 O-C-N 124.769 1.293 . . . . 10.0 110.988 -172.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -58.56 -29.68 89.65 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 123.746 2.964 . . . . 10.0 113.72 179.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.31 -60.67 2.28 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.126 0.57 . . . . 10.0 111.422 176.213 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.15 -40.05 22.64 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 125.104 1.362 . . . . 10.0 113.549 171.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -46.53 -47.47 19.54 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 125.252 1.421 . . . . 10.0 113.434 172.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -57.75 -53.06 62.43 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.438 0.695 . . . . 10.0 110.974 176.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -56.98 -50.23 73.32 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 123.044 0.538 . . . . 10.0 112.337 -179.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -54.35 -51.28 65.25 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 118.914 -0.565 . . . . 10.0 112.375 173.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.46 -61.95 1.95 Allowed 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 113.391 0.886 . . . . 10.0 113.391 177.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.3 mt -48.43 -57.76 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 C-N-CA 124.839 1.255 . . . . 10.0 110.408 178.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.3 m -68.57 -17.44 64.14 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.158 1.383 . . . . 10.0 113.724 -172.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 28.1 m -87.92 -39.63 14.6 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.45 1.1 . . . . 10.0 112.255 174.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 21.2 mt -59.19 -42.64 91.34 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 121.49 -0.756 . . . . 10.0 112.521 171.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 18.5 t -41.43 -63.84 0.75 Allowed Pre-proline 0 CA--C 1.551 0.993 0 C-N-CA 125.774 1.63 . . . . 10.0 113.491 175.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -70.22 -25.07 26.85 Favored 'Trans proline' 0 CA--C 1.544 1.017 0 C-N-CA 122.72 2.28 . . . . 10.0 114.182 176.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.5 -44.45 86.99 Favored 'General case' 0 CA--C 1.549 0.907 0 CA-C-N 120.683 1.583 . . . . 10.0 113.046 174.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 58.0 mt -54.66 -52.18 43.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 124.961 1.304 . . . . 10.0 108.998 168.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -53.14 -49.75 65.93 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.637 1.175 . . . . 10.0 112.789 176.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -50.42 -58.57 5.42 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.717 1.607 . . . . 10.0 112.574 173.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.3 m -49.38 -52.64 27.13 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.119 1.368 . . . . 10.0 110.66 178.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' MET . . . . . 0.407 ' HG3' ' CB ' ' A' ' 85' ' ' ASP . 32.8 mmt -69.41 -48.22 61.71 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 123.889 0.876 . . . . 10.0 112.82 -176.369 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -57.71 -39.29 76.88 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 116.567 -1.683 . . . . 10.0 113.111 173.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.7 tp -53.24 -54.62 33.47 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-N 120.623 1.556 . . . . 10.0 111.273 169.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 23.9 p -51.63 -41.05 61.01 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 115.257 1.577 . . . . 10.0 115.257 179.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 56.5 mtm -66.93 -50.8 61.23 Favored 'General case' 0 C--N 1.334 -0.09 0 C-N-CA 123.548 0.739 . . . . 10.0 110.485 176.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.3 tp -48.57 -52.7 21.49 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.858 0.863 . . . . 10.0 112.948 172.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.5 mt -76.86 -5.59 48.96 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 113.835 1.05 . . . . 10.0 113.835 -177.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.26 -34.72 5.54 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 115.583 0.993 . . . . 10.0 115.583 174.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -49.24 -43.13 42.52 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 115.243 1.571 . . . . 10.0 115.243 -176.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.01 3.48 61.22 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 115.329 0.892 . . . . 10.0 115.329 -178.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.25 143.41 26.44 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 127.034 2.133 . . . . 10.0 109.011 172.055 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 t -145.52 171.11 15.14 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 124.029 0.931 . . . . 10.0 111.011 166.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.95 136.06 53.39 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 123.924 0.89 . . . . 10.0 109.739 179.583 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 58.6 t -129.58 129.58 23.18 Favored Pre-proline 0 C--N 1.329 -0.295 0 C-N-CA 125.063 1.345 . . . . 10.0 110.935 -176.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -80.71 116.19 3.17 Favored 'Trans proline' 0 N--CA 1.452 -0.921 0 N-CA-C 109.443 -1.022 . . . . 10.0 109.443 -178.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -156.71 164.39 38.2 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 112.862 0.69 . . . . 10.0 112.862 172.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.39 -82.0 0.14 Allowed Glycine 0 CA--C 1.526 0.773 0 N-CA-C 110.683 -0.967 . . . . 10.0 110.683 175.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.76 -3.33 0.7 Allowed Glycine 0 CA--C 1.527 0.812 0 N-CA-C 118.641 2.216 . . . . 10.0 118.641 170.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -151.63 -171.89 4.06 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 119.379 1.59 . . . . 10.0 112.228 -165.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -91.86 93.9 9.05 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 125.521 1.528 . . . . 10.0 111.097 -175.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 60.3 m-80 -89.48 120.72 69.64 Favored Pre-proline 0 N--CA 1.45 -0.429 0 N-CA-C 112.965 0.728 . . . . 10.0 112.965 -165.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -61.53 131.94 38.26 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 124.183 3.255 . . . . 10.0 112.165 171.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.5 mm -140.09 126.3 21.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 C-N-CA 126.043 1.737 . . . . 10.0 111.732 -179.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -93.64 85.03 4.75 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 122.888 1.328 . . . . 10.0 113.053 174.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 63.6 p-90 -59.33 -28.3 66.69 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 113.911 1.078 . . . . 10.0 113.911 174.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -55.31 -35.93 65.65 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.286 1.035 . . . . 10.0 113.575 178.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 6.8 ptp180 -56.8 -40.44 75.97 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 120.209 1.368 . . . . 10.0 111.281 173.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -66.16 -43.73 86.12 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 113.887 1.069 . . . . 10.0 113.887 174.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -49.39 -47.19 47.9 Favored 'General case' 0 CA--C 1.555 1.165 0 C-N-CA 124.695 1.198 . . . . 10.0 111.002 167.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.407 ' CB ' ' HG3' ' A' ' 56' ' ' MET . 0.0 OUTLIER -61.71 -58.92 6.14 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 125.568 1.547 . . . . 10.0 112.938 173.331 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 46.9 m0 -51.82 -40.52 60.6 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 126.829 2.052 . . . . 10.0 112.777 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 27.8 tp -50.22 -45.79 54.14 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 125.944 1.697 . . . . 10.0 112.686 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -97.94 -46.86 5.76 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 123.735 0.814 . . . . 10.0 112.753 -176.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -58.8 -41.44 86.77 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.903 0.881 . . . . 10.0 112.801 -175.314 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.1 m -66.39 -47.66 58.54 Favored Pre-proline 0 CA--C 1.541 0.598 0 O-C-N 121.094 -1.004 . . . . 10.0 111.938 -174.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -51.93 -42.92 55.53 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 123.34 2.694 . . . . 10.0 115.145 166.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 53.0 mt -59.79 -48.17 82.76 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 118.877 0.762 . . . . 10.0 111.875 176.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 84.3 mt -53.77 -45.1 70.52 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.481 1.112 . . . . 10.0 112.136 172.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.6 mp -57.35 -47.86 80.52 Favored 'General case' 0 CA--C 1.546 0.796 0 O-C-N 120.97 -1.082 . . . . 10.0 112.574 169.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.87 -38.23 78.33 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 123.824 0.85 . . . . 10.0 112.877 178.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -52.28 -54.05 36.34 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 119.303 0.956 . . . . 10.0 111.215 169.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.36 -42.07 88.59 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.585 0.754 . . . . 10.0 112.119 -178.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.67 -54.75 37.61 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.972 0.909 . . . . 10.0 112.006 173.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.3 -41.16 79.34 Favored 'General case' 0 C--O 1.224 -0.237 0 C-N-CA 123.72 0.808 . . . . 10.0 112.702 174.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 32.0 tp -63.75 -38.56 91.58 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 114.445 1.276 . . . . 10.0 114.445 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.2 t -94.79 1.36 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 125.106 1.362 . . . . 10.0 112.309 179.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.2 t70 48.57 53.46 12.11 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.858 1.663 . . . . 10.0 112.139 -173.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.29 145.89 47.56 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 119.951 -1.718 . . . . 10.0 112.44 -174.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.44 135.87 54.08 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 112.759 0.651 . . . . 10.0 112.759 175.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -42.85 -39.65 2.6 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.844 1.658 . . . . 10.0 113.49 175.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -47.33 -60.23 5.32 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 125.15 1.357 . . . . 10.0 115.262 169.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.4 p -62.06 -46.77 87.65 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 117.1 -1.428 . . . . 10.0 111.332 178.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 66.9 mt -48.39 -52.92 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 125.001 1.321 . . . . 10.0 111.147 178.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.4 tp -62.66 -51.28 67.86 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 112.509 0.559 . . . . 10.0 112.509 179.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.15 -44.87 43.05 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.506 0.722 . . . . 10.0 110.967 174.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.6 -59.87 4.76 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 127.363 2.265 . . . . 10.0 114.839 174.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.4 t -60.97 -46.39 96.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 123.711 0.804 . . . . 10.0 111.373 -178.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -56.61 -50.3 64.02 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 123.662 0.649 . . . . 10.0 112.661 174.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -54.54 -46.5 73.61 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.569 0.747 . . . . 10.0 112.882 173.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -61.38 -40.62 95.0 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.887 0.875 . . . . 10.0 112.924 176.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -43.69 -59.38 3.75 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 125.995 1.76 . . . . 10.0 112.401 163.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 78.8 mt -56.66 -52.59 52.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 123.69 0.796 . . . . 10.0 110.925 175.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 46.4 ttp -46.33 -61.96 1.56 Allowed 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 126.022 1.729 . . . . 10.0 112.597 -174.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.472 0.654 0 CA-C-O 118.933 -0.556 . . . . 10.0 112.176 -177.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 61.9 t . . . . . 0 N--CA 1.478 0.94 0 N-CA-C 110.209 -0.293 . . . . 10.0 110.209 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -50.97 -61.28 6.27 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 126.18 1.848 . . . . 10.0 112.939 172.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -43.45 -41.53 4.35 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 127.993 2.517 . . . . 10.0 113.231 176.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 46.5 mt -99.92 -7.23 25.47 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 115.513 1.671 . . . . 10.0 115.513 -176.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 17.0 m -69.66 116.75 10.42 Favored 'General case' 0 N--CA 1.464 0.274 0 O-C-N 120.195 -1.566 . . . . 10.0 110.407 -178.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.552 ' HD3' ' H ' ' A' ' 129' ' ' LYS . 0.2 OUTLIER -55.5 -49.62 72.09 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 128.195 2.598 . . . . 10.0 113.288 177.758 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 60.1 t -69.58 106.32 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 123.789 0.836 . . . . 10.0 110.12 179.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -46.92 -59.49 3.06 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 124.761 1.224 . . . . 10.0 114.067 -173.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 m -46.5 -42.08 15.06 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.439 1.495 . . . . 10.0 113.512 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -70.16 -24.59 63.18 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 114.918 1.451 . . . . 10.0 114.918 -178.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 68.2 mtp85 -54.37 -41.18 68.86 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 118.876 0.762 . . . . 10.0 110.905 176.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -69.79 -31.75 69.85 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 114.34 1.237 . . . . 10.0 114.34 176.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.8 t -55.17 -52.23 46.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 CA-C-N 118.928 0.785 . . . . 10.0 109.82 168.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 65.0 m95 -59.48 -49.57 77.27 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 113.428 0.899 . . . . 10.0 113.428 173.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 83.0 t90 -48.37 -47.82 37.12 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 119.438 1.017 . . . . 10.0 113.31 173.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.595 0 C-N-CA 124.099 0.96 . . . . 10.0 111.993 176.812 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.782 0 N-CA-C 112.977 0.732 . . . . 10.0 112.977 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 42.8 ttp -57.75 -55.77 30.59 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.406 1.082 . . . . 10.0 111.969 173.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -49.79 -49.67 47.74 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.461 1.505 . . . . 10.0 110.781 177.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -51.77 -55.8 17.66 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 113.298 0.851 . . . . 10.0 113.298 173.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 49.9 mt -54.22 -54.69 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 123.598 0.759 . . . . 10.0 110.78 177.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 42.1 mt -57.14 -36.1 70.29 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 118.409 -0.805 . . . . 10.0 112.959 178.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -57.33 -58.11 9.67 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 124.026 0.93 . . . . 10.0 113.03 173.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.48 -40.89 85.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 CA-C-O 118.303 -0.855 . . . . 10.0 111.419 177.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 45.1 mt -56.83 -49.35 75.68 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 119.893 1.224 . . . . 10.0 112.115 171.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.424 ' HA ' ' HD2' ' A' ' 175' ' ' ARG . 11.9 t80 -77.03 -70.34 0.47 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 120.054 -1.654 . . . . 10.0 112.862 -175.254 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -73.73 -21.91 60.06 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.634 1.174 . . . . 10.0 113.439 -174.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -87.79 -79.08 1.26 Allowed Glycine 0 CA--C 1.527 0.783 0 C-N-CA 123.625 0.631 . . . . 10.0 113.534 171.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -53.68 -32.4 51.54 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 126.269 1.828 . . . . 10.0 113.046 -166.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.3 m -52.16 -56.39 14.85 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 113.989 1.107 . . . . 10.0 113.989 172.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.3 p -53.65 -50.63 65.33 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 122.092 0.949 . . . . 10.0 112.249 -177.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 47.6 tttm -57.11 -46.03 82.93 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.142 0.977 . . . . 10.0 112.122 173.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.8 -47.5 80.07 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 114.534 1.309 . . . . 10.0 114.534 174.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -56.45 -11.29 1.2 Allowed 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 126.054 1.741 . . . . 10.0 114.261 177.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.1 m -107.04 6.56 29.1 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 126.474 1.91 . . . . 10.0 114.896 -179.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 93.2 mmm -91.88 -92.66 0.15 Allowed 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 123.487 1.613 . . . . 10.0 114.171 -170.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -138.74 153.94 72.59 Favored Pre-proline 0 C--O 1.236 0.359 0 C-N-CA 129.802 3.241 . . . . 10.0 105.548 170.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -52.85 -46.22 35.27 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.346 2.031 . . . . 10.0 113.074 179.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . 0.462 ' CD ' ' HD3' ' A' ' 227' ' ' ARG . 0.1 OUTLIER -52.97 -46.09 68.06 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 128.979 2.912 . . . . 10.0 113.276 173.571 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 92.2 t -69.19 -52.99 27.97 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 C-N-CA 124.065 0.946 . . . . 10.0 109.8 -178.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.18 -46.82 75.81 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.319 0.648 . . . . 10.0 111.899 177.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 60.3 p -60.04 -56.17 24.98 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.876 0.87 . . . . 10.0 112.729 174.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 61.8 m -57.2 -53.17 61.13 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.184 0.994 . . . . 10.0 113.027 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -49.6 -49.49 46.55 Favored 'General case' 0 C--O 1.221 -0.414 0 C-N-CA 123.258 0.623 . . . . 10.0 111.114 174.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -57.16 -48.37 78.86 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 114.664 1.357 . . . . 10.0 114.664 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 40.4 t -56.01 -49.62 74.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 CA-C-N 118.832 0.742 . . . . 10.0 110.477 176.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 94.2 mt -58.6 -51.64 69.07 Favored 'General case' 0 C--O 1.222 -0.384 0 N-CA-C 113.141 0.793 . . . . 10.0 113.141 175.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . 0.424 ' HD2' ' HA ' ' A' ' 153' ' ' PHE . 35.5 ttp180 -47.7 -47.86 29.66 Favored 'General case' 0 C--O 1.225 -0.201 0 C-N-CA 126.852 2.061 . . . . 10.0 111.084 174.402 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 63.6 m-20 -58.48 -58.35 8.92 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 122.775 0.43 . . . . 10.0 111.234 174.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 54.6 t -51.77 -48.09 38.64 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 124.088 0.955 . . . . 10.0 111.858 179.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 28.5 m -58.19 -62.8 1.57 Allowed 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 127.959 2.503 . . . . 10.0 112.17 177.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 54.8 t -51.43 -49.18 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 124.686 1.194 . . . . 10.0 111.019 -179.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 70.9 t -59.76 -60.42 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 124.008 0.923 . . . . 10.0 112.374 177.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 77.5 mt -54.59 -52.9 60.7 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 118.414 0.552 . . . . 10.0 111.769 -178.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 9.9 m95 . . . . . 0 N--CA 1.464 0.268 0 C-N-CA 124.274 1.03 . . . . 10.0 112.35 177.944 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 58.4 t . . . . . 0 N--CA 1.475 0.821 0 CA-C-O 119.299 -0.381 . . . . 10.0 111.333 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 66.7 t90 -56.36 -54.6 43.64 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.11 0.964 . . . . 10.0 112.2 172.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 60.3 tp -52.29 -46.42 65.9 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.413 1.485 . . . . 10.0 112.29 -177.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 15.0 pt -86.09 -5.14 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 N-CA-C 115.333 1.605 . . . . 10.0 115.333 -177.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.59 -169.26 32.72 Favored Glycine 0 N--CA 1.45 -0.383 0 CA-C-O 122.57 1.095 . . . . 10.0 113.826 -168.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 23.3 t -53.12 -40.15 63.99 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 114.209 -0.996 . . . . 10.0 111.853 177.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -71.99 -13.74 61.7 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 115.357 1.614 . . . . 10.0 115.357 -174.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -130.49 -106.69 1.16 Allowed Glycine 0 CA--C 1.531 1.031 0 CA-C-N 120.218 1.372 . . . . 10.0 113.349 -174.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -89.48 127.14 35.82 Favored 'General case' 0 C--N 1.329 -0.313 0 O-C-N 120.673 -1.487 . . . . 10.0 109.352 169.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -72.43 65.33 1.35 Allowed Glycine 0 CA--C 1.532 1.127 0 N-CA-C 113.937 0.335 . . . . 10.0 113.937 173.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 60.8 mt -79.6 -42.74 23.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 126.044 1.737 . . . . 10.0 108.717 166.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 79.7 t -126.28 133.4 24.93 Favored Pre-proline 0 N--CA 1.454 -0.25 0 C-N-CA 126.467 1.907 . . . . 10.0 109.368 -174.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -68.74 153.78 72.5 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 123.811 3.007 . . . . 10.0 111.476 -176.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 12.2 tp -43.16 -39.8 3.02 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.359 1.064 . . . . 10.0 112.193 171.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -48.32 -52.41 21.66 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 114.68 1.363 . . . . 10.0 114.68 176.046 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 13.9 mm -75.91 -40.5 38.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 C-N-CA 124.401 1.08 . . . . 10.0 109.658 177.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -49.3 -49.81 42.15 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 118.593 0.633 . . . . 10.0 111.947 173.621 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 16.1 m -57.66 -47.07 83.31 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 126.083 1.753 . . . . 10.0 112.998 174.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -63.33 -52.34 62.23 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.95 0.9 . . . . 10.0 112.073 179.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 93.3 mt -52.55 -58.54 6.45 Favored 'General case' 0 C--O 1.228 -0.046 0 C-N-CA 124.32 1.048 . . . . 10.0 109.973 176.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -55.19 -44.62 75.45 Favored 'General case' 0 C--O 1.22 -0.475 0 CA-C-O 117.608 -1.187 . . . . 10.0 113.0 176.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 4.6 tmm? -51.48 -52.51 45.97 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 120.502 1.501 . . . . 10.0 112.581 173.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 79.9 t -61.06 -48.65 88.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 124.675 1.19 . . . . 10.0 111.773 178.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 5.3 mp -57.62 -53.26 60.2 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.472 1.509 . . . . 10.0 111.89 176.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -55.96 -54.95 38.59 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 126.753 2.021 . . . . 10.0 110.707 177.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 37.6 t . . . . . 0 N--CA 1.478 0.967 0 O-C-N 121.243 -0.911 . . . . 10.0 111.368 173.033 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.258 0 N-CA-C 111.876 -0.49 . . . . 10.0 111.876 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -44.19 -57.68 3.3 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.921 2.089 . . . . 10.0 112.111 166.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -55.03 -41.98 79.46 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 124.059 0.838 . . . . 10.0 113.979 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 24.0 mt -71.07 -27.16 63.43 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 115.637 1.718 . . . . 10.0 115.637 177.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 74.1 mt -63.22 -57.61 11.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 108.684 -0.858 . . . . 10.0 108.684 165.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 32.1 tp -58.82 -64.63 0.86 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.935 0.894 . . . . 10.0 113.183 -172.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 84.5 mt -71.64 5.25 2.55 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 115.27 1.582 . . . . 10.0 115.27 -171.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.7 mtp-105 -112.33 0.39 15.67 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.203 1.001 . . . . 10.0 113.292 172.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 8.8 t -108.06 177.97 4.65 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 124.06 0.944 . . . . 10.0 111.015 174.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 227' ' ' ARG . . . . . 0.462 ' HD3' ' CD ' ' A' ' 166' ' ' GLU . 41.7 ttt180 -71.63 98.15 1.85 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.795 0.838 . . . . 10.0 110.917 170.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -80.89 77.02 7.8 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.859 0.863 . . . . 10.0 112.116 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 40.11 102.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 128.833 2.853 . . . . 10.0 116.484 177.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . 0.481 0.3 OUTLIER 71.79 -55.39 0.66 Allowed 'General case' 0 C--O 1.242 0.685 0 C-N-CA 124.753 1.221 . . . . 10.0 110.68 -175.267 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -68.3 169.47 40.07 Favored Glycine 0 C--O 1.239 0.429 0 C-N-CA 129.735 3.541 . . . . 10.0 119.674 171.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.448 0 C-N-CA 128.491 2.716 . . . . 10.0 113.461 166.62 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 N--CA 1.477 0.876 0 CA-C-O 115.781 -2.057 . . . . 10.0 105.837 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 23.43 91.86 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 129.576 3.15 . . . . 10.0 117.262 160.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 28.59 65.12 0.1 Allowed 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 128.297 2.639 . . . . 10.0 114.458 155.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 86.7 mt -56.51 137.96 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 126.384 1.873 . . . . 10.0 113.343 -158.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.6 t -136.74 -165.19 1.69 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 126.353 1.861 . . . . 10.0 114.062 -174.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 70.02 2.75 40.86 Favored Glycine 0 C--N 1.339 0.743 0 C-N-CA 127.44 2.448 . . . . 10.0 111.453 168.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -158.57 -51.28 0.01 OUTLIER Pre-proline 0 N--CA 1.443 -0.805 0 CA-C-O 114.243 -2.789 . . . . 10.0 116.635 -168.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_exo -63.96 -60.62 0.15 Allowed 'Trans proline' 0 N--CA 1.465 -0.202 0 CA-C-N 123.576 2.313 . . . . 10.0 113.21 -175.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 7.9 pm0 -67.26 4.31 0.99 Allowed 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 127.831 2.452 . . . . 10.0 115.783 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.422 ' CG ' ' N ' ' A' ' 11' ' ' ILE . 11.0 p-90 -51.31 -43.17 61.63 Favored 'General case' 0 C--O 1.223 -0.34 0 O-C-N 121.5 -0.75 . . . . 10.0 112.615 176.423 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.422 ' N ' ' CG ' ' A' ' 10' ' ' TRP . 8.9 tt -60.83 -49.64 83.77 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.34 0 C-N-CA 123.885 0.874 . . . . 10.0 109.344 179.403 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 2.6 m95 -55.39 -52.58 63.08 Favored 'General case' 0 C--O 1.224 -0.259 0 C-N-CA 123.4 0.68 . . . . 10.0 111.88 175.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.2 mt -57.39 -53.63 55.96 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 123.219 0.608 . . . . 10.0 112.196 177.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.9 -46.74 52.14 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.366 1.466 . . . . 10.0 113.332 173.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 13.3 tp -65.71 -44.9 84.69 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 125.274 1.43 . . . . 10.0 113.013 179.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.94 -57.29 10.07 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 124.122 0.868 . . . . 10.0 111.16 166.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 22.5 m -48.38 -52.67 20.73 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.709 1.204 . . . . 10.0 112.347 174.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.39 -58.86 5.82 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.139 0.976 . . . . 10.0 112.188 177.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 94.3 mt -57.69 -50.23 73.88 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.696 0.799 . . . . 10.0 112.627 -179.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -53.73 -50.91 64.92 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.495 1.118 . . . . 10.0 111.395 175.066 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -57.95 -58.01 16.81 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 124.268 0.937 . . . . 10.0 113.579 176.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 81.2 mt -56.19 -45.83 79.63 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-N 118.527 1.164 . . . . 10.0 112.125 176.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.63 -41.95 75.66 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 124.854 1.216 . . . . 10.0 113.278 172.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 24.6 m -61.41 -59.5 5.16 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.984 0.913 . . . . 10.0 111.263 171.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -52.29 -40.92 62.43 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.028 0.931 . . . . 10.0 110.99 178.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -55.86 -57.98 9.78 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 124.619 1.168 . . . . 10.0 112.966 172.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -59.65 -38.75 82.26 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 113.193 0.812 . . . . 10.0 113.193 178.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.468 ' C ' ' H ' ' A' ' 30' ' ' LYS . 11.8 mt -56.08 -67.47 0.29 Allowed 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.58 1.152 . . . . 10.0 113.637 169.108 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 t -76.37 40.96 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 CA-C-O 123.802 1.763 . . . . 10.0 110.891 179.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.468 ' H ' ' C ' ' A' ' 28' ' ' LEU . 42.9 tttm -140.85 -44.82 0.39 Allowed 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 127.862 2.465 . . . . 10.0 109.317 171.12 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.9 23.1 0.86 Allowed Glycine 0 CA--C 1.529 0.908 0 N-CA-C 115.668 1.027 . . . . 10.0 115.668 173.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 37.4 mmm -59.54 -44.95 93.07 Favored 'General case' 0 C--O 1.225 -0.217 0 C-N-CA 127.19 2.196 . . . . 10.0 113.596 -178.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.74 -84.45 1.19 Allowed Glycine 0 CA--C 1.531 1.035 0 C-N-CA 123.798 0.713 . . . . 10.0 112.437 -170.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.7 t 33.06 88.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 128.358 2.663 . . . . 10.0 116.93 166.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.4 m -79.63 -50.86 10.04 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.155 -1.384 . . . . 10.0 113.879 174.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -48.95 117.46 6.39 Favored Pre-proline 0 CA--C 1.535 0.402 0 O-C-N 124.718 1.261 . . . . 10.0 110.982 -172.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -58.5 -29.68 89.44 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 123.779 2.986 . . . . 10.0 113.688 179.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.27 -60.71 2.26 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.148 0.579 . . . . 10.0 111.424 176.193 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.19 -40.05 22.94 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 125.085 1.354 . . . . 10.0 113.534 171.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -46.55 -47.45 19.65 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.21 1.404 . . . . 10.0 113.436 172.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -57.74 -53.1 61.99 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.479 0.712 . . . . 10.0 110.944 176.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -56.91 -50.28 73.02 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 123.119 0.568 . . . . 10.0 112.342 -179.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -54.34 -51.29 65.22 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 118.936 -0.554 . . . . 10.0 112.345 173.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.45 -61.99 1.92 Allowed 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 113.392 0.886 . . . . 10.0 113.392 177.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.5 mt -48.68 -56.27 2.47 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 C-N-CA 124.864 1.266 . . . . 10.0 110.64 177.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.6 m -70.17 -17.45 63.17 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.003 1.321 . . . . 10.0 113.646 -172.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 27.5 m -87.8 -37.34 16.67 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.194 0.998 . . . . 10.0 112.237 174.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 20.8 mt -60.4 -42.57 96.19 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 118.128 -0.939 . . . . 10.0 112.518 172.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . 0.349 33.2 m -52.53 -53.04 57.93 Favored Pre-proline 0 N--CA 1.487 1.386 0 CA-C-N 120.645 1.566 . . . . 10.0 115.049 -179.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -68.33 -25.11 36.52 Favored 'Trans proline' 0 CA--C 1.545 1.044 0 CA-C-N 123.02 2.114 . . . . 10.0 113.524 174.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -68.09 -45.83 72.65 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-N 120.5 1.5 . . . . 10.0 112.894 173.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 31.4 mm -54.07 -52.3 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 124.896 1.278 . . . . 10.0 109.525 168.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -52.9 -49.57 65.63 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.968 0.907 . . . . 10.0 113.04 174.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 52.3 t80 -51.78 -58.53 6.15 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.769 1.628 . . . . 10.0 112.19 175.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.1 m -49.01 -52.7 23.6 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.252 1.421 . . . . 10.0 110.629 178.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' MET . . . . . 0.418 ' HG3' ' CB ' ' A' ' 85' ' ' ASP . 32.8 mmt -69.42 -48.09 62.09 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 123.854 0.861 . . . . 10.0 112.899 -176.429 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -56.2 -40.98 74.86 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 120.321 1.419 . . . . 10.0 113.146 172.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.8 tp -53.27 -54.59 34.01 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-N 120.031 1.287 . . . . 10.0 111.292 170.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 24.0 p -51.68 -41.05 61.12 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 115.224 1.564 . . . . 10.0 115.224 178.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 57.8 mtm -66.82 -50.87 61.2 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 123.586 0.754 . . . . 10.0 110.527 176.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.4 tp -48.53 -52.67 21.46 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.857 0.863 . . . . 10.0 112.974 172.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.4 mt -76.97 -5.54 49.02 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 113.849 1.055 . . . . 10.0 113.849 -177.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.32 -34.71 5.55 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 115.55 0.98 . . . . 10.0 115.55 174.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -49.33 -43.05 43.39 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 115.235 1.568 . . . . 10.0 115.235 -175.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.05 3.58 61.04 Favored Glycine 0 CA--C 1.521 0.467 0 N-CA-C 115.358 0.903 . . . . 10.0 115.358 -179.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.3 143.41 26.43 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 127.035 2.134 . . . . 10.0 109.018 172.002 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 t -145.47 171.11 15.12 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 124.081 0.952 . . . . 10.0 111.062 166.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.04 136.07 53.37 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 123.919 0.888 . . . . 10.0 109.661 179.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 58.7 t -129.58 129.59 23.18 Favored Pre-proline 0 C--N 1.329 -0.313 0 C-N-CA 125.063 1.345 . . . . 10.0 110.96 -176.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -80.72 116.24 3.17 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 N-CA-C 109.406 -1.036 . . . . 10.0 109.406 -178.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -156.73 164.39 38.17 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 112.842 0.682 . . . . 10.0 112.842 172.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.36 -81.95 0.14 Allowed Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.693 -0.963 . . . . 10.0 110.693 175.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.77 -3.38 0.69 Allowed Glycine 0 CA--C 1.526 0.766 0 N-CA-C 118.642 2.217 . . . . 10.0 118.642 170.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -151.62 -171.87 4.05 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 119.379 1.59 . . . . 10.0 112.257 -165.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -91.89 93.9 9.04 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 125.534 1.533 . . . . 10.0 111.131 -175.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 60.4 m-80 -89.49 120.8 69.63 Favored Pre-proline 0 N--CA 1.45 -0.43 0 N-CA-C 112.933 0.716 . . . . 10.0 112.933 -165.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -61.52 131.94 38.31 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 124.205 3.27 . . . . 10.0 112.166 171.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.6 mm -140.18 126.32 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 C-N-CA 126.072 1.749 . . . . 10.0 111.712 -179.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -93.62 85.07 4.77 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 123.171 1.463 . . . . 10.0 113.041 174.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 63.7 p-90 -59.38 -28.32 66.79 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 120.729 -1.232 . . . . 10.0 113.873 174.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -54.51 -37.28 65.15 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 115.087 1.514 . . . . 10.0 115.087 178.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -59.66 -35.93 75.42 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 120.311 1.414 . . . . 10.0 112.488 172.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 -66.73 -42.91 85.52 Favored 'General case' 0 CA--C 1.545 0.752 0 O-C-N 120.997 -1.065 . . . . 10.0 112.876 173.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -49.47 -49.56 44.97 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 125.361 1.464 . . . . 10.0 111.321 166.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.418 ' CB ' ' HG3' ' A' ' 56' ' ' MET . 0.0 OUTLIER -59.46 -60.29 4.09 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.001 1.321 . . . . 10.0 112.533 173.385 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 51.8 m0 -54.82 -37.94 66.75 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 126.034 1.733 . . . . 10.0 113.161 -175.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 31.3 tp -49.84 -45.51 50.36 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 126.677 1.991 . . . . 10.0 111.86 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -97.33 -40.74 8.58 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 123.666 0.787 . . . . 10.0 112.502 -179.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -61.93 -44.98 95.64 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 113.275 0.843 . . . . 10.0 113.275 -175.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . 0.293 81.7 p -69.58 -39.19 11.34 Favored Pre-proline 0 CA--C 1.544 0.719 0 CA-C-O 117.601 -1.19 . . . . 10.0 114.032 -174.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -54.31 -44.66 47.34 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 123.722 2.948 . . . . 10.0 115.451 164.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 51.2 mt -59.17 -46.75 87.58 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 118.948 0.795 . . . . 10.0 111.434 175.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.4 tp -50.79 -47.9 59.61 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.563 1.545 . . . . 10.0 112.226 172.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.5 mp -59.86 -46.64 88.67 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.293 1.437 . . . . 10.0 112.832 170.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.81 -38.27 78.25 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 123.806 0.842 . . . . 10.0 112.866 178.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -52.26 -54.04 36.3 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 119.329 0.968 . . . . 10.0 111.21 169.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.36 -42.06 88.57 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.671 0.788 . . . . 10.0 112.119 -178.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.71 -54.77 37.54 Favored 'General case' 0 C--O 1.225 -0.186 0 C-N-CA 123.982 0.913 . . . . 10.0 111.999 173.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.27 -41.21 79.27 Favored 'General case' 0 C--O 1.224 -0.237 0 C-N-CA 123.72 0.808 . . . . 10.0 112.678 174.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.8 tp -63.74 -38.57 91.62 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 114.424 1.268 . . . . 10.0 114.424 -179.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.1 t -94.83 1.44 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 125.035 1.334 . . . . 10.0 112.308 179.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.2 t70 48.59 53.49 12.08 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.882 1.673 . . . . 10.0 112.1 -174.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.29 145.89 47.56 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 119.951 -1.718 . . . . 10.0 112.422 -174.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.5 135.91 54.29 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 112.694 0.627 . . . . 10.0 112.694 175.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -42.87 -39.68 2.62 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.863 1.665 . . . . 10.0 113.463 175.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -47.33 -60.17 5.36 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 125.133 1.349 . . . . 10.0 115.293 169.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.6 p -62.07 -46.77 87.66 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 117.098 -1.429 . . . . 10.0 111.356 178.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 66.9 mt -48.42 -52.89 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 124.979 1.312 . . . . 10.0 111.153 178.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.2 tp -62.66 -51.25 67.98 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 112.544 0.572 . . . . 10.0 112.544 179.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.19 -44.81 43.44 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.424 0.69 . . . . 10.0 110.983 174.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.56 -59.93 4.66 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 127.365 2.266 . . . . 10.0 114.838 174.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.6 t -60.99 -46.38 96.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 123.666 0.786 . . . . 10.0 111.37 -178.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -56.63 -50.26 64.35 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 123.659 0.647 . . . . 10.0 112.633 174.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -55.0 -46.62 75.18 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 113.451 0.908 . . . . 10.0 113.451 173.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -56.06 -47.14 78.49 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.466 0.706 . . . . 10.0 111.657 173.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -43.95 -54.23 6.09 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 124.88 1.229 . . . . 10.0 112.928 169.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 79.4 mt -58.22 -50.61 77.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 123.726 0.81 . . . . 10.0 111.979 173.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 53.1 ttp -49.05 -57.01 7.28 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.152 1.381 . . . . 10.0 112.061 179.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 36.5 mm . . . . . 0 N--CA 1.471 0.623 0 O-C-N 121.735 -0.603 . . . . 10.0 111.912 178.233 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 60.7 t . . . . . 0 N--CA 1.48 1.074 0 N-CA-C 111.61 0.226 . . . . 10.0 111.61 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -51.76 -59.59 8.44 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 125.893 1.711 . . . . 10.0 112.115 175.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -48.46 -37.9 18.49 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 127.027 2.131 . . . . 10.0 113.417 179.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 48.1 mt -99.4 -6.78 27.14 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 115.442 1.645 . . . . 10.0 115.442 -178.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 16.9 m -69.73 116.7 10.43 Favored 'General case' 0 N--CA 1.464 0.229 0 O-C-N 120.178 -1.576 . . . . 10.0 110.386 -178.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.551 ' HD3' ' H ' ' A' ' 129' ' ' LYS . 0.1 OUTLIER -55.4 -49.67 71.74 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 128.226 2.61 . . . . 10.0 113.299 177.751 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 60.6 t -69.61 106.31 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 C-N-CA 123.766 0.826 . . . . 10.0 110.141 179.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -46.87 -59.57 2.99 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 124.807 1.243 . . . . 10.0 114.048 -173.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 m -46.44 -42.11 14.86 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.478 1.511 . . . . 10.0 113.495 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -70.1 -24.68 63.25 Favored 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 114.958 1.466 . . . . 10.0 114.958 -178.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 69.5 mtp85 -53.76 -41.9 67.64 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 118.852 0.751 . . . . 10.0 110.814 176.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -69.43 -32.32 71.21 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.76 1.224 . . . . 10.0 114.233 176.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.8 t -55.12 -51.97 49.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-N 119.015 0.825 . . . . 10.0 109.932 169.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 69.3 m95 -59.51 -51.07 71.46 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 113.517 0.932 . . . . 10.0 113.517 174.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 86.5 t90 -48.79 -46.82 42.11 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.563 1.145 . . . . 10.0 113.494 174.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.622 0 C-N-CA 123.973 0.909 . . . . 10.0 111.683 175.796 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.815 0 N-CA-C 112.934 0.716 . . . . 10.0 112.934 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.4 -47.48 83.76 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 118.914 0.779 . . . . 10.0 111.955 175.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 61.6 tp -56.36 -49.39 74.56 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.202 1.401 . . . . 10.0 112.203 176.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 73.9 t80 -51.08 -54.25 26.67 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.97 0.908 . . . . 10.0 112.095 172.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 59.8 mt -54.07 -55.36 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 123.806 0.842 . . . . 10.0 110.662 177.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 21.8 mt -57.33 -35.35 69.76 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 118.009 -0.996 . . . . 10.0 113.067 178.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -57.31 -58.2 9.29 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 119.52 1.055 . . . . 10.0 113.011 173.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.41 -40.95 85.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-O 118.279 -0.867 . . . . 10.0 111.408 177.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 44.3 mt -56.77 -49.36 75.51 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 119.909 1.231 . . . . 10.0 112.148 171.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.424 ' HA ' ' HD2' ' A' ' 175' ' ' ARG . 11.8 t80 -77.05 -70.3 0.47 Allowed 'General case' 0 C--N 1.326 -0.447 0 O-C-N 120.056 -1.653 . . . . 10.0 112.848 -175.208 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -73.71 -21.94 60.07 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.612 1.165 . . . . 10.0 113.473 -174.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -87.85 -79.09 1.26 Allowed Glycine 0 CA--C 1.526 0.77 0 C-N-CA 123.588 0.613 . . . . 10.0 113.493 171.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -53.6 -32.48 51.28 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 126.305 1.842 . . . . 10.0 113.033 -166.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.0 m -52.03 -56.47 14.15 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 114.04 1.126 . . . . 10.0 114.04 172.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.5 p -53.68 -50.53 65.61 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 122.099 0.952 . . . . 10.0 112.308 -177.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 47.7 tttm -57.17 -45.97 83.21 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.166 0.986 . . . . 10.0 112.112 173.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.9 -47.42 80.57 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 114.497 1.295 . . . . 10.0 114.497 174.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -56.5 -11.23 1.19 Allowed 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 126.077 1.751 . . . . 10.0 114.271 177.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.1 m -107.16 6.64 28.96 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.424 1.89 . . . . 10.0 114.852 -179.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 93.3 mmm -91.89 -92.67 0.15 Allowed 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 123.475 1.607 . . . . 10.0 114.187 -170.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -138.69 153.99 72.72 Favored Pre-proline 0 C--O 1.236 0.359 0 C-N-CA 129.794 3.238 . . . . 10.0 105.56 170.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -52.85 -46.25 35.03 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.321 2.014 . . . . 10.0 113.078 179.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . 0.461 ' CD ' ' HD3' ' A' ' 227' ' ' ARG . 0.1 OUTLIER -52.98 -46.02 68.08 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 129.013 2.925 . . . . 10.0 113.276 173.573 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 92.2 t -69.25 -53.0 27.74 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.249 0 C-N-CA 124.071 0.949 . . . . 10.0 109.788 -178.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.13 -46.82 75.66 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.31 0.644 . . . . 10.0 111.947 177.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 60.0 p -59.97 -56.25 24.07 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.919 0.887 . . . . 10.0 112.708 174.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 61.5 m -57.15 -53.25 60.24 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.23 1.012 . . . . 10.0 112.995 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -49.53 -49.57 45.48 Favored 'General case' 0 C--O 1.222 -0.375 0 C-N-CA 123.252 0.621 . . . . 10.0 111.113 174.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -57.1 -48.4 78.7 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 114.703 1.371 . . . . 10.0 114.703 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 40.5 t -55.98 -49.59 74.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 CA-C-N 118.795 0.725 . . . . 10.0 110.496 176.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 94.3 mt -58.58 -51.64 69.04 Favored 'General case' 0 C--O 1.221 -0.441 0 N-CA-C 113.132 0.79 . . . . 10.0 113.132 175.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . 0.424 ' HD2' ' HA ' ' A' ' 153' ' ' PHE . 35.6 ttp180 -47.81 -47.8 30.92 Favored 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 126.846 2.059 . . . . 10.0 111.011 174.509 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 63.7 m-20 -58.48 -58.36 8.88 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 122.817 0.447 . . . . 10.0 111.277 174.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 60.0 t -51.78 -49.04 37.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 C-N-CA 124.075 0.95 . . . . 10.0 111.53 179.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 28.7 m -57.4 -62.51 1.73 Allowed 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 128.025 2.53 . . . . 10.0 112.007 178.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 54.3 t -51.55 -50.31 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 C-N-CA 124.491 1.116 . . . . 10.0 111.069 -179.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 73.6 t -58.05 -62.6 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 124.022 0.929 . . . . 10.0 111.482 177.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -56.99 -48.71 77.77 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 118.869 0.759 . . . . 10.0 112.468 -177.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 10.9 m95 . . . . . 0 N--CA 1.467 0.415 0 C-N-CA 123.94 0.896 . . . . 10.0 112.615 177.621 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 87.5 t . . . . . 0 N--CA 1.479 0.997 0 CA-C-O 119.5 -0.286 . . . . 10.0 111.374 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 26.5 t90 -55.7 -52.63 63.22 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.685 1.194 . . . . 10.0 112.388 174.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 34.6 tp -53.21 -45.49 68.64 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.778 1.231 . . . . 10.0 112.511 -179.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 14.7 pt -87.92 -5.41 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 N-CA-C 115.318 1.599 . . . . 10.0 115.318 -176.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.39 -169.23 32.98 Favored Glycine 0 N--CA 1.451 -0.341 0 CA-C-O 122.614 1.119 . . . . 10.0 113.875 -168.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 23.2 t -53.19 -40.86 64.73 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 114.153 -1.023 . . . . 10.0 111.83 177.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -53.97 -32.94 55.53 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 128.571 2.748 . . . . 10.0 115.262 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -130.85 -103.84 0.99 Allowed Glycine 0 CA--C 1.527 0.82 0 CA-C-N 119.324 0.965 . . . . 10.0 113.384 -167.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -89.49 127.14 35.82 Favored 'General case' 0 C--N 1.328 -0.33 0 O-C-N 120.624 -1.515 . . . . 10.0 109.308 169.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -72.41 65.27 1.35 Allowed Glycine 0 CA--C 1.532 1.105 0 N-CA-C 113.899 0.32 . . . . 10.0 113.899 173.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 60.7 mt -79.57 -42.73 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 C-N-CA 126.088 1.755 . . . . 10.0 108.748 166.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 79.2 t -126.27 133.4 24.92 Favored Pre-proline 0 N--CA 1.454 -0.264 0 C-N-CA 126.408 1.883 . . . . 10.0 109.364 -174.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -68.68 153.73 72.74 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 123.811 3.007 . . . . 10.0 111.471 -176.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 12.2 tp -43.08 -39.86 2.92 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.358 1.063 . . . . 10.0 112.199 171.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -48.28 -52.43 21.31 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 114.705 1.372 . . . . 10.0 114.705 176.052 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 14.0 mm -75.89 -40.55 38.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 124.39 1.076 . . . . 10.0 109.625 177.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -49.24 -49.85 41.29 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 118.596 0.635 . . . . 10.0 111.934 173.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 16.2 m -57.64 -47.1 83.17 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 126.046 1.738 . . . . 10.0 112.993 174.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -63.31 -52.34 62.31 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.947 0.899 . . . . 10.0 112.112 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 93.3 mt -52.52 -59.49 4.38 Favored 'General case' 0 CA--C 1.527 0.068 0 C-N-CA 124.321 1.048 . . . . 10.0 109.963 176.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -54.88 -42.14 71.73 Favored 'General case' 0 C--O 1.221 -0.442 0 CA-C-O 117.52 -1.229 . . . . 10.0 112.938 176.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 4.6 tmm? -53.65 -53.42 52.19 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 121.033 1.742 . . . . 10.0 112.341 173.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 79.1 t -60.55 -46.92 94.76 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 124.824 1.25 . . . . 10.0 111.674 178.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 4.3 mp -58.25 -53.19 61.08 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.368 1.467 . . . . 10.0 111.621 175.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -55.84 -53.38 57.44 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.562 1.545 . . . . 10.0 111.277 178.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 45.7 t . . . . . 0 N--CA 1.479 0.996 0 C-N-CA 124.883 1.273 . . . . 10.0 111.145 174.996 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.379 0 N-CA-C 112.832 -0.107 . . . . 10.0 112.832 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -43.24 -55.86 3.77 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.495 1.918 . . . . 10.0 112.483 167.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -59.16 -39.49 94.54 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 124.857 1.218 . . . . 10.0 113.266 179.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 24.6 mt -69.13 -27.82 65.91 Favored 'General case' 0 CA--C 1.512 -0.495 0 N-CA-C 115.742 1.756 . . . . 10.0 115.742 175.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 74.3 mt -63.37 -57.57 11.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 119.122 0.874 . . . . 10.0 108.648 165.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 32.0 tp -58.77 -64.68 0.84 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.877 0.871 . . . . 10.0 113.213 -172.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 84.0 mt -71.52 5.16 2.51 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 115.337 1.606 . . . . 10.0 115.337 -171.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.6 mtp-105 -112.35 0.44 15.67 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.139 0.976 . . . . 10.0 113.288 172.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 8.8 t -108.06 177.97 4.65 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 124.096 0.958 . . . . 10.0 111.025 174.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 227' ' ' ARG . . . . . 0.461 ' HD3' ' CD ' ' A' ' 166' ' ' GLU . 41.8 ttt180 -71.62 98.11 1.84 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.819 0.848 . . . . 10.0 110.969 170.637 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -80.91 77.03 7.83 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.859 0.864 . . . . 10.0 112.123 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 40.16 102.25 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 128.886 2.874 . . . . 10.0 116.446 177.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . 0.481 0.3 OUTLIER 71.85 -55.43 0.66 Allowed 'General case' 0 C--O 1.242 0.67 0 C-N-CA 124.711 1.205 . . . . 10.0 110.637 -175.318 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -68.28 169.47 40.01 Favored Glycine 0 C--O 1.239 0.417 0 C-N-CA 129.757 3.551 . . . . 10.0 119.653 171.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.461 0 C-N-CA 128.501 2.72 . . . . 10.0 113.462 166.617 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 N--CA 1.477 0.881 0 CA-C-O 115.768 -2.063 . . . . 10.0 105.842 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 23.35 91.83 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 129.598 3.159 . . . . 10.0 117.262 160.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 28.74 65.04 0.11 Allowed 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 128.265 2.626 . . . . 10.0 114.5 155.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 86.7 mt -56.51 138.0 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 126.353 1.861 . . . . 10.0 113.338 -158.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.6 t -136.79 -165.2 1.7 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 126.331 1.852 . . . . 10.0 114.015 -174.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 70.06 2.75 41.2 Favored Glycine 0 C--N 1.339 0.743 0 C-N-CA 127.458 2.456 . . . . 10.0 111.462 168.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -158.54 -51.29 0.01 OUTLIER Pre-proline 0 N--CA 1.443 -0.822 0 CA-C-O 114.267 -2.778 . . . . 10.0 116.694 -168.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -63.99 -60.63 0.15 Allowed 'Trans proline' 0 N--CA 1.465 -0.186 0 CA-C-N 123.502 2.286 . . . . 10.0 113.205 -175.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 7.9 pm0 -67.24 4.3 0.98 Allowed 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 127.844 2.458 . . . . 10.0 115.768 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.421 ' CG ' ' N ' ' A' ' 11' ' ' ILE . 11.1 p-90 -51.39 -43.07 61.8 Favored 'General case' 0 C--O 1.222 -0.361 0 O-C-N 121.496 -0.752 . . . . 10.0 112.594 176.481 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.421 ' N ' ' CG ' ' A' ' 10' ' ' TRP . 8.8 tt -60.91 -49.57 84.13 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.338 0 C-N-CA 123.884 0.874 . . . . 10.0 109.337 179.429 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 2.6 m95 -55.45 -52.64 62.96 Favored 'General case' 0 C--O 1.224 -0.259 0 C-N-CA 123.413 0.685 . . . . 10.0 111.819 175.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.9 mt -57.39 -53.58 56.56 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 123.184 0.594 . . . . 10.0 112.198 177.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.83 -46.82 51.63 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.39 1.476 . . . . 10.0 113.335 173.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 13.3 tp -65.67 -44.88 84.92 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.27 1.428 . . . . 10.0 113.059 179.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.4 -57.58 9.09 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 124.553 1.073 . . . . 10.0 111.045 165.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.0 m -48.91 -52.47 24.34 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.911 1.284 . . . . 10.0 112.333 175.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.4 -58.87 5.75 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.148 0.979 . . . . 10.0 112.155 177.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 96.5 mt -58.06 -49.08 78.16 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.651 0.781 . . . . 10.0 112.515 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 21.8 mmt -54.43 -51.59 64.45 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.811 0.845 . . . . 10.0 111.056 175.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -56.87 -58.48 14.31 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 124.584 1.088 . . . . 10.0 113.624 177.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 80.7 mt -56.18 -45.72 79.66 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-N 118.617 1.208 . . . . 10.0 112.107 176.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.79 -41.84 76.73 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 124.725 1.155 . . . . 10.0 113.374 172.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 19.1 m -60.43 -60.44 3.8 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.228 1.011 . . . . 10.0 111.083 171.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -52.34 -40.96 62.6 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.99 0.916 . . . . 10.0 110.925 179.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.4 t80 -55.82 -58.05 9.49 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.564 1.146 . . . . 10.0 112.943 172.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -59.59 -38.72 81.96 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 113.184 0.809 . . . . 10.0 113.184 178.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.469 ' C ' ' H ' ' A' ' 30' ' ' LYS . 11.8 mt -56.12 -67.47 0.29 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.656 1.182 . . . . 10.0 113.589 169.167 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 t -76.41 41.04 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 CA-C-O 123.775 1.75 . . . . 10.0 110.889 179.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.469 ' H ' ' C ' ' A' ' 28' ' ' LEU . 43.0 tttm -140.89 -44.83 0.39 Allowed 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 127.899 2.48 . . . . 10.0 109.337 171.166 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -73.0 23.15 0.88 Allowed Glycine 0 CA--C 1.528 0.898 0 N-CA-C 115.619 1.007 . . . . 10.0 115.619 173.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 37.4 mmm -59.51 -45.04 92.87 Favored 'General case' 0 C--O 1.224 -0.278 0 C-N-CA 127.189 2.196 . . . . 10.0 113.581 -179.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.65 -84.42 1.18 Allowed Glycine 0 CA--C 1.53 1.026 0 C-N-CA 123.743 0.687 . . . . 10.0 112.465 -170.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.8 t 33.06 88.78 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.242 0.682 0 C-N-CA 128.399 2.68 . . . . 10.0 116.905 166.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.4 m -79.63 -50.85 10.04 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.163 -1.38 . . . . 10.0 113.868 174.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -49.02 117.58 6.59 Favored Pre-proline 0 CA--C 1.536 0.418 0 O-C-N 124.767 1.292 . . . . 10.0 110.95 -172.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -58.62 -29.61 89.69 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 123.721 2.947 . . . . 10.0 113.688 179.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.32 -60.64 2.3 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.08 0.552 . . . . 10.0 111.436 176.179 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.12 -40.11 22.54 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 125.134 1.373 . . . . 10.0 113.58 171.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -46.5 -47.5 19.37 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.21 1.404 . . . . 10.0 113.425 172.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -57.73 -53.01 63.02 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.452 0.701 . . . . 10.0 111.036 176.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -56.98 -50.21 73.39 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 123.057 0.543 . . . . 10.0 112.348 -179.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -54.39 -51.27 65.36 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 118.966 -0.54 . . . . 10.0 112.369 173.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.39 -62.08 1.86 Allowed 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 113.353 0.871 . . . . 10.0 113.353 177.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.6 mt -48.62 -58.85 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 C-N-CA 124.862 1.265 . . . . 10.0 110.844 178.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 86.7 m -71.1 -13.67 62.04 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 114.128 1.159 . . . . 10.0 114.128 -173.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 29.3 m -85.26 -42.9 14.23 Favored 'General case' 0 N--CA 1.482 1.159 0 CA-C-N 120.422 1.465 . . . . 10.0 112.099 171.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 17.7 mt -56.31 -42.98 78.49 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 112.845 0.683 . . . . 10.0 112.845 174.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 37.7 t -48.76 -62.03 2.72 Favored Pre-proline 0 CA--C 1.551 1.001 0 C-N-CA 124.861 1.265 . . . . 10.0 112.728 178.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -49.92 -45.84 30.59 Favored 'Trans proline' 0 CA--C 1.543 0.934 0 C-N-CA 124.104 3.203 . . . . 10.0 115.846 164.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.0 -49.36 77.75 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 114.162 1.171 . . . . 10.0 114.162 -175.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . 0.274 16.1 tt -68.09 -36.08 74.03 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 O-C-N 120.598 -1.313 . . . . 10.0 111.421 173.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.65 -42.09 92.0 Favored 'General case' 0 CA--C 1.545 0.771 0 O-C-N 121.193 -0.942 . . . . 10.0 112.729 173.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -50.82 -56.05 13.99 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.541 1.537 . . . . 10.0 111.647 168.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 14.0 m -48.04 -53.37 16.56 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.653 1.581 . . . . 10.0 111.2 176.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 32.4 mmt -68.57 -48.25 64.69 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 123.966 0.907 . . . . 10.0 113.011 -176.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -56.06 -41.13 74.62 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 120.035 1.289 . . . . 10.0 113.342 173.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.8 tp -53.28 -54.6 33.96 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-N 119.54 1.064 . . . . 10.0 111.273 170.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 24.1 p -51.73 -41.0 61.2 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 115.217 1.562 . . . . 10.0 115.217 179.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 58.5 mtm -66.86 -50.89 61.08 Favored 'General case' 0 C--N 1.333 -0.122 0 C-N-CA 123.589 0.756 . . . . 10.0 110.491 176.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.4 tp -48.51 -52.73 21.05 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.849 0.86 . . . . 10.0 112.931 172.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.5 mt -76.89 -5.53 48.79 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 113.844 1.053 . . . . 10.0 113.844 -177.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.2 -34.63 5.61 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 115.579 0.992 . . . . 10.0 115.579 174.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -49.35 -43.05 43.56 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 115.273 1.583 . . . . 10.0 115.273 -176.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.04 3.55 61.07 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 115.314 0.885 . . . . 10.0 115.314 -179.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.28 143.42 26.42 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 127.035 2.134 . . . . 10.0 108.972 172.063 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 t -145.54 171.08 15.19 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 124.031 0.932 . . . . 10.0 111.052 166.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.95 136.1 53.36 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 123.922 0.889 . . . . 10.0 109.711 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 58.6 t -129.59 129.55 23.17 Favored Pre-proline 0 C--N 1.329 -0.315 0 C-N-CA 125.1 1.36 . . . . 10.0 110.935 -176.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -80.7 116.24 3.18 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 N-CA-C 109.441 -1.023 . . . . 10.0 109.441 -178.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -156.75 164.38 38.19 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.808 0.67 . . . . 10.0 112.808 172.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.4 -81.98 0.14 Allowed Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.681 -0.967 . . . . 10.0 110.681 175.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.76 -3.42 0.69 Allowed Glycine 0 CA--C 1.527 0.812 0 N-CA-C 118.627 2.211 . . . . 10.0 118.627 170.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -151.57 -171.89 4.06 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 119.379 1.59 . . . . 10.0 112.237 -165.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -91.79 93.81 9.04 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 125.552 1.541 . . . . 10.0 111.115 -175.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 60.2 m-80 -89.47 120.74 69.65 Favored Pre-proline 0 N--CA 1.45 -0.464 0 N-CA-C 113.002 0.741 . . . . 10.0 113.002 -165.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -61.49 131.9 38.2 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 124.183 3.255 . . . . 10.0 112.166 171.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.6 mm -140.1 126.35 22.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 C-N-CA 126.028 1.731 . . . . 10.0 111.707 -179.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -93.64 85.06 4.76 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 123.455 1.598 . . . . 10.0 113.051 174.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 63.8 p-90 -59.44 -28.21 66.75 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 120.453 -1.404 . . . . 10.0 113.942 174.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -54.68 -35.47 63.6 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.283 1.033 . . . . 10.0 113.595 178.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -63.79 -23.7 67.46 Favored 'General case' 0 N--CA 1.479 1.022 0 O-C-N 120.341 -1.474 . . . . 10.0 113.667 172.514 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 68.7 m-85 -78.46 -42.04 30.99 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 120.564 -1.335 . . . . 10.0 111.92 172.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -49.62 -49.62 46.21 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 125.164 1.385 . . . . 10.0 111.032 166.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -51.66 -69.45 0.11 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 126.769 2.027 . . . . 10.0 111.765 169.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 49.5 m0 -55.77 -35.6 66.41 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 124.407 1.083 . . . . 10.0 113.182 -172.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 28.7 tp -49.06 -46.08 43.9 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 126.277 1.831 . . . . 10.0 111.84 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -98.18 -40.35 8.42 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.805 0.842 . . . . 10.0 112.435 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 3.7 m -48.46 -57.83 5.54 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.864 1.266 . . . . 10.0 113.424 175.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . 0.286 38.3 p -67.08 -41.31 34.34 Favored Pre-proline 0 CA--C 1.544 0.736 0 CA-C-O 117.774 -1.108 . . . . 10.0 113.764 -168.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -54.14 -44.98 44.46 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 123.282 2.655 . . . . 10.0 115.998 166.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 54.5 mt -59.56 -45.73 90.96 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 118.959 0.799 . . . . 10.0 111.218 175.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.1 tp -50.94 -48.98 60.75 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.419 1.487 . . . . 10.0 112.136 172.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.0 mp -58.83 -47.15 85.85 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 125.339 1.456 . . . . 10.0 112.68 170.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.76 -38.31 78.18 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 123.87 0.868 . . . . 10.0 112.891 178.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 -52.27 -54.05 36.23 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 119.31 0.959 . . . . 10.0 111.165 169.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.34 -42.12 88.58 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.637 0.775 . . . . 10.0 112.1 -178.535 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.72 -54.66 39.0 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 123.991 0.916 . . . . 10.0 112.034 173.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.32 -41.18 79.44 Favored 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 123.724 0.81 . . . . 10.0 112.739 174.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.8 tp -63.77 -38.5 91.32 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 114.476 1.287 . . . . 10.0 114.476 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.2 t -94.84 1.44 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 125.075 1.35 . . . . 10.0 112.275 179.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.2 t70 48.5 53.55 11.89 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.874 1.67 . . . . 10.0 112.137 -173.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.28 145.89 47.57 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 120.002 -1.686 . . . . 10.0 112.46 -174.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.54 135.96 54.45 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 112.697 0.628 . . . . 10.0 112.697 175.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -42.88 -39.67 2.63 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.844 1.657 . . . . 10.0 113.489 175.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -47.33 -60.21 5.33 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 125.15 1.357 . . . . 10.0 115.234 169.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.4 p -62.06 -46.79 87.55 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 117.103 -1.427 . . . . 10.0 111.34 178.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 66.8 mt -48.41 -52.91 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 125.034 1.334 . . . . 10.0 111.127 178.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.2 tp -62.61 -51.3 67.86 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 112.574 0.583 . . . . 10.0 112.574 179.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.17 -44.85 43.27 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.465 0.706 . . . . 10.0 110.938 174.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.67 -59.83 4.81 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 127.344 2.257 . . . . 10.0 114.807 174.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.5 t -61.01 -46.37 96.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 123.705 0.802 . . . . 10.0 111.387 -178.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -56.59 -50.32 63.88 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 123.668 0.651 . . . . 10.0 112.664 174.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -54.9 -46.56 74.84 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 113.322 0.86 . . . . 10.0 113.322 173.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -55.36 -48.54 74.1 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.16 0.984 . . . . 10.0 111.276 173.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -43.02 -54.91 5.08 Favored Glycine 0 CA--C 1.533 1.213 0 C-N-CA 124.938 1.256 . . . . 10.0 113.267 169.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 82.5 mt -57.75 -52.3 59.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 123.694 0.798 . . . . 10.0 111.899 173.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 60.2 ttp -47.51 -58.09 4.63 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.312 1.445 . . . . 10.0 111.731 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 37.6 mm . . . . . 0 N--CA 1.474 0.727 0 O-C-N 121.807 -0.558 . . . . 10.0 112.169 178.796 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 65.5 t . . . . . 0 N--CA 1.476 0.838 0 N-CA-C 110.127 -0.323 . . . . 10.0 110.127 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -50.84 -60.76 6.68 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 126.227 1.87 . . . . 10.0 112.561 171.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -42.95 -42.21 3.66 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 127.488 2.315 . . . . 10.0 113.335 176.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 48.5 mt -100.9 -6.5 24.57 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 115.526 1.676 . . . . 10.0 115.526 -175.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 16.9 m -69.75 116.76 10.51 Favored 'General case' 0 N--CA 1.464 0.248 0 O-C-N 120.157 -1.589 . . . . 10.0 110.344 -178.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.553 ' HD3' ' H ' ' A' ' 129' ' ' LYS . 0.1 OUTLIER -55.46 -49.6 72.05 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 128.195 2.598 . . . . 10.0 113.287 177.748 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 61.3 t -69.74 106.34 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 123.774 0.83 . . . . 10.0 110.067 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -46.93 -59.5 3.05 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 124.737 1.215 . . . . 10.0 114.062 -173.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 m -46.46 -42.11 14.95 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.531 1.533 . . . . 10.0 113.49 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -70.17 -24.59 63.17 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 114.946 1.461 . . . . 10.0 114.946 -178.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 68.9 mtp85 -53.98 -41.74 68.21 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 118.914 0.779 . . . . 10.0 110.793 176.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -69.46 -32.08 70.77 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.813 1.245 . . . . 10.0 114.219 176.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.9 t -55.01 -51.85 49.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 CA-C-N 119.037 0.835 . . . . 10.0 109.654 168.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 67.4 m95 -61.64 -45.49 93.83 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 114.392 1.256 . . . . 10.0 114.392 175.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 88.1 t90 -51.66 -49.35 62.48 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.235 1.014 . . . . 10.0 112.71 172.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.614 0 C-N-CA 124.072 0.949 . . . . 10.0 112.03 177.073 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.818 0 N-CA-C 112.71 0.633 . . . . 10.0 112.71 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 40.3 ttp -56.16 -54.86 40.07 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.257 1.023 . . . . 10.0 112.09 172.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 8.1 tt -51.11 -50.57 58.54 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 125.941 1.697 . . . . 10.0 111.08 178.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 77.8 t80 -50.47 -54.91 18.51 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.169 0.988 . . . . 10.0 112.798 172.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 54.6 mt -53.6 -55.05 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 123.809 0.844 . . . . 10.0 110.775 177.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 44.4 mt -57.37 -35.88 70.53 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 118.349 -0.834 . . . . 10.0 112.957 178.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -57.26 -58.15 9.5 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 124.015 0.926 . . . . 10.0 113.041 173.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.44 -40.9 85.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-O 118.355 -0.831 . . . . 10.0 111.465 177.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 45.2 mt -56.79 -49.4 75.43 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 119.862 1.21 . . . . 10.0 112.131 171.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.423 ' HA ' ' HD2' ' A' ' 175' ' ' ARG . 11.9 t80 -77.01 -70.33 0.47 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 120.088 -1.632 . . . . 10.0 112.901 -175.29 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -73.66 -21.98 60.1 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.615 1.166 . . . . 10.0 113.431 -174.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -87.79 -79.12 1.26 Allowed Glycine 0 CA--C 1.527 0.783 0 C-N-CA 123.625 0.631 . . . . 10.0 113.496 171.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -53.63 -32.38 51.08 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 126.269 1.828 . . . . 10.0 113.067 -166.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.2 m -52.16 -56.44 14.57 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 114.01 1.115 . . . . 10.0 114.01 172.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.7 p -53.63 -50.61 65.34 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 122.087 0.946 . . . . 10.0 112.271 -177.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 47.7 tttm -57.09 -46.1 82.81 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.197 0.999 . . . . 10.0 112.107 173.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.76 -47.49 79.97 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 114.563 1.32 . . . . 10.0 114.563 174.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -56.47 -11.31 1.22 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 126.087 1.755 . . . . 10.0 114.261 177.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.2 m -107.09 6.67 29.11 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.374 1.87 . . . . 10.0 114.877 -179.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 93.3 mmm -91.92 -92.69 0.15 Allowed 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 123.451 1.596 . . . . 10.0 114.171 -170.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -138.63 153.96 72.79 Favored Pre-proline 0 C--O 1.236 0.349 0 C-N-CA 129.833 3.253 . . . . 10.0 105.573 170.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -52.85 -46.21 35.35 Favored 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 122.338 2.025 . . . . 10.0 113.083 179.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . 0.461 ' CD ' ' HD3' ' A' ' 227' ' ' ARG . 0.1 OUTLIER -52.99 -46.05 68.12 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 129.014 2.926 . . . . 10.0 113.266 173.577 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 91.5 t -69.26 -53.0 27.72 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 C-N-CA 124.006 0.922 . . . . 10.0 109.788 -178.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.07 -46.89 75.46 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.3 0.64 . . . . 10.0 111.923 177.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 59.9 p -59.99 -56.13 25.42 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.883 0.873 . . . . 10.0 112.742 174.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 61.8 m -57.23 -53.19 60.86 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.185 0.994 . . . . 10.0 113.011 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -49.61 -49.47 46.71 Favored 'General case' 0 C--O 1.222 -0.387 0 C-N-CA 123.324 0.65 . . . . 10.0 111.1 174.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -57.12 -48.46 78.6 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 114.671 1.36 . . . . 10.0 114.671 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 40.3 t -55.98 -49.54 74.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 CA-C-N 118.802 0.728 . . . . 10.0 110.541 176.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 93.8 mt -58.57 -51.65 69.01 Favored 'General case' 0 C--O 1.222 -0.39 0 N-CA-C 113.196 0.813 . . . . 10.0 113.196 175.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . 0.423 ' HD2' ' HA ' ' A' ' 153' ' ' PHE . 35.4 ttp180 -47.76 -47.76 30.33 Favored 'General case' 0 C--O 1.225 -0.201 0 C-N-CA 126.831 2.052 . . . . 10.0 111.095 174.405 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 63.8 m-20 -58.5 -58.4 8.71 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 122.836 0.454 . . . . 10.0 111.232 174.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 54.5 t -52.13 -46.77 44.03 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 124.067 0.947 . . . . 10.0 112.052 179.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 28.8 m -60.39 -61.79 2.34 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 127.818 2.447 . . . . 10.0 111.874 178.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 55.8 t -50.91 -50.42 23.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 124.667 1.187 . . . . 10.0 110.928 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 80.3 t -59.49 -63.01 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 124.047 0.939 . . . . 10.0 111.889 177.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 68.9 mt -53.29 -50.75 64.23 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 119.183 0.901 . . . . 10.0 112.144 -178.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 10.1 m95 . . . . . 0 N--CA 1.465 0.309 0 C-N-CA 124.116 0.966 . . . . 10.0 112.275 177.482 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 2.7 p . . . . . 0 N--CA 1.482 1.133 0 CA-C-O 118.861 -0.59 . . . . 10.0 112.083 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 59.8 t90 -56.73 -51.96 66.81 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.372 0.669 . . . . 10.0 112.422 173.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 25.8 tp -54.9 -44.95 74.6 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.49 1.116 . . . . 10.0 112.197 -178.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 14.6 pt -86.28 -5.5 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 N-CA-C 115.246 1.573 . . . . 10.0 115.246 -177.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.57 -169.26 32.74 Favored Glycine 0 N--CA 1.45 -0.383 0 CA-C-O 122.573 1.096 . . . . 10.0 113.83 -168.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 23.3 t -53.12 -41.65 65.25 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 114.203 -0.999 . . . . 10.0 111.858 177.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -66.9 -17.18 64.78 Favored 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 115.559 1.688 . . . . 10.0 115.559 -175.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -131.08 -105.87 1.08 Allowed Glycine 0 CA--C 1.532 1.106 0 CA-C-N 120.397 1.453 . . . . 10.0 113.914 -172.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -89.45 127.12 35.81 Favored 'General case' 0 C--N 1.328 -0.345 0 O-C-N 120.663 -1.492 . . . . 10.0 109.3 168.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -72.44 65.29 1.35 Allowed Glycine 0 CA--C 1.531 1.064 0 N-CA-C 113.925 0.33 . . . . 10.0 113.925 173.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 60.7 mt -79.56 -42.72 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 126.077 1.751 . . . . 10.0 108.725 166.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 79.8 t -126.32 133.41 24.94 Favored Pre-proline 0 N--CA 1.454 -0.25 0 C-N-CA 126.468 1.907 . . . . 10.0 109.368 -174.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -68.79 153.78 72.36 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 123.781 2.988 . . . . 10.0 111.461 -176.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 12.2 tp -43.14 -39.82 3.0 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.375 1.07 . . . . 10.0 112.17 171.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -48.33 -52.35 22.01 Favored 'General case' 0 CA--C 1.539 0.519 0 N-CA-C 114.728 1.381 . . . . 10.0 114.728 176.044 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 14.0 mm -75.98 -40.48 38.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 124.366 1.066 . . . . 10.0 109.625 177.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -49.26 -49.82 41.68 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 118.603 0.638 . . . . 10.0 111.981 173.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 16.2 m -57.74 -46.97 83.74 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 126.04 1.736 . . . . 10.0 112.964 174.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -63.4 -52.28 62.27 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.992 0.917 . . . . 10.0 112.101 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 93.2 mt -52.56 -59.17 4.78 Favored 'General case' 0 C--N 1.335 -0.044 0 C-N-CA 124.32 1.048 . . . . 10.0 110.003 176.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -52.29 -47.3 65.96 Favored 'General case' 0 C--O 1.217 -0.64 0 CA-C-O 117.425 -1.274 . . . . 10.0 112.164 176.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 4.6 tmm? -52.03 -51.7 55.73 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 121.073 1.76 . . . . 10.0 113.001 175.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 78.7 t -60.39 -50.0 82.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 124.646 1.178 . . . . 10.0 111.278 178.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 5.2 mp -57.52 -51.18 70.5 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.884 1.674 . . . . 10.0 112.044 175.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -56.96 -57.72 11.3 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 127.36 2.264 . . . . 10.0 110.706 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 97.3 t . . . . . 0 N--CA 1.478 0.952 0 O-C-N 121.001 -1.062 . . . . 10.0 111.417 177.802 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.281 0 CA-C-O 121.095 0.275 . . . . 10.0 113.118 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -45.45 -55.66 5.88 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.476 1.91 . . . . 10.0 112.27 166.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -55.58 -40.01 76.98 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 124.008 0.813 . . . . 10.0 113.754 178.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 24.9 mt -70.08 -27.41 64.59 Favored 'General case' 0 CA--C 1.512 -0.502 0 N-CA-C 115.833 1.79 . . . . 10.0 115.833 176.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 74.3 mt -63.49 -57.53 11.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 108.59 -0.893 . . . . 10.0 108.59 165.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 32.0 tp -58.77 -64.68 0.85 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.918 0.887 . . . . 10.0 113.206 -172.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 84.2 mt -71.53 5.19 2.51 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 115.304 1.594 . . . . 10.0 115.304 -171.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.6 mtp-105 -112.35 0.35 15.64 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.211 1.005 . . . . 10.0 113.303 172.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 8.8 t -108.03 177.94 4.66 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 124.058 0.943 . . . . 10.0 111.032 174.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 227' ' ' ARG . . . . . 0.461 ' HD3' ' CD ' ' A' ' 166' ' ' GLU . 41.8 ttt180 -71.59 98.15 1.83 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.732 0.813 . . . . 10.0 110.977 170.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -80.9 77.03 7.82 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.874 0.87 . . . . 10.0 112.095 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 40.19 102.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 128.866 2.866 . . . . 10.0 116.474 177.686 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . 0.481 0.3 OUTLIER 71.81 -55.41 0.66 Allowed 'General case' 0 C--O 1.243 0.714 0 C-N-CA 124.769 1.227 . . . . 10.0 110.603 -175.305 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -68.3 169.47 40.07 Favored Glycine 0 C--O 1.239 0.417 0 C-N-CA 129.76 3.552 . . . . 10.0 119.619 171.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.461 0 C-N-CA 128.476 2.711 . . . . 10.0 113.44 166.603 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 N--CA 1.477 0.881 0 CA-C-O 115.781 -2.057 . . . . 10.0 105.842 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 23.36 91.91 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 129.588 3.155 . . . . 10.0 117.227 160.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 28.6 65.03 0.11 Allowed 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 128.307 2.643 . . . . 10.0 114.529 155.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 86.5 mt -56.41 137.91 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 126.396 1.878 . . . . 10.0 113.372 -158.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.6 t -136.75 -165.2 1.7 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 126.327 1.851 . . . . 10.0 114.015 -174.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 70.0 2.83 41.1 Favored Glycine 0 C--N 1.339 0.743 0 C-N-CA 127.496 2.474 . . . . 10.0 111.485 168.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -158.55 -51.32 0.01 OUTLIER Pre-proline 0 N--CA 1.443 -0.783 0 CA-C-O 114.301 -2.761 . . . . 10.0 116.649 -168.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_exo -63.93 -60.72 0.14 Allowed 'Trans proline' 0 N--CA 1.465 -0.186 0 CA-C-N 123.538 2.299 . . . . 10.0 113.194 -175.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 7.9 pm0 -67.21 4.34 0.96 Allowed 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 127.886 2.475 . . . . 10.0 115.732 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.422 ' CG ' ' N ' ' A' ' 11' ' ' ILE . 11.0 p-90 -51.38 -43.12 61.8 Favored 'General case' 0 C--O 1.223 -0.315 0 O-C-N 121.509 -0.744 . . . . 10.0 112.618 176.389 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.422 ' N ' ' CG ' ' A' ' 10' ' ' TRP . 8.9 tt -60.87 -49.59 84.0 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.34 0 C-N-CA 123.872 0.869 . . . . 10.0 109.344 179.394 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 2.6 m95 -55.32 -52.69 62.65 Favored 'General case' 0 C--O 1.224 -0.259 0 C-N-CA 123.406 0.682 . . . . 10.0 111.877 175.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.4 mt -57.34 -53.64 55.79 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 123.188 0.595 . . . . 10.0 112.224 177.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.83 -46.81 51.61 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.353 1.461 . . . . 10.0 113.33 173.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 13.3 tp -65.63 -44.95 84.88 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.277 1.431 . . . . 10.0 113.059 179.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.5 -57.03 9.83 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 124.549 1.071 . . . . 10.0 111.274 165.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.1 m -49.26 -52.53 26.74 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.985 1.314 . . . . 10.0 112.232 174.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.44 -58.86 5.83 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.151 0.98 . . . . 10.0 112.161 177.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 99.6 mt -58.0 -49.07 78.11 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.471 0.709 . . . . 10.0 112.537 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 23.9 mmt -55.61 -49.22 73.38 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.858 0.863 . . . . 10.0 111.359 176.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -58.29 -58.43 14.61 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 124.388 0.994 . . . . 10.0 113.438 176.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 81.0 mt -56.24 -46.01 79.75 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-N 118.634 1.217 . . . . 10.0 112.132 176.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.73 -41.76 75.96 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 124.714 1.15 . . . . 10.0 113.242 173.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 28.2 m -62.38 -58.49 7.46 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.833 0.853 . . . . 10.0 111.347 172.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -52.27 -41.0 62.47 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.981 0.912 . . . . 10.0 110.977 177.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -55.75 -58.03 9.52 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 124.641 1.176 . . . . 10.0 112.967 172.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.1 m-30 -59.67 -38.7 82.19 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 113.223 0.823 . . . . 10.0 113.223 178.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.468 ' C ' ' H ' ' A' ' 30' ' ' LYS . 11.9 mt -56.04 -67.47 0.29 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.629 1.171 . . . . 10.0 113.65 169.104 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 t -76.34 40.89 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 CA-C-O 123.727 1.727 . . . . 10.0 110.866 179.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.468 ' H ' ' C ' ' A' ' 28' ' ' LEU . 42.8 tttm -140.8 -44.85 0.39 Allowed 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 127.915 2.486 . . . . 10.0 109.347 171.157 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.96 23.11 0.87 Allowed Glycine 0 CA--C 1.529 0.925 0 N-CA-C 115.629 1.012 . . . . 10.0 115.629 173.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 37.3 mmm -59.5 -45.0 92.96 Favored 'General case' 0 C--O 1.225 -0.211 0 C-N-CA 127.17 2.188 . . . . 10.0 113.571 -178.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.71 -84.41 1.19 Allowed Glycine 0 CA--C 1.531 1.045 0 C-N-CA 123.775 0.702 . . . . 10.0 112.446 -170.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.8 t 33.09 88.75 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.243 0.73 0 C-N-CA 128.399 2.68 . . . . 10.0 116.941 166.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.6 m -79.65 -50.92 9.93 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.23 -1.35 . . . . 10.0 113.828 174.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -48.87 117.51 6.37 Favored Pre-proline 0 CA--C 1.536 0.416 0 O-C-N 124.765 1.291 . . . . 10.0 110.972 -172.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -58.56 -29.68 89.64 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 123.757 2.971 . . . . 10.0 113.669 179.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.31 -60.66 2.29 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.126 0.57 . . . . 10.0 111.457 176.227 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.12 -40.08 22.45 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 125.134 1.373 . . . . 10.0 113.58 171.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -46.56 -47.42 19.71 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.22 1.408 . . . . 10.0 113.447 172.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -57.72 -53.1 62.01 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.5 0.72 . . . . 10.0 110.992 176.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -57.02 -50.21 73.42 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 123.084 0.554 . . . . 10.0 112.315 -179.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -54.3 -51.29 65.1 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 118.966 -0.54 . . . . 10.0 112.401 173.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.41 -62.01 1.91 Allowed 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 113.386 0.884 . . . . 10.0 113.386 177.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.4 mt -48.61 -57.76 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 124.867 1.267 . . . . 10.0 110.287 178.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.5 m -68.36 -17.74 64.31 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.114 1.365 . . . . 10.0 113.639 -172.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 27.4 m -87.12 -40.84 14.27 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 119.583 1.083 . . . . 10.0 112.137 174.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 22.0 mt -59.27 -40.98 87.77 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 121.359 -0.838 . . . . 10.0 112.835 171.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 22.7 t -43.9 -60.6 2.56 Favored Pre-proline 0 CA--C 1.549 0.941 0 C-N-CA 126.238 1.815 . . . . 10.0 113.395 176.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -72.27 -28.29 15.47 Favored 'Trans proline' 0 CA--C 1.546 1.108 0 C-N-CA 123.083 2.522 . . . . 10.0 114.182 172.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.98 -48.72 79.08 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 120.734 1.606 . . . . 10.0 113.927 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 19.5 tt -68.3 -36.16 73.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 O-C-N 120.249 -1.532 . . . . 10.0 111.376 173.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.29 -43.34 78.75 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 119.093 0.86 . . . . 10.0 112.74 171.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -50.96 -56.78 10.76 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.214 1.405 . . . . 10.0 111.68 168.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.7 m -47.88 -53.34 16.05 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 125.411 1.484 . . . . 10.0 111.18 176.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 32.7 mmt -69.09 -48.18 63.3 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 124.176 0.99 . . . . 10.0 112.871 -176.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -55.86 -41.38 74.27 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 120.203 1.365 . . . . 10.0 113.238 172.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.8 tp -53.31 -54.55 34.77 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-N 119.671 1.123 . . . . 10.0 111.301 170.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 24.0 p -51.65 -41.06 61.06 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 115.207 1.558 . . . . 10.0 115.207 179.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 56.9 mtm -66.86 -50.89 61.09 Favored 'General case' 0 C--N 1.334 -0.09 0 C-N-CA 123.597 0.759 . . . . 10.0 110.477 176.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.3 tp -48.62 -52.69 21.8 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.862 0.865 . . . . 10.0 112.904 172.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.4 mt -76.87 -5.53 48.77 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 113.848 1.055 . . . . 10.0 113.848 -177.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.24 -34.71 5.55 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 115.558 0.983 . . . . 10.0 115.558 174.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 75.3 t80 -49.28 -43.09 42.88 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 115.243 1.572 . . . . 10.0 115.243 -176.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.04 3.55 61.07 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 115.314 0.885 . . . . 10.0 115.314 -179.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.25 143.4 26.45 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 127.034 2.133 . . . . 10.0 109.031 172.015 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 t -145.51 171.09 15.17 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 124.081 0.952 . . . . 10.0 111.06 166.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.97 136.06 53.38 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 123.885 0.874 . . . . 10.0 109.722 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 58.5 t -129.56 129.64 23.19 Favored Pre-proline 0 C--N 1.33 -0.261 0 C-N-CA 125.043 1.337 . . . . 10.0 110.982 -176.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -80.76 116.24 3.16 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 N-CA-C 109.411 -1.034 . . . . 10.0 109.411 -178.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -156.71 164.41 38.17 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.808 0.669 . . . . 10.0 112.808 172.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.34 -81.92 0.14 Allowed Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.685 -0.966 . . . . 10.0 110.685 175.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.76 -3.37 0.69 Allowed Glycine 0 CA--C 1.527 0.822 0 N-CA-C 118.671 2.228 . . . . 10.0 118.671 170.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -151.6 -171.87 4.06 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 119.343 1.571 . . . . 10.0 112.187 -165.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -91.86 93.91 9.06 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 125.521 1.528 . . . . 10.0 111.097 -175.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 60.1 m-80 -89.47 120.74 69.65 Favored Pre-proline 0 C--N 1.326 -0.452 0 N-CA-C 113.001 0.741 . . . . 10.0 113.001 -165.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -61.47 131.93 38.37 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 124.16 3.24 . . . . 10.0 112.167 171.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.6 mm -140.13 126.33 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 C-N-CA 126.043 1.737 . . . . 10.0 111.682 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -93.61 85.02 4.76 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 123.316 1.531 . . . . 10.0 113.051 174.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 63.5 p-90 -59.32 -28.3 66.68 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 120.588 -1.32 . . . . 10.0 113.965 174.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -54.39 -35.88 63.33 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 114.152 1.167 . . . . 10.0 114.152 178.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 1.5 ptp180 -63.67 -25.84 68.39 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 120.419 -1.426 . . . . 10.0 113.926 174.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -76.96 -41.94 41.14 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 121.22 -0.925 . . . . 10.0 111.845 172.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -49.48 -48.62 47.68 Favored 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 125.192 1.397 . . . . 10.0 111.5 167.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -52.86 -69.77 0.11 Allowed 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 126.078 1.751 . . . . 10.0 111.671 168.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 53.4 m0 -56.8 -32.97 66.22 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 124.428 1.091 . . . . 10.0 113.042 -169.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 29.4 tp -48.74 -44.15 38.25 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 125.858 1.663 . . . . 10.0 111.721 176.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -99.44 -42.21 7.06 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.845 0.858 . . . . 10.0 112.402 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 76.8 p -61.72 -45.3 94.54 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 120.335 1.425 . . . . 10.0 113.913 -177.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . 0.325 74.8 p -60.66 -46.95 97.2 Favored Pre-proline 0 CA--C 1.546 0.826 0 CA-C-O 117.568 -1.206 . . . . 10.0 113.54 -178.367 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -54.65 -44.05 53.28 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 123.24 2.627 . . . . 10.0 115.725 169.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 51.1 mt -59.25 -45.75 90.35 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 121.433 -0.792 . . . . 10.0 111.398 175.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.8 tp -51.84 -48.88 63.77 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.437 1.495 . . . . 10.0 112.044 172.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.9 mp -57.81 -47.71 81.84 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.929 1.291 . . . . 10.0 112.392 170.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.87 -38.24 78.33 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 119.12 0.873 . . . . 10.0 112.891 179.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -52.28 -54.05 36.32 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 119.285 0.948 . . . . 10.0 111.165 169.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.34 -42.12 88.62 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.621 0.768 . . . . 10.0 112.151 -178.518 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.62 -54.73 37.68 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.958 0.903 . . . . 10.0 112.049 173.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.39 -41.15 79.69 Favored 'General case' 0 C--O 1.224 -0.237 0 C-N-CA 123.729 0.812 . . . . 10.0 112.667 174.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.9 tp -63.7 -38.61 91.75 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 114.481 1.289 . . . . 10.0 114.481 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.2 t -94.8 1.46 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 125.089 1.356 . . . . 10.0 112.304 179.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.3 t70 48.48 53.53 11.91 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.848 1.659 . . . . 10.0 112.137 -173.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.29 145.89 47.55 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 120.0 -1.688 . . . . 10.0 112.44 -174.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.47 135.89 54.17 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 112.711 0.634 . . . . 10.0 112.711 175.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -42.85 -39.69 2.61 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.857 1.663 . . . . 10.0 113.471 175.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -47.33 -60.25 5.3 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 125.15 1.357 . . . . 10.0 115.233 169.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.6 p -62.02 -46.72 87.95 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 117.103 -1.427 . . . . 10.0 111.351 178.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 66.9 mt -48.49 -52.87 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 124.998 1.319 . . . . 10.0 111.146 178.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.2 tp -62.63 -51.29 67.85 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 112.556 0.576 . . . . 10.0 112.556 179.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.14 -44.9 42.97 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.506 0.722 . . . . 10.0 110.934 174.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.61 -59.88 4.74 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 127.361 2.264 . . . . 10.0 114.778 175.005 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.7 t -60.97 -46.42 96.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 123.735 0.814 . . . . 10.0 111.398 -178.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -56.59 -50.32 63.86 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 123.641 0.639 . . . . 10.0 112.674 174.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -54.59 -46.72 73.81 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 113.261 0.837 . . . . 10.0 113.261 173.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 51.2 t0 -58.17 -45.27 87.81 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.597 0.759 . . . . 10.0 112.008 174.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -43.51 -55.74 5.14 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 125.114 1.34 . . . . 10.0 113.575 166.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 85.8 mt -55.45 -57.12 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 CA-C-O 118.438 -0.791 . . . . 10.0 110.631 173.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 48.1 ttp -44.93 -55.29 5.6 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.704 1.602 . . . . 10.0 113.28 -177.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 41.5 mm . . . . . 0 N--CA 1.474 0.735 0 O-C-N 121.703 -0.623 . . . . 10.0 111.716 177.303 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 67.6 t . . . . . 0 N--CA 1.477 0.877 0 N-CA-C 110.31 -0.256 . . . . 10.0 110.31 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -50.11 -60.87 6.23 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 126.086 1.803 . . . . 10.0 112.271 172.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -48.57 -37.66 18.53 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 126.427 1.891 . . . . 10.0 113.792 179.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 49.0 mt -99.22 -6.62 27.8 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 115.309 1.596 . . . . 10.0 115.309 -179.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 16.9 m -69.69 116.75 10.45 Favored 'General case' 0 N--CA 1.464 0.274 0 O-C-N 120.186 -1.571 . . . . 10.0 110.387 -178.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.552 ' HD3' ' H ' ' A' ' 129' ' ' LYS . 0.2 OUTLIER -55.48 -49.6 72.1 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 128.231 2.613 . . . . 10.0 113.251 177.747 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 61.1 t -69.72 106.42 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 123.746 0.818 . . . . 10.0 110.065 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -46.93 -59.57 3.01 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 124.779 1.231 . . . . 10.0 114.043 -173.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 m -46.43 -42.12 14.8 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.463 1.505 . . . . 10.0 113.485 179.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -70.15 -24.61 63.19 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 114.918 1.451 . . . . 10.0 114.918 -178.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 68.9 mtp85 -53.9 -41.67 67.86 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 118.93 0.786 . . . . 10.0 110.847 176.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -69.87 -31.61 69.53 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 114.354 1.242 . . . . 10.0 114.354 176.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.8 t -55.22 -52.23 47.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 CA-C-N 119.03 0.832 . . . . 10.0 109.543 168.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 66.1 m95 -61.72 -42.88 99.54 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 114.37 1.248 . . . . 10.0 114.37 174.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 88.9 t90 -52.78 -50.26 63.93 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.082 0.953 . . . . 10.0 112.415 171.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.532 0 C-N-CA 124.315 1.046 . . . . 10.0 111.737 178.308 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.806 0 N-CA-C 112.601 0.593 . . . . 10.0 112.601 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 38.4 ttp -55.23 -55.57 29.86 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.262 1.025 . . . . 10.0 112.163 171.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -51.71 -49.81 61.74 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.651 1.58 . . . . 10.0 111.213 179.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 77.8 t80 -50.22 -55.06 16.84 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.947 0.899 . . . . 10.0 112.687 172.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 55.6 mt -53.71 -55.09 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 123.871 0.868 . . . . 10.0 110.692 177.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 41.3 mt -57.32 -35.86 70.41 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 118.334 -0.841 . . . . 10.0 112.948 178.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -57.29 -58.19 9.32 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 124.051 0.941 . . . . 10.0 113.041 173.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.38 -40.9 85.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 CA-C-O 118.303 -0.855 . . . . 10.0 111.44 177.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 44.9 mt -56.84 -49.42 75.51 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 119.897 1.226 . . . . 10.0 112.107 171.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.423 ' HA ' ' HD2' ' A' ' 175' ' ' ARG . 12.0 t80 -77.01 -70.32 0.47 Allowed 'General case' 0 C--N 1.326 -0.447 0 O-C-N 120.022 -1.674 . . . . 10.0 112.852 -175.234 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -73.7 -21.93 60.09 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.654 1.182 . . . . 10.0 113.466 -174.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -87.84 -79.07 1.26 Allowed Glycine 0 CA--C 1.526 0.747 0 C-N-CA 123.579 0.609 . . . . 10.0 113.514 171.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -53.68 -32.42 51.63 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 126.275 1.83 . . . . 10.0 113.024 -166.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.2 m -52.02 -56.49 13.99 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 114.057 1.132 . . . . 10.0 114.057 172.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.5 p -53.71 -50.51 65.73 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 122.046 0.926 . . . . 10.0 112.295 -177.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 47.6 tttm -57.08 -46.04 82.83 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.173 0.989 . . . . 10.0 112.156 173.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.87 -47.46 80.4 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 114.512 1.301 . . . . 10.0 114.512 174.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -56.47 -11.3 1.21 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 126.087 1.755 . . . . 10.0 114.252 177.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.1 m -107.03 6.61 29.18 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.424 1.89 . . . . 10.0 114.903 -179.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 93.3 mmm -91.91 -92.6 0.15 Allowed 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 123.487 1.613 . . . . 10.0 114.164 -170.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -138.71 153.94 72.64 Favored Pre-proline 0 C--O 1.235 0.308 0 C-N-CA 129.802 3.241 . . . . 10.0 105.527 170.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -52.83 -46.25 34.97 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.267 1.978 . . . . 10.0 113.074 179.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . 0.462 ' CD ' ' HD3' ' A' ' 227' ' ' ARG . 0.1 OUTLIER -52.89 -46.08 67.8 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 129.021 2.929 . . . . 10.0 113.291 173.556 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 92.0 t -69.22 -53.04 27.62 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 C-N-CA 124.05 0.94 . . . . 10.0 109.8 -178.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.1 -46.83 75.55 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.282 0.633 . . . . 10.0 111.959 177.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 60.3 p -60.02 -56.2 24.54 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.922 0.889 . . . . 10.0 112.692 174.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 61.5 m -57.18 -53.2 60.76 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.155 0.982 . . . . 10.0 113.036 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -49.58 -49.48 46.33 Favored 'General case' 0 C--O 1.222 -0.375 0 C-N-CA 123.247 0.619 . . . . 10.0 111.132 174.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -57.15 -48.39 78.82 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 114.702 1.371 . . . . 10.0 114.702 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 40.5 t -56.01 -49.59 74.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 CA-C-N 118.749 0.704 . . . . 10.0 110.462 176.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 94.1 mt -58.63 -51.59 69.28 Favored 'General case' 0 C--O 1.222 -0.389 0 N-CA-C 113.191 0.811 . . . . 10.0 113.191 175.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . 0.423 ' HD2' ' HA ' ' A' ' 153' ' ' PHE . 35.5 ttp180 -47.75 -47.79 30.26 Favored 'General case' 0 C--O 1.225 -0.201 0 C-N-CA 126.852 2.061 . . . . 10.0 111.062 174.402 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 63.6 m-20 -58.51 -58.36 8.89 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 122.782 0.433 . . . . 10.0 111.272 174.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 54.9 t -52.19 -46.71 44.59 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 124.039 0.936 . . . . 10.0 112.044 179.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 32.1 m -60.19 -61.66 2.44 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 128.081 2.552 . . . . 10.0 111.902 178.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 56.0 t -51.43 -50.23 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 C-N-CA 124.575 1.15 . . . . 10.0 111.045 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 76.8 t -59.23 -60.06 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 124.069 0.948 . . . . 10.0 112.168 177.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 73.4 mt -56.9 -51.65 68.25 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 118.701 0.682 . . . . 10.0 112.301 -178.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 10.6 m95 . . . . . 0 N--CA 1.467 0.417 0 C-N-CA 123.959 0.904 . . . . 10.0 111.764 178.272 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 17.1 m . . . . . 0 N--CA 1.475 0.812 0 N-CA-C 112.716 0.636 . . . . 10.0 112.716 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 44.5 t90 -59.81 -55.93 28.11 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 125.191 1.396 . . . . 10.0 112.117 168.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 9.6 tt -56.49 -41.94 77.46 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.813 0.845 . . . . 10.0 112.601 -177.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 14.8 pt -82.44 -5.66 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 N-CA-C 115.151 1.537 . . . . 10.0 115.151 178.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.31 -169.29 33.1 Favored Glycine 0 N--CA 1.45 -0.404 0 CA-C-O 122.577 1.098 . . . . 10.0 113.921 -168.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 23.3 t -53.16 -40.68 64.5 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 114.197 -1.001 . . . . 10.0 111.897 177.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -55.01 -31.8 61.32 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 128.387 2.675 . . . . 10.0 115.385 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -131.06 -103.87 0.98 Allowed Glycine 0 CA--C 1.527 0.842 0 CA-C-N 119.324 0.966 . . . . 10.0 113.41 -167.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -89.41 127.12 35.79 Favored 'General case' 0 C--N 1.328 -0.352 0 O-C-N 120.621 -1.517 . . . . 10.0 109.364 169.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -72.48 65.36 1.36 Allowed Glycine 0 CA--C 1.532 1.141 0 N-CA-C 113.871 0.308 . . . . 10.0 113.871 173.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 60.6 mt -79.6 -42.71 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 126.053 1.741 . . . . 10.0 108.729 166.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 79.4 t -126.27 133.39 24.92 Favored Pre-proline 0 N--CA 1.454 -0.264 0 C-N-CA 126.502 1.921 . . . . 10.0 109.385 -174.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -68.79 153.78 72.36 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 123.781 2.988 . . . . 10.0 111.437 -176.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 12.2 tp -43.17 -39.77 3.03 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.281 1.033 . . . . 10.0 112.193 171.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -48.36 -52.38 21.99 Favored 'General case' 0 CA--C 1.539 0.519 0 N-CA-C 114.673 1.361 . . . . 10.0 114.673 176.08 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 13.9 mm -75.9 -40.5 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 C-N-CA 124.435 1.094 . . . . 10.0 109.692 177.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -49.3 -49.81 42.15 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 118.553 0.615 . . . . 10.0 111.925 173.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 16.3 m -57.72 -47.01 83.62 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 126.043 1.737 . . . . 10.0 112.96 174.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -63.33 -52.39 62.05 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.977 0.911 . . . . 10.0 112.072 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 93.1 mt -52.52 -58.74 5.81 Favored 'General case' 0 C--O 1.227 -0.088 0 C-N-CA 124.294 1.038 . . . . 10.0 110.02 176.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -52.45 -46.79 66.62 Favored 'General case' 0 C--O 1.221 -0.439 0 CA-C-O 117.805 -1.093 . . . . 10.0 112.393 176.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 4.6 tmm? -52.32 -52.0 55.6 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 120.404 1.457 . . . . 10.0 112.743 175.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 85.7 t -61.69 -46.56 96.28 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 124.782 1.233 . . . . 10.0 111.747 178.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 4.2 mp -59.95 -52.41 65.54 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 125.463 1.505 . . . . 10.0 111.989 175.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 -55.68 -57.33 12.43 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 126.36 1.864 . . . . 10.0 110.917 178.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 8.6 p . . . . . 0 N--CA 1.476 0.859 0 O-C-N 120.918 -1.114 . . . . 10.0 112.524 179.878 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.278 0 CA-C-O 121.06 0.255 . . . . 10.0 113.09 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 42.0 t80 -46.68 -56.73 5.68 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.351 1.86 . . . . 10.0 112.322 168.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -56.23 -39.44 81.63 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 124.011 0.815 . . . . 10.0 113.465 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 24.5 mt -70.51 -27.59 64.3 Favored 'General case' 0 CA--C 1.511 -0.523 0 N-CA-C 115.736 1.754 . . . . 10.0 115.736 176.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 74.4 mt -63.48 -57.48 11.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 119.274 0.943 . . . . 10.0 108.548 165.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 32.1 tp -58.86 -64.71 0.84 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.923 0.889 . . . . 10.0 113.17 -172.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 84.2 mt -71.51 5.17 2.5 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 115.313 1.597 . . . . 10.0 115.313 -171.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.6 mtp-105 -112.33 0.44 15.69 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.171 0.988 . . . . 10.0 113.319 172.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 8.8 t -108.03 177.91 4.67 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 124.092 0.957 . . . . 10.0 111.046 174.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 227' ' ' ARG . . . . . 0.462 ' HD3' ' CD ' ' A' ' 166' ' ' GLU . 41.7 ttt180 -71.59 98.15 1.83 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.765 0.826 . . . . 10.0 110.947 170.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -80.86 77.0 7.78 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.874 0.87 . . . . 10.0 112.08 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 40.18 102.24 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 128.896 2.878 . . . . 10.0 116.466 177.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . 0.481 0.3 OUTLIER 71.85 -55.43 0.66 Allowed 'General case' 0 C--O 1.241 0.647 0 C-N-CA 124.722 1.209 . . . . 10.0 110.656 -175.295 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -68.29 169.47 40.06 Favored Glycine 0 C--O 1.239 0.417 0 C-N-CA 129.73 3.538 . . . . 10.0 119.666 171.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.461 0 C-N-CA 128.441 2.696 . . . . 10.0 113.407 166.609 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 N--CA 1.477 0.913 0 CA-C-O 115.78 -2.057 . . . . 10.0 105.808 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 23.33 91.84 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 129.598 3.159 . . . . 10.0 117.286 160.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 28.68 65.05 0.11 Allowed 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 128.324 2.65 . . . . 10.0 114.468 155.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 86.4 mt -56.44 137.94 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 126.41 1.884 . . . . 10.0 113.344 -158.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.6 t -136.78 -165.21 1.7 Allowed 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 126.284 1.834 . . . . 10.0 113.991 -174.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 70.04 2.8 41.3 Favored Glycine 0 C--N 1.34 0.768 0 C-N-CA 127.475 2.464 . . . . 10.0 111.453 168.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -158.59 -51.29 0.01 OUTLIER Pre-proline 0 N--CA 1.443 -0.794 0 CA-C-O 114.301 -2.761 . . . . 10.0 116.698 -168.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -64.02 -60.58 0.15 Allowed 'Trans proline' 0 CA--C 1.528 0.179 0 CA-C-N 123.504 2.287 . . . . 10.0 113.207 -175.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 7.9 pm0 -67.22 4.27 0.98 Allowed 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 127.86 2.464 . . . . 10.0 115.765 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.421 ' CG ' ' N ' ' A' ' 11' ' ' ILE . 11.0 p-90 -51.34 -43.08 61.67 Favored 'General case' 0 C--O 1.223 -0.337 0 O-C-N 121.487 -0.758 . . . . 10.0 112.646 176.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.421 ' N ' ' CG ' ' A' ' 10' ' ' TRP . 8.9 tt -60.9 -49.64 83.82 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.338 0 C-N-CA 123.902 0.881 . . . . 10.0 109.287 179.415 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 2.6 m95 -55.33 -52.7 62.63 Favored 'General case' 0 C--O 1.224 -0.261 0 C-N-CA 123.428 0.691 . . . . 10.0 111.861 175.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.5 mt -57.37 -53.53 57.05 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 123.138 0.575 . . . . 10.0 112.27 177.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.92 -46.78 52.3 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.366 1.466 . . . . 10.0 113.332 173.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 13.3 tp -65.67 -44.94 84.72 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.304 1.442 . . . . 10.0 113.009 179.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.55 -56.57 10.92 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 124.419 1.009 . . . . 10.0 111.55 166.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.2 m -49.62 -52.44 30.52 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.898 1.279 . . . . 10.0 112.246 174.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.45 -58.89 5.69 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.163 0.985 . . . . 10.0 112.138 177.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 93.1 mt -57.12 -48.55 78.37 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.606 0.762 . . . . 10.0 112.851 -179.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 49.0 mtt -60.43 -45.77 92.45 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.148 0.979 . . . . 10.0 111.503 178.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -58.22 -58.68 13.28 Favored Glycine 0 CA--C 1.53 0.998 0 CA-C-O 118.937 -0.924 . . . . 10.0 113.872 172.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 80.8 mt -56.24 -45.86 79.83 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-N 118.714 1.257 . . . . 10.0 112.089 176.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.66 -42.19 76.64 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 124.46 1.029 . . . . 10.0 113.581 172.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 30.3 m -62.12 -58.4 7.95 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 118.329 -0.843 . . . . 10.0 111.113 172.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -52.3 -40.93 62.46 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.051 0.94 . . . . 10.0 110.95 177.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -55.83 -58.01 9.65 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.573 1.149 . . . . 10.0 112.993 172.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.1 m-30 -59.69 -38.58 81.96 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 113.252 0.834 . . . . 10.0 113.252 178.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.469 ' C ' ' H ' ' A' ' 30' ' ' LYS . 11.8 mt -56.13 -67.48 0.29 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.628 1.171 . . . . 10.0 113.589 169.092 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 t -76.36 40.95 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 CA-C-O 123.705 1.717 . . . . 10.0 110.83 179.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.469 ' H ' ' C ' ' A' ' 28' ' ' LEU . 42.9 tttm -140.86 -44.78 0.39 Allowed 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 127.89 2.476 . . . . 10.0 109.379 171.13 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.99 23.12 0.88 Allowed Glycine 0 CA--C 1.529 0.928 0 N-CA-C 115.596 0.998 . . . . 10.0 115.596 173.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 37.3 mmm -59.52 -44.98 93.01 Favored 'General case' 0 C--O 1.224 -0.277 0 C-N-CA 127.189 2.196 . . . . 10.0 113.587 -179.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.71 -84.41 1.19 Allowed Glycine 0 CA--C 1.53 0.989 0 C-N-CA 123.766 0.698 . . . . 10.0 112.471 -170.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.8 t 33.03 88.78 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.242 0.706 0 C-N-CA 128.434 2.694 . . . . 10.0 116.956 166.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.3 m -79.68 -50.85 10.01 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.184 -1.371 . . . . 10.0 113.843 174.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -48.93 117.56 6.48 Favored Pre-proline 0 CA--C 1.536 0.429 0 O-C-N 124.829 1.331 . . . . 10.0 110.991 -172.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -58.63 -29.59 89.66 Favored 'Trans proline' 0 N--CA 1.459 -0.5 0 C-N-CA 123.74 2.96 . . . . 10.0 113.706 179.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.38 -60.61 2.32 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.089 0.556 . . . . 10.0 111.437 176.199 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.19 -40.01 22.81 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 125.093 1.357 . . . . 10.0 113.58 171.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.5 tttp -46.61 -47.37 19.99 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.241 1.417 . . . . 10.0 113.434 172.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -57.79 -53.09 62.19 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.472 0.709 . . . . 10.0 110.944 176.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -56.93 -50.23 73.2 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 123.094 0.557 . . . . 10.0 112.342 -179.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -54.42 -51.29 65.38 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 118.919 -0.562 . . . . 10.0 112.337 173.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.37 -61.98 1.93 Allowed 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 113.419 0.896 . . . . 10.0 113.419 177.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.4 mt -48.65 -57.49 1.54 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 C-N-CA 124.869 1.268 . . . . 10.0 110.349 178.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.2 m -68.87 -17.17 63.95 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.144 1.378 . . . . 10.0 113.737 -172.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 27.8 m -87.9 -40.02 14.31 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.5 1.12 . . . . 10.0 112.165 174.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 25.7 mt -59.48 -42.82 92.95 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 118.93 0.786 . . . . 10.0 112.431 170.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 18.4 t -42.26 -60.06 2.34 Favored Pre-proline 0 N--CA 1.481 1.11 0 C-N-CA 125.72 1.608 . . . . 10.0 113.881 176.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -72.7 -24.3 18.5 Favored 'Trans proline' 0 CA--C 1.545 1.074 0 C-N-CA 122.951 2.434 . . . . 10.0 114.662 174.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.71 -44.69 80.98 Favored 'General case' 0 CA--C 1.548 0.879 0 CA-C-N 120.642 1.564 . . . . 10.0 113.291 176.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 38.1 mm -53.62 -53.86 22.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 124.287 1.035 . . . . 10.0 109.404 168.178 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -53.25 -46.65 69.29 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.458 1.103 . . . . 10.0 113.343 176.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 52.0 t80 -51.36 -57.26 9.4 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 120.187 1.358 . . . . 10.0 112.419 172.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 12.5 m -50.12 -52.32 36.01 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.329 1.451 . . . . 10.0 110.454 178.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 32.6 mmt -69.17 -48.01 63.41 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 123.905 0.882 . . . . 10.0 112.967 -176.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -56.36 -40.93 75.34 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 120.35 1.432 . . . . 10.0 113.262 172.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.8 tp -53.25 -54.59 33.91 Favored 'General case' 0 C--O 1.224 -0.258 0 CA-C-N 119.85 1.204 . . . . 10.0 111.281 170.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 24.0 p -51.67 -41.05 61.11 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 115.224 1.564 . . . . 10.0 115.224 179.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 61.1 mtm -66.84 -50.86 61.19 Favored 'General case' 0 C--N 1.334 -0.082 0 C-N-CA 123.556 0.742 . . . . 10.0 110.506 176.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.4 tp -48.51 -52.74 21.02 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.857 0.863 . . . . 10.0 112.952 172.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.4 mt -76.84 -5.62 49.06 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.353 1.061 . . . . 10.0 113.854 -177.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.32 -34.74 5.52 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 115.55 0.98 . . . . 10.0 115.55 174.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 75.3 t80 -49.29 -43.08 43.01 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 115.235 1.568 . . . . 10.0 115.235 -175.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.02 3.51 61.14 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 115.35 0.9 . . . . 10.0 115.35 -179.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.25 143.43 26.42 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 127.042 2.137 . . . . 10.0 109.018 172.002 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 t -145.54 171.06 15.22 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 124.048 0.939 . . . . 10.0 111.067 166.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.01 136.08 53.36 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 123.853 0.861 . . . . 10.0 109.684 179.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 58.5 t -129.6 129.61 23.17 Favored Pre-proline 0 C--N 1.33 -0.279 0 C-N-CA 125.031 1.332 . . . . 10.0 110.905 -176.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -80.73 116.24 3.17 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 N-CA-C 109.415 -1.033 . . . . 10.0 109.415 -178.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -156.68 164.39 38.2 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 112.842 0.682 . . . . 10.0 112.842 172.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.36 -81.95 0.14 Allowed Glycine 0 CA--C 1.526 0.764 0 N-CA-C 110.692 -0.963 . . . . 10.0 110.692 175.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.77 -3.41 0.69 Allowed Glycine 0 CA--C 1.527 0.836 0 N-CA-C 118.666 2.226 . . . . 10.0 118.666 170.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -151.58 -171.89 4.06 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 119.349 1.575 . . . . 10.0 112.217 -165.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -91.82 93.9 9.07 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 125.531 1.532 . . . . 10.0 111.107 -175.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 60.2 m-80 -89.47 120.78 69.65 Favored Pre-proline 0 N--CA 1.45 -0.428 0 N-CA-C 113.0 0.741 . . . . 10.0 113.0 -165.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -61.48 131.92 38.32 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 124.205 3.27 . . . . 10.0 112.167 171.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.5 mm -140.16 126.37 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 C-N-CA 126.0 1.72 . . . . 10.0 111.712 -179.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -93.64 84.99 4.74 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 122.72 1.247 . . . . 10.0 113.053 174.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 63.8 p-90 -59.37 -28.28 66.73 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 120.939 -1.101 . . . . 10.0 113.881 174.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -55.36 -23.13 22.47 Favored 'General case' 0 CA--C 1.574 1.9 0 C-N-CA 124.277 1.031 . . . . 10.0 110.038 178.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -47.57 -59.75 3.03 Favored 'General case' 0 N--CA 1.496 1.833 0 C-N-CA 126.304 1.841 . . . . 10.0 112.08 163.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -68.35 -37.39 80.43 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 123.814 0.845 . . . . 10.0 110.457 -173.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -53.8 -51.59 63.0 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 123.676 0.79 . . . . 10.0 112.748 169.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 61.8 t0 -52.96 -68.72 0.15 Allowed 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 126.143 1.777 . . . . 10.0 111.26 171.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 46.2 m0 -57.01 -33.77 67.49 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.98 1.712 . . . . 10.0 113.268 -171.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 30.0 tp -50.08 -44.63 51.93 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 126.13 1.772 . . . . 10.0 111.967 177.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -99.25 -44.4 6.25 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.185 0.994 . . . . 10.0 112.014 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 13.7 m -48.33 -52.15 22.86 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.669 1.588 . . . . 10.0 113.242 177.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . 0.314 57.5 p -67.88 -45.71 43.23 Favored Pre-proline 0 N--CA 1.476 0.872 0 N-CA-C 114.557 1.318 . . . . 10.0 114.557 -174.433 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -52.91 -42.9 60.79 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 123.39 2.727 . . . . 10.0 115.329 170.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 52.4 mt -59.18 -46.45 88.37 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.293 0.637 . . . . 10.0 111.472 175.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.4 tp -51.33 -48.13 62.49 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.411 1.485 . . . . 10.0 112.198 172.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.7 mp -58.82 -47.33 85.19 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 125.122 1.369 . . . . 10.0 112.623 170.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.8 -38.28 78.22 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 123.826 0.85 . . . . 10.0 112.906 178.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 -52.31 -54.0 37.1 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 119.282 0.946 . . . . 10.0 111.163 169.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.36 -42.12 88.48 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.635 0.774 . . . . 10.0 112.087 -178.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.64 -54.73 37.67 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.996 0.919 . . . . 10.0 112.024 173.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.33 -41.2 79.53 Favored 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 123.73 0.812 . . . . 10.0 112.668 174.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.9 tp -63.71 -38.6 91.73 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 114.494 1.294 . . . . 10.0 114.494 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.1 t -94.75 1.41 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 125.092 1.357 . . . . 10.0 112.296 179.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.2 t70 48.55 53.52 12.0 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.881 1.672 . . . . 10.0 112.077 -174.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.22 145.89 47.68 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 119.955 -1.715 . . . . 10.0 112.457 -174.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.47 135.93 54.17 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 112.697 0.629 . . . . 10.0 112.697 175.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -42.92 -39.65 2.65 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.891 1.677 . . . . 10.0 113.466 175.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -47.3 -60.21 5.31 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 125.145 1.355 . . . . 10.0 115.295 169.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 42.0 p -62.1 -46.72 87.8 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 117.101 -1.428 . . . . 10.0 111.328 178.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 66.9 mt -48.48 -52.87 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 125.032 1.333 . . . . 10.0 111.135 178.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.4 tp -62.67 -51.25 67.97 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 112.544 0.572 . . . . 10.0 112.544 179.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.2 -44.86 43.55 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.479 0.712 . . . . 10.0 110.912 174.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.56 -59.95 4.63 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 127.385 2.274 . . . . 10.0 114.791 174.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.6 t -61.02 -46.36 96.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 123.686 0.794 . . . . 10.0 111.362 -178.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -56.56 -50.41 63.19 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 123.68 0.657 . . . . 10.0 112.602 174.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -54.68 -46.74 74.14 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 113.081 0.771 . . . . 10.0 113.081 173.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -57.94 -45.07 87.2 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.998 0.919 . . . . 10.0 111.809 174.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -43.81 -55.88 5.31 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 125.123 1.344 . . . . 10.0 113.429 166.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 81.6 mt -56.63 -54.07 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 123.567 0.747 . . . . 10.0 110.962 173.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 45.5 ttp -46.14 -58.65 3.45 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.462 1.505 . . . . 10.0 112.455 -178.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 47.2 mm . . . . . 0 N--CA 1.473 0.688 0 C-N-CA 123.215 0.606 . . . . 10.0 112.012 178.65 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 62.0 t . . . . . 0 N--CA 1.47 0.545 0 N-CA-C 110.384 -0.228 . . . . 10.0 110.384 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -48.82 -61.08 5.5 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 125.751 1.643 . . . . 10.0 112.855 170.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -45.75 -40.37 9.4 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 127.004 2.122 . . . . 10.0 113.813 177.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 49.8 mt -100.14 -6.6 25.98 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 115.193 1.553 . . . . 10.0 115.193 -176.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 17.0 m -69.66 116.72 10.38 Favored 'General case' 0 N--CA 1.464 0.237 0 O-C-N 120.186 -1.571 . . . . 10.0 110.41 -178.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.553 ' HD3' ' H ' ' A' ' 129' ' ' LYS . 0.1 OUTLIER -55.44 -49.65 71.9 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 128.186 2.594 . . . . 10.0 113.267 177.754 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 60.6 t -69.62 106.37 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 123.761 0.824 . . . . 10.0 110.085 179.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -46.94 -59.49 3.06 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 124.775 1.23 . . . . 10.0 114.07 -173.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 m -46.53 -42.07 15.22 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.45 1.5 . . . . 10.0 113.484 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -70.14 -24.61 63.2 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 114.959 1.466 . . . . 10.0 114.959 -178.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 68.1 mtp85 -54.21 -41.69 68.92 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 118.869 0.759 . . . . 10.0 110.811 176.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -69.01 -32.73 72.47 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.678 1.191 . . . . 10.0 114.166 176.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.7 t -54.46 -52.03 43.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 CA-C-N 119.073 0.851 . . . . 10.0 109.659 169.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 66.2 m95 -62.0 -45.7 92.44 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 114.531 1.308 . . . . 10.0 114.531 174.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 86.5 t90 -52.13 -47.98 65.08 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.868 0.867 . . . . 10.0 112.582 172.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.599 0 C-N-CA 124.047 0.939 . . . . 10.0 111.69 176.801 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.77 0 N-CA-C 112.531 0.567 . . . . 10.0 112.531 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 40.4 ttp -55.93 -55.72 29.27 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 124.488 1.115 . . . . 10.0 111.915 171.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -51.13 -48.5 61.77 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 125.869 1.668 . . . . 10.0 111.569 178.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 78.5 t80 -52.33 -54.54 30.37 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 113.099 0.778 . . . . 10.0 113.099 172.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 56.0 mt -53.87 -54.68 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 123.943 0.897 . . . . 10.0 110.739 177.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 90.8 mt -50.69 -42.93 57.42 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 126.129 1.772 . . . . 10.0 112.818 175.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -57.32 -58.09 9.76 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 123.986 0.914 . . . . 10.0 113.084 176.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.43 -40.92 85.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 CA-C-O 118.313 -0.851 . . . . 10.0 111.408 177.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 47.2 mt -56.83 -49.45 75.39 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.878 1.217 . . . . 10.0 112.069 171.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.424 ' HA ' ' HD2' ' A' ' 175' ' ' ARG . 11.8 t80 -76.94 -70.29 0.47 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 120.06 -1.65 . . . . 10.0 112.915 -175.24 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -73.78 -21.9 60.02 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.596 1.158 . . . . 10.0 113.454 -174.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -87.83 -79.1 1.26 Allowed Glycine 0 CA--C 1.527 0.806 0 C-N-CA 123.612 0.625 . . . . 10.0 113.501 171.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -53.58 -32.47 51.06 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 126.266 1.826 . . . . 10.0 113.045 -166.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.4 m -52.1 -56.47 14.25 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 113.988 1.107 . . . . 10.0 113.988 172.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.5 p -53.6 -50.59 65.32 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 122.093 0.949 . . . . 10.0 112.297 -177.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 47.7 tttm -57.09 -46.11 82.82 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.165 0.986 . . . . 10.0 112.103 173.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.74 -47.51 79.88 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 114.55 1.315 . . . . 10.0 114.55 174.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -56.5 -11.22 1.19 Allowed 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 126.056 1.742 . . . . 10.0 114.268 177.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.1 m -107.08 6.57 29.05 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.425 1.89 . . . . 10.0 114.898 -179.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 93.3 mmm -91.9 -92.6 0.15 Allowed 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 123.485 1.612 . . . . 10.0 114.16 -170.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -138.75 153.94 72.58 Favored Pre-proline 0 C--O 1.236 0.349 0 C-N-CA 129.809 3.243 . . . . 10.0 105.529 170.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -52.86 -46.19 35.48 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 122.3 2.0 . . . . 10.0 113.08 179.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . 0.461 ' CD ' ' HD3' ' A' ' 227' ' ' ARG . 0.1 OUTLIER -53.02 -46.09 68.25 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 129.014 2.926 . . . . 10.0 113.221 173.597 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 92.0 t -69.12 -53.09 27.63 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.267 0 C-N-CA 124.068 0.947 . . . . 10.0 109.798 -178.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.11 -46.85 75.59 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.291 0.636 . . . . 10.0 111.905 177.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 60.1 p -59.98 -56.22 24.34 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.885 0.874 . . . . 10.0 112.702 174.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 62.0 m -57.12 -53.31 59.59 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.23 1.012 . . . . 10.0 112.987 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -49.52 -49.57 45.38 Favored 'General case' 0 C--O 1.222 -0.386 0 C-N-CA 123.3 0.64 . . . . 10.0 111.068 174.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -57.12 -48.37 78.82 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 114.699 1.37 . . . . 10.0 114.699 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 40.4 t -56.02 -49.57 74.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-N 118.832 0.742 . . . . 10.0 110.487 176.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 94.2 mt -58.57 -51.63 69.09 Favored 'General case' 0 C--O 1.221 -0.397 0 N-CA-C 113.152 0.797 . . . . 10.0 113.152 175.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . 0.424 ' HD2' ' HA ' ' A' ' 153' ' ' PHE . 35.5 ttp180 -47.82 -47.82 31.05 Favored 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 126.868 2.067 . . . . 10.0 111.011 174.499 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 63.6 m-20 -58.48 -58.31 9.11 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 122.805 0.442 . . . . 10.0 111.29 174.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 58.3 t -51.77 -50.25 32.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 124.086 0.954 . . . . 10.0 111.587 179.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 26.5 m -56.55 -60.34 3.67 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 127.872 2.469 . . . . 10.0 111.953 177.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 47.7 t -53.67 -49.52 56.34 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 CA-C-N 119.215 0.916 . . . . 10.0 111.312 -178.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 76.6 t -58.91 -61.67 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 124.369 1.068 . . . . 10.0 111.908 176.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -59.24 -48.82 80.17 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 118.63 0.65 . . . . 10.0 112.609 -175.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 9.8 m95 . . . . . 0 N--CA 1.469 0.524 0 CA-C-N 118.9 0.773 . . . . 10.0 111.947 176.771 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 88.3 t . . . . . 0 N--CA 1.479 0.99 0 CA-C-O 119.264 -0.398 . . . . 10.0 111.457 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 69.9 t90 -54.68 -54.56 40.18 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.331 1.052 . . . . 10.0 112.525 174.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 9.9 tt -57.55 -42.37 82.83 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 123.881 0.872 . . . . 10.0 112.166 -176.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 14.1 pt -84.79 -5.95 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 N-CA-C 115.289 1.589 . . . . 10.0 115.289 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.41 -169.29 32.97 Favored Glycine 0 N--CA 1.45 -0.404 0 CA-C-O 122.589 1.105 . . . . 10.0 113.883 -168.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 23.3 t -53.13 -42.25 65.86 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 114.16 -1.02 . . . . 10.0 111.85 177.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -69.13 -13.05 62.2 Favored 'General case' 0 CA--C 1.55 0.962 0 N-CA-C 115.155 1.539 . . . . 10.0 115.155 -174.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -132.25 -106.37 1.03 Allowed Glycine 0 CA--C 1.536 1.38 0 CA-C-N 120.716 1.598 . . . . 10.0 114.497 -174.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -89.45 127.16 35.81 Favored 'General case' 0 C--N 1.329 -0.323 0 O-C-N 120.666 -1.491 . . . . 10.0 109.305 168.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -72.47 65.32 1.36 Allowed Glycine 0 CA--C 1.532 1.105 0 N-CA-C 113.901 0.32 . . . . 10.0 113.901 173.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 60.7 mt -79.57 -42.74 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 126.107 1.763 . . . . 10.0 108.735 166.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 79.3 t -126.28 133.38 24.91 Favored Pre-proline 0 N--CA 1.453 -0.279 0 C-N-CA 126.504 1.922 . . . . 10.0 109.391 -174.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -68.7 153.76 72.63 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 123.822 3.015 . . . . 10.0 111.474 -176.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 12.2 tp -43.13 -39.82 2.98 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.319 1.047 . . . . 10.0 112.229 171.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -48.28 -52.41 21.45 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 114.684 1.365 . . . . 10.0 114.684 176.03 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 14.0 mm -75.95 -40.53 38.36 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 124.419 1.088 . . . . 10.0 109.625 177.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -49.29 -49.75 42.26 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 118.61 0.641 . . . . 10.0 112.005 173.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 16.2 m -57.75 -47.01 83.7 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 126.042 1.737 . . . . 10.0 112.991 174.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -63.35 -52.36 62.13 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.927 0.891 . . . . 10.0 112.063 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 93.3 mt -52.48 -60.0 3.76 Favored 'General case' 0 C--O 1.227 -0.115 0 C-N-CA 124.322 1.049 . . . . 10.0 109.993 176.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -53.49 -43.18 68.02 Favored 'General case' 0 C--O 1.218 -0.589 0 CA-C-O 117.432 -1.27 . . . . 10.0 112.51 176.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 4.6 tmm? -53.93 -52.52 60.33 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 121.51 1.959 . . . . 10.0 112.974 173.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 82.1 t -61.06 -47.12 95.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 124.957 1.303 . . . . 10.0 111.7 178.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 4.8 mp -58.97 -51.3 70.66 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 125.578 1.551 . . . . 10.0 111.79 175.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -55.07 -59.96 4.04 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 125.969 1.708 . . . . 10.0 109.924 176.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 35.1 t . . . . . 0 N--CA 1.475 0.811 0 C-N-CA 125.334 1.454 . . . . 10.0 111.658 175.922 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.197 0 N-CA-C 111.912 -0.475 . . . . 10.0 111.912 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 42.8 t80 -45.45 -57.78 3.84 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.142 1.777 . . . . 10.0 112.45 167.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -56.9 -40.59 90.58 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 123.834 0.73 . . . . 10.0 113.561 -179.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 24.2 mt -70.95 -27.19 63.56 Favored 'General case' 0 CA--C 1.51 -0.582 0 N-CA-C 115.52 1.674 . . . . 10.0 115.52 176.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 74.0 mt -63.2 -57.57 11.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 119.131 0.878 . . . . 10.0 108.688 165.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 32.1 tp -58.91 -64.6 0.88 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.854 0.862 . . . . 10.0 113.207 -172.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 84.0 mt -71.55 5.24 2.5 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 115.323 1.601 . . . . 10.0 115.323 -171.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.6 mtp-105 -112.34 0.36 15.65 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.165 0.986 . . . . 10.0 113.265 172.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 8.8 t -108.04 177.94 4.66 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 124.082 0.953 . . . . 10.0 111.039 174.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 227' ' ' ARG . . . . . 0.461 ' HD3' ' CD ' ' A' ' 166' ' ' GLU . 41.9 ttt180 -71.66 98.17 1.86 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.732 0.813 . . . . 10.0 110.968 170.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -80.93 77.03 7.86 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.829 0.852 . . . . 10.0 112.087 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 40.16 102.21 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 128.831 2.852 . . . . 10.0 116.502 177.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . 0.481 0.3 OUTLIER 71.83 -55.39 0.66 Allowed 'General case' 0 C--O 1.242 0.677 0 C-N-CA 124.764 1.226 . . . . 10.0 110.656 -175.277 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -68.34 169.48 40.2 Favored Glycine 0 C--O 1.239 0.417 0 C-N-CA 129.738 3.542 . . . . 10.0 119.598 171.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.489 0 C-N-CA 128.486 2.714 . . . . 10.0 113.44 166.618 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 N--CA 1.477 0.913 0 CA-C-O 115.781 -2.057 . . . . 10.0 105.833 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 23.35 91.83 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 129.598 3.159 . . . . 10.0 117.262 160.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 28.64 65.07 0.11 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 128.262 2.625 . . . . 10.0 114.511 155.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 86.7 mt -56.49 137.96 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 126.41 1.884 . . . . 10.0 113.353 -158.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.6 t -136.79 -165.2 1.7 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 126.327 1.851 . . . . 10.0 114.021 -174.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 70.0 2.83 41.1 Favored Glycine 0 C--N 1.339 0.743 0 C-N-CA 127.496 2.474 . . . . 10.0 111.485 168.076 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -158.52 -51.41 0.01 OUTLIER Pre-proline 0 N--CA 1.443 -0.783 0 CA-C-O 114.275 -2.774 . . . . 10.0 116.634 -168.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -63.89 -60.69 0.14 Allowed 'Trans proline' 0 CA--C 1.528 0.186 0 CA-C-N 123.5 2.286 . . . . 10.0 113.236 -175.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 7.9 pm0 -67.13 4.22 0.96 Allowed 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 127.878 2.471 . . . . 10.0 115.75 179.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.422 ' CG ' ' N ' ' A' ' 11' ' ' ILE . 11.0 p-90 -51.28 -43.15 61.54 Favored 'General case' 0 C--O 1.222 -0.361 0 O-C-N 121.5 -0.75 . . . . 10.0 112.646 176.425 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.422 ' N ' ' CG ' ' A' ' 10' ' ' TRP . 8.9 tt -60.85 -49.64 83.79 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.338 0 C-N-CA 123.926 0.89 . . . . 10.0 109.323 179.425 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 2.6 m95 -55.34 -52.67 62.75 Favored 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 123.406 0.682 . . . . 10.0 111.908 175.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.4 mt -57.34 -53.6 56.31 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 123.223 0.609 . . . . 10.0 112.245 177.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.91 -46.8 52.24 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.412 1.485 . . . . 10.0 113.324 173.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 13.3 tp -65.63 -44.95 84.88 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.277 1.431 . . . . 10.0 113.059 179.057 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.17 -58.37 7.99 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 124.274 0.94 . . . . 10.0 110.853 165.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.3 m -48.24 -52.41 21.25 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.625 1.17 . . . . 10.0 112.279 175.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.45 -58.83 5.93 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.122 0.969 . . . . 10.0 112.177 177.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 93.8 mt -58.25 -49.63 76.41 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.681 0.793 . . . . 10.0 112.399 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -50.73 -54.52 22.62 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.683 1.193 . . . . 10.0 110.879 173.684 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -57.17 -58.18 15.9 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 124.452 1.025 . . . . 10.0 113.574 178.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 80.8 mt -56.16 -45.54 79.65 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-N 118.626 1.213 . . . . 10.0 112.134 176.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.45 -42.57 75.71 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 124.936 1.255 . . . . 10.0 113.329 172.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 17.4 m -59.75 -60.86 3.16 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.216 1.006 . . . . 10.0 111.076 171.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -52.3 -40.99 62.55 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.061 0.944 . . . . 10.0 110.936 179.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.0 t80 -55.78 -58.03 9.56 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.552 1.141 . . . . 10.0 113.006 172.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -59.63 -38.7 82.07 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 113.226 0.825 . . . . 10.0 113.226 178.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.468 ' C ' ' H ' ' A' ' 30' ' ' LYS . 11.9 mt -56.08 -67.42 0.3 Allowed 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.592 1.157 . . . . 10.0 113.668 169.072 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 t -76.45 41.04 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 CA-C-O 123.749 1.738 . . . . 10.0 110.829 179.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.468 ' H ' ' C ' ' A' ' 28' ' ' LEU . 42.9 tttm -140.91 -44.87 0.39 Allowed 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 127.868 2.467 . . . . 10.0 109.303 171.186 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.95 23.09 0.87 Allowed Glycine 0 CA--C 1.529 0.956 0 N-CA-C 115.644 1.017 . . . . 10.0 115.644 173.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 37.4 mmm -59.54 -44.96 93.07 Favored 'General case' 0 C--O 1.224 -0.253 0 C-N-CA 127.136 2.174 . . . . 10.0 113.578 -178.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.66 -84.44 1.18 Allowed Glycine 0 CA--C 1.531 1.045 0 C-N-CA 123.741 0.686 . . . . 10.0 112.477 -170.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.8 t 33.09 88.7 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.243 0.73 0 C-N-CA 128.399 2.68 . . . . 10.0 116.941 166.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.4 m -79.58 -50.9 10.0 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.188 -1.369 . . . . 10.0 113.868 174.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -48.87 117.46 6.32 Favored Pre-proline 0 CA--C 1.536 0.428 0 O-C-N 124.719 1.262 . . . . 10.0 110.983 -172.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -58.56 -29.62 89.51 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 123.773 2.982 . . . . 10.0 113.727 179.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.38 -60.59 2.33 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.058 0.543 . . . . 10.0 111.442 176.183 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.15 -40.07 22.65 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 125.127 1.371 . . . . 10.0 113.58 171.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -46.5 -47.5 19.39 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 125.292 1.437 . . . . 10.0 113.413 172.03 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -57.79 -52.98 63.23 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.438 0.695 . . . . 10.0 110.975 176.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 44.2 m-85 -57.05 -50.18 73.54 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 123.034 0.534 . . . . 10.0 112.351 -179.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -54.37 -51.28 65.31 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 118.935 -0.555 . . . . 10.0 112.379 173.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.42 -61.97 1.94 Allowed 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 113.425 0.898 . . . . 10.0 113.425 177.168 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.7 mt -48.8 -57.54 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 C-N-CA 124.823 1.249 . . . . 10.0 110.145 177.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 4.9 m -69.42 -14.75 63.07 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.188 1.395 . . . . 10.0 113.74 -172.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 31.3 m -89.7 -42.25 11.44 Favored 'General case' 0 N--CA 1.483 1.178 0 CA-C-N 119.884 1.22 . . . . 10.0 111.946 174.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 27.9 mt -56.27 -40.01 73.55 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 118.433 0.56 . . . . 10.0 112.176 170.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . 0.254 24.3 t -47.09 -62.9 1.65 Allowed Pre-proline 0 CA--C 1.552 1.052 0 C-N-CA 125.266 1.426 . . . . 10.0 112.884 177.007 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -53.26 -42.47 64.9 Favored 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 123.919 3.079 . . . . 10.0 116.303 166.089 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.66 -46.19 89.33 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 114.199 1.185 . . . . 10.0 114.199 -174.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 48.3 mm -57.43 -51.32 71.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 O-C-N 121.194 -0.941 . . . . 10.0 109.697 171.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.76 -42.62 71.91 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 113.588 0.959 . . . . 10.0 113.588 175.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -52.85 -56.73 13.62 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 120.379 1.445 . . . . 10.0 112.01 170.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.8 m -49.55 -52.52 29.29 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.512 1.525 . . . . 10.0 110.837 177.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 32.7 mmt -69.11 -48.23 63.07 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 124.035 0.934 . . . . 10.0 112.894 -176.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -57.01 -40.11 76.01 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 117.058 -1.449 . . . . 10.0 113.135 173.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.8 tp -53.31 -54.58 34.43 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-N 120.198 1.363 . . . . 10.0 111.276 170.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 23.9 p -51.68 -41.0 61.09 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 115.261 1.578 . . . . 10.0 115.261 178.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 57.4 mtm -66.88 -50.88 61.08 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 123.534 0.734 . . . . 10.0 110.481 176.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.3 tp -48.54 -52.69 21.43 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.858 0.863 . . . . 10.0 112.926 172.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.4 mt -76.87 -5.64 49.22 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.377 1.071 . . . . 10.0 113.819 -177.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.29 -34.72 5.54 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 115.533 0.973 . . . . 10.0 115.533 174.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -49.29 -43.13 42.99 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 115.206 1.558 . . . . 10.0 115.206 -176.014 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.06 3.61 60.97 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 115.337 0.895 . . . . 10.0 115.337 -178.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.29 143.42 26.42 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 127.048 2.139 . . . . 10.0 108.972 172.014 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 t -145.54 171.05 15.24 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 124.064 0.946 . . . . 10.0 111.022 166.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.99 136.12 53.33 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 123.855 0.862 . . . . 10.0 109.683 179.602 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 58.5 t -129.6 129.55 23.17 Favored Pre-proline 0 C--N 1.329 -0.295 0 C-N-CA 125.063 1.345 . . . . 10.0 110.948 -176.048 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -80.69 116.24 3.18 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 N-CA-C 109.417 -1.032 . . . . 10.0 109.417 -178.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -156.74 164.4 38.16 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.823 0.675 . . . . 10.0 112.823 172.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.37 -81.98 0.14 Allowed Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.681 -0.967 . . . . 10.0 110.681 175.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.76 -3.32 0.7 Allowed Glycine 0 CA--C 1.527 0.822 0 N-CA-C 118.671 2.228 . . . . 10.0 118.671 170.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -151.63 -171.89 4.06 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 119.354 1.577 . . . . 10.0 112.237 -165.161 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -91.89 93.95 9.06 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 125.504 1.522 . . . . 10.0 111.066 -175.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 60.3 m-80 -89.52 120.77 69.62 Favored Pre-proline 0 N--CA 1.45 -0.43 0 N-CA-C 112.964 0.727 . . . . 10.0 112.964 -165.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -61.53 131.97 38.43 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 124.163 3.242 . . . . 10.0 112.136 171.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.5 mm -140.14 126.3 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 C-N-CA 126.072 1.749 . . . . 10.0 111.714 -179.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -93.65 85.07 4.76 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 122.714 1.245 . . . . 10.0 113.055 174.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 63.8 p-90 -59.35 -28.3 66.71 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 113.925 1.083 . . . . 10.0 113.925 174.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -55.21 -32.77 62.51 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.273 1.029 . . . . 10.0 112.654 178.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 37.7 ttm-85 -49.36 -43.51 44.0 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.917 1.687 . . . . 10.0 112.283 169.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 61.7 m-85 -78.91 -39.85 33.76 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.538 1.535 . . . . 10.0 112.428 -179.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -49.92 -48.15 51.89 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.798 1.239 . . . . 10.0 111.337 167.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -56.01 -68.8 0.17 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.426 1.49 . . . . 10.0 111.907 170.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 48.9 m0 -52.82 -33.95 51.61 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.996 1.318 . . . . 10.0 113.387 -173.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 32.6 tp -50.96 -45.65 60.83 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 125.899 1.679 . . . . 10.0 111.982 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -97.55 -47.55 5.6 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 124.478 1.111 . . . . 10.0 112.441 -177.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 51.6 m -59.77 -40.13 87.19 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.643 1.177 . . . . 10.0 112.892 -174.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.5 m -68.26 -47.58 38.07 Favored Pre-proline 0 CA--C 1.547 0.86 0 N-CA-C 113.745 1.017 . . . . 10.0 113.745 -179.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -50.03 -42.77 44.7 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 123.356 2.704 . . . . 10.0 115.362 166.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 54.1 mt -59.18 -46.94 87.07 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.264 0.626 . . . . 10.0 111.575 174.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.5 tp -49.71 -49.15 48.91 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.593 1.557 . . . . 10.0 112.162 171.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.6 mp -58.85 -47.33 85.25 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.031 1.332 . . . . 10.0 112.498 171.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.83 -38.24 78.23 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 123.844 0.857 . . . . 10.0 112.891 178.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -52.31 -54.0 37.16 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 119.324 0.966 . . . . 10.0 111.189 169.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.35 -42.17 88.46 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.656 0.782 . . . . 10.0 112.046 -178.506 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.7 -54.7 38.4 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 124.008 0.923 . . . . 10.0 112.013 173.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.3 -41.17 79.34 Favored 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 123.72 0.808 . . . . 10.0 112.702 174.779 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.9 tp -63.75 -38.62 91.77 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 114.425 1.268 . . . . 10.0 114.425 -179.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.1 t -94.79 1.49 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 125.025 1.33 . . . . 10.0 112.325 179.158 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.2 t70 48.57 53.49 12.06 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.866 1.666 . . . . 10.0 112.095 -174.033 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.3 145.94 47.51 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 119.974 -1.704 . . . . 10.0 112.437 -174.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.53 135.92 54.41 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 112.679 0.622 . . . . 10.0 112.679 175.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -42.81 -39.75 2.61 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.895 1.678 . . . . 10.0 113.443 175.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -47.35 -60.2 5.35 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 125.15 1.357 . . . . 10.0 115.22 169.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.9 p -62.07 -46.72 87.87 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 117.103 -1.427 . . . . 10.0 111.351 178.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 67.1 mt -48.47 -52.9 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 125.033 1.333 . . . . 10.0 111.085 178.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.3 tp -62.62 -51.33 67.69 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 112.502 0.556 . . . . 10.0 112.502 179.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.11 -44.9 42.7 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.47 0.708 . . . . 10.0 110.959 174.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.64 -59.89 4.72 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 127.393 2.277 . . . . 10.0 114.793 174.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.8 t -61.0 -46.31 96.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 123.704 0.802 . . . . 10.0 111.411 -178.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -56.65 -50.32 64.05 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 123.695 0.664 . . . . 10.0 112.63 174.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -54.96 -46.23 75.01 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 113.375 0.88 . . . . 10.0 113.375 173.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -55.9 -48.84 74.9 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.698 0.799 . . . . 10.0 111.129 173.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -42.52 -55.27 4.58 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 125.044 1.306 . . . . 10.0 112.997 169.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 82.2 mt -55.56 -58.19 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-O 117.571 -1.204 . . . . 10.0 110.66 173.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 5.0 ptt? -53.42 -46.35 69.74 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 120.783 1.628 . . . . 10.0 113.343 -173.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 46.5 mm . . . . . 0 N--CA 1.473 0.692 0 O-C-N 121.471 -0.768 . . . . 10.0 111.836 179.679 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 60.4 t . . . . . 0 N--CA 1.478 0.972 0 N-CA-C 110.112 -0.329 . . . . 10.0 110.112 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -50.7 -61.23 6.19 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 126.119 1.818 . . . . 10.0 112.65 171.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -43.12 -42.08 3.91 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 127.818 2.447 . . . . 10.0 113.208 176.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 47.3 mt -100.88 -6.8 24.19 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 115.536 1.68 . . . . 10.0 115.536 -175.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 16.9 m -69.66 116.71 10.37 Favored 'General case' 0 N--CA 1.464 0.229 0 O-C-N 120.195 -1.566 . . . . 10.0 110.386 -178.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.552 ' HD3' ' H ' ' A' ' 129' ' ' LYS . 0.2 OUTLIER -55.51 -49.57 72.26 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 128.157 2.583 . . . . 10.0 113.269 177.763 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 60.3 t -69.65 106.33 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 123.819 0.848 . . . . 10.0 110.103 179.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -46.9 -59.54 3.02 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 124.724 1.21 . . . . 10.0 114.055 -173.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 m -46.5 -42.05 15.01 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.45 1.5 . . . . 10.0 113.495 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -70.18 -24.64 63.17 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 114.896 1.443 . . . . 10.0 114.896 -178.103 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 68.9 mtp85 -53.95 -41.81 68.18 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 118.88 0.764 . . . . 10.0 110.776 176.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -69.62 -31.6 69.81 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 114.403 1.26 . . . . 10.0 114.403 176.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.8 t -55.09 -52.18 47.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 CA-C-N 118.993 0.815 . . . . 10.0 109.549 168.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 64.2 m95 -61.09 -43.27 99.15 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 114.185 1.18 . . . . 10.0 114.185 174.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 89.2 t90 -52.88 -49.81 65.11 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 119.255 0.934 . . . . 10.0 112.642 172.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.636 0 C-N-CA 124.225 1.01 . . . . 10.0 111.76 178.193 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.547 0.854 0 N-CA-C 112.942 0.719 . . . . 10.0 112.942 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 11.9 tmm? -55.02 -54.06 47.85 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.26 1.424 . . . . 10.0 111.956 172.234 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 58.1 tp -57.65 -42.98 84.58 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.794 1.638 . . . . 10.0 112.834 178.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -53.36 -53.6 48.71 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.537 0.735 . . . . 10.0 112.037 169.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 46.2 mt -54.62 -54.64 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 123.733 0.813 . . . . 10.0 111.061 177.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 5.1 tt -46.13 -46.91 17.46 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 127.943 2.497 . . . . 10.0 112.222 173.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -57.33 -58.15 9.5 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 124.026 0.93 . . . . 10.0 113.03 178.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.42 -40.9 85.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-O 118.343 -0.837 . . . . 10.0 111.467 177.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 47.4 mt -56.73 -49.45 75.16 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.824 1.193 . . . . 10.0 112.139 171.223 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.424 ' HA ' ' HD2' ' A' ' 175' ' ' ARG . 11.8 t80 -76.98 -70.34 0.47 Allowed 'General case' 0 C--N 1.326 -0.447 0 O-C-N 120.079 -1.638 . . . . 10.0 112.845 -175.215 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -73.76 -21.92 60.03 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.634 1.174 . . . . 10.0 113.426 -174.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -87.77 -79.08 1.26 Allowed Glycine 0 CA--C 1.526 0.761 0 C-N-CA 123.662 0.649 . . . . 10.0 113.553 171.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -53.63 -32.47 51.46 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 126.307 1.843 . . . . 10.0 113.025 -166.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.2 m -52.08 -56.45 14.35 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 114.016 1.117 . . . . 10.0 114.016 172.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.4 p -53.66 -50.56 65.52 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 122.161 0.981 . . . . 10.0 112.307 -177.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 47.6 tttm -57.08 -46.07 82.83 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.134 0.974 . . . . 10.0 112.167 173.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.86 -47.41 80.47 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 114.515 1.302 . . . . 10.0 114.515 174.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -56.47 -11.3 1.21 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 126.087 1.755 . . . . 10.0 114.252 177.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.2 m -107.1 6.64 29.08 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.416 1.886 . . . . 10.0 114.877 -179.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 93.2 mmm -91.91 -92.63 0.15 Allowed 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 123.451 1.596 . . . . 10.0 114.164 -170.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -138.71 154.0 72.7 Favored Pre-proline 0 C--O 1.236 0.359 0 C-N-CA 129.749 3.219 . . . . 10.0 105.539 170.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -52.85 -46.24 35.09 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 122.308 2.005 . . . . 10.0 113.074 179.057 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . 0.462 ' CD ' ' HD3' ' A' ' 227' ' ' ARG . 0.1 OUTLIER -52.94 -46.11 67.98 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 129.022 2.929 . . . . 10.0 113.281 173.578 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 92.2 t -69.19 -53.03 27.73 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 C-N-CA 124.034 0.934 . . . . 10.0 109.782 -178.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.09 -46.89 75.53 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.282 0.633 . . . . 10.0 111.923 177.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 60.2 p -59.97 -56.16 25.08 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.883 0.873 . . . . 10.0 112.719 174.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 61.7 m -57.23 -53.16 61.21 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.143 0.977 . . . . 10.0 113.004 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -49.59 -49.54 46.26 Favored 'General case' 0 C--O 1.222 -0.375 0 C-N-CA 123.289 0.636 . . . . 10.0 111.067 174.098 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -57.12 -48.41 78.72 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 114.671 1.36 . . . . 10.0 114.671 -179.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 40.3 t -55.95 -49.63 74.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 CA-C-N 118.832 0.742 . . . . 10.0 110.522 176.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 94.0 mt -58.54 -51.69 68.82 Favored 'General case' 0 C--O 1.222 -0.389 0 N-CA-C 113.168 0.803 . . . . 10.0 113.168 175.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . 0.424 ' HD2' ' HA ' ' A' ' 153' ' ' PHE . 35.6 ttp180 -47.72 -47.83 29.84 Favored 'General case' 0 C--O 1.224 -0.244 0 C-N-CA 126.889 2.075 . . . . 10.0 111.041 174.448 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 63.7 m-20 -58.51 -58.33 9.02 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 122.817 0.447 . . . . 10.0 111.25 174.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 53.7 t -52.09 -47.19 43.58 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 C-N-CA 124.05 0.94 . . . . 10.0 112.301 179.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 30.2 m -58.27 -65.31 0.67 Allowed 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 128.041 2.536 . . . . 10.0 111.283 177.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 55.8 t -49.66 -49.12 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 C-N-CA 124.859 1.263 . . . . 10.0 111.429 -178.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 72.0 t -58.88 -61.75 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 123.909 0.884 . . . . 10.0 112.164 177.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 85.8 mt -55.11 -46.82 75.6 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 119.251 0.932 . . . . 10.0 112.002 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 9.6 m95 . . . . . 0 N--CA 1.467 0.4 0 C-N-CA 125.174 1.39 . . . . 10.0 113.215 175.667 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 96.2 t . . . . . 0 N--CA 1.478 0.949 0 CA-C-O 119.239 -0.41 . . . . 10.0 111.462 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 61.2 t90 -55.26 -52.78 62.3 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.261 1.024 . . . . 10.0 112.511 175.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 9.5 tt -57.98 -43.69 86.68 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 123.898 0.879 . . . . 10.0 112.628 -176.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 15.3 pt -83.81 -5.59 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 N-CA-C 114.986 1.476 . . . . 10.0 114.986 -179.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.18 -169.33 33.3 Favored Glycine 0 N--CA 1.451 -0.363 0 CA-C-O 122.587 1.104 . . . . 10.0 113.966 -169.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 23.3 t -53.13 -41.45 65.09 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 114.159 -1.021 . . . . 10.0 111.879 177.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -66.83 -17.24 64.79 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 115.627 1.714 . . . . 10.0 115.627 -175.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -131.38 -105.79 1.05 Allowed Glycine 0 CA--C 1.533 1.169 0 CA-C-N 120.402 1.455 . . . . 10.0 113.911 -172.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -89.45 127.15 35.81 Favored 'General case' 0 C--N 1.329 -0.306 0 O-C-N 120.659 -1.495 . . . . 10.0 109.349 168.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -72.47 65.34 1.36 Allowed Glycine 0 CA--C 1.532 1.124 0 N-CA-C 113.906 0.322 . . . . 10.0 113.906 173.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 60.5 mt -79.51 -42.78 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 126.086 1.754 . . . . 10.0 108.764 166.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 79.8 t -126.31 133.34 24.87 Favored Pre-proline 0 N--CA 1.454 -0.264 0 C-N-CA 126.502 1.921 . . . . 10.0 109.401 -174.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -68.74 153.75 72.56 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 123.793 2.996 . . . . 10.0 111.491 -176.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 12.2 tp -43.13 -39.75 2.94 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.329 1.052 . . . . 10.0 112.227 171.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -48.37 -52.39 21.96 Favored 'General case' 0 CA--C 1.539 0.519 0 N-CA-C 114.673 1.361 . . . . 10.0 114.673 176.022 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 14.0 mm -75.91 -40.49 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 124.378 1.071 . . . . 10.0 109.647 177.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -49.32 -49.78 42.5 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 118.575 0.625 . . . . 10.0 111.956 173.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 16.1 m -57.72 -47.05 83.49 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 126.04 1.736 . . . . 10.0 112.974 174.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -63.35 -52.33 62.22 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.968 0.907 . . . . 10.0 112.061 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 93.2 mt -52.54 -58.82 5.57 Favored 'General case' 0 C--O 1.228 -0.077 0 C-N-CA 124.293 1.037 . . . . 10.0 110.003 176.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -53.97 -43.78 70.2 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 117.704 -1.141 . . . . 10.0 112.876 176.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 4.6 tmm? -53.96 -52.57 60.25 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 120.285 1.402 . . . . 10.0 112.237 174.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 78.3 t -61.45 -47.89 91.32 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 125.183 1.393 . . . . 10.0 111.897 178.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 5.1 mp -57.42 -49.54 75.9 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.025 1.33 . . . . 10.0 111.404 175.038 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -59.14 -56.83 17.12 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.697 1.199 . . . . 10.0 111.588 176.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 34.3 m . . . . . 0 N--CA 1.488 1.458 0 CA-C-N 121.89 2.132 . . . . 10.0 112.377 178.497 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.467 0 CA-C-O 121.101 0.278 . . . . 10.0 113.269 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -46.64 -56.25 6.4 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.717 2.007 . . . . 10.0 112.201 168.093 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -55.82 -38.59 74.25 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 123.817 0.722 . . . . 10.0 113.696 179.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 24.5 mt -70.64 -27.38 64.01 Favored 'General case' 0 CA--C 1.512 -0.504 0 N-CA-C 115.694 1.739 . . . . 10.0 115.694 176.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 74.4 mt -63.52 -57.51 11.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 108.561 -0.903 . . . . 10.0 108.561 165.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 32.1 tp -58.85 -64.6 0.88 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.893 0.877 . . . . 10.0 113.213 -172.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 84.2 mt -71.58 5.17 2.55 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 115.295 1.591 . . . . 10.0 115.295 -171.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.6 mtp-105 -112.31 0.34 15.68 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.172 0.989 . . . . 10.0 113.238 172.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 8.8 t -108.0 177.94 4.66 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 124.116 0.966 . . . . 10.0 111.046 174.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 227' ' ' ARG . . . . . 0.462 ' HD3' ' CD ' ' A' ' 166' ' ' GLU . 41.7 ttt180 -71.62 98.16 1.85 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.732 0.813 . . . . 10.0 110.973 170.623 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -80.86 76.99 7.78 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.874 0.87 . . . . 10.0 112.08 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 40.21 102.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 128.831 2.852 . . . . 10.0 116.474 177.672 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . 0.482 0.3 OUTLIER 71.82 -55.43 0.66 Allowed 'General case' 0 C--O 1.241 0.647 0 C-N-CA 124.749 1.22 . . . . 10.0 110.656 -175.288 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -68.29 169.47 40.06 Favored Glycine 0 C--O 1.239 0.417 0 C-N-CA 129.73 3.538 . . . . 10.0 119.666 171.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.461 0 C-N-CA 128.491 2.716 . . . . 10.0 113.461 166.583 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 N--CA 1.477 0.893 0 CA-C-O 115.781 -2.057 . . . . 10.0 105.88 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 23.28 91.89 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 129.62 3.168 . . . . 10.0 117.262 160.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 28.6 65.12 0.11 Allowed 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 128.302 2.641 . . . . 10.0 114.479 155.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 86.7 mt -56.46 137.95 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 126.407 1.883 . . . . 10.0 113.34 -158.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.5 t -136.74 -165.21 1.7 Allowed 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 126.345 1.858 . . . . 10.0 114.01 -174.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 69.97 2.84 40.9 Favored Glycine 0 C--N 1.34 0.793 0 C-N-CA 127.49 2.471 . . . . 10.0 111.496 168.049 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.8 tpp180 -158.59 -51.27 0.01 OUTLIER Pre-proline 0 N--CA 1.443 -0.822 0 CA-C-O 114.301 -2.761 . . . . 10.0 116.694 -168.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -63.97 -60.7 0.14 Allowed 'Trans proline' 0 N--CA 1.465 -0.169 0 CA-C-N 123.559 2.307 . . . . 10.0 113.2 -175.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 7.9 pm0 -67.16 4.27 0.96 Allowed 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 127.87 2.468 . . . . 10.0 115.787 179.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.422 ' CG ' ' N ' ' A' ' 11' ' ' ILE . 11.0 p-90 -51.31 -43.13 61.61 Favored 'General case' 0 C--O 1.222 -0.361 0 O-C-N 121.489 -0.757 . . . . 10.0 112.643 176.418 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.422 ' N ' ' CG ' ' A' ' 10' ' ' TRP . 8.9 tt -60.86 -49.61 83.92 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.338 0 C-N-CA 123.887 0.875 . . . . 10.0 109.316 179.416 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 2.6 m95 -55.38 -52.67 62.8 Favored 'General case' 0 C--O 1.223 -0.312 0 C-N-CA 123.455 0.702 . . . . 10.0 111.872 175.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.7 mt -57.35 -53.62 56.06 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.184 0.594 . . . . 10.0 112.213 177.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.86 -46.83 51.83 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.418 1.487 . . . . 10.0 113.288 173.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 13.3 tp -65.62 -45.0 84.77 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.312 1.445 . . . . 10.0 113.045 179.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.79 -56.29 12.15 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 124.506 1.051 . . . . 10.0 111.622 166.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 22.5 m -49.46 -52.63 27.77 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.981 1.312 . . . . 10.0 112.408 174.254 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.45 -58.84 5.88 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.109 0.964 . . . . 10.0 112.196 177.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 95.0 mt -57.52 -48.51 79.09 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.566 0.746 . . . . 10.0 112.729 -179.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 56.4 mtt -58.7 -47.17 85.45 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.345 1.058 . . . . 10.0 111.403 177.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -58.45 -58.51 14.21 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 124.356 0.979 . . . . 10.0 113.901 173.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 81.0 mt -56.19 -45.96 79.59 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-N 118.691 1.246 . . . . 10.0 112.116 176.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.75 -41.86 76.46 Favored Glycine 0 CA--C 1.533 1.214 0 C-N-CA 124.752 1.167 . . . . 10.0 113.172 173.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 28.4 m -62.29 -58.54 7.35 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.778 0.831 . . . . 10.0 111.425 171.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -52.3 -40.92 62.46 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.99 0.916 . . . . 10.0 110.962 177.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -55.82 -58.01 9.63 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.586 1.154 . . . . 10.0 112.974 172.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.1 m-30 -59.62 -38.73 82.09 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 113.184 0.809 . . . . 10.0 113.184 178.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.468 ' C ' ' H ' ' A' ' 30' ' ' LYS . 11.8 mt -56.15 -67.44 0.3 Allowed 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.621 1.168 . . . . 10.0 113.585 169.171 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 t -76.38 40.97 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-O 123.79 1.757 . . . . 10.0 110.846 179.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.468 ' H ' ' C ' ' A' ' 28' ' ' LEU . 42.9 tttm -140.87 -44.87 0.39 Allowed 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 127.9 2.48 . . . . 10.0 109.32 171.173 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.91 23.07 0.87 Allowed Glycine 0 CA--C 1.528 0.898 0 N-CA-C 115.649 1.019 . . . . 10.0 115.649 173.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 37.3 mmm -59.47 -45.03 92.8 Favored 'General case' 0 C--O 1.225 -0.228 0 C-N-CA 127.188 2.195 . . . . 10.0 113.562 -179.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.71 -84.38 1.19 Allowed Glycine 0 CA--C 1.531 1.045 0 C-N-CA 123.743 0.687 . . . . 10.0 112.47 -170.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.8 t 32.99 88.76 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.242 0.706 0 C-N-CA 128.365 2.666 . . . . 10.0 116.96 166.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 28.5 m -79.6 -50.85 10.07 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.132 -1.394 . . . . 10.0 113.93 174.101 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -48.97 117.53 6.49 Favored Pre-proline 0 CA--C 1.536 0.418 0 O-C-N 124.815 1.322 . . . . 10.0 110.95 -172.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -58.53 -29.66 89.5 Favored 'Trans proline' 0 N--CA 1.459 -0.5 0 C-N-CA 123.695 2.93 . . . . 10.0 113.74 179.095 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.29 -60.64 2.31 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.142 0.577 . . . . 10.0 111.439 176.208 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.21 -40.08 23.19 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 125.065 1.346 . . . . 10.0 113.551 171.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -46.52 -47.39 19.5 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.241 1.416 . . . . 10.0 113.444 172.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -57.79 -53.05 62.58 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.507 0.723 . . . . 10.0 110.958 176.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -57.03 -50.15 73.6 Favored 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 123.075 0.55 . . . . 10.0 112.348 -179.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -54.4 -51.29 65.35 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 118.921 -0.561 . . . . 10.0 112.377 173.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.38 -62.04 1.9 Allowed 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 113.38 0.881 . . . . 10.0 113.38 177.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.5 mt -48.42 -57.98 1.29 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 124.918 1.287 . . . . 10.0 110.323 178.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.2 m -68.42 -17.57 64.24 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.195 1.398 . . . . 10.0 113.819 -172.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 27.9 m -87.59 -40.3 14.35 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-N 119.511 1.05 . . . . 10.0 112.196 174.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 22.3 mt -58.76 -43.68 90.4 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 121.48 -0.762 . . . . 10.0 112.272 171.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 19.3 t -38.88 -66.13 0.34 Allowed Pre-proline 0 CA--C 1.552 1.032 0 C-N-CA 125.922 1.689 . . . . 10.0 112.861 175.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -69.76 -23.44 30.79 Favored 'Trans proline' 0 CA--C 1.546 1.082 0 C-N-CA 123.042 2.495 . . . . 10.0 114.66 176.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.27 -45.42 80.54 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 120.564 1.529 . . . . 10.0 113.357 175.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 32.6 mm -58.51 -46.1 89.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 O-C-N 121.072 -1.018 . . . . 10.0 109.569 169.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -51.96 -51.28 58.18 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.642 1.177 . . . . 10.0 112.127 176.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -50.37 -58.3 6.0 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 126.045 1.738 . . . . 10.0 112.321 173.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.3 m -49.17 -52.88 23.84 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 125.139 1.376 . . . . 10.0 110.755 178.093 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 33.0 mmt -69.38 -48.59 60.7 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 124.165 0.986 . . . . 10.0 112.735 -176.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -57.18 -39.58 75.64 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-O 116.766 -1.588 . . . . 10.0 113.266 173.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.8 tp -53.29 -54.53 34.98 Favored 'General case' 0 C--O 1.224 -0.238 0 CA-C-N 120.482 1.492 . . . . 10.0 111.313 169.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 24.1 p -51.69 -41.11 61.19 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 115.178 1.547 . . . . 10.0 115.178 179.019 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 59.7 mtm -66.8 -50.88 61.23 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 123.56 0.744 . . . . 10.0 110.534 176.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.3 tp -48.58 -52.66 21.75 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.826 0.851 . . . . 10.0 112.94 172.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.4 mt -76.88 -5.62 49.15 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.349 1.06 . . . . 10.0 113.828 -177.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.35 -34.74 5.52 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 115.504 0.962 . . . . 10.0 115.504 174.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -49.24 -43.13 42.49 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 115.208 1.559 . . . . 10.0 115.208 -175.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.1 3.65 60.96 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 115.377 0.911 . . . . 10.0 115.377 -178.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.33 143.47 26.36 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 126.993 2.117 . . . . 10.0 108.992 172.018 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 t -145.54 171.09 15.18 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 124.046 0.938 . . . . 10.0 111.06 166.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.02 136.11 53.33 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 123.833 0.853 . . . . 10.0 109.728 179.556 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 58.6 t -129.59 129.62 23.18 Favored Pre-proline 0 C--N 1.329 -0.299 0 C-N-CA 125.034 1.333 . . . . 10.0 110.909 -176.018 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -80.78 116.23 3.15 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 N-CA-C 109.445 -1.021 . . . . 10.0 109.445 -178.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -156.68 164.44 38.15 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.858 0.688 . . . . 10.0 112.858 172.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.34 -82.01 0.14 Allowed Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.636 -0.986 . . . . 10.0 110.636 175.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.73 -3.29 0.7 Allowed Glycine 0 CA--C 1.527 0.818 0 N-CA-C 118.706 2.242 . . . . 10.0 118.706 170.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -151.64 -171.95 4.08 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 119.353 1.577 . . . . 10.0 112.247 -165.159 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -91.79 93.85 9.06 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 125.517 1.527 . . . . 10.0 111.137 -175.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 60.1 m-80 -89.41 120.8 69.69 Favored Pre-proline 0 N--CA 1.45 -0.427 0 N-CA-C 112.97 0.73 . . . . 10.0 112.97 -165.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -61.53 131.91 38.15 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 124.219 3.279 . . . . 10.0 112.137 171.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.4 mm -140.15 126.35 21.85 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 C-N-CA 125.971 1.708 . . . . 10.0 111.684 -179.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -93.67 85.11 4.76 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 123.338 1.542 . . . . 10.0 113.026 174.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 63.8 p-90 -59.41 -28.27 66.78 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 120.619 -1.301 . . . . 10.0 113.891 174.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -54.81 -36.33 64.86 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 114.976 1.473 . . . . 10.0 114.976 178.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.4 ' HD3' ' CH2' ' A' ' 86' ' ' TRP . 0.5 OUTLIER -59.8 -35.87 75.57 Favored 'General case' 0 N--CA 1.476 0.835 0 O-C-N 120.543 -1.348 . . . . 10.0 112.168 172.103 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -66.75 -42.88 85.48 Favored 'General case' 0 CA--C 1.545 0.758 0 O-C-N 121.071 -1.018 . . . . 10.0 112.987 173.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -50.46 -48.88 56.41 Favored 'General case' 0 CA--C 1.558 1.252 0 C-N-CA 125.624 1.569 . . . . 10.0 111.513 167.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -58.61 -63.11 1.4 Allowed 'General case' 0 N--CA 1.485 1.292 0 CA-C-N 119.54 1.064 . . . . 10.0 112.465 171.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' TRP . . . . . 0.4 ' CH2' ' HD3' ' A' ' 82' ' ' ARG . 47.4 m0 -50.27 -39.42 45.09 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 126.87 2.068 . . . . 10.0 112.063 -175.075 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 32.4 tp -48.85 -48.59 41.81 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 126.434 1.893 . . . . 10.0 112.377 177.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -94.19 -46.48 7.07 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.904 0.881 . . . . 10.0 112.677 -176.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 4.7 t -62.2 -42.73 99.56 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 113.667 0.988 . . . . 10.0 113.667 -174.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . 0.308 74.5 p -63.49 -43.73 79.55 Favored Pre-proline 0 N--CA 1.473 0.697 0 O-C-N 120.977 -1.077 . . . . 10.0 112.935 -178.292 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -52.87 -44.63 46.8 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 122.912 2.408 . . . . 10.0 115.746 165.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 54.1 mt -59.84 -47.4 85.87 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 119.329 0.968 . . . . 10.0 111.714 176.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 6.1 tt -50.71 -48.95 58.6 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 126.302 1.841 . . . . 10.0 111.292 171.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.9 mp -57.46 -47.68 81.22 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.543 1.137 . . . . 10.0 113.19 169.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.77 -38.24 78.06 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 123.783 0.833 . . . . 10.0 112.925 178.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -52.32 -54.08 36.18 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 119.251 0.932 . . . . 10.0 111.15 169.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.36 -42.03 88.64 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.67 0.788 . . . . 10.0 112.094 -178.483 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.76 -54.75 37.88 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 124.0 0.92 . . . . 10.0 111.974 173.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.25 -41.16 79.11 Favored 'General case' 0 C--O 1.224 -0.237 0 C-N-CA 123.741 0.817 . . . . 10.0 112.731 174.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.9 tp -63.77 -38.58 91.65 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 114.445 1.276 . . . . 10.0 114.445 -179.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.2 t -94.85 1.49 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 124.998 1.319 . . . . 10.0 112.318 179.177 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.2 t70 48.63 53.41 12.26 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.811 1.644 . . . . 10.0 112.117 -174.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.28 145.89 47.58 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 120.017 -1.677 . . . . 10.0 112.458 -174.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.49 135.86 54.26 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 112.775 0.658 . . . . 10.0 112.775 175.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -42.82 -39.66 2.58 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.88 1.672 . . . . 10.0 113.474 175.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -47.34 -60.25 5.31 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 125.18 1.371 . . . . 10.0 115.245 169.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.0 p -61.96 -46.79 87.72 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-O 117.155 -1.402 . . . . 10.0 111.358 178.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 67.1 mt -48.49 -52.9 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 125.033 1.333 . . . . 10.0 111.115 178.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.2 tp -62.62 -51.27 67.93 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 112.549 0.574 . . . . 10.0 112.549 179.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.21 -44.84 43.62 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.465 0.706 . . . . 10.0 110.953 174.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.6 -59.91 4.69 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 127.435 2.294 . . . . 10.0 114.794 174.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.7 t -61.02 -46.31 96.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 123.743 0.817 . . . . 10.0 111.393 -178.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -56.66 -50.31 64.09 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 123.686 0.66 . . . . 10.0 112.656 174.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -55.07 -46.27 75.39 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 113.427 0.899 . . . . 10.0 113.427 173.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 53.7 t0 -58.26 -45.38 87.93 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.68 0.792 . . . . 10.0 111.679 174.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -43.31 -56.12 4.84 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 125.332 1.444 . . . . 10.0 113.322 167.062 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 82.5 mt -57.08 -55.32 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 123.811 0.844 . . . . 10.0 110.367 173.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 16.1 tmm? -48.34 -58.09 5.09 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.09 1.356 . . . . 10.0 112.785 -176.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 48.7 mm . . . . . 0 N--CA 1.475 0.784 0 O-C-N 121.662 -0.648 . . . . 10.0 112.594 177.084 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 48.6 t . . . . . 0 N--CA 1.482 1.168 0 N-CA-C 111.985 0.365 . . . . 10.0 111.985 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -52.89 -59.21 9.63 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 125.875 1.702 . . . . 10.0 112.4 175.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -42.06 -43.07 3.1 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 128.439 2.696 . . . . 10.0 113.174 175.205 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 48.3 mt -101.34 -6.53 23.97 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 115.547 1.684 . . . . 10.0 115.547 -174.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 16.9 m -69.75 116.75 10.5 Favored 'General case' 0 N--CA 1.464 0.248 0 O-C-N 120.19 -1.569 . . . . 10.0 110.366 -178.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.552 ' HD3' ' H ' ' A' ' 129' ' ' LYS . 0.1 OUTLIER -55.41 -49.67 71.78 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 128.248 2.619 . . . . 10.0 113.288 177.734 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 60.8 t -69.66 106.39 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 123.738 0.815 . . . . 10.0 110.087 179.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -46.95 -59.47 3.08 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 124.742 1.217 . . . . 10.0 114.065 -173.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 m -46.55 -42.08 15.3 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.489 1.516 . . . . 10.0 113.468 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -70.14 -24.6 63.19 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 114.959 1.466 . . . . 10.0 114.959 -178.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 69.0 mtp85 -53.94 -41.6 67.93 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 118.92 0.782 . . . . 10.0 110.787 176.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -70.11 -31.09 68.47 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 114.421 1.267 . . . . 10.0 114.421 176.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.8 t -55.49 -52.43 46.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 CA-C-N 118.989 0.813 . . . . 10.0 109.613 168.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 63.6 m95 -60.28 -44.16 95.6 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 113.914 1.079 . . . . 10.0 113.914 173.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 88.8 t90 -52.02 -49.39 63.47 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 119.469 1.032 . . . . 10.0 112.909 171.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.525 0 C-N-CA 124.166 0.987 . . . . 10.0 111.76 178.228 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.72 0 N-CA-C 112.452 0.538 . . . . 10.0 112.452 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 40.3 ttp -57.0 -53.14 61.38 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.472 1.109 . . . . 10.0 111.966 172.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 63.4 tp -52.7 -47.14 67.48 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.225 1.41 . . . . 10.0 111.858 178.284 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 77.3 t80 -50.81 -54.75 21.01 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.972 0.909 . . . . 10.0 112.587 171.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 41.5 mm -52.26 -55.89 8.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 CA-C-N 118.884 0.765 . . . . 10.0 110.35 176.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 43.0 mt -58.8 -35.15 72.38 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 118.511 -0.757 . . . . 10.0 111.761 -177.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -57.21 -58.24 9.09 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 124.018 0.927 . . . . 10.0 113.046 173.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.41 -40.88 85.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 CA-C-O 118.304 -0.855 . . . . 10.0 111.461 177.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 45.3 mt -56.78 -49.39 75.45 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.895 1.225 . . . . 10.0 112.139 171.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.423 ' HA ' ' HD2' ' A' ' 175' ' ' ARG . 11.9 t80 -77.04 -70.28 0.47 Allowed 'General case' 0 C--N 1.326 -0.435 0 O-C-N 120.083 -1.636 . . . . 10.0 112.877 -175.236 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -73.73 -21.92 60.06 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.559 1.144 . . . . 10.0 113.459 -174.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -87.78 -79.15 1.26 Allowed Glycine 0 CA--C 1.526 0.747 0 C-N-CA 123.651 0.643 . . . . 10.0 113.502 171.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -53.57 -32.44 50.92 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 126.301 1.841 . . . . 10.0 113.067 -166.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.4 m -52.15 -56.42 14.69 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 114.003 1.112 . . . . 10.0 114.003 172.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.3 p -53.69 -50.57 65.57 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 122.05 0.929 . . . . 10.0 112.269 -177.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 47.6 tttm -57.09 -46.06 82.85 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.136 0.975 . . . . 10.0 112.127 173.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.79 -47.52 80.01 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 114.513 1.301 . . . . 10.0 114.513 174.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -56.44 -11.33 1.21 Allowed 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.066 1.746 . . . . 10.0 114.235 177.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.2 m -107.08 6.69 29.15 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.382 1.873 . . . . 10.0 114.885 -179.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 93.2 mmm -91.89 -92.7 0.15 Allowed 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 123.509 1.623 . . . . 10.0 114.146 -170.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -138.69 153.91 72.66 Favored Pre-proline 0 C--O 1.236 0.367 0 C-N-CA 129.767 3.227 . . . . 10.0 105.541 170.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -52.77 -46.24 34.94 Favored 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 122.352 2.035 . . . . 10.0 113.082 179.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . 0.462 ' CD ' ' HD3' ' A' ' 227' ' ' ARG . 0.1 OUTLIER -52.94 -46.12 68.0 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 129.04 2.936 . . . . 10.0 113.292 173.569 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 92.2 t -69.19 -53.01 27.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 C-N-CA 124.034 0.933 . . . . 10.0 109.765 -178.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.19 -46.76 75.85 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.274 0.63 . . . . 10.0 111.928 177.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 60.4 p -60.03 -56.22 24.4 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.933 0.893 . . . . 10.0 112.699 174.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 61.4 m -57.17 -53.2 60.78 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.169 0.988 . . . . 10.0 113.05 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -49.55 -49.49 46.05 Favored 'General case' 0 C--O 1.222 -0.386 0 C-N-CA 123.305 0.642 . . . . 10.0 111.131 174.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -57.17 -48.42 78.77 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 114.639 1.348 . . . . 10.0 114.639 -179.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 40.4 t -55.95 -49.61 74.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 CA-C-N 118.787 0.721 . . . . 10.0 110.506 176.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 94.0 mt -58.55 -51.61 69.17 Favored 'General case' 0 C--O 1.221 -0.397 0 N-CA-C 113.207 0.818 . . . . 10.0 113.207 175.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . 0.423 ' HD2' ' HA ' ' A' ' 153' ' ' PHE . 35.7 ttp180 -47.83 -47.74 31.15 Favored 'General case' 0 C--O 1.224 -0.246 0 C-N-CA 126.818 2.047 . . . . 10.0 111.047 174.456 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 63.7 m-20 -58.53 -58.3 9.16 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 122.785 0.434 . . . . 10.0 111.252 174.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 59.4 t -51.72 -49.79 34.04 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 C-N-CA 124.078 0.951 . . . . 10.0 111.193 179.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 30.3 m -57.01 -61.5 2.4 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 128.21 2.604 . . . . 10.0 112.435 178.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 55.2 t -52.15 -49.88 38.31 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 124.471 1.108 . . . . 10.0 110.944 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 80.4 t -59.71 -61.15 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 124.299 1.04 . . . . 10.0 112.007 177.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -57.35 -50.1 74.04 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 118.78 0.718 . . . . 10.0 112.388 -176.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 10.2 m95 . . . . . 0 N--CA 1.469 0.495 0 C-N-CA 123.627 0.771 . . . . 10.0 111.935 177.453 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 93.2 t . . . . . 0 N--CA 1.479 0.997 0 CA-C-O 119.394 -0.336 . . . . 10.0 111.558 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 63.2 t90 -56.32 -52.69 63.62 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.403 1.081 . . . . 10.0 112.598 175.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 9.6 tt -57.83 -42.77 85.07 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 123.665 0.786 . . . . 10.0 112.369 -177.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 14.5 pt -83.74 -5.93 9.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 N-CA-C 115.085 1.513 . . . . 10.0 115.085 179.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.38 -169.32 33.02 Favored Glycine 0 N--CA 1.45 -0.404 0 CA-C-O 122.55 1.083 . . . . 10.0 113.925 -168.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 23.3 t -53.16 -41.43 65.16 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 114.17 -1.015 . . . . 10.0 111.854 177.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -67.98 -16.05 63.88 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 115.626 1.713 . . . . 10.0 115.626 -175.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -131.11 -106.04 1.08 Allowed Glycine 0 CA--C 1.533 1.157 0 CA-C-N 120.4 1.455 . . . . 10.0 113.908 -173.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -89.44 127.17 35.81 Favored 'General case' 0 C--N 1.328 -0.345 0 O-C-N 120.681 -1.482 . . . . 10.0 109.304 168.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -72.56 65.37 1.39 Allowed Glycine 0 CA--C 1.532 1.141 0 N-CA-C 113.871 0.308 . . . . 10.0 113.871 173.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 60.6 mt -79.54 -42.76 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 126.078 1.751 . . . . 10.0 108.759 166.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 79.7 t -126.31 133.37 24.9 Favored Pre-proline 0 N--CA 1.454 -0.25 0 C-N-CA 126.436 1.894 . . . . 10.0 109.351 -174.176 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -68.71 153.81 72.49 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 123.745 2.963 . . . . 10.0 111.479 -176.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 12.2 tp -43.18 -39.79 3.04 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.341 1.056 . . . . 10.0 112.169 171.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -48.38 -52.39 22.04 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 114.653 1.353 . . . . 10.0 114.653 176.086 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 14.0 mm -75.9 -40.51 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 C-N-CA 124.453 1.101 . . . . 10.0 109.646 177.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -49.27 -49.78 41.98 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 118.592 0.633 . . . . 10.0 111.991 173.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 16.3 m -57.75 -47.03 83.65 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 126.015 1.726 . . . . 10.0 112.97 174.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -63.36 -52.28 62.39 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.923 0.889 . . . . 10.0 112.093 179.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 93.2 mt -52.57 -59.41 4.49 Favored 'General case' 0 C--N 1.335 -0.053 0 C-N-CA 124.362 1.065 . . . . 10.0 109.954 176.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -53.11 -47.06 68.91 Favored 'General case' 0 C--O 1.216 -0.66 0 CA-C-O 117.126 -1.416 . . . . 10.0 112.001 176.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 4.6 tmm? -50.99 -52.25 44.65 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 121.454 1.934 . . . . 10.0 113.168 174.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 79.4 t -60.14 -49.15 85.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 124.708 1.203 . . . . 10.0 111.263 178.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 4.3 mp -58.16 -51.61 68.99 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.631 1.573 . . . . 10.0 112.272 175.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -55.68 -58.27 8.51 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 127.824 2.45 . . . . 10.0 110.566 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 78.7 t . . . . . 0 N--CA 1.477 0.891 0 O-C-N 121.48 -0.762 . . . . 10.0 111.764 177.234 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.246 0 CA-C-O 120.994 0.219 . . . . 10.0 112.695 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 61.1 t80 -44.3 -57.7 3.34 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.926 2.09 . . . . 10.0 112.166 166.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -55.17 -40.44 74.86 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 124.179 0.895 . . . . 10.0 114.265 177.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 24.2 mt -70.55 -27.33 64.06 Favored 'General case' 0 CA--C 1.512 -0.494 0 N-CA-C 115.528 1.677 . . . . 10.0 115.528 177.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 74.4 mt -63.27 -57.53 11.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 108.616 -0.883 . . . . 10.0 108.616 165.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 32.1 tp -58.89 -64.68 0.85 Allowed 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.95 0.9 . . . . 10.0 113.126 -172.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 84.3 mt -71.55 5.23 2.5 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 115.333 1.605 . . . . 10.0 115.333 -171.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.6 mtp-105 -112.35 0.39 15.66 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.168 0.987 . . . . 10.0 113.296 172.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 8.8 t -108.04 177.99 4.64 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 124.035 0.934 . . . . 10.0 111.002 174.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 227' ' ' ARG . . . . . 0.462 ' HD3' ' CD ' ' A' ' 166' ' ' GLU . 41.8 ttt180 -71.68 98.2 1.88 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.744 0.818 . . . . 10.0 110.953 170.673 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -80.88 76.98 7.8 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.896 0.879 . . . . 10.0 112.111 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 40.08 102.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 128.837 2.855 . . . . 10.0 116.492 177.788 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . 0.483 0.3 OUTLIER 71.92 -55.46 0.66 Allowed 'General case' 0 C--O 1.241 0.647 0 C-N-CA 124.692 1.197 . . . . 10.0 110.632 -175.346 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -68.26 169.47 39.92 Favored Glycine 0 C--O 1.238 0.376 0 C-N-CA 129.782 3.563 . . . . 10.0 119.621 171.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.461 0 C-N-CA 128.473 2.709 . . . . 10.0 113.457 166.611 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 N--CA 1.476 0.87 0 CA-C-O 115.807 -2.044 . . . . 10.0 105.858 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 23.41 91.8 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 129.598 3.159 . . . . 10.0 117.253 160.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 28.67 65.06 0.11 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 128.291 2.636 . . . . 10.0 114.474 155.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 86.7 mt -56.46 137.93 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 126.387 1.875 . . . . 10.0 113.376 -158.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.6 t -136.7 -165.22 1.7 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 126.324 1.85 . . . . 10.0 114.052 -174.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 70.01 2.83 41.23 Favored Glycine 0 C--N 1.34 0.786 0 C-N-CA 127.471 2.463 . . . . 10.0 111.485 168.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -158.56 -51.35 0.01 OUTLIER Pre-proline 0 N--CA 1.443 -0.823 0 CA-C-O 114.274 -2.774 . . . . 10.0 116.642 -168.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -63.95 -60.69 0.14 Allowed 'Trans proline' 0 N--CA 1.465 -0.202 0 CA-C-N 123.509 2.289 . . . . 10.0 113.21 -175.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 7.9 pm0 -67.16 4.35 0.94 Allowed 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 127.836 2.454 . . . . 10.0 115.764 179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.421 ' CG ' ' N ' ' A' ' 11' ' ' ILE . 11.1 p-90 -51.37 -43.14 61.78 Favored 'General case' 0 C--O 1.222 -0.361 0 O-C-N 121.516 -0.74 . . . . 10.0 112.564 176.439 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.421 ' N ' ' CG ' ' A' ' 10' ' ' TRP . 8.9 tt -60.87 -49.63 83.82 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.361 0 C-N-CA 123.926 0.89 . . . . 10.0 109.306 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 2.6 m95 -55.38 -52.62 62.93 Favored 'General case' 0 C--O 1.224 -0.259 0 C-N-CA 123.433 0.693 . . . . 10.0 111.912 175.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.6 mt -57.38 -53.61 56.24 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.112 0.565 . . . . 10.0 112.222 177.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.84 -46.79 51.67 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.391 1.476 . . . . 10.0 113.33 173.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 13.3 tp -65.62 -45.02 84.7 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 125.336 1.455 . . . . 10.0 113.047 179.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.45 -56.86 10.1 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 124.621 1.105 . . . . 10.0 111.407 165.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.2 m -49.51 -52.49 29.15 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.995 1.318 . . . . 10.0 112.242 174.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.41 -58.86 5.79 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.143 0.977 . . . . 10.0 112.176 177.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 95.3 mt -57.97 -49.34 77.16 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.678 0.791 . . . . 10.0 112.544 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 23.5 mmt -55.23 -51.04 67.86 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.587 0.755 . . . . 10.0 111.026 175.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -56.33 -58.53 13.82 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 124.441 1.019 . . . . 10.0 113.738 176.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 80.8 mt -56.21 -45.41 79.89 Favored 'General case' 0 C--O 1.221 -0.397 0 CA-C-N 118.593 1.196 . . . . 10.0 112.113 176.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.83 -42.05 77.8 Favored Glycine 0 CA--C 1.534 1.24 0 C-N-CA 124.814 1.197 . . . . 10.0 113.46 172.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 15.4 m -59.38 -61.61 2.5 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.457 1.103 . . . . 10.0 110.723 171.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -52.24 -40.96 62.37 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.039 0.936 . . . . 10.0 110.976 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -55.77 -58.08 9.32 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.611 1.165 . . . . 10.0 112.986 172.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -59.65 -38.61 81.89 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 113.255 0.835 . . . . 10.0 113.255 178.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.469 ' C ' ' H ' ' A' ' 30' ' ' LYS . 11.8 mt -56.19 -67.44 0.3 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.627 1.171 . . . . 10.0 113.597 169.118 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 t -76.37 40.98 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 CA-C-O 123.749 1.738 . . . . 10.0 110.879 179.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.469 ' H ' ' C ' ' A' ' 28' ' ' LEU . 42.9 tttm -140.87 -44.88 0.39 Allowed 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 127.87 2.468 . . . . 10.0 109.336 171.204 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.96 23.15 0.87 Allowed Glycine 0 CA--C 1.529 0.925 0 N-CA-C 115.629 1.012 . . . . 10.0 115.629 173.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 37.3 mmm -59.54 -44.97 93.06 Favored 'General case' 0 C--O 1.225 -0.235 0 C-N-CA 127.13 2.172 . . . . 10.0 113.63 -179.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.62 -84.43 1.18 Allowed Glycine 0 CA--C 1.531 1.045 0 C-N-CA 123.764 0.697 . . . . 10.0 112.508 -170.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.8 t 33.02 88.81 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.242 0.682 0 C-N-CA 128.358 2.663 . . . . 10.0 116.942 166.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.7 m -79.68 -50.85 10.01 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.167 -1.379 . . . . 10.0 113.877 174.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -48.91 117.47 6.37 Favored Pre-proline 0 CA--C 1.536 0.416 0 O-C-N 124.764 1.29 . . . . 10.0 110.949 -172.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -58.57 -29.65 89.61 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 123.726 2.951 . . . . 10.0 113.682 179.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.29 -60.64 2.3 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 123.107 0.563 . . . . 10.0 111.48 176.15 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.21 -40.02 23.0 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 125.097 1.359 . . . . 10.0 113.559 171.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.5 tttp -46.57 -47.44 19.76 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 125.243 1.417 . . . . 10.0 113.403 172.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -57.72 -53.08 62.26 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.473 0.709 . . . . 10.0 111.009 176.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -56.95 -50.24 73.24 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 123.089 0.555 . . . . 10.0 112.34 -179.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -54.44 -51.25 65.55 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 118.916 -0.564 . . . . 10.0 112.342 173.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.38 -61.98 1.93 Allowed 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 113.399 0.888 . . . . 10.0 113.399 177.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.5 mt -48.86 -56.06 2.81 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 C-N-CA 124.912 1.285 . . . . 10.0 110.832 178.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.5 m -69.49 -20.34 63.73 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.861 1.264 . . . . 10.0 113.432 -172.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 28.1 m -84.4 -38.82 19.78 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.404 1.081 . . . . 10.0 112.28 174.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 19.1 mt -59.33 -41.4 89.06 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 117.873 -1.061 . . . . 10.0 112.803 174.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . 0.405 33.0 m -58.49 -49.56 92.85 Favored Pre-proline 0 N--CA 1.486 1.36 0 CA-C-N 121.082 1.765 . . . . 10.0 114.707 -178.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -49.82 -45.32 32.66 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 123.587 2.858 . . . . 10.0 115.107 162.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.6 -46.79 84.2 Favored 'General case' 0 CA--C 1.548 0.892 0 CA-C-N 119.82 1.191 . . . . 10.0 113.704 -179.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 30.9 mm -53.22 -55.48 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 124.989 1.316 . . . . 10.0 109.595 169.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.65 -44.85 77.56 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.124 0.969 . . . . 10.0 113.567 177.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 50.2 t80 -52.59 -56.78 12.92 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.28 1.432 . . . . 10.0 111.871 172.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 14.4 m -49.92 -52.58 32.12 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.304 1.441 . . . . 10.0 110.658 177.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 32.6 mmt -69.23 -48.13 62.77 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 123.965 0.906 . . . . 10.0 113.05 -176.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -54.69 -42.55 71.55 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 120.17 1.35 . . . . 10.0 113.213 172.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.7 tp -53.33 -54.54 35.03 Favored 'General case' 0 C--O 1.224 -0.272 0 CA-C-N 119.406 1.003 . . . . 10.0 111.292 171.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 23.9 p -51.6 -41.08 60.95 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 115.239 1.57 . . . . 10.0 115.239 178.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 58.4 mtm -66.86 -50.88 61.09 Favored 'General case' 0 C--N 1.334 -0.09 0 C-N-CA 123.597 0.759 . . . . 10.0 110.477 176.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.5 tp -48.58 -52.65 21.79 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.859 0.863 . . . . 10.0 112.95 172.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.5 mt -76.94 -5.58 49.12 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.318 1.047 . . . . 10.0 113.805 -177.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.28 -34.7 5.56 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 115.504 0.962 . . . . 10.0 115.504 174.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -49.27 -43.04 42.75 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 115.278 1.584 . . . . 10.0 115.278 -176.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.05 3.52 61.2 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 115.388 0.915 . . . . 10.0 115.388 -179.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.23 143.4 26.45 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 127.016 2.126 . . . . 10.0 109.02 171.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 t -145.51 171.16 15.06 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 123.995 0.918 . . . . 10.0 111.013 166.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.02 136.05 53.39 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 123.897 0.879 . . . . 10.0 109.675 179.627 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 58.7 t -129.56 129.61 23.19 Favored Pre-proline 0 C--N 1.329 -0.295 0 C-N-CA 125.069 1.348 . . . . 10.0 110.969 -176.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -80.81 116.23 3.15 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 N-CA-C 109.367 -1.051 . . . . 10.0 109.367 -178.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -156.68 164.37 38.22 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 112.862 0.69 . . . . 10.0 112.862 172.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.36 -81.95 0.14 Allowed Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.68 -0.968 . . . . 10.0 110.68 175.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.76 -3.31 0.7 Allowed Glycine 0 CA--C 1.527 0.822 0 N-CA-C 118.684 2.234 . . . . 10.0 118.684 170.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -151.64 -171.89 4.06 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 119.327 1.564 . . . . 10.0 112.221 -165.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -91.89 93.95 9.06 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 125.456 1.502 . . . . 10.0 111.091 -175.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 60.2 m-80 -89.5 120.74 69.63 Favored Pre-proline 0 N--CA 1.45 -0.429 0 N-CA-C 112.953 0.723 . . . . 10.0 112.953 -165.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -61.47 131.93 38.36 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 124.171 3.247 . . . . 10.0 112.159 171.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.4 mm -140.16 126.3 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 C-N-CA 125.99 1.716 . . . . 10.0 111.701 -179.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -93.58 85.0 4.76 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 122.967 1.365 . . . . 10.0 113.08 174.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 63.7 p-90 -59.33 -28.28 66.68 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 120.858 -1.151 . . . . 10.0 113.96 174.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -54.14 -27.48 33.77 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 124.273 1.029 . . . . 10.0 112.2 178.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 21.4 mtt-85 -54.62 -50.21 68.65 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.92 1.288 . . . . 10.0 112.78 168.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -67.44 -39.86 85.42 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 121.409 -0.807 . . . . 10.0 112.114 178.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -52.54 -50.65 62.45 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 123.787 0.835 . . . . 10.0 112.135 170.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 54.0 t0 -52.54 -69.12 0.12 Allowed 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 126.079 1.751 . . . . 10.0 111.325 170.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 50.4 m0 -55.48 -35.23 65.3 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 125.821 1.648 . . . . 10.0 113.004 -171.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 25.5 tp -49.58 -43.41 46.17 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 126.408 1.883 . . . . 10.0 112.174 177.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -101.27 -38.5 8.05 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.833 0.853 . . . . 10.0 112.281 179.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 1.6 m -51.15 -55.02 20.0 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.88 1.272 . . . . 10.0 113.468 175.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . 0.263 44.9 p -68.12 -40.58 22.39 Favored Pre-proline 0 N--CA 1.476 0.855 0 N-CA-C 114.63 1.344 . . . . 10.0 114.63 -171.161 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -56.75 -43.04 58.45 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 123.935 3.09 . . . . 10.0 115.522 168.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 53.2 mt -60.39 -47.06 87.72 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 121.395 -0.816 . . . . 10.0 111.394 176.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 6.0 tt -50.89 -48.01 60.53 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.628 1.571 . . . . 10.0 111.596 171.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.5 mp -58.83 -46.76 86.92 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.61 1.164 . . . . 10.0 113.365 170.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.79 -38.34 78.33 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 123.824 0.849 . . . . 10.0 112.868 177.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 -52.24 -54.1 35.4 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 119.317 0.962 . . . . 10.0 111.13 169.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.31 -42.08 88.77 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.651 0.78 . . . . 10.0 112.152 -178.509 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.66 -54.73 37.84 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.962 0.905 . . . . 10.0 112.056 173.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.33 -41.15 79.44 Favored 'General case' 0 C--O 1.224 -0.237 0 C-N-CA 123.767 0.827 . . . . 10.0 112.667 174.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.9 tp -63.8 -38.51 91.38 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 114.461 1.282 . . . . 10.0 114.461 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.2 t -94.85 1.45 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 125.022 1.329 . . . . 10.0 112.316 179.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.2 t70 48.57 53.51 12.02 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.866 1.666 . . . . 10.0 112.095 -174.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.27 145.9 47.58 Favored 'General case' 0 CA--C 1.534 0.339 0 O-C-N 119.977 -1.702 . . . . 10.0 112.459 -174.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.47 135.95 54.17 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 112.715 0.635 . . . . 10.0 112.715 175.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -42.89 -39.74 2.66 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 125.906 1.682 . . . . 10.0 113.41 175.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -47.32 -60.21 5.32 Favored Glycine 0 CA--C 1.525 0.691 0 C-N-CA 125.12 1.343 . . . . 10.0 115.222 169.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.6 p -62.05 -46.8 87.54 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 117.147 -1.406 . . . . 10.0 111.321 178.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 66.9 mt -48.39 -52.92 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 125.001 1.321 . . . . 10.0 111.147 178.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.2 tp -62.64 -51.27 67.93 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 112.548 0.573 . . . . 10.0 112.548 179.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.15 -44.9 43.13 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.506 0.722 . . . . 10.0 110.905 174.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.52 -59.94 4.65 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 127.431 2.292 . . . . 10.0 114.8 174.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.5 t -61.03 -46.33 96.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 123.697 0.799 . . . . 10.0 111.388 -178.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -56.62 -50.35 63.76 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 123.695 0.664 . . . . 10.0 112.619 174.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -54.7 -46.85 74.2 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 113.275 0.843 . . . . 10.0 113.275 173.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -57.45 -45.39 84.78 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.804 0.842 . . . . 10.0 112.135 174.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -43.98 -55.65 5.53 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 125.385 1.469 . . . . 10.0 113.131 167.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 80.1 mt -55.73 -54.11 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 CA-C-O 118.03 -0.986 . . . . 10.0 110.464 173.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 63.4 ttp -46.36 -55.64 7.02 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 120.091 1.314 . . . . 10.0 112.978 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 1.7 mp -68.74 -49.99 59.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 O-C-N 121.543 -0.723 . . . . 10.0 111.591 179.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -52.49 -54.46 27.2 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 123.914 0.768 . . . . 10.0 111.958 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 18.4 m -53.62 -46.96 70.66 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 126.227 1.811 . . . . 10.0 111.798 173.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -49.48 -54.14 17.71 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 124.651 1.119 . . . . 10.0 113.587 170.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 61.7 tp -57.53 -48.35 79.54 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 125.159 1.384 . . . . 10.0 111.994 176.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 63.3 t -52.71 -51.25 37.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 123.249 0.62 . . . . 10.0 110.128 173.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -50.08 -61.18 5.97 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 125.923 1.725 . . . . 10.0 112.709 171.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -46.99 -38.84 11.4 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 127.191 2.196 . . . . 10.0 113.638 178.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 48.2 mt -99.62 -6.87 26.58 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 115.347 1.61 . . . . 10.0 115.347 -178.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 17.0 m -69.67 116.74 10.41 Favored 'General case' 0 N--CA 1.464 0.256 0 O-C-N 120.162 -1.586 . . . . 10.0 110.378 -178.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.552 ' HD3' ' H ' ' A' ' 129' ' ' LYS . 0.1 OUTLIER -55.44 -49.65 71.9 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 128.195 2.598 . . . . 10.0 113.3 177.711 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 61.3 t -69.67 106.32 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 C-N-CA 123.773 0.829 . . . . 10.0 110.121 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -46.89 -59.51 3.04 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 124.769 1.228 . . . . 10.0 114.067 -173.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 m -46.46 -42.1 14.9 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.467 1.507 . . . . 10.0 113.497 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -70.18 -24.59 63.16 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 114.917 1.451 . . . . 10.0 114.917 -178.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 68.8 mtp85 -54.01 -41.65 68.21 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 118.862 0.755 . . . . 10.0 110.864 176.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -69.59 -32.07 70.59 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.755 1.222 . . . . 10.0 114.202 176.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.9 t -54.88 -52.23 45.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-N 119.063 0.847 . . . . 10.0 109.615 168.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 64.2 m95 -61.08 -44.23 97.69 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 114.238 1.199 . . . . 10.0 114.238 174.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 90.4 t90 -53.36 -48.4 68.59 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 119.284 0.947 . . . . 10.0 112.959 172.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -56.76 -53.5 57.08 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.013 0.925 . . . . 10.0 111.607 177.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 98.3 mt -54.27 -49.0 66.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 124.937 1.295 . . . . 10.0 111.748 174.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 20.9 m -55.45 -45.49 76.86 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.63 1.172 . . . . 10.0 111.766 175.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 37.3 m -64.34 -40.47 95.94 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 125.515 1.526 . . . . 10.0 112.164 177.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -57.81 -49.03 78.0 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.972 0.909 . . . . 10.0 112.343 169.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -56.27 -46.97 79.45 Favored 'General case' 0 CA--C 1.546 0.819 0 O-C-N 121.486 -0.759 . . . . 10.0 112.235 172.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 41.4 ttp -55.47 -57.92 9.92 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.218 1.007 . . . . 10.0 112.776 174.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.3 pp -61.61 -35.84 79.04 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 118.309 -0.853 . . . . 10.0 112.147 -176.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 75.3 t80 -54.1 -55.27 29.19 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 119.312 0.96 . . . . 10.0 111.95 167.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 54.7 mt -53.59 -55.27 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 123.807 0.843 . . . . 10.0 110.741 177.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 9.9 mp -56.24 -37.06 69.23 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.23 1.012 . . . . 10.0 112.678 178.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -57.27 -58.19 9.31 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 124.057 0.943 . . . . 10.0 112.999 173.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.47 -40.91 85.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 CA-C-O 118.338 -0.839 . . . . 10.0 111.442 177.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 47.1 mt -56.72 -49.48 75.07 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 119.875 1.216 . . . . 10.0 112.098 171.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.424 ' HA ' ' HD2' ' A' ' 175' ' ' ARG . 11.8 t80 -77.01 -70.25 0.47 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 120.087 -1.633 . . . . 10.0 112.877 -175.186 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -73.76 -21.91 60.03 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.587 1.155 . . . . 10.0 113.439 -174.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -87.84 -79.02 1.26 Allowed Glycine 0 CA--C 1.526 0.761 0 C-N-CA 123.599 0.619 . . . . 10.0 113.539 171.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -53.68 -32.42 51.63 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 126.275 1.83 . . . . 10.0 113.024 -166.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.3 m -52.1 -56.46 14.28 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 114.01 1.115 . . . . 10.0 114.01 172.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.7 p -53.63 -50.55 65.48 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 122.081 0.944 . . . . 10.0 112.307 -177.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 47.7 tttm -57.14 -46.07 83.0 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.165 0.986 . . . . 10.0 112.086 173.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.81 -47.48 80.18 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 114.504 1.298 . . . . 10.0 114.504 174.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -56.42 -11.33 1.2 Allowed 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 126.095 1.758 . . . . 10.0 114.223 177.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.1 m -107.11 6.64 29.06 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.408 1.883 . . . . 10.0 114.869 -179.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 93.2 mmm -91.92 -92.68 0.15 Allowed 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 123.48 1.609 . . . . 10.0 114.139 -170.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -138.69 153.93 72.67 Favored Pre-proline 0 C--O 1.236 0.352 0 C-N-CA 129.823 3.249 . . . . 10.0 105.57 170.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -52.8 -46.25 34.99 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.296 1.998 . . . . 10.0 113.102 179.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . 0.462 ' CD ' ' HD3' ' A' ' 227' ' ' ARG . 0.1 OUTLIER -53.02 -45.99 68.21 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 128.972 2.909 . . . . 10.0 113.285 173.619 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 91.7 t -69.24 -53.01 27.74 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.237 0 C-N-CA 124.031 0.933 . . . . 10.0 109.81 -178.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.13 -46.8 75.66 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.287 0.635 . . . . 10.0 111.933 177.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 60.2 p -59.99 -56.23 24.31 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.972 0.909 . . . . 10.0 112.687 174.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 61.3 m -57.19 -53.21 60.73 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.189 0.995 . . . . 10.0 113.036 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -49.57 -49.49 46.26 Favored 'General case' 0 C--O 1.221 -0.438 0 C-N-CA 123.258 0.623 . . . . 10.0 111.098 174.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -57.19 -48.43 78.78 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 114.664 1.357 . . . . 10.0 114.664 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 40.4 t -55.91 -49.66 73.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 CA-C-N 118.802 0.728 . . . . 10.0 110.477 176.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 94.2 mt -58.54 -51.69 68.82 Favored 'General case' 0 C--O 1.222 -0.389 0 N-CA-C 113.168 0.803 . . . . 10.0 113.168 175.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . 0.424 ' HD2' ' HA ' ' A' ' 153' ' ' PHE . 35.5 ttp180 -47.76 -47.76 30.38 Favored 'General case' 0 C--O 1.225 -0.222 0 C-N-CA 126.816 2.046 . . . . 10.0 111.087 174.446 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 63.5 m-20 -58.47 -58.36 8.89 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 122.819 0.448 . . . . 10.0 111.282 174.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 54.2 t -51.92 -52.29 23.84 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 C-N-CA 124.033 0.933 . . . . 10.0 111.875 179.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 64.1 m -54.59 -61.07 2.55 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 127.408 2.283 . . . . 10.0 113.178 175.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 51.6 t -51.58 -50.13 31.28 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 CA-C-N 120.26 1.391 . . . . 10.0 110.805 -178.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 79.1 t -58.99 -61.0 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 124.211 1.004 . . . . 10.0 112.268 176.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 78.5 mt -57.47 -51.46 69.36 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 118.623 0.647 . . . . 10.0 112.403 -177.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 10.8 m95 -55.81 -48.17 75.89 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 123.66 0.784 . . . . 10.0 111.521 179.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 8.6 t -58.59 -21.9 54.56 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 114.645 1.35 . . . . 10.0 114.645 177.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -69.74 -40.21 76.32 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 119.738 1.154 . . . . 10.0 113.392 174.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -46.09 -56.0 11.8 Favored Pre-proline 0 N--CA 1.478 0.943 0 C-N-CA 125.219 1.408 . . . . 10.0 114.574 -178.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -59.22 -34.45 98.25 Favored 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 122.162 1.908 . . . . 10.0 113.6 178.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 34.7 t -66.54 -58.5 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 123.817 0.847 . . . . 10.0 110.657 177.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 16.4 m -61.65 -34.28 61.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 CA-C-O 118.898 -0.572 . . . . 10.0 112.439 -177.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 62.2 t90 -57.75 -57.59 12.09 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.344 1.457 . . . . 10.0 112.304 167.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 9.3 tt -58.24 -40.45 81.75 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.802 0.841 . . . . 10.0 112.574 -175.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 14.7 pt -82.67 -5.65 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 N-CA-C 115.195 1.554 . . . . 10.0 115.195 178.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.3 -169.26 33.11 Favored Glycine 0 N--CA 1.45 -0.404 0 CA-C-O 122.551 1.084 . . . . 10.0 113.921 -168.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 23.3 t -53.17 -39.96 63.98 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 114.166 -1.017 . . . . 10.0 111.879 177.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -68.48 -14.9 63.32 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 125.744 1.618 . . . . 10.0 115.171 -174.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -136.27 -104.81 0.75 Allowed Glycine 0 CA--C 1.541 1.662 0 C-N-CA 125.21 1.386 . . . . 10.0 114.951 -174.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -89.43 127.17 35.81 Favored 'General case' 0 C--N 1.328 -0.352 0 O-C-N 120.697 -1.473 . . . . 10.0 109.357 168.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -72.51 65.38 1.37 Allowed Glycine 0 CA--C 1.532 1.127 0 N-CA-C 113.915 0.326 . . . . 10.0 113.915 173.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 60.7 mt -79.61 -42.72 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 126.08 1.752 . . . . 10.0 108.725 166.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 79.4 t -126.34 133.38 24.91 Favored Pre-proline 0 N--CA 1.454 -0.264 0 C-N-CA 126.502 1.921 . . . . 10.0 109.417 -174.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -68.74 153.76 72.54 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 123.811 3.007 . . . . 10.0 111.476 -176.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 12.2 tp -43.13 -39.77 2.95 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.381 1.072 . . . . 10.0 112.214 171.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -48.39 -52.35 22.26 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 114.702 1.371 . . . . 10.0 114.702 176.055 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 14.0 mm -75.96 -40.44 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 124.378 1.071 . . . . 10.0 109.666 177.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -49.29 -49.8 42.08 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 118.592 0.633 . . . . 10.0 111.946 173.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 16.3 m -57.74 -47.08 83.47 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 126.045 1.738 . . . . 10.0 112.953 174.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -63.25 -52.36 62.45 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.985 0.914 . . . . 10.0 112.131 179.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 93.2 mt -52.55 -59.22 4.72 Favored 'General case' 0 C--O 1.228 -0.041 0 C-N-CA 124.278 1.031 . . . . 10.0 109.973 176.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -52.52 -46.16 66.59 Favored 'General case' 0 C--O 1.221 -0.427 0 CA-C-O 117.821 -1.085 . . . . 10.0 112.37 176.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 4.6 tmm? -52.42 -51.82 57.12 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 120.62 1.555 . . . . 10.0 113.023 175.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 79.5 t -60.9 -50.35 80.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 124.418 1.087 . . . . 10.0 111.419 178.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 4.6 mp -55.81 -52.01 65.46 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.77 1.628 . . . . 10.0 111.979 175.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -55.12 -61.85 2.05 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 126.449 1.9 . . . . 10.0 110.471 178.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 98.1 t -54.72 -42.84 63.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 CA-C-N 119.529 1.059 . . . . 10.0 111.597 -178.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 6.6 t -55.81 -52.64 63.31 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.085 0.554 . . . . 10.0 112.067 171.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -69.21 -19.49 63.96 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 115.693 1.738 . . . . 10.0 115.693 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -91.44 -74.19 0.51 Allowed 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.949 1.299 . . . . 10.0 110.544 169.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 20.8 t -77.41 -49.19 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 C-N-CA 125.726 1.61 . . . . 10.0 111.153 -168.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -55.04 -56.07 24.99 Favored Glycine 0 N--CA 1.476 1.316 0 CA-C-N 119.098 0.863 . . . . 10.0 112.753 177.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -44.32 -57.96 3.2 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 127.106 2.163 . . . . 10.0 112.316 166.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -55.82 -39.88 78.84 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 124.188 0.899 . . . . 10.0 114.032 177.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 24.4 mt -70.43 -27.53 64.34 Favored 'General case' 0 CA--C 1.511 -0.535 0 N-CA-C 115.52 1.674 . . . . 10.0 115.52 177.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 74.2 mt -63.27 -57.55 11.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 108.642 -0.873 . . . . 10.0 108.642 165.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 32.0 tp -58.79 -64.72 0.83 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.92 0.888 . . . . 10.0 113.184 -172.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 84.0 mt -71.52 5.19 2.5 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 115.332 1.604 . . . . 10.0 115.332 -171.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.6 mtp-105 -112.32 0.38 15.68 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.188 0.995 . . . . 10.0 113.316 172.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 8.8 t -108.03 177.96 4.65 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 124.046 0.938 . . . . 10.0 111.0 174.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . 0.462 ' HD3' ' CD ' ' A' ' 166' ' ' GLU . 41.7 ttt180 -71.62 98.13 1.84 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.786 0.835 . . . . 10.0 110.96 170.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -80.87 76.96 7.79 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.828 0.851 . . . . 10.0 112.116 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 40.19 102.25 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 128.857 2.863 . . . . 10.0 116.497 177.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . 0.482 0.3 OUTLIER 71.83 -55.44 0.66 Allowed 'General case' 0 C--O 1.242 0.677 0 C-N-CA 124.769 1.227 . . . . 10.0 110.637 -175.273 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -68.25 169.47 39.89 Favored Glycine 0 C--O 1.239 0.429 0 C-N-CA 129.735 3.541 . . . . 10.0 119.701 171.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.461 0 C-N-CA 128.498 2.719 . . . . 10.0 113.46 166.616 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 999' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A 1000 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A 1001 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A 1002 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A 1003 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 N--CA 1.477 0.918 0 CA-C-O 115.804 -2.046 . . . . 10.0 105.785 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 23.4 91.84 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 129.58 3.152 . . . . 10.0 117.236 160.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 28.63 65.11 0.11 Allowed 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 128.306 2.643 . . . . 10.0 114.458 155.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 86.7 mt -56.51 137.99 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 126.358 1.863 . . . . 10.0 113.372 -158.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.6 t -136.76 -165.26 1.7 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 126.329 1.852 . . . . 10.0 113.97 -174.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 70.05 2.8 41.33 Favored Glycine 0 C--N 1.34 0.768 0 C-N-CA 127.477 2.465 . . . . 10.0 111.487 168.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.8 tpp180 -158.58 -51.34 0.01 OUTLIER Pre-proline 0 N--CA 1.444 -0.772 0 CA-C-O 114.206 -2.806 . . . . 10.0 116.623 -168.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_exo -63.99 -60.6 0.15 Allowed 'Trans proline' 0 CA--C 1.528 0.185 0 CA-C-N 123.517 2.292 . . . . 10.0 113.242 -175.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 7.9 pm0 -67.19 4.22 0.99 Allowed 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 127.855 2.462 . . . . 10.0 115.735 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.422 ' CG ' ' N ' ' A' ' 11' ' ' ILE . 11.0 p-90 -51.32 -43.1 61.64 Favored 'General case' 0 C--O 1.222 -0.361 0 O-C-N 121.496 -0.752 . . . . 10.0 112.669 176.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.422 ' N ' ' CG ' ' A' ' 10' ' ' TRP . 8.9 tt -60.85 -49.65 83.74 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.319 0 C-N-CA 123.936 0.894 . . . . 10.0 109.298 179.359 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 2.6 m95 -55.34 -52.63 62.86 Favored 'General case' 0 C--O 1.224 -0.261 0 C-N-CA 123.384 0.674 . . . . 10.0 111.93 175.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.8 mt -57.36 -53.63 55.96 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 123.193 0.597 . . . . 10.0 112.186 177.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.87 -46.79 51.93 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.41 1.484 . . . . 10.0 113.326 173.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 13.2 tp -65.7 -44.9 84.71 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.302 1.441 . . . . 10.0 113.027 179.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.97 -55.89 13.69 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 124.544 1.069 . . . . 10.0 111.759 166.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 22.5 m -49.76 -52.62 30.4 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.001 1.32 . . . . 10.0 112.43 174.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.38 -58.88 5.71 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.133 0.973 . . . . 10.0 112.173 177.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 95.2 mt -57.55 -48.51 79.14 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.593 0.757 . . . . 10.0 112.816 -179.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 57.6 mtt -57.41 -49.5 76.03 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.089 0.956 . . . . 10.0 111.534 176.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -56.63 -58.85 12.35 Favored Glycine 0 CA--C 1.528 0.844 0 CA-C-O 118.873 -0.959 . . . . 10.0 113.673 174.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 81.1 mt -56.16 -46.08 79.43 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-N 118.82 1.31 . . . . 10.0 112.13 176.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.62 -41.6 74.44 Favored Glycine 0 CA--C 1.535 1.294 0 C-N-CA 124.742 1.163 . . . . 10.0 113.254 173.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 27.9 m -62.46 -58.71 6.62 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.097 0.959 . . . . 10.0 111.316 172.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -52.27 -40.96 62.44 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.001 0.92 . . . . 10.0 110.949 177.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.4 t80 -55.82 -58.02 9.59 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.583 1.153 . . . . 10.0 112.968 172.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.1 m-30 -59.64 -38.69 82.07 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 113.225 0.824 . . . . 10.0 113.225 178.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.467 ' C ' ' H ' ' A' ' 30' ' ' LYS . 11.8 mt -56.1 -67.41 0.3 Allowed 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.625 1.17 . . . . 10.0 113.628 169.104 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 t -76.41 40.95 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 CA-C-O 123.756 1.741 . . . . 10.0 110.91 179.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.467 ' H ' ' C ' ' A' ' 28' ' ' LEU . 42.8 tttm -140.84 -44.84 0.39 Allowed 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 127.872 2.469 . . . . 10.0 109.354 171.153 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.96 23.15 0.87 Allowed Glycine 0 CA--C 1.529 0.945 0 N-CA-C 115.624 1.01 . . . . 10.0 115.624 173.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 37.3 mmm -59.59 -45.01 93.16 Favored 'General case' 0 C--O 1.224 -0.272 0 C-N-CA 127.161 2.184 . . . . 10.0 113.529 -178.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.62 -84.43 1.18 Allowed Glycine 0 CA--C 1.53 1.018 0 C-N-CA 123.766 0.698 . . . . 10.0 112.47 -170.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.7 t 33.01 88.79 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.243 0.753 0 C-N-CA 128.405 2.682 . . . . 10.0 116.975 166.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.7 m -79.7 -50.83 10.03 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.193 -1.367 . . . . 10.0 113.855 174.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -48.92 117.51 6.42 Favored Pre-proline 0 CA--C 1.537 0.443 0 O-C-N 124.76 1.288 . . . . 10.0 110.983 -172.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -58.57 -29.68 89.71 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 123.713 2.942 . . . . 10.0 113.688 179.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.29 -60.63 2.31 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.122 0.569 . . . . 10.0 111.429 176.215 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.19 -40.04 22.86 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 125.072 1.349 . . . . 10.0 113.583 171.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.5 tttp -46.58 -47.42 19.79 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.275 1.43 . . . . 10.0 113.397 172.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -57.76 -53.07 62.36 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.487 0.715 . . . . 10.0 110.978 176.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 44.2 m-85 -56.96 -50.23 73.28 Favored 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 123.075 0.55 . . . . 10.0 112.345 -179.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -54.4 -51.24 65.5 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 118.926 -0.559 . . . . 10.0 112.376 173.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.41 -62.01 1.91 Allowed 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 113.374 0.879 . . . . 10.0 113.374 177.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.3 mt -48.48 -56.78 1.88 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 124.863 1.265 . . . . 10.0 110.889 178.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.8 m -68.46 -21.67 64.61 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.871 1.268 . . . . 10.0 113.413 -172.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 27.5 m -83.37 -40.05 19.9 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.423 1.089 . . . . 10.0 112.33 175.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 16.8 mt -59.14 -44.19 92.06 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 113.147 0.795 . . . . 10.0 113.147 174.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 31.9 t -43.26 -64.51 0.74 Allowed Pre-proline 0 CA--C 1.549 0.911 0 C-N-CA 124.978 1.311 . . . . 10.0 113.119 177.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -67.88 -24.64 39.8 Favored 'Trans proline' 0 CA--C 1.543 0.975 0 C-N-CA 122.383 2.056 . . . . 10.0 113.767 177.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -67.27 -48.73 66.82 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 120.316 1.416 . . . . 10.0 113.154 175.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 27.6 mt -66.12 -42.65 91.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 O-C-N 120.568 -1.333 . . . . 10.0 109.443 174.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.32 -45.56 72.64 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 113.261 0.837 . . . . 10.0 113.261 171.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 45.0 t80 -49.81 -54.96 16.03 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 125.704 1.602 . . . . 10.0 111.681 169.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 14.7 m -48.92 -53.35 20.03 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.386 1.475 . . . . 10.0 111.0 176.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 32.2 mmt -67.99 -48.62 65.27 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 124.122 0.969 . . . . 10.0 113.062 -177.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -56.83 -40.44 76.07 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 120.182 1.355 . . . . 10.0 113.322 173.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.8 tp -53.31 -54.54 34.93 Favored 'General case' 0 C--O 1.225 -0.223 0 CA-C-N 119.795 1.18 . . . . 10.0 111.272 170.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 24.0 p -51.69 -41.04 61.14 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 115.217 1.562 . . . . 10.0 115.217 179.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 59.0 mtm -66.86 -50.89 61.07 Favored 'General case' 0 C--N 1.334 -0.085 0 C-N-CA 123.571 0.748 . . . . 10.0 110.435 176.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.3 tp -48.57 -52.65 21.71 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.889 0.875 . . . . 10.0 112.939 172.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.5 mt -76.98 -5.5 48.91 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.325 1.05 . . . . 10.0 113.793 -177.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.25 -34.7 5.56 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 115.522 0.969 . . . . 10.0 115.522 174.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -49.3 -43.06 43.01 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 115.277 1.584 . . . . 10.0 115.277 -176.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.07 3.57 61.13 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 115.379 0.912 . . . . 10.0 115.379 -179.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.25 143.42 26.43 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 127.021 2.129 . . . . 10.0 109.015 171.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 t -145.51 171.11 15.13 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 124.081 0.952 . . . . 10.0 111.041 166.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.04 136.05 53.39 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 123.89 0.876 . . . . 10.0 109.706 179.633 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 58.6 t -129.58 129.55 23.18 Favored Pre-proline 0 C--N 1.33 -0.281 0 C-N-CA 125.074 1.35 . . . . 10.0 110.949 -176.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -80.7 116.27 3.18 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 N-CA-C 109.4 -1.038 . . . . 10.0 109.4 -178.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -156.74 164.41 38.15 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 112.824 0.676 . . . . 10.0 112.824 172.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.37 -81.96 0.14 Allowed Glycine 0 CA--C 1.526 0.764 0 N-CA-C 110.684 -0.966 . . . . 10.0 110.684 175.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.74 -3.39 0.7 Allowed Glycine 0 CA--C 1.527 0.808 0 N-CA-C 118.662 2.225 . . . . 10.0 118.662 170.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -151.59 -171.89 4.06 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 119.406 1.603 . . . . 10.0 112.218 -165.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -91.88 93.86 9.03 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 125.525 1.53 . . . . 10.0 111.111 -175.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 60.3 m-80 -89.41 120.79 69.69 Favored Pre-proline 0 N--CA 1.45 -0.425 0 N-CA-C 112.941 0.719 . . . . 10.0 112.941 -165.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -61.54 131.87 37.92 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 124.181 3.254 . . . . 10.0 112.201 171.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.4 mm -140.07 126.3 22.07 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 C-N-CA 126.055 1.742 . . . . 10.0 111.75 -179.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -93.6 85.02 4.76 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 123.012 1.387 . . . . 10.0 113.065 174.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 63.8 p-90 -59.36 -28.25 66.69 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 120.865 -1.147 . . . . 10.0 113.931 174.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -55.07 -28.47 52.62 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.239 1.015 . . . . 10.0 113.152 178.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.0 mtt-85 -49.88 -58.04 6.21 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.447 1.099 . . . . 10.0 111.292 168.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -62.6 -40.64 97.58 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 126.076 1.75 . . . . 10.0 112.437 -179.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -52.24 -48.92 64.92 Favored 'General case' 0 CA--C 1.568 1.647 0 CA-C-N 119.597 1.09 . . . . 10.0 111.15 168.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -59.19 -64.38 0.96 Allowed 'General case' 0 N--CA 1.494 1.753 0 CA-C-N 121.212 1.824 . . . . 10.0 110.792 169.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 48.1 m0 -50.65 -35.51 31.01 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.94 1.296 . . . . 10.0 111.865 -170.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 26.4 tp -51.29 -42.59 61.26 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.39 1.876 . . . . 10.0 113.335 176.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -101.45 -52.54 3.21 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.213 1.005 . . . . 10.0 112.645 -175.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 1.1 m -46.15 -51.01 14.85 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 125.64 1.576 . . . . 10.0 112.829 175.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.7 m -64.58 -45.89 76.75 Favored Pre-proline 0 CA--C 1.547 0.837 0 O-C-N 121.343 -0.848 . . . . 10.0 112.661 -169.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -51.29 -44.83 40.74 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 124.053 3.169 . . . . 10.0 116.749 162.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 59.4 mt -59.3 -46.67 87.93 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 119.134 0.879 . . . . 10.0 111.358 175.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.5 tp -50.31 -47.74 55.52 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.341 1.856 . . . . 10.0 111.892 172.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.9 mp -60.87 -46.5 90.36 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.414 1.486 . . . . 10.0 113.032 170.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.9 -38.22 78.37 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.82 0.848 . . . . 10.0 112.854 178.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -52.3 -54.05 36.4 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 119.269 0.94 . . . . 10.0 111.166 169.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.3 -42.11 88.79 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.621 0.768 . . . . 10.0 112.131 -178.507 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.66 -54.77 37.27 Favored 'General case' 0 C--O 1.225 -0.186 0 C-N-CA 123.995 0.918 . . . . 10.0 112.011 173.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.28 -41.18 79.23 Favored 'General case' 0 C--O 1.224 -0.239 0 C-N-CA 123.719 0.808 . . . . 10.0 112.725 174.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.9 tp -63.77 -38.56 91.54 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 114.45 1.278 . . . . 10.0 114.45 -179.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.2 t -94.82 1.47 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 125.008 1.323 . . . . 10.0 112.313 179.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.2 t70 48.61 53.4 12.25 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.829 1.652 . . . . 10.0 112.1 -174.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.17 145.88 47.77 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 119.916 -1.74 . . . . 10.0 112.474 -174.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.54 135.9 54.45 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 112.697 0.628 . . . . 10.0 112.697 175.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -42.83 -39.71 2.61 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.894 1.678 . . . . 10.0 113.456 175.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -47.32 -60.22 5.32 Favored Glycine 0 CA--C 1.526 0.731 0 C-N-CA 125.109 1.338 . . . . 10.0 115.252 169.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.4 p -62.06 -46.75 87.75 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 117.057 -1.449 . . . . 10.0 111.335 178.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 66.9 mt -48.45 -52.93 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 124.995 1.318 . . . . 10.0 111.128 178.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.1 tp -62.55 -51.35 67.74 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 112.554 0.576 . . . . 10.0 112.554 179.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.13 -44.9 42.86 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.424 0.689 . . . . 10.0 110.97 174.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.58 -59.89 4.73 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 127.363 2.265 . . . . 10.0 114.787 174.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.6 t -61.04 -46.29 96.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 123.685 0.794 . . . . 10.0 111.41 -178.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -56.64 -50.36 63.75 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 123.674 0.654 . . . . 10.0 112.642 174.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -54.21 -46.74 72.56 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.571 0.748 . . . . 10.0 112.94 173.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -60.89 -41.77 96.67 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 112.707 0.632 . . . . 10.0 112.707 176.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -43.85 -56.94 4.89 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 125.43 1.491 . . . . 10.0 113.078 164.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 85.4 mt -56.84 -50.49 75.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 CA-C-N 117.776 0.788 . . . . 10.0 111.668 175.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 47.9 ttp -48.66 -58.4 4.8 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.295 1.438 . . . . 10.0 112.056 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 36.8 mm -68.61 -44.99 82.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 O-C-N 121.959 -0.463 . . . . 10.0 112.03 178.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -51.99 -60.59 7.4 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 124.829 1.204 . . . . 10.0 112.908 177.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 42.7 p -59.51 -35.88 75.01 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.687 0.795 . . . . 10.0 112.695 174.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -47.92 -56.82 8.36 Favored Glycine 0 CA--C 1.539 1.576 0 C-N-CA 124.336 0.969 . . . . 10.0 113.673 164.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 67.4 tp -58.66 -47.39 84.63 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.623 1.569 . . . . 10.0 111.887 177.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 68.5 t -52.69 -51.48 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 123.314 0.646 . . . . 10.0 110.371 173.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -49.22 -60.92 5.8 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 125.871 1.7 . . . . 10.0 112.275 171.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -48.85 -37.71 20.29 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 126.576 1.95 . . . . 10.0 113.76 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 49.7 mt -99.31 -6.57 27.69 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 115.22 1.563 . . . . 10.0 115.22 -178.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 16.8 m -69.74 116.73 10.48 Favored 'General case' 0 N--CA 1.464 0.266 0 O-C-N 120.165 -1.584 . . . . 10.0 110.345 -178.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.553 ' HD3' ' H ' ' A' ' 129' ' ' LYS . 0.2 OUTLIER -55.45 -49.61 72.0 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 128.205 2.602 . . . . 10.0 113.305 177.728 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 60.9 t -69.64 106.35 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 123.788 0.835 . . . . 10.0 110.089 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -46.88 -59.55 3.01 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 124.809 1.244 . . . . 10.0 114.038 -173.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 m -46.47 -42.11 14.97 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.501 1.521 . . . . 10.0 113.496 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -70.2 -24.54 63.14 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 114.918 1.451 . . . . 10.0 114.918 -178.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 69.3 mtp85 -53.66 -42.18 67.6 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-N 118.923 0.783 . . . . 10.0 110.701 176.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -69.57 -31.65 69.94 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.826 1.25 . . . . 10.0 114.322 176.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.8 t -55.31 -51.74 53.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-N 119.064 0.847 . . . . 10.0 109.582 168.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 66.8 m95 -62.08 -42.77 99.54 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 114.335 1.235 . . . . 10.0 114.335 174.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 92.8 t90 -53.92 -48.63 70.0 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.265 1.026 . . . . 10.0 112.618 172.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -57.01 -52.07 66.72 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.71 0.804 . . . . 10.0 111.639 176.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 96.5 mt -55.98 -54.92 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 124.923 1.289 . . . . 10.0 112.009 176.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 5.0 p -57.01 -42.22 79.97 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 121.509 -0.745 . . . . 10.0 112.513 175.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 72.4 m -62.01 -42.72 99.47 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.741 1.216 . . . . 10.0 112.631 174.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -58.59 -47.23 85.0 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 119.424 1.011 . . . . 10.0 112.314 171.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -56.42 -48.95 75.92 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.474 0.71 . . . . 10.0 112.234 172.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 9.6 tmm? -51.67 -52.94 44.13 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.919 1.688 . . . . 10.0 111.858 173.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 7.8 tt -53.59 -52.05 61.03 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.856 1.662 . . . . 10.0 112.392 175.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 72.9 t80 -49.47 -53.91 20.58 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.225 1.01 . . . . 10.0 112.098 173.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 36.9 mm -52.81 -56.09 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 CA-C-N 118.818 0.736 . . . . 10.0 110.387 177.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 18.5 mt -58.71 -34.48 71.37 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 117.979 -1.01 . . . . 10.0 112.037 -178.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -57.26 -58.18 9.36 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 119.513 1.052 . . . . 10.0 113.076 173.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.4 -40.91 85.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 CA-C-O 118.32 -0.847 . . . . 10.0 111.438 177.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 44.1 mt -56.76 -49.42 75.3 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 119.919 1.236 . . . . 10.0 112.12 171.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.424 ' HA ' ' HD2' ' A' ' 175' ' ' ARG . 12.0 t80 -77.02 -70.31 0.47 Allowed 'General case' 0 C--N 1.326 -0.435 0 O-C-N 120.049 -1.657 . . . . 10.0 112.857 -175.216 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -73.7 -21.98 60.06 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.665 1.186 . . . . 10.0 113.411 -174.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -87.77 -79.17 1.26 Allowed Glycine 0 CA--C 1.527 0.806 0 C-N-CA 123.639 0.637 . . . . 10.0 113.49 171.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -53.52 -32.47 50.65 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 126.295 1.838 . . . . 10.0 113.067 -166.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.2 m -52.13 -56.42 14.65 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 114.018 1.118 . . . . 10.0 114.018 172.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.3 p -53.69 -50.57 65.57 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 122.079 0.942 . . . . 10.0 112.271 -177.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 47.6 tttm -57.09 -46.02 82.9 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.168 0.987 . . . . 10.0 112.16 173.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.84 -47.48 80.25 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 114.475 1.287 . . . . 10.0 114.475 174.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -56.53 -11.25 1.21 Allowed 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.034 1.734 . . . . 10.0 114.249 177.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.1 m -107.05 6.62 29.16 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.411 1.884 . . . . 10.0 114.846 -179.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 93.2 mmm -91.9 -92.67 0.15 Allowed 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 123.523 1.63 . . . . 10.0 114.146 -170.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -138.72 153.95 72.63 Favored Pre-proline 0 C--O 1.235 0.308 0 C-N-CA 129.756 3.223 . . . . 10.0 105.552 170.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -52.85 -46.19 35.46 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 122.285 1.99 . . . . 10.0 113.088 179.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . 0.462 ' CD ' ' HD3' ' A' ' 227' ' ' ARG . 0.1 OUTLIER -53.02 -46.04 68.22 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 129.049 2.94 . . . . 10.0 113.259 173.571 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 92.2 t -69.25 -53.0 27.75 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.253 0 C-N-CA 124.06 0.944 . . . . 10.0 109.771 -178.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.12 -46.86 75.63 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.284 0.634 . . . . 10.0 111.915 177.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 60.5 p -59.99 -56.15 25.28 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.908 0.883 . . . . 10.0 112.741 174.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 61.8 m -57.24 -53.18 60.97 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.13 0.972 . . . . 10.0 113.006 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -49.6 -49.51 46.42 Favored 'General case' 0 C--O 1.222 -0.375 0 C-N-CA 123.311 0.644 . . . . 10.0 111.086 174.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -57.16 -48.37 78.87 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 114.678 1.362 . . . . 10.0 114.678 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 40.3 t -56.01 -49.59 74.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 CA-C-N 118.794 0.725 . . . . 10.0 110.507 176.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 94.1 mt -58.58 -51.57 69.35 Favored 'General case' 0 C--O 1.222 -0.394 0 N-CA-C 113.197 0.814 . . . . 10.0 113.197 175.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . 0.424 ' HD2' ' HA ' ' A' ' 153' ' ' PHE . 35.5 ttp180 -47.87 -47.75 31.57 Favored 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 126.82 2.048 . . . . 10.0 111.017 174.463 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 63.6 m-20 -58.54 -58.29 9.19 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 122.809 0.444 . . . . 10.0 111.283 174.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 59.8 t -51.67 -48.86 36.55 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 124.074 0.949 . . . . 10.0 111.678 179.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 19.8 m -58.76 -62.08 2.13 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 127.267 2.227 . . . . 10.0 112.009 178.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 54.5 t -50.69 -49.44 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 C-N-CA 124.599 1.159 . . . . 10.0 110.998 -179.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 74.2 t -59.65 -62.6 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 123.883 0.873 . . . . 10.0 112.55 177.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -57.97 -45.95 85.9 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 118.669 0.668 . . . . 10.0 112.108 -175.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 9.5 m0 -56.54 -45.53 81.13 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 123.652 0.781 . . . . 10.0 113.0 176.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 49.6 m -56.33 -31.58 63.87 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 113.171 0.804 . . . . 10.0 113.171 176.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -65.57 -44.98 85.07 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 113.761 1.023 . . . . 10.0 113.761 176.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -43.49 -56.67 6.58 Favored Pre-proline 0 N--CA 1.479 1.01 0 N-CA-C 115.144 1.535 . . . . 10.0 115.144 -178.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -60.31 -36.09 88.94 Favored 'Trans proline' 0 C--N 1.355 0.889 0 C-N-CA 122.895 2.397 . . . . 10.0 113.439 177.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 34.5 t -63.94 -52.37 57.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 124.124 0.97 . . . . 10.0 110.532 176.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 98.2 t -53.38 -49.9 51.0 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 124.846 1.258 . . . . 10.0 111.418 175.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 28.1 t90 -54.63 -53.91 48.53 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.657 1.183 . . . . 10.0 112.493 174.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 10.0 tt -55.52 -44.95 77.15 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 124.187 0.995 . . . . 10.0 112.625 -178.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 15.0 pt -84.93 -5.52 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 N-CA-C 115.118 1.525 . . . . 10.0 115.118 -178.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.29 -169.27 33.13 Favored Glycine 0 N--CA 1.45 -0.397 0 CA-C-O 122.604 1.113 . . . . 10.0 113.925 -168.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 23.3 t -53.18 -41.0 64.82 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 114.156 -1.022 . . . . 10.0 111.871 177.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -54.17 -32.16 54.67 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 128.621 2.768 . . . . 10.0 115.266 179.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -131.25 -103.86 0.97 Allowed Glycine 0 CA--C 1.528 0.879 0 CA-C-N 119.346 0.976 . . . . 10.0 113.566 -167.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -89.47 127.17 35.82 Favored 'General case' 0 C--N 1.328 -0.328 0 O-C-N 120.657 -1.496 . . . . 10.0 109.32 169.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -72.42 65.31 1.35 Allowed Glycine 0 CA--C 1.532 1.138 0 N-CA-C 113.914 0.326 . . . . 10.0 113.914 173.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 60.7 mt -79.57 -42.76 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 C-N-CA 126.096 1.759 . . . . 10.0 108.766 166.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 79.2 t -126.29 133.41 24.93 Favored Pre-proline 0 N--CA 1.454 -0.25 0 C-N-CA 126.496 1.918 . . . . 10.0 109.372 -174.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -68.76 153.76 72.49 Favored 'Trans proline' 0 N--CA 1.461 -0.441 0 C-N-CA 123.834 3.023 . . . . 10.0 111.459 -176.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 12.2 tp -43.17 -39.78 3.02 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.312 1.045 . . . . 10.0 112.202 171.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -48.33 -52.37 21.86 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 114.715 1.376 . . . . 10.0 114.715 176.012 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 14.0 mm -75.93 -40.47 38.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 C-N-CA 124.39 1.076 . . . . 10.0 109.681 177.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -49.31 -49.78 42.39 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 118.546 0.612 . . . . 10.0 111.981 173.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 16.1 m -57.67 -47.07 83.35 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 126.013 1.725 . . . . 10.0 112.991 174.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -63.31 -52.38 62.16 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.024 0.93 . . . . 10.0 112.06 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 93.2 mt -52.51 -59.96 3.81 Favored 'General case' 0 C--N 1.335 -0.053 0 C-N-CA 124.363 1.065 . . . . 10.0 109.953 176.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -52.92 -45.12 67.47 Favored 'General case' 0 C--O 1.216 -0.667 0 CA-C-O 116.773 -1.584 . . . . 10.0 112.086 176.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 4.6 tmm? -52.65 -53.04 52.59 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 121.719 2.054 . . . . 10.0 113.114 174.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 81.8 t -59.96 -47.03 93.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 125.129 1.371 . . . . 10.0 111.158 178.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 4.2 mp -59.81 -50.16 74.89 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.677 1.591 . . . . 10.0 112.298 174.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 32.6 m-20 -55.57 -59.72 4.44 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 127.458 2.303 . . . . 10.0 111.069 177.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 25.4 m -60.44 -42.56 91.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 O-C-N 121.086 -1.009 . . . . 10.0 112.56 -177.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 66.5 p -65.36 -53.32 45.22 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 121.615 -0.678 . . . . 10.0 112.132 176.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -73.12 22.4 0.07 Allowed 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 125.411 1.484 . . . . 10.0 114.776 176.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 21.2 mttm -139.32 -73.38 0.38 Allowed 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 126.287 1.835 . . . . 10.0 109.669 172.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 22.8 t -69.24 -50.83 48.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 124.795 1.238 . . . . 10.0 110.993 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -55.45 -53.52 40.58 Favored Glycine 0 CA--C 1.535 1.327 0 C-N-CA 124.038 0.827 . . . . 10.0 113.157 176.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -44.9 -56.17 4.79 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 126.522 1.929 . . . . 10.0 112.007 166.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -55.67 -39.28 75.34 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 124.554 1.073 . . . . 10.0 114.003 177.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 24.9 mt -69.66 -27.81 65.35 Favored 'General case' 0 CA--C 1.512 -0.481 0 N-CA-C 115.687 1.736 . . . . 10.0 115.687 176.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 74.6 mt -63.45 -57.5 11.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 108.545 -0.909 . . . . 10.0 108.545 165.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 32.1 tp -58.81 -64.65 0.86 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.948 0.899 . . . . 10.0 113.193 -172.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 84.1 mt -71.51 5.14 2.52 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 115.347 1.61 . . . . 10.0 115.347 -171.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.6 mtp-105 -112.33 0.4 15.67 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 124.214 1.006 . . . . 10.0 113.304 172.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 8.8 t -108.06 177.98 4.65 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 124.089 0.956 . . . . 10.0 111.03 174.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . 0.462 ' HD3' ' CD ' ' A' ' 166' ' ' GLU . 41.8 ttt180 -71.65 98.16 1.86 Allowed 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.824 0.85 . . . . 10.0 110.893 170.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -80.92 77.03 7.84 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.861 0.864 . . . . 10.0 112.1 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 40.1 102.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 128.901 2.88 . . . . 10.0 116.444 177.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . 0.481 0.3 OUTLIER 71.86 -55.42 0.66 Allowed 'General case' 0 C--O 1.242 0.691 0 C-N-CA 124.749 1.22 . . . . 10.0 110.644 -175.334 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -68.32 169.48 40.13 Favored Glycine 0 C--O 1.239 0.422 0 C-N-CA 129.727 3.537 . . . . 10.0 119.655 171.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.459 0 C-N-CA 128.477 2.711 . . . . 10.0 113.438 166.655 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 999' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A 1000 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A 1001 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A 1002 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A 1003 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 N--CA 1.477 0.913 0 CA-C-O 115.813 -2.041 . . . . 10.0 105.805 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 23.35 91.93 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 129.568 3.147 . . . . 10.0 117.213 160.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 28.57 65.08 0.1 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 128.307 2.643 . . . . 10.0 114.514 155.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 86.8 mt -56.52 137.98 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 126.379 1.872 . . . . 10.0 113.336 -158.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.6 t -136.71 -165.19 1.69 Allowed 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 126.331 1.852 . . . . 10.0 114.05 -174.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 69.95 2.83 40.72 Favored Glycine 0 C--N 1.34 0.768 0 C-N-CA 127.503 2.477 . . . . 10.0 111.511 168.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.8 tpp180 -158.51 -51.39 0.01 OUTLIER Pre-proline 0 N--CA 1.443 -0.783 0 CA-C-O 114.309 -2.758 . . . . 10.0 116.665 -168.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_exo -64.0 -60.58 0.15 Allowed 'Trans proline' 0 N--CA 1.464 -0.218 0 CA-C-N 123.524 2.294 . . . . 10.0 113.215 -175.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 7.9 pm0 -67.24 4.34 0.97 Allowed 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 127.831 2.452 . . . . 10.0 115.764 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.422 ' CG ' ' N ' ' A' ' 11' ' ' ILE . 11.0 p-90 -51.43 -43.06 61.91 Favored 'General case' 0 C--O 1.223 -0.34 0 O-C-N 121.509 -0.744 . . . . 10.0 112.641 176.453 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.422 ' N ' ' CG ' ' A' ' 10' ' ' TRP . 8.9 tt -60.91 -49.61 83.94 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.34 0 C-N-CA 123.862 0.865 . . . . 10.0 109.316 179.4 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 2.6 m95 -55.35 -52.67 62.76 Favored 'General case' 0 C--O 1.224 -0.259 0 C-N-CA 123.4 0.68 . . . . 10.0 111.871 175.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.3 mt -57.3 -53.65 55.69 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 123.21 0.604 . . . . 10.0 112.227 177.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.86 -46.8 51.83 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.413 1.485 . . . . 10.0 113.324 173.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 13.4 tp -65.64 -44.96 84.8 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 125.298 1.439 . . . . 10.0 113.03 179.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -50.02 -57.15 10.35 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 124.045 0.831 . . . . 10.0 111.264 166.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 22.6 m -48.43 -52.62 21.22 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.602 1.161 . . . . 10.0 112.364 174.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.39 -58.86 5.81 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.139 0.976 . . . . 10.0 112.188 177.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 94.2 mt -57.61 -50.43 73.17 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.762 0.825 . . . . 10.0 112.578 -179.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -54.14 -50.31 67.23 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.464 1.106 . . . . 10.0 111.346 175.343 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -58.07 -57.99 16.92 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 124.271 0.939 . . . . 10.0 113.666 176.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 80.8 mt -56.24 -45.77 79.86 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-N 118.434 1.117 . . . . 10.0 112.103 176.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.28 -42.75 74.52 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 125.03 1.3 . . . . 10.0 113.167 172.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 24.1 m -60.79 -59.64 5.06 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 124.038 0.935 . . . . 10.0 111.303 171.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -52.28 -41.02 62.52 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.061 0.944 . . . . 10.0 110.974 178.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -55.75 -58.03 9.55 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.561 1.144 . . . . 10.0 113.006 172.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -59.63 -38.7 82.06 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 113.226 0.825 . . . . 10.0 113.226 178.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.468 ' C ' ' H ' ' A' ' 30' ' ' LYS . 11.8 mt -56.16 -67.47 0.29 Allowed 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.572 1.149 . . . . 10.0 113.576 169.154 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 t -76.36 41.02 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 CA-C-O 123.802 1.763 . . . . 10.0 110.891 179.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.468 ' H ' ' C ' ' A' ' 28' ' ' LEU . 43.0 tttm -140.89 -44.91 0.39 Allowed 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 127.905 2.482 . . . . 10.0 109.303 171.199 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.9 23.07 0.86 Allowed Glycine 0 CA--C 1.529 0.956 0 N-CA-C 115.644 1.017 . . . . 10.0 115.644 173.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 37.3 mmm -59.52 -44.96 93.02 Favored 'General case' 0 C--O 1.224 -0.253 0 C-N-CA 127.17 2.188 . . . . 10.0 113.578 -178.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.66 -84.45 1.18 Allowed Glycine 0 CA--C 1.531 1.045 0 C-N-CA 123.741 0.686 . . . . 10.0 112.477 -170.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.7 t 33.09 88.75 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.242 0.682 0 C-N-CA 128.36 2.664 . . . . 10.0 116.941 166.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.8 m -79.67 -50.89 9.96 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.187 -1.37 . . . . 10.0 113.832 174.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -48.86 117.47 6.33 Favored Pre-proline 0 CA--C 1.536 0.428 0 O-C-N 124.794 1.309 . . . . 10.0 110.983 -172.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -58.53 -29.66 89.51 Favored 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 123.792 2.995 . . . . 10.0 113.698 179.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.35 -60.65 2.3 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.058 0.543 . . . . 10.0 111.455 176.183 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.08 -40.15 22.33 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 125.14 1.376 . . . . 10.0 113.554 171.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -46.53 -47.4 19.57 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 125.261 1.424 . . . . 10.0 113.463 172.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -57.77 -53.01 62.99 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.425 0.69 . . . . 10.0 111.009 176.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -57.04 -50.21 73.44 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 123.049 0.54 . . . . 10.0 112.323 -179.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -54.37 -51.28 65.31 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 118.935 -0.555 . . . . 10.0 112.379 173.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.36 -62.0 1.92 Allowed 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 113.404 0.89 . . . . 10.0 113.404 177.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.5 mt -48.88 -56.35 2.51 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 C-N-CA 124.829 1.251 . . . . 10.0 110.496 178.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.5 m -70.07 -16.91 63.2 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.109 1.364 . . . . 10.0 113.688 -172.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 27.5 m -87.92 -37.72 16.2 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.134 0.973 . . . . 10.0 112.152 174.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 20.4 mt -60.88 -39.36 88.94 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-O 118.406 -0.807 . . . . 10.0 113.091 173.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . 0.35 33.3 m -55.16 -54.11 54.07 Favored Pre-proline 0 N--CA 1.485 1.278 0 N-CA-C 114.579 1.326 . . . . 10.0 114.579 179.318 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -67.61 -26.44 39.71 Favored 'Trans proline' 0 CA--C 1.545 1.055 0 CA-C-N 123.137 2.156 . . . . 10.0 113.099 173.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.44 -47.7 75.27 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-N 120.181 1.355 . . . . 10.0 113.324 175.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 19.3 tt -65.51 -41.03 89.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 O-C-N 120.431 -1.418 . . . . 10.0 111.419 171.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -49.89 -49.93 47.79 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 118.732 0.696 . . . . 10.0 112.156 170.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 53.2 t80 -51.85 -57.93 7.92 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 125.711 1.604 . . . . 10.0 112.473 173.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.5 m -49.2 -52.72 25.07 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 125.094 1.358 . . . . 10.0 110.856 178.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.435 ' HG3' ' CB ' ' A' ' 85' ' ' ASP . 32.9 mmt -70.02 -47.95 60.02 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 124.21 1.004 . . . . 10.0 112.618 -175.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -56.14 -41.07 74.79 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 120.328 1.422 . . . . 10.0 113.206 172.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.8 tp -53.3 -54.57 34.54 Favored 'General case' 0 C--O 1.224 -0.272 0 CA-C-N 120.024 1.284 . . . . 10.0 111.275 170.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 23.9 p -51.6 -41.16 61.02 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 115.203 1.557 . . . . 10.0 115.203 178.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 57.6 mtm -66.84 -50.81 61.37 Favored 'General case' 0 C--N 1.333 -0.113 0 C-N-CA 123.54 0.736 . . . . 10.0 110.481 176.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.2 tp -48.64 -52.66 22.06 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.882 0.873 . . . . 10.0 112.894 172.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.4 mt -76.9 -5.61 49.15 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.383 1.073 . . . . 10.0 113.786 -177.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.26 -34.66 5.59 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 115.53 0.972 . . . . 10.0 115.53 174.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 75.3 t80 -49.32 -43.13 43.26 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 115.206 1.558 . . . . 10.0 115.206 -176.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.02 3.54 61.06 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 115.313 0.885 . . . . 10.0 115.313 -179.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.25 143.41 26.44 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 127.035 2.134 . . . . 10.0 109.011 172.023 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 t -145.5 171.07 15.19 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 124.064 0.946 . . . . 10.0 111.019 166.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.97 136.08 53.37 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 123.947 0.899 . . . . 10.0 109.73 179.554 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 58.7 t -129.59 129.56 23.17 Favored Pre-proline 0 C--N 1.329 -0.295 0 C-N-CA 125.098 1.359 . . . . 10.0 110.966 -176.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -80.77 116.24 3.16 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 N-CA-C 109.41 -1.035 . . . . 10.0 109.41 -178.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -156.71 164.41 38.16 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 112.845 0.683 . . . . 10.0 112.845 172.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.37 -81.93 0.14 Allowed Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.681 -0.967 . . . . 10.0 110.681 175.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.8 -3.34 0.69 Allowed Glycine 0 CA--C 1.526 0.762 0 N-CA-C 118.677 2.231 . . . . 10.0 118.677 170.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -151.61 -171.89 4.06 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 119.379 1.589 . . . . 10.0 112.224 -165.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -91.84 93.88 9.05 Favored 'General case' 0 CA--C 1.519 -0.23 0 C-N-CA 125.547 1.539 . . . . 10.0 111.146 -175.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 60.5 m-80 -89.52 120.79 69.62 Favored Pre-proline 0 N--CA 1.45 -0.43 0 N-CA-C 112.933 0.716 . . . . 10.0 112.933 -165.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -61.53 131.92 38.19 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 124.208 3.272 . . . . 10.0 112.158 171.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.5 mm -140.12 126.34 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 C-N-CA 126.0 1.72 . . . . 10.0 111.71 -179.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -93.65 85.07 4.76 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 122.701 1.238 . . . . 10.0 113.055 174.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 63.8 p-90 -59.45 -28.2 66.75 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 113.921 1.082 . . . . 10.0 113.921 174.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -54.58 -28.53 46.8 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 113.809 1.04 . . . . 10.0 113.809 178.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 77.7 mtt-85 -52.15 -58.63 6.0 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 119.318 0.963 . . . . 10.0 111.263 169.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -58.67 -40.06 82.43 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 125.697 1.599 . . . . 10.0 111.967 -179.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -52.18 -50.95 60.83 Favored 'General case' 0 CA--C 1.552 1.05 0 CA-C-N 119.368 0.986 . . . . 10.0 112.133 168.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.435 ' CB ' ' HG3' ' A' ' 56' ' ' MET . 0.0 OUTLIER -60.34 -59.82 4.8 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.961 1.304 . . . . 10.0 112.388 173.18 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 52.3 m0 -54.19 -37.8 64.92 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 126.88 2.072 . . . . 10.0 112.714 -176.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 32.5 tp -50.39 -45.16 55.26 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 126.207 1.803 . . . . 10.0 111.845 178.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -97.79 -43.35 7.18 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 123.961 0.905 . . . . 10.0 112.671 -178.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -58.26 -44.09 88.2 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 113.105 0.779 . . . . 10.0 113.105 -176.446 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.5 m -68.58 -45.21 35.08 Favored Pre-proline 0 CA--C 1.544 0.735 0 O-C-N 121.302 -0.874 . . . . 10.0 112.386 -172.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -52.34 -44.43 46.68 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 123.672 2.914 . . . . 10.0 115.865 165.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 52.8 mt -59.09 -46.63 87.81 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 118.815 0.734 . . . . 10.0 111.426 175.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.2 tp -50.47 -48.73 56.51 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.65 1.58 . . . . 10.0 112.235 172.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.0 mp -59.09 -46.99 86.88 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.192 1.397 . . . . 10.0 112.714 170.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.88 -38.25 78.4 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.866 0.866 . . . . 10.0 112.837 178.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -52.24 -54.09 35.53 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 119.34 0.973 . . . . 10.0 111.187 169.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.35 -42.1 88.58 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.635 0.774 . . . . 10.0 112.113 -178.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.64 -54.79 36.95 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 124.006 0.923 . . . . 10.0 112.014 173.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.25 -41.15 79.05 Favored 'General case' 0 C--O 1.224 -0.237 0 C-N-CA 123.715 0.806 . . . . 10.0 112.764 174.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.8 tp -63.8 -38.54 91.46 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 114.436 1.273 . . . . 10.0 114.436 -179.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.2 t -94.83 1.39 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 125.069 1.347 . . . . 10.0 112.316 179.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.2 t70 48.63 53.49 12.13 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.864 1.666 . . . . 10.0 112.079 -174.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.27 145.93 47.56 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 119.988 -1.695 . . . . 10.0 112.469 -174.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.56 135.91 54.51 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 112.723 0.638 . . . . 10.0 112.723 175.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -42.87 -39.63 2.6 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.83 1.652 . . . . 10.0 113.508 175.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -47.34 -60.19 5.35 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 125.147 1.356 . . . . 10.0 115.264 169.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.6 p -62.09 -46.77 87.6 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 117.1 -1.428 . . . . 10.0 111.309 178.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 66.9 mt -48.41 -52.94 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 125.038 1.335 . . . . 10.0 111.117 178.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.2 tp -62.59 -51.31 67.84 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 112.528 0.566 . . . . 10.0 112.528 179.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.28 -44.81 44.25 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.437 0.695 . . . . 10.0 110.935 174.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.56 -59.9 4.71 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 127.393 2.277 . . . . 10.0 114.831 174.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.6 t -61.01 -46.38 96.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 123.705 0.802 . . . . 10.0 111.37 -178.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -56.6 -50.36 63.61 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 123.686 0.66 . . . . 10.0 112.631 174.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -54.64 -46.67 73.99 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 113.215 0.82 . . . . 10.0 113.215 173.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -57.74 -45.75 85.39 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.218 0.607 . . . . 10.0 111.938 174.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -43.22 -56.09 4.79 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 125.196 1.379 . . . . 10.0 113.002 167.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 88.9 mt -56.76 -52.58 52.76 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 123.518 0.727 . . . . 10.0 111.372 174.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 6.1 tmm? -51.58 -56.72 11.9 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.786 1.234 . . . . 10.0 112.566 -176.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 44.5 mm -67.53 -44.07 86.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 123.068 0.547 . . . . 10.0 112.075 177.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -54.18 -56.72 19.94 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 124.701 1.143 . . . . 10.0 113.207 177.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 38.1 p -57.22 -38.27 73.5 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.326 1.05 . . . . 10.0 112.336 172.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -49.38 -54.23 16.92 Favored Glycine 0 CA--C 1.534 1.279 0 C-N-CA 124.428 1.013 . . . . 10.0 113.172 167.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 65.6 tp -59.51 -48.01 83.3 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 125.157 1.383 . . . . 10.0 112.109 176.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 67.9 t -52.74 -51.62 34.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 123.363 0.665 . . . . 10.0 110.36 174.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -49.77 -60.7 6.24 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 125.937 1.732 . . . . 10.0 112.191 172.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -49.11 -37.49 21.9 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.558 1.943 . . . . 10.0 113.732 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 48.8 mt -99.07 -6.71 27.93 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 115.315 1.598 . . . . 10.0 115.315 -179.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 16.9 m -69.66 116.75 10.42 Favored 'General case' 0 N--CA 1.464 0.229 0 O-C-N 120.15 -1.594 . . . . 10.0 110.386 -178.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.553 ' HD3' ' H ' ' A' ' 129' ' ' LYS . 0.1 OUTLIER -55.5 -49.63 72.06 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 128.23 2.612 . . . . 10.0 113.252 177.765 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 60.3 t -69.61 106.33 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 123.819 0.848 . . . . 10.0 110.071 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -46.92 -59.56 3.01 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 124.787 1.235 . . . . 10.0 114.048 -173.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 m -46.41 -42.13 14.7 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.474 1.51 . . . . 10.0 113.513 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -70.15 -24.63 63.19 Favored 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 114.95 1.463 . . . . 10.0 114.95 -178.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 69.3 mtp85 -53.78 -41.82 67.65 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 118.857 0.753 . . . . 10.0 110.881 176.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -69.42 -32.44 71.43 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.815 1.246 . . . . 10.0 114.216 176.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 49.0 t -55.12 -52.11 47.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 CA-C-N 119.033 0.833 . . . . 10.0 109.965 169.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 69.7 m95 -59.39 -51.5 69.63 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 113.47 0.915 . . . . 10.0 113.47 174.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 85.3 t90 -47.98 -47.23 33.07 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.268 1.027 . . . . 10.0 113.304 174.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -58.5 -51.28 70.52 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.058 0.943 . . . . 10.0 111.768 176.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 97.1 mt -55.37 -51.76 53.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 125.146 1.378 . . . . 10.0 111.553 174.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 20.0 m -53.64 -47.18 70.55 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.734 1.214 . . . . 10.0 112.106 174.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 86.4 m -60.82 -47.11 87.85 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.491 1.516 . . . . 10.0 111.506 177.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -54.35 -49.65 69.29 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 119.385 0.993 . . . . 10.0 112.44 172.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -57.66 -43.83 85.24 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 123.736 0.814 . . . . 10.0 112.922 174.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 39.4 ttp -58.13 -51.41 69.83 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.19 0.996 . . . . 10.0 112.18 172.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 5.6 mp -51.65 -48.55 63.33 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 126.596 1.959 . . . . 10.0 112.042 175.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 77.9 t80 -54.07 -54.26 41.87 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.664 0.785 . . . . 10.0 113.06 172.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 49.4 mt -54.32 -55.35 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 123.566 0.746 . . . . 10.0 110.8 178.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . 0.289 3.9 pp -60.63 -31.26 70.46 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 116.833 -1.556 . . . . 10.0 113.371 179.055 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -57.26 -58.2 9.28 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 120.554 1.524 . . . . 10.0 113.064 170.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.39 -40.88 85.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-O 118.321 -0.847 . . . . 10.0 111.469 177.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 46.9 mt -56.83 -49.34 75.7 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 119.84 1.2 . . . . 10.0 112.164 171.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.423 ' HA ' ' HD2' ' A' ' 175' ' ' ARG . 11.8 t80 -76.97 -70.34 0.47 Allowed 'General case' 0 C--N 1.326 -0.447 0 O-C-N 120.056 -1.653 . . . . 10.0 112.887 -175.288 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -73.71 -21.99 60.05 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.596 1.158 . . . . 10.0 113.439 -174.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -87.78 -79.08 1.26 Allowed Glycine 0 CA--C 1.526 0.77 0 C-N-CA 123.602 0.62 . . . . 10.0 113.545 171.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 5.4 m-30 -53.61 -32.46 51.25 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 126.271 1.828 . . . . 10.0 113.019 -166.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.3 m -52.08 -56.44 14.4 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 113.991 1.108 . . . . 10.0 113.991 172.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.6 p -53.68 -50.58 65.52 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 122.121 0.962 . . . . 10.0 112.282 -177.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 47.7 tttm -57.15 -46.01 83.09 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.194 0.998 . . . . 10.0 112.11 173.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.82 -47.46 80.24 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 114.545 1.313 . . . . 10.0 114.545 174.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -56.49 -11.28 1.21 Allowed 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 126.068 1.747 . . . . 10.0 114.258 177.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.1 m -107.08 6.57 29.04 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.467 1.907 . . . . 10.0 114.881 -179.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 93.2 mmm -91.89 -92.67 0.15 Allowed 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 123.506 1.622 . . . . 10.0 114.164 -170.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -138.69 153.97 72.71 Favored Pre-proline 0 C--O 1.236 0.349 0 C-N-CA 129.848 3.259 . . . . 10.0 105.548 170.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -52.88 -46.21 35.38 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.261 1.974 . . . . 10.0 113.074 179.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . 0.462 ' CD ' ' HD3' ' A' ' 227' ' ' ARG . 0.1 OUTLIER -52.95 -46.08 68.02 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 129.022 2.929 . . . . 10.0 113.242 173.569 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 92.2 t -69.18 -52.99 28.02 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 C-N-CA 124.085 0.954 . . . . 10.0 109.85 -178.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.2 -46.8 75.89 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.238 0.615 . . . . 10.0 111.933 177.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 60.1 p -59.95 -56.25 24.06 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.972 0.909 . . . . 10.0 112.68 174.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 62.0 m -57.22 -53.19 60.94 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.202 1.001 . . . . 10.0 113.004 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -49.61 -49.49 46.65 Favored 'General case' 0 C--O 1.222 -0.375 0 C-N-CA 123.239 0.616 . . . . 10.0 111.102 174.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -57.11 -48.46 78.57 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 114.629 1.344 . . . . 10.0 114.629 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 40.4 t -55.95 -49.63 74.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 CA-C-N 118.794 0.725 . . . . 10.0 110.476 176.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 94.2 mt -58.57 -51.63 69.09 Favored 'General case' 0 C--O 1.222 -0.389 0 N-CA-C 113.201 0.815 . . . . 10.0 113.201 175.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . 0.423 ' HD2' ' HA ' ' A' ' 153' ' ' PHE . 35.5 ttp180 -47.71 -47.77 29.85 Favored 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 126.85 2.06 . . . . 10.0 111.092 174.395 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 63.4 m-20 -58.55 -58.29 9.22 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 122.799 0.44 . . . . 10.0 111.255 174.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 54.2 t -51.93 -47.61 41.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 C-N-CA 124.082 0.953 . . . . 10.0 112.143 179.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 25.0 m -59.39 -63.02 1.45 Allowed 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 127.507 2.323 . . . . 10.0 111.755 178.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 55.8 t -50.12 -49.9 21.21 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 C-N-CA 124.799 1.24 . . . . 10.0 110.975 -179.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 70.8 t -59.13 -61.65 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 123.912 0.885 . . . . 10.0 112.616 178.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 91.5 mt -58.36 -46.99 85.23 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 118.19 0.45 . . . . 10.0 111.871 -176.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 9.0 m0 -51.68 -52.34 48.88 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 124.121 0.968 . . . . 10.0 112.217 174.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 8.5 t -54.52 -27.62 39.43 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 114.147 1.166 . . . . 10.0 114.147 179.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -68.64 -41.42 79.44 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 113.595 0.961 . . . . 10.0 113.595 175.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -47.64 -55.19 17.91 Favored Pre-proline 0 N--CA 1.476 0.871 0 N-CA-C 115.558 1.688 . . . . 10.0 115.558 -175.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -59.76 -34.85 95.79 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 122.251 1.968 . . . . 10.0 112.925 177.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 24.9 t -63.98 -55.57 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 124.443 1.097 . . . . 10.0 110.469 176.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 90.4 t -53.19 -48.37 54.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 125.406 1.482 . . . . 10.0 111.657 176.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 34.7 t90 -55.79 -55.82 27.88 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.844 1.258 . . . . 10.0 112.288 174.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 9.8 tt -55.9 -44.23 78.03 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 124.289 1.036 . . . . 10.0 112.639 -177.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 14.7 pt -82.79 -5.68 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 N-CA-C 114.989 1.477 . . . . 10.0 114.989 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.58 -169.35 32.75 Favored Glycine 0 N--CA 1.45 -0.379 0 CA-C-O 122.545 1.08 . . . . 10.0 113.855 -168.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 23.2 t -53.15 -39.55 63.63 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 114.217 -0.992 . . . . 10.0 111.847 177.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -56.86 -32.39 65.76 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 128.439 2.695 . . . . 10.0 115.286 -179.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -129.61 -104.41 1.11 Allowed Glycine 0 CA--C 1.524 0.628 0 CA-C-O 122.169 0.872 . . . . 10.0 112.738 -167.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -89.39 127.17 35.79 Favored 'General case' 0 C--N 1.328 -0.352 0 O-C-N 120.64 -1.506 . . . . 10.0 109.3 170.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -72.5 65.38 1.37 Allowed Glycine 0 CA--C 1.532 1.124 0 N-CA-C 113.879 0.312 . . . . 10.0 113.879 173.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 60.6 mt -79.67 -42.69 22.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 126.083 1.753 . . . . 10.0 108.725 166.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 79.8 t -126.31 133.4 24.93 Favored Pre-proline 0 N--CA 1.454 -0.264 0 C-N-CA 126.47 1.908 . . . . 10.0 109.364 -174.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -68.73 153.75 72.57 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 123.822 3.015 . . . . 10.0 111.456 -176.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 12.2 tp -43.1 -39.87 2.96 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.358 1.063 . . . . 10.0 112.199 171.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -48.28 -52.44 21.34 Favored 'General case' 0 CA--C 1.539 0.519 0 N-CA-C 114.673 1.361 . . . . 10.0 114.673 176.052 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 14.0 mm -75.88 -40.53 38.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 124.434 1.094 . . . . 10.0 109.625 177.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.29 -49.79 42.08 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 118.61 0.641 . . . . 10.0 111.974 173.639 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 15.9 m -57.69 -47.08 83.35 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 126.046 1.738 . . . . 10.0 112.964 174.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -63.27 -52.33 62.48 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.958 0.903 . . . . 10.0 112.114 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 93.3 mt -52.58 -58.95 5.16 Favored 'General case' 0 C--O 1.227 -0.087 0 C-N-CA 124.293 1.037 . . . . 10.0 110.021 176.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -54.8 -43.73 73.17 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 117.766 -1.111 . . . . 10.0 112.912 177.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 4.6 tmm? -52.31 -53.2 47.4 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 120.277 1.399 . . . . 10.0 112.252 174.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 77.1 t -60.81 -48.13 90.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 124.525 1.13 . . . . 10.0 111.754 178.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 5.1 mp -56.74 -53.45 57.65 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.148 1.379 . . . . 10.0 111.712 175.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -55.68 -52.76 62.77 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.127 1.771 . . . . 10.0 111.594 178.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 46.0 t -49.04 -56.38 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 124.618 1.167 . . . . 10.0 110.705 173.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 6.7 t -58.01 -48.66 79.38 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.943 0.897 . . . . 10.0 111.957 179.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -68.35 -9.13 45.86 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 126.472 1.909 . . . . 10.0 115.105 -176.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 17.9 mtmm -128.83 -59.37 1.13 Allowed 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 119.709 1.141 . . . . 10.0 112.356 179.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 19.7 t -67.23 -54.26 25.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 CA-C-N 118.985 0.811 . . . . 10.0 110.254 176.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -55.79 -57.03 20.84 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 124.339 0.971 . . . . 10.0 112.929 176.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 35.6 t80 -43.94 -56.31 4.02 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.513 1.925 . . . . 10.0 112.723 168.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -58.98 -39.16 93.86 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 124.576 1.084 . . . . 10.0 113.114 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 24.7 mt -69.5 -27.92 65.61 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 115.792 1.775 . . . . 10.0 115.792 175.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 74.3 mt -63.35 -57.61 11.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 119.22 0.918 . . . . 10.0 108.634 165.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 32.2 tp -58.87 -64.66 0.86 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.924 0.89 . . . . 10.0 113.165 -172.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 84.2 mt -71.55 5.22 2.5 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 115.323 1.601 . . . . 10.0 115.323 -171.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.6 mtp-105 -112.36 0.38 15.64 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.199 1.0 . . . . 10.0 113.272 172.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 8.8 t -108.03 177.97 4.65 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 124.026 0.93 . . . . 10.0 111.015 174.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . 0.462 ' HD3' ' CD ' ' A' ' 166' ' ' GLU . 41.8 ttt180 -71.65 98.22 1.87 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.752 0.821 . . . . 10.0 110.91 170.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -80.96 77.03 7.89 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.814 0.846 . . . . 10.0 112.123 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 40.09 102.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 128.857 2.863 . . . . 10.0 116.481 177.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . 0.482 0.3 OUTLIER 71.87 -55.46 0.66 Allowed 'General case' 0 C--O 1.242 0.699 0 C-N-CA 124.711 1.205 . . . . 10.0 110.591 -175.331 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -68.28 169.47 40.01 Favored Glycine 0 C--O 1.239 0.417 0 C-N-CA 129.757 3.551 . . . . 10.0 119.653 171.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.474 0 C-N-CA 128.458 2.703 . . . . 10.0 113.43 166.573 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 999' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A 1000 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A 1001 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A 1002 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A 1003 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 N--CA 1.476 0.87 0 CA-C-O 115.817 -2.039 . . . . 10.0 105.775 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 23.44 91.84 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 129.532 3.133 . . . . 10.0 117.276 160.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 28.6 65.05 0.11 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 128.301 2.641 . . . . 10.0 114.514 155.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 86.6 mt -56.44 137.98 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 126.396 1.878 . . . . 10.0 113.338 -158.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.6 t -136.8 -165.22 1.7 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 126.286 1.834 . . . . 10.0 114.021 -174.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 70.06 2.79 41.4 Favored Glycine 0 C--N 1.34 0.786 0 C-N-CA 127.443 2.449 . . . . 10.0 111.451 168.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -158.57 -51.32 0.01 OUTLIER Pre-proline 0 N--CA 1.443 -0.783 0 CA-C-O 114.263 -2.78 . . . . 10.0 116.649 -168.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -64.03 -60.6 0.15 Allowed 'Trans proline' 0 CA--C 1.528 0.185 0 CA-C-N 123.538 2.299 . . . . 10.0 113.205 -175.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 7.9 pm0 -67.21 4.3 0.97 Allowed 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 127.886 2.475 . . . . 10.0 115.732 179.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.421 ' CG ' ' N ' ' A' ' 11' ' ' ILE . 11.1 p-90 -51.39 -43.07 61.8 Favored 'General case' 0 C--O 1.222 -0.361 0 O-C-N 121.455 -0.778 . . . . 10.0 112.617 176.43 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.421 ' N ' ' CG ' ' A' ' 10' ' ' TRP . 8.9 tt -60.83 -49.65 83.73 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.34 0 C-N-CA 123.926 0.89 . . . . 10.0 109.339 179.37 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 2.6 m95 -55.4 -52.67 62.81 Favored 'General case' 0 C--O 1.224 -0.259 0 C-N-CA 123.407 0.683 . . . . 10.0 111.871 175.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.5 mt -57.34 -53.62 56.04 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 123.175 0.59 . . . . 10.0 112.198 177.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.86 -46.82 51.89 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.427 1.491 . . . . 10.0 113.268 173.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 13.3 tp -65.68 -44.92 84.76 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 125.274 1.43 . . . . 10.0 113.012 179.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.49 -56.79 10.34 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 124.568 1.08 . . . . 10.0 111.588 166.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 22.3 m -49.22 -52.68 25.41 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.987 1.315 . . . . 10.0 112.373 174.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.42 -58.85 5.84 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.151 0.98 . . . . 10.0 112.19 177.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 93.0 mt -57.26 -49.03 77.35 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.686 0.794 . . . . 10.0 112.736 -179.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 52.8 mtt -58.83 -47.87 83.33 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.121 0.968 . . . . 10.0 111.101 177.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -57.13 -58.6 13.72 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 124.333 0.968 . . . . 10.0 113.99 173.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 80.8 mt -56.24 -45.52 79.96 Favored 'General case' 0 C--O 1.221 -0.426 0 CA-C-N 118.646 1.223 . . . . 10.0 112.112 176.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.08 -41.04 84.7 Favored Glycine 0 CA--C 1.531 1.093 0 O-C-N 120.929 -1.107 . . . . 10.0 113.652 173.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 22.1 m -60.06 -60.43 3.84 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.793 0.837 . . . . 10.0 110.831 171.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -52.22 -41.02 62.38 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.073 0.949 . . . . 10.0 110.958 179.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -55.8 -58.01 9.63 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.557 1.143 . . . . 10.0 112.991 172.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -59.65 -38.72 82.16 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 113.201 0.815 . . . . 10.0 113.201 178.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.468 ' C ' ' H ' ' A' ' 30' ' ' LYS . 11.8 mt -56.11 -67.42 0.3 Allowed 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.58 1.152 . . . . 10.0 113.627 169.131 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 t -76.37 40.93 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-O 123.77 1.747 . . . . 10.0 110.891 179.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.468 ' H ' ' C ' ' A' ' 28' ' ' LEU . 42.9 tttm -140.82 -44.82 0.39 Allowed 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 127.884 2.474 . . . . 10.0 109.35 171.187 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -73.02 23.15 0.88 Allowed Glycine 0 CA--C 1.529 0.928 0 N-CA-C 115.634 1.014 . . . . 10.0 115.634 173.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 37.3 mmm -59.54 -44.96 93.07 Favored 'General case' 0 C--O 1.223 -0.296 0 C-N-CA 127.136 2.174 . . . . 10.0 113.578 -179.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.72 -84.4 1.19 Allowed Glycine 0 CA--C 1.53 1.007 0 C-N-CA 123.718 0.675 . . . . 10.0 112.452 -170.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.8 t 33.04 88.79 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.242 0.682 0 C-N-CA 128.4 2.68 . . . . 10.0 116.961 166.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.7 m -79.62 -50.93 9.93 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.187 -1.37 . . . . 10.0 113.866 174.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -48.93 117.51 6.43 Favored Pre-proline 0 CA--C 1.537 0.454 0 O-C-N 124.719 1.262 . . . . 10.0 110.937 -172.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -58.57 -29.7 89.77 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 123.746 2.964 . . . . 10.0 113.669 179.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.26 -60.68 2.28 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.111 0.565 . . . . 10.0 111.441 176.192 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.16 -40.07 22.71 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 125.097 1.359 . . . . 10.0 113.565 171.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -46.53 -47.45 19.55 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 125.221 1.408 . . . . 10.0 113.463 172.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -57.74 -53.06 62.47 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.431 0.693 . . . . 10.0 110.99 176.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 44.2 m-85 -56.95 -50.22 73.28 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 123.09 0.556 . . . . 10.0 112.339 -179.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -54.33 -51.32 65.08 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 118.962 -0.542 . . . . 10.0 112.369 173.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.42 -62.02 1.91 Allowed 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 113.34 0.867 . . . . 10.0 113.34 177.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.6 mt -48.8 -56.98 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 124.842 1.257 . . . . 10.0 110.396 178.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.2 m -69.76 -16.45 63.31 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.085 1.354 . . . . 10.0 113.605 -172.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 30.1 m -87.0 -43.28 12.47 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 119.735 1.152 . . . . 10.0 111.842 174.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 20.1 mt -56.84 -40.94 76.98 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 112.937 0.718 . . . . 10.0 112.937 173.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 44.4 t -49.43 -62.05 2.85 Favored Pre-proline 0 CA--C 1.552 1.047 0 C-N-CA 124.473 1.109 . . . . 10.0 112.494 178.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -48.72 -46.92 22.62 Favored 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 124.593 3.529 . . . . 10.0 116.236 164.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.64 -45.7 93.07 Favored 'General case' 0 CA--C 1.548 0.901 0 CA-C-N 119.904 1.229 . . . . 10.0 113.875 -176.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 52.9 mt -57.58 -51.69 66.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 124.536 1.134 . . . . 10.0 109.376 172.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.5 -45.85 73.37 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.31 1.044 . . . . 10.0 113.056 176.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -50.52 -56.7 10.47 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 125.283 1.433 . . . . 10.0 112.228 171.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 13.2 m -49.72 -52.73 29.24 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 125.283 1.433 . . . . 10.0 110.674 177.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 32.4 mmt -68.67 -48.34 64.2 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 124.001 0.92 . . . . 10.0 113.025 -176.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -57.01 -40.16 76.11 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-O 117.083 -1.437 . . . . 10.0 113.214 173.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.8 tp -53.3 -54.54 34.82 Favored 'General case' 0 C--O 1.224 -0.272 0 CA-C-N 120.118 1.327 . . . . 10.0 111.334 170.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 24.0 p -51.64 -41.1 61.06 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 115.221 1.563 . . . . 10.0 115.221 178.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 57.9 mtm -66.86 -50.85 61.19 Favored 'General case' 0 C--N 1.334 -0.09 0 C-N-CA 123.597 0.759 . . . . 10.0 110.477 176.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.4 tp -48.58 -52.67 21.69 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.88 0.872 . . . . 10.0 112.926 172.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.5 mt -76.98 -5.53 49.01 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.358 1.063 . . . . 10.0 113.781 -177.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.29 -34.72 5.54 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 115.47 0.948 . . . . 10.0 115.47 174.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -49.29 -43.13 42.99 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 115.206 1.558 . . . . 10.0 115.206 -175.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.03 3.56 61.03 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 115.35 0.9 . . . . 10.0 115.35 -179.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.2 143.36 26.5 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 127.056 2.142 . . . . 10.0 109.038 171.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 t -145.47 171.13 15.09 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 124.023 0.929 . . . . 10.0 111.077 166.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.02 136.04 53.4 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 123.932 0.893 . . . . 10.0 109.711 179.583 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 58.9 t -129.52 129.61 23.21 Favored Pre-proline 0 C--N 1.329 -0.299 0 C-N-CA 125.109 1.364 . . . . 10.0 110.999 -176.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -80.76 116.22 3.16 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 N-CA-C 109.417 -1.032 . . . . 10.0 109.417 -178.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -156.75 164.4 38.16 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.824 0.676 . . . . 10.0 112.824 172.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.35 -81.96 0.14 Allowed Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.696 -0.961 . . . . 10.0 110.696 175.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.72 -3.4 0.7 Allowed Glycine 0 CA--C 1.527 0.836 0 N-CA-C 118.637 2.215 . . . . 10.0 118.637 170.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -151.56 -171.85 4.05 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 119.339 1.569 . . . . 10.0 112.257 -165.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -91.92 93.91 9.03 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 125.504 1.522 . . . . 10.0 111.088 -175.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 60.5 m-80 -89.51 120.82 69.62 Favored Pre-proline 0 N--CA 1.45 -0.431 0 N-CA-C 112.963 0.727 . . . . 10.0 112.963 -165.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -61.49 131.89 38.14 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 124.183 3.255 . . . . 10.0 112.199 171.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.6 mm -140.14 126.36 21.92 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 C-N-CA 125.999 1.72 . . . . 10.0 111.704 -179.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -93.66 85.04 4.74 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 122.812 1.291 . . . . 10.0 113.046 174.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 63.7 p-90 -59.35 -28.24 66.66 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 113.905 1.076 . . . . 10.0 113.905 174.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -55.39 -32.05 62.32 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.296 1.038 . . . . 10.0 111.811 178.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.437 HH11 ' HG3' ' A' ' 82' ' ' ARG . 23.4 ttm-85 -47.78 -40.63 21.38 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 126.888 2.075 . . . . 10.0 113.493 170.032 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 62.2 m-85 -86.47 -39.57 16.18 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.418 1.887 . . . . 10.0 111.755 -177.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -49.07 -47.85 44.62 Favored 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 124.555 1.142 . . . . 10.0 111.013 166.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -52.03 -71.97 0.06 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 126.471 1.908 . . . . 10.0 111.809 167.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 52.7 m0 -55.09 -33.77 63.08 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 124.095 0.958 . . . . 10.0 113.582 -170.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 24.3 tp -49.68 -40.44 40.05 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 126.285 1.834 . . . . 10.0 111.994 177.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -105.02 -40.37 5.92 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.378 0.671 . . . . 10.0 112.377 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 76.0 p -62.29 -42.16 99.12 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 120.664 1.575 . . . . 10.0 114.022 -179.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . 0.291 69.5 p -69.44 -41.32 16.85 Favored Pre-proline 0 CA--C 1.547 0.854 0 N-CA-C 114.959 1.466 . . . . 10.0 114.959 -176.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -55.11 -42.92 64.22 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 123.328 2.685 . . . . 10.0 115.137 166.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 55.0 mt -60.33 -47.39 86.22 Favored 'General case' 0 CA--C 1.544 0.724 0 O-C-N 121.507 -0.745 . . . . 10.0 111.677 176.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 6.1 tt -50.19 -49.37 52.72 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.723 1.609 . . . . 10.0 111.522 171.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.6 mp -57.26 -47.34 81.66 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.274 1.03 . . . . 10.0 113.135 170.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.86 -38.21 78.26 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 123.844 0.857 . . . . 10.0 112.9 178.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -52.32 -54.02 36.9 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 119.299 0.954 . . . . 10.0 111.21 169.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.33 -42.11 88.67 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 123.64 0.776 . . . . 10.0 112.144 -178.558 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.7 -54.68 38.59 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.98 0.912 . . . . 10.0 112.041 173.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.29 -41.18 79.32 Favored 'General case' 0 C--O 1.224 -0.24 0 C-N-CA 123.677 0.791 . . . . 10.0 112.714 174.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 32.2 tp -63.8 -38.56 91.55 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 114.436 1.273 . . . . 10.0 114.436 -179.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.2 t -94.79 1.41 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 125.005 1.322 . . . . 10.0 112.298 179.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.2 t70 48.6 53.5 12.08 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.864 1.666 . . . . 10.0 112.101 -174.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.28 145.88 47.59 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 119.951 -1.718 . . . . 10.0 112.47 -174.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.47 135.93 54.16 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 112.711 0.634 . . . . 10.0 112.711 175.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -42.89 -39.64 2.63 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.854 1.661 . . . . 10.0 113.471 175.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -47.33 -60.22 5.33 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 125.205 1.383 . . . . 10.0 115.213 169.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.5 p -62.1 -46.75 87.7 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 117.053 -1.451 . . . . 10.0 111.321 178.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 66.9 mt -48.48 -52.89 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 124.998 1.319 . . . . 10.0 111.11 178.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.1 tp -62.58 -51.37 67.62 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 112.528 0.566 . . . . 10.0 112.528 179.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.11 -44.86 42.66 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.47 0.708 . . . . 10.0 110.959 174.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.62 -59.89 4.72 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 127.404 2.281 . . . . 10.0 114.79 174.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.8 t -61.04 -46.32 96.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 123.705 0.802 . . . . 10.0 111.411 -178.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -56.62 -50.35 63.7 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 123.674 0.655 . . . . 10.0 112.642 174.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -54.93 -46.62 74.97 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 113.696 0.998 . . . . 10.0 113.696 173.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -55.02 -49.27 71.94 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.48 0.712 . . . . 10.0 111.166 173.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -42.87 -54.57 5.05 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 125.06 1.314 . . . . 10.0 113.059 170.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 86.9 mt -56.11 -54.43 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 CA-C-O 118.281 -0.866 . . . . 10.0 111.327 173.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 1.7 ptt? -56.8 -45.29 82.32 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 119.692 1.133 . . . . 10.0 113.038 -174.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 1.7 mp -68.76 -52.71 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 CA-C-N 119.051 0.841 . . . . 10.0 111.047 174.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -51.62 -53.73 27.78 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 124.233 0.921 . . . . 10.0 111.668 -179.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 80.9 m -52.72 -46.07 67.21 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 125.903 1.681 . . . . 10.0 112.444 170.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -50.84 -51.69 33.1 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 124.631 1.11 . . . . 10.0 112.599 173.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 59.6 tp -60.67 -45.85 92.57 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.247 1.419 . . . . 10.0 112.535 175.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 60.8 t -53.91 -50.26 54.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 O-C-N 121.241 -0.912 . . . . 10.0 110.14 172.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -50.79 -61.14 6.31 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 126.305 1.907 . . . . 10.0 112.646 171.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -42.83 -42.26 3.56 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 127.772 2.429 . . . . 10.0 113.208 176.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 47.7 mt -100.84 -6.81 24.27 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 115.531 1.678 . . . . 10.0 115.531 -175.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 17.0 m -69.65 116.71 10.36 Favored 'General case' 0 N--CA 1.465 0.294 0 O-C-N 120.14 -1.6 . . . . 10.0 110.398 -178.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.553 ' HD3' ' H ' ' A' ' 129' ' ' LYS . 0.2 OUTLIER -55.45 -49.6 72.05 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 128.2 2.6 . . . . 10.0 113.25 177.75 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 60.8 t -69.69 106.33 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 123.797 0.839 . . . . 10.0 110.103 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -46.87 -59.54 3.01 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 124.774 1.229 . . . . 10.0 114.089 -173.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 m -46.52 -42.05 15.1 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.488 1.515 . . . . 10.0 113.495 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -70.16 -24.61 63.18 Favored 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 114.958 1.466 . . . . 10.0 114.958 -178.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 69.0 mtp85 -54.12 -41.43 68.33 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 118.845 0.748 . . . . 10.0 110.839 176.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -69.73 -32.18 70.59 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.842 1.257 . . . . 10.0 114.217 176.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.8 t -54.84 -52.23 44.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 CA-C-N 119.013 0.824 . . . . 10.0 109.83 168.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 65.6 m95 -59.66 -49.87 76.06 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 113.458 0.911 . . . . 10.0 113.458 173.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 89.8 t90 -48.35 -48.59 36.36 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 119.504 1.047 . . . . 10.0 113.214 173.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -57.56 -51.85 67.82 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.203 1.001 . . . . 10.0 111.976 176.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 97.3 mt -55.41 -51.24 58.9 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 C-N-CA 124.89 1.276 . . . . 10.0 111.728 175.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 7.2 m -53.02 -45.42 67.94 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 121.196 -0.94 . . . . 10.0 112.662 171.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 66.5 m -61.84 -45.27 94.55 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.833 1.253 . . . . 10.0 111.854 178.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -56.54 -51.15 69.63 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 123.969 0.908 . . . . 10.0 112.365 171.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -57.19 -45.53 83.67 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.003 0.921 . . . . 10.0 112.971 175.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 38.2 ttp -57.49 -53.7 55.2 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.275 1.03 . . . . 10.0 112.005 171.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 62.7 tp -53.51 -47.0 70.28 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.191 1.396 . . . . 10.0 111.852 178.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -50.53 -54.84 19.33 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.003 0.921 . . . . 10.0 112.407 170.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 54.5 mt -53.62 -55.05 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 123.762 0.825 . . . . 10.0 110.805 177.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 38.8 mt -57.16 -35.98 70.2 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 118.365 -0.826 . . . . 10.0 112.997 178.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -57.24 -58.26 9.02 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 124.068 0.947 . . . . 10.0 113.006 173.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.34 -40.89 85.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 CA-C-O 118.343 -0.837 . . . . 10.0 111.492 177.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 45.4 mt -56.83 -49.4 75.53 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 119.845 1.202 . . . . 10.0 112.14 171.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.423 ' HA ' ' HD2' ' A' ' 175' ' ' ARG . 11.9 t80 -76.97 -70.34 0.47 Allowed 'General case' 0 C--N 1.326 -0.447 0 O-C-N 120.022 -1.674 . . . . 10.0 112.887 -175.264 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -73.74 -21.87 60.07 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.567 1.147 . . . . 10.0 113.448 -174.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -87.8 -79.16 1.26 Allowed Glycine 0 CA--C 1.527 0.783 0 C-N-CA 123.666 0.651 . . . . 10.0 113.496 171.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -53.63 -32.4 51.15 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 126.299 1.839 . . . . 10.0 113.046 -166.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.2 m -52.08 -56.5 13.99 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 114.012 1.116 . . . . 10.0 114.012 172.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.4 p -53.67 -50.53 65.61 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 122.057 0.932 . . . . 10.0 112.281 -177.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 47.6 tttm -57.13 -46.05 83.0 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.197 0.999 . . . . 10.0 112.117 173.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.82 -47.46 80.24 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 114.545 1.313 . . . . 10.0 114.545 174.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -56.5 -11.29 1.22 Allowed 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 126.089 1.755 . . . . 10.0 114.228 177.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.2 m -107.1 6.64 29.08 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.416 1.886 . . . . 10.0 114.877 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 93.2 mmm -91.88 -92.63 0.15 Allowed 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 123.521 1.629 . . . . 10.0 114.191 -170.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -138.74 153.98 72.62 Favored Pre-proline 0 C--O 1.236 0.359 0 C-N-CA 129.802 3.241 . . . . 10.0 105.548 170.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -52.86 -46.22 35.24 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 122.3 2.0 . . . . 10.0 113.088 179.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . 0.462 ' CD ' ' HD3' ' A' ' 227' ' ' ARG . 0.1 OUTLIER -52.97 -46.03 68.04 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 129.022 2.929 . . . . 10.0 113.276 173.578 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 91.7 t -69.26 -53.03 27.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 C-N-CA 124.02 0.928 . . . . 10.0 109.782 -178.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.09 -46.85 75.53 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.282 0.633 . . . . 10.0 111.923 177.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 60.5 p -60.02 -56.19 24.74 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.953 0.901 . . . . 10.0 112.67 174.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 62.0 m -57.22 -53.19 60.94 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.202 1.001 . . . . 10.0 113.004 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -49.59 -49.54 46.26 Favored 'General case' 0 C--O 1.221 -0.425 0 C-N-CA 123.289 0.636 . . . . 10.0 111.067 174.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -57.12 -48.41 78.72 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 114.671 1.36 . . . . 10.0 114.671 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 40.4 t -55.95 -49.63 74.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 CA-C-N 118.832 0.742 . . . . 10.0 110.476 176.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 94.1 mt -58.54 -51.65 68.99 Favored 'General case' 0 C--O 1.222 -0.392 0 N-CA-C 113.168 0.803 . . . . 10.0 113.168 175.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . 0.423 ' HD2' ' HA ' ' A' ' 153' ' ' PHE . 35.5 ttp180 -47.79 -47.76 30.7 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 126.824 2.05 . . . . 10.0 111.059 174.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 63.7 m-20 -58.53 -58.32 9.06 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 122.771 0.428 . . . . 10.0 111.286 174.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 59.5 t -51.85 -49.48 36.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 124.048 0.939 . . . . 10.0 111.449 179.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 35.3 m -55.74 -64.09 0.96 Allowed 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 128.428 2.691 . . . . 10.0 111.939 177.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 55.7 t -51.05 -49.56 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 124.541 1.136 . . . . 10.0 111.317 -179.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 79.6 t -59.76 -61.64 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 124.209 1.004 . . . . 10.0 112.198 177.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -57.86 -47.72 81.91 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 118.873 0.761 . . . . 10.0 112.287 -176.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 10.7 m95 -53.51 -51.25 63.44 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.878 0.871 . . . . 10.0 111.71 175.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 50.2 m -55.29 -29.82 58.94 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 114.105 1.15 . . . . 10.0 114.105 178.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -64.72 -44.5 90.0 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 113.657 0.984 . . . . 10.0 113.657 176.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 -47.03 -54.32 21.33 Favored Pre-proline 0 CA--C 1.548 0.866 0 N-CA-C 115.764 1.765 . . . . 10.0 115.764 -176.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -57.1 -38.72 94.89 Favored 'Trans proline' 0 C--N 1.355 0.896 0 C-N-CA 122.487 2.124 . . . . 10.0 113.129 176.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 24.4 t -63.5 -51.98 63.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 124.37 1.068 . . . . 10.0 110.742 177.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 93.2 t -54.11 -50.09 57.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 124.307 1.043 . . . . 10.0 111.442 175.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 52.1 t90 -55.46 -51.58 66.48 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.317 1.047 . . . . 10.0 112.498 174.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 34.4 tp -54.29 -45.63 72.56 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.878 1.271 . . . . 10.0 112.362 -178.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 15.4 pt -87.41 -5.05 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 115.17 1.544 . . . . 10.0 115.17 -177.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.49 -169.22 32.84 Favored Glycine 0 N--CA 1.451 -0.353 0 CA-C-O 122.545 1.08 . . . . 10.0 113.882 -168.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 23.2 t -53.21 -41.44 65.34 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 114.243 -0.979 . . . . 10.0 111.818 177.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -67.2 -17.05 64.66 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 115.659 1.726 . . . . 10.0 115.659 -175.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -130.99 -105.97 1.09 Allowed Glycine 0 CA--C 1.532 1.1 0 CA-C-N 120.381 1.446 . . . . 10.0 113.82 -172.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -89.42 127.15 35.8 Favored 'General case' 0 C--N 1.328 -0.352 0 O-C-N 120.64 -1.506 . . . . 10.0 109.349 168.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -72.46 65.36 1.36 Allowed Glycine 0 CA--C 1.532 1.124 0 N-CA-C 113.873 0.309 . . . . 10.0 113.873 173.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 60.7 mt -79.63 -42.74 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 126.083 1.753 . . . . 10.0 108.721 166.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 79.8 t -126.29 133.4 24.93 Favored Pre-proline 0 N--CA 1.454 -0.264 0 C-N-CA 126.502 1.921 . . . . 10.0 109.364 -174.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -68.78 153.82 72.33 Favored 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 123.751 2.967 . . . . 10.0 111.425 -176.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 12.2 tp -43.18 -39.75 3.03 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.281 1.033 . . . . 10.0 112.223 171.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -48.34 -52.39 21.82 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 114.705 1.372 . . . . 10.0 114.705 176.053 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 14.0 mm -75.91 -40.48 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 124.378 1.071 . . . . 10.0 109.674 177.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -49.29 -49.85 41.84 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 118.553 0.615 . . . . 10.0 111.946 173.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 15.9 m -57.69 -47.08 83.36 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 126.046 1.738 . . . . 10.0 112.964 174.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -63.28 -52.33 62.45 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.977 0.911 . . . . 10.0 112.101 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 93.3 mt -52.58 -59.34 4.57 Favored 'General case' 0 C--N 1.335 -0.044 0 C-N-CA 124.265 1.026 . . . . 10.0 109.989 176.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -52.75 -47.35 67.51 Favored 'General case' 0 C--O 1.219 -0.53 0 CA-C-O 117.286 -1.34 . . . . 10.0 112.102 176.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 4.6 tmm? -50.84 -52.5 40.91 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 120.976 1.716 . . . . 10.0 112.974 174.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 80.4 t -60.86 -46.93 95.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 124.798 1.239 . . . . 10.0 111.524 178.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 4.1 mp -59.45 -51.57 69.32 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.496 1.518 . . . . 10.0 112.261 175.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -55.08 -55.97 25.06 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 127.245 2.218 . . . . 10.0 110.281 175.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 38.1 t -47.41 -53.65 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 124.529 1.131 . . . . 10.0 111.488 173.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 18.7 t -54.82 -54.2 45.39 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.303 0.641 . . . . 10.0 112.193 175.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -68.14 -22.75 64.85 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 115.366 1.617 . . . . 10.0 115.366 -178.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -83.25 -74.87 0.34 Allowed 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.737 1.615 . . . . 10.0 109.906 168.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 35.8 m -92.97 -35.72 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 124.047 0.939 . . . . 10.0 113.191 -164.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -57.36 -56.77 23.31 Favored Glycine 0 N--CA 1.475 1.236 0 CA-C-N 119.851 1.205 . . . . 10.0 111.731 172.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -44.03 -58.81 2.61 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 127.2 2.2 . . . . 10.0 112.357 166.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -55.41 -41.7 81.17 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 123.991 0.805 . . . . 10.0 114.319 179.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 23.8 mt -70.63 -26.73 63.61 Favored 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 115.505 1.668 . . . . 10.0 115.505 178.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 74.0 mt -63.2 -57.56 11.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 108.741 -0.837 . . . . 10.0 108.741 165.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 32.1 tp -58.77 -64.68 0.85 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.901 0.88 . . . . 10.0 113.183 -172.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 84.0 mt -71.53 5.19 2.51 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 115.315 1.598 . . . . 10.0 115.315 -171.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.6 mtp-105 -112.31 0.33 15.67 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.231 1.012 . . . . 10.0 113.324 172.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 8.8 t -108.04 177.99 4.65 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 124.014 0.926 . . . . 10.0 111.013 174.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . 0.462 ' HD3' ' CD ' ' A' ' 166' ' ' GLU . 41.8 ttt180 -71.64 98.19 1.86 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.773 0.829 . . . . 10.0 110.924 170.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -80.96 77.07 7.89 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.836 0.854 . . . . 10.0 112.073 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 40.15 102.25 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 128.893 2.877 . . . . 10.0 116.436 177.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . 0.483 0.3 OUTLIER 71.88 -55.47 0.66 Allowed 'General case' 0 C--O 1.242 0.67 0 C-N-CA 124.692 1.197 . . . . 10.0 110.644 -175.355 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -68.25 169.43 39.98 Favored Glycine 0 C--O 1.239 0.417 0 C-N-CA 129.784 3.564 . . . . 10.0 119.629 171.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.461 0 C-N-CA 128.443 2.697 . . . . 10.0 113.409 166.61 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 999' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A 1000 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A 1001 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A 1002 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A 1003 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 N--CA 1.477 0.876 0 CA-C-O 115.801 -2.047 . . . . 10.0 105.812 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 23.38 91.92 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 129.647 3.179 . . . . 10.0 117.197 160.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 28.55 65.1 0.1 Allowed 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 128.302 2.641 . . . . 10.0 114.496 155.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 86.5 mt -56.48 137.98 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 126.379 1.872 . . . . 10.0 113.343 -158.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.6 t -136.76 -165.16 1.69 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 126.312 1.845 . . . . 10.0 114.025 -174.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 69.98 2.81 40.78 Favored Glycine 0 C--N 1.34 0.792 0 C-N-CA 127.477 2.465 . . . . 10.0 111.526 168.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -158.56 -51.4 0.01 OUTLIER Pre-proline 0 N--CA 1.443 -0.783 0 CA-C-O 114.284 -2.77 . . . . 10.0 116.665 -168.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_exo -63.91 -60.73 0.14 Allowed 'Trans proline' 0 N--CA 1.465 -0.185 0 CA-C-N 123.533 2.297 . . . . 10.0 113.201 -175.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 7.9 pm0 -67.13 4.26 0.96 Allowed 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 127.865 2.466 . . . . 10.0 115.746 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.422 ' CG ' ' N ' ' A' ' 11' ' ' ILE . 11.1 p-90 -51.35 -43.15 61.72 Favored 'General case' 0 C--O 1.223 -0.34 0 O-C-N 121.487 -0.758 . . . . 10.0 112.585 176.475 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.422 ' N ' ' CG ' ' A' ' 10' ' ' TRP . 8.9 tt -60.83 -49.64 83.78 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.338 0 C-N-CA 123.883 0.873 . . . . 10.0 109.287 179.447 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 2.6 m95 -55.38 -52.65 62.85 Favored 'General case' 0 C--O 1.224 -0.261 0 C-N-CA 123.402 0.681 . . . . 10.0 111.84 175.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 91.0 mt -57.35 -53.65 55.69 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 123.19 0.596 . . . . 10.0 112.178 177.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.88 -46.79 52.02 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.387 1.475 . . . . 10.0 113.295 173.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 13.3 tp -65.64 -44.96 84.79 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 125.282 1.433 . . . . 10.0 112.999 179.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -50.82 -54.7 20.98 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 124.297 0.951 . . . . 10.0 112.016 166.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 22.3 m -50.06 -52.67 32.59 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.961 1.304 . . . . 10.0 112.481 173.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.44 -58.82 5.97 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.181 0.992 . . . . 10.0 112.159 177.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 94.1 mt -57.39 -51.31 69.93 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.716 0.806 . . . . 10.0 112.695 -179.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.9 mpp? -57.8 -44.95 86.67 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 119.073 0.851 . . . . 10.0 111.967 176.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -58.5 -58.47 14.42 Favored Glycine 0 CA--C 1.53 1.03 0 CA-C-O 119.267 -0.741 . . . . 10.0 113.474 174.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 80.7 mt -56.24 -46.01 79.77 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-N 118.37 1.085 . . . . 10.0 112.089 175.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.38 -42.48 74.74 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 124.942 1.258 . . . . 10.0 113.179 173.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 28.6 m -61.95 -58.6 7.29 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.86 0.864 . . . . 10.0 111.373 171.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -52.3 -40.94 62.48 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.017 0.927 . . . . 10.0 110.976 177.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -55.76 -58.11 9.22 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.617 1.167 . . . . 10.0 112.943 172.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.1 m-30 -59.63 -38.61 81.84 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 113.245 0.831 . . . . 10.0 113.245 178.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.468 ' C ' ' H ' ' A' ' 30' ' ' LYS . 11.8 mt -56.23 -67.37 0.3 Allowed 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.58 1.152 . . . . 10.0 113.614 169.119 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 t -76.37 40.92 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 CA-C-O 123.745 1.736 . . . . 10.0 110.862 179.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.468 ' H ' ' C ' ' A' ' 28' ' ' LEU . 42.9 tttm -140.85 -44.8 0.39 Allowed 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 127.862 2.465 . . . . 10.0 109.317 171.164 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -73.01 23.15 0.88 Allowed Glycine 0 CA--C 1.529 0.958 0 N-CA-C 115.626 1.01 . . . . 10.0 115.626 173.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 37.3 mmm -59.53 -44.94 93.04 Favored 'General case' 0 C--O 1.224 -0.277 0 C-N-CA 127.101 2.161 . . . . 10.0 113.594 -179.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.68 -84.4 1.19 Allowed Glycine 0 CA--C 1.53 1.007 0 C-N-CA 123.709 0.671 . . . . 10.0 112.507 -170.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.8 t 33.03 88.78 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.242 0.706 0 C-N-CA 128.395 2.678 . . . . 10.0 116.956 166.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.0 m -79.63 -50.82 10.09 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.184 -1.371 . . . . 10.0 113.94 174.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -49.0 117.55 6.54 Favored Pre-proline 0 CA--C 1.536 0.418 0 O-C-N 124.753 1.283 . . . . 10.0 110.902 -172.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -58.56 -29.64 89.54 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 123.757 2.971 . . . . 10.0 113.701 179.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.38 -60.64 2.29 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.089 0.556 . . . . 10.0 111.402 176.231 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.13 -40.13 22.74 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 125.085 1.354 . . . . 10.0 113.54 171.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -46.48 -47.44 19.28 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.208 1.403 . . . . 10.0 113.468 172.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -57.75 -53.07 62.35 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.495 0.718 . . . . 10.0 110.94 176.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -56.98 -50.22 73.33 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 123.102 0.561 . . . . 10.0 112.321 -179.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -54.39 -51.27 65.36 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 118.962 -0.542 . . . . 10.0 112.369 173.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.42 -61.98 1.93 Allowed 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 113.419 0.896 . . . . 10.0 113.419 177.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.5 mt -48.65 -57.48 1.54 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 C-N-CA 124.869 1.268 . . . . 10.0 110.349 178.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.5 m -68.56 -17.87 64.23 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.109 1.364 . . . . 10.0 113.672 -172.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 27.4 m -87.14 -40.48 14.59 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.436 1.095 . . . . 10.0 112.123 174.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 23.7 mt -59.45 -42.0 90.94 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 121.321 -0.862 . . . . 10.0 112.573 171.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 24.7 t -43.24 -61.16 1.95 Allowed Pre-proline 0 N--CA 1.48 1.047 0 C-N-CA 125.57 1.548 . . . . 10.0 113.625 176.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -70.95 -28.71 19.18 Favored 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 123.135 2.557 . . . . 10.0 114.205 174.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.45 -46.24 87.17 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-N 120.709 1.595 . . . . 10.0 113.363 177.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 56.3 mt -56.14 -51.7 59.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 124.414 1.085 . . . . 10.0 109.248 171.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.65 -43.5 76.33 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 113.484 0.92 . . . . 10.0 113.484 175.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -50.96 -55.89 15.06 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 120.853 1.661 . . . . 10.0 111.818 171.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 10.6 m -49.74 -52.79 29.03 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.359 1.464 . . . . 10.0 110.877 177.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 32.6 mmt -68.88 -48.11 64.2 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 123.964 0.906 . . . . 10.0 112.938 -176.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -55.58 -41.97 74.11 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 120.342 1.428 . . . . 10.0 112.974 172.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.8 tp -53.25 -54.59 34.01 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-N 119.697 1.135 . . . . 10.0 111.281 171.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 24.0 p -51.67 -41.06 61.12 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 115.191 1.552 . . . . 10.0 115.191 179.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 55.6 mtm -66.86 -50.83 61.25 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 123.562 0.745 . . . . 10.0 110.479 176.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.5 tp -48.55 -52.7 21.4 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.846 0.858 . . . . 10.0 112.952 172.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.5 mt -76.97 -5.52 48.95 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.331 1.053 . . . . 10.0 113.799 -177.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.28 -34.77 5.5 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 115.55 0.98 . . . . 10.0 115.55 174.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 75.3 t80 -49.22 -43.09 42.22 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 115.258 1.577 . . . . 10.0 115.258 -176.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.1 3.59 61.18 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 115.348 0.899 . . . . 10.0 115.348 -179.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.25 143.43 26.42 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 127.035 2.134 . . . . 10.0 109.011 171.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 t -145.55 171.1 15.17 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 124.012 0.925 . . . . 10.0 111.045 166.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.0 136.08 53.37 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 123.853 0.861 . . . . 10.0 109.698 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 59.0 t -129.54 129.56 23.19 Favored Pre-proline 0 C--N 1.329 -0.317 0 C-N-CA 125.068 1.347 . . . . 10.0 110.988 -176.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -80.76 116.25 3.16 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 N-CA-C 109.411 -1.034 . . . . 10.0 109.411 -178.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -156.71 164.38 38.2 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 112.818 0.673 . . . . 10.0 112.818 172.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.43 -81.99 0.15 Allowed Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.644 -0.983 . . . . 10.0 110.644 175.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.76 -3.42 0.69 Allowed Glycine 0 CA--C 1.526 0.776 0 N-CA-C 118.673 2.229 . . . . 10.0 118.673 170.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -151.58 -171.89 4.06 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 119.343 1.571 . . . . 10.0 112.25 -165.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -91.86 93.91 9.06 Favored 'General case' 0 CA--C 1.519 -0.237 0 C-N-CA 125.514 1.526 . . . . 10.0 111.061 -175.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 60.4 m-80 -89.49 120.81 69.64 Favored Pre-proline 0 N--CA 1.45 -0.465 0 N-CA-C 112.982 0.734 . . . . 10.0 112.982 -165.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -61.52 131.88 38.02 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 124.205 3.27 . . . . 10.0 112.199 171.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.5 mm -140.09 126.33 22.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 C-N-CA 126.059 1.744 . . . . 10.0 111.716 -179.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -93.64 85.01 4.75 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 122.628 1.204 . . . . 10.0 113.053 174.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 63.8 p-90 -59.4 -28.25 66.74 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 113.896 1.072 . . . . 10.0 113.896 174.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -55.28 -26.02 37.67 Favored 'General case' 0 CA--C 1.562 1.415 0 C-N-CA 124.277 1.031 . . . . 10.0 111.773 178.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -45.42 -64.86 0.63 Allowed 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 125.297 1.439 . . . . 10.0 110.618 166.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 36.1 m-85 -62.67 -38.55 90.77 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 126.563 1.945 . . . . 10.0 110.936 -174.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -52.7 -49.86 64.48 Favored 'General case' 0 CA--C 1.555 1.159 0 CA-C-N 119.334 0.97 . . . . 10.0 112.048 168.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -60.06 -62.78 1.62 Allowed 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.476 1.111 . . . . 10.0 111.696 171.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 54.5 m0 -53.38 -37.06 62.09 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 125.821 1.648 . . . . 10.0 112.693 -174.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 28.2 tp -50.23 -41.44 50.05 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 126.275 1.83 . . . . 10.0 111.864 177.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -103.02 -40.7 6.38 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.883 0.873 . . . . 10.0 112.546 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 79.3 p -61.55 -42.45 98.86 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-N 120.553 1.524 . . . . 10.0 113.763 -179.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . 0.322 75.5 p -65.77 -47.69 65.05 Favored Pre-proline 0 N--CA 1.477 0.913 0 CA-C-O 117.586 -1.197 . . . . 10.0 114.22 -178.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -53.0 -42.68 62.75 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 123.232 2.621 . . . . 10.0 115.442 169.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 51.3 mt -59.75 -48.04 83.26 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 121.314 -0.866 . . . . 10.0 111.935 176.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.81 -37.49 84.61 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 119.586 1.085 . . . . 10.0 112.416 175.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.4 mp -56.39 -48.99 75.76 Favored 'General case' 0 CA--C 1.545 0.782 0 O-C-N 121.009 -1.057 . . . . 10.0 111.828 165.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.81 -38.24 78.17 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 119.164 0.893 . . . . 10.0 112.863 178.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -52.33 -54.06 36.45 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 119.322 0.965 . . . . 10.0 111.163 169.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.27 -42.07 88.97 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.63 0.772 . . . . 10.0 112.172 -178.569 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.76 -54.63 39.48 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 123.917 0.887 . . . . 10.0 112.066 173.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.38 -41.16 79.69 Favored 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 123.687 0.795 . . . . 10.0 112.681 174.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.8 tp -63.73 -38.54 91.5 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 114.485 1.291 . . . . 10.0 114.485 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.1 t -94.83 1.42 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 125.035 1.334 . . . . 10.0 112.308 179.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.2 t70 48.62 53.45 12.18 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.834 1.654 . . . . 10.0 112.1 -174.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.27 145.85 47.62 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 119.969 -1.707 . . . . 10.0 112.464 -174.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.42 135.93 53.96 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 112.697 0.629 . . . . 10.0 112.697 175.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -42.89 -39.68 2.64 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.877 1.671 . . . . 10.0 113.499 175.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -47.28 -60.22 5.29 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 125.103 1.335 . . . . 10.0 115.309 169.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.5 p -62.05 -46.82 87.46 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 117.098 -1.429 . . . . 10.0 111.332 178.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 67.0 mt -48.38 -52.92 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 125.038 1.335 . . . . 10.0 111.124 178.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.4 tp -62.67 -51.25 67.97 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 112.544 0.572 . . . . 10.0 112.544 179.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.2 -44.86 43.55 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.479 0.712 . . . . 10.0 110.912 174.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.59 -59.86 4.77 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 127.385 2.274 . . . . 10.0 114.8 174.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.1 t -61.09 -46.36 96.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 123.668 0.787 . . . . 10.0 111.362 -178.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -56.56 -50.41 63.19 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 123.68 0.657 . . . . 10.0 112.602 174.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -54.85 -46.54 74.66 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 113.278 0.844 . . . . 10.0 113.278 173.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -55.22 -48.64 73.6 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.315 1.046 . . . . 10.0 111.202 173.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -42.99 -55.33 4.9 Favored Glycine 0 CA--C 1.534 1.223 0 C-N-CA 125.1 1.333 . . . . 10.0 113.18 169.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 85.1 mt -56.91 -52.22 58.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 123.555 0.742 . . . . 10.0 111.974 174.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 54.0 ttp -48.68 -58.03 5.37 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.821 1.249 . . . . 10.0 112.226 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 40.2 mm -68.29 -43.34 84.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 O-C-N 121.566 -0.709 . . . . 10.0 111.891 179.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -53.23 -60.71 7.77 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 124.747 1.165 . . . . 10.0 112.897 176.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 40.7 p -58.15 -36.7 73.37 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.98 0.912 . . . . 10.0 112.543 174.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -49.04 -55.95 10.99 Favored Glycine 0 CA--C 1.536 1.398 0 C-N-CA 124.464 1.031 . . . . 10.0 113.788 165.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 66.2 tp -59.04 -47.45 85.18 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.464 1.506 . . . . 10.0 111.887 176.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 67.8 t -52.84 -51.66 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 123.345 0.658 . . . . 10.0 110.377 173.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -49.15 -60.53 6.08 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 125.871 1.7 . . . . 10.0 112.212 171.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -49.57 -37.47 27.46 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.497 1.919 . . . . 10.0 113.635 -179.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 50.1 mt -99.37 -6.49 27.72 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 115.207 1.558 . . . . 10.0 115.207 -178.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 16.9 m -69.64 116.73 10.37 Favored 'General case' 0 N--CA 1.465 0.275 0 O-C-N 120.228 -1.545 . . . . 10.0 110.389 -178.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.552 ' HD3' ' H ' ' A' ' 129' ' ' LYS . 0.1 OUTLIER -55.52 -49.59 72.21 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 128.222 2.609 . . . . 10.0 113.268 177.731 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 60.6 t -69.65 106.32 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 123.791 0.836 . . . . 10.0 110.085 179.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -46.87 -59.55 3.01 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 124.807 1.243 . . . . 10.0 114.048 -173.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 m -46.5 -42.1 15.1 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.5 1.52 . . . . 10.0 113.484 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -70.18 -24.53 63.15 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 114.952 1.464 . . . . 10.0 114.952 -178.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 69.4 mtp85 -53.81 -42.02 67.94 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 118.887 0.767 . . . . 10.0 110.682 176.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -69.47 -32.03 70.68 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.805 1.242 . . . . 10.0 114.27 176.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.8 t -55.11 -52.09 48.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-N 119.055 0.843 . . . . 10.0 109.7 168.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 67.8 m95 -61.38 -44.11 97.72 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 114.287 1.217 . . . . 10.0 114.287 174.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 88.0 t90 -53.34 -48.15 68.74 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 124.254 1.022 . . . . 10.0 112.704 172.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -57.43 -52.78 64.0 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.984 0.914 . . . . 10.0 111.602 177.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 97.6 mt -54.46 -50.79 55.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 125.043 1.337 . . . . 10.0 111.712 174.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 20.8 m -52.38 -47.96 65.9 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.96 1.304 . . . . 10.0 111.395 174.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 54.3 m -63.6 -41.6 98.31 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 126.167 1.787 . . . . 10.0 112.171 179.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -57.67 -50.18 74.02 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 119.274 0.943 . . . . 10.0 112.265 171.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -57.36 -47.66 81.04 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 123.83 0.852 . . . . 10.0 112.633 174.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 10.3 tmm? -52.24 -54.76 27.14 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.96 1.704 . . . . 10.0 111.903 172.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 61.4 tp -56.89 -48.94 77.0 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.994 1.718 . . . . 10.0 112.808 178.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 70.2 t80 -49.35 -53.79 20.53 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.131 0.972 . . . . 10.0 111.631 171.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 52.2 mt -54.05 -55.14 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 123.824 0.85 . . . . 10.0 110.774 177.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 19.4 mt -57.24 -35.37 69.62 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 118.055 -0.974 . . . . 10.0 113.461 177.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -57.26 -58.21 9.22 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 119.398 0.999 . . . . 10.0 113.036 172.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.42 -40.91 85.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-O 118.263 -0.875 . . . . 10.0 111.408 177.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 44.9 mt -56.8 -49.39 75.51 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 119.907 1.231 . . . . 10.0 112.148 171.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.423 ' HA ' ' HD2' ' A' ' 175' ' ' ARG . 11.9 t80 -76.95 -70.33 0.47 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 120.092 -1.63 . . . . 10.0 112.869 -175.248 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -73.78 -21.87 60.03 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.596 1.158 . . . . 10.0 113.454 -174.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -87.88 -79.07 1.26 Allowed Glycine 0 CA--C 1.527 0.784 0 C-N-CA 123.6 0.619 . . . . 10.0 113.532 171.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -53.59 -32.4 50.92 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 126.266 1.826 . . . . 10.0 113.08 -166.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.2 m -52.15 -56.44 14.54 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 113.996 1.109 . . . . 10.0 113.996 172.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.6 p -53.65 -50.57 65.47 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 122.126 0.965 . . . . 10.0 112.325 -177.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 47.6 tttm -57.11 -46.06 82.92 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.165 0.986 . . . . 10.0 112.118 173.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.86 -47.49 80.27 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 114.465 1.283 . . . . 10.0 114.465 174.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -56.41 -11.34 1.21 Allowed 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.097 1.759 . . . . 10.0 114.249 177.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.1 m -107.07 6.64 29.13 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.396 1.878 . . . . 10.0 114.891 -179.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 93.3 mmm -91.89 -92.69 0.15 Allowed 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 123.499 1.619 . . . . 10.0 114.132 -170.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -138.67 153.96 72.72 Favored Pre-proline 0 C--O 1.236 0.349 0 C-N-CA 129.807 3.243 . . . . 10.0 105.529 170.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -52.83 -46.22 35.19 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.305 2.003 . . . . 10.0 113.064 179.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . 0.461 ' CD ' ' HD3' ' A' ' 227' ' ' ARG . 0.1 OUTLIER -53.02 -46.04 68.24 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 129.006 2.922 . . . . 10.0 113.27 173.635 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 92.5 t -69.16 -53.09 27.51 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.215 0 C-N-CA 124.1 0.96 . . . . 10.0 109.798 -178.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.1 -46.89 75.56 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.273 0.629 . . . . 10.0 111.902 177.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 60.2 p -59.94 -56.21 24.54 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.932 0.893 . . . . 10.0 112.68 174.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 61.8 m -57.23 -53.16 61.22 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.169 0.988 . . . . 10.0 113.059 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -49.55 -49.47 46.13 Favored 'General case' 0 C--O 1.221 -0.438 0 C-N-CA 123.312 0.645 . . . . 10.0 111.132 174.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -57.19 -48.4 78.84 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 114.618 1.34 . . . . 10.0 114.618 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 40.5 t -56.03 -49.58 74.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-N 118.808 0.731 . . . . 10.0 110.462 176.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 93.9 mt -58.58 -51.6 69.21 Favored 'General case' 0 C--O 1.222 -0.394 0 N-CA-C 113.218 0.821 . . . . 10.0 113.218 175.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . 0.423 ' HD2' ' HA ' ' A' ' 153' ' ' PHE . 35.5 ttp180 -47.76 -47.79 30.38 Favored 'General case' 0 C--O 1.224 -0.265 0 C-N-CA 126.807 2.043 . . . . 10.0 111.078 174.411 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 63.7 m-20 -58.48 -58.35 8.94 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 122.794 0.438 . . . . 10.0 111.274 174.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 59.7 t -51.95 -48.81 39.82 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 C-N-CA 124.082 0.953 . . . . 10.0 111.457 179.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 28.8 m -57.25 -62.81 1.5 Allowed 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 128.129 2.572 . . . . 10.0 111.976 178.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 55.5 t -51.32 -50.17 28.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 C-N-CA 124.572 1.149 . . . . 10.0 111.079 -179.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 75.6 t -58.85 -60.6 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 124.053 0.941 . . . . 10.0 112.212 177.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -58.34 -48.47 80.45 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 118.663 0.665 . . . . 10.0 112.085 -177.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 9.0 m95 -54.37 -47.92 72.09 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.04 0.936 . . . . 10.0 112.759 177.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 9.5 t -58.99 -25.26 63.48 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 113.872 1.064 . . . . 10.0 113.872 177.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -68.57 -44.54 74.19 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 119.516 1.053 . . . . 10.0 113.346 177.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -45.4 -54.86 13.37 Favored Pre-proline 0 N--CA 1.476 0.872 0 N-CA-C 115.449 1.648 . . . . 10.0 115.449 -177.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -58.16 -36.96 97.4 Favored 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 122.454 2.103 . . . . 10.0 113.327 177.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 25.1 t -64.07 -53.92 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 124.213 1.005 . . . . 10.0 110.607 176.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 86.9 t -53.34 -49.62 52.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 124.782 1.233 . . . . 10.0 111.587 176.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 25.9 t90 -55.44 -53.22 58.96 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.895 1.278 . . . . 10.0 112.466 175.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 9.7 tt -56.45 -44.2 80.25 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.897 0.879 . . . . 10.0 112.675 -178.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 14.7 pt -84.61 -5.78 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 N-CA-C 115.069 1.507 . . . . 10.0 115.069 -178.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.32 -169.25 33.08 Favored Glycine 0 N--CA 1.45 -0.374 0 CA-C-O 122.522 1.068 . . . . 10.0 113.978 -168.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 23.2 t -53.2 -40.92 64.79 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 114.236 -0.982 . . . . 10.0 111.821 177.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -54.78 -31.64 59.08 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 128.472 2.709 . . . . 10.0 115.209 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -131.3 -103.89 0.97 Allowed Glycine 0 CA--C 1.529 0.943 0 CA-C-N 119.441 1.019 . . . . 10.0 113.58 -167.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -89.46 127.14 35.81 Favored 'General case' 0 C--N 1.329 -0.323 0 O-C-N 120.666 -1.491 . . . . 10.0 109.3 169.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -72.43 65.3 1.35 Allowed Glycine 0 CA--C 1.533 1.165 0 N-CA-C 113.91 0.324 . . . . 10.0 113.91 173.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 60.8 mt -79.58 -42.69 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 C-N-CA 126.031 1.732 . . . . 10.0 108.748 166.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 79.4 t -126.31 133.41 24.94 Favored Pre-proline 0 N--CA 1.455 -0.22 0 C-N-CA 126.413 1.885 . . . . 10.0 109.353 -174.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -68.72 153.83 72.46 Favored 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 123.791 2.994 . . . . 10.0 111.444 -176.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 12.2 tp -43.24 -39.73 3.12 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.399 1.08 . . . . 10.0 112.142 171.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -48.43 -52.32 22.63 Favored 'General case' 0 CA--C 1.539 0.519 0 N-CA-C 114.669 1.359 . . . . 10.0 114.669 176.08 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 14.0 mm -75.93 -40.55 38.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 124.422 1.089 . . . . 10.0 109.625 177.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -49.27 -49.84 41.68 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-O 121.446 0.641 . . . . 10.0 111.921 173.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 16.2 m -57.7 -47.0 83.61 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 126.047 1.739 . . . . 10.0 112.991 174.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -63.38 -52.33 62.12 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.966 0.906 . . . . 10.0 112.094 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 93.4 mt -52.54 -59.06 4.9 Favored 'General case' 0 C--O 1.228 -0.07 0 C-N-CA 124.321 1.048 . . . . 10.0 109.944 176.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -54.02 -41.84 68.46 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 117.938 -1.029 . . . . 10.0 113.235 176.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 4.6 tmm? -55.66 -53.05 61.27 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 120.265 1.393 . . . . 10.0 112.086 173.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 79.9 t -60.95 -45.6 98.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 124.783 1.233 . . . . 10.0 111.603 178.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 4.2 mp -59.58 -51.42 69.92 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.314 1.446 . . . . 10.0 112.003 175.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' ASP . . . . . 0.426 ' CG ' ' H2 ' ' A' 1003 ' ' HOH . 81.3 m-20 -57.75 -52.72 64.31 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.04 1.336 . . . . 10.0 111.431 176.062 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 39.2 t -47.72 -49.57 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 124.601 1.16 . . . . 10.0 111.553 172.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 25.2 m -59.18 -51.19 71.04 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.419 1.088 . . . . 10.0 112.002 176.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -67.82 -19.31 65.05 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.974 1.709 . . . . 10.0 115.018 179.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 9.2 mptt -98.69 -75.45 0.56 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.679 1.592 . . . . 10.0 109.604 177.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 21.3 t -70.86 -53.86 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 125.448 1.499 . . . . 10.0 110.784 -172.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -53.84 -58.58 12.01 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 124.151 0.881 . . . . 10.0 112.96 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -45.6 -57.76 3.94 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 126.624 1.97 . . . . 10.0 112.539 170.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -56.99 -40.81 91.81 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 124.057 0.837 . . . . 10.0 113.857 178.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 24.4 mt -70.41 -27.12 64.04 Favored 'General case' 0 CA--C 1.513 -0.464 0 N-CA-C 115.649 1.722 . . . . 10.0 115.649 177.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 74.0 mt -63.34 -57.54 11.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 108.687 -0.857 . . . . 10.0 108.687 165.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 32.0 tp -58.77 -64.71 0.84 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.905 0.882 . . . . 10.0 113.187 -172.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 84.4 mt -71.53 5.16 2.52 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 115.27 1.582 . . . . 10.0 115.27 -171.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.6 mtp-105 -112.31 0.33 15.67 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.228 1.011 . . . . 10.0 113.242 172.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 8.8 t -108.06 177.98 4.65 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 124.038 0.935 . . . . 10.0 111.026 174.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . 0.461 ' HD3' ' CD ' ' A' ' 166' ' ' GLU . 41.8 ttt180 -71.65 98.19 1.86 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.732 0.813 . . . . 10.0 110.935 170.694 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -80.86 76.97 7.77 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.896 0.878 . . . . 10.0 112.128 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 40.12 102.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 128.857 2.863 . . . . 10.0 116.464 177.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . 0.483 0.3 OUTLIER 71.86 -55.51 0.66 Allowed 'General case' 0 C--O 1.242 0.662 0 C-N-CA 124.705 1.202 . . . . 10.0 110.631 -175.331 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -68.24 169.5 39.8 Favored Glycine 0 C--O 1.239 0.429 0 C-N-CA 129.757 3.551 . . . . 10.0 119.645 171.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.474 0 C-N-CA 128.49 2.716 . . . . 10.0 113.429 166.585 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 999' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A 1000 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A 1001 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A 1002 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A 1003 ' ' HOH . . . . . 0.426 ' H2 ' ' CG ' ' A' ' 212' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 N--CA 1.476 0.87 0 CA-C-O 115.799 -2.048 . . . . 10.0 105.83 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 23.39 91.88 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 129.588 3.155 . . . . 10.0 117.203 160.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 28.63 65.04 0.11 Allowed 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 128.322 2.649 . . . . 10.0 114.48 155.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 86.6 mt -56.48 137.97 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 126.396 1.878 . . . . 10.0 113.315 -158.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.6 t -136.75 -165.26 1.71 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 126.327 1.851 . . . . 10.0 114.015 -174.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 70.06 2.78 41.34 Favored Glycine 0 C--N 1.34 0.762 0 C-N-CA 127.464 2.459 . . . . 10.0 111.485 168.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -158.52 -51.37 0.01 OUTLIER Pre-proline 0 N--CA 1.443 -0.783 0 CA-C-O 114.26 -2.781 . . . . 10.0 116.619 -168.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -63.94 -60.61 0.15 Allowed 'Trans proline' 0 N--CA 1.465 -0.202 0 CA-C-N 123.55 2.303 . . . . 10.0 113.25 -175.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 7.9 pm0 -67.25 4.3 0.99 Allowed 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 127.839 2.456 . . . . 10.0 115.755 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.422 ' CG ' ' N ' ' A' ' 11' ' ' ILE . 11.1 p-90 -51.36 -43.1 61.74 Favored 'General case' 0 C--O 1.222 -0.361 0 O-C-N 121.5 -0.75 . . . . 10.0 112.621 176.427 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.422 ' N ' ' CG ' ' A' ' 10' ' ' TRP . 8.9 tt -60.88 -49.56 84.14 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.34 0 C-N-CA 123.878 0.871 . . . . 10.0 109.336 179.407 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 2.6 m95 -55.44 -52.61 63.02 Favored 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 123.387 0.675 . . . . 10.0 111.887 175.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.6 mt -57.39 -53.53 57.06 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 123.153 0.581 . . . . 10.0 112.231 177.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.96 -46.75 52.69 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.378 1.471 . . . . 10.0 113.31 173.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 13.3 tp -65.6 -44.95 84.99 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 125.345 1.458 . . . . 10.0 113.029 179.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.54 -56.72 10.57 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 124.508 1.051 . . . . 10.0 111.441 166.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.5 m -49.6 -52.46 30.2 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.877 1.271 . . . . 10.0 112.186 174.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.43 -58.83 5.94 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.174 0.99 . . . . 10.0 112.198 177.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 93.5 mt -57.28 -49.06 77.29 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.686 0.794 . . . . 10.0 112.695 -179.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 45.6 mtt -59.02 -46.62 87.75 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.418 1.087 . . . . 10.0 111.388 177.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -58.35 -58.58 13.82 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 124.394 0.997 . . . . 10.0 113.98 173.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 80.7 mt -56.21 -45.87 79.71 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-N 118.596 1.198 . . . . 10.0 112.113 176.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.15 -40.66 84.21 Favored Glycine 0 CA--C 1.532 1.122 0 O-C-N 120.931 -1.106 . . . . 10.0 113.598 173.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 28.1 m -61.61 -58.92 6.2 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.486 0.714 . . . . 10.0 111.19 171.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -52.24 -41.01 62.42 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.073 0.949 . . . . 10.0 110.95 178.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -55.77 -58.05 9.45 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 124.599 1.159 . . . . 10.0 112.973 172.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.1 m-30 -59.62 -38.69 81.99 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 113.223 0.823 . . . . 10.0 113.223 178.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.468 ' C ' ' H ' ' A' ' 30' ' ' LYS . 11.8 mt -56.1 -67.43 0.3 Allowed 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.627 1.171 . . . . 10.0 113.637 169.099 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 t -76.37 40.92 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 CA-C-O 123.708 1.718 . . . . 10.0 110.852 179.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.468 ' H ' ' C ' ' A' ' 28' ' ' LEU . 42.9 tttm -140.84 -44.84 0.39 Allowed 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 127.883 2.473 . . . . 10.0 109.331 171.18 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.96 23.11 0.87 Allowed Glycine 0 CA--C 1.529 0.925 0 N-CA-C 115.629 1.012 . . . . 10.0 115.629 173.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 37.3 mmm -59.51 -45.0 92.98 Favored 'General case' 0 C--O 1.225 -0.235 0 C-N-CA 127.163 2.185 . . . . 10.0 113.596 -179.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.69 -84.42 1.19 Allowed Glycine 0 CA--C 1.53 1.007 0 C-N-CA 123.741 0.686 . . . . 10.0 112.483 -170.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.8 t 33.11 88.75 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.242 0.682 0 C-N-CA 128.399 2.68 . . . . 10.0 116.937 166.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.2 m -79.62 -50.91 9.96 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.152 -1.385 . . . . 10.0 113.855 174.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -48.87 117.51 6.37 Favored Pre-proline 0 CA--C 1.536 0.415 0 O-C-N 124.769 1.293 . . . . 10.0 110.988 -172.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -58.56 -29.68 89.65 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 123.746 2.964 . . . . 10.0 113.72 179.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.31 -60.67 2.28 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.126 0.57 . . . . 10.0 111.422 176.213 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.15 -40.05 22.64 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 125.104 1.362 . . . . 10.0 113.549 171.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -46.53 -47.47 19.54 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 125.252 1.421 . . . . 10.0 113.434 172.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -57.75 -53.06 62.43 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.438 0.695 . . . . 10.0 110.974 176.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -56.98 -50.23 73.32 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 123.044 0.538 . . . . 10.0 112.337 -179.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -54.35 -51.28 65.25 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 118.914 -0.565 . . . . 10.0 112.375 173.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.46 -61.95 1.95 Allowed 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 113.391 0.886 . . . . 10.0 113.391 177.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.3 mt -48.43 -57.76 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 C-N-CA 124.839 1.255 . . . . 10.0 110.408 178.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.3 m -68.57 -17.44 64.14 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.158 1.383 . . . . 10.0 113.724 -172.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 28.1 m -87.92 -39.63 14.6 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.45 1.1 . . . . 10.0 112.255 174.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 21.2 mt -59.19 -42.64 91.34 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 121.49 -0.756 . . . . 10.0 112.521 171.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 18.5 t -41.43 -63.84 0.75 Allowed Pre-proline 0 CA--C 1.551 0.993 0 C-N-CA 125.774 1.63 . . . . 10.0 113.491 175.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -70.22 -25.07 26.85 Favored 'Trans proline' 0 CA--C 1.544 1.017 0 C-N-CA 122.72 2.28 . . . . 10.0 114.182 176.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.5 -44.45 86.99 Favored 'General case' 0 CA--C 1.549 0.907 0 CA-C-N 120.683 1.583 . . . . 10.0 113.046 174.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 58.0 mt -54.66 -52.18 43.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 124.961 1.304 . . . . 10.0 108.998 168.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -53.14 -49.75 65.93 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.637 1.175 . . . . 10.0 112.789 176.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -50.42 -58.57 5.42 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.717 1.607 . . . . 10.0 112.574 173.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.3 m -49.38 -52.64 27.13 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.119 1.368 . . . . 10.0 110.66 178.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.407 ' HG3' ' CB ' ' A' ' 85' ' ' ASP . 32.8 mmt -69.41 -48.22 61.71 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 123.889 0.876 . . . . 10.0 112.82 -176.369 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -57.71 -39.29 76.88 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 116.567 -1.683 . . . . 10.0 113.111 173.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.7 tp -53.24 -54.62 33.47 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-N 120.623 1.556 . . . . 10.0 111.273 169.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 23.9 p -51.63 -41.05 61.01 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 115.257 1.577 . . . . 10.0 115.257 179.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 56.5 mtm -66.93 -50.8 61.23 Favored 'General case' 0 C--N 1.334 -0.09 0 C-N-CA 123.548 0.739 . . . . 10.0 110.485 176.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.3 tp -48.57 -52.7 21.49 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.858 0.863 . . . . 10.0 112.948 172.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.5 mt -76.86 -5.59 48.96 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 113.835 1.05 . . . . 10.0 113.835 -177.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.26 -34.72 5.54 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 115.583 0.993 . . . . 10.0 115.583 174.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -49.24 -43.13 42.52 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 115.243 1.571 . . . . 10.0 115.243 -176.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.01 3.48 61.22 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 115.329 0.892 . . . . 10.0 115.329 -178.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.25 143.41 26.44 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 127.034 2.133 . . . . 10.0 109.011 172.055 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 t -145.52 171.11 15.14 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 124.029 0.931 . . . . 10.0 111.011 166.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.95 136.06 53.39 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 123.924 0.89 . . . . 10.0 109.739 179.583 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 58.6 t -129.58 129.58 23.18 Favored Pre-proline 0 C--N 1.329 -0.295 0 C-N-CA 125.063 1.345 . . . . 10.0 110.935 -176.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -80.71 116.19 3.17 Favored 'Trans proline' 0 N--CA 1.452 -0.921 0 N-CA-C 109.443 -1.022 . . . . 10.0 109.443 -178.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -156.71 164.39 38.2 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 112.862 0.69 . . . . 10.0 112.862 172.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.39 -82.0 0.14 Allowed Glycine 0 CA--C 1.526 0.773 0 N-CA-C 110.683 -0.967 . . . . 10.0 110.683 175.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.76 -3.33 0.7 Allowed Glycine 0 CA--C 1.527 0.812 0 N-CA-C 118.641 2.216 . . . . 10.0 118.641 170.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -151.63 -171.89 4.06 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 119.379 1.59 . . . . 10.0 112.228 -165.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -91.86 93.9 9.05 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 125.521 1.528 . . . . 10.0 111.097 -175.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 60.3 m-80 -89.48 120.72 69.64 Favored Pre-proline 0 N--CA 1.45 -0.429 0 N-CA-C 112.965 0.728 . . . . 10.0 112.965 -165.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -61.53 131.94 38.26 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 124.183 3.255 . . . . 10.0 112.165 171.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.5 mm -140.09 126.3 21.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 C-N-CA 126.043 1.737 . . . . 10.0 111.732 -179.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -93.64 85.03 4.75 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 122.888 1.328 . . . . 10.0 113.053 174.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 63.6 p-90 -59.33 -28.3 66.69 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 113.911 1.078 . . . . 10.0 113.911 174.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -55.31 -35.93 65.65 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.286 1.035 . . . . 10.0 113.575 178.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 6.8 ptp180 -56.8 -40.44 75.97 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 120.209 1.368 . . . . 10.0 111.281 173.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -66.16 -43.73 86.12 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 113.887 1.069 . . . . 10.0 113.887 174.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -49.39 -47.19 47.9 Favored 'General case' 0 CA--C 1.555 1.165 0 C-N-CA 124.695 1.198 . . . . 10.0 111.002 167.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.407 ' CB ' ' HG3' ' A' ' 56' ' ' MET . 0.0 OUTLIER -61.71 -58.92 6.14 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 125.568 1.547 . . . . 10.0 112.938 173.331 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 46.9 m0 -51.82 -40.52 60.6 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 126.829 2.052 . . . . 10.0 112.777 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 27.8 tp -50.22 -45.79 54.14 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 125.944 1.697 . . . . 10.0 112.686 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -97.94 -46.86 5.76 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 123.735 0.814 . . . . 10.0 112.753 -176.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -58.8 -41.44 86.77 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.903 0.881 . . . . 10.0 112.801 -175.314 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.1 m -66.39 -47.66 58.54 Favored Pre-proline 0 CA--C 1.541 0.598 0 O-C-N 121.094 -1.004 . . . . 10.0 111.938 -174.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -51.93 -42.92 55.53 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 123.34 2.694 . . . . 10.0 115.145 166.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 53.0 mt -59.79 -48.17 82.76 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 118.877 0.762 . . . . 10.0 111.875 176.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 84.3 mt -53.77 -45.1 70.52 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.481 1.112 . . . . 10.0 112.136 172.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.6 mp -57.35 -47.86 80.52 Favored 'General case' 0 CA--C 1.546 0.796 0 O-C-N 120.97 -1.082 . . . . 10.0 112.574 169.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.87 -38.23 78.33 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 123.824 0.85 . . . . 10.0 112.877 178.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -52.28 -54.05 36.34 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 119.303 0.956 . . . . 10.0 111.215 169.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.36 -42.07 88.59 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.585 0.754 . . . . 10.0 112.119 -178.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.67 -54.75 37.61 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.972 0.909 . . . . 10.0 112.006 173.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.3 -41.16 79.34 Favored 'General case' 0 C--O 1.224 -0.237 0 C-N-CA 123.72 0.808 . . . . 10.0 112.702 174.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 32.0 tp -63.75 -38.56 91.58 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 114.445 1.276 . . . . 10.0 114.445 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.2 t -94.79 1.36 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 125.106 1.362 . . . . 10.0 112.309 179.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.2 t70 48.57 53.46 12.11 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.858 1.663 . . . . 10.0 112.139 -173.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.29 145.89 47.56 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 119.951 -1.718 . . . . 10.0 112.44 -174.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.44 135.87 54.08 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 112.759 0.651 . . . . 10.0 112.759 175.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -42.85 -39.65 2.6 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.844 1.658 . . . . 10.0 113.49 175.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -47.33 -60.23 5.32 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 125.15 1.357 . . . . 10.0 115.262 169.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.4 p -62.06 -46.77 87.65 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 117.1 -1.428 . . . . 10.0 111.332 178.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 66.9 mt -48.39 -52.92 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 125.001 1.321 . . . . 10.0 111.147 178.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.4 tp -62.66 -51.28 67.86 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 112.509 0.559 . . . . 10.0 112.509 179.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.15 -44.87 43.05 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.506 0.722 . . . . 10.0 110.967 174.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.6 -59.87 4.76 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 127.363 2.265 . . . . 10.0 114.839 174.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.4 t -60.97 -46.39 96.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 123.711 0.804 . . . . 10.0 111.373 -178.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -56.61 -50.3 64.02 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 123.662 0.649 . . . . 10.0 112.661 174.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -54.54 -46.5 73.61 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.569 0.747 . . . . 10.0 112.882 173.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -61.38 -40.62 95.0 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.887 0.875 . . . . 10.0 112.924 176.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -43.69 -59.38 3.75 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 125.995 1.76 . . . . 10.0 112.401 163.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 78.8 mt -56.66 -52.59 52.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 123.69 0.796 . . . . 10.0 110.925 175.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 46.4 ttp -46.33 -61.96 1.56 Allowed 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 126.022 1.729 . . . . 10.0 112.597 -174.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -80.93 -34.04 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 CA-C-O 118.933 -0.556 . . . . 10.0 112.176 -177.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -57.12 -48.27 81.05 Favored Glycine 0 CA--C 1.53 1.023 0 CA-C-N 119.26 0.936 . . . . 10.0 111.902 175.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 88.9 m -54.66 -44.45 73.3 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.299 1.44 . . . . 10.0 111.759 167.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -48.11 -52.01 18.44 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 124.773 1.178 . . . . 10.0 112.893 170.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 60.1 tp -59.07 -47.3 85.73 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.121 1.368 . . . . 10.0 112.201 175.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 61.9 t -53.08 -50.54 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 O-C-N 121.465 -0.772 . . . . 10.0 110.209 172.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -50.97 -61.28 6.27 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 126.18 1.848 . . . . 10.0 112.939 172.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -43.45 -41.53 4.35 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 127.993 2.517 . . . . 10.0 113.231 176.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 46.5 mt -99.92 -7.23 25.47 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 115.513 1.671 . . . . 10.0 115.513 -176.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 17.0 m -69.66 116.75 10.42 Favored 'General case' 0 N--CA 1.464 0.274 0 O-C-N 120.195 -1.566 . . . . 10.0 110.407 -178.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.552 ' HD3' ' H ' ' A' ' 129' ' ' LYS . 0.2 OUTLIER -55.5 -49.62 72.09 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 128.195 2.598 . . . . 10.0 113.288 177.758 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 60.1 t -69.58 106.32 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 123.789 0.836 . . . . 10.0 110.12 179.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -46.92 -59.49 3.06 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 124.761 1.224 . . . . 10.0 114.067 -173.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 m -46.5 -42.08 15.06 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.439 1.495 . . . . 10.0 113.512 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -70.16 -24.59 63.18 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 114.918 1.451 . . . . 10.0 114.918 -178.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 68.2 mtp85 -54.37 -41.18 68.86 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 118.876 0.762 . . . . 10.0 110.905 176.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -69.79 -31.75 69.85 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 114.34 1.237 . . . . 10.0 114.34 176.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.8 t -55.17 -52.23 46.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 CA-C-N 118.928 0.785 . . . . 10.0 109.82 168.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 65.0 m95 -59.48 -49.57 77.27 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 113.428 0.899 . . . . 10.0 113.428 173.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 83.0 t90 -48.37 -47.82 37.12 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 119.438 1.017 . . . . 10.0 113.31 173.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -58.74 -51.12 71.31 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.099 0.96 . . . . 10.0 111.993 176.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 97.2 mt -55.88 -50.89 66.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 125.023 1.329 . . . . 10.0 111.564 175.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 17.5 m -51.91 -46.17 64.52 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.241 1.016 . . . . 10.0 112.59 170.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 63.3 m -62.14 -44.3 96.92 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.775 1.23 . . . . 10.0 111.986 179.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -56.49 -50.59 71.33 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.91 0.884 . . . . 10.0 112.327 171.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -56.84 -44.23 81.89 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.799 0.84 . . . . 10.0 112.977 174.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 42.8 ttp -57.75 -55.77 30.59 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.406 1.082 . . . . 10.0 111.969 173.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -49.79 -49.67 47.74 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.461 1.505 . . . . 10.0 110.781 177.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -51.77 -55.8 17.66 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 113.298 0.851 . . . . 10.0 113.298 173.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 49.9 mt -54.22 -54.69 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 123.598 0.759 . . . . 10.0 110.78 177.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 42.1 mt -57.14 -36.1 70.29 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 118.409 -0.805 . . . . 10.0 112.959 178.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -57.33 -58.11 9.67 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 124.026 0.93 . . . . 10.0 113.03 173.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.48 -40.89 85.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 CA-C-O 118.303 -0.855 . . . . 10.0 111.419 177.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 45.1 mt -56.83 -49.35 75.68 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 119.893 1.224 . . . . 10.0 112.115 171.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.424 ' HA ' ' HD2' ' A' ' 175' ' ' ARG . 11.9 t80 -77.03 -70.34 0.47 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 120.054 -1.654 . . . . 10.0 112.862 -175.254 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -73.73 -21.91 60.06 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.634 1.174 . . . . 10.0 113.439 -174.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -87.79 -79.08 1.26 Allowed Glycine 0 CA--C 1.527 0.783 0 C-N-CA 123.625 0.631 . . . . 10.0 113.534 171.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -53.68 -32.4 51.54 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 126.269 1.828 . . . . 10.0 113.046 -166.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.3 m -52.16 -56.39 14.85 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 113.989 1.107 . . . . 10.0 113.989 172.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.3 p -53.65 -50.63 65.33 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 122.092 0.949 . . . . 10.0 112.249 -177.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 47.6 tttm -57.11 -46.03 82.93 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.142 0.977 . . . . 10.0 112.122 173.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.8 -47.5 80.07 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 114.534 1.309 . . . . 10.0 114.534 174.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -56.45 -11.29 1.2 Allowed 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 126.054 1.741 . . . . 10.0 114.261 177.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.1 m -107.04 6.56 29.1 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 126.474 1.91 . . . . 10.0 114.896 -179.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 93.2 mmm -91.88 -92.66 0.15 Allowed 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 123.487 1.613 . . . . 10.0 114.171 -170.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -138.74 153.94 72.59 Favored Pre-proline 0 C--O 1.236 0.359 0 C-N-CA 129.802 3.241 . . . . 10.0 105.548 170.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -52.85 -46.22 35.27 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.346 2.031 . . . . 10.0 113.074 179.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . 0.462 ' CD ' ' HD3' ' A' ' 227' ' ' ARG . 0.1 OUTLIER -52.97 -46.09 68.06 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 128.979 2.912 . . . . 10.0 113.276 173.571 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 92.2 t -69.19 -52.99 27.97 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 C-N-CA 124.065 0.946 . . . . 10.0 109.8 -178.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.18 -46.82 75.81 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.319 0.648 . . . . 10.0 111.899 177.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 60.3 p -60.04 -56.17 24.98 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.876 0.87 . . . . 10.0 112.729 174.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 61.8 m -57.2 -53.17 61.13 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.184 0.994 . . . . 10.0 113.027 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -49.6 -49.49 46.55 Favored 'General case' 0 C--O 1.221 -0.414 0 C-N-CA 123.258 0.623 . . . . 10.0 111.114 174.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -57.16 -48.37 78.86 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 114.664 1.357 . . . . 10.0 114.664 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 40.4 t -56.01 -49.62 74.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 CA-C-N 118.832 0.742 . . . . 10.0 110.477 176.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 94.2 mt -58.6 -51.64 69.07 Favored 'General case' 0 C--O 1.222 -0.384 0 N-CA-C 113.141 0.793 . . . . 10.0 113.141 175.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . 0.424 ' HD2' ' HA ' ' A' ' 153' ' ' PHE . 35.5 ttp180 -47.7 -47.86 29.66 Favored 'General case' 0 C--O 1.225 -0.201 0 C-N-CA 126.852 2.061 . . . . 10.0 111.084 174.402 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 63.6 m-20 -58.48 -58.35 8.92 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 122.775 0.43 . . . . 10.0 111.234 174.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 54.6 t -51.77 -48.09 38.64 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 124.088 0.955 . . . . 10.0 111.858 179.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 28.5 m -58.19 -62.8 1.57 Allowed 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 127.959 2.503 . . . . 10.0 112.17 177.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 54.8 t -51.43 -49.18 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 124.686 1.194 . . . . 10.0 111.019 -179.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 70.9 t -59.76 -60.42 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 124.008 0.923 . . . . 10.0 112.374 177.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 77.5 mt -54.59 -52.9 60.7 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 118.414 0.552 . . . . 10.0 111.769 -178.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 9.9 m95 -51.79 -50.1 61.41 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 124.274 1.03 . . . . 10.0 112.35 177.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 49.2 m -52.93 -31.98 43.15 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 113.721 1.008 . . . . 10.0 113.721 178.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -66.1 -39.39 89.92 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 113.99 1.107 . . . . 10.0 113.99 175.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 44.1 m-85 -49.04 -54.6 26.97 Favored Pre-proline 0 N--CA 1.477 0.924 0 N-CA-C 115.198 1.555 . . . . 10.0 115.198 -176.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -57.74 -35.89 98.62 Favored 'Trans proline' 0 C--N 1.355 0.876 0 C-N-CA 122.373 2.049 . . . . 10.0 112.903 175.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 22.7 t -66.22 -54.84 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 C-N-CA 124.735 1.214 . . . . 10.0 110.855 178.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 58.4 t -56.24 -45.72 81.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 124.641 1.176 . . . . 10.0 111.333 177.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 66.7 t90 -56.36 -54.6 43.64 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.11 0.964 . . . . 10.0 112.2 172.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 60.3 tp -52.29 -46.42 65.9 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.413 1.485 . . . . 10.0 112.29 -177.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 15.0 pt -86.09 -5.14 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 N-CA-C 115.333 1.605 . . . . 10.0 115.333 -177.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.59 -169.26 32.72 Favored Glycine 0 N--CA 1.45 -0.383 0 CA-C-O 122.57 1.095 . . . . 10.0 113.826 -168.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 23.3 t -53.12 -40.15 63.99 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 114.209 -0.996 . . . . 10.0 111.853 177.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -71.99 -13.74 61.7 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 115.357 1.614 . . . . 10.0 115.357 -174.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -130.49 -106.69 1.16 Allowed Glycine 0 CA--C 1.531 1.031 0 CA-C-N 120.218 1.372 . . . . 10.0 113.349 -174.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -89.48 127.14 35.82 Favored 'General case' 0 C--N 1.329 -0.313 0 O-C-N 120.673 -1.487 . . . . 10.0 109.352 169.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -72.43 65.33 1.35 Allowed Glycine 0 CA--C 1.532 1.127 0 N-CA-C 113.937 0.335 . . . . 10.0 113.937 173.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 60.8 mt -79.6 -42.74 23.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 126.044 1.737 . . . . 10.0 108.717 166.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 79.7 t -126.28 133.4 24.93 Favored Pre-proline 0 N--CA 1.454 -0.25 0 C-N-CA 126.467 1.907 . . . . 10.0 109.368 -174.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -68.74 153.78 72.5 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 123.811 3.007 . . . . 10.0 111.476 -176.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 12.2 tp -43.16 -39.8 3.02 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.359 1.064 . . . . 10.0 112.193 171.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -48.32 -52.41 21.66 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 114.68 1.363 . . . . 10.0 114.68 176.046 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 13.9 mm -75.91 -40.5 38.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 C-N-CA 124.401 1.08 . . . . 10.0 109.658 177.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -49.3 -49.81 42.15 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 118.593 0.633 . . . . 10.0 111.947 173.621 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 16.1 m -57.66 -47.07 83.31 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 126.083 1.753 . . . . 10.0 112.998 174.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -63.33 -52.34 62.23 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.95 0.9 . . . . 10.0 112.073 179.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 93.3 mt -52.55 -58.54 6.45 Favored 'General case' 0 C--O 1.228 -0.046 0 C-N-CA 124.32 1.048 . . . . 10.0 109.973 176.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -55.19 -44.62 75.45 Favored 'General case' 0 C--O 1.22 -0.475 0 CA-C-O 117.608 -1.187 . . . . 10.0 113.0 176.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 4.6 tmm? -51.48 -52.51 45.97 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 120.502 1.501 . . . . 10.0 112.581 173.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 79.9 t -61.06 -48.65 88.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 124.675 1.19 . . . . 10.0 111.773 178.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 5.3 mp -57.62 -53.26 60.2 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.472 1.509 . . . . 10.0 111.89 176.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -55.96 -54.95 38.59 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 126.753 2.021 . . . . 10.0 110.707 177.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 37.6 t -46.76 -53.51 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 O-C-N 121.243 -0.911 . . . . 10.0 111.368 173.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 5.2 t -57.94 -49.35 77.09 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.248 0.619 . . . . 10.0 112.599 176.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -62.52 -31.23 71.96 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.069 1.747 . . . . 10.0 114.24 178.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 11.9 mptt -86.34 -73.75 0.45 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.262 1.425 . . . . 10.0 110.259 177.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 33.9 m -88.72 -34.27 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 O-C-N 121.293 -0.879 . . . . 10.0 112.781 -167.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -57.92 -58.38 14.88 Favored Glycine 0 CA--C 1.534 1.258 0 CA-C-N 119.772 1.169 . . . . 10.0 111.876 172.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -44.19 -57.68 3.3 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.921 2.089 . . . . 10.0 112.111 166.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -55.03 -41.98 79.46 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 124.059 0.838 . . . . 10.0 113.979 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 24.0 mt -71.07 -27.16 63.43 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 115.637 1.718 . . . . 10.0 115.637 177.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 74.1 mt -63.22 -57.61 11.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 108.684 -0.858 . . . . 10.0 108.684 165.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 32.1 tp -58.82 -64.63 0.86 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.935 0.894 . . . . 10.0 113.183 -172.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 84.5 mt -71.64 5.25 2.55 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 115.27 1.582 . . . . 10.0 115.27 -171.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.7 mtp-105 -112.33 0.39 15.67 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.203 1.001 . . . . 10.0 113.292 172.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 8.8 t -108.06 177.97 4.65 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 124.06 0.944 . . . . 10.0 111.015 174.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . 0.462 ' HD3' ' CD ' ' A' ' 166' ' ' GLU . 41.7 ttt180 -71.63 98.15 1.85 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.795 0.838 . . . . 10.0 110.917 170.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -80.89 77.02 7.8 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.859 0.863 . . . . 10.0 112.116 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 40.11 102.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 128.833 2.853 . . . . 10.0 116.484 177.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . 0.481 0.3 OUTLIER 71.79 -55.39 0.66 Allowed 'General case' 0 C--O 1.242 0.685 0 C-N-CA 124.753 1.221 . . . . 10.0 110.68 -175.267 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -68.3 169.47 40.07 Favored Glycine 0 C--O 1.239 0.429 0 C-N-CA 129.735 3.541 . . . . 10.0 119.674 171.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.448 0 C-N-CA 128.491 2.716 . . . . 10.0 113.461 166.62 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 999' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A 1000 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A 1001 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A 1002 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A 1003 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 N--CA 1.477 0.876 0 CA-C-O 115.781 -2.057 . . . . 10.0 105.837 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 23.43 91.86 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 129.576 3.15 . . . . 10.0 117.262 160.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 28.59 65.12 0.1 Allowed 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 128.297 2.639 . . . . 10.0 114.458 155.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 86.7 mt -56.51 137.96 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 126.384 1.873 . . . . 10.0 113.343 -158.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.6 t -136.74 -165.19 1.69 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 126.353 1.861 . . . . 10.0 114.062 -174.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 70.02 2.75 40.86 Favored Glycine 0 C--N 1.339 0.743 0 C-N-CA 127.44 2.448 . . . . 10.0 111.453 168.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -158.57 -51.28 0.01 OUTLIER Pre-proline 0 N--CA 1.443 -0.805 0 CA-C-O 114.243 -2.789 . . . . 10.0 116.635 -168.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_exo -63.96 -60.62 0.15 Allowed 'Trans proline' 0 N--CA 1.465 -0.202 0 CA-C-N 123.576 2.313 . . . . 10.0 113.21 -175.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 7.9 pm0 -67.26 4.31 0.99 Allowed 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 127.831 2.452 . . . . 10.0 115.783 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.422 ' CG ' ' N ' ' A' ' 11' ' ' ILE . 11.0 p-90 -51.31 -43.17 61.63 Favored 'General case' 0 C--O 1.223 -0.34 0 O-C-N 121.5 -0.75 . . . . 10.0 112.615 176.423 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.422 ' N ' ' CG ' ' A' ' 10' ' ' TRP . 8.9 tt -60.83 -49.64 83.77 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.34 0 C-N-CA 123.885 0.874 . . . . 10.0 109.344 179.403 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 2.6 m95 -55.39 -52.58 63.08 Favored 'General case' 0 C--O 1.224 -0.259 0 C-N-CA 123.4 0.68 . . . . 10.0 111.88 175.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.2 mt -57.39 -53.63 55.96 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 123.219 0.608 . . . . 10.0 112.196 177.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.9 -46.74 52.14 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.366 1.466 . . . . 10.0 113.332 173.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 13.3 tp -65.71 -44.9 84.69 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 125.274 1.43 . . . . 10.0 113.013 179.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.94 -57.29 10.07 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 124.122 0.868 . . . . 10.0 111.16 166.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 22.5 m -48.38 -52.67 20.73 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.709 1.204 . . . . 10.0 112.347 174.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.39 -58.86 5.82 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.139 0.976 . . . . 10.0 112.188 177.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 94.3 mt -57.69 -50.23 73.88 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.696 0.799 . . . . 10.0 112.627 -179.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -53.73 -50.91 64.92 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.495 1.118 . . . . 10.0 111.395 175.066 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -57.95 -58.01 16.81 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 124.268 0.937 . . . . 10.0 113.579 176.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 81.2 mt -56.19 -45.83 79.63 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-N 118.527 1.164 . . . . 10.0 112.125 176.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.63 -41.95 75.66 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 124.854 1.216 . . . . 10.0 113.278 172.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 24.6 m -61.41 -59.5 5.16 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.984 0.913 . . . . 10.0 111.263 171.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -52.29 -40.92 62.43 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.028 0.931 . . . . 10.0 110.99 178.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -55.86 -57.98 9.78 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 124.619 1.168 . . . . 10.0 112.966 172.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -59.65 -38.75 82.26 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 113.193 0.812 . . . . 10.0 113.193 178.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.468 ' C ' ' H ' ' A' ' 30' ' ' LYS . 11.8 mt -56.08 -67.47 0.29 Allowed 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.58 1.152 . . . . 10.0 113.637 169.108 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 t -76.37 40.96 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 CA-C-O 123.802 1.763 . . . . 10.0 110.891 179.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.468 ' H ' ' C ' ' A' ' 28' ' ' LEU . 42.9 tttm -140.85 -44.82 0.39 Allowed 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 127.862 2.465 . . . . 10.0 109.317 171.12 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.9 23.1 0.86 Allowed Glycine 0 CA--C 1.529 0.908 0 N-CA-C 115.668 1.027 . . . . 10.0 115.668 173.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 37.4 mmm -59.54 -44.95 93.07 Favored 'General case' 0 C--O 1.225 -0.217 0 C-N-CA 127.19 2.196 . . . . 10.0 113.596 -178.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.74 -84.45 1.19 Allowed Glycine 0 CA--C 1.531 1.035 0 C-N-CA 123.798 0.713 . . . . 10.0 112.437 -170.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.7 t 33.06 88.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 128.358 2.663 . . . . 10.0 116.93 166.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.4 m -79.63 -50.86 10.04 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.155 -1.384 . . . . 10.0 113.879 174.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -48.95 117.46 6.39 Favored Pre-proline 0 CA--C 1.535 0.402 0 O-C-N 124.718 1.261 . . . . 10.0 110.982 -172.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -58.5 -29.68 89.44 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 123.779 2.986 . . . . 10.0 113.688 179.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.27 -60.71 2.26 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.148 0.579 . . . . 10.0 111.424 176.193 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.19 -40.05 22.94 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 125.085 1.354 . . . . 10.0 113.534 171.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -46.55 -47.45 19.65 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.21 1.404 . . . . 10.0 113.436 172.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -57.74 -53.1 61.99 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.479 0.712 . . . . 10.0 110.944 176.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -56.91 -50.28 73.02 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 123.119 0.568 . . . . 10.0 112.342 -179.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -54.34 -51.29 65.22 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 118.936 -0.554 . . . . 10.0 112.345 173.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.45 -61.99 1.92 Allowed 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 113.392 0.886 . . . . 10.0 113.392 177.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.5 mt -48.68 -56.27 2.47 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 C-N-CA 124.864 1.266 . . . . 10.0 110.64 177.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.6 m -70.17 -17.45 63.17 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.003 1.321 . . . . 10.0 113.646 -172.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 27.5 m -87.8 -37.34 16.67 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.194 0.998 . . . . 10.0 112.237 174.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 20.8 mt -60.4 -42.57 96.19 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 118.128 -0.939 . . . . 10.0 112.518 172.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . 0.349 33.2 m -52.53 -53.04 57.93 Favored Pre-proline 0 N--CA 1.487 1.386 0 CA-C-N 120.645 1.566 . . . . 10.0 115.049 -179.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -68.33 -25.11 36.52 Favored 'Trans proline' 0 CA--C 1.545 1.044 0 CA-C-N 123.02 2.114 . . . . 10.0 113.524 174.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -68.09 -45.83 72.65 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-N 120.5 1.5 . . . . 10.0 112.894 173.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 31.4 mm -54.07 -52.3 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 124.896 1.278 . . . . 10.0 109.525 168.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -52.9 -49.57 65.63 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.968 0.907 . . . . 10.0 113.04 174.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 52.3 t80 -51.78 -58.53 6.15 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.769 1.628 . . . . 10.0 112.19 175.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.1 m -49.01 -52.7 23.6 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.252 1.421 . . . . 10.0 110.629 178.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.418 ' HG3' ' CB ' ' A' ' 85' ' ' ASP . 32.8 mmt -69.42 -48.09 62.09 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 123.854 0.861 . . . . 10.0 112.899 -176.429 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -56.2 -40.98 74.86 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 120.321 1.419 . . . . 10.0 113.146 172.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.8 tp -53.27 -54.59 34.01 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-N 120.031 1.287 . . . . 10.0 111.292 170.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 24.0 p -51.68 -41.05 61.12 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 115.224 1.564 . . . . 10.0 115.224 178.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 57.8 mtm -66.82 -50.87 61.2 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 123.586 0.754 . . . . 10.0 110.527 176.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.4 tp -48.53 -52.67 21.46 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.857 0.863 . . . . 10.0 112.974 172.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.4 mt -76.97 -5.54 49.02 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 113.849 1.055 . . . . 10.0 113.849 -177.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.32 -34.71 5.55 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 115.55 0.98 . . . . 10.0 115.55 174.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -49.33 -43.05 43.39 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 115.235 1.568 . . . . 10.0 115.235 -175.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.05 3.58 61.04 Favored Glycine 0 CA--C 1.521 0.467 0 N-CA-C 115.358 0.903 . . . . 10.0 115.358 -179.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.3 143.41 26.43 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 127.035 2.134 . . . . 10.0 109.018 172.002 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 t -145.47 171.11 15.12 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 124.081 0.952 . . . . 10.0 111.062 166.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.04 136.07 53.37 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 123.919 0.888 . . . . 10.0 109.661 179.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 58.7 t -129.58 129.59 23.18 Favored Pre-proline 0 C--N 1.329 -0.313 0 C-N-CA 125.063 1.345 . . . . 10.0 110.96 -176.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -80.72 116.24 3.17 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 N-CA-C 109.406 -1.036 . . . . 10.0 109.406 -178.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -156.73 164.39 38.17 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 112.842 0.682 . . . . 10.0 112.842 172.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.36 -81.95 0.14 Allowed Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.693 -0.963 . . . . 10.0 110.693 175.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.77 -3.38 0.69 Allowed Glycine 0 CA--C 1.526 0.766 0 N-CA-C 118.642 2.217 . . . . 10.0 118.642 170.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -151.62 -171.87 4.05 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 119.379 1.59 . . . . 10.0 112.257 -165.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -91.89 93.9 9.04 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 125.534 1.533 . . . . 10.0 111.131 -175.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 60.4 m-80 -89.49 120.8 69.63 Favored Pre-proline 0 N--CA 1.45 -0.43 0 N-CA-C 112.933 0.716 . . . . 10.0 112.933 -165.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -61.52 131.94 38.31 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 124.205 3.27 . . . . 10.0 112.166 171.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.6 mm -140.18 126.32 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 C-N-CA 126.072 1.749 . . . . 10.0 111.712 -179.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -93.62 85.07 4.77 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 123.171 1.463 . . . . 10.0 113.041 174.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 63.7 p-90 -59.38 -28.32 66.79 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 120.729 -1.232 . . . . 10.0 113.873 174.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -54.51 -37.28 65.15 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 115.087 1.514 . . . . 10.0 115.087 178.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -59.66 -35.93 75.42 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 120.311 1.414 . . . . 10.0 112.488 172.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 -66.73 -42.91 85.52 Favored 'General case' 0 CA--C 1.545 0.752 0 O-C-N 120.997 -1.065 . . . . 10.0 112.876 173.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -49.47 -49.56 44.97 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 125.361 1.464 . . . . 10.0 111.321 166.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.418 ' CB ' ' HG3' ' A' ' 56' ' ' MET . 0.0 OUTLIER -59.46 -60.29 4.09 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.001 1.321 . . . . 10.0 112.533 173.385 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 51.8 m0 -54.82 -37.94 66.75 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 126.034 1.733 . . . . 10.0 113.161 -175.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 31.3 tp -49.84 -45.51 50.36 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 126.677 1.991 . . . . 10.0 111.86 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -97.33 -40.74 8.58 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 123.666 0.787 . . . . 10.0 112.502 -179.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -61.93 -44.98 95.64 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 113.275 0.843 . . . . 10.0 113.275 -175.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . 0.293 81.7 p -69.58 -39.19 11.34 Favored Pre-proline 0 CA--C 1.544 0.719 0 CA-C-O 117.601 -1.19 . . . . 10.0 114.032 -174.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -54.31 -44.66 47.34 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 123.722 2.948 . . . . 10.0 115.451 164.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 51.2 mt -59.17 -46.75 87.58 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 118.948 0.795 . . . . 10.0 111.434 175.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.4 tp -50.79 -47.9 59.61 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.563 1.545 . . . . 10.0 112.226 172.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.5 mp -59.86 -46.64 88.67 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.293 1.437 . . . . 10.0 112.832 170.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.81 -38.27 78.25 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 123.806 0.842 . . . . 10.0 112.866 178.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -52.26 -54.04 36.3 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 119.329 0.968 . . . . 10.0 111.21 169.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.36 -42.06 88.57 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.671 0.788 . . . . 10.0 112.119 -178.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.71 -54.77 37.54 Favored 'General case' 0 C--O 1.225 -0.186 0 C-N-CA 123.982 0.913 . . . . 10.0 111.999 173.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.27 -41.21 79.27 Favored 'General case' 0 C--O 1.224 -0.237 0 C-N-CA 123.72 0.808 . . . . 10.0 112.678 174.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.8 tp -63.74 -38.57 91.62 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 114.424 1.268 . . . . 10.0 114.424 -179.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.1 t -94.83 1.44 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 125.035 1.334 . . . . 10.0 112.308 179.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.2 t70 48.59 53.49 12.08 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.882 1.673 . . . . 10.0 112.1 -174.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.29 145.89 47.56 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 119.951 -1.718 . . . . 10.0 112.422 -174.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.5 135.91 54.29 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 112.694 0.627 . . . . 10.0 112.694 175.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -42.87 -39.68 2.62 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.863 1.665 . . . . 10.0 113.463 175.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -47.33 -60.17 5.36 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 125.133 1.349 . . . . 10.0 115.293 169.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.6 p -62.07 -46.77 87.66 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 117.098 -1.429 . . . . 10.0 111.356 178.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 66.9 mt -48.42 -52.89 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 124.979 1.312 . . . . 10.0 111.153 178.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.2 tp -62.66 -51.25 67.98 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 112.544 0.572 . . . . 10.0 112.544 179.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.19 -44.81 43.44 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.424 0.69 . . . . 10.0 110.983 174.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.56 -59.93 4.66 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 127.365 2.266 . . . . 10.0 114.838 174.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.6 t -60.99 -46.38 96.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 123.666 0.786 . . . . 10.0 111.37 -178.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -56.63 -50.26 64.35 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 123.659 0.647 . . . . 10.0 112.633 174.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -55.0 -46.62 75.18 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 113.451 0.908 . . . . 10.0 113.451 173.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -56.06 -47.14 78.49 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.466 0.706 . . . . 10.0 111.657 173.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -43.95 -54.23 6.09 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 124.88 1.229 . . . . 10.0 112.928 169.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 79.4 mt -58.22 -50.61 77.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 123.726 0.81 . . . . 10.0 111.979 173.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 53.1 ttp -49.05 -57.01 7.28 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.152 1.381 . . . . 10.0 112.061 179.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 36.5 mm -69.13 -44.84 80.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 O-C-N 121.735 -0.603 . . . . 10.0 111.912 178.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -51.95 -54.63 24.78 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 125.121 1.343 . . . . 10.0 113.249 176.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 35.2 p -60.85 -36.93 80.4 Favored 'General case' 0 N--CA 1.473 0.709 0 O-C-N 121.286 -1.126 . . . . 10.0 112.589 173.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -52.82 -55.24 24.33 Favored Glycine 0 CA--C 1.537 1.446 0 CA-C-N 119.215 0.916 . . . . 10.0 113.445 167.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -49.78 -50.64 43.96 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 128.58 2.752 . . . . 10.0 111.135 173.011 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 60.7 t -60.31 -50.25 81.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 124.542 1.137 . . . . 10.0 111.61 175.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -51.76 -59.59 8.44 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 125.893 1.711 . . . . 10.0 112.115 175.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -48.46 -37.9 18.49 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 127.027 2.131 . . . . 10.0 113.417 179.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 48.1 mt -99.4 -6.78 27.14 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 115.442 1.645 . . . . 10.0 115.442 -178.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 16.9 m -69.73 116.7 10.43 Favored 'General case' 0 N--CA 1.464 0.229 0 O-C-N 120.178 -1.576 . . . . 10.0 110.386 -178.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.551 ' HD3' ' H ' ' A' ' 129' ' ' LYS . 0.1 OUTLIER -55.4 -49.67 71.74 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 128.226 2.61 . . . . 10.0 113.299 177.751 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 60.6 t -69.61 106.31 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 C-N-CA 123.766 0.826 . . . . 10.0 110.141 179.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -46.87 -59.57 2.99 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 124.807 1.243 . . . . 10.0 114.048 -173.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 m -46.44 -42.11 14.86 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.478 1.511 . . . . 10.0 113.495 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -70.1 -24.68 63.25 Favored 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 114.958 1.466 . . . . 10.0 114.958 -178.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 69.5 mtp85 -53.76 -41.9 67.64 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 118.852 0.751 . . . . 10.0 110.814 176.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -69.43 -32.32 71.21 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.76 1.224 . . . . 10.0 114.233 176.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.8 t -55.12 -51.97 49.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-N 119.015 0.825 . . . . 10.0 109.932 169.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 69.3 m95 -59.51 -51.07 71.46 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 113.517 0.932 . . . . 10.0 113.517 174.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 86.5 t90 -48.79 -46.82 42.11 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.563 1.145 . . . . 10.0 113.494 174.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -58.12 -51.97 67.5 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.973 0.909 . . . . 10.0 111.683 175.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 97.6 mt -55.23 -50.52 63.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 125.062 1.345 . . . . 10.0 111.673 174.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 25.1 m -53.62 -44.91 69.9 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.495 1.118 . . . . 10.0 112.367 173.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 61.4 m -65.44 -42.0 92.88 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.051 1.34 . . . . 10.0 111.828 178.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -55.77 -48.33 75.49 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 119.368 0.985 . . . . 10.0 112.089 169.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -58.25 -48.63 79.8 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.661 0.784 . . . . 10.0 112.934 174.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.4 -47.48 83.76 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 118.914 0.779 . . . . 10.0 111.955 175.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 61.6 tp -56.36 -49.39 74.56 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.202 1.401 . . . . 10.0 112.203 176.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 73.9 t80 -51.08 -54.25 26.67 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.97 0.908 . . . . 10.0 112.095 172.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 59.8 mt -54.07 -55.36 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 123.806 0.842 . . . . 10.0 110.662 177.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 21.8 mt -57.33 -35.35 69.76 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 118.009 -0.996 . . . . 10.0 113.067 178.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -57.31 -58.2 9.29 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 119.52 1.055 . . . . 10.0 113.011 173.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.41 -40.95 85.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-O 118.279 -0.867 . . . . 10.0 111.408 177.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 44.3 mt -56.77 -49.36 75.51 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 119.909 1.231 . . . . 10.0 112.148 171.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.424 ' HA ' ' HD2' ' A' ' 175' ' ' ARG . 11.8 t80 -77.05 -70.3 0.47 Allowed 'General case' 0 C--N 1.326 -0.447 0 O-C-N 120.056 -1.653 . . . . 10.0 112.848 -175.208 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -73.71 -21.94 60.07 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.612 1.165 . . . . 10.0 113.473 -174.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -87.85 -79.09 1.26 Allowed Glycine 0 CA--C 1.526 0.77 0 C-N-CA 123.588 0.613 . . . . 10.0 113.493 171.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -53.6 -32.48 51.28 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 126.305 1.842 . . . . 10.0 113.033 -166.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.0 m -52.03 -56.47 14.15 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 114.04 1.126 . . . . 10.0 114.04 172.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.5 p -53.68 -50.53 65.61 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 122.099 0.952 . . . . 10.0 112.308 -177.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 47.7 tttm -57.17 -45.97 83.21 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.166 0.986 . . . . 10.0 112.112 173.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.9 -47.42 80.57 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 114.497 1.295 . . . . 10.0 114.497 174.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -56.5 -11.23 1.19 Allowed 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 126.077 1.751 . . . . 10.0 114.271 177.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.1 m -107.16 6.64 28.96 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.424 1.89 . . . . 10.0 114.852 -179.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 93.3 mmm -91.89 -92.67 0.15 Allowed 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 123.475 1.607 . . . . 10.0 114.187 -170.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -138.69 153.99 72.72 Favored Pre-proline 0 C--O 1.236 0.359 0 C-N-CA 129.794 3.238 . . . . 10.0 105.56 170.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -52.85 -46.25 35.03 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.321 2.014 . . . . 10.0 113.078 179.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . 0.461 ' CD ' ' HD3' ' A' ' 227' ' ' ARG . 0.1 OUTLIER -52.98 -46.02 68.08 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 129.013 2.925 . . . . 10.0 113.276 173.573 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 92.2 t -69.25 -53.0 27.74 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.249 0 C-N-CA 124.071 0.949 . . . . 10.0 109.788 -178.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.13 -46.82 75.66 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.31 0.644 . . . . 10.0 111.947 177.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 60.0 p -59.97 -56.25 24.07 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.919 0.887 . . . . 10.0 112.708 174.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 61.5 m -57.15 -53.25 60.24 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.23 1.012 . . . . 10.0 112.995 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -49.53 -49.57 45.48 Favored 'General case' 0 C--O 1.222 -0.375 0 C-N-CA 123.252 0.621 . . . . 10.0 111.113 174.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -57.1 -48.4 78.7 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 114.703 1.371 . . . . 10.0 114.703 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 40.5 t -55.98 -49.59 74.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 CA-C-N 118.795 0.725 . . . . 10.0 110.496 176.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 94.3 mt -58.58 -51.64 69.04 Favored 'General case' 0 C--O 1.221 -0.441 0 N-CA-C 113.132 0.79 . . . . 10.0 113.132 175.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . 0.424 ' HD2' ' HA ' ' A' ' 153' ' ' PHE . 35.6 ttp180 -47.81 -47.8 30.92 Favored 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 126.846 2.059 . . . . 10.0 111.011 174.509 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 63.7 m-20 -58.48 -58.36 8.88 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 122.817 0.447 . . . . 10.0 111.277 174.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 60.0 t -51.78 -49.04 37.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 C-N-CA 124.075 0.95 . . . . 10.0 111.53 179.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 28.7 m -57.4 -62.51 1.73 Allowed 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 128.025 2.53 . . . . 10.0 112.007 178.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 54.3 t -51.55 -50.31 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 C-N-CA 124.491 1.116 . . . . 10.0 111.069 -179.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 73.6 t -58.05 -62.6 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 124.022 0.929 . . . . 10.0 111.482 177.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -56.99 -48.71 77.77 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 118.869 0.759 . . . . 10.0 112.468 -177.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 10.9 m95 -55.67 -45.26 77.75 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.94 0.896 . . . . 10.0 112.615 177.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 51.2 p -56.85 -31.63 64.97 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 114.029 1.122 . . . . 10.0 114.029 176.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -65.73 -41.06 92.66 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 113.722 1.008 . . . . 10.0 113.722 178.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -47.38 -55.53 15.91 Favored Pre-proline 0 N--CA 1.477 0.887 0 N-CA-C 115.286 1.587 . . . . 10.0 115.286 -177.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -57.83 -36.48 98.26 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 122.244 1.962 . . . . 10.0 113.083 175.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 21.8 t -63.74 -53.58 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 124.105 0.962 . . . . 10.0 111.219 176.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 87.5 t -54.72 -48.63 72.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 124.408 1.083 . . . . 10.0 111.374 177.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 26.5 t90 -55.7 -52.63 63.22 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.685 1.194 . . . . 10.0 112.388 174.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 34.6 tp -53.21 -45.49 68.64 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.778 1.231 . . . . 10.0 112.511 -179.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 14.7 pt -87.92 -5.41 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 N-CA-C 115.318 1.599 . . . . 10.0 115.318 -176.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.39 -169.23 32.98 Favored Glycine 0 N--CA 1.451 -0.341 0 CA-C-O 122.614 1.119 . . . . 10.0 113.875 -168.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 23.2 t -53.19 -40.86 64.73 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 114.153 -1.023 . . . . 10.0 111.83 177.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -53.97 -32.94 55.53 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 128.571 2.748 . . . . 10.0 115.262 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -130.85 -103.84 0.99 Allowed Glycine 0 CA--C 1.527 0.82 0 CA-C-N 119.324 0.965 . . . . 10.0 113.384 -167.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -89.49 127.14 35.82 Favored 'General case' 0 C--N 1.328 -0.33 0 O-C-N 120.624 -1.515 . . . . 10.0 109.308 169.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -72.41 65.27 1.35 Allowed Glycine 0 CA--C 1.532 1.105 0 N-CA-C 113.899 0.32 . . . . 10.0 113.899 173.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 60.7 mt -79.57 -42.73 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 C-N-CA 126.088 1.755 . . . . 10.0 108.748 166.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 79.2 t -126.27 133.4 24.92 Favored Pre-proline 0 N--CA 1.454 -0.264 0 C-N-CA 126.408 1.883 . . . . 10.0 109.364 -174.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -68.68 153.73 72.74 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 123.811 3.007 . . . . 10.0 111.471 -176.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 12.2 tp -43.08 -39.86 2.92 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.358 1.063 . . . . 10.0 112.199 171.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -48.28 -52.43 21.31 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 114.705 1.372 . . . . 10.0 114.705 176.052 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 14.0 mm -75.89 -40.55 38.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 124.39 1.076 . . . . 10.0 109.625 177.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -49.24 -49.85 41.29 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 118.596 0.635 . . . . 10.0 111.934 173.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 16.2 m -57.64 -47.1 83.17 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 126.046 1.738 . . . . 10.0 112.993 174.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -63.31 -52.34 62.31 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.947 0.899 . . . . 10.0 112.112 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 93.3 mt -52.52 -59.49 4.38 Favored 'General case' 0 CA--C 1.527 0.068 0 C-N-CA 124.321 1.048 . . . . 10.0 109.963 176.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -54.88 -42.14 71.73 Favored 'General case' 0 C--O 1.221 -0.442 0 CA-C-O 117.52 -1.229 . . . . 10.0 112.938 176.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 4.6 tmm? -53.65 -53.42 52.19 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 121.033 1.742 . . . . 10.0 112.341 173.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 79.1 t -60.55 -46.92 94.76 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 124.824 1.25 . . . . 10.0 111.674 178.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 4.3 mp -58.25 -53.19 61.08 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.368 1.467 . . . . 10.0 111.621 175.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -55.84 -53.38 57.44 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.562 1.545 . . . . 10.0 111.277 178.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 45.7 t -49.12 -59.67 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 124.883 1.273 . . . . 10.0 111.145 174.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 28.5 p -62.33 -46.84 86.87 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.382 0.673 . . . . 10.0 112.503 -177.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -70.1 1.42 4.69 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 115.613 1.708 . . . . 10.0 115.613 178.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 18.8 mtmm -131.33 -63.25 0.85 Allowed 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 119.986 1.266 . . . . 10.0 112.231 173.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 21.0 t -66.34 -52.11 50.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 123.762 0.825 . . . . 10.0 110.507 178.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -56.78 -55.45 29.98 Favored Glycine 0 CA--C 1.536 1.379 0 C-N-CA 124.098 0.856 . . . . 10.0 112.832 176.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -43.24 -55.86 3.77 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.495 1.918 . . . . 10.0 112.483 167.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -59.16 -39.49 94.54 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 124.857 1.218 . . . . 10.0 113.266 179.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 24.6 mt -69.13 -27.82 65.91 Favored 'General case' 0 CA--C 1.512 -0.495 0 N-CA-C 115.742 1.756 . . . . 10.0 115.742 175.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 74.3 mt -63.37 -57.57 11.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 119.122 0.874 . . . . 10.0 108.648 165.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 32.0 tp -58.77 -64.68 0.84 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.877 0.871 . . . . 10.0 113.213 -172.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 84.0 mt -71.52 5.16 2.51 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 115.337 1.606 . . . . 10.0 115.337 -171.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.6 mtp-105 -112.35 0.44 15.67 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.139 0.976 . . . . 10.0 113.288 172.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 8.8 t -108.06 177.97 4.65 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 124.096 0.958 . . . . 10.0 111.025 174.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . 0.461 ' HD3' ' CD ' ' A' ' 166' ' ' GLU . 41.8 ttt180 -71.62 98.11 1.84 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.819 0.848 . . . . 10.0 110.969 170.637 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -80.91 77.03 7.83 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.859 0.864 . . . . 10.0 112.123 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 40.16 102.25 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 128.886 2.874 . . . . 10.0 116.446 177.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . 0.481 0.3 OUTLIER 71.85 -55.43 0.66 Allowed 'General case' 0 C--O 1.242 0.67 0 C-N-CA 124.711 1.205 . . . . 10.0 110.637 -175.318 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -68.28 169.47 40.01 Favored Glycine 0 C--O 1.239 0.417 0 C-N-CA 129.757 3.551 . . . . 10.0 119.653 171.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.461 0 C-N-CA 128.501 2.72 . . . . 10.0 113.462 166.617 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 999' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A 1000 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A 1001 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A 1002 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A 1003 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 N--CA 1.477 0.881 0 CA-C-O 115.768 -2.063 . . . . 10.0 105.842 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 23.35 91.83 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 129.598 3.159 . . . . 10.0 117.262 160.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 28.74 65.04 0.11 Allowed 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 128.265 2.626 . . . . 10.0 114.5 155.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 86.7 mt -56.51 138.0 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 126.353 1.861 . . . . 10.0 113.338 -158.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.6 t -136.79 -165.2 1.7 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 126.331 1.852 . . . . 10.0 114.015 -174.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 70.06 2.75 41.2 Favored Glycine 0 C--N 1.339 0.743 0 C-N-CA 127.458 2.456 . . . . 10.0 111.462 168.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -158.54 -51.29 0.01 OUTLIER Pre-proline 0 N--CA 1.443 -0.822 0 CA-C-O 114.267 -2.778 . . . . 10.0 116.694 -168.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -63.99 -60.63 0.15 Allowed 'Trans proline' 0 N--CA 1.465 -0.186 0 CA-C-N 123.502 2.286 . . . . 10.0 113.205 -175.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 7.9 pm0 -67.24 4.3 0.98 Allowed 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 127.844 2.458 . . . . 10.0 115.768 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.421 ' CG ' ' N ' ' A' ' 11' ' ' ILE . 11.1 p-90 -51.39 -43.07 61.8 Favored 'General case' 0 C--O 1.222 -0.361 0 O-C-N 121.496 -0.752 . . . . 10.0 112.594 176.481 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.421 ' N ' ' CG ' ' A' ' 10' ' ' TRP . 8.8 tt -60.91 -49.57 84.13 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.338 0 C-N-CA 123.884 0.874 . . . . 10.0 109.337 179.429 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 2.6 m95 -55.45 -52.64 62.96 Favored 'General case' 0 C--O 1.224 -0.259 0 C-N-CA 123.413 0.685 . . . . 10.0 111.819 175.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.9 mt -57.39 -53.58 56.56 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 123.184 0.594 . . . . 10.0 112.198 177.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.83 -46.82 51.63 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.39 1.476 . . . . 10.0 113.335 173.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 13.3 tp -65.67 -44.88 84.92 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.27 1.428 . . . . 10.0 113.059 179.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.4 -57.58 9.09 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 124.553 1.073 . . . . 10.0 111.045 165.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.0 m -48.91 -52.47 24.34 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.911 1.284 . . . . 10.0 112.333 175.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.4 -58.87 5.75 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.148 0.979 . . . . 10.0 112.155 177.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 96.5 mt -58.06 -49.08 78.16 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.651 0.781 . . . . 10.0 112.515 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 21.8 mmt -54.43 -51.59 64.45 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.811 0.845 . . . . 10.0 111.056 175.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -56.87 -58.48 14.31 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 124.584 1.088 . . . . 10.0 113.624 177.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 80.7 mt -56.18 -45.72 79.66 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-N 118.617 1.208 . . . . 10.0 112.107 176.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.79 -41.84 76.73 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 124.725 1.155 . . . . 10.0 113.374 172.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 19.1 m -60.43 -60.44 3.8 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.228 1.011 . . . . 10.0 111.083 171.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -52.34 -40.96 62.6 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.99 0.916 . . . . 10.0 110.925 179.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.4 t80 -55.82 -58.05 9.49 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.564 1.146 . . . . 10.0 112.943 172.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -59.59 -38.72 81.96 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 113.184 0.809 . . . . 10.0 113.184 178.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.469 ' C ' ' H ' ' A' ' 30' ' ' LYS . 11.8 mt -56.12 -67.47 0.29 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.656 1.182 . . . . 10.0 113.589 169.167 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 t -76.41 41.04 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 CA-C-O 123.775 1.75 . . . . 10.0 110.889 179.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.469 ' H ' ' C ' ' A' ' 28' ' ' LEU . 43.0 tttm -140.89 -44.83 0.39 Allowed 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 127.899 2.48 . . . . 10.0 109.337 171.166 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -73.0 23.15 0.88 Allowed Glycine 0 CA--C 1.528 0.898 0 N-CA-C 115.619 1.007 . . . . 10.0 115.619 173.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 37.4 mmm -59.51 -45.04 92.87 Favored 'General case' 0 C--O 1.224 -0.278 0 C-N-CA 127.189 2.196 . . . . 10.0 113.581 -179.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.65 -84.42 1.18 Allowed Glycine 0 CA--C 1.53 1.026 0 C-N-CA 123.743 0.687 . . . . 10.0 112.465 -170.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.8 t 33.06 88.78 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.242 0.682 0 C-N-CA 128.399 2.68 . . . . 10.0 116.905 166.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.4 m -79.63 -50.85 10.04 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.163 -1.38 . . . . 10.0 113.868 174.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -49.02 117.58 6.59 Favored Pre-proline 0 CA--C 1.536 0.418 0 O-C-N 124.767 1.292 . . . . 10.0 110.95 -172.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -58.62 -29.61 89.69 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 123.721 2.947 . . . . 10.0 113.688 179.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.32 -60.64 2.3 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.08 0.552 . . . . 10.0 111.436 176.179 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.12 -40.11 22.54 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 125.134 1.373 . . . . 10.0 113.58 171.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -46.5 -47.5 19.37 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.21 1.404 . . . . 10.0 113.425 172.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -57.73 -53.01 63.02 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.452 0.701 . . . . 10.0 111.036 176.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -56.98 -50.21 73.39 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 123.057 0.543 . . . . 10.0 112.348 -179.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -54.39 -51.27 65.36 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 118.966 -0.54 . . . . 10.0 112.369 173.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.39 -62.08 1.86 Allowed 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 113.353 0.871 . . . . 10.0 113.353 177.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.6 mt -48.62 -58.85 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 C-N-CA 124.862 1.265 . . . . 10.0 110.844 178.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 86.7 m -71.1 -13.67 62.04 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 114.128 1.159 . . . . 10.0 114.128 -173.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 29.3 m -85.26 -42.9 14.23 Favored 'General case' 0 N--CA 1.482 1.159 0 CA-C-N 120.422 1.465 . . . . 10.0 112.099 171.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 17.7 mt -56.31 -42.98 78.49 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 112.845 0.683 . . . . 10.0 112.845 174.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 37.7 t -48.76 -62.03 2.72 Favored Pre-proline 0 CA--C 1.551 1.001 0 C-N-CA 124.861 1.265 . . . . 10.0 112.728 178.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -49.92 -45.84 30.59 Favored 'Trans proline' 0 CA--C 1.543 0.934 0 C-N-CA 124.104 3.203 . . . . 10.0 115.846 164.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.0 -49.36 77.75 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 114.162 1.171 . . . . 10.0 114.162 -175.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . 0.274 16.1 tt -68.09 -36.08 74.03 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 O-C-N 120.598 -1.313 . . . . 10.0 111.421 173.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.65 -42.09 92.0 Favored 'General case' 0 CA--C 1.545 0.771 0 O-C-N 121.193 -0.942 . . . . 10.0 112.729 173.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -50.82 -56.05 13.99 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.541 1.537 . . . . 10.0 111.647 168.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 14.0 m -48.04 -53.37 16.56 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.653 1.581 . . . . 10.0 111.2 176.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 32.4 mmt -68.57 -48.25 64.69 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 123.966 0.907 . . . . 10.0 113.011 -176.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -56.06 -41.13 74.62 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 120.035 1.289 . . . . 10.0 113.342 173.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.8 tp -53.28 -54.6 33.96 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-N 119.54 1.064 . . . . 10.0 111.273 170.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 24.1 p -51.73 -41.0 61.2 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 115.217 1.562 . . . . 10.0 115.217 179.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 58.5 mtm -66.86 -50.89 61.08 Favored 'General case' 0 C--N 1.333 -0.122 0 C-N-CA 123.589 0.756 . . . . 10.0 110.491 176.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.4 tp -48.51 -52.73 21.05 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.849 0.86 . . . . 10.0 112.931 172.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.5 mt -76.89 -5.53 48.79 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 113.844 1.053 . . . . 10.0 113.844 -177.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.2 -34.63 5.61 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 115.579 0.992 . . . . 10.0 115.579 174.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -49.35 -43.05 43.56 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 115.273 1.583 . . . . 10.0 115.273 -176.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.04 3.55 61.07 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 115.314 0.885 . . . . 10.0 115.314 -179.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.28 143.42 26.42 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 127.035 2.134 . . . . 10.0 108.972 172.063 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 t -145.54 171.08 15.19 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 124.031 0.932 . . . . 10.0 111.052 166.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.95 136.1 53.36 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 123.922 0.889 . . . . 10.0 109.711 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 58.6 t -129.59 129.55 23.17 Favored Pre-proline 0 C--N 1.329 -0.315 0 C-N-CA 125.1 1.36 . . . . 10.0 110.935 -176.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -80.7 116.24 3.18 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 N-CA-C 109.441 -1.023 . . . . 10.0 109.441 -178.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -156.75 164.38 38.19 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.808 0.67 . . . . 10.0 112.808 172.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.4 -81.98 0.14 Allowed Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.681 -0.967 . . . . 10.0 110.681 175.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.76 -3.42 0.69 Allowed Glycine 0 CA--C 1.527 0.812 0 N-CA-C 118.627 2.211 . . . . 10.0 118.627 170.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -151.57 -171.89 4.06 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 119.379 1.59 . . . . 10.0 112.237 -165.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -91.79 93.81 9.04 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 125.552 1.541 . . . . 10.0 111.115 -175.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 60.2 m-80 -89.47 120.74 69.65 Favored Pre-proline 0 N--CA 1.45 -0.464 0 N-CA-C 113.002 0.741 . . . . 10.0 113.002 -165.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -61.49 131.9 38.2 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 124.183 3.255 . . . . 10.0 112.166 171.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.6 mm -140.1 126.35 22.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 C-N-CA 126.028 1.731 . . . . 10.0 111.707 -179.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -93.64 85.06 4.76 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 123.455 1.598 . . . . 10.0 113.051 174.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 63.8 p-90 -59.44 -28.21 66.75 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 120.453 -1.404 . . . . 10.0 113.942 174.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -54.68 -35.47 63.6 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.283 1.033 . . . . 10.0 113.595 178.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -63.79 -23.7 67.46 Favored 'General case' 0 N--CA 1.479 1.022 0 O-C-N 120.341 -1.474 . . . . 10.0 113.667 172.514 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 68.7 m-85 -78.46 -42.04 30.99 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 120.564 -1.335 . . . . 10.0 111.92 172.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -49.62 -49.62 46.21 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 125.164 1.385 . . . . 10.0 111.032 166.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -51.66 -69.45 0.11 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 126.769 2.027 . . . . 10.0 111.765 169.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 49.5 m0 -55.77 -35.6 66.41 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 124.407 1.083 . . . . 10.0 113.182 -172.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 28.7 tp -49.06 -46.08 43.9 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 126.277 1.831 . . . . 10.0 111.84 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -98.18 -40.35 8.42 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.805 0.842 . . . . 10.0 112.435 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 3.7 m -48.46 -57.83 5.54 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.864 1.266 . . . . 10.0 113.424 175.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . 0.286 38.3 p -67.08 -41.31 34.34 Favored Pre-proline 0 CA--C 1.544 0.736 0 CA-C-O 117.774 -1.108 . . . . 10.0 113.764 -168.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -54.14 -44.98 44.46 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 123.282 2.655 . . . . 10.0 115.998 166.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 54.5 mt -59.56 -45.73 90.96 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 118.959 0.799 . . . . 10.0 111.218 175.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.1 tp -50.94 -48.98 60.75 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.419 1.487 . . . . 10.0 112.136 172.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.0 mp -58.83 -47.15 85.85 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 125.339 1.456 . . . . 10.0 112.68 170.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.76 -38.31 78.18 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 123.87 0.868 . . . . 10.0 112.891 178.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 -52.27 -54.05 36.23 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 119.31 0.959 . . . . 10.0 111.165 169.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.34 -42.12 88.58 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.637 0.775 . . . . 10.0 112.1 -178.535 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.72 -54.66 39.0 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 123.991 0.916 . . . . 10.0 112.034 173.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.32 -41.18 79.44 Favored 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 123.724 0.81 . . . . 10.0 112.739 174.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.8 tp -63.77 -38.5 91.32 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 114.476 1.287 . . . . 10.0 114.476 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.2 t -94.84 1.44 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 125.075 1.35 . . . . 10.0 112.275 179.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.2 t70 48.5 53.55 11.89 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.874 1.67 . . . . 10.0 112.137 -173.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.28 145.89 47.57 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 120.002 -1.686 . . . . 10.0 112.46 -174.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.54 135.96 54.45 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 112.697 0.628 . . . . 10.0 112.697 175.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -42.88 -39.67 2.63 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.844 1.657 . . . . 10.0 113.489 175.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -47.33 -60.21 5.33 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 125.15 1.357 . . . . 10.0 115.234 169.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.4 p -62.06 -46.79 87.55 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 117.103 -1.427 . . . . 10.0 111.34 178.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 66.8 mt -48.41 -52.91 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 125.034 1.334 . . . . 10.0 111.127 178.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.2 tp -62.61 -51.3 67.86 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 112.574 0.583 . . . . 10.0 112.574 179.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.17 -44.85 43.27 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.465 0.706 . . . . 10.0 110.938 174.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.67 -59.83 4.81 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 127.344 2.257 . . . . 10.0 114.807 174.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.5 t -61.01 -46.37 96.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 123.705 0.802 . . . . 10.0 111.387 -178.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -56.59 -50.32 63.88 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 123.668 0.651 . . . . 10.0 112.664 174.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -54.9 -46.56 74.84 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 113.322 0.86 . . . . 10.0 113.322 173.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -55.36 -48.54 74.1 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.16 0.984 . . . . 10.0 111.276 173.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -43.02 -54.91 5.08 Favored Glycine 0 CA--C 1.533 1.213 0 C-N-CA 124.938 1.256 . . . . 10.0 113.267 169.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 82.5 mt -57.75 -52.3 59.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 123.694 0.798 . . . . 10.0 111.899 173.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 60.2 ttp -47.51 -58.09 4.63 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.312 1.445 . . . . 10.0 111.731 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 37.6 mm -68.81 -44.6 81.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 O-C-N 121.807 -0.558 . . . . 10.0 112.169 178.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -51.99 -59.19 9.06 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 124.703 1.144 . . . . 10.0 112.949 176.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 44.3 p -57.45 -39.11 75.59 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.467 1.107 . . . . 10.0 112.593 173.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -45.27 -59.22 4.73 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 124.656 1.122 . . . . 10.0 113.445 164.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 65.6 tp -59.11 -46.18 88.99 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.468 1.507 . . . . 10.0 112.392 178.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 65.5 t -53.9 -50.0 55.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 O-C-N 121.441 -0.787 . . . . 10.0 110.127 173.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -50.84 -60.76 6.68 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 126.227 1.87 . . . . 10.0 112.561 171.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -42.95 -42.21 3.66 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 127.488 2.315 . . . . 10.0 113.335 176.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 48.5 mt -100.9 -6.5 24.57 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 115.526 1.676 . . . . 10.0 115.526 -175.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 16.9 m -69.75 116.76 10.51 Favored 'General case' 0 N--CA 1.464 0.248 0 O-C-N 120.157 -1.589 . . . . 10.0 110.344 -178.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.553 ' HD3' ' H ' ' A' ' 129' ' ' LYS . 0.1 OUTLIER -55.46 -49.6 72.05 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 128.195 2.598 . . . . 10.0 113.287 177.748 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 61.3 t -69.74 106.34 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 123.774 0.83 . . . . 10.0 110.067 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -46.93 -59.5 3.05 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 124.737 1.215 . . . . 10.0 114.062 -173.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 m -46.46 -42.11 14.95 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.531 1.533 . . . . 10.0 113.49 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -70.17 -24.59 63.17 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 114.946 1.461 . . . . 10.0 114.946 -178.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 68.9 mtp85 -53.98 -41.74 68.21 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 118.914 0.779 . . . . 10.0 110.793 176.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -69.46 -32.08 70.77 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.813 1.245 . . . . 10.0 114.219 176.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.9 t -55.01 -51.85 49.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 CA-C-N 119.037 0.835 . . . . 10.0 109.654 168.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 67.4 m95 -61.64 -45.49 93.83 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 114.392 1.256 . . . . 10.0 114.392 175.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 88.1 t90 -51.66 -49.35 62.48 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.235 1.014 . . . . 10.0 112.71 172.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -57.28 -51.0 71.13 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.072 0.949 . . . . 10.0 112.03 177.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 96.5 mt -55.75 -52.12 51.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 124.69 1.196 . . . . 10.0 111.762 175.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 28.7 t -54.9 -44.29 74.03 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.434 1.094 . . . . 10.0 111.861 174.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 49.3 m -60.02 -45.2 93.55 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.47 1.508 . . . . 10.0 112.472 174.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -57.09 -48.5 78.44 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 119.291 0.951 . . . . 10.0 112.344 172.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -57.36 -46.35 83.44 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.819 0.848 . . . . 10.0 112.71 174.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 40.3 ttp -56.16 -54.86 40.07 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.257 1.023 . . . . 10.0 112.09 172.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 8.1 tt -51.11 -50.57 58.54 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 125.941 1.697 . . . . 10.0 111.08 178.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 77.8 t80 -50.47 -54.91 18.51 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.169 0.988 . . . . 10.0 112.798 172.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 54.6 mt -53.6 -55.05 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 123.809 0.844 . . . . 10.0 110.775 177.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 44.4 mt -57.37 -35.88 70.53 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 118.349 -0.834 . . . . 10.0 112.957 178.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -57.26 -58.15 9.5 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 124.015 0.926 . . . . 10.0 113.041 173.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.44 -40.9 85.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-O 118.355 -0.831 . . . . 10.0 111.465 177.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 45.2 mt -56.79 -49.4 75.43 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 119.862 1.21 . . . . 10.0 112.131 171.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.423 ' HA ' ' HD2' ' A' ' 175' ' ' ARG . 11.9 t80 -77.01 -70.33 0.47 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 120.088 -1.632 . . . . 10.0 112.901 -175.29 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -73.66 -21.98 60.1 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.615 1.166 . . . . 10.0 113.431 -174.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -87.79 -79.12 1.26 Allowed Glycine 0 CA--C 1.527 0.783 0 C-N-CA 123.625 0.631 . . . . 10.0 113.496 171.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -53.63 -32.38 51.08 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 126.269 1.828 . . . . 10.0 113.067 -166.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.2 m -52.16 -56.44 14.57 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 114.01 1.115 . . . . 10.0 114.01 172.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.7 p -53.63 -50.61 65.34 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 122.087 0.946 . . . . 10.0 112.271 -177.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 47.7 tttm -57.09 -46.1 82.81 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.197 0.999 . . . . 10.0 112.107 173.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.76 -47.49 79.97 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 114.563 1.32 . . . . 10.0 114.563 174.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -56.47 -11.31 1.22 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 126.087 1.755 . . . . 10.0 114.261 177.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.2 m -107.09 6.67 29.11 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.374 1.87 . . . . 10.0 114.877 -179.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 93.3 mmm -91.92 -92.69 0.15 Allowed 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 123.451 1.596 . . . . 10.0 114.171 -170.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -138.63 153.96 72.79 Favored Pre-proline 0 C--O 1.236 0.349 0 C-N-CA 129.833 3.253 . . . . 10.0 105.573 170.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -52.85 -46.21 35.35 Favored 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 122.338 2.025 . . . . 10.0 113.083 179.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . 0.461 ' CD ' ' HD3' ' A' ' 227' ' ' ARG . 0.1 OUTLIER -52.99 -46.05 68.12 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 129.014 2.926 . . . . 10.0 113.266 173.577 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 91.5 t -69.26 -53.0 27.72 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 C-N-CA 124.006 0.922 . . . . 10.0 109.788 -178.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.07 -46.89 75.46 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.3 0.64 . . . . 10.0 111.923 177.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 59.9 p -59.99 -56.13 25.42 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.883 0.873 . . . . 10.0 112.742 174.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 61.8 m -57.23 -53.19 60.86 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.185 0.994 . . . . 10.0 113.011 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -49.61 -49.47 46.71 Favored 'General case' 0 C--O 1.222 -0.387 0 C-N-CA 123.324 0.65 . . . . 10.0 111.1 174.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -57.12 -48.46 78.6 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 114.671 1.36 . . . . 10.0 114.671 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 40.3 t -55.98 -49.54 74.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 CA-C-N 118.802 0.728 . . . . 10.0 110.541 176.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 93.8 mt -58.57 -51.65 69.01 Favored 'General case' 0 C--O 1.222 -0.39 0 N-CA-C 113.196 0.813 . . . . 10.0 113.196 175.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . 0.423 ' HD2' ' HA ' ' A' ' 153' ' ' PHE . 35.4 ttp180 -47.76 -47.76 30.33 Favored 'General case' 0 C--O 1.225 -0.201 0 C-N-CA 126.831 2.052 . . . . 10.0 111.095 174.405 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 63.8 m-20 -58.5 -58.4 8.71 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 122.836 0.454 . . . . 10.0 111.232 174.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 54.5 t -52.13 -46.77 44.03 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 124.067 0.947 . . . . 10.0 112.052 179.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 28.8 m -60.39 -61.79 2.34 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 127.818 2.447 . . . . 10.0 111.874 178.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 55.8 t -50.91 -50.42 23.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 124.667 1.187 . . . . 10.0 110.928 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 80.3 t -59.49 -63.01 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 124.047 0.939 . . . . 10.0 111.889 177.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 68.9 mt -53.29 -50.75 64.23 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 119.183 0.901 . . . . 10.0 112.144 -178.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 10.1 m95 -54.67 -50.11 69.0 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 124.116 0.966 . . . . 10.0 112.275 177.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 54.3 p -52.57 -32.03 39.03 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 114.235 1.198 . . . . 10.0 114.235 179.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -65.23 -40.01 93.48 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 113.947 1.091 . . . . 10.0 113.947 176.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -47.26 -55.67 15.13 Favored Pre-proline 0 N--CA 1.479 0.98 0 N-CA-C 115.112 1.523 . . . . 10.0 115.112 -176.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -58.5 -34.04 98.47 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 121.898 1.732 . . . . 10.0 113.122 175.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 21.6 t -66.33 -56.65 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 124.471 1.109 . . . . 10.0 111.2 178.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 2.7 p -55.73 -44.62 77.83 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 CA-C-N 119.201 0.91 . . . . 10.0 112.083 176.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 59.8 t90 -56.73 -51.96 66.81 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.372 0.669 . . . . 10.0 112.422 173.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 25.8 tp -54.9 -44.95 74.6 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.49 1.116 . . . . 10.0 112.197 -178.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 14.6 pt -86.28 -5.5 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 N-CA-C 115.246 1.573 . . . . 10.0 115.246 -177.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.57 -169.26 32.74 Favored Glycine 0 N--CA 1.45 -0.383 0 CA-C-O 122.573 1.096 . . . . 10.0 113.83 -168.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 23.3 t -53.12 -41.65 65.25 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 114.203 -0.999 . . . . 10.0 111.858 177.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -66.9 -17.18 64.78 Favored 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 115.559 1.688 . . . . 10.0 115.559 -175.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -131.08 -105.87 1.08 Allowed Glycine 0 CA--C 1.532 1.106 0 CA-C-N 120.397 1.453 . . . . 10.0 113.914 -172.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -89.45 127.12 35.81 Favored 'General case' 0 C--N 1.328 -0.345 0 O-C-N 120.663 -1.492 . . . . 10.0 109.3 168.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -72.44 65.29 1.35 Allowed Glycine 0 CA--C 1.531 1.064 0 N-CA-C 113.925 0.33 . . . . 10.0 113.925 173.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 60.7 mt -79.56 -42.72 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 126.077 1.751 . . . . 10.0 108.725 166.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 79.8 t -126.32 133.41 24.94 Favored Pre-proline 0 N--CA 1.454 -0.25 0 C-N-CA 126.468 1.907 . . . . 10.0 109.368 -174.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -68.79 153.78 72.36 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 123.781 2.988 . . . . 10.0 111.461 -176.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 12.2 tp -43.14 -39.82 3.0 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.375 1.07 . . . . 10.0 112.17 171.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -48.33 -52.35 22.01 Favored 'General case' 0 CA--C 1.539 0.519 0 N-CA-C 114.728 1.381 . . . . 10.0 114.728 176.044 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 14.0 mm -75.98 -40.48 38.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 124.366 1.066 . . . . 10.0 109.625 177.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -49.26 -49.82 41.68 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 118.603 0.638 . . . . 10.0 111.981 173.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 16.2 m -57.74 -46.97 83.74 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 126.04 1.736 . . . . 10.0 112.964 174.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -63.4 -52.28 62.27 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.992 0.917 . . . . 10.0 112.101 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 93.2 mt -52.56 -59.17 4.78 Favored 'General case' 0 C--N 1.335 -0.044 0 C-N-CA 124.32 1.048 . . . . 10.0 110.003 176.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -52.29 -47.3 65.96 Favored 'General case' 0 C--O 1.217 -0.64 0 CA-C-O 117.425 -1.274 . . . . 10.0 112.164 176.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 4.6 tmm? -52.03 -51.7 55.73 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 121.073 1.76 . . . . 10.0 113.001 175.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 78.7 t -60.39 -50.0 82.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 124.646 1.178 . . . . 10.0 111.278 178.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 5.2 mp -57.52 -51.18 70.5 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.884 1.674 . . . . 10.0 112.044 175.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -56.96 -57.72 11.3 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 127.36 2.264 . . . . 10.0 110.706 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 97.3 t -57.27 -43.23 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 O-C-N 121.001 -1.062 . . . . 10.0 111.417 177.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 42.9 m -55.84 -49.32 73.63 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.451 0.7 . . . . 10.0 111.992 173.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -67.8 -25.29 65.51 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.465 1.506 . . . . 10.0 114.435 178.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -90.77 -73.65 0.52 Allowed 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.87 1.268 . . . . 10.0 109.749 178.333 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 21.2 t -78.48 -49.26 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 125.907 1.683 . . . . 10.0 111.201 -171.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -55.26 -56.32 23.94 Favored Glycine 0 CA--C 1.534 1.281 0 C-N-CA 124.092 0.853 . . . . 10.0 113.118 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -45.45 -55.66 5.88 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.476 1.91 . . . . 10.0 112.27 166.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -55.58 -40.01 76.98 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 124.008 0.813 . . . . 10.0 113.754 178.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 24.9 mt -70.08 -27.41 64.59 Favored 'General case' 0 CA--C 1.512 -0.502 0 N-CA-C 115.833 1.79 . . . . 10.0 115.833 176.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 74.3 mt -63.49 -57.53 11.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 108.59 -0.893 . . . . 10.0 108.59 165.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 32.0 tp -58.77 -64.68 0.85 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.918 0.887 . . . . 10.0 113.206 -172.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 84.2 mt -71.53 5.19 2.51 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 115.304 1.594 . . . . 10.0 115.304 -171.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.6 mtp-105 -112.35 0.35 15.64 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.211 1.005 . . . . 10.0 113.303 172.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 8.8 t -108.03 177.94 4.66 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 124.058 0.943 . . . . 10.0 111.032 174.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . 0.461 ' HD3' ' CD ' ' A' ' 166' ' ' GLU . 41.8 ttt180 -71.59 98.15 1.83 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.732 0.813 . . . . 10.0 110.977 170.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -80.9 77.03 7.82 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.874 0.87 . . . . 10.0 112.095 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 40.19 102.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 128.866 2.866 . . . . 10.0 116.474 177.686 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . 0.481 0.3 OUTLIER 71.81 -55.41 0.66 Allowed 'General case' 0 C--O 1.243 0.714 0 C-N-CA 124.769 1.227 . . . . 10.0 110.603 -175.305 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -68.3 169.47 40.07 Favored Glycine 0 C--O 1.239 0.417 0 C-N-CA 129.76 3.552 . . . . 10.0 119.619 171.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.461 0 C-N-CA 128.476 2.711 . . . . 10.0 113.44 166.603 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 999' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A 1000 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A 1001 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A 1002 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A 1003 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 N--CA 1.477 0.881 0 CA-C-O 115.781 -2.057 . . . . 10.0 105.842 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 23.36 91.91 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 129.588 3.155 . . . . 10.0 117.227 160.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 28.6 65.03 0.11 Allowed 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 128.307 2.643 . . . . 10.0 114.529 155.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 86.5 mt -56.41 137.91 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 126.396 1.878 . . . . 10.0 113.372 -158.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.6 t -136.75 -165.2 1.7 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 126.327 1.851 . . . . 10.0 114.015 -174.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 70.0 2.83 41.1 Favored Glycine 0 C--N 1.339 0.743 0 C-N-CA 127.496 2.474 . . . . 10.0 111.485 168.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -158.55 -51.32 0.01 OUTLIER Pre-proline 0 N--CA 1.443 -0.783 0 CA-C-O 114.301 -2.761 . . . . 10.0 116.649 -168.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_exo -63.93 -60.72 0.14 Allowed 'Trans proline' 0 N--CA 1.465 -0.186 0 CA-C-N 123.538 2.299 . . . . 10.0 113.194 -175.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 7.9 pm0 -67.21 4.34 0.96 Allowed 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 127.886 2.475 . . . . 10.0 115.732 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.422 ' CG ' ' N ' ' A' ' 11' ' ' ILE . 11.0 p-90 -51.38 -43.12 61.8 Favored 'General case' 0 C--O 1.223 -0.315 0 O-C-N 121.509 -0.744 . . . . 10.0 112.618 176.389 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.422 ' N ' ' CG ' ' A' ' 10' ' ' TRP . 8.9 tt -60.87 -49.59 84.0 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.34 0 C-N-CA 123.872 0.869 . . . . 10.0 109.344 179.394 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 2.6 m95 -55.32 -52.69 62.65 Favored 'General case' 0 C--O 1.224 -0.259 0 C-N-CA 123.406 0.682 . . . . 10.0 111.877 175.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.4 mt -57.34 -53.64 55.79 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 123.188 0.595 . . . . 10.0 112.224 177.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.83 -46.81 51.61 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.353 1.461 . . . . 10.0 113.33 173.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 13.3 tp -65.63 -44.95 84.88 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.277 1.431 . . . . 10.0 113.059 179.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.5 -57.03 9.83 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 124.549 1.071 . . . . 10.0 111.274 165.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.1 m -49.26 -52.53 26.74 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.985 1.314 . . . . 10.0 112.232 174.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.44 -58.86 5.83 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.151 0.98 . . . . 10.0 112.161 177.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 99.6 mt -58.0 -49.07 78.11 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.471 0.709 . . . . 10.0 112.537 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 23.9 mmt -55.61 -49.22 73.38 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.858 0.863 . . . . 10.0 111.359 176.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -58.29 -58.43 14.61 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 124.388 0.994 . . . . 10.0 113.438 176.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 81.0 mt -56.24 -46.01 79.75 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-N 118.634 1.217 . . . . 10.0 112.132 176.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.73 -41.76 75.96 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 124.714 1.15 . . . . 10.0 113.242 173.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 28.2 m -62.38 -58.49 7.46 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.833 0.853 . . . . 10.0 111.347 172.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -52.27 -41.0 62.47 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.981 0.912 . . . . 10.0 110.977 177.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -55.75 -58.03 9.52 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 124.641 1.176 . . . . 10.0 112.967 172.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.1 m-30 -59.67 -38.7 82.19 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 113.223 0.823 . . . . 10.0 113.223 178.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.468 ' C ' ' H ' ' A' ' 30' ' ' LYS . 11.9 mt -56.04 -67.47 0.29 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.629 1.171 . . . . 10.0 113.65 169.104 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 t -76.34 40.89 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 CA-C-O 123.727 1.727 . . . . 10.0 110.866 179.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.468 ' H ' ' C ' ' A' ' 28' ' ' LEU . 42.8 tttm -140.8 -44.85 0.39 Allowed 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 127.915 2.486 . . . . 10.0 109.347 171.157 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.96 23.11 0.87 Allowed Glycine 0 CA--C 1.529 0.925 0 N-CA-C 115.629 1.012 . . . . 10.0 115.629 173.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 37.3 mmm -59.5 -45.0 92.96 Favored 'General case' 0 C--O 1.225 -0.211 0 C-N-CA 127.17 2.188 . . . . 10.0 113.571 -178.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.71 -84.41 1.19 Allowed Glycine 0 CA--C 1.531 1.045 0 C-N-CA 123.775 0.702 . . . . 10.0 112.446 -170.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.8 t 33.09 88.75 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.243 0.73 0 C-N-CA 128.399 2.68 . . . . 10.0 116.941 166.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.6 m -79.65 -50.92 9.93 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.23 -1.35 . . . . 10.0 113.828 174.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -48.87 117.51 6.37 Favored Pre-proline 0 CA--C 1.536 0.416 0 O-C-N 124.765 1.291 . . . . 10.0 110.972 -172.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -58.56 -29.68 89.64 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 123.757 2.971 . . . . 10.0 113.669 179.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.31 -60.66 2.29 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.126 0.57 . . . . 10.0 111.457 176.227 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.12 -40.08 22.45 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 125.134 1.373 . . . . 10.0 113.58 171.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -46.56 -47.42 19.71 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.22 1.408 . . . . 10.0 113.447 172.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -57.72 -53.1 62.01 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.5 0.72 . . . . 10.0 110.992 176.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -57.02 -50.21 73.42 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 123.084 0.554 . . . . 10.0 112.315 -179.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -54.3 -51.29 65.1 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 118.966 -0.54 . . . . 10.0 112.401 173.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.41 -62.01 1.91 Allowed 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 113.386 0.884 . . . . 10.0 113.386 177.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.4 mt -48.61 -57.76 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 124.867 1.267 . . . . 10.0 110.287 178.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.5 m -68.36 -17.74 64.31 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.114 1.365 . . . . 10.0 113.639 -172.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 27.4 m -87.12 -40.84 14.27 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 119.583 1.083 . . . . 10.0 112.137 174.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 22.0 mt -59.27 -40.98 87.77 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 121.359 -0.838 . . . . 10.0 112.835 171.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 22.7 t -43.9 -60.6 2.56 Favored Pre-proline 0 CA--C 1.549 0.941 0 C-N-CA 126.238 1.815 . . . . 10.0 113.395 176.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -72.27 -28.29 15.47 Favored 'Trans proline' 0 CA--C 1.546 1.108 0 C-N-CA 123.083 2.522 . . . . 10.0 114.182 172.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.98 -48.72 79.08 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 120.734 1.606 . . . . 10.0 113.927 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 19.5 tt -68.3 -36.16 73.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 O-C-N 120.249 -1.532 . . . . 10.0 111.376 173.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.29 -43.34 78.75 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 119.093 0.86 . . . . 10.0 112.74 171.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -50.96 -56.78 10.76 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.214 1.405 . . . . 10.0 111.68 168.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.7 m -47.88 -53.34 16.05 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 125.411 1.484 . . . . 10.0 111.18 176.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 32.7 mmt -69.09 -48.18 63.3 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 124.176 0.99 . . . . 10.0 112.871 -176.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -55.86 -41.38 74.27 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 120.203 1.365 . . . . 10.0 113.238 172.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.8 tp -53.31 -54.55 34.77 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-N 119.671 1.123 . . . . 10.0 111.301 170.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 24.0 p -51.65 -41.06 61.06 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 115.207 1.558 . . . . 10.0 115.207 179.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 56.9 mtm -66.86 -50.89 61.09 Favored 'General case' 0 C--N 1.334 -0.09 0 C-N-CA 123.597 0.759 . . . . 10.0 110.477 176.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.3 tp -48.62 -52.69 21.8 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.862 0.865 . . . . 10.0 112.904 172.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.4 mt -76.87 -5.53 48.77 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 113.848 1.055 . . . . 10.0 113.848 -177.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.24 -34.71 5.55 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 115.558 0.983 . . . . 10.0 115.558 174.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 75.3 t80 -49.28 -43.09 42.88 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 115.243 1.572 . . . . 10.0 115.243 -176.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.04 3.55 61.07 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 115.314 0.885 . . . . 10.0 115.314 -179.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.25 143.4 26.45 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 127.034 2.133 . . . . 10.0 109.031 172.015 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 t -145.51 171.09 15.17 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 124.081 0.952 . . . . 10.0 111.06 166.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.97 136.06 53.38 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 123.885 0.874 . . . . 10.0 109.722 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 58.5 t -129.56 129.64 23.19 Favored Pre-proline 0 C--N 1.33 -0.261 0 C-N-CA 125.043 1.337 . . . . 10.0 110.982 -176.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -80.76 116.24 3.16 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 N-CA-C 109.411 -1.034 . . . . 10.0 109.411 -178.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -156.71 164.41 38.17 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.808 0.669 . . . . 10.0 112.808 172.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.34 -81.92 0.14 Allowed Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.685 -0.966 . . . . 10.0 110.685 175.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.76 -3.37 0.69 Allowed Glycine 0 CA--C 1.527 0.822 0 N-CA-C 118.671 2.228 . . . . 10.0 118.671 170.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -151.6 -171.87 4.06 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 119.343 1.571 . . . . 10.0 112.187 -165.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -91.86 93.91 9.06 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 125.521 1.528 . . . . 10.0 111.097 -175.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 60.1 m-80 -89.47 120.74 69.65 Favored Pre-proline 0 C--N 1.326 -0.452 0 N-CA-C 113.001 0.741 . . . . 10.0 113.001 -165.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -61.47 131.93 38.37 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 124.16 3.24 . . . . 10.0 112.167 171.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.6 mm -140.13 126.33 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 C-N-CA 126.043 1.737 . . . . 10.0 111.682 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -93.61 85.02 4.76 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 123.316 1.531 . . . . 10.0 113.051 174.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 63.5 p-90 -59.32 -28.3 66.68 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 120.588 -1.32 . . . . 10.0 113.965 174.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -54.39 -35.88 63.33 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 114.152 1.167 . . . . 10.0 114.152 178.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 1.5 ptp180 -63.67 -25.84 68.39 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 120.419 -1.426 . . . . 10.0 113.926 174.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -76.96 -41.94 41.14 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 121.22 -0.925 . . . . 10.0 111.845 172.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -49.48 -48.62 47.68 Favored 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 125.192 1.397 . . . . 10.0 111.5 167.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -52.86 -69.77 0.11 Allowed 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 126.078 1.751 . . . . 10.0 111.671 168.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 53.4 m0 -56.8 -32.97 66.22 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 124.428 1.091 . . . . 10.0 113.042 -169.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 29.4 tp -48.74 -44.15 38.25 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 125.858 1.663 . . . . 10.0 111.721 176.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -99.44 -42.21 7.06 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.845 0.858 . . . . 10.0 112.402 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 76.8 p -61.72 -45.3 94.54 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 120.335 1.425 . . . . 10.0 113.913 -177.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . 0.325 74.8 p -60.66 -46.95 97.2 Favored Pre-proline 0 CA--C 1.546 0.826 0 CA-C-O 117.568 -1.206 . . . . 10.0 113.54 -178.367 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -54.65 -44.05 53.28 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 123.24 2.627 . . . . 10.0 115.725 169.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 51.1 mt -59.25 -45.75 90.35 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 121.433 -0.792 . . . . 10.0 111.398 175.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.8 tp -51.84 -48.88 63.77 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.437 1.495 . . . . 10.0 112.044 172.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.9 mp -57.81 -47.71 81.84 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.929 1.291 . . . . 10.0 112.392 170.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.87 -38.24 78.33 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 119.12 0.873 . . . . 10.0 112.891 179.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -52.28 -54.05 36.32 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 119.285 0.948 . . . . 10.0 111.165 169.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.34 -42.12 88.62 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.621 0.768 . . . . 10.0 112.151 -178.518 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.62 -54.73 37.68 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.958 0.903 . . . . 10.0 112.049 173.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.39 -41.15 79.69 Favored 'General case' 0 C--O 1.224 -0.237 0 C-N-CA 123.729 0.812 . . . . 10.0 112.667 174.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.9 tp -63.7 -38.61 91.75 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 114.481 1.289 . . . . 10.0 114.481 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.2 t -94.8 1.46 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 125.089 1.356 . . . . 10.0 112.304 179.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.3 t70 48.48 53.53 11.91 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.848 1.659 . . . . 10.0 112.137 -173.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.29 145.89 47.55 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 120.0 -1.688 . . . . 10.0 112.44 -174.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.47 135.89 54.17 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 112.711 0.634 . . . . 10.0 112.711 175.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -42.85 -39.69 2.61 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.857 1.663 . . . . 10.0 113.471 175.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -47.33 -60.25 5.3 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 125.15 1.357 . . . . 10.0 115.233 169.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.6 p -62.02 -46.72 87.95 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 117.103 -1.427 . . . . 10.0 111.351 178.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 66.9 mt -48.49 -52.87 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 124.998 1.319 . . . . 10.0 111.146 178.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.2 tp -62.63 -51.29 67.85 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 112.556 0.576 . . . . 10.0 112.556 179.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.14 -44.9 42.97 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.506 0.722 . . . . 10.0 110.934 174.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.61 -59.88 4.74 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 127.361 2.264 . . . . 10.0 114.778 175.005 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.7 t -60.97 -46.42 96.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 123.735 0.814 . . . . 10.0 111.398 -178.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -56.59 -50.32 63.86 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 123.641 0.639 . . . . 10.0 112.674 174.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -54.59 -46.72 73.81 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 113.261 0.837 . . . . 10.0 113.261 173.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 51.2 t0 -58.17 -45.27 87.81 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.597 0.759 . . . . 10.0 112.008 174.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -43.51 -55.74 5.14 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 125.114 1.34 . . . . 10.0 113.575 166.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 85.8 mt -55.45 -57.12 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 CA-C-O 118.438 -0.791 . . . . 10.0 110.631 173.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 48.1 ttp -44.93 -55.29 5.6 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.704 1.602 . . . . 10.0 113.28 -177.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 41.5 mm -70.08 -42.98 79.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 O-C-N 121.703 -0.623 . . . . 10.0 111.716 177.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -49.78 -62.57 4.8 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 125.389 1.471 . . . . 10.0 113.167 174.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 37.1 p -60.03 -33.47 72.06 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 118.013 0.906 . . . . 10.0 112.422 174.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -49.95 -56.86 10.86 Favored Glycine 0 CA--C 1.536 1.349 0 C-N-CA 124.157 0.884 . . . . 10.0 113.143 166.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 64.9 tp -59.93 -48.2 82.65 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 125.588 1.555 . . . . 10.0 112.034 176.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 67.6 t -52.55 -51.3 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 123.368 0.667 . . . . 10.0 110.31 174.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -50.11 -60.87 6.23 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 126.086 1.803 . . . . 10.0 112.271 172.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -48.57 -37.66 18.53 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 126.427 1.891 . . . . 10.0 113.792 179.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 49.0 mt -99.22 -6.62 27.8 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 115.309 1.596 . . . . 10.0 115.309 -179.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 16.9 m -69.69 116.75 10.45 Favored 'General case' 0 N--CA 1.464 0.274 0 O-C-N 120.186 -1.571 . . . . 10.0 110.387 -178.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.552 ' HD3' ' H ' ' A' ' 129' ' ' LYS . 0.2 OUTLIER -55.48 -49.6 72.1 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 128.231 2.613 . . . . 10.0 113.251 177.747 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 61.1 t -69.72 106.42 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 123.746 0.818 . . . . 10.0 110.065 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -46.93 -59.57 3.01 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 124.779 1.231 . . . . 10.0 114.043 -173.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 m -46.43 -42.12 14.8 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.463 1.505 . . . . 10.0 113.485 179.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -70.15 -24.61 63.19 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 114.918 1.451 . . . . 10.0 114.918 -178.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 68.9 mtp85 -53.9 -41.67 67.86 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 118.93 0.786 . . . . 10.0 110.847 176.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -69.87 -31.61 69.53 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 114.354 1.242 . . . . 10.0 114.354 176.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.8 t -55.22 -52.23 47.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 CA-C-N 119.03 0.832 . . . . 10.0 109.543 168.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 66.1 m95 -61.72 -42.88 99.54 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 114.37 1.248 . . . . 10.0 114.37 174.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 88.9 t90 -52.78 -50.26 63.93 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.082 0.953 . . . . 10.0 112.415 171.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -56.86 -53.04 62.44 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.315 1.046 . . . . 10.0 111.737 178.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 96.4 mt -53.24 -51.41 40.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 125.069 1.348 . . . . 10.0 111.572 174.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 15.3 m -55.33 -45.56 76.38 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.483 1.113 . . . . 10.0 111.812 175.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 49.3 m -63.48 -42.08 98.57 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.367 1.467 . . . . 10.0 111.944 178.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -57.9 -49.53 76.43 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.774 0.83 . . . . 10.0 112.313 170.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -56.3 -46.34 79.84 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.878 0.871 . . . . 10.0 112.601 173.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 38.4 ttp -55.23 -55.57 29.86 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.262 1.025 . . . . 10.0 112.163 171.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -51.71 -49.81 61.74 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.651 1.58 . . . . 10.0 111.213 179.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 77.8 t80 -50.22 -55.06 16.84 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.947 0.899 . . . . 10.0 112.687 172.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 55.6 mt -53.71 -55.09 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 123.871 0.868 . . . . 10.0 110.692 177.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 41.3 mt -57.32 -35.86 70.41 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 118.334 -0.841 . . . . 10.0 112.948 178.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -57.29 -58.19 9.32 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 124.051 0.941 . . . . 10.0 113.041 173.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.38 -40.9 85.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 CA-C-O 118.303 -0.855 . . . . 10.0 111.44 177.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 44.9 mt -56.84 -49.42 75.51 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 119.897 1.226 . . . . 10.0 112.107 171.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.423 ' HA ' ' HD2' ' A' ' 175' ' ' ARG . 12.0 t80 -77.01 -70.32 0.47 Allowed 'General case' 0 C--N 1.326 -0.447 0 O-C-N 120.022 -1.674 . . . . 10.0 112.852 -175.234 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -73.7 -21.93 60.09 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.654 1.182 . . . . 10.0 113.466 -174.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -87.84 -79.07 1.26 Allowed Glycine 0 CA--C 1.526 0.747 0 C-N-CA 123.579 0.609 . . . . 10.0 113.514 171.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -53.68 -32.42 51.63 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 126.275 1.83 . . . . 10.0 113.024 -166.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.2 m -52.02 -56.49 13.99 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 114.057 1.132 . . . . 10.0 114.057 172.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.5 p -53.71 -50.51 65.73 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 122.046 0.926 . . . . 10.0 112.295 -177.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 47.6 tttm -57.08 -46.04 82.83 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.173 0.989 . . . . 10.0 112.156 173.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.87 -47.46 80.4 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 114.512 1.301 . . . . 10.0 114.512 174.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -56.47 -11.3 1.21 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 126.087 1.755 . . . . 10.0 114.252 177.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.1 m -107.03 6.61 29.18 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.424 1.89 . . . . 10.0 114.903 -179.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 93.3 mmm -91.91 -92.6 0.15 Allowed 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 123.487 1.613 . . . . 10.0 114.164 -170.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -138.71 153.94 72.64 Favored Pre-proline 0 C--O 1.235 0.308 0 C-N-CA 129.802 3.241 . . . . 10.0 105.527 170.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -52.83 -46.25 34.97 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.267 1.978 . . . . 10.0 113.074 179.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . 0.462 ' CD ' ' HD3' ' A' ' 227' ' ' ARG . 0.1 OUTLIER -52.89 -46.08 67.8 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 129.021 2.929 . . . . 10.0 113.291 173.556 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 92.0 t -69.22 -53.04 27.62 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 C-N-CA 124.05 0.94 . . . . 10.0 109.8 -178.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.1 -46.83 75.55 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.282 0.633 . . . . 10.0 111.959 177.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 60.3 p -60.02 -56.2 24.54 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.922 0.889 . . . . 10.0 112.692 174.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 61.5 m -57.18 -53.2 60.76 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.155 0.982 . . . . 10.0 113.036 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -49.58 -49.48 46.33 Favored 'General case' 0 C--O 1.222 -0.375 0 C-N-CA 123.247 0.619 . . . . 10.0 111.132 174.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -57.15 -48.39 78.82 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 114.702 1.371 . . . . 10.0 114.702 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 40.5 t -56.01 -49.59 74.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 CA-C-N 118.749 0.704 . . . . 10.0 110.462 176.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 94.1 mt -58.63 -51.59 69.28 Favored 'General case' 0 C--O 1.222 -0.389 0 N-CA-C 113.191 0.811 . . . . 10.0 113.191 175.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . 0.423 ' HD2' ' HA ' ' A' ' 153' ' ' PHE . 35.5 ttp180 -47.75 -47.79 30.26 Favored 'General case' 0 C--O 1.225 -0.201 0 C-N-CA 126.852 2.061 . . . . 10.0 111.062 174.402 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 63.6 m-20 -58.51 -58.36 8.89 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 122.782 0.433 . . . . 10.0 111.272 174.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 54.9 t -52.19 -46.71 44.59 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 124.039 0.936 . . . . 10.0 112.044 179.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 32.1 m -60.19 -61.66 2.44 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 128.081 2.552 . . . . 10.0 111.902 178.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 56.0 t -51.43 -50.23 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 C-N-CA 124.575 1.15 . . . . 10.0 111.045 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 76.8 t -59.23 -60.06 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 124.069 0.948 . . . . 10.0 112.168 177.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 73.4 mt -56.9 -51.65 68.25 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 118.701 0.682 . . . . 10.0 112.301 -178.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 10.6 m95 -53.22 -50.18 65.25 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.959 0.904 . . . . 10.0 111.764 178.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 8.6 t -56.96 -24.44 52.94 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 114.541 1.312 . . . . 10.0 114.541 178.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -69.13 -40.61 78.17 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 119.615 1.098 . . . . 10.0 113.459 175.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -47.08 -55.91 13.87 Favored Pre-proline 0 N--CA 1.476 0.844 0 N-CA-C 114.991 1.478 . . . . 10.0 114.991 -177.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -58.89 -35.16 99.06 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 122.207 1.938 . . . . 10.0 113.346 177.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 34.1 t -65.19 -58.73 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 124.152 0.981 . . . . 10.0 110.628 177.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 17.1 m -61.98 -34.51 63.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 N-CA-C 112.716 0.636 . . . . 10.0 112.716 -177.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 44.5 t90 -59.81 -55.93 28.11 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 125.191 1.396 . . . . 10.0 112.117 168.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 9.6 tt -56.49 -41.94 77.46 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.813 0.845 . . . . 10.0 112.601 -177.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 14.8 pt -82.44 -5.66 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 N-CA-C 115.151 1.537 . . . . 10.0 115.151 178.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.31 -169.29 33.1 Favored Glycine 0 N--CA 1.45 -0.404 0 CA-C-O 122.577 1.098 . . . . 10.0 113.921 -168.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 23.3 t -53.16 -40.68 64.5 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 114.197 -1.001 . . . . 10.0 111.897 177.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -55.01 -31.8 61.32 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 128.387 2.675 . . . . 10.0 115.385 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -131.06 -103.87 0.98 Allowed Glycine 0 CA--C 1.527 0.842 0 CA-C-N 119.324 0.966 . . . . 10.0 113.41 -167.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -89.41 127.12 35.79 Favored 'General case' 0 C--N 1.328 -0.352 0 O-C-N 120.621 -1.517 . . . . 10.0 109.364 169.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -72.48 65.36 1.36 Allowed Glycine 0 CA--C 1.532 1.141 0 N-CA-C 113.871 0.308 . . . . 10.0 113.871 173.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 60.6 mt -79.6 -42.71 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 126.053 1.741 . . . . 10.0 108.729 166.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 79.4 t -126.27 133.39 24.92 Favored Pre-proline 0 N--CA 1.454 -0.264 0 C-N-CA 126.502 1.921 . . . . 10.0 109.385 -174.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -68.79 153.78 72.36 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 123.781 2.988 . . . . 10.0 111.437 -176.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 12.2 tp -43.17 -39.77 3.03 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.281 1.033 . . . . 10.0 112.193 171.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -48.36 -52.38 21.99 Favored 'General case' 0 CA--C 1.539 0.519 0 N-CA-C 114.673 1.361 . . . . 10.0 114.673 176.08 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 13.9 mm -75.9 -40.5 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 C-N-CA 124.435 1.094 . . . . 10.0 109.692 177.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -49.3 -49.81 42.15 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 118.553 0.615 . . . . 10.0 111.925 173.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 16.3 m -57.72 -47.01 83.62 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 126.043 1.737 . . . . 10.0 112.96 174.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -63.33 -52.39 62.05 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.977 0.911 . . . . 10.0 112.072 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 93.1 mt -52.52 -58.74 5.81 Favored 'General case' 0 C--O 1.227 -0.088 0 C-N-CA 124.294 1.038 . . . . 10.0 110.02 176.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -52.45 -46.79 66.62 Favored 'General case' 0 C--O 1.221 -0.439 0 CA-C-O 117.805 -1.093 . . . . 10.0 112.393 176.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 4.6 tmm? -52.32 -52.0 55.6 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 120.404 1.457 . . . . 10.0 112.743 175.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 85.7 t -61.69 -46.56 96.28 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 124.782 1.233 . . . . 10.0 111.747 178.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 4.2 mp -59.95 -52.41 65.54 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 125.463 1.505 . . . . 10.0 111.989 175.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 -55.68 -57.33 12.43 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 126.36 1.864 . . . . 10.0 110.917 178.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 8.6 p -58.66 -38.76 73.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 O-C-N 120.918 -1.114 . . . . 10.0 112.524 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 38.4 m -58.55 -49.43 77.47 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.559 0.744 . . . . 10.0 111.594 171.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -66.86 -22.08 66.0 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.545 1.538 . . . . 10.0 114.593 177.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 11.9 mptt -95.22 -76.55 0.49 Allowed 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.009 1.324 . . . . 10.0 109.984 177.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 21.3 t -73.18 -50.52 31.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 C-N-CA 125.41 1.484 . . . . 10.0 110.875 -172.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -53.83 -57.42 16.26 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 124.039 0.828 . . . . 10.0 113.09 178.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 42.0 t80 -46.68 -56.73 5.68 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.351 1.86 . . . . 10.0 112.322 168.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -56.23 -39.44 81.63 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 124.011 0.815 . . . . 10.0 113.465 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 24.5 mt -70.51 -27.59 64.3 Favored 'General case' 0 CA--C 1.511 -0.523 0 N-CA-C 115.736 1.754 . . . . 10.0 115.736 176.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 74.4 mt -63.48 -57.48 11.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 119.274 0.943 . . . . 10.0 108.548 165.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 32.1 tp -58.86 -64.71 0.84 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.923 0.889 . . . . 10.0 113.17 -172.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 84.2 mt -71.51 5.17 2.5 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 115.313 1.597 . . . . 10.0 115.313 -171.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.6 mtp-105 -112.33 0.44 15.69 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.171 0.988 . . . . 10.0 113.319 172.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 8.8 t -108.03 177.91 4.67 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 124.092 0.957 . . . . 10.0 111.046 174.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . 0.462 ' HD3' ' CD ' ' A' ' 166' ' ' GLU . 41.7 ttt180 -71.59 98.15 1.83 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.765 0.826 . . . . 10.0 110.947 170.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -80.86 77.0 7.78 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.874 0.87 . . . . 10.0 112.08 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 40.18 102.24 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 128.896 2.878 . . . . 10.0 116.466 177.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . 0.481 0.3 OUTLIER 71.85 -55.43 0.66 Allowed 'General case' 0 C--O 1.241 0.647 0 C-N-CA 124.722 1.209 . . . . 10.0 110.656 -175.295 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -68.29 169.47 40.06 Favored Glycine 0 C--O 1.239 0.417 0 C-N-CA 129.73 3.538 . . . . 10.0 119.666 171.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.461 0 C-N-CA 128.441 2.696 . . . . 10.0 113.407 166.609 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 999' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A 1000 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A 1001 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A 1002 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A 1003 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 N--CA 1.477 0.913 0 CA-C-O 115.78 -2.057 . . . . 10.0 105.808 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 23.33 91.84 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 129.598 3.159 . . . . 10.0 117.286 160.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 28.68 65.05 0.11 Allowed 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 128.324 2.65 . . . . 10.0 114.468 155.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 86.4 mt -56.44 137.94 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 126.41 1.884 . . . . 10.0 113.344 -158.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.6 t -136.78 -165.21 1.7 Allowed 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 126.284 1.834 . . . . 10.0 113.991 -174.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 70.04 2.8 41.3 Favored Glycine 0 C--N 1.34 0.768 0 C-N-CA 127.475 2.464 . . . . 10.0 111.453 168.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -158.59 -51.29 0.01 OUTLIER Pre-proline 0 N--CA 1.443 -0.794 0 CA-C-O 114.301 -2.761 . . . . 10.0 116.698 -168.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -64.02 -60.58 0.15 Allowed 'Trans proline' 0 CA--C 1.528 0.179 0 CA-C-N 123.504 2.287 . . . . 10.0 113.207 -175.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 7.9 pm0 -67.22 4.27 0.98 Allowed 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 127.86 2.464 . . . . 10.0 115.765 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.421 ' CG ' ' N ' ' A' ' 11' ' ' ILE . 11.0 p-90 -51.34 -43.08 61.67 Favored 'General case' 0 C--O 1.223 -0.337 0 O-C-N 121.487 -0.758 . . . . 10.0 112.646 176.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.421 ' N ' ' CG ' ' A' ' 10' ' ' TRP . 8.9 tt -60.9 -49.64 83.82 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.338 0 C-N-CA 123.902 0.881 . . . . 10.0 109.287 179.415 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 2.6 m95 -55.33 -52.7 62.63 Favored 'General case' 0 C--O 1.224 -0.261 0 C-N-CA 123.428 0.691 . . . . 10.0 111.861 175.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.5 mt -57.37 -53.53 57.05 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 123.138 0.575 . . . . 10.0 112.27 177.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.92 -46.78 52.3 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.366 1.466 . . . . 10.0 113.332 173.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 13.3 tp -65.67 -44.94 84.72 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.304 1.442 . . . . 10.0 113.009 179.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.55 -56.57 10.92 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 124.419 1.009 . . . . 10.0 111.55 166.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.2 m -49.62 -52.44 30.52 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.898 1.279 . . . . 10.0 112.246 174.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.45 -58.89 5.69 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.163 0.985 . . . . 10.0 112.138 177.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 93.1 mt -57.12 -48.55 78.37 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.606 0.762 . . . . 10.0 112.851 -179.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 49.0 mtt -60.43 -45.77 92.45 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.148 0.979 . . . . 10.0 111.503 178.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -58.22 -58.68 13.28 Favored Glycine 0 CA--C 1.53 0.998 0 CA-C-O 118.937 -0.924 . . . . 10.0 113.872 172.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 80.8 mt -56.24 -45.86 79.83 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-N 118.714 1.257 . . . . 10.0 112.089 176.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.66 -42.19 76.64 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 124.46 1.029 . . . . 10.0 113.581 172.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 30.3 m -62.12 -58.4 7.95 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 118.329 -0.843 . . . . 10.0 111.113 172.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -52.3 -40.93 62.46 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.051 0.94 . . . . 10.0 110.95 177.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -55.83 -58.01 9.65 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.573 1.149 . . . . 10.0 112.993 172.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.1 m-30 -59.69 -38.58 81.96 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 113.252 0.834 . . . . 10.0 113.252 178.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.469 ' C ' ' H ' ' A' ' 30' ' ' LYS . 11.8 mt -56.13 -67.48 0.29 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.628 1.171 . . . . 10.0 113.589 169.092 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 t -76.36 40.95 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 CA-C-O 123.705 1.717 . . . . 10.0 110.83 179.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.469 ' H ' ' C ' ' A' ' 28' ' ' LEU . 42.9 tttm -140.86 -44.78 0.39 Allowed 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 127.89 2.476 . . . . 10.0 109.379 171.13 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.99 23.12 0.88 Allowed Glycine 0 CA--C 1.529 0.928 0 N-CA-C 115.596 0.998 . . . . 10.0 115.596 173.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 37.3 mmm -59.52 -44.98 93.01 Favored 'General case' 0 C--O 1.224 -0.277 0 C-N-CA 127.189 2.196 . . . . 10.0 113.587 -179.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.71 -84.41 1.19 Allowed Glycine 0 CA--C 1.53 0.989 0 C-N-CA 123.766 0.698 . . . . 10.0 112.471 -170.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.8 t 33.03 88.78 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.242 0.706 0 C-N-CA 128.434 2.694 . . . . 10.0 116.956 166.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.3 m -79.68 -50.85 10.01 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.184 -1.371 . . . . 10.0 113.843 174.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -48.93 117.56 6.48 Favored Pre-proline 0 CA--C 1.536 0.429 0 O-C-N 124.829 1.331 . . . . 10.0 110.991 -172.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -58.63 -29.59 89.66 Favored 'Trans proline' 0 N--CA 1.459 -0.5 0 C-N-CA 123.74 2.96 . . . . 10.0 113.706 179.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.38 -60.61 2.32 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.089 0.556 . . . . 10.0 111.437 176.199 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.19 -40.01 22.81 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 125.093 1.357 . . . . 10.0 113.58 171.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.5 tttp -46.61 -47.37 19.99 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.241 1.417 . . . . 10.0 113.434 172.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -57.79 -53.09 62.19 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.472 0.709 . . . . 10.0 110.944 176.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -56.93 -50.23 73.2 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 123.094 0.557 . . . . 10.0 112.342 -179.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -54.42 -51.29 65.38 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 118.919 -0.562 . . . . 10.0 112.337 173.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.37 -61.98 1.93 Allowed 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 113.419 0.896 . . . . 10.0 113.419 177.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.4 mt -48.65 -57.49 1.54 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 C-N-CA 124.869 1.268 . . . . 10.0 110.349 178.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.2 m -68.87 -17.17 63.95 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.144 1.378 . . . . 10.0 113.737 -172.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 27.8 m -87.9 -40.02 14.31 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.5 1.12 . . . . 10.0 112.165 174.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 25.7 mt -59.48 -42.82 92.95 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 118.93 0.786 . . . . 10.0 112.431 170.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 18.4 t -42.26 -60.06 2.34 Favored Pre-proline 0 N--CA 1.481 1.11 0 C-N-CA 125.72 1.608 . . . . 10.0 113.881 176.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -72.7 -24.3 18.5 Favored 'Trans proline' 0 CA--C 1.545 1.074 0 C-N-CA 122.951 2.434 . . . . 10.0 114.662 174.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.71 -44.69 80.98 Favored 'General case' 0 CA--C 1.548 0.879 0 CA-C-N 120.642 1.564 . . . . 10.0 113.291 176.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 38.1 mm -53.62 -53.86 22.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 124.287 1.035 . . . . 10.0 109.404 168.178 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -53.25 -46.65 69.29 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.458 1.103 . . . . 10.0 113.343 176.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 52.0 t80 -51.36 -57.26 9.4 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 120.187 1.358 . . . . 10.0 112.419 172.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 12.5 m -50.12 -52.32 36.01 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.329 1.451 . . . . 10.0 110.454 178.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 32.6 mmt -69.17 -48.01 63.41 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 123.905 0.882 . . . . 10.0 112.967 -176.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -56.36 -40.93 75.34 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 120.35 1.432 . . . . 10.0 113.262 172.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.8 tp -53.25 -54.59 33.91 Favored 'General case' 0 C--O 1.224 -0.258 0 CA-C-N 119.85 1.204 . . . . 10.0 111.281 170.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 24.0 p -51.67 -41.05 61.11 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 115.224 1.564 . . . . 10.0 115.224 179.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 61.1 mtm -66.84 -50.86 61.19 Favored 'General case' 0 C--N 1.334 -0.082 0 C-N-CA 123.556 0.742 . . . . 10.0 110.506 176.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.4 tp -48.51 -52.74 21.02 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.857 0.863 . . . . 10.0 112.952 172.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.4 mt -76.84 -5.62 49.06 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.353 1.061 . . . . 10.0 113.854 -177.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.32 -34.74 5.52 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 115.55 0.98 . . . . 10.0 115.55 174.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 75.3 t80 -49.29 -43.08 43.01 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 115.235 1.568 . . . . 10.0 115.235 -175.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.02 3.51 61.14 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 115.35 0.9 . . . . 10.0 115.35 -179.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.25 143.43 26.42 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 127.042 2.137 . . . . 10.0 109.018 172.002 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 t -145.54 171.06 15.22 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 124.048 0.939 . . . . 10.0 111.067 166.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.01 136.08 53.36 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 123.853 0.861 . . . . 10.0 109.684 179.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 58.5 t -129.6 129.61 23.17 Favored Pre-proline 0 C--N 1.33 -0.279 0 C-N-CA 125.031 1.332 . . . . 10.0 110.905 -176.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -80.73 116.24 3.17 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 N-CA-C 109.415 -1.033 . . . . 10.0 109.415 -178.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -156.68 164.39 38.2 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 112.842 0.682 . . . . 10.0 112.842 172.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.36 -81.95 0.14 Allowed Glycine 0 CA--C 1.526 0.764 0 N-CA-C 110.692 -0.963 . . . . 10.0 110.692 175.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.77 -3.41 0.69 Allowed Glycine 0 CA--C 1.527 0.836 0 N-CA-C 118.666 2.226 . . . . 10.0 118.666 170.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -151.58 -171.89 4.06 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 119.349 1.575 . . . . 10.0 112.217 -165.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -91.82 93.9 9.07 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 125.531 1.532 . . . . 10.0 111.107 -175.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 60.2 m-80 -89.47 120.78 69.65 Favored Pre-proline 0 N--CA 1.45 -0.428 0 N-CA-C 113.0 0.741 . . . . 10.0 113.0 -165.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -61.48 131.92 38.32 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 124.205 3.27 . . . . 10.0 112.167 171.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.5 mm -140.16 126.37 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 C-N-CA 126.0 1.72 . . . . 10.0 111.712 -179.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -93.64 84.99 4.74 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 122.72 1.247 . . . . 10.0 113.053 174.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 63.8 p-90 -59.37 -28.28 66.73 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 120.939 -1.101 . . . . 10.0 113.881 174.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -55.36 -23.13 22.47 Favored 'General case' 0 CA--C 1.574 1.9 0 C-N-CA 124.277 1.031 . . . . 10.0 110.038 178.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -47.57 -59.75 3.03 Favored 'General case' 0 N--CA 1.496 1.833 0 C-N-CA 126.304 1.841 . . . . 10.0 112.08 163.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -68.35 -37.39 80.43 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 123.814 0.845 . . . . 10.0 110.457 -173.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -53.8 -51.59 63.0 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 123.676 0.79 . . . . 10.0 112.748 169.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 61.8 t0 -52.96 -68.72 0.15 Allowed 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 126.143 1.777 . . . . 10.0 111.26 171.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 46.2 m0 -57.01 -33.77 67.49 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.98 1.712 . . . . 10.0 113.268 -171.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 30.0 tp -50.08 -44.63 51.93 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 126.13 1.772 . . . . 10.0 111.967 177.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -99.25 -44.4 6.25 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.185 0.994 . . . . 10.0 112.014 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 13.7 m -48.33 -52.15 22.86 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.669 1.588 . . . . 10.0 113.242 177.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . 0.314 57.5 p -67.88 -45.71 43.23 Favored Pre-proline 0 N--CA 1.476 0.872 0 N-CA-C 114.557 1.318 . . . . 10.0 114.557 -174.433 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -52.91 -42.9 60.79 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 123.39 2.727 . . . . 10.0 115.329 170.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 52.4 mt -59.18 -46.45 88.37 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.293 0.637 . . . . 10.0 111.472 175.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.4 tp -51.33 -48.13 62.49 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.411 1.485 . . . . 10.0 112.198 172.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.7 mp -58.82 -47.33 85.19 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 125.122 1.369 . . . . 10.0 112.623 170.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.8 -38.28 78.22 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 123.826 0.85 . . . . 10.0 112.906 178.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 -52.31 -54.0 37.1 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 119.282 0.946 . . . . 10.0 111.163 169.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.36 -42.12 88.48 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.635 0.774 . . . . 10.0 112.087 -178.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.64 -54.73 37.67 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.996 0.919 . . . . 10.0 112.024 173.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.33 -41.2 79.53 Favored 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 123.73 0.812 . . . . 10.0 112.668 174.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.9 tp -63.71 -38.6 91.73 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 114.494 1.294 . . . . 10.0 114.494 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.1 t -94.75 1.41 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 125.092 1.357 . . . . 10.0 112.296 179.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.2 t70 48.55 53.52 12.0 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.881 1.672 . . . . 10.0 112.077 -174.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.22 145.89 47.68 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 119.955 -1.715 . . . . 10.0 112.457 -174.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.47 135.93 54.17 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 112.697 0.629 . . . . 10.0 112.697 175.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -42.92 -39.65 2.65 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.891 1.677 . . . . 10.0 113.466 175.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -47.3 -60.21 5.31 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 125.145 1.355 . . . . 10.0 115.295 169.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 42.0 p -62.1 -46.72 87.8 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 117.101 -1.428 . . . . 10.0 111.328 178.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 66.9 mt -48.48 -52.87 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 125.032 1.333 . . . . 10.0 111.135 178.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.4 tp -62.67 -51.25 67.97 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 112.544 0.572 . . . . 10.0 112.544 179.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.2 -44.86 43.55 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.479 0.712 . . . . 10.0 110.912 174.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.56 -59.95 4.63 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 127.385 2.274 . . . . 10.0 114.791 174.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.6 t -61.02 -46.36 96.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 123.686 0.794 . . . . 10.0 111.362 -178.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -56.56 -50.41 63.19 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 123.68 0.657 . . . . 10.0 112.602 174.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -54.68 -46.74 74.14 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 113.081 0.771 . . . . 10.0 113.081 173.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -57.94 -45.07 87.2 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.998 0.919 . . . . 10.0 111.809 174.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -43.81 -55.88 5.31 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 125.123 1.344 . . . . 10.0 113.429 166.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 81.6 mt -56.63 -54.07 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 123.567 0.747 . . . . 10.0 110.962 173.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 45.5 ttp -46.14 -58.65 3.45 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.462 1.505 . . . . 10.0 112.455 -178.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 47.2 mm -70.43 -47.98 62.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 123.215 0.606 . . . . 10.0 112.012 178.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -53.2 -56.67 18.1 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 124.486 1.041 . . . . 10.0 112.873 179.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -61.63 -34.01 74.93 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.55 1.14 . . . . 10.0 112.288 174.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -50.93 -54.63 21.68 Favored Glycine 0 CA--C 1.537 1.442 0 C-N-CA 124.505 1.05 . . . . 10.0 113.395 165.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 63.4 tp -56.99 -45.67 82.82 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.366 1.467 . . . . 10.0 111.634 176.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 62.0 t -53.01 -51.35 38.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 122.959 0.503 . . . . 10.0 110.384 172.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -48.82 -61.08 5.5 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 125.751 1.643 . . . . 10.0 112.855 170.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -45.75 -40.37 9.4 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 127.004 2.122 . . . . 10.0 113.813 177.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 49.8 mt -100.14 -6.6 25.98 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 115.193 1.553 . . . . 10.0 115.193 -176.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 17.0 m -69.66 116.72 10.38 Favored 'General case' 0 N--CA 1.464 0.237 0 O-C-N 120.186 -1.571 . . . . 10.0 110.41 -178.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.553 ' HD3' ' H ' ' A' ' 129' ' ' LYS . 0.1 OUTLIER -55.44 -49.65 71.9 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 128.186 2.594 . . . . 10.0 113.267 177.754 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 60.6 t -69.62 106.37 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 123.761 0.824 . . . . 10.0 110.085 179.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -46.94 -59.49 3.06 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 124.775 1.23 . . . . 10.0 114.07 -173.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 m -46.53 -42.07 15.22 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.45 1.5 . . . . 10.0 113.484 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -70.14 -24.61 63.2 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 114.959 1.466 . . . . 10.0 114.959 -178.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 68.1 mtp85 -54.21 -41.69 68.92 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 118.869 0.759 . . . . 10.0 110.811 176.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -69.01 -32.73 72.47 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.678 1.191 . . . . 10.0 114.166 176.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.7 t -54.46 -52.03 43.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 CA-C-N 119.073 0.851 . . . . 10.0 109.659 169.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 66.2 m95 -62.0 -45.7 92.44 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 114.531 1.308 . . . . 10.0 114.531 174.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 86.5 t90 -52.13 -47.98 65.08 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.868 0.867 . . . . 10.0 112.582 172.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -57.71 -52.31 65.99 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.047 0.939 . . . . 10.0 111.69 176.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 97.3 mt -54.93 -49.99 66.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 124.732 1.213 . . . . 10.0 111.694 175.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 23.3 t -55.31 -47.98 74.81 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.323 1.049 . . . . 10.0 111.882 174.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 57.2 m -60.2 -41.86 93.89 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.412 1.485 . . . . 10.0 112.343 177.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -58.62 -49.66 76.69 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 119.117 0.871 . . . . 10.0 112.444 170.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -56.71 -45.02 82.12 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.676 0.79 . . . . 10.0 112.531 173.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 40.4 ttp -55.93 -55.72 29.27 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 124.488 1.115 . . . . 10.0 111.915 171.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -51.13 -48.5 61.77 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 125.869 1.668 . . . . 10.0 111.569 178.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 78.5 t80 -52.33 -54.54 30.37 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 113.099 0.778 . . . . 10.0 113.099 172.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 56.0 mt -53.87 -54.68 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 123.943 0.897 . . . . 10.0 110.739 177.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 90.8 mt -50.69 -42.93 57.42 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 126.129 1.772 . . . . 10.0 112.818 175.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -57.32 -58.09 9.76 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 123.986 0.914 . . . . 10.0 113.084 176.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.43 -40.92 85.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 CA-C-O 118.313 -0.851 . . . . 10.0 111.408 177.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 47.2 mt -56.83 -49.45 75.39 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.878 1.217 . . . . 10.0 112.069 171.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.424 ' HA ' ' HD2' ' A' ' 175' ' ' ARG . 11.8 t80 -76.94 -70.29 0.47 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 120.06 -1.65 . . . . 10.0 112.915 -175.24 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -73.78 -21.9 60.02 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.596 1.158 . . . . 10.0 113.454 -174.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -87.83 -79.1 1.26 Allowed Glycine 0 CA--C 1.527 0.806 0 C-N-CA 123.612 0.625 . . . . 10.0 113.501 171.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -53.58 -32.47 51.06 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 126.266 1.826 . . . . 10.0 113.045 -166.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.4 m -52.1 -56.47 14.25 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 113.988 1.107 . . . . 10.0 113.988 172.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.5 p -53.6 -50.59 65.32 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 122.093 0.949 . . . . 10.0 112.297 -177.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 47.7 tttm -57.09 -46.11 82.82 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.165 0.986 . . . . 10.0 112.103 173.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.74 -47.51 79.88 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 114.55 1.315 . . . . 10.0 114.55 174.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -56.5 -11.22 1.19 Allowed 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 126.056 1.742 . . . . 10.0 114.268 177.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.1 m -107.08 6.57 29.05 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.425 1.89 . . . . 10.0 114.898 -179.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 93.3 mmm -91.9 -92.6 0.15 Allowed 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 123.485 1.612 . . . . 10.0 114.16 -170.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -138.75 153.94 72.58 Favored Pre-proline 0 C--O 1.236 0.349 0 C-N-CA 129.809 3.243 . . . . 10.0 105.529 170.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -52.86 -46.19 35.48 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 122.3 2.0 . . . . 10.0 113.08 179.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . 0.461 ' CD ' ' HD3' ' A' ' 227' ' ' ARG . 0.1 OUTLIER -53.02 -46.09 68.25 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 129.014 2.926 . . . . 10.0 113.221 173.597 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 92.0 t -69.12 -53.09 27.63 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.267 0 C-N-CA 124.068 0.947 . . . . 10.0 109.798 -178.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.11 -46.85 75.59 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.291 0.636 . . . . 10.0 111.905 177.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 60.1 p -59.98 -56.22 24.34 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.885 0.874 . . . . 10.0 112.702 174.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 62.0 m -57.12 -53.31 59.59 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.23 1.012 . . . . 10.0 112.987 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -49.52 -49.57 45.38 Favored 'General case' 0 C--O 1.222 -0.386 0 C-N-CA 123.3 0.64 . . . . 10.0 111.068 174.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -57.12 -48.37 78.82 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 114.699 1.37 . . . . 10.0 114.699 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 40.4 t -56.02 -49.57 74.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-N 118.832 0.742 . . . . 10.0 110.487 176.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 94.2 mt -58.57 -51.63 69.09 Favored 'General case' 0 C--O 1.221 -0.397 0 N-CA-C 113.152 0.797 . . . . 10.0 113.152 175.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . 0.424 ' HD2' ' HA ' ' A' ' 153' ' ' PHE . 35.5 ttp180 -47.82 -47.82 31.05 Favored 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 126.868 2.067 . . . . 10.0 111.011 174.499 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 63.6 m-20 -58.48 -58.31 9.11 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 122.805 0.442 . . . . 10.0 111.29 174.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 58.3 t -51.77 -50.25 32.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 124.086 0.954 . . . . 10.0 111.587 179.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 26.5 m -56.55 -60.34 3.67 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 127.872 2.469 . . . . 10.0 111.953 177.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 47.7 t -53.67 -49.52 56.34 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 CA-C-N 119.215 0.916 . . . . 10.0 111.312 -178.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 76.6 t -58.91 -61.67 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 124.369 1.068 . . . . 10.0 111.908 176.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -59.24 -48.82 80.17 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 118.63 0.65 . . . . 10.0 112.609 -175.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 9.8 m95 -54.27 -49.71 68.95 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 118.9 0.773 . . . . 10.0 111.947 176.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 51.0 m -54.59 -31.37 56.76 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 114.03 1.122 . . . . 10.0 114.03 178.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -63.84 -40.61 96.98 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 113.772 1.027 . . . . 10.0 113.772 176.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 -48.23 -55.75 17.15 Favored Pre-proline 0 CA--C 1.546 0.798 0 N-CA-C 115.271 1.582 . . . . 10.0 115.271 -176.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -59.72 -33.16 96.5 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 122.32 2.013 . . . . 10.0 113.444 177.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 24.4 t -64.27 -54.54 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 123.841 0.856 . . . . 10.0 110.396 175.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 88.3 t -53.26 -49.04 54.28 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 124.739 1.216 . . . . 10.0 111.457 176.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 69.9 t90 -54.68 -54.56 40.18 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.331 1.052 . . . . 10.0 112.525 174.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 9.9 tt -57.55 -42.37 82.83 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 123.881 0.872 . . . . 10.0 112.166 -176.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 14.1 pt -84.79 -5.95 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 N-CA-C 115.289 1.589 . . . . 10.0 115.289 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.41 -169.29 32.97 Favored Glycine 0 N--CA 1.45 -0.404 0 CA-C-O 122.589 1.105 . . . . 10.0 113.883 -168.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 23.3 t -53.13 -42.25 65.86 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 114.16 -1.02 . . . . 10.0 111.85 177.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -69.13 -13.05 62.2 Favored 'General case' 0 CA--C 1.55 0.962 0 N-CA-C 115.155 1.539 . . . . 10.0 115.155 -174.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -132.25 -106.37 1.03 Allowed Glycine 0 CA--C 1.536 1.38 0 CA-C-N 120.716 1.598 . . . . 10.0 114.497 -174.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -89.45 127.16 35.81 Favored 'General case' 0 C--N 1.329 -0.323 0 O-C-N 120.666 -1.491 . . . . 10.0 109.305 168.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -72.47 65.32 1.36 Allowed Glycine 0 CA--C 1.532 1.105 0 N-CA-C 113.901 0.32 . . . . 10.0 113.901 173.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 60.7 mt -79.57 -42.74 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 126.107 1.763 . . . . 10.0 108.735 166.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 79.3 t -126.28 133.38 24.91 Favored Pre-proline 0 N--CA 1.453 -0.279 0 C-N-CA 126.504 1.922 . . . . 10.0 109.391 -174.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -68.7 153.76 72.63 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 123.822 3.015 . . . . 10.0 111.474 -176.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 12.2 tp -43.13 -39.82 2.98 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.319 1.047 . . . . 10.0 112.229 171.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -48.28 -52.41 21.45 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 114.684 1.365 . . . . 10.0 114.684 176.03 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 14.0 mm -75.95 -40.53 38.36 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 124.419 1.088 . . . . 10.0 109.625 177.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -49.29 -49.75 42.26 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 118.61 0.641 . . . . 10.0 112.005 173.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 16.2 m -57.75 -47.01 83.7 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 126.042 1.737 . . . . 10.0 112.991 174.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -63.35 -52.36 62.13 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.927 0.891 . . . . 10.0 112.063 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 93.3 mt -52.48 -60.0 3.76 Favored 'General case' 0 C--O 1.227 -0.115 0 C-N-CA 124.322 1.049 . . . . 10.0 109.993 176.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -53.49 -43.18 68.02 Favored 'General case' 0 C--O 1.218 -0.589 0 CA-C-O 117.432 -1.27 . . . . 10.0 112.51 176.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 4.6 tmm? -53.93 -52.52 60.33 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 121.51 1.959 . . . . 10.0 112.974 173.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 82.1 t -61.06 -47.12 95.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 124.957 1.303 . . . . 10.0 111.7 178.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 4.8 mp -58.97 -51.3 70.66 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 125.578 1.551 . . . . 10.0 111.79 175.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -55.07 -59.96 4.04 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 125.969 1.708 . . . . 10.0 109.924 176.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 35.1 t -45.2 -59.01 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 125.334 1.454 . . . . 10.0 111.658 175.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 26.9 p -59.98 -44.37 94.53 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 112.939 0.718 . . . . 10.0 112.939 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -67.06 -22.04 65.87 Favored 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 115.131 1.53 . . . . 10.0 115.131 173.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -87.71 -78.98 0.3 Allowed 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.76 1.624 . . . . 10.0 110.264 171.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 33.1 m -78.54 -38.37 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 O-C-N 121.133 -0.979 . . . . 10.0 112.476 -170.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -58.18 -57.63 18.8 Favored Glycine 0 N--CA 1.474 1.197 0 CA-C-N 119.822 1.192 . . . . 10.0 111.912 176.077 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 42.8 t80 -45.45 -57.78 3.84 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.142 1.777 . . . . 10.0 112.45 167.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -56.9 -40.59 90.58 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 123.834 0.73 . . . . 10.0 113.561 -179.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 24.2 mt -70.95 -27.19 63.56 Favored 'General case' 0 CA--C 1.51 -0.582 0 N-CA-C 115.52 1.674 . . . . 10.0 115.52 176.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 74.0 mt -63.2 -57.57 11.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 119.131 0.878 . . . . 10.0 108.688 165.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 32.1 tp -58.91 -64.6 0.88 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.854 0.862 . . . . 10.0 113.207 -172.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 84.0 mt -71.55 5.24 2.5 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 115.323 1.601 . . . . 10.0 115.323 -171.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.6 mtp-105 -112.34 0.36 15.65 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.165 0.986 . . . . 10.0 113.265 172.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 8.8 t -108.04 177.94 4.66 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 124.082 0.953 . . . . 10.0 111.039 174.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . 0.461 ' HD3' ' CD ' ' A' ' 166' ' ' GLU . 41.9 ttt180 -71.66 98.17 1.86 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.732 0.813 . . . . 10.0 110.968 170.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -80.93 77.03 7.86 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.829 0.852 . . . . 10.0 112.087 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 40.16 102.21 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 128.831 2.852 . . . . 10.0 116.502 177.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . 0.481 0.3 OUTLIER 71.83 -55.39 0.66 Allowed 'General case' 0 C--O 1.242 0.677 0 C-N-CA 124.764 1.226 . . . . 10.0 110.656 -175.277 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -68.34 169.48 40.2 Favored Glycine 0 C--O 1.239 0.417 0 C-N-CA 129.738 3.542 . . . . 10.0 119.598 171.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.489 0 C-N-CA 128.486 2.714 . . . . 10.0 113.44 166.618 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 999' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A 1000 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A 1001 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A 1002 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A 1003 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 N--CA 1.477 0.913 0 CA-C-O 115.781 -2.057 . . . . 10.0 105.833 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 23.35 91.83 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 129.598 3.159 . . . . 10.0 117.262 160.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 28.64 65.07 0.11 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 128.262 2.625 . . . . 10.0 114.511 155.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 86.7 mt -56.49 137.96 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 126.41 1.884 . . . . 10.0 113.353 -158.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.6 t -136.79 -165.2 1.7 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 126.327 1.851 . . . . 10.0 114.021 -174.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 70.0 2.83 41.1 Favored Glycine 0 C--N 1.339 0.743 0 C-N-CA 127.496 2.474 . . . . 10.0 111.485 168.076 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -158.52 -51.41 0.01 OUTLIER Pre-proline 0 N--CA 1.443 -0.783 0 CA-C-O 114.275 -2.774 . . . . 10.0 116.634 -168.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -63.89 -60.69 0.14 Allowed 'Trans proline' 0 CA--C 1.528 0.186 0 CA-C-N 123.5 2.286 . . . . 10.0 113.236 -175.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 7.9 pm0 -67.13 4.22 0.96 Allowed 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 127.878 2.471 . . . . 10.0 115.75 179.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.422 ' CG ' ' N ' ' A' ' 11' ' ' ILE . 11.0 p-90 -51.28 -43.15 61.54 Favored 'General case' 0 C--O 1.222 -0.361 0 O-C-N 121.5 -0.75 . . . . 10.0 112.646 176.425 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.422 ' N ' ' CG ' ' A' ' 10' ' ' TRP . 8.9 tt -60.85 -49.64 83.79 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.338 0 C-N-CA 123.926 0.89 . . . . 10.0 109.323 179.425 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 2.6 m95 -55.34 -52.67 62.75 Favored 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 123.406 0.682 . . . . 10.0 111.908 175.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.4 mt -57.34 -53.6 56.31 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 123.223 0.609 . . . . 10.0 112.245 177.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.91 -46.8 52.24 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.412 1.485 . . . . 10.0 113.324 173.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 13.3 tp -65.63 -44.95 84.88 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.277 1.431 . . . . 10.0 113.059 179.057 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.17 -58.37 7.99 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 124.274 0.94 . . . . 10.0 110.853 165.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.3 m -48.24 -52.41 21.25 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.625 1.17 . . . . 10.0 112.279 175.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.45 -58.83 5.93 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.122 0.969 . . . . 10.0 112.177 177.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 93.8 mt -58.25 -49.63 76.41 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.681 0.793 . . . . 10.0 112.399 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -50.73 -54.52 22.62 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.683 1.193 . . . . 10.0 110.879 173.684 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -57.17 -58.18 15.9 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 124.452 1.025 . . . . 10.0 113.574 178.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 80.8 mt -56.16 -45.54 79.65 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-N 118.626 1.213 . . . . 10.0 112.134 176.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.45 -42.57 75.71 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 124.936 1.255 . . . . 10.0 113.329 172.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 17.4 m -59.75 -60.86 3.16 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.216 1.006 . . . . 10.0 111.076 171.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -52.3 -40.99 62.55 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.061 0.944 . . . . 10.0 110.936 179.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.0 t80 -55.78 -58.03 9.56 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.552 1.141 . . . . 10.0 113.006 172.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -59.63 -38.7 82.07 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 113.226 0.825 . . . . 10.0 113.226 178.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.468 ' C ' ' H ' ' A' ' 30' ' ' LYS . 11.9 mt -56.08 -67.42 0.3 Allowed 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.592 1.157 . . . . 10.0 113.668 169.072 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 t -76.45 41.04 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 CA-C-O 123.749 1.738 . . . . 10.0 110.829 179.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.468 ' H ' ' C ' ' A' ' 28' ' ' LEU . 42.9 tttm -140.91 -44.87 0.39 Allowed 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 127.868 2.467 . . . . 10.0 109.303 171.186 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.95 23.09 0.87 Allowed Glycine 0 CA--C 1.529 0.956 0 N-CA-C 115.644 1.017 . . . . 10.0 115.644 173.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 37.4 mmm -59.54 -44.96 93.07 Favored 'General case' 0 C--O 1.224 -0.253 0 C-N-CA 127.136 2.174 . . . . 10.0 113.578 -178.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.66 -84.44 1.18 Allowed Glycine 0 CA--C 1.531 1.045 0 C-N-CA 123.741 0.686 . . . . 10.0 112.477 -170.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.8 t 33.09 88.7 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.243 0.73 0 C-N-CA 128.399 2.68 . . . . 10.0 116.941 166.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.4 m -79.58 -50.9 10.0 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.188 -1.369 . . . . 10.0 113.868 174.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -48.87 117.46 6.32 Favored Pre-proline 0 CA--C 1.536 0.428 0 O-C-N 124.719 1.262 . . . . 10.0 110.983 -172.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -58.56 -29.62 89.51 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 123.773 2.982 . . . . 10.0 113.727 179.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.38 -60.59 2.33 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.058 0.543 . . . . 10.0 111.442 176.183 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.15 -40.07 22.65 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 125.127 1.371 . . . . 10.0 113.58 171.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -46.5 -47.5 19.39 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 125.292 1.437 . . . . 10.0 113.413 172.03 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -57.79 -52.98 63.23 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.438 0.695 . . . . 10.0 110.975 176.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 44.2 m-85 -57.05 -50.18 73.54 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 123.034 0.534 . . . . 10.0 112.351 -179.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -54.37 -51.28 65.31 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 118.935 -0.555 . . . . 10.0 112.379 173.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.42 -61.97 1.94 Allowed 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 113.425 0.898 . . . . 10.0 113.425 177.168 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.7 mt -48.8 -57.54 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 C-N-CA 124.823 1.249 . . . . 10.0 110.145 177.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 4.9 m -69.42 -14.75 63.07 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.188 1.395 . . . . 10.0 113.74 -172.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 31.3 m -89.7 -42.25 11.44 Favored 'General case' 0 N--CA 1.483 1.178 0 CA-C-N 119.884 1.22 . . . . 10.0 111.946 174.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 27.9 mt -56.27 -40.01 73.55 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 118.433 0.56 . . . . 10.0 112.176 170.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . 0.254 24.3 t -47.09 -62.9 1.65 Allowed Pre-proline 0 CA--C 1.552 1.052 0 C-N-CA 125.266 1.426 . . . . 10.0 112.884 177.007 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -53.26 -42.47 64.9 Favored 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 123.919 3.079 . . . . 10.0 116.303 166.089 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.66 -46.19 89.33 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 114.199 1.185 . . . . 10.0 114.199 -174.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 48.3 mm -57.43 -51.32 71.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 O-C-N 121.194 -0.941 . . . . 10.0 109.697 171.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.76 -42.62 71.91 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 113.588 0.959 . . . . 10.0 113.588 175.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -52.85 -56.73 13.62 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 120.379 1.445 . . . . 10.0 112.01 170.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.8 m -49.55 -52.52 29.29 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.512 1.525 . . . . 10.0 110.837 177.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 32.7 mmt -69.11 -48.23 63.07 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 124.035 0.934 . . . . 10.0 112.894 -176.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -57.01 -40.11 76.01 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 117.058 -1.449 . . . . 10.0 113.135 173.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.8 tp -53.31 -54.58 34.43 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-N 120.198 1.363 . . . . 10.0 111.276 170.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 23.9 p -51.68 -41.0 61.09 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 115.261 1.578 . . . . 10.0 115.261 178.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 57.4 mtm -66.88 -50.88 61.08 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 123.534 0.734 . . . . 10.0 110.481 176.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.3 tp -48.54 -52.69 21.43 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.858 0.863 . . . . 10.0 112.926 172.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.4 mt -76.87 -5.64 49.22 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.377 1.071 . . . . 10.0 113.819 -177.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.29 -34.72 5.54 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 115.533 0.973 . . . . 10.0 115.533 174.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -49.29 -43.13 42.99 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 115.206 1.558 . . . . 10.0 115.206 -176.014 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.06 3.61 60.97 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 115.337 0.895 . . . . 10.0 115.337 -178.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.29 143.42 26.42 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 127.048 2.139 . . . . 10.0 108.972 172.014 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 t -145.54 171.05 15.24 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 124.064 0.946 . . . . 10.0 111.022 166.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.99 136.12 53.33 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 123.855 0.862 . . . . 10.0 109.683 179.602 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 58.5 t -129.6 129.55 23.17 Favored Pre-proline 0 C--N 1.329 -0.295 0 C-N-CA 125.063 1.345 . . . . 10.0 110.948 -176.048 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -80.69 116.24 3.18 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 N-CA-C 109.417 -1.032 . . . . 10.0 109.417 -178.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -156.74 164.4 38.16 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.823 0.675 . . . . 10.0 112.823 172.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.37 -81.98 0.14 Allowed Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.681 -0.967 . . . . 10.0 110.681 175.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.76 -3.32 0.7 Allowed Glycine 0 CA--C 1.527 0.822 0 N-CA-C 118.671 2.228 . . . . 10.0 118.671 170.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -151.63 -171.89 4.06 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 119.354 1.577 . . . . 10.0 112.237 -165.161 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -91.89 93.95 9.06 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 125.504 1.522 . . . . 10.0 111.066 -175.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 60.3 m-80 -89.52 120.77 69.62 Favored Pre-proline 0 N--CA 1.45 -0.43 0 N-CA-C 112.964 0.727 . . . . 10.0 112.964 -165.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -61.53 131.97 38.43 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 124.163 3.242 . . . . 10.0 112.136 171.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.5 mm -140.14 126.3 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 C-N-CA 126.072 1.749 . . . . 10.0 111.714 -179.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -93.65 85.07 4.76 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 122.714 1.245 . . . . 10.0 113.055 174.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 63.8 p-90 -59.35 -28.3 66.71 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 113.925 1.083 . . . . 10.0 113.925 174.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -55.21 -32.77 62.51 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.273 1.029 . . . . 10.0 112.654 178.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 37.7 ttm-85 -49.36 -43.51 44.0 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.917 1.687 . . . . 10.0 112.283 169.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 61.7 m-85 -78.91 -39.85 33.76 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.538 1.535 . . . . 10.0 112.428 -179.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -49.92 -48.15 51.89 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.798 1.239 . . . . 10.0 111.337 167.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -56.01 -68.8 0.17 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.426 1.49 . . . . 10.0 111.907 170.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 48.9 m0 -52.82 -33.95 51.61 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.996 1.318 . . . . 10.0 113.387 -173.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 32.6 tp -50.96 -45.65 60.83 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 125.899 1.679 . . . . 10.0 111.982 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -97.55 -47.55 5.6 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 124.478 1.111 . . . . 10.0 112.441 -177.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 51.6 m -59.77 -40.13 87.19 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.643 1.177 . . . . 10.0 112.892 -174.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.5 m -68.26 -47.58 38.07 Favored Pre-proline 0 CA--C 1.547 0.86 0 N-CA-C 113.745 1.017 . . . . 10.0 113.745 -179.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -50.03 -42.77 44.7 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 123.356 2.704 . . . . 10.0 115.362 166.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 54.1 mt -59.18 -46.94 87.07 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.264 0.626 . . . . 10.0 111.575 174.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.5 tp -49.71 -49.15 48.91 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.593 1.557 . . . . 10.0 112.162 171.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.6 mp -58.85 -47.33 85.25 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.031 1.332 . . . . 10.0 112.498 171.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.83 -38.24 78.23 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 123.844 0.857 . . . . 10.0 112.891 178.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -52.31 -54.0 37.16 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 119.324 0.966 . . . . 10.0 111.189 169.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.35 -42.17 88.46 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.656 0.782 . . . . 10.0 112.046 -178.506 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.7 -54.7 38.4 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 124.008 0.923 . . . . 10.0 112.013 173.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.3 -41.17 79.34 Favored 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 123.72 0.808 . . . . 10.0 112.702 174.779 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.9 tp -63.75 -38.62 91.77 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 114.425 1.268 . . . . 10.0 114.425 -179.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.1 t -94.79 1.49 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 125.025 1.33 . . . . 10.0 112.325 179.158 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.2 t70 48.57 53.49 12.06 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.866 1.666 . . . . 10.0 112.095 -174.033 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.3 145.94 47.51 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 119.974 -1.704 . . . . 10.0 112.437 -174.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.53 135.92 54.41 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 112.679 0.622 . . . . 10.0 112.679 175.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -42.81 -39.75 2.61 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.895 1.678 . . . . 10.0 113.443 175.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -47.35 -60.2 5.35 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 125.15 1.357 . . . . 10.0 115.22 169.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.9 p -62.07 -46.72 87.87 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 117.103 -1.427 . . . . 10.0 111.351 178.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 67.1 mt -48.47 -52.9 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 125.033 1.333 . . . . 10.0 111.085 178.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.3 tp -62.62 -51.33 67.69 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 112.502 0.556 . . . . 10.0 112.502 179.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.11 -44.9 42.7 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.47 0.708 . . . . 10.0 110.959 174.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.64 -59.89 4.72 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 127.393 2.277 . . . . 10.0 114.793 174.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.8 t -61.0 -46.31 96.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 123.704 0.802 . . . . 10.0 111.411 -178.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -56.65 -50.32 64.05 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 123.695 0.664 . . . . 10.0 112.63 174.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -54.96 -46.23 75.01 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 113.375 0.88 . . . . 10.0 113.375 173.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -55.9 -48.84 74.9 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.698 0.799 . . . . 10.0 111.129 173.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -42.52 -55.27 4.58 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 125.044 1.306 . . . . 10.0 112.997 169.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 82.2 mt -55.56 -58.19 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-O 117.571 -1.204 . . . . 10.0 110.66 173.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 5.0 ptt? -53.42 -46.35 69.74 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 120.783 1.628 . . . . 10.0 113.343 -173.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 46.5 mm -73.77 -47.39 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 O-C-N 121.471 -0.768 . . . . 10.0 111.836 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -54.0 -50.77 53.71 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 123.848 0.737 . . . . 10.0 112.278 175.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 23.7 m -56.53 -46.21 80.75 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.816 1.646 . . . . 10.0 111.648 172.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -45.83 -54.07 8.25 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 124.8 1.191 . . . . 10.0 113.221 168.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 61.6 tp -59.87 -46.44 89.3 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.195 1.398 . . . . 10.0 112.698 176.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 60.4 t -53.76 -49.7 56.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 O-C-N 121.284 -0.885 . . . . 10.0 110.112 172.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -50.7 -61.23 6.19 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 126.119 1.818 . . . . 10.0 112.65 171.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -43.12 -42.08 3.91 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 127.818 2.447 . . . . 10.0 113.208 176.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 47.3 mt -100.88 -6.8 24.19 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 115.536 1.68 . . . . 10.0 115.536 -175.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 16.9 m -69.66 116.71 10.37 Favored 'General case' 0 N--CA 1.464 0.229 0 O-C-N 120.195 -1.566 . . . . 10.0 110.386 -178.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.552 ' HD3' ' H ' ' A' ' 129' ' ' LYS . 0.2 OUTLIER -55.51 -49.57 72.26 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 128.157 2.583 . . . . 10.0 113.269 177.763 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 60.3 t -69.65 106.33 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 123.819 0.848 . . . . 10.0 110.103 179.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -46.9 -59.54 3.02 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 124.724 1.21 . . . . 10.0 114.055 -173.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 m -46.5 -42.05 15.01 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.45 1.5 . . . . 10.0 113.495 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -70.18 -24.64 63.17 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 114.896 1.443 . . . . 10.0 114.896 -178.103 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 68.9 mtp85 -53.95 -41.81 68.18 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 118.88 0.764 . . . . 10.0 110.776 176.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -69.62 -31.6 69.81 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 114.403 1.26 . . . . 10.0 114.403 176.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.8 t -55.09 -52.18 47.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 CA-C-N 118.993 0.815 . . . . 10.0 109.549 168.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 64.2 m95 -61.09 -43.27 99.15 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 114.185 1.18 . . . . 10.0 114.185 174.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 89.2 t90 -52.88 -49.81 65.11 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 119.255 0.934 . . . . 10.0 112.642 172.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -56.99 -52.72 64.14 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.225 1.01 . . . . 10.0 111.76 178.193 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 96.9 mt -54.42 -50.75 55.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 125.019 1.328 . . . . 10.0 111.596 175.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 19.5 m -54.49 -45.49 73.23 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.46 1.104 . . . . 10.0 111.835 174.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 53.3 m -62.25 -44.72 95.91 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.821 1.648 . . . . 10.0 112.08 177.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -56.5 -50.97 70.24 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.781 0.832 . . . . 10.0 112.265 171.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -57.51 -46.29 83.97 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.836 0.854 . . . . 10.0 112.942 175.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 11.9 tmm? -55.02 -54.06 47.85 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.26 1.424 . . . . 10.0 111.956 172.234 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 58.1 tp -57.65 -42.98 84.58 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.794 1.638 . . . . 10.0 112.834 178.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -53.36 -53.6 48.71 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.537 0.735 . . . . 10.0 112.037 169.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 46.2 mt -54.62 -54.64 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 123.733 0.813 . . . . 10.0 111.061 177.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 5.1 tt -46.13 -46.91 17.46 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 127.943 2.497 . . . . 10.0 112.222 173.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -57.33 -58.15 9.5 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 124.026 0.93 . . . . 10.0 113.03 178.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.42 -40.9 85.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-O 118.343 -0.837 . . . . 10.0 111.467 177.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 47.4 mt -56.73 -49.45 75.16 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.824 1.193 . . . . 10.0 112.139 171.223 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.424 ' HA ' ' HD2' ' A' ' 175' ' ' ARG . 11.8 t80 -76.98 -70.34 0.47 Allowed 'General case' 0 C--N 1.326 -0.447 0 O-C-N 120.079 -1.638 . . . . 10.0 112.845 -175.215 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -73.76 -21.92 60.03 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.634 1.174 . . . . 10.0 113.426 -174.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -87.77 -79.08 1.26 Allowed Glycine 0 CA--C 1.526 0.761 0 C-N-CA 123.662 0.649 . . . . 10.0 113.553 171.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -53.63 -32.47 51.46 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 126.307 1.843 . . . . 10.0 113.025 -166.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.2 m -52.08 -56.45 14.35 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 114.016 1.117 . . . . 10.0 114.016 172.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.4 p -53.66 -50.56 65.52 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 122.161 0.981 . . . . 10.0 112.307 -177.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 47.6 tttm -57.08 -46.07 82.83 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.134 0.974 . . . . 10.0 112.167 173.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.86 -47.41 80.47 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 114.515 1.302 . . . . 10.0 114.515 174.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -56.47 -11.3 1.21 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 126.087 1.755 . . . . 10.0 114.252 177.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.2 m -107.1 6.64 29.08 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.416 1.886 . . . . 10.0 114.877 -179.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 93.2 mmm -91.91 -92.63 0.15 Allowed 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 123.451 1.596 . . . . 10.0 114.164 -170.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -138.71 154.0 72.7 Favored Pre-proline 0 C--O 1.236 0.359 0 C-N-CA 129.749 3.219 . . . . 10.0 105.539 170.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -52.85 -46.24 35.09 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 122.308 2.005 . . . . 10.0 113.074 179.057 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . 0.462 ' CD ' ' HD3' ' A' ' 227' ' ' ARG . 0.1 OUTLIER -52.94 -46.11 67.98 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 129.022 2.929 . . . . 10.0 113.281 173.578 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 92.2 t -69.19 -53.03 27.73 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 C-N-CA 124.034 0.934 . . . . 10.0 109.782 -178.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.09 -46.89 75.53 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.282 0.633 . . . . 10.0 111.923 177.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 60.2 p -59.97 -56.16 25.08 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.883 0.873 . . . . 10.0 112.719 174.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 61.7 m -57.23 -53.16 61.21 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.143 0.977 . . . . 10.0 113.004 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -49.59 -49.54 46.26 Favored 'General case' 0 C--O 1.222 -0.375 0 C-N-CA 123.289 0.636 . . . . 10.0 111.067 174.098 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -57.12 -48.41 78.72 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 114.671 1.36 . . . . 10.0 114.671 -179.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 40.3 t -55.95 -49.63 74.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 CA-C-N 118.832 0.742 . . . . 10.0 110.522 176.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 94.0 mt -58.54 -51.69 68.82 Favored 'General case' 0 C--O 1.222 -0.389 0 N-CA-C 113.168 0.803 . . . . 10.0 113.168 175.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . 0.424 ' HD2' ' HA ' ' A' ' 153' ' ' PHE . 35.6 ttp180 -47.72 -47.83 29.84 Favored 'General case' 0 C--O 1.224 -0.244 0 C-N-CA 126.889 2.075 . . . . 10.0 111.041 174.448 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 63.7 m-20 -58.51 -58.33 9.02 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 122.817 0.447 . . . . 10.0 111.25 174.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 53.7 t -52.09 -47.19 43.58 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 C-N-CA 124.05 0.94 . . . . 10.0 112.301 179.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 30.2 m -58.27 -65.31 0.67 Allowed 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 128.041 2.536 . . . . 10.0 111.283 177.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 55.8 t -49.66 -49.12 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 C-N-CA 124.859 1.263 . . . . 10.0 111.429 -178.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 72.0 t -58.88 -61.75 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 123.909 0.884 . . . . 10.0 112.164 177.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 85.8 mt -55.11 -46.82 75.6 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 119.251 0.932 . . . . 10.0 112.002 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 9.6 m95 -53.13 -47.12 68.94 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 125.174 1.39 . . . . 10.0 113.215 175.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 51.3 p -57.59 -32.87 67.62 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 113.753 1.02 . . . . 10.0 113.753 175.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -67.81 -45.5 74.57 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 113.708 1.003 . . . . 10.0 113.708 -179.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -44.29 -55.36 9.96 Favored Pre-proline 0 CA--C 1.55 0.979 0 N-CA-C 115.596 1.702 . . . . 10.0 115.596 -178.342 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -57.95 -38.06 93.64 Favored 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 122.874 2.383 . . . . 10.0 113.562 176.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 30.3 t -63.67 -53.66 41.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 124.679 1.192 . . . . 10.0 110.576 177.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 96.2 t -53.55 -49.68 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 124.819 1.248 . . . . 10.0 111.462 176.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 61.2 t90 -55.26 -52.78 62.3 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.261 1.024 . . . . 10.0 112.511 175.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 9.5 tt -57.98 -43.69 86.68 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 123.898 0.879 . . . . 10.0 112.628 -176.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 15.3 pt -83.81 -5.59 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 N-CA-C 114.986 1.476 . . . . 10.0 114.986 -179.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.18 -169.33 33.3 Favored Glycine 0 N--CA 1.451 -0.363 0 CA-C-O 122.587 1.104 . . . . 10.0 113.966 -169.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 23.3 t -53.13 -41.45 65.09 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 114.159 -1.021 . . . . 10.0 111.879 177.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -66.83 -17.24 64.79 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 115.627 1.714 . . . . 10.0 115.627 -175.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -131.38 -105.79 1.05 Allowed Glycine 0 CA--C 1.533 1.169 0 CA-C-N 120.402 1.455 . . . . 10.0 113.911 -172.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -89.45 127.15 35.81 Favored 'General case' 0 C--N 1.329 -0.306 0 O-C-N 120.659 -1.495 . . . . 10.0 109.349 168.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -72.47 65.34 1.36 Allowed Glycine 0 CA--C 1.532 1.124 0 N-CA-C 113.906 0.322 . . . . 10.0 113.906 173.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 60.5 mt -79.51 -42.78 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 126.086 1.754 . . . . 10.0 108.764 166.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 79.8 t -126.31 133.34 24.87 Favored Pre-proline 0 N--CA 1.454 -0.264 0 C-N-CA 126.502 1.921 . . . . 10.0 109.401 -174.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -68.74 153.75 72.56 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 123.793 2.996 . . . . 10.0 111.491 -176.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 12.2 tp -43.13 -39.75 2.94 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.329 1.052 . . . . 10.0 112.227 171.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -48.37 -52.39 21.96 Favored 'General case' 0 CA--C 1.539 0.519 0 N-CA-C 114.673 1.361 . . . . 10.0 114.673 176.022 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 14.0 mm -75.91 -40.49 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 124.378 1.071 . . . . 10.0 109.647 177.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -49.32 -49.78 42.5 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 118.575 0.625 . . . . 10.0 111.956 173.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 16.1 m -57.72 -47.05 83.49 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 126.04 1.736 . . . . 10.0 112.974 174.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -63.35 -52.33 62.22 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.968 0.907 . . . . 10.0 112.061 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 93.2 mt -52.54 -58.82 5.57 Favored 'General case' 0 C--O 1.228 -0.077 0 C-N-CA 124.293 1.037 . . . . 10.0 110.003 176.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -53.97 -43.78 70.2 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 117.704 -1.141 . . . . 10.0 112.876 176.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 4.6 tmm? -53.96 -52.57 60.25 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 120.285 1.402 . . . . 10.0 112.237 174.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 78.3 t -61.45 -47.89 91.32 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 125.183 1.393 . . . . 10.0 111.897 178.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 5.1 mp -57.42 -49.54 75.9 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.025 1.33 . . . . 10.0 111.404 175.038 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -59.14 -56.83 17.12 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.697 1.199 . . . . 10.0 111.588 176.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 34.3 m -54.62 -39.66 47.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 CA-C-N 121.89 2.132 . . . . 10.0 112.377 178.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 19.8 m -58.46 -52.64 64.76 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.216 1.006 . . . . 10.0 112.133 171.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -71.91 -18.8 62.0 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 125.549 1.54 . . . . 10.0 114.984 -179.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -95.59 -79.8 0.43 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.575 1.55 . . . . 10.0 109.506 177.099 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 8.0 p -77.06 -42.71 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 O-C-N 121.214 -0.929 . . . . 10.0 112.192 -174.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -54.07 -57.23 17.43 Favored Glycine 0 CA--C 1.537 1.467 0 CA-C-N 119.944 1.247 . . . . 10.0 113.269 176.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -46.64 -56.25 6.4 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.717 2.007 . . . . 10.0 112.201 168.093 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -55.82 -38.59 74.25 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 123.817 0.722 . . . . 10.0 113.696 179.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 24.5 mt -70.64 -27.38 64.01 Favored 'General case' 0 CA--C 1.512 -0.504 0 N-CA-C 115.694 1.739 . . . . 10.0 115.694 176.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 74.4 mt -63.52 -57.51 11.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 108.561 -0.903 . . . . 10.0 108.561 165.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 32.1 tp -58.85 -64.6 0.88 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.893 0.877 . . . . 10.0 113.213 -172.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 84.2 mt -71.58 5.17 2.55 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 115.295 1.591 . . . . 10.0 115.295 -171.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.6 mtp-105 -112.31 0.34 15.68 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.172 0.989 . . . . 10.0 113.238 172.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 8.8 t -108.0 177.94 4.66 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 124.116 0.966 . . . . 10.0 111.046 174.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . 0.462 ' HD3' ' CD ' ' A' ' 166' ' ' GLU . 41.7 ttt180 -71.62 98.16 1.85 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.732 0.813 . . . . 10.0 110.973 170.623 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -80.86 76.99 7.78 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.874 0.87 . . . . 10.0 112.08 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 40.21 102.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 128.831 2.852 . . . . 10.0 116.474 177.672 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . 0.482 0.3 OUTLIER 71.82 -55.43 0.66 Allowed 'General case' 0 C--O 1.241 0.647 0 C-N-CA 124.749 1.22 . . . . 10.0 110.656 -175.288 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -68.29 169.47 40.06 Favored Glycine 0 C--O 1.239 0.417 0 C-N-CA 129.73 3.538 . . . . 10.0 119.666 171.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.461 0 C-N-CA 128.491 2.716 . . . . 10.0 113.461 166.583 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 999' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A 1000 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A 1001 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A 1002 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A 1003 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 N--CA 1.477 0.893 0 CA-C-O 115.781 -2.057 . . . . 10.0 105.88 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 23.28 91.89 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 129.62 3.168 . . . . 10.0 117.262 160.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 28.6 65.12 0.11 Allowed 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 128.302 2.641 . . . . 10.0 114.479 155.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 86.7 mt -56.46 137.95 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 126.407 1.883 . . . . 10.0 113.34 -158.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.5 t -136.74 -165.21 1.7 Allowed 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 126.345 1.858 . . . . 10.0 114.01 -174.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 69.97 2.84 40.9 Favored Glycine 0 C--N 1.34 0.793 0 C-N-CA 127.49 2.471 . . . . 10.0 111.496 168.049 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.8 tpp180 -158.59 -51.27 0.01 OUTLIER Pre-proline 0 N--CA 1.443 -0.822 0 CA-C-O 114.301 -2.761 . . . . 10.0 116.694 -168.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -63.97 -60.7 0.14 Allowed 'Trans proline' 0 N--CA 1.465 -0.169 0 CA-C-N 123.559 2.307 . . . . 10.0 113.2 -175.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 7.9 pm0 -67.16 4.27 0.96 Allowed 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 127.87 2.468 . . . . 10.0 115.787 179.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.422 ' CG ' ' N ' ' A' ' 11' ' ' ILE . 11.0 p-90 -51.31 -43.13 61.61 Favored 'General case' 0 C--O 1.222 -0.361 0 O-C-N 121.489 -0.757 . . . . 10.0 112.643 176.418 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.422 ' N ' ' CG ' ' A' ' 10' ' ' TRP . 8.9 tt -60.86 -49.61 83.92 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.338 0 C-N-CA 123.887 0.875 . . . . 10.0 109.316 179.416 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 2.6 m95 -55.38 -52.67 62.8 Favored 'General case' 0 C--O 1.223 -0.312 0 C-N-CA 123.455 0.702 . . . . 10.0 111.872 175.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.7 mt -57.35 -53.62 56.06 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.184 0.594 . . . . 10.0 112.213 177.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.86 -46.83 51.83 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.418 1.487 . . . . 10.0 113.288 173.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 13.3 tp -65.62 -45.0 84.77 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.312 1.445 . . . . 10.0 113.045 179.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.79 -56.29 12.15 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 124.506 1.051 . . . . 10.0 111.622 166.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 22.5 m -49.46 -52.63 27.77 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.981 1.312 . . . . 10.0 112.408 174.254 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.45 -58.84 5.88 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.109 0.964 . . . . 10.0 112.196 177.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 95.0 mt -57.52 -48.51 79.09 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.566 0.746 . . . . 10.0 112.729 -179.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 56.4 mtt -58.7 -47.17 85.45 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.345 1.058 . . . . 10.0 111.403 177.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -58.45 -58.51 14.21 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 124.356 0.979 . . . . 10.0 113.901 173.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 81.0 mt -56.19 -45.96 79.59 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-N 118.691 1.246 . . . . 10.0 112.116 176.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.75 -41.86 76.46 Favored Glycine 0 CA--C 1.533 1.214 0 C-N-CA 124.752 1.167 . . . . 10.0 113.172 173.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 28.4 m -62.29 -58.54 7.35 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.778 0.831 . . . . 10.0 111.425 171.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -52.3 -40.92 62.46 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.99 0.916 . . . . 10.0 110.962 177.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -55.82 -58.01 9.63 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.586 1.154 . . . . 10.0 112.974 172.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.1 m-30 -59.62 -38.73 82.09 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 113.184 0.809 . . . . 10.0 113.184 178.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.468 ' C ' ' H ' ' A' ' 30' ' ' LYS . 11.8 mt -56.15 -67.44 0.3 Allowed 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.621 1.168 . . . . 10.0 113.585 169.171 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 t -76.38 40.97 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-O 123.79 1.757 . . . . 10.0 110.846 179.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.468 ' H ' ' C ' ' A' ' 28' ' ' LEU . 42.9 tttm -140.87 -44.87 0.39 Allowed 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 127.9 2.48 . . . . 10.0 109.32 171.173 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.91 23.07 0.87 Allowed Glycine 0 CA--C 1.528 0.898 0 N-CA-C 115.649 1.019 . . . . 10.0 115.649 173.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 37.3 mmm -59.47 -45.03 92.8 Favored 'General case' 0 C--O 1.225 -0.228 0 C-N-CA 127.188 2.195 . . . . 10.0 113.562 -179.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.71 -84.38 1.19 Allowed Glycine 0 CA--C 1.531 1.045 0 C-N-CA 123.743 0.687 . . . . 10.0 112.47 -170.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.8 t 32.99 88.76 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.242 0.706 0 C-N-CA 128.365 2.666 . . . . 10.0 116.96 166.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 28.5 m -79.6 -50.85 10.07 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.132 -1.394 . . . . 10.0 113.93 174.101 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -48.97 117.53 6.49 Favored Pre-proline 0 CA--C 1.536 0.418 0 O-C-N 124.815 1.322 . . . . 10.0 110.95 -172.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -58.53 -29.66 89.5 Favored 'Trans proline' 0 N--CA 1.459 -0.5 0 C-N-CA 123.695 2.93 . . . . 10.0 113.74 179.095 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.29 -60.64 2.31 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.142 0.577 . . . . 10.0 111.439 176.208 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.21 -40.08 23.19 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 125.065 1.346 . . . . 10.0 113.551 171.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -46.52 -47.39 19.5 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.241 1.416 . . . . 10.0 113.444 172.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -57.79 -53.05 62.58 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.507 0.723 . . . . 10.0 110.958 176.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -57.03 -50.15 73.6 Favored 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 123.075 0.55 . . . . 10.0 112.348 -179.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -54.4 -51.29 65.35 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 118.921 -0.561 . . . . 10.0 112.377 173.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.38 -62.04 1.9 Allowed 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 113.38 0.881 . . . . 10.0 113.38 177.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.5 mt -48.42 -57.98 1.29 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 124.918 1.287 . . . . 10.0 110.323 178.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.2 m -68.42 -17.57 64.24 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.195 1.398 . . . . 10.0 113.819 -172.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 27.9 m -87.59 -40.3 14.35 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-N 119.511 1.05 . . . . 10.0 112.196 174.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 22.3 mt -58.76 -43.68 90.4 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 121.48 -0.762 . . . . 10.0 112.272 171.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 19.3 t -38.88 -66.13 0.34 Allowed Pre-proline 0 CA--C 1.552 1.032 0 C-N-CA 125.922 1.689 . . . . 10.0 112.861 175.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -69.76 -23.44 30.79 Favored 'Trans proline' 0 CA--C 1.546 1.082 0 C-N-CA 123.042 2.495 . . . . 10.0 114.66 176.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.27 -45.42 80.54 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 120.564 1.529 . . . . 10.0 113.357 175.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 32.6 mm -58.51 -46.1 89.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 O-C-N 121.072 -1.018 . . . . 10.0 109.569 169.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -51.96 -51.28 58.18 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.642 1.177 . . . . 10.0 112.127 176.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -50.37 -58.3 6.0 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 126.045 1.738 . . . . 10.0 112.321 173.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.3 m -49.17 -52.88 23.84 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 125.139 1.376 . . . . 10.0 110.755 178.093 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 33.0 mmt -69.38 -48.59 60.7 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 124.165 0.986 . . . . 10.0 112.735 -176.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -57.18 -39.58 75.64 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-O 116.766 -1.588 . . . . 10.0 113.266 173.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.8 tp -53.29 -54.53 34.98 Favored 'General case' 0 C--O 1.224 -0.238 0 CA-C-N 120.482 1.492 . . . . 10.0 111.313 169.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 24.1 p -51.69 -41.11 61.19 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 115.178 1.547 . . . . 10.0 115.178 179.019 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 59.7 mtm -66.8 -50.88 61.23 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 123.56 0.744 . . . . 10.0 110.534 176.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.3 tp -48.58 -52.66 21.75 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.826 0.851 . . . . 10.0 112.94 172.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.4 mt -76.88 -5.62 49.15 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.349 1.06 . . . . 10.0 113.828 -177.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.35 -34.74 5.52 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 115.504 0.962 . . . . 10.0 115.504 174.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -49.24 -43.13 42.49 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 115.208 1.559 . . . . 10.0 115.208 -175.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.1 3.65 60.96 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 115.377 0.911 . . . . 10.0 115.377 -178.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.33 143.47 26.36 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 126.993 2.117 . . . . 10.0 108.992 172.018 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 t -145.54 171.09 15.18 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 124.046 0.938 . . . . 10.0 111.06 166.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.02 136.11 53.33 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 123.833 0.853 . . . . 10.0 109.728 179.556 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 58.6 t -129.59 129.62 23.18 Favored Pre-proline 0 C--N 1.329 -0.299 0 C-N-CA 125.034 1.333 . . . . 10.0 110.909 -176.018 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -80.78 116.23 3.15 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 N-CA-C 109.445 -1.021 . . . . 10.0 109.445 -178.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -156.68 164.44 38.15 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.858 0.688 . . . . 10.0 112.858 172.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.34 -82.01 0.14 Allowed Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.636 -0.986 . . . . 10.0 110.636 175.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.73 -3.29 0.7 Allowed Glycine 0 CA--C 1.527 0.818 0 N-CA-C 118.706 2.242 . . . . 10.0 118.706 170.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -151.64 -171.95 4.08 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 119.353 1.577 . . . . 10.0 112.247 -165.159 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -91.79 93.85 9.06 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 125.517 1.527 . . . . 10.0 111.137 -175.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 60.1 m-80 -89.41 120.8 69.69 Favored Pre-proline 0 N--CA 1.45 -0.427 0 N-CA-C 112.97 0.73 . . . . 10.0 112.97 -165.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -61.53 131.91 38.15 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 124.219 3.279 . . . . 10.0 112.137 171.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.4 mm -140.15 126.35 21.85 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 C-N-CA 125.971 1.708 . . . . 10.0 111.684 -179.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -93.67 85.11 4.76 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 123.338 1.542 . . . . 10.0 113.026 174.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 63.8 p-90 -59.41 -28.27 66.78 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 120.619 -1.301 . . . . 10.0 113.891 174.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -54.81 -36.33 64.86 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 114.976 1.473 . . . . 10.0 114.976 178.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.4 ' HD3' ' CH2' ' A' ' 86' ' ' TRP . 0.5 OUTLIER -59.8 -35.87 75.57 Favored 'General case' 0 N--CA 1.476 0.835 0 O-C-N 120.543 -1.348 . . . . 10.0 112.168 172.103 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -66.75 -42.88 85.48 Favored 'General case' 0 CA--C 1.545 0.758 0 O-C-N 121.071 -1.018 . . . . 10.0 112.987 173.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -50.46 -48.88 56.41 Favored 'General case' 0 CA--C 1.558 1.252 0 C-N-CA 125.624 1.569 . . . . 10.0 111.513 167.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -58.61 -63.11 1.4 Allowed 'General case' 0 N--CA 1.485 1.292 0 CA-C-N 119.54 1.064 . . . . 10.0 112.465 171.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' TRP . . . . . 0.4 ' CH2' ' HD3' ' A' ' 82' ' ' ARG . 47.4 m0 -50.27 -39.42 45.09 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 126.87 2.068 . . . . 10.0 112.063 -175.075 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 32.4 tp -48.85 -48.59 41.81 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 126.434 1.893 . . . . 10.0 112.377 177.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -94.19 -46.48 7.07 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.904 0.881 . . . . 10.0 112.677 -176.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 4.7 t -62.2 -42.73 99.56 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 113.667 0.988 . . . . 10.0 113.667 -174.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . 0.308 74.5 p -63.49 -43.73 79.55 Favored Pre-proline 0 N--CA 1.473 0.697 0 O-C-N 120.977 -1.077 . . . . 10.0 112.935 -178.292 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -52.87 -44.63 46.8 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 122.912 2.408 . . . . 10.0 115.746 165.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 54.1 mt -59.84 -47.4 85.87 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 119.329 0.968 . . . . 10.0 111.714 176.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 6.1 tt -50.71 -48.95 58.6 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 126.302 1.841 . . . . 10.0 111.292 171.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.9 mp -57.46 -47.68 81.22 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.543 1.137 . . . . 10.0 113.19 169.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.77 -38.24 78.06 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 123.783 0.833 . . . . 10.0 112.925 178.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -52.32 -54.08 36.18 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 119.251 0.932 . . . . 10.0 111.15 169.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.36 -42.03 88.64 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.67 0.788 . . . . 10.0 112.094 -178.483 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.76 -54.75 37.88 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 124.0 0.92 . . . . 10.0 111.974 173.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.25 -41.16 79.11 Favored 'General case' 0 C--O 1.224 -0.237 0 C-N-CA 123.741 0.817 . . . . 10.0 112.731 174.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.9 tp -63.77 -38.58 91.65 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 114.445 1.276 . . . . 10.0 114.445 -179.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.2 t -94.85 1.49 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 124.998 1.319 . . . . 10.0 112.318 179.177 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.2 t70 48.63 53.41 12.26 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.811 1.644 . . . . 10.0 112.117 -174.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.28 145.89 47.58 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 120.017 -1.677 . . . . 10.0 112.458 -174.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.49 135.86 54.26 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 112.775 0.658 . . . . 10.0 112.775 175.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -42.82 -39.66 2.58 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.88 1.672 . . . . 10.0 113.474 175.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -47.34 -60.25 5.31 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 125.18 1.371 . . . . 10.0 115.245 169.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.0 p -61.96 -46.79 87.72 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-O 117.155 -1.402 . . . . 10.0 111.358 178.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 67.1 mt -48.49 -52.9 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 125.033 1.333 . . . . 10.0 111.115 178.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.2 tp -62.62 -51.27 67.93 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 112.549 0.574 . . . . 10.0 112.549 179.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.21 -44.84 43.62 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.465 0.706 . . . . 10.0 110.953 174.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.6 -59.91 4.69 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 127.435 2.294 . . . . 10.0 114.794 174.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.7 t -61.02 -46.31 96.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 123.743 0.817 . . . . 10.0 111.393 -178.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -56.66 -50.31 64.09 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 123.686 0.66 . . . . 10.0 112.656 174.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -55.07 -46.27 75.39 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 113.427 0.899 . . . . 10.0 113.427 173.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 53.7 t0 -58.26 -45.38 87.93 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.68 0.792 . . . . 10.0 111.679 174.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -43.31 -56.12 4.84 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 125.332 1.444 . . . . 10.0 113.322 167.062 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 82.5 mt -57.08 -55.32 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 123.811 0.844 . . . . 10.0 110.367 173.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 16.1 tmm? -48.34 -58.09 5.09 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.09 1.356 . . . . 10.0 112.785 -176.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 48.7 mm -69.72 -44.93 78.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 O-C-N 121.662 -0.648 . . . . 10.0 112.594 177.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -54.14 -45.54 72.85 Favored Glycine 0 CA--C 1.532 1.138 0 CA-C-N 119.221 0.919 . . . . 10.0 112.992 176.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 28.3 m -60.54 -45.23 94.63 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.907 1.683 . . . . 10.0 111.209 173.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -47.08 -52.37 12.44 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 124.229 0.919 . . . . 10.0 113.219 165.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.4 tt -54.26 -46.83 72.73 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 127.936 2.494 . . . . 10.0 111.472 177.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 48.6 t -61.9 -49.28 84.82 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 125.433 1.493 . . . . 10.0 111.985 171.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -52.89 -59.21 9.63 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 125.875 1.702 . . . . 10.0 112.4 175.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -42.06 -43.07 3.1 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 128.439 2.696 . . . . 10.0 113.174 175.205 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 48.3 mt -101.34 -6.53 23.97 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 115.547 1.684 . . . . 10.0 115.547 -174.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 16.9 m -69.75 116.75 10.5 Favored 'General case' 0 N--CA 1.464 0.248 0 O-C-N 120.19 -1.569 . . . . 10.0 110.366 -178.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.552 ' HD3' ' H ' ' A' ' 129' ' ' LYS . 0.1 OUTLIER -55.41 -49.67 71.78 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 128.248 2.619 . . . . 10.0 113.288 177.734 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 60.8 t -69.66 106.39 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 123.738 0.815 . . . . 10.0 110.087 179.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -46.95 -59.47 3.08 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 124.742 1.217 . . . . 10.0 114.065 -173.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 m -46.55 -42.08 15.3 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.489 1.516 . . . . 10.0 113.468 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -70.14 -24.6 63.19 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 114.959 1.466 . . . . 10.0 114.959 -178.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 69.0 mtp85 -53.94 -41.6 67.93 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 118.92 0.782 . . . . 10.0 110.787 176.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -70.11 -31.09 68.47 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 114.421 1.267 . . . . 10.0 114.421 176.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.8 t -55.49 -52.43 46.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 CA-C-N 118.989 0.813 . . . . 10.0 109.613 168.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 63.6 m95 -60.28 -44.16 95.6 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 113.914 1.079 . . . . 10.0 113.914 173.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 88.8 t90 -52.02 -49.39 63.47 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 119.469 1.032 . . . . 10.0 112.909 171.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -57.47 -52.99 63.16 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.166 0.987 . . . . 10.0 111.76 178.228 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 97.7 mt -54.03 -50.62 52.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 125.173 1.389 . . . . 10.0 111.493 175.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 16.0 m -53.93 -48.43 70.22 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.65 1.18 . . . . 10.0 111.692 174.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 60.8 m -63.1 -44.16 96.46 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.293 1.437 . . . . 10.0 111.716 -179.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -56.94 -50.65 71.94 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.175 0.99 . . . . 10.0 112.242 170.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -56.14 -46.33 79.29 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.859 0.864 . . . . 10.0 112.452 174.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 40.3 ttp -57.0 -53.14 61.38 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.472 1.109 . . . . 10.0 111.966 172.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 63.4 tp -52.7 -47.14 67.48 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.225 1.41 . . . . 10.0 111.858 178.284 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 77.3 t80 -50.81 -54.75 21.01 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.972 0.909 . . . . 10.0 112.587 171.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 41.5 mm -52.26 -55.89 8.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 CA-C-N 118.884 0.765 . . . . 10.0 110.35 176.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 43.0 mt -58.8 -35.15 72.38 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 118.511 -0.757 . . . . 10.0 111.761 -177.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -57.21 -58.24 9.09 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 124.018 0.927 . . . . 10.0 113.046 173.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.41 -40.88 85.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 CA-C-O 118.304 -0.855 . . . . 10.0 111.461 177.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 45.3 mt -56.78 -49.39 75.45 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.895 1.225 . . . . 10.0 112.139 171.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.423 ' HA ' ' HD2' ' A' ' 175' ' ' ARG . 11.9 t80 -77.04 -70.28 0.47 Allowed 'General case' 0 C--N 1.326 -0.435 0 O-C-N 120.083 -1.636 . . . . 10.0 112.877 -175.236 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -73.73 -21.92 60.06 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.559 1.144 . . . . 10.0 113.459 -174.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -87.78 -79.15 1.26 Allowed Glycine 0 CA--C 1.526 0.747 0 C-N-CA 123.651 0.643 . . . . 10.0 113.502 171.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -53.57 -32.44 50.92 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 126.301 1.841 . . . . 10.0 113.067 -166.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.4 m -52.15 -56.42 14.69 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 114.003 1.112 . . . . 10.0 114.003 172.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.3 p -53.69 -50.57 65.57 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 122.05 0.929 . . . . 10.0 112.269 -177.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 47.6 tttm -57.09 -46.06 82.85 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.136 0.975 . . . . 10.0 112.127 173.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.79 -47.52 80.01 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 114.513 1.301 . . . . 10.0 114.513 174.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -56.44 -11.33 1.21 Allowed 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.066 1.746 . . . . 10.0 114.235 177.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.2 m -107.08 6.69 29.15 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.382 1.873 . . . . 10.0 114.885 -179.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 93.2 mmm -91.89 -92.7 0.15 Allowed 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 123.509 1.623 . . . . 10.0 114.146 -170.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -138.69 153.91 72.66 Favored Pre-proline 0 C--O 1.236 0.367 0 C-N-CA 129.767 3.227 . . . . 10.0 105.541 170.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -52.77 -46.24 34.94 Favored 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 122.352 2.035 . . . . 10.0 113.082 179.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . 0.462 ' CD ' ' HD3' ' A' ' 227' ' ' ARG . 0.1 OUTLIER -52.94 -46.12 68.0 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 129.04 2.936 . . . . 10.0 113.292 173.569 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 92.2 t -69.19 -53.01 27.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 C-N-CA 124.034 0.933 . . . . 10.0 109.765 -178.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.19 -46.76 75.85 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.274 0.63 . . . . 10.0 111.928 177.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 60.4 p -60.03 -56.22 24.4 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.933 0.893 . . . . 10.0 112.699 174.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 61.4 m -57.17 -53.2 60.78 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.169 0.988 . . . . 10.0 113.05 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -49.55 -49.49 46.05 Favored 'General case' 0 C--O 1.222 -0.386 0 C-N-CA 123.305 0.642 . . . . 10.0 111.131 174.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -57.17 -48.42 78.77 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 114.639 1.348 . . . . 10.0 114.639 -179.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 40.4 t -55.95 -49.61 74.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 CA-C-N 118.787 0.721 . . . . 10.0 110.506 176.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 94.0 mt -58.55 -51.61 69.17 Favored 'General case' 0 C--O 1.221 -0.397 0 N-CA-C 113.207 0.818 . . . . 10.0 113.207 175.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . 0.423 ' HD2' ' HA ' ' A' ' 153' ' ' PHE . 35.7 ttp180 -47.83 -47.74 31.15 Favored 'General case' 0 C--O 1.224 -0.246 0 C-N-CA 126.818 2.047 . . . . 10.0 111.047 174.456 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 63.7 m-20 -58.53 -58.3 9.16 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 122.785 0.434 . . . . 10.0 111.252 174.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 59.4 t -51.72 -49.79 34.04 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 C-N-CA 124.078 0.951 . . . . 10.0 111.193 179.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 30.3 m -57.01 -61.5 2.4 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 128.21 2.604 . . . . 10.0 112.435 178.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 55.2 t -52.15 -49.88 38.31 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 124.471 1.108 . . . . 10.0 110.944 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 80.4 t -59.71 -61.15 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 124.299 1.04 . . . . 10.0 112.007 177.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -57.35 -50.1 74.04 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 118.78 0.718 . . . . 10.0 112.388 -176.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 10.2 m95 -55.26 -48.85 73.4 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.627 0.771 . . . . 10.0 111.935 177.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 51.1 m -54.32 -31.42 54.17 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 114.014 1.116 . . . . 10.0 114.014 179.101 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -63.19 -40.32 97.17 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 113.808 1.04 . . . . 10.0 113.808 176.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -49.74 -55.28 24.29 Favored Pre-proline 0 CA--C 1.546 0.79 0 N-CA-C 115.281 1.585 . . . . 10.0 115.281 -175.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -57.5 -34.92 98.78 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 122.318 2.012 . . . . 10.0 113.286 176.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 21.7 t -64.74 -55.62 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 124.228 1.011 . . . . 10.0 110.554 176.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 93.2 t -53.09 -49.88 48.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 124.995 1.318 . . . . 10.0 111.558 177.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 63.2 t90 -56.32 -52.69 63.62 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.403 1.081 . . . . 10.0 112.598 175.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 9.6 tt -57.83 -42.77 85.07 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 123.665 0.786 . . . . 10.0 112.369 -177.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 14.5 pt -83.74 -5.93 9.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 N-CA-C 115.085 1.513 . . . . 10.0 115.085 179.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.38 -169.32 33.02 Favored Glycine 0 N--CA 1.45 -0.404 0 CA-C-O 122.55 1.083 . . . . 10.0 113.925 -168.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 23.3 t -53.16 -41.43 65.16 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 114.17 -1.015 . . . . 10.0 111.854 177.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -67.98 -16.05 63.88 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 115.626 1.713 . . . . 10.0 115.626 -175.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -131.11 -106.04 1.08 Allowed Glycine 0 CA--C 1.533 1.157 0 CA-C-N 120.4 1.455 . . . . 10.0 113.908 -173.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -89.44 127.17 35.81 Favored 'General case' 0 C--N 1.328 -0.345 0 O-C-N 120.681 -1.482 . . . . 10.0 109.304 168.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -72.56 65.37 1.39 Allowed Glycine 0 CA--C 1.532 1.141 0 N-CA-C 113.871 0.308 . . . . 10.0 113.871 173.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 60.6 mt -79.54 -42.76 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 126.078 1.751 . . . . 10.0 108.759 166.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 79.7 t -126.31 133.37 24.9 Favored Pre-proline 0 N--CA 1.454 -0.25 0 C-N-CA 126.436 1.894 . . . . 10.0 109.351 -174.176 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -68.71 153.81 72.49 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 123.745 2.963 . . . . 10.0 111.479 -176.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 12.2 tp -43.18 -39.79 3.04 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.341 1.056 . . . . 10.0 112.169 171.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -48.38 -52.39 22.04 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 114.653 1.353 . . . . 10.0 114.653 176.086 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 14.0 mm -75.9 -40.51 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 C-N-CA 124.453 1.101 . . . . 10.0 109.646 177.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -49.27 -49.78 41.98 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 118.592 0.633 . . . . 10.0 111.991 173.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 16.3 m -57.75 -47.03 83.65 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 126.015 1.726 . . . . 10.0 112.97 174.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -63.36 -52.28 62.39 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.923 0.889 . . . . 10.0 112.093 179.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 93.2 mt -52.57 -59.41 4.49 Favored 'General case' 0 C--N 1.335 -0.053 0 C-N-CA 124.362 1.065 . . . . 10.0 109.954 176.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -53.11 -47.06 68.91 Favored 'General case' 0 C--O 1.216 -0.66 0 CA-C-O 117.126 -1.416 . . . . 10.0 112.001 176.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 4.6 tmm? -50.99 -52.25 44.65 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 121.454 1.934 . . . . 10.0 113.168 174.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 79.4 t -60.14 -49.15 85.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 124.708 1.203 . . . . 10.0 111.263 178.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 4.3 mp -58.16 -51.61 68.99 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.631 1.573 . . . . 10.0 112.272 175.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -55.68 -58.27 8.51 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 127.824 2.45 . . . . 10.0 110.566 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 78.7 t -56.24 -44.9 80.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 O-C-N 121.48 -0.762 . . . . 10.0 111.764 177.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 24.2 t -55.25 -55.2 34.03 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.502 0.721 . . . . 10.0 112.022 174.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -63.76 -20.35 65.69 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 115.093 1.516 . . . . 10.0 115.093 177.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.01 -75.76 0.49 Allowed 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.325 1.45 . . . . 10.0 110.137 175.486 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 21.7 t -77.78 -47.95 24.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 126.126 1.77 . . . . 10.0 111.297 -170.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -55.97 -55.98 26.35 Favored Glycine 0 CA--C 1.534 1.246 0 CA-C-N 119.042 0.837 . . . . 10.0 112.695 178.127 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 61.1 t80 -44.3 -57.7 3.34 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.926 2.09 . . . . 10.0 112.166 166.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -55.17 -40.44 74.86 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 124.179 0.895 . . . . 10.0 114.265 177.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 24.2 mt -70.55 -27.33 64.06 Favored 'General case' 0 CA--C 1.512 -0.494 0 N-CA-C 115.528 1.677 . . . . 10.0 115.528 177.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 74.4 mt -63.27 -57.53 11.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 108.616 -0.883 . . . . 10.0 108.616 165.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 32.1 tp -58.89 -64.68 0.85 Allowed 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.95 0.9 . . . . 10.0 113.126 -172.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 84.3 mt -71.55 5.23 2.5 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 115.333 1.605 . . . . 10.0 115.333 -171.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.6 mtp-105 -112.35 0.39 15.66 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.168 0.987 . . . . 10.0 113.296 172.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 8.8 t -108.04 177.99 4.64 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 124.035 0.934 . . . . 10.0 111.002 174.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 227' ' ' ARG . . . . . 0.462 ' HD3' ' CD ' ' A' ' 166' ' ' GLU . 41.8 ttt180 -71.68 98.2 1.88 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.744 0.818 . . . . 10.0 110.953 170.673 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -80.88 76.98 7.8 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.896 0.879 . . . . 10.0 112.111 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 40.08 102.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 128.837 2.855 . . . . 10.0 116.492 177.788 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . 0.483 0.3 OUTLIER 71.92 -55.46 0.66 Allowed 'General case' 0 C--O 1.241 0.647 0 C-N-CA 124.692 1.197 . . . . 10.0 110.632 -175.346 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -68.26 169.47 39.92 Favored Glycine 0 C--O 1.238 0.376 0 C-N-CA 129.782 3.563 . . . . 10.0 119.621 171.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.461 0 C-N-CA 128.473 2.709 . . . . 10.0 113.457 166.611 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 999' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A 1000 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A 1001 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A 1002 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A 1003 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 N--CA 1.476 0.87 0 CA-C-O 115.807 -2.044 . . . . 10.0 105.858 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 23.41 91.8 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 129.598 3.159 . . . . 10.0 117.253 160.793 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 28.67 65.06 0.11 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 128.291 2.636 . . . . 10.0 114.474 155.415 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 86.7 mt -56.46 137.93 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 126.387 1.875 . . . . 10.0 113.376 -158.408 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.652 HG21 ' HB3' ' A' ' 77' ' ' PRO . 7.6 t -136.7 -165.22 1.7 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 126.324 1.85 . . . . 10.0 114.052 -174.353 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 70.01 2.83 41.23 Favored Glycine 0 C--N 1.34 0.786 0 C-N-CA 127.471 2.463 . . . . 10.0 111.485 168.021 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -158.56 -51.35 0.01 OUTLIER Pre-proline 0 N--CA 1.443 -0.823 0 CA-C-O 114.274 -2.774 . . . . 10.0 116.642 -168.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -63.95 -60.69 0.14 Allowed 'Trans proline' 0 N--CA 1.465 -0.202 0 CA-C-N 123.509 2.289 . . . . 10.0 113.21 -175.336 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.411 ' H ' ' CD ' ' A' ' 9' ' ' GLU . 7.9 pm0 -67.16 4.35 0.94 Allowed 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 127.836 2.454 . . . . 10.0 115.764 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.421 ' CG ' ' N ' ' A' ' 11' ' ' ILE . 11.1 p-90 -51.37 -43.14 61.78 Favored 'General case' 0 C--O 1.222 -0.361 0 O-C-N 121.516 -0.74 . . . . 10.0 112.564 176.439 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.421 ' N ' ' CG ' ' A' ' 10' ' ' TRP . 8.9 tt -60.87 -49.63 83.82 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.361 0 C-N-CA 123.926 0.89 . . . . 10.0 109.306 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' TRP . . . . . 0.535 ' CD2' HD23 ' A' ' 206' ' ' LEU . 2.6 m95 -55.38 -52.62 62.93 Favored 'General case' 0 C--O 1.224 -0.259 0 C-N-CA 123.433 0.693 . . . . 10.0 111.912 175.617 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.6 mt -57.38 -53.61 56.24 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.112 0.565 . . . . 10.0 112.222 177.209 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.84 -46.79 51.67 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.391 1.476 . . . . 10.0 113.33 173.81 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.574 ' HB3' ' HE2' ' A' ' 209' ' ' MET . 13.3 tp -65.62 -45.02 84.7 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 125.336 1.455 . . . . 10.0 113.047 179.086 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.45 -56.86 10.1 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 124.621 1.105 . . . . 10.0 111.407 165.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.2 m -49.51 -52.49 29.15 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.995 1.318 . . . . 10.0 112.242 174.817 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.41 -58.86 5.79 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.143 0.977 . . . . 10.0 112.176 177.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 95.3 mt -57.97 -49.34 77.16 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.678 0.791 . . . . 10.0 112.544 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 23.5 mmt -55.23 -51.04 67.86 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.587 0.755 . . . . 10.0 111.026 175.86 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -56.33 -58.53 13.82 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 124.441 1.019 . . . . 10.0 113.738 176.433 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 80.8 mt -56.21 -45.41 79.89 Favored 'General case' 0 C--O 1.221 -0.397 0 CA-C-N 118.593 1.196 . . . . 10.0 112.113 176.278 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.83 -42.05 77.8 Favored Glycine 0 CA--C 1.534 1.24 0 C-N-CA 124.814 1.197 . . . . 10.0 113.46 172.393 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 15.4 m -59.38 -61.61 2.5 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.457 1.103 . . . . 10.0 110.723 171.3 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -52.24 -40.96 62.37 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.039 0.936 . . . . 10.0 110.976 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -55.77 -58.08 9.32 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.611 1.165 . . . . 10.0 112.986 172.735 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -59.65 -38.61 81.89 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 113.255 0.835 . . . . 10.0 113.255 178.844 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.402 ' C ' ' H ' ' A' ' 30' ' ' LYS . 11.8 mt -56.19 -67.44 0.3 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.627 1.171 . . . . 10.0 113.597 169.118 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 t -76.37 40.98 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 CA-C-O 123.749 1.738 . . . . 10.0 110.879 179.074 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.402 ' H ' ' C ' ' A' ' 28' ' ' LEU . 42.9 tttm -140.87 -44.88 0.39 Allowed 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 127.87 2.468 . . . . 10.0 109.336 171.204 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.96 23.15 0.87 Allowed Glycine 0 CA--C 1.529 0.925 0 N-CA-C 115.629 1.012 . . . . 10.0 115.629 173.718 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 37.3 mmm -59.54 -44.97 93.06 Favored 'General case' 0 C--O 1.225 -0.235 0 C-N-CA 127.13 2.172 . . . . 10.0 113.63 -179.023 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.62 -84.43 1.18 Allowed Glycine 0 CA--C 1.531 1.045 0 C-N-CA 123.764 0.697 . . . . 10.0 112.508 -170.188 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.8 t 33.02 88.81 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.242 0.682 0 C-N-CA 128.358 2.663 . . . . 10.0 116.942 166.478 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.7 m -79.68 -50.85 10.01 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.167 -1.379 . . . . 10.0 113.877 174.15 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -48.91 117.47 6.37 Favored Pre-proline 0 CA--C 1.536 0.416 0 O-C-N 124.764 1.29 . . . . 10.0 110.949 -172.529 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -58.57 -29.65 89.61 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 123.726 2.951 . . . . 10.0 113.682 179.105 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.29 -60.64 2.3 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 123.107 0.563 . . . . 10.0 111.48 176.15 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.21 -40.02 23.0 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 125.097 1.359 . . . . 10.0 113.559 171.618 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.5 tttp -46.57 -47.44 19.76 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 125.243 1.417 . . . . 10.0 113.403 172.06 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -57.72 -53.08 62.26 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.473 0.709 . . . . 10.0 111.009 176.627 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.476 ' CD2' ' HB1' ' A' ' 228' ' ' ALA . 43.8 m-85 -56.95 -50.24 73.24 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 123.089 0.555 . . . . 10.0 112.34 -179.178 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -54.44 -51.25 65.55 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 118.916 -0.564 . . . . 10.0 112.342 173.315 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.38 -61.98 1.93 Allowed 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 113.399 0.888 . . . . 10.0 113.399 177.135 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.5 mt -48.86 -56.06 2.81 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 C-N-CA 124.912 1.285 . . . . 10.0 110.832 178.052 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.5 m -69.49 -20.34 63.73 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.861 1.264 . . . . 10.0 113.432 -172.485 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 28.1 m -84.4 -38.82 19.78 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.404 1.081 . . . . 10.0 112.28 174.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 19.1 mt -59.33 -41.4 89.06 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 117.873 -1.061 . . . . 10.0 112.803 174.218 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.686 HG23 ' HD3' ' A' ' 50' ' ' PRO 0.405 33.0 m -58.49 -49.56 92.85 Favored Pre-proline 0 N--CA 1.486 1.36 0 CA-C-N 121.082 1.765 . . . . 10.0 114.707 -178.915 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.686 ' HD3' HG23 ' A' ' 49' ' ' VAL . 89.3 Cg_exo -49.82 -45.32 32.66 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 123.587 2.858 . . . . 10.0 115.107 162.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.6 -46.79 84.2 Favored 'General case' 0 CA--C 1.548 0.892 0 CA-C-N 119.82 1.191 . . . . 10.0 113.704 -179.335 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 30.9 mm -53.22 -55.48 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 124.989 1.316 . . . . 10.0 109.595 169.667 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.65 -44.85 77.56 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.124 0.969 . . . . 10.0 113.567 177.831 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 50.2 t80 -52.59 -56.78 12.92 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.28 1.432 . . . . 10.0 111.871 172.634 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 14.4 m -49.92 -52.58 32.12 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.304 1.441 . . . . 10.0 110.658 177.825 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 32.6 mmt -69.23 -48.13 62.77 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 123.965 0.906 . . . . 10.0 113.05 -176.658 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -54.69 -42.55 71.55 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 120.17 1.35 . . . . 10.0 113.213 172.18 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.7 tp -53.33 -54.54 35.03 Favored 'General case' 0 C--O 1.224 -0.272 0 CA-C-N 119.406 1.003 . . . . 10.0 111.292 171.414 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 23.9 p -51.6 -41.08 60.95 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 115.239 1.57 . . . . 10.0 115.239 178.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 58.4 mtm -66.86 -50.88 61.09 Favored 'General case' 0 C--N 1.334 -0.09 0 C-N-CA 123.597 0.759 . . . . 10.0 110.477 176.872 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.5 tp -48.58 -52.65 21.79 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.859 0.863 . . . . 10.0 112.95 172.341 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.5 mt -76.94 -5.58 49.12 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.318 1.047 . . . . 10.0 113.805 -177.693 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.28 -34.7 5.56 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 115.504 0.962 . . . . 10.0 115.504 174.103 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -49.27 -43.04 42.75 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 115.278 1.584 . . . . 10.0 115.278 -176.038 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.05 3.52 61.2 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 115.388 0.915 . . . . 10.0 115.388 -179.07 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.23 143.4 26.45 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 127.016 2.126 . . . . 10.0 109.02 171.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 t -145.51 171.16 15.06 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 123.995 0.918 . . . . 10.0 111.013 166.754 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.02 136.05 53.39 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 123.897 0.879 . . . . 10.0 109.675 179.627 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.436 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 58.7 t -129.56 129.61 23.19 Favored Pre-proline 0 C--N 1.329 -0.295 0 C-N-CA 125.069 1.348 . . . . 10.0 110.969 -176.095 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 69' ' ' VAL . 6.3 Cg_exo -80.81 116.23 3.15 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 N-CA-C 109.367 -1.051 . . . . 10.0 109.367 -178.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -156.68 164.37 38.22 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 112.862 0.69 . . . . 10.0 112.862 172.483 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.36 -81.95 0.14 Allowed Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.68 -0.968 . . . . 10.0 110.68 175.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.76 -3.31 0.7 Allowed Glycine 0 CA--C 1.527 0.822 0 N-CA-C 118.684 2.234 . . . . 10.0 118.684 170.395 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -151.64 -171.89 4.06 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 119.327 1.564 . . . . 10.0 112.221 -165.165 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -91.89 93.95 9.06 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 125.456 1.502 . . . . 10.0 111.091 -175.287 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.449 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 60.2 m-80 -89.5 120.74 69.63 Favored Pre-proline 0 N--CA 1.45 -0.429 0 N-CA-C 112.953 0.723 . . . . 10.0 112.953 -165.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.652 ' HB3' HG21 ' A' ' 5' ' ' THR . 76.3 Cg_exo -61.47 131.93 38.36 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 124.171 3.247 . . . . 10.0 112.159 171.572 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.4 mm -140.16 126.3 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 C-N-CA 125.99 1.716 . . . . 10.0 111.701 -179.494 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -93.58 85.0 4.76 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 122.967 1.365 . . . . 10.0 113.08 174.619 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 63.7 p-90 -59.33 -28.28 66.68 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 120.858 -1.151 . . . . 10.0 113.96 174.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -54.14 -27.48 33.77 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 124.273 1.029 . . . . 10.0 112.2 178.288 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 21.4 mtt-85 -54.62 -50.21 68.65 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.92 1.288 . . . . 10.0 112.78 168.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -67.44 -39.86 85.42 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 121.409 -0.807 . . . . 10.0 112.114 178.32 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -52.54 -50.65 62.45 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 123.787 0.835 . . . . 10.0 112.135 170.565 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 54.0 t0 -52.54 -69.12 0.12 Allowed 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 126.079 1.751 . . . . 10.0 111.325 170.335 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 50.4 m0 -55.48 -35.23 65.3 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 125.821 1.648 . . . . 10.0 113.004 -171.486 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 25.5 tp -49.58 -43.41 46.17 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 126.408 1.883 . . . . 10.0 112.174 177.597 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -101.27 -38.5 8.05 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.833 0.853 . . . . 10.0 112.281 179.315 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 1.6 m -51.15 -55.02 20.0 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.88 1.272 . . . . 10.0 113.468 175.014 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . 0.263 44.9 p -68.12 -40.58 22.39 Favored Pre-proline 0 N--CA 1.476 0.855 0 N-CA-C 114.63 1.344 . . . . 10.0 114.63 -171.161 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -56.75 -43.04 58.45 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 123.935 3.09 . . . . 10.0 115.522 168.199 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 53.2 mt -60.39 -47.06 87.72 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 121.395 -0.816 . . . . 10.0 111.394 176.108 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 6.0 tt -50.89 -48.01 60.53 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.628 1.571 . . . . 10.0 111.596 171.702 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.5 mp -58.83 -46.76 86.92 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.61 1.164 . . . . 10.0 113.365 170.438 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.79 -38.34 78.33 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 123.824 0.849 . . . . 10.0 112.868 177.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 -52.24 -54.1 35.4 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 119.317 0.962 . . . . 10.0 111.13 169.677 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.31 -42.08 88.77 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.651 0.78 . . . . 10.0 112.152 -178.509 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.66 -54.73 37.84 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.962 0.905 . . . . 10.0 112.056 173.575 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.33 -41.15 79.44 Favored 'General case' 0 C--O 1.224 -0.237 0 C-N-CA 123.767 0.827 . . . . 10.0 112.667 174.858 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.9 tp -63.8 -38.51 91.38 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 114.461 1.282 . . . . 10.0 114.461 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.2 t -94.85 1.45 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 125.022 1.329 . . . . 10.0 112.316 179.173 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.2 t70 48.57 53.51 12.02 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.866 1.666 . . . . 10.0 112.095 -174.013 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.27 145.9 47.58 Favored 'General case' 0 CA--C 1.534 0.339 0 O-C-N 119.977 -1.702 . . . . 10.0 112.459 -174.2 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.47 135.95 54.17 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 112.715 0.635 . . . . 10.0 112.715 175.154 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -42.89 -39.74 2.66 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 125.906 1.682 . . . . 10.0 113.41 175.293 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -47.32 -60.21 5.32 Favored Glycine 0 CA--C 1.525 0.691 0 C-N-CA 125.12 1.343 . . . . 10.0 115.222 169.79 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.6 p -62.05 -46.8 87.54 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 117.147 -1.406 . . . . 10.0 111.321 178.286 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 66.9 mt -48.39 -52.92 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 125.001 1.321 . . . . 10.0 111.147 178.191 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.2 tp -62.64 -51.27 67.93 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 112.548 0.573 . . . . 10.0 112.548 179.314 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.15 -44.9 43.13 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.506 0.722 . . . . 10.0 110.905 174.6 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.455 ' HA ' HD12 ' A' ' 111' ' ' LEU . 0.6 OUTLIER -59.52 -59.94 4.65 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 127.431 2.292 . . . . 10.0 114.8 174.937 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.5 t -61.03 -46.33 96.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 123.697 0.799 . . . . 10.0 111.388 -178.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -56.62 -50.35 63.76 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 123.695 0.664 . . . . 10.0 112.619 174.543 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -54.7 -46.85 74.2 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 113.275 0.843 . . . . 10.0 113.275 173.39 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -57.45 -45.39 84.78 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.804 0.842 . . . . 10.0 112.135 174.423 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -43.98 -55.65 5.53 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 125.385 1.469 . . . . 10.0 113.131 167.225 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 80.1 mt -55.73 -54.11 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 CA-C-O 118.03 -0.986 . . . . 10.0 110.464 173.207 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 63.4 ttp -46.36 -55.64 7.02 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 120.091 1.314 . . . . 10.0 112.978 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 1.7 mp . . . . . 0 N--CA 1.474 0.754 0 O-C-N 121.543 -0.723 . . . . 10.0 111.591 179.273 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 63.3 t . . . . . 0 N--CA 1.475 0.823 0 N-CA-C 110.128 -0.323 . . . . 10.0 110.128 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -50.08 -61.18 5.97 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 125.923 1.725 . . . . 10.0 112.709 171.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -46.99 -38.84 11.4 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 127.191 2.196 . . . . 10.0 113.638 178.304 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 48.2 mt -99.62 -6.87 26.58 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 115.347 1.61 . . . . 10.0 115.347 -178.051 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 17.0 m -69.67 116.74 10.41 Favored 'General case' 0 N--CA 1.464 0.256 0 O-C-N 120.162 -1.586 . . . . 10.0 110.378 -178.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.621 ' H ' ' HD3' ' A' ' 129' ' ' LYS . 0.1 OUTLIER -55.44 -49.65 71.9 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 128.195 2.598 . . . . 10.0 113.3 177.711 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 61.3 t -69.67 106.32 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 C-N-CA 123.773 0.829 . . . . 10.0 110.121 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -46.89 -59.51 3.04 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 124.769 1.228 . . . . 10.0 114.067 -173.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 m -46.46 -42.1 14.9 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.467 1.507 . . . . 10.0 113.497 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -70.18 -24.59 63.16 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 114.917 1.451 . . . . 10.0 114.917 -178.092 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 68.8 mtp85 -54.01 -41.65 68.21 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 118.862 0.755 . . . . 10.0 110.864 176.664 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -69.59 -32.07 70.59 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.755 1.222 . . . . 10.0 114.202 176.632 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.9 t -54.88 -52.23 45.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-N 119.063 0.847 . . . . 10.0 109.615 168.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 64.2 m95 -61.08 -44.23 97.69 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 114.238 1.199 . . . . 10.0 114.238 174.238 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 90.4 t90 -53.36 -48.4 68.59 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 119.284 0.947 . . . . 10.0 112.959 172.751 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.603 0 C-N-CA 124.013 0.925 . . . . 10.0 111.607 177.073 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.819 0 N-CA-C 112.235 0.457 . . . . 10.0 112.235 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 41.4 ttp -55.47 -57.92 9.92 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.218 1.007 . . . . 10.0 112.776 174.049 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.3 pp -61.61 -35.84 79.04 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 118.309 -0.853 . . . . 10.0 112.147 -176.176 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 75.3 t80 -54.1 -55.27 29.19 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 119.312 0.96 . . . . 10.0 111.95 167.677 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 54.7 mt -53.59 -55.27 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 123.807 0.843 . . . . 10.0 110.741 177.696 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 9.9 mp -56.24 -37.06 69.23 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.23 1.012 . . . . 10.0 112.678 178.365 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -57.27 -58.19 9.31 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 124.057 0.943 . . . . 10.0 112.999 173.765 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.47 -40.91 85.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 CA-C-O 118.338 -0.839 . . . . 10.0 111.442 177.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 47.1 mt -56.72 -49.48 75.07 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 119.875 1.216 . . . . 10.0 112.098 171.217 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.471 ' HA ' ' HD2' ' A' ' 175' ' ' ARG . 11.8 t80 -77.01 -70.25 0.47 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 120.087 -1.633 . . . . 10.0 112.877 -175.186 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -73.76 -21.91 60.03 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.587 1.155 . . . . 10.0 113.439 -174.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -87.84 -79.02 1.26 Allowed Glycine 0 CA--C 1.526 0.761 0 C-N-CA 123.599 0.619 . . . . 10.0 113.539 171.53 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -53.68 -32.42 51.63 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 126.275 1.83 . . . . 10.0 113.024 -166.53 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.3 m -52.1 -56.46 14.28 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 114.01 1.115 . . . . 10.0 114.01 172.123 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.7 p -53.63 -50.55 65.48 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 122.081 0.944 . . . . 10.0 112.307 -177.852 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 47.7 tttm -57.14 -46.07 83.0 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.165 0.986 . . . . 10.0 112.086 173.713 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.81 -47.48 80.18 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 114.504 1.298 . . . . 10.0 114.504 174.062 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -56.42 -11.33 1.2 Allowed 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 126.095 1.758 . . . . 10.0 114.223 177.683 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.1 m -107.11 6.64 29.06 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.408 1.883 . . . . 10.0 114.869 -179.273 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 93.2 mmm -91.92 -92.68 0.15 Allowed 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 123.48 1.609 . . . . 10.0 114.139 -170.578 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -138.69 153.93 72.67 Favored Pre-proline 0 C--O 1.236 0.352 0 C-N-CA 129.823 3.249 . . . . 10.0 105.57 170.23 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -52.8 -46.25 34.99 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.296 1.998 . . . . 10.0 113.102 179.007 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.666 ' CD ' ' HD3' ' A' ' 227' ' ' ARG . 0.1 OUTLIER -53.02 -45.99 68.21 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 128.972 2.909 . . . . 10.0 113.285 173.619 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 91.7 t -69.24 -53.01 27.74 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.237 0 C-N-CA 124.031 0.933 . . . . 10.0 109.81 -178.628 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.13 -46.8 75.66 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.287 0.635 . . . . 10.0 111.933 177.009 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 60.2 p -59.99 -56.23 24.31 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.972 0.909 . . . . 10.0 112.687 174.623 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 61.3 m -57.19 -53.21 60.73 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.189 0.995 . . . . 10.0 113.036 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -49.57 -49.49 46.26 Favored 'General case' 0 C--O 1.221 -0.438 0 C-N-CA 123.258 0.623 . . . . 10.0 111.098 174.07 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -57.19 -48.43 78.78 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 114.664 1.357 . . . . 10.0 114.664 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 40.4 t -55.91 -49.66 73.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 CA-C-N 118.802 0.728 . . . . 10.0 110.477 176.355 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 94.2 mt -58.54 -51.69 68.82 Favored 'General case' 0 C--O 1.222 -0.389 0 N-CA-C 113.168 0.803 . . . . 10.0 113.168 175.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' ARG . . . . . 0.471 ' HD2' ' HA ' ' A' ' 153' ' ' PHE . 35.5 ttp180 -47.76 -47.76 30.38 Favored 'General case' 0 C--O 1.225 -0.222 0 C-N-CA 126.816 2.046 . . . . 10.0 111.087 174.446 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 63.5 m-20 -58.47 -58.36 8.89 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 122.819 0.448 . . . . 10.0 111.282 174.358 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 54.2 t -51.92 -52.29 23.84 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 C-N-CA 124.033 0.933 . . . . 10.0 111.875 179.021 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 64.1 m -54.59 -61.07 2.55 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 127.408 2.283 . . . . 10.0 113.178 175.15 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 51.6 t -51.58 -50.13 31.28 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 CA-C-N 120.26 1.391 . . . . 10.0 110.805 -178.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 79.1 t -58.99 -61.0 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 124.211 1.004 . . . . 10.0 112.268 176.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 78.5 mt -57.47 -51.46 69.36 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 118.623 0.647 . . . . 10.0 112.403 -177.462 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 10.8 m95 . . . . . 0 N--CA 1.466 0.374 0 C-N-CA 123.66 0.784 . . . . 10.0 111.521 179.172 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 16.4 m . . . . . 0 N--CA 1.475 0.785 0 CA-C-O 118.898 -0.572 . . . . 10.0 112.439 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 62.2 t90 -57.75 -57.59 12.09 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.344 1.457 . . . . 10.0 112.304 167.763 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 9.3 tt -58.24 -40.45 81.75 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.802 0.841 . . . . 10.0 112.574 -175.257 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 14.7 pt -82.67 -5.65 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 N-CA-C 115.195 1.554 . . . . 10.0 115.195 178.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.3 -169.26 33.11 Favored Glycine 0 N--CA 1.45 -0.404 0 CA-C-O 122.551 1.084 . . . . 10.0 113.921 -168.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 23.3 t -53.17 -39.96 63.98 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 114.166 -1.017 . . . . 10.0 111.879 177.559 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -68.48 -14.9 63.32 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 125.744 1.618 . . . . 10.0 115.171 -174.301 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -136.27 -104.81 0.75 Allowed Glycine 0 CA--C 1.541 1.662 0 C-N-CA 125.21 1.386 . . . . 10.0 114.951 -174.814 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -89.43 127.17 35.81 Favored 'General case' 0 C--N 1.328 -0.352 0 O-C-N 120.697 -1.473 . . . . 10.0 109.357 168.486 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -72.51 65.38 1.37 Allowed Glycine 0 CA--C 1.532 1.127 0 N-CA-C 113.915 0.326 . . . . 10.0 113.915 173.167 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 60.7 mt -79.61 -42.72 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 126.08 1.752 . . . . 10.0 108.725 166.375 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 79.4 t -126.34 133.38 24.91 Favored Pre-proline 0 N--CA 1.454 -0.264 0 C-N-CA 126.502 1.921 . . . . 10.0 109.417 -174.212 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -68.74 153.76 72.54 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 123.811 3.007 . . . . 10.0 111.476 -176.809 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 12.2 tp -43.13 -39.77 2.95 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.381 1.072 . . . . 10.0 112.214 171.505 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -48.39 -52.35 22.26 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 114.702 1.371 . . . . 10.0 114.702 176.055 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 14.0 mm -75.96 -40.44 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 124.378 1.071 . . . . 10.0 109.666 177.575 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -49.29 -49.8 42.08 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 118.592 0.633 . . . . 10.0 111.946 173.567 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 16.3 m -57.74 -47.08 83.47 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 126.045 1.738 . . . . 10.0 112.953 174.329 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.535 HD23 ' CD2' ' A' ' 12' ' ' TRP . 1.3 tm? -63.25 -52.36 62.45 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.985 0.914 . . . . 10.0 112.131 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 93.2 mt -52.55 -59.22 4.72 Favored 'General case' 0 C--O 1.228 -0.041 0 C-N-CA 124.278 1.031 . . . . 10.0 109.973 176.458 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -52.52 -46.16 66.59 Favored 'General case' 0 C--O 1.221 -0.427 0 CA-C-O 117.821 -1.085 . . . . 10.0 112.37 176.261 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 209' ' ' MET . . . . . 0.574 ' HE2' ' HB3' ' A' ' 15' ' ' LEU . 4.6 tmm? -52.42 -51.82 57.12 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 120.62 1.555 . . . . 10.0 113.023 175.229 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 79.5 t -60.9 -50.35 80.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 124.418 1.087 . . . . 10.0 111.419 178.248 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 4.6 mp -55.81 -52.01 65.46 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.77 1.628 . . . . 10.0 111.979 175.692 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -55.12 -61.85 2.05 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 126.449 1.9 . . . . 10.0 110.471 178.32 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 98.1 t . . . . . 0 N--CA 1.478 0.962 0 CA-C-N 119.529 1.059 . . . . 10.0 111.597 -178.496 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.316 0 CA-C-O 121.091 0.273 . . . . 10.0 112.753 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -44.32 -57.96 3.2 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 127.106 2.163 . . . . 10.0 112.316 166.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -55.82 -39.88 78.84 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 124.188 0.899 . . . . 10.0 114.032 177.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 24.4 mt -70.43 -27.53 64.34 Favored 'General case' 0 CA--C 1.511 -0.535 0 N-CA-C 115.52 1.674 . . . . 10.0 115.52 177.205 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 74.2 mt -63.27 -57.55 11.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 108.642 -0.873 . . . . 10.0 108.642 165.407 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 32.0 tp -58.79 -64.72 0.83 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.92 0.888 . . . . 10.0 113.184 -172.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 84.0 mt -71.52 5.19 2.5 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 115.332 1.604 . . . . 10.0 115.332 -171.683 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.6 mtp-105 -112.32 0.38 15.68 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.188 0.995 . . . . 10.0 113.316 172.529 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 8.8 t -108.03 177.96 4.65 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 124.046 0.938 . . . . 10.0 111.0 174.661 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 227' ' ' ARG . . . . . 0.666 ' HD3' ' CD ' ' A' ' 166' ' ' GLU . 41.7 ttt180 -71.62 98.13 1.84 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.786 0.835 . . . . 10.0 110.96 170.638 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 228' ' ' ALA . . . . . 0.476 ' HB1' ' CD2' ' A' ' 42' ' ' PHE . . . -80.87 76.96 7.79 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.828 0.851 . . . . 10.0 112.116 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 40.19 102.25 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 128.857 2.863 . . . . 10.0 116.497 177.746 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . 0.482 0.3 OUTLIER 71.83 -55.44 0.66 Allowed 'General case' 0 C--O 1.242 0.677 0 C-N-CA 124.769 1.227 . . . . 10.0 110.637 -175.273 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -68.25 169.47 39.89 Favored Glycine 0 C--O 1.239 0.429 0 C-N-CA 129.735 3.541 . . . . 10.0 119.701 171.462 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.461 0 C-N-CA 128.498 2.719 . . . . 10.0 113.46 166.616 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 N--CA 1.477 0.918 0 CA-C-O 115.804 -2.046 . . . . 10.0 105.785 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 23.4 91.84 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 129.58 3.152 . . . . 10.0 117.236 160.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 28.63 65.11 0.11 Allowed 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 128.306 2.643 . . . . 10.0 114.458 155.424 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 86.7 mt -56.51 137.99 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 126.358 1.863 . . . . 10.0 113.372 -158.393 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.653 HG21 ' HB3' ' A' ' 77' ' ' PRO . 7.6 t -136.76 -165.26 1.7 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 126.329 1.852 . . . . 10.0 113.97 -174.268 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 70.05 2.8 41.33 Favored Glycine 0 C--N 1.34 0.768 0 C-N-CA 127.477 2.465 . . . . 10.0 111.487 168.02 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.8 tpp180 -158.58 -51.34 0.01 OUTLIER Pre-proline 0 N--CA 1.444 -0.772 0 CA-C-O 114.206 -2.806 . . . . 10.0 116.623 -168.884 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_exo -63.99 -60.6 0.15 Allowed 'Trans proline' 0 CA--C 1.528 0.185 0 CA-C-N 123.517 2.292 . . . . 10.0 113.242 -175.309 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.411 ' H ' ' CD ' ' A' ' 9' ' ' GLU . 7.9 pm0 -67.19 4.22 0.99 Allowed 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 127.855 2.462 . . . . 10.0 115.735 179.691 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.422 ' CG ' ' N ' ' A' ' 11' ' ' ILE . 11.0 p-90 -51.32 -43.1 61.64 Favored 'General case' 0 C--O 1.222 -0.361 0 O-C-N 121.496 -0.752 . . . . 10.0 112.669 176.438 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.422 ' N ' ' CG ' ' A' ' 10' ' ' TRP . 8.9 tt -60.85 -49.65 83.74 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.319 0 C-N-CA 123.936 0.894 . . . . 10.0 109.298 179.359 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' TRP . . . . . 0.536 ' CD2' HD23 ' A' ' 206' ' ' LEU . 2.6 m95 -55.34 -52.63 62.86 Favored 'General case' 0 C--O 1.224 -0.261 0 C-N-CA 123.384 0.674 . . . . 10.0 111.93 175.616 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.8 mt -57.36 -53.63 55.96 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 123.193 0.597 . . . . 10.0 112.186 177.254 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.87 -46.79 51.93 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.41 1.484 . . . . 10.0 113.326 173.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.576 ' HB3' ' HE2' ' A' ' 209' ' ' MET . 13.2 tp -65.7 -44.9 84.71 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.302 1.441 . . . . 10.0 113.027 179.128 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.97 -55.89 13.69 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 124.544 1.069 . . . . 10.0 111.759 166.15 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 22.5 m -49.76 -52.62 30.4 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.001 1.32 . . . . 10.0 112.43 174.051 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.38 -58.88 5.71 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.133 0.973 . . . . 10.0 112.173 177.712 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 95.2 mt -57.55 -48.51 79.14 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.593 0.757 . . . . 10.0 112.816 -179.468 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 57.6 mtt -57.41 -49.5 76.03 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.089 0.956 . . . . 10.0 111.534 176.526 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -56.63 -58.85 12.35 Favored Glycine 0 CA--C 1.528 0.844 0 CA-C-O 118.873 -0.959 . . . . 10.0 113.673 174.807 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 81.1 mt -56.16 -46.08 79.43 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-N 118.82 1.31 . . . . 10.0 112.13 176.46 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.62 -41.6 74.44 Favored Glycine 0 CA--C 1.535 1.294 0 C-N-CA 124.742 1.163 . . . . 10.0 113.254 173.239 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 27.9 m -62.46 -58.71 6.62 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.097 0.959 . . . . 10.0 111.316 172.074 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -52.27 -40.96 62.44 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.001 0.92 . . . . 10.0 110.949 177.783 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.4 t80 -55.82 -58.02 9.59 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.583 1.153 . . . . 10.0 112.968 172.808 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.1 m-30 -59.64 -38.69 82.07 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 113.225 0.824 . . . . 10.0 113.225 178.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.4 ' C ' ' H ' ' A' ' 30' ' ' LYS . 11.8 mt -56.1 -67.41 0.3 Allowed 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.625 1.17 . . . . 10.0 113.628 169.104 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 t -76.41 40.95 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 CA-C-O 123.756 1.741 . . . . 10.0 110.91 179.047 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.4 ' H ' ' C ' ' A' ' 28' ' ' LEU . 42.8 tttm -140.84 -44.84 0.39 Allowed 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 127.872 2.469 . . . . 10.0 109.354 171.153 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.96 23.15 0.87 Allowed Glycine 0 CA--C 1.529 0.945 0 N-CA-C 115.624 1.01 . . . . 10.0 115.624 173.71 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 37.3 mmm -59.59 -45.01 93.16 Favored 'General case' 0 C--O 1.224 -0.272 0 C-N-CA 127.161 2.184 . . . . 10.0 113.529 -178.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.62 -84.43 1.18 Allowed Glycine 0 CA--C 1.53 1.018 0 C-N-CA 123.766 0.698 . . . . 10.0 112.47 -170.158 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.7 t 33.01 88.79 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.243 0.753 0 C-N-CA 128.405 2.682 . . . . 10.0 116.975 166.549 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.7 m -79.7 -50.83 10.03 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.193 -1.367 . . . . 10.0 113.855 174.198 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -48.92 117.51 6.42 Favored Pre-proline 0 CA--C 1.537 0.443 0 O-C-N 124.76 1.288 . . . . 10.0 110.983 -172.569 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -58.57 -29.68 89.71 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 123.713 2.942 . . . . 10.0 113.688 179.141 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.29 -60.63 2.31 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.122 0.569 . . . . 10.0 111.429 176.215 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.19 -40.04 22.86 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 125.072 1.349 . . . . 10.0 113.583 171.625 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.5 tttp -46.58 -47.42 19.79 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.275 1.43 . . . . 10.0 113.397 172.091 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -57.76 -53.07 62.36 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.487 0.715 . . . . 10.0 110.978 176.665 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.477 ' CD2' ' HB1' ' A' ' 228' ' ' ALA . 44.2 m-85 -56.96 -50.23 73.28 Favored 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 123.075 0.55 . . . . 10.0 112.345 -179.122 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -54.4 -51.24 65.5 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 118.926 -0.559 . . . . 10.0 112.376 173.289 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.41 -62.01 1.91 Allowed 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 113.374 0.879 . . . . 10.0 113.374 177.142 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.3 mt -48.48 -56.78 1.88 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 124.863 1.265 . . . . 10.0 110.889 178.036 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.8 m -68.46 -21.67 64.61 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.871 1.268 . . . . 10.0 113.413 -172.486 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 27.5 m -83.37 -40.05 19.9 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.423 1.089 . . . . 10.0 112.33 175.495 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 16.8 mt -59.14 -44.19 92.06 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 113.147 0.795 . . . . 10.0 113.147 174.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.489 HG13 HG23 ' A' ' 89' ' ' THR . 31.9 t -43.26 -64.51 0.74 Allowed Pre-proline 0 CA--C 1.549 0.911 0 C-N-CA 124.978 1.311 . . . . 10.0 113.119 177.038 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -67.88 -24.64 39.8 Favored 'Trans proline' 0 CA--C 1.543 0.975 0 C-N-CA 122.383 2.056 . . . . 10.0 113.767 177.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -67.27 -48.73 66.82 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 120.316 1.416 . . . . 10.0 113.154 175.612 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 27.6 mt -66.12 -42.65 91.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 O-C-N 120.568 -1.333 . . . . 10.0 109.443 174.137 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.32 -45.56 72.64 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 113.261 0.837 . . . . 10.0 113.261 171.665 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 45.0 t80 -49.81 -54.96 16.03 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 125.704 1.602 . . . . 10.0 111.681 169.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 14.7 m -48.92 -53.35 20.03 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.386 1.475 . . . . 10.0 111.0 176.133 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 32.2 mmt -67.99 -48.62 65.27 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 124.122 0.969 . . . . 10.0 113.062 -177.308 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -56.83 -40.44 76.07 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 120.182 1.355 . . . . 10.0 113.322 173.562 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.8 tp -53.31 -54.54 34.93 Favored 'General case' 0 C--O 1.225 -0.223 0 CA-C-N 119.795 1.18 . . . . 10.0 111.272 170.284 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 24.0 p -51.69 -41.04 61.14 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 115.217 1.562 . . . . 10.0 115.217 179.026 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 59.0 mtm -66.86 -50.89 61.07 Favored 'General case' 0 C--N 1.334 -0.085 0 C-N-CA 123.571 0.748 . . . . 10.0 110.435 176.836 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.3 tp -48.57 -52.65 21.71 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.889 0.875 . . . . 10.0 112.939 172.407 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.5 mt -76.98 -5.5 48.91 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.325 1.05 . . . . 10.0 113.793 -177.694 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.25 -34.7 5.56 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 115.522 0.969 . . . . 10.0 115.522 174.109 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -49.3 -43.06 43.01 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 115.277 1.584 . . . . 10.0 115.277 -176.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.07 3.57 61.13 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 115.379 0.912 . . . . 10.0 115.379 -179.043 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.25 143.42 26.43 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 127.021 2.129 . . . . 10.0 109.015 171.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 t -145.51 171.11 15.13 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 124.081 0.952 . . . . 10.0 111.041 166.776 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.04 136.05 53.39 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 123.89 0.876 . . . . 10.0 109.706 179.633 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.436 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 58.6 t -129.58 129.55 23.18 Favored Pre-proline 0 C--N 1.33 -0.281 0 C-N-CA 125.074 1.35 . . . . 10.0 110.949 -176.013 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 69' ' ' VAL . 6.3 Cg_exo -80.7 116.27 3.18 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 N-CA-C 109.4 -1.038 . . . . 10.0 109.4 -178.904 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -156.74 164.41 38.15 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 112.824 0.676 . . . . 10.0 112.824 172.444 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.37 -81.96 0.14 Allowed Glycine 0 CA--C 1.526 0.764 0 N-CA-C 110.684 -0.966 . . . . 10.0 110.684 175.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.74 -3.39 0.7 Allowed Glycine 0 CA--C 1.527 0.808 0 N-CA-C 118.662 2.225 . . . . 10.0 118.662 170.388 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -151.59 -171.89 4.06 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 119.406 1.603 . . . . 10.0 112.218 -165.152 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -91.88 93.86 9.03 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 125.525 1.53 . . . . 10.0 111.111 -175.305 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.449 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 60.3 m-80 -89.41 120.79 69.69 Favored Pre-proline 0 N--CA 1.45 -0.425 0 N-CA-C 112.941 0.719 . . . . 10.0 112.941 -165.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.653 ' HB3' HG21 ' A' ' 5' ' ' THR . 76.0 Cg_exo -61.54 131.87 37.92 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 124.181 3.254 . . . . 10.0 112.201 171.528 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.4 mm -140.07 126.3 22.07 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 C-N-CA 126.055 1.742 . . . . 10.0 111.75 -179.504 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -93.6 85.02 4.76 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 123.012 1.387 . . . . 10.0 113.065 174.626 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 63.8 p-90 -59.36 -28.25 66.69 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 120.865 -1.147 . . . . 10.0 113.931 174.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -55.07 -28.47 52.62 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.239 1.015 . . . . 10.0 113.152 178.223 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.0 mtt-85 -49.88 -58.04 6.21 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.447 1.099 . . . . 10.0 111.292 168.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -62.6 -40.64 97.58 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 126.076 1.75 . . . . 10.0 112.437 -179.286 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -52.24 -48.92 64.92 Favored 'General case' 0 CA--C 1.568 1.647 0 CA-C-N 119.597 1.09 . . . . 10.0 111.15 168.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -59.19 -64.38 0.96 Allowed 'General case' 0 N--CA 1.494 1.753 0 CA-C-N 121.212 1.824 . . . . 10.0 110.792 169.615 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 48.1 m0 -50.65 -35.51 31.01 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.94 1.296 . . . . 10.0 111.865 -170.51 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 26.4 tp -51.29 -42.59 61.26 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.39 1.876 . . . . 10.0 113.335 176.508 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -101.45 -52.54 3.21 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.213 1.005 . . . . 10.0 112.645 -175.764 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.489 HG23 HG13 ' A' ' 49' ' ' VAL . 1.1 m -46.15 -51.01 14.85 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 125.64 1.576 . . . . 10.0 112.829 175.83 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.421 ' HB ' ' HD3' ' A' ' 91' ' ' PRO . 3.7 m -64.58 -45.89 76.75 Favored Pre-proline 0 CA--C 1.547 0.837 0 O-C-N 121.343 -0.848 . . . . 10.0 112.661 -169.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.421 ' HD3' ' HB ' ' A' ' 90' ' ' THR . 76.2 Cg_exo -51.29 -44.83 40.74 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 124.053 3.169 . . . . 10.0 116.749 162.388 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 59.4 mt -59.3 -46.67 87.93 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 119.134 0.879 . . . . 10.0 111.358 175.754 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.5 tp -50.31 -47.74 55.52 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.341 1.856 . . . . 10.0 111.892 172.375 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.9 mp -60.87 -46.5 90.36 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.414 1.486 . . . . 10.0 113.032 170.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.9 -38.22 78.37 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.82 0.848 . . . . 10.0 112.854 178.017 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -52.3 -54.05 36.4 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 119.269 0.94 . . . . 10.0 111.166 169.62 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.3 -42.11 88.79 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.621 0.768 . . . . 10.0 112.131 -178.507 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.66 -54.77 37.27 Favored 'General case' 0 C--O 1.225 -0.186 0 C-N-CA 123.995 0.918 . . . . 10.0 112.011 173.641 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.28 -41.18 79.23 Favored 'General case' 0 C--O 1.224 -0.239 0 C-N-CA 123.719 0.808 . . . . 10.0 112.725 174.777 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.9 tp -63.77 -38.56 91.54 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 114.45 1.278 . . . . 10.0 114.45 -179.625 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.2 t -94.82 1.47 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 125.008 1.323 . . . . 10.0 112.313 179.162 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.2 t70 48.61 53.4 12.25 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.829 1.652 . . . . 10.0 112.1 -174.057 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.17 145.88 47.77 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 119.916 -1.74 . . . . 10.0 112.474 -174.209 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.54 135.9 54.45 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 112.697 0.628 . . . . 10.0 112.697 175.158 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -42.83 -39.71 2.61 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.894 1.678 . . . . 10.0 113.456 175.31 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -47.32 -60.22 5.32 Favored Glycine 0 CA--C 1.526 0.731 0 C-N-CA 125.109 1.338 . . . . 10.0 115.252 169.743 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.4 p -62.06 -46.75 87.75 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 117.057 -1.449 . . . . 10.0 111.335 178.24 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 66.9 mt -48.45 -52.93 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 124.995 1.318 . . . . 10.0 111.128 178.194 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.1 tp -62.55 -51.35 67.74 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 112.554 0.576 . . . . 10.0 112.554 179.277 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.13 -44.9 42.86 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.424 0.689 . . . . 10.0 110.97 174.6 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.455 ' HA ' HD12 ' A' ' 111' ' ' LEU . 0.6 OUTLIER -59.58 -59.89 4.73 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 127.363 2.265 . . . . 10.0 114.787 174.968 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.6 t -61.04 -46.29 96.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 123.685 0.794 . . . . 10.0 111.41 -178.855 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -56.64 -50.36 63.75 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 123.674 0.654 . . . . 10.0 112.642 174.499 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -54.21 -46.74 72.56 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.571 0.748 . . . . 10.0 112.94 173.32 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -60.89 -41.77 96.67 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 112.707 0.632 . . . . 10.0 112.707 176.536 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -43.85 -56.94 4.89 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 125.43 1.491 . . . . 10.0 113.078 164.256 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 85.4 mt -56.84 -50.49 75.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 CA-C-N 117.776 0.788 . . . . 10.0 111.668 175.169 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 47.9 ttp -48.66 -58.4 4.8 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.295 1.438 . . . . 10.0 112.056 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 36.8 mm . . . . . 0 N--CA 1.471 0.602 0 O-C-N 121.959 -0.463 . . . . 10.0 112.03 178.736 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 68.5 t . . . . . 0 N--CA 1.475 0.794 0 N-CA-C 110.371 -0.233 . . . . 10.0 110.371 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -49.22 -60.92 5.8 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 125.871 1.7 . . . . 10.0 112.275 171.706 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -48.85 -37.71 20.29 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 126.576 1.95 . . . . 10.0 113.76 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 49.7 mt -99.31 -6.57 27.69 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 115.22 1.563 . . . . 10.0 115.22 -178.844 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 16.8 m -69.74 116.73 10.48 Favored 'General case' 0 N--CA 1.464 0.266 0 O-C-N 120.165 -1.584 . . . . 10.0 110.345 -178.844 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.623 ' H ' ' HD3' ' A' ' 129' ' ' LYS . 0.2 OUTLIER -55.45 -49.61 72.0 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 128.205 2.602 . . . . 10.0 113.305 177.728 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 60.9 t -69.64 106.35 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 123.788 0.835 . . . . 10.0 110.089 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -46.88 -59.55 3.01 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 124.809 1.244 . . . . 10.0 114.038 -173.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 m -46.47 -42.11 14.97 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.501 1.521 . . . . 10.0 113.496 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -70.2 -24.54 63.14 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 114.918 1.451 . . . . 10.0 114.918 -178.092 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 69.3 mtp85 -53.66 -42.18 67.6 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-N 118.923 0.783 . . . . 10.0 110.701 176.56 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -69.57 -31.65 69.94 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.826 1.25 . . . . 10.0 114.322 176.831 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.8 t -55.31 -51.74 53.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-N 119.064 0.847 . . . . 10.0 109.582 168.743 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 66.8 m95 -62.08 -42.77 99.54 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 114.335 1.235 . . . . 10.0 114.335 174.359 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 92.8 t90 -53.92 -48.63 70.0 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.265 1.026 . . . . 10.0 112.618 172.11 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.573 0 C-N-CA 123.71 0.804 . . . . 10.0 111.639 176.603 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.747 0 N-CA-C 112.234 0.457 . . . . 10.0 112.234 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 9.6 tmm? -51.67 -52.94 44.13 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.919 1.688 . . . . 10.0 111.858 173.437 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 7.8 tt -53.59 -52.05 61.03 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.856 1.662 . . . . 10.0 112.392 175.525 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 72.9 t80 -49.47 -53.91 20.58 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.225 1.01 . . . . 10.0 112.098 173.604 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 36.9 mm -52.81 -56.09 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 CA-C-N 118.818 0.736 . . . . 10.0 110.387 177.138 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 18.5 mt -58.71 -34.48 71.37 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 117.979 -1.01 . . . . 10.0 112.037 -178.521 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -57.26 -58.18 9.36 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 119.513 1.052 . . . . 10.0 113.076 173.134 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.4 -40.91 85.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 CA-C-O 118.32 -0.847 . . . . 10.0 111.438 177.909 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 44.1 mt -56.76 -49.42 75.3 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 119.919 1.236 . . . . 10.0 112.12 171.258 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.47 ' HA ' ' HD2' ' A' ' 175' ' ' ARG . 12.0 t80 -77.02 -70.31 0.47 Allowed 'General case' 0 C--N 1.326 -0.435 0 O-C-N 120.049 -1.657 . . . . 10.0 112.857 -175.216 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -73.7 -21.98 60.06 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.665 1.186 . . . . 10.0 113.411 -174.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -87.77 -79.17 1.26 Allowed Glycine 0 CA--C 1.527 0.806 0 C-N-CA 123.639 0.637 . . . . 10.0 113.49 171.554 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -53.52 -32.47 50.65 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 126.295 1.838 . . . . 10.0 113.067 -166.559 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.2 m -52.13 -56.42 14.65 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 114.018 1.118 . . . . 10.0 114.018 172.139 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.3 p -53.69 -50.57 65.57 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 122.079 0.942 . . . . 10.0 112.271 -177.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 47.6 tttm -57.09 -46.02 82.9 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.168 0.987 . . . . 10.0 112.16 173.624 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.84 -47.48 80.25 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 114.475 1.287 . . . . 10.0 114.475 174.068 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -56.53 -11.25 1.21 Allowed 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.034 1.734 . . . . 10.0 114.249 177.714 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.1 m -107.05 6.62 29.16 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.411 1.884 . . . . 10.0 114.846 -179.359 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 93.2 mmm -91.9 -92.67 0.15 Allowed 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 123.523 1.63 . . . . 10.0 114.146 -170.592 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -138.72 153.95 72.63 Favored Pre-proline 0 C--O 1.235 0.308 0 C-N-CA 129.756 3.223 . . . . 10.0 105.552 170.224 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -52.85 -46.19 35.46 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 122.285 1.99 . . . . 10.0 113.088 179.06 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.667 ' CD ' ' HD3' ' A' ' 227' ' ' ARG . 0.1 OUTLIER -53.02 -46.04 68.22 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 129.049 2.94 . . . . 10.0 113.259 173.571 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 92.2 t -69.25 -53.0 27.75 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.253 0 C-N-CA 124.06 0.944 . . . . 10.0 109.771 -178.627 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.12 -46.86 75.63 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.284 0.634 . . . . 10.0 111.915 177.045 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 60.5 p -59.99 -56.15 25.28 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.908 0.883 . . . . 10.0 112.741 174.644 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 61.8 m -57.24 -53.18 60.97 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.13 0.972 . . . . 10.0 113.006 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -49.6 -49.51 46.42 Favored 'General case' 0 C--O 1.222 -0.375 0 C-N-CA 123.311 0.644 . . . . 10.0 111.086 174.09 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -57.16 -48.37 78.87 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 114.678 1.362 . . . . 10.0 114.678 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 40.3 t -56.01 -49.59 74.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 CA-C-N 118.794 0.725 . . . . 10.0 110.507 176.338 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 94.1 mt -58.58 -51.57 69.35 Favored 'General case' 0 C--O 1.222 -0.394 0 N-CA-C 113.197 0.814 . . . . 10.0 113.197 175.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' ARG . . . . . 0.47 ' HD2' ' HA ' ' A' ' 153' ' ' PHE . 35.5 ttp180 -47.87 -47.75 31.57 Favored 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 126.82 2.048 . . . . 10.0 111.017 174.463 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 63.6 m-20 -58.54 -58.29 9.19 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 122.809 0.444 . . . . 10.0 111.283 174.409 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 59.8 t -51.67 -48.86 36.55 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 124.074 0.949 . . . . 10.0 111.678 179.022 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 19.8 m -58.76 -62.08 2.13 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 127.267 2.227 . . . . 10.0 112.009 178.607 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 54.5 t -50.69 -49.44 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 C-N-CA 124.599 1.159 . . . . 10.0 110.998 -179.245 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 74.2 t -59.65 -62.6 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 123.883 0.873 . . . . 10.0 112.55 177.146 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -57.97 -45.95 85.9 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 118.669 0.668 . . . . 10.0 112.108 -175.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 9.5 m0 . . . . . 0 N--CA 1.466 0.333 0 C-N-CA 123.652 0.781 . . . . 10.0 113.0 176.163 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 98.2 t . . . . . 0 N--CA 1.479 0.993 0 CA-C-O 119.381 -0.342 . . . . 10.0 111.418 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 28.1 t90 -54.63 -53.91 48.53 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.657 1.183 . . . . 10.0 112.493 174.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 10.0 tt -55.52 -44.95 77.15 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 124.187 0.995 . . . . 10.0 112.625 -178.313 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 15.0 pt -84.93 -5.52 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 N-CA-C 115.118 1.525 . . . . 10.0 115.118 -178.451 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.29 -169.27 33.13 Favored Glycine 0 N--CA 1.45 -0.397 0 CA-C-O 122.604 1.113 . . . . 10.0 113.925 -168.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 23.3 t -53.18 -41.0 64.82 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 114.156 -1.022 . . . . 10.0 111.871 177.581 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -54.17 -32.16 54.67 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 128.621 2.768 . . . . 10.0 115.266 179.604 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -131.25 -103.86 0.97 Allowed Glycine 0 CA--C 1.528 0.879 0 CA-C-N 119.346 0.976 . . . . 10.0 113.566 -167.704 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -89.47 127.17 35.82 Favored 'General case' 0 C--N 1.328 -0.328 0 O-C-N 120.657 -1.496 . . . . 10.0 109.32 169.212 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -72.42 65.31 1.35 Allowed Glycine 0 CA--C 1.532 1.138 0 N-CA-C 113.914 0.326 . . . . 10.0 113.914 173.152 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 60.7 mt -79.57 -42.76 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 C-N-CA 126.096 1.759 . . . . 10.0 108.766 166.39 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.4 ' CG1' ' HB ' ' A' ' 203' ' ' ILE . 79.2 t -126.29 133.41 24.93 Favored Pre-proline 0 N--CA 1.454 -0.25 0 C-N-CA 126.496 1.918 . . . . 10.0 109.372 -174.208 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -68.76 153.76 72.49 Favored 'Trans proline' 0 N--CA 1.461 -0.441 0 C-N-CA 123.834 3.023 . . . . 10.0 111.459 -176.861 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 12.2 tp -43.17 -39.78 3.02 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.312 1.045 . . . . 10.0 112.202 171.483 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -48.33 -52.37 21.86 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 114.715 1.376 . . . . 10.0 114.715 176.012 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 203' ' ' ILE . . . . . 0.4 ' HB ' ' CG1' ' A' ' 199' ' ' VAL . 14.0 mm -75.93 -40.47 38.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 C-N-CA 124.39 1.076 . . . . 10.0 109.681 177.553 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -49.31 -49.78 42.39 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 118.546 0.612 . . . . 10.0 111.981 173.628 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 16.1 m -57.67 -47.07 83.35 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 126.013 1.725 . . . . 10.0 112.991 174.289 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.536 HD23 ' CD2' ' A' ' 12' ' ' TRP . 1.3 tm? -63.31 -52.38 62.16 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.024 0.93 . . . . 10.0 112.06 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 93.2 mt -52.51 -59.96 3.81 Favored 'General case' 0 C--N 1.335 -0.053 0 C-N-CA 124.363 1.065 . . . . 10.0 109.953 176.451 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -52.92 -45.12 67.47 Favored 'General case' 0 C--O 1.216 -0.667 0 CA-C-O 116.773 -1.584 . . . . 10.0 112.086 176.436 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 209' ' ' MET . . . . . 0.576 ' HE2' ' HB3' ' A' ' 15' ' ' LEU . 4.6 tmm? -52.65 -53.04 52.59 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 121.719 2.054 . . . . 10.0 113.114 174.187 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 81.8 t -59.96 -47.03 93.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 125.129 1.371 . . . . 10.0 111.158 178.446 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 4.2 mp -59.81 -50.16 74.89 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.677 1.591 . . . . 10.0 112.298 174.569 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 32.6 m-20 -55.57 -59.72 4.44 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 127.458 2.303 . . . . 10.0 111.069 177.639 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 25.4 m . . . . . 0 N--CA 1.479 0.98 0 O-C-N 121.086 -1.009 . . . . 10.0 112.56 -177.812 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.327 0 CA-C-O 120.895 0.164 . . . . 10.0 113.157 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -44.9 -56.17 4.79 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 126.522 1.929 . . . . 10.0 112.007 166.697 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -55.67 -39.28 75.34 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 124.554 1.073 . . . . 10.0 114.003 177.443 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 24.9 mt -69.66 -27.81 65.35 Favored 'General case' 0 CA--C 1.512 -0.481 0 N-CA-C 115.687 1.736 . . . . 10.0 115.687 176.517 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 74.6 mt -63.45 -57.5 11.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 108.545 -0.909 . . . . 10.0 108.545 165.683 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 32.1 tp -58.81 -64.65 0.86 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.948 0.899 . . . . 10.0 113.193 -172.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 84.1 mt -71.51 5.14 2.52 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 115.347 1.61 . . . . 10.0 115.347 -171.724 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.6 mtp-105 -112.33 0.4 15.67 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 124.214 1.006 . . . . 10.0 113.304 172.592 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 8.8 t -108.06 177.98 4.65 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 124.089 0.956 . . . . 10.0 111.03 174.64 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 227' ' ' ARG . . . . . 0.667 ' HD3' ' CD ' ' A' ' 166' ' ' GLU . 41.8 ttt180 -71.65 98.16 1.86 Allowed 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.824 0.85 . . . . 10.0 110.893 170.695 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 228' ' ' ALA . . . . . 0.477 ' HB1' ' CD2' ' A' ' 42' ' ' PHE . . . -80.92 77.03 7.84 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.861 0.864 . . . . 10.0 112.1 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 40.1 102.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 128.901 2.88 . . . . 10.0 116.444 177.751 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . 0.481 0.3 OUTLIER 71.86 -55.42 0.66 Allowed 'General case' 0 C--O 1.242 0.691 0 C-N-CA 124.749 1.22 . . . . 10.0 110.644 -175.334 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -68.32 169.48 40.13 Favored Glycine 0 C--O 1.239 0.422 0 C-N-CA 129.727 3.537 . . . . 10.0 119.655 171.475 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.459 0 C-N-CA 128.477 2.711 . . . . 10.0 113.438 166.655 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 N--CA 1.477 0.913 0 CA-C-O 115.813 -2.041 . . . . 10.0 105.805 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 23.35 91.93 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 129.568 3.147 . . . . 10.0 117.213 160.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 28.57 65.08 0.1 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 128.307 2.643 . . . . 10.0 114.514 155.417 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 86.8 mt -56.52 137.98 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 126.379 1.872 . . . . 10.0 113.336 -158.341 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.652 HG21 ' HB3' ' A' ' 77' ' ' PRO . 7.6 t -136.71 -165.19 1.69 Allowed 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 126.331 1.852 . . . . 10.0 114.05 -174.357 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 69.95 2.83 40.72 Favored Glycine 0 C--N 1.34 0.768 0 C-N-CA 127.503 2.477 . . . . 10.0 111.511 168.056 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.8 tpp180 -158.51 -51.39 0.01 OUTLIER Pre-proline 0 N--CA 1.443 -0.783 0 CA-C-O 114.309 -2.758 . . . . 10.0 116.665 -168.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_exo -64.0 -60.58 0.15 Allowed 'Trans proline' 0 N--CA 1.464 -0.218 0 CA-C-N 123.524 2.294 . . . . 10.0 113.215 -175.277 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.412 ' H ' ' CD ' ' A' ' 9' ' ' GLU . 7.9 pm0 -67.24 4.34 0.97 Allowed 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 127.831 2.452 . . . . 10.0 115.764 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.422 ' CG ' ' N ' ' A' ' 11' ' ' ILE . 11.0 p-90 -51.43 -43.06 61.91 Favored 'General case' 0 C--O 1.223 -0.34 0 O-C-N 121.509 -0.744 . . . . 10.0 112.641 176.453 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.422 ' N ' ' CG ' ' A' ' 10' ' ' TRP . 8.9 tt -60.91 -49.61 83.94 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.34 0 C-N-CA 123.862 0.865 . . . . 10.0 109.316 179.4 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' TRP . . . . . 0.535 ' CD2' HD23 ' A' ' 206' ' ' LEU . 2.6 m95 -55.35 -52.67 62.76 Favored 'General case' 0 C--O 1.224 -0.259 0 C-N-CA 123.4 0.68 . . . . 10.0 111.871 175.619 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.3 mt -57.3 -53.65 55.69 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 123.21 0.604 . . . . 10.0 112.227 177.236 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.86 -46.8 51.83 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.413 1.485 . . . . 10.0 113.324 173.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.574 ' HB3' ' HE2' ' A' ' 209' ' ' MET . 13.4 tp -65.64 -44.96 84.8 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 125.298 1.439 . . . . 10.0 113.03 179.085 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -50.02 -57.15 10.35 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 124.045 0.831 . . . . 10.0 111.264 166.113 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 22.6 m -48.43 -52.62 21.22 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.602 1.161 . . . . 10.0 112.364 174.781 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.39 -58.86 5.81 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.139 0.976 . . . . 10.0 112.188 177.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 94.2 mt -57.61 -50.43 73.17 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.762 0.825 . . . . 10.0 112.578 -179.493 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -54.14 -50.31 67.23 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.464 1.106 . . . . 10.0 111.346 175.343 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -58.07 -57.99 16.92 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 124.271 0.939 . . . . 10.0 113.666 176.522 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 80.8 mt -56.24 -45.77 79.86 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-N 118.434 1.117 . . . . 10.0 112.103 176.098 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.28 -42.75 74.52 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 125.03 1.3 . . . . 10.0 113.167 172.709 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 24.1 m -60.79 -59.64 5.06 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 124.038 0.935 . . . . 10.0 111.303 171.774 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -52.28 -41.02 62.52 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.061 0.944 . . . . 10.0 110.974 178.551 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -55.75 -58.03 9.55 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.561 1.144 . . . . 10.0 113.006 172.729 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -59.63 -38.7 82.06 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 113.226 0.825 . . . . 10.0 113.226 178.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.4 ' C ' ' H ' ' A' ' 30' ' ' LYS . 11.8 mt -56.16 -67.47 0.29 Allowed 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.572 1.149 . . . . 10.0 113.576 169.154 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 t -76.36 41.02 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 CA-C-O 123.802 1.763 . . . . 10.0 110.891 179.091 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.4 ' H ' ' C ' ' A' ' 28' ' ' LEU . 43.0 tttm -140.89 -44.91 0.39 Allowed 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 127.905 2.482 . . . . 10.0 109.303 171.199 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.9 23.07 0.86 Allowed Glycine 0 CA--C 1.529 0.956 0 N-CA-C 115.644 1.017 . . . . 10.0 115.644 173.723 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 37.3 mmm -59.52 -44.96 93.02 Favored 'General case' 0 C--O 1.224 -0.253 0 C-N-CA 127.17 2.188 . . . . 10.0 113.578 -178.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.66 -84.45 1.18 Allowed Glycine 0 CA--C 1.531 1.045 0 C-N-CA 123.741 0.686 . . . . 10.0 112.477 -170.159 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.7 t 33.09 88.75 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.242 0.682 0 C-N-CA 128.36 2.664 . . . . 10.0 116.941 166.463 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.8 m -79.67 -50.89 9.96 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.187 -1.37 . . . . 10.0 113.832 174.15 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -48.86 117.47 6.33 Favored Pre-proline 0 CA--C 1.536 0.428 0 O-C-N 124.794 1.309 . . . . 10.0 110.983 -172.531 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -58.53 -29.66 89.51 Favored 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 123.792 2.995 . . . . 10.0 113.698 179.097 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.35 -60.65 2.3 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.058 0.543 . . . . 10.0 111.455 176.183 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.08 -40.15 22.33 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 125.14 1.376 . . . . 10.0 113.554 171.575 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -46.53 -47.4 19.57 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 125.261 1.424 . . . . 10.0 113.463 172.076 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -57.77 -53.01 62.99 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.425 0.69 . . . . 10.0 111.009 176.633 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.475 ' CD2' ' HB1' ' A' ' 228' ' ' ALA . 43.9 m-85 -57.04 -50.21 73.44 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 123.049 0.54 . . . . 10.0 112.323 -179.114 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -54.37 -51.28 65.31 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 118.935 -0.555 . . . . 10.0 112.379 173.273 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.36 -62.0 1.92 Allowed 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 113.404 0.89 . . . . 10.0 113.404 177.123 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.5 mt -48.88 -56.35 2.51 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 C-N-CA 124.829 1.251 . . . . 10.0 110.496 178.096 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.5 m -70.07 -16.91 63.2 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.109 1.364 . . . . 10.0 113.688 -172.557 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 27.5 m -87.92 -37.72 16.2 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.134 0.973 . . . . 10.0 112.152 174.282 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 20.4 mt -60.88 -39.36 88.94 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-O 118.406 -0.807 . . . . 10.0 113.091 173.195 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.614 HG23 ' HD3' ' A' ' 50' ' ' PRO 0.35 33.3 m -55.16 -54.11 54.07 Favored Pre-proline 0 N--CA 1.485 1.278 0 N-CA-C 114.579 1.326 . . . . 10.0 114.579 179.318 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.614 ' HD3' HG23 ' A' ' 49' ' ' VAL . 68.3 Cg_endo -67.61 -26.44 39.71 Favored 'Trans proline' 0 CA--C 1.545 1.055 0 CA-C-N 123.137 2.156 . . . . 10.0 113.099 173.49 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.44 -47.7 75.27 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-N 120.181 1.355 . . . . 10.0 113.324 175.747 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 19.3 tt -65.51 -41.03 89.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 O-C-N 120.431 -1.418 . . . . 10.0 111.419 171.132 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -49.89 -49.93 47.79 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 118.732 0.696 . . . . 10.0 112.156 170.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 53.2 t80 -51.85 -57.93 7.92 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 125.711 1.604 . . . . 10.0 112.473 173.265 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.5 m -49.2 -52.72 25.07 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 125.094 1.358 . . . . 10.0 110.856 178.04 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.457 ' HG3' ' CB ' ' A' ' 85' ' ' ASP . 32.9 mmt -70.02 -47.95 60.02 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 124.21 1.004 . . . . 10.0 112.618 -175.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -56.14 -41.07 74.79 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 120.328 1.422 . . . . 10.0 113.206 172.486 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.8 tp -53.3 -54.57 34.54 Favored 'General case' 0 C--O 1.224 -0.272 0 CA-C-N 120.024 1.284 . . . . 10.0 111.275 170.744 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 23.9 p -51.6 -41.16 61.02 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 115.203 1.557 . . . . 10.0 115.203 178.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 57.6 mtm -66.84 -50.81 61.37 Favored 'General case' 0 C--N 1.333 -0.113 0 C-N-CA 123.54 0.736 . . . . 10.0 110.481 176.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.2 tp -48.64 -52.66 22.06 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.882 0.873 . . . . 10.0 112.894 172.39 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.4 mt -76.9 -5.61 49.15 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.383 1.073 . . . . 10.0 113.786 -177.661 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.26 -34.66 5.59 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 115.53 0.972 . . . . 10.0 115.53 174.158 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 75.3 t80 -49.32 -43.13 43.26 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 115.206 1.558 . . . . 10.0 115.206 -176.01 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.02 3.54 61.06 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 115.313 0.885 . . . . 10.0 115.313 -179.007 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.25 143.41 26.44 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 127.035 2.134 . . . . 10.0 109.011 172.023 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 t -145.5 171.07 15.19 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 124.064 0.946 . . . . 10.0 111.019 166.82 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.97 136.08 53.37 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 123.947 0.899 . . . . 10.0 109.73 179.554 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.436 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 58.7 t -129.59 129.56 23.17 Favored Pre-proline 0 C--N 1.329 -0.295 0 C-N-CA 125.098 1.359 . . . . 10.0 110.966 -176.044 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 69' ' ' VAL . 6.3 Cg_exo -80.77 116.24 3.16 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 N-CA-C 109.41 -1.035 . . . . 10.0 109.41 -178.901 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -156.71 164.41 38.16 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 112.845 0.683 . . . . 10.0 112.845 172.443 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.37 -81.93 0.14 Allowed Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.681 -0.967 . . . . 10.0 110.681 175.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.8 -3.34 0.69 Allowed Glycine 0 CA--C 1.526 0.762 0 N-CA-C 118.677 2.231 . . . . 10.0 118.677 170.401 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -151.61 -171.89 4.06 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 119.379 1.589 . . . . 10.0 112.224 -165.194 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -91.84 93.88 9.05 Favored 'General case' 0 CA--C 1.519 -0.23 0 C-N-CA 125.547 1.539 . . . . 10.0 111.146 -175.319 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.451 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 60.5 m-80 -89.52 120.79 69.62 Favored Pre-proline 0 N--CA 1.45 -0.43 0 N-CA-C 112.933 0.716 . . . . 10.0 112.933 -165.895 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.652 ' HB3' HG21 ' A' ' 5' ' ' THR . 75.7 Cg_exo -61.53 131.92 38.19 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 124.208 3.272 . . . . 10.0 112.158 171.599 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.5 mm -140.12 126.34 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 C-N-CA 126.0 1.72 . . . . 10.0 111.71 -179.49 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -93.65 85.07 4.76 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 122.701 1.238 . . . . 10.0 113.055 174.626 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 63.8 p-90 -59.45 -28.2 66.75 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 113.921 1.082 . . . . 10.0 113.921 174.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -54.58 -28.53 46.8 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 113.809 1.04 . . . . 10.0 113.809 178.219 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 77.7 mtt-85 -52.15 -58.63 6.0 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 119.318 0.963 . . . . 10.0 111.263 169.358 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -58.67 -40.06 82.43 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 125.697 1.599 . . . . 10.0 111.967 -179.148 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -52.18 -50.95 60.83 Favored 'General case' 0 CA--C 1.552 1.05 0 CA-C-N 119.368 0.986 . . . . 10.0 112.133 168.198 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.457 ' CB ' ' HG3' ' A' ' 56' ' ' MET . 0.0 OUTLIER -60.34 -59.82 4.8 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.961 1.304 . . . . 10.0 112.388 173.18 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 52.3 m0 -54.19 -37.8 64.92 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 126.88 2.072 . . . . 10.0 112.714 -176.286 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 32.5 tp -50.39 -45.16 55.26 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 126.207 1.803 . . . . 10.0 111.845 178.713 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -97.79 -43.35 7.18 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 123.961 0.905 . . . . 10.0 112.671 -178.572 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -58.26 -44.09 88.2 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 113.105 0.779 . . . . 10.0 113.105 -176.446 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.427 ' HB ' ' HD3' ' A' ' 91' ' ' PRO . 3.5 m -68.58 -45.21 35.08 Favored Pre-proline 0 CA--C 1.544 0.735 0 O-C-N 121.302 -0.874 . . . . 10.0 112.386 -172.544 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.427 ' HD3' ' HB ' ' A' ' 90' ' ' THR . 73.6 Cg_exo -52.34 -44.43 46.68 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 123.672 2.914 . . . . 10.0 115.865 165.012 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 52.8 mt -59.09 -46.63 87.81 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 118.815 0.734 . . . . 10.0 111.426 175.335 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.2 tp -50.47 -48.73 56.51 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.65 1.58 . . . . 10.0 112.235 172.206 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.0 mp -59.09 -46.99 86.88 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.192 1.397 . . . . 10.0 112.714 170.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.88 -38.25 78.4 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.866 0.866 . . . . 10.0 112.837 178.528 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -52.24 -54.09 35.53 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 119.34 0.973 . . . . 10.0 111.187 169.607 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.35 -42.1 88.58 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.635 0.774 . . . . 10.0 112.113 -178.495 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.64 -54.79 36.95 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 124.006 0.923 . . . . 10.0 112.014 173.596 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.25 -41.15 79.05 Favored 'General case' 0 C--O 1.224 -0.237 0 C-N-CA 123.715 0.806 . . . . 10.0 112.764 174.812 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.8 tp -63.8 -38.54 91.46 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 114.436 1.273 . . . . 10.0 114.436 -179.626 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.2 t -94.83 1.39 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 125.069 1.347 . . . . 10.0 112.316 179.19 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.2 t70 48.63 53.49 12.13 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.864 1.666 . . . . 10.0 112.079 -174.044 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.27 145.93 47.56 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 119.988 -1.695 . . . . 10.0 112.469 -174.181 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.56 135.91 54.51 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 112.723 0.638 . . . . 10.0 112.723 175.157 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -42.87 -39.63 2.6 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.83 1.652 . . . . 10.0 113.508 175.3 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -47.34 -60.19 5.35 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 125.147 1.356 . . . . 10.0 115.264 169.703 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.6 p -62.09 -46.77 87.6 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 117.1 -1.428 . . . . 10.0 111.309 178.249 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 66.9 mt -48.41 -52.94 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 125.038 1.335 . . . . 10.0 111.117 178.196 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.2 tp -62.59 -51.31 67.84 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 112.528 0.566 . . . . 10.0 112.528 179.292 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.28 -44.81 44.25 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.437 0.695 . . . . 10.0 110.935 174.66 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.455 ' HA ' HD12 ' A' ' 111' ' ' LEU . 0.6 OUTLIER -59.56 -59.9 4.71 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 127.393 2.277 . . . . 10.0 114.831 174.874 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.6 t -61.01 -46.38 96.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 123.705 0.802 . . . . 10.0 111.37 -178.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -56.6 -50.36 63.61 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 123.686 0.66 . . . . 10.0 112.631 174.565 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -54.64 -46.67 73.99 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 113.215 0.82 . . . . 10.0 113.215 173.356 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -57.74 -45.75 85.39 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.218 0.607 . . . . 10.0 111.938 174.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -43.22 -56.09 4.79 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 125.196 1.379 . . . . 10.0 113.002 167.588 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 88.9 mt -56.76 -52.58 52.76 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 123.518 0.727 . . . . 10.0 111.372 174.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 6.1 tmm? -51.58 -56.72 11.9 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.786 1.234 . . . . 10.0 112.566 -176.385 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 44.5 mm . . . . . 0 N--CA 1.472 0.666 0 C-N-CA 123.068 0.547 . . . . 10.0 112.075 177.119 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 67.9 t . . . . . 0 N--CA 1.476 0.873 0 N-CA-C 110.36 -0.237 . . . . 10.0 110.36 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -49.77 -60.7 6.24 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 125.937 1.732 . . . . 10.0 112.191 172.068 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -49.11 -37.49 21.9 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.558 1.943 . . . . 10.0 113.732 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 48.8 mt -99.07 -6.71 27.93 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 115.315 1.598 . . . . 10.0 115.315 -179.243 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 16.9 m -69.66 116.75 10.42 Favored 'General case' 0 N--CA 1.464 0.229 0 O-C-N 120.15 -1.594 . . . . 10.0 110.386 -178.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.62 ' H ' ' HD3' ' A' ' 129' ' ' LYS . 0.1 OUTLIER -55.5 -49.63 72.06 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 128.23 2.612 . . . . 10.0 113.252 177.765 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 60.3 t -69.61 106.33 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 123.819 0.848 . . . . 10.0 110.071 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -46.92 -59.56 3.01 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 124.787 1.235 . . . . 10.0 114.048 -173.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 m -46.41 -42.13 14.7 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.474 1.51 . . . . 10.0 113.513 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -70.15 -24.63 63.19 Favored 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 114.95 1.463 . . . . 10.0 114.95 -178.131 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 69.3 mtp85 -53.78 -41.82 67.65 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 118.857 0.753 . . . . 10.0 110.881 176.559 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -69.42 -32.44 71.43 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.815 1.246 . . . . 10.0 114.216 176.594 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 49.0 t -55.12 -52.11 47.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 CA-C-N 119.033 0.833 . . . . 10.0 109.965 169.084 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 69.7 m95 -59.39 -51.5 69.63 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 113.47 0.915 . . . . 10.0 113.47 174.141 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 85.3 t90 -47.98 -47.23 33.07 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.268 1.027 . . . . 10.0 113.304 174.254 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.559 0 C-N-CA 124.058 0.943 . . . . 10.0 111.768 176.665 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.547 0.86 0 N-CA-C 112.922 0.712 . . . . 10.0 112.922 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 39.4 ttp -58.13 -51.41 69.83 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.19 0.996 . . . . 10.0 112.18 172.631 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 5.6 mp -51.65 -48.55 63.33 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 126.596 1.959 . . . . 10.0 112.042 175.342 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 77.9 t80 -54.07 -54.26 41.87 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.664 0.785 . . . . 10.0 113.06 172.574 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 49.4 mt -54.32 -55.35 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 123.566 0.746 . . . . 10.0 110.8 178.034 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . 0.289 3.9 pp -60.63 -31.26 70.46 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 116.833 -1.556 . . . . 10.0 113.371 179.055 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -57.26 -58.2 9.28 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 120.554 1.524 . . . . 10.0 113.064 170.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.39 -40.88 85.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-O 118.321 -0.847 . . . . 10.0 111.469 177.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 46.9 mt -56.83 -49.34 75.7 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 119.84 1.2 . . . . 10.0 112.164 171.246 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.47 ' HA ' ' HD2' ' A' ' 175' ' ' ARG . 11.8 t80 -76.97 -70.34 0.47 Allowed 'General case' 0 C--N 1.326 -0.447 0 O-C-N 120.056 -1.653 . . . . 10.0 112.887 -175.288 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -73.71 -21.99 60.05 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.596 1.158 . . . . 10.0 113.439 -174.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -87.78 -79.08 1.26 Allowed Glycine 0 CA--C 1.526 0.77 0 C-N-CA 123.602 0.62 . . . . 10.0 113.545 171.489 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 5.4 m-30 -53.61 -32.46 51.25 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 126.271 1.828 . . . . 10.0 113.019 -166.528 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.3 m -52.08 -56.44 14.4 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 113.991 1.108 . . . . 10.0 113.991 172.145 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.6 p -53.68 -50.58 65.52 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 122.121 0.962 . . . . 10.0 112.282 -177.849 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 47.7 tttm -57.15 -46.01 83.09 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.194 0.998 . . . . 10.0 112.11 173.702 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.82 -47.46 80.24 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 114.545 1.313 . . . . 10.0 114.545 174.007 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -56.49 -11.28 1.21 Allowed 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 126.068 1.747 . . . . 10.0 114.258 177.65 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.1 m -107.08 6.57 29.04 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.467 1.907 . . . . 10.0 114.881 -179.308 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 93.2 mmm -91.89 -92.67 0.15 Allowed 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 123.506 1.622 . . . . 10.0 114.164 -170.602 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -138.69 153.97 72.71 Favored Pre-proline 0 C--O 1.236 0.349 0 C-N-CA 129.848 3.259 . . . . 10.0 105.548 170.197 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -52.88 -46.21 35.38 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.261 1.974 . . . . 10.0 113.074 179.056 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.667 ' CD ' ' HD3' ' A' ' 227' ' ' ARG . 0.1 OUTLIER -52.95 -46.08 68.02 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 129.022 2.929 . . . . 10.0 113.242 173.569 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 92.2 t -69.18 -52.99 28.02 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 C-N-CA 124.085 0.954 . . . . 10.0 109.85 -178.64 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.2 -46.8 75.89 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.238 0.615 . . . . 10.0 111.933 177.016 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 60.1 p -59.95 -56.25 24.06 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.972 0.909 . . . . 10.0 112.68 174.623 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 62.0 m -57.22 -53.19 60.94 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.202 1.001 . . . . 10.0 113.004 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -49.61 -49.49 46.65 Favored 'General case' 0 C--O 1.222 -0.375 0 C-N-CA 123.239 0.616 . . . . 10.0 111.102 174.071 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -57.11 -48.46 78.57 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 114.629 1.344 . . . . 10.0 114.629 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 40.4 t -55.95 -49.63 74.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 CA-C-N 118.794 0.725 . . . . 10.0 110.476 176.402 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 94.2 mt -58.57 -51.63 69.09 Favored 'General case' 0 C--O 1.222 -0.389 0 N-CA-C 113.201 0.815 . . . . 10.0 113.201 175.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 175' ' ' ARG . . . . . 0.47 ' HD2' ' HA ' ' A' ' 153' ' ' PHE . 35.5 ttp180 -47.71 -47.77 29.85 Favored 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 126.85 2.06 . . . . 10.0 111.092 174.395 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 63.4 m-20 -58.55 -58.29 9.22 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 122.799 0.44 . . . . 10.0 111.255 174.409 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 54.2 t -51.93 -47.61 41.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 C-N-CA 124.082 0.953 . . . . 10.0 112.143 179.026 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 25.0 m -59.39 -63.02 1.45 Allowed 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 127.507 2.323 . . . . 10.0 111.755 178.365 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 55.8 t -50.12 -49.9 21.21 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 C-N-CA 124.799 1.24 . . . . 10.0 110.975 -179.425 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 70.8 t -59.13 -61.65 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 123.912 0.885 . . . . 10.0 112.616 178.127 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 91.5 mt -58.36 -46.99 85.23 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 118.19 0.45 . . . . 10.0 111.871 -176.609 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 9.0 m0 . . . . . 0 N--CA 1.465 0.295 0 C-N-CA 124.121 0.968 . . . . 10.0 112.217 174.67 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 90.4 t . . . . . 0 N--CA 1.479 0.991 0 CA-C-O 119.499 -0.286 . . . . 10.0 111.657 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 34.7 t90 -55.79 -55.82 27.88 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.844 1.258 . . . . 10.0 112.288 174.26 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 9.8 tt -55.9 -44.23 78.03 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 124.289 1.036 . . . . 10.0 112.639 -177.414 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 14.7 pt -82.79 -5.68 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 N-CA-C 114.989 1.477 . . . . 10.0 114.989 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.58 -169.35 32.75 Favored Glycine 0 N--CA 1.45 -0.379 0 CA-C-O 122.545 1.08 . . . . 10.0 113.855 -168.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 23.2 t -53.15 -39.55 63.63 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 114.217 -0.992 . . . . 10.0 111.847 177.613 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -56.86 -32.39 65.76 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 128.439 2.695 . . . . 10.0 115.286 -179.307 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -129.61 -104.41 1.11 Allowed Glycine 0 CA--C 1.524 0.628 0 CA-C-O 122.169 0.872 . . . . 10.0 112.738 -167.763 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -89.39 127.17 35.79 Favored 'General case' 0 C--N 1.328 -0.352 0 O-C-N 120.64 -1.506 . . . . 10.0 109.3 170.146 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -72.5 65.38 1.37 Allowed Glycine 0 CA--C 1.532 1.124 0 N-CA-C 113.879 0.312 . . . . 10.0 113.879 173.133 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 60.6 mt -79.67 -42.69 22.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 126.083 1.753 . . . . 10.0 108.725 166.392 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.4 ' CG1' ' HB ' ' A' ' 203' ' ' ILE . 79.8 t -126.31 133.4 24.93 Favored Pre-proline 0 N--CA 1.454 -0.264 0 C-N-CA 126.47 1.908 . . . . 10.0 109.364 -174.209 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -68.73 153.75 72.57 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 123.822 3.015 . . . . 10.0 111.456 -176.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 12.2 tp -43.1 -39.87 2.96 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.358 1.063 . . . . 10.0 112.199 171.473 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -48.28 -52.44 21.34 Favored 'General case' 0 CA--C 1.539 0.519 0 N-CA-C 114.673 1.361 . . . . 10.0 114.673 176.052 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 203' ' ' ILE . . . . . 0.4 ' HB ' ' CG1' ' A' ' 199' ' ' VAL . 14.0 mm -75.88 -40.53 38.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 124.434 1.094 . . . . 10.0 109.625 177.579 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.29 -49.79 42.08 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 118.61 0.641 . . . . 10.0 111.974 173.639 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 15.9 m -57.69 -47.08 83.35 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 126.046 1.738 . . . . 10.0 112.964 174.283 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.535 HD23 ' CD2' ' A' ' 12' ' ' TRP . 1.4 tm? -63.27 -52.33 62.48 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.958 0.903 . . . . 10.0 112.114 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 93.3 mt -52.58 -58.95 5.16 Favored 'General case' 0 C--O 1.227 -0.087 0 C-N-CA 124.293 1.037 . . . . 10.0 110.021 176.456 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -54.8 -43.73 73.17 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 117.766 -1.111 . . . . 10.0 112.912 177.016 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 209' ' ' MET . . . . . 0.574 ' HE2' ' HB3' ' A' ' 15' ' ' LEU . 4.6 tmm? -52.31 -53.2 47.4 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 120.277 1.399 . . . . 10.0 112.252 174.024 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 77.1 t -60.81 -48.13 90.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 124.525 1.13 . . . . 10.0 111.754 178.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 5.1 mp -56.74 -53.45 57.65 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.148 1.379 . . . . 10.0 111.712 175.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -55.68 -52.76 62.77 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.127 1.771 . . . . 10.0 111.594 178.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 46.0 t . . . . . 0 N--CA 1.479 1.012 0 C-N-CA 124.618 1.167 . . . . 10.0 110.705 173.788 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.338 0 CA-C-O 120.932 0.185 . . . . 10.0 112.929 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 35.6 t80 -43.94 -56.31 4.02 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.513 1.925 . . . . 10.0 112.723 168.816 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -58.98 -39.16 93.86 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 124.576 1.084 . . . . 10.0 113.114 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 24.7 mt -69.5 -27.92 65.61 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 115.792 1.775 . . . . 10.0 115.792 175.026 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 74.3 mt -63.35 -57.61 11.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 119.22 0.918 . . . . 10.0 108.634 165.678 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 32.2 tp -58.87 -64.66 0.86 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.924 0.89 . . . . 10.0 113.165 -172.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 84.2 mt -71.55 5.22 2.5 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 115.323 1.601 . . . . 10.0 115.323 -171.686 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.6 mtp-105 -112.36 0.38 15.64 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.199 1.0 . . . . 10.0 113.272 172.56 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 8.8 t -108.03 177.97 4.65 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 124.026 0.93 . . . . 10.0 111.015 174.661 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 227' ' ' ARG . . . . . 0.667 ' HD3' ' CD ' ' A' ' 166' ' ' GLU . 41.8 ttt180 -71.65 98.22 1.87 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.752 0.821 . . . . 10.0 110.91 170.647 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 228' ' ' ALA . . . . . 0.475 ' HB1' ' CD2' ' A' ' 42' ' ' PHE . . . -80.96 77.03 7.89 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.814 0.846 . . . . 10.0 112.123 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 40.09 102.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 128.857 2.863 . . . . 10.0 116.481 177.783 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . 0.482 0.3 OUTLIER 71.87 -55.46 0.66 Allowed 'General case' 0 C--O 1.242 0.699 0 C-N-CA 124.711 1.205 . . . . 10.0 110.591 -175.331 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -68.28 169.47 40.01 Favored Glycine 0 C--O 1.239 0.417 0 C-N-CA 129.757 3.551 . . . . 10.0 119.653 171.53 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.474 0 C-N-CA 128.458 2.703 . . . . 10.0 113.43 166.573 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 N--CA 1.476 0.87 0 CA-C-O 115.817 -2.039 . . . . 10.0 105.775 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 23.44 91.84 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 129.532 3.133 . . . . 10.0 117.276 160.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 28.6 65.05 0.11 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 128.301 2.641 . . . . 10.0 114.514 155.45 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 86.6 mt -56.44 137.98 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 126.396 1.878 . . . . 10.0 113.338 -158.382 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.652 HG21 ' HB3' ' A' ' 77' ' ' PRO . 7.6 t -136.8 -165.22 1.7 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 126.286 1.834 . . . . 10.0 114.021 -174.344 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 70.06 2.79 41.4 Favored Glycine 0 C--N 1.34 0.786 0 C-N-CA 127.443 2.449 . . . . 10.0 111.451 168.017 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -158.57 -51.32 0.01 OUTLIER Pre-proline 0 N--CA 1.443 -0.783 0 CA-C-O 114.263 -2.78 . . . . 10.0 116.649 -168.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -64.03 -60.6 0.15 Allowed 'Trans proline' 0 CA--C 1.528 0.185 0 CA-C-N 123.538 2.299 . . . . 10.0 113.205 -175.287 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.41 ' H ' ' CD ' ' A' ' 9' ' ' GLU . 7.9 pm0 -67.21 4.3 0.97 Allowed 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 127.886 2.475 . . . . 10.0 115.732 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.421 ' CG ' ' N ' ' A' ' 11' ' ' ILE . 11.1 p-90 -51.39 -43.07 61.8 Favored 'General case' 0 C--O 1.222 -0.361 0 O-C-N 121.455 -0.778 . . . . 10.0 112.617 176.43 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.421 ' N ' ' CG ' ' A' ' 10' ' ' TRP . 8.9 tt -60.83 -49.65 83.73 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.34 0 C-N-CA 123.926 0.89 . . . . 10.0 109.339 179.37 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' TRP . . . . . 0.536 ' CD2' HD23 ' A' ' 206' ' ' LEU . 2.6 m95 -55.4 -52.67 62.81 Favored 'General case' 0 C--O 1.224 -0.259 0 C-N-CA 123.407 0.683 . . . . 10.0 111.871 175.626 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.5 mt -57.34 -53.62 56.04 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 123.175 0.59 . . . . 10.0 112.198 177.241 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.86 -46.82 51.89 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.427 1.491 . . . . 10.0 113.268 173.867 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.575 ' HB3' ' HE2' ' A' ' 209' ' ' MET . 13.3 tp -65.68 -44.92 84.76 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 125.274 1.43 . . . . 10.0 113.012 179.154 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.49 -56.79 10.34 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 124.568 1.08 . . . . 10.0 111.588 166.001 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 22.3 m -49.22 -52.68 25.41 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.987 1.315 . . . . 10.0 112.373 174.397 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.42 -58.85 5.84 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.151 0.98 . . . . 10.0 112.19 177.765 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 93.0 mt -57.26 -49.03 77.35 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.686 0.794 . . . . 10.0 112.736 -179.362 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 52.8 mtt -58.83 -47.87 83.33 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.121 0.968 . . . . 10.0 111.101 177.781 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -57.13 -58.6 13.72 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 124.333 0.968 . . . . 10.0 113.99 173.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 80.8 mt -56.24 -45.52 79.96 Favored 'General case' 0 C--O 1.221 -0.426 0 CA-C-N 118.646 1.223 . . . . 10.0 112.112 176.22 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.08 -41.04 84.7 Favored Glycine 0 CA--C 1.531 1.093 0 O-C-N 120.929 -1.107 . . . . 10.0 113.652 173.003 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 22.1 m -60.06 -60.43 3.84 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.793 0.837 . . . . 10.0 110.831 171.134 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -52.22 -41.02 62.38 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.073 0.949 . . . . 10.0 110.958 179.053 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -55.8 -58.01 9.63 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.557 1.143 . . . . 10.0 112.991 172.787 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -59.65 -38.72 82.16 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 113.201 0.815 . . . . 10.0 113.201 178.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.401 ' C ' ' H ' ' A' ' 30' ' ' LYS . 11.8 mt -56.11 -67.42 0.3 Allowed 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.58 1.152 . . . . 10.0 113.627 169.131 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 t -76.37 40.93 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-O 123.77 1.747 . . . . 10.0 110.891 179.074 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.401 ' H ' ' C ' ' A' ' 28' ' ' LEU . 42.9 tttm -140.82 -44.82 0.39 Allowed 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 127.884 2.474 . . . . 10.0 109.35 171.187 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -73.02 23.15 0.88 Allowed Glycine 0 CA--C 1.529 0.928 0 N-CA-C 115.634 1.014 . . . . 10.0 115.634 173.715 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 37.3 mmm -59.54 -44.96 93.07 Favored 'General case' 0 C--O 1.223 -0.296 0 C-N-CA 127.136 2.174 . . . . 10.0 113.578 -179.026 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.72 -84.4 1.19 Allowed Glycine 0 CA--C 1.53 1.007 0 C-N-CA 123.718 0.675 . . . . 10.0 112.452 -170.121 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.8 t 33.04 88.79 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.242 0.682 0 C-N-CA 128.4 2.68 . . . . 10.0 116.961 166.499 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.7 m -79.62 -50.93 9.93 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.187 -1.37 . . . . 10.0 113.866 174.147 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -48.93 117.51 6.43 Favored Pre-proline 0 CA--C 1.537 0.454 0 O-C-N 124.719 1.262 . . . . 10.0 110.937 -172.489 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -58.57 -29.7 89.77 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 123.746 2.964 . . . . 10.0 113.669 179.139 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.26 -60.68 2.28 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.111 0.565 . . . . 10.0 111.441 176.192 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.16 -40.07 22.71 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 125.097 1.359 . . . . 10.0 113.565 171.621 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -46.53 -47.45 19.55 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 125.221 1.408 . . . . 10.0 113.463 172.046 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -57.74 -53.06 62.47 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.431 0.693 . . . . 10.0 110.99 176.628 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.476 ' CD2' ' HB1' ' A' ' 228' ' ' ALA . 44.2 m-85 -56.95 -50.22 73.28 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 123.09 0.556 . . . . 10.0 112.339 -179.115 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -54.33 -51.32 65.08 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 118.962 -0.542 . . . . 10.0 112.369 173.28 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.42 -62.02 1.91 Allowed 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 113.34 0.867 . . . . 10.0 113.34 177.185 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.6 mt -48.8 -56.98 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 124.842 1.257 . . . . 10.0 110.396 178.041 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.2 m -69.76 -16.45 63.31 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.085 1.354 . . . . 10.0 113.605 -172.369 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 30.1 m -87.0 -43.28 12.47 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 119.735 1.152 . . . . 10.0 111.842 174.381 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 20.1 mt -56.84 -40.94 76.98 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 112.937 0.718 . . . . 10.0 112.937 173.166 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 44.4 t -49.43 -62.05 2.85 Favored Pre-proline 0 CA--C 1.552 1.047 0 C-N-CA 124.473 1.109 . . . . 10.0 112.494 178.138 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -48.72 -46.92 22.62 Favored 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 124.593 3.529 . . . . 10.0 116.236 164.484 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.64 -45.7 93.07 Favored 'General case' 0 CA--C 1.548 0.901 0 CA-C-N 119.904 1.229 . . . . 10.0 113.875 -176.606 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 52.9 mt -57.58 -51.69 66.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 124.536 1.134 . . . . 10.0 109.376 172.092 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.5 -45.85 73.37 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.31 1.044 . . . . 10.0 113.056 176.756 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -50.52 -56.7 10.47 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 125.283 1.433 . . . . 10.0 112.228 171.355 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 13.2 m -49.72 -52.73 29.24 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 125.283 1.433 . . . . 10.0 110.674 177.66 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 32.4 mmt -68.67 -48.34 64.2 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 124.001 0.92 . . . . 10.0 113.025 -176.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -57.01 -40.16 76.11 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-O 117.083 -1.437 . . . . 10.0 113.214 173.245 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.8 tp -53.3 -54.54 34.82 Favored 'General case' 0 C--O 1.224 -0.272 0 CA-C-N 120.118 1.327 . . . . 10.0 111.334 170.173 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 24.0 p -51.64 -41.1 61.06 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 115.221 1.563 . . . . 10.0 115.221 178.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 57.9 mtm -66.86 -50.85 61.19 Favored 'General case' 0 C--N 1.334 -0.09 0 C-N-CA 123.597 0.759 . . . . 10.0 110.477 176.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.4 tp -48.58 -52.67 21.69 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.88 0.872 . . . . 10.0 112.926 172.346 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.5 mt -76.98 -5.53 49.01 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.358 1.063 . . . . 10.0 113.781 -177.638 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.29 -34.72 5.54 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 115.47 0.948 . . . . 10.0 115.47 174.072 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -49.29 -43.13 42.99 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 115.206 1.558 . . . . 10.0 115.206 -175.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.03 3.56 61.03 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 115.35 0.9 . . . . 10.0 115.35 -179.018 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.2 143.36 26.5 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 127.056 2.142 . . . . 10.0 109.038 171.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 t -145.47 171.13 15.09 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 124.023 0.929 . . . . 10.0 111.077 166.759 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.02 136.04 53.4 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 123.932 0.893 . . . . 10.0 109.711 179.583 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.437 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 58.9 t -129.52 129.61 23.21 Favored Pre-proline 0 C--N 1.329 -0.299 0 C-N-CA 125.109 1.364 . . . . 10.0 110.999 -176.096 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 69' ' ' VAL . 6.3 Cg_exo -80.76 116.22 3.16 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 N-CA-C 109.417 -1.032 . . . . 10.0 109.417 -178.897 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -156.75 164.4 38.16 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.824 0.676 . . . . 10.0 112.824 172.485 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.35 -81.96 0.14 Allowed Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.696 -0.961 . . . . 10.0 110.696 175.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.72 -3.4 0.7 Allowed Glycine 0 CA--C 1.527 0.836 0 N-CA-C 118.637 2.215 . . . . 10.0 118.637 170.407 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -151.56 -171.85 4.05 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 119.339 1.569 . . . . 10.0 112.257 -165.17 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -91.92 93.91 9.03 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 125.504 1.522 . . . . 10.0 111.088 -175.277 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.45 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 60.5 m-80 -89.51 120.82 69.62 Favored Pre-proline 0 N--CA 1.45 -0.431 0 N-CA-C 112.963 0.727 . . . . 10.0 112.963 -165.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.652 ' HB3' HG21 ' A' ' 5' ' ' THR . 76.6 Cg_exo -61.49 131.89 38.14 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 124.183 3.255 . . . . 10.0 112.199 171.553 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.6 mm -140.14 126.36 21.92 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 C-N-CA 125.999 1.72 . . . . 10.0 111.704 -179.504 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -93.66 85.04 4.74 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 122.812 1.291 . . . . 10.0 113.046 174.656 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 63.7 p-90 -59.35 -28.24 66.66 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 113.905 1.076 . . . . 10.0 113.905 174.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -55.39 -32.05 62.32 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.296 1.038 . . . . 10.0 111.811 178.258 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.433 ' HG3' HH11 ' A' ' 82' ' ' ARG . 23.4 ttm-85 -47.78 -40.63 21.38 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 126.888 2.075 . . . . 10.0 113.493 170.032 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 62.2 m-85 -86.47 -39.57 16.18 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.418 1.887 . . . . 10.0 111.755 -177.358 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -49.07 -47.85 44.62 Favored 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 124.555 1.142 . . . . 10.0 111.013 166.801 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -52.03 -71.97 0.06 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 126.471 1.908 . . . . 10.0 111.809 167.592 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 52.7 m0 -55.09 -33.77 63.08 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 124.095 0.958 . . . . 10.0 113.582 -170.297 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 24.3 tp -49.68 -40.44 40.05 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 126.285 1.834 . . . . 10.0 111.994 177.607 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -105.02 -40.37 5.92 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.378 0.671 . . . . 10.0 112.377 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 76.0 p -62.29 -42.16 99.12 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 120.664 1.575 . . . . 10.0 114.022 -179.21 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . 0.291 69.5 p -69.44 -41.32 16.85 Favored Pre-proline 0 CA--C 1.547 0.854 0 N-CA-C 114.959 1.466 . . . . 10.0 114.959 -176.761 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -55.11 -42.92 64.22 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 123.328 2.685 . . . . 10.0 115.137 166.261 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 55.0 mt -60.33 -47.39 86.22 Favored 'General case' 0 CA--C 1.544 0.724 0 O-C-N 121.507 -0.745 . . . . 10.0 111.677 176.017 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 6.1 tt -50.19 -49.37 52.72 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.723 1.609 . . . . 10.0 111.522 171.209 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.6 mp -57.26 -47.34 81.66 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.274 1.03 . . . . 10.0 113.135 170.458 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.86 -38.21 78.26 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 123.844 0.857 . . . . 10.0 112.9 178.354 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -52.32 -54.02 36.9 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 119.299 0.954 . . . . 10.0 111.21 169.61 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.33 -42.11 88.67 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 123.64 0.776 . . . . 10.0 112.144 -178.558 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.7 -54.68 38.59 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.98 0.912 . . . . 10.0 112.041 173.624 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.29 -41.18 79.32 Favored 'General case' 0 C--O 1.224 -0.24 0 C-N-CA 123.677 0.791 . . . . 10.0 112.714 174.782 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 32.2 tp -63.8 -38.56 91.55 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 114.436 1.273 . . . . 10.0 114.436 -179.582 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.2 t -94.79 1.41 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 125.005 1.322 . . . . 10.0 112.298 179.163 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.2 t70 48.6 53.5 12.08 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.864 1.666 . . . . 10.0 112.101 -174.029 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.28 145.88 47.59 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 119.951 -1.718 . . . . 10.0 112.47 -174.18 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.47 135.93 54.16 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 112.711 0.634 . . . . 10.0 112.711 175.156 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -42.89 -39.64 2.63 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.854 1.661 . . . . 10.0 113.471 175.286 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -47.33 -60.22 5.33 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 125.205 1.383 . . . . 10.0 115.213 169.747 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.5 p -62.1 -46.75 87.7 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 117.053 -1.451 . . . . 10.0 111.321 178.248 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 66.9 mt -48.48 -52.89 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 124.998 1.319 . . . . 10.0 111.11 178.24 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.1 tp -62.58 -51.37 67.62 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 112.528 0.566 . . . . 10.0 112.528 179.28 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.11 -44.86 42.66 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.47 0.708 . . . . 10.0 110.959 174.601 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.456 ' HA ' HD12 ' A' ' 111' ' ' LEU . 0.6 OUTLIER -59.62 -59.89 4.72 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 127.404 2.281 . . . . 10.0 114.79 174.981 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.8 t -61.04 -46.32 96.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 123.705 0.802 . . . . 10.0 111.411 -178.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -56.62 -50.35 63.7 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 123.674 0.655 . . . . 10.0 112.642 174.511 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -54.93 -46.62 74.97 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 113.696 0.998 . . . . 10.0 113.696 173.361 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -55.02 -49.27 71.94 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.48 0.712 . . . . 10.0 111.166 173.225 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -42.87 -54.57 5.05 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 125.06 1.314 . . . . 10.0 113.059 170.52 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 86.9 mt -56.11 -54.43 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 CA-C-O 118.281 -0.866 . . . . 10.0 111.327 173.739 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 1.7 ptt? -56.8 -45.29 82.32 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 119.692 1.133 . . . . 10.0 113.038 -174.228 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 1.7 mp . . . . . 0 N--CA 1.479 1.001 0 CA-C-N 119.051 0.841 . . . . 10.0 111.047 174.732 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 60.8 t . . . . . 0 N--CA 1.478 0.935 0 N-CA-C 110.14 -0.319 . . . . 10.0 110.14 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -50.79 -61.14 6.31 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 126.305 1.907 . . . . 10.0 112.646 171.66 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -42.83 -42.26 3.56 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 127.772 2.429 . . . . 10.0 113.208 176.581 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 47.7 mt -100.84 -6.81 24.27 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 115.531 1.678 . . . . 10.0 115.531 -175.176 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 17.0 m -69.65 116.71 10.36 Favored 'General case' 0 N--CA 1.465 0.294 0 O-C-N 120.14 -1.6 . . . . 10.0 110.398 -178.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.622 ' H ' ' HD3' ' A' ' 129' ' ' LYS . 0.2 OUTLIER -55.45 -49.6 72.05 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 128.2 2.6 . . . . 10.0 113.25 177.75 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 60.8 t -69.69 106.33 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 123.797 0.839 . . . . 10.0 110.103 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -46.87 -59.54 3.01 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 124.774 1.229 . . . . 10.0 114.089 -173.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 m -46.52 -42.05 15.1 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.488 1.515 . . . . 10.0 113.495 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -70.16 -24.61 63.18 Favored 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 114.958 1.466 . . . . 10.0 114.958 -178.125 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 69.0 mtp85 -54.12 -41.43 68.33 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 118.845 0.748 . . . . 10.0 110.839 176.725 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -69.73 -32.18 70.59 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.842 1.257 . . . . 10.0 114.217 176.569 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.8 t -54.84 -52.23 44.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 CA-C-N 119.013 0.824 . . . . 10.0 109.83 168.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 65.6 m95 -59.66 -49.87 76.06 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 113.458 0.911 . . . . 10.0 113.458 173.446 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 89.8 t90 -48.35 -48.59 36.36 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 119.504 1.047 . . . . 10.0 113.214 173.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.637 0 C-N-CA 124.203 1.001 . . . . 10.0 111.976 176.241 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.547 0.854 0 N-CA-C 112.971 0.73 . . . . 10.0 112.971 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 38.2 ttp -57.49 -53.7 55.2 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.275 1.03 . . . . 10.0 112.005 171.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 62.7 tp -53.51 -47.0 70.28 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.191 1.396 . . . . 10.0 111.852 178.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -50.53 -54.84 19.33 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.003 0.921 . . . . 10.0 112.407 170.489 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 54.5 mt -53.62 -55.05 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 123.762 0.825 . . . . 10.0 110.805 177.664 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 38.8 mt -57.16 -35.98 70.2 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 118.365 -0.826 . . . . 10.0 112.997 178.507 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -57.24 -58.26 9.02 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 124.068 0.947 . . . . 10.0 113.006 173.293 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.34 -40.89 85.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 CA-C-O 118.343 -0.837 . . . . 10.0 111.492 177.941 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 45.4 mt -56.83 -49.4 75.53 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 119.845 1.202 . . . . 10.0 112.14 171.254 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.469 ' HA ' ' HD2' ' A' ' 175' ' ' ARG . 11.9 t80 -76.97 -70.34 0.47 Allowed 'General case' 0 C--N 1.326 -0.447 0 O-C-N 120.022 -1.674 . . . . 10.0 112.887 -175.264 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -73.74 -21.87 60.07 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.567 1.147 . . . . 10.0 113.448 -174.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -87.8 -79.16 1.26 Allowed Glycine 0 CA--C 1.527 0.783 0 C-N-CA 123.666 0.651 . . . . 10.0 113.496 171.523 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -53.63 -32.4 51.15 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 126.299 1.839 . . . . 10.0 113.046 -166.513 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.2 m -52.08 -56.5 13.99 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 114.012 1.116 . . . . 10.0 114.012 172.086 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.4 p -53.67 -50.53 65.61 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 122.057 0.932 . . . . 10.0 112.281 -177.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 47.6 tttm -57.13 -46.05 83.0 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.197 0.999 . . . . 10.0 112.117 173.65 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.82 -47.46 80.24 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 114.545 1.313 . . . . 10.0 114.545 174.034 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -56.5 -11.29 1.22 Allowed 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 126.089 1.755 . . . . 10.0 114.228 177.677 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.2 m -107.1 6.64 29.08 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.416 1.886 . . . . 10.0 114.877 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 93.2 mmm -91.88 -92.63 0.15 Allowed 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 123.521 1.629 . . . . 10.0 114.191 -170.606 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -138.74 153.98 72.62 Favored Pre-proline 0 C--O 1.236 0.359 0 C-N-CA 129.802 3.241 . . . . 10.0 105.548 170.185 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -52.86 -46.22 35.24 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 122.3 2.0 . . . . 10.0 113.088 179.056 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.667 ' CD ' ' HD3' ' A' ' 227' ' ' ARG . 0.1 OUTLIER -52.97 -46.03 68.04 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 129.022 2.929 . . . . 10.0 113.276 173.578 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 91.7 t -69.26 -53.03 27.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 C-N-CA 124.02 0.928 . . . . 10.0 109.782 -178.616 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.09 -46.85 75.53 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.282 0.633 . . . . 10.0 111.923 177.047 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 60.5 p -60.02 -56.19 24.74 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.953 0.901 . . . . 10.0 112.67 174.672 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 62.0 m -57.22 -53.19 60.94 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.202 1.001 . . . . 10.0 113.004 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -49.59 -49.54 46.26 Favored 'General case' 0 C--O 1.221 -0.425 0 C-N-CA 123.289 0.636 . . . . 10.0 111.067 174.098 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -57.12 -48.41 78.72 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 114.671 1.36 . . . . 10.0 114.671 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 40.4 t -55.95 -49.63 74.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 CA-C-N 118.832 0.742 . . . . 10.0 110.476 176.373 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 94.1 mt -58.54 -51.65 68.99 Favored 'General case' 0 C--O 1.222 -0.392 0 N-CA-C 113.168 0.803 . . . . 10.0 113.168 175.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' ARG . . . . . 0.469 ' HD2' ' HA ' ' A' ' 153' ' ' PHE . 35.5 ttp180 -47.79 -47.76 30.7 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 126.824 2.05 . . . . 10.0 111.059 174.448 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 63.7 m-20 -58.53 -58.32 9.06 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 122.771 0.428 . . . . 10.0 111.286 174.405 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 59.5 t -51.85 -49.48 36.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 124.048 0.939 . . . . 10.0 111.449 179.029 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 35.3 m -55.74 -64.09 0.96 Allowed 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 128.428 2.691 . . . . 10.0 111.939 177.248 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 55.7 t -51.05 -49.56 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 124.541 1.136 . . . . 10.0 111.317 -179.05 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 79.6 t -59.76 -61.64 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 124.209 1.004 . . . . 10.0 112.198 177.07 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -57.86 -47.72 81.91 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 118.873 0.761 . . . . 10.0 112.287 -176.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 10.7 m95 . . . . . 0 N--CA 1.469 0.498 0 C-N-CA 123.878 0.871 . . . . 10.0 111.71 175.584 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 93.2 t . . . . . 0 N--CA 1.479 1.007 0 CA-C-O 119.252 -0.404 . . . . 10.0 111.442 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 52.1 t90 -55.46 -51.58 66.48 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.317 1.047 . . . . 10.0 112.498 174.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 34.4 tp -54.29 -45.63 72.56 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.878 1.271 . . . . 10.0 112.362 -178.152 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 15.4 pt -87.41 -5.05 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 115.17 1.544 . . . . 10.0 115.17 -177.47 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.49 -169.22 32.84 Favored Glycine 0 N--CA 1.451 -0.353 0 CA-C-O 122.545 1.08 . . . . 10.0 113.882 -168.847 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 23.2 t -53.21 -41.44 65.34 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 114.243 -0.979 . . . . 10.0 111.818 177.619 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -67.2 -17.05 64.66 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 115.659 1.726 . . . . 10.0 115.659 -175.835 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -130.99 -105.97 1.09 Allowed Glycine 0 CA--C 1.532 1.1 0 CA-C-N 120.381 1.446 . . . . 10.0 113.82 -172.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -89.42 127.15 35.8 Favored 'General case' 0 C--N 1.328 -0.352 0 O-C-N 120.64 -1.506 . . . . 10.0 109.349 168.588 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -72.46 65.36 1.36 Allowed Glycine 0 CA--C 1.532 1.124 0 N-CA-C 113.873 0.309 . . . . 10.0 113.873 173.197 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 60.7 mt -79.63 -42.74 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 126.083 1.753 . . . . 10.0 108.721 166.392 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.4 ' CG1' ' HB ' ' A' ' 203' ' ' ILE . 79.8 t -126.29 133.4 24.93 Favored Pre-proline 0 N--CA 1.454 -0.264 0 C-N-CA 126.502 1.921 . . . . 10.0 109.364 -174.179 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -68.78 153.82 72.33 Favored 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 123.751 2.967 . . . . 10.0 111.425 -176.846 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 12.2 tp -43.18 -39.75 3.03 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.281 1.033 . . . . 10.0 112.223 171.486 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -48.34 -52.39 21.82 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 114.705 1.372 . . . . 10.0 114.705 176.053 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 203' ' ' ILE . . . . . 0.4 ' HB ' ' CG1' ' A' ' 199' ' ' VAL . 14.0 mm -75.91 -40.48 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 124.378 1.071 . . . . 10.0 109.674 177.572 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -49.29 -49.85 41.84 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 118.553 0.615 . . . . 10.0 111.946 173.605 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 15.9 m -57.69 -47.08 83.36 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 126.046 1.738 . . . . 10.0 112.964 174.323 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.536 HD23 ' CD2' ' A' ' 12' ' ' TRP . 1.3 tm? -63.28 -52.33 62.45 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.977 0.911 . . . . 10.0 112.101 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 93.3 mt -52.58 -59.34 4.57 Favored 'General case' 0 C--N 1.335 -0.044 0 C-N-CA 124.265 1.026 . . . . 10.0 109.989 176.455 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -52.75 -47.35 67.51 Favored 'General case' 0 C--O 1.219 -0.53 0 CA-C-O 117.286 -1.34 . . . . 10.0 112.102 176.475 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 209' ' ' MET . . . . . 0.575 ' HE2' ' HB3' ' A' ' 15' ' ' LEU . 4.6 tmm? -50.84 -52.5 40.91 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 120.976 1.716 . . . . 10.0 112.974 174.776 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 80.4 t -60.86 -46.93 95.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 124.798 1.239 . . . . 10.0 111.524 178.332 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 4.1 mp -59.45 -51.57 69.32 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.496 1.518 . . . . 10.0 112.261 175.68 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -55.08 -55.97 25.06 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 127.245 2.218 . . . . 10.0 110.281 175.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 38.1 t . . . . . 0 N--CA 1.476 0.842 0 C-N-CA 124.529 1.131 . . . . 10.0 111.488 173.709 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.236 0 N-CA-C 111.731 -0.547 . . . . 10.0 111.731 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -44.03 -58.81 2.61 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 127.2 2.2 . . . . 10.0 112.357 166.037 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -55.41 -41.7 81.17 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 123.991 0.805 . . . . 10.0 114.319 179.284 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 23.8 mt -70.63 -26.73 63.61 Favored 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 115.505 1.668 . . . . 10.0 115.505 178.227 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 74.0 mt -63.2 -57.56 11.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 108.741 -0.837 . . . . 10.0 108.741 165.409 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 32.1 tp -58.77 -64.68 0.85 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.901 0.88 . . . . 10.0 113.183 -172.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 84.0 mt -71.53 5.19 2.51 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 115.315 1.598 . . . . 10.0 115.315 -171.648 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.6 mtp-105 -112.31 0.33 15.67 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.231 1.012 . . . . 10.0 113.324 172.535 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 8.8 t -108.04 177.99 4.65 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 124.014 0.926 . . . . 10.0 111.013 174.657 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 227' ' ' ARG . . . . . 0.667 ' HD3' ' CD ' ' A' ' 166' ' ' GLU . 41.8 ttt180 -71.64 98.19 1.86 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.773 0.829 . . . . 10.0 110.924 170.686 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 228' ' ' ALA . . . . . 0.476 ' HB1' ' CD2' ' A' ' 42' ' ' PHE . . . -80.96 77.07 7.89 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.836 0.854 . . . . 10.0 112.073 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 40.15 102.25 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 128.893 2.877 . . . . 10.0 116.436 177.705 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . 0.483 0.3 OUTLIER 71.88 -55.47 0.66 Allowed 'General case' 0 C--O 1.242 0.67 0 C-N-CA 124.692 1.197 . . . . 10.0 110.644 -175.355 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -68.25 169.43 39.98 Favored Glycine 0 C--O 1.239 0.417 0 C-N-CA 129.784 3.564 . . . . 10.0 119.629 171.477 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.461 0 C-N-CA 128.443 2.697 . . . . 10.0 113.409 166.61 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 N--CA 1.477 0.876 0 CA-C-O 115.801 -2.047 . . . . 10.0 105.812 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 23.38 91.92 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 129.647 3.179 . . . . 10.0 117.197 160.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 28.55 65.1 0.1 Allowed 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 128.302 2.641 . . . . 10.0 114.496 155.454 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 86.5 mt -56.48 137.98 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 126.379 1.872 . . . . 10.0 113.343 -158.372 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.651 HG21 ' HB3' ' A' ' 77' ' ' PRO . 7.6 t -136.76 -165.16 1.69 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 126.312 1.845 . . . . 10.0 114.025 -174.347 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 69.98 2.81 40.78 Favored Glycine 0 C--N 1.34 0.792 0 C-N-CA 127.477 2.465 . . . . 10.0 111.526 168.062 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -158.56 -51.4 0.01 OUTLIER Pre-proline 0 N--CA 1.443 -0.783 0 CA-C-O 114.284 -2.77 . . . . 10.0 116.665 -168.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_exo -63.91 -60.73 0.14 Allowed 'Trans proline' 0 N--CA 1.465 -0.185 0 CA-C-N 123.533 2.297 . . . . 10.0 113.201 -175.33 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.411 ' H ' ' CD ' ' A' ' 9' ' ' GLU . 7.9 pm0 -67.13 4.26 0.96 Allowed 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 127.865 2.466 . . . . 10.0 115.746 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.422 ' CG ' ' N ' ' A' ' 11' ' ' ILE . 11.1 p-90 -51.35 -43.15 61.72 Favored 'General case' 0 C--O 1.223 -0.34 0 O-C-N 121.487 -0.758 . . . . 10.0 112.585 176.475 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.422 ' N ' ' CG ' ' A' ' 10' ' ' TRP . 8.9 tt -60.83 -49.64 83.78 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.338 0 C-N-CA 123.883 0.873 . . . . 10.0 109.287 179.447 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' TRP . . . . . 0.535 ' CD2' HD23 ' A' ' 206' ' ' LEU . 2.6 m95 -55.38 -52.65 62.85 Favored 'General case' 0 C--O 1.224 -0.261 0 C-N-CA 123.402 0.681 . . . . 10.0 111.84 175.673 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 91.0 mt -57.35 -53.65 55.69 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 123.19 0.596 . . . . 10.0 112.178 177.297 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.88 -46.79 52.02 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.387 1.475 . . . . 10.0 113.295 173.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.575 ' HB3' ' HE2' ' A' ' 209' ' ' MET . 13.3 tp -65.64 -44.96 84.79 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 125.282 1.433 . . . . 10.0 112.999 179.147 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -50.82 -54.7 20.98 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 124.297 0.951 . . . . 10.0 112.016 166.416 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 22.3 m -50.06 -52.67 32.59 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.961 1.304 . . . . 10.0 112.481 173.416 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.44 -58.82 5.97 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.181 0.992 . . . . 10.0 112.159 177.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 94.1 mt -57.39 -51.31 69.93 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.716 0.806 . . . . 10.0 112.695 -179.597 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.9 mpp? -57.8 -44.95 86.67 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 119.073 0.851 . . . . 10.0 111.967 176.669 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -58.5 -58.47 14.42 Favored Glycine 0 CA--C 1.53 1.03 0 CA-C-O 119.267 -0.741 . . . . 10.0 113.474 174.521 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 80.7 mt -56.24 -46.01 79.77 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-N 118.37 1.085 . . . . 10.0 112.089 175.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.38 -42.48 74.74 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 124.942 1.258 . . . . 10.0 113.179 173.07 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 28.6 m -61.95 -58.6 7.29 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.86 0.864 . . . . 10.0 111.373 171.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -52.3 -40.94 62.48 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.017 0.927 . . . . 10.0 110.976 177.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -55.76 -58.11 9.22 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.617 1.167 . . . . 10.0 112.943 172.731 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.1 m-30 -59.63 -38.61 81.84 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 113.245 0.831 . . . . 10.0 113.245 178.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.401 ' C ' ' H ' ' A' ' 30' ' ' LYS . 11.8 mt -56.23 -67.37 0.3 Allowed 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.58 1.152 . . . . 10.0 113.614 169.119 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 t -76.37 40.92 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 CA-C-O 123.745 1.736 . . . . 10.0 110.862 179.074 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.401 ' H ' ' C ' ' A' ' 28' ' ' LEU . 42.9 tttm -140.85 -44.8 0.39 Allowed 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 127.862 2.465 . . . . 10.0 109.317 171.164 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -73.01 23.15 0.88 Allowed Glycine 0 CA--C 1.529 0.958 0 N-CA-C 115.626 1.01 . . . . 10.0 115.626 173.717 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 37.3 mmm -59.53 -44.94 93.04 Favored 'General case' 0 C--O 1.224 -0.277 0 C-N-CA 127.101 2.161 . . . . 10.0 113.594 -179.024 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.68 -84.4 1.19 Allowed Glycine 0 CA--C 1.53 1.007 0 C-N-CA 123.709 0.671 . . . . 10.0 112.507 -170.166 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.8 t 33.03 88.78 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.242 0.706 0 C-N-CA 128.395 2.678 . . . . 10.0 116.956 166.455 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.0 m -79.63 -50.82 10.09 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.184 -1.371 . . . . 10.0 113.94 174.138 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -49.0 117.55 6.54 Favored Pre-proline 0 CA--C 1.536 0.418 0 O-C-N 124.753 1.283 . . . . 10.0 110.902 -172.526 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -58.56 -29.64 89.54 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 123.757 2.971 . . . . 10.0 113.701 179.06 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.38 -60.64 2.29 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.089 0.556 . . . . 10.0 111.402 176.231 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.13 -40.13 22.74 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 125.085 1.354 . . . . 10.0 113.54 171.627 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -46.48 -47.44 19.28 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.208 1.403 . . . . 10.0 113.468 172.048 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -57.75 -53.07 62.35 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.495 0.718 . . . . 10.0 110.94 176.656 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.477 ' CD2' ' HB1' ' A' ' 228' ' ' ALA . 43.9 m-85 -56.98 -50.22 73.33 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 123.102 0.561 . . . . 10.0 112.321 -179.075 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -54.39 -51.27 65.36 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 118.962 -0.542 . . . . 10.0 112.369 173.283 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.42 -61.98 1.93 Allowed 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 113.419 0.896 . . . . 10.0 113.419 177.136 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.5 mt -48.65 -57.48 1.54 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 C-N-CA 124.869 1.268 . . . . 10.0 110.349 178.047 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.5 m -68.56 -17.87 64.23 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.109 1.364 . . . . 10.0 113.672 -172.647 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 27.4 m -87.14 -40.48 14.59 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.436 1.095 . . . . 10.0 112.123 174.687 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 23.7 mt -59.45 -42.0 90.94 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 121.321 -0.862 . . . . 10.0 112.573 171.447 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 24.7 t -43.24 -61.16 1.95 Allowed Pre-proline 0 N--CA 1.48 1.047 0 C-N-CA 125.57 1.548 . . . . 10.0 113.625 176.808 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -70.95 -28.71 19.18 Favored 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 123.135 2.557 . . . . 10.0 114.205 174.264 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.45 -46.24 87.17 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-N 120.709 1.595 . . . . 10.0 113.363 177.441 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 56.3 mt -56.14 -51.7 59.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 124.414 1.085 . . . . 10.0 109.248 171.153 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.65 -43.5 76.33 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 113.484 0.92 . . . . 10.0 113.484 175.538 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -50.96 -55.89 15.06 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 120.853 1.661 . . . . 10.0 111.818 171.572 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 10.6 m -49.74 -52.79 29.03 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.359 1.464 . . . . 10.0 110.877 177.014 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.41 ' HG3' ' CB ' ' A' ' 85' ' ' ASP . 32.6 mmt -68.88 -48.11 64.2 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 123.964 0.906 . . . . 10.0 112.938 -176.703 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -55.58 -41.97 74.11 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 120.342 1.428 . . . . 10.0 112.974 172.76 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.8 tp -53.25 -54.59 34.01 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-N 119.697 1.135 . . . . 10.0 111.281 171.184 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 24.0 p -51.67 -41.06 61.12 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 115.191 1.552 . . . . 10.0 115.191 179.032 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 55.6 mtm -66.86 -50.83 61.25 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 123.562 0.745 . . . . 10.0 110.479 176.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.5 tp -48.55 -52.7 21.4 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.846 0.858 . . . . 10.0 112.952 172.321 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.5 mt -76.97 -5.52 48.95 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.331 1.053 . . . . 10.0 113.799 -177.678 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.28 -34.77 5.5 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 115.55 0.98 . . . . 10.0 115.55 174.11 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 75.3 t80 -49.22 -43.09 42.22 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 115.258 1.577 . . . . 10.0 115.258 -176.055 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.1 3.59 61.18 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 115.348 0.899 . . . . 10.0 115.348 -179.015 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.25 143.43 26.42 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 127.035 2.134 . . . . 10.0 109.011 171.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 t -145.55 171.1 15.17 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 124.012 0.925 . . . . 10.0 111.045 166.75 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.0 136.08 53.37 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 123.853 0.861 . . . . 10.0 109.698 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.436 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 59.0 t -129.54 129.56 23.19 Favored Pre-proline 0 C--N 1.329 -0.317 0 C-N-CA 125.068 1.347 . . . . 10.0 110.988 -176.059 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 69' ' ' VAL . 6.3 Cg_exo -80.76 116.25 3.16 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 N-CA-C 109.411 -1.034 . . . . 10.0 109.411 -178.876 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -156.71 164.38 38.2 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 112.818 0.673 . . . . 10.0 112.818 172.492 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.43 -81.99 0.15 Allowed Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.644 -0.983 . . . . 10.0 110.644 175.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.76 -3.42 0.69 Allowed Glycine 0 CA--C 1.526 0.776 0 N-CA-C 118.673 2.229 . . . . 10.0 118.673 170.443 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -151.58 -171.89 4.06 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 119.343 1.571 . . . . 10.0 112.25 -165.157 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -91.86 93.91 9.06 Favored 'General case' 0 CA--C 1.519 -0.237 0 C-N-CA 125.514 1.526 . . . . 10.0 111.061 -175.28 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.449 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 60.4 m-80 -89.49 120.81 69.64 Favored Pre-proline 0 N--CA 1.45 -0.465 0 N-CA-C 112.982 0.734 . . . . 10.0 112.982 -165.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.651 ' HB3' HG21 ' A' ' 5' ' ' THR . 76.1 Cg_exo -61.52 131.88 38.02 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 124.205 3.27 . . . . 10.0 112.199 171.573 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.5 mm -140.09 126.33 22.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 C-N-CA 126.059 1.744 . . . . 10.0 111.716 -179.451 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -93.64 85.01 4.75 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 122.628 1.204 . . . . 10.0 113.053 174.627 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 63.8 p-90 -59.4 -28.25 66.74 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 113.896 1.072 . . . . 10.0 113.896 174.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -55.28 -26.02 37.67 Favored 'General case' 0 CA--C 1.562 1.415 0 C-N-CA 124.277 1.031 . . . . 10.0 111.773 178.214 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -45.42 -64.86 0.63 Allowed 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 125.297 1.439 . . . . 10.0 110.618 166.313 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 36.1 m-85 -62.67 -38.55 90.77 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 126.563 1.945 . . . . 10.0 110.936 -174.056 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -52.7 -49.86 64.48 Favored 'General case' 0 CA--C 1.555 1.159 0 CA-C-N 119.334 0.97 . . . . 10.0 112.048 168.419 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.41 ' CB ' ' HG3' ' A' ' 56' ' ' MET . 0.0 OUTLIER -60.06 -62.78 1.62 Allowed 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.476 1.111 . . . . 10.0 111.696 171.86 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 54.5 m0 -53.38 -37.06 62.09 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 125.821 1.648 . . . . 10.0 112.693 -174.057 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 28.2 tp -50.23 -41.44 50.05 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 126.275 1.83 . . . . 10.0 111.864 177.723 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -103.02 -40.7 6.38 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.883 0.873 . . . . 10.0 112.546 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 79.3 p -61.55 -42.45 98.86 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-N 120.553 1.524 . . . . 10.0 113.763 -179.274 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . 0.322 75.5 p -65.77 -47.69 65.05 Favored Pre-proline 0 N--CA 1.477 0.913 0 CA-C-O 117.586 -1.197 . . . . 10.0 114.22 -178.681 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -53.0 -42.68 62.75 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 123.232 2.621 . . . . 10.0 115.442 169.513 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 51.3 mt -59.75 -48.04 83.26 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 121.314 -0.866 . . . . 10.0 111.935 176.692 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.81 -37.49 84.61 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 119.586 1.085 . . . . 10.0 112.416 175.855 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.4 mp -56.39 -48.99 75.76 Favored 'General case' 0 CA--C 1.545 0.782 0 O-C-N 121.009 -1.057 . . . . 10.0 111.828 165.369 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.81 -38.24 78.17 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 119.164 0.893 . . . . 10.0 112.863 178.353 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -52.33 -54.06 36.45 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 119.322 0.965 . . . . 10.0 111.163 169.658 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.27 -42.07 88.97 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.63 0.772 . . . . 10.0 112.172 -178.569 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.76 -54.63 39.48 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 123.917 0.887 . . . . 10.0 112.066 173.618 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.38 -41.16 79.69 Favored 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 123.687 0.795 . . . . 10.0 112.681 174.83 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.8 tp -63.73 -38.54 91.5 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 114.485 1.291 . . . . 10.0 114.485 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.1 t -94.83 1.42 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 125.035 1.334 . . . . 10.0 112.308 179.186 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.2 t70 48.62 53.45 12.18 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.834 1.654 . . . . 10.0 112.1 -174.046 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.27 145.85 47.62 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 119.969 -1.707 . . . . 10.0 112.464 -174.18 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.42 135.93 53.96 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 112.697 0.629 . . . . 10.0 112.697 175.147 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -42.89 -39.68 2.64 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.877 1.671 . . . . 10.0 113.499 175.255 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -47.28 -60.22 5.29 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 125.103 1.335 . . . . 10.0 115.309 169.707 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.5 p -62.05 -46.82 87.46 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 117.098 -1.429 . . . . 10.0 111.332 178.2 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 67.0 mt -48.38 -52.92 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 125.038 1.335 . . . . 10.0 111.124 178.196 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.4 tp -62.67 -51.25 67.97 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 112.544 0.572 . . . . 10.0 112.544 179.328 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.2 -44.86 43.55 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.479 0.712 . . . . 10.0 110.912 174.607 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.455 ' HA ' HD12 ' A' ' 111' ' ' LEU . 0.6 OUTLIER -59.59 -59.86 4.77 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 127.385 2.274 . . . . 10.0 114.8 174.949 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.1 t -61.09 -46.36 96.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 123.668 0.787 . . . . 10.0 111.362 -178.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -56.56 -50.41 63.19 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 123.68 0.657 . . . . 10.0 112.602 174.534 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -54.85 -46.54 74.66 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 113.278 0.844 . . . . 10.0 113.278 173.374 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -55.22 -48.64 73.6 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.315 1.046 . . . . 10.0 111.202 173.545 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -42.99 -55.33 4.9 Favored Glycine 0 CA--C 1.534 1.223 0 C-N-CA 125.1 1.333 . . . . 10.0 113.18 169.066 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 85.1 mt -56.91 -52.22 58.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 123.555 0.742 . . . . 10.0 111.974 174.397 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 54.0 ttp -48.68 -58.03 5.37 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.821 1.249 . . . . 10.0 112.226 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 40.2 mm . . . . . 0 N--CA 1.473 0.716 0 O-C-N 121.566 -0.709 . . . . 10.0 111.891 179.548 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 67.8 t . . . . . 0 N--CA 1.476 0.849 0 N-CA-C 110.377 -0.231 . . . . 10.0 110.377 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -49.15 -60.53 6.08 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 125.871 1.7 . . . . 10.0 112.212 171.761 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -49.57 -37.47 27.46 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.497 1.919 . . . . 10.0 113.635 -179.449 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 50.1 mt -99.37 -6.49 27.72 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 115.207 1.558 . . . . 10.0 115.207 -178.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 16.9 m -69.64 116.73 10.37 Favored 'General case' 0 N--CA 1.465 0.275 0 O-C-N 120.228 -1.545 . . . . 10.0 110.389 -178.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.621 ' H ' ' HD3' ' A' ' 129' ' ' LYS . 0.1 OUTLIER -55.52 -49.59 72.21 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 128.222 2.609 . . . . 10.0 113.268 177.731 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 60.6 t -69.65 106.32 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 123.791 0.836 . . . . 10.0 110.085 179.64 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -46.87 -59.55 3.01 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 124.807 1.243 . . . . 10.0 114.048 -173.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 m -46.5 -42.1 15.1 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.5 1.52 . . . . 10.0 113.484 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -70.18 -24.53 63.15 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 114.952 1.464 . . . . 10.0 114.952 -178.114 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 69.4 mtp85 -53.81 -42.02 67.94 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 118.887 0.767 . . . . 10.0 110.682 176.592 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -69.47 -32.03 70.68 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.805 1.242 . . . . 10.0 114.27 176.761 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.8 t -55.11 -52.09 48.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-N 119.055 0.843 . . . . 10.0 109.7 168.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 67.8 m95 -61.38 -44.11 97.72 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 114.287 1.217 . . . . 10.0 114.287 174.455 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 88.0 t90 -53.34 -48.15 68.74 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 124.254 1.022 . . . . 10.0 112.704 172.82 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.557 0 C-N-CA 123.984 0.914 . . . . 10.0 111.602 177.071 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.792 0 N-CA-C 112.633 0.605 . . . . 10.0 112.633 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 10.3 tmm? -52.24 -54.76 27.14 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.96 1.704 . . . . 10.0 111.903 172.305 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 61.4 tp -56.89 -48.94 77.0 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.994 1.718 . . . . 10.0 112.808 178.156 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 70.2 t80 -49.35 -53.79 20.53 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.131 0.972 . . . . 10.0 111.631 171.536 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 52.2 mt -54.05 -55.14 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 123.824 0.85 . . . . 10.0 110.774 177.806 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 19.4 mt -57.24 -35.37 69.62 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 118.055 -0.974 . . . . 10.0 113.461 177.887 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -57.26 -58.21 9.22 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 119.398 0.999 . . . . 10.0 113.036 172.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.42 -40.91 85.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-O 118.263 -0.875 . . . . 10.0 111.408 177.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 44.9 mt -56.8 -49.39 75.51 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 119.907 1.231 . . . . 10.0 112.148 171.285 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.469 ' HA ' ' HD2' ' A' ' 175' ' ' ARG . 11.9 t80 -76.95 -70.33 0.47 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 120.092 -1.63 . . . . 10.0 112.869 -175.248 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -73.78 -21.87 60.03 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.596 1.158 . . . . 10.0 113.454 -174.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -87.88 -79.07 1.26 Allowed Glycine 0 CA--C 1.527 0.784 0 C-N-CA 123.6 0.619 . . . . 10.0 113.532 171.504 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -53.59 -32.4 50.92 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 126.266 1.826 . . . . 10.0 113.08 -166.584 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.2 m -52.15 -56.44 14.54 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 113.996 1.109 . . . . 10.0 113.996 172.158 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.6 p -53.65 -50.57 65.47 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 122.126 0.965 . . . . 10.0 112.325 -177.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 47.6 tttm -57.11 -46.06 82.92 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.165 0.986 . . . . 10.0 112.118 173.643 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.86 -47.49 80.27 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 114.465 1.283 . . . . 10.0 114.465 174.083 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -56.41 -11.34 1.21 Allowed 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.097 1.759 . . . . 10.0 114.249 177.647 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.1 m -107.07 6.64 29.13 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.396 1.878 . . . . 10.0 114.891 -179.334 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 93.3 mmm -91.89 -92.69 0.15 Allowed 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 123.499 1.619 . . . . 10.0 114.132 -170.602 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -138.67 153.96 72.72 Favored Pre-proline 0 C--O 1.236 0.349 0 C-N-CA 129.807 3.243 . . . . 10.0 105.529 170.237 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -52.83 -46.22 35.19 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.305 2.003 . . . . 10.0 113.064 179.018 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.666 ' CD ' ' HD3' ' A' ' 227' ' ' ARG . 0.1 OUTLIER -53.02 -46.04 68.24 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 129.006 2.922 . . . . 10.0 113.27 173.635 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 92.5 t -69.16 -53.09 27.51 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.215 0 C-N-CA 124.1 0.96 . . . . 10.0 109.798 -178.651 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.1 -46.89 75.56 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.273 0.629 . . . . 10.0 111.902 177.049 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 60.2 p -59.94 -56.21 24.54 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.932 0.893 . . . . 10.0 112.68 174.657 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 61.8 m -57.23 -53.16 61.22 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.169 0.988 . . . . 10.0 113.059 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -49.55 -49.47 46.13 Favored 'General case' 0 C--O 1.221 -0.438 0 C-N-CA 123.312 0.645 . . . . 10.0 111.132 174.026 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -57.19 -48.4 78.84 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 114.618 1.34 . . . . 10.0 114.618 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 40.5 t -56.03 -49.58 74.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-N 118.808 0.731 . . . . 10.0 110.462 176.443 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 93.9 mt -58.58 -51.6 69.21 Favored 'General case' 0 C--O 1.222 -0.394 0 N-CA-C 113.218 0.821 . . . . 10.0 113.218 175.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' ARG . . . . . 0.469 ' HD2' ' HA ' ' A' ' 153' ' ' PHE . 35.5 ttp180 -47.76 -47.79 30.38 Favored 'General case' 0 C--O 1.224 -0.265 0 C-N-CA 126.807 2.043 . . . . 10.0 111.078 174.411 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 63.7 m-20 -58.48 -58.35 8.94 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 122.794 0.438 . . . . 10.0 111.274 174.39 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 59.7 t -51.95 -48.81 39.82 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 C-N-CA 124.082 0.953 . . . . 10.0 111.457 179.028 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 28.8 m -57.25 -62.81 1.5 Allowed 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 128.129 2.572 . . . . 10.0 111.976 178.031 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 55.5 t -51.32 -50.17 28.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 C-N-CA 124.572 1.149 . . . . 10.0 111.079 -179.307 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 75.6 t -58.85 -60.6 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 124.053 0.941 . . . . 10.0 112.212 177.689 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -58.34 -48.47 80.45 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 118.663 0.665 . . . . 10.0 112.085 -177.84 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 9.0 m95 . . . . . 0 N--CA 1.468 0.458 0 C-N-CA 124.04 0.936 . . . . 10.0 112.759 177.302 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 86.9 t . . . . . 0 N--CA 1.478 0.947 0 CA-C-O 119.561 -0.257 . . . . 10.0 111.587 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 25.9 t90 -55.44 -53.22 58.96 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.895 1.278 . . . . 10.0 112.466 175.258 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 9.7 tt -56.45 -44.2 80.25 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.897 0.879 . . . . 10.0 112.675 -178.714 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 14.7 pt -84.61 -5.78 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 N-CA-C 115.069 1.507 . . . . 10.0 115.069 -178.769 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.32 -169.25 33.08 Favored Glycine 0 N--CA 1.45 -0.374 0 CA-C-O 122.522 1.068 . . . . 10.0 113.978 -168.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 23.2 t -53.2 -40.92 64.79 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 114.236 -0.982 . . . . 10.0 111.821 177.594 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -54.78 -31.64 59.08 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 128.472 2.709 . . . . 10.0 115.209 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -131.3 -103.89 0.97 Allowed Glycine 0 CA--C 1.529 0.943 0 CA-C-N 119.441 1.019 . . . . 10.0 113.58 -167.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -89.46 127.14 35.81 Favored 'General case' 0 C--N 1.329 -0.323 0 O-C-N 120.666 -1.491 . . . . 10.0 109.3 169.221 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -72.43 65.3 1.35 Allowed Glycine 0 CA--C 1.533 1.165 0 N-CA-C 113.91 0.324 . . . . 10.0 113.91 173.141 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 60.8 mt -79.58 -42.69 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 C-N-CA 126.031 1.732 . . . . 10.0 108.748 166.399 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 79.4 t -126.31 133.41 24.94 Favored Pre-proline 0 N--CA 1.455 -0.22 0 C-N-CA 126.413 1.885 . . . . 10.0 109.353 -174.219 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -68.72 153.83 72.46 Favored 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 123.791 2.994 . . . . 10.0 111.444 -176.862 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 12.2 tp -43.24 -39.73 3.12 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.399 1.08 . . . . 10.0 112.142 171.502 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -48.43 -52.32 22.63 Favored 'General case' 0 CA--C 1.539 0.519 0 N-CA-C 114.669 1.359 . . . . 10.0 114.669 176.08 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 14.0 mm -75.93 -40.55 38.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 124.422 1.089 . . . . 10.0 109.625 177.586 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -49.27 -49.84 41.68 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-O 121.446 0.641 . . . . 10.0 111.921 173.659 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 16.2 m -57.7 -47.0 83.61 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 126.047 1.739 . . . . 10.0 112.991 174.331 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.535 HD23 ' CD2' ' A' ' 12' ' ' TRP . 1.3 tm? -63.38 -52.33 62.12 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.966 0.906 . . . . 10.0 112.094 179.733 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 93.4 mt -52.54 -59.06 4.9 Favored 'General case' 0 C--O 1.228 -0.07 0 C-N-CA 124.321 1.048 . . . . 10.0 109.944 176.449 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -54.02 -41.84 68.46 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 117.938 -1.029 . . . . 10.0 113.235 176.494 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 209' ' ' MET . . . . . 0.575 ' HE2' ' HB3' ' A' ' 15' ' ' LEU . 4.6 tmm? -55.66 -53.05 61.27 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 120.265 1.393 . . . . 10.0 112.086 173.749 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 79.9 t -60.95 -45.6 98.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 124.783 1.233 . . . . 10.0 111.603 178.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 4.2 mp -59.58 -51.42 69.92 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.314 1.446 . . . . 10.0 112.003 175.464 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -57.75 -52.72 64.31 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.04 1.336 . . . . 10.0 111.431 176.062 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 39.2 t . . . . . 0 N--CA 1.479 0.992 0 C-N-CA 124.601 1.16 . . . . 10.0 111.553 172.965 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.287 0 CA-C-O 120.903 0.168 . . . . 10.0 112.96 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -45.6 -57.76 3.94 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 126.624 1.97 . . . . 10.0 112.539 170.09 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -56.99 -40.81 91.81 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 124.057 0.837 . . . . 10.0 113.857 178.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 24.4 mt -70.41 -27.12 64.04 Favored 'General case' 0 CA--C 1.513 -0.464 0 N-CA-C 115.649 1.722 . . . . 10.0 115.649 177.609 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 74.0 mt -63.34 -57.54 11.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 108.687 -0.857 . . . . 10.0 108.687 165.509 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 32.0 tp -58.77 -64.71 0.84 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.905 0.882 . . . . 10.0 113.187 -172.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 84.4 mt -71.53 5.16 2.52 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 115.27 1.582 . . . . 10.0 115.27 -171.64 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.6 mtp-105 -112.31 0.33 15.67 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.228 1.011 . . . . 10.0 113.242 172.61 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 8.8 t -108.06 177.98 4.65 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 124.038 0.935 . . . . 10.0 111.026 174.65 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 227' ' ' ARG . . . . . 0.666 ' HD3' ' CD ' ' A' ' 166' ' ' GLU . 41.8 ttt180 -71.65 98.19 1.86 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.732 0.813 . . . . 10.0 110.935 170.694 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 228' ' ' ALA . . . . . 0.477 ' HB1' ' CD2' ' A' ' 42' ' ' PHE . . . -80.86 76.97 7.77 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.896 0.878 . . . . 10.0 112.128 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 40.12 102.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 128.857 2.863 . . . . 10.0 116.464 177.769 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . 0.483 0.3 OUTLIER 71.86 -55.51 0.66 Allowed 'General case' 0 C--O 1.242 0.662 0 C-N-CA 124.705 1.202 . . . . 10.0 110.631 -175.331 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -68.24 169.5 39.8 Favored Glycine 0 C--O 1.239 0.429 0 C-N-CA 129.757 3.551 . . . . 10.0 119.645 171.507 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.474 0 C-N-CA 128.49 2.716 . . . . 10.0 113.429 166.585 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 N--CA 1.476 0.87 0 CA-C-O 115.799 -2.048 . . . . 10.0 105.83 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 23.39 91.88 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 129.588 3.155 . . . . 10.0 117.203 160.833 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 28.63 65.04 0.11 Allowed 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 128.322 2.649 . . . . 10.0 114.48 155.388 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 86.6 mt -56.48 137.97 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 126.396 1.878 . . . . 10.0 113.315 -158.35 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.652 HG21 ' HB3' ' A' ' 77' ' ' PRO . 7.6 t -136.75 -165.26 1.71 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 126.327 1.851 . . . . 10.0 114.015 -174.332 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 70.06 2.78 41.34 Favored Glycine 0 C--N 1.34 0.762 0 C-N-CA 127.464 2.459 . . . . 10.0 111.485 168.027 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -158.52 -51.37 0.01 OUTLIER Pre-proline 0 N--CA 1.443 -0.783 0 CA-C-O 114.26 -2.781 . . . . 10.0 116.619 -168.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -63.94 -60.61 0.15 Allowed 'Trans proline' 0 N--CA 1.465 -0.202 0 CA-C-N 123.55 2.303 . . . . 10.0 113.25 -175.301 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.411 ' H ' ' CD ' ' A' ' 9' ' ' GLU . 7.9 pm0 -67.25 4.3 0.99 Allowed 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 127.839 2.456 . . . . 10.0 115.755 179.71 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.422 ' CG ' ' N ' ' A' ' 11' ' ' ILE . 11.1 p-90 -51.36 -43.1 61.74 Favored 'General case' 0 C--O 1.222 -0.361 0 O-C-N 121.5 -0.75 . . . . 10.0 112.621 176.427 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.422 ' N ' ' CG ' ' A' ' 10' ' ' TRP . 8.9 tt -60.88 -49.56 84.14 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.34 0 C-N-CA 123.878 0.871 . . . . 10.0 109.336 179.407 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' TRP . . . . . 0.535 ' CD2' HD23 ' A' ' 206' ' ' LEU . 2.6 m95 -55.44 -52.61 63.02 Favored 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 123.387 0.675 . . . . 10.0 111.887 175.594 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.6 mt -57.39 -53.53 57.06 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 123.153 0.581 . . . . 10.0 112.231 177.247 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.96 -46.75 52.69 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.378 1.471 . . . . 10.0 113.31 173.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.575 ' HB3' ' HE2' ' A' ' 209' ' ' MET . 13.3 tp -65.6 -44.95 84.99 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 125.345 1.458 . . . . 10.0 113.029 179.056 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.54 -56.72 10.57 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 124.508 1.051 . . . . 10.0 111.441 166.061 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.5 m -49.6 -52.46 30.2 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.877 1.271 . . . . 10.0 112.186 174.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.43 -58.83 5.94 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.174 0.99 . . . . 10.0 112.198 177.739 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 93.5 mt -57.28 -49.06 77.29 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.686 0.794 . . . . 10.0 112.695 -179.374 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.451 ' SD ' ' HB1' ' A' ' 53' ' ' ALA . 45.6 mtt -59.02 -46.62 87.75 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.418 1.087 . . . . 10.0 111.388 177.871 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -58.35 -58.58 13.82 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 124.394 0.997 . . . . 10.0 113.98 173.435 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 80.7 mt -56.21 -45.87 79.71 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-N 118.596 1.198 . . . . 10.0 112.113 176.215 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.15 -40.66 84.21 Favored Glycine 0 CA--C 1.532 1.122 0 O-C-N 120.931 -1.106 . . . . 10.0 113.598 173.451 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 28.1 m -61.61 -58.92 6.2 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.486 0.714 . . . . 10.0 111.19 171.306 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -52.24 -41.01 62.42 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.073 0.949 . . . . 10.0 110.95 178.086 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -55.77 -58.05 9.45 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 124.599 1.159 . . . . 10.0 112.973 172.767 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.1 m-30 -59.62 -38.69 81.99 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 113.223 0.823 . . . . 10.0 113.223 178.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.401 ' C ' ' H ' ' A' ' 30' ' ' LYS . 11.8 mt -56.1 -67.43 0.3 Allowed 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.627 1.171 . . . . 10.0 113.637 169.099 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 t -76.37 40.92 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 CA-C-O 123.708 1.718 . . . . 10.0 110.852 179.079 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.401 ' H ' ' C ' ' A' ' 28' ' ' LEU . 42.9 tttm -140.84 -44.84 0.39 Allowed 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 127.883 2.473 . . . . 10.0 109.331 171.18 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.96 23.11 0.87 Allowed Glycine 0 CA--C 1.529 0.925 0 N-CA-C 115.629 1.012 . . . . 10.0 115.629 173.713 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 37.3 mmm -59.51 -45.0 92.98 Favored 'General case' 0 C--O 1.225 -0.235 0 C-N-CA 127.163 2.185 . . . . 10.0 113.596 -179.034 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.69 -84.42 1.19 Allowed Glycine 0 CA--C 1.53 1.007 0 C-N-CA 123.741 0.686 . . . . 10.0 112.483 -170.17 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.8 t 33.11 88.75 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.242 0.682 0 C-N-CA 128.399 2.68 . . . . 10.0 116.937 166.45 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.2 m -79.62 -50.91 9.96 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.152 -1.385 . . . . 10.0 113.855 174.153 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -48.87 117.51 6.37 Favored Pre-proline 0 CA--C 1.536 0.415 0 O-C-N 124.769 1.293 . . . . 10.0 110.988 -172.527 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -58.56 -29.68 89.65 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 123.746 2.964 . . . . 10.0 113.72 179.092 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.31 -60.67 2.28 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.126 0.57 . . . . 10.0 111.422 176.213 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.15 -40.05 22.64 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 125.104 1.362 . . . . 10.0 113.549 171.616 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -46.53 -47.47 19.54 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 125.252 1.421 . . . . 10.0 113.434 172.049 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -57.75 -53.06 62.43 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.438 0.695 . . . . 10.0 110.974 176.671 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.477 ' CD2' ' HB1' ' A' ' 228' ' ' ALA . 44.0 m-85 -56.98 -50.23 73.32 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 123.044 0.538 . . . . 10.0 112.337 -179.117 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -54.35 -51.28 65.25 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 118.914 -0.565 . . . . 10.0 112.375 173.27 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.46 -61.95 1.95 Allowed 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 113.391 0.886 . . . . 10.0 113.391 177.182 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.3 mt -48.43 -57.76 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 C-N-CA 124.839 1.255 . . . . 10.0 110.408 178.007 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.3 m -68.57 -17.44 64.14 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.158 1.383 . . . . 10.0 113.724 -172.638 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 28.1 m -87.92 -39.63 14.6 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.45 1.1 . . . . 10.0 112.255 174.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 21.2 mt -59.19 -42.64 91.34 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 121.49 -0.756 . . . . 10.0 112.521 171.396 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 18.5 t -41.43 -63.84 0.75 Allowed Pre-proline 0 CA--C 1.551 0.993 0 C-N-CA 125.774 1.63 . . . . 10.0 113.491 175.548 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -70.22 -25.07 26.85 Favored 'Trans proline' 0 CA--C 1.544 1.017 0 C-N-CA 122.72 2.28 . . . . 10.0 114.182 176.317 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.5 -44.45 86.99 Favored 'General case' 0 CA--C 1.549 0.907 0 CA-C-N 120.683 1.583 . . . . 10.0 113.046 174.44 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 58.0 mt -54.66 -52.18 43.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 124.961 1.304 . . . . 10.0 108.998 168.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.451 ' HB1' ' SD ' ' A' ' 20' ' ' MET . . . -53.14 -49.75 65.93 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.637 1.175 . . . . 10.0 112.789 176.402 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -50.42 -58.57 5.42 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.717 1.607 . . . . 10.0 112.574 173.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.3 m -49.38 -52.64 27.13 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.119 1.368 . . . . 10.0 110.66 178.361 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.425 ' HG3' ' CB ' ' A' ' 85' ' ' ASP . 32.8 mmt -69.41 -48.22 61.71 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 123.889 0.876 . . . . 10.0 112.82 -176.369 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -57.71 -39.29 76.88 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 116.567 -1.683 . . . . 10.0 113.111 173.272 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.7 tp -53.24 -54.62 33.47 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-N 120.623 1.556 . . . . 10.0 111.273 169.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 23.9 p -51.63 -41.05 61.01 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 115.257 1.577 . . . . 10.0 115.257 179.002 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 56.5 mtm -66.93 -50.8 61.23 Favored 'General case' 0 C--N 1.334 -0.09 0 C-N-CA 123.548 0.739 . . . . 10.0 110.485 176.845 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.3 tp -48.57 -52.7 21.49 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.858 0.863 . . . . 10.0 112.948 172.312 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.5 mt -76.86 -5.59 48.96 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 113.835 1.05 . . . . 10.0 113.835 -177.706 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.26 -34.72 5.54 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 115.583 0.993 . . . . 10.0 115.583 174.208 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -49.24 -43.13 42.52 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 115.243 1.571 . . . . 10.0 115.243 -176.023 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.01 3.48 61.22 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 115.329 0.892 . . . . 10.0 115.329 -178.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.25 143.41 26.44 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 127.034 2.133 . . . . 10.0 109.011 172.055 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 t -145.52 171.11 15.14 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 124.029 0.931 . . . . 10.0 111.011 166.781 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.95 136.06 53.39 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 123.924 0.89 . . . . 10.0 109.739 179.583 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.436 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 58.6 t -129.58 129.58 23.18 Favored Pre-proline 0 C--N 1.329 -0.295 0 C-N-CA 125.063 1.345 . . . . 10.0 110.935 -176.048 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 69' ' ' VAL . 6.3 Cg_exo -80.71 116.19 3.17 Favored 'Trans proline' 0 N--CA 1.452 -0.921 0 N-CA-C 109.443 -1.022 . . . . 10.0 109.443 -178.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -156.71 164.39 38.2 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 112.862 0.69 . . . . 10.0 112.862 172.49 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.39 -82.0 0.14 Allowed Glycine 0 CA--C 1.526 0.773 0 N-CA-C 110.683 -0.967 . . . . 10.0 110.683 175.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.76 -3.33 0.7 Allowed Glycine 0 CA--C 1.527 0.812 0 N-CA-C 118.641 2.216 . . . . 10.0 118.641 170.392 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -151.63 -171.89 4.06 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 119.379 1.59 . . . . 10.0 112.228 -165.159 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -91.86 93.9 9.05 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 125.521 1.528 . . . . 10.0 111.097 -175.258 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.449 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 60.3 m-80 -89.48 120.72 69.64 Favored Pre-proline 0 N--CA 1.45 -0.429 0 N-CA-C 112.965 0.728 . . . . 10.0 112.965 -165.916 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.652 ' HB3' HG21 ' A' ' 5' ' ' THR . 76.1 Cg_exo -61.53 131.94 38.26 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 124.183 3.255 . . . . 10.0 112.165 171.588 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.5 mm -140.09 126.3 21.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 C-N-CA 126.043 1.737 . . . . 10.0 111.732 -179.467 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -93.64 85.03 4.75 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 122.888 1.328 . . . . 10.0 113.053 174.618 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 63.6 p-90 -59.33 -28.3 66.69 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 113.911 1.078 . . . . 10.0 113.911 174.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -55.31 -35.93 65.65 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.286 1.035 . . . . 10.0 113.575 178.268 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 6.8 ptp180 -56.8 -40.44 75.97 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 120.209 1.368 . . . . 10.0 111.281 173.72 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -66.16 -43.73 86.12 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 113.887 1.069 . . . . 10.0 113.887 174.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -49.39 -47.19 47.9 Favored 'General case' 0 CA--C 1.555 1.165 0 C-N-CA 124.695 1.198 . . . . 10.0 111.002 167.709 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.425 ' CB ' ' HG3' ' A' ' 56' ' ' MET . 0.0 OUTLIER -61.71 -58.92 6.14 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 125.568 1.547 . . . . 10.0 112.938 173.331 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 46.9 m0 -51.82 -40.52 60.6 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 126.829 2.052 . . . . 10.0 112.777 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 27.8 tp -50.22 -45.79 54.14 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 125.944 1.697 . . . . 10.0 112.686 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -97.94 -46.86 5.76 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 123.735 0.814 . . . . 10.0 112.753 -176.582 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -58.8 -41.44 86.77 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.903 0.881 . . . . 10.0 112.801 -175.314 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.459 ' HB ' ' HD3' ' A' ' 91' ' ' PRO . 3.1 m -66.39 -47.66 58.54 Favored Pre-proline 0 CA--C 1.541 0.598 0 O-C-N 121.094 -1.004 . . . . 10.0 111.938 -174.874 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.459 ' HD3' ' HB ' ' A' ' 90' ' ' THR . 86.6 Cg_exo -51.93 -42.92 55.53 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 123.34 2.694 . . . . 10.0 115.145 166.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 53.0 mt -59.79 -48.17 82.76 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 118.877 0.762 . . . . 10.0 111.875 176.089 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 84.3 mt -53.77 -45.1 70.52 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.481 1.112 . . . . 10.0 112.136 172.435 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.6 mp -57.35 -47.86 80.52 Favored 'General case' 0 CA--C 1.546 0.796 0 O-C-N 120.97 -1.082 . . . . 10.0 112.574 169.015 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.87 -38.23 78.33 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 123.824 0.85 . . . . 10.0 112.877 178.55 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -52.28 -54.05 36.34 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 119.303 0.956 . . . . 10.0 111.215 169.616 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.36 -42.07 88.59 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.585 0.754 . . . . 10.0 112.119 -178.516 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.67 -54.75 37.61 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.972 0.909 . . . . 10.0 112.006 173.632 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.3 -41.16 79.34 Favored 'General case' 0 C--O 1.224 -0.237 0 C-N-CA 123.72 0.808 . . . . 10.0 112.702 174.859 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 32.0 tp -63.75 -38.56 91.58 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 114.445 1.276 . . . . 10.0 114.445 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.2 t -94.79 1.36 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 125.106 1.362 . . . . 10.0 112.309 179.18 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.2 t70 48.57 53.46 12.11 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.858 1.663 . . . . 10.0 112.139 -173.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.29 145.89 47.56 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 119.951 -1.718 . . . . 10.0 112.44 -174.165 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.44 135.87 54.08 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 112.759 0.651 . . . . 10.0 112.759 175.15 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -42.85 -39.65 2.6 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.844 1.658 . . . . 10.0 113.49 175.297 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -47.33 -60.23 5.32 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 125.15 1.357 . . . . 10.0 115.262 169.717 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.4 p -62.06 -46.77 87.65 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 117.1 -1.428 . . . . 10.0 111.332 178.244 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 66.9 mt -48.39 -52.92 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 125.001 1.321 . . . . 10.0 111.147 178.191 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.4 tp -62.66 -51.28 67.86 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 112.509 0.559 . . . . 10.0 112.509 179.328 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.15 -44.87 43.05 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.506 0.722 . . . . 10.0 110.967 174.602 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.454 HD12 ' HA ' ' A' ' 111' ' ' LEU . 0.6 OUTLIER -59.6 -59.87 4.76 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 127.363 2.265 . . . . 10.0 114.839 174.898 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.4 t -60.97 -46.39 96.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 123.711 0.804 . . . . 10.0 111.373 -178.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -56.61 -50.3 64.02 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 123.662 0.649 . . . . 10.0 112.661 174.548 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -54.54 -46.5 73.61 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.569 0.747 . . . . 10.0 112.882 173.331 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -61.38 -40.62 95.0 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.887 0.875 . . . . 10.0 112.924 176.633 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -43.69 -59.38 3.75 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 125.995 1.76 . . . . 10.0 112.401 163.031 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 78.8 mt -56.66 -52.59 52.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 123.69 0.796 . . . . 10.0 110.925 175.357 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 46.4 ttp -46.33 -61.96 1.56 Allowed 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 126.022 1.729 . . . . 10.0 112.597 -174.087 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.472 0.654 0 CA-C-O 118.933 -0.556 . . . . 10.0 112.176 -177.622 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 61.9 t . . . . . 0 N--CA 1.478 0.94 0 N-CA-C 110.209 -0.293 . . . . 10.0 110.209 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -50.97 -61.28 6.27 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 126.18 1.848 . . . . 10.0 112.939 172.158 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -43.45 -41.53 4.35 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 127.993 2.517 . . . . 10.0 113.231 176.414 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 46.5 mt -99.92 -7.23 25.47 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 115.513 1.671 . . . . 10.0 115.513 -176.402 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 17.0 m -69.66 116.75 10.42 Favored 'General case' 0 N--CA 1.464 0.274 0 O-C-N 120.195 -1.566 . . . . 10.0 110.407 -178.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.622 ' H ' ' HD3' ' A' ' 129' ' ' LYS . 0.2 OUTLIER -55.5 -49.62 72.09 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 128.195 2.598 . . . . 10.0 113.288 177.758 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 60.1 t -69.58 106.32 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 123.789 0.836 . . . . 10.0 110.12 179.606 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -46.92 -59.49 3.06 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 124.761 1.224 . . . . 10.0 114.067 -173.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 m -46.5 -42.08 15.06 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.439 1.495 . . . . 10.0 113.512 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -70.16 -24.59 63.18 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 114.918 1.451 . . . . 10.0 114.918 -178.108 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 68.2 mtp85 -54.37 -41.18 68.86 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 118.876 0.762 . . . . 10.0 110.905 176.805 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -69.79 -31.75 69.85 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 114.34 1.237 . . . . 10.0 114.34 176.497 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.8 t -55.17 -52.23 46.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 CA-C-N 118.928 0.785 . . . . 10.0 109.82 168.753 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 65.0 m95 -59.48 -49.57 77.27 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 113.428 0.899 . . . . 10.0 113.428 173.46 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 83.0 t90 -48.37 -47.82 37.12 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 119.438 1.017 . . . . 10.0 113.31 173.032 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.595 0 C-N-CA 124.099 0.96 . . . . 10.0 111.993 176.812 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.782 0 N-CA-C 112.977 0.732 . . . . 10.0 112.977 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 42.8 ttp -57.75 -55.77 30.59 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.406 1.082 . . . . 10.0 111.969 173.182 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -49.79 -49.67 47.74 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.461 1.505 . . . . 10.0 110.781 177.169 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -51.77 -55.8 17.66 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 113.298 0.851 . . . . 10.0 113.298 173.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 49.9 mt -54.22 -54.69 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 123.598 0.759 . . . . 10.0 110.78 177.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 42.1 mt -57.14 -36.1 70.29 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 118.409 -0.805 . . . . 10.0 112.959 178.306 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -57.33 -58.11 9.67 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 124.026 0.93 . . . . 10.0 113.03 173.405 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.48 -40.89 85.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 CA-C-O 118.303 -0.855 . . . . 10.0 111.419 177.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 45.1 mt -56.83 -49.35 75.68 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 119.893 1.224 . . . . 10.0 112.115 171.296 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.47 ' HA ' ' HD2' ' A' ' 175' ' ' ARG . 11.9 t80 -77.03 -70.34 0.47 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 120.054 -1.654 . . . . 10.0 112.862 -175.254 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -73.73 -21.91 60.06 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.634 1.174 . . . . 10.0 113.439 -174.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -87.79 -79.08 1.26 Allowed Glycine 0 CA--C 1.527 0.783 0 C-N-CA 123.625 0.631 . . . . 10.0 113.534 171.497 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -53.68 -32.4 51.54 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 126.269 1.828 . . . . 10.0 113.046 -166.539 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.3 m -52.16 -56.39 14.85 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 113.989 1.107 . . . . 10.0 113.989 172.121 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.3 p -53.65 -50.63 65.33 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 122.092 0.949 . . . . 10.0 112.249 -177.846 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 47.6 tttm -57.11 -46.03 82.93 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.142 0.977 . . . . 10.0 112.122 173.703 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.8 -47.5 80.07 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 114.534 1.309 . . . . 10.0 114.534 174.033 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -56.45 -11.29 1.2 Allowed 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 126.054 1.741 . . . . 10.0 114.261 177.69 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.1 m -107.04 6.56 29.1 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 126.474 1.91 . . . . 10.0 114.896 -179.308 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 93.2 mmm -91.88 -92.66 0.15 Allowed 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 123.487 1.613 . . . . 10.0 114.171 -170.579 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -138.74 153.94 72.59 Favored Pre-proline 0 C--O 1.236 0.359 0 C-N-CA 129.802 3.241 . . . . 10.0 105.548 170.243 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -52.85 -46.22 35.27 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.346 2.031 . . . . 10.0 113.074 179.053 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.667 ' CD ' ' HD3' ' A' ' 227' ' ' ARG . 0.1 OUTLIER -52.97 -46.09 68.06 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 128.979 2.912 . . . . 10.0 113.276 173.571 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 92.2 t -69.19 -52.99 27.97 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 C-N-CA 124.065 0.946 . . . . 10.0 109.8 -178.62 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.18 -46.82 75.81 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.319 0.648 . . . . 10.0 111.899 177.056 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 60.3 p -60.04 -56.17 24.98 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.876 0.87 . . . . 10.0 112.729 174.626 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 61.8 m -57.2 -53.17 61.13 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.184 0.994 . . . . 10.0 113.027 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -49.6 -49.49 46.55 Favored 'General case' 0 C--O 1.221 -0.414 0 C-N-CA 123.258 0.623 . . . . 10.0 111.114 174.043 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -57.16 -48.37 78.86 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 114.664 1.357 . . . . 10.0 114.664 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 40.4 t -56.01 -49.62 74.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 CA-C-N 118.832 0.742 . . . . 10.0 110.477 176.373 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 94.2 mt -58.6 -51.64 69.07 Favored 'General case' 0 C--O 1.222 -0.384 0 N-CA-C 113.141 0.793 . . . . 10.0 113.141 175.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' ARG . . . . . 0.47 ' HD2' ' HA ' ' A' ' 153' ' ' PHE . 35.5 ttp180 -47.7 -47.86 29.66 Favored 'General case' 0 C--O 1.225 -0.201 0 C-N-CA 126.852 2.061 . . . . 10.0 111.084 174.402 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 63.6 m-20 -58.48 -58.35 8.92 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 122.775 0.43 . . . . 10.0 111.234 174.397 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 54.6 t -51.77 -48.09 38.64 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 124.088 0.955 . . . . 10.0 111.858 179.061 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 28.5 m -58.19 -62.8 1.57 Allowed 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 127.959 2.503 . . . . 10.0 112.17 177.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 54.8 t -51.43 -49.18 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 124.686 1.194 . . . . 10.0 111.019 -179.158 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 70.9 t -59.76 -60.42 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 124.008 0.923 . . . . 10.0 112.374 177.483 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 77.5 mt -54.59 -52.9 60.7 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 118.414 0.552 . . . . 10.0 111.769 -178.306 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 9.9 m95 . . . . . 0 N--CA 1.464 0.268 0 C-N-CA 124.274 1.03 . . . . 10.0 112.35 177.944 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 58.4 t . . . . . 0 N--CA 1.475 0.821 0 CA-C-O 119.299 -0.381 . . . . 10.0 111.333 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 66.7 t90 -56.36 -54.6 43.64 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.11 0.964 . . . . 10.0 112.2 172.465 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 60.3 tp -52.29 -46.42 65.9 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.413 1.485 . . . . 10.0 112.29 -177.301 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 15.0 pt -86.09 -5.14 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 N-CA-C 115.333 1.605 . . . . 10.0 115.333 -177.106 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.59 -169.26 32.72 Favored Glycine 0 N--CA 1.45 -0.383 0 CA-C-O 122.57 1.095 . . . . 10.0 113.826 -168.803 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 23.3 t -53.12 -40.15 63.99 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 114.209 -0.996 . . . . 10.0 111.853 177.643 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -71.99 -13.74 61.7 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 115.357 1.614 . . . . 10.0 115.357 -174.346 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -130.49 -106.69 1.16 Allowed Glycine 0 CA--C 1.531 1.031 0 CA-C-N 120.218 1.372 . . . . 10.0 113.349 -174.388 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -89.48 127.14 35.82 Favored 'General case' 0 C--N 1.329 -0.313 0 O-C-N 120.673 -1.487 . . . . 10.0 109.352 169.293 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -72.43 65.33 1.35 Allowed Glycine 0 CA--C 1.532 1.127 0 N-CA-C 113.937 0.335 . . . . 10.0 113.937 173.153 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 60.8 mt -79.6 -42.74 23.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 126.044 1.737 . . . . 10.0 108.717 166.389 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 79.7 t -126.28 133.4 24.93 Favored Pre-proline 0 N--CA 1.454 -0.25 0 C-N-CA 126.467 1.907 . . . . 10.0 109.368 -174.168 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -68.74 153.78 72.5 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 123.811 3.007 . . . . 10.0 111.476 -176.847 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 12.2 tp -43.16 -39.8 3.02 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.359 1.064 . . . . 10.0 112.193 171.487 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -48.32 -52.41 21.66 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 114.68 1.363 . . . . 10.0 114.68 176.046 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 13.9 mm -75.91 -40.5 38.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 C-N-CA 124.401 1.08 . . . . 10.0 109.658 177.588 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -49.3 -49.81 42.15 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 118.593 0.633 . . . . 10.0 111.947 173.621 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 16.1 m -57.66 -47.07 83.31 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 126.083 1.753 . . . . 10.0 112.998 174.275 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.535 HD23 ' CD2' ' A' ' 12' ' ' TRP . 1.3 tm? -63.33 -52.34 62.23 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.95 0.9 . . . . 10.0 112.073 179.726 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 93.3 mt -52.55 -58.54 6.45 Favored 'General case' 0 C--O 1.228 -0.046 0 C-N-CA 124.32 1.048 . . . . 10.0 109.973 176.457 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -55.19 -44.62 75.45 Favored 'General case' 0 C--O 1.22 -0.475 0 CA-C-O 117.608 -1.187 . . . . 10.0 113.0 176.8 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 209' ' ' MET . . . . . 0.575 ' HE2' ' HB3' ' A' ' 15' ' ' LEU . 4.6 tmm? -51.48 -52.51 45.97 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 120.502 1.501 . . . . 10.0 112.581 173.883 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 79.9 t -61.06 -48.65 88.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 124.675 1.19 . . . . 10.0 111.773 178.65 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 5.3 mp -57.62 -53.26 60.2 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.472 1.509 . . . . 10.0 111.89 176.337 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -55.96 -54.95 38.59 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 126.753 2.021 . . . . 10.0 110.707 177.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 37.6 t . . . . . 0 N--CA 1.478 0.967 0 O-C-N 121.243 -0.911 . . . . 10.0 111.368 173.033 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.258 0 N-CA-C 111.876 -0.49 . . . . 10.0 111.876 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -44.19 -57.68 3.3 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.921 2.089 . . . . 10.0 112.111 166.436 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -55.03 -41.98 79.46 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 124.059 0.838 . . . . 10.0 113.979 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 24.0 mt -71.07 -27.16 63.43 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 115.637 1.718 . . . . 10.0 115.637 177.356 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 74.1 mt -63.22 -57.61 11.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 108.684 -0.858 . . . . 10.0 108.684 165.44 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 32.1 tp -58.82 -64.63 0.86 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.935 0.894 . . . . 10.0 113.183 -172.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 84.5 mt -71.64 5.25 2.55 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 115.27 1.582 . . . . 10.0 115.27 -171.635 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.7 mtp-105 -112.33 0.39 15.67 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.203 1.001 . . . . 10.0 113.292 172.521 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 8.8 t -108.06 177.97 4.65 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 124.06 0.944 . . . . 10.0 111.015 174.636 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 227' ' ' ARG . . . . . 0.667 ' HD3' ' CD ' ' A' ' 166' ' ' GLU . 41.7 ttt180 -71.63 98.15 1.85 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.795 0.838 . . . . 10.0 110.917 170.689 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 228' ' ' ALA . . . . . 0.477 ' HB1' ' CD2' ' A' ' 42' ' ' PHE . . . -80.89 77.02 7.8 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.859 0.863 . . . . 10.0 112.116 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 40.11 102.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 128.833 2.853 . . . . 10.0 116.484 177.743 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . 0.481 0.3 OUTLIER 71.79 -55.39 0.66 Allowed 'General case' 0 C--O 1.242 0.685 0 C-N-CA 124.753 1.221 . . . . 10.0 110.68 -175.267 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -68.3 169.47 40.07 Favored Glycine 0 C--O 1.239 0.429 0 C-N-CA 129.735 3.541 . . . . 10.0 119.674 171.429 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.448 0 C-N-CA 128.491 2.716 . . . . 10.0 113.461 166.62 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 N--CA 1.477 0.876 0 CA-C-O 115.781 -2.057 . . . . 10.0 105.837 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 23.43 91.86 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 129.576 3.15 . . . . 10.0 117.262 160.842 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 28.59 65.12 0.1 Allowed 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 128.297 2.639 . . . . 10.0 114.458 155.437 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 86.7 mt -56.51 137.96 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 126.384 1.873 . . . . 10.0 113.343 -158.363 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.653 HG21 ' HB3' ' A' ' 77' ' ' PRO . 7.6 t -136.74 -165.19 1.69 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 126.353 1.861 . . . . 10.0 114.062 -174.347 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 70.02 2.75 40.86 Favored Glycine 0 C--N 1.339 0.743 0 C-N-CA 127.44 2.448 . . . . 10.0 111.453 168.019 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -158.57 -51.28 0.01 OUTLIER Pre-proline 0 N--CA 1.443 -0.805 0 CA-C-O 114.243 -2.789 . . . . 10.0 116.635 -168.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_exo -63.96 -60.62 0.15 Allowed 'Trans proline' 0 N--CA 1.465 -0.202 0 CA-C-N 123.576 2.313 . . . . 10.0 113.21 -175.332 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.412 ' H ' ' CD ' ' A' ' 9' ' ' GLU . 7.9 pm0 -67.26 4.31 0.99 Allowed 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 127.831 2.452 . . . . 10.0 115.783 179.707 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.422 ' CG ' ' N ' ' A' ' 11' ' ' ILE . 11.0 p-90 -51.31 -43.17 61.63 Favored 'General case' 0 C--O 1.223 -0.34 0 O-C-N 121.5 -0.75 . . . . 10.0 112.615 176.423 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.422 ' N ' ' CG ' ' A' ' 10' ' ' TRP . 8.9 tt -60.83 -49.64 83.77 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.34 0 C-N-CA 123.885 0.874 . . . . 10.0 109.344 179.403 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' TRP . . . . . 0.535 ' CD2' HD23 ' A' ' 206' ' ' LEU . 2.6 m95 -55.39 -52.58 63.08 Favored 'General case' 0 C--O 1.224 -0.259 0 C-N-CA 123.4 0.68 . . . . 10.0 111.88 175.619 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.2 mt -57.39 -53.63 55.96 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 123.219 0.608 . . . . 10.0 112.196 177.248 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.9 -46.74 52.14 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.366 1.466 . . . . 10.0 113.332 173.86 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.574 ' HB3' ' HE2' ' A' ' 209' ' ' MET . 13.3 tp -65.71 -44.9 84.69 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 125.274 1.43 . . . . 10.0 113.013 179.122 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.94 -57.29 10.07 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 124.122 0.868 . . . . 10.0 111.16 166.097 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 22.5 m -48.38 -52.67 20.73 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.709 1.204 . . . . 10.0 112.347 174.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.39 -58.86 5.82 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.139 0.976 . . . . 10.0 112.188 177.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 94.3 mt -57.69 -50.23 73.88 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.696 0.799 . . . . 10.0 112.627 -179.492 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -53.73 -50.91 64.92 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.495 1.118 . . . . 10.0 111.395 175.066 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -57.95 -58.01 16.81 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 124.268 0.937 . . . . 10.0 113.579 176.774 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 81.2 mt -56.19 -45.83 79.63 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-N 118.527 1.164 . . . . 10.0 112.125 176.152 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.63 -41.95 75.66 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 124.854 1.216 . . . . 10.0 113.278 172.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 24.6 m -61.41 -59.5 5.16 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.984 0.913 . . . . 10.0 111.263 171.78 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -52.29 -40.92 62.43 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.028 0.931 . . . . 10.0 110.99 178.418 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -55.86 -57.98 9.78 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 124.619 1.168 . . . . 10.0 112.966 172.77 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -59.65 -38.75 82.26 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 113.193 0.812 . . . . 10.0 113.193 178.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.401 ' C ' ' H ' ' A' ' 30' ' ' LYS . 11.8 mt -56.08 -67.47 0.29 Allowed 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.58 1.152 . . . . 10.0 113.637 169.108 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 t -76.37 40.96 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 CA-C-O 123.802 1.763 . . . . 10.0 110.891 179.064 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.401 ' H ' ' C ' ' A' ' 28' ' ' LEU . 42.9 tttm -140.85 -44.82 0.39 Allowed 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 127.862 2.465 . . . . 10.0 109.317 171.12 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.9 23.1 0.86 Allowed Glycine 0 CA--C 1.529 0.908 0 N-CA-C 115.668 1.027 . . . . 10.0 115.668 173.68 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 37.4 mmm -59.54 -44.95 93.07 Favored 'General case' 0 C--O 1.225 -0.217 0 C-N-CA 127.19 2.196 . . . . 10.0 113.596 -178.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.74 -84.45 1.19 Allowed Glycine 0 CA--C 1.531 1.035 0 C-N-CA 123.798 0.713 . . . . 10.0 112.437 -170.141 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.7 t 33.06 88.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 128.358 2.663 . . . . 10.0 116.93 166.497 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.4 m -79.63 -50.86 10.04 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.155 -1.384 . . . . 10.0 113.879 174.109 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -48.95 117.46 6.39 Favored Pre-proline 0 CA--C 1.535 0.402 0 O-C-N 124.718 1.261 . . . . 10.0 110.982 -172.523 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -58.5 -29.68 89.44 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 123.779 2.986 . . . . 10.0 113.688 179.093 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.27 -60.71 2.26 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.148 0.579 . . . . 10.0 111.424 176.193 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.19 -40.05 22.94 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 125.085 1.354 . . . . 10.0 113.534 171.652 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -46.55 -47.45 19.65 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.21 1.404 . . . . 10.0 113.436 172.055 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -57.74 -53.1 61.99 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.479 0.712 . . . . 10.0 110.944 176.668 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.475 ' CD2' ' HB1' ' A' ' 228' ' ' ALA . 44.0 m-85 -56.91 -50.28 73.02 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 123.119 0.568 . . . . 10.0 112.342 -179.126 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -54.34 -51.29 65.22 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 118.936 -0.554 . . . . 10.0 112.345 173.269 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.45 -61.99 1.92 Allowed 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 113.392 0.886 . . . . 10.0 113.392 177.182 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.5 mt -48.68 -56.27 2.47 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 C-N-CA 124.864 1.266 . . . . 10.0 110.64 177.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.6 m -70.17 -17.45 63.17 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.003 1.321 . . . . 10.0 113.646 -172.521 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 27.5 m -87.8 -37.34 16.67 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.194 0.998 . . . . 10.0 112.237 174.366 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 20.8 mt -60.4 -42.57 96.19 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 118.128 -0.939 . . . . 10.0 112.518 172.436 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.594 HG23 ' HD3' ' A' ' 50' ' ' PRO 0.349 33.2 m -52.53 -53.04 57.93 Favored Pre-proline 0 N--CA 1.487 1.386 0 CA-C-N 120.645 1.566 . . . . 10.0 115.049 -179.745 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.594 ' HD3' HG23 ' A' ' 49' ' ' VAL . 68.7 Cg_endo -68.33 -25.11 36.52 Favored 'Trans proline' 0 CA--C 1.545 1.044 0 CA-C-N 123.02 2.114 . . . . 10.0 113.524 174.461 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -68.09 -45.83 72.65 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-N 120.5 1.5 . . . . 10.0 112.894 173.534 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 31.4 mm -54.07 -52.3 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 124.896 1.278 . . . . 10.0 109.525 168.056 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -52.9 -49.57 65.63 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.968 0.907 . . . . 10.0 113.04 174.795 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 52.3 t80 -51.78 -58.53 6.15 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.769 1.628 . . . . 10.0 112.19 175.574 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.1 m -49.01 -52.7 23.6 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.252 1.421 . . . . 10.0 110.629 178.279 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.439 ' HG3' ' CB ' ' A' ' 85' ' ' ASP . 32.8 mmt -69.42 -48.09 62.09 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 123.854 0.861 . . . . 10.0 112.899 -176.429 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -56.2 -40.98 74.86 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 120.321 1.419 . . . . 10.0 113.146 172.74 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.8 tp -53.27 -54.59 34.01 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-N 120.031 1.287 . . . . 10.0 111.292 170.688 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 24.0 p -51.68 -41.05 61.12 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 115.224 1.564 . . . . 10.0 115.224 178.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 57.8 mtm -66.82 -50.87 61.2 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 123.586 0.754 . . . . 10.0 110.527 176.802 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.4 tp -48.53 -52.67 21.46 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.857 0.863 . . . . 10.0 112.974 172.318 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.4 mt -76.97 -5.54 49.02 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 113.849 1.055 . . . . 10.0 113.849 -177.727 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.32 -34.71 5.55 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 115.55 0.98 . . . . 10.0 115.55 174.108 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -49.33 -43.05 43.39 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 115.235 1.568 . . . . 10.0 115.235 -175.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.05 3.58 61.04 Favored Glycine 0 CA--C 1.521 0.467 0 N-CA-C 115.358 0.903 . . . . 10.0 115.358 -179.053 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.3 143.41 26.43 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 127.035 2.134 . . . . 10.0 109.018 172.002 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 t -145.47 171.11 15.12 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 124.081 0.952 . . . . 10.0 111.062 166.844 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.04 136.07 53.37 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 123.919 0.888 . . . . 10.0 109.661 179.613 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.438 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 58.7 t -129.58 129.59 23.18 Favored Pre-proline 0 C--N 1.329 -0.313 0 C-N-CA 125.063 1.345 . . . . 10.0 110.96 -176.092 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 69' ' ' VAL . 6.3 Cg_exo -80.72 116.24 3.17 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 N-CA-C 109.406 -1.036 . . . . 10.0 109.406 -178.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -156.73 164.39 38.17 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 112.842 0.682 . . . . 10.0 112.842 172.491 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.36 -81.95 0.14 Allowed Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.693 -0.963 . . . . 10.0 110.693 175.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.77 -3.38 0.69 Allowed Glycine 0 CA--C 1.526 0.766 0 N-CA-C 118.642 2.217 . . . . 10.0 118.642 170.404 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -151.62 -171.87 4.05 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 119.379 1.59 . . . . 10.0 112.257 -165.151 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -91.89 93.9 9.04 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 125.534 1.533 . . . . 10.0 111.131 -175.279 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.449 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 60.4 m-80 -89.49 120.8 69.63 Favored Pre-proline 0 N--CA 1.45 -0.43 0 N-CA-C 112.933 0.716 . . . . 10.0 112.933 -165.885 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.653 ' HB3' HG21 ' A' ' 5' ' ' THR . 76.0 Cg_exo -61.52 131.94 38.31 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 124.205 3.27 . . . . 10.0 112.166 171.573 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.6 mm -140.18 126.32 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 C-N-CA 126.072 1.749 . . . . 10.0 111.712 -179.501 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -93.62 85.07 4.77 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 123.171 1.463 . . . . 10.0 113.041 174.63 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 63.7 p-90 -59.38 -28.32 66.79 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 120.729 -1.232 . . . . 10.0 113.873 174.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -54.51 -37.28 65.15 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 115.087 1.514 . . . . 10.0 115.087 178.267 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -59.66 -35.93 75.42 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 120.311 1.414 . . . . 10.0 112.488 172.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 -66.73 -42.91 85.52 Favored 'General case' 0 CA--C 1.545 0.752 0 O-C-N 120.997 -1.065 . . . . 10.0 112.876 173.788 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -49.47 -49.56 44.97 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 125.361 1.464 . . . . 10.0 111.321 166.875 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.439 ' CB ' ' HG3' ' A' ' 56' ' ' MET . 0.0 OUTLIER -59.46 -60.29 4.09 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.001 1.321 . . . . 10.0 112.533 173.385 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 51.8 m0 -54.82 -37.94 66.75 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 126.034 1.733 . . . . 10.0 113.161 -175.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 31.3 tp -49.84 -45.51 50.36 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 126.677 1.991 . . . . 10.0 111.86 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -97.33 -40.74 8.58 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 123.666 0.787 . . . . 10.0 112.502 -179.662 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -61.93 -44.98 95.64 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 113.275 0.843 . . . . 10.0 113.275 -175.581 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . 0.293 81.7 p -69.58 -39.19 11.34 Favored Pre-proline 0 CA--C 1.544 0.719 0 CA-C-O 117.601 -1.19 . . . . 10.0 114.032 -174.826 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -54.31 -44.66 47.34 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 123.722 2.948 . . . . 10.0 115.451 164.218 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 51.2 mt -59.17 -46.75 87.58 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 118.948 0.795 . . . . 10.0 111.434 175.194 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.4 tp -50.79 -47.9 59.61 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.563 1.545 . . . . 10.0 112.226 172.448 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.5 mp -59.86 -46.64 88.67 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.293 1.437 . . . . 10.0 112.832 170.726 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.81 -38.27 78.25 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 123.806 0.842 . . . . 10.0 112.866 178.29 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -52.26 -54.04 36.3 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 119.329 0.968 . . . . 10.0 111.21 169.639 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.36 -42.06 88.57 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.671 0.788 . . . . 10.0 112.119 -178.526 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.71 -54.77 37.54 Favored 'General case' 0 C--O 1.225 -0.186 0 C-N-CA 123.982 0.913 . . . . 10.0 111.999 173.611 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.27 -41.21 79.27 Favored 'General case' 0 C--O 1.224 -0.237 0 C-N-CA 123.72 0.808 . . . . 10.0 112.678 174.858 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.8 tp -63.74 -38.57 91.62 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 114.424 1.268 . . . . 10.0 114.424 -179.582 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.1 t -94.83 1.44 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 125.035 1.334 . . . . 10.0 112.308 179.186 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.2 t70 48.59 53.49 12.08 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.882 1.673 . . . . 10.0 112.1 -174.038 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.29 145.89 47.56 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 119.951 -1.718 . . . . 10.0 112.422 -174.152 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.5 135.91 54.29 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 112.694 0.627 . . . . 10.0 112.694 175.158 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -42.87 -39.68 2.62 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.863 1.665 . . . . 10.0 113.463 175.291 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -47.33 -60.17 5.36 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 125.133 1.349 . . . . 10.0 115.293 169.754 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.6 p -62.07 -46.77 87.66 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 117.098 -1.429 . . . . 10.0 111.356 178.203 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 66.9 mt -48.42 -52.89 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 124.979 1.312 . . . . 10.0 111.153 178.197 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.2 tp -62.66 -51.25 67.98 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 112.544 0.572 . . . . 10.0 112.544 179.275 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.19 -44.81 43.44 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.424 0.69 . . . . 10.0 110.983 174.598 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.455 ' HA ' HD12 ' A' ' 111' ' ' LEU . 0.6 OUTLIER -59.56 -59.93 4.66 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 127.365 2.266 . . . . 10.0 114.838 174.907 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.6 t -60.99 -46.38 96.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 123.666 0.786 . . . . 10.0 111.37 -178.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -56.63 -50.26 64.35 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 123.659 0.647 . . . . 10.0 112.633 174.56 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -55.0 -46.62 75.18 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 113.451 0.908 . . . . 10.0 113.451 173.356 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -56.06 -47.14 78.49 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.466 0.706 . . . . 10.0 111.657 173.356 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -43.95 -54.23 6.09 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 124.88 1.229 . . . . 10.0 112.928 169.36 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 79.4 mt -58.22 -50.61 77.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 123.726 0.81 . . . . 10.0 111.979 173.303 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 53.1 ttp -49.05 -57.01 7.28 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.152 1.381 . . . . 10.0 112.061 179.487 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 36.5 mm . . . . . 0 N--CA 1.471 0.623 0 O-C-N 121.735 -0.603 . . . . 10.0 111.912 178.233 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 60.7 t . . . . . 0 N--CA 1.48 1.074 0 N-CA-C 111.61 0.226 . . . . 10.0 111.61 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -51.76 -59.59 8.44 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 125.893 1.711 . . . . 10.0 112.115 175.412 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -48.46 -37.9 18.49 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 127.027 2.131 . . . . 10.0 113.417 179.04 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 48.1 mt -99.4 -6.78 27.14 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 115.442 1.645 . . . . 10.0 115.442 -178.483 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 16.9 m -69.73 116.7 10.43 Favored 'General case' 0 N--CA 1.464 0.229 0 O-C-N 120.178 -1.576 . . . . 10.0 110.386 -178.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.622 ' H ' ' HD3' ' A' ' 129' ' ' LYS . 0.1 OUTLIER -55.4 -49.67 71.74 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 128.226 2.61 . . . . 10.0 113.299 177.751 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 60.6 t -69.61 106.31 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 C-N-CA 123.766 0.826 . . . . 10.0 110.141 179.628 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -46.87 -59.57 2.99 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 124.807 1.243 . . . . 10.0 114.048 -173.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 m -46.44 -42.11 14.86 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.478 1.511 . . . . 10.0 113.495 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -70.1 -24.68 63.25 Favored 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 114.958 1.466 . . . . 10.0 114.958 -178.134 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 69.5 mtp85 -53.76 -41.9 67.64 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 118.852 0.751 . . . . 10.0 110.814 176.618 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -69.43 -32.32 71.21 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.76 1.224 . . . . 10.0 114.233 176.667 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.8 t -55.12 -51.97 49.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-N 119.015 0.825 . . . . 10.0 109.932 169.03 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 69.3 m95 -59.51 -51.07 71.46 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 113.517 0.932 . . . . 10.0 113.517 174.29 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 86.5 t90 -48.79 -46.82 42.11 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.563 1.145 . . . . 10.0 113.494 174.22 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.622 0 C-N-CA 123.973 0.909 . . . . 10.0 111.683 175.796 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.815 0 N-CA-C 112.934 0.716 . . . . 10.0 112.934 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.4 -47.48 83.76 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 118.914 0.779 . . . . 10.0 111.955 175.699 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 61.6 tp -56.36 -49.39 74.56 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.202 1.401 . . . . 10.0 112.203 176.559 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 73.9 t80 -51.08 -54.25 26.67 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.97 0.908 . . . . 10.0 112.095 172.026 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 59.8 mt -54.07 -55.36 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 123.806 0.842 . . . . 10.0 110.662 177.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 21.8 mt -57.33 -35.35 69.76 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 118.009 -0.996 . . . . 10.0 113.067 178.341 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -57.31 -58.2 9.29 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 119.52 1.055 . . . . 10.0 113.011 173.08 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.41 -40.95 85.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-O 118.279 -0.867 . . . . 10.0 111.408 177.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 44.3 mt -56.77 -49.36 75.51 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 119.909 1.231 . . . . 10.0 112.148 171.275 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.471 ' HA ' ' HD2' ' A' ' 175' ' ' ARG . 11.8 t80 -77.05 -70.3 0.47 Allowed 'General case' 0 C--N 1.326 -0.447 0 O-C-N 120.056 -1.653 . . . . 10.0 112.848 -175.208 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -73.71 -21.94 60.07 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.612 1.165 . . . . 10.0 113.473 -174.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -87.85 -79.09 1.26 Allowed Glycine 0 CA--C 1.526 0.77 0 C-N-CA 123.588 0.613 . . . . 10.0 113.493 171.529 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -53.6 -32.48 51.28 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 126.305 1.842 . . . . 10.0 113.033 -166.526 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.0 m -52.03 -56.47 14.15 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 114.04 1.126 . . . . 10.0 114.04 172.11 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.5 p -53.68 -50.53 65.61 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 122.099 0.952 . . . . 10.0 112.308 -177.854 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 47.7 tttm -57.17 -45.97 83.21 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.166 0.986 . . . . 10.0 112.112 173.667 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.9 -47.42 80.57 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 114.497 1.295 . . . . 10.0 114.497 174.066 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -56.5 -11.23 1.19 Allowed 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 126.077 1.751 . . . . 10.0 114.271 177.673 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.1 m -107.16 6.64 28.96 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.424 1.89 . . . . 10.0 114.852 -179.309 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 93.3 mmm -91.89 -92.67 0.15 Allowed 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 123.475 1.607 . . . . 10.0 114.187 -170.667 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -138.69 153.99 72.72 Favored Pre-proline 0 C--O 1.236 0.359 0 C-N-CA 129.794 3.238 . . . . 10.0 105.56 170.196 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -52.85 -46.25 35.03 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.321 2.014 . . . . 10.0 113.078 179.061 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.666 ' CD ' ' HD3' ' A' ' 227' ' ' ARG . 0.1 OUTLIER -52.98 -46.02 68.08 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 129.013 2.925 . . . . 10.0 113.276 173.573 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 92.2 t -69.25 -53.0 27.74 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.249 0 C-N-CA 124.071 0.949 . . . . 10.0 109.788 -178.628 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.13 -46.82 75.66 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.31 0.644 . . . . 10.0 111.947 177.032 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 60.0 p -59.97 -56.25 24.07 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.919 0.887 . . . . 10.0 112.708 174.613 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 61.5 m -57.15 -53.25 60.24 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.23 1.012 . . . . 10.0 112.995 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -49.53 -49.57 45.48 Favored 'General case' 0 C--O 1.222 -0.375 0 C-N-CA 123.252 0.621 . . . . 10.0 111.113 174.064 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -57.1 -48.4 78.7 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 114.703 1.371 . . . . 10.0 114.703 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 40.5 t -55.98 -49.59 74.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 CA-C-N 118.795 0.725 . . . . 10.0 110.496 176.381 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 94.3 mt -58.58 -51.64 69.04 Favored 'General case' 0 C--O 1.221 -0.441 0 N-CA-C 113.132 0.79 . . . . 10.0 113.132 175.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 175' ' ' ARG . . . . . 0.471 ' HD2' ' HA ' ' A' ' 153' ' ' PHE . 35.6 ttp180 -47.81 -47.8 30.92 Favored 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 126.846 2.059 . . . . 10.0 111.011 174.509 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 63.7 m-20 -58.48 -58.36 8.88 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 122.817 0.447 . . . . 10.0 111.277 174.404 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 60.0 t -51.78 -49.04 37.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 C-N-CA 124.075 0.95 . . . . 10.0 111.53 179.019 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 28.7 m -57.4 -62.51 1.73 Allowed 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 128.025 2.53 . . . . 10.0 112.007 178.061 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 54.3 t -51.55 -50.31 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 C-N-CA 124.491 1.116 . . . . 10.0 111.069 -179.255 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 73.6 t -58.05 -62.6 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 124.022 0.929 . . . . 10.0 111.482 177.549 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -56.99 -48.71 77.77 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 118.869 0.759 . . . . 10.0 112.468 -177.236 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 10.9 m95 . . . . . 0 N--CA 1.467 0.415 0 C-N-CA 123.94 0.896 . . . . 10.0 112.615 177.621 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 87.5 t . . . . . 0 N--CA 1.479 0.997 0 CA-C-O 119.5 -0.286 . . . . 10.0 111.374 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 26.5 t90 -55.7 -52.63 63.22 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.685 1.194 . . . . 10.0 112.388 174.318 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 34.6 tp -53.21 -45.49 68.64 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.778 1.231 . . . . 10.0 112.511 -179.126 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 14.7 pt -87.92 -5.41 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 N-CA-C 115.318 1.599 . . . . 10.0 115.318 -176.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.39 -169.23 32.98 Favored Glycine 0 N--CA 1.451 -0.341 0 CA-C-O 122.614 1.119 . . . . 10.0 113.875 -168.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 23.2 t -53.19 -40.86 64.73 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 114.153 -1.023 . . . . 10.0 111.83 177.572 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -53.97 -32.94 55.53 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 128.571 2.748 . . . . 10.0 115.262 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -130.85 -103.84 0.99 Allowed Glycine 0 CA--C 1.527 0.82 0 CA-C-N 119.324 0.965 . . . . 10.0 113.384 -167.371 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -89.49 127.14 35.82 Favored 'General case' 0 C--N 1.328 -0.33 0 O-C-N 120.624 -1.515 . . . . 10.0 109.308 169.379 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -72.41 65.27 1.35 Allowed Glycine 0 CA--C 1.532 1.105 0 N-CA-C 113.899 0.32 . . . . 10.0 113.899 173.164 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 60.7 mt -79.57 -42.73 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 C-N-CA 126.088 1.755 . . . . 10.0 108.748 166.378 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 79.2 t -126.27 133.4 24.92 Favored Pre-proline 0 N--CA 1.454 -0.264 0 C-N-CA 126.408 1.883 . . . . 10.0 109.364 -174.207 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -68.68 153.73 72.74 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 123.811 3.007 . . . . 10.0 111.471 -176.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 12.2 tp -43.08 -39.86 2.92 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.358 1.063 . . . . 10.0 112.199 171.434 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -48.28 -52.43 21.31 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 114.705 1.372 . . . . 10.0 114.705 176.052 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 14.0 mm -75.89 -40.55 38.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 124.39 1.076 . . . . 10.0 109.625 177.565 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -49.24 -49.85 41.29 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 118.596 0.635 . . . . 10.0 111.934 173.656 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 16.2 m -57.64 -47.1 83.17 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 126.046 1.738 . . . . 10.0 112.993 174.29 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.535 HD23 ' CD2' ' A' ' 12' ' ' TRP . 1.3 tm? -63.31 -52.34 62.31 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.947 0.899 . . . . 10.0 112.112 179.721 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 93.3 mt -52.52 -59.49 4.38 Favored 'General case' 0 CA--C 1.527 0.068 0 C-N-CA 124.321 1.048 . . . . 10.0 109.963 176.445 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -54.88 -42.14 71.73 Favored 'General case' 0 C--O 1.221 -0.442 0 CA-C-O 117.52 -1.229 . . . . 10.0 112.938 176.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 209' ' ' MET . . . . . 0.574 ' HE2' ' HB3' ' A' ' 15' ' ' LEU . 4.6 tmm? -53.65 -53.42 52.19 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 121.033 1.742 . . . . 10.0 112.341 173.365 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 79.1 t -60.55 -46.92 94.76 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 124.824 1.25 . . . . 10.0 111.674 178.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 4.3 mp -58.25 -53.19 61.08 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.368 1.467 . . . . 10.0 111.621 175.132 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -55.84 -53.38 57.44 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.562 1.545 . . . . 10.0 111.277 178.669 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 45.7 t . . . . . 0 N--CA 1.479 0.996 0 C-N-CA 124.883 1.273 . . . . 10.0 111.145 174.996 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.379 0 N-CA-C 112.832 -0.107 . . . . 10.0 112.832 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -43.24 -55.86 3.77 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.495 1.918 . . . . 10.0 112.483 167.844 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -59.16 -39.49 94.54 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 124.857 1.218 . . . . 10.0 113.266 179.304 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 24.6 mt -69.13 -27.82 65.91 Favored 'General case' 0 CA--C 1.512 -0.495 0 N-CA-C 115.742 1.756 . . . . 10.0 115.742 175.007 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 74.3 mt -63.37 -57.57 11.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 119.122 0.874 . . . . 10.0 108.648 165.641 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 32.0 tp -58.77 -64.68 0.84 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.877 0.871 . . . . 10.0 113.213 -172.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 84.0 mt -71.52 5.16 2.51 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 115.337 1.606 . . . . 10.0 115.337 -171.691 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.6 mtp-105 -112.35 0.44 15.67 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.139 0.976 . . . . 10.0 113.288 172.559 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 8.8 t -108.06 177.97 4.65 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 124.096 0.958 . . . . 10.0 111.025 174.659 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 227' ' ' ARG . . . . . 0.666 ' HD3' ' CD ' ' A' ' 166' ' ' GLU . 41.8 ttt180 -71.62 98.11 1.84 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.819 0.848 . . . . 10.0 110.969 170.637 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 228' ' ' ALA . . . . . 0.475 ' HB1' ' CD2' ' A' ' 42' ' ' PHE . . . -80.91 77.03 7.83 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.859 0.864 . . . . 10.0 112.123 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 40.16 102.25 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 128.886 2.874 . . . . 10.0 116.446 177.724 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . 0.481 0.3 OUTLIER 71.85 -55.43 0.66 Allowed 'General case' 0 C--O 1.242 0.67 0 C-N-CA 124.711 1.205 . . . . 10.0 110.637 -175.318 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -68.28 169.47 40.01 Favored Glycine 0 C--O 1.239 0.417 0 C-N-CA 129.757 3.551 . . . . 10.0 119.653 171.474 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.461 0 C-N-CA 128.501 2.72 . . . . 10.0 113.462 166.617 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 N--CA 1.477 0.881 0 CA-C-O 115.768 -2.063 . . . . 10.0 105.842 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 23.35 91.83 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 129.598 3.159 . . . . 10.0 117.262 160.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 28.74 65.04 0.11 Allowed 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 128.265 2.626 . . . . 10.0 114.5 155.395 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 86.7 mt -56.51 138.0 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 126.353 1.861 . . . . 10.0 113.338 -158.342 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.653 HG21 ' HB3' ' A' ' 77' ' ' PRO . 7.6 t -136.79 -165.2 1.7 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 126.331 1.852 . . . . 10.0 114.015 -174.337 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 70.06 2.75 41.2 Favored Glycine 0 C--N 1.339 0.743 0 C-N-CA 127.458 2.456 . . . . 10.0 111.462 168.024 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -158.54 -51.29 0.01 OUTLIER Pre-proline 0 N--CA 1.443 -0.822 0 CA-C-O 114.267 -2.778 . . . . 10.0 116.694 -168.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -63.99 -60.63 0.15 Allowed 'Trans proline' 0 N--CA 1.465 -0.186 0 CA-C-N 123.502 2.286 . . . . 10.0 113.205 -175.334 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.411 ' H ' ' CD ' ' A' ' 9' ' ' GLU . 7.9 pm0 -67.24 4.3 0.98 Allowed 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 127.844 2.458 . . . . 10.0 115.768 179.716 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.421 ' CG ' ' N ' ' A' ' 11' ' ' ILE . 11.1 p-90 -51.39 -43.07 61.8 Favored 'General case' 0 C--O 1.222 -0.361 0 O-C-N 121.496 -0.752 . . . . 10.0 112.594 176.481 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.421 ' N ' ' CG ' ' A' ' 10' ' ' TRP . 8.8 tt -60.91 -49.57 84.13 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.338 0 C-N-CA 123.884 0.874 . . . . 10.0 109.337 179.429 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' TRP . . . . . 0.536 ' CD2' HD23 ' A' ' 206' ' ' LEU . 2.6 m95 -55.45 -52.64 62.96 Favored 'General case' 0 C--O 1.224 -0.259 0 C-N-CA 123.413 0.685 . . . . 10.0 111.819 175.626 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.9 mt -57.39 -53.58 56.56 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 123.184 0.594 . . . . 10.0 112.198 177.29 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.83 -46.82 51.63 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.39 1.476 . . . . 10.0 113.335 173.805 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.575 ' HB3' ' HE2' ' A' ' 209' ' ' MET . 13.3 tp -65.67 -44.88 84.92 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.27 1.428 . . . . 10.0 113.059 179.12 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.4 -57.58 9.09 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 124.553 1.073 . . . . 10.0 111.045 165.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.0 m -48.91 -52.47 24.34 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.911 1.284 . . . . 10.0 112.333 175.177 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.4 -58.87 5.75 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.148 0.979 . . . . 10.0 112.155 177.794 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 96.5 mt -58.06 -49.08 78.16 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.651 0.781 . . . . 10.0 112.515 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 21.8 mmt -54.43 -51.59 64.45 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.811 0.845 . . . . 10.0 111.056 175.599 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -56.87 -58.48 14.31 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 124.584 1.088 . . . . 10.0 113.624 177.018 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 80.7 mt -56.18 -45.72 79.66 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-N 118.617 1.208 . . . . 10.0 112.107 176.298 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.79 -41.84 76.73 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 124.725 1.155 . . . . 10.0 113.374 172.747 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 19.1 m -60.43 -60.44 3.8 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.228 1.011 . . . . 10.0 111.083 171.525 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -52.34 -40.96 62.6 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.99 0.916 . . . . 10.0 110.925 179.007 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.4 t80 -55.82 -58.05 9.49 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.564 1.146 . . . . 10.0 112.943 172.808 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -59.59 -38.72 81.96 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 113.184 0.809 . . . . 10.0 113.184 178.847 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.4 ' C ' ' H ' ' A' ' 30' ' ' LYS . 11.8 mt -56.12 -67.47 0.29 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.656 1.182 . . . . 10.0 113.589 169.167 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 t -76.41 41.04 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 CA-C-O 123.775 1.75 . . . . 10.0 110.889 179.075 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.4 ' H ' ' C ' ' A' ' 28' ' ' LEU . 43.0 tttm -140.89 -44.83 0.39 Allowed 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 127.899 2.48 . . . . 10.0 109.337 171.166 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -73.0 23.15 0.88 Allowed Glycine 0 CA--C 1.528 0.898 0 N-CA-C 115.619 1.007 . . . . 10.0 115.619 173.722 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 37.4 mmm -59.51 -45.04 92.87 Favored 'General case' 0 C--O 1.224 -0.278 0 C-N-CA 127.189 2.196 . . . . 10.0 113.581 -179.018 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.65 -84.42 1.18 Allowed Glycine 0 CA--C 1.53 1.026 0 C-N-CA 123.743 0.687 . . . . 10.0 112.465 -170.155 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.8 t 33.06 88.78 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.242 0.682 0 C-N-CA 128.399 2.68 . . . . 10.0 116.905 166.499 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.4 m -79.63 -50.85 10.04 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.163 -1.38 . . . . 10.0 113.868 174.111 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -49.02 117.58 6.59 Favored Pre-proline 0 CA--C 1.536 0.418 0 O-C-N 124.767 1.292 . . . . 10.0 110.95 -172.479 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -58.62 -29.61 89.69 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 123.721 2.947 . . . . 10.0 113.688 179.16 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.32 -60.64 2.3 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.08 0.552 . . . . 10.0 111.436 176.179 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.12 -40.11 22.54 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 125.134 1.373 . . . . 10.0 113.58 171.61 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -46.5 -47.5 19.37 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.21 1.404 . . . . 10.0 113.425 172.025 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -57.73 -53.01 63.02 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.452 0.701 . . . . 10.0 111.036 176.67 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.477 ' CD2' ' HB1' ' A' ' 228' ' ' ALA . 43.9 m-85 -56.98 -50.21 73.39 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 123.057 0.543 . . . . 10.0 112.348 -179.174 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -54.39 -51.27 65.36 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 118.966 -0.54 . . . . 10.0 112.369 173.278 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.39 -62.08 1.86 Allowed 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 113.353 0.871 . . . . 10.0 113.353 177.144 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.6 mt -48.62 -58.85 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 C-N-CA 124.862 1.265 . . . . 10.0 110.844 178.03 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 86.7 m -71.1 -13.67 62.04 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 114.128 1.159 . . . . 10.0 114.128 -173.585 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 29.3 m -85.26 -42.9 14.23 Favored 'General case' 0 N--CA 1.482 1.159 0 CA-C-N 120.422 1.465 . . . . 10.0 112.099 171.238 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 17.7 mt -56.31 -42.98 78.49 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 112.845 0.683 . . . . 10.0 112.845 174.525 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 37.7 t -48.76 -62.03 2.72 Favored Pre-proline 0 CA--C 1.551 1.001 0 C-N-CA 124.861 1.265 . . . . 10.0 112.728 178.557 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -49.92 -45.84 30.59 Favored 'Trans proline' 0 CA--C 1.543 0.934 0 C-N-CA 124.104 3.203 . . . . 10.0 115.846 164.768 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.0 -49.36 77.75 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 114.162 1.171 . . . . 10.0 114.162 -175.195 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . 0.274 16.1 tt -68.09 -36.08 74.03 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 O-C-N 120.598 -1.313 . . . . 10.0 111.421 173.918 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.65 -42.09 92.0 Favored 'General case' 0 CA--C 1.545 0.771 0 O-C-N 121.193 -0.942 . . . . 10.0 112.729 173.198 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -50.82 -56.05 13.99 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.541 1.537 . . . . 10.0 111.647 168.277 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 14.0 m -48.04 -53.37 16.56 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.653 1.581 . . . . 10.0 111.2 176.762 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 32.4 mmt -68.57 -48.25 64.69 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 123.966 0.907 . . . . 10.0 113.011 -176.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -56.06 -41.13 74.62 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 120.035 1.289 . . . . 10.0 113.342 173.084 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.8 tp -53.28 -54.6 33.96 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-N 119.54 1.064 . . . . 10.0 111.273 170.75 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 24.1 p -51.73 -41.0 61.2 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 115.217 1.562 . . . . 10.0 115.217 179.057 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 58.5 mtm -66.86 -50.89 61.08 Favored 'General case' 0 C--N 1.333 -0.122 0 C-N-CA 123.589 0.756 . . . . 10.0 110.491 176.804 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.4 tp -48.51 -52.73 21.05 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.849 0.86 . . . . 10.0 112.931 172.344 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.5 mt -76.89 -5.53 48.79 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 113.844 1.053 . . . . 10.0 113.844 -177.705 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.2 -34.63 5.61 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 115.579 0.992 . . . . 10.0 115.579 174.169 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -49.35 -43.05 43.56 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 115.273 1.583 . . . . 10.0 115.273 -176.025 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.04 3.55 61.07 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 115.314 0.885 . . . . 10.0 115.314 -179.035 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.28 143.42 26.42 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 127.035 2.134 . . . . 10.0 108.972 172.063 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 t -145.54 171.08 15.19 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 124.031 0.932 . . . . 10.0 111.052 166.769 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.95 136.1 53.36 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 123.922 0.889 . . . . 10.0 109.711 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.436 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 58.6 t -129.59 129.55 23.17 Favored Pre-proline 0 C--N 1.329 -0.315 0 C-N-CA 125.1 1.36 . . . . 10.0 110.935 -176.045 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 69' ' ' VAL . 6.2 Cg_exo -80.7 116.24 3.18 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 N-CA-C 109.441 -1.023 . . . . 10.0 109.441 -178.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -156.75 164.38 38.19 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.808 0.67 . . . . 10.0 112.808 172.496 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.4 -81.98 0.14 Allowed Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.681 -0.967 . . . . 10.0 110.681 175.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.76 -3.42 0.69 Allowed Glycine 0 CA--C 1.527 0.812 0 N-CA-C 118.627 2.211 . . . . 10.0 118.627 170.437 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -151.57 -171.89 4.06 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 119.379 1.59 . . . . 10.0 112.237 -165.159 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -91.79 93.81 9.04 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 125.552 1.541 . . . . 10.0 111.115 -175.312 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.449 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 60.2 m-80 -89.47 120.74 69.65 Favored Pre-proline 0 N--CA 1.45 -0.464 0 N-CA-C 113.002 0.741 . . . . 10.0 113.002 -165.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.653 ' HB3' HG21 ' A' ' 5' ' ' THR . 76.3 Cg_exo -61.49 131.9 38.2 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 124.183 3.255 . . . . 10.0 112.166 171.6 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.6 mm -140.1 126.35 22.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 C-N-CA 126.028 1.731 . . . . 10.0 111.707 -179.501 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -93.64 85.06 4.76 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 123.455 1.598 . . . . 10.0 113.051 174.626 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 63.8 p-90 -59.44 -28.21 66.75 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 120.453 -1.404 . . . . 10.0 113.942 174.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -54.68 -35.47 63.6 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.283 1.033 . . . . 10.0 113.595 178.195 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -63.79 -23.7 67.46 Favored 'General case' 0 N--CA 1.479 1.022 0 O-C-N 120.341 -1.474 . . . . 10.0 113.667 172.514 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 68.7 m-85 -78.46 -42.04 30.99 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 120.564 -1.335 . . . . 10.0 111.92 172.183 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -49.62 -49.62 46.21 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 125.164 1.385 . . . . 10.0 111.032 166.728 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -51.66 -69.45 0.11 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 126.769 2.027 . . . . 10.0 111.765 169.681 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 49.5 m0 -55.77 -35.6 66.41 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 124.407 1.083 . . . . 10.0 113.182 -172.05 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 28.7 tp -49.06 -46.08 43.9 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 126.277 1.831 . . . . 10.0 111.84 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -98.18 -40.35 8.42 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.805 0.842 . . . . 10.0 112.435 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 3.7 m -48.46 -57.83 5.54 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.864 1.266 . . . . 10.0 113.424 175.769 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . 0.286 38.3 p -67.08 -41.31 34.34 Favored Pre-proline 0 CA--C 1.544 0.736 0 CA-C-O 117.774 -1.108 . . . . 10.0 113.764 -168.868 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -54.14 -44.98 44.46 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 123.282 2.655 . . . . 10.0 115.998 166.581 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 54.5 mt -59.56 -45.73 90.96 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 118.959 0.799 . . . . 10.0 111.218 175.582 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.1 tp -50.94 -48.98 60.75 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.419 1.487 . . . . 10.0 112.136 172.396 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.0 mp -58.83 -47.15 85.85 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 125.339 1.456 . . . . 10.0 112.68 170.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.76 -38.31 78.18 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 123.87 0.868 . . . . 10.0 112.891 178.729 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 -52.27 -54.05 36.23 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 119.31 0.959 . . . . 10.0 111.165 169.659 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.34 -42.12 88.58 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.637 0.775 . . . . 10.0 112.1 -178.535 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.72 -54.66 39.0 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 123.991 0.916 . . . . 10.0 112.034 173.673 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.32 -41.18 79.44 Favored 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 123.724 0.81 . . . . 10.0 112.739 174.782 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.8 tp -63.77 -38.5 91.32 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 114.476 1.287 . . . . 10.0 114.476 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.2 t -94.84 1.44 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 125.075 1.35 . . . . 10.0 112.275 179.172 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.2 t70 48.5 53.55 11.89 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.874 1.67 . . . . 10.0 112.137 -173.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.28 145.89 47.57 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 120.002 -1.686 . . . . 10.0 112.46 -174.199 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.54 135.96 54.45 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 112.697 0.628 . . . . 10.0 112.697 175.164 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -42.88 -39.67 2.63 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.844 1.657 . . . . 10.0 113.489 175.284 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -47.33 -60.21 5.33 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 125.15 1.357 . . . . 10.0 115.234 169.749 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.4 p -62.06 -46.79 87.55 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 117.103 -1.427 . . . . 10.0 111.34 178.241 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 66.8 mt -48.41 -52.91 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 125.034 1.334 . . . . 10.0 111.127 178.194 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.2 tp -62.61 -51.3 67.86 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 112.574 0.583 . . . . 10.0 112.574 179.281 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.17 -44.85 43.27 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.465 0.706 . . . . 10.0 110.938 174.603 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.455 ' HA ' HD12 ' A' ' 111' ' ' LEU . 0.6 OUTLIER -59.67 -59.83 4.81 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 127.344 2.257 . . . . 10.0 114.807 174.989 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.5 t -61.01 -46.37 96.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 123.705 0.802 . . . . 10.0 111.387 -178.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -56.59 -50.32 63.88 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 123.668 0.651 . . . . 10.0 112.664 174.525 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -54.9 -46.56 74.84 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 113.322 0.86 . . . . 10.0 113.322 173.359 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -55.36 -48.54 74.1 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.16 0.984 . . . . 10.0 111.276 173.515 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -43.02 -54.91 5.08 Favored Glycine 0 CA--C 1.533 1.213 0 C-N-CA 124.938 1.256 . . . . 10.0 113.267 169.087 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 82.5 mt -57.75 -52.3 59.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 123.694 0.798 . . . . 10.0 111.899 173.817 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 60.2 ttp -47.51 -58.09 4.63 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.312 1.445 . . . . 10.0 111.731 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 37.6 mm . . . . . 0 N--CA 1.474 0.727 0 O-C-N 121.807 -0.558 . . . . 10.0 112.169 178.796 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 65.5 t . . . . . 0 N--CA 1.476 0.838 0 N-CA-C 110.127 -0.323 . . . . 10.0 110.127 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -50.84 -60.76 6.68 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 126.227 1.87 . . . . 10.0 112.561 171.637 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -42.95 -42.21 3.66 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 127.488 2.315 . . . . 10.0 113.335 176.581 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 48.5 mt -100.9 -6.5 24.57 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 115.526 1.676 . . . . 10.0 115.526 -175.472 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 16.9 m -69.75 116.76 10.51 Favored 'General case' 0 N--CA 1.464 0.248 0 O-C-N 120.157 -1.589 . . . . 10.0 110.344 -178.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.62 ' H ' ' HD3' ' A' ' 129' ' ' LYS . 0.1 OUTLIER -55.46 -49.6 72.05 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 128.195 2.598 . . . . 10.0 113.287 177.748 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 61.3 t -69.74 106.34 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 123.774 0.83 . . . . 10.0 110.067 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -46.93 -59.5 3.05 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 124.737 1.215 . . . . 10.0 114.062 -173.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 m -46.46 -42.11 14.95 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.531 1.533 . . . . 10.0 113.49 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -70.17 -24.59 63.17 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 114.946 1.461 . . . . 10.0 114.946 -178.129 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 68.9 mtp85 -53.98 -41.74 68.21 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 118.914 0.779 . . . . 10.0 110.793 176.661 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -69.46 -32.08 70.77 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.813 1.245 . . . . 10.0 114.219 176.67 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.9 t -55.01 -51.85 49.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 CA-C-N 119.037 0.835 . . . . 10.0 109.654 168.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 67.4 m95 -61.64 -45.49 93.83 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 114.392 1.256 . . . . 10.0 114.392 175.023 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 88.1 t90 -51.66 -49.35 62.48 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.235 1.014 . . . . 10.0 112.71 172.369 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.614 0 C-N-CA 124.072 0.949 . . . . 10.0 112.03 177.073 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.818 0 N-CA-C 112.71 0.633 . . . . 10.0 112.71 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 40.3 ttp -56.16 -54.86 40.07 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.257 1.023 . . . . 10.0 112.09 172.366 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 8.1 tt -51.11 -50.57 58.54 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 125.941 1.697 . . . . 10.0 111.08 178.535 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 77.8 t80 -50.47 -54.91 18.51 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.169 0.988 . . . . 10.0 112.798 172.509 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 54.6 mt -53.6 -55.05 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 123.809 0.844 . . . . 10.0 110.775 177.729 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 44.4 mt -57.37 -35.88 70.53 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 118.349 -0.834 . . . . 10.0 112.957 178.568 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -57.26 -58.15 9.5 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 124.015 0.926 . . . . 10.0 113.041 173.242 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.44 -40.9 85.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-O 118.355 -0.831 . . . . 10.0 111.465 177.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 45.2 mt -56.79 -49.4 75.43 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 119.862 1.21 . . . . 10.0 112.131 171.242 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.469 ' HA ' ' HD2' ' A' ' 175' ' ' ARG . 11.9 t80 -77.01 -70.33 0.47 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 120.088 -1.632 . . . . 10.0 112.901 -175.29 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -73.66 -21.98 60.1 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.615 1.166 . . . . 10.0 113.431 -174.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -87.79 -79.12 1.26 Allowed Glycine 0 CA--C 1.527 0.783 0 C-N-CA 123.625 0.631 . . . . 10.0 113.496 171.571 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -53.63 -32.38 51.08 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 126.269 1.828 . . . . 10.0 113.067 -166.539 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.2 m -52.16 -56.44 14.57 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 114.01 1.115 . . . . 10.0 114.01 172.137 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.7 p -53.63 -50.61 65.34 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 122.087 0.946 . . . . 10.0 112.271 -177.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 47.7 tttm -57.09 -46.1 82.81 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.197 0.999 . . . . 10.0 112.107 173.704 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.76 -47.49 79.97 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 114.563 1.32 . . . . 10.0 114.563 174.001 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -56.47 -11.31 1.22 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 126.087 1.755 . . . . 10.0 114.261 177.689 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.2 m -107.09 6.67 29.11 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.374 1.87 . . . . 10.0 114.877 -179.319 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 93.3 mmm -91.92 -92.69 0.15 Allowed 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 123.451 1.596 . . . . 10.0 114.171 -170.636 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -138.63 153.96 72.79 Favored Pre-proline 0 C--O 1.236 0.349 0 C-N-CA 129.833 3.253 . . . . 10.0 105.573 170.199 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -52.85 -46.21 35.35 Favored 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 122.338 2.025 . . . . 10.0 113.083 179.01 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.667 ' CD ' ' HD3' ' A' ' 227' ' ' ARG . 0.1 OUTLIER -52.99 -46.05 68.12 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 129.014 2.926 . . . . 10.0 113.266 173.577 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 91.5 t -69.26 -53.0 27.72 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 C-N-CA 124.006 0.922 . . . . 10.0 109.788 -178.576 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.07 -46.89 75.46 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.3 0.64 . . . . 10.0 111.923 177.005 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 59.9 p -59.99 -56.13 25.42 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.883 0.873 . . . . 10.0 112.742 174.631 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 61.8 m -57.23 -53.19 60.86 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.185 0.994 . . . . 10.0 113.011 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -49.61 -49.47 46.71 Favored 'General case' 0 C--O 1.222 -0.387 0 C-N-CA 123.324 0.65 . . . . 10.0 111.1 174.121 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -57.12 -48.46 78.6 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 114.671 1.36 . . . . 10.0 114.671 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 40.3 t -55.98 -49.54 74.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 CA-C-N 118.802 0.728 . . . . 10.0 110.541 176.392 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 93.8 mt -58.57 -51.65 69.01 Favored 'General case' 0 C--O 1.222 -0.39 0 N-CA-C 113.196 0.813 . . . . 10.0 113.196 175.853 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' ARG . . . . . 0.469 ' HD2' ' HA ' ' A' ' 153' ' ' PHE . 35.4 ttp180 -47.76 -47.76 30.33 Favored 'General case' 0 C--O 1.225 -0.201 0 C-N-CA 126.831 2.052 . . . . 10.0 111.095 174.405 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 63.8 m-20 -58.5 -58.4 8.71 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 122.836 0.454 . . . . 10.0 111.232 174.376 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 54.5 t -52.13 -46.77 44.03 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 124.067 0.947 . . . . 10.0 112.052 179.012 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 28.8 m -60.39 -61.79 2.34 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 127.818 2.447 . . . . 10.0 111.874 178.78 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 55.8 t -50.91 -50.42 23.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 124.667 1.187 . . . . 10.0 110.928 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 80.3 t -59.49 -63.01 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 124.047 0.939 . . . . 10.0 111.889 177.176 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 68.9 mt -53.29 -50.75 64.23 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 119.183 0.901 . . . . 10.0 112.144 -178.13 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 10.1 m95 . . . . . 0 N--CA 1.465 0.309 0 C-N-CA 124.116 0.966 . . . . 10.0 112.275 177.482 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 2.7 p . . . . . 0 N--CA 1.482 1.133 0 CA-C-O 118.861 -0.59 . . . . 10.0 112.083 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 59.8 t90 -56.73 -51.96 66.81 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.372 0.669 . . . . 10.0 112.422 173.709 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 25.8 tp -54.9 -44.95 74.6 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.49 1.116 . . . . 10.0 112.197 -178.819 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 14.6 pt -86.28 -5.5 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 N-CA-C 115.246 1.573 . . . . 10.0 115.246 -177.842 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.57 -169.26 32.74 Favored Glycine 0 N--CA 1.45 -0.383 0 CA-C-O 122.573 1.096 . . . . 10.0 113.83 -168.821 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 23.3 t -53.12 -41.65 65.25 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 114.203 -0.999 . . . . 10.0 111.858 177.618 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -66.9 -17.18 64.78 Favored 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 115.559 1.688 . . . . 10.0 115.559 -175.849 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -131.08 -105.87 1.08 Allowed Glycine 0 CA--C 1.532 1.106 0 CA-C-N 120.397 1.453 . . . . 10.0 113.914 -172.763 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -89.45 127.12 35.81 Favored 'General case' 0 C--N 1.328 -0.345 0 O-C-N 120.663 -1.492 . . . . 10.0 109.3 168.5 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -72.44 65.29 1.35 Allowed Glycine 0 CA--C 1.531 1.064 0 N-CA-C 113.925 0.33 . . . . 10.0 113.925 173.123 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 60.7 mt -79.56 -42.72 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 126.077 1.751 . . . . 10.0 108.725 166.361 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 79.8 t -126.32 133.41 24.94 Favored Pre-proline 0 N--CA 1.454 -0.25 0 C-N-CA 126.468 1.907 . . . . 10.0 109.368 -174.192 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -68.79 153.78 72.36 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 123.781 2.988 . . . . 10.0 111.461 -176.805 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 12.2 tp -43.14 -39.82 3.0 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.375 1.07 . . . . 10.0 112.17 171.534 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -48.33 -52.35 22.01 Favored 'General case' 0 CA--C 1.539 0.519 0 N-CA-C 114.728 1.381 . . . . 10.0 114.728 176.044 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 14.0 mm -75.98 -40.48 38.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 124.366 1.066 . . . . 10.0 109.625 177.595 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -49.26 -49.82 41.68 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 118.603 0.638 . . . . 10.0 111.981 173.582 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 16.2 m -57.74 -46.97 83.74 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 126.04 1.736 . . . . 10.0 112.964 174.334 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.536 HD23 ' CD2' ' A' ' 12' ' ' TRP . 1.3 tm? -63.4 -52.28 62.27 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.992 0.917 . . . . 10.0 112.101 179.738 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 93.2 mt -52.56 -59.17 4.78 Favored 'General case' 0 C--N 1.335 -0.044 0 C-N-CA 124.32 1.048 . . . . 10.0 110.003 176.416 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -52.29 -47.3 65.96 Favored 'General case' 0 C--O 1.217 -0.64 0 CA-C-O 117.425 -1.274 . . . . 10.0 112.164 176.031 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 209' ' ' MET . . . . . 0.575 ' HE2' ' HB3' ' A' ' 15' ' ' LEU . 4.6 tmm? -52.03 -51.7 55.73 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 121.073 1.76 . . . . 10.0 113.001 175.708 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 78.7 t -60.39 -50.0 82.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 124.646 1.178 . . . . 10.0 111.278 178.489 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 5.2 mp -57.52 -51.18 70.5 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.884 1.674 . . . . 10.0 112.044 175.291 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -56.96 -57.72 11.3 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 127.36 2.264 . . . . 10.0 110.706 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 97.3 t . . . . . 0 N--CA 1.478 0.952 0 O-C-N 121.001 -1.062 . . . . 10.0 111.417 177.802 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.281 0 CA-C-O 121.095 0.275 . . . . 10.0 113.118 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -45.45 -55.66 5.88 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.476 1.91 . . . . 10.0 112.27 166.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -55.58 -40.01 76.98 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 124.008 0.813 . . . . 10.0 113.754 178.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 24.9 mt -70.08 -27.41 64.59 Favored 'General case' 0 CA--C 1.512 -0.502 0 N-CA-C 115.833 1.79 . . . . 10.0 115.833 176.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 74.3 mt -63.49 -57.53 11.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 108.59 -0.893 . . . . 10.0 108.59 165.639 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 32.0 tp -58.77 -64.68 0.85 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.918 0.887 . . . . 10.0 113.206 -172.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 84.2 mt -71.53 5.19 2.51 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 115.304 1.594 . . . . 10.0 115.304 -171.685 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.6 mtp-105 -112.35 0.35 15.64 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.211 1.005 . . . . 10.0 113.303 172.575 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 8.8 t -108.03 177.94 4.66 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 124.058 0.943 . . . . 10.0 111.032 174.634 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 227' ' ' ARG . . . . . 0.667 ' HD3' ' CD ' ' A' ' 166' ' ' GLU . 41.8 ttt180 -71.59 98.15 1.83 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.732 0.813 . . . . 10.0 110.977 170.647 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 228' ' ' ALA . . . . . 0.477 ' HB1' ' CD2' ' A' ' 42' ' ' PHE . . . -80.9 77.03 7.82 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.874 0.87 . . . . 10.0 112.095 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 40.19 102.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 128.866 2.866 . . . . 10.0 116.474 177.686 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . 0.481 0.3 OUTLIER 71.81 -55.41 0.66 Allowed 'General case' 0 C--O 1.243 0.714 0 C-N-CA 124.769 1.227 . . . . 10.0 110.603 -175.305 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -68.3 169.47 40.07 Favored Glycine 0 C--O 1.239 0.417 0 C-N-CA 129.76 3.552 . . . . 10.0 119.619 171.493 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.461 0 C-N-CA 128.476 2.711 . . . . 10.0 113.44 166.603 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 N--CA 1.477 0.881 0 CA-C-O 115.781 -2.057 . . . . 10.0 105.842 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 23.36 91.91 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 129.588 3.155 . . . . 10.0 117.227 160.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 28.6 65.03 0.11 Allowed 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 128.307 2.643 . . . . 10.0 114.529 155.431 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 86.5 mt -56.41 137.91 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 126.396 1.878 . . . . 10.0 113.372 -158.385 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.653 HG21 ' HB3' ' A' ' 77' ' ' PRO . 7.6 t -136.75 -165.2 1.7 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 126.327 1.851 . . . . 10.0 114.015 -174.315 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 70.0 2.83 41.1 Favored Glycine 0 C--N 1.339 0.743 0 C-N-CA 127.496 2.474 . . . . 10.0 111.485 168.038 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -158.55 -51.32 0.01 OUTLIER Pre-proline 0 N--CA 1.443 -0.783 0 CA-C-O 114.301 -2.761 . . . . 10.0 116.649 -168.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_exo -63.93 -60.72 0.14 Allowed 'Trans proline' 0 N--CA 1.465 -0.186 0 CA-C-N 123.538 2.299 . . . . 10.0 113.194 -175.331 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.41 ' H ' ' CD ' ' A' ' 9' ' ' GLU . 7.9 pm0 -67.21 4.34 0.96 Allowed 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 127.886 2.475 . . . . 10.0 115.732 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.422 ' CG ' ' N ' ' A' ' 11' ' ' ILE . 11.0 p-90 -51.38 -43.12 61.8 Favored 'General case' 0 C--O 1.223 -0.315 0 O-C-N 121.509 -0.744 . . . . 10.0 112.618 176.389 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.422 ' N ' ' CG ' ' A' ' 10' ' ' TRP . 8.9 tt -60.87 -49.59 84.0 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.34 0 C-N-CA 123.872 0.869 . . . . 10.0 109.344 179.394 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' TRP . . . . . 0.535 ' CD2' HD23 ' A' ' 206' ' ' LEU . 2.6 m95 -55.32 -52.69 62.65 Favored 'General case' 0 C--O 1.224 -0.259 0 C-N-CA 123.406 0.682 . . . . 10.0 111.877 175.578 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.4 mt -57.34 -53.64 55.79 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 123.188 0.595 . . . . 10.0 112.224 177.283 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.83 -46.81 51.61 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.353 1.461 . . . . 10.0 113.33 173.811 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.575 ' HB3' ' HE2' ' A' ' 209' ' ' MET . 13.3 tp -65.63 -44.95 84.88 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.277 1.431 . . . . 10.0 113.059 179.077 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.5 -57.03 9.83 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 124.549 1.071 . . . . 10.0 111.274 165.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.1 m -49.26 -52.53 26.74 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.985 1.314 . . . . 10.0 112.232 174.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.44 -58.86 5.83 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.151 0.98 . . . . 10.0 112.161 177.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 99.6 mt -58.0 -49.07 78.11 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.471 0.709 . . . . 10.0 112.537 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 23.9 mmt -55.61 -49.22 73.38 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.858 0.863 . . . . 10.0 111.359 176.175 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -58.29 -58.43 14.61 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 124.388 0.994 . . . . 10.0 113.438 176.33 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 81.0 mt -56.24 -46.01 79.75 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-N 118.634 1.217 . . . . 10.0 112.132 176.318 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.73 -41.76 75.96 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 124.714 1.15 . . . . 10.0 113.242 173.15 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 28.2 m -62.38 -58.49 7.46 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.833 0.853 . . . . 10.0 111.347 172.024 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -52.27 -41.0 62.47 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.981 0.912 . . . . 10.0 110.977 177.773 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -55.75 -58.03 9.52 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 124.641 1.176 . . . . 10.0 112.967 172.79 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.1 m-30 -59.67 -38.7 82.19 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 113.223 0.823 . . . . 10.0 113.223 178.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.401 ' C ' ' H ' ' A' ' 30' ' ' LYS . 11.9 mt -56.04 -67.47 0.29 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.629 1.171 . . . . 10.0 113.65 169.104 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 t -76.34 40.89 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 CA-C-O 123.727 1.727 . . . . 10.0 110.866 179.06 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.401 ' H ' ' C ' ' A' ' 28' ' ' LEU . 42.8 tttm -140.8 -44.85 0.39 Allowed 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 127.915 2.486 . . . . 10.0 109.347 171.157 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.96 23.11 0.87 Allowed Glycine 0 CA--C 1.529 0.925 0 N-CA-C 115.629 1.012 . . . . 10.0 115.629 173.752 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 37.3 mmm -59.5 -45.0 92.96 Favored 'General case' 0 C--O 1.225 -0.211 0 C-N-CA 127.17 2.188 . . . . 10.0 113.571 -178.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.71 -84.41 1.19 Allowed Glycine 0 CA--C 1.531 1.045 0 C-N-CA 123.775 0.702 . . . . 10.0 112.446 -170.103 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.8 t 33.09 88.75 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.243 0.73 0 C-N-CA 128.399 2.68 . . . . 10.0 116.941 166.459 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.6 m -79.65 -50.92 9.93 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.23 -1.35 . . . . 10.0 113.828 174.191 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -48.87 117.51 6.37 Favored Pre-proline 0 CA--C 1.536 0.416 0 O-C-N 124.765 1.291 . . . . 10.0 110.972 -172.535 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -58.56 -29.68 89.64 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 123.757 2.971 . . . . 10.0 113.669 179.101 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.31 -60.66 2.29 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.126 0.57 . . . . 10.0 111.457 176.227 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.12 -40.08 22.45 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 125.134 1.373 . . . . 10.0 113.58 171.578 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -46.56 -47.42 19.71 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.22 1.408 . . . . 10.0 113.447 172.029 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -57.72 -53.1 62.01 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.5 0.72 . . . . 10.0 110.992 176.625 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.477 ' CD2' ' HB1' ' A' ' 228' ' ' ALA . 43.9 m-85 -57.02 -50.21 73.42 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 123.084 0.554 . . . . 10.0 112.315 -179.076 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -54.3 -51.29 65.1 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 118.966 -0.54 . . . . 10.0 112.401 173.228 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.41 -62.01 1.91 Allowed 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 113.386 0.884 . . . . 10.0 113.386 177.144 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.4 mt -48.61 -57.76 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 124.867 1.267 . . . . 10.0 110.287 178.044 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.5 m -68.36 -17.74 64.31 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.114 1.365 . . . . 10.0 113.639 -172.614 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 27.4 m -87.12 -40.84 14.27 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 119.583 1.083 . . . . 10.0 112.137 174.622 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 22.0 mt -59.27 -40.98 87.77 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 121.359 -0.838 . . . . 10.0 112.835 171.772 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 22.7 t -43.9 -60.6 2.56 Favored Pre-proline 0 CA--C 1.549 0.941 0 C-N-CA 126.238 1.815 . . . . 10.0 113.395 176.803 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -72.27 -28.29 15.47 Favored 'Trans proline' 0 CA--C 1.546 1.108 0 C-N-CA 123.083 2.522 . . . . 10.0 114.182 172.507 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.98 -48.72 79.08 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 120.734 1.606 . . . . 10.0 113.927 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 19.5 tt -68.3 -36.16 73.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 O-C-N 120.249 -1.532 . . . . 10.0 111.376 173.062 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.29 -43.34 78.75 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 119.093 0.86 . . . . 10.0 112.74 171.298 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -50.96 -56.78 10.76 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.214 1.405 . . . . 10.0 111.68 168.471 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.7 m -47.88 -53.34 16.05 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 125.411 1.484 . . . . 10.0 111.18 176.598 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 32.7 mmt -69.09 -48.18 63.3 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 124.176 0.99 . . . . 10.0 112.871 -176.506 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -55.86 -41.38 74.27 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 120.203 1.365 . . . . 10.0 113.238 172.697 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.8 tp -53.31 -54.55 34.77 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-N 119.671 1.123 . . . . 10.0 111.301 170.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 24.0 p -51.65 -41.06 61.06 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 115.207 1.558 . . . . 10.0 115.207 179.002 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 56.9 mtm -66.86 -50.89 61.09 Favored 'General case' 0 C--N 1.334 -0.09 0 C-N-CA 123.597 0.759 . . . . 10.0 110.477 176.84 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.3 tp -48.62 -52.69 21.8 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.862 0.865 . . . . 10.0 112.904 172.409 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.4 mt -76.87 -5.53 48.77 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 113.848 1.055 . . . . 10.0 113.848 -177.726 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.24 -34.71 5.55 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 115.558 0.983 . . . . 10.0 115.558 174.142 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 75.3 t80 -49.28 -43.09 42.88 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 115.243 1.572 . . . . 10.0 115.243 -176.014 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.04 3.55 61.07 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 115.314 0.885 . . . . 10.0 115.314 -179.013 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.25 143.4 26.45 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 127.034 2.133 . . . . 10.0 109.031 172.015 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 t -145.51 171.09 15.17 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 124.081 0.952 . . . . 10.0 111.06 166.785 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.97 136.06 53.38 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 123.885 0.874 . . . . 10.0 109.722 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.437 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 58.5 t -129.56 129.64 23.19 Favored Pre-proline 0 C--N 1.33 -0.261 0 C-N-CA 125.043 1.337 . . . . 10.0 110.982 -176.109 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 69' ' ' VAL . 6.3 Cg_exo -80.76 116.24 3.16 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 N-CA-C 109.411 -1.034 . . . . 10.0 109.411 -178.864 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -156.71 164.41 38.17 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.808 0.669 . . . . 10.0 112.808 172.495 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.34 -81.92 0.14 Allowed Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.685 -0.966 . . . . 10.0 110.685 175.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.76 -3.37 0.69 Allowed Glycine 0 CA--C 1.527 0.822 0 N-CA-C 118.671 2.228 . . . . 10.0 118.671 170.395 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -151.6 -171.87 4.06 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 119.343 1.571 . . . . 10.0 112.187 -165.166 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -91.86 93.91 9.06 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 125.521 1.528 . . . . 10.0 111.097 -175.293 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.449 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 60.1 m-80 -89.47 120.74 69.65 Favored Pre-proline 0 C--N 1.326 -0.452 0 N-CA-C 113.001 0.741 . . . . 10.0 113.001 -165.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.653 ' HB3' HG21 ' A' ' 5' ' ' THR . 76.4 Cg_exo -61.47 131.93 38.37 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 124.16 3.24 . . . . 10.0 112.167 171.576 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.6 mm -140.13 126.33 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 C-N-CA 126.043 1.737 . . . . 10.0 111.682 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -93.61 85.02 4.76 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 123.316 1.531 . . . . 10.0 113.051 174.598 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 63.5 p-90 -59.32 -28.3 66.68 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 120.588 -1.32 . . . . 10.0 113.965 174.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -54.39 -35.88 63.33 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 114.152 1.167 . . . . 10.0 114.152 178.229 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 1.5 ptp180 -63.67 -25.84 68.39 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 120.419 -1.426 . . . . 10.0 113.926 174.049 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -76.96 -41.94 41.14 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 121.22 -0.925 . . . . 10.0 111.845 172.266 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -49.48 -48.62 47.68 Favored 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 125.192 1.397 . . . . 10.0 111.5 167.341 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -52.86 -69.77 0.11 Allowed 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 126.078 1.751 . . . . 10.0 111.671 168.383 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 53.4 m0 -56.8 -32.97 66.22 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 124.428 1.091 . . . . 10.0 113.042 -169.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 29.4 tp -48.74 -44.15 38.25 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 125.858 1.663 . . . . 10.0 111.721 176.231 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -99.44 -42.21 7.06 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.845 0.858 . . . . 10.0 112.402 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 76.8 p -61.72 -45.3 94.54 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 120.335 1.425 . . . . 10.0 113.913 -177.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . 0.325 74.8 p -60.66 -46.95 97.2 Favored Pre-proline 0 CA--C 1.546 0.826 0 CA-C-O 117.568 -1.206 . . . . 10.0 113.54 -178.367 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -54.65 -44.05 53.28 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 123.24 2.627 . . . . 10.0 115.725 169.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 51.1 mt -59.25 -45.75 90.35 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 121.433 -0.792 . . . . 10.0 111.398 175.438 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.8 tp -51.84 -48.88 63.77 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.437 1.495 . . . . 10.0 112.044 172.725 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.9 mp -57.81 -47.71 81.84 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.929 1.291 . . . . 10.0 112.392 170.596 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.87 -38.24 78.33 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 119.12 0.873 . . . . 10.0 112.891 179.028 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -52.28 -54.05 36.32 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 119.285 0.948 . . . . 10.0 111.165 169.627 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.34 -42.12 88.62 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.621 0.768 . . . . 10.0 112.151 -178.518 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.62 -54.73 37.68 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.958 0.903 . . . . 10.0 112.049 173.58 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.39 -41.15 79.69 Favored 'General case' 0 C--O 1.224 -0.237 0 C-N-CA 123.729 0.812 . . . . 10.0 112.667 174.871 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.9 tp -63.7 -38.61 91.75 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 114.481 1.289 . . . . 10.0 114.481 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.2 t -94.8 1.46 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 125.089 1.356 . . . . 10.0 112.304 179.193 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.3 t70 48.48 53.53 11.91 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.848 1.659 . . . . 10.0 112.137 -173.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.29 145.89 47.55 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 120.0 -1.688 . . . . 10.0 112.44 -174.201 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.47 135.89 54.17 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 112.711 0.634 . . . . 10.0 112.711 175.149 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -42.85 -39.69 2.61 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.857 1.663 . . . . 10.0 113.471 175.277 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -47.33 -60.25 5.3 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 125.15 1.357 . . . . 10.0 115.233 169.742 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.6 p -62.02 -46.72 87.95 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 117.103 -1.427 . . . . 10.0 111.351 178.238 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 66.9 mt -48.49 -52.87 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 124.998 1.319 . . . . 10.0 111.146 178.196 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.2 tp -62.63 -51.29 67.85 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 112.556 0.576 . . . . 10.0 112.556 179.271 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.14 -44.9 42.97 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.506 0.722 . . . . 10.0 110.934 174.602 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.455 ' HA ' HD12 ' A' ' 111' ' ' LEU . 0.6 OUTLIER -59.61 -59.88 4.74 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 127.361 2.264 . . . . 10.0 114.778 175.005 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.7 t -60.97 -46.42 96.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 123.735 0.814 . . . . 10.0 111.398 -178.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -56.59 -50.32 63.86 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 123.641 0.639 . . . . 10.0 112.674 174.511 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -54.59 -46.72 73.81 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 113.261 0.837 . . . . 10.0 113.261 173.326 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 51.2 t0 -58.17 -45.27 87.81 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.597 0.759 . . . . 10.0 112.008 174.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -43.51 -55.74 5.14 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 125.114 1.34 . . . . 10.0 113.575 166.686 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 85.8 mt -55.45 -57.12 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 CA-C-O 118.438 -0.791 . . . . 10.0 110.631 173.836 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 48.1 ttp -44.93 -55.29 5.6 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.704 1.602 . . . . 10.0 113.28 -177.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 41.5 mm . . . . . 0 N--CA 1.474 0.735 0 O-C-N 121.703 -0.623 . . . . 10.0 111.716 177.303 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 67.6 t . . . . . 0 N--CA 1.477 0.877 0 N-CA-C 110.31 -0.256 . . . . 10.0 110.31 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -50.11 -60.87 6.23 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 126.086 1.803 . . . . 10.0 112.271 172.197 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -48.57 -37.66 18.53 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 126.427 1.891 . . . . 10.0 113.792 179.47 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 49.0 mt -99.22 -6.62 27.8 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 115.309 1.596 . . . . 10.0 115.309 -179.023 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 16.9 m -69.69 116.75 10.45 Favored 'General case' 0 N--CA 1.464 0.274 0 O-C-N 120.186 -1.571 . . . . 10.0 110.387 -178.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.62 ' H ' ' HD3' ' A' ' 129' ' ' LYS . 0.2 OUTLIER -55.48 -49.6 72.1 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 128.231 2.613 . . . . 10.0 113.251 177.747 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 61.1 t -69.72 106.42 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 123.746 0.818 . . . . 10.0 110.065 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -46.93 -59.57 3.01 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 124.779 1.231 . . . . 10.0 114.043 -173.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 m -46.43 -42.12 14.8 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.463 1.505 . . . . 10.0 113.485 179.708 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -70.15 -24.61 63.19 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 114.918 1.451 . . . . 10.0 114.918 -178.092 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 68.9 mtp85 -53.9 -41.67 67.86 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 118.93 0.786 . . . . 10.0 110.847 176.588 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -69.87 -31.61 69.53 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 114.354 1.242 . . . . 10.0 114.354 176.638 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.8 t -55.22 -52.23 47.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 CA-C-N 119.03 0.832 . . . . 10.0 109.543 168.699 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 66.1 m95 -61.72 -42.88 99.54 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 114.37 1.248 . . . . 10.0 114.37 174.426 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 88.9 t90 -52.78 -50.26 63.93 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.082 0.953 . . . . 10.0 112.415 171.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.532 0 C-N-CA 124.315 1.046 . . . . 10.0 111.737 178.308 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.806 0 N-CA-C 112.601 0.593 . . . . 10.0 112.601 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 38.4 ttp -55.23 -55.57 29.86 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.262 1.025 . . . . 10.0 112.163 171.823 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -51.71 -49.81 61.74 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.651 1.58 . . . . 10.0 111.213 179.053 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 77.8 t80 -50.22 -55.06 16.84 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.947 0.899 . . . . 10.0 112.687 172.496 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 55.6 mt -53.71 -55.09 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 123.871 0.868 . . . . 10.0 110.692 177.808 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 41.3 mt -57.32 -35.86 70.41 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 118.334 -0.841 . . . . 10.0 112.948 178.564 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -57.29 -58.19 9.32 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 124.051 0.941 . . . . 10.0 113.041 173.242 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.38 -40.9 85.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 CA-C-O 118.303 -0.855 . . . . 10.0 111.44 177.906 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 44.9 mt -56.84 -49.42 75.51 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 119.897 1.226 . . . . 10.0 112.107 171.298 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.471 ' HA ' ' HD2' ' A' ' 175' ' ' ARG . 12.0 t80 -77.01 -70.32 0.47 Allowed 'General case' 0 C--N 1.326 -0.447 0 O-C-N 120.022 -1.674 . . . . 10.0 112.852 -175.234 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -73.7 -21.93 60.09 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.654 1.182 . . . . 10.0 113.466 -174.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -87.84 -79.07 1.26 Allowed Glycine 0 CA--C 1.526 0.747 0 C-N-CA 123.579 0.609 . . . . 10.0 113.514 171.503 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -53.68 -32.42 51.63 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 126.275 1.83 . . . . 10.0 113.024 -166.474 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.2 m -52.02 -56.49 13.99 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 114.057 1.132 . . . . 10.0 114.057 172.065 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.5 p -53.71 -50.51 65.73 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 122.046 0.926 . . . . 10.0 112.295 -177.836 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 47.6 tttm -57.08 -46.04 82.83 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.173 0.989 . . . . 10.0 112.156 173.59 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.87 -47.46 80.4 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 114.512 1.301 . . . . 10.0 114.512 174.064 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -56.47 -11.3 1.21 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 126.087 1.755 . . . . 10.0 114.252 177.66 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.1 m -107.03 6.61 29.18 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.424 1.89 . . . . 10.0 114.903 -179.369 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 93.3 mmm -91.91 -92.6 0.15 Allowed 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 123.487 1.613 . . . . 10.0 114.164 -170.599 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -138.71 153.94 72.64 Favored Pre-proline 0 C--O 1.235 0.308 0 C-N-CA 129.802 3.241 . . . . 10.0 105.527 170.243 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -52.83 -46.25 34.97 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.267 1.978 . . . . 10.0 113.074 179.01 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.667 ' CD ' ' HD3' ' A' ' 227' ' ' ARG . 0.1 OUTLIER -52.89 -46.08 67.8 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 129.021 2.929 . . . . 10.0 113.291 173.556 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 92.0 t -69.22 -53.04 27.62 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 C-N-CA 124.05 0.94 . . . . 10.0 109.8 -178.612 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.1 -46.83 75.55 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.282 0.633 . . . . 10.0 111.959 177.008 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 60.3 p -60.02 -56.2 24.54 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.922 0.889 . . . . 10.0 112.692 174.63 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 61.5 m -57.18 -53.2 60.76 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.155 0.982 . . . . 10.0 113.036 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -49.58 -49.48 46.33 Favored 'General case' 0 C--O 1.222 -0.375 0 C-N-CA 123.247 0.619 . . . . 10.0 111.132 174.034 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -57.15 -48.39 78.82 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 114.702 1.371 . . . . 10.0 114.702 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 40.5 t -56.01 -49.59 74.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 CA-C-N 118.749 0.704 . . . . 10.0 110.462 176.365 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 94.1 mt -58.63 -51.59 69.28 Favored 'General case' 0 C--O 1.222 -0.389 0 N-CA-C 113.191 0.811 . . . . 10.0 113.191 175.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 175' ' ' ARG . . . . . 0.471 ' HD2' ' HA ' ' A' ' 153' ' ' PHE . 35.5 ttp180 -47.75 -47.79 30.26 Favored 'General case' 0 C--O 1.225 -0.201 0 C-N-CA 126.852 2.061 . . . . 10.0 111.062 174.402 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 63.6 m-20 -58.51 -58.36 8.89 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 122.782 0.433 . . . . 10.0 111.272 174.399 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 54.9 t -52.19 -46.71 44.59 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 124.039 0.936 . . . . 10.0 112.044 179.009 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 32.1 m -60.19 -61.66 2.44 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 128.081 2.552 . . . . 10.0 111.902 178.683 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 56.0 t -51.43 -50.23 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 C-N-CA 124.575 1.15 . . . . 10.0 111.045 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 76.8 t -59.23 -60.06 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 124.069 0.948 . . . . 10.0 112.168 177.574 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 73.4 mt -56.9 -51.65 68.25 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 118.701 0.682 . . . . 10.0 112.301 -178.502 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 10.6 m95 . . . . . 0 N--CA 1.467 0.417 0 C-N-CA 123.959 0.904 . . . . 10.0 111.764 178.272 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 17.1 m . . . . . 0 N--CA 1.475 0.812 0 N-CA-C 112.716 0.636 . . . . 10.0 112.716 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 44.5 t90 -59.81 -55.93 28.11 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 125.191 1.396 . . . . 10.0 112.117 168.44 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 9.6 tt -56.49 -41.94 77.46 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.813 0.845 . . . . 10.0 112.601 -177.175 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 14.8 pt -82.44 -5.66 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 N-CA-C 115.151 1.537 . . . . 10.0 115.151 178.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.31 -169.29 33.1 Favored Glycine 0 N--CA 1.45 -0.404 0 CA-C-O 122.577 1.098 . . . . 10.0 113.921 -168.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 23.3 t -53.16 -40.68 64.5 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 114.197 -1.001 . . . . 10.0 111.897 177.552 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -55.01 -31.8 61.32 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 128.387 2.675 . . . . 10.0 115.385 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -131.06 -103.87 0.98 Allowed Glycine 0 CA--C 1.527 0.842 0 CA-C-N 119.324 0.966 . . . . 10.0 113.41 -167.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -89.41 127.12 35.79 Favored 'General case' 0 C--N 1.328 -0.352 0 O-C-N 120.621 -1.517 . . . . 10.0 109.364 169.253 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -72.48 65.36 1.36 Allowed Glycine 0 CA--C 1.532 1.141 0 N-CA-C 113.871 0.308 . . . . 10.0 113.871 173.175 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 60.6 mt -79.6 -42.71 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 126.053 1.741 . . . . 10.0 108.729 166.339 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.4 ' CG1' ' HB ' ' A' ' 203' ' ' ILE . 79.4 t -126.27 133.39 24.92 Favored Pre-proline 0 N--CA 1.454 -0.264 0 C-N-CA 126.502 1.921 . . . . 10.0 109.385 -174.212 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -68.79 153.78 72.36 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 123.781 2.988 . . . . 10.0 111.437 -176.844 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 12.2 tp -43.17 -39.77 3.03 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.281 1.033 . . . . 10.0 112.193 171.522 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -48.36 -52.38 21.99 Favored 'General case' 0 CA--C 1.539 0.519 0 N-CA-C 114.673 1.361 . . . . 10.0 114.673 176.08 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 203' ' ' ILE . . . . . 0.4 ' HB ' ' CG1' ' A' ' 199' ' ' VAL . 13.9 mm -75.9 -40.5 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 C-N-CA 124.435 1.094 . . . . 10.0 109.692 177.562 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -49.3 -49.81 42.15 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 118.553 0.615 . . . . 10.0 111.925 173.605 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 16.3 m -57.72 -47.01 83.62 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 126.043 1.737 . . . . 10.0 112.96 174.333 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.535 HD23 ' CD2' ' A' ' 12' ' ' TRP . 1.3 tm? -63.33 -52.39 62.05 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.977 0.911 . . . . 10.0 112.072 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 93.1 mt -52.52 -58.74 5.81 Favored 'General case' 0 C--O 1.227 -0.088 0 C-N-CA 124.294 1.038 . . . . 10.0 110.02 176.454 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -52.45 -46.79 66.62 Favored 'General case' 0 C--O 1.221 -0.439 0 CA-C-O 117.805 -1.093 . . . . 10.0 112.393 176.105 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 209' ' ' MET . . . . . 0.575 ' HE2' ' HB3' ' A' ' 15' ' ' LEU . 4.6 tmm? -52.32 -52.0 55.6 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 120.404 1.457 . . . . 10.0 112.743 175.469 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 85.7 t -61.69 -46.56 96.28 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 124.782 1.233 . . . . 10.0 111.747 178.097 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 4.2 mp -59.95 -52.41 65.54 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 125.463 1.505 . . . . 10.0 111.989 175.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 -55.68 -57.33 12.43 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 126.36 1.864 . . . . 10.0 110.917 178.183 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 8.6 p . . . . . 0 N--CA 1.476 0.859 0 O-C-N 120.918 -1.114 . . . . 10.0 112.524 179.878 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.278 0 CA-C-O 121.06 0.255 . . . . 10.0 113.09 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 42.0 t80 -46.68 -56.73 5.68 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.351 1.86 . . . . 10.0 112.322 168.631 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -56.23 -39.44 81.63 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 124.011 0.815 . . . . 10.0 113.465 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 24.5 mt -70.51 -27.59 64.3 Favored 'General case' 0 CA--C 1.511 -0.523 0 N-CA-C 115.736 1.754 . . . . 10.0 115.736 176.611 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 74.4 mt -63.48 -57.48 11.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 119.274 0.943 . . . . 10.0 108.548 165.662 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 32.1 tp -58.86 -64.71 0.84 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.923 0.889 . . . . 10.0 113.17 -172.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 84.2 mt -71.51 5.17 2.5 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 115.313 1.597 . . . . 10.0 115.313 -171.692 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.6 mtp-105 -112.33 0.44 15.69 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.171 0.988 . . . . 10.0 113.319 172.506 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 8.8 t -108.03 177.91 4.67 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 124.092 0.957 . . . . 10.0 111.046 174.608 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 227' ' ' ARG . . . . . 0.667 ' HD3' ' CD ' ' A' ' 166' ' ' GLU . 41.7 ttt180 -71.59 98.15 1.83 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.765 0.826 . . . . 10.0 110.947 170.64 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 228' ' ' ALA . . . . . 0.477 ' HB1' ' CD2' ' A' ' 42' ' ' PHE . . . -80.86 77.0 7.78 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.874 0.87 . . . . 10.0 112.08 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 40.18 102.24 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 128.896 2.878 . . . . 10.0 116.466 177.698 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . 0.481 0.3 OUTLIER 71.85 -55.43 0.66 Allowed 'General case' 0 C--O 1.241 0.647 0 C-N-CA 124.722 1.209 . . . . 10.0 110.656 -175.295 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -68.29 169.47 40.06 Favored Glycine 0 C--O 1.239 0.417 0 C-N-CA 129.73 3.538 . . . . 10.0 119.666 171.471 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.461 0 C-N-CA 128.441 2.696 . . . . 10.0 113.407 166.609 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 N--CA 1.477 0.913 0 CA-C-O 115.78 -2.057 . . . . 10.0 105.808 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 23.33 91.84 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 129.598 3.159 . . . . 10.0 117.286 160.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 28.68 65.05 0.11 Allowed 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 128.324 2.65 . . . . 10.0 114.468 155.406 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 86.4 mt -56.44 137.94 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 126.41 1.884 . . . . 10.0 113.344 -158.4 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.652 HG21 ' HB3' ' A' ' 77' ' ' PRO . 7.6 t -136.78 -165.21 1.7 Allowed 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 126.284 1.834 . . . . 10.0 113.991 -174.311 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 70.04 2.8 41.3 Favored Glycine 0 C--N 1.34 0.768 0 C-N-CA 127.475 2.464 . . . . 10.0 111.453 168.028 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -158.59 -51.29 0.01 OUTLIER Pre-proline 0 N--CA 1.443 -0.794 0 CA-C-O 114.301 -2.761 . . . . 10.0 116.698 -168.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -64.02 -60.58 0.15 Allowed 'Trans proline' 0 CA--C 1.528 0.179 0 CA-C-N 123.504 2.287 . . . . 10.0 113.207 -175.342 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.411 ' H ' ' CD ' ' A' ' 9' ' ' GLU . 7.9 pm0 -67.22 4.27 0.98 Allowed 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 127.86 2.464 . . . . 10.0 115.765 179.701 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.421 ' CG ' ' N ' ' A' ' 11' ' ' ILE . 11.0 p-90 -51.34 -43.08 61.67 Favored 'General case' 0 C--O 1.223 -0.337 0 O-C-N 121.487 -0.758 . . . . 10.0 112.646 176.417 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.421 ' N ' ' CG ' ' A' ' 10' ' ' TRP . 8.9 tt -60.9 -49.64 83.82 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.338 0 C-N-CA 123.902 0.881 . . . . 10.0 109.287 179.415 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' TRP . . . . . 0.535 ' CD2' HD23 ' A' ' 206' ' ' LEU . 2.6 m95 -55.33 -52.7 62.63 Favored 'General case' 0 C--O 1.224 -0.261 0 C-N-CA 123.428 0.691 . . . . 10.0 111.861 175.62 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.5 mt -57.37 -53.53 57.05 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 123.138 0.575 . . . . 10.0 112.27 177.245 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.92 -46.78 52.3 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.366 1.466 . . . . 10.0 113.332 173.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.575 ' HB3' ' HE2' ' A' ' 209' ' ' MET . 13.3 tp -65.67 -44.94 84.72 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.304 1.442 . . . . 10.0 113.009 179.115 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.55 -56.57 10.92 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 124.419 1.009 . . . . 10.0 111.55 166.039 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.2 m -49.62 -52.44 30.52 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.898 1.279 . . . . 10.0 112.246 174.817 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.45 -58.89 5.69 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.163 0.985 . . . . 10.0 112.138 177.753 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 93.1 mt -57.12 -48.55 78.37 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.606 0.762 . . . . 10.0 112.851 -179.372 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 49.0 mtt -60.43 -45.77 92.45 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.148 0.979 . . . . 10.0 111.503 178.274 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -58.22 -58.68 13.28 Favored Glycine 0 CA--C 1.53 0.998 0 CA-C-O 118.937 -0.924 . . . . 10.0 113.872 172.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 80.8 mt -56.24 -45.86 79.83 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-N 118.714 1.257 . . . . 10.0 112.089 176.279 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.66 -42.19 76.64 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 124.46 1.029 . . . . 10.0 113.581 172.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 30.3 m -62.12 -58.4 7.95 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 118.329 -0.843 . . . . 10.0 111.113 172.164 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -52.3 -40.93 62.46 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.051 0.94 . . . . 10.0 110.95 177.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -55.83 -58.01 9.65 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.573 1.149 . . . . 10.0 112.993 172.745 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.1 m-30 -59.69 -38.58 81.96 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 113.252 0.834 . . . . 10.0 113.252 178.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.401 ' C ' ' H ' ' A' ' 30' ' ' LYS . 11.8 mt -56.13 -67.48 0.29 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.628 1.171 . . . . 10.0 113.589 169.092 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 t -76.36 40.95 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 CA-C-O 123.705 1.717 . . . . 10.0 110.83 179.112 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.401 ' H ' ' C ' ' A' ' 28' ' ' LEU . 42.9 tttm -140.86 -44.78 0.39 Allowed 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 127.89 2.476 . . . . 10.0 109.379 171.13 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.99 23.12 0.88 Allowed Glycine 0 CA--C 1.529 0.928 0 N-CA-C 115.596 0.998 . . . . 10.0 115.596 173.697 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 37.3 mmm -59.52 -44.98 93.01 Favored 'General case' 0 C--O 1.224 -0.277 0 C-N-CA 127.189 2.196 . . . . 10.0 113.587 -179.019 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.71 -84.41 1.19 Allowed Glycine 0 CA--C 1.53 0.989 0 C-N-CA 123.766 0.698 . . . . 10.0 112.471 -170.148 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.8 t 33.03 88.78 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.242 0.706 0 C-N-CA 128.434 2.694 . . . . 10.0 116.956 166.49 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.3 m -79.68 -50.85 10.01 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.184 -1.371 . . . . 10.0 113.843 174.188 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -48.93 117.56 6.48 Favored Pre-proline 0 CA--C 1.536 0.429 0 O-C-N 124.829 1.331 . . . . 10.0 110.991 -172.531 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -58.63 -29.59 89.66 Favored 'Trans proline' 0 N--CA 1.459 -0.5 0 C-N-CA 123.74 2.96 . . . . 10.0 113.706 179.146 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.38 -60.61 2.32 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.089 0.556 . . . . 10.0 111.437 176.199 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.19 -40.01 22.81 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 125.093 1.357 . . . . 10.0 113.58 171.602 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.5 tttp -46.61 -47.37 19.99 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.241 1.417 . . . . 10.0 113.434 172.067 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -57.79 -53.09 62.19 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.472 0.709 . . . . 10.0 110.944 176.673 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.477 ' CD2' ' HB1' ' A' ' 228' ' ' ALA . 43.9 m-85 -56.93 -50.23 73.2 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 123.094 0.557 . . . . 10.0 112.342 -179.125 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -54.42 -51.29 65.38 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 118.919 -0.562 . . . . 10.0 112.337 173.324 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.37 -61.98 1.93 Allowed 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 113.419 0.896 . . . . 10.0 113.419 177.13 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.4 mt -48.65 -57.49 1.54 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 C-N-CA 124.869 1.268 . . . . 10.0 110.349 178.047 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.2 m -68.87 -17.17 63.95 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.144 1.378 . . . . 10.0 113.737 -172.603 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 27.8 m -87.9 -40.02 14.31 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.5 1.12 . . . . 10.0 112.165 174.564 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 25.7 mt -59.48 -42.82 92.95 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 118.93 0.786 . . . . 10.0 112.431 170.802 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 18.4 t -42.26 -60.06 2.34 Favored Pre-proline 0 N--CA 1.481 1.11 0 C-N-CA 125.72 1.608 . . . . 10.0 113.881 176.735 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -72.7 -24.3 18.5 Favored 'Trans proline' 0 CA--C 1.545 1.074 0 C-N-CA 122.951 2.434 . . . . 10.0 114.662 174.025 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.71 -44.69 80.98 Favored 'General case' 0 CA--C 1.548 0.879 0 CA-C-N 120.642 1.564 . . . . 10.0 113.291 176.092 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 38.1 mm -53.62 -53.86 22.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 124.287 1.035 . . . . 10.0 109.404 168.178 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -53.25 -46.65 69.29 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.458 1.103 . . . . 10.0 113.343 176.564 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 52.0 t80 -51.36 -57.26 9.4 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 120.187 1.358 . . . . 10.0 112.419 172.539 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 12.5 m -50.12 -52.32 36.01 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.329 1.451 . . . . 10.0 110.454 178.104 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 32.6 mmt -69.17 -48.01 63.41 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 123.905 0.882 . . . . 10.0 112.967 -176.632 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -56.36 -40.93 75.34 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 120.35 1.432 . . . . 10.0 113.262 172.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.8 tp -53.25 -54.59 33.91 Favored 'General case' 0 C--O 1.224 -0.258 0 CA-C-N 119.85 1.204 . . . . 10.0 111.281 170.588 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 24.0 p -51.67 -41.05 61.11 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 115.224 1.564 . . . . 10.0 115.224 179.032 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 61.1 mtm -66.84 -50.86 61.19 Favored 'General case' 0 C--N 1.334 -0.082 0 C-N-CA 123.556 0.742 . . . . 10.0 110.506 176.803 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.4 tp -48.51 -52.74 21.02 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.857 0.863 . . . . 10.0 112.952 172.319 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.4 mt -76.84 -5.62 49.06 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.353 1.061 . . . . 10.0 113.854 -177.721 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.32 -34.74 5.52 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 115.55 0.98 . . . . 10.0 115.55 174.168 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 75.3 t80 -49.29 -43.08 43.01 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 115.235 1.568 . . . . 10.0 115.235 -175.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.02 3.51 61.14 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 115.35 0.9 . . . . 10.0 115.35 -179.02 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.25 143.43 26.42 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 127.042 2.137 . . . . 10.0 109.018 172.002 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 t -145.54 171.06 15.22 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 124.048 0.939 . . . . 10.0 111.067 166.817 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.01 136.08 53.36 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 123.853 0.861 . . . . 10.0 109.684 179.617 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 58.5 t -129.6 129.61 23.17 Favored Pre-proline 0 C--N 1.33 -0.279 0 C-N-CA 125.031 1.332 . . . . 10.0 110.905 -176.017 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -80.73 116.24 3.17 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 N-CA-C 109.415 -1.033 . . . . 10.0 109.415 -178.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -156.68 164.39 38.2 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 112.842 0.682 . . . . 10.0 112.842 172.486 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.36 -81.95 0.14 Allowed Glycine 0 CA--C 1.526 0.764 0 N-CA-C 110.692 -0.963 . . . . 10.0 110.692 175.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.77 -3.41 0.69 Allowed Glycine 0 CA--C 1.527 0.836 0 N-CA-C 118.666 2.226 . . . . 10.0 118.666 170.403 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -151.58 -171.89 4.06 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 119.349 1.575 . . . . 10.0 112.217 -165.166 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -91.82 93.9 9.07 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 125.531 1.532 . . . . 10.0 111.107 -175.316 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.449 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 60.2 m-80 -89.47 120.78 69.65 Favored Pre-proline 0 N--CA 1.45 -0.428 0 N-CA-C 113.0 0.741 . . . . 10.0 113.0 -165.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.652 ' HB3' HG21 ' A' ' 5' ' ' THR . 76.1 Cg_exo -61.48 131.92 38.32 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 124.205 3.27 . . . . 10.0 112.167 171.573 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.5 mm -140.16 126.37 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 C-N-CA 126.0 1.72 . . . . 10.0 111.712 -179.532 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -93.64 84.99 4.74 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 122.72 1.247 . . . . 10.0 113.053 174.654 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 63.8 p-90 -59.37 -28.28 66.73 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 120.939 -1.101 . . . . 10.0 113.881 174.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -55.36 -23.13 22.47 Favored 'General case' 0 CA--C 1.574 1.9 0 C-N-CA 124.277 1.031 . . . . 10.0 110.038 178.214 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -47.57 -59.75 3.03 Favored 'General case' 0 N--CA 1.496 1.833 0 C-N-CA 126.304 1.841 . . . . 10.0 112.08 163.877 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -68.35 -37.39 80.43 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 123.814 0.845 . . . . 10.0 110.457 -173.802 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -53.8 -51.59 63.0 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 123.676 0.79 . . . . 10.0 112.748 169.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 61.8 t0 -52.96 -68.72 0.15 Allowed 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 126.143 1.777 . . . . 10.0 111.26 171.076 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 46.2 m0 -57.01 -33.77 67.49 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.98 1.712 . . . . 10.0 113.268 -171.552 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 30.0 tp -50.08 -44.63 51.93 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 126.13 1.772 . . . . 10.0 111.967 177.796 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -99.25 -44.4 6.25 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.185 0.994 . . . . 10.0 112.014 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 13.7 m -48.33 -52.15 22.86 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.669 1.588 . . . . 10.0 113.242 177.193 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . 0.314 57.5 p -67.88 -45.71 43.23 Favored Pre-proline 0 N--CA 1.476 0.872 0 N-CA-C 114.557 1.318 . . . . 10.0 114.557 -174.433 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -52.91 -42.9 60.79 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 123.39 2.727 . . . . 10.0 115.329 170.635 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 52.4 mt -59.18 -46.45 88.37 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.293 0.637 . . . . 10.0 111.472 175.047 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.4 tp -51.33 -48.13 62.49 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.411 1.485 . . . . 10.0 112.198 172.449 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.7 mp -58.82 -47.33 85.19 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 125.122 1.369 . . . . 10.0 112.623 170.518 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.8 -38.28 78.22 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 123.826 0.85 . . . . 10.0 112.906 178.751 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 -52.31 -54.0 37.1 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 119.282 0.946 . . . . 10.0 111.163 169.665 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.36 -42.12 88.48 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.635 0.774 . . . . 10.0 112.087 -178.519 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.64 -54.73 37.67 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.996 0.919 . . . . 10.0 112.024 173.622 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.33 -41.2 79.53 Favored 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 123.73 0.812 . . . . 10.0 112.668 174.869 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.9 tp -63.71 -38.6 91.73 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 114.494 1.294 . . . . 10.0 114.494 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.1 t -94.75 1.41 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 125.092 1.357 . . . . 10.0 112.296 179.144 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.2 t70 48.55 53.52 12.0 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.881 1.672 . . . . 10.0 112.077 -174.02 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.22 145.89 47.68 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 119.955 -1.715 . . . . 10.0 112.457 -174.221 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.47 135.93 54.17 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 112.697 0.629 . . . . 10.0 112.697 175.112 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -42.92 -39.65 2.65 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.891 1.677 . . . . 10.0 113.466 175.296 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -47.3 -60.21 5.31 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 125.145 1.355 . . . . 10.0 115.295 169.703 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 42.0 p -62.1 -46.72 87.8 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 117.101 -1.428 . . . . 10.0 111.328 178.248 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 66.9 mt -48.48 -52.87 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 125.032 1.333 . . . . 10.0 111.135 178.206 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.4 tp -62.67 -51.25 67.97 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 112.544 0.572 . . . . 10.0 112.544 179.288 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.2 -44.86 43.55 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.479 0.712 . . . . 10.0 110.912 174.607 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.455 ' HA ' HD12 ' A' ' 111' ' ' LEU . 0.6 OUTLIER -59.56 -59.95 4.63 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 127.385 2.274 . . . . 10.0 114.791 174.949 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.6 t -61.02 -46.36 96.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 123.686 0.794 . . . . 10.0 111.362 -178.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -56.56 -50.41 63.19 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 123.68 0.657 . . . . 10.0 112.602 174.534 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -54.68 -46.74 74.14 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 113.081 0.771 . . . . 10.0 113.081 173.374 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -57.94 -45.07 87.2 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.998 0.919 . . . . 10.0 111.809 174.779 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -43.81 -55.88 5.31 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 125.123 1.344 . . . . 10.0 113.429 166.686 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 81.6 mt -56.63 -54.07 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 123.567 0.747 . . . . 10.0 110.962 173.62 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 45.5 ttp -46.14 -58.65 3.45 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.462 1.505 . . . . 10.0 112.455 -178.794 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 47.2 mm . . . . . 0 N--CA 1.473 0.688 0 C-N-CA 123.215 0.606 . . . . 10.0 112.012 178.65 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 62.0 t . . . . . 0 N--CA 1.47 0.545 0 N-CA-C 110.384 -0.228 . . . . 10.0 110.384 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -48.82 -61.08 5.5 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 125.751 1.643 . . . . 10.0 112.855 170.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -45.75 -40.37 9.4 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 127.004 2.122 . . . . 10.0 113.813 177.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 49.8 mt -100.14 -6.6 25.98 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 115.193 1.553 . . . . 10.0 115.193 -176.538 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 17.0 m -69.66 116.72 10.38 Favored 'General case' 0 N--CA 1.464 0.237 0 O-C-N 120.186 -1.571 . . . . 10.0 110.41 -178.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.622 ' H ' ' HD3' ' A' ' 129' ' ' LYS . 0.1 OUTLIER -55.44 -49.65 71.9 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 128.186 2.594 . . . . 10.0 113.267 177.754 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 60.6 t -69.62 106.37 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 123.761 0.824 . . . . 10.0 110.085 179.661 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -46.94 -59.49 3.06 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 124.775 1.23 . . . . 10.0 114.07 -173.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 m -46.53 -42.07 15.22 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.45 1.5 . . . . 10.0 113.484 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -70.14 -24.61 63.2 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 114.959 1.466 . . . . 10.0 114.959 -178.13 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 68.1 mtp85 -54.21 -41.69 68.92 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 118.869 0.759 . . . . 10.0 110.811 176.801 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -69.01 -32.73 72.47 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.678 1.191 . . . . 10.0 114.166 176.512 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.7 t -54.46 -52.03 43.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 CA-C-N 119.073 0.851 . . . . 10.0 109.659 169.12 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 66.2 m95 -62.0 -45.7 92.44 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 114.531 1.308 . . . . 10.0 114.531 174.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 86.5 t90 -52.13 -47.98 65.08 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.868 0.867 . . . . 10.0 112.582 172.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.599 0 C-N-CA 124.047 0.939 . . . . 10.0 111.69 176.801 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.77 0 N-CA-C 112.531 0.567 . . . . 10.0 112.531 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 40.4 ttp -55.93 -55.72 29.27 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 124.488 1.115 . . . . 10.0 111.915 171.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -51.13 -48.5 61.77 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 125.869 1.668 . . . . 10.0 111.569 178.236 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 78.5 t80 -52.33 -54.54 30.37 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 113.099 0.778 . . . . 10.0 113.099 172.087 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 56.0 mt -53.87 -54.68 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 123.943 0.897 . . . . 10.0 110.739 177.747 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 90.8 mt -50.69 -42.93 57.42 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 126.129 1.772 . . . . 10.0 112.818 175.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -57.32 -58.09 9.76 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 123.986 0.914 . . . . 10.0 113.084 176.618 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.43 -40.92 85.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 CA-C-O 118.313 -0.851 . . . . 10.0 111.408 177.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 47.2 mt -56.83 -49.45 75.39 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.878 1.217 . . . . 10.0 112.069 171.327 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.47 ' HA ' ' HD2' ' A' ' 175' ' ' ARG . 11.8 t80 -76.94 -70.29 0.47 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 120.06 -1.65 . . . . 10.0 112.915 -175.24 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -73.78 -21.9 60.02 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.596 1.158 . . . . 10.0 113.454 -174.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -87.83 -79.1 1.26 Allowed Glycine 0 CA--C 1.527 0.806 0 C-N-CA 123.612 0.625 . . . . 10.0 113.501 171.499 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -53.58 -32.47 51.06 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 126.266 1.826 . . . . 10.0 113.045 -166.546 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.4 m -52.1 -56.47 14.25 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 113.988 1.107 . . . . 10.0 113.988 172.172 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.5 p -53.6 -50.59 65.32 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 122.093 0.949 . . . . 10.0 112.297 -177.858 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 47.7 tttm -57.09 -46.11 82.82 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.165 0.986 . . . . 10.0 112.103 173.676 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.74 -47.51 79.88 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 114.55 1.315 . . . . 10.0 114.55 174.03 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -56.5 -11.22 1.19 Allowed 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 126.056 1.742 . . . . 10.0 114.268 177.683 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.1 m -107.08 6.57 29.05 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.425 1.89 . . . . 10.0 114.898 -179.357 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 93.3 mmm -91.9 -92.6 0.15 Allowed 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 123.485 1.612 . . . . 10.0 114.16 -170.568 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -138.75 153.94 72.58 Favored Pre-proline 0 C--O 1.236 0.349 0 C-N-CA 129.809 3.243 . . . . 10.0 105.529 170.258 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -52.86 -46.19 35.48 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 122.3 2.0 . . . . 10.0 113.08 179.056 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.667 ' CD ' ' HD3' ' A' ' 227' ' ' ARG . 0.1 OUTLIER -53.02 -46.09 68.25 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 129.014 2.926 . . . . 10.0 113.221 173.597 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 92.0 t -69.12 -53.09 27.63 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.267 0 C-N-CA 124.068 0.947 . . . . 10.0 109.798 -178.632 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.11 -46.85 75.59 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.291 0.636 . . . . 10.0 111.905 177.059 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 60.1 p -59.98 -56.22 24.34 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.885 0.874 . . . . 10.0 112.702 174.629 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 62.0 m -57.12 -53.31 59.59 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.23 1.012 . . . . 10.0 112.987 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -49.52 -49.57 45.38 Favored 'General case' 0 C--O 1.222 -0.386 0 C-N-CA 123.3 0.64 . . . . 10.0 111.068 174.085 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -57.12 -48.37 78.82 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 114.699 1.37 . . . . 10.0 114.699 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 40.4 t -56.02 -49.57 74.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-N 118.832 0.742 . . . . 10.0 110.487 176.384 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 94.2 mt -58.57 -51.63 69.09 Favored 'General case' 0 C--O 1.221 -0.397 0 N-CA-C 113.152 0.797 . . . . 10.0 113.152 175.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 175' ' ' ARG . . . . . 0.47 ' HD2' ' HA ' ' A' ' 153' ' ' PHE . 35.5 ttp180 -47.82 -47.82 31.05 Favored 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 126.868 2.067 . . . . 10.0 111.011 174.499 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 63.6 m-20 -58.48 -58.31 9.11 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 122.805 0.442 . . . . 10.0 111.29 174.408 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 58.3 t -51.77 -50.25 32.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 124.086 0.954 . . . . 10.0 111.587 179.031 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 26.5 m -56.55 -60.34 3.67 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 127.872 2.469 . . . . 10.0 111.953 177.56 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 47.7 t -53.67 -49.52 56.34 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 CA-C-N 119.215 0.916 . . . . 10.0 111.312 -178.094 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 76.6 t -58.91 -61.67 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 124.369 1.068 . . . . 10.0 111.908 176.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -59.24 -48.82 80.17 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 118.63 0.65 . . . . 10.0 112.609 -175.704 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 9.8 m95 . . . . . 0 N--CA 1.469 0.524 0 CA-C-N 118.9 0.773 . . . . 10.0 111.947 176.771 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 88.3 t . . . . . 0 N--CA 1.479 0.99 0 CA-C-O 119.264 -0.398 . . . . 10.0 111.457 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 69.9 t90 -54.68 -54.56 40.18 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.331 1.052 . . . . 10.0 112.525 174.58 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 9.9 tt -57.55 -42.37 82.83 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 123.881 0.872 . . . . 10.0 112.166 -176.045 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 14.1 pt -84.79 -5.95 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 N-CA-C 115.289 1.589 . . . . 10.0 115.289 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.41 -169.29 32.97 Favored Glycine 0 N--CA 1.45 -0.404 0 CA-C-O 122.589 1.105 . . . . 10.0 113.883 -168.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 23.3 t -53.13 -42.25 65.86 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 114.16 -1.02 . . . . 10.0 111.85 177.623 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -69.13 -13.05 62.2 Favored 'General case' 0 CA--C 1.55 0.962 0 N-CA-C 115.155 1.539 . . . . 10.0 115.155 -174.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -132.25 -106.37 1.03 Allowed Glycine 0 CA--C 1.536 1.38 0 CA-C-N 120.716 1.598 . . . . 10.0 114.497 -174.145 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -89.45 127.16 35.81 Favored 'General case' 0 C--N 1.329 -0.323 0 O-C-N 120.666 -1.491 . . . . 10.0 109.305 168.074 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -72.47 65.32 1.36 Allowed Glycine 0 CA--C 1.532 1.105 0 N-CA-C 113.901 0.32 . . . . 10.0 113.901 173.143 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 60.7 mt -79.57 -42.74 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 126.107 1.763 . . . . 10.0 108.735 166.369 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 79.3 t -126.28 133.38 24.91 Favored Pre-proline 0 N--CA 1.453 -0.279 0 C-N-CA 126.504 1.922 . . . . 10.0 109.391 -174.209 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -68.7 153.76 72.63 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 123.822 3.015 . . . . 10.0 111.474 -176.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 12.2 tp -43.13 -39.82 2.98 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.319 1.047 . . . . 10.0 112.229 171.46 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -48.28 -52.41 21.45 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 114.684 1.365 . . . . 10.0 114.684 176.03 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 14.0 mm -75.95 -40.53 38.36 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 124.419 1.088 . . . . 10.0 109.625 177.609 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -49.29 -49.75 42.26 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 118.61 0.641 . . . . 10.0 112.005 173.634 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 16.2 m -57.75 -47.01 83.7 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 126.042 1.737 . . . . 10.0 112.991 174.292 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.535 HD23 ' CD2' ' A' ' 12' ' ' TRP . 1.3 tm? -63.35 -52.36 62.13 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.927 0.891 . . . . 10.0 112.063 179.732 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 93.3 mt -52.48 -60.0 3.76 Favored 'General case' 0 C--O 1.227 -0.115 0 C-N-CA 124.322 1.049 . . . . 10.0 109.993 176.443 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -53.49 -43.18 68.02 Favored 'General case' 0 C--O 1.218 -0.589 0 CA-C-O 117.432 -1.27 . . . . 10.0 112.51 176.293 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 209' ' ' MET . . . . . 0.575 ' HE2' ' HB3' ' A' ' 15' ' ' LEU . 4.6 tmm? -53.93 -52.52 60.33 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 121.51 1.959 . . . . 10.0 112.974 173.632 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 82.1 t -61.06 -47.12 95.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 124.957 1.303 . . . . 10.0 111.7 178.388 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 4.8 mp -58.97 -51.3 70.66 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 125.578 1.551 . . . . 10.0 111.79 175.006 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -55.07 -59.96 4.04 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 125.969 1.708 . . . . 10.0 109.924 176.104 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 35.1 t . . . . . 0 N--CA 1.475 0.811 0 C-N-CA 125.334 1.454 . . . . 10.0 111.658 175.922 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.197 0 N-CA-C 111.912 -0.475 . . . . 10.0 111.912 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 42.8 t80 -45.45 -57.78 3.84 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.142 1.777 . . . . 10.0 112.45 167.429 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -56.9 -40.59 90.58 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 123.834 0.73 . . . . 10.0 113.561 -179.184 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 24.2 mt -70.95 -27.19 63.56 Favored 'General case' 0 CA--C 1.51 -0.582 0 N-CA-C 115.52 1.674 . . . . 10.0 115.52 176.859 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 74.0 mt -63.2 -57.57 11.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 119.131 0.878 . . . . 10.0 108.688 165.388 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 32.1 tp -58.91 -64.6 0.88 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.854 0.862 . . . . 10.0 113.207 -172.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 84.0 mt -71.55 5.24 2.5 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 115.323 1.601 . . . . 10.0 115.323 -171.727 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.6 mtp-105 -112.34 0.36 15.65 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.165 0.986 . . . . 10.0 113.265 172.525 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 8.8 t -108.04 177.94 4.66 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 124.082 0.953 . . . . 10.0 111.039 174.651 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 227' ' ' ARG . . . . . 0.667 ' HD3' ' CD ' ' A' ' 166' ' ' GLU . 41.9 ttt180 -71.66 98.17 1.86 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.732 0.813 . . . . 10.0 110.968 170.694 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 228' ' ' ALA . . . . . 0.477 ' HB1' ' CD2' ' A' ' 42' ' ' PHE . . . -80.93 77.03 7.86 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.829 0.852 . . . . 10.0 112.087 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 40.16 102.21 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 128.831 2.852 . . . . 10.0 116.502 177.723 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . 0.481 0.3 OUTLIER 71.83 -55.39 0.66 Allowed 'General case' 0 C--O 1.242 0.677 0 C-N-CA 124.764 1.226 . . . . 10.0 110.656 -175.277 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -68.34 169.48 40.2 Favored Glycine 0 C--O 1.239 0.417 0 C-N-CA 129.738 3.542 . . . . 10.0 119.598 171.511 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.489 0 C-N-CA 128.486 2.714 . . . . 10.0 113.44 166.618 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 N--CA 1.477 0.913 0 CA-C-O 115.781 -2.057 . . . . 10.0 105.833 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 23.35 91.83 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 129.598 3.159 . . . . 10.0 117.262 160.854 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 28.64 65.07 0.11 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 128.262 2.625 . . . . 10.0 114.511 155.46 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 86.7 mt -56.49 137.96 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 126.41 1.884 . . . . 10.0 113.353 -158.369 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.652 HG21 ' HB3' ' A' ' 77' ' ' PRO . 7.6 t -136.79 -165.2 1.7 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 126.327 1.851 . . . . 10.0 114.021 -174.331 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 70.0 2.83 41.1 Favored Glycine 0 C--N 1.339 0.743 0 C-N-CA 127.496 2.474 . . . . 10.0 111.485 168.076 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -158.52 -51.41 0.01 OUTLIER Pre-proline 0 N--CA 1.443 -0.783 0 CA-C-O 114.275 -2.774 . . . . 10.0 116.634 -168.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -63.89 -60.69 0.14 Allowed 'Trans proline' 0 CA--C 1.528 0.186 0 CA-C-N 123.5 2.286 . . . . 10.0 113.236 -175.318 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.41 ' H ' ' CD ' ' A' ' 9' ' ' GLU . 7.9 pm0 -67.13 4.22 0.96 Allowed 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 127.878 2.471 . . . . 10.0 115.75 179.694 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.422 ' CG ' ' N ' ' A' ' 11' ' ' ILE . 11.0 p-90 -51.28 -43.15 61.54 Favored 'General case' 0 C--O 1.222 -0.361 0 O-C-N 121.5 -0.75 . . . . 10.0 112.646 176.425 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.422 ' N ' ' CG ' ' A' ' 10' ' ' TRP . 8.9 tt -60.85 -49.64 83.79 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.338 0 C-N-CA 123.926 0.89 . . . . 10.0 109.323 179.425 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' TRP . . . . . 0.535 ' CD2' HD23 ' A' ' 206' ' ' LEU . 2.6 m95 -55.34 -52.67 62.75 Favored 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 123.406 0.682 . . . . 10.0 111.908 175.575 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.4 mt -57.34 -53.6 56.31 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 123.223 0.609 . . . . 10.0 112.245 177.237 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.91 -46.8 52.24 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.412 1.485 . . . . 10.0 113.324 173.832 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.575 ' HB3' ' HE2' ' A' ' 209' ' ' MET . 13.3 tp -65.63 -44.95 84.88 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.277 1.431 . . . . 10.0 113.059 179.057 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.17 -58.37 7.99 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 124.274 0.94 . . . . 10.0 110.853 165.87 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.3 m -48.24 -52.41 21.25 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.625 1.17 . . . . 10.0 112.279 175.685 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.45 -58.83 5.93 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.122 0.969 . . . . 10.0 112.177 177.815 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 93.8 mt -58.25 -49.63 76.41 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.681 0.793 . . . . 10.0 112.399 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -50.73 -54.52 22.62 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.683 1.193 . . . . 10.0 110.879 173.684 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -57.17 -58.18 15.9 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 124.452 1.025 . . . . 10.0 113.574 178.895 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 80.8 mt -56.16 -45.54 79.65 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-N 118.626 1.213 . . . . 10.0 112.134 176.357 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.45 -42.57 75.71 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 124.936 1.255 . . . . 10.0 113.329 172.462 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 17.4 m -59.75 -60.86 3.16 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.216 1.006 . . . . 10.0 111.076 171.473 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -52.3 -40.99 62.55 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.061 0.944 . . . . 10.0 110.936 179.321 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.0 t80 -55.78 -58.03 9.56 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.552 1.141 . . . . 10.0 113.006 172.741 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -59.63 -38.7 82.07 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 113.226 0.825 . . . . 10.0 113.226 178.85 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.4 ' C ' ' H ' ' A' ' 30' ' ' LYS . 11.9 mt -56.08 -67.42 0.3 Allowed 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.592 1.157 . . . . 10.0 113.668 169.072 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 t -76.45 41.04 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 CA-C-O 123.749 1.738 . . . . 10.0 110.829 179.109 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.4 ' H ' ' C ' ' A' ' 28' ' ' LEU . 42.9 tttm -140.91 -44.87 0.39 Allowed 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 127.868 2.467 . . . . 10.0 109.303 171.186 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.95 23.09 0.87 Allowed Glycine 0 CA--C 1.529 0.956 0 N-CA-C 115.644 1.017 . . . . 10.0 115.644 173.729 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 37.4 mmm -59.54 -44.96 93.07 Favored 'General case' 0 C--O 1.224 -0.253 0 C-N-CA 127.136 2.174 . . . . 10.0 113.578 -178.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.66 -84.44 1.18 Allowed Glycine 0 CA--C 1.531 1.045 0 C-N-CA 123.741 0.686 . . . . 10.0 112.477 -170.159 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.8 t 33.09 88.7 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.243 0.73 0 C-N-CA 128.399 2.68 . . . . 10.0 116.941 166.459 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.4 m -79.58 -50.9 10.0 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.188 -1.369 . . . . 10.0 113.868 174.141 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -48.87 117.46 6.32 Favored Pre-proline 0 CA--C 1.536 0.428 0 O-C-N 124.719 1.262 . . . . 10.0 110.983 -172.536 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -58.56 -29.62 89.51 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 123.773 2.982 . . . . 10.0 113.727 179.123 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.38 -60.59 2.33 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.058 0.543 . . . . 10.0 111.442 176.183 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.15 -40.07 22.65 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 125.127 1.371 . . . . 10.0 113.58 171.593 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -46.5 -47.5 19.39 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 125.292 1.437 . . . . 10.0 113.413 172.03 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -57.79 -52.98 63.23 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.438 0.695 . . . . 10.0 110.975 176.711 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.476 ' CD2' ' HB1' ' A' ' 228' ' ' ALA . 44.2 m-85 -57.05 -50.18 73.54 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 123.034 0.534 . . . . 10.0 112.351 -179.145 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -54.37 -51.28 65.31 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 118.935 -0.555 . . . . 10.0 112.379 173.231 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.42 -61.97 1.94 Allowed 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 113.425 0.898 . . . . 10.0 113.425 177.168 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.7 mt -48.8 -57.54 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 C-N-CA 124.823 1.249 . . . . 10.0 110.145 177.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 4.9 m -69.42 -14.75 63.07 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.188 1.395 . . . . 10.0 113.74 -172.585 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 31.3 m -89.7 -42.25 11.44 Favored 'General case' 0 N--CA 1.483 1.178 0 CA-C-N 119.884 1.22 . . . . 10.0 111.946 174.492 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 27.9 mt -56.27 -40.01 73.55 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 118.433 0.56 . . . . 10.0 112.176 170.181 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . 0.254 24.3 t -47.09 -62.9 1.65 Allowed Pre-proline 0 CA--C 1.552 1.052 0 C-N-CA 125.266 1.426 . . . . 10.0 112.884 177.007 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -53.26 -42.47 64.9 Favored 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 123.919 3.079 . . . . 10.0 116.303 166.089 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.66 -46.19 89.33 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 114.199 1.185 . . . . 10.0 114.199 -174.864 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 48.3 mm -57.43 -51.32 71.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 O-C-N 121.194 -0.941 . . . . 10.0 109.697 171.717 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.76 -42.62 71.91 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 113.588 0.959 . . . . 10.0 113.588 175.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -52.85 -56.73 13.62 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 120.379 1.445 . . . . 10.0 112.01 170.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.8 m -49.55 -52.52 29.29 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.512 1.525 . . . . 10.0 110.837 177.679 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 32.7 mmt -69.11 -48.23 63.07 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 124.035 0.934 . . . . 10.0 112.894 -176.568 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -57.01 -40.11 76.01 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 117.058 -1.449 . . . . 10.0 113.135 173.175 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.8 tp -53.31 -54.58 34.43 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-N 120.198 1.363 . . . . 10.0 111.276 170.396 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 23.9 p -51.68 -41.0 61.09 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 115.261 1.578 . . . . 10.0 115.261 178.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 57.4 mtm -66.88 -50.88 61.08 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 123.534 0.734 . . . . 10.0 110.481 176.78 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.3 tp -48.54 -52.69 21.43 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.858 0.863 . . . . 10.0 112.926 172.344 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.4 mt -76.87 -5.64 49.22 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.377 1.071 . . . . 10.0 113.819 -177.664 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.29 -34.72 5.54 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 115.533 0.973 . . . . 10.0 115.533 174.173 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -49.29 -43.13 42.99 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 115.206 1.558 . . . . 10.0 115.206 -176.014 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.06 3.61 60.97 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 115.337 0.895 . . . . 10.0 115.337 -178.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.29 143.42 26.42 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 127.048 2.139 . . . . 10.0 108.972 172.014 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 t -145.54 171.05 15.24 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 124.064 0.946 . . . . 10.0 111.022 166.82 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.99 136.12 53.33 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 123.855 0.862 . . . . 10.0 109.683 179.602 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.436 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 58.5 t -129.6 129.55 23.17 Favored Pre-proline 0 C--N 1.329 -0.295 0 C-N-CA 125.063 1.345 . . . . 10.0 110.948 -176.048 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 69' ' ' VAL . 6.3 Cg_exo -80.69 116.24 3.18 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 N-CA-C 109.417 -1.032 . . . . 10.0 109.417 -178.899 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -156.74 164.4 38.16 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.823 0.675 . . . . 10.0 112.823 172.483 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.37 -81.98 0.14 Allowed Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.681 -0.967 . . . . 10.0 110.681 175.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.76 -3.32 0.7 Allowed Glycine 0 CA--C 1.527 0.822 0 N-CA-C 118.671 2.228 . . . . 10.0 118.671 170.395 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -151.63 -171.89 4.06 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 119.354 1.577 . . . . 10.0 112.237 -165.161 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -91.89 93.95 9.06 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 125.504 1.522 . . . . 10.0 111.066 -175.277 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.449 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 60.3 m-80 -89.52 120.77 69.62 Favored Pre-proline 0 N--CA 1.45 -0.43 0 N-CA-C 112.964 0.727 . . . . 10.0 112.964 -165.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.652 ' HB3' HG21 ' A' ' 5' ' ' THR . 75.7 Cg_exo -61.53 131.97 38.43 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 124.163 3.242 . . . . 10.0 112.136 171.625 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.5 mm -140.14 126.3 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 C-N-CA 126.072 1.749 . . . . 10.0 111.714 -179.463 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -93.65 85.07 4.76 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 122.714 1.245 . . . . 10.0 113.055 174.599 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 63.8 p-90 -59.35 -28.3 66.71 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 113.925 1.083 . . . . 10.0 113.925 174.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -55.21 -32.77 62.51 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.273 1.029 . . . . 10.0 112.654 178.245 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 37.7 ttm-85 -49.36 -43.51 44.0 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.917 1.687 . . . . 10.0 112.283 169.844 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 61.7 m-85 -78.91 -39.85 33.76 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.538 1.535 . . . . 10.0 112.428 -179.095 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -49.92 -48.15 51.89 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.798 1.239 . . . . 10.0 111.337 167.59 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -56.01 -68.8 0.17 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.426 1.49 . . . . 10.0 111.907 170.869 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 48.9 m0 -52.82 -33.95 51.61 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.996 1.318 . . . . 10.0 113.387 -173.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 32.6 tp -50.96 -45.65 60.83 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 125.899 1.679 . . . . 10.0 111.982 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -97.55 -47.55 5.6 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 124.478 1.111 . . . . 10.0 112.441 -177.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 51.6 m -59.77 -40.13 87.19 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.643 1.177 . . . . 10.0 112.892 -174.364 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.5 m -68.26 -47.58 38.07 Favored Pre-proline 0 CA--C 1.547 0.86 0 N-CA-C 113.745 1.017 . . . . 10.0 113.745 -179.153 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -50.03 -42.77 44.7 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 123.356 2.704 . . . . 10.0 115.362 166.828 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 54.1 mt -59.18 -46.94 87.07 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.264 0.626 . . . . 10.0 111.575 174.672 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.5 tp -49.71 -49.15 48.91 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.593 1.557 . . . . 10.0 112.162 171.729 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.6 mp -58.85 -47.33 85.25 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.031 1.332 . . . . 10.0 112.498 171.435 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.83 -38.24 78.23 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 123.844 0.857 . . . . 10.0 112.891 178.584 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -52.31 -54.0 37.16 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 119.324 0.966 . . . . 10.0 111.189 169.642 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.35 -42.17 88.46 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.656 0.782 . . . . 10.0 112.046 -178.506 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.7 -54.7 38.4 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 124.008 0.923 . . . . 10.0 112.013 173.686 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.3 -41.17 79.34 Favored 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 123.72 0.808 . . . . 10.0 112.702 174.779 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.9 tp -63.75 -38.62 91.77 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 114.425 1.268 . . . . 10.0 114.425 -179.627 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.1 t -94.79 1.49 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 125.025 1.33 . . . . 10.0 112.325 179.158 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.2 t70 48.57 53.49 12.06 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.866 1.666 . . . . 10.0 112.095 -174.033 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.3 145.94 47.51 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 119.974 -1.704 . . . . 10.0 112.437 -174.16 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.53 135.92 54.41 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 112.679 0.622 . . . . 10.0 112.679 175.16 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -42.81 -39.75 2.61 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.895 1.678 . . . . 10.0 113.443 175.258 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -47.35 -60.2 5.35 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 125.15 1.357 . . . . 10.0 115.22 169.789 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.9 p -62.07 -46.72 87.87 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 117.103 -1.427 . . . . 10.0 111.351 178.244 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 67.1 mt -48.47 -52.9 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 125.033 1.333 . . . . 10.0 111.085 178.2 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.3 tp -62.62 -51.33 67.69 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 112.502 0.556 . . . . 10.0 112.502 179.324 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.11 -44.9 42.7 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.47 0.708 . . . . 10.0 110.959 174.601 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.456 ' HA ' HD12 ' A' ' 111' ' ' LEU . 0.6 OUTLIER -59.64 -59.89 4.72 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 127.393 2.277 . . . . 10.0 114.793 174.972 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.8 t -61.0 -46.31 96.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 123.704 0.802 . . . . 10.0 111.411 -178.903 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -56.65 -50.32 64.05 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 123.695 0.664 . . . . 10.0 112.63 174.543 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -54.96 -46.23 75.01 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 113.375 0.88 . . . . 10.0 113.375 173.361 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -55.9 -48.84 74.9 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.698 0.799 . . . . 10.0 111.129 173.848 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -42.52 -55.27 4.58 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 125.044 1.306 . . . . 10.0 112.997 169.717 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 82.2 mt -55.56 -58.19 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-O 117.571 -1.204 . . . . 10.0 110.66 173.323 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 5.0 ptt? -53.42 -46.35 69.74 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 120.783 1.628 . . . . 10.0 113.343 -173.606 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 46.5 mm . . . . . 0 N--CA 1.473 0.692 0 O-C-N 121.471 -0.768 . . . . 10.0 111.836 179.679 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 60.4 t . . . . . 0 N--CA 1.478 0.972 0 N-CA-C 110.112 -0.329 . . . . 10.0 110.112 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -50.7 -61.23 6.19 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 126.119 1.818 . . . . 10.0 112.65 171.592 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -43.12 -42.08 3.91 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 127.818 2.447 . . . . 10.0 113.208 176.878 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 47.3 mt -100.88 -6.8 24.19 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 115.536 1.68 . . . . 10.0 115.536 -175.128 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 16.9 m -69.66 116.71 10.37 Favored 'General case' 0 N--CA 1.464 0.229 0 O-C-N 120.195 -1.566 . . . . 10.0 110.386 -178.883 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.621 ' H ' ' HD3' ' A' ' 129' ' ' LYS . 0.2 OUTLIER -55.51 -49.57 72.26 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 128.157 2.583 . . . . 10.0 113.269 177.763 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 60.3 t -69.65 106.33 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 123.819 0.848 . . . . 10.0 110.103 179.643 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -46.9 -59.54 3.02 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 124.724 1.21 . . . . 10.0 114.055 -173.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 m -46.5 -42.05 15.01 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.45 1.5 . . . . 10.0 113.495 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -70.18 -24.64 63.17 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 114.896 1.443 . . . . 10.0 114.896 -178.103 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 68.9 mtp85 -53.95 -41.81 68.18 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 118.88 0.764 . . . . 10.0 110.776 176.638 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -69.62 -31.6 69.81 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 114.403 1.26 . . . . 10.0 114.403 176.637 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.8 t -55.09 -52.18 47.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 CA-C-N 118.993 0.815 . . . . 10.0 109.549 168.703 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 64.2 m95 -61.09 -43.27 99.15 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 114.185 1.18 . . . . 10.0 114.185 174.085 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 89.2 t90 -52.88 -49.81 65.11 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 119.255 0.934 . . . . 10.0 112.642 172.05 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.636 0 C-N-CA 124.225 1.01 . . . . 10.0 111.76 178.193 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.547 0.854 0 N-CA-C 112.942 0.719 . . . . 10.0 112.942 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 11.9 tmm? -55.02 -54.06 47.85 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.26 1.424 . . . . 10.0 111.956 172.234 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 58.1 tp -57.65 -42.98 84.58 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.794 1.638 . . . . 10.0 112.834 178.594 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -53.36 -53.6 48.71 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.537 0.735 . . . . 10.0 112.037 169.544 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 46.2 mt -54.62 -54.64 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 123.733 0.813 . . . . 10.0 111.061 177.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 5.1 tt -46.13 -46.91 17.46 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 127.943 2.497 . . . . 10.0 112.222 173.418 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -57.33 -58.15 9.5 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 124.026 0.93 . . . . 10.0 113.03 178.346 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.42 -40.9 85.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-O 118.343 -0.837 . . . . 10.0 111.467 177.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 47.4 mt -56.73 -49.45 75.16 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.824 1.193 . . . . 10.0 112.139 171.223 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.47 ' HA ' ' HD2' ' A' ' 175' ' ' ARG . 11.8 t80 -76.98 -70.34 0.47 Allowed 'General case' 0 C--N 1.326 -0.447 0 O-C-N 120.079 -1.638 . . . . 10.0 112.845 -175.215 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -73.76 -21.92 60.03 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.634 1.174 . . . . 10.0 113.426 -174.877 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -87.77 -79.08 1.26 Allowed Glycine 0 CA--C 1.526 0.761 0 C-N-CA 123.662 0.649 . . . . 10.0 113.553 171.488 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -53.63 -32.47 51.46 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 126.307 1.843 . . . . 10.0 113.025 -166.54 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.2 m -52.08 -56.45 14.35 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 114.016 1.117 . . . . 10.0 114.016 172.143 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.4 p -53.66 -50.56 65.52 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 122.161 0.981 . . . . 10.0 112.307 -177.846 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 47.6 tttm -57.08 -46.07 82.83 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.134 0.974 . . . . 10.0 112.167 173.634 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.86 -47.41 80.47 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 114.515 1.302 . . . . 10.0 114.515 174.069 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -56.47 -11.3 1.21 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 126.087 1.755 . . . . 10.0 114.252 177.66 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.2 m -107.1 6.64 29.08 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.416 1.886 . . . . 10.0 114.877 -179.321 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 93.2 mmm -91.91 -92.63 0.15 Allowed 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 123.451 1.596 . . . . 10.0 114.164 -170.635 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -138.71 154.0 72.7 Favored Pre-proline 0 C--O 1.236 0.359 0 C-N-CA 129.749 3.219 . . . . 10.0 105.539 170.241 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -52.85 -46.24 35.09 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 122.308 2.005 . . . . 10.0 113.074 179.057 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.667 ' CD ' ' HD3' ' A' ' 227' ' ' ARG . 0.1 OUTLIER -52.94 -46.11 67.98 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 129.022 2.929 . . . . 10.0 113.281 173.578 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 92.2 t -69.19 -53.03 27.73 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 C-N-CA 124.034 0.934 . . . . 10.0 109.782 -178.609 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.09 -46.89 75.53 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.282 0.633 . . . . 10.0 111.923 177.047 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 60.2 p -59.97 -56.16 25.08 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.883 0.873 . . . . 10.0 112.719 174.631 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 61.7 m -57.23 -53.16 61.21 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.143 0.977 . . . . 10.0 113.004 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -49.59 -49.54 46.26 Favored 'General case' 0 C--O 1.222 -0.375 0 C-N-CA 123.289 0.636 . . . . 10.0 111.067 174.098 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -57.12 -48.41 78.72 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 114.671 1.36 . . . . 10.0 114.671 -179.732 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 40.3 t -55.95 -49.63 74.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 CA-C-N 118.832 0.742 . . . . 10.0 110.522 176.378 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 94.0 mt -58.54 -51.69 68.82 Favored 'General case' 0 C--O 1.222 -0.389 0 N-CA-C 113.168 0.803 . . . . 10.0 113.168 175.877 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 175' ' ' ARG . . . . . 0.47 ' HD2' ' HA ' ' A' ' 153' ' ' PHE . 35.6 ttp180 -47.72 -47.83 29.84 Favored 'General case' 0 C--O 1.224 -0.244 0 C-N-CA 126.889 2.075 . . . . 10.0 111.041 174.448 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 63.7 m-20 -58.51 -58.33 9.02 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 122.817 0.447 . . . . 10.0 111.25 174.426 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 53.7 t -52.09 -47.19 43.58 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 C-N-CA 124.05 0.94 . . . . 10.0 112.301 179.063 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 30.2 m -58.27 -65.31 0.67 Allowed 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 128.041 2.536 . . . . 10.0 111.283 177.518 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 55.8 t -49.66 -49.12 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 C-N-CA 124.859 1.263 . . . . 10.0 111.429 -178.846 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 72.0 t -58.88 -61.75 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 123.909 0.884 . . . . 10.0 112.164 177.425 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 85.8 mt -55.11 -46.82 75.6 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 119.251 0.932 . . . . 10.0 112.002 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 9.6 m95 . . . . . 0 N--CA 1.467 0.4 0 C-N-CA 125.174 1.39 . . . . 10.0 113.215 175.667 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 96.2 t . . . . . 0 N--CA 1.478 0.949 0 CA-C-O 119.239 -0.41 . . . . 10.0 111.462 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 61.2 t90 -55.26 -52.78 62.3 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.261 1.024 . . . . 10.0 112.511 175.059 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 9.5 tt -57.98 -43.69 86.68 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 123.898 0.879 . . . . 10.0 112.628 -176.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 15.3 pt -83.81 -5.59 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 N-CA-C 114.986 1.476 . . . . 10.0 114.986 -179.565 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.18 -169.33 33.3 Favored Glycine 0 N--CA 1.451 -0.363 0 CA-C-O 122.587 1.104 . . . . 10.0 113.966 -169.047 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 23.3 t -53.13 -41.45 65.09 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 114.159 -1.021 . . . . 10.0 111.879 177.526 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -66.83 -17.24 64.79 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 115.627 1.714 . . . . 10.0 115.627 -175.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -131.38 -105.79 1.05 Allowed Glycine 0 CA--C 1.533 1.169 0 CA-C-N 120.402 1.455 . . . . 10.0 113.911 -172.816 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -89.45 127.15 35.81 Favored 'General case' 0 C--N 1.329 -0.306 0 O-C-N 120.659 -1.495 . . . . 10.0 109.349 168.535 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -72.47 65.34 1.36 Allowed Glycine 0 CA--C 1.532 1.124 0 N-CA-C 113.906 0.322 . . . . 10.0 113.906 173.175 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 60.5 mt -79.51 -42.78 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 126.086 1.754 . . . . 10.0 108.764 166.321 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 79.8 t -126.31 133.34 24.87 Favored Pre-proline 0 N--CA 1.454 -0.264 0 C-N-CA 126.502 1.921 . . . . 10.0 109.401 -174.179 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -68.74 153.75 72.56 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 123.793 2.996 . . . . 10.0 111.491 -176.833 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 12.2 tp -43.13 -39.75 2.94 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.329 1.052 . . . . 10.0 112.227 171.503 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -48.37 -52.39 21.96 Favored 'General case' 0 CA--C 1.539 0.519 0 N-CA-C 114.673 1.361 . . . . 10.0 114.673 176.022 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 14.0 mm -75.91 -40.49 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 124.378 1.071 . . . . 10.0 109.647 177.588 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -49.32 -49.78 42.5 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 118.575 0.625 . . . . 10.0 111.956 173.638 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 16.1 m -57.72 -47.05 83.49 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 126.04 1.736 . . . . 10.0 112.974 174.294 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.535 HD23 ' CD2' ' A' ' 12' ' ' TRP . 1.3 tm? -63.35 -52.33 62.22 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.968 0.907 . . . . 10.0 112.061 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 93.2 mt -52.54 -58.82 5.57 Favored 'General case' 0 C--O 1.228 -0.077 0 C-N-CA 124.293 1.037 . . . . 10.0 110.003 176.408 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -53.97 -43.78 70.2 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 117.704 -1.141 . . . . 10.0 112.876 176.69 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 209' ' ' MET . . . . . 0.575 ' HE2' ' HB3' ' A' ' 15' ' ' LEU . 4.6 tmm? -53.96 -52.57 60.25 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 120.285 1.402 . . . . 10.0 112.237 174.235 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 78.3 t -61.45 -47.89 91.32 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 125.183 1.393 . . . . 10.0 111.897 178.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 5.1 mp -57.42 -49.54 75.9 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.025 1.33 . . . . 10.0 111.404 175.038 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -59.14 -56.83 17.12 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.697 1.199 . . . . 10.0 111.588 176.391 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 34.3 m . . . . . 0 N--CA 1.488 1.458 0 CA-C-N 121.89 2.132 . . . . 10.0 112.377 178.497 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.467 0 CA-C-O 121.101 0.278 . . . . 10.0 113.269 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -46.64 -56.25 6.4 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.717 2.007 . . . . 10.0 112.201 168.093 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -55.82 -38.59 74.25 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 123.817 0.722 . . . . 10.0 113.696 179.399 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 24.5 mt -70.64 -27.38 64.01 Favored 'General case' 0 CA--C 1.512 -0.504 0 N-CA-C 115.694 1.739 . . . . 10.0 115.694 176.859 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 74.4 mt -63.52 -57.51 11.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 108.561 -0.903 . . . . 10.0 108.561 165.576 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 32.1 tp -58.85 -64.6 0.88 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.893 0.877 . . . . 10.0 113.213 -172.907 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 84.2 mt -71.58 5.17 2.55 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 115.295 1.591 . . . . 10.0 115.295 -171.679 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.6 mtp-105 -112.31 0.34 15.68 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.172 0.989 . . . . 10.0 113.238 172.592 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 8.8 t -108.0 177.94 4.66 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 124.116 0.966 . . . . 10.0 111.046 174.653 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 227' ' ' ARG . . . . . 0.667 ' HD3' ' CD ' ' A' ' 166' ' ' GLU . 41.7 ttt180 -71.62 98.16 1.85 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.732 0.813 . . . . 10.0 110.973 170.623 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 228' ' ' ALA . . . . . 0.476 ' HB1' ' CD2' ' A' ' 42' ' ' PHE . . . -80.86 76.99 7.78 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.874 0.87 . . . . 10.0 112.08 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 40.21 102.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 128.831 2.852 . . . . 10.0 116.474 177.672 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . 0.482 0.3 OUTLIER 71.82 -55.43 0.66 Allowed 'General case' 0 C--O 1.241 0.647 0 C-N-CA 124.749 1.22 . . . . 10.0 110.656 -175.288 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -68.29 169.47 40.06 Favored Glycine 0 C--O 1.239 0.417 0 C-N-CA 129.73 3.538 . . . . 10.0 119.666 171.471 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.461 0 C-N-CA 128.491 2.716 . . . . 10.0 113.461 166.583 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 N--CA 1.477 0.893 0 CA-C-O 115.781 -2.057 . . . . 10.0 105.88 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 23.28 91.89 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 129.62 3.168 . . . . 10.0 117.262 160.865 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 28.6 65.12 0.11 Allowed 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 128.302 2.641 . . . . 10.0 114.479 155.468 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 86.7 mt -56.46 137.95 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 126.407 1.883 . . . . 10.0 113.34 -158.388 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.652 HG21 ' HB3' ' A' ' 77' ' ' PRO . 7.5 t -136.74 -165.21 1.7 Allowed 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 126.345 1.858 . . . . 10.0 114.01 -174.337 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 69.97 2.84 40.9 Favored Glycine 0 C--N 1.34 0.793 0 C-N-CA 127.49 2.471 . . . . 10.0 111.496 168.049 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.8 tpp180 -158.59 -51.27 0.01 OUTLIER Pre-proline 0 N--CA 1.443 -0.822 0 CA-C-O 114.301 -2.761 . . . . 10.0 116.694 -168.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -63.97 -60.7 0.14 Allowed 'Trans proline' 0 N--CA 1.465 -0.169 0 CA-C-N 123.559 2.307 . . . . 10.0 113.2 -175.372 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.41 ' H ' ' CD ' ' A' ' 9' ' ' GLU . 7.9 pm0 -67.16 4.27 0.96 Allowed 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 127.87 2.468 . . . . 10.0 115.787 179.693 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.422 ' CG ' ' N ' ' A' ' 11' ' ' ILE . 11.0 p-90 -51.31 -43.13 61.61 Favored 'General case' 0 C--O 1.222 -0.361 0 O-C-N 121.489 -0.757 . . . . 10.0 112.643 176.418 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.422 ' N ' ' CG ' ' A' ' 10' ' ' TRP . 8.9 tt -60.86 -49.61 83.92 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.338 0 C-N-CA 123.887 0.875 . . . . 10.0 109.316 179.416 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' TRP . . . . . 0.535 ' CD2' HD23 ' A' ' 206' ' ' LEU . 2.6 m95 -55.38 -52.67 62.8 Favored 'General case' 0 C--O 1.223 -0.312 0 C-N-CA 123.455 0.702 . . . . 10.0 111.872 175.627 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.7 mt -57.35 -53.62 56.06 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.184 0.594 . . . . 10.0 112.213 177.239 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.86 -46.83 51.83 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.418 1.487 . . . . 10.0 113.288 173.834 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.575 ' HB3' ' HE2' ' A' ' 209' ' ' MET . 13.3 tp -65.62 -45.0 84.77 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.312 1.445 . . . . 10.0 113.045 179.122 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.79 -56.29 12.15 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 124.506 1.051 . . . . 10.0 111.622 166.134 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 22.5 m -49.46 -52.63 27.77 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.981 1.312 . . . . 10.0 112.408 174.254 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.45 -58.84 5.88 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.109 0.964 . . . . 10.0 112.196 177.789 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 95.0 mt -57.52 -48.51 79.09 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.566 0.746 . . . . 10.0 112.729 -179.405 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.549 ' SD ' ' HB1' ' A' ' 53' ' ' ALA . 56.4 mtt -58.7 -47.17 85.45 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.345 1.058 . . . . 10.0 111.403 177.497 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -58.45 -58.51 14.21 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 124.356 0.979 . . . . 10.0 113.901 173.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 81.0 mt -56.19 -45.96 79.59 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-N 118.691 1.246 . . . . 10.0 112.116 176.255 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.75 -41.86 76.46 Favored Glycine 0 CA--C 1.533 1.214 0 C-N-CA 124.752 1.167 . . . . 10.0 113.172 173.151 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 28.4 m -62.29 -58.54 7.35 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.778 0.831 . . . . 10.0 111.425 171.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -52.3 -40.92 62.46 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.99 0.916 . . . . 10.0 110.962 177.868 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -55.82 -58.01 9.63 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.586 1.154 . . . . 10.0 112.974 172.745 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.1 m-30 -59.62 -38.73 82.09 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 113.184 0.809 . . . . 10.0 113.184 178.85 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.401 ' C ' ' H ' ' A' ' 30' ' ' LYS . 11.8 mt -56.15 -67.44 0.3 Allowed 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.621 1.168 . . . . 10.0 113.585 169.171 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 t -76.38 40.97 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-O 123.79 1.757 . . . . 10.0 110.846 179.111 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.401 ' H ' ' C ' ' A' ' 28' ' ' LEU . 42.9 tttm -140.87 -44.87 0.39 Allowed 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 127.9 2.48 . . . . 10.0 109.32 171.173 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.91 23.07 0.87 Allowed Glycine 0 CA--C 1.528 0.898 0 N-CA-C 115.649 1.019 . . . . 10.0 115.649 173.704 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 37.3 mmm -59.47 -45.03 92.8 Favored 'General case' 0 C--O 1.225 -0.228 0 C-N-CA 127.188 2.195 . . . . 10.0 113.562 -179.013 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.71 -84.38 1.19 Allowed Glycine 0 CA--C 1.531 1.045 0 C-N-CA 123.743 0.687 . . . . 10.0 112.47 -170.11 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.8 t 32.99 88.76 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.242 0.706 0 C-N-CA 128.365 2.666 . . . . 10.0 116.96 166.508 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 28.5 m -79.6 -50.85 10.07 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.132 -1.394 . . . . 10.0 113.93 174.101 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -48.97 117.53 6.49 Favored Pre-proline 0 CA--C 1.536 0.418 0 O-C-N 124.815 1.322 . . . . 10.0 110.95 -172.534 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -58.53 -29.66 89.5 Favored 'Trans proline' 0 N--CA 1.459 -0.5 0 C-N-CA 123.695 2.93 . . . . 10.0 113.74 179.095 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.29 -60.64 2.31 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.142 0.577 . . . . 10.0 111.439 176.208 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.21 -40.08 23.19 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 125.065 1.346 . . . . 10.0 113.551 171.634 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -46.52 -47.39 19.5 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.241 1.416 . . . . 10.0 113.444 172.042 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -57.79 -53.05 62.58 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.507 0.723 . . . . 10.0 110.958 176.669 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.476 ' CD2' ' HB1' ' A' ' 228' ' ' ALA . 44.0 m-85 -57.03 -50.15 73.6 Favored 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 123.075 0.55 . . . . 10.0 112.348 -179.109 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -54.4 -51.29 65.35 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 118.921 -0.561 . . . . 10.0 112.377 173.232 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.38 -62.04 1.9 Allowed 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 113.38 0.881 . . . . 10.0 113.38 177.13 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.5 mt -48.42 -57.98 1.29 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 124.918 1.287 . . . . 10.0 110.323 178.077 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.2 m -68.42 -17.57 64.24 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.195 1.398 . . . . 10.0 113.819 -172.731 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 27.9 m -87.59 -40.3 14.35 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-N 119.511 1.05 . . . . 10.0 112.196 174.516 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 22.3 mt -58.76 -43.68 90.4 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 121.48 -0.762 . . . . 10.0 112.272 171.151 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 19.3 t -38.88 -66.13 0.34 Allowed Pre-proline 0 CA--C 1.552 1.032 0 C-N-CA 125.922 1.689 . . . . 10.0 112.861 175.367 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -69.76 -23.44 30.79 Favored 'Trans proline' 0 CA--C 1.546 1.082 0 C-N-CA 123.042 2.495 . . . . 10.0 114.66 176.185 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.27 -45.42 80.54 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 120.564 1.529 . . . . 10.0 113.357 175.796 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 32.6 mm -58.51 -46.1 89.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 O-C-N 121.072 -1.018 . . . . 10.0 109.569 169.314 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.549 ' HB1' ' SD ' ' A' ' 20' ' ' MET . . . -51.96 -51.28 58.18 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.642 1.177 . . . . 10.0 112.127 176.613 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -50.37 -58.3 6.0 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 126.045 1.738 . . . . 10.0 112.321 173.26 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.3 m -49.17 -52.88 23.84 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 125.139 1.376 . . . . 10.0 110.755 178.093 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.407 ' HG3' ' HB2' ' A' ' 85' ' ' ASP . 33.0 mmt -69.38 -48.59 60.7 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 124.165 0.986 . . . . 10.0 112.735 -176.362 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -57.18 -39.58 75.64 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-O 116.766 -1.588 . . . . 10.0 113.266 173.098 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.8 tp -53.29 -54.53 34.98 Favored 'General case' 0 C--O 1.224 -0.238 0 CA-C-N 120.482 1.492 . . . . 10.0 111.313 169.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 24.1 p -51.69 -41.11 61.19 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 115.178 1.547 . . . . 10.0 115.178 179.019 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 59.7 mtm -66.8 -50.88 61.23 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 123.56 0.744 . . . . 10.0 110.534 176.799 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.3 tp -48.58 -52.66 21.75 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.826 0.851 . . . . 10.0 112.94 172.353 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.4 mt -76.88 -5.62 49.15 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.349 1.06 . . . . 10.0 113.828 -177.701 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.35 -34.74 5.52 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 115.504 0.962 . . . . 10.0 115.504 174.128 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -49.24 -43.13 42.49 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 115.208 1.559 . . . . 10.0 115.208 -175.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.1 3.65 60.96 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 115.377 0.911 . . . . 10.0 115.377 -178.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.33 143.47 26.36 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 126.993 2.117 . . . . 10.0 108.992 172.018 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 t -145.54 171.09 15.18 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 124.046 0.938 . . . . 10.0 111.06 166.813 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.02 136.11 53.33 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 123.833 0.853 . . . . 10.0 109.728 179.556 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 58.6 t -129.59 129.62 23.18 Favored Pre-proline 0 C--N 1.329 -0.299 0 C-N-CA 125.034 1.333 . . . . 10.0 110.909 -176.018 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -80.78 116.23 3.15 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 N-CA-C 109.445 -1.021 . . . . 10.0 109.445 -178.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -156.68 164.44 38.15 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.858 0.688 . . . . 10.0 112.858 172.503 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.34 -82.01 0.14 Allowed Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.636 -0.986 . . . . 10.0 110.636 175.891 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.73 -3.29 0.7 Allowed Glycine 0 CA--C 1.527 0.818 0 N-CA-C 118.706 2.242 . . . . 10.0 118.706 170.38 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -151.64 -171.95 4.08 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 119.353 1.577 . . . . 10.0 112.247 -165.159 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -91.79 93.85 9.06 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 125.517 1.527 . . . . 10.0 111.137 -175.322 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.449 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 60.1 m-80 -89.41 120.8 69.69 Favored Pre-proline 0 N--CA 1.45 -0.427 0 N-CA-C 112.97 0.73 . . . . 10.0 112.97 -165.957 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.652 ' HB3' HG21 ' A' ' 5' ' ' THR . 76.0 Cg_exo -61.53 131.91 38.15 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 124.219 3.279 . . . . 10.0 112.137 171.554 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.4 mm -140.15 126.35 21.85 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 C-N-CA 125.971 1.708 . . . . 10.0 111.684 -179.525 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -93.67 85.11 4.76 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 123.338 1.542 . . . . 10.0 113.026 174.652 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 63.8 p-90 -59.41 -28.27 66.78 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 120.619 -1.301 . . . . 10.0 113.891 174.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -54.81 -36.33 64.86 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 114.976 1.473 . . . . 10.0 114.976 178.214 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -59.8 -35.87 75.57 Favored 'General case' 0 N--CA 1.476 0.835 0 O-C-N 120.543 -1.348 . . . . 10.0 112.168 172.103 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -66.75 -42.88 85.48 Favored 'General case' 0 CA--C 1.545 0.758 0 O-C-N 121.071 -1.018 . . . . 10.0 112.987 173.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -50.46 -48.88 56.41 Favored 'General case' 0 CA--C 1.558 1.252 0 C-N-CA 125.624 1.569 . . . . 10.0 111.513 167.541 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.407 ' HB2' ' HG3' ' A' ' 56' ' ' MET . 27.5 t70 -58.61 -63.11 1.4 Allowed 'General case' 0 N--CA 1.485 1.292 0 CA-C-N 119.54 1.064 . . . . 10.0 112.465 171.571 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' TRP . . . . . 0.427 ' HA ' HG22 ' A' ' 89' ' ' THR . 47.4 m0 -50.27 -39.42 45.09 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 126.87 2.068 . . . . 10.0 112.063 -175.075 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 32.4 tp -48.85 -48.59 41.81 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 126.434 1.893 . . . . 10.0 112.377 177.899 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -94.19 -46.48 7.07 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.904 0.881 . . . . 10.0 112.677 -176.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.427 HG22 ' HA ' ' A' ' 86' ' ' TRP . 4.7 t -62.2 -42.73 99.56 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 113.667 0.988 . . . . 10.0 113.667 -174.214 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . 0.308 74.5 p -63.49 -43.73 79.55 Favored Pre-proline 0 N--CA 1.473 0.697 0 O-C-N 120.977 -1.077 . . . . 10.0 112.935 -178.292 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -52.87 -44.63 46.8 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 122.912 2.408 . . . . 10.0 115.746 165.355 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 54.1 mt -59.84 -47.4 85.87 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 119.329 0.968 . . . . 10.0 111.714 176.233 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 6.1 tt -50.71 -48.95 58.6 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 126.302 1.841 . . . . 10.0 111.292 171.771 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.9 mp -57.46 -47.68 81.22 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.543 1.137 . . . . 10.0 113.19 169.794 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.77 -38.24 78.06 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 123.783 0.833 . . . . 10.0 112.925 178.498 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -52.32 -54.08 36.18 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 119.251 0.932 . . . . 10.0 111.15 169.638 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.36 -42.03 88.64 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.67 0.788 . . . . 10.0 112.094 -178.483 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.76 -54.75 37.88 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 124.0 0.92 . . . . 10.0 111.974 173.644 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.25 -41.16 79.11 Favored 'General case' 0 C--O 1.224 -0.237 0 C-N-CA 123.741 0.817 . . . . 10.0 112.731 174.816 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.9 tp -63.77 -38.58 91.65 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 114.445 1.276 . . . . 10.0 114.445 -179.625 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.2 t -94.85 1.49 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 124.998 1.319 . . . . 10.0 112.318 179.177 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.2 t70 48.63 53.41 12.26 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.811 1.644 . . . . 10.0 112.117 -174.079 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.28 145.89 47.58 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 120.017 -1.677 . . . . 10.0 112.458 -174.171 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.49 135.86 54.26 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 112.775 0.658 . . . . 10.0 112.775 175.149 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -42.82 -39.66 2.58 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.88 1.672 . . . . 10.0 113.474 175.326 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -47.34 -60.25 5.31 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 125.18 1.371 . . . . 10.0 115.245 169.741 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.0 p -61.96 -46.79 87.72 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-O 117.155 -1.402 . . . . 10.0 111.358 178.193 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 67.1 mt -48.49 -52.9 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 125.033 1.333 . . . . 10.0 111.115 178.25 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.2 tp -62.62 -51.27 67.93 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 112.549 0.574 . . . . 10.0 112.549 179.277 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.21 -44.84 43.62 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.465 0.706 . . . . 10.0 110.953 174.592 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.455 ' HA ' HD12 ' A' ' 111' ' ' LEU . 0.6 OUTLIER -59.6 -59.91 4.69 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 127.435 2.294 . . . . 10.0 114.794 174.944 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.7 t -61.02 -46.31 96.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 123.743 0.817 . . . . 10.0 111.393 -178.891 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -56.66 -50.31 64.09 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 123.686 0.66 . . . . 10.0 112.656 174.506 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -55.07 -46.27 75.39 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 113.427 0.899 . . . . 10.0 113.427 173.357 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 53.7 t0 -58.26 -45.38 87.93 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.68 0.792 . . . . 10.0 111.679 174.524 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -43.31 -56.12 4.84 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 125.332 1.444 . . . . 10.0 113.322 167.062 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 82.5 mt -57.08 -55.32 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 123.811 0.844 . . . . 10.0 110.367 173.346 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 16.1 tmm? -48.34 -58.09 5.09 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.09 1.356 . . . . 10.0 112.785 -176.061 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 48.7 mm . . . . . 0 N--CA 1.475 0.784 0 O-C-N 121.662 -0.648 . . . . 10.0 112.594 177.084 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 48.6 t . . . . . 0 N--CA 1.482 1.168 0 N-CA-C 111.985 0.365 . . . . 10.0 111.985 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -52.89 -59.21 9.63 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 125.875 1.702 . . . . 10.0 112.4 175.792 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -42.06 -43.07 3.1 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 128.439 2.696 . . . . 10.0 113.174 175.205 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 48.3 mt -101.34 -6.53 23.97 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 115.547 1.684 . . . . 10.0 115.547 -174.301 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 16.9 m -69.75 116.75 10.5 Favored 'General case' 0 N--CA 1.464 0.248 0 O-C-N 120.19 -1.569 . . . . 10.0 110.366 -178.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.621 ' H ' ' HD3' ' A' ' 129' ' ' LYS . 0.1 OUTLIER -55.41 -49.67 71.78 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 128.248 2.619 . . . . 10.0 113.288 177.734 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 60.8 t -69.66 106.39 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 123.738 0.815 . . . . 10.0 110.087 179.666 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -46.95 -59.47 3.08 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 124.742 1.217 . . . . 10.0 114.065 -173.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 m -46.55 -42.08 15.3 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.489 1.516 . . . . 10.0 113.468 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -70.14 -24.6 63.19 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 114.959 1.466 . . . . 10.0 114.959 -178.149 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 69.0 mtp85 -53.94 -41.6 67.93 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 118.92 0.782 . . . . 10.0 110.787 176.594 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -70.11 -31.09 68.47 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 114.421 1.267 . . . . 10.0 114.421 176.705 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.8 t -55.49 -52.43 46.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 CA-C-N 118.989 0.813 . . . . 10.0 109.613 168.501 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 63.6 m95 -60.28 -44.16 95.6 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 113.914 1.079 . . . . 10.0 113.914 173.288 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 88.8 t90 -52.02 -49.39 63.47 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 119.469 1.032 . . . . 10.0 112.909 171.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.525 0 C-N-CA 124.166 0.987 . . . . 10.0 111.76 178.228 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.72 0 N-CA-C 112.452 0.538 . . . . 10.0 112.452 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 40.3 ttp -57.0 -53.14 61.38 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.472 1.109 . . . . 10.0 111.966 172.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 63.4 tp -52.7 -47.14 67.48 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.225 1.41 . . . . 10.0 111.858 178.284 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 77.3 t80 -50.81 -54.75 21.01 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.972 0.909 . . . . 10.0 112.587 171.589 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 41.5 mm -52.26 -55.89 8.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 CA-C-N 118.884 0.765 . . . . 10.0 110.35 176.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 43.0 mt -58.8 -35.15 72.38 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 118.511 -0.757 . . . . 10.0 111.761 -177.841 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -57.21 -58.24 9.09 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 124.018 0.927 . . . . 10.0 113.046 173.402 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.41 -40.88 85.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 CA-C-O 118.304 -0.855 . . . . 10.0 111.461 177.946 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 45.3 mt -56.78 -49.39 75.45 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.895 1.225 . . . . 10.0 112.139 171.23 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.471 ' HA ' ' HD2' ' A' ' 175' ' ' ARG . 11.9 t80 -77.04 -70.28 0.47 Allowed 'General case' 0 C--N 1.326 -0.435 0 O-C-N 120.083 -1.636 . . . . 10.0 112.877 -175.236 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -73.73 -21.92 60.06 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.559 1.144 . . . . 10.0 113.459 -174.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -87.78 -79.15 1.26 Allowed Glycine 0 CA--C 1.526 0.747 0 C-N-CA 123.651 0.643 . . . . 10.0 113.502 171.52 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -53.57 -32.44 50.92 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 126.301 1.841 . . . . 10.0 113.067 -166.532 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.4 m -52.15 -56.42 14.69 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 114.003 1.112 . . . . 10.0 114.003 172.14 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.3 p -53.69 -50.57 65.57 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 122.05 0.929 . . . . 10.0 112.269 -177.85 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 47.6 tttm -57.09 -46.06 82.85 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.136 0.975 . . . . 10.0 112.127 173.628 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.79 -47.52 80.01 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 114.513 1.301 . . . . 10.0 114.513 174.063 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -56.44 -11.33 1.21 Allowed 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.066 1.746 . . . . 10.0 114.235 177.687 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.2 m -107.08 6.69 29.15 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.382 1.873 . . . . 10.0 114.885 -179.336 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 93.2 mmm -91.89 -92.7 0.15 Allowed 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 123.509 1.623 . . . . 10.0 114.146 -170.629 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -138.69 153.91 72.66 Favored Pre-proline 0 C--O 1.236 0.367 0 C-N-CA 129.767 3.227 . . . . 10.0 105.541 170.25 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -52.77 -46.24 34.94 Favored 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 122.352 2.035 . . . . 10.0 113.082 179.007 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.667 ' CD ' ' HD3' ' A' ' 227' ' ' ARG . 0.1 OUTLIER -52.94 -46.12 68.0 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 129.04 2.936 . . . . 10.0 113.292 173.569 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 92.2 t -69.19 -53.01 27.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 C-N-CA 124.034 0.933 . . . . 10.0 109.765 -178.611 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.19 -46.76 75.85 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.274 0.63 . . . . 10.0 111.928 177.07 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 60.4 p -60.03 -56.22 24.4 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.933 0.893 . . . . 10.0 112.699 174.642 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 61.4 m -57.17 -53.2 60.78 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.169 0.988 . . . . 10.0 113.05 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -49.55 -49.49 46.05 Favored 'General case' 0 C--O 1.222 -0.386 0 C-N-CA 123.305 0.642 . . . . 10.0 111.131 174.024 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -57.17 -48.42 78.77 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 114.639 1.348 . . . . 10.0 114.639 -179.727 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 40.4 t -55.95 -49.61 74.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 CA-C-N 118.787 0.721 . . . . 10.0 110.506 176.403 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 94.0 mt -58.55 -51.61 69.17 Favored 'General case' 0 C--O 1.221 -0.397 0 N-CA-C 113.207 0.818 . . . . 10.0 113.207 175.892 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 175' ' ' ARG . . . . . 0.471 ' HD2' ' HA ' ' A' ' 153' ' ' PHE . 35.7 ttp180 -47.83 -47.74 31.15 Favored 'General case' 0 C--O 1.224 -0.246 0 C-N-CA 126.818 2.047 . . . . 10.0 111.047 174.456 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 63.7 m-20 -58.53 -58.3 9.16 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 122.785 0.434 . . . . 10.0 111.252 174.419 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 59.4 t -51.72 -49.79 34.04 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 C-N-CA 124.078 0.951 . . . . 10.0 111.193 179.017 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 30.3 m -57.01 -61.5 2.4 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 128.21 2.604 . . . . 10.0 112.435 178.276 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 55.2 t -52.15 -49.88 38.31 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 124.471 1.108 . . . . 10.0 110.944 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 80.4 t -59.71 -61.15 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 124.299 1.04 . . . . 10.0 112.007 177.037 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -57.35 -50.1 74.04 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 118.78 0.718 . . . . 10.0 112.388 -176.849 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 10.2 m95 . . . . . 0 N--CA 1.469 0.495 0 C-N-CA 123.627 0.771 . . . . 10.0 111.935 177.453 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 93.2 t . . . . . 0 N--CA 1.479 0.997 0 CA-C-O 119.394 -0.336 . . . . 10.0 111.558 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 63.2 t90 -56.32 -52.69 63.62 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.403 1.081 . . . . 10.0 112.598 175.629 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 9.6 tt -57.83 -42.77 85.07 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 123.665 0.786 . . . . 10.0 112.369 -177.593 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 14.5 pt -83.74 -5.93 9.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 N-CA-C 115.085 1.513 . . . . 10.0 115.085 179.575 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.38 -169.32 33.02 Favored Glycine 0 N--CA 1.45 -0.404 0 CA-C-O 122.55 1.083 . . . . 10.0 113.925 -168.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 23.3 t -53.16 -41.43 65.16 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 114.17 -1.015 . . . . 10.0 111.854 177.582 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -67.98 -16.05 63.88 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 115.626 1.713 . . . . 10.0 115.626 -175.57 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -131.11 -106.04 1.08 Allowed Glycine 0 CA--C 1.533 1.157 0 CA-C-N 120.4 1.455 . . . . 10.0 113.908 -173.221 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -89.44 127.17 35.81 Favored 'General case' 0 C--N 1.328 -0.345 0 O-C-N 120.681 -1.482 . . . . 10.0 109.304 168.498 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -72.56 65.37 1.39 Allowed Glycine 0 CA--C 1.532 1.141 0 N-CA-C 113.871 0.308 . . . . 10.0 113.871 173.175 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 60.6 mt -79.54 -42.76 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 126.078 1.751 . . . . 10.0 108.759 166.333 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 79.7 t -126.31 133.37 24.9 Favored Pre-proline 0 N--CA 1.454 -0.25 0 C-N-CA 126.436 1.894 . . . . 10.0 109.351 -174.176 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -68.71 153.81 72.49 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 123.745 2.963 . . . . 10.0 111.479 -176.85 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 12.2 tp -43.18 -39.79 3.04 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.341 1.056 . . . . 10.0 112.169 171.486 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -48.38 -52.39 22.04 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 114.653 1.353 . . . . 10.0 114.653 176.086 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 14.0 mm -75.9 -40.51 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 C-N-CA 124.453 1.101 . . . . 10.0 109.646 177.586 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -49.27 -49.78 41.98 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 118.592 0.633 . . . . 10.0 111.991 173.615 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 16.3 m -57.75 -47.03 83.65 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 126.015 1.726 . . . . 10.0 112.97 174.297 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.535 HD23 ' CD2' ' A' ' 12' ' ' TRP . 1.3 tm? -63.36 -52.28 62.39 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.923 0.889 . . . . 10.0 112.093 179.735 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 93.2 mt -52.57 -59.41 4.49 Favored 'General case' 0 C--N 1.335 -0.053 0 C-N-CA 124.362 1.065 . . . . 10.0 109.954 176.457 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -53.11 -47.06 68.91 Favored 'General case' 0 C--O 1.216 -0.66 0 CA-C-O 117.126 -1.416 . . . . 10.0 112.001 176.544 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 209' ' ' MET . . . . . 0.575 ' HE2' ' HB3' ' A' ' 15' ' ' LEU . 4.6 tmm? -50.99 -52.25 44.65 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 121.454 1.934 . . . . 10.0 113.168 174.895 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 79.4 t -60.14 -49.15 85.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 124.708 1.203 . . . . 10.0 111.263 178.37 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 4.3 mp -58.16 -51.61 68.99 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.631 1.573 . . . . 10.0 112.272 175.508 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -55.68 -58.27 8.51 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 127.824 2.45 . . . . 10.0 110.566 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 78.7 t . . . . . 0 N--CA 1.477 0.891 0 O-C-N 121.48 -0.762 . . . . 10.0 111.764 177.234 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.246 0 CA-C-O 120.994 0.219 . . . . 10.0 112.695 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 61.1 t80 -44.3 -57.7 3.34 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.926 2.09 . . . . 10.0 112.166 166.534 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -55.17 -40.44 74.86 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 124.179 0.895 . . . . 10.0 114.265 177.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 24.2 mt -70.55 -27.33 64.06 Favored 'General case' 0 CA--C 1.512 -0.494 0 N-CA-C 115.528 1.677 . . . . 10.0 115.528 177.62 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 74.4 mt -63.27 -57.53 11.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 108.616 -0.883 . . . . 10.0 108.616 165.432 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 32.1 tp -58.89 -64.68 0.85 Allowed 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.95 0.9 . . . . 10.0 113.126 -172.861 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 84.3 mt -71.55 5.23 2.5 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 115.333 1.605 . . . . 10.0 115.333 -171.671 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.6 mtp-105 -112.35 0.39 15.66 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.168 0.987 . . . . 10.0 113.296 172.524 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 8.8 t -108.04 177.99 4.64 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 124.035 0.934 . . . . 10.0 111.002 174.633 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 227' ' ' ARG . . . . . 0.667 ' HD3' ' CD ' ' A' ' 166' ' ' GLU . 41.8 ttt180 -71.68 98.2 1.88 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.744 0.818 . . . . 10.0 110.953 170.673 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 228' ' ' ALA . . . . . 0.476 ' HB1' ' CD2' ' A' ' 42' ' ' PHE . . . -80.88 76.98 7.8 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.896 0.879 . . . . 10.0 112.111 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 40.08 102.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 128.837 2.855 . . . . 10.0 116.492 177.788 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . 0.483 0.3 OUTLIER 71.92 -55.46 0.66 Allowed 'General case' 0 C--O 1.241 0.647 0 C-N-CA 124.692 1.197 . . . . 10.0 110.632 -175.346 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -68.26 169.47 39.92 Favored Glycine 0 C--O 1.238 0.376 0 C-N-CA 129.782 3.563 . . . . 10.0 119.621 171.482 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.461 0 C-N-CA 128.473 2.709 . . . . 10.0 113.457 166.611 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 N--CA 1.476 0.87 0 CA-C-O 115.807 -2.044 . . . . 10.0 105.858 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 23.41 91.8 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 129.598 3.159 . . . . 10.0 117.253 160.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 28.67 65.06 0.11 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 128.291 2.636 . . . . 10.0 114.474 155.415 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 86.7 mt -56.46 137.93 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 126.387 1.875 . . . . 10.0 113.376 -158.408 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.652 HG21 ' HB3' ' A' ' 77' ' ' PRO . 7.6 t -136.7 -165.22 1.7 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 126.324 1.85 . . . . 10.0 114.052 -174.353 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 70.01 2.83 41.23 Favored Glycine 0 C--N 1.34 0.786 0 C-N-CA 127.471 2.463 . . . . 10.0 111.485 168.021 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -158.56 -51.35 0.01 OUTLIER Pre-proline 0 N--CA 1.443 -0.823 0 CA-C-O 114.274 -2.774 . . . . 10.0 116.642 -168.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -63.95 -60.69 0.14 Allowed 'Trans proline' 0 N--CA 1.465 -0.202 0 CA-C-N 123.509 2.289 . . . . 10.0 113.21 -175.336 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.411 ' H ' ' CD ' ' A' ' 9' ' ' GLU . 7.9 pm0 -67.16 4.35 0.94 Allowed 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 127.836 2.454 . . . . 10.0 115.764 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.421 ' CG ' ' N ' ' A' ' 11' ' ' ILE . 11.1 p-90 -51.37 -43.14 61.78 Favored 'General case' 0 C--O 1.222 -0.361 0 O-C-N 121.516 -0.74 . . . . 10.0 112.564 176.439 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.421 ' N ' ' CG ' ' A' ' 10' ' ' TRP . 8.9 tt -60.87 -49.63 83.82 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.361 0 C-N-CA 123.926 0.89 . . . . 10.0 109.306 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.535 ' CD2' HD23 ' A' ' 206' ' ' LEU . 2.6 m95 -55.38 -52.62 62.93 Favored 'General case' 0 C--O 1.224 -0.259 0 C-N-CA 123.433 0.693 . . . . 10.0 111.912 175.617 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.6 mt -57.38 -53.61 56.24 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.112 0.565 . . . . 10.0 112.222 177.209 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.84 -46.79 51.67 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.391 1.476 . . . . 10.0 113.33 173.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.574 ' HB3' ' HE2' ' A' ' 209' ' ' MET . 13.3 tp -65.62 -45.02 84.7 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 125.336 1.455 . . . . 10.0 113.047 179.086 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.45 -56.86 10.1 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 124.621 1.105 . . . . 10.0 111.407 165.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.2 m -49.51 -52.49 29.15 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.995 1.318 . . . . 10.0 112.242 174.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.41 -58.86 5.79 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.143 0.977 . . . . 10.0 112.176 177.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 95.3 mt -57.97 -49.34 77.16 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.678 0.791 . . . . 10.0 112.544 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 23.5 mmt -55.23 -51.04 67.86 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.587 0.755 . . . . 10.0 111.026 175.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -56.33 -58.53 13.82 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 124.441 1.019 . . . . 10.0 113.738 176.433 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 80.8 mt -56.21 -45.41 79.89 Favored 'General case' 0 C--O 1.221 -0.397 0 CA-C-N 118.593 1.196 . . . . 10.0 112.113 176.278 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.83 -42.05 77.8 Favored Glycine 0 CA--C 1.534 1.24 0 C-N-CA 124.814 1.197 . . . . 10.0 113.46 172.393 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 15.4 m -59.38 -61.61 2.5 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.457 1.103 . . . . 10.0 110.723 171.3 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -52.24 -40.96 62.37 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.039 0.936 . . . . 10.0 110.976 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -55.77 -58.08 9.32 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.611 1.165 . . . . 10.0 112.986 172.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -59.65 -38.61 81.89 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 113.255 0.835 . . . . 10.0 113.255 178.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.402 ' C ' ' H ' ' A' ' 30' ' ' LYS . 11.8 mt -56.19 -67.44 0.3 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.627 1.171 . . . . 10.0 113.597 169.118 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 t -76.37 40.98 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 CA-C-O 123.749 1.738 . . . . 10.0 110.879 179.074 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.402 ' H ' ' C ' ' A' ' 28' ' ' LEU . 42.9 tttm -140.87 -44.88 0.39 Allowed 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 127.87 2.468 . . . . 10.0 109.336 171.204 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.96 23.15 0.87 Allowed Glycine 0 CA--C 1.529 0.925 0 N-CA-C 115.629 1.012 . . . . 10.0 115.629 173.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 37.3 mmm -59.54 -44.97 93.06 Favored 'General case' 0 C--O 1.225 -0.235 0 C-N-CA 127.13 2.172 . . . . 10.0 113.63 -179.023 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.62 -84.43 1.18 Allowed Glycine 0 CA--C 1.531 1.045 0 C-N-CA 123.764 0.697 . . . . 10.0 112.508 -170.188 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.8 t 33.02 88.81 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.242 0.682 0 C-N-CA 128.358 2.663 . . . . 10.0 116.942 166.478 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.7 m -79.68 -50.85 10.01 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.167 -1.379 . . . . 10.0 113.877 174.15 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -48.91 117.47 6.37 Favored Pre-proline 0 CA--C 1.536 0.416 0 O-C-N 124.764 1.29 . . . . 10.0 110.949 -172.529 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -58.57 -29.65 89.61 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 123.726 2.951 . . . . 10.0 113.682 179.105 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.29 -60.64 2.3 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 123.107 0.563 . . . . 10.0 111.48 176.15 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.21 -40.02 23.0 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 125.097 1.359 . . . . 10.0 113.559 171.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.5 tttp -46.57 -47.44 19.76 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 125.243 1.417 . . . . 10.0 113.403 172.06 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -57.72 -53.08 62.26 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.473 0.709 . . . . 10.0 111.009 176.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.476 ' CD2' ' HB1' ' A' ' 228' ' ' ALA . 43.8 m-85 -56.95 -50.24 73.24 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 123.089 0.555 . . . . 10.0 112.34 -179.178 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -54.44 -51.25 65.55 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 118.916 -0.564 . . . . 10.0 112.342 173.315 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.38 -61.98 1.93 Allowed 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 113.399 0.888 . . . . 10.0 113.399 177.135 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.5 mt -48.86 -56.06 2.81 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 C-N-CA 124.912 1.285 . . . . 10.0 110.832 178.052 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.5 m -69.49 -20.34 63.73 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.861 1.264 . . . . 10.0 113.432 -172.485 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 28.1 m -84.4 -38.82 19.78 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.404 1.081 . . . . 10.0 112.28 174.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 19.1 mt -59.33 -41.4 89.06 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 117.873 -1.061 . . . . 10.0 112.803 174.218 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.686 HG23 ' HD3' ' A' ' 50' ' ' PRO 0.405 33.0 m -58.49 -49.56 92.85 Favored Pre-proline 0 N--CA 1.486 1.36 0 CA-C-N 121.082 1.765 . . . . 10.0 114.707 -178.915 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.686 ' HD3' HG23 ' A' ' 49' ' ' VAL . 89.3 Cg_exo -49.82 -45.32 32.66 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 123.587 2.858 . . . . 10.0 115.107 162.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.6 -46.79 84.2 Favored 'General case' 0 CA--C 1.548 0.892 0 CA-C-N 119.82 1.191 . . . . 10.0 113.704 -179.335 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 30.9 mm -53.22 -55.48 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 124.989 1.316 . . . . 10.0 109.595 169.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.65 -44.85 77.56 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.124 0.969 . . . . 10.0 113.567 177.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 50.2 t80 -52.59 -56.78 12.92 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.28 1.432 . . . . 10.0 111.871 172.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 14.4 m -49.92 -52.58 32.12 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.304 1.441 . . . . 10.0 110.658 177.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 32.6 mmt -69.23 -48.13 62.77 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 123.965 0.906 . . . . 10.0 113.05 -176.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -54.69 -42.55 71.55 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 120.17 1.35 . . . . 10.0 113.213 172.18 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.7 tp -53.33 -54.54 35.03 Favored 'General case' 0 C--O 1.224 -0.272 0 CA-C-N 119.406 1.003 . . . . 10.0 111.292 171.414 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 23.9 p -51.6 -41.08 60.95 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 115.239 1.57 . . . . 10.0 115.239 178.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 58.4 mtm -66.86 -50.88 61.09 Favored 'General case' 0 C--N 1.334 -0.09 0 C-N-CA 123.597 0.759 . . . . 10.0 110.477 176.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.5 tp -48.58 -52.65 21.79 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.859 0.863 . . . . 10.0 112.95 172.341 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.5 mt -76.94 -5.58 49.12 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.318 1.047 . . . . 10.0 113.805 -177.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.28 -34.7 5.56 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 115.504 0.962 . . . . 10.0 115.504 174.103 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -49.27 -43.04 42.75 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 115.278 1.584 . . . . 10.0 115.278 -176.038 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.05 3.52 61.2 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 115.388 0.915 . . . . 10.0 115.388 -179.07 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.23 143.4 26.45 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 127.016 2.126 . . . . 10.0 109.02 171.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 t -145.51 171.16 15.06 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 123.995 0.918 . . . . 10.0 111.013 166.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.02 136.05 53.39 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 123.897 0.879 . . . . 10.0 109.675 179.627 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.436 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 58.7 t -129.56 129.61 23.19 Favored Pre-proline 0 C--N 1.329 -0.295 0 C-N-CA 125.069 1.348 . . . . 10.0 110.969 -176.095 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 69' ' ' VAL . 6.3 Cg_exo -80.81 116.23 3.15 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 N-CA-C 109.367 -1.051 . . . . 10.0 109.367 -178.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -156.68 164.37 38.22 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 112.862 0.69 . . . . 10.0 112.862 172.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.36 -81.95 0.14 Allowed Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.68 -0.968 . . . . 10.0 110.68 175.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.76 -3.31 0.7 Allowed Glycine 0 CA--C 1.527 0.822 0 N-CA-C 118.684 2.234 . . . . 10.0 118.684 170.395 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -151.64 -171.89 4.06 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 119.327 1.564 . . . . 10.0 112.221 -165.165 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -91.89 93.95 9.06 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 125.456 1.502 . . . . 10.0 111.091 -175.287 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.449 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 60.2 m-80 -89.5 120.74 69.63 Favored Pre-proline 0 N--CA 1.45 -0.429 0 N-CA-C 112.953 0.723 . . . . 10.0 112.953 -165.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.652 ' HB3' HG21 ' A' ' 5' ' ' THR . 76.3 Cg_exo -61.47 131.93 38.36 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 124.171 3.247 . . . . 10.0 112.159 171.572 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.4 mm -140.16 126.3 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 C-N-CA 125.99 1.716 . . . . 10.0 111.701 -179.494 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -93.58 85.0 4.76 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 122.967 1.365 . . . . 10.0 113.08 174.619 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 63.7 p-90 -59.33 -28.28 66.68 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 120.858 -1.151 . . . . 10.0 113.96 174.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -54.14 -27.48 33.77 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 124.273 1.029 . . . . 10.0 112.2 178.288 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 21.4 mtt-85 -54.62 -50.21 68.65 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.92 1.288 . . . . 10.0 112.78 168.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.413 ' HE1' H162 ' A' ' 999' ' ' RET . 98.3 m-85 -67.44 -39.86 85.42 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 121.409 -0.807 . . . . 10.0 112.114 178.32 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -52.54 -50.65 62.45 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 123.787 0.835 . . . . 10.0 112.135 170.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 54.0 t0 -52.54 -69.12 0.12 Allowed 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 126.079 1.751 . . . . 10.0 111.325 170.335 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 50.4 m0 -55.48 -35.23 65.3 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 125.821 1.648 . . . . 10.0 113.004 -171.486 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 25.5 tp -49.58 -43.41 46.17 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 126.408 1.883 . . . . 10.0 112.174 177.597 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -101.27 -38.5 8.05 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.833 0.853 . . . . 10.0 112.281 179.315 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 1.6 m -51.15 -55.02 20.0 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.88 1.272 . . . . 10.0 113.468 175.014 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . 0.263 44.9 p -68.12 -40.58 22.39 Favored Pre-proline 0 N--CA 1.476 0.855 0 N-CA-C 114.63 1.344 . . . . 10.0 114.63 -171.161 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -56.75 -43.04 58.45 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 123.935 3.09 . . . . 10.0 115.522 168.199 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 53.2 mt -60.39 -47.06 87.72 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 121.395 -0.816 . . . . 10.0 111.394 176.108 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 6.0 tt -50.89 -48.01 60.53 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.628 1.571 . . . . 10.0 111.596 171.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.5 mp -58.83 -46.76 86.92 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.61 1.164 . . . . 10.0 113.365 170.438 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.79 -38.34 78.33 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 123.824 0.849 . . . . 10.0 112.868 177.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 -52.24 -54.1 35.4 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 119.317 0.962 . . . . 10.0 111.13 169.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.31 -42.08 88.77 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.651 0.78 . . . . 10.0 112.152 -178.509 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.66 -54.73 37.84 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.962 0.905 . . . . 10.0 112.056 173.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.33 -41.15 79.44 Favored 'General case' 0 C--O 1.224 -0.237 0 C-N-CA 123.767 0.827 . . . . 10.0 112.667 174.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.9 tp -63.8 -38.51 91.38 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 114.461 1.282 . . . . 10.0 114.461 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.2 t -94.85 1.45 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 125.022 1.329 . . . . 10.0 112.316 179.173 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.2 t70 48.57 53.51 12.02 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.866 1.666 . . . . 10.0 112.095 -174.013 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.27 145.9 47.58 Favored 'General case' 0 CA--C 1.534 0.339 0 O-C-N 119.977 -1.702 . . . . 10.0 112.459 -174.2 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.47 135.95 54.17 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 112.715 0.635 . . . . 10.0 112.715 175.154 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -42.89 -39.74 2.66 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 125.906 1.682 . . . . 10.0 113.41 175.293 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -47.32 -60.21 5.32 Favored Glycine 0 CA--C 1.525 0.691 0 C-N-CA 125.12 1.343 . . . . 10.0 115.222 169.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.6 p -62.05 -46.8 87.54 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 117.147 -1.406 . . . . 10.0 111.321 178.286 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 66.9 mt -48.39 -52.92 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 125.001 1.321 . . . . 10.0 111.147 178.191 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.2 tp -62.64 -51.27 67.93 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 112.548 0.573 . . . . 10.0 112.548 179.314 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.15 -44.9 43.13 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.506 0.722 . . . . 10.0 110.905 174.6 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.455 ' HA ' HD12 ' A' ' 111' ' ' LEU . 0.6 OUTLIER -59.52 -59.94 4.65 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 127.431 2.292 . . . . 10.0 114.8 174.937 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.5 t -61.03 -46.33 96.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 123.697 0.799 . . . . 10.0 111.388 -178.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -56.62 -50.35 63.76 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 123.695 0.664 . . . . 10.0 112.619 174.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -54.7 -46.85 74.2 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 113.275 0.843 . . . . 10.0 113.275 173.39 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -57.45 -45.39 84.78 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.804 0.842 . . . . 10.0 112.135 174.423 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -43.98 -55.65 5.53 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 125.385 1.469 . . . . 10.0 113.131 167.225 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 80.1 mt -55.73 -54.11 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 CA-C-O 118.03 -0.986 . . . . 10.0 110.464 173.207 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 63.4 ttp -46.36 -55.64 7.02 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 120.091 1.314 . . . . 10.0 112.978 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 1.7 mp -68.74 -49.99 59.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 O-C-N 121.543 -0.723 . . . . 10.0 111.591 179.273 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -52.49 -54.46 27.2 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 123.914 0.768 . . . . 10.0 111.958 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 18.4 m -53.62 -46.96 70.66 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 126.227 1.811 . . . . 10.0 111.798 173.477 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -49.48 -54.14 17.71 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 124.651 1.119 . . . . 10.0 113.587 170.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 61.7 tp -57.53 -48.35 79.54 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 125.159 1.384 . . . . 10.0 111.994 176.3 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 63.3 t -52.71 -51.25 37.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 123.249 0.62 . . . . 10.0 110.128 173.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -50.08 -61.18 5.97 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 125.923 1.725 . . . . 10.0 112.709 171.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -46.99 -38.84 11.4 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 127.191 2.196 . . . . 10.0 113.638 178.304 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 48.2 mt -99.62 -6.87 26.58 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 115.347 1.61 . . . . 10.0 115.347 -178.051 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 17.0 m -69.67 116.74 10.41 Favored 'General case' 0 N--CA 1.464 0.256 0 O-C-N 120.162 -1.586 . . . . 10.0 110.378 -178.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.621 ' H ' ' HD3' ' A' ' 129' ' ' LYS . 0.1 OUTLIER -55.44 -49.65 71.9 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 128.195 2.598 . . . . 10.0 113.3 177.711 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 61.3 t -69.67 106.32 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 C-N-CA 123.773 0.829 . . . . 10.0 110.121 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -46.89 -59.51 3.04 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 124.769 1.228 . . . . 10.0 114.067 -173.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 m -46.46 -42.1 14.9 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.467 1.507 . . . . 10.0 113.497 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -70.18 -24.59 63.16 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 114.917 1.451 . . . . 10.0 114.917 -178.092 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 68.8 mtp85 -54.01 -41.65 68.21 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 118.862 0.755 . . . . 10.0 110.864 176.664 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -69.59 -32.07 70.59 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.755 1.222 . . . . 10.0 114.202 176.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.9 t -54.88 -52.23 45.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-N 119.063 0.847 . . . . 10.0 109.615 168.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 64.2 m95 -61.08 -44.23 97.69 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 114.238 1.199 . . . . 10.0 114.238 174.238 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 90.4 t90 -53.36 -48.4 68.59 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 119.284 0.947 . . . . 10.0 112.959 172.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -56.76 -53.5 57.08 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.013 0.925 . . . . 10.0 111.607 177.073 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 98.3 mt -54.27 -49.0 66.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 124.937 1.295 . . . . 10.0 111.748 174.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 20.9 m -55.45 -45.49 76.86 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.63 1.172 . . . . 10.0 111.766 175.408 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 37.3 m -64.34 -40.47 95.94 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 125.515 1.526 . . . . 10.0 112.164 177.296 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -57.81 -49.03 78.0 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.972 0.909 . . . . 10.0 112.343 169.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -56.27 -46.97 79.45 Favored 'General case' 0 CA--C 1.546 0.819 0 O-C-N 121.486 -0.759 . . . . 10.0 112.235 172.516 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 41.4 ttp -55.47 -57.92 9.92 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.218 1.007 . . . . 10.0 112.776 174.049 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.3 pp -61.61 -35.84 79.04 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 118.309 -0.853 . . . . 10.0 112.147 -176.176 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 75.3 t80 -54.1 -55.27 29.19 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 119.312 0.96 . . . . 10.0 111.95 167.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 54.7 mt -53.59 -55.27 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 123.807 0.843 . . . . 10.0 110.741 177.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 9.9 mp -56.24 -37.06 69.23 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.23 1.012 . . . . 10.0 112.678 178.365 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -57.27 -58.19 9.31 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 124.057 0.943 . . . . 10.0 112.999 173.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.47 -40.91 85.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 CA-C-O 118.338 -0.839 . . . . 10.0 111.442 177.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 47.1 mt -56.72 -49.48 75.07 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 119.875 1.216 . . . . 10.0 112.098 171.217 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.471 ' HA ' ' HD2' ' A' ' 175' ' ' ARG . 11.8 t80 -77.01 -70.25 0.47 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 120.087 -1.633 . . . . 10.0 112.877 -175.186 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -73.76 -21.91 60.03 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.587 1.155 . . . . 10.0 113.439 -174.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -87.84 -79.02 1.26 Allowed Glycine 0 CA--C 1.526 0.761 0 C-N-CA 123.599 0.619 . . . . 10.0 113.539 171.53 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -53.68 -32.42 51.63 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 126.275 1.83 . . . . 10.0 113.024 -166.53 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.3 m -52.1 -56.46 14.28 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 114.01 1.115 . . . . 10.0 114.01 172.123 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.7 p -53.63 -50.55 65.48 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 122.081 0.944 . . . . 10.0 112.307 -177.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 47.7 tttm -57.14 -46.07 83.0 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.165 0.986 . . . . 10.0 112.086 173.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.81 -47.48 80.18 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 114.504 1.298 . . . . 10.0 114.504 174.062 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -56.42 -11.33 1.2 Allowed 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 126.095 1.758 . . . . 10.0 114.223 177.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.1 m -107.11 6.64 29.06 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.408 1.883 . . . . 10.0 114.869 -179.273 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 93.2 mmm -91.92 -92.68 0.15 Allowed 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 123.48 1.609 . . . . 10.0 114.139 -170.578 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -138.69 153.93 72.67 Favored Pre-proline 0 C--O 1.236 0.352 0 C-N-CA 129.823 3.249 . . . . 10.0 105.57 170.23 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -52.8 -46.25 34.99 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.296 1.998 . . . . 10.0 113.102 179.007 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.666 ' CD ' ' HD3' ' A' ' 227' ' ' ARG . 0.1 OUTLIER -53.02 -45.99 68.21 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 128.972 2.909 . . . . 10.0 113.285 173.619 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 91.7 t -69.24 -53.01 27.74 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.237 0 C-N-CA 124.031 0.933 . . . . 10.0 109.81 -178.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.13 -46.8 75.66 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.287 0.635 . . . . 10.0 111.933 177.009 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 60.2 p -59.99 -56.23 24.31 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.972 0.909 . . . . 10.0 112.687 174.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 61.3 m -57.19 -53.21 60.73 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.189 0.995 . . . . 10.0 113.036 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -49.57 -49.49 46.26 Favored 'General case' 0 C--O 1.221 -0.438 0 C-N-CA 123.258 0.623 . . . . 10.0 111.098 174.07 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -57.19 -48.43 78.78 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 114.664 1.357 . . . . 10.0 114.664 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 40.4 t -55.91 -49.66 73.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 CA-C-N 118.802 0.728 . . . . 10.0 110.477 176.355 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 94.2 mt -58.54 -51.69 68.82 Favored 'General case' 0 C--O 1.222 -0.389 0 N-CA-C 113.168 0.803 . . . . 10.0 113.168 175.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' ARG . . . . . 0.471 ' HD2' ' HA ' ' A' ' 153' ' ' PHE . 35.5 ttp180 -47.76 -47.76 30.38 Favored 'General case' 0 C--O 1.225 -0.222 0 C-N-CA 126.816 2.046 . . . . 10.0 111.087 174.446 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 63.5 m-20 -58.47 -58.36 8.89 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 122.819 0.448 . . . . 10.0 111.282 174.358 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 54.2 t -51.92 -52.29 23.84 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 C-N-CA 124.033 0.933 . . . . 10.0 111.875 179.021 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 64.1 m -54.59 -61.07 2.55 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 127.408 2.283 . . . . 10.0 113.178 175.15 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 51.6 t -51.58 -50.13 31.28 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 CA-C-N 120.26 1.391 . . . . 10.0 110.805 -178.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 79.1 t -58.99 -61.0 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 124.211 1.004 . . . . 10.0 112.268 176.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 78.5 mt -57.47 -51.46 69.36 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 118.623 0.647 . . . . 10.0 112.403 -177.462 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 10.8 m95 -55.81 -48.17 75.89 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 123.66 0.784 . . . . 10.0 111.521 179.172 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 8.6 t -58.59 -21.9 54.56 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 114.645 1.35 . . . . 10.0 114.645 177.561 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -69.74 -40.21 76.32 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 119.738 1.154 . . . . 10.0 113.392 174.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -46.09 -56.0 11.8 Favored Pre-proline 0 N--CA 1.478 0.943 0 C-N-CA 125.219 1.408 . . . . 10.0 114.574 -178.436 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' PRO . . . . . 0.532 ' HB3' H183 ' A' ' 999' ' ' RET . 27.9 Cg_endo -59.22 -34.45 98.25 Favored 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 122.162 1.908 . . . . 10.0 113.6 178.194 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 34.7 t -66.54 -58.5 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 123.817 0.847 . . . . 10.0 110.657 177.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 16.4 m -61.65 -34.28 61.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 CA-C-O 118.898 -0.572 . . . . 10.0 112.439 -177.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 62.2 t90 -57.75 -57.59 12.09 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.344 1.457 . . . . 10.0 112.304 167.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 9.3 tt -58.24 -40.45 81.75 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.802 0.841 . . . . 10.0 112.574 -175.257 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 14.7 pt -82.67 -5.65 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 N-CA-C 115.195 1.554 . . . . 10.0 115.195 178.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.3 -169.26 33.11 Favored Glycine 0 N--CA 1.45 -0.404 0 CA-C-O 122.551 1.084 . . . . 10.0 113.921 -168.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 23.3 t -53.17 -39.96 63.98 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 114.166 -1.017 . . . . 10.0 111.879 177.559 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -68.48 -14.9 63.32 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 125.744 1.618 . . . . 10.0 115.171 -174.301 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -136.27 -104.81 0.75 Allowed Glycine 0 CA--C 1.541 1.662 0 C-N-CA 125.21 1.386 . . . . 10.0 114.951 -174.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -89.43 127.17 35.81 Favored 'General case' 0 C--N 1.328 -0.352 0 O-C-N 120.697 -1.473 . . . . 10.0 109.357 168.486 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -72.51 65.38 1.37 Allowed Glycine 0 CA--C 1.532 1.127 0 N-CA-C 113.915 0.326 . . . . 10.0 113.915 173.167 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 60.7 mt -79.61 -42.72 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 126.08 1.752 . . . . 10.0 108.725 166.375 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 79.4 t -126.34 133.38 24.91 Favored Pre-proline 0 N--CA 1.454 -0.264 0 C-N-CA 126.502 1.921 . . . . 10.0 109.417 -174.212 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -68.74 153.76 72.54 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 123.811 3.007 . . . . 10.0 111.476 -176.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 12.2 tp -43.13 -39.77 2.95 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.381 1.072 . . . . 10.0 112.214 171.505 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -48.39 -52.35 22.26 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 114.702 1.371 . . . . 10.0 114.702 176.055 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 14.0 mm -75.96 -40.44 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 124.378 1.071 . . . . 10.0 109.666 177.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -49.29 -49.8 42.08 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 118.592 0.633 . . . . 10.0 111.946 173.567 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 16.3 m -57.74 -47.08 83.47 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 126.045 1.738 . . . . 10.0 112.953 174.329 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.535 HD23 ' CD2' ' A' ' 12' ' ' TRP . 1.3 tm? -63.25 -52.36 62.45 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.985 0.914 . . . . 10.0 112.131 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 93.2 mt -52.55 -59.22 4.72 Favored 'General case' 0 C--O 1.228 -0.041 0 C-N-CA 124.278 1.031 . . . . 10.0 109.973 176.458 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -52.52 -46.16 66.59 Favored 'General case' 0 C--O 1.221 -0.427 0 CA-C-O 117.821 -1.085 . . . . 10.0 112.37 176.261 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 209' ' ' MET . . . . . 0.574 ' HE2' ' HB3' ' A' ' 15' ' ' LEU . 4.6 tmm? -52.42 -51.82 57.12 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 120.62 1.555 . . . . 10.0 113.023 175.229 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 79.5 t -60.9 -50.35 80.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 124.418 1.087 . . . . 10.0 111.419 178.248 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 4.6 mp -55.81 -52.01 65.46 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.77 1.628 . . . . 10.0 111.979 175.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -55.12 -61.85 2.05 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 126.449 1.9 . . . . 10.0 110.471 178.32 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 98.1 t -54.72 -42.84 63.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 CA-C-N 119.529 1.059 . . . . 10.0 111.597 -178.496 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 6.6 t -55.81 -52.64 63.31 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.085 0.554 . . . . 10.0 112.067 171.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -69.21 -19.49 63.96 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 115.693 1.738 . . . . 10.0 115.693 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -91.44 -74.19 0.51 Allowed 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.949 1.299 . . . . 10.0 110.544 169.61 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 20.8 t -77.41 -49.19 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 C-N-CA 125.726 1.61 . . . . 10.0 111.153 -168.406 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -55.04 -56.07 24.99 Favored Glycine 0 N--CA 1.476 1.316 0 CA-C-N 119.098 0.863 . . . . 10.0 112.753 177.243 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -44.32 -57.96 3.2 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 127.106 2.163 . . . . 10.0 112.316 166.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -55.82 -39.88 78.84 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 124.188 0.899 . . . . 10.0 114.032 177.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 24.4 mt -70.43 -27.53 64.34 Favored 'General case' 0 CA--C 1.511 -0.535 0 N-CA-C 115.52 1.674 . . . . 10.0 115.52 177.205 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 74.2 mt -63.27 -57.55 11.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 108.642 -0.873 . . . . 10.0 108.642 165.407 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 32.0 tp -58.79 -64.72 0.83 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.92 0.888 . . . . 10.0 113.184 -172.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 84.0 mt -71.52 5.19 2.5 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 115.332 1.604 . . . . 10.0 115.332 -171.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.6 mtp-105 -112.32 0.38 15.68 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.188 0.995 . . . . 10.0 113.316 172.529 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 8.8 t -108.03 177.96 4.65 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 124.046 0.938 . . . . 10.0 111.0 174.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 227' ' ' ARG . . . . . 0.666 ' HD3' ' CD ' ' A' ' 166' ' ' GLU . 41.7 ttt180 -71.62 98.13 1.84 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.786 0.835 . . . . 10.0 110.96 170.638 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 228' ' ' ALA . . . . . 0.476 ' HB1' ' CD2' ' A' ' 42' ' ' PHE . . . -80.87 76.96 7.79 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.828 0.851 . . . . 10.0 112.116 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 40.19 102.25 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 128.857 2.863 . . . . 10.0 116.497 177.746 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . 0.482 0.3 OUTLIER 71.83 -55.44 0.66 Allowed 'General case' 0 C--O 1.242 0.677 0 C-N-CA 124.769 1.227 . . . . 10.0 110.637 -175.273 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -68.25 169.47 39.89 Favored Glycine 0 C--O 1.239 0.429 0 C-N-CA 129.735 3.541 . . . . 10.0 119.701 171.462 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.461 0 C-N-CA 128.498 2.719 . . . . 10.0 113.46 166.616 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 999' ' ' RET . . . . . 0.723 ' H8 ' H161 ' A' ' 999' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1000 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A 1001 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A 1002 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A 1003 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 N--CA 1.477 0.918 0 CA-C-O 115.804 -2.046 . . . . 10.0 105.785 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 23.4 91.84 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 129.58 3.152 . . . . 10.0 117.236 160.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 28.63 65.11 0.11 Allowed 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 128.306 2.643 . . . . 10.0 114.458 155.424 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 86.7 mt -56.51 137.99 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 126.358 1.863 . . . . 10.0 113.372 -158.393 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.653 HG21 ' HB3' ' A' ' 77' ' ' PRO . 7.6 t -136.76 -165.26 1.7 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 126.329 1.852 . . . . 10.0 113.97 -174.268 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 70.05 2.8 41.33 Favored Glycine 0 C--N 1.34 0.768 0 C-N-CA 127.477 2.465 . . . . 10.0 111.487 168.02 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.8 tpp180 -158.58 -51.34 0.01 OUTLIER Pre-proline 0 N--CA 1.444 -0.772 0 CA-C-O 114.206 -2.806 . . . . 10.0 116.623 -168.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_exo -63.99 -60.6 0.15 Allowed 'Trans proline' 0 CA--C 1.528 0.185 0 CA-C-N 123.517 2.292 . . . . 10.0 113.242 -175.309 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.411 ' H ' ' CD ' ' A' ' 9' ' ' GLU . 7.9 pm0 -67.19 4.22 0.99 Allowed 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 127.855 2.462 . . . . 10.0 115.735 179.691 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.422 ' CG ' ' N ' ' A' ' 11' ' ' ILE . 11.0 p-90 -51.32 -43.1 61.64 Favored 'General case' 0 C--O 1.222 -0.361 0 O-C-N 121.496 -0.752 . . . . 10.0 112.669 176.438 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.422 ' N ' ' CG ' ' A' ' 10' ' ' TRP . 8.9 tt -60.85 -49.65 83.74 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.319 0 C-N-CA 123.936 0.894 . . . . 10.0 109.298 179.359 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.536 ' CD2' HD23 ' A' ' 206' ' ' LEU . 2.6 m95 -55.34 -52.63 62.86 Favored 'General case' 0 C--O 1.224 -0.261 0 C-N-CA 123.384 0.674 . . . . 10.0 111.93 175.616 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.8 mt -57.36 -53.63 55.96 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 123.193 0.597 . . . . 10.0 112.186 177.254 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.87 -46.79 51.93 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.41 1.484 . . . . 10.0 113.326 173.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.576 ' HB3' ' HE2' ' A' ' 209' ' ' MET . 13.2 tp -65.7 -44.9 84.71 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.302 1.441 . . . . 10.0 113.027 179.128 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.97 -55.89 13.69 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 124.544 1.069 . . . . 10.0 111.759 166.15 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 22.5 m -49.76 -52.62 30.4 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.001 1.32 . . . . 10.0 112.43 174.051 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.38 -58.88 5.71 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.133 0.973 . . . . 10.0 112.173 177.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 95.2 mt -57.55 -48.51 79.14 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.593 0.757 . . . . 10.0 112.816 -179.468 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 57.6 mtt -57.41 -49.5 76.03 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.089 0.956 . . . . 10.0 111.534 176.526 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -56.63 -58.85 12.35 Favored Glycine 0 CA--C 1.528 0.844 0 CA-C-O 118.873 -0.959 . . . . 10.0 113.673 174.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 81.1 mt -56.16 -46.08 79.43 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-N 118.82 1.31 . . . . 10.0 112.13 176.46 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.62 -41.6 74.44 Favored Glycine 0 CA--C 1.535 1.294 0 C-N-CA 124.742 1.163 . . . . 10.0 113.254 173.239 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 27.9 m -62.46 -58.71 6.62 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.097 0.959 . . . . 10.0 111.316 172.074 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -52.27 -40.96 62.44 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.001 0.92 . . . . 10.0 110.949 177.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.4 t80 -55.82 -58.02 9.59 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.583 1.153 . . . . 10.0 112.968 172.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.1 m-30 -59.64 -38.69 82.07 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 113.225 0.824 . . . . 10.0 113.225 178.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.4 ' C ' ' H ' ' A' ' 30' ' ' LYS . 11.8 mt -56.1 -67.41 0.3 Allowed 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.625 1.17 . . . . 10.0 113.628 169.104 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 t -76.41 40.95 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 CA-C-O 123.756 1.741 . . . . 10.0 110.91 179.047 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.4 ' H ' ' C ' ' A' ' 28' ' ' LEU . 42.8 tttm -140.84 -44.84 0.39 Allowed 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 127.872 2.469 . . . . 10.0 109.354 171.153 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.96 23.15 0.87 Allowed Glycine 0 CA--C 1.529 0.945 0 N-CA-C 115.624 1.01 . . . . 10.0 115.624 173.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 37.3 mmm -59.59 -45.01 93.16 Favored 'General case' 0 C--O 1.224 -0.272 0 C-N-CA 127.161 2.184 . . . . 10.0 113.529 -178.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.62 -84.43 1.18 Allowed Glycine 0 CA--C 1.53 1.018 0 C-N-CA 123.766 0.698 . . . . 10.0 112.47 -170.158 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.7 t 33.01 88.79 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.243 0.753 0 C-N-CA 128.405 2.682 . . . . 10.0 116.975 166.549 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.7 m -79.7 -50.83 10.03 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.193 -1.367 . . . . 10.0 113.855 174.198 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -48.92 117.51 6.42 Favored Pre-proline 0 CA--C 1.537 0.443 0 O-C-N 124.76 1.288 . . . . 10.0 110.983 -172.569 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -58.57 -29.68 89.71 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 123.713 2.942 . . . . 10.0 113.688 179.141 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.29 -60.63 2.31 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.122 0.569 . . . . 10.0 111.429 176.215 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.19 -40.04 22.86 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 125.072 1.349 . . . . 10.0 113.583 171.625 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.5 tttp -46.58 -47.42 19.79 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.275 1.43 . . . . 10.0 113.397 172.091 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -57.76 -53.07 62.36 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.487 0.715 . . . . 10.0 110.978 176.665 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.477 ' CD2' ' HB1' ' A' ' 228' ' ' ALA . 44.2 m-85 -56.96 -50.23 73.28 Favored 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 123.075 0.55 . . . . 10.0 112.345 -179.122 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -54.4 -51.24 65.5 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 118.926 -0.559 . . . . 10.0 112.376 173.289 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.41 -62.01 1.91 Allowed 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 113.374 0.879 . . . . 10.0 113.374 177.142 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.3 mt -48.48 -56.78 1.88 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 124.863 1.265 . . . . 10.0 110.889 178.036 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.8 m -68.46 -21.67 64.61 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.871 1.268 . . . . 10.0 113.413 -172.486 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 27.5 m -83.37 -40.05 19.9 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.423 1.089 . . . . 10.0 112.33 175.495 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 16.8 mt -59.14 -44.19 92.06 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 113.147 0.795 . . . . 10.0 113.147 174.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.489 HG13 HG23 ' A' ' 89' ' ' THR . 31.9 t -43.26 -64.51 0.74 Allowed Pre-proline 0 CA--C 1.549 0.911 0 C-N-CA 124.978 1.311 . . . . 10.0 113.119 177.038 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -67.88 -24.64 39.8 Favored 'Trans proline' 0 CA--C 1.543 0.975 0 C-N-CA 122.383 2.056 . . . . 10.0 113.767 177.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -67.27 -48.73 66.82 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 120.316 1.416 . . . . 10.0 113.154 175.612 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 27.6 mt -66.12 -42.65 91.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 O-C-N 120.568 -1.333 . . . . 10.0 109.443 174.137 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.32 -45.56 72.64 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 113.261 0.837 . . . . 10.0 113.261 171.665 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 45.0 t80 -49.81 -54.96 16.03 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 125.704 1.602 . . . . 10.0 111.681 169.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 14.7 m -48.92 -53.35 20.03 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.386 1.475 . . . . 10.0 111.0 176.133 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 32.2 mmt -67.99 -48.62 65.27 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 124.122 0.969 . . . . 10.0 113.062 -177.308 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -56.83 -40.44 76.07 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 120.182 1.355 . . . . 10.0 113.322 173.562 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.8 tp -53.31 -54.54 34.93 Favored 'General case' 0 C--O 1.225 -0.223 0 CA-C-N 119.795 1.18 . . . . 10.0 111.272 170.284 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 24.0 p -51.69 -41.04 61.14 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 115.217 1.562 . . . . 10.0 115.217 179.026 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 59.0 mtm -66.86 -50.89 61.07 Favored 'General case' 0 C--N 1.334 -0.085 0 C-N-CA 123.571 0.748 . . . . 10.0 110.435 176.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.3 tp -48.57 -52.65 21.71 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.889 0.875 . . . . 10.0 112.939 172.407 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.5 mt -76.98 -5.5 48.91 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.325 1.05 . . . . 10.0 113.793 -177.694 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.25 -34.7 5.56 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 115.522 0.969 . . . . 10.0 115.522 174.109 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -49.3 -43.06 43.01 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 115.277 1.584 . . . . 10.0 115.277 -176.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.07 3.57 61.13 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 115.379 0.912 . . . . 10.0 115.379 -179.043 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.25 143.42 26.43 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 127.021 2.129 . . . . 10.0 109.015 171.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 t -145.51 171.11 15.13 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 124.081 0.952 . . . . 10.0 111.041 166.776 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.04 136.05 53.39 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 123.89 0.876 . . . . 10.0 109.706 179.633 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.436 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 58.6 t -129.58 129.55 23.18 Favored Pre-proline 0 C--N 1.33 -0.281 0 C-N-CA 125.074 1.35 . . . . 10.0 110.949 -176.013 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 69' ' ' VAL . 6.3 Cg_exo -80.7 116.27 3.18 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 N-CA-C 109.4 -1.038 . . . . 10.0 109.4 -178.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -156.74 164.41 38.15 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 112.824 0.676 . . . . 10.0 112.824 172.444 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.37 -81.96 0.14 Allowed Glycine 0 CA--C 1.526 0.764 0 N-CA-C 110.684 -0.966 . . . . 10.0 110.684 175.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.74 -3.39 0.7 Allowed Glycine 0 CA--C 1.527 0.808 0 N-CA-C 118.662 2.225 . . . . 10.0 118.662 170.388 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -151.59 -171.89 4.06 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 119.406 1.603 . . . . 10.0 112.218 -165.152 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -91.88 93.86 9.03 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 125.525 1.53 . . . . 10.0 111.111 -175.305 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.449 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 60.3 m-80 -89.41 120.79 69.69 Favored Pre-proline 0 N--CA 1.45 -0.425 0 N-CA-C 112.941 0.719 . . . . 10.0 112.941 -165.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.653 ' HB3' HG21 ' A' ' 5' ' ' THR . 76.0 Cg_exo -61.54 131.87 37.92 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 124.181 3.254 . . . . 10.0 112.201 171.528 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.4 mm -140.07 126.3 22.07 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 C-N-CA 126.055 1.742 . . . . 10.0 111.75 -179.504 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -93.6 85.02 4.76 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 123.012 1.387 . . . . 10.0 113.065 174.626 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 63.8 p-90 -59.36 -28.25 66.69 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 120.865 -1.147 . . . . 10.0 113.931 174.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -55.07 -28.47 52.62 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.239 1.015 . . . . 10.0 113.152 178.223 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.0 mtt-85 -49.88 -58.04 6.21 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.447 1.099 . . . . 10.0 111.292 168.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -62.6 -40.64 97.58 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 126.076 1.75 . . . . 10.0 112.437 -179.286 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -52.24 -48.92 64.92 Favored 'General case' 0 CA--C 1.568 1.647 0 CA-C-N 119.597 1.09 . . . . 10.0 111.15 168.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -59.19 -64.38 0.96 Allowed 'General case' 0 N--CA 1.494 1.753 0 CA-C-N 121.212 1.824 . . . . 10.0 110.792 169.615 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 48.1 m0 -50.65 -35.51 31.01 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.94 1.296 . . . . 10.0 111.865 -170.51 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 26.4 tp -51.29 -42.59 61.26 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.39 1.876 . . . . 10.0 113.335 176.508 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -101.45 -52.54 3.21 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.213 1.005 . . . . 10.0 112.645 -175.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.489 HG23 HG13 ' A' ' 49' ' ' VAL . 1.1 m -46.15 -51.01 14.85 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 125.64 1.576 . . . . 10.0 112.829 175.83 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.421 ' HB ' ' HD3' ' A' ' 91' ' ' PRO . 3.7 m -64.58 -45.89 76.75 Favored Pre-proline 0 CA--C 1.547 0.837 0 O-C-N 121.343 -0.848 . . . . 10.0 112.661 -169.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.421 ' HD3' ' HB ' ' A' ' 90' ' ' THR . 76.2 Cg_exo -51.29 -44.83 40.74 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 124.053 3.169 . . . . 10.0 116.749 162.388 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 59.4 mt -59.3 -46.67 87.93 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 119.134 0.879 . . . . 10.0 111.358 175.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.5 tp -50.31 -47.74 55.52 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.341 1.856 . . . . 10.0 111.892 172.375 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.9 mp -60.87 -46.5 90.36 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.414 1.486 . . . . 10.0 113.032 170.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.9 -38.22 78.37 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.82 0.848 . . . . 10.0 112.854 178.017 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -52.3 -54.05 36.4 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 119.269 0.94 . . . . 10.0 111.166 169.62 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.3 -42.11 88.79 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.621 0.768 . . . . 10.0 112.131 -178.507 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.66 -54.77 37.27 Favored 'General case' 0 C--O 1.225 -0.186 0 C-N-CA 123.995 0.918 . . . . 10.0 112.011 173.641 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.28 -41.18 79.23 Favored 'General case' 0 C--O 1.224 -0.239 0 C-N-CA 123.719 0.808 . . . . 10.0 112.725 174.777 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.9 tp -63.77 -38.56 91.54 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 114.45 1.278 . . . . 10.0 114.45 -179.625 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.2 t -94.82 1.47 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 125.008 1.323 . . . . 10.0 112.313 179.162 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.2 t70 48.61 53.4 12.25 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.829 1.652 . . . . 10.0 112.1 -174.057 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.17 145.88 47.77 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 119.916 -1.74 . . . . 10.0 112.474 -174.209 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.54 135.9 54.45 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 112.697 0.628 . . . . 10.0 112.697 175.158 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -42.83 -39.71 2.61 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.894 1.678 . . . . 10.0 113.456 175.31 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -47.32 -60.22 5.32 Favored Glycine 0 CA--C 1.526 0.731 0 C-N-CA 125.109 1.338 . . . . 10.0 115.252 169.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.4 p -62.06 -46.75 87.75 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 117.057 -1.449 . . . . 10.0 111.335 178.24 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 66.9 mt -48.45 -52.93 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 124.995 1.318 . . . . 10.0 111.128 178.194 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.1 tp -62.55 -51.35 67.74 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 112.554 0.576 . . . . 10.0 112.554 179.277 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.13 -44.9 42.86 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.424 0.689 . . . . 10.0 110.97 174.6 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.455 ' HA ' HD12 ' A' ' 111' ' ' LEU . 0.6 OUTLIER -59.58 -59.89 4.73 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 127.363 2.265 . . . . 10.0 114.787 174.968 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.6 t -61.04 -46.29 96.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 123.685 0.794 . . . . 10.0 111.41 -178.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -56.64 -50.36 63.75 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 123.674 0.654 . . . . 10.0 112.642 174.499 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -54.21 -46.74 72.56 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.571 0.748 . . . . 10.0 112.94 173.32 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -60.89 -41.77 96.67 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 112.707 0.632 . . . . 10.0 112.707 176.536 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -43.85 -56.94 4.89 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 125.43 1.491 . . . . 10.0 113.078 164.256 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 85.4 mt -56.84 -50.49 75.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 CA-C-N 117.776 0.788 . . . . 10.0 111.668 175.169 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 47.9 ttp -48.66 -58.4 4.8 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.295 1.438 . . . . 10.0 112.056 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 36.8 mm -68.61 -44.99 82.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 O-C-N 121.959 -0.463 . . . . 10.0 112.03 178.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -51.99 -60.59 7.4 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 124.829 1.204 . . . . 10.0 112.908 177.388 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 42.7 p -59.51 -35.88 75.01 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.687 0.795 . . . . 10.0 112.695 174.443 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -47.92 -56.82 8.36 Favored Glycine 0 CA--C 1.539 1.576 0 C-N-CA 124.336 0.969 . . . . 10.0 113.673 164.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 67.4 tp -58.66 -47.39 84.63 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.623 1.569 . . . . 10.0 111.887 177.163 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 68.5 t -52.69 -51.48 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 123.314 0.646 . . . . 10.0 110.371 173.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -49.22 -60.92 5.8 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 125.871 1.7 . . . . 10.0 112.275 171.706 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -48.85 -37.71 20.29 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 126.576 1.95 . . . . 10.0 113.76 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 49.7 mt -99.31 -6.57 27.69 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 115.22 1.563 . . . . 10.0 115.22 -178.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 16.8 m -69.74 116.73 10.48 Favored 'General case' 0 N--CA 1.464 0.266 0 O-C-N 120.165 -1.584 . . . . 10.0 110.345 -178.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.623 ' H ' ' HD3' ' A' ' 129' ' ' LYS . 0.2 OUTLIER -55.45 -49.61 72.0 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 128.205 2.602 . . . . 10.0 113.305 177.728 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 60.9 t -69.64 106.35 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 123.788 0.835 . . . . 10.0 110.089 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -46.88 -59.55 3.01 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 124.809 1.244 . . . . 10.0 114.038 -173.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 m -46.47 -42.11 14.97 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.501 1.521 . . . . 10.0 113.496 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -70.2 -24.54 63.14 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 114.918 1.451 . . . . 10.0 114.918 -178.092 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 69.3 mtp85 -53.66 -42.18 67.6 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-N 118.923 0.783 . . . . 10.0 110.701 176.56 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -69.57 -31.65 69.94 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.826 1.25 . . . . 10.0 114.322 176.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.8 t -55.31 -51.74 53.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-N 119.064 0.847 . . . . 10.0 109.582 168.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 66.8 m95 -62.08 -42.77 99.54 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 114.335 1.235 . . . . 10.0 114.335 174.359 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 92.8 t90 -53.92 -48.63 70.0 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.265 1.026 . . . . 10.0 112.618 172.11 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -57.01 -52.07 66.72 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.71 0.804 . . . . 10.0 111.639 176.603 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 96.5 mt -55.98 -54.92 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 124.923 1.289 . . . . 10.0 112.009 176.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 5.0 p -57.01 -42.22 79.97 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 121.509 -0.745 . . . . 10.0 112.513 175.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 72.4 m -62.01 -42.72 99.47 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.741 1.216 . . . . 10.0 112.631 174.182 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -58.59 -47.23 85.0 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 119.424 1.011 . . . . 10.0 112.314 171.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -56.42 -48.95 75.92 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.474 0.71 . . . . 10.0 112.234 172.311 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 9.6 tmm? -51.67 -52.94 44.13 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.919 1.688 . . . . 10.0 111.858 173.437 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 7.8 tt -53.59 -52.05 61.03 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.856 1.662 . . . . 10.0 112.392 175.525 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 72.9 t80 -49.47 -53.91 20.58 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.225 1.01 . . . . 10.0 112.098 173.604 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 36.9 mm -52.81 -56.09 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 CA-C-N 118.818 0.736 . . . . 10.0 110.387 177.138 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 18.5 mt -58.71 -34.48 71.37 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 117.979 -1.01 . . . . 10.0 112.037 -178.521 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -57.26 -58.18 9.36 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 119.513 1.052 . . . . 10.0 113.076 173.134 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.4 -40.91 85.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 CA-C-O 118.32 -0.847 . . . . 10.0 111.438 177.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 44.1 mt -56.76 -49.42 75.3 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 119.919 1.236 . . . . 10.0 112.12 171.258 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.47 ' HA ' ' HD2' ' A' ' 175' ' ' ARG . 12.0 t80 -77.02 -70.31 0.47 Allowed 'General case' 0 C--N 1.326 -0.435 0 O-C-N 120.049 -1.657 . . . . 10.0 112.857 -175.216 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -73.7 -21.98 60.06 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.665 1.186 . . . . 10.0 113.411 -174.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -87.77 -79.17 1.26 Allowed Glycine 0 CA--C 1.527 0.806 0 C-N-CA 123.639 0.637 . . . . 10.0 113.49 171.554 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -53.52 -32.47 50.65 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 126.295 1.838 . . . . 10.0 113.067 -166.559 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.2 m -52.13 -56.42 14.65 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 114.018 1.118 . . . . 10.0 114.018 172.139 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.3 p -53.69 -50.57 65.57 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 122.079 0.942 . . . . 10.0 112.271 -177.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 47.6 tttm -57.09 -46.02 82.9 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.168 0.987 . . . . 10.0 112.16 173.624 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.84 -47.48 80.25 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 114.475 1.287 . . . . 10.0 114.475 174.068 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -56.53 -11.25 1.21 Allowed 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.034 1.734 . . . . 10.0 114.249 177.714 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.1 m -107.05 6.62 29.16 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.411 1.884 . . . . 10.0 114.846 -179.359 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 93.2 mmm -91.9 -92.67 0.15 Allowed 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 123.523 1.63 . . . . 10.0 114.146 -170.592 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -138.72 153.95 72.63 Favored Pre-proline 0 C--O 1.235 0.308 0 C-N-CA 129.756 3.223 . . . . 10.0 105.552 170.224 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -52.85 -46.19 35.46 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 122.285 1.99 . . . . 10.0 113.088 179.06 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.667 ' CD ' ' HD3' ' A' ' 227' ' ' ARG . 0.1 OUTLIER -53.02 -46.04 68.22 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 129.049 2.94 . . . . 10.0 113.259 173.571 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 92.2 t -69.25 -53.0 27.75 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.253 0 C-N-CA 124.06 0.944 . . . . 10.0 109.771 -178.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.12 -46.86 75.63 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.284 0.634 . . . . 10.0 111.915 177.045 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 60.5 p -59.99 -56.15 25.28 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.908 0.883 . . . . 10.0 112.741 174.644 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 61.8 m -57.24 -53.18 60.97 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.13 0.972 . . . . 10.0 113.006 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -49.6 -49.51 46.42 Favored 'General case' 0 C--O 1.222 -0.375 0 C-N-CA 123.311 0.644 . . . . 10.0 111.086 174.09 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -57.16 -48.37 78.87 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 114.678 1.362 . . . . 10.0 114.678 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 40.3 t -56.01 -49.59 74.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 CA-C-N 118.794 0.725 . . . . 10.0 110.507 176.338 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 94.1 mt -58.58 -51.57 69.35 Favored 'General case' 0 C--O 1.222 -0.394 0 N-CA-C 113.197 0.814 . . . . 10.0 113.197 175.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' ARG . . . . . 0.47 ' HD2' ' HA ' ' A' ' 153' ' ' PHE . 35.5 ttp180 -47.87 -47.75 31.57 Favored 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 126.82 2.048 . . . . 10.0 111.017 174.463 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 63.6 m-20 -58.54 -58.29 9.19 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 122.809 0.444 . . . . 10.0 111.283 174.409 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 59.8 t -51.67 -48.86 36.55 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 124.074 0.949 . . . . 10.0 111.678 179.022 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 19.8 m -58.76 -62.08 2.13 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 127.267 2.227 . . . . 10.0 112.009 178.607 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 54.5 t -50.69 -49.44 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 C-N-CA 124.599 1.159 . . . . 10.0 110.998 -179.245 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 74.2 t -59.65 -62.6 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 123.883 0.873 . . . . 10.0 112.55 177.146 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -57.97 -45.95 85.9 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 118.669 0.668 . . . . 10.0 112.108 -175.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 9.5 m0 -56.54 -45.53 81.13 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 123.652 0.781 . . . . 10.0 113.0 176.163 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 49.6 m -56.33 -31.58 63.87 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 113.171 0.804 . . . . 10.0 113.171 176.415 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -65.57 -44.98 85.07 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 113.761 1.023 . . . . 10.0 113.761 176.468 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -43.49 -56.67 6.58 Favored Pre-proline 0 N--CA 1.479 1.01 0 N-CA-C 115.144 1.535 . . . . 10.0 115.144 -178.43 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' PRO . . . . . 0.486 ' HB3' H183 ' A' ' 999' ' ' RET . 29.2 Cg_endo -60.31 -36.09 88.94 Favored 'Trans proline' 0 C--N 1.355 0.889 0 C-N-CA 122.895 2.397 . . . . 10.0 113.439 177.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 34.5 t -63.94 -52.37 57.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 124.124 0.97 . . . . 10.0 110.532 176.476 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 98.2 t -53.38 -49.9 51.0 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 124.846 1.258 . . . . 10.0 111.418 175.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 28.1 t90 -54.63 -53.91 48.53 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.657 1.183 . . . . 10.0 112.493 174.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 10.0 tt -55.52 -44.95 77.15 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 124.187 0.995 . . . . 10.0 112.625 -178.313 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 15.0 pt -84.93 -5.52 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 N-CA-C 115.118 1.525 . . . . 10.0 115.118 -178.451 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.29 -169.27 33.13 Favored Glycine 0 N--CA 1.45 -0.397 0 CA-C-O 122.604 1.113 . . . . 10.0 113.925 -168.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 23.3 t -53.18 -41.0 64.82 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 114.156 -1.022 . . . . 10.0 111.871 177.581 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -54.17 -32.16 54.67 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 128.621 2.768 . . . . 10.0 115.266 179.604 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -131.25 -103.86 0.97 Allowed Glycine 0 CA--C 1.528 0.879 0 CA-C-N 119.346 0.976 . . . . 10.0 113.566 -167.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -89.47 127.17 35.82 Favored 'General case' 0 C--N 1.328 -0.328 0 O-C-N 120.657 -1.496 . . . . 10.0 109.32 169.212 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -72.42 65.31 1.35 Allowed Glycine 0 CA--C 1.532 1.138 0 N-CA-C 113.914 0.326 . . . . 10.0 113.914 173.152 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 60.7 mt -79.57 -42.76 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 C-N-CA 126.096 1.759 . . . . 10.0 108.766 166.39 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.4 ' CG1' ' HB ' ' A' ' 203' ' ' ILE . 79.2 t -126.29 133.41 24.93 Favored Pre-proline 0 N--CA 1.454 -0.25 0 C-N-CA 126.496 1.918 . . . . 10.0 109.372 -174.208 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -68.76 153.76 72.49 Favored 'Trans proline' 0 N--CA 1.461 -0.441 0 C-N-CA 123.834 3.023 . . . . 10.0 111.459 -176.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 12.2 tp -43.17 -39.78 3.02 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.312 1.045 . . . . 10.0 112.202 171.483 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -48.33 -52.37 21.86 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 114.715 1.376 . . . . 10.0 114.715 176.012 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 203' ' ' ILE . . . . . 0.4 ' HB ' ' CG1' ' A' ' 199' ' ' VAL . 14.0 mm -75.93 -40.47 38.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 C-N-CA 124.39 1.076 . . . . 10.0 109.681 177.553 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -49.31 -49.78 42.39 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 118.546 0.612 . . . . 10.0 111.981 173.628 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 16.1 m -57.67 -47.07 83.35 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 126.013 1.725 . . . . 10.0 112.991 174.289 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.536 HD23 ' CD2' ' A' ' 12' ' ' TRP . 1.3 tm? -63.31 -52.38 62.16 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.024 0.93 . . . . 10.0 112.06 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 93.2 mt -52.51 -59.96 3.81 Favored 'General case' 0 C--N 1.335 -0.053 0 C-N-CA 124.363 1.065 . . . . 10.0 109.953 176.451 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -52.92 -45.12 67.47 Favored 'General case' 0 C--O 1.216 -0.667 0 CA-C-O 116.773 -1.584 . . . . 10.0 112.086 176.436 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 209' ' ' MET . . . . . 0.576 ' HE2' ' HB3' ' A' ' 15' ' ' LEU . 4.6 tmm? -52.65 -53.04 52.59 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 121.719 2.054 . . . . 10.0 113.114 174.187 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 81.8 t -59.96 -47.03 93.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 125.129 1.371 . . . . 10.0 111.158 178.446 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 4.2 mp -59.81 -50.16 74.89 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.677 1.591 . . . . 10.0 112.298 174.569 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 32.6 m-20 -55.57 -59.72 4.44 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 127.458 2.303 . . . . 10.0 111.069 177.639 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 25.4 m -60.44 -42.56 91.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 O-C-N 121.086 -1.009 . . . . 10.0 112.56 -177.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 66.5 p -65.36 -53.32 45.22 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 121.615 -0.678 . . . . 10.0 112.132 176.357 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -73.12 22.4 0.07 Allowed 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 125.411 1.484 . . . . 10.0 114.776 176.413 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 21.2 mttm -139.32 -73.38 0.38 Allowed 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 126.287 1.835 . . . . 10.0 109.669 172.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 22.8 t -69.24 -50.83 48.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 124.795 1.238 . . . . 10.0 110.993 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -55.45 -53.52 40.58 Favored Glycine 0 CA--C 1.535 1.327 0 C-N-CA 124.038 0.827 . . . . 10.0 113.157 176.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -44.9 -56.17 4.79 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 126.522 1.929 . . . . 10.0 112.007 166.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -55.67 -39.28 75.34 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 124.554 1.073 . . . . 10.0 114.003 177.443 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 24.9 mt -69.66 -27.81 65.35 Favored 'General case' 0 CA--C 1.512 -0.481 0 N-CA-C 115.687 1.736 . . . . 10.0 115.687 176.517 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 74.6 mt -63.45 -57.5 11.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 108.545 -0.909 . . . . 10.0 108.545 165.683 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 32.1 tp -58.81 -64.65 0.86 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.948 0.899 . . . . 10.0 113.193 -172.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 84.1 mt -71.51 5.14 2.52 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 115.347 1.61 . . . . 10.0 115.347 -171.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.6 mtp-105 -112.33 0.4 15.67 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 124.214 1.006 . . . . 10.0 113.304 172.592 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 8.8 t -108.06 177.98 4.65 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 124.089 0.956 . . . . 10.0 111.03 174.64 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 227' ' ' ARG . . . . . 0.667 ' HD3' ' CD ' ' A' ' 166' ' ' GLU . 41.8 ttt180 -71.65 98.16 1.86 Allowed 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.824 0.85 . . . . 10.0 110.893 170.695 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 228' ' ' ALA . . . . . 0.477 ' HB1' ' CD2' ' A' ' 42' ' ' PHE . . . -80.92 77.03 7.84 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.861 0.864 . . . . 10.0 112.1 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 40.1 102.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 128.901 2.88 . . . . 10.0 116.444 177.751 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . 0.481 0.3 OUTLIER 71.86 -55.42 0.66 Allowed 'General case' 0 C--O 1.242 0.691 0 C-N-CA 124.749 1.22 . . . . 10.0 110.644 -175.334 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -68.32 169.48 40.13 Favored Glycine 0 C--O 1.239 0.422 0 C-N-CA 129.727 3.537 . . . . 10.0 119.655 171.475 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.459 0 C-N-CA 128.477 2.711 . . . . 10.0 113.438 166.655 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 999' ' ' RET . . . . . 0.515 H181 ' H7 ' ' A' ' 999' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1000 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A 1001 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A 1002 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A 1003 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 N--CA 1.477 0.913 0 CA-C-O 115.813 -2.041 . . . . 10.0 105.805 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 23.35 91.93 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 129.568 3.147 . . . . 10.0 117.213 160.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 28.57 65.08 0.1 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 128.307 2.643 . . . . 10.0 114.514 155.417 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 86.8 mt -56.52 137.98 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 126.379 1.872 . . . . 10.0 113.336 -158.341 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.652 HG21 ' HB3' ' A' ' 77' ' ' PRO . 7.6 t -136.71 -165.19 1.69 Allowed 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 126.331 1.852 . . . . 10.0 114.05 -174.357 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 69.95 2.83 40.72 Favored Glycine 0 C--N 1.34 0.768 0 C-N-CA 127.503 2.477 . . . . 10.0 111.511 168.056 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.8 tpp180 -158.51 -51.39 0.01 OUTLIER Pre-proline 0 N--CA 1.443 -0.783 0 CA-C-O 114.309 -2.758 . . . . 10.0 116.665 -168.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_exo -64.0 -60.58 0.15 Allowed 'Trans proline' 0 N--CA 1.464 -0.218 0 CA-C-N 123.524 2.294 . . . . 10.0 113.215 -175.277 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.412 ' H ' ' CD ' ' A' ' 9' ' ' GLU . 7.9 pm0 -67.24 4.34 0.97 Allowed 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 127.831 2.452 . . . . 10.0 115.764 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.422 ' CG ' ' N ' ' A' ' 11' ' ' ILE . 11.0 p-90 -51.43 -43.06 61.91 Favored 'General case' 0 C--O 1.223 -0.34 0 O-C-N 121.509 -0.744 . . . . 10.0 112.641 176.453 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.422 ' N ' ' CG ' ' A' ' 10' ' ' TRP . 8.9 tt -60.91 -49.61 83.94 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.34 0 C-N-CA 123.862 0.865 . . . . 10.0 109.316 179.4 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.535 ' CD2' HD23 ' A' ' 206' ' ' LEU . 2.6 m95 -55.35 -52.67 62.76 Favored 'General case' 0 C--O 1.224 -0.259 0 C-N-CA 123.4 0.68 . . . . 10.0 111.871 175.619 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.3 mt -57.3 -53.65 55.69 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 123.21 0.604 . . . . 10.0 112.227 177.236 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.86 -46.8 51.83 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.413 1.485 . . . . 10.0 113.324 173.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.574 ' HB3' ' HE2' ' A' ' 209' ' ' MET . 13.4 tp -65.64 -44.96 84.8 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 125.298 1.439 . . . . 10.0 113.03 179.085 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -50.02 -57.15 10.35 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 124.045 0.831 . . . . 10.0 111.264 166.113 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 22.6 m -48.43 -52.62 21.22 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.602 1.161 . . . . 10.0 112.364 174.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.39 -58.86 5.81 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.139 0.976 . . . . 10.0 112.188 177.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 94.2 mt -57.61 -50.43 73.17 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.762 0.825 . . . . 10.0 112.578 -179.493 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -54.14 -50.31 67.23 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.464 1.106 . . . . 10.0 111.346 175.343 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -58.07 -57.99 16.92 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 124.271 0.939 . . . . 10.0 113.666 176.522 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 80.8 mt -56.24 -45.77 79.86 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-N 118.434 1.117 . . . . 10.0 112.103 176.098 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.28 -42.75 74.52 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 125.03 1.3 . . . . 10.0 113.167 172.709 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 24.1 m -60.79 -59.64 5.06 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 124.038 0.935 . . . . 10.0 111.303 171.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -52.28 -41.02 62.52 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.061 0.944 . . . . 10.0 110.974 178.551 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -55.75 -58.03 9.55 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.561 1.144 . . . . 10.0 113.006 172.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -59.63 -38.7 82.06 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 113.226 0.825 . . . . 10.0 113.226 178.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.4 ' C ' ' H ' ' A' ' 30' ' ' LYS . 11.8 mt -56.16 -67.47 0.29 Allowed 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.572 1.149 . . . . 10.0 113.576 169.154 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 t -76.36 41.02 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 CA-C-O 123.802 1.763 . . . . 10.0 110.891 179.091 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.4 ' H ' ' C ' ' A' ' 28' ' ' LEU . 43.0 tttm -140.89 -44.91 0.39 Allowed 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 127.905 2.482 . . . . 10.0 109.303 171.199 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.9 23.07 0.86 Allowed Glycine 0 CA--C 1.529 0.956 0 N-CA-C 115.644 1.017 . . . . 10.0 115.644 173.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 37.3 mmm -59.52 -44.96 93.02 Favored 'General case' 0 C--O 1.224 -0.253 0 C-N-CA 127.17 2.188 . . . . 10.0 113.578 -178.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.66 -84.45 1.18 Allowed Glycine 0 CA--C 1.531 1.045 0 C-N-CA 123.741 0.686 . . . . 10.0 112.477 -170.159 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.7 t 33.09 88.75 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.242 0.682 0 C-N-CA 128.36 2.664 . . . . 10.0 116.941 166.463 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.8 m -79.67 -50.89 9.96 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.187 -1.37 . . . . 10.0 113.832 174.15 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -48.86 117.47 6.33 Favored Pre-proline 0 CA--C 1.536 0.428 0 O-C-N 124.794 1.309 . . . . 10.0 110.983 -172.531 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -58.53 -29.66 89.51 Favored 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 123.792 2.995 . . . . 10.0 113.698 179.097 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.35 -60.65 2.3 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.058 0.543 . . . . 10.0 111.455 176.183 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.08 -40.15 22.33 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 125.14 1.376 . . . . 10.0 113.554 171.575 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -46.53 -47.4 19.57 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 125.261 1.424 . . . . 10.0 113.463 172.076 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -57.77 -53.01 62.99 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.425 0.69 . . . . 10.0 111.009 176.633 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.475 ' CD2' ' HB1' ' A' ' 228' ' ' ALA . 43.9 m-85 -57.04 -50.21 73.44 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 123.049 0.54 . . . . 10.0 112.323 -179.114 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -54.37 -51.28 65.31 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 118.935 -0.555 . . . . 10.0 112.379 173.273 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.36 -62.0 1.92 Allowed 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 113.404 0.89 . . . . 10.0 113.404 177.123 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.5 mt -48.88 -56.35 2.51 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 C-N-CA 124.829 1.251 . . . . 10.0 110.496 178.096 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.5 m -70.07 -16.91 63.2 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.109 1.364 . . . . 10.0 113.688 -172.557 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 27.5 m -87.92 -37.72 16.2 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.134 0.973 . . . . 10.0 112.152 174.282 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 20.4 mt -60.88 -39.36 88.94 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-O 118.406 -0.807 . . . . 10.0 113.091 173.195 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.614 HG23 ' HD3' ' A' ' 50' ' ' PRO 0.35 33.3 m -55.16 -54.11 54.07 Favored Pre-proline 0 N--CA 1.485 1.278 0 N-CA-C 114.579 1.326 . . . . 10.0 114.579 179.318 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.614 ' HD3' HG23 ' A' ' 49' ' ' VAL . 68.3 Cg_endo -67.61 -26.44 39.71 Favored 'Trans proline' 0 CA--C 1.545 1.055 0 CA-C-N 123.137 2.156 . . . . 10.0 113.099 173.49 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.44 -47.7 75.27 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-N 120.181 1.355 . . . . 10.0 113.324 175.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 19.3 tt -65.51 -41.03 89.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 O-C-N 120.431 -1.418 . . . . 10.0 111.419 171.132 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -49.89 -49.93 47.79 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 118.732 0.696 . . . . 10.0 112.156 170.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 53.2 t80 -51.85 -57.93 7.92 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 125.711 1.604 . . . . 10.0 112.473 173.265 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.5 m -49.2 -52.72 25.07 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 125.094 1.358 . . . . 10.0 110.856 178.04 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.457 ' HG3' ' CB ' ' A' ' 85' ' ' ASP . 32.9 mmt -70.02 -47.95 60.02 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 124.21 1.004 . . . . 10.0 112.618 -175.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -56.14 -41.07 74.79 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 120.328 1.422 . . . . 10.0 113.206 172.486 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.8 tp -53.3 -54.57 34.54 Favored 'General case' 0 C--O 1.224 -0.272 0 CA-C-N 120.024 1.284 . . . . 10.0 111.275 170.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 23.9 p -51.6 -41.16 61.02 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 115.203 1.557 . . . . 10.0 115.203 178.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 57.6 mtm -66.84 -50.81 61.37 Favored 'General case' 0 C--N 1.333 -0.113 0 C-N-CA 123.54 0.736 . . . . 10.0 110.481 176.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.2 tp -48.64 -52.66 22.06 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.882 0.873 . . . . 10.0 112.894 172.39 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.4 mt -76.9 -5.61 49.15 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.383 1.073 . . . . 10.0 113.786 -177.661 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.26 -34.66 5.59 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 115.53 0.972 . . . . 10.0 115.53 174.158 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 75.3 t80 -49.32 -43.13 43.26 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 115.206 1.558 . . . . 10.0 115.206 -176.01 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.02 3.54 61.06 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 115.313 0.885 . . . . 10.0 115.313 -179.007 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.25 143.41 26.44 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 127.035 2.134 . . . . 10.0 109.011 172.023 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 t -145.5 171.07 15.19 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 124.064 0.946 . . . . 10.0 111.019 166.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.97 136.08 53.37 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 123.947 0.899 . . . . 10.0 109.73 179.554 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.436 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 58.7 t -129.59 129.56 23.17 Favored Pre-proline 0 C--N 1.329 -0.295 0 C-N-CA 125.098 1.359 . . . . 10.0 110.966 -176.044 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 69' ' ' VAL . 6.3 Cg_exo -80.77 116.24 3.16 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 N-CA-C 109.41 -1.035 . . . . 10.0 109.41 -178.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -156.71 164.41 38.16 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 112.845 0.683 . . . . 10.0 112.845 172.443 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.37 -81.93 0.14 Allowed Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.681 -0.967 . . . . 10.0 110.681 175.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.8 -3.34 0.69 Allowed Glycine 0 CA--C 1.526 0.762 0 N-CA-C 118.677 2.231 . . . . 10.0 118.677 170.401 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -151.61 -171.89 4.06 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 119.379 1.589 . . . . 10.0 112.224 -165.194 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -91.84 93.88 9.05 Favored 'General case' 0 CA--C 1.519 -0.23 0 C-N-CA 125.547 1.539 . . . . 10.0 111.146 -175.319 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.451 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 60.5 m-80 -89.52 120.79 69.62 Favored Pre-proline 0 N--CA 1.45 -0.43 0 N-CA-C 112.933 0.716 . . . . 10.0 112.933 -165.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.652 ' HB3' HG21 ' A' ' 5' ' ' THR . 75.7 Cg_exo -61.53 131.92 38.19 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 124.208 3.272 . . . . 10.0 112.158 171.599 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.5 mm -140.12 126.34 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 C-N-CA 126.0 1.72 . . . . 10.0 111.71 -179.49 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -93.65 85.07 4.76 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 122.701 1.238 . . . . 10.0 113.055 174.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 63.8 p-90 -59.45 -28.2 66.75 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 113.921 1.082 . . . . 10.0 113.921 174.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -54.58 -28.53 46.8 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 113.809 1.04 . . . . 10.0 113.809 178.219 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 77.7 mtt-85 -52.15 -58.63 6.0 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 119.318 0.963 . . . . 10.0 111.263 169.358 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -58.67 -40.06 82.43 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 125.697 1.599 . . . . 10.0 111.967 -179.148 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -52.18 -50.95 60.83 Favored 'General case' 0 CA--C 1.552 1.05 0 CA-C-N 119.368 0.986 . . . . 10.0 112.133 168.198 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.457 ' CB ' ' HG3' ' A' ' 56' ' ' MET . 0.0 OUTLIER -60.34 -59.82 4.8 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.961 1.304 . . . . 10.0 112.388 173.18 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 52.3 m0 -54.19 -37.8 64.92 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 126.88 2.072 . . . . 10.0 112.714 -176.286 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 32.5 tp -50.39 -45.16 55.26 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 126.207 1.803 . . . . 10.0 111.845 178.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -97.79 -43.35 7.18 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 123.961 0.905 . . . . 10.0 112.671 -178.572 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -58.26 -44.09 88.2 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 113.105 0.779 . . . . 10.0 113.105 -176.446 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.427 ' HB ' ' HD3' ' A' ' 91' ' ' PRO . 3.5 m -68.58 -45.21 35.08 Favored Pre-proline 0 CA--C 1.544 0.735 0 O-C-N 121.302 -0.874 . . . . 10.0 112.386 -172.544 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.427 ' HD3' ' HB ' ' A' ' 90' ' ' THR . 73.6 Cg_exo -52.34 -44.43 46.68 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 123.672 2.914 . . . . 10.0 115.865 165.012 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 52.8 mt -59.09 -46.63 87.81 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 118.815 0.734 . . . . 10.0 111.426 175.335 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.2 tp -50.47 -48.73 56.51 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.65 1.58 . . . . 10.0 112.235 172.206 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.0 mp -59.09 -46.99 86.88 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.192 1.397 . . . . 10.0 112.714 170.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.88 -38.25 78.4 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.866 0.866 . . . . 10.0 112.837 178.528 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -52.24 -54.09 35.53 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 119.34 0.973 . . . . 10.0 111.187 169.607 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.35 -42.1 88.58 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.635 0.774 . . . . 10.0 112.113 -178.495 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.64 -54.79 36.95 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 124.006 0.923 . . . . 10.0 112.014 173.596 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.25 -41.15 79.05 Favored 'General case' 0 C--O 1.224 -0.237 0 C-N-CA 123.715 0.806 . . . . 10.0 112.764 174.812 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.8 tp -63.8 -38.54 91.46 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 114.436 1.273 . . . . 10.0 114.436 -179.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.2 t -94.83 1.39 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 125.069 1.347 . . . . 10.0 112.316 179.19 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.2 t70 48.63 53.49 12.13 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.864 1.666 . . . . 10.0 112.079 -174.044 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.27 145.93 47.56 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 119.988 -1.695 . . . . 10.0 112.469 -174.181 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.56 135.91 54.51 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 112.723 0.638 . . . . 10.0 112.723 175.157 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -42.87 -39.63 2.6 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.83 1.652 . . . . 10.0 113.508 175.3 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -47.34 -60.19 5.35 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 125.147 1.356 . . . . 10.0 115.264 169.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.6 p -62.09 -46.77 87.6 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 117.1 -1.428 . . . . 10.0 111.309 178.249 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 66.9 mt -48.41 -52.94 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 125.038 1.335 . . . . 10.0 111.117 178.196 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.2 tp -62.59 -51.31 67.84 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 112.528 0.566 . . . . 10.0 112.528 179.292 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.28 -44.81 44.25 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.437 0.695 . . . . 10.0 110.935 174.66 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.455 HD12 ' HA ' ' A' ' 111' ' ' LEU . 0.6 OUTLIER -59.56 -59.9 4.71 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 127.393 2.277 . . . . 10.0 114.831 174.874 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.6 t -61.01 -46.38 96.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 123.705 0.802 . . . . 10.0 111.37 -178.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -56.6 -50.36 63.61 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 123.686 0.66 . . . . 10.0 112.631 174.565 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -54.64 -46.67 73.99 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 113.215 0.82 . . . . 10.0 113.215 173.356 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -57.74 -45.75 85.39 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.218 0.607 . . . . 10.0 111.938 174.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -43.22 -56.09 4.79 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 125.196 1.379 . . . . 10.0 113.002 167.588 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 88.9 mt -56.76 -52.58 52.76 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 123.518 0.727 . . . . 10.0 111.372 174.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 6.1 tmm? -51.58 -56.72 11.9 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.786 1.234 . . . . 10.0 112.566 -176.385 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 44.5 mm -67.53 -44.07 86.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 123.068 0.547 . . . . 10.0 112.075 177.119 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -54.18 -56.72 19.94 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 124.701 1.143 . . . . 10.0 113.207 177.551 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 38.1 p -57.22 -38.27 73.5 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.326 1.05 . . . . 10.0 112.336 172.301 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -49.38 -54.23 16.92 Favored Glycine 0 CA--C 1.534 1.279 0 C-N-CA 124.428 1.013 . . . . 10.0 113.172 167.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 65.6 tp -59.51 -48.01 83.3 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 125.157 1.383 . . . . 10.0 112.109 176.196 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 67.9 t -52.74 -51.62 34.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 123.363 0.665 . . . . 10.0 110.36 174.008 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -49.77 -60.7 6.24 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 125.937 1.732 . . . . 10.0 112.191 172.068 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -49.11 -37.49 21.9 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.558 1.943 . . . . 10.0 113.732 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 48.8 mt -99.07 -6.71 27.93 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 115.315 1.598 . . . . 10.0 115.315 -179.243 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 16.9 m -69.66 116.75 10.42 Favored 'General case' 0 N--CA 1.464 0.229 0 O-C-N 120.15 -1.594 . . . . 10.0 110.386 -178.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.62 ' H ' ' HD3' ' A' ' 129' ' ' LYS . 0.1 OUTLIER -55.5 -49.63 72.06 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 128.23 2.612 . . . . 10.0 113.252 177.765 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 60.3 t -69.61 106.33 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 123.819 0.848 . . . . 10.0 110.071 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -46.92 -59.56 3.01 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 124.787 1.235 . . . . 10.0 114.048 -173.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 m -46.41 -42.13 14.7 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.474 1.51 . . . . 10.0 113.513 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -70.15 -24.63 63.19 Favored 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 114.95 1.463 . . . . 10.0 114.95 -178.131 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 69.3 mtp85 -53.78 -41.82 67.65 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 118.857 0.753 . . . . 10.0 110.881 176.559 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -69.42 -32.44 71.43 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.815 1.246 . . . . 10.0 114.216 176.594 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 49.0 t -55.12 -52.11 47.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 CA-C-N 119.033 0.833 . . . . 10.0 109.965 169.084 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 69.7 m95 -59.39 -51.5 69.63 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 113.47 0.915 . . . . 10.0 113.47 174.141 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 85.3 t90 -47.98 -47.23 33.07 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.268 1.027 . . . . 10.0 113.304 174.254 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -58.5 -51.28 70.52 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.058 0.943 . . . . 10.0 111.768 176.665 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 97.1 mt -55.37 -51.76 53.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 125.146 1.378 . . . . 10.0 111.553 174.675 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 20.0 m -53.64 -47.18 70.55 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.734 1.214 . . . . 10.0 112.106 174.106 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 86.4 m -60.82 -47.11 87.85 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.491 1.516 . . . . 10.0 111.506 177.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -54.35 -49.65 69.29 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 119.385 0.993 . . . . 10.0 112.44 172.057 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -57.66 -43.83 85.24 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 123.736 0.814 . . . . 10.0 112.922 174.028 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 39.4 ttp -58.13 -51.41 69.83 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.19 0.996 . . . . 10.0 112.18 172.631 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 5.6 mp -51.65 -48.55 63.33 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 126.596 1.959 . . . . 10.0 112.042 175.342 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 77.9 t80 -54.07 -54.26 41.87 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.664 0.785 . . . . 10.0 113.06 172.574 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 49.4 mt -54.32 -55.35 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 123.566 0.746 . . . . 10.0 110.8 178.034 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . 0.289 3.9 pp -60.63 -31.26 70.46 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 116.833 -1.556 . . . . 10.0 113.371 179.055 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -57.26 -58.2 9.28 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 120.554 1.524 . . . . 10.0 113.064 170.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.39 -40.88 85.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-O 118.321 -0.847 . . . . 10.0 111.469 177.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 46.9 mt -56.83 -49.34 75.7 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 119.84 1.2 . . . . 10.0 112.164 171.246 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.47 ' HA ' ' HD2' ' A' ' 175' ' ' ARG . 11.8 t80 -76.97 -70.34 0.47 Allowed 'General case' 0 C--N 1.326 -0.447 0 O-C-N 120.056 -1.653 . . . . 10.0 112.887 -175.288 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -73.71 -21.99 60.05 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.596 1.158 . . . . 10.0 113.439 -174.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -87.78 -79.08 1.26 Allowed Glycine 0 CA--C 1.526 0.77 0 C-N-CA 123.602 0.62 . . . . 10.0 113.545 171.489 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 5.4 m-30 -53.61 -32.46 51.25 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 126.271 1.828 . . . . 10.0 113.019 -166.528 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.3 m -52.08 -56.44 14.4 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 113.991 1.108 . . . . 10.0 113.991 172.145 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.6 p -53.68 -50.58 65.52 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 122.121 0.962 . . . . 10.0 112.282 -177.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 47.7 tttm -57.15 -46.01 83.09 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.194 0.998 . . . . 10.0 112.11 173.702 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.82 -47.46 80.24 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 114.545 1.313 . . . . 10.0 114.545 174.007 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -56.49 -11.28 1.21 Allowed 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 126.068 1.747 . . . . 10.0 114.258 177.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.1 m -107.08 6.57 29.04 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.467 1.907 . . . . 10.0 114.881 -179.308 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 93.2 mmm -91.89 -92.67 0.15 Allowed 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 123.506 1.622 . . . . 10.0 114.164 -170.602 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -138.69 153.97 72.71 Favored Pre-proline 0 C--O 1.236 0.349 0 C-N-CA 129.848 3.259 . . . . 10.0 105.548 170.197 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -52.88 -46.21 35.38 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.261 1.974 . . . . 10.0 113.074 179.056 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.667 ' CD ' ' HD3' ' A' ' 227' ' ' ARG . 0.1 OUTLIER -52.95 -46.08 68.02 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 129.022 2.929 . . . . 10.0 113.242 173.569 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 92.2 t -69.18 -52.99 28.02 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 C-N-CA 124.085 0.954 . . . . 10.0 109.85 -178.64 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.2 -46.8 75.89 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.238 0.615 . . . . 10.0 111.933 177.016 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 60.1 p -59.95 -56.25 24.06 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.972 0.909 . . . . 10.0 112.68 174.623 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 62.0 m -57.22 -53.19 60.94 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.202 1.001 . . . . 10.0 113.004 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -49.61 -49.49 46.65 Favored 'General case' 0 C--O 1.222 -0.375 0 C-N-CA 123.239 0.616 . . . . 10.0 111.102 174.071 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -57.11 -48.46 78.57 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 114.629 1.344 . . . . 10.0 114.629 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 40.4 t -55.95 -49.63 74.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 CA-C-N 118.794 0.725 . . . . 10.0 110.476 176.402 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 94.2 mt -58.57 -51.63 69.09 Favored 'General case' 0 C--O 1.222 -0.389 0 N-CA-C 113.201 0.815 . . . . 10.0 113.201 175.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' ARG . . . . . 0.47 ' HD2' ' HA ' ' A' ' 153' ' ' PHE . 35.5 ttp180 -47.71 -47.77 29.85 Favored 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 126.85 2.06 . . . . 10.0 111.092 174.395 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 63.4 m-20 -58.55 -58.29 9.22 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 122.799 0.44 . . . . 10.0 111.255 174.409 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 54.2 t -51.93 -47.61 41.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 C-N-CA 124.082 0.953 . . . . 10.0 112.143 179.026 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 25.0 m -59.39 -63.02 1.45 Allowed 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 127.507 2.323 . . . . 10.0 111.755 178.365 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 55.8 t -50.12 -49.9 21.21 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 C-N-CA 124.799 1.24 . . . . 10.0 110.975 -179.425 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 70.8 t -59.13 -61.65 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 123.912 0.885 . . . . 10.0 112.616 178.127 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 91.5 mt -58.36 -46.99 85.23 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 118.19 0.45 . . . . 10.0 111.871 -176.609 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 9.0 m0 -51.68 -52.34 48.88 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 124.121 0.968 . . . . 10.0 112.217 174.67 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 8.5 t -54.52 -27.62 39.43 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 114.147 1.166 . . . . 10.0 114.147 179.045 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -68.64 -41.42 79.44 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 113.595 0.961 . . . . 10.0 113.595 175.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -47.64 -55.19 17.91 Favored Pre-proline 0 N--CA 1.476 0.871 0 N-CA-C 115.558 1.688 . . . . 10.0 115.558 -175.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' PRO . . . . . 0.494 ' HB3' H183 ' A' ' 999' ' ' RET . 28.5 Cg_endo -59.76 -34.85 95.79 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 122.251 1.968 . . . . 10.0 112.925 177.298 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 24.9 t -63.98 -55.57 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 124.443 1.097 . . . . 10.0 110.469 176.35 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 90.4 t -53.19 -48.37 54.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 125.406 1.482 . . . . 10.0 111.657 176.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 34.7 t90 -55.79 -55.82 27.88 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.844 1.258 . . . . 10.0 112.288 174.26 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 9.8 tt -55.9 -44.23 78.03 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 124.289 1.036 . . . . 10.0 112.639 -177.414 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 14.7 pt -82.79 -5.68 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 N-CA-C 114.989 1.477 . . . . 10.0 114.989 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.58 -169.35 32.75 Favored Glycine 0 N--CA 1.45 -0.379 0 CA-C-O 122.545 1.08 . . . . 10.0 113.855 -168.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 23.2 t -53.15 -39.55 63.63 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 114.217 -0.992 . . . . 10.0 111.847 177.613 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -56.86 -32.39 65.76 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 128.439 2.695 . . . . 10.0 115.286 -179.307 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -129.61 -104.41 1.11 Allowed Glycine 0 CA--C 1.524 0.628 0 CA-C-O 122.169 0.872 . . . . 10.0 112.738 -167.763 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -89.39 127.17 35.79 Favored 'General case' 0 C--N 1.328 -0.352 0 O-C-N 120.64 -1.506 . . . . 10.0 109.3 170.146 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -72.5 65.38 1.37 Allowed Glycine 0 CA--C 1.532 1.124 0 N-CA-C 113.879 0.312 . . . . 10.0 113.879 173.133 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 60.6 mt -79.67 -42.69 22.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 126.083 1.753 . . . . 10.0 108.725 166.392 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.4 ' CG1' ' HB ' ' A' ' 203' ' ' ILE . 79.8 t -126.31 133.4 24.93 Favored Pre-proline 0 N--CA 1.454 -0.264 0 C-N-CA 126.47 1.908 . . . . 10.0 109.364 -174.209 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -68.73 153.75 72.57 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 123.822 3.015 . . . . 10.0 111.456 -176.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 12.2 tp -43.1 -39.87 2.96 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.358 1.063 . . . . 10.0 112.199 171.473 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -48.28 -52.44 21.34 Favored 'General case' 0 CA--C 1.539 0.519 0 N-CA-C 114.673 1.361 . . . . 10.0 114.673 176.052 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 203' ' ' ILE . . . . . 0.4 ' HB ' ' CG1' ' A' ' 199' ' ' VAL . 14.0 mm -75.88 -40.53 38.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 124.434 1.094 . . . . 10.0 109.625 177.579 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.29 -49.79 42.08 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 118.61 0.641 . . . . 10.0 111.974 173.639 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 15.9 m -57.69 -47.08 83.35 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 126.046 1.738 . . . . 10.0 112.964 174.283 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.535 HD23 ' CD2' ' A' ' 12' ' ' TRP . 1.4 tm? -63.27 -52.33 62.48 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.958 0.903 . . . . 10.0 112.114 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 93.3 mt -52.58 -58.95 5.16 Favored 'General case' 0 C--O 1.227 -0.087 0 C-N-CA 124.293 1.037 . . . . 10.0 110.021 176.456 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -54.8 -43.73 73.17 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 117.766 -1.111 . . . . 10.0 112.912 177.016 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 209' ' ' MET . . . . . 0.574 ' HE2' ' HB3' ' A' ' 15' ' ' LEU . 4.6 tmm? -52.31 -53.2 47.4 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 120.277 1.399 . . . . 10.0 112.252 174.024 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 77.1 t -60.81 -48.13 90.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 124.525 1.13 . . . . 10.0 111.754 178.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 5.1 mp -56.74 -53.45 57.65 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.148 1.379 . . . . 10.0 111.712 175.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -55.68 -52.76 62.77 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.127 1.771 . . . . 10.0 111.594 178.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 46.0 t -49.04 -56.38 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 124.618 1.167 . . . . 10.0 110.705 173.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 6.7 t -58.01 -48.66 79.38 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.943 0.897 . . . . 10.0 111.957 179.074 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -68.35 -9.13 45.86 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 126.472 1.909 . . . . 10.0 115.105 -176.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 17.9 mtmm -128.83 -59.37 1.13 Allowed 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 119.709 1.141 . . . . 10.0 112.356 179.192 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 19.7 t -67.23 -54.26 25.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 CA-C-N 118.985 0.811 . . . . 10.0 110.254 176.645 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -55.79 -57.03 20.84 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 124.339 0.971 . . . . 10.0 112.929 176.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 35.6 t80 -43.94 -56.31 4.02 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.513 1.925 . . . . 10.0 112.723 168.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -58.98 -39.16 93.86 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 124.576 1.084 . . . . 10.0 113.114 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 24.7 mt -69.5 -27.92 65.61 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 115.792 1.775 . . . . 10.0 115.792 175.026 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 74.3 mt -63.35 -57.61 11.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 119.22 0.918 . . . . 10.0 108.634 165.678 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 32.2 tp -58.87 -64.66 0.86 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.924 0.89 . . . . 10.0 113.165 -172.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 84.2 mt -71.55 5.22 2.5 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 115.323 1.601 . . . . 10.0 115.323 -171.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.6 mtp-105 -112.36 0.38 15.64 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.199 1.0 . . . . 10.0 113.272 172.56 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 8.8 t -108.03 177.97 4.65 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 124.026 0.93 . . . . 10.0 111.015 174.661 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 227' ' ' ARG . . . . . 0.667 ' HD3' ' CD ' ' A' ' 166' ' ' GLU . 41.8 ttt180 -71.65 98.22 1.87 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.752 0.821 . . . . 10.0 110.91 170.647 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 228' ' ' ALA . . . . . 0.475 ' HB1' ' CD2' ' A' ' 42' ' ' PHE . . . -80.96 77.03 7.89 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.814 0.846 . . . . 10.0 112.123 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 40.09 102.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 128.857 2.863 . . . . 10.0 116.481 177.783 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . 0.482 0.3 OUTLIER 71.87 -55.46 0.66 Allowed 'General case' 0 C--O 1.242 0.699 0 C-N-CA 124.711 1.205 . . . . 10.0 110.591 -175.331 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -68.28 169.47 40.01 Favored Glycine 0 C--O 1.239 0.417 0 C-N-CA 129.757 3.551 . . . . 10.0 119.653 171.53 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.474 0 C-N-CA 128.458 2.703 . . . . 10.0 113.43 166.573 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 999' ' ' RET . . . . . 0.5 H181 ' H7 ' ' A' ' 999' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1000 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A 1001 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A 1002 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A 1003 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 N--CA 1.476 0.87 0 CA-C-O 115.817 -2.039 . . . . 10.0 105.775 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 23.44 91.84 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 129.532 3.133 . . . . 10.0 117.276 160.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 28.6 65.05 0.11 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 128.301 2.641 . . . . 10.0 114.514 155.45 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 86.6 mt -56.44 137.98 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 126.396 1.878 . . . . 10.0 113.338 -158.382 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.652 HG21 ' HB3' ' A' ' 77' ' ' PRO . 7.6 t -136.8 -165.22 1.7 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 126.286 1.834 . . . . 10.0 114.021 -174.344 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 70.06 2.79 41.4 Favored Glycine 0 C--N 1.34 0.786 0 C-N-CA 127.443 2.449 . . . . 10.0 111.451 168.017 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -158.57 -51.32 0.01 OUTLIER Pre-proline 0 N--CA 1.443 -0.783 0 CA-C-O 114.263 -2.78 . . . . 10.0 116.649 -168.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -64.03 -60.6 0.15 Allowed 'Trans proline' 0 CA--C 1.528 0.185 0 CA-C-N 123.538 2.299 . . . . 10.0 113.205 -175.287 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.41 ' H ' ' CD ' ' A' ' 9' ' ' GLU . 7.9 pm0 -67.21 4.3 0.97 Allowed 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 127.886 2.475 . . . . 10.0 115.732 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.421 ' CG ' ' N ' ' A' ' 11' ' ' ILE . 11.1 p-90 -51.39 -43.07 61.8 Favored 'General case' 0 C--O 1.222 -0.361 0 O-C-N 121.455 -0.778 . . . . 10.0 112.617 176.43 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.421 ' N ' ' CG ' ' A' ' 10' ' ' TRP . 8.9 tt -60.83 -49.65 83.73 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.34 0 C-N-CA 123.926 0.89 . . . . 10.0 109.339 179.37 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.536 ' CD2' HD23 ' A' ' 206' ' ' LEU . 2.6 m95 -55.4 -52.67 62.81 Favored 'General case' 0 C--O 1.224 -0.259 0 C-N-CA 123.407 0.683 . . . . 10.0 111.871 175.626 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.5 mt -57.34 -53.62 56.04 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 123.175 0.59 . . . . 10.0 112.198 177.241 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.86 -46.82 51.89 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.427 1.491 . . . . 10.0 113.268 173.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.575 ' HB3' ' HE2' ' A' ' 209' ' ' MET . 13.3 tp -65.68 -44.92 84.76 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 125.274 1.43 . . . . 10.0 113.012 179.154 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.49 -56.79 10.34 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 124.568 1.08 . . . . 10.0 111.588 166.001 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 22.3 m -49.22 -52.68 25.41 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.987 1.315 . . . . 10.0 112.373 174.397 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.42 -58.85 5.84 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.151 0.98 . . . . 10.0 112.19 177.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 93.0 mt -57.26 -49.03 77.35 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.686 0.794 . . . . 10.0 112.736 -179.362 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 52.8 mtt -58.83 -47.87 83.33 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.121 0.968 . . . . 10.0 111.101 177.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -57.13 -58.6 13.72 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 124.333 0.968 . . . . 10.0 113.99 173.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 80.8 mt -56.24 -45.52 79.96 Favored 'General case' 0 C--O 1.221 -0.426 0 CA-C-N 118.646 1.223 . . . . 10.0 112.112 176.22 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.08 -41.04 84.7 Favored Glycine 0 CA--C 1.531 1.093 0 O-C-N 120.929 -1.107 . . . . 10.0 113.652 173.003 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 22.1 m -60.06 -60.43 3.84 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.793 0.837 . . . . 10.0 110.831 171.134 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -52.22 -41.02 62.38 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.073 0.949 . . . . 10.0 110.958 179.053 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -55.8 -58.01 9.63 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.557 1.143 . . . . 10.0 112.991 172.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -59.65 -38.72 82.16 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 113.201 0.815 . . . . 10.0 113.201 178.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.401 ' C ' ' H ' ' A' ' 30' ' ' LYS . 11.8 mt -56.11 -67.42 0.3 Allowed 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.58 1.152 . . . . 10.0 113.627 169.131 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 t -76.37 40.93 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-O 123.77 1.747 . . . . 10.0 110.891 179.074 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.401 ' H ' ' C ' ' A' ' 28' ' ' LEU . 42.9 tttm -140.82 -44.82 0.39 Allowed 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 127.884 2.474 . . . . 10.0 109.35 171.187 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -73.02 23.15 0.88 Allowed Glycine 0 CA--C 1.529 0.928 0 N-CA-C 115.634 1.014 . . . . 10.0 115.634 173.715 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 37.3 mmm -59.54 -44.96 93.07 Favored 'General case' 0 C--O 1.223 -0.296 0 C-N-CA 127.136 2.174 . . . . 10.0 113.578 -179.026 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.72 -84.4 1.19 Allowed Glycine 0 CA--C 1.53 1.007 0 C-N-CA 123.718 0.675 . . . . 10.0 112.452 -170.121 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.8 t 33.04 88.79 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.242 0.682 0 C-N-CA 128.4 2.68 . . . . 10.0 116.961 166.499 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.7 m -79.62 -50.93 9.93 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.187 -1.37 . . . . 10.0 113.866 174.147 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -48.93 117.51 6.43 Favored Pre-proline 0 CA--C 1.537 0.454 0 O-C-N 124.719 1.262 . . . . 10.0 110.937 -172.489 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -58.57 -29.7 89.77 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 123.746 2.964 . . . . 10.0 113.669 179.139 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.26 -60.68 2.28 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.111 0.565 . . . . 10.0 111.441 176.192 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.16 -40.07 22.71 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 125.097 1.359 . . . . 10.0 113.565 171.621 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -46.53 -47.45 19.55 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 125.221 1.408 . . . . 10.0 113.463 172.046 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -57.74 -53.06 62.47 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.431 0.693 . . . . 10.0 110.99 176.628 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.476 ' CD2' ' HB1' ' A' ' 228' ' ' ALA . 44.2 m-85 -56.95 -50.22 73.28 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 123.09 0.556 . . . . 10.0 112.339 -179.115 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -54.33 -51.32 65.08 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 118.962 -0.542 . . . . 10.0 112.369 173.28 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.42 -62.02 1.91 Allowed 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 113.34 0.867 . . . . 10.0 113.34 177.185 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.6 mt -48.8 -56.98 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 124.842 1.257 . . . . 10.0 110.396 178.041 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.2 m -69.76 -16.45 63.31 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.085 1.354 . . . . 10.0 113.605 -172.369 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 30.1 m -87.0 -43.28 12.47 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 119.735 1.152 . . . . 10.0 111.842 174.381 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 20.1 mt -56.84 -40.94 76.98 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 112.937 0.718 . . . . 10.0 112.937 173.166 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 44.4 t -49.43 -62.05 2.85 Favored Pre-proline 0 CA--C 1.552 1.047 0 C-N-CA 124.473 1.109 . . . . 10.0 112.494 178.138 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -48.72 -46.92 22.62 Favored 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 124.593 3.529 . . . . 10.0 116.236 164.484 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.64 -45.7 93.07 Favored 'General case' 0 CA--C 1.548 0.901 0 CA-C-N 119.904 1.229 . . . . 10.0 113.875 -176.606 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 52.9 mt -57.58 -51.69 66.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 124.536 1.134 . . . . 10.0 109.376 172.092 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.5 -45.85 73.37 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.31 1.044 . . . . 10.0 113.056 176.756 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -50.52 -56.7 10.47 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 125.283 1.433 . . . . 10.0 112.228 171.355 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 13.2 m -49.72 -52.73 29.24 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 125.283 1.433 . . . . 10.0 110.674 177.66 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 32.4 mmt -68.67 -48.34 64.2 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 124.001 0.92 . . . . 10.0 113.025 -176.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -57.01 -40.16 76.11 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-O 117.083 -1.437 . . . . 10.0 113.214 173.245 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.8 tp -53.3 -54.54 34.82 Favored 'General case' 0 C--O 1.224 -0.272 0 CA-C-N 120.118 1.327 . . . . 10.0 111.334 170.173 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 24.0 p -51.64 -41.1 61.06 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 115.221 1.563 . . . . 10.0 115.221 178.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 57.9 mtm -66.86 -50.85 61.19 Favored 'General case' 0 C--N 1.334 -0.09 0 C-N-CA 123.597 0.759 . . . . 10.0 110.477 176.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.4 tp -48.58 -52.67 21.69 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.88 0.872 . . . . 10.0 112.926 172.346 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.5 mt -76.98 -5.53 49.01 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.358 1.063 . . . . 10.0 113.781 -177.638 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.29 -34.72 5.54 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 115.47 0.948 . . . . 10.0 115.47 174.072 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -49.29 -43.13 42.99 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 115.206 1.558 . . . . 10.0 115.206 -175.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.03 3.56 61.03 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 115.35 0.9 . . . . 10.0 115.35 -179.018 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.2 143.36 26.5 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 127.056 2.142 . . . . 10.0 109.038 171.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 t -145.47 171.13 15.09 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 124.023 0.929 . . . . 10.0 111.077 166.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.02 136.04 53.4 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 123.932 0.893 . . . . 10.0 109.711 179.583 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.437 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 58.9 t -129.52 129.61 23.21 Favored Pre-proline 0 C--N 1.329 -0.299 0 C-N-CA 125.109 1.364 . . . . 10.0 110.999 -176.096 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 69' ' ' VAL . 6.3 Cg_exo -80.76 116.22 3.16 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 N-CA-C 109.417 -1.032 . . . . 10.0 109.417 -178.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -156.75 164.4 38.16 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.824 0.676 . . . . 10.0 112.824 172.485 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.35 -81.96 0.14 Allowed Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.696 -0.961 . . . . 10.0 110.696 175.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.72 -3.4 0.7 Allowed Glycine 0 CA--C 1.527 0.836 0 N-CA-C 118.637 2.215 . . . . 10.0 118.637 170.407 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -151.56 -171.85 4.05 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 119.339 1.569 . . . . 10.0 112.257 -165.17 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -91.92 93.91 9.03 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 125.504 1.522 . . . . 10.0 111.088 -175.277 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.45 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 60.5 m-80 -89.51 120.82 69.62 Favored Pre-proline 0 N--CA 1.45 -0.431 0 N-CA-C 112.963 0.727 . . . . 10.0 112.963 -165.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.652 ' HB3' HG21 ' A' ' 5' ' ' THR . 76.6 Cg_exo -61.49 131.89 38.14 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 124.183 3.255 . . . . 10.0 112.199 171.553 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.6 mm -140.14 126.36 21.92 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 C-N-CA 125.999 1.72 . . . . 10.0 111.704 -179.504 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -93.66 85.04 4.74 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 122.812 1.291 . . . . 10.0 113.046 174.656 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 63.7 p-90 -59.35 -28.24 66.66 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 113.905 1.076 . . . . 10.0 113.905 174.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -55.39 -32.05 62.32 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.296 1.038 . . . . 10.0 111.811 178.258 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.433 ' HG3' HH11 ' A' ' 82' ' ' ARG . 23.4 ttm-85 -47.78 -40.63 21.38 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 126.888 2.075 . . . . 10.0 113.493 170.032 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 62.2 m-85 -86.47 -39.57 16.18 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.418 1.887 . . . . 10.0 111.755 -177.358 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -49.07 -47.85 44.62 Favored 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 124.555 1.142 . . . . 10.0 111.013 166.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -52.03 -71.97 0.06 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 126.471 1.908 . . . . 10.0 111.809 167.592 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 52.7 m0 -55.09 -33.77 63.08 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 124.095 0.958 . . . . 10.0 113.582 -170.297 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 24.3 tp -49.68 -40.44 40.05 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 126.285 1.834 . . . . 10.0 111.994 177.607 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -105.02 -40.37 5.92 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.378 0.671 . . . . 10.0 112.377 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 76.0 p -62.29 -42.16 99.12 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 120.664 1.575 . . . . 10.0 114.022 -179.21 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . 0.291 69.5 p -69.44 -41.32 16.85 Favored Pre-proline 0 CA--C 1.547 0.854 0 N-CA-C 114.959 1.466 . . . . 10.0 114.959 -176.761 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -55.11 -42.92 64.22 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 123.328 2.685 . . . . 10.0 115.137 166.261 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 55.0 mt -60.33 -47.39 86.22 Favored 'General case' 0 CA--C 1.544 0.724 0 O-C-N 121.507 -0.745 . . . . 10.0 111.677 176.017 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 6.1 tt -50.19 -49.37 52.72 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.723 1.609 . . . . 10.0 111.522 171.209 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.6 mp -57.26 -47.34 81.66 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.274 1.03 . . . . 10.0 113.135 170.458 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.86 -38.21 78.26 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 123.844 0.857 . . . . 10.0 112.9 178.354 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -52.32 -54.02 36.9 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 119.299 0.954 . . . . 10.0 111.21 169.61 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.33 -42.11 88.67 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 123.64 0.776 . . . . 10.0 112.144 -178.558 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.7 -54.68 38.59 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.98 0.912 . . . . 10.0 112.041 173.624 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.29 -41.18 79.32 Favored 'General case' 0 C--O 1.224 -0.24 0 C-N-CA 123.677 0.791 . . . . 10.0 112.714 174.782 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 32.2 tp -63.8 -38.56 91.55 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 114.436 1.273 . . . . 10.0 114.436 -179.582 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.2 t -94.79 1.41 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 125.005 1.322 . . . . 10.0 112.298 179.163 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.2 t70 48.6 53.5 12.08 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.864 1.666 . . . . 10.0 112.101 -174.029 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.28 145.88 47.59 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 119.951 -1.718 . . . . 10.0 112.47 -174.18 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.47 135.93 54.16 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 112.711 0.634 . . . . 10.0 112.711 175.156 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -42.89 -39.64 2.63 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.854 1.661 . . . . 10.0 113.471 175.286 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -47.33 -60.22 5.33 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 125.205 1.383 . . . . 10.0 115.213 169.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.5 p -62.1 -46.75 87.7 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 117.053 -1.451 . . . . 10.0 111.321 178.248 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 66.9 mt -48.48 -52.89 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 124.998 1.319 . . . . 10.0 111.11 178.24 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.1 tp -62.58 -51.37 67.62 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 112.528 0.566 . . . . 10.0 112.528 179.28 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.11 -44.86 42.66 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.47 0.708 . . . . 10.0 110.959 174.601 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.456 ' HA ' HD12 ' A' ' 111' ' ' LEU . 0.6 OUTLIER -59.62 -59.89 4.72 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 127.404 2.281 . . . . 10.0 114.79 174.981 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.8 t -61.04 -46.32 96.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 123.705 0.802 . . . . 10.0 111.411 -178.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -56.62 -50.35 63.7 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 123.674 0.655 . . . . 10.0 112.642 174.511 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -54.93 -46.62 74.97 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 113.696 0.998 . . . . 10.0 113.696 173.361 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -55.02 -49.27 71.94 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.48 0.712 . . . . 10.0 111.166 173.225 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -42.87 -54.57 5.05 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 125.06 1.314 . . . . 10.0 113.059 170.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 86.9 mt -56.11 -54.43 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 CA-C-O 118.281 -0.866 . . . . 10.0 111.327 173.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 1.7 ptt? -56.8 -45.29 82.32 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 119.692 1.133 . . . . 10.0 113.038 -174.228 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 1.7 mp -68.76 -52.71 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 CA-C-N 119.051 0.841 . . . . 10.0 111.047 174.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -51.62 -53.73 27.78 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 124.233 0.921 . . . . 10.0 111.668 -179.464 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 80.9 m -52.72 -46.07 67.21 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 125.903 1.681 . . . . 10.0 112.444 170.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -50.84 -51.69 33.1 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 124.631 1.11 . . . . 10.0 112.599 173.03 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 59.6 tp -60.67 -45.85 92.57 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.247 1.419 . . . . 10.0 112.535 175.384 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 60.8 t -53.91 -50.26 54.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 O-C-N 121.241 -0.912 . . . . 10.0 110.14 172.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -50.79 -61.14 6.31 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 126.305 1.907 . . . . 10.0 112.646 171.66 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -42.83 -42.26 3.56 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 127.772 2.429 . . . . 10.0 113.208 176.581 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 47.7 mt -100.84 -6.81 24.27 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 115.531 1.678 . . . . 10.0 115.531 -175.176 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 17.0 m -69.65 116.71 10.36 Favored 'General case' 0 N--CA 1.465 0.294 0 O-C-N 120.14 -1.6 . . . . 10.0 110.398 -178.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.622 ' H ' ' HD3' ' A' ' 129' ' ' LYS . 0.2 OUTLIER -55.45 -49.6 72.05 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 128.2 2.6 . . . . 10.0 113.25 177.75 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 60.8 t -69.69 106.33 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 123.797 0.839 . . . . 10.0 110.103 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -46.87 -59.54 3.01 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 124.774 1.229 . . . . 10.0 114.089 -173.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 m -46.52 -42.05 15.1 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.488 1.515 . . . . 10.0 113.495 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -70.16 -24.61 63.18 Favored 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 114.958 1.466 . . . . 10.0 114.958 -178.125 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 69.0 mtp85 -54.12 -41.43 68.33 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 118.845 0.748 . . . . 10.0 110.839 176.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -69.73 -32.18 70.59 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.842 1.257 . . . . 10.0 114.217 176.569 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.8 t -54.84 -52.23 44.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 CA-C-N 119.013 0.824 . . . . 10.0 109.83 168.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 65.6 m95 -59.66 -49.87 76.06 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 113.458 0.911 . . . . 10.0 113.458 173.446 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 89.8 t90 -48.35 -48.59 36.36 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 119.504 1.047 . . . . 10.0 113.214 173.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -57.56 -51.85 67.82 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.203 1.001 . . . . 10.0 111.976 176.241 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 97.3 mt -55.41 -51.24 58.9 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 C-N-CA 124.89 1.276 . . . . 10.0 111.728 175.532 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 7.2 m -53.02 -45.42 67.94 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 121.196 -0.94 . . . . 10.0 112.662 171.491 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 66.5 m -61.84 -45.27 94.55 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.833 1.253 . . . . 10.0 111.854 178.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -56.54 -51.15 69.63 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 123.969 0.908 . . . . 10.0 112.365 171.399 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -57.19 -45.53 83.67 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.003 0.921 . . . . 10.0 112.971 175.618 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 38.2 ttp -57.49 -53.7 55.2 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.275 1.03 . . . . 10.0 112.005 171.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 62.7 tp -53.51 -47.0 70.28 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.191 1.396 . . . . 10.0 111.852 178.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -50.53 -54.84 19.33 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.003 0.921 . . . . 10.0 112.407 170.489 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 54.5 mt -53.62 -55.05 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 123.762 0.825 . . . . 10.0 110.805 177.664 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 38.8 mt -57.16 -35.98 70.2 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 118.365 -0.826 . . . . 10.0 112.997 178.507 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -57.24 -58.26 9.02 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 124.068 0.947 . . . . 10.0 113.006 173.293 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.34 -40.89 85.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 CA-C-O 118.343 -0.837 . . . . 10.0 111.492 177.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 45.4 mt -56.83 -49.4 75.53 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 119.845 1.202 . . . . 10.0 112.14 171.254 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.469 ' HA ' ' HD2' ' A' ' 175' ' ' ARG . 11.9 t80 -76.97 -70.34 0.47 Allowed 'General case' 0 C--N 1.326 -0.447 0 O-C-N 120.022 -1.674 . . . . 10.0 112.887 -175.264 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -73.74 -21.87 60.07 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.567 1.147 . . . . 10.0 113.448 -174.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -87.8 -79.16 1.26 Allowed Glycine 0 CA--C 1.527 0.783 0 C-N-CA 123.666 0.651 . . . . 10.0 113.496 171.523 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -53.63 -32.4 51.15 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 126.299 1.839 . . . . 10.0 113.046 -166.513 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.2 m -52.08 -56.5 13.99 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 114.012 1.116 . . . . 10.0 114.012 172.086 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.4 p -53.67 -50.53 65.61 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 122.057 0.932 . . . . 10.0 112.281 -177.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 47.6 tttm -57.13 -46.05 83.0 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.197 0.999 . . . . 10.0 112.117 173.65 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.82 -47.46 80.24 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 114.545 1.313 . . . . 10.0 114.545 174.034 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -56.5 -11.29 1.22 Allowed 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 126.089 1.755 . . . . 10.0 114.228 177.677 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.2 m -107.1 6.64 29.08 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.416 1.886 . . . . 10.0 114.877 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 93.2 mmm -91.88 -92.63 0.15 Allowed 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 123.521 1.629 . . . . 10.0 114.191 -170.606 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -138.74 153.98 72.62 Favored Pre-proline 0 C--O 1.236 0.359 0 C-N-CA 129.802 3.241 . . . . 10.0 105.548 170.185 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -52.86 -46.22 35.24 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 122.3 2.0 . . . . 10.0 113.088 179.056 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.667 ' CD ' ' HD3' ' A' ' 227' ' ' ARG . 0.1 OUTLIER -52.97 -46.03 68.04 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 129.022 2.929 . . . . 10.0 113.276 173.578 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 91.7 t -69.26 -53.03 27.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 C-N-CA 124.02 0.928 . . . . 10.0 109.782 -178.616 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.09 -46.85 75.53 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.282 0.633 . . . . 10.0 111.923 177.047 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 60.5 p -60.02 -56.19 24.74 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.953 0.901 . . . . 10.0 112.67 174.672 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 62.0 m -57.22 -53.19 60.94 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.202 1.001 . . . . 10.0 113.004 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -49.59 -49.54 46.26 Favored 'General case' 0 C--O 1.221 -0.425 0 C-N-CA 123.289 0.636 . . . . 10.0 111.067 174.098 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -57.12 -48.41 78.72 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 114.671 1.36 . . . . 10.0 114.671 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 40.4 t -55.95 -49.63 74.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 CA-C-N 118.832 0.742 . . . . 10.0 110.476 176.373 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 94.1 mt -58.54 -51.65 68.99 Favored 'General case' 0 C--O 1.222 -0.392 0 N-CA-C 113.168 0.803 . . . . 10.0 113.168 175.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' ARG . . . . . 0.469 ' HD2' ' HA ' ' A' ' 153' ' ' PHE . 35.5 ttp180 -47.79 -47.76 30.7 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 126.824 2.05 . . . . 10.0 111.059 174.448 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 63.7 m-20 -58.53 -58.32 9.06 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 122.771 0.428 . . . . 10.0 111.286 174.405 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 59.5 t -51.85 -49.48 36.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 124.048 0.939 . . . . 10.0 111.449 179.029 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 35.3 m -55.74 -64.09 0.96 Allowed 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 128.428 2.691 . . . . 10.0 111.939 177.248 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 55.7 t -51.05 -49.56 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 124.541 1.136 . . . . 10.0 111.317 -179.05 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 79.6 t -59.76 -61.64 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 124.209 1.004 . . . . 10.0 112.198 177.07 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -57.86 -47.72 81.91 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 118.873 0.761 . . . . 10.0 112.287 -176.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 10.7 m95 -53.51 -51.25 63.44 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.878 0.871 . . . . 10.0 111.71 175.584 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 50.2 m -55.29 -29.82 58.94 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 114.105 1.15 . . . . 10.0 114.105 178.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -64.72 -44.5 90.0 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 113.657 0.984 . . . . 10.0 113.657 176.066 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 -47.03 -54.32 21.33 Favored Pre-proline 0 CA--C 1.548 0.866 0 N-CA-C 115.764 1.765 . . . . 10.0 115.764 -176.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 186' ' ' PRO . . . . . 0.555 ' HB3' H183 ' A' ' 999' ' ' RET . 19.0 Cg_endo -57.1 -38.72 94.89 Favored 'Trans proline' 0 C--N 1.355 0.896 0 C-N-CA 122.487 2.124 . . . . 10.0 113.129 176.419 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 24.4 t -63.5 -51.98 63.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 124.37 1.068 . . . . 10.0 110.742 177.399 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 93.2 t -54.11 -50.09 57.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 124.307 1.043 . . . . 10.0 111.442 175.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 52.1 t90 -55.46 -51.58 66.48 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.317 1.047 . . . . 10.0 112.498 174.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 34.4 tp -54.29 -45.63 72.56 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.878 1.271 . . . . 10.0 112.362 -178.152 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 15.4 pt -87.41 -5.05 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 115.17 1.544 . . . . 10.0 115.17 -177.47 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.49 -169.22 32.84 Favored Glycine 0 N--CA 1.451 -0.353 0 CA-C-O 122.545 1.08 . . . . 10.0 113.882 -168.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 23.2 t -53.21 -41.44 65.34 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 114.243 -0.979 . . . . 10.0 111.818 177.619 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -67.2 -17.05 64.66 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 115.659 1.726 . . . . 10.0 115.659 -175.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -130.99 -105.97 1.09 Allowed Glycine 0 CA--C 1.532 1.1 0 CA-C-N 120.381 1.446 . . . . 10.0 113.82 -172.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -89.42 127.15 35.8 Favored 'General case' 0 C--N 1.328 -0.352 0 O-C-N 120.64 -1.506 . . . . 10.0 109.349 168.588 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -72.46 65.36 1.36 Allowed Glycine 0 CA--C 1.532 1.124 0 N-CA-C 113.873 0.309 . . . . 10.0 113.873 173.197 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 60.7 mt -79.63 -42.74 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 126.083 1.753 . . . . 10.0 108.721 166.392 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.4 ' CG1' ' HB ' ' A' ' 203' ' ' ILE . 79.8 t -126.29 133.4 24.93 Favored Pre-proline 0 N--CA 1.454 -0.264 0 C-N-CA 126.502 1.921 . . . . 10.0 109.364 -174.179 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -68.78 153.82 72.33 Favored 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 123.751 2.967 . . . . 10.0 111.425 -176.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 12.2 tp -43.18 -39.75 3.03 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.281 1.033 . . . . 10.0 112.223 171.486 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -48.34 -52.39 21.82 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 114.705 1.372 . . . . 10.0 114.705 176.053 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 203' ' ' ILE . . . . . 0.4 ' HB ' ' CG1' ' A' ' 199' ' ' VAL . 14.0 mm -75.91 -40.48 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 124.378 1.071 . . . . 10.0 109.674 177.572 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -49.29 -49.85 41.84 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 118.553 0.615 . . . . 10.0 111.946 173.605 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 15.9 m -57.69 -47.08 83.36 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 126.046 1.738 . . . . 10.0 112.964 174.323 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.536 HD23 ' CD2' ' A' ' 12' ' ' TRP . 1.3 tm? -63.28 -52.33 62.45 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.977 0.911 . . . . 10.0 112.101 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 93.3 mt -52.58 -59.34 4.57 Favored 'General case' 0 C--N 1.335 -0.044 0 C-N-CA 124.265 1.026 . . . . 10.0 109.989 176.455 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -52.75 -47.35 67.51 Favored 'General case' 0 C--O 1.219 -0.53 0 CA-C-O 117.286 -1.34 . . . . 10.0 112.102 176.475 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 209' ' ' MET . . . . . 0.575 ' HE2' ' HB3' ' A' ' 15' ' ' LEU . 4.6 tmm? -50.84 -52.5 40.91 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 120.976 1.716 . . . . 10.0 112.974 174.776 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 80.4 t -60.86 -46.93 95.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 124.798 1.239 . . . . 10.0 111.524 178.332 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 4.1 mp -59.45 -51.57 69.32 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.496 1.518 . . . . 10.0 112.261 175.68 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -55.08 -55.97 25.06 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 127.245 2.218 . . . . 10.0 110.281 175.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 38.1 t -47.41 -53.65 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 124.529 1.131 . . . . 10.0 111.488 173.709 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 18.7 t -54.82 -54.2 45.39 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.303 0.641 . . . . 10.0 112.193 175.364 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -68.14 -22.75 64.85 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 115.366 1.617 . . . . 10.0 115.366 -178.148 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -83.25 -74.87 0.34 Allowed 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.737 1.615 . . . . 10.0 109.906 168.736 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 35.8 m -92.97 -35.72 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 124.047 0.939 . . . . 10.0 113.191 -164.068 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -57.36 -56.77 23.31 Favored Glycine 0 N--CA 1.475 1.236 0 CA-C-N 119.851 1.205 . . . . 10.0 111.731 172.691 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -44.03 -58.81 2.61 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 127.2 2.2 . . . . 10.0 112.357 166.037 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -55.41 -41.7 81.17 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 123.991 0.805 . . . . 10.0 114.319 179.284 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 23.8 mt -70.63 -26.73 63.61 Favored 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 115.505 1.668 . . . . 10.0 115.505 178.227 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 74.0 mt -63.2 -57.56 11.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 108.741 -0.837 . . . . 10.0 108.741 165.409 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 32.1 tp -58.77 -64.68 0.85 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.901 0.88 . . . . 10.0 113.183 -172.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 84.0 mt -71.53 5.19 2.51 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 115.315 1.598 . . . . 10.0 115.315 -171.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.6 mtp-105 -112.31 0.33 15.67 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.231 1.012 . . . . 10.0 113.324 172.535 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 8.8 t -108.04 177.99 4.65 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 124.014 0.926 . . . . 10.0 111.013 174.657 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 227' ' ' ARG . . . . . 0.667 ' HD3' ' CD ' ' A' ' 166' ' ' GLU . 41.8 ttt180 -71.64 98.19 1.86 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.773 0.829 . . . . 10.0 110.924 170.686 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 228' ' ' ALA . . . . . 0.476 ' HB1' ' CD2' ' A' ' 42' ' ' PHE . . . -80.96 77.07 7.89 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.836 0.854 . . . . 10.0 112.073 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 40.15 102.25 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 128.893 2.877 . . . . 10.0 116.436 177.705 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . 0.483 0.3 OUTLIER 71.88 -55.47 0.66 Allowed 'General case' 0 C--O 1.242 0.67 0 C-N-CA 124.692 1.197 . . . . 10.0 110.644 -175.355 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -68.25 169.43 39.98 Favored Glycine 0 C--O 1.239 0.417 0 C-N-CA 129.784 3.564 . . . . 10.0 119.629 171.477 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.461 0 C-N-CA 128.443 2.697 . . . . 10.0 113.409 166.61 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 999' ' ' RET . . . . . 0.555 H183 ' HB3' ' A' ' 186' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1000 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A 1001 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A 1002 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A 1003 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 N--CA 1.477 0.876 0 CA-C-O 115.801 -2.047 . . . . 10.0 105.812 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 23.38 91.92 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 129.647 3.179 . . . . 10.0 117.197 160.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 28.55 65.1 0.1 Allowed 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 128.302 2.641 . . . . 10.0 114.496 155.454 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 86.5 mt -56.48 137.98 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 126.379 1.872 . . . . 10.0 113.343 -158.372 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.651 HG21 ' HB3' ' A' ' 77' ' ' PRO . 7.6 t -136.76 -165.16 1.69 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 126.312 1.845 . . . . 10.0 114.025 -174.347 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 69.98 2.81 40.78 Favored Glycine 0 C--N 1.34 0.792 0 C-N-CA 127.477 2.465 . . . . 10.0 111.526 168.062 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -158.56 -51.4 0.01 OUTLIER Pre-proline 0 N--CA 1.443 -0.783 0 CA-C-O 114.284 -2.77 . . . . 10.0 116.665 -168.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_exo -63.91 -60.73 0.14 Allowed 'Trans proline' 0 N--CA 1.465 -0.185 0 CA-C-N 123.533 2.297 . . . . 10.0 113.201 -175.33 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.411 ' H ' ' CD ' ' A' ' 9' ' ' GLU . 7.9 pm0 -67.13 4.26 0.96 Allowed 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 127.865 2.466 . . . . 10.0 115.746 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.422 ' CG ' ' N ' ' A' ' 11' ' ' ILE . 11.1 p-90 -51.35 -43.15 61.72 Favored 'General case' 0 C--O 1.223 -0.34 0 O-C-N 121.487 -0.758 . . . . 10.0 112.585 176.475 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.422 ' N ' ' CG ' ' A' ' 10' ' ' TRP . 8.9 tt -60.83 -49.64 83.78 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.338 0 C-N-CA 123.883 0.873 . . . . 10.0 109.287 179.447 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.535 ' CD2' HD23 ' A' ' 206' ' ' LEU . 2.6 m95 -55.38 -52.65 62.85 Favored 'General case' 0 C--O 1.224 -0.261 0 C-N-CA 123.402 0.681 . . . . 10.0 111.84 175.673 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 91.0 mt -57.35 -53.65 55.69 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 123.19 0.596 . . . . 10.0 112.178 177.297 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.88 -46.79 52.02 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.387 1.475 . . . . 10.0 113.295 173.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.575 ' HB3' ' HE2' ' A' ' 209' ' ' MET . 13.3 tp -65.64 -44.96 84.79 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 125.282 1.433 . . . . 10.0 112.999 179.147 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -50.82 -54.7 20.98 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 124.297 0.951 . . . . 10.0 112.016 166.416 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 22.3 m -50.06 -52.67 32.59 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.961 1.304 . . . . 10.0 112.481 173.416 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.44 -58.82 5.97 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.181 0.992 . . . . 10.0 112.159 177.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 94.1 mt -57.39 -51.31 69.93 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.716 0.806 . . . . 10.0 112.695 -179.597 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.9 mpp? -57.8 -44.95 86.67 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 119.073 0.851 . . . . 10.0 111.967 176.669 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -58.5 -58.47 14.42 Favored Glycine 0 CA--C 1.53 1.03 0 CA-C-O 119.267 -0.741 . . . . 10.0 113.474 174.521 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 80.7 mt -56.24 -46.01 79.77 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-N 118.37 1.085 . . . . 10.0 112.089 175.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.38 -42.48 74.74 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 124.942 1.258 . . . . 10.0 113.179 173.07 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 28.6 m -61.95 -58.6 7.29 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.86 0.864 . . . . 10.0 111.373 171.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -52.3 -40.94 62.48 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.017 0.927 . . . . 10.0 110.976 177.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -55.76 -58.11 9.22 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.617 1.167 . . . . 10.0 112.943 172.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.1 m-30 -59.63 -38.61 81.84 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 113.245 0.831 . . . . 10.0 113.245 178.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.401 ' C ' ' H ' ' A' ' 30' ' ' LYS . 11.8 mt -56.23 -67.37 0.3 Allowed 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.58 1.152 . . . . 10.0 113.614 169.119 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 t -76.37 40.92 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 CA-C-O 123.745 1.736 . . . . 10.0 110.862 179.074 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.401 ' H ' ' C ' ' A' ' 28' ' ' LEU . 42.9 tttm -140.85 -44.8 0.39 Allowed 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 127.862 2.465 . . . . 10.0 109.317 171.164 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -73.01 23.15 0.88 Allowed Glycine 0 CA--C 1.529 0.958 0 N-CA-C 115.626 1.01 . . . . 10.0 115.626 173.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 37.3 mmm -59.53 -44.94 93.04 Favored 'General case' 0 C--O 1.224 -0.277 0 C-N-CA 127.101 2.161 . . . . 10.0 113.594 -179.024 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.68 -84.4 1.19 Allowed Glycine 0 CA--C 1.53 1.007 0 C-N-CA 123.709 0.671 . . . . 10.0 112.507 -170.166 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.8 t 33.03 88.78 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.242 0.706 0 C-N-CA 128.395 2.678 . . . . 10.0 116.956 166.455 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.0 m -79.63 -50.82 10.09 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.184 -1.371 . . . . 10.0 113.94 174.138 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -49.0 117.55 6.54 Favored Pre-proline 0 CA--C 1.536 0.418 0 O-C-N 124.753 1.283 . . . . 10.0 110.902 -172.526 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -58.56 -29.64 89.54 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 123.757 2.971 . . . . 10.0 113.701 179.06 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.38 -60.64 2.29 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.089 0.556 . . . . 10.0 111.402 176.231 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.13 -40.13 22.74 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 125.085 1.354 . . . . 10.0 113.54 171.627 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -46.48 -47.44 19.28 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.208 1.403 . . . . 10.0 113.468 172.048 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -57.75 -53.07 62.35 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.495 0.718 . . . . 10.0 110.94 176.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.477 ' CD2' ' HB1' ' A' ' 228' ' ' ALA . 43.9 m-85 -56.98 -50.22 73.33 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 123.102 0.561 . . . . 10.0 112.321 -179.075 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -54.39 -51.27 65.36 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 118.962 -0.542 . . . . 10.0 112.369 173.283 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.42 -61.98 1.93 Allowed 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 113.419 0.896 . . . . 10.0 113.419 177.136 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.5 mt -48.65 -57.48 1.54 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 C-N-CA 124.869 1.268 . . . . 10.0 110.349 178.047 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.5 m -68.56 -17.87 64.23 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.109 1.364 . . . . 10.0 113.672 -172.647 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 27.4 m -87.14 -40.48 14.59 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.436 1.095 . . . . 10.0 112.123 174.687 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 23.7 mt -59.45 -42.0 90.94 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 121.321 -0.862 . . . . 10.0 112.573 171.447 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 24.7 t -43.24 -61.16 1.95 Allowed Pre-proline 0 N--CA 1.48 1.047 0 C-N-CA 125.57 1.548 . . . . 10.0 113.625 176.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -70.95 -28.71 19.18 Favored 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 123.135 2.557 . . . . 10.0 114.205 174.264 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.45 -46.24 87.17 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-N 120.709 1.595 . . . . 10.0 113.363 177.441 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 56.3 mt -56.14 -51.7 59.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 124.414 1.085 . . . . 10.0 109.248 171.153 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.65 -43.5 76.33 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 113.484 0.92 . . . . 10.0 113.484 175.538 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -50.96 -55.89 15.06 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 120.853 1.661 . . . . 10.0 111.818 171.572 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 10.6 m -49.74 -52.79 29.03 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.359 1.464 . . . . 10.0 110.877 177.014 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.41 ' HG3' ' CB ' ' A' ' 85' ' ' ASP . 32.6 mmt -68.88 -48.11 64.2 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 123.964 0.906 . . . . 10.0 112.938 -176.703 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -55.58 -41.97 74.11 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 120.342 1.428 . . . . 10.0 112.974 172.76 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.8 tp -53.25 -54.59 34.01 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-N 119.697 1.135 . . . . 10.0 111.281 171.184 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 24.0 p -51.67 -41.06 61.12 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 115.191 1.552 . . . . 10.0 115.191 179.032 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 55.6 mtm -66.86 -50.83 61.25 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 123.562 0.745 . . . . 10.0 110.479 176.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.5 tp -48.55 -52.7 21.4 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.846 0.858 . . . . 10.0 112.952 172.321 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.5 mt -76.97 -5.52 48.95 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.331 1.053 . . . . 10.0 113.799 -177.678 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.28 -34.77 5.5 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 115.55 0.98 . . . . 10.0 115.55 174.11 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 75.3 t80 -49.22 -43.09 42.22 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 115.258 1.577 . . . . 10.0 115.258 -176.055 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.1 3.59 61.18 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 115.348 0.899 . . . . 10.0 115.348 -179.015 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.25 143.43 26.42 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 127.035 2.134 . . . . 10.0 109.011 171.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 t -145.55 171.1 15.17 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 124.012 0.925 . . . . 10.0 111.045 166.75 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.0 136.08 53.37 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 123.853 0.861 . . . . 10.0 109.698 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.436 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 59.0 t -129.54 129.56 23.19 Favored Pre-proline 0 C--N 1.329 -0.317 0 C-N-CA 125.068 1.347 . . . . 10.0 110.988 -176.059 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 69' ' ' VAL . 6.3 Cg_exo -80.76 116.25 3.16 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 N-CA-C 109.411 -1.034 . . . . 10.0 109.411 -178.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -156.71 164.38 38.2 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 112.818 0.673 . . . . 10.0 112.818 172.492 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.43 -81.99 0.15 Allowed Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.644 -0.983 . . . . 10.0 110.644 175.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.76 -3.42 0.69 Allowed Glycine 0 CA--C 1.526 0.776 0 N-CA-C 118.673 2.229 . . . . 10.0 118.673 170.443 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -151.58 -171.89 4.06 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 119.343 1.571 . . . . 10.0 112.25 -165.157 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -91.86 93.91 9.06 Favored 'General case' 0 CA--C 1.519 -0.237 0 C-N-CA 125.514 1.526 . . . . 10.0 111.061 -175.28 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.449 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 60.4 m-80 -89.49 120.81 69.64 Favored Pre-proline 0 N--CA 1.45 -0.465 0 N-CA-C 112.982 0.734 . . . . 10.0 112.982 -165.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.651 ' HB3' HG21 ' A' ' 5' ' ' THR . 76.1 Cg_exo -61.52 131.88 38.02 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 124.205 3.27 . . . . 10.0 112.199 171.573 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.5 mm -140.09 126.33 22.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 C-N-CA 126.059 1.744 . . . . 10.0 111.716 -179.451 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -93.64 85.01 4.75 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 122.628 1.204 . . . . 10.0 113.053 174.627 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 63.8 p-90 -59.4 -28.25 66.74 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 113.896 1.072 . . . . 10.0 113.896 174.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -55.28 -26.02 37.67 Favored 'General case' 0 CA--C 1.562 1.415 0 C-N-CA 124.277 1.031 . . . . 10.0 111.773 178.214 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -45.42 -64.86 0.63 Allowed 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 125.297 1.439 . . . . 10.0 110.618 166.313 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 36.1 m-85 -62.67 -38.55 90.77 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 126.563 1.945 . . . . 10.0 110.936 -174.056 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -52.7 -49.86 64.48 Favored 'General case' 0 CA--C 1.555 1.159 0 CA-C-N 119.334 0.97 . . . . 10.0 112.048 168.419 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.41 ' CB ' ' HG3' ' A' ' 56' ' ' MET . 0.0 OUTLIER -60.06 -62.78 1.62 Allowed 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.476 1.111 . . . . 10.0 111.696 171.86 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 54.5 m0 -53.38 -37.06 62.09 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 125.821 1.648 . . . . 10.0 112.693 -174.057 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 28.2 tp -50.23 -41.44 50.05 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 126.275 1.83 . . . . 10.0 111.864 177.723 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -103.02 -40.7 6.38 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.883 0.873 . . . . 10.0 112.546 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 79.3 p -61.55 -42.45 98.86 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-N 120.553 1.524 . . . . 10.0 113.763 -179.274 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . 0.322 75.5 p -65.77 -47.69 65.05 Favored Pre-proline 0 N--CA 1.477 0.913 0 CA-C-O 117.586 -1.197 . . . . 10.0 114.22 -178.681 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -53.0 -42.68 62.75 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 123.232 2.621 . . . . 10.0 115.442 169.513 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 51.3 mt -59.75 -48.04 83.26 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 121.314 -0.866 . . . . 10.0 111.935 176.692 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.81 -37.49 84.61 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 119.586 1.085 . . . . 10.0 112.416 175.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.4 mp -56.39 -48.99 75.76 Favored 'General case' 0 CA--C 1.545 0.782 0 O-C-N 121.009 -1.057 . . . . 10.0 111.828 165.369 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.81 -38.24 78.17 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 119.164 0.893 . . . . 10.0 112.863 178.353 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -52.33 -54.06 36.45 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 119.322 0.965 . . . . 10.0 111.163 169.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.27 -42.07 88.97 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.63 0.772 . . . . 10.0 112.172 -178.569 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.76 -54.63 39.48 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 123.917 0.887 . . . . 10.0 112.066 173.618 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.38 -41.16 79.69 Favored 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 123.687 0.795 . . . . 10.0 112.681 174.83 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.8 tp -63.73 -38.54 91.5 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 114.485 1.291 . . . . 10.0 114.485 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.1 t -94.83 1.42 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 125.035 1.334 . . . . 10.0 112.308 179.186 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.2 t70 48.62 53.45 12.18 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.834 1.654 . . . . 10.0 112.1 -174.046 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.27 145.85 47.62 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 119.969 -1.707 . . . . 10.0 112.464 -174.18 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.42 135.93 53.96 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 112.697 0.629 . . . . 10.0 112.697 175.147 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -42.89 -39.68 2.64 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.877 1.671 . . . . 10.0 113.499 175.255 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -47.28 -60.22 5.29 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 125.103 1.335 . . . . 10.0 115.309 169.707 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.5 p -62.05 -46.82 87.46 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 117.098 -1.429 . . . . 10.0 111.332 178.2 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 67.0 mt -48.38 -52.92 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 125.038 1.335 . . . . 10.0 111.124 178.196 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.4 tp -62.67 -51.25 67.97 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 112.544 0.572 . . . . 10.0 112.544 179.328 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.2 -44.86 43.55 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.479 0.712 . . . . 10.0 110.912 174.607 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.455 ' HA ' HD12 ' A' ' 111' ' ' LEU . 0.6 OUTLIER -59.59 -59.86 4.77 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 127.385 2.274 . . . . 10.0 114.8 174.949 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.1 t -61.09 -46.36 96.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 123.668 0.787 . . . . 10.0 111.362 -178.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -56.56 -50.41 63.19 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 123.68 0.657 . . . . 10.0 112.602 174.534 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -54.85 -46.54 74.66 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 113.278 0.844 . . . . 10.0 113.278 173.374 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -55.22 -48.64 73.6 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.315 1.046 . . . . 10.0 111.202 173.545 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -42.99 -55.33 4.9 Favored Glycine 0 CA--C 1.534 1.223 0 C-N-CA 125.1 1.333 . . . . 10.0 113.18 169.066 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 85.1 mt -56.91 -52.22 58.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 123.555 0.742 . . . . 10.0 111.974 174.397 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 54.0 ttp -48.68 -58.03 5.37 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.821 1.249 . . . . 10.0 112.226 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 40.2 mm -68.29 -43.34 84.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 O-C-N 121.566 -0.709 . . . . 10.0 111.891 179.548 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -53.23 -60.71 7.77 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 124.747 1.165 . . . . 10.0 112.897 176.302 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 40.7 p -58.15 -36.7 73.37 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.98 0.912 . . . . 10.0 112.543 174.31 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -49.04 -55.95 10.99 Favored Glycine 0 CA--C 1.536 1.398 0 C-N-CA 124.464 1.031 . . . . 10.0 113.788 165.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 66.2 tp -59.04 -47.45 85.18 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.464 1.506 . . . . 10.0 111.887 176.709 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 67.8 t -52.84 -51.66 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 123.345 0.658 . . . . 10.0 110.377 173.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -49.15 -60.53 6.08 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 125.871 1.7 . . . . 10.0 112.212 171.761 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -49.57 -37.47 27.46 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.497 1.919 . . . . 10.0 113.635 -179.449 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 50.1 mt -99.37 -6.49 27.72 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 115.207 1.558 . . . . 10.0 115.207 -178.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 16.9 m -69.64 116.73 10.37 Favored 'General case' 0 N--CA 1.465 0.275 0 O-C-N 120.228 -1.545 . . . . 10.0 110.389 -178.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.621 ' H ' ' HD3' ' A' ' 129' ' ' LYS . 0.1 OUTLIER -55.52 -49.59 72.21 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 128.222 2.609 . . . . 10.0 113.268 177.731 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 60.6 t -69.65 106.32 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 123.791 0.836 . . . . 10.0 110.085 179.64 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -46.87 -59.55 3.01 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 124.807 1.243 . . . . 10.0 114.048 -173.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 m -46.5 -42.1 15.1 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.5 1.52 . . . . 10.0 113.484 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -70.18 -24.53 63.15 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 114.952 1.464 . . . . 10.0 114.952 -178.114 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 69.4 mtp85 -53.81 -42.02 67.94 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 118.887 0.767 . . . . 10.0 110.682 176.592 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -69.47 -32.03 70.68 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.805 1.242 . . . . 10.0 114.27 176.761 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.8 t -55.11 -52.09 48.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-N 119.055 0.843 . . . . 10.0 109.7 168.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 67.8 m95 -61.38 -44.11 97.72 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 114.287 1.217 . . . . 10.0 114.287 174.455 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 88.0 t90 -53.34 -48.15 68.74 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 124.254 1.022 . . . . 10.0 112.704 172.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -57.43 -52.78 64.0 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.984 0.914 . . . . 10.0 111.602 177.071 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 97.6 mt -54.46 -50.79 55.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 125.043 1.337 . . . . 10.0 111.712 174.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 20.8 m -52.38 -47.96 65.9 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.96 1.304 . . . . 10.0 111.395 174.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 54.3 m -63.6 -41.6 98.31 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 126.167 1.787 . . . . 10.0 112.171 179.14 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -57.67 -50.18 74.02 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 119.274 0.943 . . . . 10.0 112.265 171.494 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -57.36 -47.66 81.04 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 123.83 0.852 . . . . 10.0 112.633 174.178 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 10.3 tmm? -52.24 -54.76 27.14 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.96 1.704 . . . . 10.0 111.903 172.305 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 61.4 tp -56.89 -48.94 77.0 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.994 1.718 . . . . 10.0 112.808 178.156 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 70.2 t80 -49.35 -53.79 20.53 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.131 0.972 . . . . 10.0 111.631 171.536 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 52.2 mt -54.05 -55.14 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 123.824 0.85 . . . . 10.0 110.774 177.806 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 19.4 mt -57.24 -35.37 69.62 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 118.055 -0.974 . . . . 10.0 113.461 177.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -57.26 -58.21 9.22 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 119.398 0.999 . . . . 10.0 113.036 172.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.42 -40.91 85.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-O 118.263 -0.875 . . . . 10.0 111.408 177.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 44.9 mt -56.8 -49.39 75.51 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 119.907 1.231 . . . . 10.0 112.148 171.285 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.469 ' HA ' ' HD2' ' A' ' 175' ' ' ARG . 11.9 t80 -76.95 -70.33 0.47 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 120.092 -1.63 . . . . 10.0 112.869 -175.248 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -73.78 -21.87 60.03 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.596 1.158 . . . . 10.0 113.454 -174.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -87.88 -79.07 1.26 Allowed Glycine 0 CA--C 1.527 0.784 0 C-N-CA 123.6 0.619 . . . . 10.0 113.532 171.504 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -53.59 -32.4 50.92 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 126.266 1.826 . . . . 10.0 113.08 -166.584 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.2 m -52.15 -56.44 14.54 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 113.996 1.109 . . . . 10.0 113.996 172.158 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.6 p -53.65 -50.57 65.47 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 122.126 0.965 . . . . 10.0 112.325 -177.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 47.6 tttm -57.11 -46.06 82.92 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.165 0.986 . . . . 10.0 112.118 173.643 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.86 -47.49 80.27 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 114.465 1.283 . . . . 10.0 114.465 174.083 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -56.41 -11.34 1.21 Allowed 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.097 1.759 . . . . 10.0 114.249 177.647 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.1 m -107.07 6.64 29.13 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.396 1.878 . . . . 10.0 114.891 -179.334 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 93.3 mmm -91.89 -92.69 0.15 Allowed 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 123.499 1.619 . . . . 10.0 114.132 -170.602 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -138.67 153.96 72.72 Favored Pre-proline 0 C--O 1.236 0.349 0 C-N-CA 129.807 3.243 . . . . 10.0 105.529 170.237 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -52.83 -46.22 35.19 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.305 2.003 . . . . 10.0 113.064 179.018 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.666 ' CD ' ' HD3' ' A' ' 227' ' ' ARG . 0.1 OUTLIER -53.02 -46.04 68.24 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 129.006 2.922 . . . . 10.0 113.27 173.635 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 92.5 t -69.16 -53.09 27.51 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.215 0 C-N-CA 124.1 0.96 . . . . 10.0 109.798 -178.651 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.1 -46.89 75.56 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.273 0.629 . . . . 10.0 111.902 177.049 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 60.2 p -59.94 -56.21 24.54 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.932 0.893 . . . . 10.0 112.68 174.657 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 61.8 m -57.23 -53.16 61.22 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.169 0.988 . . . . 10.0 113.059 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -49.55 -49.47 46.13 Favored 'General case' 0 C--O 1.221 -0.438 0 C-N-CA 123.312 0.645 . . . . 10.0 111.132 174.026 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -57.19 -48.4 78.84 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 114.618 1.34 . . . . 10.0 114.618 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 40.5 t -56.03 -49.58 74.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-N 118.808 0.731 . . . . 10.0 110.462 176.443 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 93.9 mt -58.58 -51.6 69.21 Favored 'General case' 0 C--O 1.222 -0.394 0 N-CA-C 113.218 0.821 . . . . 10.0 113.218 175.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' ARG . . . . . 0.469 ' HD2' ' HA ' ' A' ' 153' ' ' PHE . 35.5 ttp180 -47.76 -47.79 30.38 Favored 'General case' 0 C--O 1.224 -0.265 0 C-N-CA 126.807 2.043 . . . . 10.0 111.078 174.411 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 63.7 m-20 -58.48 -58.35 8.94 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 122.794 0.438 . . . . 10.0 111.274 174.39 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 59.7 t -51.95 -48.81 39.82 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 C-N-CA 124.082 0.953 . . . . 10.0 111.457 179.028 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 28.8 m -57.25 -62.81 1.5 Allowed 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 128.129 2.572 . . . . 10.0 111.976 178.031 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 55.5 t -51.32 -50.17 28.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 C-N-CA 124.572 1.149 . . . . 10.0 111.079 -179.307 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 75.6 t -58.85 -60.6 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 124.053 0.941 . . . . 10.0 112.212 177.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -58.34 -48.47 80.45 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 118.663 0.665 . . . . 10.0 112.085 -177.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 9.0 m95 -54.37 -47.92 72.09 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.04 0.936 . . . . 10.0 112.759 177.302 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 9.5 t -58.99 -25.26 63.48 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 113.872 1.064 . . . . 10.0 113.872 177.494 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -68.57 -44.54 74.19 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 119.516 1.053 . . . . 10.0 113.346 177.113 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -45.4 -54.86 13.37 Favored Pre-proline 0 N--CA 1.476 0.872 0 N-CA-C 115.449 1.648 . . . . 10.0 115.449 -177.593 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 186' ' ' PRO . . . . . 0.555 ' HB3' H183 ' A' ' 999' ' ' RET . 18.5 Cg_endo -58.16 -36.96 97.4 Favored 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 122.454 2.103 . . . . 10.0 113.327 177.062 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 25.1 t -64.07 -53.92 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 124.213 1.005 . . . . 10.0 110.607 176.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 86.9 t -53.34 -49.62 52.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 124.782 1.233 . . . . 10.0 111.587 176.723 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 25.9 t90 -55.44 -53.22 58.96 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.895 1.278 . . . . 10.0 112.466 175.258 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 9.7 tt -56.45 -44.2 80.25 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.897 0.879 . . . . 10.0 112.675 -178.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 14.7 pt -84.61 -5.78 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 N-CA-C 115.069 1.507 . . . . 10.0 115.069 -178.769 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.32 -169.25 33.08 Favored Glycine 0 N--CA 1.45 -0.374 0 CA-C-O 122.522 1.068 . . . . 10.0 113.978 -168.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 23.2 t -53.2 -40.92 64.79 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 114.236 -0.982 . . . . 10.0 111.821 177.594 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -54.78 -31.64 59.08 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 128.472 2.709 . . . . 10.0 115.209 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -131.3 -103.89 0.97 Allowed Glycine 0 CA--C 1.529 0.943 0 CA-C-N 119.441 1.019 . . . . 10.0 113.58 -167.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -89.46 127.14 35.81 Favored 'General case' 0 C--N 1.329 -0.323 0 O-C-N 120.666 -1.491 . . . . 10.0 109.3 169.221 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -72.43 65.3 1.35 Allowed Glycine 0 CA--C 1.533 1.165 0 N-CA-C 113.91 0.324 . . . . 10.0 113.91 173.141 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 60.8 mt -79.58 -42.69 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 C-N-CA 126.031 1.732 . . . . 10.0 108.748 166.399 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 79.4 t -126.31 133.41 24.94 Favored Pre-proline 0 N--CA 1.455 -0.22 0 C-N-CA 126.413 1.885 . . . . 10.0 109.353 -174.219 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -68.72 153.83 72.46 Favored 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 123.791 2.994 . . . . 10.0 111.444 -176.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 12.2 tp -43.24 -39.73 3.12 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.399 1.08 . . . . 10.0 112.142 171.502 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -48.43 -52.32 22.63 Favored 'General case' 0 CA--C 1.539 0.519 0 N-CA-C 114.669 1.359 . . . . 10.0 114.669 176.08 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 14.0 mm -75.93 -40.55 38.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 124.422 1.089 . . . . 10.0 109.625 177.586 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -49.27 -49.84 41.68 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-O 121.446 0.641 . . . . 10.0 111.921 173.659 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 16.2 m -57.7 -47.0 83.61 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 126.047 1.739 . . . . 10.0 112.991 174.331 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.535 HD23 ' CD2' ' A' ' 12' ' ' TRP . 1.3 tm? -63.38 -52.33 62.12 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.966 0.906 . . . . 10.0 112.094 179.733 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 93.4 mt -52.54 -59.06 4.9 Favored 'General case' 0 C--O 1.228 -0.07 0 C-N-CA 124.321 1.048 . . . . 10.0 109.944 176.449 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -54.02 -41.84 68.46 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 117.938 -1.029 . . . . 10.0 113.235 176.494 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 209' ' ' MET . . . . . 0.575 ' HE2' ' HB3' ' A' ' 15' ' ' LEU . 4.6 tmm? -55.66 -53.05 61.27 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 120.265 1.393 . . . . 10.0 112.086 173.749 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 79.9 t -60.95 -45.6 98.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 124.783 1.233 . . . . 10.0 111.603 178.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 4.2 mp -59.58 -51.42 69.92 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.314 1.446 . . . . 10.0 112.003 175.464 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -57.75 -52.72 64.31 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.04 1.336 . . . . 10.0 111.431 176.062 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 39.2 t -47.72 -49.57 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 124.601 1.16 . . . . 10.0 111.553 172.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 25.2 m -59.18 -51.19 71.04 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.419 1.088 . . . . 10.0 112.002 176.105 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -67.82 -19.31 65.05 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.974 1.709 . . . . 10.0 115.018 179.402 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 9.2 mptt -98.69 -75.45 0.56 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.679 1.592 . . . . 10.0 109.604 177.091 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 21.3 t -70.86 -53.86 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 125.448 1.499 . . . . 10.0 110.784 -172.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -53.84 -58.58 12.01 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 124.151 0.881 . . . . 10.0 112.96 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -45.6 -57.76 3.94 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 126.624 1.97 . . . . 10.0 112.539 170.09 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -56.99 -40.81 91.81 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 124.057 0.837 . . . . 10.0 113.857 178.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 24.4 mt -70.41 -27.12 64.04 Favored 'General case' 0 CA--C 1.513 -0.464 0 N-CA-C 115.649 1.722 . . . . 10.0 115.649 177.609 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 74.0 mt -63.34 -57.54 11.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 108.687 -0.857 . . . . 10.0 108.687 165.509 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 32.0 tp -58.77 -64.71 0.84 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.905 0.882 . . . . 10.0 113.187 -172.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 84.4 mt -71.53 5.16 2.52 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 115.27 1.582 . . . . 10.0 115.27 -171.64 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.6 mtp-105 -112.31 0.33 15.67 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.228 1.011 . . . . 10.0 113.242 172.61 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 8.8 t -108.06 177.98 4.65 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 124.038 0.935 . . . . 10.0 111.026 174.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 227' ' ' ARG . . . . . 0.666 ' HD3' ' CD ' ' A' ' 166' ' ' GLU . 41.8 ttt180 -71.65 98.19 1.86 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.732 0.813 . . . . 10.0 110.935 170.694 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 228' ' ' ALA . . . . . 0.477 ' HB1' ' CD2' ' A' ' 42' ' ' PHE . . . -80.86 76.97 7.77 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.896 0.878 . . . . 10.0 112.128 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 40.12 102.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 128.857 2.863 . . . . 10.0 116.464 177.769 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . 0.483 0.3 OUTLIER 71.86 -55.51 0.66 Allowed 'General case' 0 C--O 1.242 0.662 0 C-N-CA 124.705 1.202 . . . . 10.0 110.631 -175.331 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -68.24 169.5 39.8 Favored Glycine 0 C--O 1.239 0.429 0 C-N-CA 129.757 3.551 . . . . 10.0 119.645 171.507 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.474 0 C-N-CA 128.49 2.716 . . . . 10.0 113.429 166.585 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 999' ' ' RET . . . . . 0.555 H183 ' HB3' ' A' ' 186' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1000 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A 1001 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A 1002 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A 1003 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 N--CA 1.476 0.87 0 CA-C-O 115.799 -2.048 . . . . 10.0 105.83 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 23.39 91.88 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 129.588 3.155 . . . . 10.0 117.203 160.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 28.63 65.04 0.11 Allowed 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 128.322 2.649 . . . . 10.0 114.48 155.388 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 86.6 mt -56.48 137.97 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 126.396 1.878 . . . . 10.0 113.315 -158.35 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.652 HG21 ' HB3' ' A' ' 77' ' ' PRO . 7.6 t -136.75 -165.26 1.71 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 126.327 1.851 . . . . 10.0 114.015 -174.332 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 70.06 2.78 41.34 Favored Glycine 0 C--N 1.34 0.762 0 C-N-CA 127.464 2.459 . . . . 10.0 111.485 168.027 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -158.52 -51.37 0.01 OUTLIER Pre-proline 0 N--CA 1.443 -0.783 0 CA-C-O 114.26 -2.781 . . . . 10.0 116.619 -168.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -63.94 -60.61 0.15 Allowed 'Trans proline' 0 N--CA 1.465 -0.202 0 CA-C-N 123.55 2.303 . . . . 10.0 113.25 -175.301 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.411 ' H ' ' CD ' ' A' ' 9' ' ' GLU . 7.9 pm0 -67.25 4.3 0.99 Allowed 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 127.839 2.456 . . . . 10.0 115.755 179.71 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.422 ' CG ' ' N ' ' A' ' 11' ' ' ILE . 11.1 p-90 -51.36 -43.1 61.74 Favored 'General case' 0 C--O 1.222 -0.361 0 O-C-N 121.5 -0.75 . . . . 10.0 112.621 176.427 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.422 ' N ' ' CG ' ' A' ' 10' ' ' TRP . 8.9 tt -60.88 -49.56 84.14 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.34 0 C-N-CA 123.878 0.871 . . . . 10.0 109.336 179.407 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.535 ' CD2' HD23 ' A' ' 206' ' ' LEU . 2.6 m95 -55.44 -52.61 63.02 Favored 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 123.387 0.675 . . . . 10.0 111.887 175.594 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.6 mt -57.39 -53.53 57.06 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 123.153 0.581 . . . . 10.0 112.231 177.247 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.96 -46.75 52.69 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.378 1.471 . . . . 10.0 113.31 173.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.575 ' HB3' ' HE2' ' A' ' 209' ' ' MET . 13.3 tp -65.6 -44.95 84.99 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 125.345 1.458 . . . . 10.0 113.029 179.056 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.54 -56.72 10.57 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 124.508 1.051 . . . . 10.0 111.441 166.061 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.5 m -49.6 -52.46 30.2 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.877 1.271 . . . . 10.0 112.186 174.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.43 -58.83 5.94 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.174 0.99 . . . . 10.0 112.198 177.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 93.5 mt -57.28 -49.06 77.29 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.686 0.794 . . . . 10.0 112.695 -179.374 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.451 ' SD ' ' HB1' ' A' ' 53' ' ' ALA . 45.6 mtt -59.02 -46.62 87.75 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.418 1.087 . . . . 10.0 111.388 177.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -58.35 -58.58 13.82 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 124.394 0.997 . . . . 10.0 113.98 173.435 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 80.7 mt -56.21 -45.87 79.71 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-N 118.596 1.198 . . . . 10.0 112.113 176.215 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.15 -40.66 84.21 Favored Glycine 0 CA--C 1.532 1.122 0 O-C-N 120.931 -1.106 . . . . 10.0 113.598 173.451 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 28.1 m -61.61 -58.92 6.2 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.486 0.714 . . . . 10.0 111.19 171.306 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -52.24 -41.01 62.42 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.073 0.949 . . . . 10.0 110.95 178.086 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -55.77 -58.05 9.45 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 124.599 1.159 . . . . 10.0 112.973 172.767 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.1 m-30 -59.62 -38.69 81.99 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 113.223 0.823 . . . . 10.0 113.223 178.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.401 ' C ' ' H ' ' A' ' 30' ' ' LYS . 11.8 mt -56.1 -67.43 0.3 Allowed 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.627 1.171 . . . . 10.0 113.637 169.099 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 t -76.37 40.92 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 CA-C-O 123.708 1.718 . . . . 10.0 110.852 179.079 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.401 ' H ' ' C ' ' A' ' 28' ' ' LEU . 42.9 tttm -140.84 -44.84 0.39 Allowed 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 127.883 2.473 . . . . 10.0 109.331 171.18 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.96 23.11 0.87 Allowed Glycine 0 CA--C 1.529 0.925 0 N-CA-C 115.629 1.012 . . . . 10.0 115.629 173.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 37.3 mmm -59.51 -45.0 92.98 Favored 'General case' 0 C--O 1.225 -0.235 0 C-N-CA 127.163 2.185 . . . . 10.0 113.596 -179.034 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.69 -84.42 1.19 Allowed Glycine 0 CA--C 1.53 1.007 0 C-N-CA 123.741 0.686 . . . . 10.0 112.483 -170.17 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.8 t 33.11 88.75 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.242 0.682 0 C-N-CA 128.399 2.68 . . . . 10.0 116.937 166.45 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.2 m -79.62 -50.91 9.96 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.152 -1.385 . . . . 10.0 113.855 174.153 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -48.87 117.51 6.37 Favored Pre-proline 0 CA--C 1.536 0.415 0 O-C-N 124.769 1.293 . . . . 10.0 110.988 -172.527 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -58.56 -29.68 89.65 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 123.746 2.964 . . . . 10.0 113.72 179.092 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.31 -60.67 2.28 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.126 0.57 . . . . 10.0 111.422 176.213 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.15 -40.05 22.64 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 125.104 1.362 . . . . 10.0 113.549 171.616 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -46.53 -47.47 19.54 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 125.252 1.421 . . . . 10.0 113.434 172.049 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -57.75 -53.06 62.43 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.438 0.695 . . . . 10.0 110.974 176.671 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.477 ' CD2' ' HB1' ' A' ' 228' ' ' ALA . 44.0 m-85 -56.98 -50.23 73.32 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 123.044 0.538 . . . . 10.0 112.337 -179.117 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -54.35 -51.28 65.25 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 118.914 -0.565 . . . . 10.0 112.375 173.27 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.46 -61.95 1.95 Allowed 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 113.391 0.886 . . . . 10.0 113.391 177.182 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.3 mt -48.43 -57.76 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 C-N-CA 124.839 1.255 . . . . 10.0 110.408 178.007 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.3 m -68.57 -17.44 64.14 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.158 1.383 . . . . 10.0 113.724 -172.638 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 28.1 m -87.92 -39.63 14.6 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.45 1.1 . . . . 10.0 112.255 174.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 21.2 mt -59.19 -42.64 91.34 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 121.49 -0.756 . . . . 10.0 112.521 171.396 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 18.5 t -41.43 -63.84 0.75 Allowed Pre-proline 0 CA--C 1.551 0.993 0 C-N-CA 125.774 1.63 . . . . 10.0 113.491 175.548 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -70.22 -25.07 26.85 Favored 'Trans proline' 0 CA--C 1.544 1.017 0 C-N-CA 122.72 2.28 . . . . 10.0 114.182 176.317 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.5 -44.45 86.99 Favored 'General case' 0 CA--C 1.549 0.907 0 CA-C-N 120.683 1.583 . . . . 10.0 113.046 174.44 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 58.0 mt -54.66 -52.18 43.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 124.961 1.304 . . . . 10.0 108.998 168.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.451 ' HB1' ' SD ' ' A' ' 20' ' ' MET . . . -53.14 -49.75 65.93 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.637 1.175 . . . . 10.0 112.789 176.402 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -50.42 -58.57 5.42 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.717 1.607 . . . . 10.0 112.574 173.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.3 m -49.38 -52.64 27.13 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.119 1.368 . . . . 10.0 110.66 178.361 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.425 ' HG3' ' CB ' ' A' ' 85' ' ' ASP . 32.8 mmt -69.41 -48.22 61.71 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 123.889 0.876 . . . . 10.0 112.82 -176.369 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -57.71 -39.29 76.88 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 116.567 -1.683 . . . . 10.0 113.111 173.272 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.7 tp -53.24 -54.62 33.47 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-N 120.623 1.556 . . . . 10.0 111.273 169.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 23.9 p -51.63 -41.05 61.01 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 115.257 1.577 . . . . 10.0 115.257 179.002 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 56.5 mtm -66.93 -50.8 61.23 Favored 'General case' 0 C--N 1.334 -0.09 0 C-N-CA 123.548 0.739 . . . . 10.0 110.485 176.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.3 tp -48.57 -52.7 21.49 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.858 0.863 . . . . 10.0 112.948 172.312 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.5 mt -76.86 -5.59 48.96 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 113.835 1.05 . . . . 10.0 113.835 -177.706 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.26 -34.72 5.54 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 115.583 0.993 . . . . 10.0 115.583 174.208 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -49.24 -43.13 42.52 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 115.243 1.571 . . . . 10.0 115.243 -176.023 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.01 3.48 61.22 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 115.329 0.892 . . . . 10.0 115.329 -178.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.25 143.41 26.44 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 127.034 2.133 . . . . 10.0 109.011 172.055 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 t -145.52 171.11 15.14 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 124.029 0.931 . . . . 10.0 111.011 166.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.95 136.06 53.39 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 123.924 0.89 . . . . 10.0 109.739 179.583 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.436 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 58.6 t -129.58 129.58 23.18 Favored Pre-proline 0 C--N 1.329 -0.295 0 C-N-CA 125.063 1.345 . . . . 10.0 110.935 -176.048 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 69' ' ' VAL . 6.3 Cg_exo -80.71 116.19 3.17 Favored 'Trans proline' 0 N--CA 1.452 -0.921 0 N-CA-C 109.443 -1.022 . . . . 10.0 109.443 -178.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -156.71 164.39 38.2 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 112.862 0.69 . . . . 10.0 112.862 172.49 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.39 -82.0 0.14 Allowed Glycine 0 CA--C 1.526 0.773 0 N-CA-C 110.683 -0.967 . . . . 10.0 110.683 175.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.76 -3.33 0.7 Allowed Glycine 0 CA--C 1.527 0.812 0 N-CA-C 118.641 2.216 . . . . 10.0 118.641 170.392 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -151.63 -171.89 4.06 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 119.379 1.59 . . . . 10.0 112.228 -165.159 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -91.86 93.9 9.05 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 125.521 1.528 . . . . 10.0 111.097 -175.258 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.449 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 60.3 m-80 -89.48 120.72 69.64 Favored Pre-proline 0 N--CA 1.45 -0.429 0 N-CA-C 112.965 0.728 . . . . 10.0 112.965 -165.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.652 ' HB3' HG21 ' A' ' 5' ' ' THR . 76.1 Cg_exo -61.53 131.94 38.26 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 124.183 3.255 . . . . 10.0 112.165 171.588 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.5 mm -140.09 126.3 21.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 C-N-CA 126.043 1.737 . . . . 10.0 111.732 -179.467 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -93.64 85.03 4.75 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 122.888 1.328 . . . . 10.0 113.053 174.618 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 63.6 p-90 -59.33 -28.3 66.69 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 113.911 1.078 . . . . 10.0 113.911 174.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -55.31 -35.93 65.65 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.286 1.035 . . . . 10.0 113.575 178.268 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 6.8 ptp180 -56.8 -40.44 75.97 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 120.209 1.368 . . . . 10.0 111.281 173.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -66.16 -43.73 86.12 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 113.887 1.069 . . . . 10.0 113.887 174.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -49.39 -47.19 47.9 Favored 'General case' 0 CA--C 1.555 1.165 0 C-N-CA 124.695 1.198 . . . . 10.0 111.002 167.709 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.425 ' CB ' ' HG3' ' A' ' 56' ' ' MET . 0.0 OUTLIER -61.71 -58.92 6.14 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 125.568 1.547 . . . . 10.0 112.938 173.331 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 46.9 m0 -51.82 -40.52 60.6 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 126.829 2.052 . . . . 10.0 112.777 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 27.8 tp -50.22 -45.79 54.14 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 125.944 1.697 . . . . 10.0 112.686 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -97.94 -46.86 5.76 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 123.735 0.814 . . . . 10.0 112.753 -176.582 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -58.8 -41.44 86.77 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.903 0.881 . . . . 10.0 112.801 -175.314 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.459 ' HB ' ' HD3' ' A' ' 91' ' ' PRO . 3.1 m -66.39 -47.66 58.54 Favored Pre-proline 0 CA--C 1.541 0.598 0 O-C-N 121.094 -1.004 . . . . 10.0 111.938 -174.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.459 ' HD3' ' HB ' ' A' ' 90' ' ' THR . 86.6 Cg_exo -51.93 -42.92 55.53 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 123.34 2.694 . . . . 10.0 115.145 166.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 53.0 mt -59.79 -48.17 82.76 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 118.877 0.762 . . . . 10.0 111.875 176.089 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 84.3 mt -53.77 -45.1 70.52 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.481 1.112 . . . . 10.0 112.136 172.435 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.6 mp -57.35 -47.86 80.52 Favored 'General case' 0 CA--C 1.546 0.796 0 O-C-N 120.97 -1.082 . . . . 10.0 112.574 169.015 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.87 -38.23 78.33 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 123.824 0.85 . . . . 10.0 112.877 178.55 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -52.28 -54.05 36.34 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 119.303 0.956 . . . . 10.0 111.215 169.616 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.36 -42.07 88.59 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.585 0.754 . . . . 10.0 112.119 -178.516 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.67 -54.75 37.61 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.972 0.909 . . . . 10.0 112.006 173.632 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.3 -41.16 79.34 Favored 'General case' 0 C--O 1.224 -0.237 0 C-N-CA 123.72 0.808 . . . . 10.0 112.702 174.859 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 32.0 tp -63.75 -38.56 91.58 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 114.445 1.276 . . . . 10.0 114.445 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.2 t -94.79 1.36 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 125.106 1.362 . . . . 10.0 112.309 179.18 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.2 t70 48.57 53.46 12.11 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.858 1.663 . . . . 10.0 112.139 -173.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.29 145.89 47.56 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 119.951 -1.718 . . . . 10.0 112.44 -174.165 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.44 135.87 54.08 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 112.759 0.651 . . . . 10.0 112.759 175.15 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -42.85 -39.65 2.6 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.844 1.658 . . . . 10.0 113.49 175.297 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -47.33 -60.23 5.32 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 125.15 1.357 . . . . 10.0 115.262 169.717 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.4 p -62.06 -46.77 87.65 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 117.1 -1.428 . . . . 10.0 111.332 178.244 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 66.9 mt -48.39 -52.92 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 125.001 1.321 . . . . 10.0 111.147 178.191 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.4 tp -62.66 -51.28 67.86 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 112.509 0.559 . . . . 10.0 112.509 179.328 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.15 -44.87 43.05 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.506 0.722 . . . . 10.0 110.967 174.602 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.454 HD12 ' HA ' ' A' ' 111' ' ' LEU . 0.6 OUTLIER -59.6 -59.87 4.76 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 127.363 2.265 . . . . 10.0 114.839 174.898 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.4 t -60.97 -46.39 96.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 123.711 0.804 . . . . 10.0 111.373 -178.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -56.61 -50.3 64.02 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 123.662 0.649 . . . . 10.0 112.661 174.548 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -54.54 -46.5 73.61 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.569 0.747 . . . . 10.0 112.882 173.331 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -61.38 -40.62 95.0 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.887 0.875 . . . . 10.0 112.924 176.633 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -43.69 -59.38 3.75 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 125.995 1.76 . . . . 10.0 112.401 163.031 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 78.8 mt -56.66 -52.59 52.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 123.69 0.796 . . . . 10.0 110.925 175.357 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 46.4 ttp -46.33 -61.96 1.56 Allowed 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 126.022 1.729 . . . . 10.0 112.597 -174.087 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -80.93 -34.04 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 CA-C-O 118.933 -0.556 . . . . 10.0 112.176 -177.622 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -57.12 -48.27 81.05 Favored Glycine 0 CA--C 1.53 1.023 0 CA-C-N 119.26 0.936 . . . . 10.0 111.902 175.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 88.9 m -54.66 -44.45 73.3 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.299 1.44 . . . . 10.0 111.759 167.626 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -48.11 -52.01 18.44 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 124.773 1.178 . . . . 10.0 112.893 170.156 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 60.1 tp -59.07 -47.3 85.73 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.121 1.368 . . . . 10.0 112.201 175.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 61.9 t -53.08 -50.54 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 O-C-N 121.465 -0.772 . . . . 10.0 110.209 172.709 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -50.97 -61.28 6.27 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 126.18 1.848 . . . . 10.0 112.939 172.158 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -43.45 -41.53 4.35 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 127.993 2.517 . . . . 10.0 113.231 176.414 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 46.5 mt -99.92 -7.23 25.47 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 115.513 1.671 . . . . 10.0 115.513 -176.402 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 17.0 m -69.66 116.75 10.42 Favored 'General case' 0 N--CA 1.464 0.274 0 O-C-N 120.195 -1.566 . . . . 10.0 110.407 -178.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.622 ' H ' ' HD3' ' A' ' 129' ' ' LYS . 0.2 OUTLIER -55.5 -49.62 72.09 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 128.195 2.598 . . . . 10.0 113.288 177.758 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 60.1 t -69.58 106.32 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 123.789 0.836 . . . . 10.0 110.12 179.606 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -46.92 -59.49 3.06 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 124.761 1.224 . . . . 10.0 114.067 -173.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 m -46.5 -42.08 15.06 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.439 1.495 . . . . 10.0 113.512 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -70.16 -24.59 63.18 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 114.918 1.451 . . . . 10.0 114.918 -178.108 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 68.2 mtp85 -54.37 -41.18 68.86 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 118.876 0.762 . . . . 10.0 110.905 176.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -69.79 -31.75 69.85 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 114.34 1.237 . . . . 10.0 114.34 176.497 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.8 t -55.17 -52.23 46.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 CA-C-N 118.928 0.785 . . . . 10.0 109.82 168.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 65.0 m95 -59.48 -49.57 77.27 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 113.428 0.899 . . . . 10.0 113.428 173.46 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 83.0 t90 -48.37 -47.82 37.12 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 119.438 1.017 . . . . 10.0 113.31 173.032 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -58.74 -51.12 71.31 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.099 0.96 . . . . 10.0 111.993 176.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 97.2 mt -55.88 -50.89 66.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 125.023 1.329 . . . . 10.0 111.564 175.462 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 17.5 m -51.91 -46.17 64.52 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.241 1.016 . . . . 10.0 112.59 170.414 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 63.3 m -62.14 -44.3 96.92 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.775 1.23 . . . . 10.0 111.986 179.12 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -56.49 -50.59 71.33 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.91 0.884 . . . . 10.0 112.327 171.082 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -56.84 -44.23 81.89 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.799 0.84 . . . . 10.0 112.977 174.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 42.8 ttp -57.75 -55.77 30.59 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.406 1.082 . . . . 10.0 111.969 173.182 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -49.79 -49.67 47.74 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.461 1.505 . . . . 10.0 110.781 177.169 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -51.77 -55.8 17.66 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 113.298 0.851 . . . . 10.0 113.298 173.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 49.9 mt -54.22 -54.69 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 123.598 0.759 . . . . 10.0 110.78 177.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 42.1 mt -57.14 -36.1 70.29 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 118.409 -0.805 . . . . 10.0 112.959 178.306 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -57.33 -58.11 9.67 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 124.026 0.93 . . . . 10.0 113.03 173.405 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.48 -40.89 85.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 CA-C-O 118.303 -0.855 . . . . 10.0 111.419 177.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 45.1 mt -56.83 -49.35 75.68 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 119.893 1.224 . . . . 10.0 112.115 171.296 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.47 ' HA ' ' HD2' ' A' ' 175' ' ' ARG . 11.9 t80 -77.03 -70.34 0.47 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 120.054 -1.654 . . . . 10.0 112.862 -175.254 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -73.73 -21.91 60.06 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.634 1.174 . . . . 10.0 113.439 -174.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -87.79 -79.08 1.26 Allowed Glycine 0 CA--C 1.527 0.783 0 C-N-CA 123.625 0.631 . . . . 10.0 113.534 171.497 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -53.68 -32.4 51.54 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 126.269 1.828 . . . . 10.0 113.046 -166.539 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.3 m -52.16 -56.39 14.85 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 113.989 1.107 . . . . 10.0 113.989 172.121 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.3 p -53.65 -50.63 65.33 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 122.092 0.949 . . . . 10.0 112.249 -177.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 47.6 tttm -57.11 -46.03 82.93 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.142 0.977 . . . . 10.0 112.122 173.703 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.8 -47.5 80.07 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 114.534 1.309 . . . . 10.0 114.534 174.033 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -56.45 -11.29 1.2 Allowed 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 126.054 1.741 . . . . 10.0 114.261 177.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.1 m -107.04 6.56 29.1 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 126.474 1.91 . . . . 10.0 114.896 -179.308 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 93.2 mmm -91.88 -92.66 0.15 Allowed 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 123.487 1.613 . . . . 10.0 114.171 -170.579 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -138.74 153.94 72.59 Favored Pre-proline 0 C--O 1.236 0.359 0 C-N-CA 129.802 3.241 . . . . 10.0 105.548 170.243 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -52.85 -46.22 35.27 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.346 2.031 . . . . 10.0 113.074 179.053 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.667 ' CD ' ' HD3' ' A' ' 227' ' ' ARG . 0.1 OUTLIER -52.97 -46.09 68.06 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 128.979 2.912 . . . . 10.0 113.276 173.571 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 92.2 t -69.19 -52.99 27.97 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 C-N-CA 124.065 0.946 . . . . 10.0 109.8 -178.62 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.18 -46.82 75.81 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.319 0.648 . . . . 10.0 111.899 177.056 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 60.3 p -60.04 -56.17 24.98 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.876 0.87 . . . . 10.0 112.729 174.626 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 61.8 m -57.2 -53.17 61.13 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.184 0.994 . . . . 10.0 113.027 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -49.6 -49.49 46.55 Favored 'General case' 0 C--O 1.221 -0.414 0 C-N-CA 123.258 0.623 . . . . 10.0 111.114 174.043 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -57.16 -48.37 78.86 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 114.664 1.357 . . . . 10.0 114.664 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 40.4 t -56.01 -49.62 74.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 CA-C-N 118.832 0.742 . . . . 10.0 110.477 176.373 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 94.2 mt -58.6 -51.64 69.07 Favored 'General case' 0 C--O 1.222 -0.384 0 N-CA-C 113.141 0.793 . . . . 10.0 113.141 175.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' ARG . . . . . 0.47 ' HD2' ' HA ' ' A' ' 153' ' ' PHE . 35.5 ttp180 -47.7 -47.86 29.66 Favored 'General case' 0 C--O 1.225 -0.201 0 C-N-CA 126.852 2.061 . . . . 10.0 111.084 174.402 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 63.6 m-20 -58.48 -58.35 8.92 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 122.775 0.43 . . . . 10.0 111.234 174.397 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 54.6 t -51.77 -48.09 38.64 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 124.088 0.955 . . . . 10.0 111.858 179.061 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 28.5 m -58.19 -62.8 1.57 Allowed 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 127.959 2.503 . . . . 10.0 112.17 177.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 54.8 t -51.43 -49.18 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 124.686 1.194 . . . . 10.0 111.019 -179.158 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 70.9 t -59.76 -60.42 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 124.008 0.923 . . . . 10.0 112.374 177.483 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 77.5 mt -54.59 -52.9 60.7 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 118.414 0.552 . . . . 10.0 111.769 -178.306 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 9.9 m95 -51.79 -50.1 61.41 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 124.274 1.03 . . . . 10.0 112.35 177.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 49.2 m -52.93 -31.98 43.15 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 113.721 1.008 . . . . 10.0 113.721 178.629 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -66.1 -39.39 89.92 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 113.99 1.107 . . . . 10.0 113.99 175.393 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 44.1 m-85 -49.04 -54.6 26.97 Favored Pre-proline 0 N--CA 1.477 0.924 0 N-CA-C 115.198 1.555 . . . . 10.0 115.198 -176.016 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 186' ' ' PRO . . . . . 0.56 ' HB3' H183 ' A' ' 999' ' ' RET . 19.2 Cg_endo -57.74 -35.89 98.62 Favored 'Trans proline' 0 C--N 1.355 0.876 0 C-N-CA 122.373 2.049 . . . . 10.0 112.903 175.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 22.7 t -66.22 -54.84 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 C-N-CA 124.735 1.214 . . . . 10.0 110.855 178.463 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 58.4 t -56.24 -45.72 81.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 124.641 1.176 . . . . 10.0 111.333 177.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 66.7 t90 -56.36 -54.6 43.64 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.11 0.964 . . . . 10.0 112.2 172.465 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 60.3 tp -52.29 -46.42 65.9 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.413 1.485 . . . . 10.0 112.29 -177.301 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 15.0 pt -86.09 -5.14 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 N-CA-C 115.333 1.605 . . . . 10.0 115.333 -177.106 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.59 -169.26 32.72 Favored Glycine 0 N--CA 1.45 -0.383 0 CA-C-O 122.57 1.095 . . . . 10.0 113.826 -168.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 23.3 t -53.12 -40.15 63.99 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 114.209 -0.996 . . . . 10.0 111.853 177.643 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -71.99 -13.74 61.7 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 115.357 1.614 . . . . 10.0 115.357 -174.346 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -130.49 -106.69 1.16 Allowed Glycine 0 CA--C 1.531 1.031 0 CA-C-N 120.218 1.372 . . . . 10.0 113.349 -174.388 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -89.48 127.14 35.82 Favored 'General case' 0 C--N 1.329 -0.313 0 O-C-N 120.673 -1.487 . . . . 10.0 109.352 169.293 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -72.43 65.33 1.35 Allowed Glycine 0 CA--C 1.532 1.127 0 N-CA-C 113.937 0.335 . . . . 10.0 113.937 173.153 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 60.8 mt -79.6 -42.74 23.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 126.044 1.737 . . . . 10.0 108.717 166.389 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 79.7 t -126.28 133.4 24.93 Favored Pre-proline 0 N--CA 1.454 -0.25 0 C-N-CA 126.467 1.907 . . . . 10.0 109.368 -174.168 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -68.74 153.78 72.5 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 123.811 3.007 . . . . 10.0 111.476 -176.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 12.2 tp -43.16 -39.8 3.02 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.359 1.064 . . . . 10.0 112.193 171.487 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -48.32 -52.41 21.66 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 114.68 1.363 . . . . 10.0 114.68 176.046 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 13.9 mm -75.91 -40.5 38.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 C-N-CA 124.401 1.08 . . . . 10.0 109.658 177.588 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -49.3 -49.81 42.15 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 118.593 0.633 . . . . 10.0 111.947 173.621 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 16.1 m -57.66 -47.07 83.31 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 126.083 1.753 . . . . 10.0 112.998 174.275 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.535 HD23 ' CD2' ' A' ' 12' ' ' TRP . 1.3 tm? -63.33 -52.34 62.23 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.95 0.9 . . . . 10.0 112.073 179.726 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 93.3 mt -52.55 -58.54 6.45 Favored 'General case' 0 C--O 1.228 -0.046 0 C-N-CA 124.32 1.048 . . . . 10.0 109.973 176.457 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -55.19 -44.62 75.45 Favored 'General case' 0 C--O 1.22 -0.475 0 CA-C-O 117.608 -1.187 . . . . 10.0 113.0 176.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 209' ' ' MET . . . . . 0.575 ' HE2' ' HB3' ' A' ' 15' ' ' LEU . 4.6 tmm? -51.48 -52.51 45.97 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 120.502 1.501 . . . . 10.0 112.581 173.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 79.9 t -61.06 -48.65 88.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 124.675 1.19 . . . . 10.0 111.773 178.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 5.3 mp -57.62 -53.26 60.2 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.472 1.509 . . . . 10.0 111.89 176.337 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -55.96 -54.95 38.59 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 126.753 2.021 . . . . 10.0 110.707 177.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 37.6 t -46.76 -53.51 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 O-C-N 121.243 -0.911 . . . . 10.0 111.368 173.033 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 5.2 t -57.94 -49.35 77.09 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.248 0.619 . . . . 10.0 112.599 176.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -62.52 -31.23 71.96 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.069 1.747 . . . . 10.0 114.24 178.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 11.9 mptt -86.34 -73.75 0.45 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.262 1.425 . . . . 10.0 110.259 177.106 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 33.9 m -88.72 -34.27 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 O-C-N 121.293 -0.879 . . . . 10.0 112.781 -167.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -57.92 -58.38 14.88 Favored Glycine 0 CA--C 1.534 1.258 0 CA-C-N 119.772 1.169 . . . . 10.0 111.876 172.474 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -44.19 -57.68 3.3 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.921 2.089 . . . . 10.0 112.111 166.436 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -55.03 -41.98 79.46 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 124.059 0.838 . . . . 10.0 113.979 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 24.0 mt -71.07 -27.16 63.43 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 115.637 1.718 . . . . 10.0 115.637 177.356 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 74.1 mt -63.22 -57.61 11.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 108.684 -0.858 . . . . 10.0 108.684 165.44 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 32.1 tp -58.82 -64.63 0.86 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.935 0.894 . . . . 10.0 113.183 -172.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 84.5 mt -71.64 5.25 2.55 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 115.27 1.582 . . . . 10.0 115.27 -171.635 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.7 mtp-105 -112.33 0.39 15.67 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.203 1.001 . . . . 10.0 113.292 172.521 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 8.8 t -108.06 177.97 4.65 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 124.06 0.944 . . . . 10.0 111.015 174.636 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 227' ' ' ARG . . . . . 0.667 ' HD3' ' CD ' ' A' ' 166' ' ' GLU . 41.7 ttt180 -71.63 98.15 1.85 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.795 0.838 . . . . 10.0 110.917 170.689 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 228' ' ' ALA . . . . . 0.477 ' HB1' ' CD2' ' A' ' 42' ' ' PHE . . . -80.89 77.02 7.8 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.859 0.863 . . . . 10.0 112.116 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 40.11 102.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 128.833 2.853 . . . . 10.0 116.484 177.743 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . 0.481 0.3 OUTLIER 71.79 -55.39 0.66 Allowed 'General case' 0 C--O 1.242 0.685 0 C-N-CA 124.753 1.221 . . . . 10.0 110.68 -175.267 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -68.3 169.47 40.07 Favored Glycine 0 C--O 1.239 0.429 0 C-N-CA 129.735 3.541 . . . . 10.0 119.674 171.429 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.448 0 C-N-CA 128.491 2.716 . . . . 10.0 113.461 166.62 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 999' ' ' RET . . . . . 0.56 H183 ' HB3' ' A' ' 186' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1000 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A 1001 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A 1002 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A 1003 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 N--CA 1.477 0.876 0 CA-C-O 115.781 -2.057 . . . . 10.0 105.837 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 23.43 91.86 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 129.576 3.15 . . . . 10.0 117.262 160.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 28.59 65.12 0.1 Allowed 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 128.297 2.639 . . . . 10.0 114.458 155.437 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 86.7 mt -56.51 137.96 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 126.384 1.873 . . . . 10.0 113.343 -158.363 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.653 HG21 ' HB3' ' A' ' 77' ' ' PRO . 7.6 t -136.74 -165.19 1.69 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 126.353 1.861 . . . . 10.0 114.062 -174.347 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 70.02 2.75 40.86 Favored Glycine 0 C--N 1.339 0.743 0 C-N-CA 127.44 2.448 . . . . 10.0 111.453 168.019 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -158.57 -51.28 0.01 OUTLIER Pre-proline 0 N--CA 1.443 -0.805 0 CA-C-O 114.243 -2.789 . . . . 10.0 116.635 -168.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_exo -63.96 -60.62 0.15 Allowed 'Trans proline' 0 N--CA 1.465 -0.202 0 CA-C-N 123.576 2.313 . . . . 10.0 113.21 -175.332 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.412 ' H ' ' CD ' ' A' ' 9' ' ' GLU . 7.9 pm0 -67.26 4.31 0.99 Allowed 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 127.831 2.452 . . . . 10.0 115.783 179.707 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.422 ' CG ' ' N ' ' A' ' 11' ' ' ILE . 11.0 p-90 -51.31 -43.17 61.63 Favored 'General case' 0 C--O 1.223 -0.34 0 O-C-N 121.5 -0.75 . . . . 10.0 112.615 176.423 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.422 ' N ' ' CG ' ' A' ' 10' ' ' TRP . 8.9 tt -60.83 -49.64 83.77 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.34 0 C-N-CA 123.885 0.874 . . . . 10.0 109.344 179.403 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.535 ' CD2' HD23 ' A' ' 206' ' ' LEU . 2.6 m95 -55.39 -52.58 63.08 Favored 'General case' 0 C--O 1.224 -0.259 0 C-N-CA 123.4 0.68 . . . . 10.0 111.88 175.619 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.2 mt -57.39 -53.63 55.96 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 123.219 0.608 . . . . 10.0 112.196 177.248 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.9 -46.74 52.14 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.366 1.466 . . . . 10.0 113.332 173.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.574 ' HB3' ' HE2' ' A' ' 209' ' ' MET . 13.3 tp -65.71 -44.9 84.69 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 125.274 1.43 . . . . 10.0 113.013 179.122 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.94 -57.29 10.07 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 124.122 0.868 . . . . 10.0 111.16 166.097 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 22.5 m -48.38 -52.67 20.73 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.709 1.204 . . . . 10.0 112.347 174.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.39 -58.86 5.82 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.139 0.976 . . . . 10.0 112.188 177.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 94.3 mt -57.69 -50.23 73.88 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.696 0.799 . . . . 10.0 112.627 -179.492 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -53.73 -50.91 64.92 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.495 1.118 . . . . 10.0 111.395 175.066 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -57.95 -58.01 16.81 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 124.268 0.937 . . . . 10.0 113.579 176.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 81.2 mt -56.19 -45.83 79.63 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-N 118.527 1.164 . . . . 10.0 112.125 176.152 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.63 -41.95 75.66 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 124.854 1.216 . . . . 10.0 113.278 172.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 24.6 m -61.41 -59.5 5.16 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.984 0.913 . . . . 10.0 111.263 171.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -52.29 -40.92 62.43 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.028 0.931 . . . . 10.0 110.99 178.418 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -55.86 -57.98 9.78 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 124.619 1.168 . . . . 10.0 112.966 172.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -59.65 -38.75 82.26 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 113.193 0.812 . . . . 10.0 113.193 178.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.401 ' C ' ' H ' ' A' ' 30' ' ' LYS . 11.8 mt -56.08 -67.47 0.29 Allowed 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.58 1.152 . . . . 10.0 113.637 169.108 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 t -76.37 40.96 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 CA-C-O 123.802 1.763 . . . . 10.0 110.891 179.064 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.401 ' H ' ' C ' ' A' ' 28' ' ' LEU . 42.9 tttm -140.85 -44.82 0.39 Allowed 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 127.862 2.465 . . . . 10.0 109.317 171.12 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.9 23.1 0.86 Allowed Glycine 0 CA--C 1.529 0.908 0 N-CA-C 115.668 1.027 . . . . 10.0 115.668 173.68 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 37.4 mmm -59.54 -44.95 93.07 Favored 'General case' 0 C--O 1.225 -0.217 0 C-N-CA 127.19 2.196 . . . . 10.0 113.596 -178.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.74 -84.45 1.19 Allowed Glycine 0 CA--C 1.531 1.035 0 C-N-CA 123.798 0.713 . . . . 10.0 112.437 -170.141 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.7 t 33.06 88.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 128.358 2.663 . . . . 10.0 116.93 166.497 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.4 m -79.63 -50.86 10.04 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.155 -1.384 . . . . 10.0 113.879 174.109 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -48.95 117.46 6.39 Favored Pre-proline 0 CA--C 1.535 0.402 0 O-C-N 124.718 1.261 . . . . 10.0 110.982 -172.523 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -58.5 -29.68 89.44 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 123.779 2.986 . . . . 10.0 113.688 179.093 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.27 -60.71 2.26 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.148 0.579 . . . . 10.0 111.424 176.193 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.19 -40.05 22.94 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 125.085 1.354 . . . . 10.0 113.534 171.652 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -46.55 -47.45 19.65 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.21 1.404 . . . . 10.0 113.436 172.055 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -57.74 -53.1 61.99 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.479 0.712 . . . . 10.0 110.944 176.668 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.475 ' CD2' ' HB1' ' A' ' 228' ' ' ALA . 44.0 m-85 -56.91 -50.28 73.02 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 123.119 0.568 . . . . 10.0 112.342 -179.126 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -54.34 -51.29 65.22 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 118.936 -0.554 . . . . 10.0 112.345 173.269 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.45 -61.99 1.92 Allowed 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 113.392 0.886 . . . . 10.0 113.392 177.182 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.5 mt -48.68 -56.27 2.47 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 C-N-CA 124.864 1.266 . . . . 10.0 110.64 177.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.6 m -70.17 -17.45 63.17 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.003 1.321 . . . . 10.0 113.646 -172.521 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 27.5 m -87.8 -37.34 16.67 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.194 0.998 . . . . 10.0 112.237 174.366 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 20.8 mt -60.4 -42.57 96.19 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 118.128 -0.939 . . . . 10.0 112.518 172.436 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.594 HG23 ' HD3' ' A' ' 50' ' ' PRO 0.349 33.2 m -52.53 -53.04 57.93 Favored Pre-proline 0 N--CA 1.487 1.386 0 CA-C-N 120.645 1.566 . . . . 10.0 115.049 -179.745 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.594 ' HD3' HG23 ' A' ' 49' ' ' VAL . 68.7 Cg_endo -68.33 -25.11 36.52 Favored 'Trans proline' 0 CA--C 1.545 1.044 0 CA-C-N 123.02 2.114 . . . . 10.0 113.524 174.461 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -68.09 -45.83 72.65 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-N 120.5 1.5 . . . . 10.0 112.894 173.534 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 31.4 mm -54.07 -52.3 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 124.896 1.278 . . . . 10.0 109.525 168.056 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -52.9 -49.57 65.63 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.968 0.907 . . . . 10.0 113.04 174.795 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 52.3 t80 -51.78 -58.53 6.15 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.769 1.628 . . . . 10.0 112.19 175.574 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.1 m -49.01 -52.7 23.6 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.252 1.421 . . . . 10.0 110.629 178.279 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.439 ' HG3' ' CB ' ' A' ' 85' ' ' ASP . 32.8 mmt -69.42 -48.09 62.09 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 123.854 0.861 . . . . 10.0 112.899 -176.429 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -56.2 -40.98 74.86 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 120.321 1.419 . . . . 10.0 113.146 172.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.8 tp -53.27 -54.59 34.01 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-N 120.031 1.287 . . . . 10.0 111.292 170.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 24.0 p -51.68 -41.05 61.12 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 115.224 1.564 . . . . 10.0 115.224 178.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 57.8 mtm -66.82 -50.87 61.2 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 123.586 0.754 . . . . 10.0 110.527 176.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.4 tp -48.53 -52.67 21.46 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.857 0.863 . . . . 10.0 112.974 172.318 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.4 mt -76.97 -5.54 49.02 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 113.849 1.055 . . . . 10.0 113.849 -177.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.32 -34.71 5.55 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 115.55 0.98 . . . . 10.0 115.55 174.108 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -49.33 -43.05 43.39 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 115.235 1.568 . . . . 10.0 115.235 -175.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.05 3.58 61.04 Favored Glycine 0 CA--C 1.521 0.467 0 N-CA-C 115.358 0.903 . . . . 10.0 115.358 -179.053 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.3 143.41 26.43 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 127.035 2.134 . . . . 10.0 109.018 172.002 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 t -145.47 171.11 15.12 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 124.081 0.952 . . . . 10.0 111.062 166.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.04 136.07 53.37 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 123.919 0.888 . . . . 10.0 109.661 179.613 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.438 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 58.7 t -129.58 129.59 23.18 Favored Pre-proline 0 C--N 1.329 -0.313 0 C-N-CA 125.063 1.345 . . . . 10.0 110.96 -176.092 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 69' ' ' VAL . 6.3 Cg_exo -80.72 116.24 3.17 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 N-CA-C 109.406 -1.036 . . . . 10.0 109.406 -178.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -156.73 164.39 38.17 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 112.842 0.682 . . . . 10.0 112.842 172.491 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.36 -81.95 0.14 Allowed Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.693 -0.963 . . . . 10.0 110.693 175.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.77 -3.38 0.69 Allowed Glycine 0 CA--C 1.526 0.766 0 N-CA-C 118.642 2.217 . . . . 10.0 118.642 170.404 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -151.62 -171.87 4.05 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 119.379 1.59 . . . . 10.0 112.257 -165.151 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -91.89 93.9 9.04 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 125.534 1.533 . . . . 10.0 111.131 -175.279 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.449 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 60.4 m-80 -89.49 120.8 69.63 Favored Pre-proline 0 N--CA 1.45 -0.43 0 N-CA-C 112.933 0.716 . . . . 10.0 112.933 -165.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.653 ' HB3' HG21 ' A' ' 5' ' ' THR . 76.0 Cg_exo -61.52 131.94 38.31 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 124.205 3.27 . . . . 10.0 112.166 171.573 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.6 mm -140.18 126.32 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 C-N-CA 126.072 1.749 . . . . 10.0 111.712 -179.501 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -93.62 85.07 4.77 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 123.171 1.463 . . . . 10.0 113.041 174.63 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 63.7 p-90 -59.38 -28.32 66.79 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 120.729 -1.232 . . . . 10.0 113.873 174.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -54.51 -37.28 65.15 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 115.087 1.514 . . . . 10.0 115.087 178.267 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -59.66 -35.93 75.42 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 120.311 1.414 . . . . 10.0 112.488 172.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 -66.73 -42.91 85.52 Favored 'General case' 0 CA--C 1.545 0.752 0 O-C-N 120.997 -1.065 . . . . 10.0 112.876 173.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -49.47 -49.56 44.97 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 125.361 1.464 . . . . 10.0 111.321 166.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.439 ' CB ' ' HG3' ' A' ' 56' ' ' MET . 0.0 OUTLIER -59.46 -60.29 4.09 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.001 1.321 . . . . 10.0 112.533 173.385 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 51.8 m0 -54.82 -37.94 66.75 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 126.034 1.733 . . . . 10.0 113.161 -175.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 31.3 tp -49.84 -45.51 50.36 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 126.677 1.991 . . . . 10.0 111.86 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -97.33 -40.74 8.58 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 123.666 0.787 . . . . 10.0 112.502 -179.662 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -61.93 -44.98 95.64 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 113.275 0.843 . . . . 10.0 113.275 -175.581 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . 0.293 81.7 p -69.58 -39.19 11.34 Favored Pre-proline 0 CA--C 1.544 0.719 0 CA-C-O 117.601 -1.19 . . . . 10.0 114.032 -174.826 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -54.31 -44.66 47.34 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 123.722 2.948 . . . . 10.0 115.451 164.218 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 51.2 mt -59.17 -46.75 87.58 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 118.948 0.795 . . . . 10.0 111.434 175.194 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.4 tp -50.79 -47.9 59.61 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.563 1.545 . . . . 10.0 112.226 172.448 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.5 mp -59.86 -46.64 88.67 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.293 1.437 . . . . 10.0 112.832 170.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.81 -38.27 78.25 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 123.806 0.842 . . . . 10.0 112.866 178.29 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -52.26 -54.04 36.3 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 119.329 0.968 . . . . 10.0 111.21 169.639 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.36 -42.06 88.57 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.671 0.788 . . . . 10.0 112.119 -178.526 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.71 -54.77 37.54 Favored 'General case' 0 C--O 1.225 -0.186 0 C-N-CA 123.982 0.913 . . . . 10.0 111.999 173.611 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.27 -41.21 79.27 Favored 'General case' 0 C--O 1.224 -0.237 0 C-N-CA 123.72 0.808 . . . . 10.0 112.678 174.858 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.8 tp -63.74 -38.57 91.62 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 114.424 1.268 . . . . 10.0 114.424 -179.582 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.1 t -94.83 1.44 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 125.035 1.334 . . . . 10.0 112.308 179.186 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.2 t70 48.59 53.49 12.08 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.882 1.673 . . . . 10.0 112.1 -174.038 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.29 145.89 47.56 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 119.951 -1.718 . . . . 10.0 112.422 -174.152 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.5 135.91 54.29 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 112.694 0.627 . . . . 10.0 112.694 175.158 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -42.87 -39.68 2.62 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.863 1.665 . . . . 10.0 113.463 175.291 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -47.33 -60.17 5.36 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 125.133 1.349 . . . . 10.0 115.293 169.754 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.6 p -62.07 -46.77 87.66 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 117.098 -1.429 . . . . 10.0 111.356 178.203 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 66.9 mt -48.42 -52.89 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 124.979 1.312 . . . . 10.0 111.153 178.197 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.2 tp -62.66 -51.25 67.98 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 112.544 0.572 . . . . 10.0 112.544 179.275 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.19 -44.81 43.44 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.424 0.69 . . . . 10.0 110.983 174.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.455 ' HA ' HD12 ' A' ' 111' ' ' LEU . 0.6 OUTLIER -59.56 -59.93 4.66 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 127.365 2.266 . . . . 10.0 114.838 174.907 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.6 t -60.99 -46.38 96.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 123.666 0.786 . . . . 10.0 111.37 -178.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -56.63 -50.26 64.35 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 123.659 0.647 . . . . 10.0 112.633 174.56 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -55.0 -46.62 75.18 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 113.451 0.908 . . . . 10.0 113.451 173.356 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -56.06 -47.14 78.49 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.466 0.706 . . . . 10.0 111.657 173.356 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -43.95 -54.23 6.09 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 124.88 1.229 . . . . 10.0 112.928 169.36 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 79.4 mt -58.22 -50.61 77.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 123.726 0.81 . . . . 10.0 111.979 173.303 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 53.1 ttp -49.05 -57.01 7.28 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.152 1.381 . . . . 10.0 112.061 179.487 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 36.5 mm -69.13 -44.84 80.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 O-C-N 121.735 -0.603 . . . . 10.0 111.912 178.233 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -51.95 -54.63 24.78 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 125.121 1.343 . . . . 10.0 113.249 176.485 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 35.2 p -60.85 -36.93 80.4 Favored 'General case' 0 N--CA 1.473 0.709 0 O-C-N 121.286 -1.126 . . . . 10.0 112.589 173.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -52.82 -55.24 24.33 Favored Glycine 0 CA--C 1.537 1.446 0 CA-C-N 119.215 0.916 . . . . 10.0 113.445 167.282 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -49.78 -50.64 43.96 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 128.58 2.752 . . . . 10.0 111.135 173.011 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 60.7 t -60.31 -50.25 81.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 124.542 1.137 . . . . 10.0 111.61 175.257 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -51.76 -59.59 8.44 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 125.893 1.711 . . . . 10.0 112.115 175.412 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -48.46 -37.9 18.49 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 127.027 2.131 . . . . 10.0 113.417 179.04 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 48.1 mt -99.4 -6.78 27.14 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 115.442 1.645 . . . . 10.0 115.442 -178.483 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 16.9 m -69.73 116.7 10.43 Favored 'General case' 0 N--CA 1.464 0.229 0 O-C-N 120.178 -1.576 . . . . 10.0 110.386 -178.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.622 ' H ' ' HD3' ' A' ' 129' ' ' LYS . 0.1 OUTLIER -55.4 -49.67 71.74 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 128.226 2.61 . . . . 10.0 113.299 177.751 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 60.6 t -69.61 106.31 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 C-N-CA 123.766 0.826 . . . . 10.0 110.141 179.628 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -46.87 -59.57 2.99 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 124.807 1.243 . . . . 10.0 114.048 -173.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 m -46.44 -42.11 14.86 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.478 1.511 . . . . 10.0 113.495 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -70.1 -24.68 63.25 Favored 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 114.958 1.466 . . . . 10.0 114.958 -178.134 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 69.5 mtp85 -53.76 -41.9 67.64 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 118.852 0.751 . . . . 10.0 110.814 176.618 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -69.43 -32.32 71.21 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.76 1.224 . . . . 10.0 114.233 176.667 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.8 t -55.12 -51.97 49.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-N 119.015 0.825 . . . . 10.0 109.932 169.03 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 69.3 m95 -59.51 -51.07 71.46 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 113.517 0.932 . . . . 10.0 113.517 174.29 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 86.5 t90 -48.79 -46.82 42.11 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.563 1.145 . . . . 10.0 113.494 174.22 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -58.12 -51.97 67.5 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.973 0.909 . . . . 10.0 111.683 175.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 97.6 mt -55.23 -50.52 63.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 125.062 1.345 . . . . 10.0 111.673 174.707 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 25.1 m -53.62 -44.91 69.9 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.495 1.118 . . . . 10.0 112.367 173.22 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 61.4 m -65.44 -42.0 92.88 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.051 1.34 . . . . 10.0 111.828 178.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -55.77 -48.33 75.49 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 119.368 0.985 . . . . 10.0 112.089 169.687 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -58.25 -48.63 79.8 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.661 0.784 . . . . 10.0 112.934 174.362 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.4 -47.48 83.76 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 118.914 0.779 . . . . 10.0 111.955 175.699 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 61.6 tp -56.36 -49.39 74.56 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.202 1.401 . . . . 10.0 112.203 176.559 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 73.9 t80 -51.08 -54.25 26.67 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.97 0.908 . . . . 10.0 112.095 172.026 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 59.8 mt -54.07 -55.36 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 123.806 0.842 . . . . 10.0 110.662 177.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 21.8 mt -57.33 -35.35 69.76 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 118.009 -0.996 . . . . 10.0 113.067 178.341 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -57.31 -58.2 9.29 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 119.52 1.055 . . . . 10.0 113.011 173.08 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.41 -40.95 85.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-O 118.279 -0.867 . . . . 10.0 111.408 177.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 44.3 mt -56.77 -49.36 75.51 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 119.909 1.231 . . . . 10.0 112.148 171.275 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.471 ' HA ' ' HD2' ' A' ' 175' ' ' ARG . 11.8 t80 -77.05 -70.3 0.47 Allowed 'General case' 0 C--N 1.326 -0.447 0 O-C-N 120.056 -1.653 . . . . 10.0 112.848 -175.208 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -73.71 -21.94 60.07 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.612 1.165 . . . . 10.0 113.473 -174.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -87.85 -79.09 1.26 Allowed Glycine 0 CA--C 1.526 0.77 0 C-N-CA 123.588 0.613 . . . . 10.0 113.493 171.529 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -53.6 -32.48 51.28 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 126.305 1.842 . . . . 10.0 113.033 -166.526 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.0 m -52.03 -56.47 14.15 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 114.04 1.126 . . . . 10.0 114.04 172.11 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.5 p -53.68 -50.53 65.61 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 122.099 0.952 . . . . 10.0 112.308 -177.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 47.7 tttm -57.17 -45.97 83.21 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.166 0.986 . . . . 10.0 112.112 173.667 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.9 -47.42 80.57 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 114.497 1.295 . . . . 10.0 114.497 174.066 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -56.5 -11.23 1.19 Allowed 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 126.077 1.751 . . . . 10.0 114.271 177.673 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.1 m -107.16 6.64 28.96 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.424 1.89 . . . . 10.0 114.852 -179.309 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 93.3 mmm -91.89 -92.67 0.15 Allowed 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 123.475 1.607 . . . . 10.0 114.187 -170.667 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -138.69 153.99 72.72 Favored Pre-proline 0 C--O 1.236 0.359 0 C-N-CA 129.794 3.238 . . . . 10.0 105.56 170.196 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -52.85 -46.25 35.03 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.321 2.014 . . . . 10.0 113.078 179.061 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.666 ' CD ' ' HD3' ' A' ' 227' ' ' ARG . 0.1 OUTLIER -52.98 -46.02 68.08 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 129.013 2.925 . . . . 10.0 113.276 173.573 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 92.2 t -69.25 -53.0 27.74 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.249 0 C-N-CA 124.071 0.949 . . . . 10.0 109.788 -178.628 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.13 -46.82 75.66 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.31 0.644 . . . . 10.0 111.947 177.032 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 60.0 p -59.97 -56.25 24.07 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.919 0.887 . . . . 10.0 112.708 174.613 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 61.5 m -57.15 -53.25 60.24 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.23 1.012 . . . . 10.0 112.995 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -49.53 -49.57 45.48 Favored 'General case' 0 C--O 1.222 -0.375 0 C-N-CA 123.252 0.621 . . . . 10.0 111.113 174.064 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -57.1 -48.4 78.7 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 114.703 1.371 . . . . 10.0 114.703 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 40.5 t -55.98 -49.59 74.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 CA-C-N 118.795 0.725 . . . . 10.0 110.496 176.381 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 94.3 mt -58.58 -51.64 69.04 Favored 'General case' 0 C--O 1.221 -0.441 0 N-CA-C 113.132 0.79 . . . . 10.0 113.132 175.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' ARG . . . . . 0.471 ' HD2' ' HA ' ' A' ' 153' ' ' PHE . 35.6 ttp180 -47.81 -47.8 30.92 Favored 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 126.846 2.059 . . . . 10.0 111.011 174.509 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 63.7 m-20 -58.48 -58.36 8.88 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 122.817 0.447 . . . . 10.0 111.277 174.404 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 60.0 t -51.78 -49.04 37.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 C-N-CA 124.075 0.95 . . . . 10.0 111.53 179.019 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 28.7 m -57.4 -62.51 1.73 Allowed 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 128.025 2.53 . . . . 10.0 112.007 178.061 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 54.3 t -51.55 -50.31 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 C-N-CA 124.491 1.116 . . . . 10.0 111.069 -179.255 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 73.6 t -58.05 -62.6 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 124.022 0.929 . . . . 10.0 111.482 177.549 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -56.99 -48.71 77.77 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 118.869 0.759 . . . . 10.0 112.468 -177.236 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 10.9 m95 -55.67 -45.26 77.75 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.94 0.896 . . . . 10.0 112.615 177.621 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 51.2 p -56.85 -31.63 64.97 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 114.029 1.122 . . . . 10.0 114.029 176.478 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -65.73 -41.06 92.66 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 113.722 1.008 . . . . 10.0 113.722 178.289 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -47.38 -55.53 15.91 Favored Pre-proline 0 N--CA 1.477 0.887 0 N-CA-C 115.286 1.587 . . . . 10.0 115.286 -177.128 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' PRO . . . . . 0.482 ' HB3' H183 ' A' ' 999' ' ' RET . 19.1 Cg_endo -57.83 -36.48 98.26 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 122.244 1.962 . . . . 10.0 113.083 175.832 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 21.8 t -63.74 -53.58 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 124.105 0.962 . . . . 10.0 111.219 176.396 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 87.5 t -54.72 -48.63 72.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 124.408 1.083 . . . . 10.0 111.374 177.374 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 26.5 t90 -55.7 -52.63 63.22 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.685 1.194 . . . . 10.0 112.388 174.318 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 34.6 tp -53.21 -45.49 68.64 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.778 1.231 . . . . 10.0 112.511 -179.126 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 14.7 pt -87.92 -5.41 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 N-CA-C 115.318 1.599 . . . . 10.0 115.318 -176.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.39 -169.23 32.98 Favored Glycine 0 N--CA 1.451 -0.341 0 CA-C-O 122.614 1.119 . . . . 10.0 113.875 -168.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 23.2 t -53.19 -40.86 64.73 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 114.153 -1.023 . . . . 10.0 111.83 177.572 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -53.97 -32.94 55.53 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 128.571 2.748 . . . . 10.0 115.262 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -130.85 -103.84 0.99 Allowed Glycine 0 CA--C 1.527 0.82 0 CA-C-N 119.324 0.965 . . . . 10.0 113.384 -167.371 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -89.49 127.14 35.82 Favored 'General case' 0 C--N 1.328 -0.33 0 O-C-N 120.624 -1.515 . . . . 10.0 109.308 169.379 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -72.41 65.27 1.35 Allowed Glycine 0 CA--C 1.532 1.105 0 N-CA-C 113.899 0.32 . . . . 10.0 113.899 173.164 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 60.7 mt -79.57 -42.73 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 C-N-CA 126.088 1.755 . . . . 10.0 108.748 166.378 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 79.2 t -126.27 133.4 24.92 Favored Pre-proline 0 N--CA 1.454 -0.264 0 C-N-CA 126.408 1.883 . . . . 10.0 109.364 -174.207 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -68.68 153.73 72.74 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 123.811 3.007 . . . . 10.0 111.471 -176.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 12.2 tp -43.08 -39.86 2.92 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.358 1.063 . . . . 10.0 112.199 171.434 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -48.28 -52.43 21.31 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 114.705 1.372 . . . . 10.0 114.705 176.052 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 14.0 mm -75.89 -40.55 38.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 124.39 1.076 . . . . 10.0 109.625 177.565 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -49.24 -49.85 41.29 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 118.596 0.635 . . . . 10.0 111.934 173.656 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 16.2 m -57.64 -47.1 83.17 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 126.046 1.738 . . . . 10.0 112.993 174.29 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.535 HD23 ' CD2' ' A' ' 12' ' ' TRP . 1.3 tm? -63.31 -52.34 62.31 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.947 0.899 . . . . 10.0 112.112 179.721 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 93.3 mt -52.52 -59.49 4.38 Favored 'General case' 0 CA--C 1.527 0.068 0 C-N-CA 124.321 1.048 . . . . 10.0 109.963 176.445 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -54.88 -42.14 71.73 Favored 'General case' 0 C--O 1.221 -0.442 0 CA-C-O 117.52 -1.229 . . . . 10.0 112.938 176.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 209' ' ' MET . . . . . 0.574 ' HE2' ' HB3' ' A' ' 15' ' ' LEU . 4.6 tmm? -53.65 -53.42 52.19 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 121.033 1.742 . . . . 10.0 112.341 173.365 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 79.1 t -60.55 -46.92 94.76 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 124.824 1.25 . . . . 10.0 111.674 178.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 4.3 mp -58.25 -53.19 61.08 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.368 1.467 . . . . 10.0 111.621 175.132 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -55.84 -53.38 57.44 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.562 1.545 . . . . 10.0 111.277 178.669 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 45.7 t -49.12 -59.67 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 124.883 1.273 . . . . 10.0 111.145 174.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 28.5 p -62.33 -46.84 86.87 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.382 0.673 . . . . 10.0 112.503 -177.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -70.1 1.42 4.69 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 115.613 1.708 . . . . 10.0 115.613 178.428 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 18.8 mtmm -131.33 -63.25 0.85 Allowed 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 119.986 1.266 . . . . 10.0 112.231 173.485 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 21.0 t -66.34 -52.11 50.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 123.762 0.825 . . . . 10.0 110.507 178.345 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -56.78 -55.45 29.98 Favored Glycine 0 CA--C 1.536 1.379 0 C-N-CA 124.098 0.856 . . . . 10.0 112.832 176.08 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -43.24 -55.86 3.77 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.495 1.918 . . . . 10.0 112.483 167.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -59.16 -39.49 94.54 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 124.857 1.218 . . . . 10.0 113.266 179.304 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 24.6 mt -69.13 -27.82 65.91 Favored 'General case' 0 CA--C 1.512 -0.495 0 N-CA-C 115.742 1.756 . . . . 10.0 115.742 175.007 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 74.3 mt -63.37 -57.57 11.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 119.122 0.874 . . . . 10.0 108.648 165.641 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 32.0 tp -58.77 -64.68 0.84 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.877 0.871 . . . . 10.0 113.213 -172.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 84.0 mt -71.52 5.16 2.51 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 115.337 1.606 . . . . 10.0 115.337 -171.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.6 mtp-105 -112.35 0.44 15.67 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.139 0.976 . . . . 10.0 113.288 172.559 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 8.8 t -108.06 177.97 4.65 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 124.096 0.958 . . . . 10.0 111.025 174.659 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 227' ' ' ARG . . . . . 0.666 ' HD3' ' CD ' ' A' ' 166' ' ' GLU . 41.8 ttt180 -71.62 98.11 1.84 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.819 0.848 . . . . 10.0 110.969 170.637 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 228' ' ' ALA . . . . . 0.475 ' HB1' ' CD2' ' A' ' 42' ' ' PHE . . . -80.91 77.03 7.83 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.859 0.864 . . . . 10.0 112.123 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 40.16 102.25 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 128.886 2.874 . . . . 10.0 116.446 177.724 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . 0.481 0.3 OUTLIER 71.85 -55.43 0.66 Allowed 'General case' 0 C--O 1.242 0.67 0 C-N-CA 124.711 1.205 . . . . 10.0 110.637 -175.318 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -68.28 169.47 40.01 Favored Glycine 0 C--O 1.239 0.417 0 C-N-CA 129.757 3.551 . . . . 10.0 119.653 171.474 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.461 0 C-N-CA 128.501 2.72 . . . . 10.0 113.462 166.617 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 999' ' ' RET . . . . . 0.492 H181 ' H7 ' ' A' ' 999' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1000 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A 1001 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A 1002 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A 1003 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 N--CA 1.477 0.881 0 CA-C-O 115.768 -2.063 . . . . 10.0 105.842 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 23.35 91.83 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 129.598 3.159 . . . . 10.0 117.262 160.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 28.74 65.04 0.11 Allowed 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 128.265 2.626 . . . . 10.0 114.5 155.395 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 86.7 mt -56.51 138.0 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 126.353 1.861 . . . . 10.0 113.338 -158.342 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.653 HG21 ' HB3' ' A' ' 77' ' ' PRO . 7.6 t -136.79 -165.2 1.7 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 126.331 1.852 . . . . 10.0 114.015 -174.337 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 70.06 2.75 41.2 Favored Glycine 0 C--N 1.339 0.743 0 C-N-CA 127.458 2.456 . . . . 10.0 111.462 168.024 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -158.54 -51.29 0.01 OUTLIER Pre-proline 0 N--CA 1.443 -0.822 0 CA-C-O 114.267 -2.778 . . . . 10.0 116.694 -168.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -63.99 -60.63 0.15 Allowed 'Trans proline' 0 N--CA 1.465 -0.186 0 CA-C-N 123.502 2.286 . . . . 10.0 113.205 -175.334 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.411 ' H ' ' CD ' ' A' ' 9' ' ' GLU . 7.9 pm0 -67.24 4.3 0.98 Allowed 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 127.844 2.458 . . . . 10.0 115.768 179.716 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.421 ' CG ' ' N ' ' A' ' 11' ' ' ILE . 11.1 p-90 -51.39 -43.07 61.8 Favored 'General case' 0 C--O 1.222 -0.361 0 O-C-N 121.496 -0.752 . . . . 10.0 112.594 176.481 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.421 ' N ' ' CG ' ' A' ' 10' ' ' TRP . 8.8 tt -60.91 -49.57 84.13 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.338 0 C-N-CA 123.884 0.874 . . . . 10.0 109.337 179.429 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.536 ' CD2' HD23 ' A' ' 206' ' ' LEU . 2.6 m95 -55.45 -52.64 62.96 Favored 'General case' 0 C--O 1.224 -0.259 0 C-N-CA 123.413 0.685 . . . . 10.0 111.819 175.626 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.9 mt -57.39 -53.58 56.56 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 123.184 0.594 . . . . 10.0 112.198 177.29 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.83 -46.82 51.63 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.39 1.476 . . . . 10.0 113.335 173.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.575 ' HB3' ' HE2' ' A' ' 209' ' ' MET . 13.3 tp -65.67 -44.88 84.92 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.27 1.428 . . . . 10.0 113.059 179.12 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.4 -57.58 9.09 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 124.553 1.073 . . . . 10.0 111.045 165.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.0 m -48.91 -52.47 24.34 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.911 1.284 . . . . 10.0 112.333 175.177 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.4 -58.87 5.75 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.148 0.979 . . . . 10.0 112.155 177.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 96.5 mt -58.06 -49.08 78.16 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.651 0.781 . . . . 10.0 112.515 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 21.8 mmt -54.43 -51.59 64.45 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.811 0.845 . . . . 10.0 111.056 175.599 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -56.87 -58.48 14.31 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 124.584 1.088 . . . . 10.0 113.624 177.018 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 80.7 mt -56.18 -45.72 79.66 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-N 118.617 1.208 . . . . 10.0 112.107 176.298 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.79 -41.84 76.73 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 124.725 1.155 . . . . 10.0 113.374 172.747 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 19.1 m -60.43 -60.44 3.8 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.228 1.011 . . . . 10.0 111.083 171.525 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -52.34 -40.96 62.6 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.99 0.916 . . . . 10.0 110.925 179.007 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.4 t80 -55.82 -58.05 9.49 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.564 1.146 . . . . 10.0 112.943 172.808 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -59.59 -38.72 81.96 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 113.184 0.809 . . . . 10.0 113.184 178.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.4 ' C ' ' H ' ' A' ' 30' ' ' LYS . 11.8 mt -56.12 -67.47 0.29 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.656 1.182 . . . . 10.0 113.589 169.167 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 t -76.41 41.04 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 CA-C-O 123.775 1.75 . . . . 10.0 110.889 179.075 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.4 ' H ' ' C ' ' A' ' 28' ' ' LEU . 43.0 tttm -140.89 -44.83 0.39 Allowed 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 127.899 2.48 . . . . 10.0 109.337 171.166 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -73.0 23.15 0.88 Allowed Glycine 0 CA--C 1.528 0.898 0 N-CA-C 115.619 1.007 . . . . 10.0 115.619 173.722 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 37.4 mmm -59.51 -45.04 92.87 Favored 'General case' 0 C--O 1.224 -0.278 0 C-N-CA 127.189 2.196 . . . . 10.0 113.581 -179.018 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.65 -84.42 1.18 Allowed Glycine 0 CA--C 1.53 1.026 0 C-N-CA 123.743 0.687 . . . . 10.0 112.465 -170.155 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.8 t 33.06 88.78 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.242 0.682 0 C-N-CA 128.399 2.68 . . . . 10.0 116.905 166.499 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.4 m -79.63 -50.85 10.04 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.163 -1.38 . . . . 10.0 113.868 174.111 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -49.02 117.58 6.59 Favored Pre-proline 0 CA--C 1.536 0.418 0 O-C-N 124.767 1.292 . . . . 10.0 110.95 -172.479 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -58.62 -29.61 89.69 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 123.721 2.947 . . . . 10.0 113.688 179.16 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.32 -60.64 2.3 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.08 0.552 . . . . 10.0 111.436 176.179 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.12 -40.11 22.54 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 125.134 1.373 . . . . 10.0 113.58 171.61 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -46.5 -47.5 19.37 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.21 1.404 . . . . 10.0 113.425 172.025 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -57.73 -53.01 63.02 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.452 0.701 . . . . 10.0 111.036 176.67 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.477 ' CD2' ' HB1' ' A' ' 228' ' ' ALA . 43.9 m-85 -56.98 -50.21 73.39 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 123.057 0.543 . . . . 10.0 112.348 -179.174 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -54.39 -51.27 65.36 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 118.966 -0.54 . . . . 10.0 112.369 173.278 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.39 -62.08 1.86 Allowed 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 113.353 0.871 . . . . 10.0 113.353 177.144 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.6 mt -48.62 -58.85 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 C-N-CA 124.862 1.265 . . . . 10.0 110.844 178.03 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 86.7 m -71.1 -13.67 62.04 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 114.128 1.159 . . . . 10.0 114.128 -173.585 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 29.3 m -85.26 -42.9 14.23 Favored 'General case' 0 N--CA 1.482 1.159 0 CA-C-N 120.422 1.465 . . . . 10.0 112.099 171.238 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 17.7 mt -56.31 -42.98 78.49 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 112.845 0.683 . . . . 10.0 112.845 174.525 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 37.7 t -48.76 -62.03 2.72 Favored Pre-proline 0 CA--C 1.551 1.001 0 C-N-CA 124.861 1.265 . . . . 10.0 112.728 178.557 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -49.92 -45.84 30.59 Favored 'Trans proline' 0 CA--C 1.543 0.934 0 C-N-CA 124.104 3.203 . . . . 10.0 115.846 164.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.0 -49.36 77.75 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 114.162 1.171 . . . . 10.0 114.162 -175.195 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.477 HG23 ' O ' ' A' 1001 ' ' HOH 0.274 16.1 tt -68.09 -36.08 74.03 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 O-C-N 120.598 -1.313 . . . . 10.0 111.421 173.918 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.65 -42.09 92.0 Favored 'General case' 0 CA--C 1.545 0.771 0 O-C-N 121.193 -0.942 . . . . 10.0 112.729 173.198 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -50.82 -56.05 13.99 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.541 1.537 . . . . 10.0 111.647 168.277 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 14.0 m -48.04 -53.37 16.56 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.653 1.581 . . . . 10.0 111.2 176.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 32.4 mmt -68.57 -48.25 64.69 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 123.966 0.907 . . . . 10.0 113.011 -176.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -56.06 -41.13 74.62 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 120.035 1.289 . . . . 10.0 113.342 173.084 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.8 tp -53.28 -54.6 33.96 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-N 119.54 1.064 . . . . 10.0 111.273 170.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 24.1 p -51.73 -41.0 61.2 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 115.217 1.562 . . . . 10.0 115.217 179.057 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 58.5 mtm -66.86 -50.89 61.08 Favored 'General case' 0 C--N 1.333 -0.122 0 C-N-CA 123.589 0.756 . . . . 10.0 110.491 176.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.4 tp -48.51 -52.73 21.05 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.849 0.86 . . . . 10.0 112.931 172.344 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.5 mt -76.89 -5.53 48.79 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 113.844 1.053 . . . . 10.0 113.844 -177.705 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.2 -34.63 5.61 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 115.579 0.992 . . . . 10.0 115.579 174.169 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -49.35 -43.05 43.56 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 115.273 1.583 . . . . 10.0 115.273 -176.025 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.04 3.55 61.07 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 115.314 0.885 . . . . 10.0 115.314 -179.035 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.28 143.42 26.42 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 127.035 2.134 . . . . 10.0 108.972 172.063 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 t -145.54 171.08 15.19 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 124.031 0.932 . . . . 10.0 111.052 166.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.95 136.1 53.36 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 123.922 0.889 . . . . 10.0 109.711 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.436 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 58.6 t -129.59 129.55 23.17 Favored Pre-proline 0 C--N 1.329 -0.315 0 C-N-CA 125.1 1.36 . . . . 10.0 110.935 -176.045 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 69' ' ' VAL . 6.2 Cg_exo -80.7 116.24 3.18 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 N-CA-C 109.441 -1.023 . . . . 10.0 109.441 -178.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -156.75 164.38 38.19 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.808 0.67 . . . . 10.0 112.808 172.496 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.4 -81.98 0.14 Allowed Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.681 -0.967 . . . . 10.0 110.681 175.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.76 -3.42 0.69 Allowed Glycine 0 CA--C 1.527 0.812 0 N-CA-C 118.627 2.211 . . . . 10.0 118.627 170.437 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -151.57 -171.89 4.06 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 119.379 1.59 . . . . 10.0 112.237 -165.159 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -91.79 93.81 9.04 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 125.552 1.541 . . . . 10.0 111.115 -175.312 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.449 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 60.2 m-80 -89.47 120.74 69.65 Favored Pre-proline 0 N--CA 1.45 -0.464 0 N-CA-C 113.002 0.741 . . . . 10.0 113.002 -165.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.653 ' HB3' HG21 ' A' ' 5' ' ' THR . 76.3 Cg_exo -61.49 131.9 38.2 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 124.183 3.255 . . . . 10.0 112.166 171.6 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.6 mm -140.1 126.35 22.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 C-N-CA 126.028 1.731 . . . . 10.0 111.707 -179.501 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -93.64 85.06 4.76 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 123.455 1.598 . . . . 10.0 113.051 174.626 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 63.8 p-90 -59.44 -28.21 66.75 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 120.453 -1.404 . . . . 10.0 113.942 174.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -54.68 -35.47 63.6 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.283 1.033 . . . . 10.0 113.595 178.195 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -63.79 -23.7 67.46 Favored 'General case' 0 N--CA 1.479 1.022 0 O-C-N 120.341 -1.474 . . . . 10.0 113.667 172.514 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 68.7 m-85 -78.46 -42.04 30.99 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 120.564 -1.335 . . . . 10.0 111.92 172.183 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -49.62 -49.62 46.21 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 125.164 1.385 . . . . 10.0 111.032 166.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -51.66 -69.45 0.11 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 126.769 2.027 . . . . 10.0 111.765 169.681 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 49.5 m0 -55.77 -35.6 66.41 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 124.407 1.083 . . . . 10.0 113.182 -172.05 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 28.7 tp -49.06 -46.08 43.9 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 126.277 1.831 . . . . 10.0 111.84 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -98.18 -40.35 8.42 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.805 0.842 . . . . 10.0 112.435 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 3.7 m -48.46 -57.83 5.54 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.864 1.266 . . . . 10.0 113.424 175.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . 0.286 38.3 p -67.08 -41.31 34.34 Favored Pre-proline 0 CA--C 1.544 0.736 0 CA-C-O 117.774 -1.108 . . . . 10.0 113.764 -168.868 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -54.14 -44.98 44.46 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 123.282 2.655 . . . . 10.0 115.998 166.581 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 54.5 mt -59.56 -45.73 90.96 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 118.959 0.799 . . . . 10.0 111.218 175.582 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.1 tp -50.94 -48.98 60.75 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.419 1.487 . . . . 10.0 112.136 172.396 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.0 mp -58.83 -47.15 85.85 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 125.339 1.456 . . . . 10.0 112.68 170.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.76 -38.31 78.18 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 123.87 0.868 . . . . 10.0 112.891 178.729 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 -52.27 -54.05 36.23 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 119.31 0.959 . . . . 10.0 111.165 169.659 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.34 -42.12 88.58 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.637 0.775 . . . . 10.0 112.1 -178.535 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.72 -54.66 39.0 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 123.991 0.916 . . . . 10.0 112.034 173.673 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.32 -41.18 79.44 Favored 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 123.724 0.81 . . . . 10.0 112.739 174.782 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.8 tp -63.77 -38.5 91.32 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 114.476 1.287 . . . . 10.0 114.476 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.2 t -94.84 1.44 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 125.075 1.35 . . . . 10.0 112.275 179.172 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.2 t70 48.5 53.55 11.89 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.874 1.67 . . . . 10.0 112.137 -173.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.28 145.89 47.57 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 120.002 -1.686 . . . . 10.0 112.46 -174.199 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.54 135.96 54.45 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 112.697 0.628 . . . . 10.0 112.697 175.164 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -42.88 -39.67 2.63 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.844 1.657 . . . . 10.0 113.489 175.284 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -47.33 -60.21 5.33 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 125.15 1.357 . . . . 10.0 115.234 169.749 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.4 p -62.06 -46.79 87.55 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 117.103 -1.427 . . . . 10.0 111.34 178.241 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 66.8 mt -48.41 -52.91 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 125.034 1.334 . . . . 10.0 111.127 178.194 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.2 tp -62.61 -51.3 67.86 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 112.574 0.583 . . . . 10.0 112.574 179.281 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.17 -44.85 43.27 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.465 0.706 . . . . 10.0 110.938 174.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.455 ' HA ' HD12 ' A' ' 111' ' ' LEU . 0.6 OUTLIER -59.67 -59.83 4.81 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 127.344 2.257 . . . . 10.0 114.807 174.989 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.5 t -61.01 -46.37 96.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 123.705 0.802 . . . . 10.0 111.387 -178.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -56.59 -50.32 63.88 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 123.668 0.651 . . . . 10.0 112.664 174.525 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -54.9 -46.56 74.84 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 113.322 0.86 . . . . 10.0 113.322 173.359 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -55.36 -48.54 74.1 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.16 0.984 . . . . 10.0 111.276 173.515 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -43.02 -54.91 5.08 Favored Glycine 0 CA--C 1.533 1.213 0 C-N-CA 124.938 1.256 . . . . 10.0 113.267 169.087 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 82.5 mt -57.75 -52.3 59.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 123.694 0.798 . . . . 10.0 111.899 173.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 60.2 ttp -47.51 -58.09 4.63 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.312 1.445 . . . . 10.0 111.731 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 37.6 mm -68.81 -44.6 81.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 O-C-N 121.807 -0.558 . . . . 10.0 112.169 178.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -51.99 -59.19 9.06 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 124.703 1.144 . . . . 10.0 112.949 176.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 44.3 p -57.45 -39.11 75.59 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.467 1.107 . . . . 10.0 112.593 173.487 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -45.27 -59.22 4.73 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 124.656 1.122 . . . . 10.0 113.445 164.576 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 65.6 tp -59.11 -46.18 88.99 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.468 1.507 . . . . 10.0 112.392 178.345 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 65.5 t -53.9 -50.0 55.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 O-C-N 121.441 -0.787 . . . . 10.0 110.127 173.437 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -50.84 -60.76 6.68 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 126.227 1.87 . . . . 10.0 112.561 171.637 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -42.95 -42.21 3.66 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 127.488 2.315 . . . . 10.0 113.335 176.581 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 48.5 mt -100.9 -6.5 24.57 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 115.526 1.676 . . . . 10.0 115.526 -175.472 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 16.9 m -69.75 116.76 10.51 Favored 'General case' 0 N--CA 1.464 0.248 0 O-C-N 120.157 -1.589 . . . . 10.0 110.344 -178.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.62 ' H ' ' HD3' ' A' ' 129' ' ' LYS . 0.1 OUTLIER -55.46 -49.6 72.05 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 128.195 2.598 . . . . 10.0 113.287 177.748 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 61.3 t -69.74 106.34 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 123.774 0.83 . . . . 10.0 110.067 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -46.93 -59.5 3.05 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 124.737 1.215 . . . . 10.0 114.062 -173.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 m -46.46 -42.11 14.95 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.531 1.533 . . . . 10.0 113.49 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -70.17 -24.59 63.17 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 114.946 1.461 . . . . 10.0 114.946 -178.129 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 68.9 mtp85 -53.98 -41.74 68.21 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 118.914 0.779 . . . . 10.0 110.793 176.661 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -69.46 -32.08 70.77 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.813 1.245 . . . . 10.0 114.219 176.67 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.9 t -55.01 -51.85 49.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 CA-C-N 119.037 0.835 . . . . 10.0 109.654 168.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 67.4 m95 -61.64 -45.49 93.83 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 114.392 1.256 . . . . 10.0 114.392 175.023 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 88.1 t90 -51.66 -49.35 62.48 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.235 1.014 . . . . 10.0 112.71 172.369 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -57.28 -51.0 71.13 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.072 0.949 . . . . 10.0 112.03 177.073 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 96.5 mt -55.75 -52.12 51.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 124.69 1.196 . . . . 10.0 111.762 175.329 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 28.7 t -54.9 -44.29 74.03 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.434 1.094 . . . . 10.0 111.861 174.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 49.3 m -60.02 -45.2 93.55 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.47 1.508 . . . . 10.0 112.472 174.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -57.09 -48.5 78.44 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 119.291 0.951 . . . . 10.0 112.344 172.146 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -57.36 -46.35 83.44 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.819 0.848 . . . . 10.0 112.71 174.078 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 40.3 ttp -56.16 -54.86 40.07 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.257 1.023 . . . . 10.0 112.09 172.366 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 8.1 tt -51.11 -50.57 58.54 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 125.941 1.697 . . . . 10.0 111.08 178.535 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 77.8 t80 -50.47 -54.91 18.51 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.169 0.988 . . . . 10.0 112.798 172.509 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 54.6 mt -53.6 -55.05 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 123.809 0.844 . . . . 10.0 110.775 177.729 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 44.4 mt -57.37 -35.88 70.53 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 118.349 -0.834 . . . . 10.0 112.957 178.568 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -57.26 -58.15 9.5 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 124.015 0.926 . . . . 10.0 113.041 173.242 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.44 -40.9 85.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-O 118.355 -0.831 . . . . 10.0 111.465 177.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 45.2 mt -56.79 -49.4 75.43 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 119.862 1.21 . . . . 10.0 112.131 171.242 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.469 ' HA ' ' HD2' ' A' ' 175' ' ' ARG . 11.9 t80 -77.01 -70.33 0.47 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 120.088 -1.632 . . . . 10.0 112.901 -175.29 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -73.66 -21.98 60.1 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.615 1.166 . . . . 10.0 113.431 -174.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -87.79 -79.12 1.26 Allowed Glycine 0 CA--C 1.527 0.783 0 C-N-CA 123.625 0.631 . . . . 10.0 113.496 171.571 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -53.63 -32.38 51.08 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 126.269 1.828 . . . . 10.0 113.067 -166.539 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.2 m -52.16 -56.44 14.57 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 114.01 1.115 . . . . 10.0 114.01 172.137 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.7 p -53.63 -50.61 65.34 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 122.087 0.946 . . . . 10.0 112.271 -177.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 47.7 tttm -57.09 -46.1 82.81 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.197 0.999 . . . . 10.0 112.107 173.704 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.76 -47.49 79.97 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 114.563 1.32 . . . . 10.0 114.563 174.001 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -56.47 -11.31 1.22 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 126.087 1.755 . . . . 10.0 114.261 177.689 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.2 m -107.09 6.67 29.11 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.374 1.87 . . . . 10.0 114.877 -179.319 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 93.3 mmm -91.92 -92.69 0.15 Allowed 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 123.451 1.596 . . . . 10.0 114.171 -170.636 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -138.63 153.96 72.79 Favored Pre-proline 0 C--O 1.236 0.349 0 C-N-CA 129.833 3.253 . . . . 10.0 105.573 170.199 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -52.85 -46.21 35.35 Favored 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 122.338 2.025 . . . . 10.0 113.083 179.01 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.667 ' CD ' ' HD3' ' A' ' 227' ' ' ARG . 0.1 OUTLIER -52.99 -46.05 68.12 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 129.014 2.926 . . . . 10.0 113.266 173.577 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 91.5 t -69.26 -53.0 27.72 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 C-N-CA 124.006 0.922 . . . . 10.0 109.788 -178.576 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.07 -46.89 75.46 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.3 0.64 . . . . 10.0 111.923 177.005 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 59.9 p -59.99 -56.13 25.42 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.883 0.873 . . . . 10.0 112.742 174.631 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 61.8 m -57.23 -53.19 60.86 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.185 0.994 . . . . 10.0 113.011 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -49.61 -49.47 46.71 Favored 'General case' 0 C--O 1.222 -0.387 0 C-N-CA 123.324 0.65 . . . . 10.0 111.1 174.121 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -57.12 -48.46 78.6 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 114.671 1.36 . . . . 10.0 114.671 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 40.3 t -55.98 -49.54 74.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 CA-C-N 118.802 0.728 . . . . 10.0 110.541 176.392 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 93.8 mt -58.57 -51.65 69.01 Favored 'General case' 0 C--O 1.222 -0.39 0 N-CA-C 113.196 0.813 . . . . 10.0 113.196 175.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' ARG . . . . . 0.469 ' HD2' ' HA ' ' A' ' 153' ' ' PHE . 35.4 ttp180 -47.76 -47.76 30.33 Favored 'General case' 0 C--O 1.225 -0.201 0 C-N-CA 126.831 2.052 . . . . 10.0 111.095 174.405 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 63.8 m-20 -58.5 -58.4 8.71 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 122.836 0.454 . . . . 10.0 111.232 174.376 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 54.5 t -52.13 -46.77 44.03 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 124.067 0.947 . . . . 10.0 112.052 179.012 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 28.8 m -60.39 -61.79 2.34 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 127.818 2.447 . . . . 10.0 111.874 178.78 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 55.8 t -50.91 -50.42 23.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 124.667 1.187 . . . . 10.0 110.928 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 80.3 t -59.49 -63.01 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 124.047 0.939 . . . . 10.0 111.889 177.176 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 68.9 mt -53.29 -50.75 64.23 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 119.183 0.901 . . . . 10.0 112.144 -178.13 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 10.1 m95 -54.67 -50.11 69.0 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 124.116 0.966 . . . . 10.0 112.275 177.482 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 54.3 p -52.57 -32.03 39.03 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 114.235 1.198 . . . . 10.0 114.235 179.168 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -65.23 -40.01 93.48 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 113.947 1.091 . . . . 10.0 113.947 176.653 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -47.26 -55.67 15.13 Favored Pre-proline 0 N--CA 1.479 0.98 0 N-CA-C 115.112 1.523 . . . . 10.0 115.112 -176.216 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 186' ' ' PRO . . . . . 0.456 ' HB3' H183 ' A' ' 999' ' ' RET . 21.1 Cg_endo -58.5 -34.04 98.47 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 121.898 1.732 . . . . 10.0 113.122 175.492 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 21.6 t -66.33 -56.65 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 124.471 1.109 . . . . 10.0 111.2 178.364 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 2.7 p -55.73 -44.62 77.83 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 CA-C-N 119.201 0.91 . . . . 10.0 112.083 176.551 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 59.8 t90 -56.73 -51.96 66.81 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.372 0.669 . . . . 10.0 112.422 173.709 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 25.8 tp -54.9 -44.95 74.6 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.49 1.116 . . . . 10.0 112.197 -178.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 14.6 pt -86.28 -5.5 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 N-CA-C 115.246 1.573 . . . . 10.0 115.246 -177.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.57 -169.26 32.74 Favored Glycine 0 N--CA 1.45 -0.383 0 CA-C-O 122.573 1.096 . . . . 10.0 113.83 -168.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 23.3 t -53.12 -41.65 65.25 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 114.203 -0.999 . . . . 10.0 111.858 177.618 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -66.9 -17.18 64.78 Favored 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 115.559 1.688 . . . . 10.0 115.559 -175.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -131.08 -105.87 1.08 Allowed Glycine 0 CA--C 1.532 1.106 0 CA-C-N 120.397 1.453 . . . . 10.0 113.914 -172.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -89.45 127.12 35.81 Favored 'General case' 0 C--N 1.328 -0.345 0 O-C-N 120.663 -1.492 . . . . 10.0 109.3 168.5 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -72.44 65.29 1.35 Allowed Glycine 0 CA--C 1.531 1.064 0 N-CA-C 113.925 0.33 . . . . 10.0 113.925 173.123 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 60.7 mt -79.56 -42.72 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 126.077 1.751 . . . . 10.0 108.725 166.361 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 79.8 t -126.32 133.41 24.94 Favored Pre-proline 0 N--CA 1.454 -0.25 0 C-N-CA 126.468 1.907 . . . . 10.0 109.368 -174.192 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -68.79 153.78 72.36 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 123.781 2.988 . . . . 10.0 111.461 -176.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 12.2 tp -43.14 -39.82 3.0 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.375 1.07 . . . . 10.0 112.17 171.534 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -48.33 -52.35 22.01 Favored 'General case' 0 CA--C 1.539 0.519 0 N-CA-C 114.728 1.381 . . . . 10.0 114.728 176.044 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 14.0 mm -75.98 -40.48 38.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 124.366 1.066 . . . . 10.0 109.625 177.595 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -49.26 -49.82 41.68 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 118.603 0.638 . . . . 10.0 111.981 173.582 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 16.2 m -57.74 -46.97 83.74 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 126.04 1.736 . . . . 10.0 112.964 174.334 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.536 HD23 ' CD2' ' A' ' 12' ' ' TRP . 1.3 tm? -63.4 -52.28 62.27 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.992 0.917 . . . . 10.0 112.101 179.738 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 93.2 mt -52.56 -59.17 4.78 Favored 'General case' 0 C--N 1.335 -0.044 0 C-N-CA 124.32 1.048 . . . . 10.0 110.003 176.416 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -52.29 -47.3 65.96 Favored 'General case' 0 C--O 1.217 -0.64 0 CA-C-O 117.425 -1.274 . . . . 10.0 112.164 176.031 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 209' ' ' MET . . . . . 0.575 ' HE2' ' HB3' ' A' ' 15' ' ' LEU . 4.6 tmm? -52.03 -51.7 55.73 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 121.073 1.76 . . . . 10.0 113.001 175.708 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 78.7 t -60.39 -50.0 82.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 124.646 1.178 . . . . 10.0 111.278 178.489 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 5.2 mp -57.52 -51.18 70.5 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.884 1.674 . . . . 10.0 112.044 175.291 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -56.96 -57.72 11.3 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 127.36 2.264 . . . . 10.0 110.706 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 97.3 t -57.27 -43.23 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 O-C-N 121.001 -1.062 . . . . 10.0 111.417 177.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 42.9 m -55.84 -49.32 73.63 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.451 0.7 . . . . 10.0 111.992 173.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -67.8 -25.29 65.51 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.465 1.506 . . . . 10.0 114.435 178.461 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -90.77 -73.65 0.52 Allowed 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.87 1.268 . . . . 10.0 109.749 178.333 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 21.2 t -78.48 -49.26 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 125.907 1.683 . . . . 10.0 111.201 -171.609 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -55.26 -56.32 23.94 Favored Glycine 0 CA--C 1.534 1.281 0 C-N-CA 124.092 0.853 . . . . 10.0 113.118 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -45.45 -55.66 5.88 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.476 1.91 . . . . 10.0 112.27 166.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -55.58 -40.01 76.98 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 124.008 0.813 . . . . 10.0 113.754 178.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 24.9 mt -70.08 -27.41 64.59 Favored 'General case' 0 CA--C 1.512 -0.502 0 N-CA-C 115.833 1.79 . . . . 10.0 115.833 176.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 74.3 mt -63.49 -57.53 11.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 108.59 -0.893 . . . . 10.0 108.59 165.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 32.0 tp -58.77 -64.68 0.85 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.918 0.887 . . . . 10.0 113.206 -172.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 84.2 mt -71.53 5.19 2.51 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 115.304 1.594 . . . . 10.0 115.304 -171.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.6 mtp-105 -112.35 0.35 15.64 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.211 1.005 . . . . 10.0 113.303 172.575 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 8.8 t -108.03 177.94 4.66 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 124.058 0.943 . . . . 10.0 111.032 174.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 227' ' ' ARG . . . . . 0.667 ' HD3' ' CD ' ' A' ' 166' ' ' GLU . 41.8 ttt180 -71.59 98.15 1.83 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.732 0.813 . . . . 10.0 110.977 170.647 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 228' ' ' ALA . . . . . 0.477 ' HB1' ' CD2' ' A' ' 42' ' ' PHE . . . -80.9 77.03 7.82 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.874 0.87 . . . . 10.0 112.095 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 40.19 102.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 128.866 2.866 . . . . 10.0 116.474 177.686 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . 0.481 0.3 OUTLIER 71.81 -55.41 0.66 Allowed 'General case' 0 C--O 1.243 0.714 0 C-N-CA 124.769 1.227 . . . . 10.0 110.603 -175.305 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -68.3 169.47 40.07 Favored Glycine 0 C--O 1.239 0.417 0 C-N-CA 129.76 3.552 . . . . 10.0 119.619 171.493 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.461 0 C-N-CA 128.476 2.711 . . . . 10.0 113.44 166.603 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 999' ' ' RET . . . . . 0.535 H181 ' H7 ' ' A' ' 999' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1000 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A 1001 ' ' HOH . . . . . 0.477 ' O ' HG23 ' A' ' 52' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1002 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A 1003 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 N--CA 1.477 0.881 0 CA-C-O 115.781 -2.057 . . . . 10.0 105.842 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 23.36 91.91 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 129.588 3.155 . . . . 10.0 117.227 160.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 28.6 65.03 0.11 Allowed 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 128.307 2.643 . . . . 10.0 114.529 155.431 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 86.5 mt -56.41 137.91 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 126.396 1.878 . . . . 10.0 113.372 -158.385 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.653 HG21 ' HB3' ' A' ' 77' ' ' PRO . 7.6 t -136.75 -165.2 1.7 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 126.327 1.851 . . . . 10.0 114.015 -174.315 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 70.0 2.83 41.1 Favored Glycine 0 C--N 1.339 0.743 0 C-N-CA 127.496 2.474 . . . . 10.0 111.485 168.038 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -158.55 -51.32 0.01 OUTLIER Pre-proline 0 N--CA 1.443 -0.783 0 CA-C-O 114.301 -2.761 . . . . 10.0 116.649 -168.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_exo -63.93 -60.72 0.14 Allowed 'Trans proline' 0 N--CA 1.465 -0.186 0 CA-C-N 123.538 2.299 . . . . 10.0 113.194 -175.331 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.41 ' H ' ' CD ' ' A' ' 9' ' ' GLU . 7.9 pm0 -67.21 4.34 0.96 Allowed 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 127.886 2.475 . . . . 10.0 115.732 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.422 ' CG ' ' N ' ' A' ' 11' ' ' ILE . 11.0 p-90 -51.38 -43.12 61.8 Favored 'General case' 0 C--O 1.223 -0.315 0 O-C-N 121.509 -0.744 . . . . 10.0 112.618 176.389 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.422 ' N ' ' CG ' ' A' ' 10' ' ' TRP . 8.9 tt -60.87 -49.59 84.0 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.34 0 C-N-CA 123.872 0.869 . . . . 10.0 109.344 179.394 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.535 ' CD2' HD23 ' A' ' 206' ' ' LEU . 2.6 m95 -55.32 -52.69 62.65 Favored 'General case' 0 C--O 1.224 -0.259 0 C-N-CA 123.406 0.682 . . . . 10.0 111.877 175.578 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.4 mt -57.34 -53.64 55.79 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 123.188 0.595 . . . . 10.0 112.224 177.283 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.83 -46.81 51.61 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.353 1.461 . . . . 10.0 113.33 173.811 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.575 ' HB3' ' HE2' ' A' ' 209' ' ' MET . 13.3 tp -65.63 -44.95 84.88 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.277 1.431 . . . . 10.0 113.059 179.077 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.5 -57.03 9.83 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 124.549 1.071 . . . . 10.0 111.274 165.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.1 m -49.26 -52.53 26.74 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.985 1.314 . . . . 10.0 112.232 174.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.44 -58.86 5.83 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.151 0.98 . . . . 10.0 112.161 177.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 99.6 mt -58.0 -49.07 78.11 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.471 0.709 . . . . 10.0 112.537 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 23.9 mmt -55.61 -49.22 73.38 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.858 0.863 . . . . 10.0 111.359 176.175 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -58.29 -58.43 14.61 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 124.388 0.994 . . . . 10.0 113.438 176.33 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 81.0 mt -56.24 -46.01 79.75 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-N 118.634 1.217 . . . . 10.0 112.132 176.318 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.73 -41.76 75.96 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 124.714 1.15 . . . . 10.0 113.242 173.15 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 28.2 m -62.38 -58.49 7.46 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.833 0.853 . . . . 10.0 111.347 172.024 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -52.27 -41.0 62.47 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.981 0.912 . . . . 10.0 110.977 177.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -55.75 -58.03 9.52 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 124.641 1.176 . . . . 10.0 112.967 172.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.1 m-30 -59.67 -38.7 82.19 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 113.223 0.823 . . . . 10.0 113.223 178.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.401 ' C ' ' H ' ' A' ' 30' ' ' LYS . 11.9 mt -56.04 -67.47 0.29 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.629 1.171 . . . . 10.0 113.65 169.104 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 t -76.34 40.89 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 CA-C-O 123.727 1.727 . . . . 10.0 110.866 179.06 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.401 ' H ' ' C ' ' A' ' 28' ' ' LEU . 42.8 tttm -140.8 -44.85 0.39 Allowed 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 127.915 2.486 . . . . 10.0 109.347 171.157 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.96 23.11 0.87 Allowed Glycine 0 CA--C 1.529 0.925 0 N-CA-C 115.629 1.012 . . . . 10.0 115.629 173.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 37.3 mmm -59.5 -45.0 92.96 Favored 'General case' 0 C--O 1.225 -0.211 0 C-N-CA 127.17 2.188 . . . . 10.0 113.571 -178.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.71 -84.41 1.19 Allowed Glycine 0 CA--C 1.531 1.045 0 C-N-CA 123.775 0.702 . . . . 10.0 112.446 -170.103 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.8 t 33.09 88.75 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.243 0.73 0 C-N-CA 128.399 2.68 . . . . 10.0 116.941 166.459 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.6 m -79.65 -50.92 9.93 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.23 -1.35 . . . . 10.0 113.828 174.191 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -48.87 117.51 6.37 Favored Pre-proline 0 CA--C 1.536 0.416 0 O-C-N 124.765 1.291 . . . . 10.0 110.972 -172.535 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -58.56 -29.68 89.64 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 123.757 2.971 . . . . 10.0 113.669 179.101 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.31 -60.66 2.29 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.126 0.57 . . . . 10.0 111.457 176.227 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.12 -40.08 22.45 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 125.134 1.373 . . . . 10.0 113.58 171.578 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -46.56 -47.42 19.71 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.22 1.408 . . . . 10.0 113.447 172.029 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -57.72 -53.1 62.01 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.5 0.72 . . . . 10.0 110.992 176.625 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.477 ' CD2' ' HB1' ' A' ' 228' ' ' ALA . 43.9 m-85 -57.02 -50.21 73.42 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 123.084 0.554 . . . . 10.0 112.315 -179.076 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -54.3 -51.29 65.1 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 118.966 -0.54 . . . . 10.0 112.401 173.228 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.41 -62.01 1.91 Allowed 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 113.386 0.884 . . . . 10.0 113.386 177.144 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.4 mt -48.61 -57.76 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 124.867 1.267 . . . . 10.0 110.287 178.044 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.5 m -68.36 -17.74 64.31 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.114 1.365 . . . . 10.0 113.639 -172.614 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 27.4 m -87.12 -40.84 14.27 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 119.583 1.083 . . . . 10.0 112.137 174.622 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 22.0 mt -59.27 -40.98 87.77 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 121.359 -0.838 . . . . 10.0 112.835 171.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 22.7 t -43.9 -60.6 2.56 Favored Pre-proline 0 CA--C 1.549 0.941 0 C-N-CA 126.238 1.815 . . . . 10.0 113.395 176.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -72.27 -28.29 15.47 Favored 'Trans proline' 0 CA--C 1.546 1.108 0 C-N-CA 123.083 2.522 . . . . 10.0 114.182 172.507 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.98 -48.72 79.08 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 120.734 1.606 . . . . 10.0 113.927 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 19.5 tt -68.3 -36.16 73.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 O-C-N 120.249 -1.532 . . . . 10.0 111.376 173.062 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.29 -43.34 78.75 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 119.093 0.86 . . . . 10.0 112.74 171.298 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -50.96 -56.78 10.76 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.214 1.405 . . . . 10.0 111.68 168.471 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.7 m -47.88 -53.34 16.05 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 125.411 1.484 . . . . 10.0 111.18 176.598 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 32.7 mmt -69.09 -48.18 63.3 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 124.176 0.99 . . . . 10.0 112.871 -176.506 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -55.86 -41.38 74.27 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 120.203 1.365 . . . . 10.0 113.238 172.697 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.8 tp -53.31 -54.55 34.77 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-N 119.671 1.123 . . . . 10.0 111.301 170.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 24.0 p -51.65 -41.06 61.06 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 115.207 1.558 . . . . 10.0 115.207 179.002 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 56.9 mtm -66.86 -50.89 61.09 Favored 'General case' 0 C--N 1.334 -0.09 0 C-N-CA 123.597 0.759 . . . . 10.0 110.477 176.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.3 tp -48.62 -52.69 21.8 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.862 0.865 . . . . 10.0 112.904 172.409 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.4 mt -76.87 -5.53 48.77 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 113.848 1.055 . . . . 10.0 113.848 -177.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.24 -34.71 5.55 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 115.558 0.983 . . . . 10.0 115.558 174.142 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 75.3 t80 -49.28 -43.09 42.88 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 115.243 1.572 . . . . 10.0 115.243 -176.014 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.04 3.55 61.07 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 115.314 0.885 . . . . 10.0 115.314 -179.013 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.25 143.4 26.45 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 127.034 2.133 . . . . 10.0 109.031 172.015 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 t -145.51 171.09 15.17 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 124.081 0.952 . . . . 10.0 111.06 166.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.97 136.06 53.38 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 123.885 0.874 . . . . 10.0 109.722 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.437 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 58.5 t -129.56 129.64 23.19 Favored Pre-proline 0 C--N 1.33 -0.261 0 C-N-CA 125.043 1.337 . . . . 10.0 110.982 -176.109 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 69' ' ' VAL . 6.3 Cg_exo -80.76 116.24 3.16 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 N-CA-C 109.411 -1.034 . . . . 10.0 109.411 -178.864 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -156.71 164.41 38.17 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.808 0.669 . . . . 10.0 112.808 172.495 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.34 -81.92 0.14 Allowed Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.685 -0.966 . . . . 10.0 110.685 175.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.76 -3.37 0.69 Allowed Glycine 0 CA--C 1.527 0.822 0 N-CA-C 118.671 2.228 . . . . 10.0 118.671 170.395 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -151.6 -171.87 4.06 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 119.343 1.571 . . . . 10.0 112.187 -165.166 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -91.86 93.91 9.06 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 125.521 1.528 . . . . 10.0 111.097 -175.293 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.449 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 60.1 m-80 -89.47 120.74 69.65 Favored Pre-proline 0 C--N 1.326 -0.452 0 N-CA-C 113.001 0.741 . . . . 10.0 113.001 -165.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.653 ' HB3' HG21 ' A' ' 5' ' ' THR . 76.4 Cg_exo -61.47 131.93 38.37 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 124.16 3.24 . . . . 10.0 112.167 171.576 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.6 mm -140.13 126.33 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 C-N-CA 126.043 1.737 . . . . 10.0 111.682 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -93.61 85.02 4.76 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 123.316 1.531 . . . . 10.0 113.051 174.598 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 63.5 p-90 -59.32 -28.3 66.68 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 120.588 -1.32 . . . . 10.0 113.965 174.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -54.39 -35.88 63.33 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 114.152 1.167 . . . . 10.0 114.152 178.229 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 1.5 ptp180 -63.67 -25.84 68.39 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 120.419 -1.426 . . . . 10.0 113.926 174.049 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -76.96 -41.94 41.14 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 121.22 -0.925 . . . . 10.0 111.845 172.266 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -49.48 -48.62 47.68 Favored 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 125.192 1.397 . . . . 10.0 111.5 167.341 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -52.86 -69.77 0.11 Allowed 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 126.078 1.751 . . . . 10.0 111.671 168.383 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 53.4 m0 -56.8 -32.97 66.22 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 124.428 1.091 . . . . 10.0 113.042 -169.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 29.4 tp -48.74 -44.15 38.25 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 125.858 1.663 . . . . 10.0 111.721 176.231 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -99.44 -42.21 7.06 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.845 0.858 . . . . 10.0 112.402 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 76.8 p -61.72 -45.3 94.54 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 120.335 1.425 . . . . 10.0 113.913 -177.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . 0.325 74.8 p -60.66 -46.95 97.2 Favored Pre-proline 0 CA--C 1.546 0.826 0 CA-C-O 117.568 -1.206 . . . . 10.0 113.54 -178.367 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -54.65 -44.05 53.28 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 123.24 2.627 . . . . 10.0 115.725 169.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 51.1 mt -59.25 -45.75 90.35 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 121.433 -0.792 . . . . 10.0 111.398 175.438 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.8 tp -51.84 -48.88 63.77 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.437 1.495 . . . . 10.0 112.044 172.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.9 mp -57.81 -47.71 81.84 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.929 1.291 . . . . 10.0 112.392 170.596 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.87 -38.24 78.33 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 119.12 0.873 . . . . 10.0 112.891 179.028 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -52.28 -54.05 36.32 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 119.285 0.948 . . . . 10.0 111.165 169.627 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.34 -42.12 88.62 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.621 0.768 . . . . 10.0 112.151 -178.518 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.62 -54.73 37.68 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.958 0.903 . . . . 10.0 112.049 173.58 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.39 -41.15 79.69 Favored 'General case' 0 C--O 1.224 -0.237 0 C-N-CA 123.729 0.812 . . . . 10.0 112.667 174.871 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.9 tp -63.7 -38.61 91.75 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 114.481 1.289 . . . . 10.0 114.481 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.2 t -94.8 1.46 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 125.089 1.356 . . . . 10.0 112.304 179.193 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.3 t70 48.48 53.53 11.91 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.848 1.659 . . . . 10.0 112.137 -173.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.29 145.89 47.55 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 120.0 -1.688 . . . . 10.0 112.44 -174.201 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.47 135.89 54.17 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 112.711 0.634 . . . . 10.0 112.711 175.149 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -42.85 -39.69 2.61 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.857 1.663 . . . . 10.0 113.471 175.277 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -47.33 -60.25 5.3 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 125.15 1.357 . . . . 10.0 115.233 169.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.6 p -62.02 -46.72 87.95 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 117.103 -1.427 . . . . 10.0 111.351 178.238 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 66.9 mt -48.49 -52.87 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 124.998 1.319 . . . . 10.0 111.146 178.196 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.2 tp -62.63 -51.29 67.85 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 112.556 0.576 . . . . 10.0 112.556 179.271 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.14 -44.9 42.97 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.506 0.722 . . . . 10.0 110.934 174.602 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.455 ' HA ' HD12 ' A' ' 111' ' ' LEU . 0.6 OUTLIER -59.61 -59.88 4.74 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 127.361 2.264 . . . . 10.0 114.778 175.005 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.7 t -60.97 -46.42 96.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 123.735 0.814 . . . . 10.0 111.398 -178.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -56.59 -50.32 63.86 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 123.641 0.639 . . . . 10.0 112.674 174.511 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -54.59 -46.72 73.81 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 113.261 0.837 . . . . 10.0 113.261 173.326 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 51.2 t0 -58.17 -45.27 87.81 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.597 0.759 . . . . 10.0 112.008 174.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -43.51 -55.74 5.14 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 125.114 1.34 . . . . 10.0 113.575 166.686 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 85.8 mt -55.45 -57.12 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 CA-C-O 118.438 -0.791 . . . . 10.0 110.631 173.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 48.1 ttp -44.93 -55.29 5.6 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.704 1.602 . . . . 10.0 113.28 -177.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 41.5 mm -70.08 -42.98 79.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 O-C-N 121.703 -0.623 . . . . 10.0 111.716 177.303 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -49.78 -62.57 4.8 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 125.389 1.471 . . . . 10.0 113.167 174.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 37.1 p -60.03 -33.47 72.06 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 118.013 0.906 . . . . 10.0 112.422 174.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -49.95 -56.86 10.86 Favored Glycine 0 CA--C 1.536 1.349 0 C-N-CA 124.157 0.884 . . . . 10.0 113.143 166.128 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 64.9 tp -59.93 -48.2 82.65 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 125.588 1.555 . . . . 10.0 112.034 176.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 67.6 t -52.55 -51.3 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 123.368 0.667 . . . . 10.0 110.31 174.096 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -50.11 -60.87 6.23 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 126.086 1.803 . . . . 10.0 112.271 172.197 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -48.57 -37.66 18.53 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 126.427 1.891 . . . . 10.0 113.792 179.47 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 49.0 mt -99.22 -6.62 27.8 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 115.309 1.596 . . . . 10.0 115.309 -179.023 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 16.9 m -69.69 116.75 10.45 Favored 'General case' 0 N--CA 1.464 0.274 0 O-C-N 120.186 -1.571 . . . . 10.0 110.387 -178.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.62 ' H ' ' HD3' ' A' ' 129' ' ' LYS . 0.2 OUTLIER -55.48 -49.6 72.1 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 128.231 2.613 . . . . 10.0 113.251 177.747 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 61.1 t -69.72 106.42 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 123.746 0.818 . . . . 10.0 110.065 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -46.93 -59.57 3.01 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 124.779 1.231 . . . . 10.0 114.043 -173.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 m -46.43 -42.12 14.8 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.463 1.505 . . . . 10.0 113.485 179.708 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -70.15 -24.61 63.19 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 114.918 1.451 . . . . 10.0 114.918 -178.092 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 68.9 mtp85 -53.9 -41.67 67.86 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 118.93 0.786 . . . . 10.0 110.847 176.588 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -69.87 -31.61 69.53 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 114.354 1.242 . . . . 10.0 114.354 176.638 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.8 t -55.22 -52.23 47.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 CA-C-N 119.03 0.832 . . . . 10.0 109.543 168.699 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 66.1 m95 -61.72 -42.88 99.54 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 114.37 1.248 . . . . 10.0 114.37 174.426 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 88.9 t90 -52.78 -50.26 63.93 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.082 0.953 . . . . 10.0 112.415 171.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -56.86 -53.04 62.44 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.315 1.046 . . . . 10.0 111.737 178.308 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 96.4 mt -53.24 -51.41 40.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 125.069 1.348 . . . . 10.0 111.572 174.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 15.3 m -55.33 -45.56 76.38 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.483 1.113 . . . . 10.0 111.812 175.699 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 49.3 m -63.48 -42.08 98.57 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.367 1.467 . . . . 10.0 111.944 178.488 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -57.9 -49.53 76.43 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.774 0.83 . . . . 10.0 112.313 170.54 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -56.3 -46.34 79.84 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.878 0.871 . . . . 10.0 112.601 173.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 38.4 ttp -55.23 -55.57 29.86 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.262 1.025 . . . . 10.0 112.163 171.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -51.71 -49.81 61.74 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.651 1.58 . . . . 10.0 111.213 179.053 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 77.8 t80 -50.22 -55.06 16.84 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.947 0.899 . . . . 10.0 112.687 172.496 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 55.6 mt -53.71 -55.09 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 123.871 0.868 . . . . 10.0 110.692 177.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 41.3 mt -57.32 -35.86 70.41 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 118.334 -0.841 . . . . 10.0 112.948 178.564 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -57.29 -58.19 9.32 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 124.051 0.941 . . . . 10.0 113.041 173.242 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.38 -40.9 85.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 CA-C-O 118.303 -0.855 . . . . 10.0 111.44 177.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 44.9 mt -56.84 -49.42 75.51 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 119.897 1.226 . . . . 10.0 112.107 171.298 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.471 ' HA ' ' HD2' ' A' ' 175' ' ' ARG . 12.0 t80 -77.01 -70.32 0.47 Allowed 'General case' 0 C--N 1.326 -0.447 0 O-C-N 120.022 -1.674 . . . . 10.0 112.852 -175.234 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -73.7 -21.93 60.09 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.654 1.182 . . . . 10.0 113.466 -174.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -87.84 -79.07 1.26 Allowed Glycine 0 CA--C 1.526 0.747 0 C-N-CA 123.579 0.609 . . . . 10.0 113.514 171.503 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -53.68 -32.42 51.63 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 126.275 1.83 . . . . 10.0 113.024 -166.474 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.2 m -52.02 -56.49 13.99 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 114.057 1.132 . . . . 10.0 114.057 172.065 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.5 p -53.71 -50.51 65.73 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 122.046 0.926 . . . . 10.0 112.295 -177.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 47.6 tttm -57.08 -46.04 82.83 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.173 0.989 . . . . 10.0 112.156 173.59 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.87 -47.46 80.4 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 114.512 1.301 . . . . 10.0 114.512 174.064 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -56.47 -11.3 1.21 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 126.087 1.755 . . . . 10.0 114.252 177.66 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.1 m -107.03 6.61 29.18 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.424 1.89 . . . . 10.0 114.903 -179.369 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 93.3 mmm -91.91 -92.6 0.15 Allowed 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 123.487 1.613 . . . . 10.0 114.164 -170.599 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -138.71 153.94 72.64 Favored Pre-proline 0 C--O 1.235 0.308 0 C-N-CA 129.802 3.241 . . . . 10.0 105.527 170.243 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -52.83 -46.25 34.97 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.267 1.978 . . . . 10.0 113.074 179.01 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.667 ' CD ' ' HD3' ' A' ' 227' ' ' ARG . 0.1 OUTLIER -52.89 -46.08 67.8 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 129.021 2.929 . . . . 10.0 113.291 173.556 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 92.0 t -69.22 -53.04 27.62 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 C-N-CA 124.05 0.94 . . . . 10.0 109.8 -178.612 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.1 -46.83 75.55 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.282 0.633 . . . . 10.0 111.959 177.008 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 60.3 p -60.02 -56.2 24.54 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.922 0.889 . . . . 10.0 112.692 174.63 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 61.5 m -57.18 -53.2 60.76 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.155 0.982 . . . . 10.0 113.036 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -49.58 -49.48 46.33 Favored 'General case' 0 C--O 1.222 -0.375 0 C-N-CA 123.247 0.619 . . . . 10.0 111.132 174.034 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -57.15 -48.39 78.82 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 114.702 1.371 . . . . 10.0 114.702 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 40.5 t -56.01 -49.59 74.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 CA-C-N 118.749 0.704 . . . . 10.0 110.462 176.365 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 94.1 mt -58.63 -51.59 69.28 Favored 'General case' 0 C--O 1.222 -0.389 0 N-CA-C 113.191 0.811 . . . . 10.0 113.191 175.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' ARG . . . . . 0.471 ' HD2' ' HA ' ' A' ' 153' ' ' PHE . 35.5 ttp180 -47.75 -47.79 30.26 Favored 'General case' 0 C--O 1.225 -0.201 0 C-N-CA 126.852 2.061 . . . . 10.0 111.062 174.402 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 63.6 m-20 -58.51 -58.36 8.89 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 122.782 0.433 . . . . 10.0 111.272 174.399 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 54.9 t -52.19 -46.71 44.59 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 124.039 0.936 . . . . 10.0 112.044 179.009 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 32.1 m -60.19 -61.66 2.44 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 128.081 2.552 . . . . 10.0 111.902 178.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 56.0 t -51.43 -50.23 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 C-N-CA 124.575 1.15 . . . . 10.0 111.045 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 76.8 t -59.23 -60.06 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 124.069 0.948 . . . . 10.0 112.168 177.574 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 73.4 mt -56.9 -51.65 68.25 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 118.701 0.682 . . . . 10.0 112.301 -178.502 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 10.6 m95 -53.22 -50.18 65.25 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.959 0.904 . . . . 10.0 111.764 178.272 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 8.6 t -56.96 -24.44 52.94 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 114.541 1.312 . . . . 10.0 114.541 178.684 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -69.13 -40.61 78.17 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 119.615 1.098 . . . . 10.0 113.459 175.594 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -47.08 -55.91 13.87 Favored Pre-proline 0 N--CA 1.476 0.844 0 N-CA-C 114.991 1.478 . . . . 10.0 114.991 -177.558 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' PRO . . . . . 0.52 ' HB3' H183 ' A' ' 999' ' ' RET . 27.4 Cg_endo -58.89 -35.16 99.06 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 122.207 1.938 . . . . 10.0 113.346 177.37 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 34.1 t -65.19 -58.73 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 124.152 0.981 . . . . 10.0 110.628 177.597 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 17.1 m -61.98 -34.51 63.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 N-CA-C 112.716 0.636 . . . . 10.0 112.716 -177.204 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 44.5 t90 -59.81 -55.93 28.11 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 125.191 1.396 . . . . 10.0 112.117 168.44 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 9.6 tt -56.49 -41.94 77.46 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.813 0.845 . . . . 10.0 112.601 -177.175 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 14.8 pt -82.44 -5.66 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 N-CA-C 115.151 1.537 . . . . 10.0 115.151 178.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.31 -169.29 33.1 Favored Glycine 0 N--CA 1.45 -0.404 0 CA-C-O 122.577 1.098 . . . . 10.0 113.921 -168.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 23.3 t -53.16 -40.68 64.5 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 114.197 -1.001 . . . . 10.0 111.897 177.552 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -55.01 -31.8 61.32 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 128.387 2.675 . . . . 10.0 115.385 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -131.06 -103.87 0.98 Allowed Glycine 0 CA--C 1.527 0.842 0 CA-C-N 119.324 0.966 . . . . 10.0 113.41 -167.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -89.41 127.12 35.79 Favored 'General case' 0 C--N 1.328 -0.352 0 O-C-N 120.621 -1.517 . . . . 10.0 109.364 169.253 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -72.48 65.36 1.36 Allowed Glycine 0 CA--C 1.532 1.141 0 N-CA-C 113.871 0.308 . . . . 10.0 113.871 173.175 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 60.6 mt -79.6 -42.71 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 126.053 1.741 . . . . 10.0 108.729 166.339 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.4 ' CG1' ' HB ' ' A' ' 203' ' ' ILE . 79.4 t -126.27 133.39 24.92 Favored Pre-proline 0 N--CA 1.454 -0.264 0 C-N-CA 126.502 1.921 . . . . 10.0 109.385 -174.212 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -68.79 153.78 72.36 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 123.781 2.988 . . . . 10.0 111.437 -176.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 12.2 tp -43.17 -39.77 3.03 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.281 1.033 . . . . 10.0 112.193 171.522 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -48.36 -52.38 21.99 Favored 'General case' 0 CA--C 1.539 0.519 0 N-CA-C 114.673 1.361 . . . . 10.0 114.673 176.08 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 203' ' ' ILE . . . . . 0.4 ' HB ' ' CG1' ' A' ' 199' ' ' VAL . 13.9 mm -75.9 -40.5 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 C-N-CA 124.435 1.094 . . . . 10.0 109.692 177.562 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -49.3 -49.81 42.15 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 118.553 0.615 . . . . 10.0 111.925 173.605 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 16.3 m -57.72 -47.01 83.62 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 126.043 1.737 . . . . 10.0 112.96 174.333 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.535 HD23 ' CD2' ' A' ' 12' ' ' TRP . 1.3 tm? -63.33 -52.39 62.05 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.977 0.911 . . . . 10.0 112.072 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 93.1 mt -52.52 -58.74 5.81 Favored 'General case' 0 C--O 1.227 -0.088 0 C-N-CA 124.294 1.038 . . . . 10.0 110.02 176.454 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -52.45 -46.79 66.62 Favored 'General case' 0 C--O 1.221 -0.439 0 CA-C-O 117.805 -1.093 . . . . 10.0 112.393 176.105 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 209' ' ' MET . . . . . 0.575 ' HE2' ' HB3' ' A' ' 15' ' ' LEU . 4.6 tmm? -52.32 -52.0 55.6 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 120.404 1.457 . . . . 10.0 112.743 175.469 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 85.7 t -61.69 -46.56 96.28 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 124.782 1.233 . . . . 10.0 111.747 178.097 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 4.2 mp -59.95 -52.41 65.54 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 125.463 1.505 . . . . 10.0 111.989 175.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 -55.68 -57.33 12.43 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 126.36 1.864 . . . . 10.0 110.917 178.183 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 8.6 p -58.66 -38.76 73.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 O-C-N 120.918 -1.114 . . . . 10.0 112.524 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 38.4 m -58.55 -49.43 77.47 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.559 0.744 . . . . 10.0 111.594 171.161 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -66.86 -22.08 66.0 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.545 1.538 . . . . 10.0 114.593 177.656 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 11.9 mptt -95.22 -76.55 0.49 Allowed 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.009 1.324 . . . . 10.0 109.984 177.356 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 21.3 t -73.18 -50.52 31.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 C-N-CA 125.41 1.484 . . . . 10.0 110.875 -172.413 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -53.83 -57.42 16.26 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 124.039 0.828 . . . . 10.0 113.09 178.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 42.0 t80 -46.68 -56.73 5.68 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.351 1.86 . . . . 10.0 112.322 168.631 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -56.23 -39.44 81.63 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 124.011 0.815 . . . . 10.0 113.465 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 24.5 mt -70.51 -27.59 64.3 Favored 'General case' 0 CA--C 1.511 -0.523 0 N-CA-C 115.736 1.754 . . . . 10.0 115.736 176.611 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 74.4 mt -63.48 -57.48 11.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 119.274 0.943 . . . . 10.0 108.548 165.662 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 32.1 tp -58.86 -64.71 0.84 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.923 0.889 . . . . 10.0 113.17 -172.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 84.2 mt -71.51 5.17 2.5 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 115.313 1.597 . . . . 10.0 115.313 -171.692 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.6 mtp-105 -112.33 0.44 15.69 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.171 0.988 . . . . 10.0 113.319 172.506 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 8.8 t -108.03 177.91 4.67 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 124.092 0.957 . . . . 10.0 111.046 174.608 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 227' ' ' ARG . . . . . 0.667 ' HD3' ' CD ' ' A' ' 166' ' ' GLU . 41.7 ttt180 -71.59 98.15 1.83 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.765 0.826 . . . . 10.0 110.947 170.64 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 228' ' ' ALA . . . . . 0.477 ' HB1' ' CD2' ' A' ' 42' ' ' PHE . . . -80.86 77.0 7.78 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.874 0.87 . . . . 10.0 112.08 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 40.18 102.24 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 128.896 2.878 . . . . 10.0 116.466 177.698 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . 0.481 0.3 OUTLIER 71.85 -55.43 0.66 Allowed 'General case' 0 C--O 1.241 0.647 0 C-N-CA 124.722 1.209 . . . . 10.0 110.656 -175.295 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -68.29 169.47 40.06 Favored Glycine 0 C--O 1.239 0.417 0 C-N-CA 129.73 3.538 . . . . 10.0 119.666 171.471 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.461 0 C-N-CA 128.441 2.696 . . . . 10.0 113.407 166.609 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 999' ' ' RET . . . . . 0.52 H183 ' HB3' ' A' ' 186' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1000 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A 1001 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A 1002 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A 1003 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 N--CA 1.477 0.913 0 CA-C-O 115.78 -2.057 . . . . 10.0 105.808 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 23.33 91.84 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 129.598 3.159 . . . . 10.0 117.286 160.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 28.68 65.05 0.11 Allowed 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 128.324 2.65 . . . . 10.0 114.468 155.406 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 86.4 mt -56.44 137.94 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 126.41 1.884 . . . . 10.0 113.344 -158.4 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.652 HG21 ' HB3' ' A' ' 77' ' ' PRO . 7.6 t -136.78 -165.21 1.7 Allowed 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 126.284 1.834 . . . . 10.0 113.991 -174.311 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 70.04 2.8 41.3 Favored Glycine 0 C--N 1.34 0.768 0 C-N-CA 127.475 2.464 . . . . 10.0 111.453 168.028 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -158.59 -51.29 0.01 OUTLIER Pre-proline 0 N--CA 1.443 -0.794 0 CA-C-O 114.301 -2.761 . . . . 10.0 116.698 -168.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -64.02 -60.58 0.15 Allowed 'Trans proline' 0 CA--C 1.528 0.179 0 CA-C-N 123.504 2.287 . . . . 10.0 113.207 -175.342 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.411 ' H ' ' CD ' ' A' ' 9' ' ' GLU . 7.9 pm0 -67.22 4.27 0.98 Allowed 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 127.86 2.464 . . . . 10.0 115.765 179.701 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.421 ' CG ' ' N ' ' A' ' 11' ' ' ILE . 11.0 p-90 -51.34 -43.08 61.67 Favored 'General case' 0 C--O 1.223 -0.337 0 O-C-N 121.487 -0.758 . . . . 10.0 112.646 176.417 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.421 ' N ' ' CG ' ' A' ' 10' ' ' TRP . 8.9 tt -60.9 -49.64 83.82 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.338 0 C-N-CA 123.902 0.881 . . . . 10.0 109.287 179.415 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.535 ' CD2' HD23 ' A' ' 206' ' ' LEU . 2.6 m95 -55.33 -52.7 62.63 Favored 'General case' 0 C--O 1.224 -0.261 0 C-N-CA 123.428 0.691 . . . . 10.0 111.861 175.62 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.5 mt -57.37 -53.53 57.05 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 123.138 0.575 . . . . 10.0 112.27 177.245 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.92 -46.78 52.3 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.366 1.466 . . . . 10.0 113.332 173.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.575 ' HB3' ' HE2' ' A' ' 209' ' ' MET . 13.3 tp -65.67 -44.94 84.72 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.304 1.442 . . . . 10.0 113.009 179.115 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.55 -56.57 10.92 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 124.419 1.009 . . . . 10.0 111.55 166.039 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.2 m -49.62 -52.44 30.52 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.898 1.279 . . . . 10.0 112.246 174.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.45 -58.89 5.69 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.163 0.985 . . . . 10.0 112.138 177.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 93.1 mt -57.12 -48.55 78.37 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.606 0.762 . . . . 10.0 112.851 -179.372 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 49.0 mtt -60.43 -45.77 92.45 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.148 0.979 . . . . 10.0 111.503 178.274 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -58.22 -58.68 13.28 Favored Glycine 0 CA--C 1.53 0.998 0 CA-C-O 118.937 -0.924 . . . . 10.0 113.872 172.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 80.8 mt -56.24 -45.86 79.83 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-N 118.714 1.257 . . . . 10.0 112.089 176.279 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.66 -42.19 76.64 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 124.46 1.029 . . . . 10.0 113.581 172.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 30.3 m -62.12 -58.4 7.95 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 118.329 -0.843 . . . . 10.0 111.113 172.164 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -52.3 -40.93 62.46 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.051 0.94 . . . . 10.0 110.95 177.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -55.83 -58.01 9.65 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.573 1.149 . . . . 10.0 112.993 172.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.1 m-30 -59.69 -38.58 81.96 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 113.252 0.834 . . . . 10.0 113.252 178.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.401 ' C ' ' H ' ' A' ' 30' ' ' LYS . 11.8 mt -56.13 -67.48 0.29 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.628 1.171 . . . . 10.0 113.589 169.092 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 t -76.36 40.95 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 CA-C-O 123.705 1.717 . . . . 10.0 110.83 179.112 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.401 ' H ' ' C ' ' A' ' 28' ' ' LEU . 42.9 tttm -140.86 -44.78 0.39 Allowed 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 127.89 2.476 . . . . 10.0 109.379 171.13 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.99 23.12 0.88 Allowed Glycine 0 CA--C 1.529 0.928 0 N-CA-C 115.596 0.998 . . . . 10.0 115.596 173.697 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 37.3 mmm -59.52 -44.98 93.01 Favored 'General case' 0 C--O 1.224 -0.277 0 C-N-CA 127.189 2.196 . . . . 10.0 113.587 -179.019 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.71 -84.41 1.19 Allowed Glycine 0 CA--C 1.53 0.989 0 C-N-CA 123.766 0.698 . . . . 10.0 112.471 -170.148 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.8 t 33.03 88.78 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.242 0.706 0 C-N-CA 128.434 2.694 . . . . 10.0 116.956 166.49 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.3 m -79.68 -50.85 10.01 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.184 -1.371 . . . . 10.0 113.843 174.188 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -48.93 117.56 6.48 Favored Pre-proline 0 CA--C 1.536 0.429 0 O-C-N 124.829 1.331 . . . . 10.0 110.991 -172.531 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -58.63 -29.59 89.66 Favored 'Trans proline' 0 N--CA 1.459 -0.5 0 C-N-CA 123.74 2.96 . . . . 10.0 113.706 179.146 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.38 -60.61 2.32 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.089 0.556 . . . . 10.0 111.437 176.199 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.19 -40.01 22.81 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 125.093 1.357 . . . . 10.0 113.58 171.602 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.5 tttp -46.61 -47.37 19.99 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.241 1.417 . . . . 10.0 113.434 172.067 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -57.79 -53.09 62.19 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.472 0.709 . . . . 10.0 110.944 176.673 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.477 ' CD2' ' HB1' ' A' ' 228' ' ' ALA . 43.9 m-85 -56.93 -50.23 73.2 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 123.094 0.557 . . . . 10.0 112.342 -179.125 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -54.42 -51.29 65.38 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 118.919 -0.562 . . . . 10.0 112.337 173.324 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.37 -61.98 1.93 Allowed 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 113.419 0.896 . . . . 10.0 113.419 177.13 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.4 mt -48.65 -57.49 1.54 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 C-N-CA 124.869 1.268 . . . . 10.0 110.349 178.047 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.2 m -68.87 -17.17 63.95 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.144 1.378 . . . . 10.0 113.737 -172.603 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 27.8 m -87.9 -40.02 14.31 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.5 1.12 . . . . 10.0 112.165 174.564 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 25.7 mt -59.48 -42.82 92.95 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 118.93 0.786 . . . . 10.0 112.431 170.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 18.4 t -42.26 -60.06 2.34 Favored Pre-proline 0 N--CA 1.481 1.11 0 C-N-CA 125.72 1.608 . . . . 10.0 113.881 176.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -72.7 -24.3 18.5 Favored 'Trans proline' 0 CA--C 1.545 1.074 0 C-N-CA 122.951 2.434 . . . . 10.0 114.662 174.025 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.71 -44.69 80.98 Favored 'General case' 0 CA--C 1.548 0.879 0 CA-C-N 120.642 1.564 . . . . 10.0 113.291 176.092 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 38.1 mm -53.62 -53.86 22.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 124.287 1.035 . . . . 10.0 109.404 168.178 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -53.25 -46.65 69.29 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.458 1.103 . . . . 10.0 113.343 176.564 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 52.0 t80 -51.36 -57.26 9.4 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 120.187 1.358 . . . . 10.0 112.419 172.539 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 12.5 m -50.12 -52.32 36.01 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.329 1.451 . . . . 10.0 110.454 178.104 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 32.6 mmt -69.17 -48.01 63.41 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 123.905 0.882 . . . . 10.0 112.967 -176.632 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -56.36 -40.93 75.34 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 120.35 1.432 . . . . 10.0 113.262 172.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.8 tp -53.25 -54.59 33.91 Favored 'General case' 0 C--O 1.224 -0.258 0 CA-C-N 119.85 1.204 . . . . 10.0 111.281 170.588 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 24.0 p -51.67 -41.05 61.11 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 115.224 1.564 . . . . 10.0 115.224 179.032 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 61.1 mtm -66.84 -50.86 61.19 Favored 'General case' 0 C--N 1.334 -0.082 0 C-N-CA 123.556 0.742 . . . . 10.0 110.506 176.803 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.4 tp -48.51 -52.74 21.02 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.857 0.863 . . . . 10.0 112.952 172.319 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.4 mt -76.84 -5.62 49.06 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.353 1.061 . . . . 10.0 113.854 -177.721 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.32 -34.74 5.52 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 115.55 0.98 . . . . 10.0 115.55 174.168 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 75.3 t80 -49.29 -43.08 43.01 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 115.235 1.568 . . . . 10.0 115.235 -175.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.02 3.51 61.14 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 115.35 0.9 . . . . 10.0 115.35 -179.02 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.25 143.43 26.42 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 127.042 2.137 . . . . 10.0 109.018 172.002 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 t -145.54 171.06 15.22 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 124.048 0.939 . . . . 10.0 111.067 166.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.01 136.08 53.36 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 123.853 0.861 . . . . 10.0 109.684 179.617 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 58.5 t -129.6 129.61 23.17 Favored Pre-proline 0 C--N 1.33 -0.279 0 C-N-CA 125.031 1.332 . . . . 10.0 110.905 -176.017 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -80.73 116.24 3.17 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 N-CA-C 109.415 -1.033 . . . . 10.0 109.415 -178.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -156.68 164.39 38.2 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 112.842 0.682 . . . . 10.0 112.842 172.486 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.36 -81.95 0.14 Allowed Glycine 0 CA--C 1.526 0.764 0 N-CA-C 110.692 -0.963 . . . . 10.0 110.692 175.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.77 -3.41 0.69 Allowed Glycine 0 CA--C 1.527 0.836 0 N-CA-C 118.666 2.226 . . . . 10.0 118.666 170.403 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -151.58 -171.89 4.06 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 119.349 1.575 . . . . 10.0 112.217 -165.166 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -91.82 93.9 9.07 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 125.531 1.532 . . . . 10.0 111.107 -175.316 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.449 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 60.2 m-80 -89.47 120.78 69.65 Favored Pre-proline 0 N--CA 1.45 -0.428 0 N-CA-C 113.0 0.741 . . . . 10.0 113.0 -165.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.652 ' HB3' HG21 ' A' ' 5' ' ' THR . 76.1 Cg_exo -61.48 131.92 38.32 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 124.205 3.27 . . . . 10.0 112.167 171.573 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.5 mm -140.16 126.37 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 C-N-CA 126.0 1.72 . . . . 10.0 111.712 -179.532 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -93.64 84.99 4.74 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 122.72 1.247 . . . . 10.0 113.053 174.654 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 63.8 p-90 -59.37 -28.28 66.73 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 120.939 -1.101 . . . . 10.0 113.881 174.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -55.36 -23.13 22.47 Favored 'General case' 0 CA--C 1.574 1.9 0 C-N-CA 124.277 1.031 . . . . 10.0 110.038 178.214 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -47.57 -59.75 3.03 Favored 'General case' 0 N--CA 1.496 1.833 0 C-N-CA 126.304 1.841 . . . . 10.0 112.08 163.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -68.35 -37.39 80.43 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 123.814 0.845 . . . . 10.0 110.457 -173.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -53.8 -51.59 63.0 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 123.676 0.79 . . . . 10.0 112.748 169.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 61.8 t0 -52.96 -68.72 0.15 Allowed 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 126.143 1.777 . . . . 10.0 111.26 171.076 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 46.2 m0 -57.01 -33.77 67.49 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.98 1.712 . . . . 10.0 113.268 -171.552 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 30.0 tp -50.08 -44.63 51.93 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 126.13 1.772 . . . . 10.0 111.967 177.796 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -99.25 -44.4 6.25 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.185 0.994 . . . . 10.0 112.014 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 13.7 m -48.33 -52.15 22.86 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.669 1.588 . . . . 10.0 113.242 177.193 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . 0.314 57.5 p -67.88 -45.71 43.23 Favored Pre-proline 0 N--CA 1.476 0.872 0 N-CA-C 114.557 1.318 . . . . 10.0 114.557 -174.433 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -52.91 -42.9 60.79 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 123.39 2.727 . . . . 10.0 115.329 170.635 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 52.4 mt -59.18 -46.45 88.37 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.293 0.637 . . . . 10.0 111.472 175.047 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.4 tp -51.33 -48.13 62.49 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.411 1.485 . . . . 10.0 112.198 172.449 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.7 mp -58.82 -47.33 85.19 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 125.122 1.369 . . . . 10.0 112.623 170.518 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.8 -38.28 78.22 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 123.826 0.85 . . . . 10.0 112.906 178.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 -52.31 -54.0 37.1 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 119.282 0.946 . . . . 10.0 111.163 169.665 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.36 -42.12 88.48 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.635 0.774 . . . . 10.0 112.087 -178.519 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.64 -54.73 37.67 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.996 0.919 . . . . 10.0 112.024 173.622 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.33 -41.2 79.53 Favored 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 123.73 0.812 . . . . 10.0 112.668 174.869 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.9 tp -63.71 -38.6 91.73 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 114.494 1.294 . . . . 10.0 114.494 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.1 t -94.75 1.41 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 125.092 1.357 . . . . 10.0 112.296 179.144 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.2 t70 48.55 53.52 12.0 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.881 1.672 . . . . 10.0 112.077 -174.02 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.22 145.89 47.68 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 119.955 -1.715 . . . . 10.0 112.457 -174.221 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.47 135.93 54.17 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 112.697 0.629 . . . . 10.0 112.697 175.112 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -42.92 -39.65 2.65 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.891 1.677 . . . . 10.0 113.466 175.296 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -47.3 -60.21 5.31 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 125.145 1.355 . . . . 10.0 115.295 169.703 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 42.0 p -62.1 -46.72 87.8 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 117.101 -1.428 . . . . 10.0 111.328 178.248 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 66.9 mt -48.48 -52.87 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 125.032 1.333 . . . . 10.0 111.135 178.206 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.4 tp -62.67 -51.25 67.97 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 112.544 0.572 . . . . 10.0 112.544 179.288 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.2 -44.86 43.55 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.479 0.712 . . . . 10.0 110.912 174.607 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.455 ' HA ' HD12 ' A' ' 111' ' ' LEU . 0.6 OUTLIER -59.56 -59.95 4.63 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 127.385 2.274 . . . . 10.0 114.791 174.949 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.6 t -61.02 -46.36 96.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 123.686 0.794 . . . . 10.0 111.362 -178.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -56.56 -50.41 63.19 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 123.68 0.657 . . . . 10.0 112.602 174.534 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -54.68 -46.74 74.14 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 113.081 0.771 . . . . 10.0 113.081 173.374 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -57.94 -45.07 87.2 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.998 0.919 . . . . 10.0 111.809 174.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -43.81 -55.88 5.31 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 125.123 1.344 . . . . 10.0 113.429 166.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 81.6 mt -56.63 -54.07 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 123.567 0.747 . . . . 10.0 110.962 173.62 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 45.5 ttp -46.14 -58.65 3.45 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.462 1.505 . . . . 10.0 112.455 -178.794 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 47.2 mm -70.43 -47.98 62.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 123.215 0.606 . . . . 10.0 112.012 178.65 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -53.2 -56.67 18.1 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 124.486 1.041 . . . . 10.0 112.873 179.649 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -61.63 -34.01 74.93 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.55 1.14 . . . . 10.0 112.288 174.744 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -50.93 -54.63 21.68 Favored Glycine 0 CA--C 1.537 1.442 0 C-N-CA 124.505 1.05 . . . . 10.0 113.395 165.307 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 63.4 tp -56.99 -45.67 82.82 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.366 1.467 . . . . 10.0 111.634 176.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 62.0 t -53.01 -51.35 38.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 122.959 0.503 . . . . 10.0 110.384 172.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -48.82 -61.08 5.5 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 125.751 1.643 . . . . 10.0 112.855 170.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -45.75 -40.37 9.4 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 127.004 2.122 . . . . 10.0 113.813 177.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 49.8 mt -100.14 -6.6 25.98 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 115.193 1.553 . . . . 10.0 115.193 -176.538 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 17.0 m -69.66 116.72 10.38 Favored 'General case' 0 N--CA 1.464 0.237 0 O-C-N 120.186 -1.571 . . . . 10.0 110.41 -178.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.622 ' H ' ' HD3' ' A' ' 129' ' ' LYS . 0.1 OUTLIER -55.44 -49.65 71.9 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 128.186 2.594 . . . . 10.0 113.267 177.754 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 60.6 t -69.62 106.37 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 123.761 0.824 . . . . 10.0 110.085 179.661 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -46.94 -59.49 3.06 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 124.775 1.23 . . . . 10.0 114.07 -173.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 m -46.53 -42.07 15.22 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.45 1.5 . . . . 10.0 113.484 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -70.14 -24.61 63.2 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 114.959 1.466 . . . . 10.0 114.959 -178.13 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 68.1 mtp85 -54.21 -41.69 68.92 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 118.869 0.759 . . . . 10.0 110.811 176.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -69.01 -32.73 72.47 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.678 1.191 . . . . 10.0 114.166 176.512 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.7 t -54.46 -52.03 43.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 CA-C-N 119.073 0.851 . . . . 10.0 109.659 169.12 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 66.2 m95 -62.0 -45.7 92.44 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 114.531 1.308 . . . . 10.0 114.531 174.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 86.5 t90 -52.13 -47.98 65.08 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.868 0.867 . . . . 10.0 112.582 172.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -57.71 -52.31 65.99 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.047 0.939 . . . . 10.0 111.69 176.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 97.3 mt -54.93 -49.99 66.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 124.732 1.213 . . . . 10.0 111.694 175.222 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 23.3 t -55.31 -47.98 74.81 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.323 1.049 . . . . 10.0 111.882 174.194 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 57.2 m -60.2 -41.86 93.89 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.412 1.485 . . . . 10.0 112.343 177.345 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -58.62 -49.66 76.69 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 119.117 0.871 . . . . 10.0 112.444 170.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -56.71 -45.02 82.12 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.676 0.79 . . . . 10.0 112.531 173.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 40.4 ttp -55.93 -55.72 29.27 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 124.488 1.115 . . . . 10.0 111.915 171.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -51.13 -48.5 61.77 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 125.869 1.668 . . . . 10.0 111.569 178.236 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 78.5 t80 -52.33 -54.54 30.37 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 113.099 0.778 . . . . 10.0 113.099 172.087 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 56.0 mt -53.87 -54.68 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 123.943 0.897 . . . . 10.0 110.739 177.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 90.8 mt -50.69 -42.93 57.42 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 126.129 1.772 . . . . 10.0 112.818 175.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -57.32 -58.09 9.76 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 123.986 0.914 . . . . 10.0 113.084 176.618 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.43 -40.92 85.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 CA-C-O 118.313 -0.851 . . . . 10.0 111.408 177.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 47.2 mt -56.83 -49.45 75.39 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.878 1.217 . . . . 10.0 112.069 171.327 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.47 ' HA ' ' HD2' ' A' ' 175' ' ' ARG . 11.8 t80 -76.94 -70.29 0.47 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 120.06 -1.65 . . . . 10.0 112.915 -175.24 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -73.78 -21.9 60.02 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.596 1.158 . . . . 10.0 113.454 -174.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -87.83 -79.1 1.26 Allowed Glycine 0 CA--C 1.527 0.806 0 C-N-CA 123.612 0.625 . . . . 10.0 113.501 171.499 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -53.58 -32.47 51.06 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 126.266 1.826 . . . . 10.0 113.045 -166.546 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.4 m -52.1 -56.47 14.25 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 113.988 1.107 . . . . 10.0 113.988 172.172 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.5 p -53.6 -50.59 65.32 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 122.093 0.949 . . . . 10.0 112.297 -177.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 47.7 tttm -57.09 -46.11 82.82 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.165 0.986 . . . . 10.0 112.103 173.676 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.74 -47.51 79.88 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 114.55 1.315 . . . . 10.0 114.55 174.03 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -56.5 -11.22 1.19 Allowed 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 126.056 1.742 . . . . 10.0 114.268 177.683 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.1 m -107.08 6.57 29.05 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.425 1.89 . . . . 10.0 114.898 -179.357 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 93.3 mmm -91.9 -92.6 0.15 Allowed 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 123.485 1.612 . . . . 10.0 114.16 -170.568 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -138.75 153.94 72.58 Favored Pre-proline 0 C--O 1.236 0.349 0 C-N-CA 129.809 3.243 . . . . 10.0 105.529 170.258 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -52.86 -46.19 35.48 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 122.3 2.0 . . . . 10.0 113.08 179.056 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.667 ' CD ' ' HD3' ' A' ' 227' ' ' ARG . 0.1 OUTLIER -53.02 -46.09 68.25 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 129.014 2.926 . . . . 10.0 113.221 173.597 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 92.0 t -69.12 -53.09 27.63 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.267 0 C-N-CA 124.068 0.947 . . . . 10.0 109.798 -178.632 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.11 -46.85 75.59 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.291 0.636 . . . . 10.0 111.905 177.059 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 60.1 p -59.98 -56.22 24.34 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.885 0.874 . . . . 10.0 112.702 174.629 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 62.0 m -57.12 -53.31 59.59 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.23 1.012 . . . . 10.0 112.987 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -49.52 -49.57 45.38 Favored 'General case' 0 C--O 1.222 -0.386 0 C-N-CA 123.3 0.64 . . . . 10.0 111.068 174.085 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -57.12 -48.37 78.82 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 114.699 1.37 . . . . 10.0 114.699 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 40.4 t -56.02 -49.57 74.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-N 118.832 0.742 . . . . 10.0 110.487 176.384 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 94.2 mt -58.57 -51.63 69.09 Favored 'General case' 0 C--O 1.221 -0.397 0 N-CA-C 113.152 0.797 . . . . 10.0 113.152 175.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' ARG . . . . . 0.47 ' HD2' ' HA ' ' A' ' 153' ' ' PHE . 35.5 ttp180 -47.82 -47.82 31.05 Favored 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 126.868 2.067 . . . . 10.0 111.011 174.499 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 63.6 m-20 -58.48 -58.31 9.11 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 122.805 0.442 . . . . 10.0 111.29 174.408 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 58.3 t -51.77 -50.25 32.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 124.086 0.954 . . . . 10.0 111.587 179.031 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 26.5 m -56.55 -60.34 3.67 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 127.872 2.469 . . . . 10.0 111.953 177.56 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 47.7 t -53.67 -49.52 56.34 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 CA-C-N 119.215 0.916 . . . . 10.0 111.312 -178.094 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 76.6 t -58.91 -61.67 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 124.369 1.068 . . . . 10.0 111.908 176.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -59.24 -48.82 80.17 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 118.63 0.65 . . . . 10.0 112.609 -175.704 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 9.8 m95 -54.27 -49.71 68.95 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 118.9 0.773 . . . . 10.0 111.947 176.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 51.0 m -54.59 -31.37 56.76 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 114.03 1.122 . . . . 10.0 114.03 178.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -63.84 -40.61 96.98 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 113.772 1.027 . . . . 10.0 113.772 176.13 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 -48.23 -55.75 17.15 Favored Pre-proline 0 CA--C 1.546 0.798 0 N-CA-C 115.271 1.582 . . . . 10.0 115.271 -176.012 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -59.72 -33.16 96.5 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 122.32 2.013 . . . . 10.0 113.444 177.221 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 24.4 t -64.27 -54.54 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 123.841 0.856 . . . . 10.0 110.396 175.057 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 88.3 t -53.26 -49.04 54.28 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 124.739 1.216 . . . . 10.0 111.457 176.199 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 69.9 t90 -54.68 -54.56 40.18 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.331 1.052 . . . . 10.0 112.525 174.58 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 9.9 tt -57.55 -42.37 82.83 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 123.881 0.872 . . . . 10.0 112.166 -176.045 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 14.1 pt -84.79 -5.95 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 N-CA-C 115.289 1.589 . . . . 10.0 115.289 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.41 -169.29 32.97 Favored Glycine 0 N--CA 1.45 -0.404 0 CA-C-O 122.589 1.105 . . . . 10.0 113.883 -168.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 23.3 t -53.13 -42.25 65.86 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 114.16 -1.02 . . . . 10.0 111.85 177.623 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -69.13 -13.05 62.2 Favored 'General case' 0 CA--C 1.55 0.962 0 N-CA-C 115.155 1.539 . . . . 10.0 115.155 -174.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -132.25 -106.37 1.03 Allowed Glycine 0 CA--C 1.536 1.38 0 CA-C-N 120.716 1.598 . . . . 10.0 114.497 -174.145 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -89.45 127.16 35.81 Favored 'General case' 0 C--N 1.329 -0.323 0 O-C-N 120.666 -1.491 . . . . 10.0 109.305 168.074 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -72.47 65.32 1.36 Allowed Glycine 0 CA--C 1.532 1.105 0 N-CA-C 113.901 0.32 . . . . 10.0 113.901 173.143 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 60.7 mt -79.57 -42.74 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 126.107 1.763 . . . . 10.0 108.735 166.369 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 79.3 t -126.28 133.38 24.91 Favored Pre-proline 0 N--CA 1.453 -0.279 0 C-N-CA 126.504 1.922 . . . . 10.0 109.391 -174.209 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -68.7 153.76 72.63 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 123.822 3.015 . . . . 10.0 111.474 -176.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 12.2 tp -43.13 -39.82 2.98 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.319 1.047 . . . . 10.0 112.229 171.46 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -48.28 -52.41 21.45 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 114.684 1.365 . . . . 10.0 114.684 176.03 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 14.0 mm -75.95 -40.53 38.36 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 124.419 1.088 . . . . 10.0 109.625 177.609 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -49.29 -49.75 42.26 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 118.61 0.641 . . . . 10.0 112.005 173.634 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 16.2 m -57.75 -47.01 83.7 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 126.042 1.737 . . . . 10.0 112.991 174.292 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.535 HD23 ' CD2' ' A' ' 12' ' ' TRP . 1.3 tm? -63.35 -52.36 62.13 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.927 0.891 . . . . 10.0 112.063 179.732 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 93.3 mt -52.48 -60.0 3.76 Favored 'General case' 0 C--O 1.227 -0.115 0 C-N-CA 124.322 1.049 . . . . 10.0 109.993 176.443 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -53.49 -43.18 68.02 Favored 'General case' 0 C--O 1.218 -0.589 0 CA-C-O 117.432 -1.27 . . . . 10.0 112.51 176.293 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 209' ' ' MET . . . . . 0.575 ' HE2' ' HB3' ' A' ' 15' ' ' LEU . 4.6 tmm? -53.93 -52.52 60.33 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 121.51 1.959 . . . . 10.0 112.974 173.632 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 82.1 t -61.06 -47.12 95.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 124.957 1.303 . . . . 10.0 111.7 178.388 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 4.8 mp -58.97 -51.3 70.66 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 125.578 1.551 . . . . 10.0 111.79 175.006 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -55.07 -59.96 4.04 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 125.969 1.708 . . . . 10.0 109.924 176.104 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 35.1 t -45.2 -59.01 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 125.334 1.454 . . . . 10.0 111.658 175.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 26.9 p -59.98 -44.37 94.53 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 112.939 0.718 . . . . 10.0 112.939 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -67.06 -22.04 65.87 Favored 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 115.131 1.53 . . . . 10.0 115.131 173.803 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -87.71 -78.98 0.3 Allowed 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.76 1.624 . . . . 10.0 110.264 171.706 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 33.1 m -78.54 -38.37 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 O-C-N 121.133 -0.979 . . . . 10.0 112.476 -170.403 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -58.18 -57.63 18.8 Favored Glycine 0 N--CA 1.474 1.197 0 CA-C-N 119.822 1.192 . . . . 10.0 111.912 176.077 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 42.8 t80 -45.45 -57.78 3.84 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.142 1.777 . . . . 10.0 112.45 167.429 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -56.9 -40.59 90.58 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 123.834 0.73 . . . . 10.0 113.561 -179.184 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 24.2 mt -70.95 -27.19 63.56 Favored 'General case' 0 CA--C 1.51 -0.582 0 N-CA-C 115.52 1.674 . . . . 10.0 115.52 176.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 74.0 mt -63.2 -57.57 11.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 119.131 0.878 . . . . 10.0 108.688 165.388 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 32.1 tp -58.91 -64.6 0.88 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.854 0.862 . . . . 10.0 113.207 -172.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 84.0 mt -71.55 5.24 2.5 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 115.323 1.601 . . . . 10.0 115.323 -171.727 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.6 mtp-105 -112.34 0.36 15.65 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.165 0.986 . . . . 10.0 113.265 172.525 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 8.8 t -108.04 177.94 4.66 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 124.082 0.953 . . . . 10.0 111.039 174.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 227' ' ' ARG . . . . . 0.667 ' HD3' ' CD ' ' A' ' 166' ' ' GLU . 41.9 ttt180 -71.66 98.17 1.86 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.732 0.813 . . . . 10.0 110.968 170.694 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 228' ' ' ALA . . . . . 0.477 ' HB1' ' CD2' ' A' ' 42' ' ' PHE . . . -80.93 77.03 7.86 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.829 0.852 . . . . 10.0 112.087 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 40.16 102.21 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 128.831 2.852 . . . . 10.0 116.502 177.723 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . 0.481 0.3 OUTLIER 71.83 -55.39 0.66 Allowed 'General case' 0 C--O 1.242 0.677 0 C-N-CA 124.764 1.226 . . . . 10.0 110.656 -175.277 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -68.34 169.48 40.2 Favored Glycine 0 C--O 1.239 0.417 0 C-N-CA 129.738 3.542 . . . . 10.0 119.598 171.511 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.489 0 C-N-CA 128.486 2.714 . . . . 10.0 113.44 166.618 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 999' ' ' RET . . . . . 0.535 H181 ' H7 ' ' A' ' 999' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1000 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A 1001 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A 1002 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A 1003 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 N--CA 1.477 0.913 0 CA-C-O 115.781 -2.057 . . . . 10.0 105.833 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 23.35 91.83 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 129.598 3.159 . . . . 10.0 117.262 160.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 28.64 65.07 0.11 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 128.262 2.625 . . . . 10.0 114.511 155.46 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 86.7 mt -56.49 137.96 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 126.41 1.884 . . . . 10.0 113.353 -158.369 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.652 HG21 ' HB3' ' A' ' 77' ' ' PRO . 7.6 t -136.79 -165.2 1.7 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 126.327 1.851 . . . . 10.0 114.021 -174.331 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 70.0 2.83 41.1 Favored Glycine 0 C--N 1.339 0.743 0 C-N-CA 127.496 2.474 . . . . 10.0 111.485 168.076 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -158.52 -51.41 0.01 OUTLIER Pre-proline 0 N--CA 1.443 -0.783 0 CA-C-O 114.275 -2.774 . . . . 10.0 116.634 -168.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -63.89 -60.69 0.14 Allowed 'Trans proline' 0 CA--C 1.528 0.186 0 CA-C-N 123.5 2.286 . . . . 10.0 113.236 -175.318 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.41 ' H ' ' CD ' ' A' ' 9' ' ' GLU . 7.9 pm0 -67.13 4.22 0.96 Allowed 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 127.878 2.471 . . . . 10.0 115.75 179.694 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.422 ' CG ' ' N ' ' A' ' 11' ' ' ILE . 11.0 p-90 -51.28 -43.15 61.54 Favored 'General case' 0 C--O 1.222 -0.361 0 O-C-N 121.5 -0.75 . . . . 10.0 112.646 176.425 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.422 ' N ' ' CG ' ' A' ' 10' ' ' TRP . 8.9 tt -60.85 -49.64 83.79 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.338 0 C-N-CA 123.926 0.89 . . . . 10.0 109.323 179.425 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.535 ' CD2' HD23 ' A' ' 206' ' ' LEU . 2.6 m95 -55.34 -52.67 62.75 Favored 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 123.406 0.682 . . . . 10.0 111.908 175.575 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.4 mt -57.34 -53.6 56.31 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 123.223 0.609 . . . . 10.0 112.245 177.237 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.91 -46.8 52.24 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.412 1.485 . . . . 10.0 113.324 173.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.575 ' HB3' ' HE2' ' A' ' 209' ' ' MET . 13.3 tp -65.63 -44.95 84.88 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.277 1.431 . . . . 10.0 113.059 179.057 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.17 -58.37 7.99 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 124.274 0.94 . . . . 10.0 110.853 165.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.3 m -48.24 -52.41 21.25 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.625 1.17 . . . . 10.0 112.279 175.685 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.45 -58.83 5.93 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.122 0.969 . . . . 10.0 112.177 177.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 93.8 mt -58.25 -49.63 76.41 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.681 0.793 . . . . 10.0 112.399 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -50.73 -54.52 22.62 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.683 1.193 . . . . 10.0 110.879 173.684 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -57.17 -58.18 15.9 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 124.452 1.025 . . . . 10.0 113.574 178.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 80.8 mt -56.16 -45.54 79.65 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-N 118.626 1.213 . . . . 10.0 112.134 176.357 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.45 -42.57 75.71 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 124.936 1.255 . . . . 10.0 113.329 172.462 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 17.4 m -59.75 -60.86 3.16 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.216 1.006 . . . . 10.0 111.076 171.473 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -52.3 -40.99 62.55 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.061 0.944 . . . . 10.0 110.936 179.321 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.0 t80 -55.78 -58.03 9.56 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.552 1.141 . . . . 10.0 113.006 172.741 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -59.63 -38.7 82.07 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 113.226 0.825 . . . . 10.0 113.226 178.85 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.4 ' C ' ' H ' ' A' ' 30' ' ' LYS . 11.9 mt -56.08 -67.42 0.3 Allowed 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.592 1.157 . . . . 10.0 113.668 169.072 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 t -76.45 41.04 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 CA-C-O 123.749 1.738 . . . . 10.0 110.829 179.109 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.4 ' H ' ' C ' ' A' ' 28' ' ' LEU . 42.9 tttm -140.91 -44.87 0.39 Allowed 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 127.868 2.467 . . . . 10.0 109.303 171.186 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.95 23.09 0.87 Allowed Glycine 0 CA--C 1.529 0.956 0 N-CA-C 115.644 1.017 . . . . 10.0 115.644 173.729 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 37.4 mmm -59.54 -44.96 93.07 Favored 'General case' 0 C--O 1.224 -0.253 0 C-N-CA 127.136 2.174 . . . . 10.0 113.578 -178.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.66 -84.44 1.18 Allowed Glycine 0 CA--C 1.531 1.045 0 C-N-CA 123.741 0.686 . . . . 10.0 112.477 -170.159 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.8 t 33.09 88.7 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.243 0.73 0 C-N-CA 128.399 2.68 . . . . 10.0 116.941 166.459 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.4 m -79.58 -50.9 10.0 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.188 -1.369 . . . . 10.0 113.868 174.141 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -48.87 117.46 6.32 Favored Pre-proline 0 CA--C 1.536 0.428 0 O-C-N 124.719 1.262 . . . . 10.0 110.983 -172.536 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -58.56 -29.62 89.51 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 123.773 2.982 . . . . 10.0 113.727 179.123 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.38 -60.59 2.33 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.058 0.543 . . . . 10.0 111.442 176.183 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.15 -40.07 22.65 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 125.127 1.371 . . . . 10.0 113.58 171.593 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -46.5 -47.5 19.39 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 125.292 1.437 . . . . 10.0 113.413 172.03 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -57.79 -52.98 63.23 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.438 0.695 . . . . 10.0 110.975 176.711 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.476 ' CD2' ' HB1' ' A' ' 228' ' ' ALA . 44.2 m-85 -57.05 -50.18 73.54 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 123.034 0.534 . . . . 10.0 112.351 -179.145 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -54.37 -51.28 65.31 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 118.935 -0.555 . . . . 10.0 112.379 173.231 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.42 -61.97 1.94 Allowed 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 113.425 0.898 . . . . 10.0 113.425 177.168 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.7 mt -48.8 -57.54 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 C-N-CA 124.823 1.249 . . . . 10.0 110.145 177.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 4.9 m -69.42 -14.75 63.07 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.188 1.395 . . . . 10.0 113.74 -172.585 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 31.3 m -89.7 -42.25 11.44 Favored 'General case' 0 N--CA 1.483 1.178 0 CA-C-N 119.884 1.22 . . . . 10.0 111.946 174.492 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 27.9 mt -56.27 -40.01 73.55 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 118.433 0.56 . . . . 10.0 112.176 170.181 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . 0.254 24.3 t -47.09 -62.9 1.65 Allowed Pre-proline 0 CA--C 1.552 1.052 0 C-N-CA 125.266 1.426 . . . . 10.0 112.884 177.007 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -53.26 -42.47 64.9 Favored 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 123.919 3.079 . . . . 10.0 116.303 166.089 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.66 -46.19 89.33 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 114.199 1.185 . . . . 10.0 114.199 -174.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 48.3 mm -57.43 -51.32 71.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 O-C-N 121.194 -0.941 . . . . 10.0 109.697 171.717 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.76 -42.62 71.91 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 113.588 0.959 . . . . 10.0 113.588 175.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -52.85 -56.73 13.62 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 120.379 1.445 . . . . 10.0 112.01 170.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.8 m -49.55 -52.52 29.29 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.512 1.525 . . . . 10.0 110.837 177.679 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 32.7 mmt -69.11 -48.23 63.07 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 124.035 0.934 . . . . 10.0 112.894 -176.568 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -57.01 -40.11 76.01 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 117.058 -1.449 . . . . 10.0 113.135 173.175 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.8 tp -53.31 -54.58 34.43 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-N 120.198 1.363 . . . . 10.0 111.276 170.396 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 23.9 p -51.68 -41.0 61.09 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 115.261 1.578 . . . . 10.0 115.261 178.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 57.4 mtm -66.88 -50.88 61.08 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 123.534 0.734 . . . . 10.0 110.481 176.78 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.3 tp -48.54 -52.69 21.43 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.858 0.863 . . . . 10.0 112.926 172.344 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.4 mt -76.87 -5.64 49.22 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.377 1.071 . . . . 10.0 113.819 -177.664 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.29 -34.72 5.54 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 115.533 0.973 . . . . 10.0 115.533 174.173 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -49.29 -43.13 42.99 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 115.206 1.558 . . . . 10.0 115.206 -176.014 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.06 3.61 60.97 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 115.337 0.895 . . . . 10.0 115.337 -178.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.29 143.42 26.42 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 127.048 2.139 . . . . 10.0 108.972 172.014 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 t -145.54 171.05 15.24 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 124.064 0.946 . . . . 10.0 111.022 166.82 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.99 136.12 53.33 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 123.855 0.862 . . . . 10.0 109.683 179.602 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.436 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 58.5 t -129.6 129.55 23.17 Favored Pre-proline 0 C--N 1.329 -0.295 0 C-N-CA 125.063 1.345 . . . . 10.0 110.948 -176.048 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 69' ' ' VAL . 6.3 Cg_exo -80.69 116.24 3.18 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 N-CA-C 109.417 -1.032 . . . . 10.0 109.417 -178.899 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -156.74 164.4 38.16 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.823 0.675 . . . . 10.0 112.823 172.483 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.37 -81.98 0.14 Allowed Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.681 -0.967 . . . . 10.0 110.681 175.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.76 -3.32 0.7 Allowed Glycine 0 CA--C 1.527 0.822 0 N-CA-C 118.671 2.228 . . . . 10.0 118.671 170.395 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -151.63 -171.89 4.06 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 119.354 1.577 . . . . 10.0 112.237 -165.161 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -91.89 93.95 9.06 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 125.504 1.522 . . . . 10.0 111.066 -175.277 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.449 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 60.3 m-80 -89.52 120.77 69.62 Favored Pre-proline 0 N--CA 1.45 -0.43 0 N-CA-C 112.964 0.727 . . . . 10.0 112.964 -165.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.652 ' HB3' HG21 ' A' ' 5' ' ' THR . 75.7 Cg_exo -61.53 131.97 38.43 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 124.163 3.242 . . . . 10.0 112.136 171.625 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.5 mm -140.14 126.3 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 C-N-CA 126.072 1.749 . . . . 10.0 111.714 -179.463 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -93.65 85.07 4.76 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 122.714 1.245 . . . . 10.0 113.055 174.599 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 63.8 p-90 -59.35 -28.3 66.71 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 113.925 1.083 . . . . 10.0 113.925 174.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -55.21 -32.77 62.51 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.273 1.029 . . . . 10.0 112.654 178.245 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 37.7 ttm-85 -49.36 -43.51 44.0 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.917 1.687 . . . . 10.0 112.283 169.844 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 61.7 m-85 -78.91 -39.85 33.76 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.538 1.535 . . . . 10.0 112.428 -179.095 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -49.92 -48.15 51.89 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.798 1.239 . . . . 10.0 111.337 167.59 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -56.01 -68.8 0.17 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.426 1.49 . . . . 10.0 111.907 170.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 48.9 m0 -52.82 -33.95 51.61 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.996 1.318 . . . . 10.0 113.387 -173.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 32.6 tp -50.96 -45.65 60.83 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 125.899 1.679 . . . . 10.0 111.982 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -97.55 -47.55 5.6 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 124.478 1.111 . . . . 10.0 112.441 -177.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.4 HG21 ' HD2' ' A' ' 216' ' ' LYS . 51.6 m -59.77 -40.13 87.19 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.643 1.177 . . . . 10.0 112.892 -174.364 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.5 m -68.26 -47.58 38.07 Favored Pre-proline 0 CA--C 1.547 0.86 0 N-CA-C 113.745 1.017 . . . . 10.0 113.745 -179.153 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -50.03 -42.77 44.7 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 123.356 2.704 . . . . 10.0 115.362 166.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 54.1 mt -59.18 -46.94 87.07 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.264 0.626 . . . . 10.0 111.575 174.672 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.5 tp -49.71 -49.15 48.91 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.593 1.557 . . . . 10.0 112.162 171.729 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.6 mp -58.85 -47.33 85.25 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.031 1.332 . . . . 10.0 112.498 171.435 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.83 -38.24 78.23 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 123.844 0.857 . . . . 10.0 112.891 178.584 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -52.31 -54.0 37.16 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 119.324 0.966 . . . . 10.0 111.189 169.642 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.35 -42.17 88.46 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.656 0.782 . . . . 10.0 112.046 -178.506 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.7 -54.7 38.4 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 124.008 0.923 . . . . 10.0 112.013 173.686 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.3 -41.17 79.34 Favored 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 123.72 0.808 . . . . 10.0 112.702 174.779 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.9 tp -63.75 -38.62 91.77 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 114.425 1.268 . . . . 10.0 114.425 -179.627 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.1 t -94.79 1.49 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 125.025 1.33 . . . . 10.0 112.325 179.158 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.2 t70 48.57 53.49 12.06 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.866 1.666 . . . . 10.0 112.095 -174.033 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.3 145.94 47.51 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 119.974 -1.704 . . . . 10.0 112.437 -174.16 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.53 135.92 54.41 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 112.679 0.622 . . . . 10.0 112.679 175.16 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -42.81 -39.75 2.61 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.895 1.678 . . . . 10.0 113.443 175.258 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -47.35 -60.2 5.35 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 125.15 1.357 . . . . 10.0 115.22 169.789 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.9 p -62.07 -46.72 87.87 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 117.103 -1.427 . . . . 10.0 111.351 178.244 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 67.1 mt -48.47 -52.9 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 125.033 1.333 . . . . 10.0 111.085 178.2 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.3 tp -62.62 -51.33 67.69 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 112.502 0.556 . . . . 10.0 112.502 179.324 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.11 -44.9 42.7 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.47 0.708 . . . . 10.0 110.959 174.601 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.456 ' HA ' HD12 ' A' ' 111' ' ' LEU . 0.6 OUTLIER -59.64 -59.89 4.72 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 127.393 2.277 . . . . 10.0 114.793 174.972 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.8 t -61.0 -46.31 96.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 123.704 0.802 . . . . 10.0 111.411 -178.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -56.65 -50.32 64.05 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 123.695 0.664 . . . . 10.0 112.63 174.543 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -54.96 -46.23 75.01 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 113.375 0.88 . . . . 10.0 113.375 173.361 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -55.9 -48.84 74.9 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.698 0.799 . . . . 10.0 111.129 173.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -42.52 -55.27 4.58 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 125.044 1.306 . . . . 10.0 112.997 169.717 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 82.2 mt -55.56 -58.19 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-O 117.571 -1.204 . . . . 10.0 110.66 173.323 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 5.0 ptt? -53.42 -46.35 69.74 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 120.783 1.628 . . . . 10.0 113.343 -173.606 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 46.5 mm -73.77 -47.39 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 O-C-N 121.471 -0.768 . . . . 10.0 111.836 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -54.0 -50.77 53.71 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 123.848 0.737 . . . . 10.0 112.278 175.145 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 23.7 m -56.53 -46.21 80.75 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.816 1.646 . . . . 10.0 111.648 172.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -45.83 -54.07 8.25 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 124.8 1.191 . . . . 10.0 113.221 168.109 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 61.6 tp -59.87 -46.44 89.3 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.195 1.398 . . . . 10.0 112.698 176.701 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 60.4 t -53.76 -49.7 56.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 O-C-N 121.284 -0.885 . . . . 10.0 110.112 172.861 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -50.7 -61.23 6.19 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 126.119 1.818 . . . . 10.0 112.65 171.592 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -43.12 -42.08 3.91 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 127.818 2.447 . . . . 10.0 113.208 176.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 47.3 mt -100.88 -6.8 24.19 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 115.536 1.68 . . . . 10.0 115.536 -175.128 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 16.9 m -69.66 116.71 10.37 Favored 'General case' 0 N--CA 1.464 0.229 0 O-C-N 120.195 -1.566 . . . . 10.0 110.386 -178.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.621 ' H ' ' HD3' ' A' ' 129' ' ' LYS . 0.2 OUTLIER -55.51 -49.57 72.26 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 128.157 2.583 . . . . 10.0 113.269 177.763 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 60.3 t -69.65 106.33 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 123.819 0.848 . . . . 10.0 110.103 179.643 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -46.9 -59.54 3.02 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 124.724 1.21 . . . . 10.0 114.055 -173.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 m -46.5 -42.05 15.01 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.45 1.5 . . . . 10.0 113.495 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -70.18 -24.64 63.17 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 114.896 1.443 . . . . 10.0 114.896 -178.103 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 68.9 mtp85 -53.95 -41.81 68.18 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 118.88 0.764 . . . . 10.0 110.776 176.638 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -69.62 -31.6 69.81 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 114.403 1.26 . . . . 10.0 114.403 176.637 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.8 t -55.09 -52.18 47.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 CA-C-N 118.993 0.815 . . . . 10.0 109.549 168.703 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 64.2 m95 -61.09 -43.27 99.15 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 114.185 1.18 . . . . 10.0 114.185 174.085 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 89.2 t90 -52.88 -49.81 65.11 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 119.255 0.934 . . . . 10.0 112.642 172.05 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -56.99 -52.72 64.14 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.225 1.01 . . . . 10.0 111.76 178.193 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 96.9 mt -54.42 -50.75 55.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 125.019 1.328 . . . . 10.0 111.596 175.255 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 19.5 m -54.49 -45.49 73.23 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.46 1.104 . . . . 10.0 111.835 174.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 53.3 m -62.25 -44.72 95.91 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.821 1.648 . . . . 10.0 112.08 177.819 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -56.5 -50.97 70.24 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.781 0.832 . . . . 10.0 112.265 171.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -57.51 -46.29 83.97 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.836 0.854 . . . . 10.0 112.942 175.204 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 11.9 tmm? -55.02 -54.06 47.85 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.26 1.424 . . . . 10.0 111.956 172.234 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 58.1 tp -57.65 -42.98 84.58 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.794 1.638 . . . . 10.0 112.834 178.594 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -53.36 -53.6 48.71 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.537 0.735 . . . . 10.0 112.037 169.544 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 46.2 mt -54.62 -54.64 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 123.733 0.813 . . . . 10.0 111.061 177.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 5.1 tt -46.13 -46.91 17.46 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 127.943 2.497 . . . . 10.0 112.222 173.418 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -57.33 -58.15 9.5 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 124.026 0.93 . . . . 10.0 113.03 178.346 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.42 -40.9 85.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-O 118.343 -0.837 . . . . 10.0 111.467 177.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 47.4 mt -56.73 -49.45 75.16 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.824 1.193 . . . . 10.0 112.139 171.223 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.47 ' HA ' ' HD2' ' A' ' 175' ' ' ARG . 11.8 t80 -76.98 -70.34 0.47 Allowed 'General case' 0 C--N 1.326 -0.447 0 O-C-N 120.079 -1.638 . . . . 10.0 112.845 -175.215 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -73.76 -21.92 60.03 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.634 1.174 . . . . 10.0 113.426 -174.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -87.77 -79.08 1.26 Allowed Glycine 0 CA--C 1.526 0.761 0 C-N-CA 123.662 0.649 . . . . 10.0 113.553 171.488 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -53.63 -32.47 51.46 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 126.307 1.843 . . . . 10.0 113.025 -166.54 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.2 m -52.08 -56.45 14.35 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 114.016 1.117 . . . . 10.0 114.016 172.143 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.4 p -53.66 -50.56 65.52 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 122.161 0.981 . . . . 10.0 112.307 -177.846 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 47.6 tttm -57.08 -46.07 82.83 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.134 0.974 . . . . 10.0 112.167 173.634 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.86 -47.41 80.47 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 114.515 1.302 . . . . 10.0 114.515 174.069 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -56.47 -11.3 1.21 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 126.087 1.755 . . . . 10.0 114.252 177.66 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.2 m -107.1 6.64 29.08 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.416 1.886 . . . . 10.0 114.877 -179.321 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 93.2 mmm -91.91 -92.63 0.15 Allowed 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 123.451 1.596 . . . . 10.0 114.164 -170.635 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -138.71 154.0 72.7 Favored Pre-proline 0 C--O 1.236 0.359 0 C-N-CA 129.749 3.219 . . . . 10.0 105.539 170.241 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -52.85 -46.24 35.09 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 122.308 2.005 . . . . 10.0 113.074 179.057 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.667 ' CD ' ' HD3' ' A' ' 227' ' ' ARG . 0.1 OUTLIER -52.94 -46.11 67.98 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 129.022 2.929 . . . . 10.0 113.281 173.578 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 92.2 t -69.19 -53.03 27.73 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 C-N-CA 124.034 0.934 . . . . 10.0 109.782 -178.609 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.09 -46.89 75.53 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.282 0.633 . . . . 10.0 111.923 177.047 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 60.2 p -59.97 -56.16 25.08 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.883 0.873 . . . . 10.0 112.719 174.631 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 61.7 m -57.23 -53.16 61.21 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.143 0.977 . . . . 10.0 113.004 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -49.59 -49.54 46.26 Favored 'General case' 0 C--O 1.222 -0.375 0 C-N-CA 123.289 0.636 . . . . 10.0 111.067 174.098 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -57.12 -48.41 78.72 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 114.671 1.36 . . . . 10.0 114.671 -179.732 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 40.3 t -55.95 -49.63 74.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 CA-C-N 118.832 0.742 . . . . 10.0 110.522 176.378 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 94.0 mt -58.54 -51.69 68.82 Favored 'General case' 0 C--O 1.222 -0.389 0 N-CA-C 113.168 0.803 . . . . 10.0 113.168 175.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' ARG . . . . . 0.47 ' HD2' ' HA ' ' A' ' 153' ' ' PHE . 35.6 ttp180 -47.72 -47.83 29.84 Favored 'General case' 0 C--O 1.224 -0.244 0 C-N-CA 126.889 2.075 . . . . 10.0 111.041 174.448 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 63.7 m-20 -58.51 -58.33 9.02 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 122.817 0.447 . . . . 10.0 111.25 174.426 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 53.7 t -52.09 -47.19 43.58 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 C-N-CA 124.05 0.94 . . . . 10.0 112.301 179.063 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 30.2 m -58.27 -65.31 0.67 Allowed 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 128.041 2.536 . . . . 10.0 111.283 177.518 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 55.8 t -49.66 -49.12 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 C-N-CA 124.859 1.263 . . . . 10.0 111.429 -178.846 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 72.0 t -58.88 -61.75 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 123.909 0.884 . . . . 10.0 112.164 177.425 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 85.8 mt -55.11 -46.82 75.6 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 119.251 0.932 . . . . 10.0 112.002 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 9.6 m95 -53.13 -47.12 68.94 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 125.174 1.39 . . . . 10.0 113.215 175.667 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 51.3 p -57.59 -32.87 67.62 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 113.753 1.02 . . . . 10.0 113.753 175.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -67.81 -45.5 74.57 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 113.708 1.003 . . . . 10.0 113.708 -179.798 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -44.29 -55.36 9.96 Favored Pre-proline 0 CA--C 1.55 0.979 0 N-CA-C 115.596 1.702 . . . . 10.0 115.596 -178.342 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 186' ' ' PRO . . . . . 0.563 ' HB3' H183 ' A' ' 999' ' ' RET . 19.1 Cg_endo -57.95 -38.06 93.64 Favored 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 122.874 2.383 . . . . 10.0 113.562 176.419 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 30.3 t -63.67 -53.66 41.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 124.679 1.192 . . . . 10.0 110.576 177.713 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 96.2 t -53.55 -49.68 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 124.819 1.248 . . . . 10.0 111.462 176.56 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 61.2 t90 -55.26 -52.78 62.3 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.261 1.024 . . . . 10.0 112.511 175.059 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 9.5 tt -57.98 -43.69 86.68 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 123.898 0.879 . . . . 10.0 112.628 -176.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 15.3 pt -83.81 -5.59 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 N-CA-C 114.986 1.476 . . . . 10.0 114.986 -179.565 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.18 -169.33 33.3 Favored Glycine 0 N--CA 1.451 -0.363 0 CA-C-O 122.587 1.104 . . . . 10.0 113.966 -169.047 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 23.3 t -53.13 -41.45 65.09 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 114.159 -1.021 . . . . 10.0 111.879 177.526 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -66.83 -17.24 64.79 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 115.627 1.714 . . . . 10.0 115.627 -175.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -131.38 -105.79 1.05 Allowed Glycine 0 CA--C 1.533 1.169 0 CA-C-N 120.402 1.455 . . . . 10.0 113.911 -172.816 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -89.45 127.15 35.81 Favored 'General case' 0 C--N 1.329 -0.306 0 O-C-N 120.659 -1.495 . . . . 10.0 109.349 168.535 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -72.47 65.34 1.36 Allowed Glycine 0 CA--C 1.532 1.124 0 N-CA-C 113.906 0.322 . . . . 10.0 113.906 173.175 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 60.5 mt -79.51 -42.78 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 126.086 1.754 . . . . 10.0 108.764 166.321 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 79.8 t -126.31 133.34 24.87 Favored Pre-proline 0 N--CA 1.454 -0.264 0 C-N-CA 126.502 1.921 . . . . 10.0 109.401 -174.179 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -68.74 153.75 72.56 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 123.793 2.996 . . . . 10.0 111.491 -176.833 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 12.2 tp -43.13 -39.75 2.94 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.329 1.052 . . . . 10.0 112.227 171.503 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -48.37 -52.39 21.96 Favored 'General case' 0 CA--C 1.539 0.519 0 N-CA-C 114.673 1.361 . . . . 10.0 114.673 176.022 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 14.0 mm -75.91 -40.49 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 124.378 1.071 . . . . 10.0 109.647 177.588 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -49.32 -49.78 42.5 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 118.575 0.625 . . . . 10.0 111.956 173.638 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 16.1 m -57.72 -47.05 83.49 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 126.04 1.736 . . . . 10.0 112.974 174.294 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.535 HD23 ' CD2' ' A' ' 12' ' ' TRP . 1.3 tm? -63.35 -52.33 62.22 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.968 0.907 . . . . 10.0 112.061 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 93.2 mt -52.54 -58.82 5.57 Favored 'General case' 0 C--O 1.228 -0.077 0 C-N-CA 124.293 1.037 . . . . 10.0 110.003 176.408 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -53.97 -43.78 70.2 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 117.704 -1.141 . . . . 10.0 112.876 176.69 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 209' ' ' MET . . . . . 0.575 ' HE2' ' HB3' ' A' ' 15' ' ' LEU . 4.6 tmm? -53.96 -52.57 60.25 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 120.285 1.402 . . . . 10.0 112.237 174.235 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 78.3 t -61.45 -47.89 91.32 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 125.183 1.393 . . . . 10.0 111.897 178.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 5.1 mp -57.42 -49.54 75.9 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.025 1.33 . . . . 10.0 111.404 175.038 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -59.14 -56.83 17.12 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.697 1.199 . . . . 10.0 111.588 176.391 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 34.3 m -54.62 -39.66 47.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 CA-C-N 121.89 2.132 . . . . 10.0 112.377 178.497 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 19.8 m -58.46 -52.64 64.76 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.216 1.006 . . . . 10.0 112.133 171.448 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -71.91 -18.8 62.0 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 125.549 1.54 . . . . 10.0 114.984 -179.066 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 216' ' ' LYS . . . . . 0.4 ' HD2' HG21 ' A' ' 89' ' ' THR . 0.3 OUTLIER -95.59 -79.8 0.43 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.575 1.55 . . . . 10.0 109.506 177.099 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 8.0 p -77.06 -42.71 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 O-C-N 121.214 -0.929 . . . . 10.0 112.192 -174.228 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -54.07 -57.23 17.43 Favored Glycine 0 CA--C 1.537 1.467 0 CA-C-N 119.944 1.247 . . . . 10.0 113.269 176.391 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -46.64 -56.25 6.4 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.717 2.007 . . . . 10.0 112.201 168.093 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -55.82 -38.59 74.25 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 123.817 0.722 . . . . 10.0 113.696 179.399 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 24.5 mt -70.64 -27.38 64.01 Favored 'General case' 0 CA--C 1.512 -0.504 0 N-CA-C 115.694 1.739 . . . . 10.0 115.694 176.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 74.4 mt -63.52 -57.51 11.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 108.561 -0.903 . . . . 10.0 108.561 165.576 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 32.1 tp -58.85 -64.6 0.88 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.893 0.877 . . . . 10.0 113.213 -172.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 84.2 mt -71.58 5.17 2.55 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 115.295 1.591 . . . . 10.0 115.295 -171.679 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.6 mtp-105 -112.31 0.34 15.68 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.172 0.989 . . . . 10.0 113.238 172.592 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 8.8 t -108.0 177.94 4.66 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 124.116 0.966 . . . . 10.0 111.046 174.653 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 227' ' ' ARG . . . . . 0.667 ' HD3' ' CD ' ' A' ' 166' ' ' GLU . 41.7 ttt180 -71.62 98.16 1.85 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.732 0.813 . . . . 10.0 110.973 170.623 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 228' ' ' ALA . . . . . 0.476 ' HB1' ' CD2' ' A' ' 42' ' ' PHE . . . -80.86 76.99 7.78 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.874 0.87 . . . . 10.0 112.08 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 40.21 102.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 128.831 2.852 . . . . 10.0 116.474 177.672 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . 0.482 0.3 OUTLIER 71.82 -55.43 0.66 Allowed 'General case' 0 C--O 1.241 0.647 0 C-N-CA 124.749 1.22 . . . . 10.0 110.656 -175.288 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -68.29 169.47 40.06 Favored Glycine 0 C--O 1.239 0.417 0 C-N-CA 129.73 3.538 . . . . 10.0 119.666 171.471 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.461 0 C-N-CA 128.491 2.716 . . . . 10.0 113.461 166.583 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 999' ' ' RET . . . . . 0.563 H183 ' HB3' ' A' ' 186' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1000 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A 1001 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A 1002 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A 1003 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 N--CA 1.477 0.893 0 CA-C-O 115.781 -2.057 . . . . 10.0 105.88 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 23.28 91.89 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 129.62 3.168 . . . . 10.0 117.262 160.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 28.6 65.12 0.11 Allowed 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 128.302 2.641 . . . . 10.0 114.479 155.468 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 86.7 mt -56.46 137.95 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 126.407 1.883 . . . . 10.0 113.34 -158.388 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.652 HG21 ' HB3' ' A' ' 77' ' ' PRO . 7.5 t -136.74 -165.21 1.7 Allowed 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 126.345 1.858 . . . . 10.0 114.01 -174.337 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 69.97 2.84 40.9 Favored Glycine 0 C--N 1.34 0.793 0 C-N-CA 127.49 2.471 . . . . 10.0 111.496 168.049 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.8 tpp180 -158.59 -51.27 0.01 OUTLIER Pre-proline 0 N--CA 1.443 -0.822 0 CA-C-O 114.301 -2.761 . . . . 10.0 116.694 -168.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -63.97 -60.7 0.14 Allowed 'Trans proline' 0 N--CA 1.465 -0.169 0 CA-C-N 123.559 2.307 . . . . 10.0 113.2 -175.372 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.41 ' H ' ' CD ' ' A' ' 9' ' ' GLU . 7.9 pm0 -67.16 4.27 0.96 Allowed 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 127.87 2.468 . . . . 10.0 115.787 179.693 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.422 ' CG ' ' N ' ' A' ' 11' ' ' ILE . 11.0 p-90 -51.31 -43.13 61.61 Favored 'General case' 0 C--O 1.222 -0.361 0 O-C-N 121.489 -0.757 . . . . 10.0 112.643 176.418 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.422 ' N ' ' CG ' ' A' ' 10' ' ' TRP . 8.9 tt -60.86 -49.61 83.92 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.338 0 C-N-CA 123.887 0.875 . . . . 10.0 109.316 179.416 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.535 ' CD2' HD23 ' A' ' 206' ' ' LEU . 2.6 m95 -55.38 -52.67 62.8 Favored 'General case' 0 C--O 1.223 -0.312 0 C-N-CA 123.455 0.702 . . . . 10.0 111.872 175.627 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.7 mt -57.35 -53.62 56.06 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.184 0.594 . . . . 10.0 112.213 177.239 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.86 -46.83 51.83 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.418 1.487 . . . . 10.0 113.288 173.834 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.575 ' HB3' ' HE2' ' A' ' 209' ' ' MET . 13.3 tp -65.62 -45.0 84.77 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.312 1.445 . . . . 10.0 113.045 179.122 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.79 -56.29 12.15 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 124.506 1.051 . . . . 10.0 111.622 166.134 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 22.5 m -49.46 -52.63 27.77 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.981 1.312 . . . . 10.0 112.408 174.254 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.45 -58.84 5.88 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.109 0.964 . . . . 10.0 112.196 177.789 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 95.0 mt -57.52 -48.51 79.09 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.566 0.746 . . . . 10.0 112.729 -179.405 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.549 ' SD ' ' HB1' ' A' ' 53' ' ' ALA . 56.4 mtt -58.7 -47.17 85.45 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.345 1.058 . . . . 10.0 111.403 177.497 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -58.45 -58.51 14.21 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 124.356 0.979 . . . . 10.0 113.901 173.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 81.0 mt -56.19 -45.96 79.59 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-N 118.691 1.246 . . . . 10.0 112.116 176.255 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.75 -41.86 76.46 Favored Glycine 0 CA--C 1.533 1.214 0 C-N-CA 124.752 1.167 . . . . 10.0 113.172 173.151 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 28.4 m -62.29 -58.54 7.35 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.778 0.831 . . . . 10.0 111.425 171.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -52.3 -40.92 62.46 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.99 0.916 . . . . 10.0 110.962 177.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -55.82 -58.01 9.63 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.586 1.154 . . . . 10.0 112.974 172.745 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.1 m-30 -59.62 -38.73 82.09 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 113.184 0.809 . . . . 10.0 113.184 178.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.401 ' C ' ' H ' ' A' ' 30' ' ' LYS . 11.8 mt -56.15 -67.44 0.3 Allowed 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.621 1.168 . . . . 10.0 113.585 169.171 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 t -76.38 40.97 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-O 123.79 1.757 . . . . 10.0 110.846 179.111 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.401 ' H ' ' C ' ' A' ' 28' ' ' LEU . 42.9 tttm -140.87 -44.87 0.39 Allowed 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 127.9 2.48 . . . . 10.0 109.32 171.173 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.91 23.07 0.87 Allowed Glycine 0 CA--C 1.528 0.898 0 N-CA-C 115.649 1.019 . . . . 10.0 115.649 173.704 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 37.3 mmm -59.47 -45.03 92.8 Favored 'General case' 0 C--O 1.225 -0.228 0 C-N-CA 127.188 2.195 . . . . 10.0 113.562 -179.013 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.71 -84.38 1.19 Allowed Glycine 0 CA--C 1.531 1.045 0 C-N-CA 123.743 0.687 . . . . 10.0 112.47 -170.11 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.8 t 32.99 88.76 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.242 0.706 0 C-N-CA 128.365 2.666 . . . . 10.0 116.96 166.508 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 28.5 m -79.6 -50.85 10.07 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.132 -1.394 . . . . 10.0 113.93 174.101 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -48.97 117.53 6.49 Favored Pre-proline 0 CA--C 1.536 0.418 0 O-C-N 124.815 1.322 . . . . 10.0 110.95 -172.534 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -58.53 -29.66 89.5 Favored 'Trans proline' 0 N--CA 1.459 -0.5 0 C-N-CA 123.695 2.93 . . . . 10.0 113.74 179.095 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.29 -60.64 2.31 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.142 0.577 . . . . 10.0 111.439 176.208 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.21 -40.08 23.19 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 125.065 1.346 . . . . 10.0 113.551 171.634 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -46.52 -47.39 19.5 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.241 1.416 . . . . 10.0 113.444 172.042 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -57.79 -53.05 62.58 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.507 0.723 . . . . 10.0 110.958 176.669 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.476 ' CD2' ' HB1' ' A' ' 228' ' ' ALA . 44.0 m-85 -57.03 -50.15 73.6 Favored 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 123.075 0.55 . . . . 10.0 112.348 -179.109 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -54.4 -51.29 65.35 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 118.921 -0.561 . . . . 10.0 112.377 173.232 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.38 -62.04 1.9 Allowed 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 113.38 0.881 . . . . 10.0 113.38 177.13 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.5 mt -48.42 -57.98 1.29 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 124.918 1.287 . . . . 10.0 110.323 178.077 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.2 m -68.42 -17.57 64.24 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.195 1.398 . . . . 10.0 113.819 -172.731 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 27.9 m -87.59 -40.3 14.35 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-N 119.511 1.05 . . . . 10.0 112.196 174.516 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 22.3 mt -58.76 -43.68 90.4 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 121.48 -0.762 . . . . 10.0 112.272 171.151 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 19.3 t -38.88 -66.13 0.34 Allowed Pre-proline 0 CA--C 1.552 1.032 0 C-N-CA 125.922 1.689 . . . . 10.0 112.861 175.367 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -69.76 -23.44 30.79 Favored 'Trans proline' 0 CA--C 1.546 1.082 0 C-N-CA 123.042 2.495 . . . . 10.0 114.66 176.185 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.27 -45.42 80.54 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 120.564 1.529 . . . . 10.0 113.357 175.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 32.6 mm -58.51 -46.1 89.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 O-C-N 121.072 -1.018 . . . . 10.0 109.569 169.314 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.549 ' HB1' ' SD ' ' A' ' 20' ' ' MET . . . -51.96 -51.28 58.18 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.642 1.177 . . . . 10.0 112.127 176.613 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -50.37 -58.3 6.0 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 126.045 1.738 . . . . 10.0 112.321 173.26 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.3 m -49.17 -52.88 23.84 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 125.139 1.376 . . . . 10.0 110.755 178.093 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.407 ' HG3' ' HB2' ' A' ' 85' ' ' ASP . 33.0 mmt -69.38 -48.59 60.7 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 124.165 0.986 . . . . 10.0 112.735 -176.362 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -57.18 -39.58 75.64 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-O 116.766 -1.588 . . . . 10.0 113.266 173.098 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.8 tp -53.29 -54.53 34.98 Favored 'General case' 0 C--O 1.224 -0.238 0 CA-C-N 120.482 1.492 . . . . 10.0 111.313 169.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 24.1 p -51.69 -41.11 61.19 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 115.178 1.547 . . . . 10.0 115.178 179.019 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 59.7 mtm -66.8 -50.88 61.23 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 123.56 0.744 . . . . 10.0 110.534 176.799 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.3 tp -48.58 -52.66 21.75 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.826 0.851 . . . . 10.0 112.94 172.353 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.4 mt -76.88 -5.62 49.15 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.349 1.06 . . . . 10.0 113.828 -177.701 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.35 -34.74 5.52 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 115.504 0.962 . . . . 10.0 115.504 174.128 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -49.24 -43.13 42.49 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 115.208 1.559 . . . . 10.0 115.208 -175.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.1 3.65 60.96 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 115.377 0.911 . . . . 10.0 115.377 -178.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.33 143.47 26.36 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 126.993 2.117 . . . . 10.0 108.992 172.018 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 t -145.54 171.09 15.18 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 124.046 0.938 . . . . 10.0 111.06 166.813 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.02 136.11 53.33 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 123.833 0.853 . . . . 10.0 109.728 179.556 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 58.6 t -129.59 129.62 23.18 Favored Pre-proline 0 C--N 1.329 -0.299 0 C-N-CA 125.034 1.333 . . . . 10.0 110.909 -176.018 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -80.78 116.23 3.15 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 N-CA-C 109.445 -1.021 . . . . 10.0 109.445 -178.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -156.68 164.44 38.15 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.858 0.688 . . . . 10.0 112.858 172.503 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.34 -82.01 0.14 Allowed Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.636 -0.986 . . . . 10.0 110.636 175.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.73 -3.29 0.7 Allowed Glycine 0 CA--C 1.527 0.818 0 N-CA-C 118.706 2.242 . . . . 10.0 118.706 170.38 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -151.64 -171.95 4.08 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 119.353 1.577 . . . . 10.0 112.247 -165.159 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -91.79 93.85 9.06 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 125.517 1.527 . . . . 10.0 111.137 -175.322 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.449 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 60.1 m-80 -89.41 120.8 69.69 Favored Pre-proline 0 N--CA 1.45 -0.427 0 N-CA-C 112.97 0.73 . . . . 10.0 112.97 -165.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.652 ' HB3' HG21 ' A' ' 5' ' ' THR . 76.0 Cg_exo -61.53 131.91 38.15 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 124.219 3.279 . . . . 10.0 112.137 171.554 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.4 mm -140.15 126.35 21.85 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 C-N-CA 125.971 1.708 . . . . 10.0 111.684 -179.525 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -93.67 85.11 4.76 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 123.338 1.542 . . . . 10.0 113.026 174.652 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 63.8 p-90 -59.41 -28.27 66.78 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 120.619 -1.301 . . . . 10.0 113.891 174.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -54.81 -36.33 64.86 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 114.976 1.473 . . . . 10.0 114.976 178.214 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -59.8 -35.87 75.57 Favored 'General case' 0 N--CA 1.476 0.835 0 O-C-N 120.543 -1.348 . . . . 10.0 112.168 172.103 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -66.75 -42.88 85.48 Favored 'General case' 0 CA--C 1.545 0.758 0 O-C-N 121.071 -1.018 . . . . 10.0 112.987 173.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -50.46 -48.88 56.41 Favored 'General case' 0 CA--C 1.558 1.252 0 C-N-CA 125.624 1.569 . . . . 10.0 111.513 167.541 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.407 ' HB2' ' HG3' ' A' ' 56' ' ' MET . 27.5 t70 -58.61 -63.11 1.4 Allowed 'General case' 0 N--CA 1.485 1.292 0 CA-C-N 119.54 1.064 . . . . 10.0 112.465 171.571 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' TRP . . . . . 0.427 ' HA ' HG22 ' A' ' 89' ' ' THR . 47.4 m0 -50.27 -39.42 45.09 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 126.87 2.068 . . . . 10.0 112.063 -175.075 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 32.4 tp -48.85 -48.59 41.81 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 126.434 1.893 . . . . 10.0 112.377 177.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -94.19 -46.48 7.07 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.904 0.881 . . . . 10.0 112.677 -176.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.427 HG22 ' HA ' ' A' ' 86' ' ' TRP . 4.7 t -62.2 -42.73 99.56 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 113.667 0.988 . . . . 10.0 113.667 -174.214 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . 0.308 74.5 p -63.49 -43.73 79.55 Favored Pre-proline 0 N--CA 1.473 0.697 0 O-C-N 120.977 -1.077 . . . . 10.0 112.935 -178.292 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -52.87 -44.63 46.8 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 122.912 2.408 . . . . 10.0 115.746 165.355 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 54.1 mt -59.84 -47.4 85.87 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 119.329 0.968 . . . . 10.0 111.714 176.233 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 6.1 tt -50.71 -48.95 58.6 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 126.302 1.841 . . . . 10.0 111.292 171.771 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.9 mp -57.46 -47.68 81.22 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.543 1.137 . . . . 10.0 113.19 169.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.77 -38.24 78.06 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 123.783 0.833 . . . . 10.0 112.925 178.498 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -52.32 -54.08 36.18 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 119.251 0.932 . . . . 10.0 111.15 169.638 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.36 -42.03 88.64 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.67 0.788 . . . . 10.0 112.094 -178.483 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.76 -54.75 37.88 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 124.0 0.92 . . . . 10.0 111.974 173.644 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.25 -41.16 79.11 Favored 'General case' 0 C--O 1.224 -0.237 0 C-N-CA 123.741 0.817 . . . . 10.0 112.731 174.816 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.9 tp -63.77 -38.58 91.65 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 114.445 1.276 . . . . 10.0 114.445 -179.625 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.2 t -94.85 1.49 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 124.998 1.319 . . . . 10.0 112.318 179.177 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.2 t70 48.63 53.41 12.26 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.811 1.644 . . . . 10.0 112.117 -174.079 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.28 145.89 47.58 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 120.017 -1.677 . . . . 10.0 112.458 -174.171 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.49 135.86 54.26 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 112.775 0.658 . . . . 10.0 112.775 175.149 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -42.82 -39.66 2.58 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.88 1.672 . . . . 10.0 113.474 175.326 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -47.34 -60.25 5.31 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 125.18 1.371 . . . . 10.0 115.245 169.741 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.0 p -61.96 -46.79 87.72 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-O 117.155 -1.402 . . . . 10.0 111.358 178.193 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 67.1 mt -48.49 -52.9 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 125.033 1.333 . . . . 10.0 111.115 178.25 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.2 tp -62.62 -51.27 67.93 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 112.549 0.574 . . . . 10.0 112.549 179.277 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.21 -44.84 43.62 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.465 0.706 . . . . 10.0 110.953 174.592 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.455 ' HA ' HD12 ' A' ' 111' ' ' LEU . 0.6 OUTLIER -59.6 -59.91 4.69 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 127.435 2.294 . . . . 10.0 114.794 174.944 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.7 t -61.02 -46.31 96.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 123.743 0.817 . . . . 10.0 111.393 -178.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -56.66 -50.31 64.09 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 123.686 0.66 . . . . 10.0 112.656 174.506 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -55.07 -46.27 75.39 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 113.427 0.899 . . . . 10.0 113.427 173.357 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 53.7 t0 -58.26 -45.38 87.93 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.68 0.792 . . . . 10.0 111.679 174.524 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -43.31 -56.12 4.84 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 125.332 1.444 . . . . 10.0 113.322 167.062 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 82.5 mt -57.08 -55.32 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 123.811 0.844 . . . . 10.0 110.367 173.346 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 16.1 tmm? -48.34 -58.09 5.09 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.09 1.356 . . . . 10.0 112.785 -176.061 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 48.7 mm -69.72 -44.93 78.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 O-C-N 121.662 -0.648 . . . . 10.0 112.594 177.084 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -54.14 -45.54 72.85 Favored Glycine 0 CA--C 1.532 1.138 0 CA-C-N 119.221 0.919 . . . . 10.0 112.992 176.66 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 28.3 m -60.54 -45.23 94.63 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.907 1.683 . . . . 10.0 111.209 173.185 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -47.08 -52.37 12.44 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 124.229 0.919 . . . . 10.0 113.219 165.497 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.4 tt -54.26 -46.83 72.73 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 127.936 2.494 . . . . 10.0 111.472 177.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 48.6 t -61.9 -49.28 84.82 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 125.433 1.493 . . . . 10.0 111.985 171.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -52.89 -59.21 9.63 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 125.875 1.702 . . . . 10.0 112.4 175.792 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -42.06 -43.07 3.1 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 128.439 2.696 . . . . 10.0 113.174 175.205 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 48.3 mt -101.34 -6.53 23.97 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 115.547 1.684 . . . . 10.0 115.547 -174.301 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 16.9 m -69.75 116.75 10.5 Favored 'General case' 0 N--CA 1.464 0.248 0 O-C-N 120.19 -1.569 . . . . 10.0 110.366 -178.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.621 ' H ' ' HD3' ' A' ' 129' ' ' LYS . 0.1 OUTLIER -55.41 -49.67 71.78 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 128.248 2.619 . . . . 10.0 113.288 177.734 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 60.8 t -69.66 106.39 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 123.738 0.815 . . . . 10.0 110.087 179.666 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -46.95 -59.47 3.08 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 124.742 1.217 . . . . 10.0 114.065 -173.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 m -46.55 -42.08 15.3 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.489 1.516 . . . . 10.0 113.468 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -70.14 -24.6 63.19 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 114.959 1.466 . . . . 10.0 114.959 -178.149 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 69.0 mtp85 -53.94 -41.6 67.93 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 118.92 0.782 . . . . 10.0 110.787 176.594 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -70.11 -31.09 68.47 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 114.421 1.267 . . . . 10.0 114.421 176.705 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.8 t -55.49 -52.43 46.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 CA-C-N 118.989 0.813 . . . . 10.0 109.613 168.501 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 63.6 m95 -60.28 -44.16 95.6 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 113.914 1.079 . . . . 10.0 113.914 173.288 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 88.8 t90 -52.02 -49.39 63.47 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 119.469 1.032 . . . . 10.0 112.909 171.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -57.47 -52.99 63.16 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.166 0.987 . . . . 10.0 111.76 178.228 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 97.7 mt -54.03 -50.62 52.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 125.173 1.389 . . . . 10.0 111.493 175.297 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 16.0 m -53.93 -48.43 70.22 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.65 1.18 . . . . 10.0 111.692 174.424 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 60.8 m -63.1 -44.16 96.46 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.293 1.437 . . . . 10.0 111.716 -179.364 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -56.94 -50.65 71.94 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.175 0.99 . . . . 10.0 112.242 170.732 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -56.14 -46.33 79.29 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.859 0.864 . . . . 10.0 112.452 174.437 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 40.3 ttp -57.0 -53.14 61.38 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.472 1.109 . . . . 10.0 111.966 172.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 63.4 tp -52.7 -47.14 67.48 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.225 1.41 . . . . 10.0 111.858 178.284 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 77.3 t80 -50.81 -54.75 21.01 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.972 0.909 . . . . 10.0 112.587 171.589 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 41.5 mm -52.26 -55.89 8.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 CA-C-N 118.884 0.765 . . . . 10.0 110.35 176.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 43.0 mt -58.8 -35.15 72.38 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 118.511 -0.757 . . . . 10.0 111.761 -177.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -57.21 -58.24 9.09 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 124.018 0.927 . . . . 10.0 113.046 173.402 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.41 -40.88 85.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 CA-C-O 118.304 -0.855 . . . . 10.0 111.461 177.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 45.3 mt -56.78 -49.39 75.45 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.895 1.225 . . . . 10.0 112.139 171.23 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.471 ' HA ' ' HD2' ' A' ' 175' ' ' ARG . 11.9 t80 -77.04 -70.28 0.47 Allowed 'General case' 0 C--N 1.326 -0.435 0 O-C-N 120.083 -1.636 . . . . 10.0 112.877 -175.236 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -73.73 -21.92 60.06 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.559 1.144 . . . . 10.0 113.459 -174.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -87.78 -79.15 1.26 Allowed Glycine 0 CA--C 1.526 0.747 0 C-N-CA 123.651 0.643 . . . . 10.0 113.502 171.52 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -53.57 -32.44 50.92 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 126.301 1.841 . . . . 10.0 113.067 -166.532 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.4 m -52.15 -56.42 14.69 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 114.003 1.112 . . . . 10.0 114.003 172.14 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.3 p -53.69 -50.57 65.57 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 122.05 0.929 . . . . 10.0 112.269 -177.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 47.6 tttm -57.09 -46.06 82.85 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.136 0.975 . . . . 10.0 112.127 173.628 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.79 -47.52 80.01 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 114.513 1.301 . . . . 10.0 114.513 174.063 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -56.44 -11.33 1.21 Allowed 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.066 1.746 . . . . 10.0 114.235 177.687 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.2 m -107.08 6.69 29.15 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.382 1.873 . . . . 10.0 114.885 -179.336 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 93.2 mmm -91.89 -92.7 0.15 Allowed 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 123.509 1.623 . . . . 10.0 114.146 -170.629 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -138.69 153.91 72.66 Favored Pre-proline 0 C--O 1.236 0.367 0 C-N-CA 129.767 3.227 . . . . 10.0 105.541 170.25 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -52.77 -46.24 34.94 Favored 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 122.352 2.035 . . . . 10.0 113.082 179.007 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.667 ' CD ' ' HD3' ' A' ' 227' ' ' ARG . 0.1 OUTLIER -52.94 -46.12 68.0 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 129.04 2.936 . . . . 10.0 113.292 173.569 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 92.2 t -69.19 -53.01 27.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 C-N-CA 124.034 0.933 . . . . 10.0 109.765 -178.611 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.19 -46.76 75.85 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.274 0.63 . . . . 10.0 111.928 177.07 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 60.4 p -60.03 -56.22 24.4 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.933 0.893 . . . . 10.0 112.699 174.642 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 61.4 m -57.17 -53.2 60.78 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.169 0.988 . . . . 10.0 113.05 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -49.55 -49.49 46.05 Favored 'General case' 0 C--O 1.222 -0.386 0 C-N-CA 123.305 0.642 . . . . 10.0 111.131 174.024 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -57.17 -48.42 78.77 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 114.639 1.348 . . . . 10.0 114.639 -179.727 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 40.4 t -55.95 -49.61 74.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 CA-C-N 118.787 0.721 . . . . 10.0 110.506 176.403 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 94.0 mt -58.55 -51.61 69.17 Favored 'General case' 0 C--O 1.221 -0.397 0 N-CA-C 113.207 0.818 . . . . 10.0 113.207 175.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' ARG . . . . . 0.471 ' HD2' ' HA ' ' A' ' 153' ' ' PHE . 35.7 ttp180 -47.83 -47.74 31.15 Favored 'General case' 0 C--O 1.224 -0.246 0 C-N-CA 126.818 2.047 . . . . 10.0 111.047 174.456 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 63.7 m-20 -58.53 -58.3 9.16 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 122.785 0.434 . . . . 10.0 111.252 174.419 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 59.4 t -51.72 -49.79 34.04 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 C-N-CA 124.078 0.951 . . . . 10.0 111.193 179.017 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 30.3 m -57.01 -61.5 2.4 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 128.21 2.604 . . . . 10.0 112.435 178.276 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 55.2 t -52.15 -49.88 38.31 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 124.471 1.108 . . . . 10.0 110.944 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 80.4 t -59.71 -61.15 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 124.299 1.04 . . . . 10.0 112.007 177.037 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -57.35 -50.1 74.04 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 118.78 0.718 . . . . 10.0 112.388 -176.849 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 10.2 m95 -55.26 -48.85 73.4 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.627 0.771 . . . . 10.0 111.935 177.453 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 51.1 m -54.32 -31.42 54.17 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 114.014 1.116 . . . . 10.0 114.014 179.101 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -63.19 -40.32 97.17 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 113.808 1.04 . . . . 10.0 113.808 176.689 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -49.74 -55.28 24.29 Favored Pre-proline 0 CA--C 1.546 0.79 0 N-CA-C 115.281 1.585 . . . . 10.0 115.281 -175.122 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 186' ' ' PRO . . . . . 0.487 ' HB3' H183 ' A' ' 999' ' ' RET . 18.4 Cg_endo -57.5 -34.92 98.78 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 122.318 2.012 . . . . 10.0 113.286 176.175 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 21.7 t -64.74 -55.62 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 124.228 1.011 . . . . 10.0 110.554 176.067 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 93.2 t -53.09 -49.88 48.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 124.995 1.318 . . . . 10.0 111.558 177.392 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 63.2 t90 -56.32 -52.69 63.62 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.403 1.081 . . . . 10.0 112.598 175.629 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 9.6 tt -57.83 -42.77 85.07 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 123.665 0.786 . . . . 10.0 112.369 -177.593 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 14.5 pt -83.74 -5.93 9.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 N-CA-C 115.085 1.513 . . . . 10.0 115.085 179.575 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.38 -169.32 33.02 Favored Glycine 0 N--CA 1.45 -0.404 0 CA-C-O 122.55 1.083 . . . . 10.0 113.925 -168.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 23.3 t -53.16 -41.43 65.16 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 114.17 -1.015 . . . . 10.0 111.854 177.582 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -67.98 -16.05 63.88 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 115.626 1.713 . . . . 10.0 115.626 -175.57 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -131.11 -106.04 1.08 Allowed Glycine 0 CA--C 1.533 1.157 0 CA-C-N 120.4 1.455 . . . . 10.0 113.908 -173.221 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -89.44 127.17 35.81 Favored 'General case' 0 C--N 1.328 -0.345 0 O-C-N 120.681 -1.482 . . . . 10.0 109.304 168.498 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -72.56 65.37 1.39 Allowed Glycine 0 CA--C 1.532 1.141 0 N-CA-C 113.871 0.308 . . . . 10.0 113.871 173.175 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 60.6 mt -79.54 -42.76 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 126.078 1.751 . . . . 10.0 108.759 166.333 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 79.7 t -126.31 133.37 24.9 Favored Pre-proline 0 N--CA 1.454 -0.25 0 C-N-CA 126.436 1.894 . . . . 10.0 109.351 -174.176 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -68.71 153.81 72.49 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 123.745 2.963 . . . . 10.0 111.479 -176.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 12.2 tp -43.18 -39.79 3.04 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.341 1.056 . . . . 10.0 112.169 171.486 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -48.38 -52.39 22.04 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 114.653 1.353 . . . . 10.0 114.653 176.086 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 14.0 mm -75.9 -40.51 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 C-N-CA 124.453 1.101 . . . . 10.0 109.646 177.586 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -49.27 -49.78 41.98 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 118.592 0.633 . . . . 10.0 111.991 173.615 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 16.3 m -57.75 -47.03 83.65 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 126.015 1.726 . . . . 10.0 112.97 174.297 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.535 HD23 ' CD2' ' A' ' 12' ' ' TRP . 1.3 tm? -63.36 -52.28 62.39 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.923 0.889 . . . . 10.0 112.093 179.735 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 93.2 mt -52.57 -59.41 4.49 Favored 'General case' 0 C--N 1.335 -0.053 0 C-N-CA 124.362 1.065 . . . . 10.0 109.954 176.457 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -53.11 -47.06 68.91 Favored 'General case' 0 C--O 1.216 -0.66 0 CA-C-O 117.126 -1.416 . . . . 10.0 112.001 176.544 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 209' ' ' MET . . . . . 0.575 ' HE2' ' HB3' ' A' ' 15' ' ' LEU . 4.6 tmm? -50.99 -52.25 44.65 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 121.454 1.934 . . . . 10.0 113.168 174.895 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 79.4 t -60.14 -49.15 85.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 124.708 1.203 . . . . 10.0 111.263 178.37 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 4.3 mp -58.16 -51.61 68.99 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.631 1.573 . . . . 10.0 112.272 175.508 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -55.68 -58.27 8.51 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 127.824 2.45 . . . . 10.0 110.566 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 78.7 t -56.24 -44.9 80.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 O-C-N 121.48 -0.762 . . . . 10.0 111.764 177.234 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 24.2 t -55.25 -55.2 34.03 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.502 0.721 . . . . 10.0 112.022 174.303 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -63.76 -20.35 65.69 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 115.093 1.516 . . . . 10.0 115.093 177.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.01 -75.76 0.49 Allowed 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.325 1.45 . . . . 10.0 110.137 175.486 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 21.7 t -77.78 -47.95 24.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 126.126 1.77 . . . . 10.0 111.297 -170.698 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -55.97 -55.98 26.35 Favored Glycine 0 CA--C 1.534 1.246 0 CA-C-N 119.042 0.837 . . . . 10.0 112.695 178.127 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 61.1 t80 -44.3 -57.7 3.34 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.926 2.09 . . . . 10.0 112.166 166.534 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -55.17 -40.44 74.86 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 124.179 0.895 . . . . 10.0 114.265 177.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 24.2 mt -70.55 -27.33 64.06 Favored 'General case' 0 CA--C 1.512 -0.494 0 N-CA-C 115.528 1.677 . . . . 10.0 115.528 177.62 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 74.4 mt -63.27 -57.53 11.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 108.616 -0.883 . . . . 10.0 108.616 165.432 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 32.1 tp -58.89 -64.68 0.85 Allowed 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.95 0.9 . . . . 10.0 113.126 -172.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 84.3 mt -71.55 5.23 2.5 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 115.333 1.605 . . . . 10.0 115.333 -171.671 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.6 mtp-105 -112.35 0.39 15.66 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.168 0.987 . . . . 10.0 113.296 172.524 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 8.8 t -108.04 177.99 4.64 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 124.035 0.934 . . . . 10.0 111.002 174.633 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 227' ' ' ARG . . . . . 0.667 ' HD3' ' CD ' ' A' ' 166' ' ' GLU . 41.8 ttt180 -71.68 98.2 1.88 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.744 0.818 . . . . 10.0 110.953 170.673 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 228' ' ' ALA . . . . . 0.476 ' HB1' ' CD2' ' A' ' 42' ' ' PHE . . . -80.88 76.98 7.8 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.896 0.879 . . . . 10.0 112.111 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 40.08 102.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 128.837 2.855 . . . . 10.0 116.492 177.788 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . 0.483 0.3 OUTLIER 71.92 -55.46 0.66 Allowed 'General case' 0 C--O 1.241 0.647 0 C-N-CA 124.692 1.197 . . . . 10.0 110.632 -175.346 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -68.26 169.47 39.92 Favored Glycine 0 C--O 1.238 0.376 0 C-N-CA 129.782 3.563 . . . . 10.0 119.621 171.482 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.461 0 C-N-CA 128.473 2.709 . . . . 10.0 113.457 166.611 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 999' ' ' RET . . . . . 0.522 H181 ' H7 ' ' A' ' 999' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1000 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A 1001 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A 1002 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A 1003 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 N--CA 1.476 0.87 0 CA-C-O 115.807 -2.044 . . . . 10.0 105.858 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 23.41 91.8 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 129.598 3.159 . . . . 10.0 117.253 160.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 28.67 65.06 0.11 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 128.291 2.636 . . . . 10.0 114.474 155.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 86.7 mt -56.46 137.93 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 126.387 1.875 . . . . 10.0 113.376 -158.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.652 HG21 ' HB3' ' A' ' 77' ' ' PRO . 7.6 t -136.7 -165.22 1.7 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 126.324 1.85 . . . . 10.0 114.052 -174.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 70.01 2.83 41.23 Favored Glycine 0 C--N 1.34 0.786 0 C-N-CA 127.471 2.463 . . . . 10.0 111.485 168.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -158.56 -51.35 0.01 OUTLIER Pre-proline 0 N--CA 1.443 -0.823 0 CA-C-O 114.274 -2.774 . . . . 10.0 116.642 -168.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -63.95 -60.69 0.14 Allowed 'Trans proline' 0 N--CA 1.465 -0.202 0 CA-C-N 123.509 2.289 . . . . 10.0 113.21 -175.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.411 ' H ' ' CD ' ' A' ' 9' ' ' GLU . 7.9 pm0 -67.16 4.35 0.94 Allowed 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 127.836 2.454 . . . . 10.0 115.764 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.421 ' CG ' ' N ' ' A' ' 11' ' ' ILE . 11.1 p-90 -51.37 -43.14 61.78 Favored 'General case' 0 C--O 1.222 -0.361 0 O-C-N 121.516 -0.74 . . . . 10.0 112.564 176.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.421 ' N ' ' CG ' ' A' ' 10' ' ' TRP . 8.9 tt -60.87 -49.63 83.82 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.361 0 C-N-CA 123.926 0.89 . . . . 10.0 109.306 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . 0.535 ' CD2' HD23 ' A' ' 206' ' ' LEU . 2.6 m95 -55.38 -52.62 62.93 Favored 'General case' 0 C--O 1.224 -0.259 0 C-N-CA 123.433 0.693 . . . . 10.0 111.912 175.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.6 mt -57.38 -53.61 56.24 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.112 0.565 . . . . 10.0 112.222 177.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.84 -46.79 51.67 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.391 1.476 . . . . 10.0 113.33 173.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.574 ' HB3' ' HE2' ' A' ' 209' ' ' MET . 13.3 tp -65.62 -45.02 84.7 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 125.336 1.455 . . . . 10.0 113.047 179.086 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.45 -56.86 10.1 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 124.621 1.105 . . . . 10.0 111.407 165.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.2 m -49.51 -52.49 29.15 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.995 1.318 . . . . 10.0 112.242 174.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.41 -58.86 5.79 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.143 0.977 . . . . 10.0 112.176 177.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 95.3 mt -57.97 -49.34 77.16 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.678 0.791 . . . . 10.0 112.544 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 23.5 mmt -55.23 -51.04 67.86 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.587 0.755 . . . . 10.0 111.026 175.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -56.33 -58.53 13.82 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 124.441 1.019 . . . . 10.0 113.738 176.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 80.8 mt -56.21 -45.41 79.89 Favored 'General case' 0 C--O 1.221 -0.397 0 CA-C-N 118.593 1.196 . . . . 10.0 112.113 176.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.83 -42.05 77.8 Favored Glycine 0 CA--C 1.534 1.24 0 C-N-CA 124.814 1.197 . . . . 10.0 113.46 172.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 15.4 m -59.38 -61.61 2.5 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.457 1.103 . . . . 10.0 110.723 171.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -52.24 -40.96 62.37 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.039 0.936 . . . . 10.0 110.976 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -55.77 -58.08 9.32 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.611 1.165 . . . . 10.0 112.986 172.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -59.65 -38.61 81.89 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 113.255 0.835 . . . . 10.0 113.255 178.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.402 ' C ' ' H ' ' A' ' 30' ' ' LYS . 11.8 mt -56.19 -67.44 0.3 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.627 1.171 . . . . 10.0 113.597 169.118 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 t -76.37 40.98 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 CA-C-O 123.749 1.738 . . . . 10.0 110.879 179.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.402 ' H ' ' C ' ' A' ' 28' ' ' LEU . 42.9 tttm -140.87 -44.88 0.39 Allowed 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 127.87 2.468 . . . . 10.0 109.336 171.204 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.96 23.15 0.87 Allowed Glycine 0 CA--C 1.529 0.925 0 N-CA-C 115.629 1.012 . . . . 10.0 115.629 173.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 37.3 mmm -59.54 -44.97 93.06 Favored 'General case' 0 C--O 1.225 -0.235 0 C-N-CA 127.13 2.172 . . . . 10.0 113.63 -179.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.62 -84.43 1.18 Allowed Glycine 0 CA--C 1.531 1.045 0 C-N-CA 123.764 0.697 . . . . 10.0 112.508 -170.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.8 t 33.02 88.81 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.242 0.682 0 C-N-CA 128.358 2.663 . . . . 10.0 116.942 166.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.7 m -79.68 -50.85 10.01 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.167 -1.379 . . . . 10.0 113.877 174.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -48.91 117.47 6.37 Favored Pre-proline 0 CA--C 1.536 0.416 0 O-C-N 124.764 1.29 . . . . 10.0 110.949 -172.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -58.57 -29.65 89.61 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 123.726 2.951 . . . . 10.0 113.682 179.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.29 -60.64 2.3 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 123.107 0.563 . . . . 10.0 111.48 176.15 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.21 -40.02 23.0 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 125.097 1.359 . . . . 10.0 113.559 171.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.5 tttp -46.57 -47.44 19.76 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 125.243 1.417 . . . . 10.0 113.403 172.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -57.72 -53.08 62.26 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.473 0.709 . . . . 10.0 111.009 176.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.476 ' CD2' ' HB1' ' A' ' 228' ' ' ALA . 43.8 m-85 -56.95 -50.24 73.24 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 123.089 0.555 . . . . 10.0 112.34 -179.178 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -54.44 -51.25 65.55 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 118.916 -0.564 . . . . 10.0 112.342 173.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.38 -61.98 1.93 Allowed 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 113.399 0.888 . . . . 10.0 113.399 177.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.5 mt -48.86 -56.06 2.81 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 C-N-CA 124.912 1.285 . . . . 10.0 110.832 178.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.5 m -69.49 -20.34 63.73 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.861 1.264 . . . . 10.0 113.432 -172.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 28.1 m -84.4 -38.82 19.78 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.404 1.081 . . . . 10.0 112.28 174.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 19.1 mt -59.33 -41.4 89.06 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 117.873 -1.061 . . . . 10.0 112.803 174.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.686 HG23 ' HD3' ' A' ' 50' ' ' PRO 0.405 33.0 m -58.49 -49.56 92.85 Favored Pre-proline 0 N--CA 1.486 1.36 0 CA-C-N 121.082 1.765 . . . . 10.0 114.707 -178.915 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.686 ' HD3' HG23 ' A' ' 49' ' ' VAL . 89.3 Cg_exo -49.82 -45.32 32.66 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 123.587 2.858 . . . . 10.0 115.107 162.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.6 -46.79 84.2 Favored 'General case' 0 CA--C 1.548 0.892 0 CA-C-N 119.82 1.191 . . . . 10.0 113.704 -179.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 30.9 mm -53.22 -55.48 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 124.989 1.316 . . . . 10.0 109.595 169.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.65 -44.85 77.56 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.124 0.969 . . . . 10.0 113.567 177.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 50.2 t80 -52.59 -56.78 12.92 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.28 1.432 . . . . 10.0 111.871 172.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 14.4 m -49.92 -52.58 32.12 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.304 1.441 . . . . 10.0 110.658 177.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 32.6 mmt -69.23 -48.13 62.77 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 123.965 0.906 . . . . 10.0 113.05 -176.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -54.69 -42.55 71.55 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 120.17 1.35 . . . . 10.0 113.213 172.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.7 tp -53.33 -54.54 35.03 Favored 'General case' 0 C--O 1.224 -0.272 0 CA-C-N 119.406 1.003 . . . . 10.0 111.292 171.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 23.9 p -51.6 -41.08 60.95 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 115.239 1.57 . . . . 10.0 115.239 178.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 58.4 mtm -66.86 -50.88 61.09 Favored 'General case' 0 C--N 1.334 -0.09 0 C-N-CA 123.597 0.759 . . . . 10.0 110.477 176.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.5 tp -48.58 -52.65 21.79 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.859 0.863 . . . . 10.0 112.95 172.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.5 mt -76.94 -5.58 49.12 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.318 1.047 . . . . 10.0 113.805 -177.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.28 -34.7 5.56 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 115.504 0.962 . . . . 10.0 115.504 174.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -49.27 -43.04 42.75 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 115.278 1.584 . . . . 10.0 115.278 -176.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.05 3.52 61.2 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 115.388 0.915 . . . . 10.0 115.388 -179.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.23 143.4 26.45 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 127.016 2.126 . . . . 10.0 109.02 171.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 t -145.51 171.16 15.06 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 123.995 0.918 . . . . 10.0 111.013 166.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.02 136.05 53.39 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 123.897 0.879 . . . . 10.0 109.675 179.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.436 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 58.7 t -129.56 129.61 23.19 Favored Pre-proline 0 C--N 1.329 -0.295 0 C-N-CA 125.069 1.348 . . . . 10.0 110.969 -176.095 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 69' ' ' VAL . 6.3 Cg_exo -80.81 116.23 3.15 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 N-CA-C 109.367 -1.051 . . . . 10.0 109.367 -178.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -156.68 164.37 38.22 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 112.862 0.69 . . . . 10.0 112.862 172.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.36 -81.95 0.14 Allowed Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.68 -0.968 . . . . 10.0 110.68 175.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.76 -3.31 0.7 Allowed Glycine 0 CA--C 1.527 0.822 0 N-CA-C 118.684 2.234 . . . . 10.0 118.684 170.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -151.64 -171.89 4.06 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 119.327 1.564 . . . . 10.0 112.221 -165.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -91.89 93.95 9.06 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 125.456 1.502 . . . . 10.0 111.091 -175.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.449 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 60.2 m-80 -89.5 120.74 69.63 Favored Pre-proline 0 N--CA 1.45 -0.429 0 N-CA-C 112.953 0.723 . . . . 10.0 112.953 -165.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.652 ' HB3' HG21 ' A' ' 5' ' ' THR . 76.3 Cg_exo -61.47 131.93 38.36 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 124.171 3.247 . . . . 10.0 112.159 171.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.4 mm -140.16 126.3 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 C-N-CA 125.99 1.716 . . . . 10.0 111.701 -179.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -93.58 85.0 4.76 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 122.967 1.365 . . . . 10.0 113.08 174.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 63.7 p-90 -59.33 -28.28 66.68 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 120.858 -1.151 . . . . 10.0 113.96 174.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -54.14 -27.48 33.77 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 124.273 1.029 . . . . 10.0 112.2 178.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 21.4 mtt-85 -54.62 -50.21 68.65 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.92 1.288 . . . . 10.0 112.78 168.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -67.44 -39.86 85.42 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 121.409 -0.807 . . . . 10.0 112.114 178.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -52.54 -50.65 62.45 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 123.787 0.835 . . . . 10.0 112.135 170.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 54.0 t0 -52.54 -69.12 0.12 Allowed 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 126.079 1.751 . . . . 10.0 111.325 170.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 50.4 m0 -55.48 -35.23 65.3 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 125.821 1.648 . . . . 10.0 113.004 -171.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 25.5 tp -49.58 -43.41 46.17 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 126.408 1.883 . . . . 10.0 112.174 177.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -101.27 -38.5 8.05 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.833 0.853 . . . . 10.0 112.281 179.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 1.6 m -51.15 -55.02 20.0 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.88 1.272 . . . . 10.0 113.468 175.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . 0.263 44.9 p -68.12 -40.58 22.39 Favored Pre-proline 0 N--CA 1.476 0.855 0 N-CA-C 114.63 1.344 . . . . 10.0 114.63 -171.161 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -56.75 -43.04 58.45 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 123.935 3.09 . . . . 10.0 115.522 168.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 53.2 mt -60.39 -47.06 87.72 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 121.395 -0.816 . . . . 10.0 111.394 176.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 6.0 tt -50.89 -48.01 60.53 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.628 1.571 . . . . 10.0 111.596 171.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.5 mp -58.83 -46.76 86.92 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.61 1.164 . . . . 10.0 113.365 170.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.79 -38.34 78.33 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 123.824 0.849 . . . . 10.0 112.868 177.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 -52.24 -54.1 35.4 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 119.317 0.962 . . . . 10.0 111.13 169.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.31 -42.08 88.77 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.651 0.78 . . . . 10.0 112.152 -178.509 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.66 -54.73 37.84 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.962 0.905 . . . . 10.0 112.056 173.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.33 -41.15 79.44 Favored 'General case' 0 C--O 1.224 -0.237 0 C-N-CA 123.767 0.827 . . . . 10.0 112.667 174.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.9 tp -63.8 -38.51 91.38 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 114.461 1.282 . . . . 10.0 114.461 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.2 t -94.85 1.45 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 125.022 1.329 . . . . 10.0 112.316 179.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.2 t70 48.57 53.51 12.02 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.866 1.666 . . . . 10.0 112.095 -174.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.27 145.9 47.58 Favored 'General case' 0 CA--C 1.534 0.339 0 O-C-N 119.977 -1.702 . . . . 10.0 112.459 -174.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.47 135.95 54.17 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 112.715 0.635 . . . . 10.0 112.715 175.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -42.89 -39.74 2.66 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 125.906 1.682 . . . . 10.0 113.41 175.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -47.32 -60.21 5.32 Favored Glycine 0 CA--C 1.525 0.691 0 C-N-CA 125.12 1.343 . . . . 10.0 115.222 169.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.6 p -62.05 -46.8 87.54 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 117.147 -1.406 . . . . 10.0 111.321 178.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 66.9 mt -48.39 -52.92 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 125.001 1.321 . . . . 10.0 111.147 178.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.2 tp -62.64 -51.27 67.93 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 112.548 0.573 . . . . 10.0 112.548 179.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.15 -44.9 43.13 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.506 0.722 . . . . 10.0 110.905 174.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.455 ' HA ' HD12 ' A' ' 111' ' ' LEU . 0.6 OUTLIER -59.52 -59.94 4.65 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 127.431 2.292 . . . . 10.0 114.8 174.937 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.5 t -61.03 -46.33 96.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 123.697 0.799 . . . . 10.0 111.388 -178.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -56.62 -50.35 63.76 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 123.695 0.664 . . . . 10.0 112.619 174.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -54.7 -46.85 74.2 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 113.275 0.843 . . . . 10.0 113.275 173.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -57.45 -45.39 84.78 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.804 0.842 . . . . 10.0 112.135 174.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -43.98 -55.65 5.53 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 125.385 1.469 . . . . 10.0 113.131 167.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 80.1 mt -55.73 -54.11 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 CA-C-O 118.03 -0.986 . . . . 10.0 110.464 173.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 63.4 ttp -46.36 -55.64 7.02 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 120.091 1.314 . . . . 10.0 112.978 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 1.7 mp . . . . . 0 N--CA 1.474 0.754 0 O-C-N 121.543 -0.723 . . . . 10.0 111.591 179.273 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 63.3 t . . . . . 0 N--CA 1.475 0.823 0 N-CA-C 110.128 -0.323 . . . . 10.0 110.128 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -50.08 -61.18 5.97 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 125.923 1.725 . . . . 10.0 112.709 171.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -46.99 -38.84 11.4 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 127.191 2.196 . . . . 10.0 113.638 178.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 48.2 mt -99.62 -6.87 26.58 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 115.347 1.61 . . . . 10.0 115.347 -178.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 17.0 m -69.67 116.74 10.41 Favored 'General case' 0 N--CA 1.464 0.256 0 O-C-N 120.162 -1.586 . . . . 10.0 110.378 -178.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.621 ' H ' ' HD3' ' A' ' 129' ' ' LYS . 0.1 OUTLIER -55.44 -49.65 71.9 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 128.195 2.598 . . . . 10.0 113.3 177.711 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 61.3 t -69.67 106.32 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 C-N-CA 123.773 0.829 . . . . 10.0 110.121 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -46.89 -59.51 3.04 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 124.769 1.228 . . . . 10.0 114.067 -173.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 m -46.46 -42.1 14.9 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.467 1.507 . . . . 10.0 113.497 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -70.18 -24.59 63.16 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 114.917 1.451 . . . . 10.0 114.917 -178.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 68.8 mtp85 -54.01 -41.65 68.21 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 118.862 0.755 . . . . 10.0 110.864 176.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -69.59 -32.07 70.59 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.755 1.222 . . . . 10.0 114.202 176.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.9 t -54.88 -52.23 45.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-N 119.063 0.847 . . . . 10.0 109.615 168.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 64.2 m95 -61.08 -44.23 97.69 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 114.238 1.199 . . . . 10.0 114.238 174.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 90.4 t90 -53.36 -48.4 68.59 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 119.284 0.947 . . . . 10.0 112.959 172.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.603 0 C-N-CA 124.013 0.925 . . . . 10.0 111.607 177.073 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.819 0 N-CA-C 112.235 0.457 . . . . 10.0 112.235 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 41.4 ttp -55.47 -57.92 9.92 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.218 1.007 . . . . 10.0 112.776 174.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.3 pp -61.61 -35.84 79.04 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 118.309 -0.853 . . . . 10.0 112.147 -176.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 75.3 t80 -54.1 -55.27 29.19 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 119.312 0.96 . . . . 10.0 111.95 167.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 54.7 mt -53.59 -55.27 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 123.807 0.843 . . . . 10.0 110.741 177.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 9.9 mp -56.24 -37.06 69.23 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.23 1.012 . . . . 10.0 112.678 178.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -57.27 -58.19 9.31 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 124.057 0.943 . . . . 10.0 112.999 173.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.47 -40.91 85.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 CA-C-O 118.338 -0.839 . . . . 10.0 111.442 177.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 47.1 mt -56.72 -49.48 75.07 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 119.875 1.216 . . . . 10.0 112.098 171.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.471 ' HA ' ' HD2' ' A' ' 175' ' ' ARG . 11.8 t80 -77.01 -70.25 0.47 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 120.087 -1.633 . . . . 10.0 112.877 -175.186 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -73.76 -21.91 60.03 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.587 1.155 . . . . 10.0 113.439 -174.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -87.84 -79.02 1.26 Allowed Glycine 0 CA--C 1.526 0.761 0 C-N-CA 123.599 0.619 . . . . 10.0 113.539 171.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -53.68 -32.42 51.63 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 126.275 1.83 . . . . 10.0 113.024 -166.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.3 m -52.1 -56.46 14.28 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 114.01 1.115 . . . . 10.0 114.01 172.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.7 p -53.63 -50.55 65.48 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 122.081 0.944 . . . . 10.0 112.307 -177.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 47.7 tttm -57.14 -46.07 83.0 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.165 0.986 . . . . 10.0 112.086 173.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.81 -47.48 80.18 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 114.504 1.298 . . . . 10.0 114.504 174.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -56.42 -11.33 1.2 Allowed 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 126.095 1.758 . . . . 10.0 114.223 177.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.1 m -107.11 6.64 29.06 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.408 1.883 . . . . 10.0 114.869 -179.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 93.2 mmm -91.92 -92.68 0.15 Allowed 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 123.48 1.609 . . . . 10.0 114.139 -170.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -138.69 153.93 72.67 Favored Pre-proline 0 C--O 1.236 0.352 0 C-N-CA 129.823 3.249 . . . . 10.0 105.57 170.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -52.8 -46.25 34.99 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.296 1.998 . . . . 10.0 113.102 179.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.666 ' CD ' ' HD3' ' A' ' 227' ' ' ARG . 0.1 OUTLIER -53.02 -45.99 68.21 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 128.972 2.909 . . . . 10.0 113.285 173.619 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 91.7 t -69.24 -53.01 27.74 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.237 0 C-N-CA 124.031 0.933 . . . . 10.0 109.81 -178.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.13 -46.8 75.66 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.287 0.635 . . . . 10.0 111.933 177.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 60.2 p -59.99 -56.23 24.31 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.972 0.909 . . . . 10.0 112.687 174.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 61.3 m -57.19 -53.21 60.73 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.189 0.995 . . . . 10.0 113.036 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -49.57 -49.49 46.26 Favored 'General case' 0 C--O 1.221 -0.438 0 C-N-CA 123.258 0.623 . . . . 10.0 111.098 174.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -57.19 -48.43 78.78 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 114.664 1.357 . . . . 10.0 114.664 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 40.4 t -55.91 -49.66 73.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 CA-C-N 118.802 0.728 . . . . 10.0 110.477 176.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 94.2 mt -58.54 -51.69 68.82 Favored 'General case' 0 C--O 1.222 -0.389 0 N-CA-C 113.168 0.803 . . . . 10.0 113.168 175.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . 0.471 ' HD2' ' HA ' ' A' ' 153' ' ' PHE . 35.5 ttp180 -47.76 -47.76 30.38 Favored 'General case' 0 C--O 1.225 -0.222 0 C-N-CA 126.816 2.046 . . . . 10.0 111.087 174.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 63.5 m-20 -58.47 -58.36 8.89 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 122.819 0.448 . . . . 10.0 111.282 174.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 54.2 t -51.92 -52.29 23.84 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 C-N-CA 124.033 0.933 . . . . 10.0 111.875 179.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 64.1 m -54.59 -61.07 2.55 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 127.408 2.283 . . . . 10.0 113.178 175.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 51.6 t -51.58 -50.13 31.28 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 CA-C-N 120.26 1.391 . . . . 10.0 110.805 -178.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 79.1 t -58.99 -61.0 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 124.211 1.004 . . . . 10.0 112.268 176.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 78.5 mt -57.47 -51.46 69.36 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 118.623 0.647 . . . . 10.0 112.403 -177.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 10.8 m95 . . . . . 0 N--CA 1.466 0.374 0 C-N-CA 123.66 0.784 . . . . 10.0 111.521 179.172 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 16.4 m . . . . . 0 N--CA 1.475 0.785 0 CA-C-O 118.898 -0.572 . . . . 10.0 112.439 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 62.2 t90 -57.75 -57.59 12.09 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.344 1.457 . . . . 10.0 112.304 167.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 9.3 tt -58.24 -40.45 81.75 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.802 0.841 . . . . 10.0 112.574 -175.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 14.7 pt -82.67 -5.65 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 N-CA-C 115.195 1.554 . . . . 10.0 115.195 178.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.3 -169.26 33.11 Favored Glycine 0 N--CA 1.45 -0.404 0 CA-C-O 122.551 1.084 . . . . 10.0 113.921 -168.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 23.3 t -53.17 -39.96 63.98 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 114.166 -1.017 . . . . 10.0 111.879 177.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -68.48 -14.9 63.32 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 125.744 1.618 . . . . 10.0 115.171 -174.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -136.27 -104.81 0.75 Allowed Glycine 0 CA--C 1.541 1.662 0 C-N-CA 125.21 1.386 . . . . 10.0 114.951 -174.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -89.43 127.17 35.81 Favored 'General case' 0 C--N 1.328 -0.352 0 O-C-N 120.697 -1.473 . . . . 10.0 109.357 168.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -72.51 65.38 1.37 Allowed Glycine 0 CA--C 1.532 1.127 0 N-CA-C 113.915 0.326 . . . . 10.0 113.915 173.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 60.7 mt -79.61 -42.72 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 126.08 1.752 . . . . 10.0 108.725 166.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 79.4 t -126.34 133.38 24.91 Favored Pre-proline 0 N--CA 1.454 -0.264 0 C-N-CA 126.502 1.921 . . . . 10.0 109.417 -174.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -68.74 153.76 72.54 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 123.811 3.007 . . . . 10.0 111.476 -176.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 12.2 tp -43.13 -39.77 2.95 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.381 1.072 . . . . 10.0 112.214 171.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -48.39 -52.35 22.26 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 114.702 1.371 . . . . 10.0 114.702 176.055 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 14.0 mm -75.96 -40.44 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 124.378 1.071 . . . . 10.0 109.666 177.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -49.29 -49.8 42.08 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 118.592 0.633 . . . . 10.0 111.946 173.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 16.3 m -57.74 -47.08 83.47 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 126.045 1.738 . . . . 10.0 112.953 174.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.535 HD23 ' CD2' ' A' ' 12' ' ' TRP . 1.3 tm? -63.25 -52.36 62.45 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.985 0.914 . . . . 10.0 112.131 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 93.2 mt -52.55 -59.22 4.72 Favored 'General case' 0 C--O 1.228 -0.041 0 C-N-CA 124.278 1.031 . . . . 10.0 109.973 176.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -52.52 -46.16 66.59 Favored 'General case' 0 C--O 1.221 -0.427 0 CA-C-O 117.821 -1.085 . . . . 10.0 112.37 176.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' MET . . . . . 0.574 ' HE2' ' HB3' ' A' ' 15' ' ' LEU . 4.6 tmm? -52.42 -51.82 57.12 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 120.62 1.555 . . . . 10.0 113.023 175.229 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 79.5 t -60.9 -50.35 80.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 124.418 1.087 . . . . 10.0 111.419 178.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 4.6 mp -55.81 -52.01 65.46 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.77 1.628 . . . . 10.0 111.979 175.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -55.12 -61.85 2.05 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 126.449 1.9 . . . . 10.0 110.471 178.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 98.1 t . . . . . 0 N--CA 1.478 0.962 0 CA-C-N 119.529 1.059 . . . . 10.0 111.597 -178.496 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.316 0 CA-C-O 121.091 0.273 . . . . 10.0 112.753 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -44.32 -57.96 3.2 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 127.106 2.163 . . . . 10.0 112.316 166.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -55.82 -39.88 78.84 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 124.188 0.899 . . . . 10.0 114.032 177.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 24.4 mt -70.43 -27.53 64.34 Favored 'General case' 0 CA--C 1.511 -0.535 0 N-CA-C 115.52 1.674 . . . . 10.0 115.52 177.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 74.2 mt -63.27 -57.55 11.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 108.642 -0.873 . . . . 10.0 108.642 165.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 32.0 tp -58.79 -64.72 0.83 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.92 0.888 . . . . 10.0 113.184 -172.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 84.0 mt -71.52 5.19 2.5 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 115.332 1.604 . . . . 10.0 115.332 -171.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.6 mtp-105 -112.32 0.38 15.68 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.188 0.995 . . . . 10.0 113.316 172.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 8.8 t -108.03 177.96 4.65 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 124.046 0.938 . . . . 10.0 111.0 174.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 227' ' ' ARG . . . . . 0.666 ' HD3' ' CD ' ' A' ' 166' ' ' GLU . 41.7 ttt180 -71.62 98.13 1.84 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.786 0.835 . . . . 10.0 110.96 170.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . 0.476 ' HB1' ' CD2' ' A' ' 42' ' ' PHE . . . -80.87 76.96 7.79 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.828 0.851 . . . . 10.0 112.116 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 40.19 102.25 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 128.857 2.863 . . . . 10.0 116.497 177.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . 0.482 0.3 OUTLIER 71.83 -55.44 0.66 Allowed 'General case' 0 C--O 1.242 0.677 0 C-N-CA 124.769 1.227 . . . . 10.0 110.637 -175.273 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -68.25 169.47 39.89 Favored Glycine 0 C--O 1.239 0.429 0 C-N-CA 129.735 3.541 . . . . 10.0 119.701 171.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.461 0 C-N-CA 128.498 2.719 . . . . 10.0 113.46 166.616 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 N--CA 1.477 0.918 0 CA-C-O 115.804 -2.046 . . . . 10.0 105.785 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 23.4 91.84 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 129.58 3.152 . . . . 10.0 117.236 160.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 28.63 65.11 0.11 Allowed 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 128.306 2.643 . . . . 10.0 114.458 155.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 86.7 mt -56.51 137.99 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 126.358 1.863 . . . . 10.0 113.372 -158.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.653 HG21 ' HB3' ' A' ' 77' ' ' PRO . 7.6 t -136.76 -165.26 1.7 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 126.329 1.852 . . . . 10.0 113.97 -174.268 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 70.05 2.8 41.33 Favored Glycine 0 C--N 1.34 0.768 0 C-N-CA 127.477 2.465 . . . . 10.0 111.487 168.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.8 tpp180 -158.58 -51.34 0.01 OUTLIER Pre-proline 0 N--CA 1.444 -0.772 0 CA-C-O 114.206 -2.806 . . . . 10.0 116.623 -168.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_exo -63.99 -60.6 0.15 Allowed 'Trans proline' 0 CA--C 1.528 0.185 0 CA-C-N 123.517 2.292 . . . . 10.0 113.242 -175.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.411 ' H ' ' CD ' ' A' ' 9' ' ' GLU . 7.9 pm0 -67.19 4.22 0.99 Allowed 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 127.855 2.462 . . . . 10.0 115.735 179.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.422 ' CG ' ' N ' ' A' ' 11' ' ' ILE . 11.0 p-90 -51.32 -43.1 61.64 Favored 'General case' 0 C--O 1.222 -0.361 0 O-C-N 121.496 -0.752 . . . . 10.0 112.669 176.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.422 ' N ' ' CG ' ' A' ' 10' ' ' TRP . 8.9 tt -60.85 -49.65 83.74 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.319 0 C-N-CA 123.936 0.894 . . . . 10.0 109.298 179.359 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . 0.536 ' CD2' HD23 ' A' ' 206' ' ' LEU . 2.6 m95 -55.34 -52.63 62.86 Favored 'General case' 0 C--O 1.224 -0.261 0 C-N-CA 123.384 0.674 . . . . 10.0 111.93 175.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.8 mt -57.36 -53.63 55.96 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 123.193 0.597 . . . . 10.0 112.186 177.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.87 -46.79 51.93 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.41 1.484 . . . . 10.0 113.326 173.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.576 ' HB3' ' HE2' ' A' ' 209' ' ' MET . 13.2 tp -65.7 -44.9 84.71 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.302 1.441 . . . . 10.0 113.027 179.128 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.97 -55.89 13.69 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 124.544 1.069 . . . . 10.0 111.759 166.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 22.5 m -49.76 -52.62 30.4 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.001 1.32 . . . . 10.0 112.43 174.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.38 -58.88 5.71 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.133 0.973 . . . . 10.0 112.173 177.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 95.2 mt -57.55 -48.51 79.14 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.593 0.757 . . . . 10.0 112.816 -179.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 57.6 mtt -57.41 -49.5 76.03 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.089 0.956 . . . . 10.0 111.534 176.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -56.63 -58.85 12.35 Favored Glycine 0 CA--C 1.528 0.844 0 CA-C-O 118.873 -0.959 . . . . 10.0 113.673 174.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 81.1 mt -56.16 -46.08 79.43 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-N 118.82 1.31 . . . . 10.0 112.13 176.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.62 -41.6 74.44 Favored Glycine 0 CA--C 1.535 1.294 0 C-N-CA 124.742 1.163 . . . . 10.0 113.254 173.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 27.9 m -62.46 -58.71 6.62 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.097 0.959 . . . . 10.0 111.316 172.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -52.27 -40.96 62.44 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.001 0.92 . . . . 10.0 110.949 177.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.4 t80 -55.82 -58.02 9.59 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.583 1.153 . . . . 10.0 112.968 172.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.1 m-30 -59.64 -38.69 82.07 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 113.225 0.824 . . . . 10.0 113.225 178.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.4 ' C ' ' H ' ' A' ' 30' ' ' LYS . 11.8 mt -56.1 -67.41 0.3 Allowed 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.625 1.17 . . . . 10.0 113.628 169.104 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 t -76.41 40.95 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 CA-C-O 123.756 1.741 . . . . 10.0 110.91 179.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.4 ' H ' ' C ' ' A' ' 28' ' ' LEU . 42.8 tttm -140.84 -44.84 0.39 Allowed 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 127.872 2.469 . . . . 10.0 109.354 171.153 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.96 23.15 0.87 Allowed Glycine 0 CA--C 1.529 0.945 0 N-CA-C 115.624 1.01 . . . . 10.0 115.624 173.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 37.3 mmm -59.59 -45.01 93.16 Favored 'General case' 0 C--O 1.224 -0.272 0 C-N-CA 127.161 2.184 . . . . 10.0 113.529 -178.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.62 -84.43 1.18 Allowed Glycine 0 CA--C 1.53 1.018 0 C-N-CA 123.766 0.698 . . . . 10.0 112.47 -170.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.7 t 33.01 88.79 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.243 0.753 0 C-N-CA 128.405 2.682 . . . . 10.0 116.975 166.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.7 m -79.7 -50.83 10.03 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.193 -1.367 . . . . 10.0 113.855 174.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -48.92 117.51 6.42 Favored Pre-proline 0 CA--C 1.537 0.443 0 O-C-N 124.76 1.288 . . . . 10.0 110.983 -172.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -58.57 -29.68 89.71 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 123.713 2.942 . . . . 10.0 113.688 179.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.29 -60.63 2.31 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.122 0.569 . . . . 10.0 111.429 176.215 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.19 -40.04 22.86 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 125.072 1.349 . . . . 10.0 113.583 171.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.5 tttp -46.58 -47.42 19.79 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.275 1.43 . . . . 10.0 113.397 172.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -57.76 -53.07 62.36 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.487 0.715 . . . . 10.0 110.978 176.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.477 ' CD2' ' HB1' ' A' ' 228' ' ' ALA . 44.2 m-85 -56.96 -50.23 73.28 Favored 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 123.075 0.55 . . . . 10.0 112.345 -179.122 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -54.4 -51.24 65.5 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 118.926 -0.559 . . . . 10.0 112.376 173.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.41 -62.01 1.91 Allowed 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 113.374 0.879 . . . . 10.0 113.374 177.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.3 mt -48.48 -56.78 1.88 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 124.863 1.265 . . . . 10.0 110.889 178.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.8 m -68.46 -21.67 64.61 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.871 1.268 . . . . 10.0 113.413 -172.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 27.5 m -83.37 -40.05 19.9 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.423 1.089 . . . . 10.0 112.33 175.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 16.8 mt -59.14 -44.19 92.06 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 113.147 0.795 . . . . 10.0 113.147 174.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.489 HG13 HG23 ' A' ' 89' ' ' THR . 31.9 t -43.26 -64.51 0.74 Allowed Pre-proline 0 CA--C 1.549 0.911 0 C-N-CA 124.978 1.311 . . . . 10.0 113.119 177.038 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -67.88 -24.64 39.8 Favored 'Trans proline' 0 CA--C 1.543 0.975 0 C-N-CA 122.383 2.056 . . . . 10.0 113.767 177.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -67.27 -48.73 66.82 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 120.316 1.416 . . . . 10.0 113.154 175.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 27.6 mt -66.12 -42.65 91.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 O-C-N 120.568 -1.333 . . . . 10.0 109.443 174.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.32 -45.56 72.64 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 113.261 0.837 . . . . 10.0 113.261 171.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 45.0 t80 -49.81 -54.96 16.03 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 125.704 1.602 . . . . 10.0 111.681 169.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 14.7 m -48.92 -53.35 20.03 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.386 1.475 . . . . 10.0 111.0 176.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 32.2 mmt -67.99 -48.62 65.27 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 124.122 0.969 . . . . 10.0 113.062 -177.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -56.83 -40.44 76.07 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 120.182 1.355 . . . . 10.0 113.322 173.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.8 tp -53.31 -54.54 34.93 Favored 'General case' 0 C--O 1.225 -0.223 0 CA-C-N 119.795 1.18 . . . . 10.0 111.272 170.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 24.0 p -51.69 -41.04 61.14 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 115.217 1.562 . . . . 10.0 115.217 179.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 59.0 mtm -66.86 -50.89 61.07 Favored 'General case' 0 C--N 1.334 -0.085 0 C-N-CA 123.571 0.748 . . . . 10.0 110.435 176.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.3 tp -48.57 -52.65 21.71 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.889 0.875 . . . . 10.0 112.939 172.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.5 mt -76.98 -5.5 48.91 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.325 1.05 . . . . 10.0 113.793 -177.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.25 -34.7 5.56 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 115.522 0.969 . . . . 10.0 115.522 174.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -49.3 -43.06 43.01 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 115.277 1.584 . . . . 10.0 115.277 -176.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.07 3.57 61.13 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 115.379 0.912 . . . . 10.0 115.379 -179.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.25 143.42 26.43 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 127.021 2.129 . . . . 10.0 109.015 171.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 t -145.51 171.11 15.13 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 124.081 0.952 . . . . 10.0 111.041 166.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.04 136.05 53.39 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 123.89 0.876 . . . . 10.0 109.706 179.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.436 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 58.6 t -129.58 129.55 23.18 Favored Pre-proline 0 C--N 1.33 -0.281 0 C-N-CA 125.074 1.35 . . . . 10.0 110.949 -176.013 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 69' ' ' VAL . 6.3 Cg_exo -80.7 116.27 3.18 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 N-CA-C 109.4 -1.038 . . . . 10.0 109.4 -178.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -156.74 164.41 38.15 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 112.824 0.676 . . . . 10.0 112.824 172.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.37 -81.96 0.14 Allowed Glycine 0 CA--C 1.526 0.764 0 N-CA-C 110.684 -0.966 . . . . 10.0 110.684 175.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.74 -3.39 0.7 Allowed Glycine 0 CA--C 1.527 0.808 0 N-CA-C 118.662 2.225 . . . . 10.0 118.662 170.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -151.59 -171.89 4.06 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 119.406 1.603 . . . . 10.0 112.218 -165.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -91.88 93.86 9.03 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 125.525 1.53 . . . . 10.0 111.111 -175.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.449 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 60.3 m-80 -89.41 120.79 69.69 Favored Pre-proline 0 N--CA 1.45 -0.425 0 N-CA-C 112.941 0.719 . . . . 10.0 112.941 -165.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.653 ' HB3' HG21 ' A' ' 5' ' ' THR . 76.0 Cg_exo -61.54 131.87 37.92 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 124.181 3.254 . . . . 10.0 112.201 171.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.4 mm -140.07 126.3 22.07 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 C-N-CA 126.055 1.742 . . . . 10.0 111.75 -179.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -93.6 85.02 4.76 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 123.012 1.387 . . . . 10.0 113.065 174.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 63.8 p-90 -59.36 -28.25 66.69 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 120.865 -1.147 . . . . 10.0 113.931 174.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -55.07 -28.47 52.62 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.239 1.015 . . . . 10.0 113.152 178.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.0 mtt-85 -49.88 -58.04 6.21 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.447 1.099 . . . . 10.0 111.292 168.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -62.6 -40.64 97.58 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 126.076 1.75 . . . . 10.0 112.437 -179.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -52.24 -48.92 64.92 Favored 'General case' 0 CA--C 1.568 1.647 0 CA-C-N 119.597 1.09 . . . . 10.0 111.15 168.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -59.19 -64.38 0.96 Allowed 'General case' 0 N--CA 1.494 1.753 0 CA-C-N 121.212 1.824 . . . . 10.0 110.792 169.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 48.1 m0 -50.65 -35.51 31.01 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.94 1.296 . . . . 10.0 111.865 -170.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 26.4 tp -51.29 -42.59 61.26 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.39 1.876 . . . . 10.0 113.335 176.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -101.45 -52.54 3.21 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.213 1.005 . . . . 10.0 112.645 -175.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.489 HG23 HG13 ' A' ' 49' ' ' VAL . 1.1 m -46.15 -51.01 14.85 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 125.64 1.576 . . . . 10.0 112.829 175.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.421 ' HB ' ' HD3' ' A' ' 91' ' ' PRO . 3.7 m -64.58 -45.89 76.75 Favored Pre-proline 0 CA--C 1.547 0.837 0 O-C-N 121.343 -0.848 . . . . 10.0 112.661 -169.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.421 ' HD3' ' HB ' ' A' ' 90' ' ' THR . 76.2 Cg_exo -51.29 -44.83 40.74 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 124.053 3.169 . . . . 10.0 116.749 162.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 59.4 mt -59.3 -46.67 87.93 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 119.134 0.879 . . . . 10.0 111.358 175.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.5 tp -50.31 -47.74 55.52 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.341 1.856 . . . . 10.0 111.892 172.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.9 mp -60.87 -46.5 90.36 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.414 1.486 . . . . 10.0 113.032 170.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.9 -38.22 78.37 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.82 0.848 . . . . 10.0 112.854 178.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -52.3 -54.05 36.4 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 119.269 0.94 . . . . 10.0 111.166 169.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.3 -42.11 88.79 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.621 0.768 . . . . 10.0 112.131 -178.507 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.66 -54.77 37.27 Favored 'General case' 0 C--O 1.225 -0.186 0 C-N-CA 123.995 0.918 . . . . 10.0 112.011 173.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.28 -41.18 79.23 Favored 'General case' 0 C--O 1.224 -0.239 0 C-N-CA 123.719 0.808 . . . . 10.0 112.725 174.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.9 tp -63.77 -38.56 91.54 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 114.45 1.278 . . . . 10.0 114.45 -179.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.2 t -94.82 1.47 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 125.008 1.323 . . . . 10.0 112.313 179.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.2 t70 48.61 53.4 12.25 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.829 1.652 . . . . 10.0 112.1 -174.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.17 145.88 47.77 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 119.916 -1.74 . . . . 10.0 112.474 -174.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.54 135.9 54.45 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 112.697 0.628 . . . . 10.0 112.697 175.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -42.83 -39.71 2.61 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.894 1.678 . . . . 10.0 113.456 175.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -47.32 -60.22 5.32 Favored Glycine 0 CA--C 1.526 0.731 0 C-N-CA 125.109 1.338 . . . . 10.0 115.252 169.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.4 p -62.06 -46.75 87.75 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 117.057 -1.449 . . . . 10.0 111.335 178.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 66.9 mt -48.45 -52.93 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 124.995 1.318 . . . . 10.0 111.128 178.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.1 tp -62.55 -51.35 67.74 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 112.554 0.576 . . . . 10.0 112.554 179.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.13 -44.9 42.86 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.424 0.689 . . . . 10.0 110.97 174.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.455 ' HA ' HD12 ' A' ' 111' ' ' LEU . 0.6 OUTLIER -59.58 -59.89 4.73 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 127.363 2.265 . . . . 10.0 114.787 174.968 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.6 t -61.04 -46.29 96.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 123.685 0.794 . . . . 10.0 111.41 -178.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -56.64 -50.36 63.75 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 123.674 0.654 . . . . 10.0 112.642 174.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -54.21 -46.74 72.56 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.571 0.748 . . . . 10.0 112.94 173.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -60.89 -41.77 96.67 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 112.707 0.632 . . . . 10.0 112.707 176.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -43.85 -56.94 4.89 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 125.43 1.491 . . . . 10.0 113.078 164.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 85.4 mt -56.84 -50.49 75.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 CA-C-N 117.776 0.788 . . . . 10.0 111.668 175.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 47.9 ttp -48.66 -58.4 4.8 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.295 1.438 . . . . 10.0 112.056 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 36.8 mm . . . . . 0 N--CA 1.471 0.602 0 O-C-N 121.959 -0.463 . . . . 10.0 112.03 178.736 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 68.5 t . . . . . 0 N--CA 1.475 0.794 0 N-CA-C 110.371 -0.233 . . . . 10.0 110.371 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -49.22 -60.92 5.8 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 125.871 1.7 . . . . 10.0 112.275 171.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -48.85 -37.71 20.29 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 126.576 1.95 . . . . 10.0 113.76 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 49.7 mt -99.31 -6.57 27.69 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 115.22 1.563 . . . . 10.0 115.22 -178.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 16.8 m -69.74 116.73 10.48 Favored 'General case' 0 N--CA 1.464 0.266 0 O-C-N 120.165 -1.584 . . . . 10.0 110.345 -178.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.623 ' H ' ' HD3' ' A' ' 129' ' ' LYS . 0.2 OUTLIER -55.45 -49.61 72.0 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 128.205 2.602 . . . . 10.0 113.305 177.728 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 60.9 t -69.64 106.35 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 123.788 0.835 . . . . 10.0 110.089 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -46.88 -59.55 3.01 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 124.809 1.244 . . . . 10.0 114.038 -173.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 m -46.47 -42.11 14.97 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.501 1.521 . . . . 10.0 113.496 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -70.2 -24.54 63.14 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 114.918 1.451 . . . . 10.0 114.918 -178.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 69.3 mtp85 -53.66 -42.18 67.6 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-N 118.923 0.783 . . . . 10.0 110.701 176.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -69.57 -31.65 69.94 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.826 1.25 . . . . 10.0 114.322 176.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.8 t -55.31 -51.74 53.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-N 119.064 0.847 . . . . 10.0 109.582 168.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 66.8 m95 -62.08 -42.77 99.54 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 114.335 1.235 . . . . 10.0 114.335 174.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 92.8 t90 -53.92 -48.63 70.0 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.265 1.026 . . . . 10.0 112.618 172.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.573 0 C-N-CA 123.71 0.804 . . . . 10.0 111.639 176.603 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.747 0 N-CA-C 112.234 0.457 . . . . 10.0 112.234 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 9.6 tmm? -51.67 -52.94 44.13 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.919 1.688 . . . . 10.0 111.858 173.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 7.8 tt -53.59 -52.05 61.03 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.856 1.662 . . . . 10.0 112.392 175.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 72.9 t80 -49.47 -53.91 20.58 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.225 1.01 . . . . 10.0 112.098 173.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 36.9 mm -52.81 -56.09 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 CA-C-N 118.818 0.736 . . . . 10.0 110.387 177.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 18.5 mt -58.71 -34.48 71.37 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 117.979 -1.01 . . . . 10.0 112.037 -178.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -57.26 -58.18 9.36 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 119.513 1.052 . . . . 10.0 113.076 173.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.4 -40.91 85.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 CA-C-O 118.32 -0.847 . . . . 10.0 111.438 177.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 44.1 mt -56.76 -49.42 75.3 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 119.919 1.236 . . . . 10.0 112.12 171.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.47 ' HA ' ' HD2' ' A' ' 175' ' ' ARG . 12.0 t80 -77.02 -70.31 0.47 Allowed 'General case' 0 C--N 1.326 -0.435 0 O-C-N 120.049 -1.657 . . . . 10.0 112.857 -175.216 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -73.7 -21.98 60.06 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.665 1.186 . . . . 10.0 113.411 -174.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -87.77 -79.17 1.26 Allowed Glycine 0 CA--C 1.527 0.806 0 C-N-CA 123.639 0.637 . . . . 10.0 113.49 171.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -53.52 -32.47 50.65 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 126.295 1.838 . . . . 10.0 113.067 -166.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.2 m -52.13 -56.42 14.65 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 114.018 1.118 . . . . 10.0 114.018 172.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.3 p -53.69 -50.57 65.57 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 122.079 0.942 . . . . 10.0 112.271 -177.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 47.6 tttm -57.09 -46.02 82.9 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.168 0.987 . . . . 10.0 112.16 173.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.84 -47.48 80.25 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 114.475 1.287 . . . . 10.0 114.475 174.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -56.53 -11.25 1.21 Allowed 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.034 1.734 . . . . 10.0 114.249 177.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.1 m -107.05 6.62 29.16 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.411 1.884 . . . . 10.0 114.846 -179.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 93.2 mmm -91.9 -92.67 0.15 Allowed 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 123.523 1.63 . . . . 10.0 114.146 -170.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -138.72 153.95 72.63 Favored Pre-proline 0 C--O 1.235 0.308 0 C-N-CA 129.756 3.223 . . . . 10.0 105.552 170.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -52.85 -46.19 35.46 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 122.285 1.99 . . . . 10.0 113.088 179.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.667 ' CD ' ' HD3' ' A' ' 227' ' ' ARG . 0.1 OUTLIER -53.02 -46.04 68.22 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 129.049 2.94 . . . . 10.0 113.259 173.571 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 92.2 t -69.25 -53.0 27.75 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.253 0 C-N-CA 124.06 0.944 . . . . 10.0 109.771 -178.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.12 -46.86 75.63 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.284 0.634 . . . . 10.0 111.915 177.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 60.5 p -59.99 -56.15 25.28 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.908 0.883 . . . . 10.0 112.741 174.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 61.8 m -57.24 -53.18 60.97 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.13 0.972 . . . . 10.0 113.006 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -49.6 -49.51 46.42 Favored 'General case' 0 C--O 1.222 -0.375 0 C-N-CA 123.311 0.644 . . . . 10.0 111.086 174.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -57.16 -48.37 78.87 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 114.678 1.362 . . . . 10.0 114.678 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 40.3 t -56.01 -49.59 74.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 CA-C-N 118.794 0.725 . . . . 10.0 110.507 176.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 94.1 mt -58.58 -51.57 69.35 Favored 'General case' 0 C--O 1.222 -0.394 0 N-CA-C 113.197 0.814 . . . . 10.0 113.197 175.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . 0.47 ' HD2' ' HA ' ' A' ' 153' ' ' PHE . 35.5 ttp180 -47.87 -47.75 31.57 Favored 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 126.82 2.048 . . . . 10.0 111.017 174.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 63.6 m-20 -58.54 -58.29 9.19 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 122.809 0.444 . . . . 10.0 111.283 174.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 59.8 t -51.67 -48.86 36.55 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 124.074 0.949 . . . . 10.0 111.678 179.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 19.8 m -58.76 -62.08 2.13 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 127.267 2.227 . . . . 10.0 112.009 178.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 54.5 t -50.69 -49.44 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 C-N-CA 124.599 1.159 . . . . 10.0 110.998 -179.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 74.2 t -59.65 -62.6 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 123.883 0.873 . . . . 10.0 112.55 177.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -57.97 -45.95 85.9 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 118.669 0.668 . . . . 10.0 112.108 -175.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 9.5 m0 . . . . . 0 N--CA 1.466 0.333 0 C-N-CA 123.652 0.781 . . . . 10.0 113.0 176.163 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 98.2 t . . . . . 0 N--CA 1.479 0.993 0 CA-C-O 119.381 -0.342 . . . . 10.0 111.418 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 28.1 t90 -54.63 -53.91 48.53 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.657 1.183 . . . . 10.0 112.493 174.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 10.0 tt -55.52 -44.95 77.15 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 124.187 0.995 . . . . 10.0 112.625 -178.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 15.0 pt -84.93 -5.52 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 N-CA-C 115.118 1.525 . . . . 10.0 115.118 -178.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.29 -169.27 33.13 Favored Glycine 0 N--CA 1.45 -0.397 0 CA-C-O 122.604 1.113 . . . . 10.0 113.925 -168.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 23.3 t -53.18 -41.0 64.82 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 114.156 -1.022 . . . . 10.0 111.871 177.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -54.17 -32.16 54.67 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 128.621 2.768 . . . . 10.0 115.266 179.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -131.25 -103.86 0.97 Allowed Glycine 0 CA--C 1.528 0.879 0 CA-C-N 119.346 0.976 . . . . 10.0 113.566 -167.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -89.47 127.17 35.82 Favored 'General case' 0 C--N 1.328 -0.328 0 O-C-N 120.657 -1.496 . . . . 10.0 109.32 169.212 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -72.42 65.31 1.35 Allowed Glycine 0 CA--C 1.532 1.138 0 N-CA-C 113.914 0.326 . . . . 10.0 113.914 173.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 60.7 mt -79.57 -42.76 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 C-N-CA 126.096 1.759 . . . . 10.0 108.766 166.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.4 ' CG1' ' HB ' ' A' ' 203' ' ' ILE . 79.2 t -126.29 133.41 24.93 Favored Pre-proline 0 N--CA 1.454 -0.25 0 C-N-CA 126.496 1.918 . . . . 10.0 109.372 -174.208 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -68.76 153.76 72.49 Favored 'Trans proline' 0 N--CA 1.461 -0.441 0 C-N-CA 123.834 3.023 . . . . 10.0 111.459 -176.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 12.2 tp -43.17 -39.78 3.02 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.312 1.045 . . . . 10.0 112.202 171.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -48.33 -52.37 21.86 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 114.715 1.376 . . . . 10.0 114.715 176.012 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . 0.4 ' HB ' ' CG1' ' A' ' 199' ' ' VAL . 14.0 mm -75.93 -40.47 38.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 C-N-CA 124.39 1.076 . . . . 10.0 109.681 177.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -49.31 -49.78 42.39 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 118.546 0.612 . . . . 10.0 111.981 173.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 16.1 m -57.67 -47.07 83.35 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 126.013 1.725 . . . . 10.0 112.991 174.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.536 HD23 ' CD2' ' A' ' 12' ' ' TRP . 1.3 tm? -63.31 -52.38 62.16 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.024 0.93 . . . . 10.0 112.06 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 93.2 mt -52.51 -59.96 3.81 Favored 'General case' 0 C--N 1.335 -0.053 0 C-N-CA 124.363 1.065 . . . . 10.0 109.953 176.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -52.92 -45.12 67.47 Favored 'General case' 0 C--O 1.216 -0.667 0 CA-C-O 116.773 -1.584 . . . . 10.0 112.086 176.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' MET . . . . . 0.576 ' HE2' ' HB3' ' A' ' 15' ' ' LEU . 4.6 tmm? -52.65 -53.04 52.59 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 121.719 2.054 . . . . 10.0 113.114 174.187 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 81.8 t -59.96 -47.03 93.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 125.129 1.371 . . . . 10.0 111.158 178.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 4.2 mp -59.81 -50.16 74.89 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.677 1.591 . . . . 10.0 112.298 174.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 32.6 m-20 -55.57 -59.72 4.44 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 127.458 2.303 . . . . 10.0 111.069 177.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 25.4 m . . . . . 0 N--CA 1.479 0.98 0 O-C-N 121.086 -1.009 . . . . 10.0 112.56 -177.812 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.327 0 CA-C-O 120.895 0.164 . . . . 10.0 113.157 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -44.9 -56.17 4.79 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 126.522 1.929 . . . . 10.0 112.007 166.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -55.67 -39.28 75.34 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 124.554 1.073 . . . . 10.0 114.003 177.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 24.9 mt -69.66 -27.81 65.35 Favored 'General case' 0 CA--C 1.512 -0.481 0 N-CA-C 115.687 1.736 . . . . 10.0 115.687 176.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 74.6 mt -63.45 -57.5 11.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 108.545 -0.909 . . . . 10.0 108.545 165.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 32.1 tp -58.81 -64.65 0.86 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.948 0.899 . . . . 10.0 113.193 -172.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 84.1 mt -71.51 5.14 2.52 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 115.347 1.61 . . . . 10.0 115.347 -171.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.6 mtp-105 -112.33 0.4 15.67 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 124.214 1.006 . . . . 10.0 113.304 172.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 8.8 t -108.06 177.98 4.65 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 124.089 0.956 . . . . 10.0 111.03 174.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 227' ' ' ARG . . . . . 0.667 ' HD3' ' CD ' ' A' ' 166' ' ' GLU . 41.8 ttt180 -71.65 98.16 1.86 Allowed 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.824 0.85 . . . . 10.0 110.893 170.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . 0.477 ' HB1' ' CD2' ' A' ' 42' ' ' PHE . . . -80.92 77.03 7.84 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.861 0.864 . . . . 10.0 112.1 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 40.1 102.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 128.901 2.88 . . . . 10.0 116.444 177.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . 0.481 0.3 OUTLIER 71.86 -55.42 0.66 Allowed 'General case' 0 C--O 1.242 0.691 0 C-N-CA 124.749 1.22 . . . . 10.0 110.644 -175.334 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -68.32 169.48 40.13 Favored Glycine 0 C--O 1.239 0.422 0 C-N-CA 129.727 3.537 . . . . 10.0 119.655 171.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.459 0 C-N-CA 128.477 2.711 . . . . 10.0 113.438 166.655 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 N--CA 1.477 0.913 0 CA-C-O 115.813 -2.041 . . . . 10.0 105.805 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 23.35 91.93 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 129.568 3.147 . . . . 10.0 117.213 160.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 28.57 65.08 0.1 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 128.307 2.643 . . . . 10.0 114.514 155.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 86.8 mt -56.52 137.98 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 126.379 1.872 . . . . 10.0 113.336 -158.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.652 HG21 ' HB3' ' A' ' 77' ' ' PRO . 7.6 t -136.71 -165.19 1.69 Allowed 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 126.331 1.852 . . . . 10.0 114.05 -174.357 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 69.95 2.83 40.72 Favored Glycine 0 C--N 1.34 0.768 0 C-N-CA 127.503 2.477 . . . . 10.0 111.511 168.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.8 tpp180 -158.51 -51.39 0.01 OUTLIER Pre-proline 0 N--CA 1.443 -0.783 0 CA-C-O 114.309 -2.758 . . . . 10.0 116.665 -168.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_exo -64.0 -60.58 0.15 Allowed 'Trans proline' 0 N--CA 1.464 -0.218 0 CA-C-N 123.524 2.294 . . . . 10.0 113.215 -175.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.412 ' H ' ' CD ' ' A' ' 9' ' ' GLU . 7.9 pm0 -67.24 4.34 0.97 Allowed 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 127.831 2.452 . . . . 10.0 115.764 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.422 ' CG ' ' N ' ' A' ' 11' ' ' ILE . 11.0 p-90 -51.43 -43.06 61.91 Favored 'General case' 0 C--O 1.223 -0.34 0 O-C-N 121.509 -0.744 . . . . 10.0 112.641 176.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.422 ' N ' ' CG ' ' A' ' 10' ' ' TRP . 8.9 tt -60.91 -49.61 83.94 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.34 0 C-N-CA 123.862 0.865 . . . . 10.0 109.316 179.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . 0.535 ' CD2' HD23 ' A' ' 206' ' ' LEU . 2.6 m95 -55.35 -52.67 62.76 Favored 'General case' 0 C--O 1.224 -0.259 0 C-N-CA 123.4 0.68 . . . . 10.0 111.871 175.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.3 mt -57.3 -53.65 55.69 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 123.21 0.604 . . . . 10.0 112.227 177.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.86 -46.8 51.83 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.413 1.485 . . . . 10.0 113.324 173.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.574 ' HB3' ' HE2' ' A' ' 209' ' ' MET . 13.4 tp -65.64 -44.96 84.8 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 125.298 1.439 . . . . 10.0 113.03 179.085 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -50.02 -57.15 10.35 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 124.045 0.831 . . . . 10.0 111.264 166.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 22.6 m -48.43 -52.62 21.22 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.602 1.161 . . . . 10.0 112.364 174.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.39 -58.86 5.81 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.139 0.976 . . . . 10.0 112.188 177.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 94.2 mt -57.61 -50.43 73.17 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.762 0.825 . . . . 10.0 112.578 -179.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -54.14 -50.31 67.23 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.464 1.106 . . . . 10.0 111.346 175.343 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -58.07 -57.99 16.92 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 124.271 0.939 . . . . 10.0 113.666 176.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 80.8 mt -56.24 -45.77 79.86 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-N 118.434 1.117 . . . . 10.0 112.103 176.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.28 -42.75 74.52 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 125.03 1.3 . . . . 10.0 113.167 172.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 24.1 m -60.79 -59.64 5.06 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 124.038 0.935 . . . . 10.0 111.303 171.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -52.28 -41.02 62.52 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.061 0.944 . . . . 10.0 110.974 178.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -55.75 -58.03 9.55 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.561 1.144 . . . . 10.0 113.006 172.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -59.63 -38.7 82.06 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 113.226 0.825 . . . . 10.0 113.226 178.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.4 ' C ' ' H ' ' A' ' 30' ' ' LYS . 11.8 mt -56.16 -67.47 0.29 Allowed 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.572 1.149 . . . . 10.0 113.576 169.154 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 t -76.36 41.02 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 CA-C-O 123.802 1.763 . . . . 10.0 110.891 179.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.4 ' H ' ' C ' ' A' ' 28' ' ' LEU . 43.0 tttm -140.89 -44.91 0.39 Allowed 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 127.905 2.482 . . . . 10.0 109.303 171.199 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.9 23.07 0.86 Allowed Glycine 0 CA--C 1.529 0.956 0 N-CA-C 115.644 1.017 . . . . 10.0 115.644 173.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 37.3 mmm -59.52 -44.96 93.02 Favored 'General case' 0 C--O 1.224 -0.253 0 C-N-CA 127.17 2.188 . . . . 10.0 113.578 -178.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.66 -84.45 1.18 Allowed Glycine 0 CA--C 1.531 1.045 0 C-N-CA 123.741 0.686 . . . . 10.0 112.477 -170.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.7 t 33.09 88.75 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.242 0.682 0 C-N-CA 128.36 2.664 . . . . 10.0 116.941 166.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.8 m -79.67 -50.89 9.96 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.187 -1.37 . . . . 10.0 113.832 174.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -48.86 117.47 6.33 Favored Pre-proline 0 CA--C 1.536 0.428 0 O-C-N 124.794 1.309 . . . . 10.0 110.983 -172.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -58.53 -29.66 89.51 Favored 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 123.792 2.995 . . . . 10.0 113.698 179.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.35 -60.65 2.3 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.058 0.543 . . . . 10.0 111.455 176.183 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.08 -40.15 22.33 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 125.14 1.376 . . . . 10.0 113.554 171.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -46.53 -47.4 19.57 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 125.261 1.424 . . . . 10.0 113.463 172.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -57.77 -53.01 62.99 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.425 0.69 . . . . 10.0 111.009 176.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.475 ' CD2' ' HB1' ' A' ' 228' ' ' ALA . 43.9 m-85 -57.04 -50.21 73.44 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 123.049 0.54 . . . . 10.0 112.323 -179.114 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -54.37 -51.28 65.31 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 118.935 -0.555 . . . . 10.0 112.379 173.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.36 -62.0 1.92 Allowed 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 113.404 0.89 . . . . 10.0 113.404 177.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.5 mt -48.88 -56.35 2.51 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 C-N-CA 124.829 1.251 . . . . 10.0 110.496 178.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.5 m -70.07 -16.91 63.2 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.109 1.364 . . . . 10.0 113.688 -172.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 27.5 m -87.92 -37.72 16.2 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.134 0.973 . . . . 10.0 112.152 174.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 20.4 mt -60.88 -39.36 88.94 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-O 118.406 -0.807 . . . . 10.0 113.091 173.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.614 HG23 ' HD3' ' A' ' 50' ' ' PRO 0.35 33.3 m -55.16 -54.11 54.07 Favored Pre-proline 0 N--CA 1.485 1.278 0 N-CA-C 114.579 1.326 . . . . 10.0 114.579 179.318 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.614 ' HD3' HG23 ' A' ' 49' ' ' VAL . 68.3 Cg_endo -67.61 -26.44 39.71 Favored 'Trans proline' 0 CA--C 1.545 1.055 0 CA-C-N 123.137 2.156 . . . . 10.0 113.099 173.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.44 -47.7 75.27 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-N 120.181 1.355 . . . . 10.0 113.324 175.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 19.3 tt -65.51 -41.03 89.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 O-C-N 120.431 -1.418 . . . . 10.0 111.419 171.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -49.89 -49.93 47.79 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 118.732 0.696 . . . . 10.0 112.156 170.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 53.2 t80 -51.85 -57.93 7.92 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 125.711 1.604 . . . . 10.0 112.473 173.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.5 m -49.2 -52.72 25.07 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 125.094 1.358 . . . . 10.0 110.856 178.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.457 ' HG3' ' CB ' ' A' ' 85' ' ' ASP . 32.9 mmt -70.02 -47.95 60.02 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 124.21 1.004 . . . . 10.0 112.618 -175.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -56.14 -41.07 74.79 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 120.328 1.422 . . . . 10.0 113.206 172.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.8 tp -53.3 -54.57 34.54 Favored 'General case' 0 C--O 1.224 -0.272 0 CA-C-N 120.024 1.284 . . . . 10.0 111.275 170.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 23.9 p -51.6 -41.16 61.02 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 115.203 1.557 . . . . 10.0 115.203 178.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 57.6 mtm -66.84 -50.81 61.37 Favored 'General case' 0 C--N 1.333 -0.113 0 C-N-CA 123.54 0.736 . . . . 10.0 110.481 176.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.2 tp -48.64 -52.66 22.06 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.882 0.873 . . . . 10.0 112.894 172.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.4 mt -76.9 -5.61 49.15 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.383 1.073 . . . . 10.0 113.786 -177.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.26 -34.66 5.59 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 115.53 0.972 . . . . 10.0 115.53 174.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 75.3 t80 -49.32 -43.13 43.26 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 115.206 1.558 . . . . 10.0 115.206 -176.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.02 3.54 61.06 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 115.313 0.885 . . . . 10.0 115.313 -179.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.25 143.41 26.44 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 127.035 2.134 . . . . 10.0 109.011 172.023 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 t -145.5 171.07 15.19 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 124.064 0.946 . . . . 10.0 111.019 166.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.97 136.08 53.37 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 123.947 0.899 . . . . 10.0 109.73 179.554 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.436 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 58.7 t -129.59 129.56 23.17 Favored Pre-proline 0 C--N 1.329 -0.295 0 C-N-CA 125.098 1.359 . . . . 10.0 110.966 -176.044 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 69' ' ' VAL . 6.3 Cg_exo -80.77 116.24 3.16 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 N-CA-C 109.41 -1.035 . . . . 10.0 109.41 -178.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -156.71 164.41 38.16 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 112.845 0.683 . . . . 10.0 112.845 172.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.37 -81.93 0.14 Allowed Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.681 -0.967 . . . . 10.0 110.681 175.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.8 -3.34 0.69 Allowed Glycine 0 CA--C 1.526 0.762 0 N-CA-C 118.677 2.231 . . . . 10.0 118.677 170.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -151.61 -171.89 4.06 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 119.379 1.589 . . . . 10.0 112.224 -165.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -91.84 93.88 9.05 Favored 'General case' 0 CA--C 1.519 -0.23 0 C-N-CA 125.547 1.539 . . . . 10.0 111.146 -175.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.451 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 60.5 m-80 -89.52 120.79 69.62 Favored Pre-proline 0 N--CA 1.45 -0.43 0 N-CA-C 112.933 0.716 . . . . 10.0 112.933 -165.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.652 ' HB3' HG21 ' A' ' 5' ' ' THR . 75.7 Cg_exo -61.53 131.92 38.19 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 124.208 3.272 . . . . 10.0 112.158 171.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.5 mm -140.12 126.34 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 C-N-CA 126.0 1.72 . . . . 10.0 111.71 -179.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -93.65 85.07 4.76 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 122.701 1.238 . . . . 10.0 113.055 174.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 63.8 p-90 -59.45 -28.2 66.75 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 113.921 1.082 . . . . 10.0 113.921 174.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -54.58 -28.53 46.8 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 113.809 1.04 . . . . 10.0 113.809 178.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 77.7 mtt-85 -52.15 -58.63 6.0 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 119.318 0.963 . . . . 10.0 111.263 169.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -58.67 -40.06 82.43 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 125.697 1.599 . . . . 10.0 111.967 -179.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -52.18 -50.95 60.83 Favored 'General case' 0 CA--C 1.552 1.05 0 CA-C-N 119.368 0.986 . . . . 10.0 112.133 168.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.457 ' CB ' ' HG3' ' A' ' 56' ' ' MET . 0.0 OUTLIER -60.34 -59.82 4.8 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.961 1.304 . . . . 10.0 112.388 173.18 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 52.3 m0 -54.19 -37.8 64.92 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 126.88 2.072 . . . . 10.0 112.714 -176.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 32.5 tp -50.39 -45.16 55.26 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 126.207 1.803 . . . . 10.0 111.845 178.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -97.79 -43.35 7.18 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 123.961 0.905 . . . . 10.0 112.671 -178.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -58.26 -44.09 88.2 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 113.105 0.779 . . . . 10.0 113.105 -176.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.427 ' HB ' ' HD3' ' A' ' 91' ' ' PRO . 3.5 m -68.58 -45.21 35.08 Favored Pre-proline 0 CA--C 1.544 0.735 0 O-C-N 121.302 -0.874 . . . . 10.0 112.386 -172.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.427 ' HD3' ' HB ' ' A' ' 90' ' ' THR . 73.6 Cg_exo -52.34 -44.43 46.68 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 123.672 2.914 . . . . 10.0 115.865 165.012 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 52.8 mt -59.09 -46.63 87.81 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 118.815 0.734 . . . . 10.0 111.426 175.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.2 tp -50.47 -48.73 56.51 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.65 1.58 . . . . 10.0 112.235 172.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.0 mp -59.09 -46.99 86.88 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.192 1.397 . . . . 10.0 112.714 170.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.88 -38.25 78.4 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.866 0.866 . . . . 10.0 112.837 178.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -52.24 -54.09 35.53 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 119.34 0.973 . . . . 10.0 111.187 169.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.35 -42.1 88.58 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.635 0.774 . . . . 10.0 112.113 -178.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.64 -54.79 36.95 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 124.006 0.923 . . . . 10.0 112.014 173.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.25 -41.15 79.05 Favored 'General case' 0 C--O 1.224 -0.237 0 C-N-CA 123.715 0.806 . . . . 10.0 112.764 174.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.8 tp -63.8 -38.54 91.46 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 114.436 1.273 . . . . 10.0 114.436 -179.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.2 t -94.83 1.39 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 125.069 1.347 . . . . 10.0 112.316 179.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.2 t70 48.63 53.49 12.13 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.864 1.666 . . . . 10.0 112.079 -174.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.27 145.93 47.56 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 119.988 -1.695 . . . . 10.0 112.469 -174.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.56 135.91 54.51 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 112.723 0.638 . . . . 10.0 112.723 175.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -42.87 -39.63 2.6 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.83 1.652 . . . . 10.0 113.508 175.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -47.34 -60.19 5.35 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 125.147 1.356 . . . . 10.0 115.264 169.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.6 p -62.09 -46.77 87.6 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 117.1 -1.428 . . . . 10.0 111.309 178.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 66.9 mt -48.41 -52.94 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 125.038 1.335 . . . . 10.0 111.117 178.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.2 tp -62.59 -51.31 67.84 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 112.528 0.566 . . . . 10.0 112.528 179.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.28 -44.81 44.25 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.437 0.695 . . . . 10.0 110.935 174.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.455 ' HA ' HD12 ' A' ' 111' ' ' LEU . 0.6 OUTLIER -59.56 -59.9 4.71 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 127.393 2.277 . . . . 10.0 114.831 174.874 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.6 t -61.01 -46.38 96.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 123.705 0.802 . . . . 10.0 111.37 -178.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -56.6 -50.36 63.61 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 123.686 0.66 . . . . 10.0 112.631 174.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -54.64 -46.67 73.99 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 113.215 0.82 . . . . 10.0 113.215 173.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -57.74 -45.75 85.39 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.218 0.607 . . . . 10.0 111.938 174.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -43.22 -56.09 4.79 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 125.196 1.379 . . . . 10.0 113.002 167.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 88.9 mt -56.76 -52.58 52.76 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 123.518 0.727 . . . . 10.0 111.372 174.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 6.1 tmm? -51.58 -56.72 11.9 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.786 1.234 . . . . 10.0 112.566 -176.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 44.5 mm . . . . . 0 N--CA 1.472 0.666 0 C-N-CA 123.068 0.547 . . . . 10.0 112.075 177.119 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 67.9 t . . . . . 0 N--CA 1.476 0.873 0 N-CA-C 110.36 -0.237 . . . . 10.0 110.36 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -49.77 -60.7 6.24 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 125.937 1.732 . . . . 10.0 112.191 172.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -49.11 -37.49 21.9 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.558 1.943 . . . . 10.0 113.732 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 48.8 mt -99.07 -6.71 27.93 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 115.315 1.598 . . . . 10.0 115.315 -179.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 16.9 m -69.66 116.75 10.42 Favored 'General case' 0 N--CA 1.464 0.229 0 O-C-N 120.15 -1.594 . . . . 10.0 110.386 -178.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.62 ' H ' ' HD3' ' A' ' 129' ' ' LYS . 0.1 OUTLIER -55.5 -49.63 72.06 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 128.23 2.612 . . . . 10.0 113.252 177.765 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 60.3 t -69.61 106.33 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 123.819 0.848 . . . . 10.0 110.071 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -46.92 -59.56 3.01 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 124.787 1.235 . . . . 10.0 114.048 -173.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 m -46.41 -42.13 14.7 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.474 1.51 . . . . 10.0 113.513 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -70.15 -24.63 63.19 Favored 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 114.95 1.463 . . . . 10.0 114.95 -178.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 69.3 mtp85 -53.78 -41.82 67.65 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 118.857 0.753 . . . . 10.0 110.881 176.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -69.42 -32.44 71.43 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.815 1.246 . . . . 10.0 114.216 176.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 49.0 t -55.12 -52.11 47.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 CA-C-N 119.033 0.833 . . . . 10.0 109.965 169.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 69.7 m95 -59.39 -51.5 69.63 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 113.47 0.915 . . . . 10.0 113.47 174.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 85.3 t90 -47.98 -47.23 33.07 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.268 1.027 . . . . 10.0 113.304 174.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.559 0 C-N-CA 124.058 0.943 . . . . 10.0 111.768 176.665 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.547 0.86 0 N-CA-C 112.922 0.712 . . . . 10.0 112.922 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 39.4 ttp -58.13 -51.41 69.83 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.19 0.996 . . . . 10.0 112.18 172.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 5.6 mp -51.65 -48.55 63.33 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 126.596 1.959 . . . . 10.0 112.042 175.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 77.9 t80 -54.07 -54.26 41.87 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.664 0.785 . . . . 10.0 113.06 172.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 49.4 mt -54.32 -55.35 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 123.566 0.746 . . . . 10.0 110.8 178.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . 0.289 3.9 pp -60.63 -31.26 70.46 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 116.833 -1.556 . . . . 10.0 113.371 179.055 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -57.26 -58.2 9.28 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 120.554 1.524 . . . . 10.0 113.064 170.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.39 -40.88 85.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-O 118.321 -0.847 . . . . 10.0 111.469 177.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 46.9 mt -56.83 -49.34 75.7 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 119.84 1.2 . . . . 10.0 112.164 171.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.47 ' HA ' ' HD2' ' A' ' 175' ' ' ARG . 11.8 t80 -76.97 -70.34 0.47 Allowed 'General case' 0 C--N 1.326 -0.447 0 O-C-N 120.056 -1.653 . . . . 10.0 112.887 -175.288 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -73.71 -21.99 60.05 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.596 1.158 . . . . 10.0 113.439 -174.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -87.78 -79.08 1.26 Allowed Glycine 0 CA--C 1.526 0.77 0 C-N-CA 123.602 0.62 . . . . 10.0 113.545 171.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 5.4 m-30 -53.61 -32.46 51.25 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 126.271 1.828 . . . . 10.0 113.019 -166.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.3 m -52.08 -56.44 14.4 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 113.991 1.108 . . . . 10.0 113.991 172.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.6 p -53.68 -50.58 65.52 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 122.121 0.962 . . . . 10.0 112.282 -177.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 47.7 tttm -57.15 -46.01 83.09 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.194 0.998 . . . . 10.0 112.11 173.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.82 -47.46 80.24 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 114.545 1.313 . . . . 10.0 114.545 174.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -56.49 -11.28 1.21 Allowed 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 126.068 1.747 . . . . 10.0 114.258 177.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.1 m -107.08 6.57 29.04 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.467 1.907 . . . . 10.0 114.881 -179.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 93.2 mmm -91.89 -92.67 0.15 Allowed 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 123.506 1.622 . . . . 10.0 114.164 -170.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -138.69 153.97 72.71 Favored Pre-proline 0 C--O 1.236 0.349 0 C-N-CA 129.848 3.259 . . . . 10.0 105.548 170.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -52.88 -46.21 35.38 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.261 1.974 . . . . 10.0 113.074 179.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.667 ' CD ' ' HD3' ' A' ' 227' ' ' ARG . 0.1 OUTLIER -52.95 -46.08 68.02 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 129.022 2.929 . . . . 10.0 113.242 173.569 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 92.2 t -69.18 -52.99 28.02 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 C-N-CA 124.085 0.954 . . . . 10.0 109.85 -178.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.2 -46.8 75.89 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.238 0.615 . . . . 10.0 111.933 177.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 60.1 p -59.95 -56.25 24.06 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.972 0.909 . . . . 10.0 112.68 174.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 62.0 m -57.22 -53.19 60.94 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.202 1.001 . . . . 10.0 113.004 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -49.61 -49.49 46.65 Favored 'General case' 0 C--O 1.222 -0.375 0 C-N-CA 123.239 0.616 . . . . 10.0 111.102 174.071 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -57.11 -48.46 78.57 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 114.629 1.344 . . . . 10.0 114.629 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 40.4 t -55.95 -49.63 74.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 CA-C-N 118.794 0.725 . . . . 10.0 110.476 176.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 94.2 mt -58.57 -51.63 69.09 Favored 'General case' 0 C--O 1.222 -0.389 0 N-CA-C 113.201 0.815 . . . . 10.0 113.201 175.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . 0.47 ' HD2' ' HA ' ' A' ' 153' ' ' PHE . 35.5 ttp180 -47.71 -47.77 29.85 Favored 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 126.85 2.06 . . . . 10.0 111.092 174.395 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 63.4 m-20 -58.55 -58.29 9.22 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 122.799 0.44 . . . . 10.0 111.255 174.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 54.2 t -51.93 -47.61 41.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 C-N-CA 124.082 0.953 . . . . 10.0 112.143 179.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 25.0 m -59.39 -63.02 1.45 Allowed 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 127.507 2.323 . . . . 10.0 111.755 178.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 55.8 t -50.12 -49.9 21.21 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 C-N-CA 124.799 1.24 . . . . 10.0 110.975 -179.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 70.8 t -59.13 -61.65 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 123.912 0.885 . . . . 10.0 112.616 178.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 91.5 mt -58.36 -46.99 85.23 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 118.19 0.45 . . . . 10.0 111.871 -176.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 9.0 m0 . . . . . 0 N--CA 1.465 0.295 0 C-N-CA 124.121 0.968 . . . . 10.0 112.217 174.67 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 90.4 t . . . . . 0 N--CA 1.479 0.991 0 CA-C-O 119.499 -0.286 . . . . 10.0 111.657 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 34.7 t90 -55.79 -55.82 27.88 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.844 1.258 . . . . 10.0 112.288 174.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 9.8 tt -55.9 -44.23 78.03 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 124.289 1.036 . . . . 10.0 112.639 -177.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 14.7 pt -82.79 -5.68 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 N-CA-C 114.989 1.477 . . . . 10.0 114.989 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.58 -169.35 32.75 Favored Glycine 0 N--CA 1.45 -0.379 0 CA-C-O 122.545 1.08 . . . . 10.0 113.855 -168.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 23.2 t -53.15 -39.55 63.63 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 114.217 -0.992 . . . . 10.0 111.847 177.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -56.86 -32.39 65.76 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 128.439 2.695 . . . . 10.0 115.286 -179.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -129.61 -104.41 1.11 Allowed Glycine 0 CA--C 1.524 0.628 0 CA-C-O 122.169 0.872 . . . . 10.0 112.738 -167.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -89.39 127.17 35.79 Favored 'General case' 0 C--N 1.328 -0.352 0 O-C-N 120.64 -1.506 . . . . 10.0 109.3 170.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -72.5 65.38 1.37 Allowed Glycine 0 CA--C 1.532 1.124 0 N-CA-C 113.879 0.312 . . . . 10.0 113.879 173.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 60.6 mt -79.67 -42.69 22.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 126.083 1.753 . . . . 10.0 108.725 166.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.4 ' CG1' ' HB ' ' A' ' 203' ' ' ILE . 79.8 t -126.31 133.4 24.93 Favored Pre-proline 0 N--CA 1.454 -0.264 0 C-N-CA 126.47 1.908 . . . . 10.0 109.364 -174.209 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -68.73 153.75 72.57 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 123.822 3.015 . . . . 10.0 111.456 -176.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 12.2 tp -43.1 -39.87 2.96 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.358 1.063 . . . . 10.0 112.199 171.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -48.28 -52.44 21.34 Favored 'General case' 0 CA--C 1.539 0.519 0 N-CA-C 114.673 1.361 . . . . 10.0 114.673 176.052 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . 0.4 ' HB ' ' CG1' ' A' ' 199' ' ' VAL . 14.0 mm -75.88 -40.53 38.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 124.434 1.094 . . . . 10.0 109.625 177.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.29 -49.79 42.08 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 118.61 0.641 . . . . 10.0 111.974 173.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 15.9 m -57.69 -47.08 83.35 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 126.046 1.738 . . . . 10.0 112.964 174.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.535 HD23 ' CD2' ' A' ' 12' ' ' TRP . 1.4 tm? -63.27 -52.33 62.48 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.958 0.903 . . . . 10.0 112.114 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 93.3 mt -52.58 -58.95 5.16 Favored 'General case' 0 C--O 1.227 -0.087 0 C-N-CA 124.293 1.037 . . . . 10.0 110.021 176.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -54.8 -43.73 73.17 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 117.766 -1.111 . . . . 10.0 112.912 177.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' MET . . . . . 0.574 ' HE2' ' HB3' ' A' ' 15' ' ' LEU . 4.6 tmm? -52.31 -53.2 47.4 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 120.277 1.399 . . . . 10.0 112.252 174.024 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 77.1 t -60.81 -48.13 90.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 124.525 1.13 . . . . 10.0 111.754 178.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 5.1 mp -56.74 -53.45 57.65 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.148 1.379 . . . . 10.0 111.712 175.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -55.68 -52.76 62.77 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.127 1.771 . . . . 10.0 111.594 178.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 46.0 t . . . . . 0 N--CA 1.479 1.012 0 C-N-CA 124.618 1.167 . . . . 10.0 110.705 173.788 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.338 0 CA-C-O 120.932 0.185 . . . . 10.0 112.929 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 35.6 t80 -43.94 -56.31 4.02 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.513 1.925 . . . . 10.0 112.723 168.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -58.98 -39.16 93.86 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 124.576 1.084 . . . . 10.0 113.114 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 24.7 mt -69.5 -27.92 65.61 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 115.792 1.775 . . . . 10.0 115.792 175.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 74.3 mt -63.35 -57.61 11.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 119.22 0.918 . . . . 10.0 108.634 165.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 32.2 tp -58.87 -64.66 0.86 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.924 0.89 . . . . 10.0 113.165 -172.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 84.2 mt -71.55 5.22 2.5 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 115.323 1.601 . . . . 10.0 115.323 -171.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.6 mtp-105 -112.36 0.38 15.64 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.199 1.0 . . . . 10.0 113.272 172.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 8.8 t -108.03 177.97 4.65 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 124.026 0.93 . . . . 10.0 111.015 174.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 227' ' ' ARG . . . . . 0.667 ' HD3' ' CD ' ' A' ' 166' ' ' GLU . 41.8 ttt180 -71.65 98.22 1.87 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.752 0.821 . . . . 10.0 110.91 170.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . 0.475 ' HB1' ' CD2' ' A' ' 42' ' ' PHE . . . -80.96 77.03 7.89 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.814 0.846 . . . . 10.0 112.123 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 40.09 102.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 128.857 2.863 . . . . 10.0 116.481 177.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . 0.482 0.3 OUTLIER 71.87 -55.46 0.66 Allowed 'General case' 0 C--O 1.242 0.699 0 C-N-CA 124.711 1.205 . . . . 10.0 110.591 -175.331 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -68.28 169.47 40.01 Favored Glycine 0 C--O 1.239 0.417 0 C-N-CA 129.757 3.551 . . . . 10.0 119.653 171.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.474 0 C-N-CA 128.458 2.703 . . . . 10.0 113.43 166.573 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 N--CA 1.476 0.87 0 CA-C-O 115.817 -2.039 . . . . 10.0 105.775 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 23.44 91.84 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 129.532 3.133 . . . . 10.0 117.276 160.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 28.6 65.05 0.11 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 128.301 2.641 . . . . 10.0 114.514 155.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 86.6 mt -56.44 137.98 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 126.396 1.878 . . . . 10.0 113.338 -158.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.652 HG21 ' HB3' ' A' ' 77' ' ' PRO . 7.6 t -136.8 -165.22 1.7 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 126.286 1.834 . . . . 10.0 114.021 -174.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 70.06 2.79 41.4 Favored Glycine 0 C--N 1.34 0.786 0 C-N-CA 127.443 2.449 . . . . 10.0 111.451 168.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -158.57 -51.32 0.01 OUTLIER Pre-proline 0 N--CA 1.443 -0.783 0 CA-C-O 114.263 -2.78 . . . . 10.0 116.649 -168.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -64.03 -60.6 0.15 Allowed 'Trans proline' 0 CA--C 1.528 0.185 0 CA-C-N 123.538 2.299 . . . . 10.0 113.205 -175.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.41 ' H ' ' CD ' ' A' ' 9' ' ' GLU . 7.9 pm0 -67.21 4.3 0.97 Allowed 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 127.886 2.475 . . . . 10.0 115.732 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.421 ' CG ' ' N ' ' A' ' 11' ' ' ILE . 11.1 p-90 -51.39 -43.07 61.8 Favored 'General case' 0 C--O 1.222 -0.361 0 O-C-N 121.455 -0.778 . . . . 10.0 112.617 176.43 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.421 ' N ' ' CG ' ' A' ' 10' ' ' TRP . 8.9 tt -60.83 -49.65 83.73 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.34 0 C-N-CA 123.926 0.89 . . . . 10.0 109.339 179.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . 0.536 ' CD2' HD23 ' A' ' 206' ' ' LEU . 2.6 m95 -55.4 -52.67 62.81 Favored 'General case' 0 C--O 1.224 -0.259 0 C-N-CA 123.407 0.683 . . . . 10.0 111.871 175.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.5 mt -57.34 -53.62 56.04 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 123.175 0.59 . . . . 10.0 112.198 177.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.86 -46.82 51.89 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.427 1.491 . . . . 10.0 113.268 173.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.575 ' HB3' ' HE2' ' A' ' 209' ' ' MET . 13.3 tp -65.68 -44.92 84.76 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 125.274 1.43 . . . . 10.0 113.012 179.154 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.49 -56.79 10.34 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 124.568 1.08 . . . . 10.0 111.588 166.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 22.3 m -49.22 -52.68 25.41 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.987 1.315 . . . . 10.0 112.373 174.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.42 -58.85 5.84 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.151 0.98 . . . . 10.0 112.19 177.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 93.0 mt -57.26 -49.03 77.35 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.686 0.794 . . . . 10.0 112.736 -179.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 52.8 mtt -58.83 -47.87 83.33 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.121 0.968 . . . . 10.0 111.101 177.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -57.13 -58.6 13.72 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 124.333 0.968 . . . . 10.0 113.99 173.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 80.8 mt -56.24 -45.52 79.96 Favored 'General case' 0 C--O 1.221 -0.426 0 CA-C-N 118.646 1.223 . . . . 10.0 112.112 176.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.08 -41.04 84.7 Favored Glycine 0 CA--C 1.531 1.093 0 O-C-N 120.929 -1.107 . . . . 10.0 113.652 173.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 22.1 m -60.06 -60.43 3.84 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.793 0.837 . . . . 10.0 110.831 171.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -52.22 -41.02 62.38 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.073 0.949 . . . . 10.0 110.958 179.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -55.8 -58.01 9.63 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.557 1.143 . . . . 10.0 112.991 172.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -59.65 -38.72 82.16 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 113.201 0.815 . . . . 10.0 113.201 178.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.401 ' C ' ' H ' ' A' ' 30' ' ' LYS . 11.8 mt -56.11 -67.42 0.3 Allowed 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.58 1.152 . . . . 10.0 113.627 169.131 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 t -76.37 40.93 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-O 123.77 1.747 . . . . 10.0 110.891 179.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.401 ' H ' ' C ' ' A' ' 28' ' ' LEU . 42.9 tttm -140.82 -44.82 0.39 Allowed 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 127.884 2.474 . . . . 10.0 109.35 171.187 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -73.02 23.15 0.88 Allowed Glycine 0 CA--C 1.529 0.928 0 N-CA-C 115.634 1.014 . . . . 10.0 115.634 173.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 37.3 mmm -59.54 -44.96 93.07 Favored 'General case' 0 C--O 1.223 -0.296 0 C-N-CA 127.136 2.174 . . . . 10.0 113.578 -179.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.72 -84.4 1.19 Allowed Glycine 0 CA--C 1.53 1.007 0 C-N-CA 123.718 0.675 . . . . 10.0 112.452 -170.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.8 t 33.04 88.79 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.242 0.682 0 C-N-CA 128.4 2.68 . . . . 10.0 116.961 166.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.7 m -79.62 -50.93 9.93 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.187 -1.37 . . . . 10.0 113.866 174.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -48.93 117.51 6.43 Favored Pre-proline 0 CA--C 1.537 0.454 0 O-C-N 124.719 1.262 . . . . 10.0 110.937 -172.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -58.57 -29.7 89.77 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 123.746 2.964 . . . . 10.0 113.669 179.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.26 -60.68 2.28 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.111 0.565 . . . . 10.0 111.441 176.192 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.16 -40.07 22.71 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 125.097 1.359 . . . . 10.0 113.565 171.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -46.53 -47.45 19.55 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 125.221 1.408 . . . . 10.0 113.463 172.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -57.74 -53.06 62.47 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.431 0.693 . . . . 10.0 110.99 176.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.476 ' CD2' ' HB1' ' A' ' 228' ' ' ALA . 44.2 m-85 -56.95 -50.22 73.28 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 123.09 0.556 . . . . 10.0 112.339 -179.115 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -54.33 -51.32 65.08 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 118.962 -0.542 . . . . 10.0 112.369 173.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.42 -62.02 1.91 Allowed 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 113.34 0.867 . . . . 10.0 113.34 177.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.6 mt -48.8 -56.98 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 124.842 1.257 . . . . 10.0 110.396 178.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.2 m -69.76 -16.45 63.31 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.085 1.354 . . . . 10.0 113.605 -172.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 30.1 m -87.0 -43.28 12.47 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 119.735 1.152 . . . . 10.0 111.842 174.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 20.1 mt -56.84 -40.94 76.98 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 112.937 0.718 . . . . 10.0 112.937 173.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 44.4 t -49.43 -62.05 2.85 Favored Pre-proline 0 CA--C 1.552 1.047 0 C-N-CA 124.473 1.109 . . . . 10.0 112.494 178.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -48.72 -46.92 22.62 Favored 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 124.593 3.529 . . . . 10.0 116.236 164.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.64 -45.7 93.07 Favored 'General case' 0 CA--C 1.548 0.901 0 CA-C-N 119.904 1.229 . . . . 10.0 113.875 -176.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 52.9 mt -57.58 -51.69 66.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 124.536 1.134 . . . . 10.0 109.376 172.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.5 -45.85 73.37 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.31 1.044 . . . . 10.0 113.056 176.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -50.52 -56.7 10.47 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 125.283 1.433 . . . . 10.0 112.228 171.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 13.2 m -49.72 -52.73 29.24 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 125.283 1.433 . . . . 10.0 110.674 177.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 32.4 mmt -68.67 -48.34 64.2 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 124.001 0.92 . . . . 10.0 113.025 -176.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -57.01 -40.16 76.11 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-O 117.083 -1.437 . . . . 10.0 113.214 173.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.8 tp -53.3 -54.54 34.82 Favored 'General case' 0 C--O 1.224 -0.272 0 CA-C-N 120.118 1.327 . . . . 10.0 111.334 170.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 24.0 p -51.64 -41.1 61.06 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 115.221 1.563 . . . . 10.0 115.221 178.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 57.9 mtm -66.86 -50.85 61.19 Favored 'General case' 0 C--N 1.334 -0.09 0 C-N-CA 123.597 0.759 . . . . 10.0 110.477 176.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.4 tp -48.58 -52.67 21.69 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.88 0.872 . . . . 10.0 112.926 172.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.5 mt -76.98 -5.53 49.01 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.358 1.063 . . . . 10.0 113.781 -177.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.29 -34.72 5.54 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 115.47 0.948 . . . . 10.0 115.47 174.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -49.29 -43.13 42.99 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 115.206 1.558 . . . . 10.0 115.206 -175.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.03 3.56 61.03 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 115.35 0.9 . . . . 10.0 115.35 -179.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.2 143.36 26.5 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 127.056 2.142 . . . . 10.0 109.038 171.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 t -145.47 171.13 15.09 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 124.023 0.929 . . . . 10.0 111.077 166.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.02 136.04 53.4 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 123.932 0.893 . . . . 10.0 109.711 179.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.437 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 58.9 t -129.52 129.61 23.21 Favored Pre-proline 0 C--N 1.329 -0.299 0 C-N-CA 125.109 1.364 . . . . 10.0 110.999 -176.096 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 69' ' ' VAL . 6.3 Cg_exo -80.76 116.22 3.16 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 N-CA-C 109.417 -1.032 . . . . 10.0 109.417 -178.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -156.75 164.4 38.16 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.824 0.676 . . . . 10.0 112.824 172.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.35 -81.96 0.14 Allowed Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.696 -0.961 . . . . 10.0 110.696 175.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.72 -3.4 0.7 Allowed Glycine 0 CA--C 1.527 0.836 0 N-CA-C 118.637 2.215 . . . . 10.0 118.637 170.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -151.56 -171.85 4.05 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 119.339 1.569 . . . . 10.0 112.257 -165.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -91.92 93.91 9.03 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 125.504 1.522 . . . . 10.0 111.088 -175.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.45 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 60.5 m-80 -89.51 120.82 69.62 Favored Pre-proline 0 N--CA 1.45 -0.431 0 N-CA-C 112.963 0.727 . . . . 10.0 112.963 -165.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.652 ' HB3' HG21 ' A' ' 5' ' ' THR . 76.6 Cg_exo -61.49 131.89 38.14 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 124.183 3.255 . . . . 10.0 112.199 171.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.6 mm -140.14 126.36 21.92 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 C-N-CA 125.999 1.72 . . . . 10.0 111.704 -179.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -93.66 85.04 4.74 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 122.812 1.291 . . . . 10.0 113.046 174.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 63.7 p-90 -59.35 -28.24 66.66 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 113.905 1.076 . . . . 10.0 113.905 174.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -55.39 -32.05 62.32 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.296 1.038 . . . . 10.0 111.811 178.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.433 ' HG3' HH11 ' A' ' 82' ' ' ARG . 23.4 ttm-85 -47.78 -40.63 21.38 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 126.888 2.075 . . . . 10.0 113.493 170.032 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 62.2 m-85 -86.47 -39.57 16.18 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.418 1.887 . . . . 10.0 111.755 -177.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -49.07 -47.85 44.62 Favored 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 124.555 1.142 . . . . 10.0 111.013 166.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -52.03 -71.97 0.06 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 126.471 1.908 . . . . 10.0 111.809 167.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 52.7 m0 -55.09 -33.77 63.08 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 124.095 0.958 . . . . 10.0 113.582 -170.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 24.3 tp -49.68 -40.44 40.05 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 126.285 1.834 . . . . 10.0 111.994 177.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -105.02 -40.37 5.92 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.378 0.671 . . . . 10.0 112.377 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 76.0 p -62.29 -42.16 99.12 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 120.664 1.575 . . . . 10.0 114.022 -179.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . 0.291 69.5 p -69.44 -41.32 16.85 Favored Pre-proline 0 CA--C 1.547 0.854 0 N-CA-C 114.959 1.466 . . . . 10.0 114.959 -176.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -55.11 -42.92 64.22 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 123.328 2.685 . . . . 10.0 115.137 166.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 55.0 mt -60.33 -47.39 86.22 Favored 'General case' 0 CA--C 1.544 0.724 0 O-C-N 121.507 -0.745 . . . . 10.0 111.677 176.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 6.1 tt -50.19 -49.37 52.72 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.723 1.609 . . . . 10.0 111.522 171.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.6 mp -57.26 -47.34 81.66 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.274 1.03 . . . . 10.0 113.135 170.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.86 -38.21 78.26 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 123.844 0.857 . . . . 10.0 112.9 178.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -52.32 -54.02 36.9 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 119.299 0.954 . . . . 10.0 111.21 169.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.33 -42.11 88.67 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 123.64 0.776 . . . . 10.0 112.144 -178.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.7 -54.68 38.59 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.98 0.912 . . . . 10.0 112.041 173.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.29 -41.18 79.32 Favored 'General case' 0 C--O 1.224 -0.24 0 C-N-CA 123.677 0.791 . . . . 10.0 112.714 174.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 32.2 tp -63.8 -38.56 91.55 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 114.436 1.273 . . . . 10.0 114.436 -179.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.2 t -94.79 1.41 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 125.005 1.322 . . . . 10.0 112.298 179.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.2 t70 48.6 53.5 12.08 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.864 1.666 . . . . 10.0 112.101 -174.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.28 145.88 47.59 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 119.951 -1.718 . . . . 10.0 112.47 -174.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.47 135.93 54.16 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 112.711 0.634 . . . . 10.0 112.711 175.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -42.89 -39.64 2.63 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.854 1.661 . . . . 10.0 113.471 175.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -47.33 -60.22 5.33 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 125.205 1.383 . . . . 10.0 115.213 169.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.5 p -62.1 -46.75 87.7 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 117.053 -1.451 . . . . 10.0 111.321 178.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 66.9 mt -48.48 -52.89 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 124.998 1.319 . . . . 10.0 111.11 178.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.1 tp -62.58 -51.37 67.62 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 112.528 0.566 . . . . 10.0 112.528 179.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.11 -44.86 42.66 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.47 0.708 . . . . 10.0 110.959 174.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.456 ' HA ' HD12 ' A' ' 111' ' ' LEU . 0.6 OUTLIER -59.62 -59.89 4.72 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 127.404 2.281 . . . . 10.0 114.79 174.981 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.8 t -61.04 -46.32 96.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 123.705 0.802 . . . . 10.0 111.411 -178.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -56.62 -50.35 63.7 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 123.674 0.655 . . . . 10.0 112.642 174.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -54.93 -46.62 74.97 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 113.696 0.998 . . . . 10.0 113.696 173.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -55.02 -49.27 71.94 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.48 0.712 . . . . 10.0 111.166 173.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -42.87 -54.57 5.05 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 125.06 1.314 . . . . 10.0 113.059 170.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 86.9 mt -56.11 -54.43 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 CA-C-O 118.281 -0.866 . . . . 10.0 111.327 173.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 1.7 ptt? -56.8 -45.29 82.32 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 119.692 1.133 . . . . 10.0 113.038 -174.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 1.7 mp . . . . . 0 N--CA 1.479 1.001 0 CA-C-N 119.051 0.841 . . . . 10.0 111.047 174.732 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 60.8 t . . . . . 0 N--CA 1.478 0.935 0 N-CA-C 110.14 -0.319 . . . . 10.0 110.14 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -50.79 -61.14 6.31 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 126.305 1.907 . . . . 10.0 112.646 171.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -42.83 -42.26 3.56 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 127.772 2.429 . . . . 10.0 113.208 176.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 47.7 mt -100.84 -6.81 24.27 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 115.531 1.678 . . . . 10.0 115.531 -175.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 17.0 m -69.65 116.71 10.36 Favored 'General case' 0 N--CA 1.465 0.294 0 O-C-N 120.14 -1.6 . . . . 10.0 110.398 -178.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.622 ' H ' ' HD3' ' A' ' 129' ' ' LYS . 0.2 OUTLIER -55.45 -49.6 72.05 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 128.2 2.6 . . . . 10.0 113.25 177.75 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 60.8 t -69.69 106.33 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 123.797 0.839 . . . . 10.0 110.103 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -46.87 -59.54 3.01 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 124.774 1.229 . . . . 10.0 114.089 -173.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 m -46.52 -42.05 15.1 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.488 1.515 . . . . 10.0 113.495 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -70.16 -24.61 63.18 Favored 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 114.958 1.466 . . . . 10.0 114.958 -178.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 69.0 mtp85 -54.12 -41.43 68.33 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 118.845 0.748 . . . . 10.0 110.839 176.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -69.73 -32.18 70.59 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.842 1.257 . . . . 10.0 114.217 176.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.8 t -54.84 -52.23 44.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 CA-C-N 119.013 0.824 . . . . 10.0 109.83 168.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 65.6 m95 -59.66 -49.87 76.06 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 113.458 0.911 . . . . 10.0 113.458 173.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 89.8 t90 -48.35 -48.59 36.36 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 119.504 1.047 . . . . 10.0 113.214 173.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.637 0 C-N-CA 124.203 1.001 . . . . 10.0 111.976 176.241 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.547 0.854 0 N-CA-C 112.971 0.73 . . . . 10.0 112.971 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 38.2 ttp -57.49 -53.7 55.2 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.275 1.03 . . . . 10.0 112.005 171.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 62.7 tp -53.51 -47.0 70.28 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.191 1.396 . . . . 10.0 111.852 178.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -50.53 -54.84 19.33 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.003 0.921 . . . . 10.0 112.407 170.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 54.5 mt -53.62 -55.05 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 123.762 0.825 . . . . 10.0 110.805 177.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 38.8 mt -57.16 -35.98 70.2 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 118.365 -0.826 . . . . 10.0 112.997 178.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -57.24 -58.26 9.02 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 124.068 0.947 . . . . 10.0 113.006 173.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.34 -40.89 85.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 CA-C-O 118.343 -0.837 . . . . 10.0 111.492 177.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 45.4 mt -56.83 -49.4 75.53 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 119.845 1.202 . . . . 10.0 112.14 171.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.469 ' HA ' ' HD2' ' A' ' 175' ' ' ARG . 11.9 t80 -76.97 -70.34 0.47 Allowed 'General case' 0 C--N 1.326 -0.447 0 O-C-N 120.022 -1.674 . . . . 10.0 112.887 -175.264 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -73.74 -21.87 60.07 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.567 1.147 . . . . 10.0 113.448 -174.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -87.8 -79.16 1.26 Allowed Glycine 0 CA--C 1.527 0.783 0 C-N-CA 123.666 0.651 . . . . 10.0 113.496 171.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -53.63 -32.4 51.15 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 126.299 1.839 . . . . 10.0 113.046 -166.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.2 m -52.08 -56.5 13.99 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 114.012 1.116 . . . . 10.0 114.012 172.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.4 p -53.67 -50.53 65.61 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 122.057 0.932 . . . . 10.0 112.281 -177.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 47.6 tttm -57.13 -46.05 83.0 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.197 0.999 . . . . 10.0 112.117 173.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.82 -47.46 80.24 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 114.545 1.313 . . . . 10.0 114.545 174.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -56.5 -11.29 1.22 Allowed 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 126.089 1.755 . . . . 10.0 114.228 177.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.2 m -107.1 6.64 29.08 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.416 1.886 . . . . 10.0 114.877 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 93.2 mmm -91.88 -92.63 0.15 Allowed 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 123.521 1.629 . . . . 10.0 114.191 -170.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -138.74 153.98 72.62 Favored Pre-proline 0 C--O 1.236 0.359 0 C-N-CA 129.802 3.241 . . . . 10.0 105.548 170.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -52.86 -46.22 35.24 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 122.3 2.0 . . . . 10.0 113.088 179.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.667 ' CD ' ' HD3' ' A' ' 227' ' ' ARG . 0.1 OUTLIER -52.97 -46.03 68.04 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 129.022 2.929 . . . . 10.0 113.276 173.578 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 91.7 t -69.26 -53.03 27.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 C-N-CA 124.02 0.928 . . . . 10.0 109.782 -178.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.09 -46.85 75.53 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.282 0.633 . . . . 10.0 111.923 177.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 60.5 p -60.02 -56.19 24.74 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.953 0.901 . . . . 10.0 112.67 174.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 62.0 m -57.22 -53.19 60.94 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.202 1.001 . . . . 10.0 113.004 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -49.59 -49.54 46.26 Favored 'General case' 0 C--O 1.221 -0.425 0 C-N-CA 123.289 0.636 . . . . 10.0 111.067 174.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -57.12 -48.41 78.72 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 114.671 1.36 . . . . 10.0 114.671 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 40.4 t -55.95 -49.63 74.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 CA-C-N 118.832 0.742 . . . . 10.0 110.476 176.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 94.1 mt -58.54 -51.65 68.99 Favored 'General case' 0 C--O 1.222 -0.392 0 N-CA-C 113.168 0.803 . . . . 10.0 113.168 175.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . 0.469 ' HD2' ' HA ' ' A' ' 153' ' ' PHE . 35.5 ttp180 -47.79 -47.76 30.7 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 126.824 2.05 . . . . 10.0 111.059 174.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 63.7 m-20 -58.53 -58.32 9.06 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 122.771 0.428 . . . . 10.0 111.286 174.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 59.5 t -51.85 -49.48 36.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 124.048 0.939 . . . . 10.0 111.449 179.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 35.3 m -55.74 -64.09 0.96 Allowed 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 128.428 2.691 . . . . 10.0 111.939 177.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 55.7 t -51.05 -49.56 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 124.541 1.136 . . . . 10.0 111.317 -179.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 79.6 t -59.76 -61.64 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 124.209 1.004 . . . . 10.0 112.198 177.07 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -57.86 -47.72 81.91 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 118.873 0.761 . . . . 10.0 112.287 -176.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 10.7 m95 . . . . . 0 N--CA 1.469 0.498 0 C-N-CA 123.878 0.871 . . . . 10.0 111.71 175.584 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 93.2 t . . . . . 0 N--CA 1.479 1.007 0 CA-C-O 119.252 -0.404 . . . . 10.0 111.442 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 52.1 t90 -55.46 -51.58 66.48 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.317 1.047 . . . . 10.0 112.498 174.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 34.4 tp -54.29 -45.63 72.56 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.878 1.271 . . . . 10.0 112.362 -178.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 15.4 pt -87.41 -5.05 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 115.17 1.544 . . . . 10.0 115.17 -177.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.49 -169.22 32.84 Favored Glycine 0 N--CA 1.451 -0.353 0 CA-C-O 122.545 1.08 . . . . 10.0 113.882 -168.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 23.2 t -53.21 -41.44 65.34 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 114.243 -0.979 . . . . 10.0 111.818 177.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -67.2 -17.05 64.66 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 115.659 1.726 . . . . 10.0 115.659 -175.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -130.99 -105.97 1.09 Allowed Glycine 0 CA--C 1.532 1.1 0 CA-C-N 120.381 1.446 . . . . 10.0 113.82 -172.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -89.42 127.15 35.8 Favored 'General case' 0 C--N 1.328 -0.352 0 O-C-N 120.64 -1.506 . . . . 10.0 109.349 168.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -72.46 65.36 1.36 Allowed Glycine 0 CA--C 1.532 1.124 0 N-CA-C 113.873 0.309 . . . . 10.0 113.873 173.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 60.7 mt -79.63 -42.74 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 126.083 1.753 . . . . 10.0 108.721 166.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.4 ' CG1' ' HB ' ' A' ' 203' ' ' ILE . 79.8 t -126.29 133.4 24.93 Favored Pre-proline 0 N--CA 1.454 -0.264 0 C-N-CA 126.502 1.921 . . . . 10.0 109.364 -174.179 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -68.78 153.82 72.33 Favored 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 123.751 2.967 . . . . 10.0 111.425 -176.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 12.2 tp -43.18 -39.75 3.03 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.281 1.033 . . . . 10.0 112.223 171.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -48.34 -52.39 21.82 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 114.705 1.372 . . . . 10.0 114.705 176.053 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . 0.4 ' HB ' ' CG1' ' A' ' 199' ' ' VAL . 14.0 mm -75.91 -40.48 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 124.378 1.071 . . . . 10.0 109.674 177.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -49.29 -49.85 41.84 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 118.553 0.615 . . . . 10.0 111.946 173.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 15.9 m -57.69 -47.08 83.36 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 126.046 1.738 . . . . 10.0 112.964 174.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.536 HD23 ' CD2' ' A' ' 12' ' ' TRP . 1.3 tm? -63.28 -52.33 62.45 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.977 0.911 . . . . 10.0 112.101 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 93.3 mt -52.58 -59.34 4.57 Favored 'General case' 0 C--N 1.335 -0.044 0 C-N-CA 124.265 1.026 . . . . 10.0 109.989 176.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -52.75 -47.35 67.51 Favored 'General case' 0 C--O 1.219 -0.53 0 CA-C-O 117.286 -1.34 . . . . 10.0 112.102 176.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' MET . . . . . 0.575 ' HE2' ' HB3' ' A' ' 15' ' ' LEU . 4.6 tmm? -50.84 -52.5 40.91 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 120.976 1.716 . . . . 10.0 112.974 174.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 80.4 t -60.86 -46.93 95.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 124.798 1.239 . . . . 10.0 111.524 178.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 4.1 mp -59.45 -51.57 69.32 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.496 1.518 . . . . 10.0 112.261 175.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -55.08 -55.97 25.06 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 127.245 2.218 . . . . 10.0 110.281 175.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 38.1 t . . . . . 0 N--CA 1.476 0.842 0 C-N-CA 124.529 1.131 . . . . 10.0 111.488 173.709 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.236 0 N-CA-C 111.731 -0.547 . . . . 10.0 111.731 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -44.03 -58.81 2.61 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 127.2 2.2 . . . . 10.0 112.357 166.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -55.41 -41.7 81.17 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 123.991 0.805 . . . . 10.0 114.319 179.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 23.8 mt -70.63 -26.73 63.61 Favored 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 115.505 1.668 . . . . 10.0 115.505 178.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 74.0 mt -63.2 -57.56 11.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 108.741 -0.837 . . . . 10.0 108.741 165.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 32.1 tp -58.77 -64.68 0.85 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.901 0.88 . . . . 10.0 113.183 -172.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 84.0 mt -71.53 5.19 2.51 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 115.315 1.598 . . . . 10.0 115.315 -171.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.6 mtp-105 -112.31 0.33 15.67 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.231 1.012 . . . . 10.0 113.324 172.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 8.8 t -108.04 177.99 4.65 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 124.014 0.926 . . . . 10.0 111.013 174.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 227' ' ' ARG . . . . . 0.667 ' HD3' ' CD ' ' A' ' 166' ' ' GLU . 41.8 ttt180 -71.64 98.19 1.86 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.773 0.829 . . . . 10.0 110.924 170.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . 0.476 ' HB1' ' CD2' ' A' ' 42' ' ' PHE . . . -80.96 77.07 7.89 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.836 0.854 . . . . 10.0 112.073 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 40.15 102.25 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 128.893 2.877 . . . . 10.0 116.436 177.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . 0.483 0.3 OUTLIER 71.88 -55.47 0.66 Allowed 'General case' 0 C--O 1.242 0.67 0 C-N-CA 124.692 1.197 . . . . 10.0 110.644 -175.355 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -68.25 169.43 39.98 Favored Glycine 0 C--O 1.239 0.417 0 C-N-CA 129.784 3.564 . . . . 10.0 119.629 171.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.461 0 C-N-CA 128.443 2.697 . . . . 10.0 113.409 166.61 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 N--CA 1.477 0.876 0 CA-C-O 115.801 -2.047 . . . . 10.0 105.812 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 23.38 91.92 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 129.647 3.179 . . . . 10.0 117.197 160.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 28.55 65.1 0.1 Allowed 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 128.302 2.641 . . . . 10.0 114.496 155.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 86.5 mt -56.48 137.98 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 126.379 1.872 . . . . 10.0 113.343 -158.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.651 HG21 ' HB3' ' A' ' 77' ' ' PRO . 7.6 t -136.76 -165.16 1.69 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 126.312 1.845 . . . . 10.0 114.025 -174.347 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 69.98 2.81 40.78 Favored Glycine 0 C--N 1.34 0.792 0 C-N-CA 127.477 2.465 . . . . 10.0 111.526 168.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -158.56 -51.4 0.01 OUTLIER Pre-proline 0 N--CA 1.443 -0.783 0 CA-C-O 114.284 -2.77 . . . . 10.0 116.665 -168.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_exo -63.91 -60.73 0.14 Allowed 'Trans proline' 0 N--CA 1.465 -0.185 0 CA-C-N 123.533 2.297 . . . . 10.0 113.201 -175.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.411 ' H ' ' CD ' ' A' ' 9' ' ' GLU . 7.9 pm0 -67.13 4.26 0.96 Allowed 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 127.865 2.466 . . . . 10.0 115.746 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.422 ' CG ' ' N ' ' A' ' 11' ' ' ILE . 11.1 p-90 -51.35 -43.15 61.72 Favored 'General case' 0 C--O 1.223 -0.34 0 O-C-N 121.487 -0.758 . . . . 10.0 112.585 176.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.422 ' N ' ' CG ' ' A' ' 10' ' ' TRP . 8.9 tt -60.83 -49.64 83.78 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.338 0 C-N-CA 123.883 0.873 . . . . 10.0 109.287 179.447 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . 0.535 ' CD2' HD23 ' A' ' 206' ' ' LEU . 2.6 m95 -55.38 -52.65 62.85 Favored 'General case' 0 C--O 1.224 -0.261 0 C-N-CA 123.402 0.681 . . . . 10.0 111.84 175.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 91.0 mt -57.35 -53.65 55.69 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 123.19 0.596 . . . . 10.0 112.178 177.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.88 -46.79 52.02 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.387 1.475 . . . . 10.0 113.295 173.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.575 ' HB3' ' HE2' ' A' ' 209' ' ' MET . 13.3 tp -65.64 -44.96 84.79 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 125.282 1.433 . . . . 10.0 112.999 179.147 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -50.82 -54.7 20.98 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 124.297 0.951 . . . . 10.0 112.016 166.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 22.3 m -50.06 -52.67 32.59 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.961 1.304 . . . . 10.0 112.481 173.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.44 -58.82 5.97 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.181 0.992 . . . . 10.0 112.159 177.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 94.1 mt -57.39 -51.31 69.93 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.716 0.806 . . . . 10.0 112.695 -179.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.9 mpp? -57.8 -44.95 86.67 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 119.073 0.851 . . . . 10.0 111.967 176.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -58.5 -58.47 14.42 Favored Glycine 0 CA--C 1.53 1.03 0 CA-C-O 119.267 -0.741 . . . . 10.0 113.474 174.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 80.7 mt -56.24 -46.01 79.77 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-N 118.37 1.085 . . . . 10.0 112.089 175.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.38 -42.48 74.74 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 124.942 1.258 . . . . 10.0 113.179 173.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 28.6 m -61.95 -58.6 7.29 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.86 0.864 . . . . 10.0 111.373 171.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -52.3 -40.94 62.48 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.017 0.927 . . . . 10.0 110.976 177.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -55.76 -58.11 9.22 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.617 1.167 . . . . 10.0 112.943 172.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.1 m-30 -59.63 -38.61 81.84 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 113.245 0.831 . . . . 10.0 113.245 178.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.401 ' C ' ' H ' ' A' ' 30' ' ' LYS . 11.8 mt -56.23 -67.37 0.3 Allowed 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.58 1.152 . . . . 10.0 113.614 169.119 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 t -76.37 40.92 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 CA-C-O 123.745 1.736 . . . . 10.0 110.862 179.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.401 ' H ' ' C ' ' A' ' 28' ' ' LEU . 42.9 tttm -140.85 -44.8 0.39 Allowed 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 127.862 2.465 . . . . 10.0 109.317 171.164 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -73.01 23.15 0.88 Allowed Glycine 0 CA--C 1.529 0.958 0 N-CA-C 115.626 1.01 . . . . 10.0 115.626 173.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 37.3 mmm -59.53 -44.94 93.04 Favored 'General case' 0 C--O 1.224 -0.277 0 C-N-CA 127.101 2.161 . . . . 10.0 113.594 -179.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.68 -84.4 1.19 Allowed Glycine 0 CA--C 1.53 1.007 0 C-N-CA 123.709 0.671 . . . . 10.0 112.507 -170.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.8 t 33.03 88.78 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.242 0.706 0 C-N-CA 128.395 2.678 . . . . 10.0 116.956 166.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.0 m -79.63 -50.82 10.09 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.184 -1.371 . . . . 10.0 113.94 174.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -49.0 117.55 6.54 Favored Pre-proline 0 CA--C 1.536 0.418 0 O-C-N 124.753 1.283 . . . . 10.0 110.902 -172.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -58.56 -29.64 89.54 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 123.757 2.971 . . . . 10.0 113.701 179.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.38 -60.64 2.29 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.089 0.556 . . . . 10.0 111.402 176.231 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.13 -40.13 22.74 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 125.085 1.354 . . . . 10.0 113.54 171.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -46.48 -47.44 19.28 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.208 1.403 . . . . 10.0 113.468 172.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -57.75 -53.07 62.35 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.495 0.718 . . . . 10.0 110.94 176.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.477 ' CD2' ' HB1' ' A' ' 228' ' ' ALA . 43.9 m-85 -56.98 -50.22 73.33 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 123.102 0.561 . . . . 10.0 112.321 -179.075 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -54.39 -51.27 65.36 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 118.962 -0.542 . . . . 10.0 112.369 173.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.42 -61.98 1.93 Allowed 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 113.419 0.896 . . . . 10.0 113.419 177.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.5 mt -48.65 -57.48 1.54 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 C-N-CA 124.869 1.268 . . . . 10.0 110.349 178.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.5 m -68.56 -17.87 64.23 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.109 1.364 . . . . 10.0 113.672 -172.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 27.4 m -87.14 -40.48 14.59 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.436 1.095 . . . . 10.0 112.123 174.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 23.7 mt -59.45 -42.0 90.94 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 121.321 -0.862 . . . . 10.0 112.573 171.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 24.7 t -43.24 -61.16 1.95 Allowed Pre-proline 0 N--CA 1.48 1.047 0 C-N-CA 125.57 1.548 . . . . 10.0 113.625 176.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -70.95 -28.71 19.18 Favored 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 123.135 2.557 . . . . 10.0 114.205 174.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.45 -46.24 87.17 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-N 120.709 1.595 . . . . 10.0 113.363 177.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 56.3 mt -56.14 -51.7 59.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 124.414 1.085 . . . . 10.0 109.248 171.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.65 -43.5 76.33 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 113.484 0.92 . . . . 10.0 113.484 175.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -50.96 -55.89 15.06 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 120.853 1.661 . . . . 10.0 111.818 171.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 10.6 m -49.74 -52.79 29.03 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.359 1.464 . . . . 10.0 110.877 177.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.41 ' HG3' ' CB ' ' A' ' 85' ' ' ASP . 32.6 mmt -68.88 -48.11 64.2 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 123.964 0.906 . . . . 10.0 112.938 -176.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -55.58 -41.97 74.11 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 120.342 1.428 . . . . 10.0 112.974 172.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.8 tp -53.25 -54.59 34.01 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-N 119.697 1.135 . . . . 10.0 111.281 171.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 24.0 p -51.67 -41.06 61.12 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 115.191 1.552 . . . . 10.0 115.191 179.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 55.6 mtm -66.86 -50.83 61.25 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 123.562 0.745 . . . . 10.0 110.479 176.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.5 tp -48.55 -52.7 21.4 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.846 0.858 . . . . 10.0 112.952 172.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.5 mt -76.97 -5.52 48.95 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.331 1.053 . . . . 10.0 113.799 -177.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.28 -34.77 5.5 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 115.55 0.98 . . . . 10.0 115.55 174.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 75.3 t80 -49.22 -43.09 42.22 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 115.258 1.577 . . . . 10.0 115.258 -176.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.1 3.59 61.18 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 115.348 0.899 . . . . 10.0 115.348 -179.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.25 143.43 26.42 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 127.035 2.134 . . . . 10.0 109.011 171.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 t -145.55 171.1 15.17 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 124.012 0.925 . . . . 10.0 111.045 166.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.0 136.08 53.37 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 123.853 0.861 . . . . 10.0 109.698 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.436 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 59.0 t -129.54 129.56 23.19 Favored Pre-proline 0 C--N 1.329 -0.317 0 C-N-CA 125.068 1.347 . . . . 10.0 110.988 -176.059 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 69' ' ' VAL . 6.3 Cg_exo -80.76 116.25 3.16 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 N-CA-C 109.411 -1.034 . . . . 10.0 109.411 -178.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -156.71 164.38 38.2 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 112.818 0.673 . . . . 10.0 112.818 172.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.43 -81.99 0.15 Allowed Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.644 -0.983 . . . . 10.0 110.644 175.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.76 -3.42 0.69 Allowed Glycine 0 CA--C 1.526 0.776 0 N-CA-C 118.673 2.229 . . . . 10.0 118.673 170.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -151.58 -171.89 4.06 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 119.343 1.571 . . . . 10.0 112.25 -165.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -91.86 93.91 9.06 Favored 'General case' 0 CA--C 1.519 -0.237 0 C-N-CA 125.514 1.526 . . . . 10.0 111.061 -175.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.449 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 60.4 m-80 -89.49 120.81 69.64 Favored Pre-proline 0 N--CA 1.45 -0.465 0 N-CA-C 112.982 0.734 . . . . 10.0 112.982 -165.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.651 ' HB3' HG21 ' A' ' 5' ' ' THR . 76.1 Cg_exo -61.52 131.88 38.02 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 124.205 3.27 . . . . 10.0 112.199 171.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.5 mm -140.09 126.33 22.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 C-N-CA 126.059 1.744 . . . . 10.0 111.716 -179.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -93.64 85.01 4.75 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 122.628 1.204 . . . . 10.0 113.053 174.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 63.8 p-90 -59.4 -28.25 66.74 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 113.896 1.072 . . . . 10.0 113.896 174.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -55.28 -26.02 37.67 Favored 'General case' 0 CA--C 1.562 1.415 0 C-N-CA 124.277 1.031 . . . . 10.0 111.773 178.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -45.42 -64.86 0.63 Allowed 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 125.297 1.439 . . . . 10.0 110.618 166.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 36.1 m-85 -62.67 -38.55 90.77 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 126.563 1.945 . . . . 10.0 110.936 -174.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -52.7 -49.86 64.48 Favored 'General case' 0 CA--C 1.555 1.159 0 CA-C-N 119.334 0.97 . . . . 10.0 112.048 168.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.41 ' CB ' ' HG3' ' A' ' 56' ' ' MET . 0.0 OUTLIER -60.06 -62.78 1.62 Allowed 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.476 1.111 . . . . 10.0 111.696 171.86 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 54.5 m0 -53.38 -37.06 62.09 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 125.821 1.648 . . . . 10.0 112.693 -174.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 28.2 tp -50.23 -41.44 50.05 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 126.275 1.83 . . . . 10.0 111.864 177.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -103.02 -40.7 6.38 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.883 0.873 . . . . 10.0 112.546 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 79.3 p -61.55 -42.45 98.86 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-N 120.553 1.524 . . . . 10.0 113.763 -179.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . 0.322 75.5 p -65.77 -47.69 65.05 Favored Pre-proline 0 N--CA 1.477 0.913 0 CA-C-O 117.586 -1.197 . . . . 10.0 114.22 -178.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -53.0 -42.68 62.75 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 123.232 2.621 . . . . 10.0 115.442 169.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 51.3 mt -59.75 -48.04 83.26 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 121.314 -0.866 . . . . 10.0 111.935 176.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.81 -37.49 84.61 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 119.586 1.085 . . . . 10.0 112.416 175.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.4 mp -56.39 -48.99 75.76 Favored 'General case' 0 CA--C 1.545 0.782 0 O-C-N 121.009 -1.057 . . . . 10.0 111.828 165.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.81 -38.24 78.17 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 119.164 0.893 . . . . 10.0 112.863 178.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -52.33 -54.06 36.45 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 119.322 0.965 . . . . 10.0 111.163 169.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.27 -42.07 88.97 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.63 0.772 . . . . 10.0 112.172 -178.569 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.76 -54.63 39.48 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 123.917 0.887 . . . . 10.0 112.066 173.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.38 -41.16 79.69 Favored 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 123.687 0.795 . . . . 10.0 112.681 174.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.8 tp -63.73 -38.54 91.5 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 114.485 1.291 . . . . 10.0 114.485 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.1 t -94.83 1.42 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 125.035 1.334 . . . . 10.0 112.308 179.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.2 t70 48.62 53.45 12.18 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.834 1.654 . . . . 10.0 112.1 -174.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.27 145.85 47.62 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 119.969 -1.707 . . . . 10.0 112.464 -174.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.42 135.93 53.96 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 112.697 0.629 . . . . 10.0 112.697 175.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -42.89 -39.68 2.64 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.877 1.671 . . . . 10.0 113.499 175.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -47.28 -60.22 5.29 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 125.103 1.335 . . . . 10.0 115.309 169.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.5 p -62.05 -46.82 87.46 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 117.098 -1.429 . . . . 10.0 111.332 178.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 67.0 mt -48.38 -52.92 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 125.038 1.335 . . . . 10.0 111.124 178.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.4 tp -62.67 -51.25 67.97 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 112.544 0.572 . . . . 10.0 112.544 179.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.2 -44.86 43.55 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.479 0.712 . . . . 10.0 110.912 174.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.455 ' HA ' HD12 ' A' ' 111' ' ' LEU . 0.6 OUTLIER -59.59 -59.86 4.77 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 127.385 2.274 . . . . 10.0 114.8 174.949 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.1 t -61.09 -46.36 96.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 123.668 0.787 . . . . 10.0 111.362 -178.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -56.56 -50.41 63.19 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 123.68 0.657 . . . . 10.0 112.602 174.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -54.85 -46.54 74.66 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 113.278 0.844 . . . . 10.0 113.278 173.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -55.22 -48.64 73.6 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.315 1.046 . . . . 10.0 111.202 173.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -42.99 -55.33 4.9 Favored Glycine 0 CA--C 1.534 1.223 0 C-N-CA 125.1 1.333 . . . . 10.0 113.18 169.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 85.1 mt -56.91 -52.22 58.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 123.555 0.742 . . . . 10.0 111.974 174.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 54.0 ttp -48.68 -58.03 5.37 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.821 1.249 . . . . 10.0 112.226 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 40.2 mm . . . . . 0 N--CA 1.473 0.716 0 O-C-N 121.566 -0.709 . . . . 10.0 111.891 179.548 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 67.8 t . . . . . 0 N--CA 1.476 0.849 0 N-CA-C 110.377 -0.231 . . . . 10.0 110.377 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -49.15 -60.53 6.08 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 125.871 1.7 . . . . 10.0 112.212 171.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -49.57 -37.47 27.46 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.497 1.919 . . . . 10.0 113.635 -179.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 50.1 mt -99.37 -6.49 27.72 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 115.207 1.558 . . . . 10.0 115.207 -178.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 16.9 m -69.64 116.73 10.37 Favored 'General case' 0 N--CA 1.465 0.275 0 O-C-N 120.228 -1.545 . . . . 10.0 110.389 -178.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.621 ' H ' ' HD3' ' A' ' 129' ' ' LYS . 0.1 OUTLIER -55.52 -49.59 72.21 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 128.222 2.609 . . . . 10.0 113.268 177.731 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 60.6 t -69.65 106.32 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 123.791 0.836 . . . . 10.0 110.085 179.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -46.87 -59.55 3.01 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 124.807 1.243 . . . . 10.0 114.048 -173.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 m -46.5 -42.1 15.1 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.5 1.52 . . . . 10.0 113.484 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -70.18 -24.53 63.15 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 114.952 1.464 . . . . 10.0 114.952 -178.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 69.4 mtp85 -53.81 -42.02 67.94 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 118.887 0.767 . . . . 10.0 110.682 176.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -69.47 -32.03 70.68 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.805 1.242 . . . . 10.0 114.27 176.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.8 t -55.11 -52.09 48.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-N 119.055 0.843 . . . . 10.0 109.7 168.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 67.8 m95 -61.38 -44.11 97.72 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 114.287 1.217 . . . . 10.0 114.287 174.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 88.0 t90 -53.34 -48.15 68.74 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 124.254 1.022 . . . . 10.0 112.704 172.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.557 0 C-N-CA 123.984 0.914 . . . . 10.0 111.602 177.071 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.792 0 N-CA-C 112.633 0.605 . . . . 10.0 112.633 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 10.3 tmm? -52.24 -54.76 27.14 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.96 1.704 . . . . 10.0 111.903 172.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 61.4 tp -56.89 -48.94 77.0 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.994 1.718 . . . . 10.0 112.808 178.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 70.2 t80 -49.35 -53.79 20.53 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.131 0.972 . . . . 10.0 111.631 171.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 52.2 mt -54.05 -55.14 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 123.824 0.85 . . . . 10.0 110.774 177.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 19.4 mt -57.24 -35.37 69.62 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 118.055 -0.974 . . . . 10.0 113.461 177.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -57.26 -58.21 9.22 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 119.398 0.999 . . . . 10.0 113.036 172.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.42 -40.91 85.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-O 118.263 -0.875 . . . . 10.0 111.408 177.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 44.9 mt -56.8 -49.39 75.51 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 119.907 1.231 . . . . 10.0 112.148 171.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.469 ' HA ' ' HD2' ' A' ' 175' ' ' ARG . 11.9 t80 -76.95 -70.33 0.47 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 120.092 -1.63 . . . . 10.0 112.869 -175.248 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -73.78 -21.87 60.03 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.596 1.158 . . . . 10.0 113.454 -174.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -87.88 -79.07 1.26 Allowed Glycine 0 CA--C 1.527 0.784 0 C-N-CA 123.6 0.619 . . . . 10.0 113.532 171.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -53.59 -32.4 50.92 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 126.266 1.826 . . . . 10.0 113.08 -166.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.2 m -52.15 -56.44 14.54 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 113.996 1.109 . . . . 10.0 113.996 172.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.6 p -53.65 -50.57 65.47 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 122.126 0.965 . . . . 10.0 112.325 -177.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 47.6 tttm -57.11 -46.06 82.92 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.165 0.986 . . . . 10.0 112.118 173.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.86 -47.49 80.27 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 114.465 1.283 . . . . 10.0 114.465 174.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -56.41 -11.34 1.21 Allowed 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.097 1.759 . . . . 10.0 114.249 177.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.1 m -107.07 6.64 29.13 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.396 1.878 . . . . 10.0 114.891 -179.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 93.3 mmm -91.89 -92.69 0.15 Allowed 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 123.499 1.619 . . . . 10.0 114.132 -170.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -138.67 153.96 72.72 Favored Pre-proline 0 C--O 1.236 0.349 0 C-N-CA 129.807 3.243 . . . . 10.0 105.529 170.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -52.83 -46.22 35.19 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.305 2.003 . . . . 10.0 113.064 179.018 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.666 ' CD ' ' HD3' ' A' ' 227' ' ' ARG . 0.1 OUTLIER -53.02 -46.04 68.24 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 129.006 2.922 . . . . 10.0 113.27 173.635 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 92.5 t -69.16 -53.09 27.51 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.215 0 C-N-CA 124.1 0.96 . . . . 10.0 109.798 -178.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.1 -46.89 75.56 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.273 0.629 . . . . 10.0 111.902 177.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 60.2 p -59.94 -56.21 24.54 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.932 0.893 . . . . 10.0 112.68 174.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 61.8 m -57.23 -53.16 61.22 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.169 0.988 . . . . 10.0 113.059 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -49.55 -49.47 46.13 Favored 'General case' 0 C--O 1.221 -0.438 0 C-N-CA 123.312 0.645 . . . . 10.0 111.132 174.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -57.19 -48.4 78.84 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 114.618 1.34 . . . . 10.0 114.618 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 40.5 t -56.03 -49.58 74.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-N 118.808 0.731 . . . . 10.0 110.462 176.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 93.9 mt -58.58 -51.6 69.21 Favored 'General case' 0 C--O 1.222 -0.394 0 N-CA-C 113.218 0.821 . . . . 10.0 113.218 175.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . 0.469 ' HD2' ' HA ' ' A' ' 153' ' ' PHE . 35.5 ttp180 -47.76 -47.79 30.38 Favored 'General case' 0 C--O 1.224 -0.265 0 C-N-CA 126.807 2.043 . . . . 10.0 111.078 174.411 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 63.7 m-20 -58.48 -58.35 8.94 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 122.794 0.438 . . . . 10.0 111.274 174.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 59.7 t -51.95 -48.81 39.82 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 C-N-CA 124.082 0.953 . . . . 10.0 111.457 179.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 28.8 m -57.25 -62.81 1.5 Allowed 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 128.129 2.572 . . . . 10.0 111.976 178.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 55.5 t -51.32 -50.17 28.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 C-N-CA 124.572 1.149 . . . . 10.0 111.079 -179.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 75.6 t -58.85 -60.6 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 124.053 0.941 . . . . 10.0 112.212 177.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -58.34 -48.47 80.45 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 118.663 0.665 . . . . 10.0 112.085 -177.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 9.0 m95 . . . . . 0 N--CA 1.468 0.458 0 C-N-CA 124.04 0.936 . . . . 10.0 112.759 177.302 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 86.9 t . . . . . 0 N--CA 1.478 0.947 0 CA-C-O 119.561 -0.257 . . . . 10.0 111.587 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 25.9 t90 -55.44 -53.22 58.96 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.895 1.278 . . . . 10.0 112.466 175.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 9.7 tt -56.45 -44.2 80.25 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.897 0.879 . . . . 10.0 112.675 -178.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 14.7 pt -84.61 -5.78 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 N-CA-C 115.069 1.507 . . . . 10.0 115.069 -178.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.32 -169.25 33.08 Favored Glycine 0 N--CA 1.45 -0.374 0 CA-C-O 122.522 1.068 . . . . 10.0 113.978 -168.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 23.2 t -53.2 -40.92 64.79 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 114.236 -0.982 . . . . 10.0 111.821 177.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -54.78 -31.64 59.08 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 128.472 2.709 . . . . 10.0 115.209 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -131.3 -103.89 0.97 Allowed Glycine 0 CA--C 1.529 0.943 0 CA-C-N 119.441 1.019 . . . . 10.0 113.58 -167.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -89.46 127.14 35.81 Favored 'General case' 0 C--N 1.329 -0.323 0 O-C-N 120.666 -1.491 . . . . 10.0 109.3 169.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -72.43 65.3 1.35 Allowed Glycine 0 CA--C 1.533 1.165 0 N-CA-C 113.91 0.324 . . . . 10.0 113.91 173.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 60.8 mt -79.58 -42.69 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 C-N-CA 126.031 1.732 . . . . 10.0 108.748 166.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 79.4 t -126.31 133.41 24.94 Favored Pre-proline 0 N--CA 1.455 -0.22 0 C-N-CA 126.413 1.885 . . . . 10.0 109.353 -174.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -68.72 153.83 72.46 Favored 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 123.791 2.994 . . . . 10.0 111.444 -176.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 12.2 tp -43.24 -39.73 3.12 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.399 1.08 . . . . 10.0 112.142 171.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -48.43 -52.32 22.63 Favored 'General case' 0 CA--C 1.539 0.519 0 N-CA-C 114.669 1.359 . . . . 10.0 114.669 176.08 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 14.0 mm -75.93 -40.55 38.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 124.422 1.089 . . . . 10.0 109.625 177.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -49.27 -49.84 41.68 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-O 121.446 0.641 . . . . 10.0 111.921 173.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 16.2 m -57.7 -47.0 83.61 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 126.047 1.739 . . . . 10.0 112.991 174.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.535 HD23 ' CD2' ' A' ' 12' ' ' TRP . 1.3 tm? -63.38 -52.33 62.12 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.966 0.906 . . . . 10.0 112.094 179.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 93.4 mt -52.54 -59.06 4.9 Favored 'General case' 0 C--O 1.228 -0.07 0 C-N-CA 124.321 1.048 . . . . 10.0 109.944 176.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -54.02 -41.84 68.46 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 117.938 -1.029 . . . . 10.0 113.235 176.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' MET . . . . . 0.575 ' HE2' ' HB3' ' A' ' 15' ' ' LEU . 4.6 tmm? -55.66 -53.05 61.27 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 120.265 1.393 . . . . 10.0 112.086 173.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 79.9 t -60.95 -45.6 98.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 124.783 1.233 . . . . 10.0 111.603 178.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 4.2 mp -59.58 -51.42 69.92 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.314 1.446 . . . . 10.0 112.003 175.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -57.75 -52.72 64.31 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.04 1.336 . . . . 10.0 111.431 176.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 39.2 t . . . . . 0 N--CA 1.479 0.992 0 C-N-CA 124.601 1.16 . . . . 10.0 111.553 172.965 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.287 0 CA-C-O 120.903 0.168 . . . . 10.0 112.96 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -45.6 -57.76 3.94 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 126.624 1.97 . . . . 10.0 112.539 170.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -56.99 -40.81 91.81 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 124.057 0.837 . . . . 10.0 113.857 178.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 24.4 mt -70.41 -27.12 64.04 Favored 'General case' 0 CA--C 1.513 -0.464 0 N-CA-C 115.649 1.722 . . . . 10.0 115.649 177.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 74.0 mt -63.34 -57.54 11.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 108.687 -0.857 . . . . 10.0 108.687 165.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 32.0 tp -58.77 -64.71 0.84 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.905 0.882 . . . . 10.0 113.187 -172.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 84.4 mt -71.53 5.16 2.52 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 115.27 1.582 . . . . 10.0 115.27 -171.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.6 mtp-105 -112.31 0.33 15.67 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.228 1.011 . . . . 10.0 113.242 172.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 8.8 t -108.06 177.98 4.65 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 124.038 0.935 . . . . 10.0 111.026 174.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 227' ' ' ARG . . . . . 0.666 ' HD3' ' CD ' ' A' ' 166' ' ' GLU . 41.8 ttt180 -71.65 98.19 1.86 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.732 0.813 . . . . 10.0 110.935 170.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . 0.477 ' HB1' ' CD2' ' A' ' 42' ' ' PHE . . . -80.86 76.97 7.77 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.896 0.878 . . . . 10.0 112.128 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 40.12 102.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 128.857 2.863 . . . . 10.0 116.464 177.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . 0.483 0.3 OUTLIER 71.86 -55.51 0.66 Allowed 'General case' 0 C--O 1.242 0.662 0 C-N-CA 124.705 1.202 . . . . 10.0 110.631 -175.331 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -68.24 169.5 39.8 Favored Glycine 0 C--O 1.239 0.429 0 C-N-CA 129.757 3.551 . . . . 10.0 119.645 171.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.474 0 C-N-CA 128.49 2.716 . . . . 10.0 113.429 166.585 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 N--CA 1.476 0.87 0 CA-C-O 115.799 -2.048 . . . . 10.0 105.83 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 23.39 91.88 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 129.588 3.155 . . . . 10.0 117.203 160.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 28.63 65.04 0.11 Allowed 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 128.322 2.649 . . . . 10.0 114.48 155.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 86.6 mt -56.48 137.97 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 126.396 1.878 . . . . 10.0 113.315 -158.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.652 HG21 ' HB3' ' A' ' 77' ' ' PRO . 7.6 t -136.75 -165.26 1.71 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 126.327 1.851 . . . . 10.0 114.015 -174.332 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 70.06 2.78 41.34 Favored Glycine 0 C--N 1.34 0.762 0 C-N-CA 127.464 2.459 . . . . 10.0 111.485 168.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -158.52 -51.37 0.01 OUTLIER Pre-proline 0 N--CA 1.443 -0.783 0 CA-C-O 114.26 -2.781 . . . . 10.0 116.619 -168.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -63.94 -60.61 0.15 Allowed 'Trans proline' 0 N--CA 1.465 -0.202 0 CA-C-N 123.55 2.303 . . . . 10.0 113.25 -175.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.411 ' H ' ' CD ' ' A' ' 9' ' ' GLU . 7.9 pm0 -67.25 4.3 0.99 Allowed 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 127.839 2.456 . . . . 10.0 115.755 179.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.422 ' CG ' ' N ' ' A' ' 11' ' ' ILE . 11.1 p-90 -51.36 -43.1 61.74 Favored 'General case' 0 C--O 1.222 -0.361 0 O-C-N 121.5 -0.75 . . . . 10.0 112.621 176.427 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.422 ' N ' ' CG ' ' A' ' 10' ' ' TRP . 8.9 tt -60.88 -49.56 84.14 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.34 0 C-N-CA 123.878 0.871 . . . . 10.0 109.336 179.407 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . 0.535 ' CD2' HD23 ' A' ' 206' ' ' LEU . 2.6 m95 -55.44 -52.61 63.02 Favored 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 123.387 0.675 . . . . 10.0 111.887 175.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.6 mt -57.39 -53.53 57.06 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 123.153 0.581 . . . . 10.0 112.231 177.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.96 -46.75 52.69 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.378 1.471 . . . . 10.0 113.31 173.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.575 ' HB3' ' HE2' ' A' ' 209' ' ' MET . 13.3 tp -65.6 -44.95 84.99 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 125.345 1.458 . . . . 10.0 113.029 179.056 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.54 -56.72 10.57 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 124.508 1.051 . . . . 10.0 111.441 166.061 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.5 m -49.6 -52.46 30.2 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.877 1.271 . . . . 10.0 112.186 174.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.43 -58.83 5.94 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.174 0.99 . . . . 10.0 112.198 177.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 93.5 mt -57.28 -49.06 77.29 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.686 0.794 . . . . 10.0 112.695 -179.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.451 ' SD ' ' HB1' ' A' ' 53' ' ' ALA . 45.6 mtt -59.02 -46.62 87.75 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.418 1.087 . . . . 10.0 111.388 177.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -58.35 -58.58 13.82 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 124.394 0.997 . . . . 10.0 113.98 173.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 80.7 mt -56.21 -45.87 79.71 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-N 118.596 1.198 . . . . 10.0 112.113 176.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.15 -40.66 84.21 Favored Glycine 0 CA--C 1.532 1.122 0 O-C-N 120.931 -1.106 . . . . 10.0 113.598 173.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 28.1 m -61.61 -58.92 6.2 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.486 0.714 . . . . 10.0 111.19 171.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -52.24 -41.01 62.42 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.073 0.949 . . . . 10.0 110.95 178.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -55.77 -58.05 9.45 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 124.599 1.159 . . . . 10.0 112.973 172.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.1 m-30 -59.62 -38.69 81.99 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 113.223 0.823 . . . . 10.0 113.223 178.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.401 ' C ' ' H ' ' A' ' 30' ' ' LYS . 11.8 mt -56.1 -67.43 0.3 Allowed 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.627 1.171 . . . . 10.0 113.637 169.099 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 t -76.37 40.92 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 CA-C-O 123.708 1.718 . . . . 10.0 110.852 179.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.401 ' H ' ' C ' ' A' ' 28' ' ' LEU . 42.9 tttm -140.84 -44.84 0.39 Allowed 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 127.883 2.473 . . . . 10.0 109.331 171.18 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.96 23.11 0.87 Allowed Glycine 0 CA--C 1.529 0.925 0 N-CA-C 115.629 1.012 . . . . 10.0 115.629 173.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 37.3 mmm -59.51 -45.0 92.98 Favored 'General case' 0 C--O 1.225 -0.235 0 C-N-CA 127.163 2.185 . . . . 10.0 113.596 -179.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.69 -84.42 1.19 Allowed Glycine 0 CA--C 1.53 1.007 0 C-N-CA 123.741 0.686 . . . . 10.0 112.483 -170.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.8 t 33.11 88.75 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.242 0.682 0 C-N-CA 128.399 2.68 . . . . 10.0 116.937 166.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.2 m -79.62 -50.91 9.96 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.152 -1.385 . . . . 10.0 113.855 174.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -48.87 117.51 6.37 Favored Pre-proline 0 CA--C 1.536 0.415 0 O-C-N 124.769 1.293 . . . . 10.0 110.988 -172.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -58.56 -29.68 89.65 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 123.746 2.964 . . . . 10.0 113.72 179.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.31 -60.67 2.28 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.126 0.57 . . . . 10.0 111.422 176.213 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.15 -40.05 22.64 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 125.104 1.362 . . . . 10.0 113.549 171.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -46.53 -47.47 19.54 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 125.252 1.421 . . . . 10.0 113.434 172.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -57.75 -53.06 62.43 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.438 0.695 . . . . 10.0 110.974 176.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.477 ' CD2' ' HB1' ' A' ' 228' ' ' ALA . 44.0 m-85 -56.98 -50.23 73.32 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 123.044 0.538 . . . . 10.0 112.337 -179.117 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -54.35 -51.28 65.25 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 118.914 -0.565 . . . . 10.0 112.375 173.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.46 -61.95 1.95 Allowed 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 113.391 0.886 . . . . 10.0 113.391 177.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.3 mt -48.43 -57.76 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 C-N-CA 124.839 1.255 . . . . 10.0 110.408 178.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.3 m -68.57 -17.44 64.14 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.158 1.383 . . . . 10.0 113.724 -172.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 28.1 m -87.92 -39.63 14.6 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.45 1.1 . . . . 10.0 112.255 174.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 21.2 mt -59.19 -42.64 91.34 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 121.49 -0.756 . . . . 10.0 112.521 171.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 18.5 t -41.43 -63.84 0.75 Allowed Pre-proline 0 CA--C 1.551 0.993 0 C-N-CA 125.774 1.63 . . . . 10.0 113.491 175.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -70.22 -25.07 26.85 Favored 'Trans proline' 0 CA--C 1.544 1.017 0 C-N-CA 122.72 2.28 . . . . 10.0 114.182 176.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.5 -44.45 86.99 Favored 'General case' 0 CA--C 1.549 0.907 0 CA-C-N 120.683 1.583 . . . . 10.0 113.046 174.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 58.0 mt -54.66 -52.18 43.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 124.961 1.304 . . . . 10.0 108.998 168.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.451 ' HB1' ' SD ' ' A' ' 20' ' ' MET . . . -53.14 -49.75 65.93 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.637 1.175 . . . . 10.0 112.789 176.402 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -50.42 -58.57 5.42 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.717 1.607 . . . . 10.0 112.574 173.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.3 m -49.38 -52.64 27.13 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.119 1.368 . . . . 10.0 110.66 178.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.425 ' HG3' ' CB ' ' A' ' 85' ' ' ASP . 32.8 mmt -69.41 -48.22 61.71 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 123.889 0.876 . . . . 10.0 112.82 -176.369 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -57.71 -39.29 76.88 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 116.567 -1.683 . . . . 10.0 113.111 173.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.7 tp -53.24 -54.62 33.47 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-N 120.623 1.556 . . . . 10.0 111.273 169.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 23.9 p -51.63 -41.05 61.01 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 115.257 1.577 . . . . 10.0 115.257 179.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 56.5 mtm -66.93 -50.8 61.23 Favored 'General case' 0 C--N 1.334 -0.09 0 C-N-CA 123.548 0.739 . . . . 10.0 110.485 176.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.3 tp -48.57 -52.7 21.49 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.858 0.863 . . . . 10.0 112.948 172.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.5 mt -76.86 -5.59 48.96 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 113.835 1.05 . . . . 10.0 113.835 -177.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.26 -34.72 5.54 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 115.583 0.993 . . . . 10.0 115.583 174.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -49.24 -43.13 42.52 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 115.243 1.571 . . . . 10.0 115.243 -176.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.01 3.48 61.22 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 115.329 0.892 . . . . 10.0 115.329 -178.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.25 143.41 26.44 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 127.034 2.133 . . . . 10.0 109.011 172.055 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 t -145.52 171.11 15.14 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 124.029 0.931 . . . . 10.0 111.011 166.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.95 136.06 53.39 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 123.924 0.89 . . . . 10.0 109.739 179.583 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.436 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 58.6 t -129.58 129.58 23.18 Favored Pre-proline 0 C--N 1.329 -0.295 0 C-N-CA 125.063 1.345 . . . . 10.0 110.935 -176.048 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 69' ' ' VAL . 6.3 Cg_exo -80.71 116.19 3.17 Favored 'Trans proline' 0 N--CA 1.452 -0.921 0 N-CA-C 109.443 -1.022 . . . . 10.0 109.443 -178.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -156.71 164.39 38.2 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 112.862 0.69 . . . . 10.0 112.862 172.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.39 -82.0 0.14 Allowed Glycine 0 CA--C 1.526 0.773 0 N-CA-C 110.683 -0.967 . . . . 10.0 110.683 175.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.76 -3.33 0.7 Allowed Glycine 0 CA--C 1.527 0.812 0 N-CA-C 118.641 2.216 . . . . 10.0 118.641 170.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -151.63 -171.89 4.06 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 119.379 1.59 . . . . 10.0 112.228 -165.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -91.86 93.9 9.05 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 125.521 1.528 . . . . 10.0 111.097 -175.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.449 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 60.3 m-80 -89.48 120.72 69.64 Favored Pre-proline 0 N--CA 1.45 -0.429 0 N-CA-C 112.965 0.728 . . . . 10.0 112.965 -165.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.652 ' HB3' HG21 ' A' ' 5' ' ' THR . 76.1 Cg_exo -61.53 131.94 38.26 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 124.183 3.255 . . . . 10.0 112.165 171.588 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.5 mm -140.09 126.3 21.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 C-N-CA 126.043 1.737 . . . . 10.0 111.732 -179.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -93.64 85.03 4.75 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 122.888 1.328 . . . . 10.0 113.053 174.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 63.6 p-90 -59.33 -28.3 66.69 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 113.911 1.078 . . . . 10.0 113.911 174.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -55.31 -35.93 65.65 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.286 1.035 . . . . 10.0 113.575 178.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 6.8 ptp180 -56.8 -40.44 75.97 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 120.209 1.368 . . . . 10.0 111.281 173.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -66.16 -43.73 86.12 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 113.887 1.069 . . . . 10.0 113.887 174.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -49.39 -47.19 47.9 Favored 'General case' 0 CA--C 1.555 1.165 0 C-N-CA 124.695 1.198 . . . . 10.0 111.002 167.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.425 ' CB ' ' HG3' ' A' ' 56' ' ' MET . 0.0 OUTLIER -61.71 -58.92 6.14 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 125.568 1.547 . . . . 10.0 112.938 173.331 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 46.9 m0 -51.82 -40.52 60.6 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 126.829 2.052 . . . . 10.0 112.777 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 27.8 tp -50.22 -45.79 54.14 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 125.944 1.697 . . . . 10.0 112.686 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -97.94 -46.86 5.76 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 123.735 0.814 . . . . 10.0 112.753 -176.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -58.8 -41.44 86.77 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.903 0.881 . . . . 10.0 112.801 -175.314 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.459 ' HB ' ' HD3' ' A' ' 91' ' ' PRO . 3.1 m -66.39 -47.66 58.54 Favored Pre-proline 0 CA--C 1.541 0.598 0 O-C-N 121.094 -1.004 . . . . 10.0 111.938 -174.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.459 ' HD3' ' HB ' ' A' ' 90' ' ' THR . 86.6 Cg_exo -51.93 -42.92 55.53 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 123.34 2.694 . . . . 10.0 115.145 166.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 53.0 mt -59.79 -48.17 82.76 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 118.877 0.762 . . . . 10.0 111.875 176.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 84.3 mt -53.77 -45.1 70.52 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.481 1.112 . . . . 10.0 112.136 172.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.6 mp -57.35 -47.86 80.52 Favored 'General case' 0 CA--C 1.546 0.796 0 O-C-N 120.97 -1.082 . . . . 10.0 112.574 169.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.87 -38.23 78.33 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 123.824 0.85 . . . . 10.0 112.877 178.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -52.28 -54.05 36.34 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 119.303 0.956 . . . . 10.0 111.215 169.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.36 -42.07 88.59 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.585 0.754 . . . . 10.0 112.119 -178.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.67 -54.75 37.61 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.972 0.909 . . . . 10.0 112.006 173.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.3 -41.16 79.34 Favored 'General case' 0 C--O 1.224 -0.237 0 C-N-CA 123.72 0.808 . . . . 10.0 112.702 174.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 32.0 tp -63.75 -38.56 91.58 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 114.445 1.276 . . . . 10.0 114.445 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.2 t -94.79 1.36 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 125.106 1.362 . . . . 10.0 112.309 179.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.2 t70 48.57 53.46 12.11 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.858 1.663 . . . . 10.0 112.139 -173.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.29 145.89 47.56 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 119.951 -1.718 . . . . 10.0 112.44 -174.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.44 135.87 54.08 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 112.759 0.651 . . . . 10.0 112.759 175.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -42.85 -39.65 2.6 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.844 1.658 . . . . 10.0 113.49 175.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -47.33 -60.23 5.32 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 125.15 1.357 . . . . 10.0 115.262 169.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.4 p -62.06 -46.77 87.65 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 117.1 -1.428 . . . . 10.0 111.332 178.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 66.9 mt -48.39 -52.92 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 125.001 1.321 . . . . 10.0 111.147 178.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.4 tp -62.66 -51.28 67.86 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 112.509 0.559 . . . . 10.0 112.509 179.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.15 -44.87 43.05 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.506 0.722 . . . . 10.0 110.967 174.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.454 HD12 ' HA ' ' A' ' 111' ' ' LEU . 0.6 OUTLIER -59.6 -59.87 4.76 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 127.363 2.265 . . . . 10.0 114.839 174.898 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.4 t -60.97 -46.39 96.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 123.711 0.804 . . . . 10.0 111.373 -178.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -56.61 -50.3 64.02 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 123.662 0.649 . . . . 10.0 112.661 174.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -54.54 -46.5 73.61 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.569 0.747 . . . . 10.0 112.882 173.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -61.38 -40.62 95.0 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.887 0.875 . . . . 10.0 112.924 176.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -43.69 -59.38 3.75 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 125.995 1.76 . . . . 10.0 112.401 163.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 78.8 mt -56.66 -52.59 52.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 123.69 0.796 . . . . 10.0 110.925 175.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 46.4 ttp -46.33 -61.96 1.56 Allowed 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 126.022 1.729 . . . . 10.0 112.597 -174.087 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.472 0.654 0 CA-C-O 118.933 -0.556 . . . . 10.0 112.176 -177.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 61.9 t . . . . . 0 N--CA 1.478 0.94 0 N-CA-C 110.209 -0.293 . . . . 10.0 110.209 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -50.97 -61.28 6.27 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 126.18 1.848 . . . . 10.0 112.939 172.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -43.45 -41.53 4.35 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 127.993 2.517 . . . . 10.0 113.231 176.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 46.5 mt -99.92 -7.23 25.47 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 115.513 1.671 . . . . 10.0 115.513 -176.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 17.0 m -69.66 116.75 10.42 Favored 'General case' 0 N--CA 1.464 0.274 0 O-C-N 120.195 -1.566 . . . . 10.0 110.407 -178.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.622 ' H ' ' HD3' ' A' ' 129' ' ' LYS . 0.2 OUTLIER -55.5 -49.62 72.09 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 128.195 2.598 . . . . 10.0 113.288 177.758 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 60.1 t -69.58 106.32 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 123.789 0.836 . . . . 10.0 110.12 179.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -46.92 -59.49 3.06 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 124.761 1.224 . . . . 10.0 114.067 -173.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 m -46.5 -42.08 15.06 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.439 1.495 . . . . 10.0 113.512 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -70.16 -24.59 63.18 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 114.918 1.451 . . . . 10.0 114.918 -178.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 68.2 mtp85 -54.37 -41.18 68.86 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 118.876 0.762 . . . . 10.0 110.905 176.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -69.79 -31.75 69.85 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 114.34 1.237 . . . . 10.0 114.34 176.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.8 t -55.17 -52.23 46.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 CA-C-N 118.928 0.785 . . . . 10.0 109.82 168.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 65.0 m95 -59.48 -49.57 77.27 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 113.428 0.899 . . . . 10.0 113.428 173.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 83.0 t90 -48.37 -47.82 37.12 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 119.438 1.017 . . . . 10.0 113.31 173.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.595 0 C-N-CA 124.099 0.96 . . . . 10.0 111.993 176.812 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.782 0 N-CA-C 112.977 0.732 . . . . 10.0 112.977 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 42.8 ttp -57.75 -55.77 30.59 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.406 1.082 . . . . 10.0 111.969 173.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -49.79 -49.67 47.74 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.461 1.505 . . . . 10.0 110.781 177.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -51.77 -55.8 17.66 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 113.298 0.851 . . . . 10.0 113.298 173.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 49.9 mt -54.22 -54.69 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 123.598 0.759 . . . . 10.0 110.78 177.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 42.1 mt -57.14 -36.1 70.29 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 118.409 -0.805 . . . . 10.0 112.959 178.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -57.33 -58.11 9.67 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 124.026 0.93 . . . . 10.0 113.03 173.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.48 -40.89 85.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 CA-C-O 118.303 -0.855 . . . . 10.0 111.419 177.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 45.1 mt -56.83 -49.35 75.68 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 119.893 1.224 . . . . 10.0 112.115 171.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.47 ' HA ' ' HD2' ' A' ' 175' ' ' ARG . 11.9 t80 -77.03 -70.34 0.47 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 120.054 -1.654 . . . . 10.0 112.862 -175.254 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -73.73 -21.91 60.06 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.634 1.174 . . . . 10.0 113.439 -174.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -87.79 -79.08 1.26 Allowed Glycine 0 CA--C 1.527 0.783 0 C-N-CA 123.625 0.631 . . . . 10.0 113.534 171.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -53.68 -32.4 51.54 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 126.269 1.828 . . . . 10.0 113.046 -166.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.3 m -52.16 -56.39 14.85 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 113.989 1.107 . . . . 10.0 113.989 172.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.3 p -53.65 -50.63 65.33 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 122.092 0.949 . . . . 10.0 112.249 -177.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 47.6 tttm -57.11 -46.03 82.93 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.142 0.977 . . . . 10.0 112.122 173.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.8 -47.5 80.07 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 114.534 1.309 . . . . 10.0 114.534 174.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -56.45 -11.29 1.2 Allowed 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 126.054 1.741 . . . . 10.0 114.261 177.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.1 m -107.04 6.56 29.1 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 126.474 1.91 . . . . 10.0 114.896 -179.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 93.2 mmm -91.88 -92.66 0.15 Allowed 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 123.487 1.613 . . . . 10.0 114.171 -170.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -138.74 153.94 72.59 Favored Pre-proline 0 C--O 1.236 0.359 0 C-N-CA 129.802 3.241 . . . . 10.0 105.548 170.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -52.85 -46.22 35.27 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.346 2.031 . . . . 10.0 113.074 179.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.667 ' CD ' ' HD3' ' A' ' 227' ' ' ARG . 0.1 OUTLIER -52.97 -46.09 68.06 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 128.979 2.912 . . . . 10.0 113.276 173.571 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 92.2 t -69.19 -52.99 27.97 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 C-N-CA 124.065 0.946 . . . . 10.0 109.8 -178.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.18 -46.82 75.81 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.319 0.648 . . . . 10.0 111.899 177.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 60.3 p -60.04 -56.17 24.98 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.876 0.87 . . . . 10.0 112.729 174.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 61.8 m -57.2 -53.17 61.13 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.184 0.994 . . . . 10.0 113.027 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -49.6 -49.49 46.55 Favored 'General case' 0 C--O 1.221 -0.414 0 C-N-CA 123.258 0.623 . . . . 10.0 111.114 174.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -57.16 -48.37 78.86 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 114.664 1.357 . . . . 10.0 114.664 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 40.4 t -56.01 -49.62 74.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 CA-C-N 118.832 0.742 . . . . 10.0 110.477 176.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 94.2 mt -58.6 -51.64 69.07 Favored 'General case' 0 C--O 1.222 -0.384 0 N-CA-C 113.141 0.793 . . . . 10.0 113.141 175.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . 0.47 ' HD2' ' HA ' ' A' ' 153' ' ' PHE . 35.5 ttp180 -47.7 -47.86 29.66 Favored 'General case' 0 C--O 1.225 -0.201 0 C-N-CA 126.852 2.061 . . . . 10.0 111.084 174.402 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 63.6 m-20 -58.48 -58.35 8.92 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 122.775 0.43 . . . . 10.0 111.234 174.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 54.6 t -51.77 -48.09 38.64 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 124.088 0.955 . . . . 10.0 111.858 179.061 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 28.5 m -58.19 -62.8 1.57 Allowed 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 127.959 2.503 . . . . 10.0 112.17 177.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 54.8 t -51.43 -49.18 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 124.686 1.194 . . . . 10.0 111.019 -179.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 70.9 t -59.76 -60.42 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 124.008 0.923 . . . . 10.0 112.374 177.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 77.5 mt -54.59 -52.9 60.7 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 118.414 0.552 . . . . 10.0 111.769 -178.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 9.9 m95 . . . . . 0 N--CA 1.464 0.268 0 C-N-CA 124.274 1.03 . . . . 10.0 112.35 177.944 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 58.4 t . . . . . 0 N--CA 1.475 0.821 0 CA-C-O 119.299 -0.381 . . . . 10.0 111.333 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 66.7 t90 -56.36 -54.6 43.64 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.11 0.964 . . . . 10.0 112.2 172.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 60.3 tp -52.29 -46.42 65.9 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.413 1.485 . . . . 10.0 112.29 -177.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 15.0 pt -86.09 -5.14 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 N-CA-C 115.333 1.605 . . . . 10.0 115.333 -177.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.59 -169.26 32.72 Favored Glycine 0 N--CA 1.45 -0.383 0 CA-C-O 122.57 1.095 . . . . 10.0 113.826 -168.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 23.3 t -53.12 -40.15 63.99 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 114.209 -0.996 . . . . 10.0 111.853 177.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -71.99 -13.74 61.7 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 115.357 1.614 . . . . 10.0 115.357 -174.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -130.49 -106.69 1.16 Allowed Glycine 0 CA--C 1.531 1.031 0 CA-C-N 120.218 1.372 . . . . 10.0 113.349 -174.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -89.48 127.14 35.82 Favored 'General case' 0 C--N 1.329 -0.313 0 O-C-N 120.673 -1.487 . . . . 10.0 109.352 169.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -72.43 65.33 1.35 Allowed Glycine 0 CA--C 1.532 1.127 0 N-CA-C 113.937 0.335 . . . . 10.0 113.937 173.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 60.8 mt -79.6 -42.74 23.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 126.044 1.737 . . . . 10.0 108.717 166.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 79.7 t -126.28 133.4 24.93 Favored Pre-proline 0 N--CA 1.454 -0.25 0 C-N-CA 126.467 1.907 . . . . 10.0 109.368 -174.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -68.74 153.78 72.5 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 123.811 3.007 . . . . 10.0 111.476 -176.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 12.2 tp -43.16 -39.8 3.02 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.359 1.064 . . . . 10.0 112.193 171.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -48.32 -52.41 21.66 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 114.68 1.363 . . . . 10.0 114.68 176.046 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 13.9 mm -75.91 -40.5 38.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 C-N-CA 124.401 1.08 . . . . 10.0 109.658 177.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -49.3 -49.81 42.15 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 118.593 0.633 . . . . 10.0 111.947 173.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 16.1 m -57.66 -47.07 83.31 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 126.083 1.753 . . . . 10.0 112.998 174.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.535 HD23 ' CD2' ' A' ' 12' ' ' TRP . 1.3 tm? -63.33 -52.34 62.23 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.95 0.9 . . . . 10.0 112.073 179.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 93.3 mt -52.55 -58.54 6.45 Favored 'General case' 0 C--O 1.228 -0.046 0 C-N-CA 124.32 1.048 . . . . 10.0 109.973 176.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -55.19 -44.62 75.45 Favored 'General case' 0 C--O 1.22 -0.475 0 CA-C-O 117.608 -1.187 . . . . 10.0 113.0 176.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' MET . . . . . 0.575 ' HE2' ' HB3' ' A' ' 15' ' ' LEU . 4.6 tmm? -51.48 -52.51 45.97 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 120.502 1.501 . . . . 10.0 112.581 173.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 79.9 t -61.06 -48.65 88.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 124.675 1.19 . . . . 10.0 111.773 178.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 5.3 mp -57.62 -53.26 60.2 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.472 1.509 . . . . 10.0 111.89 176.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -55.96 -54.95 38.59 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 126.753 2.021 . . . . 10.0 110.707 177.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 37.6 t . . . . . 0 N--CA 1.478 0.967 0 O-C-N 121.243 -0.911 . . . . 10.0 111.368 173.033 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.258 0 N-CA-C 111.876 -0.49 . . . . 10.0 111.876 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -44.19 -57.68 3.3 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.921 2.089 . . . . 10.0 112.111 166.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -55.03 -41.98 79.46 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 124.059 0.838 . . . . 10.0 113.979 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 24.0 mt -71.07 -27.16 63.43 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 115.637 1.718 . . . . 10.0 115.637 177.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 74.1 mt -63.22 -57.61 11.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 108.684 -0.858 . . . . 10.0 108.684 165.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 32.1 tp -58.82 -64.63 0.86 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.935 0.894 . . . . 10.0 113.183 -172.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 84.5 mt -71.64 5.25 2.55 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 115.27 1.582 . . . . 10.0 115.27 -171.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.7 mtp-105 -112.33 0.39 15.67 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.203 1.001 . . . . 10.0 113.292 172.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 8.8 t -108.06 177.97 4.65 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 124.06 0.944 . . . . 10.0 111.015 174.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 227' ' ' ARG . . . . . 0.667 ' HD3' ' CD ' ' A' ' 166' ' ' GLU . 41.7 ttt180 -71.63 98.15 1.85 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.795 0.838 . . . . 10.0 110.917 170.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . 0.477 ' HB1' ' CD2' ' A' ' 42' ' ' PHE . . . -80.89 77.02 7.8 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.859 0.863 . . . . 10.0 112.116 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 40.11 102.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 128.833 2.853 . . . . 10.0 116.484 177.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . 0.481 0.3 OUTLIER 71.79 -55.39 0.66 Allowed 'General case' 0 C--O 1.242 0.685 0 C-N-CA 124.753 1.221 . . . . 10.0 110.68 -175.267 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -68.3 169.47 40.07 Favored Glycine 0 C--O 1.239 0.429 0 C-N-CA 129.735 3.541 . . . . 10.0 119.674 171.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.448 0 C-N-CA 128.491 2.716 . . . . 10.0 113.461 166.62 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 N--CA 1.477 0.876 0 CA-C-O 115.781 -2.057 . . . . 10.0 105.837 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 23.43 91.86 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 129.576 3.15 . . . . 10.0 117.262 160.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 28.59 65.12 0.1 Allowed 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 128.297 2.639 . . . . 10.0 114.458 155.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 86.7 mt -56.51 137.96 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 126.384 1.873 . . . . 10.0 113.343 -158.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.653 HG21 ' HB3' ' A' ' 77' ' ' PRO . 7.6 t -136.74 -165.19 1.69 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 126.353 1.861 . . . . 10.0 114.062 -174.347 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 70.02 2.75 40.86 Favored Glycine 0 C--N 1.339 0.743 0 C-N-CA 127.44 2.448 . . . . 10.0 111.453 168.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -158.57 -51.28 0.01 OUTLIER Pre-proline 0 N--CA 1.443 -0.805 0 CA-C-O 114.243 -2.789 . . . . 10.0 116.635 -168.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_exo -63.96 -60.62 0.15 Allowed 'Trans proline' 0 N--CA 1.465 -0.202 0 CA-C-N 123.576 2.313 . . . . 10.0 113.21 -175.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.412 ' H ' ' CD ' ' A' ' 9' ' ' GLU . 7.9 pm0 -67.26 4.31 0.99 Allowed 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 127.831 2.452 . . . . 10.0 115.783 179.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.422 ' CG ' ' N ' ' A' ' 11' ' ' ILE . 11.0 p-90 -51.31 -43.17 61.63 Favored 'General case' 0 C--O 1.223 -0.34 0 O-C-N 121.5 -0.75 . . . . 10.0 112.615 176.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.422 ' N ' ' CG ' ' A' ' 10' ' ' TRP . 8.9 tt -60.83 -49.64 83.77 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.34 0 C-N-CA 123.885 0.874 . . . . 10.0 109.344 179.403 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . 0.535 ' CD2' HD23 ' A' ' 206' ' ' LEU . 2.6 m95 -55.39 -52.58 63.08 Favored 'General case' 0 C--O 1.224 -0.259 0 C-N-CA 123.4 0.68 . . . . 10.0 111.88 175.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.2 mt -57.39 -53.63 55.96 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 123.219 0.608 . . . . 10.0 112.196 177.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.9 -46.74 52.14 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.366 1.466 . . . . 10.0 113.332 173.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.574 ' HB3' ' HE2' ' A' ' 209' ' ' MET . 13.3 tp -65.71 -44.9 84.69 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 125.274 1.43 . . . . 10.0 113.013 179.122 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.94 -57.29 10.07 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 124.122 0.868 . . . . 10.0 111.16 166.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 22.5 m -48.38 -52.67 20.73 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.709 1.204 . . . . 10.0 112.347 174.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.39 -58.86 5.82 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.139 0.976 . . . . 10.0 112.188 177.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 94.3 mt -57.69 -50.23 73.88 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.696 0.799 . . . . 10.0 112.627 -179.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -53.73 -50.91 64.92 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.495 1.118 . . . . 10.0 111.395 175.066 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -57.95 -58.01 16.81 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 124.268 0.937 . . . . 10.0 113.579 176.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 81.2 mt -56.19 -45.83 79.63 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-N 118.527 1.164 . . . . 10.0 112.125 176.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.63 -41.95 75.66 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 124.854 1.216 . . . . 10.0 113.278 172.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 24.6 m -61.41 -59.5 5.16 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.984 0.913 . . . . 10.0 111.263 171.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -52.29 -40.92 62.43 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.028 0.931 . . . . 10.0 110.99 178.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -55.86 -57.98 9.78 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 124.619 1.168 . . . . 10.0 112.966 172.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -59.65 -38.75 82.26 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 113.193 0.812 . . . . 10.0 113.193 178.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.401 ' C ' ' H ' ' A' ' 30' ' ' LYS . 11.8 mt -56.08 -67.47 0.29 Allowed 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.58 1.152 . . . . 10.0 113.637 169.108 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 t -76.37 40.96 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 CA-C-O 123.802 1.763 . . . . 10.0 110.891 179.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.401 ' H ' ' C ' ' A' ' 28' ' ' LEU . 42.9 tttm -140.85 -44.82 0.39 Allowed 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 127.862 2.465 . . . . 10.0 109.317 171.12 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.9 23.1 0.86 Allowed Glycine 0 CA--C 1.529 0.908 0 N-CA-C 115.668 1.027 . . . . 10.0 115.668 173.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 37.4 mmm -59.54 -44.95 93.07 Favored 'General case' 0 C--O 1.225 -0.217 0 C-N-CA 127.19 2.196 . . . . 10.0 113.596 -178.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.74 -84.45 1.19 Allowed Glycine 0 CA--C 1.531 1.035 0 C-N-CA 123.798 0.713 . . . . 10.0 112.437 -170.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.7 t 33.06 88.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 128.358 2.663 . . . . 10.0 116.93 166.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.4 m -79.63 -50.86 10.04 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.155 -1.384 . . . . 10.0 113.879 174.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -48.95 117.46 6.39 Favored Pre-proline 0 CA--C 1.535 0.402 0 O-C-N 124.718 1.261 . . . . 10.0 110.982 -172.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -58.5 -29.68 89.44 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 123.779 2.986 . . . . 10.0 113.688 179.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.27 -60.71 2.26 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.148 0.579 . . . . 10.0 111.424 176.193 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.19 -40.05 22.94 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 125.085 1.354 . . . . 10.0 113.534 171.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -46.55 -47.45 19.65 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.21 1.404 . . . . 10.0 113.436 172.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -57.74 -53.1 61.99 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.479 0.712 . . . . 10.0 110.944 176.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.475 ' CD2' ' HB1' ' A' ' 228' ' ' ALA . 44.0 m-85 -56.91 -50.28 73.02 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 123.119 0.568 . . . . 10.0 112.342 -179.126 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -54.34 -51.29 65.22 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 118.936 -0.554 . . . . 10.0 112.345 173.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.45 -61.99 1.92 Allowed 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 113.392 0.886 . . . . 10.0 113.392 177.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.5 mt -48.68 -56.27 2.47 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 C-N-CA 124.864 1.266 . . . . 10.0 110.64 177.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.6 m -70.17 -17.45 63.17 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.003 1.321 . . . . 10.0 113.646 -172.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 27.5 m -87.8 -37.34 16.67 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.194 0.998 . . . . 10.0 112.237 174.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 20.8 mt -60.4 -42.57 96.19 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 118.128 -0.939 . . . . 10.0 112.518 172.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.594 HG23 ' HD3' ' A' ' 50' ' ' PRO 0.349 33.2 m -52.53 -53.04 57.93 Favored Pre-proline 0 N--CA 1.487 1.386 0 CA-C-N 120.645 1.566 . . . . 10.0 115.049 -179.745 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.594 ' HD3' HG23 ' A' ' 49' ' ' VAL . 68.7 Cg_endo -68.33 -25.11 36.52 Favored 'Trans proline' 0 CA--C 1.545 1.044 0 CA-C-N 123.02 2.114 . . . . 10.0 113.524 174.461 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -68.09 -45.83 72.65 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-N 120.5 1.5 . . . . 10.0 112.894 173.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 31.4 mm -54.07 -52.3 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 124.896 1.278 . . . . 10.0 109.525 168.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -52.9 -49.57 65.63 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.968 0.907 . . . . 10.0 113.04 174.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 52.3 t80 -51.78 -58.53 6.15 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.769 1.628 . . . . 10.0 112.19 175.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.1 m -49.01 -52.7 23.6 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.252 1.421 . . . . 10.0 110.629 178.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.439 ' HG3' ' CB ' ' A' ' 85' ' ' ASP . 32.8 mmt -69.42 -48.09 62.09 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 123.854 0.861 . . . . 10.0 112.899 -176.429 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -56.2 -40.98 74.86 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 120.321 1.419 . . . . 10.0 113.146 172.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.8 tp -53.27 -54.59 34.01 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-N 120.031 1.287 . . . . 10.0 111.292 170.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 24.0 p -51.68 -41.05 61.12 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 115.224 1.564 . . . . 10.0 115.224 178.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 57.8 mtm -66.82 -50.87 61.2 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 123.586 0.754 . . . . 10.0 110.527 176.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.4 tp -48.53 -52.67 21.46 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.857 0.863 . . . . 10.0 112.974 172.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.4 mt -76.97 -5.54 49.02 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 113.849 1.055 . . . . 10.0 113.849 -177.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.32 -34.71 5.55 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 115.55 0.98 . . . . 10.0 115.55 174.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -49.33 -43.05 43.39 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 115.235 1.568 . . . . 10.0 115.235 -175.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.05 3.58 61.04 Favored Glycine 0 CA--C 1.521 0.467 0 N-CA-C 115.358 0.903 . . . . 10.0 115.358 -179.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.3 143.41 26.43 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 127.035 2.134 . . . . 10.0 109.018 172.002 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 t -145.47 171.11 15.12 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 124.081 0.952 . . . . 10.0 111.062 166.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.04 136.07 53.37 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 123.919 0.888 . . . . 10.0 109.661 179.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.438 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 58.7 t -129.58 129.59 23.18 Favored Pre-proline 0 C--N 1.329 -0.313 0 C-N-CA 125.063 1.345 . . . . 10.0 110.96 -176.092 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 69' ' ' VAL . 6.3 Cg_exo -80.72 116.24 3.17 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 N-CA-C 109.406 -1.036 . . . . 10.0 109.406 -178.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -156.73 164.39 38.17 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 112.842 0.682 . . . . 10.0 112.842 172.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.36 -81.95 0.14 Allowed Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.693 -0.963 . . . . 10.0 110.693 175.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.77 -3.38 0.69 Allowed Glycine 0 CA--C 1.526 0.766 0 N-CA-C 118.642 2.217 . . . . 10.0 118.642 170.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -151.62 -171.87 4.05 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 119.379 1.59 . . . . 10.0 112.257 -165.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -91.89 93.9 9.04 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 125.534 1.533 . . . . 10.0 111.131 -175.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.449 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 60.4 m-80 -89.49 120.8 69.63 Favored Pre-proline 0 N--CA 1.45 -0.43 0 N-CA-C 112.933 0.716 . . . . 10.0 112.933 -165.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.653 ' HB3' HG21 ' A' ' 5' ' ' THR . 76.0 Cg_exo -61.52 131.94 38.31 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 124.205 3.27 . . . . 10.0 112.166 171.573 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.6 mm -140.18 126.32 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 C-N-CA 126.072 1.749 . . . . 10.0 111.712 -179.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -93.62 85.07 4.77 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 123.171 1.463 . . . . 10.0 113.041 174.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 63.7 p-90 -59.38 -28.32 66.79 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 120.729 -1.232 . . . . 10.0 113.873 174.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -54.51 -37.28 65.15 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 115.087 1.514 . . . . 10.0 115.087 178.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -59.66 -35.93 75.42 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 120.311 1.414 . . . . 10.0 112.488 172.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 -66.73 -42.91 85.52 Favored 'General case' 0 CA--C 1.545 0.752 0 O-C-N 120.997 -1.065 . . . . 10.0 112.876 173.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -49.47 -49.56 44.97 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 125.361 1.464 . . . . 10.0 111.321 166.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.439 ' CB ' ' HG3' ' A' ' 56' ' ' MET . 0.0 OUTLIER -59.46 -60.29 4.09 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.001 1.321 . . . . 10.0 112.533 173.385 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 51.8 m0 -54.82 -37.94 66.75 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 126.034 1.733 . . . . 10.0 113.161 -175.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 31.3 tp -49.84 -45.51 50.36 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 126.677 1.991 . . . . 10.0 111.86 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -97.33 -40.74 8.58 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 123.666 0.787 . . . . 10.0 112.502 -179.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -61.93 -44.98 95.64 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 113.275 0.843 . . . . 10.0 113.275 -175.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . 0.293 81.7 p -69.58 -39.19 11.34 Favored Pre-proline 0 CA--C 1.544 0.719 0 CA-C-O 117.601 -1.19 . . . . 10.0 114.032 -174.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -54.31 -44.66 47.34 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 123.722 2.948 . . . . 10.0 115.451 164.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 51.2 mt -59.17 -46.75 87.58 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 118.948 0.795 . . . . 10.0 111.434 175.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.4 tp -50.79 -47.9 59.61 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.563 1.545 . . . . 10.0 112.226 172.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.5 mp -59.86 -46.64 88.67 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.293 1.437 . . . . 10.0 112.832 170.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.81 -38.27 78.25 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 123.806 0.842 . . . . 10.0 112.866 178.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -52.26 -54.04 36.3 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 119.329 0.968 . . . . 10.0 111.21 169.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.36 -42.06 88.57 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.671 0.788 . . . . 10.0 112.119 -178.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.71 -54.77 37.54 Favored 'General case' 0 C--O 1.225 -0.186 0 C-N-CA 123.982 0.913 . . . . 10.0 111.999 173.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.27 -41.21 79.27 Favored 'General case' 0 C--O 1.224 -0.237 0 C-N-CA 123.72 0.808 . . . . 10.0 112.678 174.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.8 tp -63.74 -38.57 91.62 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 114.424 1.268 . . . . 10.0 114.424 -179.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.1 t -94.83 1.44 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 125.035 1.334 . . . . 10.0 112.308 179.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.2 t70 48.59 53.49 12.08 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.882 1.673 . . . . 10.0 112.1 -174.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.29 145.89 47.56 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 119.951 -1.718 . . . . 10.0 112.422 -174.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.5 135.91 54.29 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 112.694 0.627 . . . . 10.0 112.694 175.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -42.87 -39.68 2.62 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.863 1.665 . . . . 10.0 113.463 175.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -47.33 -60.17 5.36 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 125.133 1.349 . . . . 10.0 115.293 169.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.6 p -62.07 -46.77 87.66 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 117.098 -1.429 . . . . 10.0 111.356 178.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 66.9 mt -48.42 -52.89 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 124.979 1.312 . . . . 10.0 111.153 178.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.2 tp -62.66 -51.25 67.98 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 112.544 0.572 . . . . 10.0 112.544 179.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.19 -44.81 43.44 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.424 0.69 . . . . 10.0 110.983 174.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.455 ' HA ' HD12 ' A' ' 111' ' ' LEU . 0.6 OUTLIER -59.56 -59.93 4.66 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 127.365 2.266 . . . . 10.0 114.838 174.907 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.6 t -60.99 -46.38 96.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 123.666 0.786 . . . . 10.0 111.37 -178.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -56.63 -50.26 64.35 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 123.659 0.647 . . . . 10.0 112.633 174.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -55.0 -46.62 75.18 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 113.451 0.908 . . . . 10.0 113.451 173.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -56.06 -47.14 78.49 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.466 0.706 . . . . 10.0 111.657 173.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -43.95 -54.23 6.09 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 124.88 1.229 . . . . 10.0 112.928 169.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 79.4 mt -58.22 -50.61 77.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 123.726 0.81 . . . . 10.0 111.979 173.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 53.1 ttp -49.05 -57.01 7.28 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.152 1.381 . . . . 10.0 112.061 179.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 36.5 mm . . . . . 0 N--CA 1.471 0.623 0 O-C-N 121.735 -0.603 . . . . 10.0 111.912 178.233 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 60.7 t . . . . . 0 N--CA 1.48 1.074 0 N-CA-C 111.61 0.226 . . . . 10.0 111.61 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -51.76 -59.59 8.44 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 125.893 1.711 . . . . 10.0 112.115 175.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -48.46 -37.9 18.49 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 127.027 2.131 . . . . 10.0 113.417 179.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 48.1 mt -99.4 -6.78 27.14 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 115.442 1.645 . . . . 10.0 115.442 -178.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 16.9 m -69.73 116.7 10.43 Favored 'General case' 0 N--CA 1.464 0.229 0 O-C-N 120.178 -1.576 . . . . 10.0 110.386 -178.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.622 ' H ' ' HD3' ' A' ' 129' ' ' LYS . 0.1 OUTLIER -55.4 -49.67 71.74 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 128.226 2.61 . . . . 10.0 113.299 177.751 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 60.6 t -69.61 106.31 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 C-N-CA 123.766 0.826 . . . . 10.0 110.141 179.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -46.87 -59.57 2.99 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 124.807 1.243 . . . . 10.0 114.048 -173.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 m -46.44 -42.11 14.86 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.478 1.511 . . . . 10.0 113.495 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -70.1 -24.68 63.25 Favored 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 114.958 1.466 . . . . 10.0 114.958 -178.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 69.5 mtp85 -53.76 -41.9 67.64 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 118.852 0.751 . . . . 10.0 110.814 176.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -69.43 -32.32 71.21 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.76 1.224 . . . . 10.0 114.233 176.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.8 t -55.12 -51.97 49.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-N 119.015 0.825 . . . . 10.0 109.932 169.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 69.3 m95 -59.51 -51.07 71.46 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 113.517 0.932 . . . . 10.0 113.517 174.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 86.5 t90 -48.79 -46.82 42.11 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.563 1.145 . . . . 10.0 113.494 174.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.622 0 C-N-CA 123.973 0.909 . . . . 10.0 111.683 175.796 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.815 0 N-CA-C 112.934 0.716 . . . . 10.0 112.934 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.4 -47.48 83.76 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 118.914 0.779 . . . . 10.0 111.955 175.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 61.6 tp -56.36 -49.39 74.56 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.202 1.401 . . . . 10.0 112.203 176.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 73.9 t80 -51.08 -54.25 26.67 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.97 0.908 . . . . 10.0 112.095 172.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 59.8 mt -54.07 -55.36 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 123.806 0.842 . . . . 10.0 110.662 177.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 21.8 mt -57.33 -35.35 69.76 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 118.009 -0.996 . . . . 10.0 113.067 178.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -57.31 -58.2 9.29 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 119.52 1.055 . . . . 10.0 113.011 173.08 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.41 -40.95 85.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-O 118.279 -0.867 . . . . 10.0 111.408 177.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 44.3 mt -56.77 -49.36 75.51 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 119.909 1.231 . . . . 10.0 112.148 171.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.471 ' HA ' ' HD2' ' A' ' 175' ' ' ARG . 11.8 t80 -77.05 -70.3 0.47 Allowed 'General case' 0 C--N 1.326 -0.447 0 O-C-N 120.056 -1.653 . . . . 10.0 112.848 -175.208 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -73.71 -21.94 60.07 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.612 1.165 . . . . 10.0 113.473 -174.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -87.85 -79.09 1.26 Allowed Glycine 0 CA--C 1.526 0.77 0 C-N-CA 123.588 0.613 . . . . 10.0 113.493 171.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -53.6 -32.48 51.28 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 126.305 1.842 . . . . 10.0 113.033 -166.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.0 m -52.03 -56.47 14.15 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 114.04 1.126 . . . . 10.0 114.04 172.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.5 p -53.68 -50.53 65.61 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 122.099 0.952 . . . . 10.0 112.308 -177.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 47.7 tttm -57.17 -45.97 83.21 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.166 0.986 . . . . 10.0 112.112 173.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.9 -47.42 80.57 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 114.497 1.295 . . . . 10.0 114.497 174.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -56.5 -11.23 1.19 Allowed 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 126.077 1.751 . . . . 10.0 114.271 177.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.1 m -107.16 6.64 28.96 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.424 1.89 . . . . 10.0 114.852 -179.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 93.3 mmm -91.89 -92.67 0.15 Allowed 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 123.475 1.607 . . . . 10.0 114.187 -170.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -138.69 153.99 72.72 Favored Pre-proline 0 C--O 1.236 0.359 0 C-N-CA 129.794 3.238 . . . . 10.0 105.56 170.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -52.85 -46.25 35.03 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.321 2.014 . . . . 10.0 113.078 179.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.666 ' CD ' ' HD3' ' A' ' 227' ' ' ARG . 0.1 OUTLIER -52.98 -46.02 68.08 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 129.013 2.925 . . . . 10.0 113.276 173.573 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 92.2 t -69.25 -53.0 27.74 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.249 0 C-N-CA 124.071 0.949 . . . . 10.0 109.788 -178.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.13 -46.82 75.66 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.31 0.644 . . . . 10.0 111.947 177.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 60.0 p -59.97 -56.25 24.07 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.919 0.887 . . . . 10.0 112.708 174.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 61.5 m -57.15 -53.25 60.24 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.23 1.012 . . . . 10.0 112.995 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -49.53 -49.57 45.48 Favored 'General case' 0 C--O 1.222 -0.375 0 C-N-CA 123.252 0.621 . . . . 10.0 111.113 174.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -57.1 -48.4 78.7 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 114.703 1.371 . . . . 10.0 114.703 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 40.5 t -55.98 -49.59 74.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 CA-C-N 118.795 0.725 . . . . 10.0 110.496 176.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 94.3 mt -58.58 -51.64 69.04 Favored 'General case' 0 C--O 1.221 -0.441 0 N-CA-C 113.132 0.79 . . . . 10.0 113.132 175.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . 0.471 ' HD2' ' HA ' ' A' ' 153' ' ' PHE . 35.6 ttp180 -47.81 -47.8 30.92 Favored 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 126.846 2.059 . . . . 10.0 111.011 174.509 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 63.7 m-20 -58.48 -58.36 8.88 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 122.817 0.447 . . . . 10.0 111.277 174.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 60.0 t -51.78 -49.04 37.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 C-N-CA 124.075 0.95 . . . . 10.0 111.53 179.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 28.7 m -57.4 -62.51 1.73 Allowed 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 128.025 2.53 . . . . 10.0 112.007 178.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 54.3 t -51.55 -50.31 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 C-N-CA 124.491 1.116 . . . . 10.0 111.069 -179.255 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 73.6 t -58.05 -62.6 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 124.022 0.929 . . . . 10.0 111.482 177.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -56.99 -48.71 77.77 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 118.869 0.759 . . . . 10.0 112.468 -177.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 10.9 m95 . . . . . 0 N--CA 1.467 0.415 0 C-N-CA 123.94 0.896 . . . . 10.0 112.615 177.621 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 87.5 t . . . . . 0 N--CA 1.479 0.997 0 CA-C-O 119.5 -0.286 . . . . 10.0 111.374 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 26.5 t90 -55.7 -52.63 63.22 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.685 1.194 . . . . 10.0 112.388 174.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 34.6 tp -53.21 -45.49 68.64 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.778 1.231 . . . . 10.0 112.511 -179.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 14.7 pt -87.92 -5.41 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 N-CA-C 115.318 1.599 . . . . 10.0 115.318 -176.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.39 -169.23 32.98 Favored Glycine 0 N--CA 1.451 -0.341 0 CA-C-O 122.614 1.119 . . . . 10.0 113.875 -168.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 23.2 t -53.19 -40.86 64.73 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 114.153 -1.023 . . . . 10.0 111.83 177.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -53.97 -32.94 55.53 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 128.571 2.748 . . . . 10.0 115.262 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -130.85 -103.84 0.99 Allowed Glycine 0 CA--C 1.527 0.82 0 CA-C-N 119.324 0.965 . . . . 10.0 113.384 -167.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -89.49 127.14 35.82 Favored 'General case' 0 C--N 1.328 -0.33 0 O-C-N 120.624 -1.515 . . . . 10.0 109.308 169.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -72.41 65.27 1.35 Allowed Glycine 0 CA--C 1.532 1.105 0 N-CA-C 113.899 0.32 . . . . 10.0 113.899 173.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 60.7 mt -79.57 -42.73 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 C-N-CA 126.088 1.755 . . . . 10.0 108.748 166.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 79.2 t -126.27 133.4 24.92 Favored Pre-proline 0 N--CA 1.454 -0.264 0 C-N-CA 126.408 1.883 . . . . 10.0 109.364 -174.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -68.68 153.73 72.74 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 123.811 3.007 . . . . 10.0 111.471 -176.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 12.2 tp -43.08 -39.86 2.92 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.358 1.063 . . . . 10.0 112.199 171.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -48.28 -52.43 21.31 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 114.705 1.372 . . . . 10.0 114.705 176.052 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 14.0 mm -75.89 -40.55 38.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 124.39 1.076 . . . . 10.0 109.625 177.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -49.24 -49.85 41.29 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 118.596 0.635 . . . . 10.0 111.934 173.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 16.2 m -57.64 -47.1 83.17 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 126.046 1.738 . . . . 10.0 112.993 174.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.535 HD23 ' CD2' ' A' ' 12' ' ' TRP . 1.3 tm? -63.31 -52.34 62.31 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.947 0.899 . . . . 10.0 112.112 179.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 93.3 mt -52.52 -59.49 4.38 Favored 'General case' 0 CA--C 1.527 0.068 0 C-N-CA 124.321 1.048 . . . . 10.0 109.963 176.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -54.88 -42.14 71.73 Favored 'General case' 0 C--O 1.221 -0.442 0 CA-C-O 117.52 -1.229 . . . . 10.0 112.938 176.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' MET . . . . . 0.574 ' HE2' ' HB3' ' A' ' 15' ' ' LEU . 4.6 tmm? -53.65 -53.42 52.19 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 121.033 1.742 . . . . 10.0 112.341 173.365 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 79.1 t -60.55 -46.92 94.76 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 124.824 1.25 . . . . 10.0 111.674 178.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 4.3 mp -58.25 -53.19 61.08 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.368 1.467 . . . . 10.0 111.621 175.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -55.84 -53.38 57.44 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.562 1.545 . . . . 10.0 111.277 178.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 45.7 t . . . . . 0 N--CA 1.479 0.996 0 C-N-CA 124.883 1.273 . . . . 10.0 111.145 174.996 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 1.379 0 N-CA-C 112.832 -0.107 . . . . 10.0 112.832 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -43.24 -55.86 3.77 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.495 1.918 . . . . 10.0 112.483 167.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -59.16 -39.49 94.54 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 124.857 1.218 . . . . 10.0 113.266 179.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 24.6 mt -69.13 -27.82 65.91 Favored 'General case' 0 CA--C 1.512 -0.495 0 N-CA-C 115.742 1.756 . . . . 10.0 115.742 175.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 74.3 mt -63.37 -57.57 11.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 119.122 0.874 . . . . 10.0 108.648 165.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 32.0 tp -58.77 -64.68 0.84 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.877 0.871 . . . . 10.0 113.213 -172.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 84.0 mt -71.52 5.16 2.51 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 115.337 1.606 . . . . 10.0 115.337 -171.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.6 mtp-105 -112.35 0.44 15.67 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.139 0.976 . . . . 10.0 113.288 172.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 8.8 t -108.06 177.97 4.65 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 124.096 0.958 . . . . 10.0 111.025 174.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 227' ' ' ARG . . . . . 0.666 ' HD3' ' CD ' ' A' ' 166' ' ' GLU . 41.8 ttt180 -71.62 98.11 1.84 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.819 0.848 . . . . 10.0 110.969 170.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . 0.475 ' HB1' ' CD2' ' A' ' 42' ' ' PHE . . . -80.91 77.03 7.83 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.859 0.864 . . . . 10.0 112.123 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 40.16 102.25 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 128.886 2.874 . . . . 10.0 116.446 177.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . 0.481 0.3 OUTLIER 71.85 -55.43 0.66 Allowed 'General case' 0 C--O 1.242 0.67 0 C-N-CA 124.711 1.205 . . . . 10.0 110.637 -175.318 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -68.28 169.47 40.01 Favored Glycine 0 C--O 1.239 0.417 0 C-N-CA 129.757 3.551 . . . . 10.0 119.653 171.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.461 0 C-N-CA 128.501 2.72 . . . . 10.0 113.462 166.617 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 N--CA 1.477 0.881 0 CA-C-O 115.768 -2.063 . . . . 10.0 105.842 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 23.35 91.83 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 129.598 3.159 . . . . 10.0 117.262 160.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 28.74 65.04 0.11 Allowed 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 128.265 2.626 . . . . 10.0 114.5 155.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 86.7 mt -56.51 138.0 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 126.353 1.861 . . . . 10.0 113.338 -158.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.653 HG21 ' HB3' ' A' ' 77' ' ' PRO . 7.6 t -136.79 -165.2 1.7 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 126.331 1.852 . . . . 10.0 114.015 -174.337 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 70.06 2.75 41.2 Favored Glycine 0 C--N 1.339 0.743 0 C-N-CA 127.458 2.456 . . . . 10.0 111.462 168.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -158.54 -51.29 0.01 OUTLIER Pre-proline 0 N--CA 1.443 -0.822 0 CA-C-O 114.267 -2.778 . . . . 10.0 116.694 -168.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -63.99 -60.63 0.15 Allowed 'Trans proline' 0 N--CA 1.465 -0.186 0 CA-C-N 123.502 2.286 . . . . 10.0 113.205 -175.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.411 ' H ' ' CD ' ' A' ' 9' ' ' GLU . 7.9 pm0 -67.24 4.3 0.98 Allowed 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 127.844 2.458 . . . . 10.0 115.768 179.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.421 ' CG ' ' N ' ' A' ' 11' ' ' ILE . 11.1 p-90 -51.39 -43.07 61.8 Favored 'General case' 0 C--O 1.222 -0.361 0 O-C-N 121.496 -0.752 . . . . 10.0 112.594 176.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.421 ' N ' ' CG ' ' A' ' 10' ' ' TRP . 8.8 tt -60.91 -49.57 84.13 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.338 0 C-N-CA 123.884 0.874 . . . . 10.0 109.337 179.429 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . 0.536 ' CD2' HD23 ' A' ' 206' ' ' LEU . 2.6 m95 -55.45 -52.64 62.96 Favored 'General case' 0 C--O 1.224 -0.259 0 C-N-CA 123.413 0.685 . . . . 10.0 111.819 175.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.9 mt -57.39 -53.58 56.56 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 123.184 0.594 . . . . 10.0 112.198 177.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.83 -46.82 51.63 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.39 1.476 . . . . 10.0 113.335 173.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.575 ' HB3' ' HE2' ' A' ' 209' ' ' MET . 13.3 tp -65.67 -44.88 84.92 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.27 1.428 . . . . 10.0 113.059 179.12 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.4 -57.58 9.09 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 124.553 1.073 . . . . 10.0 111.045 165.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.0 m -48.91 -52.47 24.34 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.911 1.284 . . . . 10.0 112.333 175.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.4 -58.87 5.75 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.148 0.979 . . . . 10.0 112.155 177.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 96.5 mt -58.06 -49.08 78.16 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.651 0.781 . . . . 10.0 112.515 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 21.8 mmt -54.43 -51.59 64.45 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.811 0.845 . . . . 10.0 111.056 175.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -56.87 -58.48 14.31 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 124.584 1.088 . . . . 10.0 113.624 177.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 80.7 mt -56.18 -45.72 79.66 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-N 118.617 1.208 . . . . 10.0 112.107 176.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.79 -41.84 76.73 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 124.725 1.155 . . . . 10.0 113.374 172.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 19.1 m -60.43 -60.44 3.8 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.228 1.011 . . . . 10.0 111.083 171.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -52.34 -40.96 62.6 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.99 0.916 . . . . 10.0 110.925 179.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.4 t80 -55.82 -58.05 9.49 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.564 1.146 . . . . 10.0 112.943 172.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -59.59 -38.72 81.96 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 113.184 0.809 . . . . 10.0 113.184 178.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.4 ' C ' ' H ' ' A' ' 30' ' ' LYS . 11.8 mt -56.12 -67.47 0.29 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.656 1.182 . . . . 10.0 113.589 169.167 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 t -76.41 41.04 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 CA-C-O 123.775 1.75 . . . . 10.0 110.889 179.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.4 ' H ' ' C ' ' A' ' 28' ' ' LEU . 43.0 tttm -140.89 -44.83 0.39 Allowed 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 127.899 2.48 . . . . 10.0 109.337 171.166 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -73.0 23.15 0.88 Allowed Glycine 0 CA--C 1.528 0.898 0 N-CA-C 115.619 1.007 . . . . 10.0 115.619 173.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 37.4 mmm -59.51 -45.04 92.87 Favored 'General case' 0 C--O 1.224 -0.278 0 C-N-CA 127.189 2.196 . . . . 10.0 113.581 -179.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.65 -84.42 1.18 Allowed Glycine 0 CA--C 1.53 1.026 0 C-N-CA 123.743 0.687 . . . . 10.0 112.465 -170.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.8 t 33.06 88.78 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.242 0.682 0 C-N-CA 128.399 2.68 . . . . 10.0 116.905 166.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.4 m -79.63 -50.85 10.04 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.163 -1.38 . . . . 10.0 113.868 174.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -49.02 117.58 6.59 Favored Pre-proline 0 CA--C 1.536 0.418 0 O-C-N 124.767 1.292 . . . . 10.0 110.95 -172.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -58.62 -29.61 89.69 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 123.721 2.947 . . . . 10.0 113.688 179.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.32 -60.64 2.3 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.08 0.552 . . . . 10.0 111.436 176.179 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.12 -40.11 22.54 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 125.134 1.373 . . . . 10.0 113.58 171.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -46.5 -47.5 19.37 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.21 1.404 . . . . 10.0 113.425 172.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -57.73 -53.01 63.02 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.452 0.701 . . . . 10.0 111.036 176.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.477 ' CD2' ' HB1' ' A' ' 228' ' ' ALA . 43.9 m-85 -56.98 -50.21 73.39 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 123.057 0.543 . . . . 10.0 112.348 -179.174 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -54.39 -51.27 65.36 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 118.966 -0.54 . . . . 10.0 112.369 173.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.39 -62.08 1.86 Allowed 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 113.353 0.871 . . . . 10.0 113.353 177.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.6 mt -48.62 -58.85 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 C-N-CA 124.862 1.265 . . . . 10.0 110.844 178.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 86.7 m -71.1 -13.67 62.04 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 114.128 1.159 . . . . 10.0 114.128 -173.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 29.3 m -85.26 -42.9 14.23 Favored 'General case' 0 N--CA 1.482 1.159 0 CA-C-N 120.422 1.465 . . . . 10.0 112.099 171.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 17.7 mt -56.31 -42.98 78.49 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 112.845 0.683 . . . . 10.0 112.845 174.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 37.7 t -48.76 -62.03 2.72 Favored Pre-proline 0 CA--C 1.551 1.001 0 C-N-CA 124.861 1.265 . . . . 10.0 112.728 178.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -49.92 -45.84 30.59 Favored 'Trans proline' 0 CA--C 1.543 0.934 0 C-N-CA 124.104 3.203 . . . . 10.0 115.846 164.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.0 -49.36 77.75 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 114.162 1.171 . . . . 10.0 114.162 -175.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . 0.274 16.1 tt -68.09 -36.08 74.03 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 O-C-N 120.598 -1.313 . . . . 10.0 111.421 173.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.65 -42.09 92.0 Favored 'General case' 0 CA--C 1.545 0.771 0 O-C-N 121.193 -0.942 . . . . 10.0 112.729 173.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -50.82 -56.05 13.99 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.541 1.537 . . . . 10.0 111.647 168.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 14.0 m -48.04 -53.37 16.56 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.653 1.581 . . . . 10.0 111.2 176.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 32.4 mmt -68.57 -48.25 64.69 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 123.966 0.907 . . . . 10.0 113.011 -176.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -56.06 -41.13 74.62 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 120.035 1.289 . . . . 10.0 113.342 173.084 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.8 tp -53.28 -54.6 33.96 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-N 119.54 1.064 . . . . 10.0 111.273 170.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 24.1 p -51.73 -41.0 61.2 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 115.217 1.562 . . . . 10.0 115.217 179.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 58.5 mtm -66.86 -50.89 61.08 Favored 'General case' 0 C--N 1.333 -0.122 0 C-N-CA 123.589 0.756 . . . . 10.0 110.491 176.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.4 tp -48.51 -52.73 21.05 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.849 0.86 . . . . 10.0 112.931 172.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.5 mt -76.89 -5.53 48.79 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 113.844 1.053 . . . . 10.0 113.844 -177.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.2 -34.63 5.61 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 115.579 0.992 . . . . 10.0 115.579 174.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -49.35 -43.05 43.56 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 115.273 1.583 . . . . 10.0 115.273 -176.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.04 3.55 61.07 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 115.314 0.885 . . . . 10.0 115.314 -179.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.28 143.42 26.42 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 127.035 2.134 . . . . 10.0 108.972 172.063 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 t -145.54 171.08 15.19 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 124.031 0.932 . . . . 10.0 111.052 166.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.95 136.1 53.36 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 123.922 0.889 . . . . 10.0 109.711 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.436 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 58.6 t -129.59 129.55 23.17 Favored Pre-proline 0 C--N 1.329 -0.315 0 C-N-CA 125.1 1.36 . . . . 10.0 110.935 -176.045 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 69' ' ' VAL . 6.2 Cg_exo -80.7 116.24 3.18 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 N-CA-C 109.441 -1.023 . . . . 10.0 109.441 -178.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -156.75 164.38 38.19 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.808 0.67 . . . . 10.0 112.808 172.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.4 -81.98 0.14 Allowed Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.681 -0.967 . . . . 10.0 110.681 175.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.76 -3.42 0.69 Allowed Glycine 0 CA--C 1.527 0.812 0 N-CA-C 118.627 2.211 . . . . 10.0 118.627 170.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -151.57 -171.89 4.06 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 119.379 1.59 . . . . 10.0 112.237 -165.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -91.79 93.81 9.04 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 125.552 1.541 . . . . 10.0 111.115 -175.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.449 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 60.2 m-80 -89.47 120.74 69.65 Favored Pre-proline 0 N--CA 1.45 -0.464 0 N-CA-C 113.002 0.741 . . . . 10.0 113.002 -165.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.653 ' HB3' HG21 ' A' ' 5' ' ' THR . 76.3 Cg_exo -61.49 131.9 38.2 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 124.183 3.255 . . . . 10.0 112.166 171.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.6 mm -140.1 126.35 22.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 C-N-CA 126.028 1.731 . . . . 10.0 111.707 -179.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -93.64 85.06 4.76 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 123.455 1.598 . . . . 10.0 113.051 174.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 63.8 p-90 -59.44 -28.21 66.75 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 120.453 -1.404 . . . . 10.0 113.942 174.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -54.68 -35.47 63.6 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.283 1.033 . . . . 10.0 113.595 178.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -63.79 -23.7 67.46 Favored 'General case' 0 N--CA 1.479 1.022 0 O-C-N 120.341 -1.474 . . . . 10.0 113.667 172.514 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 68.7 m-85 -78.46 -42.04 30.99 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 120.564 -1.335 . . . . 10.0 111.92 172.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -49.62 -49.62 46.21 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 125.164 1.385 . . . . 10.0 111.032 166.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -51.66 -69.45 0.11 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 126.769 2.027 . . . . 10.0 111.765 169.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 49.5 m0 -55.77 -35.6 66.41 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 124.407 1.083 . . . . 10.0 113.182 -172.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 28.7 tp -49.06 -46.08 43.9 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 126.277 1.831 . . . . 10.0 111.84 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -98.18 -40.35 8.42 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.805 0.842 . . . . 10.0 112.435 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 3.7 m -48.46 -57.83 5.54 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.864 1.266 . . . . 10.0 113.424 175.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . 0.286 38.3 p -67.08 -41.31 34.34 Favored Pre-proline 0 CA--C 1.544 0.736 0 CA-C-O 117.774 -1.108 . . . . 10.0 113.764 -168.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -54.14 -44.98 44.46 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 123.282 2.655 . . . . 10.0 115.998 166.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 54.5 mt -59.56 -45.73 90.96 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 118.959 0.799 . . . . 10.0 111.218 175.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.1 tp -50.94 -48.98 60.75 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.419 1.487 . . . . 10.0 112.136 172.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.0 mp -58.83 -47.15 85.85 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 125.339 1.456 . . . . 10.0 112.68 170.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.76 -38.31 78.18 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 123.87 0.868 . . . . 10.0 112.891 178.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 -52.27 -54.05 36.23 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 119.31 0.959 . . . . 10.0 111.165 169.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.34 -42.12 88.58 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.637 0.775 . . . . 10.0 112.1 -178.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.72 -54.66 39.0 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 123.991 0.916 . . . . 10.0 112.034 173.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.32 -41.18 79.44 Favored 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 123.724 0.81 . . . . 10.0 112.739 174.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.8 tp -63.77 -38.5 91.32 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 114.476 1.287 . . . . 10.0 114.476 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.2 t -94.84 1.44 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 125.075 1.35 . . . . 10.0 112.275 179.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.2 t70 48.5 53.55 11.89 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.874 1.67 . . . . 10.0 112.137 -173.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.28 145.89 47.57 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 120.002 -1.686 . . . . 10.0 112.46 -174.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.54 135.96 54.45 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 112.697 0.628 . . . . 10.0 112.697 175.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -42.88 -39.67 2.63 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.844 1.657 . . . . 10.0 113.489 175.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -47.33 -60.21 5.33 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 125.15 1.357 . . . . 10.0 115.234 169.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.4 p -62.06 -46.79 87.55 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 117.103 -1.427 . . . . 10.0 111.34 178.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 66.8 mt -48.41 -52.91 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 125.034 1.334 . . . . 10.0 111.127 178.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.2 tp -62.61 -51.3 67.86 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 112.574 0.583 . . . . 10.0 112.574 179.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.17 -44.85 43.27 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.465 0.706 . . . . 10.0 110.938 174.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.455 ' HA ' HD12 ' A' ' 111' ' ' LEU . 0.6 OUTLIER -59.67 -59.83 4.81 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 127.344 2.257 . . . . 10.0 114.807 174.989 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.5 t -61.01 -46.37 96.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 123.705 0.802 . . . . 10.0 111.387 -178.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -56.59 -50.32 63.88 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 123.668 0.651 . . . . 10.0 112.664 174.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -54.9 -46.56 74.84 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 113.322 0.86 . . . . 10.0 113.322 173.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -55.36 -48.54 74.1 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.16 0.984 . . . . 10.0 111.276 173.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -43.02 -54.91 5.08 Favored Glycine 0 CA--C 1.533 1.213 0 C-N-CA 124.938 1.256 . . . . 10.0 113.267 169.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 82.5 mt -57.75 -52.3 59.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 123.694 0.798 . . . . 10.0 111.899 173.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 60.2 ttp -47.51 -58.09 4.63 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.312 1.445 . . . . 10.0 111.731 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 37.6 mm . . . . . 0 N--CA 1.474 0.727 0 O-C-N 121.807 -0.558 . . . . 10.0 112.169 178.796 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 65.5 t . . . . . 0 N--CA 1.476 0.838 0 N-CA-C 110.127 -0.323 . . . . 10.0 110.127 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -50.84 -60.76 6.68 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 126.227 1.87 . . . . 10.0 112.561 171.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -42.95 -42.21 3.66 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 127.488 2.315 . . . . 10.0 113.335 176.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 48.5 mt -100.9 -6.5 24.57 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 115.526 1.676 . . . . 10.0 115.526 -175.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 16.9 m -69.75 116.76 10.51 Favored 'General case' 0 N--CA 1.464 0.248 0 O-C-N 120.157 -1.589 . . . . 10.0 110.344 -178.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.62 ' H ' ' HD3' ' A' ' 129' ' ' LYS . 0.1 OUTLIER -55.46 -49.6 72.05 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 128.195 2.598 . . . . 10.0 113.287 177.748 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 61.3 t -69.74 106.34 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 123.774 0.83 . . . . 10.0 110.067 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -46.93 -59.5 3.05 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 124.737 1.215 . . . . 10.0 114.062 -173.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 m -46.46 -42.11 14.95 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.531 1.533 . . . . 10.0 113.49 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -70.17 -24.59 63.17 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 114.946 1.461 . . . . 10.0 114.946 -178.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 68.9 mtp85 -53.98 -41.74 68.21 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 118.914 0.779 . . . . 10.0 110.793 176.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -69.46 -32.08 70.77 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.813 1.245 . . . . 10.0 114.219 176.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.9 t -55.01 -51.85 49.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 CA-C-N 119.037 0.835 . . . . 10.0 109.654 168.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 67.4 m95 -61.64 -45.49 93.83 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 114.392 1.256 . . . . 10.0 114.392 175.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 88.1 t90 -51.66 -49.35 62.48 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.235 1.014 . . . . 10.0 112.71 172.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.614 0 C-N-CA 124.072 0.949 . . . . 10.0 112.03 177.073 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.818 0 N-CA-C 112.71 0.633 . . . . 10.0 112.71 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 40.3 ttp -56.16 -54.86 40.07 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.257 1.023 . . . . 10.0 112.09 172.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 8.1 tt -51.11 -50.57 58.54 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 125.941 1.697 . . . . 10.0 111.08 178.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 77.8 t80 -50.47 -54.91 18.51 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.169 0.988 . . . . 10.0 112.798 172.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 54.6 mt -53.6 -55.05 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 123.809 0.844 . . . . 10.0 110.775 177.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 44.4 mt -57.37 -35.88 70.53 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 118.349 -0.834 . . . . 10.0 112.957 178.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -57.26 -58.15 9.5 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 124.015 0.926 . . . . 10.0 113.041 173.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.44 -40.9 85.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-O 118.355 -0.831 . . . . 10.0 111.465 177.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 45.2 mt -56.79 -49.4 75.43 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 119.862 1.21 . . . . 10.0 112.131 171.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.469 ' HA ' ' HD2' ' A' ' 175' ' ' ARG . 11.9 t80 -77.01 -70.33 0.47 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 120.088 -1.632 . . . . 10.0 112.901 -175.29 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -73.66 -21.98 60.1 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.615 1.166 . . . . 10.0 113.431 -174.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -87.79 -79.12 1.26 Allowed Glycine 0 CA--C 1.527 0.783 0 C-N-CA 123.625 0.631 . . . . 10.0 113.496 171.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -53.63 -32.38 51.08 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 126.269 1.828 . . . . 10.0 113.067 -166.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.2 m -52.16 -56.44 14.57 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 114.01 1.115 . . . . 10.0 114.01 172.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.7 p -53.63 -50.61 65.34 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 122.087 0.946 . . . . 10.0 112.271 -177.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 47.7 tttm -57.09 -46.1 82.81 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.197 0.999 . . . . 10.0 112.107 173.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.76 -47.49 79.97 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 114.563 1.32 . . . . 10.0 114.563 174.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -56.47 -11.31 1.22 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 126.087 1.755 . . . . 10.0 114.261 177.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.2 m -107.09 6.67 29.11 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.374 1.87 . . . . 10.0 114.877 -179.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 93.3 mmm -91.92 -92.69 0.15 Allowed 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 123.451 1.596 . . . . 10.0 114.171 -170.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -138.63 153.96 72.79 Favored Pre-proline 0 C--O 1.236 0.349 0 C-N-CA 129.833 3.253 . . . . 10.0 105.573 170.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -52.85 -46.21 35.35 Favored 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 122.338 2.025 . . . . 10.0 113.083 179.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.667 ' CD ' ' HD3' ' A' ' 227' ' ' ARG . 0.1 OUTLIER -52.99 -46.05 68.12 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 129.014 2.926 . . . . 10.0 113.266 173.577 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 91.5 t -69.26 -53.0 27.72 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 C-N-CA 124.006 0.922 . . . . 10.0 109.788 -178.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.07 -46.89 75.46 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.3 0.64 . . . . 10.0 111.923 177.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 59.9 p -59.99 -56.13 25.42 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.883 0.873 . . . . 10.0 112.742 174.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 61.8 m -57.23 -53.19 60.86 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.185 0.994 . . . . 10.0 113.011 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -49.61 -49.47 46.71 Favored 'General case' 0 C--O 1.222 -0.387 0 C-N-CA 123.324 0.65 . . . . 10.0 111.1 174.121 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -57.12 -48.46 78.6 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 114.671 1.36 . . . . 10.0 114.671 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 40.3 t -55.98 -49.54 74.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 CA-C-N 118.802 0.728 . . . . 10.0 110.541 176.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 93.8 mt -58.57 -51.65 69.01 Favored 'General case' 0 C--O 1.222 -0.39 0 N-CA-C 113.196 0.813 . . . . 10.0 113.196 175.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . 0.469 ' HD2' ' HA ' ' A' ' 153' ' ' PHE . 35.4 ttp180 -47.76 -47.76 30.33 Favored 'General case' 0 C--O 1.225 -0.201 0 C-N-CA 126.831 2.052 . . . . 10.0 111.095 174.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 63.8 m-20 -58.5 -58.4 8.71 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 122.836 0.454 . . . . 10.0 111.232 174.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 54.5 t -52.13 -46.77 44.03 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 124.067 0.947 . . . . 10.0 112.052 179.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 28.8 m -60.39 -61.79 2.34 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 127.818 2.447 . . . . 10.0 111.874 178.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 55.8 t -50.91 -50.42 23.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 124.667 1.187 . . . . 10.0 110.928 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 80.3 t -59.49 -63.01 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 124.047 0.939 . . . . 10.0 111.889 177.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 68.9 mt -53.29 -50.75 64.23 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 119.183 0.901 . . . . 10.0 112.144 -178.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 10.1 m95 . . . . . 0 N--CA 1.465 0.309 0 C-N-CA 124.116 0.966 . . . . 10.0 112.275 177.482 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 2.7 p . . . . . 0 N--CA 1.482 1.133 0 CA-C-O 118.861 -0.59 . . . . 10.0 112.083 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 59.8 t90 -56.73 -51.96 66.81 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.372 0.669 . . . . 10.0 112.422 173.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 25.8 tp -54.9 -44.95 74.6 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.49 1.116 . . . . 10.0 112.197 -178.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 14.6 pt -86.28 -5.5 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 N-CA-C 115.246 1.573 . . . . 10.0 115.246 -177.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.57 -169.26 32.74 Favored Glycine 0 N--CA 1.45 -0.383 0 CA-C-O 122.573 1.096 . . . . 10.0 113.83 -168.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 23.3 t -53.12 -41.65 65.25 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 114.203 -0.999 . . . . 10.0 111.858 177.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -66.9 -17.18 64.78 Favored 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 115.559 1.688 . . . . 10.0 115.559 -175.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -131.08 -105.87 1.08 Allowed Glycine 0 CA--C 1.532 1.106 0 CA-C-N 120.397 1.453 . . . . 10.0 113.914 -172.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -89.45 127.12 35.81 Favored 'General case' 0 C--N 1.328 -0.345 0 O-C-N 120.663 -1.492 . . . . 10.0 109.3 168.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -72.44 65.29 1.35 Allowed Glycine 0 CA--C 1.531 1.064 0 N-CA-C 113.925 0.33 . . . . 10.0 113.925 173.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 60.7 mt -79.56 -42.72 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 126.077 1.751 . . . . 10.0 108.725 166.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 79.8 t -126.32 133.41 24.94 Favored Pre-proline 0 N--CA 1.454 -0.25 0 C-N-CA 126.468 1.907 . . . . 10.0 109.368 -174.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -68.79 153.78 72.36 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 123.781 2.988 . . . . 10.0 111.461 -176.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 12.2 tp -43.14 -39.82 3.0 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.375 1.07 . . . . 10.0 112.17 171.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -48.33 -52.35 22.01 Favored 'General case' 0 CA--C 1.539 0.519 0 N-CA-C 114.728 1.381 . . . . 10.0 114.728 176.044 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 14.0 mm -75.98 -40.48 38.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 124.366 1.066 . . . . 10.0 109.625 177.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -49.26 -49.82 41.68 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 118.603 0.638 . . . . 10.0 111.981 173.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 16.2 m -57.74 -46.97 83.74 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 126.04 1.736 . . . . 10.0 112.964 174.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.536 HD23 ' CD2' ' A' ' 12' ' ' TRP . 1.3 tm? -63.4 -52.28 62.27 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.992 0.917 . . . . 10.0 112.101 179.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 93.2 mt -52.56 -59.17 4.78 Favored 'General case' 0 C--N 1.335 -0.044 0 C-N-CA 124.32 1.048 . . . . 10.0 110.003 176.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -52.29 -47.3 65.96 Favored 'General case' 0 C--O 1.217 -0.64 0 CA-C-O 117.425 -1.274 . . . . 10.0 112.164 176.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' MET . . . . . 0.575 ' HE2' ' HB3' ' A' ' 15' ' ' LEU . 4.6 tmm? -52.03 -51.7 55.73 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 121.073 1.76 . . . . 10.0 113.001 175.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 78.7 t -60.39 -50.0 82.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 124.646 1.178 . . . . 10.0 111.278 178.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 5.2 mp -57.52 -51.18 70.5 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.884 1.674 . . . . 10.0 112.044 175.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -56.96 -57.72 11.3 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 127.36 2.264 . . . . 10.0 110.706 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 97.3 t . . . . . 0 N--CA 1.478 0.952 0 O-C-N 121.001 -1.062 . . . . 10.0 111.417 177.802 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.281 0 CA-C-O 121.095 0.275 . . . . 10.0 113.118 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -45.45 -55.66 5.88 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.476 1.91 . . . . 10.0 112.27 166.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -55.58 -40.01 76.98 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 124.008 0.813 . . . . 10.0 113.754 178.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 24.9 mt -70.08 -27.41 64.59 Favored 'General case' 0 CA--C 1.512 -0.502 0 N-CA-C 115.833 1.79 . . . . 10.0 115.833 176.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 74.3 mt -63.49 -57.53 11.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 108.59 -0.893 . . . . 10.0 108.59 165.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 32.0 tp -58.77 -64.68 0.85 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.918 0.887 . . . . 10.0 113.206 -172.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 84.2 mt -71.53 5.19 2.51 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 115.304 1.594 . . . . 10.0 115.304 -171.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.6 mtp-105 -112.35 0.35 15.64 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.211 1.005 . . . . 10.0 113.303 172.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 8.8 t -108.03 177.94 4.66 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 124.058 0.943 . . . . 10.0 111.032 174.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 227' ' ' ARG . . . . . 0.667 ' HD3' ' CD ' ' A' ' 166' ' ' GLU . 41.8 ttt180 -71.59 98.15 1.83 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.732 0.813 . . . . 10.0 110.977 170.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . 0.477 ' HB1' ' CD2' ' A' ' 42' ' ' PHE . . . -80.9 77.03 7.82 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.874 0.87 . . . . 10.0 112.095 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 40.19 102.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 128.866 2.866 . . . . 10.0 116.474 177.686 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . 0.481 0.3 OUTLIER 71.81 -55.41 0.66 Allowed 'General case' 0 C--O 1.243 0.714 0 C-N-CA 124.769 1.227 . . . . 10.0 110.603 -175.305 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -68.3 169.47 40.07 Favored Glycine 0 C--O 1.239 0.417 0 C-N-CA 129.76 3.552 . . . . 10.0 119.619 171.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.461 0 C-N-CA 128.476 2.711 . . . . 10.0 113.44 166.603 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 N--CA 1.477 0.881 0 CA-C-O 115.781 -2.057 . . . . 10.0 105.842 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 23.36 91.91 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 129.588 3.155 . . . . 10.0 117.227 160.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 28.6 65.03 0.11 Allowed 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 128.307 2.643 . . . . 10.0 114.529 155.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 86.5 mt -56.41 137.91 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 126.396 1.878 . . . . 10.0 113.372 -158.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.653 HG21 ' HB3' ' A' ' 77' ' ' PRO . 7.6 t -136.75 -165.2 1.7 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 126.327 1.851 . . . . 10.0 114.015 -174.315 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 70.0 2.83 41.1 Favored Glycine 0 C--N 1.339 0.743 0 C-N-CA 127.496 2.474 . . . . 10.0 111.485 168.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -158.55 -51.32 0.01 OUTLIER Pre-proline 0 N--CA 1.443 -0.783 0 CA-C-O 114.301 -2.761 . . . . 10.0 116.649 -168.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_exo -63.93 -60.72 0.14 Allowed 'Trans proline' 0 N--CA 1.465 -0.186 0 CA-C-N 123.538 2.299 . . . . 10.0 113.194 -175.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.41 ' H ' ' CD ' ' A' ' 9' ' ' GLU . 7.9 pm0 -67.21 4.34 0.96 Allowed 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 127.886 2.475 . . . . 10.0 115.732 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.422 ' CG ' ' N ' ' A' ' 11' ' ' ILE . 11.0 p-90 -51.38 -43.12 61.8 Favored 'General case' 0 C--O 1.223 -0.315 0 O-C-N 121.509 -0.744 . . . . 10.0 112.618 176.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.422 ' N ' ' CG ' ' A' ' 10' ' ' TRP . 8.9 tt -60.87 -49.59 84.0 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.34 0 C-N-CA 123.872 0.869 . . . . 10.0 109.344 179.394 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . 0.535 ' CD2' HD23 ' A' ' 206' ' ' LEU . 2.6 m95 -55.32 -52.69 62.65 Favored 'General case' 0 C--O 1.224 -0.259 0 C-N-CA 123.406 0.682 . . . . 10.0 111.877 175.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.4 mt -57.34 -53.64 55.79 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 123.188 0.595 . . . . 10.0 112.224 177.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.83 -46.81 51.61 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.353 1.461 . . . . 10.0 113.33 173.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.575 ' HB3' ' HE2' ' A' ' 209' ' ' MET . 13.3 tp -65.63 -44.95 84.88 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.277 1.431 . . . . 10.0 113.059 179.077 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.5 -57.03 9.83 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 124.549 1.071 . . . . 10.0 111.274 165.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.1 m -49.26 -52.53 26.74 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.985 1.314 . . . . 10.0 112.232 174.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.44 -58.86 5.83 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.151 0.98 . . . . 10.0 112.161 177.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 99.6 mt -58.0 -49.07 78.11 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.471 0.709 . . . . 10.0 112.537 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 23.9 mmt -55.61 -49.22 73.38 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.858 0.863 . . . . 10.0 111.359 176.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -58.29 -58.43 14.61 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 124.388 0.994 . . . . 10.0 113.438 176.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 81.0 mt -56.24 -46.01 79.75 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-N 118.634 1.217 . . . . 10.0 112.132 176.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.73 -41.76 75.96 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 124.714 1.15 . . . . 10.0 113.242 173.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 28.2 m -62.38 -58.49 7.46 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.833 0.853 . . . . 10.0 111.347 172.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -52.27 -41.0 62.47 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.981 0.912 . . . . 10.0 110.977 177.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -55.75 -58.03 9.52 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 124.641 1.176 . . . . 10.0 112.967 172.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.1 m-30 -59.67 -38.7 82.19 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 113.223 0.823 . . . . 10.0 113.223 178.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.401 ' C ' ' H ' ' A' ' 30' ' ' LYS . 11.9 mt -56.04 -67.47 0.29 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.629 1.171 . . . . 10.0 113.65 169.104 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 t -76.34 40.89 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 CA-C-O 123.727 1.727 . . . . 10.0 110.866 179.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.401 ' H ' ' C ' ' A' ' 28' ' ' LEU . 42.8 tttm -140.8 -44.85 0.39 Allowed 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 127.915 2.486 . . . . 10.0 109.347 171.157 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.96 23.11 0.87 Allowed Glycine 0 CA--C 1.529 0.925 0 N-CA-C 115.629 1.012 . . . . 10.0 115.629 173.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 37.3 mmm -59.5 -45.0 92.96 Favored 'General case' 0 C--O 1.225 -0.211 0 C-N-CA 127.17 2.188 . . . . 10.0 113.571 -178.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.71 -84.41 1.19 Allowed Glycine 0 CA--C 1.531 1.045 0 C-N-CA 123.775 0.702 . . . . 10.0 112.446 -170.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.8 t 33.09 88.75 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.243 0.73 0 C-N-CA 128.399 2.68 . . . . 10.0 116.941 166.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.6 m -79.65 -50.92 9.93 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.23 -1.35 . . . . 10.0 113.828 174.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -48.87 117.51 6.37 Favored Pre-proline 0 CA--C 1.536 0.416 0 O-C-N 124.765 1.291 . . . . 10.0 110.972 -172.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -58.56 -29.68 89.64 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 123.757 2.971 . . . . 10.0 113.669 179.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.31 -60.66 2.29 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.126 0.57 . . . . 10.0 111.457 176.227 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.12 -40.08 22.45 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 125.134 1.373 . . . . 10.0 113.58 171.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -46.56 -47.42 19.71 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.22 1.408 . . . . 10.0 113.447 172.029 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -57.72 -53.1 62.01 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.5 0.72 . . . . 10.0 110.992 176.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.477 ' CD2' ' HB1' ' A' ' 228' ' ' ALA . 43.9 m-85 -57.02 -50.21 73.42 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 123.084 0.554 . . . . 10.0 112.315 -179.076 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -54.3 -51.29 65.1 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 118.966 -0.54 . . . . 10.0 112.401 173.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.41 -62.01 1.91 Allowed 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 113.386 0.884 . . . . 10.0 113.386 177.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.4 mt -48.61 -57.76 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 124.867 1.267 . . . . 10.0 110.287 178.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.5 m -68.36 -17.74 64.31 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.114 1.365 . . . . 10.0 113.639 -172.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 27.4 m -87.12 -40.84 14.27 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 119.583 1.083 . . . . 10.0 112.137 174.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 22.0 mt -59.27 -40.98 87.77 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 121.359 -0.838 . . . . 10.0 112.835 171.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 22.7 t -43.9 -60.6 2.56 Favored Pre-proline 0 CA--C 1.549 0.941 0 C-N-CA 126.238 1.815 . . . . 10.0 113.395 176.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -72.27 -28.29 15.47 Favored 'Trans proline' 0 CA--C 1.546 1.108 0 C-N-CA 123.083 2.522 . . . . 10.0 114.182 172.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.98 -48.72 79.08 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 120.734 1.606 . . . . 10.0 113.927 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 19.5 tt -68.3 -36.16 73.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 O-C-N 120.249 -1.532 . . . . 10.0 111.376 173.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.29 -43.34 78.75 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 119.093 0.86 . . . . 10.0 112.74 171.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -50.96 -56.78 10.76 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.214 1.405 . . . . 10.0 111.68 168.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.7 m -47.88 -53.34 16.05 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 125.411 1.484 . . . . 10.0 111.18 176.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 32.7 mmt -69.09 -48.18 63.3 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 124.176 0.99 . . . . 10.0 112.871 -176.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -55.86 -41.38 74.27 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 120.203 1.365 . . . . 10.0 113.238 172.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.8 tp -53.31 -54.55 34.77 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-N 119.671 1.123 . . . . 10.0 111.301 170.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 24.0 p -51.65 -41.06 61.06 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 115.207 1.558 . . . . 10.0 115.207 179.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 56.9 mtm -66.86 -50.89 61.09 Favored 'General case' 0 C--N 1.334 -0.09 0 C-N-CA 123.597 0.759 . . . . 10.0 110.477 176.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.3 tp -48.62 -52.69 21.8 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.862 0.865 . . . . 10.0 112.904 172.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.4 mt -76.87 -5.53 48.77 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 113.848 1.055 . . . . 10.0 113.848 -177.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.24 -34.71 5.55 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 115.558 0.983 . . . . 10.0 115.558 174.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 75.3 t80 -49.28 -43.09 42.88 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 115.243 1.572 . . . . 10.0 115.243 -176.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.04 3.55 61.07 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 115.314 0.885 . . . . 10.0 115.314 -179.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.25 143.4 26.45 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 127.034 2.133 . . . . 10.0 109.031 172.015 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 t -145.51 171.09 15.17 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 124.081 0.952 . . . . 10.0 111.06 166.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.97 136.06 53.38 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 123.885 0.874 . . . . 10.0 109.722 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.437 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 58.5 t -129.56 129.64 23.19 Favored Pre-proline 0 C--N 1.33 -0.261 0 C-N-CA 125.043 1.337 . . . . 10.0 110.982 -176.109 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 69' ' ' VAL . 6.3 Cg_exo -80.76 116.24 3.16 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 N-CA-C 109.411 -1.034 . . . . 10.0 109.411 -178.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -156.71 164.41 38.17 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.808 0.669 . . . . 10.0 112.808 172.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.34 -81.92 0.14 Allowed Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.685 -0.966 . . . . 10.0 110.685 175.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.76 -3.37 0.69 Allowed Glycine 0 CA--C 1.527 0.822 0 N-CA-C 118.671 2.228 . . . . 10.0 118.671 170.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -151.6 -171.87 4.06 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 119.343 1.571 . . . . 10.0 112.187 -165.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -91.86 93.91 9.06 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 125.521 1.528 . . . . 10.0 111.097 -175.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.449 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 60.1 m-80 -89.47 120.74 69.65 Favored Pre-proline 0 C--N 1.326 -0.452 0 N-CA-C 113.001 0.741 . . . . 10.0 113.001 -165.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.653 ' HB3' HG21 ' A' ' 5' ' ' THR . 76.4 Cg_exo -61.47 131.93 38.37 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 124.16 3.24 . . . . 10.0 112.167 171.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.6 mm -140.13 126.33 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 C-N-CA 126.043 1.737 . . . . 10.0 111.682 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -93.61 85.02 4.76 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 123.316 1.531 . . . . 10.0 113.051 174.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 63.5 p-90 -59.32 -28.3 66.68 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 120.588 -1.32 . . . . 10.0 113.965 174.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -54.39 -35.88 63.33 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 114.152 1.167 . . . . 10.0 114.152 178.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 1.5 ptp180 -63.67 -25.84 68.39 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 120.419 -1.426 . . . . 10.0 113.926 174.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -76.96 -41.94 41.14 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 121.22 -0.925 . . . . 10.0 111.845 172.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -49.48 -48.62 47.68 Favored 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 125.192 1.397 . . . . 10.0 111.5 167.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -52.86 -69.77 0.11 Allowed 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 126.078 1.751 . . . . 10.0 111.671 168.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 53.4 m0 -56.8 -32.97 66.22 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 124.428 1.091 . . . . 10.0 113.042 -169.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 29.4 tp -48.74 -44.15 38.25 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 125.858 1.663 . . . . 10.0 111.721 176.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -99.44 -42.21 7.06 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.845 0.858 . . . . 10.0 112.402 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 76.8 p -61.72 -45.3 94.54 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 120.335 1.425 . . . . 10.0 113.913 -177.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . 0.325 74.8 p -60.66 -46.95 97.2 Favored Pre-proline 0 CA--C 1.546 0.826 0 CA-C-O 117.568 -1.206 . . . . 10.0 113.54 -178.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -54.65 -44.05 53.28 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 123.24 2.627 . . . . 10.0 115.725 169.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 51.1 mt -59.25 -45.75 90.35 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 121.433 -0.792 . . . . 10.0 111.398 175.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.8 tp -51.84 -48.88 63.77 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.437 1.495 . . . . 10.0 112.044 172.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.9 mp -57.81 -47.71 81.84 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.929 1.291 . . . . 10.0 112.392 170.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.87 -38.24 78.33 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 119.12 0.873 . . . . 10.0 112.891 179.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -52.28 -54.05 36.32 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 119.285 0.948 . . . . 10.0 111.165 169.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.34 -42.12 88.62 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.621 0.768 . . . . 10.0 112.151 -178.518 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.62 -54.73 37.68 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.958 0.903 . . . . 10.0 112.049 173.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.39 -41.15 79.69 Favored 'General case' 0 C--O 1.224 -0.237 0 C-N-CA 123.729 0.812 . . . . 10.0 112.667 174.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.9 tp -63.7 -38.61 91.75 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 114.481 1.289 . . . . 10.0 114.481 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.2 t -94.8 1.46 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 125.089 1.356 . . . . 10.0 112.304 179.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.3 t70 48.48 53.53 11.91 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.848 1.659 . . . . 10.0 112.137 -173.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.29 145.89 47.55 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 120.0 -1.688 . . . . 10.0 112.44 -174.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.47 135.89 54.17 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 112.711 0.634 . . . . 10.0 112.711 175.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -42.85 -39.69 2.61 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.857 1.663 . . . . 10.0 113.471 175.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -47.33 -60.25 5.3 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 125.15 1.357 . . . . 10.0 115.233 169.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.6 p -62.02 -46.72 87.95 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 117.103 -1.427 . . . . 10.0 111.351 178.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 66.9 mt -48.49 -52.87 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 124.998 1.319 . . . . 10.0 111.146 178.196 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.2 tp -62.63 -51.29 67.85 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 112.556 0.576 . . . . 10.0 112.556 179.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.14 -44.9 42.97 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.506 0.722 . . . . 10.0 110.934 174.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.455 ' HA ' HD12 ' A' ' 111' ' ' LEU . 0.6 OUTLIER -59.61 -59.88 4.74 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 127.361 2.264 . . . . 10.0 114.778 175.005 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.7 t -60.97 -46.42 96.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 123.735 0.814 . . . . 10.0 111.398 -178.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -56.59 -50.32 63.86 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 123.641 0.639 . . . . 10.0 112.674 174.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -54.59 -46.72 73.81 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 113.261 0.837 . . . . 10.0 113.261 173.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 51.2 t0 -58.17 -45.27 87.81 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.597 0.759 . . . . 10.0 112.008 174.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -43.51 -55.74 5.14 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 125.114 1.34 . . . . 10.0 113.575 166.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 85.8 mt -55.45 -57.12 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 CA-C-O 118.438 -0.791 . . . . 10.0 110.631 173.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 48.1 ttp -44.93 -55.29 5.6 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.704 1.602 . . . . 10.0 113.28 -177.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 41.5 mm . . . . . 0 N--CA 1.474 0.735 0 O-C-N 121.703 -0.623 . . . . 10.0 111.716 177.303 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 67.6 t . . . . . 0 N--CA 1.477 0.877 0 N-CA-C 110.31 -0.256 . . . . 10.0 110.31 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -50.11 -60.87 6.23 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 126.086 1.803 . . . . 10.0 112.271 172.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -48.57 -37.66 18.53 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 126.427 1.891 . . . . 10.0 113.792 179.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 49.0 mt -99.22 -6.62 27.8 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 115.309 1.596 . . . . 10.0 115.309 -179.023 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 16.9 m -69.69 116.75 10.45 Favored 'General case' 0 N--CA 1.464 0.274 0 O-C-N 120.186 -1.571 . . . . 10.0 110.387 -178.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.62 ' H ' ' HD3' ' A' ' 129' ' ' LYS . 0.2 OUTLIER -55.48 -49.6 72.1 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 128.231 2.613 . . . . 10.0 113.251 177.747 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 61.1 t -69.72 106.42 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 123.746 0.818 . . . . 10.0 110.065 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -46.93 -59.57 3.01 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 124.779 1.231 . . . . 10.0 114.043 -173.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 m -46.43 -42.12 14.8 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.463 1.505 . . . . 10.0 113.485 179.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -70.15 -24.61 63.19 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 114.918 1.451 . . . . 10.0 114.918 -178.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 68.9 mtp85 -53.9 -41.67 67.86 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 118.93 0.786 . . . . 10.0 110.847 176.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -69.87 -31.61 69.53 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 114.354 1.242 . . . . 10.0 114.354 176.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.8 t -55.22 -52.23 47.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 CA-C-N 119.03 0.832 . . . . 10.0 109.543 168.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 66.1 m95 -61.72 -42.88 99.54 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 114.37 1.248 . . . . 10.0 114.37 174.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 88.9 t90 -52.78 -50.26 63.93 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.082 0.953 . . . . 10.0 112.415 171.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.532 0 C-N-CA 124.315 1.046 . . . . 10.0 111.737 178.308 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.806 0 N-CA-C 112.601 0.593 . . . . 10.0 112.601 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 38.4 ttp -55.23 -55.57 29.86 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.262 1.025 . . . . 10.0 112.163 171.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -51.71 -49.81 61.74 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.651 1.58 . . . . 10.0 111.213 179.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 77.8 t80 -50.22 -55.06 16.84 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.947 0.899 . . . . 10.0 112.687 172.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 55.6 mt -53.71 -55.09 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 123.871 0.868 . . . . 10.0 110.692 177.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 41.3 mt -57.32 -35.86 70.41 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 118.334 -0.841 . . . . 10.0 112.948 178.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -57.29 -58.19 9.32 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 124.051 0.941 . . . . 10.0 113.041 173.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.38 -40.9 85.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 CA-C-O 118.303 -0.855 . . . . 10.0 111.44 177.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 44.9 mt -56.84 -49.42 75.51 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 119.897 1.226 . . . . 10.0 112.107 171.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.471 ' HA ' ' HD2' ' A' ' 175' ' ' ARG . 12.0 t80 -77.01 -70.32 0.47 Allowed 'General case' 0 C--N 1.326 -0.447 0 O-C-N 120.022 -1.674 . . . . 10.0 112.852 -175.234 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -73.7 -21.93 60.09 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.654 1.182 . . . . 10.0 113.466 -174.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -87.84 -79.07 1.26 Allowed Glycine 0 CA--C 1.526 0.747 0 C-N-CA 123.579 0.609 . . . . 10.0 113.514 171.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -53.68 -32.42 51.63 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 126.275 1.83 . . . . 10.0 113.024 -166.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.2 m -52.02 -56.49 13.99 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 114.057 1.132 . . . . 10.0 114.057 172.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.5 p -53.71 -50.51 65.73 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 122.046 0.926 . . . . 10.0 112.295 -177.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 47.6 tttm -57.08 -46.04 82.83 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.173 0.989 . . . . 10.0 112.156 173.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.87 -47.46 80.4 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 114.512 1.301 . . . . 10.0 114.512 174.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -56.47 -11.3 1.21 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 126.087 1.755 . . . . 10.0 114.252 177.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.1 m -107.03 6.61 29.18 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.424 1.89 . . . . 10.0 114.903 -179.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 93.3 mmm -91.91 -92.6 0.15 Allowed 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 123.487 1.613 . . . . 10.0 114.164 -170.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -138.71 153.94 72.64 Favored Pre-proline 0 C--O 1.235 0.308 0 C-N-CA 129.802 3.241 . . . . 10.0 105.527 170.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -52.83 -46.25 34.97 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.267 1.978 . . . . 10.0 113.074 179.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.667 ' CD ' ' HD3' ' A' ' 227' ' ' ARG . 0.1 OUTLIER -52.89 -46.08 67.8 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 129.021 2.929 . . . . 10.0 113.291 173.556 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 92.0 t -69.22 -53.04 27.62 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 C-N-CA 124.05 0.94 . . . . 10.0 109.8 -178.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.1 -46.83 75.55 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.282 0.633 . . . . 10.0 111.959 177.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 60.3 p -60.02 -56.2 24.54 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.922 0.889 . . . . 10.0 112.692 174.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 61.5 m -57.18 -53.2 60.76 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.155 0.982 . . . . 10.0 113.036 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -49.58 -49.48 46.33 Favored 'General case' 0 C--O 1.222 -0.375 0 C-N-CA 123.247 0.619 . . . . 10.0 111.132 174.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -57.15 -48.39 78.82 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 114.702 1.371 . . . . 10.0 114.702 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 40.5 t -56.01 -49.59 74.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 CA-C-N 118.749 0.704 . . . . 10.0 110.462 176.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 94.1 mt -58.63 -51.59 69.28 Favored 'General case' 0 C--O 1.222 -0.389 0 N-CA-C 113.191 0.811 . . . . 10.0 113.191 175.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . 0.471 ' HD2' ' HA ' ' A' ' 153' ' ' PHE . 35.5 ttp180 -47.75 -47.79 30.26 Favored 'General case' 0 C--O 1.225 -0.201 0 C-N-CA 126.852 2.061 . . . . 10.0 111.062 174.402 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 63.6 m-20 -58.51 -58.36 8.89 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 122.782 0.433 . . . . 10.0 111.272 174.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 54.9 t -52.19 -46.71 44.59 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 124.039 0.936 . . . . 10.0 112.044 179.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 32.1 m -60.19 -61.66 2.44 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 128.081 2.552 . . . . 10.0 111.902 178.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 56.0 t -51.43 -50.23 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 C-N-CA 124.575 1.15 . . . . 10.0 111.045 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 76.8 t -59.23 -60.06 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 124.069 0.948 . . . . 10.0 112.168 177.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 73.4 mt -56.9 -51.65 68.25 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 118.701 0.682 . . . . 10.0 112.301 -178.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 10.6 m95 . . . . . 0 N--CA 1.467 0.417 0 C-N-CA 123.959 0.904 . . . . 10.0 111.764 178.272 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 17.1 m . . . . . 0 N--CA 1.475 0.812 0 N-CA-C 112.716 0.636 . . . . 10.0 112.716 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 44.5 t90 -59.81 -55.93 28.11 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 125.191 1.396 . . . . 10.0 112.117 168.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 9.6 tt -56.49 -41.94 77.46 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.813 0.845 . . . . 10.0 112.601 -177.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 14.8 pt -82.44 -5.66 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 N-CA-C 115.151 1.537 . . . . 10.0 115.151 178.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.31 -169.29 33.1 Favored Glycine 0 N--CA 1.45 -0.404 0 CA-C-O 122.577 1.098 . . . . 10.0 113.921 -168.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 23.3 t -53.16 -40.68 64.5 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 114.197 -1.001 . . . . 10.0 111.897 177.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -55.01 -31.8 61.32 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 128.387 2.675 . . . . 10.0 115.385 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -131.06 -103.87 0.98 Allowed Glycine 0 CA--C 1.527 0.842 0 CA-C-N 119.324 0.966 . . . . 10.0 113.41 -167.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -89.41 127.12 35.79 Favored 'General case' 0 C--N 1.328 -0.352 0 O-C-N 120.621 -1.517 . . . . 10.0 109.364 169.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -72.48 65.36 1.36 Allowed Glycine 0 CA--C 1.532 1.141 0 N-CA-C 113.871 0.308 . . . . 10.0 113.871 173.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 60.6 mt -79.6 -42.71 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 126.053 1.741 . . . . 10.0 108.729 166.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.4 ' CG1' ' HB ' ' A' ' 203' ' ' ILE . 79.4 t -126.27 133.39 24.92 Favored Pre-proline 0 N--CA 1.454 -0.264 0 C-N-CA 126.502 1.921 . . . . 10.0 109.385 -174.212 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -68.79 153.78 72.36 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 123.781 2.988 . . . . 10.0 111.437 -176.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 12.2 tp -43.17 -39.77 3.03 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.281 1.033 . . . . 10.0 112.193 171.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -48.36 -52.38 21.99 Favored 'General case' 0 CA--C 1.539 0.519 0 N-CA-C 114.673 1.361 . . . . 10.0 114.673 176.08 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . 0.4 ' HB ' ' CG1' ' A' ' 199' ' ' VAL . 13.9 mm -75.9 -40.5 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 C-N-CA 124.435 1.094 . . . . 10.0 109.692 177.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -49.3 -49.81 42.15 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 118.553 0.615 . . . . 10.0 111.925 173.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 16.3 m -57.72 -47.01 83.62 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 126.043 1.737 . . . . 10.0 112.96 174.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.535 HD23 ' CD2' ' A' ' 12' ' ' TRP . 1.3 tm? -63.33 -52.39 62.05 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.977 0.911 . . . . 10.0 112.072 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 93.1 mt -52.52 -58.74 5.81 Favored 'General case' 0 C--O 1.227 -0.088 0 C-N-CA 124.294 1.038 . . . . 10.0 110.02 176.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -52.45 -46.79 66.62 Favored 'General case' 0 C--O 1.221 -0.439 0 CA-C-O 117.805 -1.093 . . . . 10.0 112.393 176.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' MET . . . . . 0.575 ' HE2' ' HB3' ' A' ' 15' ' ' LEU . 4.6 tmm? -52.32 -52.0 55.6 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 120.404 1.457 . . . . 10.0 112.743 175.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 85.7 t -61.69 -46.56 96.28 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 124.782 1.233 . . . . 10.0 111.747 178.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 4.2 mp -59.95 -52.41 65.54 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 125.463 1.505 . . . . 10.0 111.989 175.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 -55.68 -57.33 12.43 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 126.36 1.864 . . . . 10.0 110.917 178.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 8.6 p . . . . . 0 N--CA 1.476 0.859 0 O-C-N 120.918 -1.114 . . . . 10.0 112.524 179.878 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.278 0 CA-C-O 121.06 0.255 . . . . 10.0 113.09 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 42.0 t80 -46.68 -56.73 5.68 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.351 1.86 . . . . 10.0 112.322 168.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -56.23 -39.44 81.63 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 124.011 0.815 . . . . 10.0 113.465 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 24.5 mt -70.51 -27.59 64.3 Favored 'General case' 0 CA--C 1.511 -0.523 0 N-CA-C 115.736 1.754 . . . . 10.0 115.736 176.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 74.4 mt -63.48 -57.48 11.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 119.274 0.943 . . . . 10.0 108.548 165.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 32.1 tp -58.86 -64.71 0.84 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.923 0.889 . . . . 10.0 113.17 -172.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 84.2 mt -71.51 5.17 2.5 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 115.313 1.597 . . . . 10.0 115.313 -171.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.6 mtp-105 -112.33 0.44 15.69 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.171 0.988 . . . . 10.0 113.319 172.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 8.8 t -108.03 177.91 4.67 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 124.092 0.957 . . . . 10.0 111.046 174.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 227' ' ' ARG . . . . . 0.667 ' HD3' ' CD ' ' A' ' 166' ' ' GLU . 41.7 ttt180 -71.59 98.15 1.83 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.765 0.826 . . . . 10.0 110.947 170.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . 0.477 ' HB1' ' CD2' ' A' ' 42' ' ' PHE . . . -80.86 77.0 7.78 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.874 0.87 . . . . 10.0 112.08 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 40.18 102.24 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 128.896 2.878 . . . . 10.0 116.466 177.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . 0.481 0.3 OUTLIER 71.85 -55.43 0.66 Allowed 'General case' 0 C--O 1.241 0.647 0 C-N-CA 124.722 1.209 . . . . 10.0 110.656 -175.295 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -68.29 169.47 40.06 Favored Glycine 0 C--O 1.239 0.417 0 C-N-CA 129.73 3.538 . . . . 10.0 119.666 171.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.461 0 C-N-CA 128.441 2.696 . . . . 10.0 113.407 166.609 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 N--CA 1.477 0.913 0 CA-C-O 115.78 -2.057 . . . . 10.0 105.808 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 23.33 91.84 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 129.598 3.159 . . . . 10.0 117.286 160.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 28.68 65.05 0.11 Allowed 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 128.324 2.65 . . . . 10.0 114.468 155.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 86.4 mt -56.44 137.94 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 126.41 1.884 . . . . 10.0 113.344 -158.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.652 HG21 ' HB3' ' A' ' 77' ' ' PRO . 7.6 t -136.78 -165.21 1.7 Allowed 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 126.284 1.834 . . . . 10.0 113.991 -174.311 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 70.04 2.8 41.3 Favored Glycine 0 C--N 1.34 0.768 0 C-N-CA 127.475 2.464 . . . . 10.0 111.453 168.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -158.59 -51.29 0.01 OUTLIER Pre-proline 0 N--CA 1.443 -0.794 0 CA-C-O 114.301 -2.761 . . . . 10.0 116.698 -168.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -64.02 -60.58 0.15 Allowed 'Trans proline' 0 CA--C 1.528 0.179 0 CA-C-N 123.504 2.287 . . . . 10.0 113.207 -175.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.411 ' H ' ' CD ' ' A' ' 9' ' ' GLU . 7.9 pm0 -67.22 4.27 0.98 Allowed 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 127.86 2.464 . . . . 10.0 115.765 179.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.421 ' CG ' ' N ' ' A' ' 11' ' ' ILE . 11.0 p-90 -51.34 -43.08 61.67 Favored 'General case' 0 C--O 1.223 -0.337 0 O-C-N 121.487 -0.758 . . . . 10.0 112.646 176.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.421 ' N ' ' CG ' ' A' ' 10' ' ' TRP . 8.9 tt -60.9 -49.64 83.82 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.338 0 C-N-CA 123.902 0.881 . . . . 10.0 109.287 179.415 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . 0.535 ' CD2' HD23 ' A' ' 206' ' ' LEU . 2.6 m95 -55.33 -52.7 62.63 Favored 'General case' 0 C--O 1.224 -0.261 0 C-N-CA 123.428 0.691 . . . . 10.0 111.861 175.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.5 mt -57.37 -53.53 57.05 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 123.138 0.575 . . . . 10.0 112.27 177.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.92 -46.78 52.3 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.366 1.466 . . . . 10.0 113.332 173.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.575 ' HB3' ' HE2' ' A' ' 209' ' ' MET . 13.3 tp -65.67 -44.94 84.72 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.304 1.442 . . . . 10.0 113.009 179.115 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.55 -56.57 10.92 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 124.419 1.009 . . . . 10.0 111.55 166.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.2 m -49.62 -52.44 30.52 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.898 1.279 . . . . 10.0 112.246 174.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.45 -58.89 5.69 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.163 0.985 . . . . 10.0 112.138 177.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 93.1 mt -57.12 -48.55 78.37 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.606 0.762 . . . . 10.0 112.851 -179.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 49.0 mtt -60.43 -45.77 92.45 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.148 0.979 . . . . 10.0 111.503 178.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -58.22 -58.68 13.28 Favored Glycine 0 CA--C 1.53 0.998 0 CA-C-O 118.937 -0.924 . . . . 10.0 113.872 172.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 80.8 mt -56.24 -45.86 79.83 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-N 118.714 1.257 . . . . 10.0 112.089 176.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.66 -42.19 76.64 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 124.46 1.029 . . . . 10.0 113.581 172.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 30.3 m -62.12 -58.4 7.95 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 118.329 -0.843 . . . . 10.0 111.113 172.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -52.3 -40.93 62.46 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.051 0.94 . . . . 10.0 110.95 177.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -55.83 -58.01 9.65 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.573 1.149 . . . . 10.0 112.993 172.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.1 m-30 -59.69 -38.58 81.96 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 113.252 0.834 . . . . 10.0 113.252 178.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.401 ' C ' ' H ' ' A' ' 30' ' ' LYS . 11.8 mt -56.13 -67.48 0.29 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.628 1.171 . . . . 10.0 113.589 169.092 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 t -76.36 40.95 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 CA-C-O 123.705 1.717 . . . . 10.0 110.83 179.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.401 ' H ' ' C ' ' A' ' 28' ' ' LEU . 42.9 tttm -140.86 -44.78 0.39 Allowed 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 127.89 2.476 . . . . 10.0 109.379 171.13 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.99 23.12 0.88 Allowed Glycine 0 CA--C 1.529 0.928 0 N-CA-C 115.596 0.998 . . . . 10.0 115.596 173.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 37.3 mmm -59.52 -44.98 93.01 Favored 'General case' 0 C--O 1.224 -0.277 0 C-N-CA 127.189 2.196 . . . . 10.0 113.587 -179.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.71 -84.41 1.19 Allowed Glycine 0 CA--C 1.53 0.989 0 C-N-CA 123.766 0.698 . . . . 10.0 112.471 -170.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.8 t 33.03 88.78 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.242 0.706 0 C-N-CA 128.434 2.694 . . . . 10.0 116.956 166.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.3 m -79.68 -50.85 10.01 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.184 -1.371 . . . . 10.0 113.843 174.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -48.93 117.56 6.48 Favored Pre-proline 0 CA--C 1.536 0.429 0 O-C-N 124.829 1.331 . . . . 10.0 110.991 -172.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -58.63 -29.59 89.66 Favored 'Trans proline' 0 N--CA 1.459 -0.5 0 C-N-CA 123.74 2.96 . . . . 10.0 113.706 179.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.38 -60.61 2.32 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.089 0.556 . . . . 10.0 111.437 176.199 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.19 -40.01 22.81 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 125.093 1.357 . . . . 10.0 113.58 171.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.5 tttp -46.61 -47.37 19.99 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.241 1.417 . . . . 10.0 113.434 172.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -57.79 -53.09 62.19 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.472 0.709 . . . . 10.0 110.944 176.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.477 ' CD2' ' HB1' ' A' ' 228' ' ' ALA . 43.9 m-85 -56.93 -50.23 73.2 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 123.094 0.557 . . . . 10.0 112.342 -179.125 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -54.42 -51.29 65.38 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 118.919 -0.562 . . . . 10.0 112.337 173.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.37 -61.98 1.93 Allowed 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 113.419 0.896 . . . . 10.0 113.419 177.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.4 mt -48.65 -57.49 1.54 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 C-N-CA 124.869 1.268 . . . . 10.0 110.349 178.047 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.2 m -68.87 -17.17 63.95 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.144 1.378 . . . . 10.0 113.737 -172.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 27.8 m -87.9 -40.02 14.31 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.5 1.12 . . . . 10.0 112.165 174.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 25.7 mt -59.48 -42.82 92.95 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 118.93 0.786 . . . . 10.0 112.431 170.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 18.4 t -42.26 -60.06 2.34 Favored Pre-proline 0 N--CA 1.481 1.11 0 C-N-CA 125.72 1.608 . . . . 10.0 113.881 176.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -72.7 -24.3 18.5 Favored 'Trans proline' 0 CA--C 1.545 1.074 0 C-N-CA 122.951 2.434 . . . . 10.0 114.662 174.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.71 -44.69 80.98 Favored 'General case' 0 CA--C 1.548 0.879 0 CA-C-N 120.642 1.564 . . . . 10.0 113.291 176.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 38.1 mm -53.62 -53.86 22.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 124.287 1.035 . . . . 10.0 109.404 168.178 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -53.25 -46.65 69.29 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.458 1.103 . . . . 10.0 113.343 176.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 52.0 t80 -51.36 -57.26 9.4 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 120.187 1.358 . . . . 10.0 112.419 172.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 12.5 m -50.12 -52.32 36.01 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.329 1.451 . . . . 10.0 110.454 178.104 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 32.6 mmt -69.17 -48.01 63.41 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 123.905 0.882 . . . . 10.0 112.967 -176.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -56.36 -40.93 75.34 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 120.35 1.432 . . . . 10.0 113.262 172.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.8 tp -53.25 -54.59 33.91 Favored 'General case' 0 C--O 1.224 -0.258 0 CA-C-N 119.85 1.204 . . . . 10.0 111.281 170.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 24.0 p -51.67 -41.05 61.11 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 115.224 1.564 . . . . 10.0 115.224 179.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 61.1 mtm -66.84 -50.86 61.19 Favored 'General case' 0 C--N 1.334 -0.082 0 C-N-CA 123.556 0.742 . . . . 10.0 110.506 176.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.4 tp -48.51 -52.74 21.02 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.857 0.863 . . . . 10.0 112.952 172.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.4 mt -76.84 -5.62 49.06 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.353 1.061 . . . . 10.0 113.854 -177.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.32 -34.74 5.52 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 115.55 0.98 . . . . 10.0 115.55 174.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 75.3 t80 -49.29 -43.08 43.01 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 115.235 1.568 . . . . 10.0 115.235 -175.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.02 3.51 61.14 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 115.35 0.9 . . . . 10.0 115.35 -179.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.25 143.43 26.42 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 127.042 2.137 . . . . 10.0 109.018 172.002 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 t -145.54 171.06 15.22 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 124.048 0.939 . . . . 10.0 111.067 166.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.01 136.08 53.36 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 123.853 0.861 . . . . 10.0 109.684 179.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 58.5 t -129.6 129.61 23.17 Favored Pre-proline 0 C--N 1.33 -0.279 0 C-N-CA 125.031 1.332 . . . . 10.0 110.905 -176.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -80.73 116.24 3.17 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 N-CA-C 109.415 -1.033 . . . . 10.0 109.415 -178.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -156.68 164.39 38.2 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 112.842 0.682 . . . . 10.0 112.842 172.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.36 -81.95 0.14 Allowed Glycine 0 CA--C 1.526 0.764 0 N-CA-C 110.692 -0.963 . . . . 10.0 110.692 175.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.77 -3.41 0.69 Allowed Glycine 0 CA--C 1.527 0.836 0 N-CA-C 118.666 2.226 . . . . 10.0 118.666 170.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -151.58 -171.89 4.06 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 119.349 1.575 . . . . 10.0 112.217 -165.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -91.82 93.9 9.07 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 125.531 1.532 . . . . 10.0 111.107 -175.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.449 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 60.2 m-80 -89.47 120.78 69.65 Favored Pre-proline 0 N--CA 1.45 -0.428 0 N-CA-C 113.0 0.741 . . . . 10.0 113.0 -165.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.652 ' HB3' HG21 ' A' ' 5' ' ' THR . 76.1 Cg_exo -61.48 131.92 38.32 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 124.205 3.27 . . . . 10.0 112.167 171.573 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.5 mm -140.16 126.37 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 C-N-CA 126.0 1.72 . . . . 10.0 111.712 -179.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -93.64 84.99 4.74 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 122.72 1.247 . . . . 10.0 113.053 174.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 63.8 p-90 -59.37 -28.28 66.73 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 120.939 -1.101 . . . . 10.0 113.881 174.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -55.36 -23.13 22.47 Favored 'General case' 0 CA--C 1.574 1.9 0 C-N-CA 124.277 1.031 . . . . 10.0 110.038 178.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -47.57 -59.75 3.03 Favored 'General case' 0 N--CA 1.496 1.833 0 C-N-CA 126.304 1.841 . . . . 10.0 112.08 163.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -68.35 -37.39 80.43 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 123.814 0.845 . . . . 10.0 110.457 -173.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -53.8 -51.59 63.0 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 123.676 0.79 . . . . 10.0 112.748 169.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 61.8 t0 -52.96 -68.72 0.15 Allowed 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 126.143 1.777 . . . . 10.0 111.26 171.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 46.2 m0 -57.01 -33.77 67.49 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.98 1.712 . . . . 10.0 113.268 -171.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 30.0 tp -50.08 -44.63 51.93 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 126.13 1.772 . . . . 10.0 111.967 177.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -99.25 -44.4 6.25 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.185 0.994 . . . . 10.0 112.014 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 13.7 m -48.33 -52.15 22.86 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.669 1.588 . . . . 10.0 113.242 177.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . 0.314 57.5 p -67.88 -45.71 43.23 Favored Pre-proline 0 N--CA 1.476 0.872 0 N-CA-C 114.557 1.318 . . . . 10.0 114.557 -174.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -52.91 -42.9 60.79 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 123.39 2.727 . . . . 10.0 115.329 170.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 52.4 mt -59.18 -46.45 88.37 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.293 0.637 . . . . 10.0 111.472 175.047 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.4 tp -51.33 -48.13 62.49 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.411 1.485 . . . . 10.0 112.198 172.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.7 mp -58.82 -47.33 85.19 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 125.122 1.369 . . . . 10.0 112.623 170.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.8 -38.28 78.22 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 123.826 0.85 . . . . 10.0 112.906 178.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 -52.31 -54.0 37.1 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 119.282 0.946 . . . . 10.0 111.163 169.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.36 -42.12 88.48 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.635 0.774 . . . . 10.0 112.087 -178.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.64 -54.73 37.67 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.996 0.919 . . . . 10.0 112.024 173.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.33 -41.2 79.53 Favored 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 123.73 0.812 . . . . 10.0 112.668 174.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.9 tp -63.71 -38.6 91.73 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 114.494 1.294 . . . . 10.0 114.494 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.1 t -94.75 1.41 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 125.092 1.357 . . . . 10.0 112.296 179.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.2 t70 48.55 53.52 12.0 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.881 1.672 . . . . 10.0 112.077 -174.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.22 145.89 47.68 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 119.955 -1.715 . . . . 10.0 112.457 -174.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.47 135.93 54.17 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 112.697 0.629 . . . . 10.0 112.697 175.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -42.92 -39.65 2.65 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.891 1.677 . . . . 10.0 113.466 175.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -47.3 -60.21 5.31 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 125.145 1.355 . . . . 10.0 115.295 169.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 42.0 p -62.1 -46.72 87.8 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 117.101 -1.428 . . . . 10.0 111.328 178.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 66.9 mt -48.48 -52.87 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 125.032 1.333 . . . . 10.0 111.135 178.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.4 tp -62.67 -51.25 67.97 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 112.544 0.572 . . . . 10.0 112.544 179.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.2 -44.86 43.55 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.479 0.712 . . . . 10.0 110.912 174.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.455 ' HA ' HD12 ' A' ' 111' ' ' LEU . 0.6 OUTLIER -59.56 -59.95 4.63 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 127.385 2.274 . . . . 10.0 114.791 174.949 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.6 t -61.02 -46.36 96.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 123.686 0.794 . . . . 10.0 111.362 -178.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -56.56 -50.41 63.19 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 123.68 0.657 . . . . 10.0 112.602 174.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -54.68 -46.74 74.14 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 113.081 0.771 . . . . 10.0 113.081 173.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -57.94 -45.07 87.2 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.998 0.919 . . . . 10.0 111.809 174.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -43.81 -55.88 5.31 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 125.123 1.344 . . . . 10.0 113.429 166.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 81.6 mt -56.63 -54.07 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 123.567 0.747 . . . . 10.0 110.962 173.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 45.5 ttp -46.14 -58.65 3.45 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.462 1.505 . . . . 10.0 112.455 -178.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 47.2 mm . . . . . 0 N--CA 1.473 0.688 0 C-N-CA 123.215 0.606 . . . . 10.0 112.012 178.65 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 62.0 t . . . . . 0 N--CA 1.47 0.545 0 N-CA-C 110.384 -0.228 . . . . 10.0 110.384 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -48.82 -61.08 5.5 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 125.751 1.643 . . . . 10.0 112.855 170.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -45.75 -40.37 9.4 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 127.004 2.122 . . . . 10.0 113.813 177.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 49.8 mt -100.14 -6.6 25.98 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 115.193 1.553 . . . . 10.0 115.193 -176.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 17.0 m -69.66 116.72 10.38 Favored 'General case' 0 N--CA 1.464 0.237 0 O-C-N 120.186 -1.571 . . . . 10.0 110.41 -178.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.622 ' H ' ' HD3' ' A' ' 129' ' ' LYS . 0.1 OUTLIER -55.44 -49.65 71.9 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 128.186 2.594 . . . . 10.0 113.267 177.754 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 60.6 t -69.62 106.37 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 123.761 0.824 . . . . 10.0 110.085 179.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -46.94 -59.49 3.06 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 124.775 1.23 . . . . 10.0 114.07 -173.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 m -46.53 -42.07 15.22 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.45 1.5 . . . . 10.0 113.484 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -70.14 -24.61 63.2 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 114.959 1.466 . . . . 10.0 114.959 -178.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 68.1 mtp85 -54.21 -41.69 68.92 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 118.869 0.759 . . . . 10.0 110.811 176.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -69.01 -32.73 72.47 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.678 1.191 . . . . 10.0 114.166 176.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.7 t -54.46 -52.03 43.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 CA-C-N 119.073 0.851 . . . . 10.0 109.659 169.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 66.2 m95 -62.0 -45.7 92.44 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 114.531 1.308 . . . . 10.0 114.531 174.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 86.5 t90 -52.13 -47.98 65.08 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.868 0.867 . . . . 10.0 112.582 172.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.599 0 C-N-CA 124.047 0.939 . . . . 10.0 111.69 176.801 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.77 0 N-CA-C 112.531 0.567 . . . . 10.0 112.531 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 40.4 ttp -55.93 -55.72 29.27 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 124.488 1.115 . . . . 10.0 111.915 171.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -51.13 -48.5 61.77 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 125.869 1.668 . . . . 10.0 111.569 178.236 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 78.5 t80 -52.33 -54.54 30.37 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 113.099 0.778 . . . . 10.0 113.099 172.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 56.0 mt -53.87 -54.68 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 123.943 0.897 . . . . 10.0 110.739 177.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 90.8 mt -50.69 -42.93 57.42 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 126.129 1.772 . . . . 10.0 112.818 175.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -57.32 -58.09 9.76 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 123.986 0.914 . . . . 10.0 113.084 176.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.43 -40.92 85.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 CA-C-O 118.313 -0.851 . . . . 10.0 111.408 177.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 47.2 mt -56.83 -49.45 75.39 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.878 1.217 . . . . 10.0 112.069 171.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.47 ' HA ' ' HD2' ' A' ' 175' ' ' ARG . 11.8 t80 -76.94 -70.29 0.47 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 120.06 -1.65 . . . . 10.0 112.915 -175.24 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -73.78 -21.9 60.02 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.596 1.158 . . . . 10.0 113.454 -174.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -87.83 -79.1 1.26 Allowed Glycine 0 CA--C 1.527 0.806 0 C-N-CA 123.612 0.625 . . . . 10.0 113.501 171.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -53.58 -32.47 51.06 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 126.266 1.826 . . . . 10.0 113.045 -166.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.4 m -52.1 -56.47 14.25 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 113.988 1.107 . . . . 10.0 113.988 172.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.5 p -53.6 -50.59 65.32 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 122.093 0.949 . . . . 10.0 112.297 -177.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 47.7 tttm -57.09 -46.11 82.82 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.165 0.986 . . . . 10.0 112.103 173.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.74 -47.51 79.88 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 114.55 1.315 . . . . 10.0 114.55 174.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -56.5 -11.22 1.19 Allowed 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 126.056 1.742 . . . . 10.0 114.268 177.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.1 m -107.08 6.57 29.05 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.425 1.89 . . . . 10.0 114.898 -179.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 93.3 mmm -91.9 -92.6 0.15 Allowed 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 123.485 1.612 . . . . 10.0 114.16 -170.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -138.75 153.94 72.58 Favored Pre-proline 0 C--O 1.236 0.349 0 C-N-CA 129.809 3.243 . . . . 10.0 105.529 170.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -52.86 -46.19 35.48 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 122.3 2.0 . . . . 10.0 113.08 179.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.667 ' CD ' ' HD3' ' A' ' 227' ' ' ARG . 0.1 OUTLIER -53.02 -46.09 68.25 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 129.014 2.926 . . . . 10.0 113.221 173.597 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 92.0 t -69.12 -53.09 27.63 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.267 0 C-N-CA 124.068 0.947 . . . . 10.0 109.798 -178.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.11 -46.85 75.59 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.291 0.636 . . . . 10.0 111.905 177.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 60.1 p -59.98 -56.22 24.34 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.885 0.874 . . . . 10.0 112.702 174.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 62.0 m -57.12 -53.31 59.59 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.23 1.012 . . . . 10.0 112.987 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -49.52 -49.57 45.38 Favored 'General case' 0 C--O 1.222 -0.386 0 C-N-CA 123.3 0.64 . . . . 10.0 111.068 174.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -57.12 -48.37 78.82 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 114.699 1.37 . . . . 10.0 114.699 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 40.4 t -56.02 -49.57 74.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-N 118.832 0.742 . . . . 10.0 110.487 176.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 94.2 mt -58.57 -51.63 69.09 Favored 'General case' 0 C--O 1.221 -0.397 0 N-CA-C 113.152 0.797 . . . . 10.0 113.152 175.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . 0.47 ' HD2' ' HA ' ' A' ' 153' ' ' PHE . 35.5 ttp180 -47.82 -47.82 31.05 Favored 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 126.868 2.067 . . . . 10.0 111.011 174.499 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 63.6 m-20 -58.48 -58.31 9.11 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 122.805 0.442 . . . . 10.0 111.29 174.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 58.3 t -51.77 -50.25 32.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 124.086 0.954 . . . . 10.0 111.587 179.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 26.5 m -56.55 -60.34 3.67 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 127.872 2.469 . . . . 10.0 111.953 177.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 47.7 t -53.67 -49.52 56.34 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 CA-C-N 119.215 0.916 . . . . 10.0 111.312 -178.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 76.6 t -58.91 -61.67 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 124.369 1.068 . . . . 10.0 111.908 176.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -59.24 -48.82 80.17 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 118.63 0.65 . . . . 10.0 112.609 -175.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 9.8 m95 . . . . . 0 N--CA 1.469 0.524 0 CA-C-N 118.9 0.773 . . . . 10.0 111.947 176.771 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 88.3 t . . . . . 0 N--CA 1.479 0.99 0 CA-C-O 119.264 -0.398 . . . . 10.0 111.457 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 69.9 t90 -54.68 -54.56 40.18 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.331 1.052 . . . . 10.0 112.525 174.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 9.9 tt -57.55 -42.37 82.83 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 123.881 0.872 . . . . 10.0 112.166 -176.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 14.1 pt -84.79 -5.95 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 N-CA-C 115.289 1.589 . . . . 10.0 115.289 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.41 -169.29 32.97 Favored Glycine 0 N--CA 1.45 -0.404 0 CA-C-O 122.589 1.105 . . . . 10.0 113.883 -168.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 23.3 t -53.13 -42.25 65.86 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 114.16 -1.02 . . . . 10.0 111.85 177.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -69.13 -13.05 62.2 Favored 'General case' 0 CA--C 1.55 0.962 0 N-CA-C 115.155 1.539 . . . . 10.0 115.155 -174.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -132.25 -106.37 1.03 Allowed Glycine 0 CA--C 1.536 1.38 0 CA-C-N 120.716 1.598 . . . . 10.0 114.497 -174.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -89.45 127.16 35.81 Favored 'General case' 0 C--N 1.329 -0.323 0 O-C-N 120.666 -1.491 . . . . 10.0 109.305 168.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -72.47 65.32 1.36 Allowed Glycine 0 CA--C 1.532 1.105 0 N-CA-C 113.901 0.32 . . . . 10.0 113.901 173.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 60.7 mt -79.57 -42.74 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 126.107 1.763 . . . . 10.0 108.735 166.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 79.3 t -126.28 133.38 24.91 Favored Pre-proline 0 N--CA 1.453 -0.279 0 C-N-CA 126.504 1.922 . . . . 10.0 109.391 -174.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -68.7 153.76 72.63 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 123.822 3.015 . . . . 10.0 111.474 -176.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 12.2 tp -43.13 -39.82 2.98 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.319 1.047 . . . . 10.0 112.229 171.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -48.28 -52.41 21.45 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 114.684 1.365 . . . . 10.0 114.684 176.03 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 14.0 mm -75.95 -40.53 38.36 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 124.419 1.088 . . . . 10.0 109.625 177.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -49.29 -49.75 42.26 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 118.61 0.641 . . . . 10.0 112.005 173.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 16.2 m -57.75 -47.01 83.7 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 126.042 1.737 . . . . 10.0 112.991 174.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.535 HD23 ' CD2' ' A' ' 12' ' ' TRP . 1.3 tm? -63.35 -52.36 62.13 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.927 0.891 . . . . 10.0 112.063 179.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 93.3 mt -52.48 -60.0 3.76 Favored 'General case' 0 C--O 1.227 -0.115 0 C-N-CA 124.322 1.049 . . . . 10.0 109.993 176.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -53.49 -43.18 68.02 Favored 'General case' 0 C--O 1.218 -0.589 0 CA-C-O 117.432 -1.27 . . . . 10.0 112.51 176.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' MET . . . . . 0.575 ' HE2' ' HB3' ' A' ' 15' ' ' LEU . 4.6 tmm? -53.93 -52.52 60.33 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 121.51 1.959 . . . . 10.0 112.974 173.632 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 82.1 t -61.06 -47.12 95.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 124.957 1.303 . . . . 10.0 111.7 178.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 4.8 mp -58.97 -51.3 70.66 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 125.578 1.551 . . . . 10.0 111.79 175.006 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -55.07 -59.96 4.04 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 125.969 1.708 . . . . 10.0 109.924 176.104 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 35.1 t . . . . . 0 N--CA 1.475 0.811 0 C-N-CA 125.334 1.454 . . . . 10.0 111.658 175.922 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.197 0 N-CA-C 111.912 -0.475 . . . . 10.0 111.912 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 42.8 t80 -45.45 -57.78 3.84 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.142 1.777 . . . . 10.0 112.45 167.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -56.9 -40.59 90.58 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 123.834 0.73 . . . . 10.0 113.561 -179.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 24.2 mt -70.95 -27.19 63.56 Favored 'General case' 0 CA--C 1.51 -0.582 0 N-CA-C 115.52 1.674 . . . . 10.0 115.52 176.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 74.0 mt -63.2 -57.57 11.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 119.131 0.878 . . . . 10.0 108.688 165.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 32.1 tp -58.91 -64.6 0.88 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.854 0.862 . . . . 10.0 113.207 -172.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 84.0 mt -71.55 5.24 2.5 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 115.323 1.601 . . . . 10.0 115.323 -171.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.6 mtp-105 -112.34 0.36 15.65 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.165 0.986 . . . . 10.0 113.265 172.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 8.8 t -108.04 177.94 4.66 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 124.082 0.953 . . . . 10.0 111.039 174.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 227' ' ' ARG . . . . . 0.667 ' HD3' ' CD ' ' A' ' 166' ' ' GLU . 41.9 ttt180 -71.66 98.17 1.86 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.732 0.813 . . . . 10.0 110.968 170.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . 0.477 ' HB1' ' CD2' ' A' ' 42' ' ' PHE . . . -80.93 77.03 7.86 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.829 0.852 . . . . 10.0 112.087 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 40.16 102.21 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 128.831 2.852 . . . . 10.0 116.502 177.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . 0.481 0.3 OUTLIER 71.83 -55.39 0.66 Allowed 'General case' 0 C--O 1.242 0.677 0 C-N-CA 124.764 1.226 . . . . 10.0 110.656 -175.277 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -68.34 169.48 40.2 Favored Glycine 0 C--O 1.239 0.417 0 C-N-CA 129.738 3.542 . . . . 10.0 119.598 171.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.489 0 C-N-CA 128.486 2.714 . . . . 10.0 113.44 166.618 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 N--CA 1.477 0.913 0 CA-C-O 115.781 -2.057 . . . . 10.0 105.833 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 23.35 91.83 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 129.598 3.159 . . . . 10.0 117.262 160.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 28.64 65.07 0.11 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 128.262 2.625 . . . . 10.0 114.511 155.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 86.7 mt -56.49 137.96 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 126.41 1.884 . . . . 10.0 113.353 -158.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.652 HG21 ' HB3' ' A' ' 77' ' ' PRO . 7.6 t -136.79 -165.2 1.7 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 126.327 1.851 . . . . 10.0 114.021 -174.331 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 70.0 2.83 41.1 Favored Glycine 0 C--N 1.339 0.743 0 C-N-CA 127.496 2.474 . . . . 10.0 111.485 168.076 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -158.52 -51.41 0.01 OUTLIER Pre-proline 0 N--CA 1.443 -0.783 0 CA-C-O 114.275 -2.774 . . . . 10.0 116.634 -168.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -63.89 -60.69 0.14 Allowed 'Trans proline' 0 CA--C 1.528 0.186 0 CA-C-N 123.5 2.286 . . . . 10.0 113.236 -175.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.41 ' H ' ' CD ' ' A' ' 9' ' ' GLU . 7.9 pm0 -67.13 4.22 0.96 Allowed 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 127.878 2.471 . . . . 10.0 115.75 179.694 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.422 ' CG ' ' N ' ' A' ' 11' ' ' ILE . 11.0 p-90 -51.28 -43.15 61.54 Favored 'General case' 0 C--O 1.222 -0.361 0 O-C-N 121.5 -0.75 . . . . 10.0 112.646 176.425 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.422 ' N ' ' CG ' ' A' ' 10' ' ' TRP . 8.9 tt -60.85 -49.64 83.79 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.338 0 C-N-CA 123.926 0.89 . . . . 10.0 109.323 179.425 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . 0.535 ' CD2' HD23 ' A' ' 206' ' ' LEU . 2.6 m95 -55.34 -52.67 62.75 Favored 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 123.406 0.682 . . . . 10.0 111.908 175.575 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.4 mt -57.34 -53.6 56.31 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 123.223 0.609 . . . . 10.0 112.245 177.237 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.91 -46.8 52.24 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.412 1.485 . . . . 10.0 113.324 173.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.575 ' HB3' ' HE2' ' A' ' 209' ' ' MET . 13.3 tp -65.63 -44.95 84.88 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.277 1.431 . . . . 10.0 113.059 179.057 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.17 -58.37 7.99 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 124.274 0.94 . . . . 10.0 110.853 165.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.3 m -48.24 -52.41 21.25 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.625 1.17 . . . . 10.0 112.279 175.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.45 -58.83 5.93 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.122 0.969 . . . . 10.0 112.177 177.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 93.8 mt -58.25 -49.63 76.41 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.681 0.793 . . . . 10.0 112.399 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -50.73 -54.52 22.62 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.683 1.193 . . . . 10.0 110.879 173.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -57.17 -58.18 15.9 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 124.452 1.025 . . . . 10.0 113.574 178.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 80.8 mt -56.16 -45.54 79.65 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-N 118.626 1.213 . . . . 10.0 112.134 176.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.45 -42.57 75.71 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 124.936 1.255 . . . . 10.0 113.329 172.462 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 17.4 m -59.75 -60.86 3.16 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.216 1.006 . . . . 10.0 111.076 171.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -52.3 -40.99 62.55 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.061 0.944 . . . . 10.0 110.936 179.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.0 t80 -55.78 -58.03 9.56 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.552 1.141 . . . . 10.0 113.006 172.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -59.63 -38.7 82.07 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 113.226 0.825 . . . . 10.0 113.226 178.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.4 ' C ' ' H ' ' A' ' 30' ' ' LYS . 11.9 mt -56.08 -67.42 0.3 Allowed 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.592 1.157 . . . . 10.0 113.668 169.072 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 t -76.45 41.04 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 CA-C-O 123.749 1.738 . . . . 10.0 110.829 179.109 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.4 ' H ' ' C ' ' A' ' 28' ' ' LEU . 42.9 tttm -140.91 -44.87 0.39 Allowed 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 127.868 2.467 . . . . 10.0 109.303 171.186 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.95 23.09 0.87 Allowed Glycine 0 CA--C 1.529 0.956 0 N-CA-C 115.644 1.017 . . . . 10.0 115.644 173.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 37.4 mmm -59.54 -44.96 93.07 Favored 'General case' 0 C--O 1.224 -0.253 0 C-N-CA 127.136 2.174 . . . . 10.0 113.578 -178.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.66 -84.44 1.18 Allowed Glycine 0 CA--C 1.531 1.045 0 C-N-CA 123.741 0.686 . . . . 10.0 112.477 -170.159 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.8 t 33.09 88.7 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.243 0.73 0 C-N-CA 128.399 2.68 . . . . 10.0 116.941 166.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.4 m -79.58 -50.9 10.0 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.188 -1.369 . . . . 10.0 113.868 174.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -48.87 117.46 6.32 Favored Pre-proline 0 CA--C 1.536 0.428 0 O-C-N 124.719 1.262 . . . . 10.0 110.983 -172.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -58.56 -29.62 89.51 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 123.773 2.982 . . . . 10.0 113.727 179.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.38 -60.59 2.33 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.058 0.543 . . . . 10.0 111.442 176.183 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.15 -40.07 22.65 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 125.127 1.371 . . . . 10.0 113.58 171.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -46.5 -47.5 19.39 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 125.292 1.437 . . . . 10.0 113.413 172.03 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -57.79 -52.98 63.23 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.438 0.695 . . . . 10.0 110.975 176.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.476 ' CD2' ' HB1' ' A' ' 228' ' ' ALA . 44.2 m-85 -57.05 -50.18 73.54 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 123.034 0.534 . . . . 10.0 112.351 -179.145 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -54.37 -51.28 65.31 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 118.935 -0.555 . . . . 10.0 112.379 173.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.42 -61.97 1.94 Allowed 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 113.425 0.898 . . . . 10.0 113.425 177.168 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.7 mt -48.8 -57.54 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 C-N-CA 124.823 1.249 . . . . 10.0 110.145 177.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 4.9 m -69.42 -14.75 63.07 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.188 1.395 . . . . 10.0 113.74 -172.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 31.3 m -89.7 -42.25 11.44 Favored 'General case' 0 N--CA 1.483 1.178 0 CA-C-N 119.884 1.22 . . . . 10.0 111.946 174.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 27.9 mt -56.27 -40.01 73.55 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 118.433 0.56 . . . . 10.0 112.176 170.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . 0.254 24.3 t -47.09 -62.9 1.65 Allowed Pre-proline 0 CA--C 1.552 1.052 0 C-N-CA 125.266 1.426 . . . . 10.0 112.884 177.007 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -53.26 -42.47 64.9 Favored 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 123.919 3.079 . . . . 10.0 116.303 166.089 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.66 -46.19 89.33 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 114.199 1.185 . . . . 10.0 114.199 -174.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 48.3 mm -57.43 -51.32 71.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 O-C-N 121.194 -0.941 . . . . 10.0 109.697 171.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.76 -42.62 71.91 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 113.588 0.959 . . . . 10.0 113.588 175.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -52.85 -56.73 13.62 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 120.379 1.445 . . . . 10.0 112.01 170.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.8 m -49.55 -52.52 29.29 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.512 1.525 . . . . 10.0 110.837 177.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 32.7 mmt -69.11 -48.23 63.07 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 124.035 0.934 . . . . 10.0 112.894 -176.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -57.01 -40.11 76.01 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 117.058 -1.449 . . . . 10.0 113.135 173.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.8 tp -53.31 -54.58 34.43 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-N 120.198 1.363 . . . . 10.0 111.276 170.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 23.9 p -51.68 -41.0 61.09 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 115.261 1.578 . . . . 10.0 115.261 178.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 57.4 mtm -66.88 -50.88 61.08 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 123.534 0.734 . . . . 10.0 110.481 176.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.3 tp -48.54 -52.69 21.43 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.858 0.863 . . . . 10.0 112.926 172.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.4 mt -76.87 -5.64 49.22 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.377 1.071 . . . . 10.0 113.819 -177.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.29 -34.72 5.54 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 115.533 0.973 . . . . 10.0 115.533 174.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -49.29 -43.13 42.99 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 115.206 1.558 . . . . 10.0 115.206 -176.014 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.06 3.61 60.97 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 115.337 0.895 . . . . 10.0 115.337 -178.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.29 143.42 26.42 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 127.048 2.139 . . . . 10.0 108.972 172.014 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 t -145.54 171.05 15.24 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 124.064 0.946 . . . . 10.0 111.022 166.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.99 136.12 53.33 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 123.855 0.862 . . . . 10.0 109.683 179.602 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.436 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 58.5 t -129.6 129.55 23.17 Favored Pre-proline 0 C--N 1.329 -0.295 0 C-N-CA 125.063 1.345 . . . . 10.0 110.948 -176.048 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 69' ' ' VAL . 6.3 Cg_exo -80.69 116.24 3.18 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 N-CA-C 109.417 -1.032 . . . . 10.0 109.417 -178.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -156.74 164.4 38.16 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.823 0.675 . . . . 10.0 112.823 172.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.37 -81.98 0.14 Allowed Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.681 -0.967 . . . . 10.0 110.681 175.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.76 -3.32 0.7 Allowed Glycine 0 CA--C 1.527 0.822 0 N-CA-C 118.671 2.228 . . . . 10.0 118.671 170.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -151.63 -171.89 4.06 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 119.354 1.577 . . . . 10.0 112.237 -165.161 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -91.89 93.95 9.06 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 125.504 1.522 . . . . 10.0 111.066 -175.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.449 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 60.3 m-80 -89.52 120.77 69.62 Favored Pre-proline 0 N--CA 1.45 -0.43 0 N-CA-C 112.964 0.727 . . . . 10.0 112.964 -165.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.652 ' HB3' HG21 ' A' ' 5' ' ' THR . 75.7 Cg_exo -61.53 131.97 38.43 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 124.163 3.242 . . . . 10.0 112.136 171.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.5 mm -140.14 126.3 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 C-N-CA 126.072 1.749 . . . . 10.0 111.714 -179.463 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -93.65 85.07 4.76 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 122.714 1.245 . . . . 10.0 113.055 174.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 63.8 p-90 -59.35 -28.3 66.71 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 113.925 1.083 . . . . 10.0 113.925 174.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -55.21 -32.77 62.51 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.273 1.029 . . . . 10.0 112.654 178.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 37.7 ttm-85 -49.36 -43.51 44.0 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.917 1.687 . . . . 10.0 112.283 169.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 61.7 m-85 -78.91 -39.85 33.76 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.538 1.535 . . . . 10.0 112.428 -179.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -49.92 -48.15 51.89 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.798 1.239 . . . . 10.0 111.337 167.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -56.01 -68.8 0.17 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.426 1.49 . . . . 10.0 111.907 170.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 48.9 m0 -52.82 -33.95 51.61 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.996 1.318 . . . . 10.0 113.387 -173.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 32.6 tp -50.96 -45.65 60.83 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 125.899 1.679 . . . . 10.0 111.982 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -97.55 -47.55 5.6 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 124.478 1.111 . . . . 10.0 112.441 -177.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 51.6 m -59.77 -40.13 87.19 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.643 1.177 . . . . 10.0 112.892 -174.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.5 m -68.26 -47.58 38.07 Favored Pre-proline 0 CA--C 1.547 0.86 0 N-CA-C 113.745 1.017 . . . . 10.0 113.745 -179.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -50.03 -42.77 44.7 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 123.356 2.704 . . . . 10.0 115.362 166.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 54.1 mt -59.18 -46.94 87.07 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.264 0.626 . . . . 10.0 111.575 174.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.5 tp -49.71 -49.15 48.91 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.593 1.557 . . . . 10.0 112.162 171.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.6 mp -58.85 -47.33 85.25 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.031 1.332 . . . . 10.0 112.498 171.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.83 -38.24 78.23 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 123.844 0.857 . . . . 10.0 112.891 178.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -52.31 -54.0 37.16 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 119.324 0.966 . . . . 10.0 111.189 169.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.35 -42.17 88.46 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.656 0.782 . . . . 10.0 112.046 -178.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.7 -54.7 38.4 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 124.008 0.923 . . . . 10.0 112.013 173.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.3 -41.17 79.34 Favored 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 123.72 0.808 . . . . 10.0 112.702 174.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.9 tp -63.75 -38.62 91.77 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 114.425 1.268 . . . . 10.0 114.425 -179.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.1 t -94.79 1.49 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 125.025 1.33 . . . . 10.0 112.325 179.158 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.2 t70 48.57 53.49 12.06 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.866 1.666 . . . . 10.0 112.095 -174.033 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.3 145.94 47.51 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 119.974 -1.704 . . . . 10.0 112.437 -174.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.53 135.92 54.41 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 112.679 0.622 . . . . 10.0 112.679 175.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -42.81 -39.75 2.61 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.895 1.678 . . . . 10.0 113.443 175.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -47.35 -60.2 5.35 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 125.15 1.357 . . . . 10.0 115.22 169.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.9 p -62.07 -46.72 87.87 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 117.103 -1.427 . . . . 10.0 111.351 178.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 67.1 mt -48.47 -52.9 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 125.033 1.333 . . . . 10.0 111.085 178.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.3 tp -62.62 -51.33 67.69 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 112.502 0.556 . . . . 10.0 112.502 179.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.11 -44.9 42.7 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.47 0.708 . . . . 10.0 110.959 174.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.456 ' HA ' HD12 ' A' ' 111' ' ' LEU . 0.6 OUTLIER -59.64 -59.89 4.72 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 127.393 2.277 . . . . 10.0 114.793 174.972 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.8 t -61.0 -46.31 96.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 123.704 0.802 . . . . 10.0 111.411 -178.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -56.65 -50.32 64.05 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 123.695 0.664 . . . . 10.0 112.63 174.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -54.96 -46.23 75.01 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 113.375 0.88 . . . . 10.0 113.375 173.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -55.9 -48.84 74.9 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.698 0.799 . . . . 10.0 111.129 173.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -42.52 -55.27 4.58 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 125.044 1.306 . . . . 10.0 112.997 169.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 82.2 mt -55.56 -58.19 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-O 117.571 -1.204 . . . . 10.0 110.66 173.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 5.0 ptt? -53.42 -46.35 69.74 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 120.783 1.628 . . . . 10.0 113.343 -173.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 46.5 mm . . . . . 0 N--CA 1.473 0.692 0 O-C-N 121.471 -0.768 . . . . 10.0 111.836 179.679 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 60.4 t . . . . . 0 N--CA 1.478 0.972 0 N-CA-C 110.112 -0.329 . . . . 10.0 110.112 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -50.7 -61.23 6.19 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 126.119 1.818 . . . . 10.0 112.65 171.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -43.12 -42.08 3.91 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 127.818 2.447 . . . . 10.0 113.208 176.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 47.3 mt -100.88 -6.8 24.19 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 115.536 1.68 . . . . 10.0 115.536 -175.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 16.9 m -69.66 116.71 10.37 Favored 'General case' 0 N--CA 1.464 0.229 0 O-C-N 120.195 -1.566 . . . . 10.0 110.386 -178.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.621 ' H ' ' HD3' ' A' ' 129' ' ' LYS . 0.2 OUTLIER -55.51 -49.57 72.26 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 128.157 2.583 . . . . 10.0 113.269 177.763 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 60.3 t -69.65 106.33 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 123.819 0.848 . . . . 10.0 110.103 179.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -46.9 -59.54 3.02 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 124.724 1.21 . . . . 10.0 114.055 -173.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 m -46.5 -42.05 15.01 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.45 1.5 . . . . 10.0 113.495 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -70.18 -24.64 63.17 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 114.896 1.443 . . . . 10.0 114.896 -178.103 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 68.9 mtp85 -53.95 -41.81 68.18 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 118.88 0.764 . . . . 10.0 110.776 176.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -69.62 -31.6 69.81 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 114.403 1.26 . . . . 10.0 114.403 176.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.8 t -55.09 -52.18 47.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 CA-C-N 118.993 0.815 . . . . 10.0 109.549 168.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 64.2 m95 -61.09 -43.27 99.15 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 114.185 1.18 . . . . 10.0 114.185 174.085 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 89.2 t90 -52.88 -49.81 65.11 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 119.255 0.934 . . . . 10.0 112.642 172.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.636 0 C-N-CA 124.225 1.01 . . . . 10.0 111.76 178.193 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.547 0.854 0 N-CA-C 112.942 0.719 . . . . 10.0 112.942 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 11.9 tmm? -55.02 -54.06 47.85 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.26 1.424 . . . . 10.0 111.956 172.234 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 58.1 tp -57.65 -42.98 84.58 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.794 1.638 . . . . 10.0 112.834 178.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -53.36 -53.6 48.71 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.537 0.735 . . . . 10.0 112.037 169.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 46.2 mt -54.62 -54.64 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 123.733 0.813 . . . . 10.0 111.061 177.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 5.1 tt -46.13 -46.91 17.46 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 127.943 2.497 . . . . 10.0 112.222 173.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -57.33 -58.15 9.5 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 124.026 0.93 . . . . 10.0 113.03 178.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.42 -40.9 85.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-O 118.343 -0.837 . . . . 10.0 111.467 177.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 47.4 mt -56.73 -49.45 75.16 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.824 1.193 . . . . 10.0 112.139 171.223 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.47 ' HA ' ' HD2' ' A' ' 175' ' ' ARG . 11.8 t80 -76.98 -70.34 0.47 Allowed 'General case' 0 C--N 1.326 -0.447 0 O-C-N 120.079 -1.638 . . . . 10.0 112.845 -175.215 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -73.76 -21.92 60.03 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.634 1.174 . . . . 10.0 113.426 -174.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -87.77 -79.08 1.26 Allowed Glycine 0 CA--C 1.526 0.761 0 C-N-CA 123.662 0.649 . . . . 10.0 113.553 171.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -53.63 -32.47 51.46 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 126.307 1.843 . . . . 10.0 113.025 -166.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.2 m -52.08 -56.45 14.35 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 114.016 1.117 . . . . 10.0 114.016 172.143 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.4 p -53.66 -50.56 65.52 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 122.161 0.981 . . . . 10.0 112.307 -177.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 47.6 tttm -57.08 -46.07 82.83 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.134 0.974 . . . . 10.0 112.167 173.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.86 -47.41 80.47 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 114.515 1.302 . . . . 10.0 114.515 174.069 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -56.47 -11.3 1.21 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 126.087 1.755 . . . . 10.0 114.252 177.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.2 m -107.1 6.64 29.08 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.416 1.886 . . . . 10.0 114.877 -179.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 93.2 mmm -91.91 -92.63 0.15 Allowed 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 123.451 1.596 . . . . 10.0 114.164 -170.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -138.71 154.0 72.7 Favored Pre-proline 0 C--O 1.236 0.359 0 C-N-CA 129.749 3.219 . . . . 10.0 105.539 170.241 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -52.85 -46.24 35.09 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 122.308 2.005 . . . . 10.0 113.074 179.057 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.667 ' CD ' ' HD3' ' A' ' 227' ' ' ARG . 0.1 OUTLIER -52.94 -46.11 67.98 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 129.022 2.929 . . . . 10.0 113.281 173.578 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 92.2 t -69.19 -53.03 27.73 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 C-N-CA 124.034 0.934 . . . . 10.0 109.782 -178.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.09 -46.89 75.53 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.282 0.633 . . . . 10.0 111.923 177.047 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 60.2 p -59.97 -56.16 25.08 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.883 0.873 . . . . 10.0 112.719 174.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 61.7 m -57.23 -53.16 61.21 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.143 0.977 . . . . 10.0 113.004 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -49.59 -49.54 46.26 Favored 'General case' 0 C--O 1.222 -0.375 0 C-N-CA 123.289 0.636 . . . . 10.0 111.067 174.098 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -57.12 -48.41 78.72 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 114.671 1.36 . . . . 10.0 114.671 -179.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 40.3 t -55.95 -49.63 74.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 CA-C-N 118.832 0.742 . . . . 10.0 110.522 176.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 94.0 mt -58.54 -51.69 68.82 Favored 'General case' 0 C--O 1.222 -0.389 0 N-CA-C 113.168 0.803 . . . . 10.0 113.168 175.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . 0.47 ' HD2' ' HA ' ' A' ' 153' ' ' PHE . 35.6 ttp180 -47.72 -47.83 29.84 Favored 'General case' 0 C--O 1.224 -0.244 0 C-N-CA 126.889 2.075 . . . . 10.0 111.041 174.448 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 63.7 m-20 -58.51 -58.33 9.02 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 122.817 0.447 . . . . 10.0 111.25 174.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 53.7 t -52.09 -47.19 43.58 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 C-N-CA 124.05 0.94 . . . . 10.0 112.301 179.063 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 30.2 m -58.27 -65.31 0.67 Allowed 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 128.041 2.536 . . . . 10.0 111.283 177.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 55.8 t -49.66 -49.12 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 C-N-CA 124.859 1.263 . . . . 10.0 111.429 -178.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 72.0 t -58.88 -61.75 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 123.909 0.884 . . . . 10.0 112.164 177.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 85.8 mt -55.11 -46.82 75.6 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 119.251 0.932 . . . . 10.0 112.002 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 9.6 m95 . . . . . 0 N--CA 1.467 0.4 0 C-N-CA 125.174 1.39 . . . . 10.0 113.215 175.667 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 96.2 t . . . . . 0 N--CA 1.478 0.949 0 CA-C-O 119.239 -0.41 . . . . 10.0 111.462 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 61.2 t90 -55.26 -52.78 62.3 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.261 1.024 . . . . 10.0 112.511 175.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 9.5 tt -57.98 -43.69 86.68 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 123.898 0.879 . . . . 10.0 112.628 -176.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 15.3 pt -83.81 -5.59 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 N-CA-C 114.986 1.476 . . . . 10.0 114.986 -179.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.18 -169.33 33.3 Favored Glycine 0 N--CA 1.451 -0.363 0 CA-C-O 122.587 1.104 . . . . 10.0 113.966 -169.047 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 23.3 t -53.13 -41.45 65.09 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 114.159 -1.021 . . . . 10.0 111.879 177.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -66.83 -17.24 64.79 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 115.627 1.714 . . . . 10.0 115.627 -175.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -131.38 -105.79 1.05 Allowed Glycine 0 CA--C 1.533 1.169 0 CA-C-N 120.402 1.455 . . . . 10.0 113.911 -172.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -89.45 127.15 35.81 Favored 'General case' 0 C--N 1.329 -0.306 0 O-C-N 120.659 -1.495 . . . . 10.0 109.349 168.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -72.47 65.34 1.36 Allowed Glycine 0 CA--C 1.532 1.124 0 N-CA-C 113.906 0.322 . . . . 10.0 113.906 173.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 60.5 mt -79.51 -42.78 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 126.086 1.754 . . . . 10.0 108.764 166.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 79.8 t -126.31 133.34 24.87 Favored Pre-proline 0 N--CA 1.454 -0.264 0 C-N-CA 126.502 1.921 . . . . 10.0 109.401 -174.179 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -68.74 153.75 72.56 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 123.793 2.996 . . . . 10.0 111.491 -176.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 12.2 tp -43.13 -39.75 2.94 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.329 1.052 . . . . 10.0 112.227 171.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -48.37 -52.39 21.96 Favored 'General case' 0 CA--C 1.539 0.519 0 N-CA-C 114.673 1.361 . . . . 10.0 114.673 176.022 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 14.0 mm -75.91 -40.49 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 124.378 1.071 . . . . 10.0 109.647 177.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -49.32 -49.78 42.5 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 118.575 0.625 . . . . 10.0 111.956 173.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 16.1 m -57.72 -47.05 83.49 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 126.04 1.736 . . . . 10.0 112.974 174.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.535 HD23 ' CD2' ' A' ' 12' ' ' TRP . 1.3 tm? -63.35 -52.33 62.22 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.968 0.907 . . . . 10.0 112.061 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 93.2 mt -52.54 -58.82 5.57 Favored 'General case' 0 C--O 1.228 -0.077 0 C-N-CA 124.293 1.037 . . . . 10.0 110.003 176.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -53.97 -43.78 70.2 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 117.704 -1.141 . . . . 10.0 112.876 176.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 209' ' ' MET . . . . . 0.575 ' HE2' ' HB3' ' A' ' 15' ' ' LEU . 4.6 tmm? -53.96 -52.57 60.25 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 120.285 1.402 . . . . 10.0 112.237 174.235 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 78.3 t -61.45 -47.89 91.32 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 125.183 1.393 . . . . 10.0 111.897 178.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 5.1 mp -57.42 -49.54 75.9 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.025 1.33 . . . . 10.0 111.404 175.038 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -59.14 -56.83 17.12 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.697 1.199 . . . . 10.0 111.588 176.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 34.3 m . . . . . 0 N--CA 1.488 1.458 0 CA-C-N 121.89 2.132 . . . . 10.0 112.377 178.497 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.467 0 CA-C-O 121.101 0.278 . . . . 10.0 113.269 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -46.64 -56.25 6.4 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.717 2.007 . . . . 10.0 112.201 168.093 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -55.82 -38.59 74.25 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 123.817 0.722 . . . . 10.0 113.696 179.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 24.5 mt -70.64 -27.38 64.01 Favored 'General case' 0 CA--C 1.512 -0.504 0 N-CA-C 115.694 1.739 . . . . 10.0 115.694 176.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 74.4 mt -63.52 -57.51 11.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 108.561 -0.903 . . . . 10.0 108.561 165.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 32.1 tp -58.85 -64.6 0.88 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.893 0.877 . . . . 10.0 113.213 -172.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 84.2 mt -71.58 5.17 2.55 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 115.295 1.591 . . . . 10.0 115.295 -171.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.6 mtp-105 -112.31 0.34 15.68 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.172 0.989 . . . . 10.0 113.238 172.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 8.8 t -108.0 177.94 4.66 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 124.116 0.966 . . . . 10.0 111.046 174.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 227' ' ' ARG . . . . . 0.667 ' HD3' ' CD ' ' A' ' 166' ' ' GLU . 41.7 ttt180 -71.62 98.16 1.85 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.732 0.813 . . . . 10.0 110.973 170.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . 0.476 ' HB1' ' CD2' ' A' ' 42' ' ' PHE . . . -80.86 76.99 7.78 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.874 0.87 . . . . 10.0 112.08 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 40.21 102.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 128.831 2.852 . . . . 10.0 116.474 177.672 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . 0.482 0.3 OUTLIER 71.82 -55.43 0.66 Allowed 'General case' 0 C--O 1.241 0.647 0 C-N-CA 124.749 1.22 . . . . 10.0 110.656 -175.288 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -68.29 169.47 40.06 Favored Glycine 0 C--O 1.239 0.417 0 C-N-CA 129.73 3.538 . . . . 10.0 119.666 171.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.461 0 C-N-CA 128.491 2.716 . . . . 10.0 113.461 166.583 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 N--CA 1.477 0.893 0 CA-C-O 115.781 -2.057 . . . . 10.0 105.88 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 23.28 91.89 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 129.62 3.168 . . . . 10.0 117.262 160.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 28.6 65.12 0.11 Allowed 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 128.302 2.641 . . . . 10.0 114.479 155.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 86.7 mt -56.46 137.95 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 126.407 1.883 . . . . 10.0 113.34 -158.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.652 HG21 ' HB3' ' A' ' 77' ' ' PRO . 7.5 t -136.74 -165.21 1.7 Allowed 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 126.345 1.858 . . . . 10.0 114.01 -174.337 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 69.97 2.84 40.9 Favored Glycine 0 C--N 1.34 0.793 0 C-N-CA 127.49 2.471 . . . . 10.0 111.496 168.049 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.8 tpp180 -158.59 -51.27 0.01 OUTLIER Pre-proline 0 N--CA 1.443 -0.822 0 CA-C-O 114.301 -2.761 . . . . 10.0 116.694 -168.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -63.97 -60.7 0.14 Allowed 'Trans proline' 0 N--CA 1.465 -0.169 0 CA-C-N 123.559 2.307 . . . . 10.0 113.2 -175.372 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.41 ' H ' ' CD ' ' A' ' 9' ' ' GLU . 7.9 pm0 -67.16 4.27 0.96 Allowed 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 127.87 2.468 . . . . 10.0 115.787 179.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.422 ' CG ' ' N ' ' A' ' 11' ' ' ILE . 11.0 p-90 -51.31 -43.13 61.61 Favored 'General case' 0 C--O 1.222 -0.361 0 O-C-N 121.489 -0.757 . . . . 10.0 112.643 176.418 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.422 ' N ' ' CG ' ' A' ' 10' ' ' TRP . 8.9 tt -60.86 -49.61 83.92 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.338 0 C-N-CA 123.887 0.875 . . . . 10.0 109.316 179.416 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . 0.535 ' CD2' HD23 ' A' ' 206' ' ' LEU . 2.6 m95 -55.38 -52.67 62.8 Favored 'General case' 0 C--O 1.223 -0.312 0 C-N-CA 123.455 0.702 . . . . 10.0 111.872 175.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.7 mt -57.35 -53.62 56.06 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.184 0.594 . . . . 10.0 112.213 177.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.86 -46.83 51.83 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.418 1.487 . . . . 10.0 113.288 173.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.575 ' HB3' ' HE2' ' A' ' 209' ' ' MET . 13.3 tp -65.62 -45.0 84.77 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.312 1.445 . . . . 10.0 113.045 179.122 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.79 -56.29 12.15 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 124.506 1.051 . . . . 10.0 111.622 166.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 22.5 m -49.46 -52.63 27.77 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.981 1.312 . . . . 10.0 112.408 174.254 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.45 -58.84 5.88 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.109 0.964 . . . . 10.0 112.196 177.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 95.0 mt -57.52 -48.51 79.09 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.566 0.746 . . . . 10.0 112.729 -179.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.549 ' SD ' ' HB1' ' A' ' 53' ' ' ALA . 56.4 mtt -58.7 -47.17 85.45 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.345 1.058 . . . . 10.0 111.403 177.497 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -58.45 -58.51 14.21 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 124.356 0.979 . . . . 10.0 113.901 173.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 81.0 mt -56.19 -45.96 79.59 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-N 118.691 1.246 . . . . 10.0 112.116 176.255 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.75 -41.86 76.46 Favored Glycine 0 CA--C 1.533 1.214 0 C-N-CA 124.752 1.167 . . . . 10.0 113.172 173.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 28.4 m -62.29 -58.54 7.35 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.778 0.831 . . . . 10.0 111.425 171.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -52.3 -40.92 62.46 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.99 0.916 . . . . 10.0 110.962 177.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -55.82 -58.01 9.63 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.586 1.154 . . . . 10.0 112.974 172.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.1 m-30 -59.62 -38.73 82.09 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 113.184 0.809 . . . . 10.0 113.184 178.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.401 ' C ' ' H ' ' A' ' 30' ' ' LYS . 11.8 mt -56.15 -67.44 0.3 Allowed 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.621 1.168 . . . . 10.0 113.585 169.171 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 t -76.38 40.97 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-O 123.79 1.757 . . . . 10.0 110.846 179.111 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.401 ' H ' ' C ' ' A' ' 28' ' ' LEU . 42.9 tttm -140.87 -44.87 0.39 Allowed 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 127.9 2.48 . . . . 10.0 109.32 171.173 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.91 23.07 0.87 Allowed Glycine 0 CA--C 1.528 0.898 0 N-CA-C 115.649 1.019 . . . . 10.0 115.649 173.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 37.3 mmm -59.47 -45.03 92.8 Favored 'General case' 0 C--O 1.225 -0.228 0 C-N-CA 127.188 2.195 . . . . 10.0 113.562 -179.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.71 -84.38 1.19 Allowed Glycine 0 CA--C 1.531 1.045 0 C-N-CA 123.743 0.687 . . . . 10.0 112.47 -170.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.8 t 32.99 88.76 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.242 0.706 0 C-N-CA 128.365 2.666 . . . . 10.0 116.96 166.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 28.5 m -79.6 -50.85 10.07 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.132 -1.394 . . . . 10.0 113.93 174.101 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -48.97 117.53 6.49 Favored Pre-proline 0 CA--C 1.536 0.418 0 O-C-N 124.815 1.322 . . . . 10.0 110.95 -172.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -58.53 -29.66 89.5 Favored 'Trans proline' 0 N--CA 1.459 -0.5 0 C-N-CA 123.695 2.93 . . . . 10.0 113.74 179.095 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.29 -60.64 2.31 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.142 0.577 . . . . 10.0 111.439 176.208 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.21 -40.08 23.19 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 125.065 1.346 . . . . 10.0 113.551 171.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -46.52 -47.39 19.5 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.241 1.416 . . . . 10.0 113.444 172.042 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -57.79 -53.05 62.58 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.507 0.723 . . . . 10.0 110.958 176.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.476 ' CD2' ' HB1' ' A' ' 228' ' ' ALA . 44.0 m-85 -57.03 -50.15 73.6 Favored 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 123.075 0.55 . . . . 10.0 112.348 -179.109 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -54.4 -51.29 65.35 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 118.921 -0.561 . . . . 10.0 112.377 173.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.38 -62.04 1.9 Allowed 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 113.38 0.881 . . . . 10.0 113.38 177.13 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.5 mt -48.42 -57.98 1.29 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 124.918 1.287 . . . . 10.0 110.323 178.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.2 m -68.42 -17.57 64.24 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.195 1.398 . . . . 10.0 113.819 -172.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 27.9 m -87.59 -40.3 14.35 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-N 119.511 1.05 . . . . 10.0 112.196 174.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 22.3 mt -58.76 -43.68 90.4 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 121.48 -0.762 . . . . 10.0 112.272 171.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 19.3 t -38.88 -66.13 0.34 Allowed Pre-proline 0 CA--C 1.552 1.032 0 C-N-CA 125.922 1.689 . . . . 10.0 112.861 175.367 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -69.76 -23.44 30.79 Favored 'Trans proline' 0 CA--C 1.546 1.082 0 C-N-CA 123.042 2.495 . . . . 10.0 114.66 176.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.27 -45.42 80.54 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 120.564 1.529 . . . . 10.0 113.357 175.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 32.6 mm -58.51 -46.1 89.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 O-C-N 121.072 -1.018 . . . . 10.0 109.569 169.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.549 ' HB1' ' SD ' ' A' ' 20' ' ' MET . . . -51.96 -51.28 58.18 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.642 1.177 . . . . 10.0 112.127 176.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -50.37 -58.3 6.0 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 126.045 1.738 . . . . 10.0 112.321 173.26 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.3 m -49.17 -52.88 23.84 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 125.139 1.376 . . . . 10.0 110.755 178.093 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.407 ' HG3' ' HB2' ' A' ' 85' ' ' ASP . 33.0 mmt -69.38 -48.59 60.7 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 124.165 0.986 . . . . 10.0 112.735 -176.362 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -57.18 -39.58 75.64 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-O 116.766 -1.588 . . . . 10.0 113.266 173.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.8 tp -53.29 -54.53 34.98 Favored 'General case' 0 C--O 1.224 -0.238 0 CA-C-N 120.482 1.492 . . . . 10.0 111.313 169.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 24.1 p -51.69 -41.11 61.19 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 115.178 1.547 . . . . 10.0 115.178 179.019 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 59.7 mtm -66.8 -50.88 61.23 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 123.56 0.744 . . . . 10.0 110.534 176.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.3 tp -48.58 -52.66 21.75 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.826 0.851 . . . . 10.0 112.94 172.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.4 mt -76.88 -5.62 49.15 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.349 1.06 . . . . 10.0 113.828 -177.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.35 -34.74 5.52 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 115.504 0.962 . . . . 10.0 115.504 174.128 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -49.24 -43.13 42.49 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 115.208 1.559 . . . . 10.0 115.208 -175.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.1 3.65 60.96 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 115.377 0.911 . . . . 10.0 115.377 -178.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.33 143.47 26.36 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 126.993 2.117 . . . . 10.0 108.992 172.018 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 t -145.54 171.09 15.18 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 124.046 0.938 . . . . 10.0 111.06 166.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.02 136.11 53.33 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 123.833 0.853 . . . . 10.0 109.728 179.556 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 58.6 t -129.59 129.62 23.18 Favored Pre-proline 0 C--N 1.329 -0.299 0 C-N-CA 125.034 1.333 . . . . 10.0 110.909 -176.018 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -80.78 116.23 3.15 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 N-CA-C 109.445 -1.021 . . . . 10.0 109.445 -178.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -156.68 164.44 38.15 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.858 0.688 . . . . 10.0 112.858 172.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.34 -82.01 0.14 Allowed Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.636 -0.986 . . . . 10.0 110.636 175.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.73 -3.29 0.7 Allowed Glycine 0 CA--C 1.527 0.818 0 N-CA-C 118.706 2.242 . . . . 10.0 118.706 170.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -151.64 -171.95 4.08 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 119.353 1.577 . . . . 10.0 112.247 -165.159 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -91.79 93.85 9.06 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 125.517 1.527 . . . . 10.0 111.137 -175.322 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.449 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 60.1 m-80 -89.41 120.8 69.69 Favored Pre-proline 0 N--CA 1.45 -0.427 0 N-CA-C 112.97 0.73 . . . . 10.0 112.97 -165.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.652 ' HB3' HG21 ' A' ' 5' ' ' THR . 76.0 Cg_exo -61.53 131.91 38.15 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 124.219 3.279 . . . . 10.0 112.137 171.554 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.4 mm -140.15 126.35 21.85 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 C-N-CA 125.971 1.708 . . . . 10.0 111.684 -179.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -93.67 85.11 4.76 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 123.338 1.542 . . . . 10.0 113.026 174.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 63.8 p-90 -59.41 -28.27 66.78 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 120.619 -1.301 . . . . 10.0 113.891 174.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -54.81 -36.33 64.86 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 114.976 1.473 . . . . 10.0 114.976 178.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -59.8 -35.87 75.57 Favored 'General case' 0 N--CA 1.476 0.835 0 O-C-N 120.543 -1.348 . . . . 10.0 112.168 172.103 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -66.75 -42.88 85.48 Favored 'General case' 0 CA--C 1.545 0.758 0 O-C-N 121.071 -1.018 . . . . 10.0 112.987 173.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -50.46 -48.88 56.41 Favored 'General case' 0 CA--C 1.558 1.252 0 C-N-CA 125.624 1.569 . . . . 10.0 111.513 167.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.407 ' HB2' ' HG3' ' A' ' 56' ' ' MET . 27.5 t70 -58.61 -63.11 1.4 Allowed 'General case' 0 N--CA 1.485 1.292 0 CA-C-N 119.54 1.064 . . . . 10.0 112.465 171.571 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' TRP . . . . . 0.427 ' HA ' HG22 ' A' ' 89' ' ' THR . 47.4 m0 -50.27 -39.42 45.09 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 126.87 2.068 . . . . 10.0 112.063 -175.075 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 32.4 tp -48.85 -48.59 41.81 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 126.434 1.893 . . . . 10.0 112.377 177.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -94.19 -46.48 7.07 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.904 0.881 . . . . 10.0 112.677 -176.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.427 HG22 ' HA ' ' A' ' 86' ' ' TRP . 4.7 t -62.2 -42.73 99.56 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 113.667 0.988 . . . . 10.0 113.667 -174.214 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . 0.308 74.5 p -63.49 -43.73 79.55 Favored Pre-proline 0 N--CA 1.473 0.697 0 O-C-N 120.977 -1.077 . . . . 10.0 112.935 -178.292 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -52.87 -44.63 46.8 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 122.912 2.408 . . . . 10.0 115.746 165.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 54.1 mt -59.84 -47.4 85.87 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 119.329 0.968 . . . . 10.0 111.714 176.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 6.1 tt -50.71 -48.95 58.6 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 126.302 1.841 . . . . 10.0 111.292 171.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.9 mp -57.46 -47.68 81.22 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.543 1.137 . . . . 10.0 113.19 169.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.77 -38.24 78.06 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 123.783 0.833 . . . . 10.0 112.925 178.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -52.32 -54.08 36.18 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 119.251 0.932 . . . . 10.0 111.15 169.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.36 -42.03 88.64 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.67 0.788 . . . . 10.0 112.094 -178.483 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.76 -54.75 37.88 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 124.0 0.92 . . . . 10.0 111.974 173.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.25 -41.16 79.11 Favored 'General case' 0 C--O 1.224 -0.237 0 C-N-CA 123.741 0.817 . . . . 10.0 112.731 174.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.9 tp -63.77 -38.58 91.65 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 114.445 1.276 . . . . 10.0 114.445 -179.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.2 t -94.85 1.49 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 124.998 1.319 . . . . 10.0 112.318 179.177 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.2 t70 48.63 53.41 12.26 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.811 1.644 . . . . 10.0 112.117 -174.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.28 145.89 47.58 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 120.017 -1.677 . . . . 10.0 112.458 -174.171 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.49 135.86 54.26 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 112.775 0.658 . . . . 10.0 112.775 175.149 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -42.82 -39.66 2.58 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.88 1.672 . . . . 10.0 113.474 175.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -47.34 -60.25 5.31 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 125.18 1.371 . . . . 10.0 115.245 169.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.0 p -61.96 -46.79 87.72 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-O 117.155 -1.402 . . . . 10.0 111.358 178.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 67.1 mt -48.49 -52.9 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 125.033 1.333 . . . . 10.0 111.115 178.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.2 tp -62.62 -51.27 67.93 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 112.549 0.574 . . . . 10.0 112.549 179.277 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.21 -44.84 43.62 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.465 0.706 . . . . 10.0 110.953 174.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.455 ' HA ' HD12 ' A' ' 111' ' ' LEU . 0.6 OUTLIER -59.6 -59.91 4.69 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 127.435 2.294 . . . . 10.0 114.794 174.944 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.7 t -61.02 -46.31 96.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 123.743 0.817 . . . . 10.0 111.393 -178.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -56.66 -50.31 64.09 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 123.686 0.66 . . . . 10.0 112.656 174.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -55.07 -46.27 75.39 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 113.427 0.899 . . . . 10.0 113.427 173.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 53.7 t0 -58.26 -45.38 87.93 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.68 0.792 . . . . 10.0 111.679 174.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -43.31 -56.12 4.84 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 125.332 1.444 . . . . 10.0 113.322 167.062 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 82.5 mt -57.08 -55.32 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 123.811 0.844 . . . . 10.0 110.367 173.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 16.1 tmm? -48.34 -58.09 5.09 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.09 1.356 . . . . 10.0 112.785 -176.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 48.7 mm . . . . . 0 N--CA 1.475 0.784 0 O-C-N 121.662 -0.648 . . . . 10.0 112.594 177.084 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 48.6 t . . . . . 0 N--CA 1.482 1.168 0 N-CA-C 111.985 0.365 . . . . 10.0 111.985 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -52.89 -59.21 9.63 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 125.875 1.702 . . . . 10.0 112.4 175.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -42.06 -43.07 3.1 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 128.439 2.696 . . . . 10.0 113.174 175.205 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 48.3 mt -101.34 -6.53 23.97 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 115.547 1.684 . . . . 10.0 115.547 -174.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 16.9 m -69.75 116.75 10.5 Favored 'General case' 0 N--CA 1.464 0.248 0 O-C-N 120.19 -1.569 . . . . 10.0 110.366 -178.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.621 ' H ' ' HD3' ' A' ' 129' ' ' LYS . 0.1 OUTLIER -55.41 -49.67 71.78 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 128.248 2.619 . . . . 10.0 113.288 177.734 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 60.8 t -69.66 106.39 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 123.738 0.815 . . . . 10.0 110.087 179.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -46.95 -59.47 3.08 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 124.742 1.217 . . . . 10.0 114.065 -173.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 m -46.55 -42.08 15.3 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.489 1.516 . . . . 10.0 113.468 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -70.14 -24.6 63.19 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 114.959 1.466 . . . . 10.0 114.959 -178.149 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 69.0 mtp85 -53.94 -41.6 67.93 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 118.92 0.782 . . . . 10.0 110.787 176.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -70.11 -31.09 68.47 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 114.421 1.267 . . . . 10.0 114.421 176.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.8 t -55.49 -52.43 46.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 CA-C-N 118.989 0.813 . . . . 10.0 109.613 168.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 63.6 m95 -60.28 -44.16 95.6 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 113.914 1.079 . . . . 10.0 113.914 173.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 88.8 t90 -52.02 -49.39 63.47 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 119.469 1.032 . . . . 10.0 112.909 171.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.525 0 C-N-CA 124.166 0.987 . . . . 10.0 111.76 178.228 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.72 0 N-CA-C 112.452 0.538 . . . . 10.0 112.452 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 40.3 ttp -57.0 -53.14 61.38 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.472 1.109 . . . . 10.0 111.966 172.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 63.4 tp -52.7 -47.14 67.48 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.225 1.41 . . . . 10.0 111.858 178.284 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 77.3 t80 -50.81 -54.75 21.01 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.972 0.909 . . . . 10.0 112.587 171.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 41.5 mm -52.26 -55.89 8.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 CA-C-N 118.884 0.765 . . . . 10.0 110.35 176.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 43.0 mt -58.8 -35.15 72.38 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 118.511 -0.757 . . . . 10.0 111.761 -177.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -57.21 -58.24 9.09 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 124.018 0.927 . . . . 10.0 113.046 173.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.41 -40.88 85.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 CA-C-O 118.304 -0.855 . . . . 10.0 111.461 177.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 45.3 mt -56.78 -49.39 75.45 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.895 1.225 . . . . 10.0 112.139 171.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.471 ' HA ' ' HD2' ' A' ' 175' ' ' ARG . 11.9 t80 -77.04 -70.28 0.47 Allowed 'General case' 0 C--N 1.326 -0.435 0 O-C-N 120.083 -1.636 . . . . 10.0 112.877 -175.236 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -73.73 -21.92 60.06 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.559 1.144 . . . . 10.0 113.459 -174.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -87.78 -79.15 1.26 Allowed Glycine 0 CA--C 1.526 0.747 0 C-N-CA 123.651 0.643 . . . . 10.0 113.502 171.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -53.57 -32.44 50.92 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 126.301 1.841 . . . . 10.0 113.067 -166.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.4 m -52.15 -56.42 14.69 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 114.003 1.112 . . . . 10.0 114.003 172.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.3 p -53.69 -50.57 65.57 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 122.05 0.929 . . . . 10.0 112.269 -177.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 47.6 tttm -57.09 -46.06 82.85 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.136 0.975 . . . . 10.0 112.127 173.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.79 -47.52 80.01 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 114.513 1.301 . . . . 10.0 114.513 174.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -56.44 -11.33 1.21 Allowed 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.066 1.746 . . . . 10.0 114.235 177.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.2 m -107.08 6.69 29.15 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.382 1.873 . . . . 10.0 114.885 -179.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 93.2 mmm -91.89 -92.7 0.15 Allowed 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 123.509 1.623 . . . . 10.0 114.146 -170.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -138.69 153.91 72.66 Favored Pre-proline 0 C--O 1.236 0.367 0 C-N-CA 129.767 3.227 . . . . 10.0 105.541 170.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -52.77 -46.24 34.94 Favored 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 122.352 2.035 . . . . 10.0 113.082 179.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.667 ' CD ' ' HD3' ' A' ' 227' ' ' ARG . 0.1 OUTLIER -52.94 -46.12 68.0 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 129.04 2.936 . . . . 10.0 113.292 173.569 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 92.2 t -69.19 -53.01 27.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 C-N-CA 124.034 0.933 . . . . 10.0 109.765 -178.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.19 -46.76 75.85 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.274 0.63 . . . . 10.0 111.928 177.07 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 60.4 p -60.03 -56.22 24.4 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.933 0.893 . . . . 10.0 112.699 174.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 61.4 m -57.17 -53.2 60.78 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.169 0.988 . . . . 10.0 113.05 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -49.55 -49.49 46.05 Favored 'General case' 0 C--O 1.222 -0.386 0 C-N-CA 123.305 0.642 . . . . 10.0 111.131 174.024 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -57.17 -48.42 78.77 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 114.639 1.348 . . . . 10.0 114.639 -179.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 40.4 t -55.95 -49.61 74.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 CA-C-N 118.787 0.721 . . . . 10.0 110.506 176.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 94.0 mt -58.55 -51.61 69.17 Favored 'General case' 0 C--O 1.221 -0.397 0 N-CA-C 113.207 0.818 . . . . 10.0 113.207 175.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . 0.471 ' HD2' ' HA ' ' A' ' 153' ' ' PHE . 35.7 ttp180 -47.83 -47.74 31.15 Favored 'General case' 0 C--O 1.224 -0.246 0 C-N-CA 126.818 2.047 . . . . 10.0 111.047 174.456 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 63.7 m-20 -58.53 -58.3 9.16 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 122.785 0.434 . . . . 10.0 111.252 174.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 59.4 t -51.72 -49.79 34.04 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 C-N-CA 124.078 0.951 . . . . 10.0 111.193 179.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 30.3 m -57.01 -61.5 2.4 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 128.21 2.604 . . . . 10.0 112.435 178.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 55.2 t -52.15 -49.88 38.31 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 124.471 1.108 . . . . 10.0 110.944 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 80.4 t -59.71 -61.15 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 124.299 1.04 . . . . 10.0 112.007 177.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -57.35 -50.1 74.04 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 118.78 0.718 . . . . 10.0 112.388 -176.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 10.2 m95 . . . . . 0 N--CA 1.469 0.495 0 C-N-CA 123.627 0.771 . . . . 10.0 111.935 177.453 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 93.2 t . . . . . 0 N--CA 1.479 0.997 0 CA-C-O 119.394 -0.336 . . . . 10.0 111.558 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 63.2 t90 -56.32 -52.69 63.62 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.403 1.081 . . . . 10.0 112.598 175.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 9.6 tt -57.83 -42.77 85.07 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 123.665 0.786 . . . . 10.0 112.369 -177.593 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 14.5 pt -83.74 -5.93 9.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 N-CA-C 115.085 1.513 . . . . 10.0 115.085 179.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.38 -169.32 33.02 Favored Glycine 0 N--CA 1.45 -0.404 0 CA-C-O 122.55 1.083 . . . . 10.0 113.925 -168.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 23.3 t -53.16 -41.43 65.16 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 114.17 -1.015 . . . . 10.0 111.854 177.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -67.98 -16.05 63.88 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 115.626 1.713 . . . . 10.0 115.626 -175.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -131.11 -106.04 1.08 Allowed Glycine 0 CA--C 1.533 1.157 0 CA-C-N 120.4 1.455 . . . . 10.0 113.908 -173.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -89.44 127.17 35.81 Favored 'General case' 0 C--N 1.328 -0.345 0 O-C-N 120.681 -1.482 . . . . 10.0 109.304 168.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -72.56 65.37 1.39 Allowed Glycine 0 CA--C 1.532 1.141 0 N-CA-C 113.871 0.308 . . . . 10.0 113.871 173.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 60.6 mt -79.54 -42.76 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 126.078 1.751 . . . . 10.0 108.759 166.333 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 79.7 t -126.31 133.37 24.9 Favored Pre-proline 0 N--CA 1.454 -0.25 0 C-N-CA 126.436 1.894 . . . . 10.0 109.351 -174.176 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -68.71 153.81 72.49 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 123.745 2.963 . . . . 10.0 111.479 -176.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 12.2 tp -43.18 -39.79 3.04 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.341 1.056 . . . . 10.0 112.169 171.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -48.38 -52.39 22.04 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 114.653 1.353 . . . . 10.0 114.653 176.086 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 14.0 mm -75.9 -40.51 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 C-N-CA 124.453 1.101 . . . . 10.0 109.646 177.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -49.27 -49.78 41.98 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 118.592 0.633 . . . . 10.0 111.991 173.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 16.3 m -57.75 -47.03 83.65 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 126.015 1.726 . . . . 10.0 112.97 174.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.535 HD23 ' CD2' ' A' ' 12' ' ' TRP . 1.3 tm? -63.36 -52.28 62.39 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.923 0.889 . . . . 10.0 112.093 179.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 93.2 mt -52.57 -59.41 4.49 Favored 'General case' 0 C--N 1.335 -0.053 0 C-N-CA 124.362 1.065 . . . . 10.0 109.954 176.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -53.11 -47.06 68.91 Favored 'General case' 0 C--O 1.216 -0.66 0 CA-C-O 117.126 -1.416 . . . . 10.0 112.001 176.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 209' ' ' MET . . . . . 0.575 ' HE2' ' HB3' ' A' ' 15' ' ' LEU . 4.6 tmm? -50.99 -52.25 44.65 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 121.454 1.934 . . . . 10.0 113.168 174.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 79.4 t -60.14 -49.15 85.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 124.708 1.203 . . . . 10.0 111.263 178.37 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 4.3 mp -58.16 -51.61 68.99 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.631 1.573 . . . . 10.0 112.272 175.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -55.68 -58.27 8.51 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 127.824 2.45 . . . . 10.0 110.566 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 78.7 t . . . . . 0 N--CA 1.477 0.891 0 O-C-N 121.48 -0.762 . . . . 10.0 111.764 177.234 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.246 0 CA-C-O 120.994 0.219 . . . . 10.0 112.695 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 61.1 t80 -44.3 -57.7 3.34 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.926 2.09 . . . . 10.0 112.166 166.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -55.17 -40.44 74.86 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 124.179 0.895 . . . . 10.0 114.265 177.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 24.2 mt -70.55 -27.33 64.06 Favored 'General case' 0 CA--C 1.512 -0.494 0 N-CA-C 115.528 1.677 . . . . 10.0 115.528 177.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 74.4 mt -63.27 -57.53 11.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 108.616 -0.883 . . . . 10.0 108.616 165.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 32.1 tp -58.89 -64.68 0.85 Allowed 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.95 0.9 . . . . 10.0 113.126 -172.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 84.3 mt -71.55 5.23 2.5 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 115.333 1.605 . . . . 10.0 115.333 -171.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.6 mtp-105 -112.35 0.39 15.66 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.168 0.987 . . . . 10.0 113.296 172.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 8.8 t -108.04 177.99 4.64 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 124.035 0.934 . . . . 10.0 111.002 174.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 227' ' ' ARG . . . . . 0.667 ' HD3' ' CD ' ' A' ' 166' ' ' GLU . 41.8 ttt180 -71.68 98.2 1.88 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.744 0.818 . . . . 10.0 110.953 170.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . 0.476 ' HB1' ' CD2' ' A' ' 42' ' ' PHE . . . -80.88 76.98 7.8 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.896 0.879 . . . . 10.0 112.111 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 40.08 102.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 128.837 2.855 . . . . 10.0 116.492 177.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . 0.483 0.3 OUTLIER 71.92 -55.46 0.66 Allowed 'General case' 0 C--O 1.241 0.647 0 C-N-CA 124.692 1.197 . . . . 10.0 110.632 -175.346 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -68.26 169.47 39.92 Favored Glycine 0 C--O 1.238 0.376 0 C-N-CA 129.782 3.563 . . . . 10.0 119.621 171.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.461 0 C-N-CA 128.473 2.709 . . . . 10.0 113.457 166.611 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 N--CA 1.476 0.87 0 CA-C-O 115.807 -2.044 . . . . 10.0 105.858 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 23.41 91.8 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 129.598 3.159 . . . . 10.0 117.253 160.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 28.67 65.06 0.11 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 128.291 2.636 . . . . 10.0 114.474 155.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 86.7 mt -56.46 137.93 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 126.387 1.875 . . . . 10.0 113.376 -158.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.652 HG21 ' HB3' ' A' ' 77' ' ' PRO . 7.6 t -136.7 -165.22 1.7 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 126.324 1.85 . . . . 10.0 114.052 -174.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 70.01 2.83 41.23 Favored Glycine 0 C--N 1.34 0.786 0 C-N-CA 127.471 2.463 . . . . 10.0 111.485 168.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -158.56 -51.35 0.01 OUTLIER Pre-proline 0 N--CA 1.443 -0.823 0 CA-C-O 114.274 -2.774 . . . . 10.0 116.642 -168.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -63.95 -60.69 0.14 Allowed 'Trans proline' 0 N--CA 1.465 -0.202 0 CA-C-N 123.509 2.289 . . . . 10.0 113.21 -175.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.411 ' H ' ' CD ' ' A' ' 9' ' ' GLU . 7.9 pm0 -67.16 4.35 0.94 Allowed 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 127.836 2.454 . . . . 10.0 115.764 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.421 ' CG ' ' N ' ' A' ' 11' ' ' ILE . 11.1 p-90 -51.37 -43.14 61.78 Favored 'General case' 0 C--O 1.222 -0.361 0 O-C-N 121.516 -0.74 . . . . 10.0 112.564 176.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.421 ' N ' ' CG ' ' A' ' 10' ' ' TRP . 8.9 tt -60.87 -49.63 83.82 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.361 0 C-N-CA 123.926 0.89 . . . . 10.0 109.306 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.535 ' CD2' HD23 ' A' ' 206' ' ' LEU . 2.6 m95 -55.38 -52.62 62.93 Favored 'General case' 0 C--O 1.224 -0.259 0 C-N-CA 123.433 0.693 . . . . 10.0 111.912 175.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.6 mt -57.38 -53.61 56.24 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.112 0.565 . . . . 10.0 112.222 177.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.84 -46.79 51.67 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.391 1.476 . . . . 10.0 113.33 173.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.574 ' HB3' ' HE2' ' A' ' 209' ' ' MET . 13.3 tp -65.62 -45.02 84.7 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 125.336 1.455 . . . . 10.0 113.047 179.086 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.45 -56.86 10.1 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 124.621 1.105 . . . . 10.0 111.407 165.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.2 m -49.51 -52.49 29.15 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.995 1.318 . . . . 10.0 112.242 174.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.41 -58.86 5.79 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.143 0.977 . . . . 10.0 112.176 177.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 95.3 mt -57.97 -49.34 77.16 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.678 0.791 . . . . 10.0 112.544 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 23.5 mmt -55.23 -51.04 67.86 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.587 0.755 . . . . 10.0 111.026 175.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -56.33 -58.53 13.82 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 124.441 1.019 . . . . 10.0 113.738 176.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 80.8 mt -56.21 -45.41 79.89 Favored 'General case' 0 C--O 1.221 -0.397 0 CA-C-N 118.593 1.196 . . . . 10.0 112.113 176.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.83 -42.05 77.8 Favored Glycine 0 CA--C 1.534 1.24 0 C-N-CA 124.814 1.197 . . . . 10.0 113.46 172.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 15.4 m -59.38 -61.61 2.5 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.457 1.103 . . . . 10.0 110.723 171.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -52.24 -40.96 62.37 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.039 0.936 . . . . 10.0 110.976 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -55.77 -58.08 9.32 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.611 1.165 . . . . 10.0 112.986 172.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -59.65 -38.61 81.89 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 113.255 0.835 . . . . 10.0 113.255 178.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.402 ' C ' ' H ' ' A' ' 30' ' ' LYS . 11.8 mt -56.19 -67.44 0.3 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.627 1.171 . . . . 10.0 113.597 169.118 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 t -76.37 40.98 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 CA-C-O 123.749 1.738 . . . . 10.0 110.879 179.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.402 ' H ' ' C ' ' A' ' 28' ' ' LEU . 42.9 tttm -140.87 -44.88 0.39 Allowed 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 127.87 2.468 . . . . 10.0 109.336 171.204 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.96 23.15 0.87 Allowed Glycine 0 CA--C 1.529 0.925 0 N-CA-C 115.629 1.012 . . . . 10.0 115.629 173.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 37.3 mmm -59.54 -44.97 93.06 Favored 'General case' 0 C--O 1.225 -0.235 0 C-N-CA 127.13 2.172 . . . . 10.0 113.63 -179.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.62 -84.43 1.18 Allowed Glycine 0 CA--C 1.531 1.045 0 C-N-CA 123.764 0.697 . . . . 10.0 112.508 -170.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.8 t 33.02 88.81 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.242 0.682 0 C-N-CA 128.358 2.663 . . . . 10.0 116.942 166.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.7 m -79.68 -50.85 10.01 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.167 -1.379 . . . . 10.0 113.877 174.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -48.91 117.47 6.37 Favored Pre-proline 0 CA--C 1.536 0.416 0 O-C-N 124.764 1.29 . . . . 10.0 110.949 -172.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -58.57 -29.65 89.61 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 123.726 2.951 . . . . 10.0 113.682 179.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.29 -60.64 2.3 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 123.107 0.563 . . . . 10.0 111.48 176.15 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.21 -40.02 23.0 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 125.097 1.359 . . . . 10.0 113.559 171.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.5 tttp -46.57 -47.44 19.76 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 125.243 1.417 . . . . 10.0 113.403 172.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -57.72 -53.08 62.26 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.473 0.709 . . . . 10.0 111.009 176.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.476 ' CD2' ' HB1' ' A' ' 228' ' ' ALA . 43.8 m-85 -56.95 -50.24 73.24 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 123.089 0.555 . . . . 10.0 112.34 -179.178 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -54.44 -51.25 65.55 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 118.916 -0.564 . . . . 10.0 112.342 173.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.38 -61.98 1.93 Allowed 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 113.399 0.888 . . . . 10.0 113.399 177.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.5 mt -48.86 -56.06 2.81 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 C-N-CA 124.912 1.285 . . . . 10.0 110.832 178.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.5 m -69.49 -20.34 63.73 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.861 1.264 . . . . 10.0 113.432 -172.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 28.1 m -84.4 -38.82 19.78 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.404 1.081 . . . . 10.0 112.28 174.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 19.1 mt -59.33 -41.4 89.06 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 117.873 -1.061 . . . . 10.0 112.803 174.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.686 HG23 ' HD3' ' A' ' 50' ' ' PRO 0.405 33.0 m -58.49 -49.56 92.85 Favored Pre-proline 0 N--CA 1.486 1.36 0 CA-C-N 121.082 1.765 . . . . 10.0 114.707 -178.915 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.686 ' HD3' HG23 ' A' ' 49' ' ' VAL . 89.3 Cg_exo -49.82 -45.32 32.66 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 123.587 2.858 . . . . 10.0 115.107 162.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.6 -46.79 84.2 Favored 'General case' 0 CA--C 1.548 0.892 0 CA-C-N 119.82 1.191 . . . . 10.0 113.704 -179.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 30.9 mm -53.22 -55.48 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 124.989 1.316 . . . . 10.0 109.595 169.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.65 -44.85 77.56 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.124 0.969 . . . . 10.0 113.567 177.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 50.2 t80 -52.59 -56.78 12.92 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.28 1.432 . . . . 10.0 111.871 172.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 14.4 m -49.92 -52.58 32.12 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.304 1.441 . . . . 10.0 110.658 177.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 32.6 mmt -69.23 -48.13 62.77 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 123.965 0.906 . . . . 10.0 113.05 -176.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -54.69 -42.55 71.55 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 120.17 1.35 . . . . 10.0 113.213 172.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.7 tp -53.33 -54.54 35.03 Favored 'General case' 0 C--O 1.224 -0.272 0 CA-C-N 119.406 1.003 . . . . 10.0 111.292 171.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 23.9 p -51.6 -41.08 60.95 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 115.239 1.57 . . . . 10.0 115.239 178.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 58.4 mtm -66.86 -50.88 61.09 Favored 'General case' 0 C--N 1.334 -0.09 0 C-N-CA 123.597 0.759 . . . . 10.0 110.477 176.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.5 tp -48.58 -52.65 21.79 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.859 0.863 . . . . 10.0 112.95 172.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.5 mt -76.94 -5.58 49.12 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.318 1.047 . . . . 10.0 113.805 -177.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.28 -34.7 5.56 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 115.504 0.962 . . . . 10.0 115.504 174.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -49.27 -43.04 42.75 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 115.278 1.584 . . . . 10.0 115.278 -176.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.05 3.52 61.2 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 115.388 0.915 . . . . 10.0 115.388 -179.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.23 143.4 26.45 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 127.016 2.126 . . . . 10.0 109.02 171.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 t -145.51 171.16 15.06 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 123.995 0.918 . . . . 10.0 111.013 166.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.02 136.05 53.39 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 123.897 0.879 . . . . 10.0 109.675 179.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.436 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 58.7 t -129.56 129.61 23.19 Favored Pre-proline 0 C--N 1.329 -0.295 0 C-N-CA 125.069 1.348 . . . . 10.0 110.969 -176.095 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 69' ' ' VAL . 6.3 Cg_exo -80.81 116.23 3.15 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 N-CA-C 109.367 -1.051 . . . . 10.0 109.367 -178.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -156.68 164.37 38.22 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 112.862 0.69 . . . . 10.0 112.862 172.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.36 -81.95 0.14 Allowed Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.68 -0.968 . . . . 10.0 110.68 175.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.76 -3.31 0.7 Allowed Glycine 0 CA--C 1.527 0.822 0 N-CA-C 118.684 2.234 . . . . 10.0 118.684 170.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -151.64 -171.89 4.06 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 119.327 1.564 . . . . 10.0 112.221 -165.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -91.89 93.95 9.06 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 125.456 1.502 . . . . 10.0 111.091 -175.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.449 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 60.2 m-80 -89.5 120.74 69.63 Favored Pre-proline 0 N--CA 1.45 -0.429 0 N-CA-C 112.953 0.723 . . . . 10.0 112.953 -165.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.652 ' HB3' HG21 ' A' ' 5' ' ' THR . 76.3 Cg_exo -61.47 131.93 38.36 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 124.171 3.247 . . . . 10.0 112.159 171.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.4 mm -140.16 126.3 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 C-N-CA 125.99 1.716 . . . . 10.0 111.701 -179.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -93.58 85.0 4.76 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 122.967 1.365 . . . . 10.0 113.08 174.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 63.7 p-90 -59.33 -28.28 66.68 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 120.858 -1.151 . . . . 10.0 113.96 174.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -54.14 -27.48 33.77 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 124.273 1.029 . . . . 10.0 112.2 178.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 21.4 mtt-85 -54.62 -50.21 68.65 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.92 1.288 . . . . 10.0 112.78 168.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.413 ' HE1' H162 ' A' ' 999' ' ' RET . 98.3 m-85 -67.44 -39.86 85.42 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 121.409 -0.807 . . . . 10.0 112.114 178.32 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -52.54 -50.65 62.45 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 123.787 0.835 . . . . 10.0 112.135 170.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 54.0 t0 -52.54 -69.12 0.12 Allowed 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 126.079 1.751 . . . . 10.0 111.325 170.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 50.4 m0 -55.48 -35.23 65.3 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 125.821 1.648 . . . . 10.0 113.004 -171.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 25.5 tp -49.58 -43.41 46.17 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 126.408 1.883 . . . . 10.0 112.174 177.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -101.27 -38.5 8.05 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.833 0.853 . . . . 10.0 112.281 179.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 1.6 m -51.15 -55.02 20.0 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.88 1.272 . . . . 10.0 113.468 175.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . 0.263 44.9 p -68.12 -40.58 22.39 Favored Pre-proline 0 N--CA 1.476 0.855 0 N-CA-C 114.63 1.344 . . . . 10.0 114.63 -171.161 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -56.75 -43.04 58.45 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 123.935 3.09 . . . . 10.0 115.522 168.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 53.2 mt -60.39 -47.06 87.72 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 121.395 -0.816 . . . . 10.0 111.394 176.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 6.0 tt -50.89 -48.01 60.53 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.628 1.571 . . . . 10.0 111.596 171.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.5 mp -58.83 -46.76 86.92 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.61 1.164 . . . . 10.0 113.365 170.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.79 -38.34 78.33 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 123.824 0.849 . . . . 10.0 112.868 177.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 -52.24 -54.1 35.4 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 119.317 0.962 . . . . 10.0 111.13 169.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.31 -42.08 88.77 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.651 0.78 . . . . 10.0 112.152 -178.509 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.66 -54.73 37.84 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.962 0.905 . . . . 10.0 112.056 173.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.33 -41.15 79.44 Favored 'General case' 0 C--O 1.224 -0.237 0 C-N-CA 123.767 0.827 . . . . 10.0 112.667 174.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.9 tp -63.8 -38.51 91.38 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 114.461 1.282 . . . . 10.0 114.461 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.2 t -94.85 1.45 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 125.022 1.329 . . . . 10.0 112.316 179.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.2 t70 48.57 53.51 12.02 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.866 1.666 . . . . 10.0 112.095 -174.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.27 145.9 47.58 Favored 'General case' 0 CA--C 1.534 0.339 0 O-C-N 119.977 -1.702 . . . . 10.0 112.459 -174.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.47 135.95 54.17 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 112.715 0.635 . . . . 10.0 112.715 175.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -42.89 -39.74 2.66 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 125.906 1.682 . . . . 10.0 113.41 175.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -47.32 -60.21 5.32 Favored Glycine 0 CA--C 1.525 0.691 0 C-N-CA 125.12 1.343 . . . . 10.0 115.222 169.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.6 p -62.05 -46.8 87.54 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 117.147 -1.406 . . . . 10.0 111.321 178.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 66.9 mt -48.39 -52.92 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 125.001 1.321 . . . . 10.0 111.147 178.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.2 tp -62.64 -51.27 67.93 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 112.548 0.573 . . . . 10.0 112.548 179.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.15 -44.9 43.13 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.506 0.722 . . . . 10.0 110.905 174.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.455 ' HA ' HD12 ' A' ' 111' ' ' LEU . 0.6 OUTLIER -59.52 -59.94 4.65 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 127.431 2.292 . . . . 10.0 114.8 174.937 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.5 t -61.03 -46.33 96.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 123.697 0.799 . . . . 10.0 111.388 -178.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -56.62 -50.35 63.76 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 123.695 0.664 . . . . 10.0 112.619 174.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -54.7 -46.85 74.2 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 113.275 0.843 . . . . 10.0 113.275 173.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -57.45 -45.39 84.78 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.804 0.842 . . . . 10.0 112.135 174.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -43.98 -55.65 5.53 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 125.385 1.469 . . . . 10.0 113.131 167.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 80.1 mt -55.73 -54.11 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 CA-C-O 118.03 -0.986 . . . . 10.0 110.464 173.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 63.4 ttp -46.36 -55.64 7.02 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 120.091 1.314 . . . . 10.0 112.978 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 1.7 mp -68.74 -49.99 59.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 O-C-N 121.543 -0.723 . . . . 10.0 111.591 179.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -52.49 -54.46 27.2 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 123.914 0.768 . . . . 10.0 111.958 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 18.4 m -53.62 -46.96 70.66 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 126.227 1.811 . . . . 10.0 111.798 173.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -49.48 -54.14 17.71 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 124.651 1.119 . . . . 10.0 113.587 170.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 61.7 tp -57.53 -48.35 79.54 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 125.159 1.384 . . . . 10.0 111.994 176.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 63.3 t -52.71 -51.25 37.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 123.249 0.62 . . . . 10.0 110.128 173.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -50.08 -61.18 5.97 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 125.923 1.725 . . . . 10.0 112.709 171.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -46.99 -38.84 11.4 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 127.191 2.196 . . . . 10.0 113.638 178.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 48.2 mt -99.62 -6.87 26.58 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 115.347 1.61 . . . . 10.0 115.347 -178.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 17.0 m -69.67 116.74 10.41 Favored 'General case' 0 N--CA 1.464 0.256 0 O-C-N 120.162 -1.586 . . . . 10.0 110.378 -178.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.621 ' H ' ' HD3' ' A' ' 129' ' ' LYS . 0.1 OUTLIER -55.44 -49.65 71.9 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 128.195 2.598 . . . . 10.0 113.3 177.711 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 61.3 t -69.67 106.32 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 C-N-CA 123.773 0.829 . . . . 10.0 110.121 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -46.89 -59.51 3.04 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 124.769 1.228 . . . . 10.0 114.067 -173.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 m -46.46 -42.1 14.9 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.467 1.507 . . . . 10.0 113.497 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -70.18 -24.59 63.16 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 114.917 1.451 . . . . 10.0 114.917 -178.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 68.8 mtp85 -54.01 -41.65 68.21 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 118.862 0.755 . . . . 10.0 110.864 176.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -69.59 -32.07 70.59 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.755 1.222 . . . . 10.0 114.202 176.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.9 t -54.88 -52.23 45.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-N 119.063 0.847 . . . . 10.0 109.615 168.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 64.2 m95 -61.08 -44.23 97.69 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 114.238 1.199 . . . . 10.0 114.238 174.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 90.4 t90 -53.36 -48.4 68.59 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 119.284 0.947 . . . . 10.0 112.959 172.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -56.76 -53.5 57.08 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.013 0.925 . . . . 10.0 111.607 177.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 98.3 mt -54.27 -49.0 66.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 124.937 1.295 . . . . 10.0 111.748 174.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 20.9 m -55.45 -45.49 76.86 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.63 1.172 . . . . 10.0 111.766 175.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 37.3 m -64.34 -40.47 95.94 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 125.515 1.526 . . . . 10.0 112.164 177.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -57.81 -49.03 78.0 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.972 0.909 . . . . 10.0 112.343 169.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -56.27 -46.97 79.45 Favored 'General case' 0 CA--C 1.546 0.819 0 O-C-N 121.486 -0.759 . . . . 10.0 112.235 172.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 41.4 ttp -55.47 -57.92 9.92 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.218 1.007 . . . . 10.0 112.776 174.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 2.3 pp -61.61 -35.84 79.04 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 118.309 -0.853 . . . . 10.0 112.147 -176.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 75.3 t80 -54.1 -55.27 29.19 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 119.312 0.96 . . . . 10.0 111.95 167.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 54.7 mt -53.59 -55.27 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 123.807 0.843 . . . . 10.0 110.741 177.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 9.9 mp -56.24 -37.06 69.23 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.23 1.012 . . . . 10.0 112.678 178.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -57.27 -58.19 9.31 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 124.057 0.943 . . . . 10.0 112.999 173.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.47 -40.91 85.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 CA-C-O 118.338 -0.839 . . . . 10.0 111.442 177.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 47.1 mt -56.72 -49.48 75.07 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 119.875 1.216 . . . . 10.0 112.098 171.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.471 ' HA ' ' HD2' ' A' ' 175' ' ' ARG . 11.8 t80 -77.01 -70.25 0.47 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 120.087 -1.633 . . . . 10.0 112.877 -175.186 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -73.76 -21.91 60.03 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.587 1.155 . . . . 10.0 113.439 -174.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -87.84 -79.02 1.26 Allowed Glycine 0 CA--C 1.526 0.761 0 C-N-CA 123.599 0.619 . . . . 10.0 113.539 171.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -53.68 -32.42 51.63 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 126.275 1.83 . . . . 10.0 113.024 -166.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.3 m -52.1 -56.46 14.28 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 114.01 1.115 . . . . 10.0 114.01 172.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.7 p -53.63 -50.55 65.48 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 122.081 0.944 . . . . 10.0 112.307 -177.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 47.7 tttm -57.14 -46.07 83.0 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.165 0.986 . . . . 10.0 112.086 173.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.81 -47.48 80.18 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 114.504 1.298 . . . . 10.0 114.504 174.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -56.42 -11.33 1.2 Allowed 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 126.095 1.758 . . . . 10.0 114.223 177.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.1 m -107.11 6.64 29.06 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.408 1.883 . . . . 10.0 114.869 -179.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 93.2 mmm -91.92 -92.68 0.15 Allowed 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 123.48 1.609 . . . . 10.0 114.139 -170.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -138.69 153.93 72.67 Favored Pre-proline 0 C--O 1.236 0.352 0 C-N-CA 129.823 3.249 . . . . 10.0 105.57 170.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -52.8 -46.25 34.99 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.296 1.998 . . . . 10.0 113.102 179.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.666 ' CD ' ' HD3' ' A' ' 227' ' ' ARG . 0.1 OUTLIER -53.02 -45.99 68.21 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 128.972 2.909 . . . . 10.0 113.285 173.619 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 91.7 t -69.24 -53.01 27.74 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.237 0 C-N-CA 124.031 0.933 . . . . 10.0 109.81 -178.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.13 -46.8 75.66 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.287 0.635 . . . . 10.0 111.933 177.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 60.2 p -59.99 -56.23 24.31 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.972 0.909 . . . . 10.0 112.687 174.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 61.3 m -57.19 -53.21 60.73 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.189 0.995 . . . . 10.0 113.036 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -49.57 -49.49 46.26 Favored 'General case' 0 C--O 1.221 -0.438 0 C-N-CA 123.258 0.623 . . . . 10.0 111.098 174.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -57.19 -48.43 78.78 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 114.664 1.357 . . . . 10.0 114.664 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 40.4 t -55.91 -49.66 73.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 CA-C-N 118.802 0.728 . . . . 10.0 110.477 176.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 94.2 mt -58.54 -51.69 68.82 Favored 'General case' 0 C--O 1.222 -0.389 0 N-CA-C 113.168 0.803 . . . . 10.0 113.168 175.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . 0.471 ' HD2' ' HA ' ' A' ' 153' ' ' PHE . 35.5 ttp180 -47.76 -47.76 30.38 Favored 'General case' 0 C--O 1.225 -0.222 0 C-N-CA 126.816 2.046 . . . . 10.0 111.087 174.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 63.5 m-20 -58.47 -58.36 8.89 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 122.819 0.448 . . . . 10.0 111.282 174.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 54.2 t -51.92 -52.29 23.84 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 C-N-CA 124.033 0.933 . . . . 10.0 111.875 179.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 64.1 m -54.59 -61.07 2.55 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 127.408 2.283 . . . . 10.0 113.178 175.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 51.6 t -51.58 -50.13 31.28 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 CA-C-N 120.26 1.391 . . . . 10.0 110.805 -178.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 79.1 t -58.99 -61.0 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 124.211 1.004 . . . . 10.0 112.268 176.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 78.5 mt -57.47 -51.46 69.36 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 118.623 0.647 . . . . 10.0 112.403 -177.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 10.8 m95 -55.81 -48.17 75.89 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 123.66 0.784 . . . . 10.0 111.521 179.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 8.6 t -58.59 -21.9 54.56 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 114.645 1.35 . . . . 10.0 114.645 177.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -69.74 -40.21 76.32 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 119.738 1.154 . . . . 10.0 113.392 174.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -46.09 -56.0 11.8 Favored Pre-proline 0 N--CA 1.478 0.943 0 C-N-CA 125.219 1.408 . . . . 10.0 114.574 -178.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 0.532 ' HB3' H183 ' A' ' 999' ' ' RET . 27.9 Cg_endo -59.22 -34.45 98.25 Favored 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 122.162 1.908 . . . . 10.0 113.6 178.194 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 34.7 t -66.54 -58.5 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 123.817 0.847 . . . . 10.0 110.657 177.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 16.4 m -61.65 -34.28 61.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 CA-C-O 118.898 -0.572 . . . . 10.0 112.439 -177.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 62.2 t90 -57.75 -57.59 12.09 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.344 1.457 . . . . 10.0 112.304 167.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 9.3 tt -58.24 -40.45 81.75 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.802 0.841 . . . . 10.0 112.574 -175.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 14.7 pt -82.67 -5.65 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 N-CA-C 115.195 1.554 . . . . 10.0 115.195 178.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.3 -169.26 33.11 Favored Glycine 0 N--CA 1.45 -0.404 0 CA-C-O 122.551 1.084 . . . . 10.0 113.921 -168.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 23.3 t -53.17 -39.96 63.98 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 114.166 -1.017 . . . . 10.0 111.879 177.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -68.48 -14.9 63.32 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 125.744 1.618 . . . . 10.0 115.171 -174.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -136.27 -104.81 0.75 Allowed Glycine 0 CA--C 1.541 1.662 0 C-N-CA 125.21 1.386 . . . . 10.0 114.951 -174.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -89.43 127.17 35.81 Favored 'General case' 0 C--N 1.328 -0.352 0 O-C-N 120.697 -1.473 . . . . 10.0 109.357 168.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -72.51 65.38 1.37 Allowed Glycine 0 CA--C 1.532 1.127 0 N-CA-C 113.915 0.326 . . . . 10.0 113.915 173.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 60.7 mt -79.61 -42.72 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 126.08 1.752 . . . . 10.0 108.725 166.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 79.4 t -126.34 133.38 24.91 Favored Pre-proline 0 N--CA 1.454 -0.264 0 C-N-CA 126.502 1.921 . . . . 10.0 109.417 -174.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -68.74 153.76 72.54 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 123.811 3.007 . . . . 10.0 111.476 -176.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 12.2 tp -43.13 -39.77 2.95 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.381 1.072 . . . . 10.0 112.214 171.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -48.39 -52.35 22.26 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 114.702 1.371 . . . . 10.0 114.702 176.055 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 14.0 mm -75.96 -40.44 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 124.378 1.071 . . . . 10.0 109.666 177.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -49.29 -49.8 42.08 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 118.592 0.633 . . . . 10.0 111.946 173.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 16.3 m -57.74 -47.08 83.47 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 126.045 1.738 . . . . 10.0 112.953 174.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.535 HD23 ' CD2' ' A' ' 12' ' ' TRP . 1.3 tm? -63.25 -52.36 62.45 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.985 0.914 . . . . 10.0 112.131 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 93.2 mt -52.55 -59.22 4.72 Favored 'General case' 0 C--O 1.228 -0.041 0 C-N-CA 124.278 1.031 . . . . 10.0 109.973 176.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -52.52 -46.16 66.59 Favored 'General case' 0 C--O 1.221 -0.427 0 CA-C-O 117.821 -1.085 . . . . 10.0 112.37 176.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' MET . . . . . 0.574 ' HE2' ' HB3' ' A' ' 15' ' ' LEU . 4.6 tmm? -52.42 -51.82 57.12 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 120.62 1.555 . . . . 10.0 113.023 175.229 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 79.5 t -60.9 -50.35 80.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 124.418 1.087 . . . . 10.0 111.419 178.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 4.6 mp -55.81 -52.01 65.46 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.77 1.628 . . . . 10.0 111.979 175.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -55.12 -61.85 2.05 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 126.449 1.9 . . . . 10.0 110.471 178.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 98.1 t -54.72 -42.84 63.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 CA-C-N 119.529 1.059 . . . . 10.0 111.597 -178.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 6.6 t -55.81 -52.64 63.31 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.085 0.554 . . . . 10.0 112.067 171.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -69.21 -19.49 63.96 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 115.693 1.738 . . . . 10.0 115.693 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -91.44 -74.19 0.51 Allowed 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.949 1.299 . . . . 10.0 110.544 169.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 20.8 t -77.41 -49.19 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 C-N-CA 125.726 1.61 . . . . 10.0 111.153 -168.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -55.04 -56.07 24.99 Favored Glycine 0 N--CA 1.476 1.316 0 CA-C-N 119.098 0.863 . . . . 10.0 112.753 177.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -44.32 -57.96 3.2 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 127.106 2.163 . . . . 10.0 112.316 166.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -55.82 -39.88 78.84 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 124.188 0.899 . . . . 10.0 114.032 177.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 24.4 mt -70.43 -27.53 64.34 Favored 'General case' 0 CA--C 1.511 -0.535 0 N-CA-C 115.52 1.674 . . . . 10.0 115.52 177.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 74.2 mt -63.27 -57.55 11.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 108.642 -0.873 . . . . 10.0 108.642 165.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 32.0 tp -58.79 -64.72 0.83 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.92 0.888 . . . . 10.0 113.184 -172.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 84.0 mt -71.52 5.19 2.5 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 115.332 1.604 . . . . 10.0 115.332 -171.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.6 mtp-105 -112.32 0.38 15.68 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.188 0.995 . . . . 10.0 113.316 172.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 8.8 t -108.03 177.96 4.65 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 124.046 0.938 . . . . 10.0 111.0 174.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . 0.666 ' HD3' ' CD ' ' A' ' 166' ' ' GLU . 41.7 ttt180 -71.62 98.13 1.84 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.786 0.835 . . . . 10.0 110.96 170.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . 0.476 ' HB1' ' CD2' ' A' ' 42' ' ' PHE . . . -80.87 76.96 7.79 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.828 0.851 . . . . 10.0 112.116 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 40.19 102.25 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 128.857 2.863 . . . . 10.0 116.497 177.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . 0.482 0.3 OUTLIER 71.83 -55.44 0.66 Allowed 'General case' 0 C--O 1.242 0.677 0 C-N-CA 124.769 1.227 . . . . 10.0 110.637 -175.273 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -68.25 169.47 39.89 Favored Glycine 0 C--O 1.239 0.429 0 C-N-CA 129.735 3.541 . . . . 10.0 119.701 171.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.461 0 C-N-CA 128.498 2.719 . . . . 10.0 113.46 166.616 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 999' ' ' RET . . . . . 0.723 ' H8 ' H161 ' A' ' 999' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1000 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A 1001 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A 1002 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A 1003 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 N--CA 1.477 0.918 0 CA-C-O 115.804 -2.046 . . . . 10.0 105.785 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 23.4 91.84 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 129.58 3.152 . . . . 10.0 117.236 160.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 28.63 65.11 0.11 Allowed 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 128.306 2.643 . . . . 10.0 114.458 155.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 86.7 mt -56.51 137.99 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 126.358 1.863 . . . . 10.0 113.372 -158.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.653 HG21 ' HB3' ' A' ' 77' ' ' PRO . 7.6 t -136.76 -165.26 1.7 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 126.329 1.852 . . . . 10.0 113.97 -174.268 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 70.05 2.8 41.33 Favored Glycine 0 C--N 1.34 0.768 0 C-N-CA 127.477 2.465 . . . . 10.0 111.487 168.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.8 tpp180 -158.58 -51.34 0.01 OUTLIER Pre-proline 0 N--CA 1.444 -0.772 0 CA-C-O 114.206 -2.806 . . . . 10.0 116.623 -168.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_exo -63.99 -60.6 0.15 Allowed 'Trans proline' 0 CA--C 1.528 0.185 0 CA-C-N 123.517 2.292 . . . . 10.0 113.242 -175.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.411 ' H ' ' CD ' ' A' ' 9' ' ' GLU . 7.9 pm0 -67.19 4.22 0.99 Allowed 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 127.855 2.462 . . . . 10.0 115.735 179.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.422 ' CG ' ' N ' ' A' ' 11' ' ' ILE . 11.0 p-90 -51.32 -43.1 61.64 Favored 'General case' 0 C--O 1.222 -0.361 0 O-C-N 121.496 -0.752 . . . . 10.0 112.669 176.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.422 ' N ' ' CG ' ' A' ' 10' ' ' TRP . 8.9 tt -60.85 -49.65 83.74 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.319 0 C-N-CA 123.936 0.894 . . . . 10.0 109.298 179.359 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.536 ' CD2' HD23 ' A' ' 206' ' ' LEU . 2.6 m95 -55.34 -52.63 62.86 Favored 'General case' 0 C--O 1.224 -0.261 0 C-N-CA 123.384 0.674 . . . . 10.0 111.93 175.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.8 mt -57.36 -53.63 55.96 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 123.193 0.597 . . . . 10.0 112.186 177.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.87 -46.79 51.93 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.41 1.484 . . . . 10.0 113.326 173.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.576 ' HB3' ' HE2' ' A' ' 209' ' ' MET . 13.2 tp -65.7 -44.9 84.71 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.302 1.441 . . . . 10.0 113.027 179.128 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.97 -55.89 13.69 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 124.544 1.069 . . . . 10.0 111.759 166.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 22.5 m -49.76 -52.62 30.4 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.001 1.32 . . . . 10.0 112.43 174.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.38 -58.88 5.71 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.133 0.973 . . . . 10.0 112.173 177.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 95.2 mt -57.55 -48.51 79.14 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.593 0.757 . . . . 10.0 112.816 -179.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 57.6 mtt -57.41 -49.5 76.03 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.089 0.956 . . . . 10.0 111.534 176.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -56.63 -58.85 12.35 Favored Glycine 0 CA--C 1.528 0.844 0 CA-C-O 118.873 -0.959 . . . . 10.0 113.673 174.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 81.1 mt -56.16 -46.08 79.43 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-N 118.82 1.31 . . . . 10.0 112.13 176.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.62 -41.6 74.44 Favored Glycine 0 CA--C 1.535 1.294 0 C-N-CA 124.742 1.163 . . . . 10.0 113.254 173.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 27.9 m -62.46 -58.71 6.62 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.097 0.959 . . . . 10.0 111.316 172.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -52.27 -40.96 62.44 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.001 0.92 . . . . 10.0 110.949 177.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.4 t80 -55.82 -58.02 9.59 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.583 1.153 . . . . 10.0 112.968 172.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.1 m-30 -59.64 -38.69 82.07 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 113.225 0.824 . . . . 10.0 113.225 178.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.4 ' C ' ' H ' ' A' ' 30' ' ' LYS . 11.8 mt -56.1 -67.41 0.3 Allowed 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.625 1.17 . . . . 10.0 113.628 169.104 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 t -76.41 40.95 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 CA-C-O 123.756 1.741 . . . . 10.0 110.91 179.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.4 ' H ' ' C ' ' A' ' 28' ' ' LEU . 42.8 tttm -140.84 -44.84 0.39 Allowed 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 127.872 2.469 . . . . 10.0 109.354 171.153 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.96 23.15 0.87 Allowed Glycine 0 CA--C 1.529 0.945 0 N-CA-C 115.624 1.01 . . . . 10.0 115.624 173.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 37.3 mmm -59.59 -45.01 93.16 Favored 'General case' 0 C--O 1.224 -0.272 0 C-N-CA 127.161 2.184 . . . . 10.0 113.529 -178.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.62 -84.43 1.18 Allowed Glycine 0 CA--C 1.53 1.018 0 C-N-CA 123.766 0.698 . . . . 10.0 112.47 -170.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.7 t 33.01 88.79 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.243 0.753 0 C-N-CA 128.405 2.682 . . . . 10.0 116.975 166.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.7 m -79.7 -50.83 10.03 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.193 -1.367 . . . . 10.0 113.855 174.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -48.92 117.51 6.42 Favored Pre-proline 0 CA--C 1.537 0.443 0 O-C-N 124.76 1.288 . . . . 10.0 110.983 -172.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -58.57 -29.68 89.71 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 123.713 2.942 . . . . 10.0 113.688 179.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.29 -60.63 2.31 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.122 0.569 . . . . 10.0 111.429 176.215 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.19 -40.04 22.86 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 125.072 1.349 . . . . 10.0 113.583 171.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.5 tttp -46.58 -47.42 19.79 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.275 1.43 . . . . 10.0 113.397 172.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -57.76 -53.07 62.36 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.487 0.715 . . . . 10.0 110.978 176.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.477 ' CD2' ' HB1' ' A' ' 228' ' ' ALA . 44.2 m-85 -56.96 -50.23 73.28 Favored 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 123.075 0.55 . . . . 10.0 112.345 -179.122 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -54.4 -51.24 65.5 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 118.926 -0.559 . . . . 10.0 112.376 173.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.41 -62.01 1.91 Allowed 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 113.374 0.879 . . . . 10.0 113.374 177.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.3 mt -48.48 -56.78 1.88 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 124.863 1.265 . . . . 10.0 110.889 178.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.8 m -68.46 -21.67 64.61 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.871 1.268 . . . . 10.0 113.413 -172.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 27.5 m -83.37 -40.05 19.9 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.423 1.089 . . . . 10.0 112.33 175.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 16.8 mt -59.14 -44.19 92.06 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 113.147 0.795 . . . . 10.0 113.147 174.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.489 HG13 HG23 ' A' ' 89' ' ' THR . 31.9 t -43.26 -64.51 0.74 Allowed Pre-proline 0 CA--C 1.549 0.911 0 C-N-CA 124.978 1.311 . . . . 10.0 113.119 177.038 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -67.88 -24.64 39.8 Favored 'Trans proline' 0 CA--C 1.543 0.975 0 C-N-CA 122.383 2.056 . . . . 10.0 113.767 177.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -67.27 -48.73 66.82 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 120.316 1.416 . . . . 10.0 113.154 175.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 27.6 mt -66.12 -42.65 91.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 O-C-N 120.568 -1.333 . . . . 10.0 109.443 174.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.32 -45.56 72.64 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 113.261 0.837 . . . . 10.0 113.261 171.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 45.0 t80 -49.81 -54.96 16.03 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 125.704 1.602 . . . . 10.0 111.681 169.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 14.7 m -48.92 -53.35 20.03 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.386 1.475 . . . . 10.0 111.0 176.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 32.2 mmt -67.99 -48.62 65.27 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 124.122 0.969 . . . . 10.0 113.062 -177.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -56.83 -40.44 76.07 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 120.182 1.355 . . . . 10.0 113.322 173.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.8 tp -53.31 -54.54 34.93 Favored 'General case' 0 C--O 1.225 -0.223 0 CA-C-N 119.795 1.18 . . . . 10.0 111.272 170.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 24.0 p -51.69 -41.04 61.14 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 115.217 1.562 . . . . 10.0 115.217 179.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 59.0 mtm -66.86 -50.89 61.07 Favored 'General case' 0 C--N 1.334 -0.085 0 C-N-CA 123.571 0.748 . . . . 10.0 110.435 176.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.3 tp -48.57 -52.65 21.71 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 123.889 0.875 . . . . 10.0 112.939 172.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.5 mt -76.98 -5.5 48.91 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.325 1.05 . . . . 10.0 113.793 -177.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.25 -34.7 5.56 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 115.522 0.969 . . . . 10.0 115.522 174.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -49.3 -43.06 43.01 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 115.277 1.584 . . . . 10.0 115.277 -176.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.07 3.57 61.13 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 115.379 0.912 . . . . 10.0 115.379 -179.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.25 143.42 26.43 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 127.021 2.129 . . . . 10.0 109.015 171.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 t -145.51 171.11 15.13 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 124.081 0.952 . . . . 10.0 111.041 166.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.04 136.05 53.39 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 123.89 0.876 . . . . 10.0 109.706 179.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.436 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 58.6 t -129.58 129.55 23.18 Favored Pre-proline 0 C--N 1.33 -0.281 0 C-N-CA 125.074 1.35 . . . . 10.0 110.949 -176.013 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 69' ' ' VAL . 6.3 Cg_exo -80.7 116.27 3.18 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 N-CA-C 109.4 -1.038 . . . . 10.0 109.4 -178.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -156.74 164.41 38.15 Favored 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 112.824 0.676 . . . . 10.0 112.824 172.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.37 -81.96 0.14 Allowed Glycine 0 CA--C 1.526 0.764 0 N-CA-C 110.684 -0.966 . . . . 10.0 110.684 175.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.74 -3.39 0.7 Allowed Glycine 0 CA--C 1.527 0.808 0 N-CA-C 118.662 2.225 . . . . 10.0 118.662 170.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -151.59 -171.89 4.06 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 119.406 1.603 . . . . 10.0 112.218 -165.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -91.88 93.86 9.03 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 125.525 1.53 . . . . 10.0 111.111 -175.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.449 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 60.3 m-80 -89.41 120.79 69.69 Favored Pre-proline 0 N--CA 1.45 -0.425 0 N-CA-C 112.941 0.719 . . . . 10.0 112.941 -165.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.653 ' HB3' HG21 ' A' ' 5' ' ' THR . 76.0 Cg_exo -61.54 131.87 37.92 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 124.181 3.254 . . . . 10.0 112.201 171.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.4 mm -140.07 126.3 22.07 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 C-N-CA 126.055 1.742 . . . . 10.0 111.75 -179.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -93.6 85.02 4.76 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 123.012 1.387 . . . . 10.0 113.065 174.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 63.8 p-90 -59.36 -28.25 66.69 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 120.865 -1.147 . . . . 10.0 113.931 174.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -55.07 -28.47 52.62 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.239 1.015 . . . . 10.0 113.152 178.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.0 mtt-85 -49.88 -58.04 6.21 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.447 1.099 . . . . 10.0 111.292 168.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -62.6 -40.64 97.58 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 126.076 1.75 . . . . 10.0 112.437 -179.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -52.24 -48.92 64.92 Favored 'General case' 0 CA--C 1.568 1.647 0 CA-C-N 119.597 1.09 . . . . 10.0 111.15 168.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -59.19 -64.38 0.96 Allowed 'General case' 0 N--CA 1.494 1.753 0 CA-C-N 121.212 1.824 . . . . 10.0 110.792 169.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 48.1 m0 -50.65 -35.51 31.01 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.94 1.296 . . . . 10.0 111.865 -170.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 26.4 tp -51.29 -42.59 61.26 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.39 1.876 . . . . 10.0 113.335 176.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -101.45 -52.54 3.21 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.213 1.005 . . . . 10.0 112.645 -175.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.489 HG23 HG13 ' A' ' 49' ' ' VAL . 1.1 m -46.15 -51.01 14.85 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 125.64 1.576 . . . . 10.0 112.829 175.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.421 ' HB ' ' HD3' ' A' ' 91' ' ' PRO . 3.7 m -64.58 -45.89 76.75 Favored Pre-proline 0 CA--C 1.547 0.837 0 O-C-N 121.343 -0.848 . . . . 10.0 112.661 -169.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.421 ' HD3' ' HB ' ' A' ' 90' ' ' THR . 76.2 Cg_exo -51.29 -44.83 40.74 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 124.053 3.169 . . . . 10.0 116.749 162.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 59.4 mt -59.3 -46.67 87.93 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 119.134 0.879 . . . . 10.0 111.358 175.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.5 tp -50.31 -47.74 55.52 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.341 1.856 . . . . 10.0 111.892 172.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.9 mp -60.87 -46.5 90.36 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.414 1.486 . . . . 10.0 113.032 170.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.9 -38.22 78.37 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.82 0.848 . . . . 10.0 112.854 178.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -52.3 -54.05 36.4 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 119.269 0.94 . . . . 10.0 111.166 169.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.3 -42.11 88.79 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.621 0.768 . . . . 10.0 112.131 -178.507 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.66 -54.77 37.27 Favored 'General case' 0 C--O 1.225 -0.186 0 C-N-CA 123.995 0.918 . . . . 10.0 112.011 173.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.28 -41.18 79.23 Favored 'General case' 0 C--O 1.224 -0.239 0 C-N-CA 123.719 0.808 . . . . 10.0 112.725 174.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.9 tp -63.77 -38.56 91.54 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 114.45 1.278 . . . . 10.0 114.45 -179.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.2 t -94.82 1.47 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 125.008 1.323 . . . . 10.0 112.313 179.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.2 t70 48.61 53.4 12.25 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.829 1.652 . . . . 10.0 112.1 -174.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.17 145.88 47.77 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 119.916 -1.74 . . . . 10.0 112.474 -174.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.54 135.9 54.45 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 112.697 0.628 . . . . 10.0 112.697 175.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -42.83 -39.71 2.61 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.894 1.678 . . . . 10.0 113.456 175.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -47.32 -60.22 5.32 Favored Glycine 0 CA--C 1.526 0.731 0 C-N-CA 125.109 1.338 . . . . 10.0 115.252 169.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.4 p -62.06 -46.75 87.75 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 117.057 -1.449 . . . . 10.0 111.335 178.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 66.9 mt -48.45 -52.93 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 124.995 1.318 . . . . 10.0 111.128 178.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.1 tp -62.55 -51.35 67.74 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 112.554 0.576 . . . . 10.0 112.554 179.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.13 -44.9 42.86 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.424 0.689 . . . . 10.0 110.97 174.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.455 ' HA ' HD12 ' A' ' 111' ' ' LEU . 0.6 OUTLIER -59.58 -59.89 4.73 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 127.363 2.265 . . . . 10.0 114.787 174.968 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.6 t -61.04 -46.29 96.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 123.685 0.794 . . . . 10.0 111.41 -178.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -56.64 -50.36 63.75 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 123.674 0.654 . . . . 10.0 112.642 174.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -54.21 -46.74 72.56 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.571 0.748 . . . . 10.0 112.94 173.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -60.89 -41.77 96.67 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 112.707 0.632 . . . . 10.0 112.707 176.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -43.85 -56.94 4.89 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 125.43 1.491 . . . . 10.0 113.078 164.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 85.4 mt -56.84 -50.49 75.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 CA-C-N 117.776 0.788 . . . . 10.0 111.668 175.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 47.9 ttp -48.66 -58.4 4.8 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.295 1.438 . . . . 10.0 112.056 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 36.8 mm -68.61 -44.99 82.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 O-C-N 121.959 -0.463 . . . . 10.0 112.03 178.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -51.99 -60.59 7.4 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 124.829 1.204 . . . . 10.0 112.908 177.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 42.7 p -59.51 -35.88 75.01 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.687 0.795 . . . . 10.0 112.695 174.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -47.92 -56.82 8.36 Favored Glycine 0 CA--C 1.539 1.576 0 C-N-CA 124.336 0.969 . . . . 10.0 113.673 164.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 67.4 tp -58.66 -47.39 84.63 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.623 1.569 . . . . 10.0 111.887 177.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 68.5 t -52.69 -51.48 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 123.314 0.646 . . . . 10.0 110.371 173.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -49.22 -60.92 5.8 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 125.871 1.7 . . . . 10.0 112.275 171.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -48.85 -37.71 20.29 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 126.576 1.95 . . . . 10.0 113.76 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 49.7 mt -99.31 -6.57 27.69 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 115.22 1.563 . . . . 10.0 115.22 -178.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 16.8 m -69.74 116.73 10.48 Favored 'General case' 0 N--CA 1.464 0.266 0 O-C-N 120.165 -1.584 . . . . 10.0 110.345 -178.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.623 ' H ' ' HD3' ' A' ' 129' ' ' LYS . 0.2 OUTLIER -55.45 -49.61 72.0 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 128.205 2.602 . . . . 10.0 113.305 177.728 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 60.9 t -69.64 106.35 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 123.788 0.835 . . . . 10.0 110.089 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -46.88 -59.55 3.01 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 124.809 1.244 . . . . 10.0 114.038 -173.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 m -46.47 -42.11 14.97 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.501 1.521 . . . . 10.0 113.496 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -70.2 -24.54 63.14 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 114.918 1.451 . . . . 10.0 114.918 -178.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 69.3 mtp85 -53.66 -42.18 67.6 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-N 118.923 0.783 . . . . 10.0 110.701 176.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -69.57 -31.65 69.94 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.826 1.25 . . . . 10.0 114.322 176.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.8 t -55.31 -51.74 53.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 CA-C-N 119.064 0.847 . . . . 10.0 109.582 168.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 66.8 m95 -62.08 -42.77 99.54 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 114.335 1.235 . . . . 10.0 114.335 174.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 92.8 t90 -53.92 -48.63 70.0 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.265 1.026 . . . . 10.0 112.618 172.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -57.01 -52.07 66.72 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.71 0.804 . . . . 10.0 111.639 176.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 96.5 mt -55.98 -54.92 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 124.923 1.289 . . . . 10.0 112.009 176.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 5.0 p -57.01 -42.22 79.97 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 121.509 -0.745 . . . . 10.0 112.513 175.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 72.4 m -62.01 -42.72 99.47 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.741 1.216 . . . . 10.0 112.631 174.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -58.59 -47.23 85.0 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 119.424 1.011 . . . . 10.0 112.314 171.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -56.42 -48.95 75.92 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.474 0.71 . . . . 10.0 112.234 172.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 9.6 tmm? -51.67 -52.94 44.13 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.919 1.688 . . . . 10.0 111.858 173.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 7.8 tt -53.59 -52.05 61.03 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.856 1.662 . . . . 10.0 112.392 175.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 72.9 t80 -49.47 -53.91 20.58 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.225 1.01 . . . . 10.0 112.098 173.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 36.9 mm -52.81 -56.09 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 CA-C-N 118.818 0.736 . . . . 10.0 110.387 177.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 18.5 mt -58.71 -34.48 71.37 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 117.979 -1.01 . . . . 10.0 112.037 -178.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -57.26 -58.18 9.36 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 119.513 1.052 . . . . 10.0 113.076 173.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.4 -40.91 85.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 CA-C-O 118.32 -0.847 . . . . 10.0 111.438 177.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 44.1 mt -56.76 -49.42 75.3 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 119.919 1.236 . . . . 10.0 112.12 171.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.47 ' HA ' ' HD2' ' A' ' 175' ' ' ARG . 12.0 t80 -77.02 -70.31 0.47 Allowed 'General case' 0 C--N 1.326 -0.435 0 O-C-N 120.049 -1.657 . . . . 10.0 112.857 -175.216 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -73.7 -21.98 60.06 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.665 1.186 . . . . 10.0 113.411 -174.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -87.77 -79.17 1.26 Allowed Glycine 0 CA--C 1.527 0.806 0 C-N-CA 123.639 0.637 . . . . 10.0 113.49 171.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -53.52 -32.47 50.65 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 126.295 1.838 . . . . 10.0 113.067 -166.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.2 m -52.13 -56.42 14.65 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 114.018 1.118 . . . . 10.0 114.018 172.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.3 p -53.69 -50.57 65.57 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 122.079 0.942 . . . . 10.0 112.271 -177.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 47.6 tttm -57.09 -46.02 82.9 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.168 0.987 . . . . 10.0 112.16 173.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.84 -47.48 80.25 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 114.475 1.287 . . . . 10.0 114.475 174.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -56.53 -11.25 1.21 Allowed 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.034 1.734 . . . . 10.0 114.249 177.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.1 m -107.05 6.62 29.16 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.411 1.884 . . . . 10.0 114.846 -179.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 93.2 mmm -91.9 -92.67 0.15 Allowed 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 123.523 1.63 . . . . 10.0 114.146 -170.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -138.72 153.95 72.63 Favored Pre-proline 0 C--O 1.235 0.308 0 C-N-CA 129.756 3.223 . . . . 10.0 105.552 170.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -52.85 -46.19 35.46 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 122.285 1.99 . . . . 10.0 113.088 179.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.667 ' CD ' ' HD3' ' A' ' 227' ' ' ARG . 0.1 OUTLIER -53.02 -46.04 68.22 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 129.049 2.94 . . . . 10.0 113.259 173.571 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 92.2 t -69.25 -53.0 27.75 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.253 0 C-N-CA 124.06 0.944 . . . . 10.0 109.771 -178.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.12 -46.86 75.63 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.284 0.634 . . . . 10.0 111.915 177.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 60.5 p -59.99 -56.15 25.28 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.908 0.883 . . . . 10.0 112.741 174.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 61.8 m -57.24 -53.18 60.97 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.13 0.972 . . . . 10.0 113.006 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -49.6 -49.51 46.42 Favored 'General case' 0 C--O 1.222 -0.375 0 C-N-CA 123.311 0.644 . . . . 10.0 111.086 174.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -57.16 -48.37 78.87 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 114.678 1.362 . . . . 10.0 114.678 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 40.3 t -56.01 -49.59 74.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 CA-C-N 118.794 0.725 . . . . 10.0 110.507 176.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 94.1 mt -58.58 -51.57 69.35 Favored 'General case' 0 C--O 1.222 -0.394 0 N-CA-C 113.197 0.814 . . . . 10.0 113.197 175.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . 0.47 ' HD2' ' HA ' ' A' ' 153' ' ' PHE . 35.5 ttp180 -47.87 -47.75 31.57 Favored 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 126.82 2.048 . . . . 10.0 111.017 174.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 63.6 m-20 -58.54 -58.29 9.19 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 122.809 0.444 . . . . 10.0 111.283 174.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 59.8 t -51.67 -48.86 36.55 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 124.074 0.949 . . . . 10.0 111.678 179.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 19.8 m -58.76 -62.08 2.13 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 127.267 2.227 . . . . 10.0 112.009 178.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 54.5 t -50.69 -49.44 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 C-N-CA 124.599 1.159 . . . . 10.0 110.998 -179.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 74.2 t -59.65 -62.6 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 123.883 0.873 . . . . 10.0 112.55 177.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -57.97 -45.95 85.9 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 118.669 0.668 . . . . 10.0 112.108 -175.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 9.5 m0 -56.54 -45.53 81.13 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 123.652 0.781 . . . . 10.0 113.0 176.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 49.6 m -56.33 -31.58 63.87 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 113.171 0.804 . . . . 10.0 113.171 176.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -65.57 -44.98 85.07 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 113.761 1.023 . . . . 10.0 113.761 176.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -43.49 -56.67 6.58 Favored Pre-proline 0 N--CA 1.479 1.01 0 N-CA-C 115.144 1.535 . . . . 10.0 115.144 -178.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 0.486 ' HB3' H183 ' A' ' 999' ' ' RET . 29.2 Cg_endo -60.31 -36.09 88.94 Favored 'Trans proline' 0 C--N 1.355 0.889 0 C-N-CA 122.895 2.397 . . . . 10.0 113.439 177.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 34.5 t -63.94 -52.37 57.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 124.124 0.97 . . . . 10.0 110.532 176.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 98.2 t -53.38 -49.9 51.0 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 124.846 1.258 . . . . 10.0 111.418 175.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 28.1 t90 -54.63 -53.91 48.53 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.657 1.183 . . . . 10.0 112.493 174.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 10.0 tt -55.52 -44.95 77.15 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 124.187 0.995 . . . . 10.0 112.625 -178.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 15.0 pt -84.93 -5.52 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 N-CA-C 115.118 1.525 . . . . 10.0 115.118 -178.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.29 -169.27 33.13 Favored Glycine 0 N--CA 1.45 -0.397 0 CA-C-O 122.604 1.113 . . . . 10.0 113.925 -168.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 23.3 t -53.18 -41.0 64.82 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 114.156 -1.022 . . . . 10.0 111.871 177.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -54.17 -32.16 54.67 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 128.621 2.768 . . . . 10.0 115.266 179.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -131.25 -103.86 0.97 Allowed Glycine 0 CA--C 1.528 0.879 0 CA-C-N 119.346 0.976 . . . . 10.0 113.566 -167.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -89.47 127.17 35.82 Favored 'General case' 0 C--N 1.328 -0.328 0 O-C-N 120.657 -1.496 . . . . 10.0 109.32 169.212 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -72.42 65.31 1.35 Allowed Glycine 0 CA--C 1.532 1.138 0 N-CA-C 113.914 0.326 . . . . 10.0 113.914 173.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 60.7 mt -79.57 -42.76 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 C-N-CA 126.096 1.759 . . . . 10.0 108.766 166.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.4 ' CG1' ' HB ' ' A' ' 203' ' ' ILE . 79.2 t -126.29 133.41 24.93 Favored Pre-proline 0 N--CA 1.454 -0.25 0 C-N-CA 126.496 1.918 . . . . 10.0 109.372 -174.208 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -68.76 153.76 72.49 Favored 'Trans proline' 0 N--CA 1.461 -0.441 0 C-N-CA 123.834 3.023 . . . . 10.0 111.459 -176.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 12.2 tp -43.17 -39.78 3.02 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.312 1.045 . . . . 10.0 112.202 171.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -48.33 -52.37 21.86 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 114.715 1.376 . . . . 10.0 114.715 176.012 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . 0.4 ' HB ' ' CG1' ' A' ' 199' ' ' VAL . 14.0 mm -75.93 -40.47 38.43 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 C-N-CA 124.39 1.076 . . . . 10.0 109.681 177.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -49.31 -49.78 42.39 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 118.546 0.612 . . . . 10.0 111.981 173.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 16.1 m -57.67 -47.07 83.35 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 126.013 1.725 . . . . 10.0 112.991 174.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.536 HD23 ' CD2' ' A' ' 12' ' ' TRP . 1.3 tm? -63.31 -52.38 62.16 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.024 0.93 . . . . 10.0 112.06 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 93.2 mt -52.51 -59.96 3.81 Favored 'General case' 0 C--N 1.335 -0.053 0 C-N-CA 124.363 1.065 . . . . 10.0 109.953 176.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -52.92 -45.12 67.47 Favored 'General case' 0 C--O 1.216 -0.667 0 CA-C-O 116.773 -1.584 . . . . 10.0 112.086 176.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' MET . . . . . 0.576 ' HE2' ' HB3' ' A' ' 15' ' ' LEU . 4.6 tmm? -52.65 -53.04 52.59 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 121.719 2.054 . . . . 10.0 113.114 174.187 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 81.8 t -59.96 -47.03 93.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 125.129 1.371 . . . . 10.0 111.158 178.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 4.2 mp -59.81 -50.16 74.89 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.677 1.591 . . . . 10.0 112.298 174.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 32.6 m-20 -55.57 -59.72 4.44 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 127.458 2.303 . . . . 10.0 111.069 177.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 25.4 m -60.44 -42.56 91.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 O-C-N 121.086 -1.009 . . . . 10.0 112.56 -177.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 66.5 p -65.36 -53.32 45.22 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 121.615 -0.678 . . . . 10.0 112.132 176.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -73.12 22.4 0.07 Allowed 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 125.411 1.484 . . . . 10.0 114.776 176.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 21.2 mttm -139.32 -73.38 0.38 Allowed 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 126.287 1.835 . . . . 10.0 109.669 172.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 22.8 t -69.24 -50.83 48.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 124.795 1.238 . . . . 10.0 110.993 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -55.45 -53.52 40.58 Favored Glycine 0 CA--C 1.535 1.327 0 C-N-CA 124.038 0.827 . . . . 10.0 113.157 176.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -44.9 -56.17 4.79 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 126.522 1.929 . . . . 10.0 112.007 166.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -55.67 -39.28 75.34 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 124.554 1.073 . . . . 10.0 114.003 177.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 24.9 mt -69.66 -27.81 65.35 Favored 'General case' 0 CA--C 1.512 -0.481 0 N-CA-C 115.687 1.736 . . . . 10.0 115.687 176.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 74.6 mt -63.45 -57.5 11.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 108.545 -0.909 . . . . 10.0 108.545 165.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 32.1 tp -58.81 -64.65 0.86 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.948 0.899 . . . . 10.0 113.193 -172.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 84.1 mt -71.51 5.14 2.52 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 115.347 1.61 . . . . 10.0 115.347 -171.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.6 mtp-105 -112.33 0.4 15.67 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 124.214 1.006 . . . . 10.0 113.304 172.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 8.8 t -108.06 177.98 4.65 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 124.089 0.956 . . . . 10.0 111.03 174.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . 0.667 ' HD3' ' CD ' ' A' ' 166' ' ' GLU . 41.8 ttt180 -71.65 98.16 1.86 Allowed 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.824 0.85 . . . . 10.0 110.893 170.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . 0.477 ' HB1' ' CD2' ' A' ' 42' ' ' PHE . . . -80.92 77.03 7.84 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.861 0.864 . . . . 10.0 112.1 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 40.1 102.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 128.901 2.88 . . . . 10.0 116.444 177.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . 0.481 0.3 OUTLIER 71.86 -55.42 0.66 Allowed 'General case' 0 C--O 1.242 0.691 0 C-N-CA 124.749 1.22 . . . . 10.0 110.644 -175.334 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -68.32 169.48 40.13 Favored Glycine 0 C--O 1.239 0.422 0 C-N-CA 129.727 3.537 . . . . 10.0 119.655 171.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.459 0 C-N-CA 128.477 2.711 . . . . 10.0 113.438 166.655 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 999' ' ' RET . . . . . 0.515 H181 ' H7 ' ' A' ' 999' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1000 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A 1001 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A 1002 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A 1003 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 N--CA 1.477 0.913 0 CA-C-O 115.813 -2.041 . . . . 10.0 105.805 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 23.35 91.93 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 129.568 3.147 . . . . 10.0 117.213 160.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 28.57 65.08 0.1 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 128.307 2.643 . . . . 10.0 114.514 155.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 86.8 mt -56.52 137.98 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 126.379 1.872 . . . . 10.0 113.336 -158.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.652 HG21 ' HB3' ' A' ' 77' ' ' PRO . 7.6 t -136.71 -165.19 1.69 Allowed 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 126.331 1.852 . . . . 10.0 114.05 -174.357 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 69.95 2.83 40.72 Favored Glycine 0 C--N 1.34 0.768 0 C-N-CA 127.503 2.477 . . . . 10.0 111.511 168.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.8 tpp180 -158.51 -51.39 0.01 OUTLIER Pre-proline 0 N--CA 1.443 -0.783 0 CA-C-O 114.309 -2.758 . . . . 10.0 116.665 -168.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_exo -64.0 -60.58 0.15 Allowed 'Trans proline' 0 N--CA 1.464 -0.218 0 CA-C-N 123.524 2.294 . . . . 10.0 113.215 -175.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.412 ' H ' ' CD ' ' A' ' 9' ' ' GLU . 7.9 pm0 -67.24 4.34 0.97 Allowed 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 127.831 2.452 . . . . 10.0 115.764 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.422 ' CG ' ' N ' ' A' ' 11' ' ' ILE . 11.0 p-90 -51.43 -43.06 61.91 Favored 'General case' 0 C--O 1.223 -0.34 0 O-C-N 121.509 -0.744 . . . . 10.0 112.641 176.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.422 ' N ' ' CG ' ' A' ' 10' ' ' TRP . 8.9 tt -60.91 -49.61 83.94 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.34 0 C-N-CA 123.862 0.865 . . . . 10.0 109.316 179.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.535 ' CD2' HD23 ' A' ' 206' ' ' LEU . 2.6 m95 -55.35 -52.67 62.76 Favored 'General case' 0 C--O 1.224 -0.259 0 C-N-CA 123.4 0.68 . . . . 10.0 111.871 175.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.3 mt -57.3 -53.65 55.69 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 123.21 0.604 . . . . 10.0 112.227 177.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.86 -46.8 51.83 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.413 1.485 . . . . 10.0 113.324 173.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.574 ' HB3' ' HE2' ' A' ' 209' ' ' MET . 13.4 tp -65.64 -44.96 84.8 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 125.298 1.439 . . . . 10.0 113.03 179.085 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -50.02 -57.15 10.35 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 124.045 0.831 . . . . 10.0 111.264 166.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 22.6 m -48.43 -52.62 21.22 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.602 1.161 . . . . 10.0 112.364 174.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.39 -58.86 5.81 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.139 0.976 . . . . 10.0 112.188 177.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 94.2 mt -57.61 -50.43 73.17 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.762 0.825 . . . . 10.0 112.578 -179.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -54.14 -50.31 67.23 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.464 1.106 . . . . 10.0 111.346 175.343 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -58.07 -57.99 16.92 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 124.271 0.939 . . . . 10.0 113.666 176.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 80.8 mt -56.24 -45.77 79.86 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-N 118.434 1.117 . . . . 10.0 112.103 176.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.28 -42.75 74.52 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 125.03 1.3 . . . . 10.0 113.167 172.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 24.1 m -60.79 -59.64 5.06 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 124.038 0.935 . . . . 10.0 111.303 171.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -52.28 -41.02 62.52 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.061 0.944 . . . . 10.0 110.974 178.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.1 t80 -55.75 -58.03 9.55 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.561 1.144 . . . . 10.0 113.006 172.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -59.63 -38.7 82.06 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 113.226 0.825 . . . . 10.0 113.226 178.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.4 ' C ' ' H ' ' A' ' 30' ' ' LYS . 11.8 mt -56.16 -67.47 0.29 Allowed 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.572 1.149 . . . . 10.0 113.576 169.154 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 t -76.36 41.02 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 CA-C-O 123.802 1.763 . . . . 10.0 110.891 179.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.4 ' H ' ' C ' ' A' ' 28' ' ' LEU . 43.0 tttm -140.89 -44.91 0.39 Allowed 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 127.905 2.482 . . . . 10.0 109.303 171.199 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.9 23.07 0.86 Allowed Glycine 0 CA--C 1.529 0.956 0 N-CA-C 115.644 1.017 . . . . 10.0 115.644 173.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 37.3 mmm -59.52 -44.96 93.02 Favored 'General case' 0 C--O 1.224 -0.253 0 C-N-CA 127.17 2.188 . . . . 10.0 113.578 -178.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.66 -84.45 1.18 Allowed Glycine 0 CA--C 1.531 1.045 0 C-N-CA 123.741 0.686 . . . . 10.0 112.477 -170.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.7 t 33.09 88.75 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.242 0.682 0 C-N-CA 128.36 2.664 . . . . 10.0 116.941 166.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.8 m -79.67 -50.89 9.96 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.187 -1.37 . . . . 10.0 113.832 174.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -48.86 117.47 6.33 Favored Pre-proline 0 CA--C 1.536 0.428 0 O-C-N 124.794 1.309 . . . . 10.0 110.983 -172.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -58.53 -29.66 89.51 Favored 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 123.792 2.995 . . . . 10.0 113.698 179.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.35 -60.65 2.3 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.058 0.543 . . . . 10.0 111.455 176.183 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.08 -40.15 22.33 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 125.14 1.376 . . . . 10.0 113.554 171.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -46.53 -47.4 19.57 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 125.261 1.424 . . . . 10.0 113.463 172.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -57.77 -53.01 62.99 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.425 0.69 . . . . 10.0 111.009 176.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.475 ' CD2' ' HB1' ' A' ' 228' ' ' ALA . 43.9 m-85 -57.04 -50.21 73.44 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 123.049 0.54 . . . . 10.0 112.323 -179.114 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -54.37 -51.28 65.31 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 118.935 -0.555 . . . . 10.0 112.379 173.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.36 -62.0 1.92 Allowed 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 113.404 0.89 . . . . 10.0 113.404 177.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.5 mt -48.88 -56.35 2.51 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 C-N-CA 124.829 1.251 . . . . 10.0 110.496 178.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.5 m -70.07 -16.91 63.2 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.109 1.364 . . . . 10.0 113.688 -172.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 27.5 m -87.92 -37.72 16.2 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.134 0.973 . . . . 10.0 112.152 174.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 20.4 mt -60.88 -39.36 88.94 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-O 118.406 -0.807 . . . . 10.0 113.091 173.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.614 HG23 ' HD3' ' A' ' 50' ' ' PRO 0.35 33.3 m -55.16 -54.11 54.07 Favored Pre-proline 0 N--CA 1.485 1.278 0 N-CA-C 114.579 1.326 . . . . 10.0 114.579 179.318 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.614 ' HD3' HG23 ' A' ' 49' ' ' VAL . 68.3 Cg_endo -67.61 -26.44 39.71 Favored 'Trans proline' 0 CA--C 1.545 1.055 0 CA-C-N 123.137 2.156 . . . . 10.0 113.099 173.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.44 -47.7 75.27 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-N 120.181 1.355 . . . . 10.0 113.324 175.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 19.3 tt -65.51 -41.03 89.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 O-C-N 120.431 -1.418 . . . . 10.0 111.419 171.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -49.89 -49.93 47.79 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 118.732 0.696 . . . . 10.0 112.156 170.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 53.2 t80 -51.85 -57.93 7.92 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 125.711 1.604 . . . . 10.0 112.473 173.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.5 m -49.2 -52.72 25.07 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 125.094 1.358 . . . . 10.0 110.856 178.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.457 ' HG3' ' CB ' ' A' ' 85' ' ' ASP . 32.9 mmt -70.02 -47.95 60.02 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 124.21 1.004 . . . . 10.0 112.618 -175.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -56.14 -41.07 74.79 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 120.328 1.422 . . . . 10.0 113.206 172.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.8 tp -53.3 -54.57 34.54 Favored 'General case' 0 C--O 1.224 -0.272 0 CA-C-N 120.024 1.284 . . . . 10.0 111.275 170.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 23.9 p -51.6 -41.16 61.02 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 115.203 1.557 . . . . 10.0 115.203 178.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 57.6 mtm -66.84 -50.81 61.37 Favored 'General case' 0 C--N 1.333 -0.113 0 C-N-CA 123.54 0.736 . . . . 10.0 110.481 176.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.2 tp -48.64 -52.66 22.06 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.882 0.873 . . . . 10.0 112.894 172.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.4 mt -76.9 -5.61 49.15 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.383 1.073 . . . . 10.0 113.786 -177.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.26 -34.66 5.59 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 115.53 0.972 . . . . 10.0 115.53 174.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 75.3 t80 -49.32 -43.13 43.26 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 115.206 1.558 . . . . 10.0 115.206 -176.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.02 3.54 61.06 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 115.313 0.885 . . . . 10.0 115.313 -179.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.25 143.41 26.44 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 127.035 2.134 . . . . 10.0 109.011 172.023 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 t -145.5 171.07 15.19 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 124.064 0.946 . . . . 10.0 111.019 166.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.97 136.08 53.37 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 123.947 0.899 . . . . 10.0 109.73 179.554 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.436 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 58.7 t -129.59 129.56 23.17 Favored Pre-proline 0 C--N 1.329 -0.295 0 C-N-CA 125.098 1.359 . . . . 10.0 110.966 -176.044 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 69' ' ' VAL . 6.3 Cg_exo -80.77 116.24 3.16 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 N-CA-C 109.41 -1.035 . . . . 10.0 109.41 -178.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -156.71 164.41 38.16 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 112.845 0.683 . . . . 10.0 112.845 172.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.37 -81.93 0.14 Allowed Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.681 -0.967 . . . . 10.0 110.681 175.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.8 -3.34 0.69 Allowed Glycine 0 CA--C 1.526 0.762 0 N-CA-C 118.677 2.231 . . . . 10.0 118.677 170.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -151.61 -171.89 4.06 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 119.379 1.589 . . . . 10.0 112.224 -165.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -91.84 93.88 9.05 Favored 'General case' 0 CA--C 1.519 -0.23 0 C-N-CA 125.547 1.539 . . . . 10.0 111.146 -175.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.451 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 60.5 m-80 -89.52 120.79 69.62 Favored Pre-proline 0 N--CA 1.45 -0.43 0 N-CA-C 112.933 0.716 . . . . 10.0 112.933 -165.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.652 ' HB3' HG21 ' A' ' 5' ' ' THR . 75.7 Cg_exo -61.53 131.92 38.19 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 124.208 3.272 . . . . 10.0 112.158 171.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.5 mm -140.12 126.34 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 C-N-CA 126.0 1.72 . . . . 10.0 111.71 -179.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -93.65 85.07 4.76 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 122.701 1.238 . . . . 10.0 113.055 174.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 63.8 p-90 -59.45 -28.2 66.75 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 113.921 1.082 . . . . 10.0 113.921 174.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -54.58 -28.53 46.8 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 113.809 1.04 . . . . 10.0 113.809 178.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 77.7 mtt-85 -52.15 -58.63 6.0 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 119.318 0.963 . . . . 10.0 111.263 169.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -58.67 -40.06 82.43 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 125.697 1.599 . . . . 10.0 111.967 -179.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -52.18 -50.95 60.83 Favored 'General case' 0 CA--C 1.552 1.05 0 CA-C-N 119.368 0.986 . . . . 10.0 112.133 168.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.457 ' CB ' ' HG3' ' A' ' 56' ' ' MET . 0.0 OUTLIER -60.34 -59.82 4.8 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.961 1.304 . . . . 10.0 112.388 173.18 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 52.3 m0 -54.19 -37.8 64.92 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 126.88 2.072 . . . . 10.0 112.714 -176.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 32.5 tp -50.39 -45.16 55.26 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 126.207 1.803 . . . . 10.0 111.845 178.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -97.79 -43.35 7.18 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 123.961 0.905 . . . . 10.0 112.671 -178.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -58.26 -44.09 88.2 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 113.105 0.779 . . . . 10.0 113.105 -176.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.427 ' HB ' ' HD3' ' A' ' 91' ' ' PRO . 3.5 m -68.58 -45.21 35.08 Favored Pre-proline 0 CA--C 1.544 0.735 0 O-C-N 121.302 -0.874 . . . . 10.0 112.386 -172.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.427 ' HD3' ' HB ' ' A' ' 90' ' ' THR . 73.6 Cg_exo -52.34 -44.43 46.68 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 123.672 2.914 . . . . 10.0 115.865 165.012 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 52.8 mt -59.09 -46.63 87.81 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 118.815 0.734 . . . . 10.0 111.426 175.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.2 tp -50.47 -48.73 56.51 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.65 1.58 . . . . 10.0 112.235 172.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.0 mp -59.09 -46.99 86.88 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.192 1.397 . . . . 10.0 112.714 170.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.88 -38.25 78.4 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.866 0.866 . . . . 10.0 112.837 178.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -52.24 -54.09 35.53 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 119.34 0.973 . . . . 10.0 111.187 169.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.35 -42.1 88.58 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.635 0.774 . . . . 10.0 112.113 -178.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.64 -54.79 36.95 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 124.006 0.923 . . . . 10.0 112.014 173.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.25 -41.15 79.05 Favored 'General case' 0 C--O 1.224 -0.237 0 C-N-CA 123.715 0.806 . . . . 10.0 112.764 174.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.8 tp -63.8 -38.54 91.46 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 114.436 1.273 . . . . 10.0 114.436 -179.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.2 t -94.83 1.39 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 125.069 1.347 . . . . 10.0 112.316 179.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.2 t70 48.63 53.49 12.13 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.864 1.666 . . . . 10.0 112.079 -174.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.27 145.93 47.56 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 119.988 -1.695 . . . . 10.0 112.469 -174.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.56 135.91 54.51 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 112.723 0.638 . . . . 10.0 112.723 175.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -42.87 -39.63 2.6 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.83 1.652 . . . . 10.0 113.508 175.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -47.34 -60.19 5.35 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 125.147 1.356 . . . . 10.0 115.264 169.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.6 p -62.09 -46.77 87.6 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 117.1 -1.428 . . . . 10.0 111.309 178.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 66.9 mt -48.41 -52.94 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 125.038 1.335 . . . . 10.0 111.117 178.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.2 tp -62.59 -51.31 67.84 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 112.528 0.566 . . . . 10.0 112.528 179.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.28 -44.81 44.25 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.437 0.695 . . . . 10.0 110.935 174.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.455 HD12 ' HA ' ' A' ' 111' ' ' LEU . 0.6 OUTLIER -59.56 -59.9 4.71 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 127.393 2.277 . . . . 10.0 114.831 174.874 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.6 t -61.01 -46.38 96.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 123.705 0.802 . . . . 10.0 111.37 -178.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -56.6 -50.36 63.61 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 123.686 0.66 . . . . 10.0 112.631 174.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -54.64 -46.67 73.99 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 113.215 0.82 . . . . 10.0 113.215 173.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -57.74 -45.75 85.39 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.218 0.607 . . . . 10.0 111.938 174.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -43.22 -56.09 4.79 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 125.196 1.379 . . . . 10.0 113.002 167.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 88.9 mt -56.76 -52.58 52.76 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 123.518 0.727 . . . . 10.0 111.372 174.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 6.1 tmm? -51.58 -56.72 11.9 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.786 1.234 . . . . 10.0 112.566 -176.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 44.5 mm -67.53 -44.07 86.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 123.068 0.547 . . . . 10.0 112.075 177.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -54.18 -56.72 19.94 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 124.701 1.143 . . . . 10.0 113.207 177.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 38.1 p -57.22 -38.27 73.5 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.326 1.05 . . . . 10.0 112.336 172.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -49.38 -54.23 16.92 Favored Glycine 0 CA--C 1.534 1.279 0 C-N-CA 124.428 1.013 . . . . 10.0 113.172 167.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 65.6 tp -59.51 -48.01 83.3 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 125.157 1.383 . . . . 10.0 112.109 176.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 67.9 t -52.74 -51.62 34.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 123.363 0.665 . . . . 10.0 110.36 174.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -49.77 -60.7 6.24 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 125.937 1.732 . . . . 10.0 112.191 172.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -49.11 -37.49 21.9 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.558 1.943 . . . . 10.0 113.732 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 48.8 mt -99.07 -6.71 27.93 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 115.315 1.598 . . . . 10.0 115.315 -179.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 16.9 m -69.66 116.75 10.42 Favored 'General case' 0 N--CA 1.464 0.229 0 O-C-N 120.15 -1.594 . . . . 10.0 110.386 -178.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.62 ' H ' ' HD3' ' A' ' 129' ' ' LYS . 0.1 OUTLIER -55.5 -49.63 72.06 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 128.23 2.612 . . . . 10.0 113.252 177.765 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 60.3 t -69.61 106.33 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 123.819 0.848 . . . . 10.0 110.071 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -46.92 -59.56 3.01 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 124.787 1.235 . . . . 10.0 114.048 -173.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 m -46.41 -42.13 14.7 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.474 1.51 . . . . 10.0 113.513 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -70.15 -24.63 63.19 Favored 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 114.95 1.463 . . . . 10.0 114.95 -178.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 69.3 mtp85 -53.78 -41.82 67.65 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 118.857 0.753 . . . . 10.0 110.881 176.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -69.42 -32.44 71.43 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.815 1.246 . . . . 10.0 114.216 176.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 49.0 t -55.12 -52.11 47.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 CA-C-N 119.033 0.833 . . . . 10.0 109.965 169.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 69.7 m95 -59.39 -51.5 69.63 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 113.47 0.915 . . . . 10.0 113.47 174.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 85.3 t90 -47.98 -47.23 33.07 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.268 1.027 . . . . 10.0 113.304 174.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -58.5 -51.28 70.52 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.058 0.943 . . . . 10.0 111.768 176.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 97.1 mt -55.37 -51.76 53.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 125.146 1.378 . . . . 10.0 111.553 174.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 20.0 m -53.64 -47.18 70.55 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.734 1.214 . . . . 10.0 112.106 174.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 86.4 m -60.82 -47.11 87.85 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.491 1.516 . . . . 10.0 111.506 177.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -54.35 -49.65 69.29 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 119.385 0.993 . . . . 10.0 112.44 172.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -57.66 -43.83 85.24 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 123.736 0.814 . . . . 10.0 112.922 174.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 39.4 ttp -58.13 -51.41 69.83 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.19 0.996 . . . . 10.0 112.18 172.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 5.6 mp -51.65 -48.55 63.33 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 126.596 1.959 . . . . 10.0 112.042 175.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 77.9 t80 -54.07 -54.26 41.87 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.664 0.785 . . . . 10.0 113.06 172.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 49.4 mt -54.32 -55.35 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 123.566 0.746 . . . . 10.0 110.8 178.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . 0.289 3.9 pp -60.63 -31.26 70.46 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 116.833 -1.556 . . . . 10.0 113.371 179.055 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -57.26 -58.2 9.28 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 120.554 1.524 . . . . 10.0 113.064 170.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.39 -40.88 85.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-O 118.321 -0.847 . . . . 10.0 111.469 177.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 46.9 mt -56.83 -49.34 75.7 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 119.84 1.2 . . . . 10.0 112.164 171.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.47 ' HA ' ' HD2' ' A' ' 175' ' ' ARG . 11.8 t80 -76.97 -70.34 0.47 Allowed 'General case' 0 C--N 1.326 -0.447 0 O-C-N 120.056 -1.653 . . . . 10.0 112.887 -175.288 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -73.71 -21.99 60.05 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.596 1.158 . . . . 10.0 113.439 -174.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -87.78 -79.08 1.26 Allowed Glycine 0 CA--C 1.526 0.77 0 C-N-CA 123.602 0.62 . . . . 10.0 113.545 171.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 5.4 m-30 -53.61 -32.46 51.25 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 126.271 1.828 . . . . 10.0 113.019 -166.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.3 m -52.08 -56.44 14.4 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 113.991 1.108 . . . . 10.0 113.991 172.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.6 p -53.68 -50.58 65.52 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 122.121 0.962 . . . . 10.0 112.282 -177.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 47.7 tttm -57.15 -46.01 83.09 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.194 0.998 . . . . 10.0 112.11 173.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.82 -47.46 80.24 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 114.545 1.313 . . . . 10.0 114.545 174.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -56.49 -11.28 1.21 Allowed 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 126.068 1.747 . . . . 10.0 114.258 177.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.1 m -107.08 6.57 29.04 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.467 1.907 . . . . 10.0 114.881 -179.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 93.2 mmm -91.89 -92.67 0.15 Allowed 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 123.506 1.622 . . . . 10.0 114.164 -170.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -138.69 153.97 72.71 Favored Pre-proline 0 C--O 1.236 0.349 0 C-N-CA 129.848 3.259 . . . . 10.0 105.548 170.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -52.88 -46.21 35.38 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.261 1.974 . . . . 10.0 113.074 179.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.667 ' CD ' ' HD3' ' A' ' 227' ' ' ARG . 0.1 OUTLIER -52.95 -46.08 68.02 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 129.022 2.929 . . . . 10.0 113.242 173.569 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 92.2 t -69.18 -52.99 28.02 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 C-N-CA 124.085 0.954 . . . . 10.0 109.85 -178.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.2 -46.8 75.89 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.238 0.615 . . . . 10.0 111.933 177.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 60.1 p -59.95 -56.25 24.06 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.972 0.909 . . . . 10.0 112.68 174.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 62.0 m -57.22 -53.19 60.94 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.202 1.001 . . . . 10.0 113.004 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -49.61 -49.49 46.65 Favored 'General case' 0 C--O 1.222 -0.375 0 C-N-CA 123.239 0.616 . . . . 10.0 111.102 174.071 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -57.11 -48.46 78.57 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 114.629 1.344 . . . . 10.0 114.629 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 40.4 t -55.95 -49.63 74.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 CA-C-N 118.794 0.725 . . . . 10.0 110.476 176.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 94.2 mt -58.57 -51.63 69.09 Favored 'General case' 0 C--O 1.222 -0.389 0 N-CA-C 113.201 0.815 . . . . 10.0 113.201 175.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . 0.47 ' HD2' ' HA ' ' A' ' 153' ' ' PHE . 35.5 ttp180 -47.71 -47.77 29.85 Favored 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 126.85 2.06 . . . . 10.0 111.092 174.395 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 63.4 m-20 -58.55 -58.29 9.22 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 122.799 0.44 . . . . 10.0 111.255 174.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 54.2 t -51.93 -47.61 41.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 C-N-CA 124.082 0.953 . . . . 10.0 112.143 179.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 25.0 m -59.39 -63.02 1.45 Allowed 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 127.507 2.323 . . . . 10.0 111.755 178.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 55.8 t -50.12 -49.9 21.21 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 C-N-CA 124.799 1.24 . . . . 10.0 110.975 -179.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 70.8 t -59.13 -61.65 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 123.912 0.885 . . . . 10.0 112.616 178.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 91.5 mt -58.36 -46.99 85.23 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 118.19 0.45 . . . . 10.0 111.871 -176.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 9.0 m0 -51.68 -52.34 48.88 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 124.121 0.968 . . . . 10.0 112.217 174.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 8.5 t -54.52 -27.62 39.43 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 114.147 1.166 . . . . 10.0 114.147 179.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -68.64 -41.42 79.44 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 113.595 0.961 . . . . 10.0 113.595 175.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -47.64 -55.19 17.91 Favored Pre-proline 0 N--CA 1.476 0.871 0 N-CA-C 115.558 1.688 . . . . 10.0 115.558 -175.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 0.494 ' HB3' H183 ' A' ' 999' ' ' RET . 28.5 Cg_endo -59.76 -34.85 95.79 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 122.251 1.968 . . . . 10.0 112.925 177.298 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 24.9 t -63.98 -55.57 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 124.443 1.097 . . . . 10.0 110.469 176.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 90.4 t -53.19 -48.37 54.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 125.406 1.482 . . . . 10.0 111.657 176.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 34.7 t90 -55.79 -55.82 27.88 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.844 1.258 . . . . 10.0 112.288 174.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 9.8 tt -55.9 -44.23 78.03 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 124.289 1.036 . . . . 10.0 112.639 -177.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 14.7 pt -82.79 -5.68 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 N-CA-C 114.989 1.477 . . . . 10.0 114.989 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.58 -169.35 32.75 Favored Glycine 0 N--CA 1.45 -0.379 0 CA-C-O 122.545 1.08 . . . . 10.0 113.855 -168.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 23.2 t -53.15 -39.55 63.63 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 114.217 -0.992 . . . . 10.0 111.847 177.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -56.86 -32.39 65.76 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 128.439 2.695 . . . . 10.0 115.286 -179.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -129.61 -104.41 1.11 Allowed Glycine 0 CA--C 1.524 0.628 0 CA-C-O 122.169 0.872 . . . . 10.0 112.738 -167.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -89.39 127.17 35.79 Favored 'General case' 0 C--N 1.328 -0.352 0 O-C-N 120.64 -1.506 . . . . 10.0 109.3 170.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -72.5 65.38 1.37 Allowed Glycine 0 CA--C 1.532 1.124 0 N-CA-C 113.879 0.312 . . . . 10.0 113.879 173.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 60.6 mt -79.67 -42.69 22.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 126.083 1.753 . . . . 10.0 108.725 166.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.4 ' CG1' ' HB ' ' A' ' 203' ' ' ILE . 79.8 t -126.31 133.4 24.93 Favored Pre-proline 0 N--CA 1.454 -0.264 0 C-N-CA 126.47 1.908 . . . . 10.0 109.364 -174.209 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -68.73 153.75 72.57 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 123.822 3.015 . . . . 10.0 111.456 -176.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 12.2 tp -43.1 -39.87 2.96 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.358 1.063 . . . . 10.0 112.199 171.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -48.28 -52.44 21.34 Favored 'General case' 0 CA--C 1.539 0.519 0 N-CA-C 114.673 1.361 . . . . 10.0 114.673 176.052 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . 0.4 ' HB ' ' CG1' ' A' ' 199' ' ' VAL . 14.0 mm -75.88 -40.53 38.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 124.434 1.094 . . . . 10.0 109.625 177.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.29 -49.79 42.08 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 118.61 0.641 . . . . 10.0 111.974 173.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 15.9 m -57.69 -47.08 83.35 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 126.046 1.738 . . . . 10.0 112.964 174.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.535 HD23 ' CD2' ' A' ' 12' ' ' TRP . 1.4 tm? -63.27 -52.33 62.48 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.958 0.903 . . . . 10.0 112.114 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 93.3 mt -52.58 -58.95 5.16 Favored 'General case' 0 C--O 1.227 -0.087 0 C-N-CA 124.293 1.037 . . . . 10.0 110.021 176.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -54.8 -43.73 73.17 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 117.766 -1.111 . . . . 10.0 112.912 177.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' MET . . . . . 0.574 ' HE2' ' HB3' ' A' ' 15' ' ' LEU . 4.6 tmm? -52.31 -53.2 47.4 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 120.277 1.399 . . . . 10.0 112.252 174.024 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 77.1 t -60.81 -48.13 90.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 124.525 1.13 . . . . 10.0 111.754 178.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 5.1 mp -56.74 -53.45 57.65 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.148 1.379 . . . . 10.0 111.712 175.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -55.68 -52.76 62.77 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.127 1.771 . . . . 10.0 111.594 178.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 46.0 t -49.04 -56.38 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 124.618 1.167 . . . . 10.0 110.705 173.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 6.7 t -58.01 -48.66 79.38 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.943 0.897 . . . . 10.0 111.957 179.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -68.35 -9.13 45.86 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 126.472 1.909 . . . . 10.0 115.105 -176.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 17.9 mtmm -128.83 -59.37 1.13 Allowed 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 119.709 1.141 . . . . 10.0 112.356 179.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 19.7 t -67.23 -54.26 25.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 CA-C-N 118.985 0.811 . . . . 10.0 110.254 176.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -55.79 -57.03 20.84 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 124.339 0.971 . . . . 10.0 112.929 176.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 35.6 t80 -43.94 -56.31 4.02 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.513 1.925 . . . . 10.0 112.723 168.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -58.98 -39.16 93.86 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 124.576 1.084 . . . . 10.0 113.114 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 24.7 mt -69.5 -27.92 65.61 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 115.792 1.775 . . . . 10.0 115.792 175.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 74.3 mt -63.35 -57.61 11.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 119.22 0.918 . . . . 10.0 108.634 165.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 32.2 tp -58.87 -64.66 0.86 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.924 0.89 . . . . 10.0 113.165 -172.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 84.2 mt -71.55 5.22 2.5 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 115.323 1.601 . . . . 10.0 115.323 -171.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.6 mtp-105 -112.36 0.38 15.64 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.199 1.0 . . . . 10.0 113.272 172.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 8.8 t -108.03 177.97 4.65 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 124.026 0.93 . . . . 10.0 111.015 174.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . 0.667 ' HD3' ' CD ' ' A' ' 166' ' ' GLU . 41.8 ttt180 -71.65 98.22 1.87 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.752 0.821 . . . . 10.0 110.91 170.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . 0.475 ' HB1' ' CD2' ' A' ' 42' ' ' PHE . . . -80.96 77.03 7.89 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.814 0.846 . . . . 10.0 112.123 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 40.09 102.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 128.857 2.863 . . . . 10.0 116.481 177.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . 0.482 0.3 OUTLIER 71.87 -55.46 0.66 Allowed 'General case' 0 C--O 1.242 0.699 0 C-N-CA 124.711 1.205 . . . . 10.0 110.591 -175.331 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -68.28 169.47 40.01 Favored Glycine 0 C--O 1.239 0.417 0 C-N-CA 129.757 3.551 . . . . 10.0 119.653 171.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.474 0 C-N-CA 128.458 2.703 . . . . 10.0 113.43 166.573 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 999' ' ' RET . . . . . 0.5 H181 ' H7 ' ' A' ' 999' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1000 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A 1001 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A 1002 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A 1003 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 N--CA 1.476 0.87 0 CA-C-O 115.817 -2.039 . . . . 10.0 105.775 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 23.44 91.84 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 129.532 3.133 . . . . 10.0 117.276 160.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 28.6 65.05 0.11 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 128.301 2.641 . . . . 10.0 114.514 155.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 86.6 mt -56.44 137.98 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 126.396 1.878 . . . . 10.0 113.338 -158.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.652 HG21 ' HB3' ' A' ' 77' ' ' PRO . 7.6 t -136.8 -165.22 1.7 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 126.286 1.834 . . . . 10.0 114.021 -174.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 70.06 2.79 41.4 Favored Glycine 0 C--N 1.34 0.786 0 C-N-CA 127.443 2.449 . . . . 10.0 111.451 168.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -158.57 -51.32 0.01 OUTLIER Pre-proline 0 N--CA 1.443 -0.783 0 CA-C-O 114.263 -2.78 . . . . 10.0 116.649 -168.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -64.03 -60.6 0.15 Allowed 'Trans proline' 0 CA--C 1.528 0.185 0 CA-C-N 123.538 2.299 . . . . 10.0 113.205 -175.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.41 ' H ' ' CD ' ' A' ' 9' ' ' GLU . 7.9 pm0 -67.21 4.3 0.97 Allowed 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 127.886 2.475 . . . . 10.0 115.732 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.421 ' CG ' ' N ' ' A' ' 11' ' ' ILE . 11.1 p-90 -51.39 -43.07 61.8 Favored 'General case' 0 C--O 1.222 -0.361 0 O-C-N 121.455 -0.778 . . . . 10.0 112.617 176.43 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.421 ' N ' ' CG ' ' A' ' 10' ' ' TRP . 8.9 tt -60.83 -49.65 83.73 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.34 0 C-N-CA 123.926 0.89 . . . . 10.0 109.339 179.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.536 ' CD2' HD23 ' A' ' 206' ' ' LEU . 2.6 m95 -55.4 -52.67 62.81 Favored 'General case' 0 C--O 1.224 -0.259 0 C-N-CA 123.407 0.683 . . . . 10.0 111.871 175.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.5 mt -57.34 -53.62 56.04 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 123.175 0.59 . . . . 10.0 112.198 177.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.86 -46.82 51.89 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.427 1.491 . . . . 10.0 113.268 173.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.575 ' HB3' ' HE2' ' A' ' 209' ' ' MET . 13.3 tp -65.68 -44.92 84.76 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 125.274 1.43 . . . . 10.0 113.012 179.154 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.49 -56.79 10.34 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 124.568 1.08 . . . . 10.0 111.588 166.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 22.3 m -49.22 -52.68 25.41 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.987 1.315 . . . . 10.0 112.373 174.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.42 -58.85 5.84 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.151 0.98 . . . . 10.0 112.19 177.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 93.0 mt -57.26 -49.03 77.35 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.686 0.794 . . . . 10.0 112.736 -179.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 52.8 mtt -58.83 -47.87 83.33 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.121 0.968 . . . . 10.0 111.101 177.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -57.13 -58.6 13.72 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 124.333 0.968 . . . . 10.0 113.99 173.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 80.8 mt -56.24 -45.52 79.96 Favored 'General case' 0 C--O 1.221 -0.426 0 CA-C-N 118.646 1.223 . . . . 10.0 112.112 176.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.08 -41.04 84.7 Favored Glycine 0 CA--C 1.531 1.093 0 O-C-N 120.929 -1.107 . . . . 10.0 113.652 173.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 22.1 m -60.06 -60.43 3.84 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.793 0.837 . . . . 10.0 110.831 171.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -52.22 -41.02 62.38 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.073 0.949 . . . . 10.0 110.958 179.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -55.8 -58.01 9.63 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.557 1.143 . . . . 10.0 112.991 172.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -59.65 -38.72 82.16 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 113.201 0.815 . . . . 10.0 113.201 178.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.401 ' C ' ' H ' ' A' ' 30' ' ' LYS . 11.8 mt -56.11 -67.42 0.3 Allowed 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.58 1.152 . . . . 10.0 113.627 169.131 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 t -76.37 40.93 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-O 123.77 1.747 . . . . 10.0 110.891 179.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.401 ' H ' ' C ' ' A' ' 28' ' ' LEU . 42.9 tttm -140.82 -44.82 0.39 Allowed 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 127.884 2.474 . . . . 10.0 109.35 171.187 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -73.02 23.15 0.88 Allowed Glycine 0 CA--C 1.529 0.928 0 N-CA-C 115.634 1.014 . . . . 10.0 115.634 173.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 37.3 mmm -59.54 -44.96 93.07 Favored 'General case' 0 C--O 1.223 -0.296 0 C-N-CA 127.136 2.174 . . . . 10.0 113.578 -179.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.72 -84.4 1.19 Allowed Glycine 0 CA--C 1.53 1.007 0 C-N-CA 123.718 0.675 . . . . 10.0 112.452 -170.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.8 t 33.04 88.79 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.242 0.682 0 C-N-CA 128.4 2.68 . . . . 10.0 116.961 166.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.7 m -79.62 -50.93 9.93 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.187 -1.37 . . . . 10.0 113.866 174.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -48.93 117.51 6.43 Favored Pre-proline 0 CA--C 1.537 0.454 0 O-C-N 124.719 1.262 . . . . 10.0 110.937 -172.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -58.57 -29.7 89.77 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 123.746 2.964 . . . . 10.0 113.669 179.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.26 -60.68 2.28 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.111 0.565 . . . . 10.0 111.441 176.192 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.16 -40.07 22.71 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 125.097 1.359 . . . . 10.0 113.565 171.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -46.53 -47.45 19.55 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 125.221 1.408 . . . . 10.0 113.463 172.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -57.74 -53.06 62.47 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.431 0.693 . . . . 10.0 110.99 176.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.476 ' CD2' ' HB1' ' A' ' 228' ' ' ALA . 44.2 m-85 -56.95 -50.22 73.28 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 123.09 0.556 . . . . 10.0 112.339 -179.115 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -54.33 -51.32 65.08 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 118.962 -0.542 . . . . 10.0 112.369 173.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.42 -62.02 1.91 Allowed 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 113.34 0.867 . . . . 10.0 113.34 177.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.6 mt -48.8 -56.98 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 124.842 1.257 . . . . 10.0 110.396 178.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.2 m -69.76 -16.45 63.31 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.085 1.354 . . . . 10.0 113.605 -172.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 30.1 m -87.0 -43.28 12.47 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 119.735 1.152 . . . . 10.0 111.842 174.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 20.1 mt -56.84 -40.94 76.98 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 112.937 0.718 . . . . 10.0 112.937 173.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 44.4 t -49.43 -62.05 2.85 Favored Pre-proline 0 CA--C 1.552 1.047 0 C-N-CA 124.473 1.109 . . . . 10.0 112.494 178.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -48.72 -46.92 22.62 Favored 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 124.593 3.529 . . . . 10.0 116.236 164.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.64 -45.7 93.07 Favored 'General case' 0 CA--C 1.548 0.901 0 CA-C-N 119.904 1.229 . . . . 10.0 113.875 -176.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 52.9 mt -57.58 -51.69 66.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 124.536 1.134 . . . . 10.0 109.376 172.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.5 -45.85 73.37 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.31 1.044 . . . . 10.0 113.056 176.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -50.52 -56.7 10.47 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 125.283 1.433 . . . . 10.0 112.228 171.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 13.2 m -49.72 -52.73 29.24 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 125.283 1.433 . . . . 10.0 110.674 177.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 32.4 mmt -68.67 -48.34 64.2 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 124.001 0.92 . . . . 10.0 113.025 -176.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -57.01 -40.16 76.11 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-O 117.083 -1.437 . . . . 10.0 113.214 173.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.8 tp -53.3 -54.54 34.82 Favored 'General case' 0 C--O 1.224 -0.272 0 CA-C-N 120.118 1.327 . . . . 10.0 111.334 170.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 24.0 p -51.64 -41.1 61.06 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 115.221 1.563 . . . . 10.0 115.221 178.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 57.9 mtm -66.86 -50.85 61.19 Favored 'General case' 0 C--N 1.334 -0.09 0 C-N-CA 123.597 0.759 . . . . 10.0 110.477 176.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.4 tp -48.58 -52.67 21.69 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.88 0.872 . . . . 10.0 112.926 172.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.5 mt -76.98 -5.53 49.01 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.358 1.063 . . . . 10.0 113.781 -177.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.29 -34.72 5.54 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 115.47 0.948 . . . . 10.0 115.47 174.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -49.29 -43.13 42.99 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 115.206 1.558 . . . . 10.0 115.206 -175.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.03 3.56 61.03 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 115.35 0.9 . . . . 10.0 115.35 -179.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.2 143.36 26.5 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 127.056 2.142 . . . . 10.0 109.038 171.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 t -145.47 171.13 15.09 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 124.023 0.929 . . . . 10.0 111.077 166.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.02 136.04 53.4 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 123.932 0.893 . . . . 10.0 109.711 179.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.437 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 58.9 t -129.52 129.61 23.21 Favored Pre-proline 0 C--N 1.329 -0.299 0 C-N-CA 125.109 1.364 . . . . 10.0 110.999 -176.096 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 69' ' ' VAL . 6.3 Cg_exo -80.76 116.22 3.16 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 N-CA-C 109.417 -1.032 . . . . 10.0 109.417 -178.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -156.75 164.4 38.16 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.824 0.676 . . . . 10.0 112.824 172.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.35 -81.96 0.14 Allowed Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.696 -0.961 . . . . 10.0 110.696 175.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.72 -3.4 0.7 Allowed Glycine 0 CA--C 1.527 0.836 0 N-CA-C 118.637 2.215 . . . . 10.0 118.637 170.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -151.56 -171.85 4.05 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 119.339 1.569 . . . . 10.0 112.257 -165.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -91.92 93.91 9.03 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 125.504 1.522 . . . . 10.0 111.088 -175.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.45 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 60.5 m-80 -89.51 120.82 69.62 Favored Pre-proline 0 N--CA 1.45 -0.431 0 N-CA-C 112.963 0.727 . . . . 10.0 112.963 -165.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.652 ' HB3' HG21 ' A' ' 5' ' ' THR . 76.6 Cg_exo -61.49 131.89 38.14 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 124.183 3.255 . . . . 10.0 112.199 171.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.6 mm -140.14 126.36 21.92 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 C-N-CA 125.999 1.72 . . . . 10.0 111.704 -179.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -93.66 85.04 4.74 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 122.812 1.291 . . . . 10.0 113.046 174.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 63.7 p-90 -59.35 -28.24 66.66 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 113.905 1.076 . . . . 10.0 113.905 174.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -55.39 -32.05 62.32 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.296 1.038 . . . . 10.0 111.811 178.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.433 ' HG3' HH11 ' A' ' 82' ' ' ARG . 23.4 ttm-85 -47.78 -40.63 21.38 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 126.888 2.075 . . . . 10.0 113.493 170.032 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 62.2 m-85 -86.47 -39.57 16.18 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.418 1.887 . . . . 10.0 111.755 -177.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -49.07 -47.85 44.62 Favored 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 124.555 1.142 . . . . 10.0 111.013 166.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 12.4 t0 -52.03 -71.97 0.06 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 126.471 1.908 . . . . 10.0 111.809 167.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 52.7 m0 -55.09 -33.77 63.08 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 124.095 0.958 . . . . 10.0 113.582 -170.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 24.3 tp -49.68 -40.44 40.05 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 126.285 1.834 . . . . 10.0 111.994 177.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -105.02 -40.37 5.92 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.378 0.671 . . . . 10.0 112.377 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 76.0 p -62.29 -42.16 99.12 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 120.664 1.575 . . . . 10.0 114.022 -179.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . 0.291 69.5 p -69.44 -41.32 16.85 Favored Pre-proline 0 CA--C 1.547 0.854 0 N-CA-C 114.959 1.466 . . . . 10.0 114.959 -176.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -55.11 -42.92 64.22 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 123.328 2.685 . . . . 10.0 115.137 166.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 55.0 mt -60.33 -47.39 86.22 Favored 'General case' 0 CA--C 1.544 0.724 0 O-C-N 121.507 -0.745 . . . . 10.0 111.677 176.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 6.1 tt -50.19 -49.37 52.72 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.723 1.609 . . . . 10.0 111.522 171.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.6 mp -57.26 -47.34 81.66 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.274 1.03 . . . . 10.0 113.135 170.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.86 -38.21 78.26 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 123.844 0.857 . . . . 10.0 112.9 178.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -52.32 -54.02 36.9 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 119.299 0.954 . . . . 10.0 111.21 169.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.33 -42.11 88.67 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 123.64 0.776 . . . . 10.0 112.144 -178.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.7 -54.68 38.59 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.98 0.912 . . . . 10.0 112.041 173.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.29 -41.18 79.32 Favored 'General case' 0 C--O 1.224 -0.24 0 C-N-CA 123.677 0.791 . . . . 10.0 112.714 174.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 32.2 tp -63.8 -38.56 91.55 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 114.436 1.273 . . . . 10.0 114.436 -179.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.2 t -94.79 1.41 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 125.005 1.322 . . . . 10.0 112.298 179.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.2 t70 48.6 53.5 12.08 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.864 1.666 . . . . 10.0 112.101 -174.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.28 145.88 47.59 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 119.951 -1.718 . . . . 10.0 112.47 -174.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.47 135.93 54.16 Favored 'General case' 0 C--O 1.239 0.525 0 N-CA-C 112.711 0.634 . . . . 10.0 112.711 175.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -42.89 -39.64 2.63 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.854 1.661 . . . . 10.0 113.471 175.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -47.33 -60.22 5.33 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 125.205 1.383 . . . . 10.0 115.213 169.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.5 p -62.1 -46.75 87.7 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 117.053 -1.451 . . . . 10.0 111.321 178.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 66.9 mt -48.48 -52.89 7.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 124.998 1.319 . . . . 10.0 111.11 178.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.1 tp -62.58 -51.37 67.62 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 112.528 0.566 . . . . 10.0 112.528 179.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.11 -44.86 42.66 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.47 0.708 . . . . 10.0 110.959 174.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.456 ' HA ' HD12 ' A' ' 111' ' ' LEU . 0.6 OUTLIER -59.62 -59.89 4.72 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 127.404 2.281 . . . . 10.0 114.79 174.981 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.8 t -61.04 -46.32 96.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 123.705 0.802 . . . . 10.0 111.411 -178.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -56.62 -50.35 63.7 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 123.674 0.655 . . . . 10.0 112.642 174.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -54.93 -46.62 74.97 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 113.696 0.998 . . . . 10.0 113.696 173.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -55.02 -49.27 71.94 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 123.48 0.712 . . . . 10.0 111.166 173.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -42.87 -54.57 5.05 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 125.06 1.314 . . . . 10.0 113.059 170.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 86.9 mt -56.11 -54.43 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 CA-C-O 118.281 -0.866 . . . . 10.0 111.327 173.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 1.7 ptt? -56.8 -45.29 82.32 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 119.692 1.133 . . . . 10.0 113.038 -174.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 1.7 mp -68.76 -52.71 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 CA-C-N 119.051 0.841 . . . . 10.0 111.047 174.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -51.62 -53.73 27.78 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 124.233 0.921 . . . . 10.0 111.668 -179.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 80.9 m -52.72 -46.07 67.21 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 125.903 1.681 . . . . 10.0 112.444 170.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -50.84 -51.69 33.1 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 124.631 1.11 . . . . 10.0 112.599 173.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 59.6 tp -60.67 -45.85 92.57 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.247 1.419 . . . . 10.0 112.535 175.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 60.8 t -53.91 -50.26 54.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 O-C-N 121.241 -0.912 . . . . 10.0 110.14 172.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -50.79 -61.14 6.31 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 126.305 1.907 . . . . 10.0 112.646 171.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -42.83 -42.26 3.56 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 127.772 2.429 . . . . 10.0 113.208 176.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 47.7 mt -100.84 -6.81 24.27 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 115.531 1.678 . . . . 10.0 115.531 -175.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 17.0 m -69.65 116.71 10.36 Favored 'General case' 0 N--CA 1.465 0.294 0 O-C-N 120.14 -1.6 . . . . 10.0 110.398 -178.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.622 ' H ' ' HD3' ' A' ' 129' ' ' LYS . 0.2 OUTLIER -55.45 -49.6 72.05 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 128.2 2.6 . . . . 10.0 113.25 177.75 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 60.8 t -69.69 106.33 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 123.797 0.839 . . . . 10.0 110.103 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -46.87 -59.54 3.01 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 124.774 1.229 . . . . 10.0 114.089 -173.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 m -46.52 -42.05 15.1 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.488 1.515 . . . . 10.0 113.495 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -70.16 -24.61 63.18 Favored 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 114.958 1.466 . . . . 10.0 114.958 -178.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 69.0 mtp85 -54.12 -41.43 68.33 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 118.845 0.748 . . . . 10.0 110.839 176.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -69.73 -32.18 70.59 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.842 1.257 . . . . 10.0 114.217 176.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.8 t -54.84 -52.23 44.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 CA-C-N 119.013 0.824 . . . . 10.0 109.83 168.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 65.6 m95 -59.66 -49.87 76.06 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 113.458 0.911 . . . . 10.0 113.458 173.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 89.8 t90 -48.35 -48.59 36.36 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 119.504 1.047 . . . . 10.0 113.214 173.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -57.56 -51.85 67.82 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.203 1.001 . . . . 10.0 111.976 176.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 97.3 mt -55.41 -51.24 58.9 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 C-N-CA 124.89 1.276 . . . . 10.0 111.728 175.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 7.2 m -53.02 -45.42 67.94 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 121.196 -0.94 . . . . 10.0 112.662 171.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 66.5 m -61.84 -45.27 94.55 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.833 1.253 . . . . 10.0 111.854 178.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -56.54 -51.15 69.63 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 123.969 0.908 . . . . 10.0 112.365 171.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -57.19 -45.53 83.67 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.003 0.921 . . . . 10.0 112.971 175.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 38.2 ttp -57.49 -53.7 55.2 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.275 1.03 . . . . 10.0 112.005 171.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 62.7 tp -53.51 -47.0 70.28 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.191 1.396 . . . . 10.0 111.852 178.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -50.53 -54.84 19.33 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.003 0.921 . . . . 10.0 112.407 170.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 54.5 mt -53.62 -55.05 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 123.762 0.825 . . . . 10.0 110.805 177.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 38.8 mt -57.16 -35.98 70.2 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 118.365 -0.826 . . . . 10.0 112.997 178.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -57.24 -58.26 9.02 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 124.068 0.947 . . . . 10.0 113.006 173.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.34 -40.89 85.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 CA-C-O 118.343 -0.837 . . . . 10.0 111.492 177.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 45.4 mt -56.83 -49.4 75.53 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 119.845 1.202 . . . . 10.0 112.14 171.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.469 ' HA ' ' HD2' ' A' ' 175' ' ' ARG . 11.9 t80 -76.97 -70.34 0.47 Allowed 'General case' 0 C--N 1.326 -0.447 0 O-C-N 120.022 -1.674 . . . . 10.0 112.887 -175.264 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -73.74 -21.87 60.07 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.567 1.147 . . . . 10.0 113.448 -174.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -87.8 -79.16 1.26 Allowed Glycine 0 CA--C 1.527 0.783 0 C-N-CA 123.666 0.651 . . . . 10.0 113.496 171.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -53.63 -32.4 51.15 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 126.299 1.839 . . . . 10.0 113.046 -166.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.2 m -52.08 -56.5 13.99 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 114.012 1.116 . . . . 10.0 114.012 172.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.4 p -53.67 -50.53 65.61 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 122.057 0.932 . . . . 10.0 112.281 -177.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 47.6 tttm -57.13 -46.05 83.0 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.197 0.999 . . . . 10.0 112.117 173.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.82 -47.46 80.24 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 114.545 1.313 . . . . 10.0 114.545 174.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -56.5 -11.29 1.22 Allowed 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 126.089 1.755 . . . . 10.0 114.228 177.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.2 m -107.1 6.64 29.08 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.416 1.886 . . . . 10.0 114.877 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 93.2 mmm -91.88 -92.63 0.15 Allowed 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 123.521 1.629 . . . . 10.0 114.191 -170.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -138.74 153.98 72.62 Favored Pre-proline 0 C--O 1.236 0.359 0 C-N-CA 129.802 3.241 . . . . 10.0 105.548 170.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -52.86 -46.22 35.24 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 122.3 2.0 . . . . 10.0 113.088 179.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.667 ' CD ' ' HD3' ' A' ' 227' ' ' ARG . 0.1 OUTLIER -52.97 -46.03 68.04 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 129.022 2.929 . . . . 10.0 113.276 173.578 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 91.7 t -69.26 -53.03 27.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 C-N-CA 124.02 0.928 . . . . 10.0 109.782 -178.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.09 -46.85 75.53 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.282 0.633 . . . . 10.0 111.923 177.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 60.5 p -60.02 -56.19 24.74 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.953 0.901 . . . . 10.0 112.67 174.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 62.0 m -57.22 -53.19 60.94 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.202 1.001 . . . . 10.0 113.004 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -49.59 -49.54 46.26 Favored 'General case' 0 C--O 1.221 -0.425 0 C-N-CA 123.289 0.636 . . . . 10.0 111.067 174.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -57.12 -48.41 78.72 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 114.671 1.36 . . . . 10.0 114.671 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 40.4 t -55.95 -49.63 74.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 CA-C-N 118.832 0.742 . . . . 10.0 110.476 176.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 94.1 mt -58.54 -51.65 68.99 Favored 'General case' 0 C--O 1.222 -0.392 0 N-CA-C 113.168 0.803 . . . . 10.0 113.168 175.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . 0.469 ' HD2' ' HA ' ' A' ' 153' ' ' PHE . 35.5 ttp180 -47.79 -47.76 30.7 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 126.824 2.05 . . . . 10.0 111.059 174.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 63.7 m-20 -58.53 -58.32 9.06 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 122.771 0.428 . . . . 10.0 111.286 174.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 59.5 t -51.85 -49.48 36.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 124.048 0.939 . . . . 10.0 111.449 179.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 35.3 m -55.74 -64.09 0.96 Allowed 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 128.428 2.691 . . . . 10.0 111.939 177.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 55.7 t -51.05 -49.56 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 124.541 1.136 . . . . 10.0 111.317 -179.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 79.6 t -59.76 -61.64 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 124.209 1.004 . . . . 10.0 112.198 177.07 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -57.86 -47.72 81.91 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 118.873 0.761 . . . . 10.0 112.287 -176.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 10.7 m95 -53.51 -51.25 63.44 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.878 0.871 . . . . 10.0 111.71 175.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 50.2 m -55.29 -29.82 58.94 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 114.105 1.15 . . . . 10.0 114.105 178.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -64.72 -44.5 90.0 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 113.657 0.984 . . . . 10.0 113.657 176.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 -47.03 -54.32 21.33 Favored Pre-proline 0 CA--C 1.548 0.866 0 N-CA-C 115.764 1.765 . . . . 10.0 115.764 -176.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 0.555 ' HB3' H183 ' A' ' 999' ' ' RET . 19.0 Cg_endo -57.1 -38.72 94.89 Favored 'Trans proline' 0 C--N 1.355 0.896 0 C-N-CA 122.487 2.124 . . . . 10.0 113.129 176.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 24.4 t -63.5 -51.98 63.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 124.37 1.068 . . . . 10.0 110.742 177.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 93.2 t -54.11 -50.09 57.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 124.307 1.043 . . . . 10.0 111.442 175.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 52.1 t90 -55.46 -51.58 66.48 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.317 1.047 . . . . 10.0 112.498 174.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 34.4 tp -54.29 -45.63 72.56 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.878 1.271 . . . . 10.0 112.362 -178.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 15.4 pt -87.41 -5.05 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 115.17 1.544 . . . . 10.0 115.17 -177.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.49 -169.22 32.84 Favored Glycine 0 N--CA 1.451 -0.353 0 CA-C-O 122.545 1.08 . . . . 10.0 113.882 -168.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 23.2 t -53.21 -41.44 65.34 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 114.243 -0.979 . . . . 10.0 111.818 177.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -67.2 -17.05 64.66 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 115.659 1.726 . . . . 10.0 115.659 -175.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -130.99 -105.97 1.09 Allowed Glycine 0 CA--C 1.532 1.1 0 CA-C-N 120.381 1.446 . . . . 10.0 113.82 -172.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -89.42 127.15 35.8 Favored 'General case' 0 C--N 1.328 -0.352 0 O-C-N 120.64 -1.506 . . . . 10.0 109.349 168.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -72.46 65.36 1.36 Allowed Glycine 0 CA--C 1.532 1.124 0 N-CA-C 113.873 0.309 . . . . 10.0 113.873 173.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 60.7 mt -79.63 -42.74 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 126.083 1.753 . . . . 10.0 108.721 166.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.4 ' CG1' ' HB ' ' A' ' 203' ' ' ILE . 79.8 t -126.29 133.4 24.93 Favored Pre-proline 0 N--CA 1.454 -0.264 0 C-N-CA 126.502 1.921 . . . . 10.0 109.364 -174.179 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -68.78 153.82 72.33 Favored 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 123.751 2.967 . . . . 10.0 111.425 -176.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 12.2 tp -43.18 -39.75 3.03 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.281 1.033 . . . . 10.0 112.223 171.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -48.34 -52.39 21.82 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 114.705 1.372 . . . . 10.0 114.705 176.053 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . 0.4 ' HB ' ' CG1' ' A' ' 199' ' ' VAL . 14.0 mm -75.91 -40.48 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 124.378 1.071 . . . . 10.0 109.674 177.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -49.29 -49.85 41.84 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 118.553 0.615 . . . . 10.0 111.946 173.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 15.9 m -57.69 -47.08 83.36 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 126.046 1.738 . . . . 10.0 112.964 174.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.536 HD23 ' CD2' ' A' ' 12' ' ' TRP . 1.3 tm? -63.28 -52.33 62.45 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.977 0.911 . . . . 10.0 112.101 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 93.3 mt -52.58 -59.34 4.57 Favored 'General case' 0 C--N 1.335 -0.044 0 C-N-CA 124.265 1.026 . . . . 10.0 109.989 176.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -52.75 -47.35 67.51 Favored 'General case' 0 C--O 1.219 -0.53 0 CA-C-O 117.286 -1.34 . . . . 10.0 112.102 176.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' MET . . . . . 0.575 ' HE2' ' HB3' ' A' ' 15' ' ' LEU . 4.6 tmm? -50.84 -52.5 40.91 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 120.976 1.716 . . . . 10.0 112.974 174.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 80.4 t -60.86 -46.93 95.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 124.798 1.239 . . . . 10.0 111.524 178.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 4.1 mp -59.45 -51.57 69.32 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.496 1.518 . . . . 10.0 112.261 175.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -55.08 -55.97 25.06 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 127.245 2.218 . . . . 10.0 110.281 175.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 38.1 t -47.41 -53.65 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 124.529 1.131 . . . . 10.0 111.488 173.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 18.7 t -54.82 -54.2 45.39 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.303 0.641 . . . . 10.0 112.193 175.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -68.14 -22.75 64.85 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 115.366 1.617 . . . . 10.0 115.366 -178.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -83.25 -74.87 0.34 Allowed 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.737 1.615 . . . . 10.0 109.906 168.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 35.8 m -92.97 -35.72 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 124.047 0.939 . . . . 10.0 113.191 -164.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -57.36 -56.77 23.31 Favored Glycine 0 N--CA 1.475 1.236 0 CA-C-N 119.851 1.205 . . . . 10.0 111.731 172.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -44.03 -58.81 2.61 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 127.2 2.2 . . . . 10.0 112.357 166.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -55.41 -41.7 81.17 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 123.991 0.805 . . . . 10.0 114.319 179.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 23.8 mt -70.63 -26.73 63.61 Favored 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 115.505 1.668 . . . . 10.0 115.505 178.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 74.0 mt -63.2 -57.56 11.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 108.741 -0.837 . . . . 10.0 108.741 165.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 32.1 tp -58.77 -64.68 0.85 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.901 0.88 . . . . 10.0 113.183 -172.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 84.0 mt -71.53 5.19 2.51 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 115.315 1.598 . . . . 10.0 115.315 -171.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.6 mtp-105 -112.31 0.33 15.67 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.231 1.012 . . . . 10.0 113.324 172.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 8.8 t -108.04 177.99 4.65 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 124.014 0.926 . . . . 10.0 111.013 174.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . 0.667 ' HD3' ' CD ' ' A' ' 166' ' ' GLU . 41.8 ttt180 -71.64 98.19 1.86 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.773 0.829 . . . . 10.0 110.924 170.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . 0.476 ' HB1' ' CD2' ' A' ' 42' ' ' PHE . . . -80.96 77.07 7.89 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.836 0.854 . . . . 10.0 112.073 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 40.15 102.25 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 128.893 2.877 . . . . 10.0 116.436 177.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . 0.483 0.3 OUTLIER 71.88 -55.47 0.66 Allowed 'General case' 0 C--O 1.242 0.67 0 C-N-CA 124.692 1.197 . . . . 10.0 110.644 -175.355 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -68.25 169.43 39.98 Favored Glycine 0 C--O 1.239 0.417 0 C-N-CA 129.784 3.564 . . . . 10.0 119.629 171.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.461 0 C-N-CA 128.443 2.697 . . . . 10.0 113.409 166.61 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 999' ' ' RET . . . . . 0.555 H183 ' HB3' ' A' ' 186' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1000 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A 1001 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A 1002 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A 1003 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 N--CA 1.477 0.876 0 CA-C-O 115.801 -2.047 . . . . 10.0 105.812 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 23.38 91.92 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 129.647 3.179 . . . . 10.0 117.197 160.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 28.55 65.1 0.1 Allowed 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 128.302 2.641 . . . . 10.0 114.496 155.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 86.5 mt -56.48 137.98 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 126.379 1.872 . . . . 10.0 113.343 -158.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.651 HG21 ' HB3' ' A' ' 77' ' ' PRO . 7.6 t -136.76 -165.16 1.69 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 126.312 1.845 . . . . 10.0 114.025 -174.347 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 69.98 2.81 40.78 Favored Glycine 0 C--N 1.34 0.792 0 C-N-CA 127.477 2.465 . . . . 10.0 111.526 168.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -158.56 -51.4 0.01 OUTLIER Pre-proline 0 N--CA 1.443 -0.783 0 CA-C-O 114.284 -2.77 . . . . 10.0 116.665 -168.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_exo -63.91 -60.73 0.14 Allowed 'Trans proline' 0 N--CA 1.465 -0.185 0 CA-C-N 123.533 2.297 . . . . 10.0 113.201 -175.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.411 ' H ' ' CD ' ' A' ' 9' ' ' GLU . 7.9 pm0 -67.13 4.26 0.96 Allowed 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 127.865 2.466 . . . . 10.0 115.746 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.422 ' CG ' ' N ' ' A' ' 11' ' ' ILE . 11.1 p-90 -51.35 -43.15 61.72 Favored 'General case' 0 C--O 1.223 -0.34 0 O-C-N 121.487 -0.758 . . . . 10.0 112.585 176.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.422 ' N ' ' CG ' ' A' ' 10' ' ' TRP . 8.9 tt -60.83 -49.64 83.78 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.338 0 C-N-CA 123.883 0.873 . . . . 10.0 109.287 179.447 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.535 ' CD2' HD23 ' A' ' 206' ' ' LEU . 2.6 m95 -55.38 -52.65 62.85 Favored 'General case' 0 C--O 1.224 -0.261 0 C-N-CA 123.402 0.681 . . . . 10.0 111.84 175.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 91.0 mt -57.35 -53.65 55.69 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 123.19 0.596 . . . . 10.0 112.178 177.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.88 -46.79 52.02 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.387 1.475 . . . . 10.0 113.295 173.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.575 ' HB3' ' HE2' ' A' ' 209' ' ' MET . 13.3 tp -65.64 -44.96 84.79 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 125.282 1.433 . . . . 10.0 112.999 179.147 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -50.82 -54.7 20.98 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 124.297 0.951 . . . . 10.0 112.016 166.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 22.3 m -50.06 -52.67 32.59 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.961 1.304 . . . . 10.0 112.481 173.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.44 -58.82 5.97 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.181 0.992 . . . . 10.0 112.159 177.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 94.1 mt -57.39 -51.31 69.93 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.716 0.806 . . . . 10.0 112.695 -179.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.9 mpp? -57.8 -44.95 86.67 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 119.073 0.851 . . . . 10.0 111.967 176.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -58.5 -58.47 14.42 Favored Glycine 0 CA--C 1.53 1.03 0 CA-C-O 119.267 -0.741 . . . . 10.0 113.474 174.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 80.7 mt -56.24 -46.01 79.77 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-N 118.37 1.085 . . . . 10.0 112.089 175.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.38 -42.48 74.74 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 124.942 1.258 . . . . 10.0 113.179 173.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 28.6 m -61.95 -58.6 7.29 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.86 0.864 . . . . 10.0 111.373 171.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -52.3 -40.94 62.48 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.017 0.927 . . . . 10.0 110.976 177.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -55.76 -58.11 9.22 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.617 1.167 . . . . 10.0 112.943 172.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.1 m-30 -59.63 -38.61 81.84 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 113.245 0.831 . . . . 10.0 113.245 178.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.401 ' C ' ' H ' ' A' ' 30' ' ' LYS . 11.8 mt -56.23 -67.37 0.3 Allowed 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.58 1.152 . . . . 10.0 113.614 169.119 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 t -76.37 40.92 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 CA-C-O 123.745 1.736 . . . . 10.0 110.862 179.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.401 ' H ' ' C ' ' A' ' 28' ' ' LEU . 42.9 tttm -140.85 -44.8 0.39 Allowed 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 127.862 2.465 . . . . 10.0 109.317 171.164 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -73.01 23.15 0.88 Allowed Glycine 0 CA--C 1.529 0.958 0 N-CA-C 115.626 1.01 . . . . 10.0 115.626 173.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 37.3 mmm -59.53 -44.94 93.04 Favored 'General case' 0 C--O 1.224 -0.277 0 C-N-CA 127.101 2.161 . . . . 10.0 113.594 -179.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.68 -84.4 1.19 Allowed Glycine 0 CA--C 1.53 1.007 0 C-N-CA 123.709 0.671 . . . . 10.0 112.507 -170.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.8 t 33.03 88.78 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.242 0.706 0 C-N-CA 128.395 2.678 . . . . 10.0 116.956 166.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.0 m -79.63 -50.82 10.09 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.184 -1.371 . . . . 10.0 113.94 174.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -49.0 117.55 6.54 Favored Pre-proline 0 CA--C 1.536 0.418 0 O-C-N 124.753 1.283 . . . . 10.0 110.902 -172.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -58.56 -29.64 89.54 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 123.757 2.971 . . . . 10.0 113.701 179.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.38 -60.64 2.29 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.089 0.556 . . . . 10.0 111.402 176.231 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.13 -40.13 22.74 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 125.085 1.354 . . . . 10.0 113.54 171.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -46.48 -47.44 19.28 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.208 1.403 . . . . 10.0 113.468 172.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -57.75 -53.07 62.35 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.495 0.718 . . . . 10.0 110.94 176.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.477 ' CD2' ' HB1' ' A' ' 228' ' ' ALA . 43.9 m-85 -56.98 -50.22 73.33 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 123.102 0.561 . . . . 10.0 112.321 -179.075 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -54.39 -51.27 65.36 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 118.962 -0.542 . . . . 10.0 112.369 173.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.42 -61.98 1.93 Allowed 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 113.419 0.896 . . . . 10.0 113.419 177.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.5 mt -48.65 -57.48 1.54 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 C-N-CA 124.869 1.268 . . . . 10.0 110.349 178.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.5 m -68.56 -17.87 64.23 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.109 1.364 . . . . 10.0 113.672 -172.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 27.4 m -87.14 -40.48 14.59 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.436 1.095 . . . . 10.0 112.123 174.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 23.7 mt -59.45 -42.0 90.94 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 121.321 -0.862 . . . . 10.0 112.573 171.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 24.7 t -43.24 -61.16 1.95 Allowed Pre-proline 0 N--CA 1.48 1.047 0 C-N-CA 125.57 1.548 . . . . 10.0 113.625 176.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -70.95 -28.71 19.18 Favored 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 123.135 2.557 . . . . 10.0 114.205 174.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.45 -46.24 87.17 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-N 120.709 1.595 . . . . 10.0 113.363 177.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 56.3 mt -56.14 -51.7 59.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 124.414 1.085 . . . . 10.0 109.248 171.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.65 -43.5 76.33 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 113.484 0.92 . . . . 10.0 113.484 175.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -50.96 -55.89 15.06 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 120.853 1.661 . . . . 10.0 111.818 171.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 10.6 m -49.74 -52.79 29.03 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.359 1.464 . . . . 10.0 110.877 177.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.41 ' HG3' ' CB ' ' A' ' 85' ' ' ASP . 32.6 mmt -68.88 -48.11 64.2 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 123.964 0.906 . . . . 10.0 112.938 -176.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -55.58 -41.97 74.11 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 120.342 1.428 . . . . 10.0 112.974 172.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.8 tp -53.25 -54.59 34.01 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-N 119.697 1.135 . . . . 10.0 111.281 171.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 24.0 p -51.67 -41.06 61.12 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 115.191 1.552 . . . . 10.0 115.191 179.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 55.6 mtm -66.86 -50.83 61.25 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 123.562 0.745 . . . . 10.0 110.479 176.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.5 tp -48.55 -52.7 21.4 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.846 0.858 . . . . 10.0 112.952 172.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.5 mt -76.97 -5.52 48.95 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.331 1.053 . . . . 10.0 113.799 -177.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.28 -34.77 5.5 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 115.55 0.98 . . . . 10.0 115.55 174.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 75.3 t80 -49.22 -43.09 42.22 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 115.258 1.577 . . . . 10.0 115.258 -176.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.1 3.59 61.18 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 115.348 0.899 . . . . 10.0 115.348 -179.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.25 143.43 26.42 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 127.035 2.134 . . . . 10.0 109.011 171.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 t -145.55 171.1 15.17 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 124.012 0.925 . . . . 10.0 111.045 166.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.0 136.08 53.37 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 123.853 0.861 . . . . 10.0 109.698 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.436 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 59.0 t -129.54 129.56 23.19 Favored Pre-proline 0 C--N 1.329 -0.317 0 C-N-CA 125.068 1.347 . . . . 10.0 110.988 -176.059 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 69' ' ' VAL . 6.3 Cg_exo -80.76 116.25 3.16 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 N-CA-C 109.411 -1.034 . . . . 10.0 109.411 -178.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -156.71 164.38 38.2 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 112.818 0.673 . . . . 10.0 112.818 172.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.43 -81.99 0.15 Allowed Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.644 -0.983 . . . . 10.0 110.644 175.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.76 -3.42 0.69 Allowed Glycine 0 CA--C 1.526 0.776 0 N-CA-C 118.673 2.229 . . . . 10.0 118.673 170.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -151.58 -171.89 4.06 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 119.343 1.571 . . . . 10.0 112.25 -165.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -91.86 93.91 9.06 Favored 'General case' 0 CA--C 1.519 -0.237 0 C-N-CA 125.514 1.526 . . . . 10.0 111.061 -175.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.449 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 60.4 m-80 -89.49 120.81 69.64 Favored Pre-proline 0 N--CA 1.45 -0.465 0 N-CA-C 112.982 0.734 . . . . 10.0 112.982 -165.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.651 ' HB3' HG21 ' A' ' 5' ' ' THR . 76.1 Cg_exo -61.52 131.88 38.02 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 124.205 3.27 . . . . 10.0 112.199 171.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.5 mm -140.09 126.33 22.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 C-N-CA 126.059 1.744 . . . . 10.0 111.716 -179.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -93.64 85.01 4.75 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 122.628 1.204 . . . . 10.0 113.053 174.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 63.8 p-90 -59.4 -28.25 66.74 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 113.896 1.072 . . . . 10.0 113.896 174.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -55.28 -26.02 37.67 Favored 'General case' 0 CA--C 1.562 1.415 0 C-N-CA 124.277 1.031 . . . . 10.0 111.773 178.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -45.42 -64.86 0.63 Allowed 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 125.297 1.439 . . . . 10.0 110.618 166.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 36.1 m-85 -62.67 -38.55 90.77 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 126.563 1.945 . . . . 10.0 110.936 -174.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -52.7 -49.86 64.48 Favored 'General case' 0 CA--C 1.555 1.159 0 CA-C-N 119.334 0.97 . . . . 10.0 112.048 168.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.41 ' CB ' ' HG3' ' A' ' 56' ' ' MET . 0.0 OUTLIER -60.06 -62.78 1.62 Allowed 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.476 1.111 . . . . 10.0 111.696 171.86 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 54.5 m0 -53.38 -37.06 62.09 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 125.821 1.648 . . . . 10.0 112.693 -174.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 28.2 tp -50.23 -41.44 50.05 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 126.275 1.83 . . . . 10.0 111.864 177.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -103.02 -40.7 6.38 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.883 0.873 . . . . 10.0 112.546 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 79.3 p -61.55 -42.45 98.86 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-N 120.553 1.524 . . . . 10.0 113.763 -179.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . 0.322 75.5 p -65.77 -47.69 65.05 Favored Pre-proline 0 N--CA 1.477 0.913 0 CA-C-O 117.586 -1.197 . . . . 10.0 114.22 -178.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -53.0 -42.68 62.75 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 123.232 2.621 . . . . 10.0 115.442 169.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 51.3 mt -59.75 -48.04 83.26 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 121.314 -0.866 . . . . 10.0 111.935 176.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.81 -37.49 84.61 Favored 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 119.586 1.085 . . . . 10.0 112.416 175.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.4 mp -56.39 -48.99 75.76 Favored 'General case' 0 CA--C 1.545 0.782 0 O-C-N 121.009 -1.057 . . . . 10.0 111.828 165.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.81 -38.24 78.17 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 119.164 0.893 . . . . 10.0 112.863 178.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -52.33 -54.06 36.45 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 119.322 0.965 . . . . 10.0 111.163 169.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.27 -42.07 88.97 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.63 0.772 . . . . 10.0 112.172 -178.569 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.76 -54.63 39.48 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 123.917 0.887 . . . . 10.0 112.066 173.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.38 -41.16 79.69 Favored 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 123.687 0.795 . . . . 10.0 112.681 174.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.8 tp -63.73 -38.54 91.5 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 114.485 1.291 . . . . 10.0 114.485 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.1 t -94.83 1.42 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 125.035 1.334 . . . . 10.0 112.308 179.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.2 t70 48.62 53.45 12.18 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.834 1.654 . . . . 10.0 112.1 -174.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.27 145.85 47.62 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 119.969 -1.707 . . . . 10.0 112.464 -174.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.42 135.93 53.96 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 112.697 0.629 . . . . 10.0 112.697 175.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -42.89 -39.68 2.64 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.877 1.671 . . . . 10.0 113.499 175.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -47.28 -60.22 5.29 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 125.103 1.335 . . . . 10.0 115.309 169.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.5 p -62.05 -46.82 87.46 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 117.098 -1.429 . . . . 10.0 111.332 178.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 67.0 mt -48.38 -52.92 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 125.038 1.335 . . . . 10.0 111.124 178.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.4 tp -62.67 -51.25 67.97 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 112.544 0.572 . . . . 10.0 112.544 179.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.2 -44.86 43.55 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.479 0.712 . . . . 10.0 110.912 174.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.455 ' HA ' HD12 ' A' ' 111' ' ' LEU . 0.6 OUTLIER -59.59 -59.86 4.77 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 127.385 2.274 . . . . 10.0 114.8 174.949 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.1 t -61.09 -46.36 96.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 123.668 0.787 . . . . 10.0 111.362 -178.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -56.56 -50.41 63.19 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 123.68 0.657 . . . . 10.0 112.602 174.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -54.85 -46.54 74.66 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 113.278 0.844 . . . . 10.0 113.278 173.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -55.22 -48.64 73.6 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.315 1.046 . . . . 10.0 111.202 173.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -42.99 -55.33 4.9 Favored Glycine 0 CA--C 1.534 1.223 0 C-N-CA 125.1 1.333 . . . . 10.0 113.18 169.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 85.1 mt -56.91 -52.22 58.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 123.555 0.742 . . . . 10.0 111.974 174.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 54.0 ttp -48.68 -58.03 5.37 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.821 1.249 . . . . 10.0 112.226 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 40.2 mm -68.29 -43.34 84.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 O-C-N 121.566 -0.709 . . . . 10.0 111.891 179.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -53.23 -60.71 7.77 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 124.747 1.165 . . . . 10.0 112.897 176.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 40.7 p -58.15 -36.7 73.37 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.98 0.912 . . . . 10.0 112.543 174.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -49.04 -55.95 10.99 Favored Glycine 0 CA--C 1.536 1.398 0 C-N-CA 124.464 1.031 . . . . 10.0 113.788 165.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 66.2 tp -59.04 -47.45 85.18 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.464 1.506 . . . . 10.0 111.887 176.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 67.8 t -52.84 -51.66 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 123.345 0.658 . . . . 10.0 110.377 173.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -49.15 -60.53 6.08 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 125.871 1.7 . . . . 10.0 112.212 171.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -49.57 -37.47 27.46 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.497 1.919 . . . . 10.0 113.635 -179.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 50.1 mt -99.37 -6.49 27.72 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 115.207 1.558 . . . . 10.0 115.207 -178.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 16.9 m -69.64 116.73 10.37 Favored 'General case' 0 N--CA 1.465 0.275 0 O-C-N 120.228 -1.545 . . . . 10.0 110.389 -178.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.621 ' H ' ' HD3' ' A' ' 129' ' ' LYS . 0.1 OUTLIER -55.52 -49.59 72.21 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 128.222 2.609 . . . . 10.0 113.268 177.731 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 60.6 t -69.65 106.32 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 123.791 0.836 . . . . 10.0 110.085 179.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -46.87 -59.55 3.01 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 124.807 1.243 . . . . 10.0 114.048 -173.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 m -46.5 -42.1 15.1 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.5 1.52 . . . . 10.0 113.484 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -70.18 -24.53 63.15 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 114.952 1.464 . . . . 10.0 114.952 -178.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 69.4 mtp85 -53.81 -42.02 67.94 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 118.887 0.767 . . . . 10.0 110.682 176.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -69.47 -32.03 70.68 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.805 1.242 . . . . 10.0 114.27 176.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.8 t -55.11 -52.09 48.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-N 119.055 0.843 . . . . 10.0 109.7 168.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 67.8 m95 -61.38 -44.11 97.72 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 114.287 1.217 . . . . 10.0 114.287 174.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 88.0 t90 -53.34 -48.15 68.74 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 124.254 1.022 . . . . 10.0 112.704 172.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -57.43 -52.78 64.0 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.984 0.914 . . . . 10.0 111.602 177.071 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 97.6 mt -54.46 -50.79 55.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 125.043 1.337 . . . . 10.0 111.712 174.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 20.8 m -52.38 -47.96 65.9 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.96 1.304 . . . . 10.0 111.395 174.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 54.3 m -63.6 -41.6 98.31 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 126.167 1.787 . . . . 10.0 112.171 179.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -57.67 -50.18 74.02 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 119.274 0.943 . . . . 10.0 112.265 171.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -57.36 -47.66 81.04 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 123.83 0.852 . . . . 10.0 112.633 174.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 10.3 tmm? -52.24 -54.76 27.14 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.96 1.704 . . . . 10.0 111.903 172.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 61.4 tp -56.89 -48.94 77.0 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.994 1.718 . . . . 10.0 112.808 178.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 70.2 t80 -49.35 -53.79 20.53 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.131 0.972 . . . . 10.0 111.631 171.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 52.2 mt -54.05 -55.14 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 123.824 0.85 . . . . 10.0 110.774 177.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 19.4 mt -57.24 -35.37 69.62 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 118.055 -0.974 . . . . 10.0 113.461 177.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -57.26 -58.21 9.22 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 119.398 0.999 . . . . 10.0 113.036 172.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.42 -40.91 85.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-O 118.263 -0.875 . . . . 10.0 111.408 177.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 44.9 mt -56.8 -49.39 75.51 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 119.907 1.231 . . . . 10.0 112.148 171.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.469 ' HA ' ' HD2' ' A' ' 175' ' ' ARG . 11.9 t80 -76.95 -70.33 0.47 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 120.092 -1.63 . . . . 10.0 112.869 -175.248 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -73.78 -21.87 60.03 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.596 1.158 . . . . 10.0 113.454 -174.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -87.88 -79.07 1.26 Allowed Glycine 0 CA--C 1.527 0.784 0 C-N-CA 123.6 0.619 . . . . 10.0 113.532 171.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -53.59 -32.4 50.92 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 126.266 1.826 . . . . 10.0 113.08 -166.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.2 m -52.15 -56.44 14.54 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 113.996 1.109 . . . . 10.0 113.996 172.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.6 p -53.65 -50.57 65.47 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 122.126 0.965 . . . . 10.0 112.325 -177.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 47.6 tttm -57.11 -46.06 82.92 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.165 0.986 . . . . 10.0 112.118 173.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.86 -47.49 80.27 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 114.465 1.283 . . . . 10.0 114.465 174.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -56.41 -11.34 1.21 Allowed 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.097 1.759 . . . . 10.0 114.249 177.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.1 m -107.07 6.64 29.13 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.396 1.878 . . . . 10.0 114.891 -179.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 93.3 mmm -91.89 -92.69 0.15 Allowed 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 123.499 1.619 . . . . 10.0 114.132 -170.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -138.67 153.96 72.72 Favored Pre-proline 0 C--O 1.236 0.349 0 C-N-CA 129.807 3.243 . . . . 10.0 105.529 170.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -52.83 -46.22 35.19 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.305 2.003 . . . . 10.0 113.064 179.018 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.666 ' CD ' ' HD3' ' A' ' 227' ' ' ARG . 0.1 OUTLIER -53.02 -46.04 68.24 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 129.006 2.922 . . . . 10.0 113.27 173.635 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 92.5 t -69.16 -53.09 27.51 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.215 0 C-N-CA 124.1 0.96 . . . . 10.0 109.798 -178.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.1 -46.89 75.56 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.273 0.629 . . . . 10.0 111.902 177.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 60.2 p -59.94 -56.21 24.54 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.932 0.893 . . . . 10.0 112.68 174.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 61.8 m -57.23 -53.16 61.22 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.169 0.988 . . . . 10.0 113.059 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -49.55 -49.47 46.13 Favored 'General case' 0 C--O 1.221 -0.438 0 C-N-CA 123.312 0.645 . . . . 10.0 111.132 174.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -57.19 -48.4 78.84 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 114.618 1.34 . . . . 10.0 114.618 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 40.5 t -56.03 -49.58 74.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-N 118.808 0.731 . . . . 10.0 110.462 176.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 93.9 mt -58.58 -51.6 69.21 Favored 'General case' 0 C--O 1.222 -0.394 0 N-CA-C 113.218 0.821 . . . . 10.0 113.218 175.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . 0.469 ' HD2' ' HA ' ' A' ' 153' ' ' PHE . 35.5 ttp180 -47.76 -47.79 30.38 Favored 'General case' 0 C--O 1.224 -0.265 0 C-N-CA 126.807 2.043 . . . . 10.0 111.078 174.411 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 63.7 m-20 -58.48 -58.35 8.94 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 122.794 0.438 . . . . 10.0 111.274 174.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 59.7 t -51.95 -48.81 39.82 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 C-N-CA 124.082 0.953 . . . . 10.0 111.457 179.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 28.8 m -57.25 -62.81 1.5 Allowed 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 128.129 2.572 . . . . 10.0 111.976 178.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 55.5 t -51.32 -50.17 28.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 C-N-CA 124.572 1.149 . . . . 10.0 111.079 -179.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 75.6 t -58.85 -60.6 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 124.053 0.941 . . . . 10.0 112.212 177.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -58.34 -48.47 80.45 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 118.663 0.665 . . . . 10.0 112.085 -177.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 9.0 m95 -54.37 -47.92 72.09 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.04 0.936 . . . . 10.0 112.759 177.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 9.5 t -58.99 -25.26 63.48 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 113.872 1.064 . . . . 10.0 113.872 177.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -68.57 -44.54 74.19 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 119.516 1.053 . . . . 10.0 113.346 177.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -45.4 -54.86 13.37 Favored Pre-proline 0 N--CA 1.476 0.872 0 N-CA-C 115.449 1.648 . . . . 10.0 115.449 -177.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 0.555 ' HB3' H183 ' A' ' 999' ' ' RET . 18.5 Cg_endo -58.16 -36.96 97.4 Favored 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 122.454 2.103 . . . . 10.0 113.327 177.062 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 25.1 t -64.07 -53.92 37.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 124.213 1.005 . . . . 10.0 110.607 176.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 86.9 t -53.34 -49.62 52.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 124.782 1.233 . . . . 10.0 111.587 176.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 25.9 t90 -55.44 -53.22 58.96 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.895 1.278 . . . . 10.0 112.466 175.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 9.7 tt -56.45 -44.2 80.25 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.897 0.879 . . . . 10.0 112.675 -178.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 14.7 pt -84.61 -5.78 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 N-CA-C 115.069 1.507 . . . . 10.0 115.069 -178.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.32 -169.25 33.08 Favored Glycine 0 N--CA 1.45 -0.374 0 CA-C-O 122.522 1.068 . . . . 10.0 113.978 -168.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 23.2 t -53.2 -40.92 64.79 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 114.236 -0.982 . . . . 10.0 111.821 177.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 -54.78 -31.64 59.08 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 128.472 2.709 . . . . 10.0 115.209 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -131.3 -103.89 0.97 Allowed Glycine 0 CA--C 1.529 0.943 0 CA-C-N 119.441 1.019 . . . . 10.0 113.58 -167.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -89.46 127.14 35.81 Favored 'General case' 0 C--N 1.329 -0.323 0 O-C-N 120.666 -1.491 . . . . 10.0 109.3 169.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -72.43 65.3 1.35 Allowed Glycine 0 CA--C 1.533 1.165 0 N-CA-C 113.91 0.324 . . . . 10.0 113.91 173.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 60.8 mt -79.58 -42.69 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 C-N-CA 126.031 1.732 . . . . 10.0 108.748 166.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 79.4 t -126.31 133.41 24.94 Favored Pre-proline 0 N--CA 1.455 -0.22 0 C-N-CA 126.413 1.885 . . . . 10.0 109.353 -174.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -68.72 153.83 72.46 Favored 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 123.791 2.994 . . . . 10.0 111.444 -176.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 12.2 tp -43.24 -39.73 3.12 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.399 1.08 . . . . 10.0 112.142 171.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -48.43 -52.32 22.63 Favored 'General case' 0 CA--C 1.539 0.519 0 N-CA-C 114.669 1.359 . . . . 10.0 114.669 176.08 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 14.0 mm -75.93 -40.55 38.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 124.422 1.089 . . . . 10.0 109.625 177.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -49.27 -49.84 41.68 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-O 121.446 0.641 . . . . 10.0 111.921 173.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 16.2 m -57.7 -47.0 83.61 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 126.047 1.739 . . . . 10.0 112.991 174.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.535 HD23 ' CD2' ' A' ' 12' ' ' TRP . 1.3 tm? -63.38 -52.33 62.12 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.966 0.906 . . . . 10.0 112.094 179.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 93.4 mt -52.54 -59.06 4.9 Favored 'General case' 0 C--O 1.228 -0.07 0 C-N-CA 124.321 1.048 . . . . 10.0 109.944 176.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -54.02 -41.84 68.46 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 117.938 -1.029 . . . . 10.0 113.235 176.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' MET . . . . . 0.575 ' HE2' ' HB3' ' A' ' 15' ' ' LEU . 4.6 tmm? -55.66 -53.05 61.27 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 120.265 1.393 . . . . 10.0 112.086 173.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 79.9 t -60.95 -45.6 98.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 124.783 1.233 . . . . 10.0 111.603 178.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 4.2 mp -59.58 -51.42 69.92 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.314 1.446 . . . . 10.0 112.003 175.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -57.75 -52.72 64.31 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.04 1.336 . . . . 10.0 111.431 176.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 39.2 t -47.72 -49.57 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 124.601 1.16 . . . . 10.0 111.553 172.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 25.2 m -59.18 -51.19 71.04 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.419 1.088 . . . . 10.0 112.002 176.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -67.82 -19.31 65.05 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.974 1.709 . . . . 10.0 115.018 179.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 9.2 mptt -98.69 -75.45 0.56 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.679 1.592 . . . . 10.0 109.604 177.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 21.3 t -70.86 -53.86 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 125.448 1.499 . . . . 10.0 110.784 -172.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -53.84 -58.58 12.01 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 124.151 0.881 . . . . 10.0 112.96 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -45.6 -57.76 3.94 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 126.624 1.97 . . . . 10.0 112.539 170.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -56.99 -40.81 91.81 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 124.057 0.837 . . . . 10.0 113.857 178.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 24.4 mt -70.41 -27.12 64.04 Favored 'General case' 0 CA--C 1.513 -0.464 0 N-CA-C 115.649 1.722 . . . . 10.0 115.649 177.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 74.0 mt -63.34 -57.54 11.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 108.687 -0.857 . . . . 10.0 108.687 165.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 32.0 tp -58.77 -64.71 0.84 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.905 0.882 . . . . 10.0 113.187 -172.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 84.4 mt -71.53 5.16 2.52 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 115.27 1.582 . . . . 10.0 115.27 -171.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.6 mtp-105 -112.31 0.33 15.67 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.228 1.011 . . . . 10.0 113.242 172.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 8.8 t -108.06 177.98 4.65 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 124.038 0.935 . . . . 10.0 111.026 174.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . 0.666 ' HD3' ' CD ' ' A' ' 166' ' ' GLU . 41.8 ttt180 -71.65 98.19 1.86 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.732 0.813 . . . . 10.0 110.935 170.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . 0.477 ' HB1' ' CD2' ' A' ' 42' ' ' PHE . . . -80.86 76.97 7.77 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.896 0.878 . . . . 10.0 112.128 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 40.12 102.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 128.857 2.863 . . . . 10.0 116.464 177.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . 0.483 0.3 OUTLIER 71.86 -55.51 0.66 Allowed 'General case' 0 C--O 1.242 0.662 0 C-N-CA 124.705 1.202 . . . . 10.0 110.631 -175.331 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -68.24 169.5 39.8 Favored Glycine 0 C--O 1.239 0.429 0 C-N-CA 129.757 3.551 . . . . 10.0 119.645 171.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.474 0 C-N-CA 128.49 2.716 . . . . 10.0 113.429 166.585 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 999' ' ' RET . . . . . 0.555 H183 ' HB3' ' A' ' 186' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1000 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A 1001 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A 1002 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A 1003 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 N--CA 1.476 0.87 0 CA-C-O 115.799 -2.048 . . . . 10.0 105.83 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 23.39 91.88 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 129.588 3.155 . . . . 10.0 117.203 160.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 28.63 65.04 0.11 Allowed 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 128.322 2.649 . . . . 10.0 114.48 155.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 86.6 mt -56.48 137.97 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 126.396 1.878 . . . . 10.0 113.315 -158.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.652 HG21 ' HB3' ' A' ' 77' ' ' PRO . 7.6 t -136.75 -165.26 1.71 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 126.327 1.851 . . . . 10.0 114.015 -174.332 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 70.06 2.78 41.34 Favored Glycine 0 C--N 1.34 0.762 0 C-N-CA 127.464 2.459 . . . . 10.0 111.485 168.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -158.52 -51.37 0.01 OUTLIER Pre-proline 0 N--CA 1.443 -0.783 0 CA-C-O 114.26 -2.781 . . . . 10.0 116.619 -168.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -63.94 -60.61 0.15 Allowed 'Trans proline' 0 N--CA 1.465 -0.202 0 CA-C-N 123.55 2.303 . . . . 10.0 113.25 -175.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.411 ' H ' ' CD ' ' A' ' 9' ' ' GLU . 7.9 pm0 -67.25 4.3 0.99 Allowed 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 127.839 2.456 . . . . 10.0 115.755 179.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.422 ' CG ' ' N ' ' A' ' 11' ' ' ILE . 11.1 p-90 -51.36 -43.1 61.74 Favored 'General case' 0 C--O 1.222 -0.361 0 O-C-N 121.5 -0.75 . . . . 10.0 112.621 176.427 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.422 ' N ' ' CG ' ' A' ' 10' ' ' TRP . 8.9 tt -60.88 -49.56 84.14 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.34 0 C-N-CA 123.878 0.871 . . . . 10.0 109.336 179.407 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.535 ' CD2' HD23 ' A' ' 206' ' ' LEU . 2.6 m95 -55.44 -52.61 63.02 Favored 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 123.387 0.675 . . . . 10.0 111.887 175.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.6 mt -57.39 -53.53 57.06 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 123.153 0.581 . . . . 10.0 112.231 177.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.96 -46.75 52.69 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.378 1.471 . . . . 10.0 113.31 173.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.575 ' HB3' ' HE2' ' A' ' 209' ' ' MET . 13.3 tp -65.6 -44.95 84.99 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 125.345 1.458 . . . . 10.0 113.029 179.056 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.54 -56.72 10.57 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 124.508 1.051 . . . . 10.0 111.441 166.061 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.5 m -49.6 -52.46 30.2 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.877 1.271 . . . . 10.0 112.186 174.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.43 -58.83 5.94 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.174 0.99 . . . . 10.0 112.198 177.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 93.5 mt -57.28 -49.06 77.29 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.686 0.794 . . . . 10.0 112.695 -179.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.451 ' SD ' ' HB1' ' A' ' 53' ' ' ALA . 45.6 mtt -59.02 -46.62 87.75 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.418 1.087 . . . . 10.0 111.388 177.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -58.35 -58.58 13.82 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 124.394 0.997 . . . . 10.0 113.98 173.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 80.7 mt -56.21 -45.87 79.71 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-N 118.596 1.198 . . . . 10.0 112.113 176.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.15 -40.66 84.21 Favored Glycine 0 CA--C 1.532 1.122 0 O-C-N 120.931 -1.106 . . . . 10.0 113.598 173.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 28.1 m -61.61 -58.92 6.2 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.486 0.714 . . . . 10.0 111.19 171.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -52.24 -41.01 62.42 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.073 0.949 . . . . 10.0 110.95 178.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -55.77 -58.05 9.45 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 124.599 1.159 . . . . 10.0 112.973 172.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.1 m-30 -59.62 -38.69 81.99 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 113.223 0.823 . . . . 10.0 113.223 178.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.401 ' C ' ' H ' ' A' ' 30' ' ' LYS . 11.8 mt -56.1 -67.43 0.3 Allowed 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.627 1.171 . . . . 10.0 113.637 169.099 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 t -76.37 40.92 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 CA-C-O 123.708 1.718 . . . . 10.0 110.852 179.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.401 ' H ' ' C ' ' A' ' 28' ' ' LEU . 42.9 tttm -140.84 -44.84 0.39 Allowed 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 127.883 2.473 . . . . 10.0 109.331 171.18 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.96 23.11 0.87 Allowed Glycine 0 CA--C 1.529 0.925 0 N-CA-C 115.629 1.012 . . . . 10.0 115.629 173.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 37.3 mmm -59.51 -45.0 92.98 Favored 'General case' 0 C--O 1.225 -0.235 0 C-N-CA 127.163 2.185 . . . . 10.0 113.596 -179.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.69 -84.42 1.19 Allowed Glycine 0 CA--C 1.53 1.007 0 C-N-CA 123.741 0.686 . . . . 10.0 112.483 -170.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.8 t 33.11 88.75 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.242 0.682 0 C-N-CA 128.399 2.68 . . . . 10.0 116.937 166.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.2 m -79.62 -50.91 9.96 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.152 -1.385 . . . . 10.0 113.855 174.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -48.87 117.51 6.37 Favored Pre-proline 0 CA--C 1.536 0.415 0 O-C-N 124.769 1.293 . . . . 10.0 110.988 -172.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -58.56 -29.68 89.65 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 123.746 2.964 . . . . 10.0 113.72 179.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.31 -60.67 2.28 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.126 0.57 . . . . 10.0 111.422 176.213 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.15 -40.05 22.64 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 125.104 1.362 . . . . 10.0 113.549 171.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -46.53 -47.47 19.54 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 125.252 1.421 . . . . 10.0 113.434 172.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -57.75 -53.06 62.43 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.438 0.695 . . . . 10.0 110.974 176.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.477 ' CD2' ' HB1' ' A' ' 228' ' ' ALA . 44.0 m-85 -56.98 -50.23 73.32 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 123.044 0.538 . . . . 10.0 112.337 -179.117 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -54.35 -51.28 65.25 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 118.914 -0.565 . . . . 10.0 112.375 173.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.46 -61.95 1.95 Allowed 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 113.391 0.886 . . . . 10.0 113.391 177.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.3 mt -48.43 -57.76 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 C-N-CA 124.839 1.255 . . . . 10.0 110.408 178.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.3 m -68.57 -17.44 64.14 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.158 1.383 . . . . 10.0 113.724 -172.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 28.1 m -87.92 -39.63 14.6 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.45 1.1 . . . . 10.0 112.255 174.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 21.2 mt -59.19 -42.64 91.34 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 121.49 -0.756 . . . . 10.0 112.521 171.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 18.5 t -41.43 -63.84 0.75 Allowed Pre-proline 0 CA--C 1.551 0.993 0 C-N-CA 125.774 1.63 . . . . 10.0 113.491 175.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -70.22 -25.07 26.85 Favored 'Trans proline' 0 CA--C 1.544 1.017 0 C-N-CA 122.72 2.28 . . . . 10.0 114.182 176.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.5 -44.45 86.99 Favored 'General case' 0 CA--C 1.549 0.907 0 CA-C-N 120.683 1.583 . . . . 10.0 113.046 174.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 58.0 mt -54.66 -52.18 43.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 124.961 1.304 . . . . 10.0 108.998 168.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.451 ' HB1' ' SD ' ' A' ' 20' ' ' MET . . . -53.14 -49.75 65.93 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.637 1.175 . . . . 10.0 112.789 176.402 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -50.42 -58.57 5.42 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 125.717 1.607 . . . . 10.0 112.574 173.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.3 m -49.38 -52.64 27.13 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.119 1.368 . . . . 10.0 110.66 178.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.425 ' HG3' ' CB ' ' A' ' 85' ' ' ASP . 32.8 mmt -69.41 -48.22 61.71 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 123.889 0.876 . . . . 10.0 112.82 -176.369 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -57.71 -39.29 76.88 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 116.567 -1.683 . . . . 10.0 113.111 173.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.7 tp -53.24 -54.62 33.47 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-N 120.623 1.556 . . . . 10.0 111.273 169.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 23.9 p -51.63 -41.05 61.01 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 115.257 1.577 . . . . 10.0 115.257 179.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 56.5 mtm -66.93 -50.8 61.23 Favored 'General case' 0 C--N 1.334 -0.09 0 C-N-CA 123.548 0.739 . . . . 10.0 110.485 176.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.3 tp -48.57 -52.7 21.49 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.858 0.863 . . . . 10.0 112.948 172.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.5 mt -76.86 -5.59 48.96 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 113.835 1.05 . . . . 10.0 113.835 -177.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.26 -34.72 5.54 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 115.583 0.993 . . . . 10.0 115.583 174.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -49.24 -43.13 42.52 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 115.243 1.571 . . . . 10.0 115.243 -176.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.01 3.48 61.22 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 115.329 0.892 . . . . 10.0 115.329 -178.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.25 143.41 26.44 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 127.034 2.133 . . . . 10.0 109.011 172.055 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 t -145.52 171.11 15.14 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 124.029 0.931 . . . . 10.0 111.011 166.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.95 136.06 53.39 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 123.924 0.89 . . . . 10.0 109.739 179.583 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.436 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 58.6 t -129.58 129.58 23.18 Favored Pre-proline 0 C--N 1.329 -0.295 0 C-N-CA 125.063 1.345 . . . . 10.0 110.935 -176.048 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 69' ' ' VAL . 6.3 Cg_exo -80.71 116.19 3.17 Favored 'Trans proline' 0 N--CA 1.452 -0.921 0 N-CA-C 109.443 -1.022 . . . . 10.0 109.443 -178.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -156.71 164.39 38.2 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 112.862 0.69 . . . . 10.0 112.862 172.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.39 -82.0 0.14 Allowed Glycine 0 CA--C 1.526 0.773 0 N-CA-C 110.683 -0.967 . . . . 10.0 110.683 175.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.76 -3.33 0.7 Allowed Glycine 0 CA--C 1.527 0.812 0 N-CA-C 118.641 2.216 . . . . 10.0 118.641 170.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -151.63 -171.89 4.06 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 119.379 1.59 . . . . 10.0 112.228 -165.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -91.86 93.9 9.05 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 125.521 1.528 . . . . 10.0 111.097 -175.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.449 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 60.3 m-80 -89.48 120.72 69.64 Favored Pre-proline 0 N--CA 1.45 -0.429 0 N-CA-C 112.965 0.728 . . . . 10.0 112.965 -165.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.652 ' HB3' HG21 ' A' ' 5' ' ' THR . 76.1 Cg_exo -61.53 131.94 38.26 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 124.183 3.255 . . . . 10.0 112.165 171.588 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.5 mm -140.09 126.3 21.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 C-N-CA 126.043 1.737 . . . . 10.0 111.732 -179.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -93.64 85.03 4.75 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 122.888 1.328 . . . . 10.0 113.053 174.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 63.6 p-90 -59.33 -28.3 66.69 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 113.911 1.078 . . . . 10.0 113.911 174.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -55.31 -35.93 65.65 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.286 1.035 . . . . 10.0 113.575 178.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 6.8 ptp180 -56.8 -40.44 75.97 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 120.209 1.368 . . . . 10.0 111.281 173.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -66.16 -43.73 86.12 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 113.887 1.069 . . . . 10.0 113.887 174.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -49.39 -47.19 47.9 Favored 'General case' 0 CA--C 1.555 1.165 0 C-N-CA 124.695 1.198 . . . . 10.0 111.002 167.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.425 ' CB ' ' HG3' ' A' ' 56' ' ' MET . 0.0 OUTLIER -61.71 -58.92 6.14 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 125.568 1.547 . . . . 10.0 112.938 173.331 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 46.9 m0 -51.82 -40.52 60.6 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 126.829 2.052 . . . . 10.0 112.777 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 27.8 tp -50.22 -45.79 54.14 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 125.944 1.697 . . . . 10.0 112.686 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -97.94 -46.86 5.76 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 123.735 0.814 . . . . 10.0 112.753 -176.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -58.8 -41.44 86.77 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.903 0.881 . . . . 10.0 112.801 -175.314 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.459 ' HB ' ' HD3' ' A' ' 91' ' ' PRO . 3.1 m -66.39 -47.66 58.54 Favored Pre-proline 0 CA--C 1.541 0.598 0 O-C-N 121.094 -1.004 . . . . 10.0 111.938 -174.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.459 ' HD3' ' HB ' ' A' ' 90' ' ' THR . 86.6 Cg_exo -51.93 -42.92 55.53 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 123.34 2.694 . . . . 10.0 115.145 166.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 53.0 mt -59.79 -48.17 82.76 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 118.877 0.762 . . . . 10.0 111.875 176.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 84.3 mt -53.77 -45.1 70.52 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.481 1.112 . . . . 10.0 112.136 172.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.6 mp -57.35 -47.86 80.52 Favored 'General case' 0 CA--C 1.546 0.796 0 O-C-N 120.97 -1.082 . . . . 10.0 112.574 169.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.87 -38.23 78.33 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 123.824 0.85 . . . . 10.0 112.877 178.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -52.28 -54.05 36.34 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 119.303 0.956 . . . . 10.0 111.215 169.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.36 -42.07 88.59 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.585 0.754 . . . . 10.0 112.119 -178.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.67 -54.75 37.61 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.972 0.909 . . . . 10.0 112.006 173.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.3 -41.16 79.34 Favored 'General case' 0 C--O 1.224 -0.237 0 C-N-CA 123.72 0.808 . . . . 10.0 112.702 174.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 32.0 tp -63.75 -38.56 91.58 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 114.445 1.276 . . . . 10.0 114.445 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.2 t -94.79 1.36 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 125.106 1.362 . . . . 10.0 112.309 179.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.2 t70 48.57 53.46 12.11 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.858 1.663 . . . . 10.0 112.139 -173.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.29 145.89 47.56 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 119.951 -1.718 . . . . 10.0 112.44 -174.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.44 135.87 54.08 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 112.759 0.651 . . . . 10.0 112.759 175.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -42.85 -39.65 2.6 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.844 1.658 . . . . 10.0 113.49 175.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -47.33 -60.23 5.32 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 125.15 1.357 . . . . 10.0 115.262 169.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.4 p -62.06 -46.77 87.65 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 117.1 -1.428 . . . . 10.0 111.332 178.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 66.9 mt -48.39 -52.92 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 125.001 1.321 . . . . 10.0 111.147 178.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.4 tp -62.66 -51.28 67.86 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 112.509 0.559 . . . . 10.0 112.509 179.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.15 -44.87 43.05 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.506 0.722 . . . . 10.0 110.967 174.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.454 HD12 ' HA ' ' A' ' 111' ' ' LEU . 0.6 OUTLIER -59.6 -59.87 4.76 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 127.363 2.265 . . . . 10.0 114.839 174.898 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.4 t -60.97 -46.39 96.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 123.711 0.804 . . . . 10.0 111.373 -178.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -56.61 -50.3 64.02 Favored Glycine 0 CA--C 1.533 1.163 0 C-N-CA 123.662 0.649 . . . . 10.0 112.661 174.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -54.54 -46.5 73.61 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.569 0.747 . . . . 10.0 112.882 173.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -61.38 -40.62 95.0 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 123.887 0.875 . . . . 10.0 112.924 176.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -43.69 -59.38 3.75 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 125.995 1.76 . . . . 10.0 112.401 163.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 78.8 mt -56.66 -52.59 52.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 123.69 0.796 . . . . 10.0 110.925 175.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 46.4 ttp -46.33 -61.96 1.56 Allowed 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 126.022 1.729 . . . . 10.0 112.597 -174.087 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -80.93 -34.04 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 CA-C-O 118.933 -0.556 . . . . 10.0 112.176 -177.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -57.12 -48.27 81.05 Favored Glycine 0 CA--C 1.53 1.023 0 CA-C-N 119.26 0.936 . . . . 10.0 111.902 175.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 88.9 m -54.66 -44.45 73.3 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.299 1.44 . . . . 10.0 111.759 167.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -48.11 -52.01 18.44 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 124.773 1.178 . . . . 10.0 112.893 170.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 60.1 tp -59.07 -47.3 85.73 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.121 1.368 . . . . 10.0 112.201 175.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 61.9 t -53.08 -50.54 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 O-C-N 121.465 -0.772 . . . . 10.0 110.209 172.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -50.97 -61.28 6.27 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 126.18 1.848 . . . . 10.0 112.939 172.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -43.45 -41.53 4.35 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 127.993 2.517 . . . . 10.0 113.231 176.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 46.5 mt -99.92 -7.23 25.47 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 115.513 1.671 . . . . 10.0 115.513 -176.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 17.0 m -69.66 116.75 10.42 Favored 'General case' 0 N--CA 1.464 0.274 0 O-C-N 120.195 -1.566 . . . . 10.0 110.407 -178.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.622 ' H ' ' HD3' ' A' ' 129' ' ' LYS . 0.2 OUTLIER -55.5 -49.62 72.09 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 128.195 2.598 . . . . 10.0 113.288 177.758 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 60.1 t -69.58 106.32 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 123.789 0.836 . . . . 10.0 110.12 179.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -46.92 -59.49 3.06 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 124.761 1.224 . . . . 10.0 114.067 -173.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 m -46.5 -42.08 15.06 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.439 1.495 . . . . 10.0 113.512 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -70.16 -24.59 63.18 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 114.918 1.451 . . . . 10.0 114.918 -178.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 68.2 mtp85 -54.37 -41.18 68.86 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 118.876 0.762 . . . . 10.0 110.905 176.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -69.79 -31.75 69.85 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 114.34 1.237 . . . . 10.0 114.34 176.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.8 t -55.17 -52.23 46.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 CA-C-N 118.928 0.785 . . . . 10.0 109.82 168.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 65.0 m95 -59.48 -49.57 77.27 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 113.428 0.899 . . . . 10.0 113.428 173.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 83.0 t90 -48.37 -47.82 37.12 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 119.438 1.017 . . . . 10.0 113.31 173.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -58.74 -51.12 71.31 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.099 0.96 . . . . 10.0 111.993 176.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 97.2 mt -55.88 -50.89 66.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 125.023 1.329 . . . . 10.0 111.564 175.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 17.5 m -51.91 -46.17 64.52 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.241 1.016 . . . . 10.0 112.59 170.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 63.3 m -62.14 -44.3 96.92 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.775 1.23 . . . . 10.0 111.986 179.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -56.49 -50.59 71.33 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.91 0.884 . . . . 10.0 112.327 171.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -56.84 -44.23 81.89 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.799 0.84 . . . . 10.0 112.977 174.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 42.8 ttp -57.75 -55.77 30.59 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.406 1.082 . . . . 10.0 111.969 173.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -49.79 -49.67 47.74 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.461 1.505 . . . . 10.0 110.781 177.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -51.77 -55.8 17.66 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 113.298 0.851 . . . . 10.0 113.298 173.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 49.9 mt -54.22 -54.69 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 123.598 0.759 . . . . 10.0 110.78 177.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 42.1 mt -57.14 -36.1 70.29 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 118.409 -0.805 . . . . 10.0 112.959 178.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -57.33 -58.11 9.67 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 124.026 0.93 . . . . 10.0 113.03 173.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.48 -40.89 85.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 CA-C-O 118.303 -0.855 . . . . 10.0 111.419 177.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 45.1 mt -56.83 -49.35 75.68 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 119.893 1.224 . . . . 10.0 112.115 171.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.47 ' HA ' ' HD2' ' A' ' 175' ' ' ARG . 11.9 t80 -77.03 -70.34 0.47 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 120.054 -1.654 . . . . 10.0 112.862 -175.254 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -73.73 -21.91 60.06 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.634 1.174 . . . . 10.0 113.439 -174.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -87.79 -79.08 1.26 Allowed Glycine 0 CA--C 1.527 0.783 0 C-N-CA 123.625 0.631 . . . . 10.0 113.534 171.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -53.68 -32.4 51.54 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 126.269 1.828 . . . . 10.0 113.046 -166.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.3 m -52.16 -56.39 14.85 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 113.989 1.107 . . . . 10.0 113.989 172.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.3 p -53.65 -50.63 65.33 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 122.092 0.949 . . . . 10.0 112.249 -177.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 47.6 tttm -57.11 -46.03 82.93 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.142 0.977 . . . . 10.0 112.122 173.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.8 -47.5 80.07 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 114.534 1.309 . . . . 10.0 114.534 174.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -56.45 -11.29 1.2 Allowed 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 126.054 1.741 . . . . 10.0 114.261 177.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.1 m -107.04 6.56 29.1 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 126.474 1.91 . . . . 10.0 114.896 -179.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 93.2 mmm -91.88 -92.66 0.15 Allowed 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 123.487 1.613 . . . . 10.0 114.171 -170.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -138.74 153.94 72.59 Favored Pre-proline 0 C--O 1.236 0.359 0 C-N-CA 129.802 3.241 . . . . 10.0 105.548 170.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -52.85 -46.22 35.27 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.346 2.031 . . . . 10.0 113.074 179.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.667 ' CD ' ' HD3' ' A' ' 227' ' ' ARG . 0.1 OUTLIER -52.97 -46.09 68.06 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 128.979 2.912 . . . . 10.0 113.276 173.571 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 92.2 t -69.19 -52.99 27.97 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 C-N-CA 124.065 0.946 . . . . 10.0 109.8 -178.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.18 -46.82 75.81 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.319 0.648 . . . . 10.0 111.899 177.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 60.3 p -60.04 -56.17 24.98 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.876 0.87 . . . . 10.0 112.729 174.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 61.8 m -57.2 -53.17 61.13 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.184 0.994 . . . . 10.0 113.027 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -49.6 -49.49 46.55 Favored 'General case' 0 C--O 1.221 -0.414 0 C-N-CA 123.258 0.623 . . . . 10.0 111.114 174.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -57.16 -48.37 78.86 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 114.664 1.357 . . . . 10.0 114.664 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 40.4 t -56.01 -49.62 74.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 CA-C-N 118.832 0.742 . . . . 10.0 110.477 176.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 94.2 mt -58.6 -51.64 69.07 Favored 'General case' 0 C--O 1.222 -0.384 0 N-CA-C 113.141 0.793 . . . . 10.0 113.141 175.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . 0.47 ' HD2' ' HA ' ' A' ' 153' ' ' PHE . 35.5 ttp180 -47.7 -47.86 29.66 Favored 'General case' 0 C--O 1.225 -0.201 0 C-N-CA 126.852 2.061 . . . . 10.0 111.084 174.402 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 63.6 m-20 -58.48 -58.35 8.92 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 122.775 0.43 . . . . 10.0 111.234 174.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 54.6 t -51.77 -48.09 38.64 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 C-N-CA 124.088 0.955 . . . . 10.0 111.858 179.061 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 28.5 m -58.19 -62.8 1.57 Allowed 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 127.959 2.503 . . . . 10.0 112.17 177.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 54.8 t -51.43 -49.18 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 124.686 1.194 . . . . 10.0 111.019 -179.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 70.9 t -59.76 -60.42 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 124.008 0.923 . . . . 10.0 112.374 177.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 77.5 mt -54.59 -52.9 60.7 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 118.414 0.552 . . . . 10.0 111.769 -178.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 9.9 m95 -51.79 -50.1 61.41 Favored 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 124.274 1.03 . . . . 10.0 112.35 177.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 49.2 m -52.93 -31.98 43.15 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 113.721 1.008 . . . . 10.0 113.721 178.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -66.1 -39.39 89.92 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 113.99 1.107 . . . . 10.0 113.99 175.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 44.1 m-85 -49.04 -54.6 26.97 Favored Pre-proline 0 N--CA 1.477 0.924 0 N-CA-C 115.198 1.555 . . . . 10.0 115.198 -176.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 0.56 ' HB3' H183 ' A' ' 999' ' ' RET . 19.2 Cg_endo -57.74 -35.89 98.62 Favored 'Trans proline' 0 C--N 1.355 0.876 0 C-N-CA 122.373 2.049 . . . . 10.0 112.903 175.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 22.7 t -66.22 -54.84 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 C-N-CA 124.735 1.214 . . . . 10.0 110.855 178.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 58.4 t -56.24 -45.72 81.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 124.641 1.176 . . . . 10.0 111.333 177.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 66.7 t90 -56.36 -54.6 43.64 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.11 0.964 . . . . 10.0 112.2 172.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 60.3 tp -52.29 -46.42 65.9 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.413 1.485 . . . . 10.0 112.29 -177.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 15.0 pt -86.09 -5.14 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 N-CA-C 115.333 1.605 . . . . 10.0 115.333 -177.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.59 -169.26 32.72 Favored Glycine 0 N--CA 1.45 -0.383 0 CA-C-O 122.57 1.095 . . . . 10.0 113.826 -168.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 23.3 t -53.12 -40.15 63.99 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 114.209 -0.996 . . . . 10.0 111.853 177.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -71.99 -13.74 61.7 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 115.357 1.614 . . . . 10.0 115.357 -174.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -130.49 -106.69 1.16 Allowed Glycine 0 CA--C 1.531 1.031 0 CA-C-N 120.218 1.372 . . . . 10.0 113.349 -174.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -89.48 127.14 35.82 Favored 'General case' 0 C--N 1.329 -0.313 0 O-C-N 120.673 -1.487 . . . . 10.0 109.352 169.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -72.43 65.33 1.35 Allowed Glycine 0 CA--C 1.532 1.127 0 N-CA-C 113.937 0.335 . . . . 10.0 113.937 173.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 60.8 mt -79.6 -42.74 23.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 126.044 1.737 . . . . 10.0 108.717 166.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 79.7 t -126.28 133.4 24.93 Favored Pre-proline 0 N--CA 1.454 -0.25 0 C-N-CA 126.467 1.907 . . . . 10.0 109.368 -174.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -68.74 153.78 72.5 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 123.811 3.007 . . . . 10.0 111.476 -176.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 12.2 tp -43.16 -39.8 3.02 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.359 1.064 . . . . 10.0 112.193 171.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -48.32 -52.41 21.66 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 114.68 1.363 . . . . 10.0 114.68 176.046 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 13.9 mm -75.91 -40.5 38.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 C-N-CA 124.401 1.08 . . . . 10.0 109.658 177.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -49.3 -49.81 42.15 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 118.593 0.633 . . . . 10.0 111.947 173.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 16.1 m -57.66 -47.07 83.31 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 126.083 1.753 . . . . 10.0 112.998 174.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.535 HD23 ' CD2' ' A' ' 12' ' ' TRP . 1.3 tm? -63.33 -52.34 62.23 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.95 0.9 . . . . 10.0 112.073 179.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 93.3 mt -52.55 -58.54 6.45 Favored 'General case' 0 C--O 1.228 -0.046 0 C-N-CA 124.32 1.048 . . . . 10.0 109.973 176.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -55.19 -44.62 75.45 Favored 'General case' 0 C--O 1.22 -0.475 0 CA-C-O 117.608 -1.187 . . . . 10.0 113.0 176.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' MET . . . . . 0.575 ' HE2' ' HB3' ' A' ' 15' ' ' LEU . 4.6 tmm? -51.48 -52.51 45.97 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 120.502 1.501 . . . . 10.0 112.581 173.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 79.9 t -61.06 -48.65 88.09 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 124.675 1.19 . . . . 10.0 111.773 178.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 5.3 mp -57.62 -53.26 60.2 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.472 1.509 . . . . 10.0 111.89 176.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -55.96 -54.95 38.59 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 126.753 2.021 . . . . 10.0 110.707 177.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 37.6 t -46.76 -53.51 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 O-C-N 121.243 -0.911 . . . . 10.0 111.368 173.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 5.2 t -57.94 -49.35 77.09 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 123.248 0.619 . . . . 10.0 112.599 176.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -62.52 -31.23 71.96 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.069 1.747 . . . . 10.0 114.24 178.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 11.9 mptt -86.34 -73.75 0.45 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.262 1.425 . . . . 10.0 110.259 177.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 33.9 m -88.72 -34.27 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 O-C-N 121.293 -0.879 . . . . 10.0 112.781 -167.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -57.92 -58.38 14.88 Favored Glycine 0 CA--C 1.534 1.258 0 CA-C-N 119.772 1.169 . . . . 10.0 111.876 172.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -44.19 -57.68 3.3 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.921 2.089 . . . . 10.0 112.111 166.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -55.03 -41.98 79.46 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 124.059 0.838 . . . . 10.0 113.979 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 24.0 mt -71.07 -27.16 63.43 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 115.637 1.718 . . . . 10.0 115.637 177.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 74.1 mt -63.22 -57.61 11.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 108.684 -0.858 . . . . 10.0 108.684 165.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 32.1 tp -58.82 -64.63 0.86 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.935 0.894 . . . . 10.0 113.183 -172.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 84.5 mt -71.64 5.25 2.55 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 115.27 1.582 . . . . 10.0 115.27 -171.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.7 mtp-105 -112.33 0.39 15.67 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 124.203 1.001 . . . . 10.0 113.292 172.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 8.8 t -108.06 177.97 4.65 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 124.06 0.944 . . . . 10.0 111.015 174.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . 0.667 ' HD3' ' CD ' ' A' ' 166' ' ' GLU . 41.7 ttt180 -71.63 98.15 1.85 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.795 0.838 . . . . 10.0 110.917 170.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . 0.477 ' HB1' ' CD2' ' A' ' 42' ' ' PHE . . . -80.89 77.02 7.8 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.859 0.863 . . . . 10.0 112.116 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 40.11 102.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 128.833 2.853 . . . . 10.0 116.484 177.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . 0.481 0.3 OUTLIER 71.79 -55.39 0.66 Allowed 'General case' 0 C--O 1.242 0.685 0 C-N-CA 124.753 1.221 . . . . 10.0 110.68 -175.267 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -68.3 169.47 40.07 Favored Glycine 0 C--O 1.239 0.429 0 C-N-CA 129.735 3.541 . . . . 10.0 119.674 171.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.448 0 C-N-CA 128.491 2.716 . . . . 10.0 113.461 166.62 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 999' ' ' RET . . . . . 0.56 H183 ' HB3' ' A' ' 186' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1000 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A 1001 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A 1002 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A 1003 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 N--CA 1.477 0.876 0 CA-C-O 115.781 -2.057 . . . . 10.0 105.837 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 23.43 91.86 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 129.576 3.15 . . . . 10.0 117.262 160.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 28.59 65.12 0.1 Allowed 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 128.297 2.639 . . . . 10.0 114.458 155.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 86.7 mt -56.51 137.96 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 126.384 1.873 . . . . 10.0 113.343 -158.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.653 HG21 ' HB3' ' A' ' 77' ' ' PRO . 7.6 t -136.74 -165.19 1.69 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 126.353 1.861 . . . . 10.0 114.062 -174.347 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 70.02 2.75 40.86 Favored Glycine 0 C--N 1.339 0.743 0 C-N-CA 127.44 2.448 . . . . 10.0 111.453 168.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -158.57 -51.28 0.01 OUTLIER Pre-proline 0 N--CA 1.443 -0.805 0 CA-C-O 114.243 -2.789 . . . . 10.0 116.635 -168.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_exo -63.96 -60.62 0.15 Allowed 'Trans proline' 0 N--CA 1.465 -0.202 0 CA-C-N 123.576 2.313 . . . . 10.0 113.21 -175.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.412 ' H ' ' CD ' ' A' ' 9' ' ' GLU . 7.9 pm0 -67.26 4.31 0.99 Allowed 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 127.831 2.452 . . . . 10.0 115.783 179.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.422 ' CG ' ' N ' ' A' ' 11' ' ' ILE . 11.0 p-90 -51.31 -43.17 61.63 Favored 'General case' 0 C--O 1.223 -0.34 0 O-C-N 121.5 -0.75 . . . . 10.0 112.615 176.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.422 ' N ' ' CG ' ' A' ' 10' ' ' TRP . 8.9 tt -60.83 -49.64 83.77 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.34 0 C-N-CA 123.885 0.874 . . . . 10.0 109.344 179.403 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.535 ' CD2' HD23 ' A' ' 206' ' ' LEU . 2.6 m95 -55.39 -52.58 63.08 Favored 'General case' 0 C--O 1.224 -0.259 0 C-N-CA 123.4 0.68 . . . . 10.0 111.88 175.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.2 mt -57.39 -53.63 55.96 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 123.219 0.608 . . . . 10.0 112.196 177.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.9 -46.74 52.14 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.366 1.466 . . . . 10.0 113.332 173.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.574 ' HB3' ' HE2' ' A' ' 209' ' ' MET . 13.3 tp -65.71 -44.9 84.69 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 125.274 1.43 . . . . 10.0 113.013 179.122 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.94 -57.29 10.07 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 124.122 0.868 . . . . 10.0 111.16 166.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 22.5 m -48.38 -52.67 20.73 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.709 1.204 . . . . 10.0 112.347 174.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.39 -58.86 5.82 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.139 0.976 . . . . 10.0 112.188 177.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 94.3 mt -57.69 -50.23 73.88 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.696 0.799 . . . . 10.0 112.627 -179.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -53.73 -50.91 64.92 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.495 1.118 . . . . 10.0 111.395 175.066 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -57.95 -58.01 16.81 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 124.268 0.937 . . . . 10.0 113.579 176.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 81.2 mt -56.19 -45.83 79.63 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-N 118.527 1.164 . . . . 10.0 112.125 176.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.63 -41.95 75.66 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 124.854 1.216 . . . . 10.0 113.278 172.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 24.6 m -61.41 -59.5 5.16 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.984 0.913 . . . . 10.0 111.263 171.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -52.29 -40.92 62.43 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.028 0.931 . . . . 10.0 110.99 178.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -55.86 -57.98 9.78 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 124.619 1.168 . . . . 10.0 112.966 172.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -59.65 -38.75 82.26 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 113.193 0.812 . . . . 10.0 113.193 178.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.401 ' C ' ' H ' ' A' ' 30' ' ' LYS . 11.8 mt -56.08 -67.47 0.29 Allowed 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.58 1.152 . . . . 10.0 113.637 169.108 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 t -76.37 40.96 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 CA-C-O 123.802 1.763 . . . . 10.0 110.891 179.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.401 ' H ' ' C ' ' A' ' 28' ' ' LEU . 42.9 tttm -140.85 -44.82 0.39 Allowed 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 127.862 2.465 . . . . 10.0 109.317 171.12 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.9 23.1 0.86 Allowed Glycine 0 CA--C 1.529 0.908 0 N-CA-C 115.668 1.027 . . . . 10.0 115.668 173.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 37.4 mmm -59.54 -44.95 93.07 Favored 'General case' 0 C--O 1.225 -0.217 0 C-N-CA 127.19 2.196 . . . . 10.0 113.596 -178.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.74 -84.45 1.19 Allowed Glycine 0 CA--C 1.531 1.035 0 C-N-CA 123.798 0.713 . . . . 10.0 112.437 -170.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.7 t 33.06 88.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 128.358 2.663 . . . . 10.0 116.93 166.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.4 m -79.63 -50.86 10.04 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.155 -1.384 . . . . 10.0 113.879 174.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -48.95 117.46 6.39 Favored Pre-proline 0 CA--C 1.535 0.402 0 O-C-N 124.718 1.261 . . . . 10.0 110.982 -172.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -58.5 -29.68 89.44 Favored 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 123.779 2.986 . . . . 10.0 113.688 179.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.27 -60.71 2.26 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.148 0.579 . . . . 10.0 111.424 176.193 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.19 -40.05 22.94 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 125.085 1.354 . . . . 10.0 113.534 171.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -46.55 -47.45 19.65 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.21 1.404 . . . . 10.0 113.436 172.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -57.74 -53.1 61.99 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.479 0.712 . . . . 10.0 110.944 176.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.475 ' CD2' ' HB1' ' A' ' 228' ' ' ALA . 44.0 m-85 -56.91 -50.28 73.02 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 123.119 0.568 . . . . 10.0 112.342 -179.126 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -54.34 -51.29 65.22 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 118.936 -0.554 . . . . 10.0 112.345 173.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.45 -61.99 1.92 Allowed 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 113.392 0.886 . . . . 10.0 113.392 177.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.5 mt -48.68 -56.27 2.47 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 C-N-CA 124.864 1.266 . . . . 10.0 110.64 177.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.6 m -70.17 -17.45 63.17 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.003 1.321 . . . . 10.0 113.646 -172.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 27.5 m -87.8 -37.34 16.67 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.194 0.998 . . . . 10.0 112.237 174.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 20.8 mt -60.4 -42.57 96.19 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 118.128 -0.939 . . . . 10.0 112.518 172.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.594 HG23 ' HD3' ' A' ' 50' ' ' PRO 0.349 33.2 m -52.53 -53.04 57.93 Favored Pre-proline 0 N--CA 1.487 1.386 0 CA-C-N 120.645 1.566 . . . . 10.0 115.049 -179.745 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.594 ' HD3' HG23 ' A' ' 49' ' ' VAL . 68.7 Cg_endo -68.33 -25.11 36.52 Favored 'Trans proline' 0 CA--C 1.545 1.044 0 CA-C-N 123.02 2.114 . . . . 10.0 113.524 174.461 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -68.09 -45.83 72.65 Favored 'General case' 0 CA--C 1.548 0.896 0 CA-C-N 120.5 1.5 . . . . 10.0 112.894 173.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 31.4 mm -54.07 -52.3 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 124.896 1.278 . . . . 10.0 109.525 168.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -52.9 -49.57 65.63 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.968 0.907 . . . . 10.0 113.04 174.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 52.3 t80 -51.78 -58.53 6.15 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.769 1.628 . . . . 10.0 112.19 175.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.1 m -49.01 -52.7 23.6 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 125.252 1.421 . . . . 10.0 110.629 178.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.439 ' HG3' ' CB ' ' A' ' 85' ' ' ASP . 32.8 mmt -69.42 -48.09 62.09 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 123.854 0.861 . . . . 10.0 112.899 -176.429 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -56.2 -40.98 74.86 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 120.321 1.419 . . . . 10.0 113.146 172.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.8 tp -53.27 -54.59 34.01 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-N 120.031 1.287 . . . . 10.0 111.292 170.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 24.0 p -51.68 -41.05 61.12 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 115.224 1.564 . . . . 10.0 115.224 178.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 57.8 mtm -66.82 -50.87 61.2 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 123.586 0.754 . . . . 10.0 110.527 176.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.4 tp -48.53 -52.67 21.46 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.857 0.863 . . . . 10.0 112.974 172.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.4 mt -76.97 -5.54 49.02 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 113.849 1.055 . . . . 10.0 113.849 -177.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.32 -34.71 5.55 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 115.55 0.98 . . . . 10.0 115.55 174.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -49.33 -43.05 43.39 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 115.235 1.568 . . . . 10.0 115.235 -175.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.05 3.58 61.04 Favored Glycine 0 CA--C 1.521 0.467 0 N-CA-C 115.358 0.903 . . . . 10.0 115.358 -179.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.3 143.41 26.43 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 127.035 2.134 . . . . 10.0 109.018 172.002 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 t -145.47 171.11 15.12 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 124.081 0.952 . . . . 10.0 111.062 166.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.04 136.07 53.37 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 123.919 0.888 . . . . 10.0 109.661 179.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.438 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 58.7 t -129.58 129.59 23.18 Favored Pre-proline 0 C--N 1.329 -0.313 0 C-N-CA 125.063 1.345 . . . . 10.0 110.96 -176.092 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 69' ' ' VAL . 6.3 Cg_exo -80.72 116.24 3.17 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 N-CA-C 109.406 -1.036 . . . . 10.0 109.406 -178.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -156.73 164.39 38.17 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 112.842 0.682 . . . . 10.0 112.842 172.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.36 -81.95 0.14 Allowed Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.693 -0.963 . . . . 10.0 110.693 175.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.77 -3.38 0.69 Allowed Glycine 0 CA--C 1.526 0.766 0 N-CA-C 118.642 2.217 . . . . 10.0 118.642 170.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -151.62 -171.87 4.05 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 119.379 1.59 . . . . 10.0 112.257 -165.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -91.89 93.9 9.04 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 125.534 1.533 . . . . 10.0 111.131 -175.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.449 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 60.4 m-80 -89.49 120.8 69.63 Favored Pre-proline 0 N--CA 1.45 -0.43 0 N-CA-C 112.933 0.716 . . . . 10.0 112.933 -165.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.653 ' HB3' HG21 ' A' ' 5' ' ' THR . 76.0 Cg_exo -61.52 131.94 38.31 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 124.205 3.27 . . . . 10.0 112.166 171.573 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.6 mm -140.18 126.32 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 C-N-CA 126.072 1.749 . . . . 10.0 111.712 -179.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -93.62 85.07 4.77 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 123.171 1.463 . . . . 10.0 113.041 174.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 63.7 p-90 -59.38 -28.32 66.79 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 120.729 -1.232 . . . . 10.0 113.873 174.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -54.51 -37.28 65.15 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 115.087 1.514 . . . . 10.0 115.087 178.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -59.66 -35.93 75.42 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 120.311 1.414 . . . . 10.0 112.488 172.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 -66.73 -42.91 85.52 Favored 'General case' 0 CA--C 1.545 0.752 0 O-C-N 120.997 -1.065 . . . . 10.0 112.876 173.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -49.47 -49.56 44.97 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 125.361 1.464 . . . . 10.0 111.321 166.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.439 ' CB ' ' HG3' ' A' ' 56' ' ' MET . 0.0 OUTLIER -59.46 -60.29 4.09 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.001 1.321 . . . . 10.0 112.533 173.385 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 51.8 m0 -54.82 -37.94 66.75 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 126.034 1.733 . . . . 10.0 113.161 -175.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 31.3 tp -49.84 -45.51 50.36 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 126.677 1.991 . . . . 10.0 111.86 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -97.33 -40.74 8.58 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 123.666 0.787 . . . . 10.0 112.502 -179.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -61.93 -44.98 95.64 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 113.275 0.843 . . . . 10.0 113.275 -175.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . 0.293 81.7 p -69.58 -39.19 11.34 Favored Pre-proline 0 CA--C 1.544 0.719 0 CA-C-O 117.601 -1.19 . . . . 10.0 114.032 -174.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -54.31 -44.66 47.34 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 123.722 2.948 . . . . 10.0 115.451 164.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 51.2 mt -59.17 -46.75 87.58 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 118.948 0.795 . . . . 10.0 111.434 175.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.4 tp -50.79 -47.9 59.61 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.563 1.545 . . . . 10.0 112.226 172.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.5 mp -59.86 -46.64 88.67 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.293 1.437 . . . . 10.0 112.832 170.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.81 -38.27 78.25 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 123.806 0.842 . . . . 10.0 112.866 178.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -52.26 -54.04 36.3 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 119.329 0.968 . . . . 10.0 111.21 169.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.36 -42.06 88.57 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.671 0.788 . . . . 10.0 112.119 -178.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.71 -54.77 37.54 Favored 'General case' 0 C--O 1.225 -0.186 0 C-N-CA 123.982 0.913 . . . . 10.0 111.999 173.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.27 -41.21 79.27 Favored 'General case' 0 C--O 1.224 -0.237 0 C-N-CA 123.72 0.808 . . . . 10.0 112.678 174.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.8 tp -63.74 -38.57 91.62 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 114.424 1.268 . . . . 10.0 114.424 -179.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.1 t -94.83 1.44 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 125.035 1.334 . . . . 10.0 112.308 179.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.2 t70 48.59 53.49 12.08 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.882 1.673 . . . . 10.0 112.1 -174.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.29 145.89 47.56 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 119.951 -1.718 . . . . 10.0 112.422 -174.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.5 135.91 54.29 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 112.694 0.627 . . . . 10.0 112.694 175.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -42.87 -39.68 2.62 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.863 1.665 . . . . 10.0 113.463 175.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -47.33 -60.17 5.36 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 125.133 1.349 . . . . 10.0 115.293 169.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.6 p -62.07 -46.77 87.66 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 117.098 -1.429 . . . . 10.0 111.356 178.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 66.9 mt -48.42 -52.89 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 124.979 1.312 . . . . 10.0 111.153 178.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.2 tp -62.66 -51.25 67.98 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 112.544 0.572 . . . . 10.0 112.544 179.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.19 -44.81 43.44 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.424 0.69 . . . . 10.0 110.983 174.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.455 ' HA ' HD12 ' A' ' 111' ' ' LEU . 0.6 OUTLIER -59.56 -59.93 4.66 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 127.365 2.266 . . . . 10.0 114.838 174.907 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.6 t -60.99 -46.38 96.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 123.666 0.786 . . . . 10.0 111.37 -178.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -56.63 -50.26 64.35 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 123.659 0.647 . . . . 10.0 112.633 174.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -55.0 -46.62 75.18 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 113.451 0.908 . . . . 10.0 113.451 173.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -56.06 -47.14 78.49 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.466 0.706 . . . . 10.0 111.657 173.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -43.95 -54.23 6.09 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 124.88 1.229 . . . . 10.0 112.928 169.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 79.4 mt -58.22 -50.61 77.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 123.726 0.81 . . . . 10.0 111.979 173.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 53.1 ttp -49.05 -57.01 7.28 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.152 1.381 . . . . 10.0 112.061 179.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 36.5 mm -69.13 -44.84 80.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 O-C-N 121.735 -0.603 . . . . 10.0 111.912 178.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -51.95 -54.63 24.78 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 125.121 1.343 . . . . 10.0 113.249 176.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 35.2 p -60.85 -36.93 80.4 Favored 'General case' 0 N--CA 1.473 0.709 0 O-C-N 121.286 -1.126 . . . . 10.0 112.589 173.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -52.82 -55.24 24.33 Favored Glycine 0 CA--C 1.537 1.446 0 CA-C-N 119.215 0.916 . . . . 10.0 113.445 167.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -49.78 -50.64 43.96 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 128.58 2.752 . . . . 10.0 111.135 173.011 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 60.7 t -60.31 -50.25 81.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 124.542 1.137 . . . . 10.0 111.61 175.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -51.76 -59.59 8.44 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 125.893 1.711 . . . . 10.0 112.115 175.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -48.46 -37.9 18.49 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 127.027 2.131 . . . . 10.0 113.417 179.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 48.1 mt -99.4 -6.78 27.14 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 115.442 1.645 . . . . 10.0 115.442 -178.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 16.9 m -69.73 116.7 10.43 Favored 'General case' 0 N--CA 1.464 0.229 0 O-C-N 120.178 -1.576 . . . . 10.0 110.386 -178.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.622 ' H ' ' HD3' ' A' ' 129' ' ' LYS . 0.1 OUTLIER -55.4 -49.67 71.74 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 128.226 2.61 . . . . 10.0 113.299 177.751 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 60.6 t -69.61 106.31 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 C-N-CA 123.766 0.826 . . . . 10.0 110.141 179.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -46.87 -59.57 2.99 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 124.807 1.243 . . . . 10.0 114.048 -173.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 m -46.44 -42.11 14.86 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.478 1.511 . . . . 10.0 113.495 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -70.1 -24.68 63.25 Favored 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 114.958 1.466 . . . . 10.0 114.958 -178.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 69.5 mtp85 -53.76 -41.9 67.64 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 118.852 0.751 . . . . 10.0 110.814 176.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -69.43 -32.32 71.21 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.76 1.224 . . . . 10.0 114.233 176.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.8 t -55.12 -51.97 49.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-N 119.015 0.825 . . . . 10.0 109.932 169.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 69.3 m95 -59.51 -51.07 71.46 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 113.517 0.932 . . . . 10.0 113.517 174.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 86.5 t90 -48.79 -46.82 42.11 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.563 1.145 . . . . 10.0 113.494 174.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -58.12 -51.97 67.5 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.973 0.909 . . . . 10.0 111.683 175.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 97.6 mt -55.23 -50.52 63.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 125.062 1.345 . . . . 10.0 111.673 174.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 25.1 m -53.62 -44.91 69.9 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.495 1.118 . . . . 10.0 112.367 173.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 61.4 m -65.44 -42.0 92.88 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.051 1.34 . . . . 10.0 111.828 178.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -55.77 -48.33 75.49 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 119.368 0.985 . . . . 10.0 112.089 169.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -58.25 -48.63 79.8 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.661 0.784 . . . . 10.0 112.934 174.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.4 -47.48 83.76 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 118.914 0.779 . . . . 10.0 111.955 175.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 61.6 tp -56.36 -49.39 74.56 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.202 1.401 . . . . 10.0 112.203 176.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 73.9 t80 -51.08 -54.25 26.67 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.97 0.908 . . . . 10.0 112.095 172.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 59.8 mt -54.07 -55.36 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 123.806 0.842 . . . . 10.0 110.662 177.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 21.8 mt -57.33 -35.35 69.76 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 118.009 -0.996 . . . . 10.0 113.067 178.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -57.31 -58.2 9.29 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 119.52 1.055 . . . . 10.0 113.011 173.08 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.41 -40.95 85.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-O 118.279 -0.867 . . . . 10.0 111.408 177.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 44.3 mt -56.77 -49.36 75.51 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 119.909 1.231 . . . . 10.0 112.148 171.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.471 ' HA ' ' HD2' ' A' ' 175' ' ' ARG . 11.8 t80 -77.05 -70.3 0.47 Allowed 'General case' 0 C--N 1.326 -0.447 0 O-C-N 120.056 -1.653 . . . . 10.0 112.848 -175.208 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -73.71 -21.94 60.07 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.612 1.165 . . . . 10.0 113.473 -174.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -87.85 -79.09 1.26 Allowed Glycine 0 CA--C 1.526 0.77 0 C-N-CA 123.588 0.613 . . . . 10.0 113.493 171.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -53.6 -32.48 51.28 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 126.305 1.842 . . . . 10.0 113.033 -166.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.0 m -52.03 -56.47 14.15 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 114.04 1.126 . . . . 10.0 114.04 172.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.5 p -53.68 -50.53 65.61 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 122.099 0.952 . . . . 10.0 112.308 -177.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 47.7 tttm -57.17 -45.97 83.21 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.166 0.986 . . . . 10.0 112.112 173.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.9 -47.42 80.57 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 114.497 1.295 . . . . 10.0 114.497 174.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -56.5 -11.23 1.19 Allowed 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 126.077 1.751 . . . . 10.0 114.271 177.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.1 m -107.16 6.64 28.96 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.424 1.89 . . . . 10.0 114.852 -179.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 93.3 mmm -91.89 -92.67 0.15 Allowed 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 123.475 1.607 . . . . 10.0 114.187 -170.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -138.69 153.99 72.72 Favored Pre-proline 0 C--O 1.236 0.359 0 C-N-CA 129.794 3.238 . . . . 10.0 105.56 170.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -52.85 -46.25 35.03 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.321 2.014 . . . . 10.0 113.078 179.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.666 ' CD ' ' HD3' ' A' ' 227' ' ' ARG . 0.1 OUTLIER -52.98 -46.02 68.08 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 129.013 2.925 . . . . 10.0 113.276 173.573 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 92.2 t -69.25 -53.0 27.74 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.249 0 C-N-CA 124.071 0.949 . . . . 10.0 109.788 -178.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.13 -46.82 75.66 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.31 0.644 . . . . 10.0 111.947 177.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 60.0 p -59.97 -56.25 24.07 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.919 0.887 . . . . 10.0 112.708 174.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 61.5 m -57.15 -53.25 60.24 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.23 1.012 . . . . 10.0 112.995 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -49.53 -49.57 45.48 Favored 'General case' 0 C--O 1.222 -0.375 0 C-N-CA 123.252 0.621 . . . . 10.0 111.113 174.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -57.1 -48.4 78.7 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 114.703 1.371 . . . . 10.0 114.703 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 40.5 t -55.98 -49.59 74.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 CA-C-N 118.795 0.725 . . . . 10.0 110.496 176.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 94.3 mt -58.58 -51.64 69.04 Favored 'General case' 0 C--O 1.221 -0.441 0 N-CA-C 113.132 0.79 . . . . 10.0 113.132 175.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . 0.471 ' HD2' ' HA ' ' A' ' 153' ' ' PHE . 35.6 ttp180 -47.81 -47.8 30.92 Favored 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 126.846 2.059 . . . . 10.0 111.011 174.509 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 63.7 m-20 -58.48 -58.36 8.88 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 122.817 0.447 . . . . 10.0 111.277 174.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 60.0 t -51.78 -49.04 37.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 C-N-CA 124.075 0.95 . . . . 10.0 111.53 179.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 28.7 m -57.4 -62.51 1.73 Allowed 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 128.025 2.53 . . . . 10.0 112.007 178.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 54.3 t -51.55 -50.31 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 C-N-CA 124.491 1.116 . . . . 10.0 111.069 -179.255 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 73.6 t -58.05 -62.6 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 124.022 0.929 . . . . 10.0 111.482 177.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -56.99 -48.71 77.77 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 118.869 0.759 . . . . 10.0 112.468 -177.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 10.9 m95 -55.67 -45.26 77.75 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.94 0.896 . . . . 10.0 112.615 177.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 51.2 p -56.85 -31.63 64.97 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 114.029 1.122 . . . . 10.0 114.029 176.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -65.73 -41.06 92.66 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 113.722 1.008 . . . . 10.0 113.722 178.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -47.38 -55.53 15.91 Favored Pre-proline 0 N--CA 1.477 0.887 0 N-CA-C 115.286 1.587 . . . . 10.0 115.286 -177.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 0.482 ' HB3' H183 ' A' ' 999' ' ' RET . 19.1 Cg_endo -57.83 -36.48 98.26 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 122.244 1.962 . . . . 10.0 113.083 175.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 21.8 t -63.74 -53.58 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 124.105 0.962 . . . . 10.0 111.219 176.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 87.5 t -54.72 -48.63 72.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 124.408 1.083 . . . . 10.0 111.374 177.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 26.5 t90 -55.7 -52.63 63.22 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.685 1.194 . . . . 10.0 112.388 174.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 34.6 tp -53.21 -45.49 68.64 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.778 1.231 . . . . 10.0 112.511 -179.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 14.7 pt -87.92 -5.41 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 N-CA-C 115.318 1.599 . . . . 10.0 115.318 -176.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.39 -169.23 32.98 Favored Glycine 0 N--CA 1.451 -0.341 0 CA-C-O 122.614 1.119 . . . . 10.0 113.875 -168.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 23.2 t -53.19 -40.86 64.73 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 114.153 -1.023 . . . . 10.0 111.83 177.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -53.97 -32.94 55.53 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 128.571 2.748 . . . . 10.0 115.262 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -130.85 -103.84 0.99 Allowed Glycine 0 CA--C 1.527 0.82 0 CA-C-N 119.324 0.965 . . . . 10.0 113.384 -167.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -89.49 127.14 35.82 Favored 'General case' 0 C--N 1.328 -0.33 0 O-C-N 120.624 -1.515 . . . . 10.0 109.308 169.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -72.41 65.27 1.35 Allowed Glycine 0 CA--C 1.532 1.105 0 N-CA-C 113.899 0.32 . . . . 10.0 113.899 173.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 60.7 mt -79.57 -42.73 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 C-N-CA 126.088 1.755 . . . . 10.0 108.748 166.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 79.2 t -126.27 133.4 24.92 Favored Pre-proline 0 N--CA 1.454 -0.264 0 C-N-CA 126.408 1.883 . . . . 10.0 109.364 -174.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -68.68 153.73 72.74 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 123.811 3.007 . . . . 10.0 111.471 -176.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 12.2 tp -43.08 -39.86 2.92 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.358 1.063 . . . . 10.0 112.199 171.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -48.28 -52.43 21.31 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 114.705 1.372 . . . . 10.0 114.705 176.052 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 14.0 mm -75.89 -40.55 38.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 124.39 1.076 . . . . 10.0 109.625 177.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -49.24 -49.85 41.29 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 118.596 0.635 . . . . 10.0 111.934 173.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 16.2 m -57.64 -47.1 83.17 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 126.046 1.738 . . . . 10.0 112.993 174.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.535 HD23 ' CD2' ' A' ' 12' ' ' TRP . 1.3 tm? -63.31 -52.34 62.31 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.947 0.899 . . . . 10.0 112.112 179.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 93.3 mt -52.52 -59.49 4.38 Favored 'General case' 0 CA--C 1.527 0.068 0 C-N-CA 124.321 1.048 . . . . 10.0 109.963 176.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -54.88 -42.14 71.73 Favored 'General case' 0 C--O 1.221 -0.442 0 CA-C-O 117.52 -1.229 . . . . 10.0 112.938 176.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' MET . . . . . 0.574 ' HE2' ' HB3' ' A' ' 15' ' ' LEU . 4.6 tmm? -53.65 -53.42 52.19 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 121.033 1.742 . . . . 10.0 112.341 173.365 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 79.1 t -60.55 -46.92 94.76 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 124.824 1.25 . . . . 10.0 111.674 178.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 4.3 mp -58.25 -53.19 61.08 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.368 1.467 . . . . 10.0 111.621 175.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -55.84 -53.38 57.44 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.562 1.545 . . . . 10.0 111.277 178.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 45.7 t -49.12 -59.67 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 124.883 1.273 . . . . 10.0 111.145 174.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 28.5 p -62.33 -46.84 86.87 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.382 0.673 . . . . 10.0 112.503 -177.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -70.1 1.42 4.69 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 115.613 1.708 . . . . 10.0 115.613 178.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 18.8 mtmm -131.33 -63.25 0.85 Allowed 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 119.986 1.266 . . . . 10.0 112.231 173.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 21.0 t -66.34 -52.11 50.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 123.762 0.825 . . . . 10.0 110.507 178.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -56.78 -55.45 29.98 Favored Glycine 0 CA--C 1.536 1.379 0 C-N-CA 124.098 0.856 . . . . 10.0 112.832 176.08 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -43.24 -55.86 3.77 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.495 1.918 . . . . 10.0 112.483 167.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -59.16 -39.49 94.54 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 124.857 1.218 . . . . 10.0 113.266 179.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 24.6 mt -69.13 -27.82 65.91 Favored 'General case' 0 CA--C 1.512 -0.495 0 N-CA-C 115.742 1.756 . . . . 10.0 115.742 175.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 74.3 mt -63.37 -57.57 11.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 119.122 0.874 . . . . 10.0 108.648 165.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 32.0 tp -58.77 -64.68 0.84 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.877 0.871 . . . . 10.0 113.213 -172.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 84.0 mt -71.52 5.16 2.51 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 115.337 1.606 . . . . 10.0 115.337 -171.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.6 mtp-105 -112.35 0.44 15.67 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.139 0.976 . . . . 10.0 113.288 172.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 8.8 t -108.06 177.97 4.65 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 124.096 0.958 . . . . 10.0 111.025 174.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . 0.666 ' HD3' ' CD ' ' A' ' 166' ' ' GLU . 41.8 ttt180 -71.62 98.11 1.84 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.819 0.848 . . . . 10.0 110.969 170.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . 0.475 ' HB1' ' CD2' ' A' ' 42' ' ' PHE . . . -80.91 77.03 7.83 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.859 0.864 . . . . 10.0 112.123 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 40.16 102.25 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 128.886 2.874 . . . . 10.0 116.446 177.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . 0.481 0.3 OUTLIER 71.85 -55.43 0.66 Allowed 'General case' 0 C--O 1.242 0.67 0 C-N-CA 124.711 1.205 . . . . 10.0 110.637 -175.318 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -68.28 169.47 40.01 Favored Glycine 0 C--O 1.239 0.417 0 C-N-CA 129.757 3.551 . . . . 10.0 119.653 171.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.461 0 C-N-CA 128.501 2.72 . . . . 10.0 113.462 166.617 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 999' ' ' RET . . . . . 0.492 H181 ' H7 ' ' A' ' 999' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1000 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A 1001 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A 1002 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A 1003 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 N--CA 1.477 0.881 0 CA-C-O 115.768 -2.063 . . . . 10.0 105.842 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 23.35 91.83 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 129.598 3.159 . . . . 10.0 117.262 160.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 28.74 65.04 0.11 Allowed 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 128.265 2.626 . . . . 10.0 114.5 155.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 86.7 mt -56.51 138.0 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 126.353 1.861 . . . . 10.0 113.338 -158.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.653 HG21 ' HB3' ' A' ' 77' ' ' PRO . 7.6 t -136.79 -165.2 1.7 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 126.331 1.852 . . . . 10.0 114.015 -174.337 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 70.06 2.75 41.2 Favored Glycine 0 C--N 1.339 0.743 0 C-N-CA 127.458 2.456 . . . . 10.0 111.462 168.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -158.54 -51.29 0.01 OUTLIER Pre-proline 0 N--CA 1.443 -0.822 0 CA-C-O 114.267 -2.778 . . . . 10.0 116.694 -168.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -63.99 -60.63 0.15 Allowed 'Trans proline' 0 N--CA 1.465 -0.186 0 CA-C-N 123.502 2.286 . . . . 10.0 113.205 -175.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.411 ' H ' ' CD ' ' A' ' 9' ' ' GLU . 7.9 pm0 -67.24 4.3 0.98 Allowed 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 127.844 2.458 . . . . 10.0 115.768 179.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.421 ' CG ' ' N ' ' A' ' 11' ' ' ILE . 11.1 p-90 -51.39 -43.07 61.8 Favored 'General case' 0 C--O 1.222 -0.361 0 O-C-N 121.496 -0.752 . . . . 10.0 112.594 176.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.421 ' N ' ' CG ' ' A' ' 10' ' ' TRP . 8.8 tt -60.91 -49.57 84.13 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.338 0 C-N-CA 123.884 0.874 . . . . 10.0 109.337 179.429 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.536 ' CD2' HD23 ' A' ' 206' ' ' LEU . 2.6 m95 -55.45 -52.64 62.96 Favored 'General case' 0 C--O 1.224 -0.259 0 C-N-CA 123.413 0.685 . . . . 10.0 111.819 175.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.9 mt -57.39 -53.58 56.56 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 123.184 0.594 . . . . 10.0 112.198 177.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.83 -46.82 51.63 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.39 1.476 . . . . 10.0 113.335 173.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.575 ' HB3' ' HE2' ' A' ' 209' ' ' MET . 13.3 tp -65.67 -44.88 84.92 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.27 1.428 . . . . 10.0 113.059 179.12 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.4 -57.58 9.09 Favored Glycine 0 CA--C 1.527 0.839 0 C-N-CA 124.553 1.073 . . . . 10.0 111.045 165.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.0 m -48.91 -52.47 24.34 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.911 1.284 . . . . 10.0 112.333 175.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.4 -58.87 5.75 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.148 0.979 . . . . 10.0 112.155 177.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 96.5 mt -58.06 -49.08 78.16 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.651 0.781 . . . . 10.0 112.515 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 21.8 mmt -54.43 -51.59 64.45 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.811 0.845 . . . . 10.0 111.056 175.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -56.87 -58.48 14.31 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 124.584 1.088 . . . . 10.0 113.624 177.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 80.7 mt -56.18 -45.72 79.66 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-N 118.617 1.208 . . . . 10.0 112.107 176.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.79 -41.84 76.73 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 124.725 1.155 . . . . 10.0 113.374 172.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 19.1 m -60.43 -60.44 3.8 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.228 1.011 . . . . 10.0 111.083 171.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -52.34 -40.96 62.6 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.99 0.916 . . . . 10.0 110.925 179.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.4 t80 -55.82 -58.05 9.49 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.564 1.146 . . . . 10.0 112.943 172.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -59.59 -38.72 81.96 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 113.184 0.809 . . . . 10.0 113.184 178.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.4 ' C ' ' H ' ' A' ' 30' ' ' LYS . 11.8 mt -56.12 -67.47 0.29 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.656 1.182 . . . . 10.0 113.589 169.167 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 t -76.41 41.04 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 CA-C-O 123.775 1.75 . . . . 10.0 110.889 179.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.4 ' H ' ' C ' ' A' ' 28' ' ' LEU . 43.0 tttm -140.89 -44.83 0.39 Allowed 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 127.899 2.48 . . . . 10.0 109.337 171.166 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -73.0 23.15 0.88 Allowed Glycine 0 CA--C 1.528 0.898 0 N-CA-C 115.619 1.007 . . . . 10.0 115.619 173.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 37.4 mmm -59.51 -45.04 92.87 Favored 'General case' 0 C--O 1.224 -0.278 0 C-N-CA 127.189 2.196 . . . . 10.0 113.581 -179.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.65 -84.42 1.18 Allowed Glycine 0 CA--C 1.53 1.026 0 C-N-CA 123.743 0.687 . . . . 10.0 112.465 -170.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.8 t 33.06 88.78 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.242 0.682 0 C-N-CA 128.399 2.68 . . . . 10.0 116.905 166.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.4 m -79.63 -50.85 10.04 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.163 -1.38 . . . . 10.0 113.868 174.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -49.02 117.58 6.59 Favored Pre-proline 0 CA--C 1.536 0.418 0 O-C-N 124.767 1.292 . . . . 10.0 110.95 -172.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -58.62 -29.61 89.69 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 123.721 2.947 . . . . 10.0 113.688 179.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.32 -60.64 2.3 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.08 0.552 . . . . 10.0 111.436 176.179 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.12 -40.11 22.54 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 125.134 1.373 . . . . 10.0 113.58 171.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -46.5 -47.5 19.37 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.21 1.404 . . . . 10.0 113.425 172.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -57.73 -53.01 63.02 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.452 0.701 . . . . 10.0 111.036 176.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.477 ' CD2' ' HB1' ' A' ' 228' ' ' ALA . 43.9 m-85 -56.98 -50.21 73.39 Favored 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 123.057 0.543 . . . . 10.0 112.348 -179.174 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -54.39 -51.27 65.36 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 118.966 -0.54 . . . . 10.0 112.369 173.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.39 -62.08 1.86 Allowed 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 113.353 0.871 . . . . 10.0 113.353 177.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.6 mt -48.62 -58.85 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 C-N-CA 124.862 1.265 . . . . 10.0 110.844 178.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 86.7 m -71.1 -13.67 62.04 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 114.128 1.159 . . . . 10.0 114.128 -173.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 29.3 m -85.26 -42.9 14.23 Favored 'General case' 0 N--CA 1.482 1.159 0 CA-C-N 120.422 1.465 . . . . 10.0 112.099 171.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 17.7 mt -56.31 -42.98 78.49 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 112.845 0.683 . . . . 10.0 112.845 174.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 37.7 t -48.76 -62.03 2.72 Favored Pre-proline 0 CA--C 1.551 1.001 0 C-N-CA 124.861 1.265 . . . . 10.0 112.728 178.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -49.92 -45.84 30.59 Favored 'Trans proline' 0 CA--C 1.543 0.934 0 C-N-CA 124.104 3.203 . . . . 10.0 115.846 164.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.0 -49.36 77.75 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 114.162 1.171 . . . . 10.0 114.162 -175.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.477 HG23 ' O ' ' A' 1001 ' ' HOH 0.274 16.1 tt -68.09 -36.08 74.03 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 O-C-N 120.598 -1.313 . . . . 10.0 111.421 173.918 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.65 -42.09 92.0 Favored 'General case' 0 CA--C 1.545 0.771 0 O-C-N 121.193 -0.942 . . . . 10.0 112.729 173.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -50.82 -56.05 13.99 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.541 1.537 . . . . 10.0 111.647 168.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 14.0 m -48.04 -53.37 16.56 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.653 1.581 . . . . 10.0 111.2 176.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 32.4 mmt -68.57 -48.25 64.69 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 123.966 0.907 . . . . 10.0 113.011 -176.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -56.06 -41.13 74.62 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 120.035 1.289 . . . . 10.0 113.342 173.084 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.8 tp -53.28 -54.6 33.96 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-N 119.54 1.064 . . . . 10.0 111.273 170.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 24.1 p -51.73 -41.0 61.2 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 115.217 1.562 . . . . 10.0 115.217 179.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 58.5 mtm -66.86 -50.89 61.08 Favored 'General case' 0 C--N 1.333 -0.122 0 C-N-CA 123.589 0.756 . . . . 10.0 110.491 176.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.4 tp -48.51 -52.73 21.05 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.849 0.86 . . . . 10.0 112.931 172.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.5 mt -76.89 -5.53 48.79 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 113.844 1.053 . . . . 10.0 113.844 -177.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.2 -34.63 5.61 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 115.579 0.992 . . . . 10.0 115.579 174.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -49.35 -43.05 43.56 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 115.273 1.583 . . . . 10.0 115.273 -176.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.04 3.55 61.07 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 115.314 0.885 . . . . 10.0 115.314 -179.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.28 143.42 26.42 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 127.035 2.134 . . . . 10.0 108.972 172.063 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 t -145.54 171.08 15.19 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 124.031 0.932 . . . . 10.0 111.052 166.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.95 136.1 53.36 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 123.922 0.889 . . . . 10.0 109.711 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.436 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 58.6 t -129.59 129.55 23.17 Favored Pre-proline 0 C--N 1.329 -0.315 0 C-N-CA 125.1 1.36 . . . . 10.0 110.935 -176.045 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 69' ' ' VAL . 6.2 Cg_exo -80.7 116.24 3.18 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 N-CA-C 109.441 -1.023 . . . . 10.0 109.441 -178.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -156.75 164.38 38.19 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.808 0.67 . . . . 10.0 112.808 172.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.4 -81.98 0.14 Allowed Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.681 -0.967 . . . . 10.0 110.681 175.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.76 -3.42 0.69 Allowed Glycine 0 CA--C 1.527 0.812 0 N-CA-C 118.627 2.211 . . . . 10.0 118.627 170.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -151.57 -171.89 4.06 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 119.379 1.59 . . . . 10.0 112.237 -165.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -91.79 93.81 9.04 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 125.552 1.541 . . . . 10.0 111.115 -175.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.449 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 60.2 m-80 -89.47 120.74 69.65 Favored Pre-proline 0 N--CA 1.45 -0.464 0 N-CA-C 113.002 0.741 . . . . 10.0 113.002 -165.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.653 ' HB3' HG21 ' A' ' 5' ' ' THR . 76.3 Cg_exo -61.49 131.9 38.2 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 124.183 3.255 . . . . 10.0 112.166 171.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.6 mm -140.1 126.35 22.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 C-N-CA 126.028 1.731 . . . . 10.0 111.707 -179.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -93.64 85.06 4.76 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 123.455 1.598 . . . . 10.0 113.051 174.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 63.8 p-90 -59.44 -28.21 66.75 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 120.453 -1.404 . . . . 10.0 113.942 174.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -54.68 -35.47 63.6 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.283 1.033 . . . . 10.0 113.595 178.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -63.79 -23.7 67.46 Favored 'General case' 0 N--CA 1.479 1.022 0 O-C-N 120.341 -1.474 . . . . 10.0 113.667 172.514 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 68.7 m-85 -78.46 -42.04 30.99 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 120.564 -1.335 . . . . 10.0 111.92 172.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -49.62 -49.62 46.21 Favored 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 125.164 1.385 . . . . 10.0 111.032 166.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -51.66 -69.45 0.11 Allowed 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 126.769 2.027 . . . . 10.0 111.765 169.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 49.5 m0 -55.77 -35.6 66.41 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 124.407 1.083 . . . . 10.0 113.182 -172.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 28.7 tp -49.06 -46.08 43.9 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 126.277 1.831 . . . . 10.0 111.84 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -98.18 -40.35 8.42 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.805 0.842 . . . . 10.0 112.435 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 3.7 m -48.46 -57.83 5.54 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.864 1.266 . . . . 10.0 113.424 175.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . 0.286 38.3 p -67.08 -41.31 34.34 Favored Pre-proline 0 CA--C 1.544 0.736 0 CA-C-O 117.774 -1.108 . . . . 10.0 113.764 -168.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -54.14 -44.98 44.46 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 123.282 2.655 . . . . 10.0 115.998 166.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 54.5 mt -59.56 -45.73 90.96 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 118.959 0.799 . . . . 10.0 111.218 175.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.1 tp -50.94 -48.98 60.75 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.419 1.487 . . . . 10.0 112.136 172.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.0 mp -58.83 -47.15 85.85 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 125.339 1.456 . . . . 10.0 112.68 170.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.76 -38.31 78.18 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 123.87 0.868 . . . . 10.0 112.891 178.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 -52.27 -54.05 36.23 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 119.31 0.959 . . . . 10.0 111.165 169.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.34 -42.12 88.58 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.637 0.775 . . . . 10.0 112.1 -178.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.72 -54.66 39.0 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 123.991 0.916 . . . . 10.0 112.034 173.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.32 -41.18 79.44 Favored 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 123.724 0.81 . . . . 10.0 112.739 174.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.8 tp -63.77 -38.5 91.32 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 114.476 1.287 . . . . 10.0 114.476 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.2 t -94.84 1.44 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 125.075 1.35 . . . . 10.0 112.275 179.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.2 t70 48.5 53.55 11.89 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.874 1.67 . . . . 10.0 112.137 -173.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.28 145.89 47.57 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 120.002 -1.686 . . . . 10.0 112.46 -174.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.54 135.96 54.45 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 112.697 0.628 . . . . 10.0 112.697 175.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -42.88 -39.67 2.63 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.844 1.657 . . . . 10.0 113.489 175.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -47.33 -60.21 5.33 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 125.15 1.357 . . . . 10.0 115.234 169.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.4 p -62.06 -46.79 87.55 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 117.103 -1.427 . . . . 10.0 111.34 178.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 66.8 mt -48.41 -52.91 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 125.034 1.334 . . . . 10.0 111.127 178.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.2 tp -62.61 -51.3 67.86 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 112.574 0.583 . . . . 10.0 112.574 179.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.17 -44.85 43.27 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.465 0.706 . . . . 10.0 110.938 174.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.455 ' HA ' HD12 ' A' ' 111' ' ' LEU . 0.6 OUTLIER -59.67 -59.83 4.81 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 127.344 2.257 . . . . 10.0 114.807 174.989 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.5 t -61.01 -46.37 96.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 123.705 0.802 . . . . 10.0 111.387 -178.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -56.59 -50.32 63.88 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 123.668 0.651 . . . . 10.0 112.664 174.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -54.9 -46.56 74.84 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 113.322 0.86 . . . . 10.0 113.322 173.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -55.36 -48.54 74.1 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.16 0.984 . . . . 10.0 111.276 173.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -43.02 -54.91 5.08 Favored Glycine 0 CA--C 1.533 1.213 0 C-N-CA 124.938 1.256 . . . . 10.0 113.267 169.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 82.5 mt -57.75 -52.3 59.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 123.694 0.798 . . . . 10.0 111.899 173.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 60.2 ttp -47.51 -58.09 4.63 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.312 1.445 . . . . 10.0 111.731 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 37.6 mm -68.81 -44.6 81.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 O-C-N 121.807 -0.558 . . . . 10.0 112.169 178.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -51.99 -59.19 9.06 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 124.703 1.144 . . . . 10.0 112.949 176.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 44.3 p -57.45 -39.11 75.59 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.467 1.107 . . . . 10.0 112.593 173.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -45.27 -59.22 4.73 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 124.656 1.122 . . . . 10.0 113.445 164.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 65.6 tp -59.11 -46.18 88.99 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.468 1.507 . . . . 10.0 112.392 178.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 65.5 t -53.9 -50.0 55.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 O-C-N 121.441 -0.787 . . . . 10.0 110.127 173.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -50.84 -60.76 6.68 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 126.227 1.87 . . . . 10.0 112.561 171.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -42.95 -42.21 3.66 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 127.488 2.315 . . . . 10.0 113.335 176.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 48.5 mt -100.9 -6.5 24.57 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 115.526 1.676 . . . . 10.0 115.526 -175.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 16.9 m -69.75 116.76 10.51 Favored 'General case' 0 N--CA 1.464 0.248 0 O-C-N 120.157 -1.589 . . . . 10.0 110.344 -178.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.62 ' H ' ' HD3' ' A' ' 129' ' ' LYS . 0.1 OUTLIER -55.46 -49.6 72.05 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 128.195 2.598 . . . . 10.0 113.287 177.748 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 61.3 t -69.74 106.34 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 123.774 0.83 . . . . 10.0 110.067 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -46.93 -59.5 3.05 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 124.737 1.215 . . . . 10.0 114.062 -173.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 m -46.46 -42.11 14.95 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.531 1.533 . . . . 10.0 113.49 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -70.17 -24.59 63.17 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 114.946 1.461 . . . . 10.0 114.946 -178.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 68.9 mtp85 -53.98 -41.74 68.21 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 118.914 0.779 . . . . 10.0 110.793 176.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -69.46 -32.08 70.77 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.813 1.245 . . . . 10.0 114.219 176.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.9 t -55.01 -51.85 49.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 CA-C-N 119.037 0.835 . . . . 10.0 109.654 168.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 67.4 m95 -61.64 -45.49 93.83 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 114.392 1.256 . . . . 10.0 114.392 175.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 88.1 t90 -51.66 -49.35 62.48 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.235 1.014 . . . . 10.0 112.71 172.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -57.28 -51.0 71.13 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.072 0.949 . . . . 10.0 112.03 177.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 96.5 mt -55.75 -52.12 51.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 124.69 1.196 . . . . 10.0 111.762 175.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 28.7 t -54.9 -44.29 74.03 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.434 1.094 . . . . 10.0 111.861 174.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 49.3 m -60.02 -45.2 93.55 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.47 1.508 . . . . 10.0 112.472 174.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -57.09 -48.5 78.44 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 119.291 0.951 . . . . 10.0 112.344 172.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -57.36 -46.35 83.44 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.819 0.848 . . . . 10.0 112.71 174.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 40.3 ttp -56.16 -54.86 40.07 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.257 1.023 . . . . 10.0 112.09 172.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 8.1 tt -51.11 -50.57 58.54 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 125.941 1.697 . . . . 10.0 111.08 178.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 77.8 t80 -50.47 -54.91 18.51 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.169 0.988 . . . . 10.0 112.798 172.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 54.6 mt -53.6 -55.05 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 123.809 0.844 . . . . 10.0 110.775 177.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 44.4 mt -57.37 -35.88 70.53 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 118.349 -0.834 . . . . 10.0 112.957 178.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -57.26 -58.15 9.5 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 124.015 0.926 . . . . 10.0 113.041 173.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.44 -40.9 85.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-O 118.355 -0.831 . . . . 10.0 111.465 177.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 45.2 mt -56.79 -49.4 75.43 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 119.862 1.21 . . . . 10.0 112.131 171.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.469 ' HA ' ' HD2' ' A' ' 175' ' ' ARG . 11.9 t80 -77.01 -70.33 0.47 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 120.088 -1.632 . . . . 10.0 112.901 -175.29 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -73.66 -21.98 60.1 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.615 1.166 . . . . 10.0 113.431 -174.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -87.79 -79.12 1.26 Allowed Glycine 0 CA--C 1.527 0.783 0 C-N-CA 123.625 0.631 . . . . 10.0 113.496 171.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -53.63 -32.38 51.08 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 126.269 1.828 . . . . 10.0 113.067 -166.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.2 m -52.16 -56.44 14.57 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 114.01 1.115 . . . . 10.0 114.01 172.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.7 p -53.63 -50.61 65.34 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 122.087 0.946 . . . . 10.0 112.271 -177.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 47.7 tttm -57.09 -46.1 82.81 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.197 0.999 . . . . 10.0 112.107 173.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.76 -47.49 79.97 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 114.563 1.32 . . . . 10.0 114.563 174.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -56.47 -11.31 1.22 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 126.087 1.755 . . . . 10.0 114.261 177.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.2 m -107.09 6.67 29.11 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.374 1.87 . . . . 10.0 114.877 -179.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 93.3 mmm -91.92 -92.69 0.15 Allowed 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 123.451 1.596 . . . . 10.0 114.171 -170.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -138.63 153.96 72.79 Favored Pre-proline 0 C--O 1.236 0.349 0 C-N-CA 129.833 3.253 . . . . 10.0 105.573 170.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -52.85 -46.21 35.35 Favored 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 122.338 2.025 . . . . 10.0 113.083 179.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.667 ' CD ' ' HD3' ' A' ' 227' ' ' ARG . 0.1 OUTLIER -52.99 -46.05 68.12 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 129.014 2.926 . . . . 10.0 113.266 173.577 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 91.5 t -69.26 -53.0 27.72 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 C-N-CA 124.006 0.922 . . . . 10.0 109.788 -178.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.07 -46.89 75.46 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.3 0.64 . . . . 10.0 111.923 177.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 59.9 p -59.99 -56.13 25.42 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.883 0.873 . . . . 10.0 112.742 174.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 61.8 m -57.23 -53.19 60.86 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.185 0.994 . . . . 10.0 113.011 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -49.61 -49.47 46.71 Favored 'General case' 0 C--O 1.222 -0.387 0 C-N-CA 123.324 0.65 . . . . 10.0 111.1 174.121 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -57.12 -48.46 78.6 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 114.671 1.36 . . . . 10.0 114.671 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 40.3 t -55.98 -49.54 74.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 CA-C-N 118.802 0.728 . . . . 10.0 110.541 176.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 93.8 mt -58.57 -51.65 69.01 Favored 'General case' 0 C--O 1.222 -0.39 0 N-CA-C 113.196 0.813 . . . . 10.0 113.196 175.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . 0.469 ' HD2' ' HA ' ' A' ' 153' ' ' PHE . 35.4 ttp180 -47.76 -47.76 30.33 Favored 'General case' 0 C--O 1.225 -0.201 0 C-N-CA 126.831 2.052 . . . . 10.0 111.095 174.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 63.8 m-20 -58.5 -58.4 8.71 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 122.836 0.454 . . . . 10.0 111.232 174.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 54.5 t -52.13 -46.77 44.03 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 124.067 0.947 . . . . 10.0 112.052 179.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 28.8 m -60.39 -61.79 2.34 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 127.818 2.447 . . . . 10.0 111.874 178.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 55.8 t -50.91 -50.42 23.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 124.667 1.187 . . . . 10.0 110.928 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 80.3 t -59.49 -63.01 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 124.047 0.939 . . . . 10.0 111.889 177.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 68.9 mt -53.29 -50.75 64.23 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 119.183 0.901 . . . . 10.0 112.144 -178.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 10.1 m95 -54.67 -50.11 69.0 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 124.116 0.966 . . . . 10.0 112.275 177.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 54.3 p -52.57 -32.03 39.03 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 114.235 1.198 . . . . 10.0 114.235 179.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -65.23 -40.01 93.48 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 113.947 1.091 . . . . 10.0 113.947 176.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -47.26 -55.67 15.13 Favored Pre-proline 0 N--CA 1.479 0.98 0 N-CA-C 115.112 1.523 . . . . 10.0 115.112 -176.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 0.456 ' HB3' H183 ' A' ' 999' ' ' RET . 21.1 Cg_endo -58.5 -34.04 98.47 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 121.898 1.732 . . . . 10.0 113.122 175.492 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 21.6 t -66.33 -56.65 13.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 124.471 1.109 . . . . 10.0 111.2 178.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 2.7 p -55.73 -44.62 77.83 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 CA-C-N 119.201 0.91 . . . . 10.0 112.083 176.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 59.8 t90 -56.73 -51.96 66.81 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.372 0.669 . . . . 10.0 112.422 173.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 25.8 tp -54.9 -44.95 74.6 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.49 1.116 . . . . 10.0 112.197 -178.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 14.6 pt -86.28 -5.5 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 N-CA-C 115.246 1.573 . . . . 10.0 115.246 -177.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.57 -169.26 32.74 Favored Glycine 0 N--CA 1.45 -0.383 0 CA-C-O 122.573 1.096 . . . . 10.0 113.83 -168.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 23.3 t -53.12 -41.65 65.25 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 114.203 -0.999 . . . . 10.0 111.858 177.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -66.9 -17.18 64.78 Favored 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 115.559 1.688 . . . . 10.0 115.559 -175.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -131.08 -105.87 1.08 Allowed Glycine 0 CA--C 1.532 1.106 0 CA-C-N 120.397 1.453 . . . . 10.0 113.914 -172.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -89.45 127.12 35.81 Favored 'General case' 0 C--N 1.328 -0.345 0 O-C-N 120.663 -1.492 . . . . 10.0 109.3 168.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -72.44 65.29 1.35 Allowed Glycine 0 CA--C 1.531 1.064 0 N-CA-C 113.925 0.33 . . . . 10.0 113.925 173.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 60.7 mt -79.56 -42.72 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 C-N-CA 126.077 1.751 . . . . 10.0 108.725 166.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 79.8 t -126.32 133.41 24.94 Favored Pre-proline 0 N--CA 1.454 -0.25 0 C-N-CA 126.468 1.907 . . . . 10.0 109.368 -174.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -68.79 153.78 72.36 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 123.781 2.988 . . . . 10.0 111.461 -176.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 12.2 tp -43.14 -39.82 3.0 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.375 1.07 . . . . 10.0 112.17 171.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -48.33 -52.35 22.01 Favored 'General case' 0 CA--C 1.539 0.519 0 N-CA-C 114.728 1.381 . . . . 10.0 114.728 176.044 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 14.0 mm -75.98 -40.48 38.09 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 124.366 1.066 . . . . 10.0 109.625 177.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -49.26 -49.82 41.68 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 118.603 0.638 . . . . 10.0 111.981 173.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 16.2 m -57.74 -46.97 83.74 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 126.04 1.736 . . . . 10.0 112.964 174.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.536 HD23 ' CD2' ' A' ' 12' ' ' TRP . 1.3 tm? -63.4 -52.28 62.27 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.992 0.917 . . . . 10.0 112.101 179.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 93.2 mt -52.56 -59.17 4.78 Favored 'General case' 0 C--N 1.335 -0.044 0 C-N-CA 124.32 1.048 . . . . 10.0 110.003 176.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -52.29 -47.3 65.96 Favored 'General case' 0 C--O 1.217 -0.64 0 CA-C-O 117.425 -1.274 . . . . 10.0 112.164 176.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' MET . . . . . 0.575 ' HE2' ' HB3' ' A' ' 15' ' ' LEU . 4.6 tmm? -52.03 -51.7 55.73 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 121.073 1.76 . . . . 10.0 113.001 175.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 78.7 t -60.39 -50.0 82.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 124.646 1.178 . . . . 10.0 111.278 178.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 5.2 mp -57.52 -51.18 70.5 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.884 1.674 . . . . 10.0 112.044 175.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -56.96 -57.72 11.3 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 127.36 2.264 . . . . 10.0 110.706 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 97.3 t -57.27 -43.23 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 O-C-N 121.001 -1.062 . . . . 10.0 111.417 177.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 42.9 m -55.84 -49.32 73.63 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.451 0.7 . . . . 10.0 111.992 173.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -67.8 -25.29 65.51 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.465 1.506 . . . . 10.0 114.435 178.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -90.77 -73.65 0.52 Allowed 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.87 1.268 . . . . 10.0 109.749 178.333 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 21.2 t -78.48 -49.26 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 125.907 1.683 . . . . 10.0 111.201 -171.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -55.26 -56.32 23.94 Favored Glycine 0 CA--C 1.534 1.281 0 C-N-CA 124.092 0.853 . . . . 10.0 113.118 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -45.45 -55.66 5.88 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.476 1.91 . . . . 10.0 112.27 166.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -55.58 -40.01 76.98 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 124.008 0.813 . . . . 10.0 113.754 178.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 24.9 mt -70.08 -27.41 64.59 Favored 'General case' 0 CA--C 1.512 -0.502 0 N-CA-C 115.833 1.79 . . . . 10.0 115.833 176.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 74.3 mt -63.49 -57.53 11.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 108.59 -0.893 . . . . 10.0 108.59 165.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 32.0 tp -58.77 -64.68 0.85 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.918 0.887 . . . . 10.0 113.206 -172.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 84.2 mt -71.53 5.19 2.51 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 115.304 1.594 . . . . 10.0 115.304 -171.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.6 mtp-105 -112.35 0.35 15.64 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.211 1.005 . . . . 10.0 113.303 172.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 8.8 t -108.03 177.94 4.66 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 124.058 0.943 . . . . 10.0 111.032 174.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . 0.667 ' HD3' ' CD ' ' A' ' 166' ' ' GLU . 41.8 ttt180 -71.59 98.15 1.83 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.732 0.813 . . . . 10.0 110.977 170.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . 0.477 ' HB1' ' CD2' ' A' ' 42' ' ' PHE . . . -80.9 77.03 7.82 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.874 0.87 . . . . 10.0 112.095 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 40.19 102.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 128.866 2.866 . . . . 10.0 116.474 177.686 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . 0.481 0.3 OUTLIER 71.81 -55.41 0.66 Allowed 'General case' 0 C--O 1.243 0.714 0 C-N-CA 124.769 1.227 . . . . 10.0 110.603 -175.305 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -68.3 169.47 40.07 Favored Glycine 0 C--O 1.239 0.417 0 C-N-CA 129.76 3.552 . . . . 10.0 119.619 171.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.461 0 C-N-CA 128.476 2.711 . . . . 10.0 113.44 166.603 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 999' ' ' RET . . . . . 0.535 H181 ' H7 ' ' A' ' 999' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1000 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A 1001 ' ' HOH . . . . . 0.477 ' O ' HG23 ' A' ' 52' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1002 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A 1003 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 N--CA 1.477 0.881 0 CA-C-O 115.781 -2.057 . . . . 10.0 105.842 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 23.36 91.91 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 129.588 3.155 . . . . 10.0 117.227 160.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 28.6 65.03 0.11 Allowed 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 128.307 2.643 . . . . 10.0 114.529 155.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 86.5 mt -56.41 137.91 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 126.396 1.878 . . . . 10.0 113.372 -158.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.653 HG21 ' HB3' ' A' ' 77' ' ' PRO . 7.6 t -136.75 -165.2 1.7 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 126.327 1.851 . . . . 10.0 114.015 -174.315 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 70.0 2.83 41.1 Favored Glycine 0 C--N 1.339 0.743 0 C-N-CA 127.496 2.474 . . . . 10.0 111.485 168.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -158.55 -51.32 0.01 OUTLIER Pre-proline 0 N--CA 1.443 -0.783 0 CA-C-O 114.301 -2.761 . . . . 10.0 116.649 -168.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_exo -63.93 -60.72 0.14 Allowed 'Trans proline' 0 N--CA 1.465 -0.186 0 CA-C-N 123.538 2.299 . . . . 10.0 113.194 -175.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.41 ' H ' ' CD ' ' A' ' 9' ' ' GLU . 7.9 pm0 -67.21 4.34 0.96 Allowed 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 127.886 2.475 . . . . 10.0 115.732 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.422 ' CG ' ' N ' ' A' ' 11' ' ' ILE . 11.0 p-90 -51.38 -43.12 61.8 Favored 'General case' 0 C--O 1.223 -0.315 0 O-C-N 121.509 -0.744 . . . . 10.0 112.618 176.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.422 ' N ' ' CG ' ' A' ' 10' ' ' TRP . 8.9 tt -60.87 -49.59 84.0 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.34 0 C-N-CA 123.872 0.869 . . . . 10.0 109.344 179.394 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.535 ' CD2' HD23 ' A' ' 206' ' ' LEU . 2.6 m95 -55.32 -52.69 62.65 Favored 'General case' 0 C--O 1.224 -0.259 0 C-N-CA 123.406 0.682 . . . . 10.0 111.877 175.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.4 mt -57.34 -53.64 55.79 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 123.188 0.595 . . . . 10.0 112.224 177.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.83 -46.81 51.61 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.353 1.461 . . . . 10.0 113.33 173.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.575 ' HB3' ' HE2' ' A' ' 209' ' ' MET . 13.3 tp -65.63 -44.95 84.88 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.277 1.431 . . . . 10.0 113.059 179.077 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.5 -57.03 9.83 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 124.549 1.071 . . . . 10.0 111.274 165.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.1 m -49.26 -52.53 26.74 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.985 1.314 . . . . 10.0 112.232 174.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.44 -58.86 5.83 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.151 0.98 . . . . 10.0 112.161 177.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 99.6 mt -58.0 -49.07 78.11 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.471 0.709 . . . . 10.0 112.537 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 23.9 mmt -55.61 -49.22 73.38 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.858 0.863 . . . . 10.0 111.359 176.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -58.29 -58.43 14.61 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 124.388 0.994 . . . . 10.0 113.438 176.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 81.0 mt -56.24 -46.01 79.75 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-N 118.634 1.217 . . . . 10.0 112.132 176.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.73 -41.76 75.96 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 124.714 1.15 . . . . 10.0 113.242 173.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 28.2 m -62.38 -58.49 7.46 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.833 0.853 . . . . 10.0 111.347 172.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -52.27 -41.0 62.47 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.981 0.912 . . . . 10.0 110.977 177.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -55.75 -58.03 9.52 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 124.641 1.176 . . . . 10.0 112.967 172.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.1 m-30 -59.67 -38.7 82.19 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 113.223 0.823 . . . . 10.0 113.223 178.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.401 ' C ' ' H ' ' A' ' 30' ' ' LYS . 11.9 mt -56.04 -67.47 0.29 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.629 1.171 . . . . 10.0 113.65 169.104 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 t -76.34 40.89 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 CA-C-O 123.727 1.727 . . . . 10.0 110.866 179.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.401 ' H ' ' C ' ' A' ' 28' ' ' LEU . 42.8 tttm -140.8 -44.85 0.39 Allowed 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 127.915 2.486 . . . . 10.0 109.347 171.157 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.96 23.11 0.87 Allowed Glycine 0 CA--C 1.529 0.925 0 N-CA-C 115.629 1.012 . . . . 10.0 115.629 173.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 37.3 mmm -59.5 -45.0 92.96 Favored 'General case' 0 C--O 1.225 -0.211 0 C-N-CA 127.17 2.188 . . . . 10.0 113.571 -178.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.71 -84.41 1.19 Allowed Glycine 0 CA--C 1.531 1.045 0 C-N-CA 123.775 0.702 . . . . 10.0 112.446 -170.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.8 t 33.09 88.75 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.243 0.73 0 C-N-CA 128.399 2.68 . . . . 10.0 116.941 166.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.6 m -79.65 -50.92 9.93 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.23 -1.35 . . . . 10.0 113.828 174.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -48.87 117.51 6.37 Favored Pre-proline 0 CA--C 1.536 0.416 0 O-C-N 124.765 1.291 . . . . 10.0 110.972 -172.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -58.56 -29.68 89.64 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 123.757 2.971 . . . . 10.0 113.669 179.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.31 -60.66 2.29 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.126 0.57 . . . . 10.0 111.457 176.227 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.12 -40.08 22.45 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 125.134 1.373 . . . . 10.0 113.58 171.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -46.56 -47.42 19.71 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.22 1.408 . . . . 10.0 113.447 172.029 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -57.72 -53.1 62.01 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.5 0.72 . . . . 10.0 110.992 176.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.477 ' CD2' ' HB1' ' A' ' 228' ' ' ALA . 43.9 m-85 -57.02 -50.21 73.42 Favored 'General case' 0 N--CA 1.462 0.167 0 C-N-CA 123.084 0.554 . . . . 10.0 112.315 -179.076 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -54.3 -51.29 65.1 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 118.966 -0.54 . . . . 10.0 112.401 173.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.41 -62.01 1.91 Allowed 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 113.386 0.884 . . . . 10.0 113.386 177.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.4 mt -48.61 -57.76 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 124.867 1.267 . . . . 10.0 110.287 178.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.5 m -68.36 -17.74 64.31 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.114 1.365 . . . . 10.0 113.639 -172.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 27.4 m -87.12 -40.84 14.27 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 119.583 1.083 . . . . 10.0 112.137 174.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 22.0 mt -59.27 -40.98 87.77 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 121.359 -0.838 . . . . 10.0 112.835 171.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 22.7 t -43.9 -60.6 2.56 Favored Pre-proline 0 CA--C 1.549 0.941 0 C-N-CA 126.238 1.815 . . . . 10.0 113.395 176.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -72.27 -28.29 15.47 Favored 'Trans proline' 0 CA--C 1.546 1.108 0 C-N-CA 123.083 2.522 . . . . 10.0 114.182 172.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.98 -48.72 79.08 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 120.734 1.606 . . . . 10.0 113.927 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 19.5 tt -68.3 -36.16 73.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 O-C-N 120.249 -1.532 . . . . 10.0 111.376 173.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.29 -43.34 78.75 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 119.093 0.86 . . . . 10.0 112.74 171.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -50.96 -56.78 10.76 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.214 1.405 . . . . 10.0 111.68 168.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.7 m -47.88 -53.34 16.05 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 125.411 1.484 . . . . 10.0 111.18 176.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 32.7 mmt -69.09 -48.18 63.3 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 124.176 0.99 . . . . 10.0 112.871 -176.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -55.86 -41.38 74.27 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 120.203 1.365 . . . . 10.0 113.238 172.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.8 tp -53.31 -54.55 34.77 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-N 119.671 1.123 . . . . 10.0 111.301 170.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 24.0 p -51.65 -41.06 61.06 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 115.207 1.558 . . . . 10.0 115.207 179.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 56.9 mtm -66.86 -50.89 61.09 Favored 'General case' 0 C--N 1.334 -0.09 0 C-N-CA 123.597 0.759 . . . . 10.0 110.477 176.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.3 tp -48.62 -52.69 21.8 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.862 0.865 . . . . 10.0 112.904 172.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.4 mt -76.87 -5.53 48.77 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 113.848 1.055 . . . . 10.0 113.848 -177.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.24 -34.71 5.55 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 115.558 0.983 . . . . 10.0 115.558 174.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 75.3 t80 -49.28 -43.09 42.88 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 115.243 1.572 . . . . 10.0 115.243 -176.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.04 3.55 61.07 Favored Glycine 0 CA--C 1.522 0.528 0 N-CA-C 115.314 0.885 . . . . 10.0 115.314 -179.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.25 143.4 26.45 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 127.034 2.133 . . . . 10.0 109.031 172.015 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 t -145.51 171.09 15.17 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 124.081 0.952 . . . . 10.0 111.06 166.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.97 136.06 53.38 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 123.885 0.874 . . . . 10.0 109.722 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.437 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 58.5 t -129.56 129.64 23.19 Favored Pre-proline 0 C--N 1.33 -0.261 0 C-N-CA 125.043 1.337 . . . . 10.0 110.982 -176.109 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 69' ' ' VAL . 6.3 Cg_exo -80.76 116.24 3.16 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 N-CA-C 109.411 -1.034 . . . . 10.0 109.411 -178.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -156.71 164.41 38.17 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.808 0.669 . . . . 10.0 112.808 172.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.34 -81.92 0.14 Allowed Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.685 -0.966 . . . . 10.0 110.685 175.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.76 -3.37 0.69 Allowed Glycine 0 CA--C 1.527 0.822 0 N-CA-C 118.671 2.228 . . . . 10.0 118.671 170.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -151.6 -171.87 4.06 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 119.343 1.571 . . . . 10.0 112.187 -165.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -91.86 93.91 9.06 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 125.521 1.528 . . . . 10.0 111.097 -175.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.449 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 60.1 m-80 -89.47 120.74 69.65 Favored Pre-proline 0 C--N 1.326 -0.452 0 N-CA-C 113.001 0.741 . . . . 10.0 113.001 -165.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.653 ' HB3' HG21 ' A' ' 5' ' ' THR . 76.4 Cg_exo -61.47 131.93 38.37 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 124.16 3.24 . . . . 10.0 112.167 171.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.6 mm -140.13 126.33 21.88 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 C-N-CA 126.043 1.737 . . . . 10.0 111.682 -179.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -93.61 85.02 4.76 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 123.316 1.531 . . . . 10.0 113.051 174.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 63.5 p-90 -59.32 -28.3 66.68 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 120.588 -1.32 . . . . 10.0 113.965 174.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -54.39 -35.88 63.33 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 114.152 1.167 . . . . 10.0 114.152 178.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 1.5 ptp180 -63.67 -25.84 68.39 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 120.419 -1.426 . . . . 10.0 113.926 174.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -76.96 -41.94 41.14 Favored 'General case' 0 CA--C 1.54 0.595 0 O-C-N 121.22 -0.925 . . . . 10.0 111.845 172.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -49.48 -48.62 47.68 Favored 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 125.192 1.397 . . . . 10.0 111.5 167.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -52.86 -69.77 0.11 Allowed 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 126.078 1.751 . . . . 10.0 111.671 168.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 53.4 m0 -56.8 -32.97 66.22 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 124.428 1.091 . . . . 10.0 113.042 -169.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 29.4 tp -48.74 -44.15 38.25 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 125.858 1.663 . . . . 10.0 111.721 176.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -99.44 -42.21 7.06 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.845 0.858 . . . . 10.0 112.402 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 76.8 p -61.72 -45.3 94.54 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 120.335 1.425 . . . . 10.0 113.913 -177.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . 0.325 74.8 p -60.66 -46.95 97.2 Favored Pre-proline 0 CA--C 1.546 0.826 0 CA-C-O 117.568 -1.206 . . . . 10.0 113.54 -178.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -54.65 -44.05 53.28 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 123.24 2.627 . . . . 10.0 115.725 169.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 51.1 mt -59.25 -45.75 90.35 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 121.433 -0.792 . . . . 10.0 111.398 175.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.8 tp -51.84 -48.88 63.77 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.437 1.495 . . . . 10.0 112.044 172.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.9 mp -57.81 -47.71 81.84 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.929 1.291 . . . . 10.0 112.392 170.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.87 -38.24 78.33 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 119.12 0.873 . . . . 10.0 112.891 179.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.3 m-20 -52.28 -54.05 36.32 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 119.285 0.948 . . . . 10.0 111.165 169.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.34 -42.12 88.62 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.621 0.768 . . . . 10.0 112.151 -178.518 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.62 -54.73 37.68 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.958 0.903 . . . . 10.0 112.049 173.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.39 -41.15 79.69 Favored 'General case' 0 C--O 1.224 -0.237 0 C-N-CA 123.729 0.812 . . . . 10.0 112.667 174.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.9 tp -63.7 -38.61 91.75 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 114.481 1.289 . . . . 10.0 114.481 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.2 t -94.8 1.46 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 125.089 1.356 . . . . 10.0 112.304 179.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.3 t70 48.48 53.53 11.91 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.848 1.659 . . . . 10.0 112.137 -173.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.29 145.89 47.55 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 120.0 -1.688 . . . . 10.0 112.44 -174.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.47 135.89 54.17 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 112.711 0.634 . . . . 10.0 112.711 175.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -42.85 -39.69 2.61 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.857 1.663 . . . . 10.0 113.471 175.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -47.33 -60.25 5.3 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 125.15 1.357 . . . . 10.0 115.233 169.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.6 p -62.02 -46.72 87.95 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 117.103 -1.427 . . . . 10.0 111.351 178.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 66.9 mt -48.49 -52.87 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 124.998 1.319 . . . . 10.0 111.146 178.196 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.2 tp -62.63 -51.29 67.85 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 112.556 0.576 . . . . 10.0 112.556 179.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.14 -44.9 42.97 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.506 0.722 . . . . 10.0 110.934 174.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.455 ' HA ' HD12 ' A' ' 111' ' ' LEU . 0.6 OUTLIER -59.61 -59.88 4.74 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 127.361 2.264 . . . . 10.0 114.778 175.005 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.7 t -60.97 -46.42 96.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 123.735 0.814 . . . . 10.0 111.398 -178.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -56.59 -50.32 63.86 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 123.641 0.639 . . . . 10.0 112.674 174.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -54.59 -46.72 73.81 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 113.261 0.837 . . . . 10.0 113.261 173.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 51.2 t0 -58.17 -45.27 87.81 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.597 0.759 . . . . 10.0 112.008 174.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -43.51 -55.74 5.14 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 125.114 1.34 . . . . 10.0 113.575 166.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 85.8 mt -55.45 -57.12 8.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 CA-C-O 118.438 -0.791 . . . . 10.0 110.631 173.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 48.1 ttp -44.93 -55.29 5.6 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.704 1.602 . . . . 10.0 113.28 -177.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 41.5 mm -70.08 -42.98 79.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 O-C-N 121.703 -0.623 . . . . 10.0 111.716 177.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -49.78 -62.57 4.8 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 125.389 1.471 . . . . 10.0 113.167 174.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 37.1 p -60.03 -33.47 72.06 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 118.013 0.906 . . . . 10.0 112.422 174.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -49.95 -56.86 10.86 Favored Glycine 0 CA--C 1.536 1.349 0 C-N-CA 124.157 0.884 . . . . 10.0 113.143 166.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 64.9 tp -59.93 -48.2 82.65 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 125.588 1.555 . . . . 10.0 112.034 176.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 67.6 t -52.55 -51.3 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 123.368 0.667 . . . . 10.0 110.31 174.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -50.11 -60.87 6.23 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 126.086 1.803 . . . . 10.0 112.271 172.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -48.57 -37.66 18.53 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 126.427 1.891 . . . . 10.0 113.792 179.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 49.0 mt -99.22 -6.62 27.8 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 115.309 1.596 . . . . 10.0 115.309 -179.023 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 16.9 m -69.69 116.75 10.45 Favored 'General case' 0 N--CA 1.464 0.274 0 O-C-N 120.186 -1.571 . . . . 10.0 110.387 -178.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.62 ' H ' ' HD3' ' A' ' 129' ' ' LYS . 0.2 OUTLIER -55.48 -49.6 72.1 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 128.231 2.613 . . . . 10.0 113.251 177.747 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 61.1 t -69.72 106.42 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 123.746 0.818 . . . . 10.0 110.065 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -46.93 -59.57 3.01 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 124.779 1.231 . . . . 10.0 114.043 -173.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 m -46.43 -42.12 14.8 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.463 1.505 . . . . 10.0 113.485 179.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -70.15 -24.61 63.19 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 114.918 1.451 . . . . 10.0 114.918 -178.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 68.9 mtp85 -53.9 -41.67 67.86 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 118.93 0.786 . . . . 10.0 110.847 176.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -69.87 -31.61 69.53 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 114.354 1.242 . . . . 10.0 114.354 176.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.8 t -55.22 -52.23 47.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 CA-C-N 119.03 0.832 . . . . 10.0 109.543 168.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 66.1 m95 -61.72 -42.88 99.54 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 114.37 1.248 . . . . 10.0 114.37 174.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 88.9 t90 -52.78 -50.26 63.93 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.082 0.953 . . . . 10.0 112.415 171.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -56.86 -53.04 62.44 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.315 1.046 . . . . 10.0 111.737 178.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 96.4 mt -53.24 -51.41 40.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 125.069 1.348 . . . . 10.0 111.572 174.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 15.3 m -55.33 -45.56 76.38 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.483 1.113 . . . . 10.0 111.812 175.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 49.3 m -63.48 -42.08 98.57 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.367 1.467 . . . . 10.0 111.944 178.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -57.9 -49.53 76.43 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.774 0.83 . . . . 10.0 112.313 170.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -56.3 -46.34 79.84 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.878 0.871 . . . . 10.0 112.601 173.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 38.4 ttp -55.23 -55.57 29.86 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.262 1.025 . . . . 10.0 112.163 171.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -51.71 -49.81 61.74 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.651 1.58 . . . . 10.0 111.213 179.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 77.8 t80 -50.22 -55.06 16.84 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.947 0.899 . . . . 10.0 112.687 172.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 55.6 mt -53.71 -55.09 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 123.871 0.868 . . . . 10.0 110.692 177.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 41.3 mt -57.32 -35.86 70.41 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 118.334 -0.841 . . . . 10.0 112.948 178.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -57.29 -58.19 9.32 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 124.051 0.941 . . . . 10.0 113.041 173.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.38 -40.9 85.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 CA-C-O 118.303 -0.855 . . . . 10.0 111.44 177.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 44.9 mt -56.84 -49.42 75.51 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 119.897 1.226 . . . . 10.0 112.107 171.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.471 ' HA ' ' HD2' ' A' ' 175' ' ' ARG . 12.0 t80 -77.01 -70.32 0.47 Allowed 'General case' 0 C--N 1.326 -0.447 0 O-C-N 120.022 -1.674 . . . . 10.0 112.852 -175.234 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -73.7 -21.93 60.09 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.654 1.182 . . . . 10.0 113.466 -174.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -87.84 -79.07 1.26 Allowed Glycine 0 CA--C 1.526 0.747 0 C-N-CA 123.579 0.609 . . . . 10.0 113.514 171.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -53.68 -32.42 51.63 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 126.275 1.83 . . . . 10.0 113.024 -166.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.2 m -52.02 -56.49 13.99 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 114.057 1.132 . . . . 10.0 114.057 172.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.5 p -53.71 -50.51 65.73 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 122.046 0.926 . . . . 10.0 112.295 -177.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 47.6 tttm -57.08 -46.04 82.83 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.173 0.989 . . . . 10.0 112.156 173.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.87 -47.46 80.4 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 114.512 1.301 . . . . 10.0 114.512 174.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -56.47 -11.3 1.21 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 126.087 1.755 . . . . 10.0 114.252 177.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.1 m -107.03 6.61 29.18 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.424 1.89 . . . . 10.0 114.903 -179.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 93.3 mmm -91.91 -92.6 0.15 Allowed 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 123.487 1.613 . . . . 10.0 114.164 -170.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -138.71 153.94 72.64 Favored Pre-proline 0 C--O 1.235 0.308 0 C-N-CA 129.802 3.241 . . . . 10.0 105.527 170.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -52.83 -46.25 34.97 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.267 1.978 . . . . 10.0 113.074 179.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.667 ' CD ' ' HD3' ' A' ' 227' ' ' ARG . 0.1 OUTLIER -52.89 -46.08 67.8 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 129.021 2.929 . . . . 10.0 113.291 173.556 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 92.0 t -69.22 -53.04 27.62 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 C-N-CA 124.05 0.94 . . . . 10.0 109.8 -178.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.1 -46.83 75.55 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.282 0.633 . . . . 10.0 111.959 177.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 60.3 p -60.02 -56.2 24.54 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.922 0.889 . . . . 10.0 112.692 174.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 61.5 m -57.18 -53.2 60.76 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.155 0.982 . . . . 10.0 113.036 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -49.58 -49.48 46.33 Favored 'General case' 0 C--O 1.222 -0.375 0 C-N-CA 123.247 0.619 . . . . 10.0 111.132 174.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -57.15 -48.39 78.82 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 114.702 1.371 . . . . 10.0 114.702 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 40.5 t -56.01 -49.59 74.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 CA-C-N 118.749 0.704 . . . . 10.0 110.462 176.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 94.1 mt -58.63 -51.59 69.28 Favored 'General case' 0 C--O 1.222 -0.389 0 N-CA-C 113.191 0.811 . . . . 10.0 113.191 175.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . 0.471 ' HD2' ' HA ' ' A' ' 153' ' ' PHE . 35.5 ttp180 -47.75 -47.79 30.26 Favored 'General case' 0 C--O 1.225 -0.201 0 C-N-CA 126.852 2.061 . . . . 10.0 111.062 174.402 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 63.6 m-20 -58.51 -58.36 8.89 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 122.782 0.433 . . . . 10.0 111.272 174.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 54.9 t -52.19 -46.71 44.59 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 124.039 0.936 . . . . 10.0 112.044 179.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 32.1 m -60.19 -61.66 2.44 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 128.081 2.552 . . . . 10.0 111.902 178.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 56.0 t -51.43 -50.23 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 C-N-CA 124.575 1.15 . . . . 10.0 111.045 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 76.8 t -59.23 -60.06 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 124.069 0.948 . . . . 10.0 112.168 177.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 73.4 mt -56.9 -51.65 68.25 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 118.701 0.682 . . . . 10.0 112.301 -178.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 10.6 m95 -53.22 -50.18 65.25 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.959 0.904 . . . . 10.0 111.764 178.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 8.6 t -56.96 -24.44 52.94 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 114.541 1.312 . . . . 10.0 114.541 178.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -69.13 -40.61 78.17 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 119.615 1.098 . . . . 10.0 113.459 175.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -47.08 -55.91 13.87 Favored Pre-proline 0 N--CA 1.476 0.844 0 N-CA-C 114.991 1.478 . . . . 10.0 114.991 -177.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 0.52 ' HB3' H183 ' A' ' 999' ' ' RET . 27.4 Cg_endo -58.89 -35.16 99.06 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 122.207 1.938 . . . . 10.0 113.346 177.37 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 34.1 t -65.19 -58.73 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 124.152 0.981 . . . . 10.0 110.628 177.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 17.1 m -61.98 -34.51 63.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 N-CA-C 112.716 0.636 . . . . 10.0 112.716 -177.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 44.5 t90 -59.81 -55.93 28.11 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 125.191 1.396 . . . . 10.0 112.117 168.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 9.6 tt -56.49 -41.94 77.46 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.813 0.845 . . . . 10.0 112.601 -177.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 14.8 pt -82.44 -5.66 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 N-CA-C 115.151 1.537 . . . . 10.0 115.151 178.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.31 -169.29 33.1 Favored Glycine 0 N--CA 1.45 -0.404 0 CA-C-O 122.577 1.098 . . . . 10.0 113.921 -168.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 23.3 t -53.16 -40.68 64.5 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 114.197 -1.001 . . . . 10.0 111.897 177.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -55.01 -31.8 61.32 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 128.387 2.675 . . . . 10.0 115.385 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -131.06 -103.87 0.98 Allowed Glycine 0 CA--C 1.527 0.842 0 CA-C-N 119.324 0.966 . . . . 10.0 113.41 -167.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -89.41 127.12 35.79 Favored 'General case' 0 C--N 1.328 -0.352 0 O-C-N 120.621 -1.517 . . . . 10.0 109.364 169.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -72.48 65.36 1.36 Allowed Glycine 0 CA--C 1.532 1.141 0 N-CA-C 113.871 0.308 . . . . 10.0 113.871 173.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 60.6 mt -79.6 -42.71 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 126.053 1.741 . . . . 10.0 108.729 166.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.4 ' CG1' ' HB ' ' A' ' 203' ' ' ILE . 79.4 t -126.27 133.39 24.92 Favored Pre-proline 0 N--CA 1.454 -0.264 0 C-N-CA 126.502 1.921 . . . . 10.0 109.385 -174.212 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -68.79 153.78 72.36 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 123.781 2.988 . . . . 10.0 111.437 -176.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 12.2 tp -43.17 -39.77 3.03 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.281 1.033 . . . . 10.0 112.193 171.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -48.36 -52.38 21.99 Favored 'General case' 0 CA--C 1.539 0.519 0 N-CA-C 114.673 1.361 . . . . 10.0 114.673 176.08 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . 0.4 ' HB ' ' CG1' ' A' ' 199' ' ' VAL . 13.9 mm -75.9 -40.5 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 C-N-CA 124.435 1.094 . . . . 10.0 109.692 177.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -49.3 -49.81 42.15 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 118.553 0.615 . . . . 10.0 111.925 173.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 16.3 m -57.72 -47.01 83.62 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 126.043 1.737 . . . . 10.0 112.96 174.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.535 HD23 ' CD2' ' A' ' 12' ' ' TRP . 1.3 tm? -63.33 -52.39 62.05 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.977 0.911 . . . . 10.0 112.072 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 93.1 mt -52.52 -58.74 5.81 Favored 'General case' 0 C--O 1.227 -0.088 0 C-N-CA 124.294 1.038 . . . . 10.0 110.02 176.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -52.45 -46.79 66.62 Favored 'General case' 0 C--O 1.221 -0.439 0 CA-C-O 117.805 -1.093 . . . . 10.0 112.393 176.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' MET . . . . . 0.575 ' HE2' ' HB3' ' A' ' 15' ' ' LEU . 4.6 tmm? -52.32 -52.0 55.6 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 120.404 1.457 . . . . 10.0 112.743 175.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 85.7 t -61.69 -46.56 96.28 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 124.782 1.233 . . . . 10.0 111.747 178.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 4.2 mp -59.95 -52.41 65.54 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 125.463 1.505 . . . . 10.0 111.989 175.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 -55.68 -57.33 12.43 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 126.36 1.864 . . . . 10.0 110.917 178.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 8.6 p -58.66 -38.76 73.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 O-C-N 120.918 -1.114 . . . . 10.0 112.524 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 38.4 m -58.55 -49.43 77.47 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.559 0.744 . . . . 10.0 111.594 171.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -66.86 -22.08 66.0 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.545 1.538 . . . . 10.0 114.593 177.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 11.9 mptt -95.22 -76.55 0.49 Allowed 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.009 1.324 . . . . 10.0 109.984 177.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 21.3 t -73.18 -50.52 31.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 C-N-CA 125.41 1.484 . . . . 10.0 110.875 -172.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -53.83 -57.42 16.26 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 124.039 0.828 . . . . 10.0 113.09 178.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 42.0 t80 -46.68 -56.73 5.68 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.351 1.86 . . . . 10.0 112.322 168.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -56.23 -39.44 81.63 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 124.011 0.815 . . . . 10.0 113.465 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 24.5 mt -70.51 -27.59 64.3 Favored 'General case' 0 CA--C 1.511 -0.523 0 N-CA-C 115.736 1.754 . . . . 10.0 115.736 176.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 74.4 mt -63.48 -57.48 11.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 119.274 0.943 . . . . 10.0 108.548 165.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 32.1 tp -58.86 -64.71 0.84 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.923 0.889 . . . . 10.0 113.17 -172.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 84.2 mt -71.51 5.17 2.5 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 115.313 1.597 . . . . 10.0 115.313 -171.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.6 mtp-105 -112.33 0.44 15.69 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.171 0.988 . . . . 10.0 113.319 172.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 8.8 t -108.03 177.91 4.67 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 124.092 0.957 . . . . 10.0 111.046 174.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . 0.667 ' HD3' ' CD ' ' A' ' 166' ' ' GLU . 41.7 ttt180 -71.59 98.15 1.83 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.765 0.826 . . . . 10.0 110.947 170.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . 0.477 ' HB1' ' CD2' ' A' ' 42' ' ' PHE . . . -80.86 77.0 7.78 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.874 0.87 . . . . 10.0 112.08 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 40.18 102.24 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 128.896 2.878 . . . . 10.0 116.466 177.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . 0.481 0.3 OUTLIER 71.85 -55.43 0.66 Allowed 'General case' 0 C--O 1.241 0.647 0 C-N-CA 124.722 1.209 . . . . 10.0 110.656 -175.295 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -68.29 169.47 40.06 Favored Glycine 0 C--O 1.239 0.417 0 C-N-CA 129.73 3.538 . . . . 10.0 119.666 171.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.461 0 C-N-CA 128.441 2.696 . . . . 10.0 113.407 166.609 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 999' ' ' RET . . . . . 0.52 H183 ' HB3' ' A' ' 186' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1000 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A 1001 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A 1002 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A 1003 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 N--CA 1.477 0.913 0 CA-C-O 115.78 -2.057 . . . . 10.0 105.808 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 23.33 91.84 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 129.598 3.159 . . . . 10.0 117.286 160.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 28.68 65.05 0.11 Allowed 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 128.324 2.65 . . . . 10.0 114.468 155.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 86.4 mt -56.44 137.94 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 126.41 1.884 . . . . 10.0 113.344 -158.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.652 HG21 ' HB3' ' A' ' 77' ' ' PRO . 7.6 t -136.78 -165.21 1.7 Allowed 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 126.284 1.834 . . . . 10.0 113.991 -174.311 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 70.04 2.8 41.3 Favored Glycine 0 C--N 1.34 0.768 0 C-N-CA 127.475 2.464 . . . . 10.0 111.453 168.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -158.59 -51.29 0.01 OUTLIER Pre-proline 0 N--CA 1.443 -0.794 0 CA-C-O 114.301 -2.761 . . . . 10.0 116.698 -168.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -64.02 -60.58 0.15 Allowed 'Trans proline' 0 CA--C 1.528 0.179 0 CA-C-N 123.504 2.287 . . . . 10.0 113.207 -175.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.411 ' H ' ' CD ' ' A' ' 9' ' ' GLU . 7.9 pm0 -67.22 4.27 0.98 Allowed 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 127.86 2.464 . . . . 10.0 115.765 179.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.421 ' CG ' ' N ' ' A' ' 11' ' ' ILE . 11.0 p-90 -51.34 -43.08 61.67 Favored 'General case' 0 C--O 1.223 -0.337 0 O-C-N 121.487 -0.758 . . . . 10.0 112.646 176.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.421 ' N ' ' CG ' ' A' ' 10' ' ' TRP . 8.9 tt -60.9 -49.64 83.82 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.338 0 C-N-CA 123.902 0.881 . . . . 10.0 109.287 179.415 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.535 ' CD2' HD23 ' A' ' 206' ' ' LEU . 2.6 m95 -55.33 -52.7 62.63 Favored 'General case' 0 C--O 1.224 -0.261 0 C-N-CA 123.428 0.691 . . . . 10.0 111.861 175.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.5 mt -57.37 -53.53 57.05 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 123.138 0.575 . . . . 10.0 112.27 177.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.92 -46.78 52.3 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.366 1.466 . . . . 10.0 113.332 173.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.575 ' HB3' ' HE2' ' A' ' 209' ' ' MET . 13.3 tp -65.67 -44.94 84.72 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.304 1.442 . . . . 10.0 113.009 179.115 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.55 -56.57 10.92 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 124.419 1.009 . . . . 10.0 111.55 166.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.2 m -49.62 -52.44 30.52 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.898 1.279 . . . . 10.0 112.246 174.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.45 -58.89 5.69 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.163 0.985 . . . . 10.0 112.138 177.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 93.1 mt -57.12 -48.55 78.37 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.606 0.762 . . . . 10.0 112.851 -179.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 49.0 mtt -60.43 -45.77 92.45 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.148 0.979 . . . . 10.0 111.503 178.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -58.22 -58.68 13.28 Favored Glycine 0 CA--C 1.53 0.998 0 CA-C-O 118.937 -0.924 . . . . 10.0 113.872 172.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 80.8 mt -56.24 -45.86 79.83 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-N 118.714 1.257 . . . . 10.0 112.089 176.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.66 -42.19 76.64 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 124.46 1.029 . . . . 10.0 113.581 172.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 30.3 m -62.12 -58.4 7.95 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 118.329 -0.843 . . . . 10.0 111.113 172.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -52.3 -40.93 62.46 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.051 0.94 . . . . 10.0 110.95 177.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -55.83 -58.01 9.65 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.573 1.149 . . . . 10.0 112.993 172.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.1 m-30 -59.69 -38.58 81.96 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 113.252 0.834 . . . . 10.0 113.252 178.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.401 ' C ' ' H ' ' A' ' 30' ' ' LYS . 11.8 mt -56.13 -67.48 0.29 Allowed 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.628 1.171 . . . . 10.0 113.589 169.092 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 t -76.36 40.95 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 CA-C-O 123.705 1.717 . . . . 10.0 110.83 179.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.401 ' H ' ' C ' ' A' ' 28' ' ' LEU . 42.9 tttm -140.86 -44.78 0.39 Allowed 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 127.89 2.476 . . . . 10.0 109.379 171.13 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.99 23.12 0.88 Allowed Glycine 0 CA--C 1.529 0.928 0 N-CA-C 115.596 0.998 . . . . 10.0 115.596 173.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 37.3 mmm -59.52 -44.98 93.01 Favored 'General case' 0 C--O 1.224 -0.277 0 C-N-CA 127.189 2.196 . . . . 10.0 113.587 -179.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.71 -84.41 1.19 Allowed Glycine 0 CA--C 1.53 0.989 0 C-N-CA 123.766 0.698 . . . . 10.0 112.471 -170.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.8 t 33.03 88.78 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.242 0.706 0 C-N-CA 128.434 2.694 . . . . 10.0 116.956 166.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.3 m -79.68 -50.85 10.01 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.184 -1.371 . . . . 10.0 113.843 174.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -48.93 117.56 6.48 Favored Pre-proline 0 CA--C 1.536 0.429 0 O-C-N 124.829 1.331 . . . . 10.0 110.991 -172.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -58.63 -29.59 89.66 Favored 'Trans proline' 0 N--CA 1.459 -0.5 0 C-N-CA 123.74 2.96 . . . . 10.0 113.706 179.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.38 -60.61 2.32 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.089 0.556 . . . . 10.0 111.437 176.199 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.19 -40.01 22.81 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 125.093 1.357 . . . . 10.0 113.58 171.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.5 tttp -46.61 -47.37 19.99 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.241 1.417 . . . . 10.0 113.434 172.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -57.79 -53.09 62.19 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.472 0.709 . . . . 10.0 110.944 176.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.477 ' CD2' ' HB1' ' A' ' 228' ' ' ALA . 43.9 m-85 -56.93 -50.23 73.2 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 123.094 0.557 . . . . 10.0 112.342 -179.125 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -54.42 -51.29 65.38 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 118.919 -0.562 . . . . 10.0 112.337 173.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.37 -61.98 1.93 Allowed 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 113.419 0.896 . . . . 10.0 113.419 177.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.4 mt -48.65 -57.49 1.54 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 C-N-CA 124.869 1.268 . . . . 10.0 110.349 178.047 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.2 m -68.87 -17.17 63.95 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.144 1.378 . . . . 10.0 113.737 -172.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 27.8 m -87.9 -40.02 14.31 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.5 1.12 . . . . 10.0 112.165 174.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 25.7 mt -59.48 -42.82 92.95 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 118.93 0.786 . . . . 10.0 112.431 170.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 18.4 t -42.26 -60.06 2.34 Favored Pre-proline 0 N--CA 1.481 1.11 0 C-N-CA 125.72 1.608 . . . . 10.0 113.881 176.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -72.7 -24.3 18.5 Favored 'Trans proline' 0 CA--C 1.545 1.074 0 C-N-CA 122.951 2.434 . . . . 10.0 114.662 174.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.71 -44.69 80.98 Favored 'General case' 0 CA--C 1.548 0.879 0 CA-C-N 120.642 1.564 . . . . 10.0 113.291 176.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 38.1 mm -53.62 -53.86 22.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 124.287 1.035 . . . . 10.0 109.404 168.178 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -53.25 -46.65 69.29 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.458 1.103 . . . . 10.0 113.343 176.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 52.0 t80 -51.36 -57.26 9.4 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 120.187 1.358 . . . . 10.0 112.419 172.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 12.5 m -50.12 -52.32 36.01 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.329 1.451 . . . . 10.0 110.454 178.104 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 32.6 mmt -69.17 -48.01 63.41 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 123.905 0.882 . . . . 10.0 112.967 -176.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -56.36 -40.93 75.34 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 120.35 1.432 . . . . 10.0 113.262 172.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.8 tp -53.25 -54.59 33.91 Favored 'General case' 0 C--O 1.224 -0.258 0 CA-C-N 119.85 1.204 . . . . 10.0 111.281 170.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 24.0 p -51.67 -41.05 61.11 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 115.224 1.564 . . . . 10.0 115.224 179.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 61.1 mtm -66.84 -50.86 61.19 Favored 'General case' 0 C--N 1.334 -0.082 0 C-N-CA 123.556 0.742 . . . . 10.0 110.506 176.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.4 tp -48.51 -52.74 21.02 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.857 0.863 . . . . 10.0 112.952 172.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.4 mt -76.84 -5.62 49.06 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.353 1.061 . . . . 10.0 113.854 -177.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.32 -34.74 5.52 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 115.55 0.98 . . . . 10.0 115.55 174.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 75.3 t80 -49.29 -43.08 43.01 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 115.235 1.568 . . . . 10.0 115.235 -175.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.02 3.51 61.14 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 115.35 0.9 . . . . 10.0 115.35 -179.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.25 143.43 26.42 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 127.042 2.137 . . . . 10.0 109.018 172.002 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 t -145.54 171.06 15.22 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 124.048 0.939 . . . . 10.0 111.067 166.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.01 136.08 53.36 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 123.853 0.861 . . . . 10.0 109.684 179.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 58.5 t -129.6 129.61 23.17 Favored Pre-proline 0 C--N 1.33 -0.279 0 C-N-CA 125.031 1.332 . . . . 10.0 110.905 -176.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -80.73 116.24 3.17 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 N-CA-C 109.415 -1.033 . . . . 10.0 109.415 -178.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -156.68 164.39 38.2 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 112.842 0.682 . . . . 10.0 112.842 172.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.36 -81.95 0.14 Allowed Glycine 0 CA--C 1.526 0.764 0 N-CA-C 110.692 -0.963 . . . . 10.0 110.692 175.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.77 -3.41 0.69 Allowed Glycine 0 CA--C 1.527 0.836 0 N-CA-C 118.666 2.226 . . . . 10.0 118.666 170.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -151.58 -171.89 4.06 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 119.349 1.575 . . . . 10.0 112.217 -165.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -91.82 93.9 9.07 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 125.531 1.532 . . . . 10.0 111.107 -175.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.449 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 60.2 m-80 -89.47 120.78 69.65 Favored Pre-proline 0 N--CA 1.45 -0.428 0 N-CA-C 113.0 0.741 . . . . 10.0 113.0 -165.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.652 ' HB3' HG21 ' A' ' 5' ' ' THR . 76.1 Cg_exo -61.48 131.92 38.32 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 124.205 3.27 . . . . 10.0 112.167 171.573 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.5 mm -140.16 126.37 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 C-N-CA 126.0 1.72 . . . . 10.0 111.712 -179.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -93.64 84.99 4.74 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 122.72 1.247 . . . . 10.0 113.053 174.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 63.8 p-90 -59.37 -28.28 66.73 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 120.939 -1.101 . . . . 10.0 113.881 174.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -55.36 -23.13 22.47 Favored 'General case' 0 CA--C 1.574 1.9 0 C-N-CA 124.277 1.031 . . . . 10.0 110.038 178.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -47.57 -59.75 3.03 Favored 'General case' 0 N--CA 1.496 1.833 0 C-N-CA 126.304 1.841 . . . . 10.0 112.08 163.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -68.35 -37.39 80.43 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 123.814 0.845 . . . . 10.0 110.457 -173.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -53.8 -51.59 63.0 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 123.676 0.79 . . . . 10.0 112.748 169.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 61.8 t0 -52.96 -68.72 0.15 Allowed 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 126.143 1.777 . . . . 10.0 111.26 171.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 46.2 m0 -57.01 -33.77 67.49 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.98 1.712 . . . . 10.0 113.268 -171.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 30.0 tp -50.08 -44.63 51.93 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 126.13 1.772 . . . . 10.0 111.967 177.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -99.25 -44.4 6.25 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.185 0.994 . . . . 10.0 112.014 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 13.7 m -48.33 -52.15 22.86 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.669 1.588 . . . . 10.0 113.242 177.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . 0.314 57.5 p -67.88 -45.71 43.23 Favored Pre-proline 0 N--CA 1.476 0.872 0 N-CA-C 114.557 1.318 . . . . 10.0 114.557 -174.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -52.91 -42.9 60.79 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 123.39 2.727 . . . . 10.0 115.329 170.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 52.4 mt -59.18 -46.45 88.37 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.293 0.637 . . . . 10.0 111.472 175.047 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.4 tp -51.33 -48.13 62.49 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.411 1.485 . . . . 10.0 112.198 172.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.7 mp -58.82 -47.33 85.19 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 125.122 1.369 . . . . 10.0 112.623 170.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.8 -38.28 78.22 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 123.826 0.85 . . . . 10.0 112.906 178.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 -52.31 -54.0 37.1 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 119.282 0.946 . . . . 10.0 111.163 169.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.36 -42.12 88.48 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.635 0.774 . . . . 10.0 112.087 -178.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.64 -54.73 37.67 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.996 0.919 . . . . 10.0 112.024 173.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.33 -41.2 79.53 Favored 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 123.73 0.812 . . . . 10.0 112.668 174.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.9 tp -63.71 -38.6 91.73 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 114.494 1.294 . . . . 10.0 114.494 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.1 t -94.75 1.41 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 125.092 1.357 . . . . 10.0 112.296 179.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.2 t70 48.55 53.52 12.0 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.881 1.672 . . . . 10.0 112.077 -174.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.22 145.89 47.68 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 119.955 -1.715 . . . . 10.0 112.457 -174.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.47 135.93 54.17 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 112.697 0.629 . . . . 10.0 112.697 175.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -42.92 -39.65 2.65 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.891 1.677 . . . . 10.0 113.466 175.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -47.3 -60.21 5.31 Favored Glycine 0 CA--C 1.525 0.69 0 C-N-CA 125.145 1.355 . . . . 10.0 115.295 169.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 42.0 p -62.1 -46.72 87.8 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 117.101 -1.428 . . . . 10.0 111.328 178.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 66.9 mt -48.48 -52.87 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 125.032 1.333 . . . . 10.0 111.135 178.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.4 tp -62.67 -51.25 67.97 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 112.544 0.572 . . . . 10.0 112.544 179.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.2 -44.86 43.55 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.479 0.712 . . . . 10.0 110.912 174.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.455 ' HA ' HD12 ' A' ' 111' ' ' LEU . 0.6 OUTLIER -59.56 -59.95 4.63 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 127.385 2.274 . . . . 10.0 114.791 174.949 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.6 t -61.02 -46.36 96.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 123.686 0.794 . . . . 10.0 111.362 -178.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -56.56 -50.41 63.19 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 123.68 0.657 . . . . 10.0 112.602 174.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -54.68 -46.74 74.14 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 113.081 0.771 . . . . 10.0 113.081 173.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -57.94 -45.07 87.2 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.998 0.919 . . . . 10.0 111.809 174.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -43.81 -55.88 5.31 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 125.123 1.344 . . . . 10.0 113.429 166.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 81.6 mt -56.63 -54.07 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 123.567 0.747 . . . . 10.0 110.962 173.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 45.5 ttp -46.14 -58.65 3.45 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.462 1.505 . . . . 10.0 112.455 -178.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 47.2 mm -70.43 -47.98 62.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 123.215 0.606 . . . . 10.0 112.012 178.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -53.2 -56.67 18.1 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 124.486 1.041 . . . . 10.0 112.873 179.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -61.63 -34.01 74.93 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.55 1.14 . . . . 10.0 112.288 174.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -50.93 -54.63 21.68 Favored Glycine 0 CA--C 1.537 1.442 0 C-N-CA 124.505 1.05 . . . . 10.0 113.395 165.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 63.4 tp -56.99 -45.67 82.82 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.366 1.467 . . . . 10.0 111.634 176.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 62.0 t -53.01 -51.35 38.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 122.959 0.503 . . . . 10.0 110.384 172.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -48.82 -61.08 5.5 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 125.751 1.643 . . . . 10.0 112.855 170.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -45.75 -40.37 9.4 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 127.004 2.122 . . . . 10.0 113.813 177.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 49.8 mt -100.14 -6.6 25.98 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 115.193 1.553 . . . . 10.0 115.193 -176.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 17.0 m -69.66 116.72 10.38 Favored 'General case' 0 N--CA 1.464 0.237 0 O-C-N 120.186 -1.571 . . . . 10.0 110.41 -178.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.622 ' H ' ' HD3' ' A' ' 129' ' ' LYS . 0.1 OUTLIER -55.44 -49.65 71.9 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 128.186 2.594 . . . . 10.0 113.267 177.754 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 60.6 t -69.62 106.37 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 123.761 0.824 . . . . 10.0 110.085 179.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -46.94 -59.49 3.06 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 124.775 1.23 . . . . 10.0 114.07 -173.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 m -46.53 -42.07 15.22 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.45 1.5 . . . . 10.0 113.484 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -70.14 -24.61 63.2 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 114.959 1.466 . . . . 10.0 114.959 -178.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 68.1 mtp85 -54.21 -41.69 68.92 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 118.869 0.759 . . . . 10.0 110.811 176.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -69.01 -32.73 72.47 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.678 1.191 . . . . 10.0 114.166 176.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.7 t -54.46 -52.03 43.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 CA-C-N 119.073 0.851 . . . . 10.0 109.659 169.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 66.2 m95 -62.0 -45.7 92.44 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 114.531 1.308 . . . . 10.0 114.531 174.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 86.5 t90 -52.13 -47.98 65.08 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.868 0.867 . . . . 10.0 112.582 172.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -57.71 -52.31 65.99 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.047 0.939 . . . . 10.0 111.69 176.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 97.3 mt -54.93 -49.99 66.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 124.732 1.213 . . . . 10.0 111.694 175.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 23.3 t -55.31 -47.98 74.81 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.323 1.049 . . . . 10.0 111.882 174.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 57.2 m -60.2 -41.86 93.89 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.412 1.485 . . . . 10.0 112.343 177.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -58.62 -49.66 76.69 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 119.117 0.871 . . . . 10.0 112.444 170.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -56.71 -45.02 82.12 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.676 0.79 . . . . 10.0 112.531 173.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 40.4 ttp -55.93 -55.72 29.27 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 124.488 1.115 . . . . 10.0 111.915 171.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -51.13 -48.5 61.77 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 125.869 1.668 . . . . 10.0 111.569 178.236 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 78.5 t80 -52.33 -54.54 30.37 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 113.099 0.778 . . . . 10.0 113.099 172.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 56.0 mt -53.87 -54.68 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 123.943 0.897 . . . . 10.0 110.739 177.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 90.8 mt -50.69 -42.93 57.42 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 126.129 1.772 . . . . 10.0 112.818 175.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -57.32 -58.09 9.76 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 123.986 0.914 . . . . 10.0 113.084 176.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.43 -40.92 85.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 CA-C-O 118.313 -0.851 . . . . 10.0 111.408 177.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 47.2 mt -56.83 -49.45 75.39 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.878 1.217 . . . . 10.0 112.069 171.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.47 ' HA ' ' HD2' ' A' ' 175' ' ' ARG . 11.8 t80 -76.94 -70.29 0.47 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 120.06 -1.65 . . . . 10.0 112.915 -175.24 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -73.78 -21.9 60.02 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.596 1.158 . . . . 10.0 113.454 -174.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -87.83 -79.1 1.26 Allowed Glycine 0 CA--C 1.527 0.806 0 C-N-CA 123.612 0.625 . . . . 10.0 113.501 171.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -53.58 -32.47 51.06 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 126.266 1.826 . . . . 10.0 113.045 -166.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.4 m -52.1 -56.47 14.25 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 113.988 1.107 . . . . 10.0 113.988 172.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.5 p -53.6 -50.59 65.32 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 122.093 0.949 . . . . 10.0 112.297 -177.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 47.7 tttm -57.09 -46.11 82.82 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.165 0.986 . . . . 10.0 112.103 173.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.74 -47.51 79.88 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 114.55 1.315 . . . . 10.0 114.55 174.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -56.5 -11.22 1.19 Allowed 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 126.056 1.742 . . . . 10.0 114.268 177.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.1 m -107.08 6.57 29.05 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.425 1.89 . . . . 10.0 114.898 -179.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 93.3 mmm -91.9 -92.6 0.15 Allowed 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 123.485 1.612 . . . . 10.0 114.16 -170.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -138.75 153.94 72.58 Favored Pre-proline 0 C--O 1.236 0.349 0 C-N-CA 129.809 3.243 . . . . 10.0 105.529 170.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -52.86 -46.19 35.48 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 122.3 2.0 . . . . 10.0 113.08 179.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.667 ' CD ' ' HD3' ' A' ' 227' ' ' ARG . 0.1 OUTLIER -53.02 -46.09 68.25 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 129.014 2.926 . . . . 10.0 113.221 173.597 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 92.0 t -69.12 -53.09 27.63 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.267 0 C-N-CA 124.068 0.947 . . . . 10.0 109.798 -178.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.11 -46.85 75.59 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.291 0.636 . . . . 10.0 111.905 177.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 60.1 p -59.98 -56.22 24.34 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.885 0.874 . . . . 10.0 112.702 174.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 62.0 m -57.12 -53.31 59.59 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.23 1.012 . . . . 10.0 112.987 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -49.52 -49.57 45.38 Favored 'General case' 0 C--O 1.222 -0.386 0 C-N-CA 123.3 0.64 . . . . 10.0 111.068 174.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -57.12 -48.37 78.82 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 114.699 1.37 . . . . 10.0 114.699 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 40.4 t -56.02 -49.57 74.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 CA-C-N 118.832 0.742 . . . . 10.0 110.487 176.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 94.2 mt -58.57 -51.63 69.09 Favored 'General case' 0 C--O 1.221 -0.397 0 N-CA-C 113.152 0.797 . . . . 10.0 113.152 175.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . 0.47 ' HD2' ' HA ' ' A' ' 153' ' ' PHE . 35.5 ttp180 -47.82 -47.82 31.05 Favored 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 126.868 2.067 . . . . 10.0 111.011 174.499 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 63.6 m-20 -58.48 -58.31 9.11 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 122.805 0.442 . . . . 10.0 111.29 174.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 58.3 t -51.77 -50.25 32.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 124.086 0.954 . . . . 10.0 111.587 179.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 26.5 m -56.55 -60.34 3.67 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 127.872 2.469 . . . . 10.0 111.953 177.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 47.7 t -53.67 -49.52 56.34 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 CA-C-N 119.215 0.916 . . . . 10.0 111.312 -178.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 76.6 t -58.91 -61.67 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 124.369 1.068 . . . . 10.0 111.908 176.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -59.24 -48.82 80.17 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 118.63 0.65 . . . . 10.0 112.609 -175.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 9.8 m95 -54.27 -49.71 68.95 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 118.9 0.773 . . . . 10.0 111.947 176.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 51.0 m -54.59 -31.37 56.76 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 114.03 1.122 . . . . 10.0 114.03 178.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -63.84 -40.61 96.98 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 113.772 1.027 . . . . 10.0 113.772 176.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 -48.23 -55.75 17.15 Favored Pre-proline 0 CA--C 1.546 0.798 0 N-CA-C 115.271 1.582 . . . . 10.0 115.271 -176.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -59.72 -33.16 96.5 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 122.32 2.013 . . . . 10.0 113.444 177.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 24.4 t -64.27 -54.54 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 123.841 0.856 . . . . 10.0 110.396 175.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 88.3 t -53.26 -49.04 54.28 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 124.739 1.216 . . . . 10.0 111.457 176.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 69.9 t90 -54.68 -54.56 40.18 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.331 1.052 . . . . 10.0 112.525 174.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 9.9 tt -57.55 -42.37 82.83 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 123.881 0.872 . . . . 10.0 112.166 -176.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 14.1 pt -84.79 -5.95 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 N-CA-C 115.289 1.589 . . . . 10.0 115.289 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.41 -169.29 32.97 Favored Glycine 0 N--CA 1.45 -0.404 0 CA-C-O 122.589 1.105 . . . . 10.0 113.883 -168.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 23.3 t -53.13 -42.25 65.86 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 114.16 -1.02 . . . . 10.0 111.85 177.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -69.13 -13.05 62.2 Favored 'General case' 0 CA--C 1.55 0.962 0 N-CA-C 115.155 1.539 . . . . 10.0 115.155 -174.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -132.25 -106.37 1.03 Allowed Glycine 0 CA--C 1.536 1.38 0 CA-C-N 120.716 1.598 . . . . 10.0 114.497 -174.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -89.45 127.16 35.81 Favored 'General case' 0 C--N 1.329 -0.323 0 O-C-N 120.666 -1.491 . . . . 10.0 109.305 168.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -72.47 65.32 1.36 Allowed Glycine 0 CA--C 1.532 1.105 0 N-CA-C 113.901 0.32 . . . . 10.0 113.901 173.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 60.7 mt -79.57 -42.74 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 126.107 1.763 . . . . 10.0 108.735 166.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 79.3 t -126.28 133.38 24.91 Favored Pre-proline 0 N--CA 1.453 -0.279 0 C-N-CA 126.504 1.922 . . . . 10.0 109.391 -174.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -68.7 153.76 72.63 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 123.822 3.015 . . . . 10.0 111.474 -176.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 12.2 tp -43.13 -39.82 2.98 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.319 1.047 . . . . 10.0 112.229 171.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -48.28 -52.41 21.45 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 114.684 1.365 . . . . 10.0 114.684 176.03 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 14.0 mm -75.95 -40.53 38.36 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 124.419 1.088 . . . . 10.0 109.625 177.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -49.29 -49.75 42.26 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 118.61 0.641 . . . . 10.0 112.005 173.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 16.2 m -57.75 -47.01 83.7 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 126.042 1.737 . . . . 10.0 112.991 174.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.535 HD23 ' CD2' ' A' ' 12' ' ' TRP . 1.3 tm? -63.35 -52.36 62.13 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.927 0.891 . . . . 10.0 112.063 179.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 93.3 mt -52.48 -60.0 3.76 Favored 'General case' 0 C--O 1.227 -0.115 0 C-N-CA 124.322 1.049 . . . . 10.0 109.993 176.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -53.49 -43.18 68.02 Favored 'General case' 0 C--O 1.218 -0.589 0 CA-C-O 117.432 -1.27 . . . . 10.0 112.51 176.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' MET . . . . . 0.575 ' HE2' ' HB3' ' A' ' 15' ' ' LEU . 4.6 tmm? -53.93 -52.52 60.33 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 121.51 1.959 . . . . 10.0 112.974 173.632 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 82.1 t -61.06 -47.12 95.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 124.957 1.303 . . . . 10.0 111.7 178.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 4.8 mp -58.97 -51.3 70.66 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 125.578 1.551 . . . . 10.0 111.79 175.006 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -55.07 -59.96 4.04 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 125.969 1.708 . . . . 10.0 109.924 176.104 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 35.1 t -45.2 -59.01 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 125.334 1.454 . . . . 10.0 111.658 175.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 26.9 p -59.98 -44.37 94.53 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 112.939 0.718 . . . . 10.0 112.939 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -67.06 -22.04 65.87 Favored 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 115.131 1.53 . . . . 10.0 115.131 173.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -87.71 -78.98 0.3 Allowed 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.76 1.624 . . . . 10.0 110.264 171.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 33.1 m -78.54 -38.37 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 O-C-N 121.133 -0.979 . . . . 10.0 112.476 -170.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -58.18 -57.63 18.8 Favored Glycine 0 N--CA 1.474 1.197 0 CA-C-N 119.822 1.192 . . . . 10.0 111.912 176.077 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 42.8 t80 -45.45 -57.78 3.84 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.142 1.777 . . . . 10.0 112.45 167.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -56.9 -40.59 90.58 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 123.834 0.73 . . . . 10.0 113.561 -179.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 24.2 mt -70.95 -27.19 63.56 Favored 'General case' 0 CA--C 1.51 -0.582 0 N-CA-C 115.52 1.674 . . . . 10.0 115.52 176.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 74.0 mt -63.2 -57.57 11.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 119.131 0.878 . . . . 10.0 108.688 165.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 32.1 tp -58.91 -64.6 0.88 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.854 0.862 . . . . 10.0 113.207 -172.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 84.0 mt -71.55 5.24 2.5 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 115.323 1.601 . . . . 10.0 115.323 -171.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.6 mtp-105 -112.34 0.36 15.65 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.165 0.986 . . . . 10.0 113.265 172.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 8.8 t -108.04 177.94 4.66 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 124.082 0.953 . . . . 10.0 111.039 174.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . 0.667 ' HD3' ' CD ' ' A' ' 166' ' ' GLU . 41.9 ttt180 -71.66 98.17 1.86 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.732 0.813 . . . . 10.0 110.968 170.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . 0.477 ' HB1' ' CD2' ' A' ' 42' ' ' PHE . . . -80.93 77.03 7.86 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.829 0.852 . . . . 10.0 112.087 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 40.16 102.21 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 128.831 2.852 . . . . 10.0 116.502 177.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . 0.481 0.3 OUTLIER 71.83 -55.39 0.66 Allowed 'General case' 0 C--O 1.242 0.677 0 C-N-CA 124.764 1.226 . . . . 10.0 110.656 -175.277 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -68.34 169.48 40.2 Favored Glycine 0 C--O 1.239 0.417 0 C-N-CA 129.738 3.542 . . . . 10.0 119.598 171.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.489 0 C-N-CA 128.486 2.714 . . . . 10.0 113.44 166.618 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 999' ' ' RET . . . . . 0.535 H181 ' H7 ' ' A' ' 999' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1000 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A 1001 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A 1002 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A 1003 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 N--CA 1.477 0.913 0 CA-C-O 115.781 -2.057 . . . . 10.0 105.833 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 23.35 91.83 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 129.598 3.159 . . . . 10.0 117.262 160.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 28.64 65.07 0.11 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 128.262 2.625 . . . . 10.0 114.511 155.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 86.7 mt -56.49 137.96 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 126.41 1.884 . . . . 10.0 113.353 -158.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.652 HG21 ' HB3' ' A' ' 77' ' ' PRO . 7.6 t -136.79 -165.2 1.7 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 126.327 1.851 . . . . 10.0 114.021 -174.331 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 70.0 2.83 41.1 Favored Glycine 0 C--N 1.339 0.743 0 C-N-CA 127.496 2.474 . . . . 10.0 111.485 168.076 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.9 tpp180 -158.52 -51.41 0.01 OUTLIER Pre-proline 0 N--CA 1.443 -0.783 0 CA-C-O 114.275 -2.774 . . . . 10.0 116.634 -168.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -63.89 -60.69 0.14 Allowed 'Trans proline' 0 CA--C 1.528 0.186 0 CA-C-N 123.5 2.286 . . . . 10.0 113.236 -175.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.41 ' H ' ' CD ' ' A' ' 9' ' ' GLU . 7.9 pm0 -67.13 4.22 0.96 Allowed 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 127.878 2.471 . . . . 10.0 115.75 179.694 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.422 ' CG ' ' N ' ' A' ' 11' ' ' ILE . 11.0 p-90 -51.28 -43.15 61.54 Favored 'General case' 0 C--O 1.222 -0.361 0 O-C-N 121.5 -0.75 . . . . 10.0 112.646 176.425 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.422 ' N ' ' CG ' ' A' ' 10' ' ' TRP . 8.9 tt -60.85 -49.64 83.79 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.338 0 C-N-CA 123.926 0.89 . . . . 10.0 109.323 179.425 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.535 ' CD2' HD23 ' A' ' 206' ' ' LEU . 2.6 m95 -55.34 -52.67 62.75 Favored 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 123.406 0.682 . . . . 10.0 111.908 175.575 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.4 mt -57.34 -53.6 56.31 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 123.223 0.609 . . . . 10.0 112.245 177.237 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.91 -46.8 52.24 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 125.412 1.485 . . . . 10.0 113.324 173.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.575 ' HB3' ' HE2' ' A' ' 209' ' ' MET . 13.3 tp -65.63 -44.95 84.88 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.277 1.431 . . . . 10.0 113.059 179.057 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.17 -58.37 7.99 Favored Glycine 0 CA--C 1.527 0.795 0 C-N-CA 124.274 0.94 . . . . 10.0 110.853 165.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.3 m -48.24 -52.41 21.25 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.625 1.17 . . . . 10.0 112.279 175.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.45 -58.83 5.93 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.122 0.969 . . . . 10.0 112.177 177.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 93.8 mt -58.25 -49.63 76.41 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.681 0.793 . . . . 10.0 112.399 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -50.73 -54.52 22.62 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.683 1.193 . . . . 10.0 110.879 173.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -57.17 -58.18 15.9 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 124.452 1.025 . . . . 10.0 113.574 178.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 80.8 mt -56.16 -45.54 79.65 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-N 118.626 1.213 . . . . 10.0 112.134 176.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.45 -42.57 75.71 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 124.936 1.255 . . . . 10.0 113.329 172.462 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 17.4 m -59.75 -60.86 3.16 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.216 1.006 . . . . 10.0 111.076 171.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -52.3 -40.99 62.55 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.061 0.944 . . . . 10.0 110.936 179.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.0 t80 -55.78 -58.03 9.56 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.552 1.141 . . . . 10.0 113.006 172.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -59.63 -38.7 82.07 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 113.226 0.825 . . . . 10.0 113.226 178.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.4 ' C ' ' H ' ' A' ' 30' ' ' LYS . 11.9 mt -56.08 -67.42 0.3 Allowed 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.592 1.157 . . . . 10.0 113.668 169.072 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 t -76.45 41.04 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 CA-C-O 123.749 1.738 . . . . 10.0 110.829 179.109 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.4 ' H ' ' C ' ' A' ' 28' ' ' LEU . 42.9 tttm -140.91 -44.87 0.39 Allowed 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 127.868 2.467 . . . . 10.0 109.303 171.186 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.95 23.09 0.87 Allowed Glycine 0 CA--C 1.529 0.956 0 N-CA-C 115.644 1.017 . . . . 10.0 115.644 173.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 37.4 mmm -59.54 -44.96 93.07 Favored 'General case' 0 C--O 1.224 -0.253 0 C-N-CA 127.136 2.174 . . . . 10.0 113.578 -178.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.66 -84.44 1.18 Allowed Glycine 0 CA--C 1.531 1.045 0 C-N-CA 123.741 0.686 . . . . 10.0 112.477 -170.159 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.8 t 33.09 88.7 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.243 0.73 0 C-N-CA 128.399 2.68 . . . . 10.0 116.941 166.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.4 m -79.58 -50.9 10.0 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.188 -1.369 . . . . 10.0 113.868 174.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -48.87 117.46 6.32 Favored Pre-proline 0 CA--C 1.536 0.428 0 O-C-N 124.719 1.262 . . . . 10.0 110.983 -172.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -58.56 -29.62 89.51 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 123.773 2.982 . . . . 10.0 113.727 179.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.38 -60.59 2.33 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.058 0.543 . . . . 10.0 111.442 176.183 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.15 -40.07 22.65 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 125.127 1.371 . . . . 10.0 113.58 171.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -46.5 -47.5 19.39 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 125.292 1.437 . . . . 10.0 113.413 172.03 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -57.79 -52.98 63.23 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.438 0.695 . . . . 10.0 110.975 176.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.476 ' CD2' ' HB1' ' A' ' 228' ' ' ALA . 44.2 m-85 -57.05 -50.18 73.54 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 123.034 0.534 . . . . 10.0 112.351 -179.145 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -54.37 -51.28 65.31 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 118.935 -0.555 . . . . 10.0 112.379 173.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.42 -61.97 1.94 Allowed 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 113.425 0.898 . . . . 10.0 113.425 177.168 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.7 mt -48.8 -57.54 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 C-N-CA 124.823 1.249 . . . . 10.0 110.145 177.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 4.9 m -69.42 -14.75 63.07 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.188 1.395 . . . . 10.0 113.74 -172.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 31.3 m -89.7 -42.25 11.44 Favored 'General case' 0 N--CA 1.483 1.178 0 CA-C-N 119.884 1.22 . . . . 10.0 111.946 174.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 27.9 mt -56.27 -40.01 73.55 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 118.433 0.56 . . . . 10.0 112.176 170.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . 0.254 24.3 t -47.09 -62.9 1.65 Allowed Pre-proline 0 CA--C 1.552 1.052 0 C-N-CA 125.266 1.426 . . . . 10.0 112.884 177.007 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -53.26 -42.47 64.9 Favored 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 123.919 3.079 . . . . 10.0 116.303 166.089 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.66 -46.19 89.33 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 114.199 1.185 . . . . 10.0 114.199 -174.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 48.3 mm -57.43 -51.32 71.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 O-C-N 121.194 -0.941 . . . . 10.0 109.697 171.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.76 -42.62 71.91 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 113.588 0.959 . . . . 10.0 113.588 175.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -52.85 -56.73 13.62 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 120.379 1.445 . . . . 10.0 112.01 170.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.8 m -49.55 -52.52 29.29 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.512 1.525 . . . . 10.0 110.837 177.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 32.7 mmt -69.11 -48.23 63.07 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 124.035 0.934 . . . . 10.0 112.894 -176.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -57.01 -40.11 76.01 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 117.058 -1.449 . . . . 10.0 113.135 173.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.8 tp -53.31 -54.58 34.43 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-N 120.198 1.363 . . . . 10.0 111.276 170.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 23.9 p -51.68 -41.0 61.09 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 115.261 1.578 . . . . 10.0 115.261 178.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 57.4 mtm -66.88 -50.88 61.08 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 123.534 0.734 . . . . 10.0 110.481 176.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.3 tp -48.54 -52.69 21.43 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.858 0.863 . . . . 10.0 112.926 172.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.4 mt -76.87 -5.64 49.22 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.377 1.071 . . . . 10.0 113.819 -177.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.29 -34.72 5.54 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 115.533 0.973 . . . . 10.0 115.533 174.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -49.29 -43.13 42.99 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 115.206 1.558 . . . . 10.0 115.206 -176.014 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.06 3.61 60.97 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 115.337 0.895 . . . . 10.0 115.337 -178.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.29 143.42 26.42 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 127.048 2.139 . . . . 10.0 108.972 172.014 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 t -145.54 171.05 15.24 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 124.064 0.946 . . . . 10.0 111.022 166.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.99 136.12 53.33 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 123.855 0.862 . . . . 10.0 109.683 179.602 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.436 ' HA ' ' HD3' ' A' ' 70' ' ' PRO . 58.5 t -129.6 129.55 23.17 Favored Pre-proline 0 C--N 1.329 -0.295 0 C-N-CA 125.063 1.345 . . . . 10.0 110.948 -176.048 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 69' ' ' VAL . 6.3 Cg_exo -80.69 116.24 3.18 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 N-CA-C 109.417 -1.032 . . . . 10.0 109.417 -178.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -156.74 164.4 38.16 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.823 0.675 . . . . 10.0 112.823 172.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.37 -81.98 0.14 Allowed Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.681 -0.967 . . . . 10.0 110.681 175.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.76 -3.32 0.7 Allowed Glycine 0 CA--C 1.527 0.822 0 N-CA-C 118.671 2.228 . . . . 10.0 118.671 170.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -151.63 -171.89 4.06 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 119.354 1.577 . . . . 10.0 112.237 -165.161 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -91.89 93.95 9.06 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 125.504 1.522 . . . . 10.0 111.066 -175.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.449 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 60.3 m-80 -89.52 120.77 69.62 Favored Pre-proline 0 N--CA 1.45 -0.43 0 N-CA-C 112.964 0.727 . . . . 10.0 112.964 -165.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.652 ' HB3' HG21 ' A' ' 5' ' ' THR . 75.7 Cg_exo -61.53 131.97 38.43 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 124.163 3.242 . . . . 10.0 112.136 171.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.5 mm -140.14 126.3 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 C-N-CA 126.072 1.749 . . . . 10.0 111.714 -179.463 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -93.65 85.07 4.76 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 122.714 1.245 . . . . 10.0 113.055 174.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 63.8 p-90 -59.35 -28.3 66.71 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 113.925 1.083 . . . . 10.0 113.925 174.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -55.21 -32.77 62.51 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.273 1.029 . . . . 10.0 112.654 178.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 37.7 ttm-85 -49.36 -43.51 44.0 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.917 1.687 . . . . 10.0 112.283 169.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 61.7 m-85 -78.91 -39.85 33.76 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 125.538 1.535 . . . . 10.0 112.428 -179.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -49.92 -48.15 51.89 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.798 1.239 . . . . 10.0 111.337 167.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -56.01 -68.8 0.17 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.426 1.49 . . . . 10.0 111.907 170.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . . . . . . . . . 48.9 m0 -52.82 -33.95 51.61 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.996 1.318 . . . . 10.0 113.387 -173.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 32.6 tp -50.96 -45.65 60.83 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 125.899 1.679 . . . . 10.0 111.982 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -97.55 -47.55 5.6 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 124.478 1.111 . . . . 10.0 112.441 -177.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.4 HG21 ' HD2' ' A' ' 216' ' ' LYS . 51.6 m -59.77 -40.13 87.19 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.643 1.177 . . . . 10.0 112.892 -174.364 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.5 m -68.26 -47.58 38.07 Favored Pre-proline 0 CA--C 1.547 0.86 0 N-CA-C 113.745 1.017 . . . . 10.0 113.745 -179.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -50.03 -42.77 44.7 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 123.356 2.704 . . . . 10.0 115.362 166.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 54.1 mt -59.18 -46.94 87.07 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.264 0.626 . . . . 10.0 111.575 174.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.5 tp -49.71 -49.15 48.91 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.593 1.557 . . . . 10.0 112.162 171.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.6 mp -58.85 -47.33 85.25 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.031 1.332 . . . . 10.0 112.498 171.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.83 -38.24 78.23 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 123.844 0.857 . . . . 10.0 112.891 178.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -52.31 -54.0 37.16 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 119.324 0.966 . . . . 10.0 111.189 169.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.35 -42.17 88.46 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.656 0.782 . . . . 10.0 112.046 -178.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.7 -54.7 38.4 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 124.008 0.923 . . . . 10.0 112.013 173.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.3 -41.17 79.34 Favored 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 123.72 0.808 . . . . 10.0 112.702 174.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.9 tp -63.75 -38.62 91.77 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 114.425 1.268 . . . . 10.0 114.425 -179.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.1 t -94.79 1.49 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 125.025 1.33 . . . . 10.0 112.325 179.158 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.2 t70 48.57 53.49 12.06 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.866 1.666 . . . . 10.0 112.095 -174.033 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.3 145.94 47.51 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 119.974 -1.704 . . . . 10.0 112.437 -174.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.53 135.92 54.41 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 112.679 0.622 . . . . 10.0 112.679 175.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -42.81 -39.75 2.61 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.895 1.678 . . . . 10.0 113.443 175.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -47.35 -60.2 5.35 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 125.15 1.357 . . . . 10.0 115.22 169.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.9 p -62.07 -46.72 87.87 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-O 117.103 -1.427 . . . . 10.0 111.351 178.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 67.1 mt -48.47 -52.9 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 125.033 1.333 . . . . 10.0 111.085 178.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.3 tp -62.62 -51.33 67.69 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 112.502 0.556 . . . . 10.0 112.502 179.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.11 -44.9 42.7 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.47 0.708 . . . . 10.0 110.959 174.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.456 ' HA ' HD12 ' A' ' 111' ' ' LEU . 0.6 OUTLIER -59.64 -59.89 4.72 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 127.393 2.277 . . . . 10.0 114.793 174.972 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.8 t -61.0 -46.31 96.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 123.704 0.802 . . . . 10.0 111.411 -178.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -56.65 -50.32 64.05 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 123.695 0.664 . . . . 10.0 112.63 174.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -54.96 -46.23 75.01 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 113.375 0.88 . . . . 10.0 113.375 173.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -55.9 -48.84 74.9 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.698 0.799 . . . . 10.0 111.129 173.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -42.52 -55.27 4.58 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 125.044 1.306 . . . . 10.0 112.997 169.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 82.2 mt -55.56 -58.19 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-O 117.571 -1.204 . . . . 10.0 110.66 173.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 5.0 ptt? -53.42 -46.35 69.74 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 120.783 1.628 . . . . 10.0 113.343 -173.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 46.5 mm -73.77 -47.39 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 O-C-N 121.471 -0.768 . . . . 10.0 111.836 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -54.0 -50.77 53.71 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 123.848 0.737 . . . . 10.0 112.278 175.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 23.7 m -56.53 -46.21 80.75 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.816 1.646 . . . . 10.0 111.648 172.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -45.83 -54.07 8.25 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 124.8 1.191 . . . . 10.0 113.221 168.109 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 61.6 tp -59.87 -46.44 89.3 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.195 1.398 . . . . 10.0 112.698 176.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 60.4 t -53.76 -49.7 56.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 O-C-N 121.284 -0.885 . . . . 10.0 110.112 172.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -50.7 -61.23 6.19 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 126.119 1.818 . . . . 10.0 112.65 171.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -43.12 -42.08 3.91 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 127.818 2.447 . . . . 10.0 113.208 176.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 47.3 mt -100.88 -6.8 24.19 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 115.536 1.68 . . . . 10.0 115.536 -175.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 16.9 m -69.66 116.71 10.37 Favored 'General case' 0 N--CA 1.464 0.229 0 O-C-N 120.195 -1.566 . . . . 10.0 110.386 -178.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.621 ' H ' ' HD3' ' A' ' 129' ' ' LYS . 0.2 OUTLIER -55.51 -49.57 72.26 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 128.157 2.583 . . . . 10.0 113.269 177.763 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 60.3 t -69.65 106.33 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 123.819 0.848 . . . . 10.0 110.103 179.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -46.9 -59.54 3.02 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 124.724 1.21 . . . . 10.0 114.055 -173.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 m -46.5 -42.05 15.01 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.45 1.5 . . . . 10.0 113.495 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -70.18 -24.64 63.17 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 114.896 1.443 . . . . 10.0 114.896 -178.103 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 68.9 mtp85 -53.95 -41.81 68.18 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 118.88 0.764 . . . . 10.0 110.776 176.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -69.62 -31.6 69.81 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 114.403 1.26 . . . . 10.0 114.403 176.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.8 t -55.09 -52.18 47.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 CA-C-N 118.993 0.815 . . . . 10.0 109.549 168.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 64.2 m95 -61.09 -43.27 99.15 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 114.185 1.18 . . . . 10.0 114.185 174.085 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 89.2 t90 -52.88 -49.81 65.11 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 119.255 0.934 . . . . 10.0 112.642 172.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -56.99 -52.72 64.14 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.225 1.01 . . . . 10.0 111.76 178.193 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 96.9 mt -54.42 -50.75 55.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 125.019 1.328 . . . . 10.0 111.596 175.255 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 19.5 m -54.49 -45.49 73.23 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.46 1.104 . . . . 10.0 111.835 174.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 53.3 m -62.25 -44.72 95.91 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.821 1.648 . . . . 10.0 112.08 177.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -56.5 -50.97 70.24 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.781 0.832 . . . . 10.0 112.265 171.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -57.51 -46.29 83.97 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.836 0.854 . . . . 10.0 112.942 175.204 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 11.9 tmm? -55.02 -54.06 47.85 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.26 1.424 . . . . 10.0 111.956 172.234 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 58.1 tp -57.65 -42.98 84.58 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.794 1.638 . . . . 10.0 112.834 178.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -53.36 -53.6 48.71 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.537 0.735 . . . . 10.0 112.037 169.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 46.2 mt -54.62 -54.64 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 123.733 0.813 . . . . 10.0 111.061 177.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 5.1 tt -46.13 -46.91 17.46 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 127.943 2.497 . . . . 10.0 112.222 173.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -57.33 -58.15 9.5 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 124.026 0.93 . . . . 10.0 113.03 178.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.42 -40.9 85.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 CA-C-O 118.343 -0.837 . . . . 10.0 111.467 177.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 47.4 mt -56.73 -49.45 75.16 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.824 1.193 . . . . 10.0 112.139 171.223 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.47 ' HA ' ' HD2' ' A' ' 175' ' ' ARG . 11.8 t80 -76.98 -70.34 0.47 Allowed 'General case' 0 C--N 1.326 -0.447 0 O-C-N 120.079 -1.638 . . . . 10.0 112.845 -175.215 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -73.76 -21.92 60.03 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.634 1.174 . . . . 10.0 113.426 -174.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -87.77 -79.08 1.26 Allowed Glycine 0 CA--C 1.526 0.761 0 C-N-CA 123.662 0.649 . . . . 10.0 113.553 171.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -53.63 -32.47 51.46 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 126.307 1.843 . . . . 10.0 113.025 -166.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.2 m -52.08 -56.45 14.35 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 114.016 1.117 . . . . 10.0 114.016 172.143 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.4 p -53.66 -50.56 65.52 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 122.161 0.981 . . . . 10.0 112.307 -177.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 47.6 tttm -57.08 -46.07 82.83 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.134 0.974 . . . . 10.0 112.167 173.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.86 -47.41 80.47 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 114.515 1.302 . . . . 10.0 114.515 174.069 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -56.47 -11.3 1.21 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 126.087 1.755 . . . . 10.0 114.252 177.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.2 m -107.1 6.64 29.08 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 126.416 1.886 . . . . 10.0 114.877 -179.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 93.2 mmm -91.91 -92.63 0.15 Allowed 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 123.451 1.596 . . . . 10.0 114.164 -170.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -138.71 154.0 72.7 Favored Pre-proline 0 C--O 1.236 0.359 0 C-N-CA 129.749 3.219 . . . . 10.0 105.539 170.241 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -52.85 -46.24 35.09 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 122.308 2.005 . . . . 10.0 113.074 179.057 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.667 ' CD ' ' HD3' ' A' ' 227' ' ' ARG . 0.1 OUTLIER -52.94 -46.11 67.98 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 129.022 2.929 . . . . 10.0 113.281 173.578 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 92.2 t -69.19 -53.03 27.73 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 C-N-CA 124.034 0.934 . . . . 10.0 109.782 -178.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.09 -46.89 75.53 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.282 0.633 . . . . 10.0 111.923 177.047 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 60.2 p -59.97 -56.16 25.08 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.883 0.873 . . . . 10.0 112.719 174.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 61.7 m -57.23 -53.16 61.21 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.143 0.977 . . . . 10.0 113.004 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -49.59 -49.54 46.26 Favored 'General case' 0 C--O 1.222 -0.375 0 C-N-CA 123.289 0.636 . . . . 10.0 111.067 174.098 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -57.12 -48.41 78.72 Favored 'General case' 0 N--CA 1.465 0.317 0 N-CA-C 114.671 1.36 . . . . 10.0 114.671 -179.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 40.3 t -55.95 -49.63 74.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 CA-C-N 118.832 0.742 . . . . 10.0 110.522 176.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 94.0 mt -58.54 -51.69 68.82 Favored 'General case' 0 C--O 1.222 -0.389 0 N-CA-C 113.168 0.803 . . . . 10.0 113.168 175.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . 0.47 ' HD2' ' HA ' ' A' ' 153' ' ' PHE . 35.6 ttp180 -47.72 -47.83 29.84 Favored 'General case' 0 C--O 1.224 -0.244 0 C-N-CA 126.889 2.075 . . . . 10.0 111.041 174.448 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 63.7 m-20 -58.51 -58.33 9.02 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 122.817 0.447 . . . . 10.0 111.25 174.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 53.7 t -52.09 -47.19 43.58 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 C-N-CA 124.05 0.94 . . . . 10.0 112.301 179.063 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 30.2 m -58.27 -65.31 0.67 Allowed 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 128.041 2.536 . . . . 10.0 111.283 177.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 55.8 t -49.66 -49.12 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 C-N-CA 124.859 1.263 . . . . 10.0 111.429 -178.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 72.0 t -58.88 -61.75 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 123.909 0.884 . . . . 10.0 112.164 177.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 85.8 mt -55.11 -46.82 75.6 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 119.251 0.932 . . . . 10.0 112.002 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 9.6 m95 -53.13 -47.12 68.94 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 125.174 1.39 . . . . 10.0 113.215 175.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 51.3 p -57.59 -32.87 67.62 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 113.753 1.02 . . . . 10.0 113.753 175.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -67.81 -45.5 74.57 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 113.708 1.003 . . . . 10.0 113.708 -179.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -44.29 -55.36 9.96 Favored Pre-proline 0 CA--C 1.55 0.979 0 N-CA-C 115.596 1.702 . . . . 10.0 115.596 -178.342 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 0.563 ' HB3' H183 ' A' ' 999' ' ' RET . 19.1 Cg_endo -57.95 -38.06 93.64 Favored 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 122.874 2.383 . . . . 10.0 113.562 176.419 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 30.3 t -63.67 -53.66 41.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 124.679 1.192 . . . . 10.0 110.576 177.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 96.2 t -53.55 -49.68 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 124.819 1.248 . . . . 10.0 111.462 176.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 61.2 t90 -55.26 -52.78 62.3 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.261 1.024 . . . . 10.0 112.511 175.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 9.5 tt -57.98 -43.69 86.68 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 123.898 0.879 . . . . 10.0 112.628 -176.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 15.3 pt -83.81 -5.59 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 N-CA-C 114.986 1.476 . . . . 10.0 114.986 -179.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.18 -169.33 33.3 Favored Glycine 0 N--CA 1.451 -0.363 0 CA-C-O 122.587 1.104 . . . . 10.0 113.966 -169.047 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 23.3 t -53.13 -41.45 65.09 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 114.159 -1.021 . . . . 10.0 111.879 177.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -66.83 -17.24 64.79 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 115.627 1.714 . . . . 10.0 115.627 -175.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -131.38 -105.79 1.05 Allowed Glycine 0 CA--C 1.533 1.169 0 CA-C-N 120.402 1.455 . . . . 10.0 113.911 -172.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -89.45 127.15 35.81 Favored 'General case' 0 C--N 1.329 -0.306 0 O-C-N 120.659 -1.495 . . . . 10.0 109.349 168.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -72.47 65.34 1.36 Allowed Glycine 0 CA--C 1.532 1.124 0 N-CA-C 113.906 0.322 . . . . 10.0 113.906 173.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 60.5 mt -79.51 -42.78 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 126.086 1.754 . . . . 10.0 108.764 166.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 79.8 t -126.31 133.34 24.87 Favored Pre-proline 0 N--CA 1.454 -0.264 0 C-N-CA 126.502 1.921 . . . . 10.0 109.401 -174.179 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -68.74 153.75 72.56 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 123.793 2.996 . . . . 10.0 111.491 -176.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 12.2 tp -43.13 -39.75 2.94 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.329 1.052 . . . . 10.0 112.227 171.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -48.37 -52.39 21.96 Favored 'General case' 0 CA--C 1.539 0.519 0 N-CA-C 114.673 1.361 . . . . 10.0 114.673 176.022 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 14.0 mm -75.91 -40.49 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 124.378 1.071 . . . . 10.0 109.647 177.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -49.32 -49.78 42.5 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 118.575 0.625 . . . . 10.0 111.956 173.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 16.1 m -57.72 -47.05 83.49 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 126.04 1.736 . . . . 10.0 112.974 174.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.535 HD23 ' CD2' ' A' ' 12' ' ' TRP . 1.3 tm? -63.35 -52.33 62.22 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.968 0.907 . . . . 10.0 112.061 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 93.2 mt -52.54 -58.82 5.57 Favored 'General case' 0 C--O 1.228 -0.077 0 C-N-CA 124.293 1.037 . . . . 10.0 110.003 176.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -53.97 -43.78 70.2 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 117.704 -1.141 . . . . 10.0 112.876 176.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 209' ' ' MET . . . . . 0.575 ' HE2' ' HB3' ' A' ' 15' ' ' LEU . 4.6 tmm? -53.96 -52.57 60.25 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 120.285 1.402 . . . . 10.0 112.237 174.235 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 78.3 t -61.45 -47.89 91.32 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 125.183 1.393 . . . . 10.0 111.897 178.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 5.1 mp -57.42 -49.54 75.9 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.025 1.33 . . . . 10.0 111.404 175.038 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -59.14 -56.83 17.12 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.697 1.199 . . . . 10.0 111.588 176.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 34.3 m -54.62 -39.66 47.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 CA-C-N 121.89 2.132 . . . . 10.0 112.377 178.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 19.8 m -58.46 -52.64 64.76 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.216 1.006 . . . . 10.0 112.133 171.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -71.91 -18.8 62.0 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 125.549 1.54 . . . . 10.0 114.984 -179.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . 0.4 ' HD2' HG21 ' A' ' 89' ' ' THR . 0.3 OUTLIER -95.59 -79.8 0.43 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.575 1.55 . . . . 10.0 109.506 177.099 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 8.0 p -77.06 -42.71 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 O-C-N 121.214 -0.929 . . . . 10.0 112.192 -174.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -54.07 -57.23 17.43 Favored Glycine 0 CA--C 1.537 1.467 0 CA-C-N 119.944 1.247 . . . . 10.0 113.269 176.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -46.64 -56.25 6.4 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.717 2.007 . . . . 10.0 112.201 168.093 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -55.82 -38.59 74.25 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 123.817 0.722 . . . . 10.0 113.696 179.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 24.5 mt -70.64 -27.38 64.01 Favored 'General case' 0 CA--C 1.512 -0.504 0 N-CA-C 115.694 1.739 . . . . 10.0 115.694 176.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 74.4 mt -63.52 -57.51 11.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 108.561 -0.903 . . . . 10.0 108.561 165.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 32.1 tp -58.85 -64.6 0.88 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.893 0.877 . . . . 10.0 113.213 -172.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 84.2 mt -71.58 5.17 2.55 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 115.295 1.591 . . . . 10.0 115.295 -171.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.6 mtp-105 -112.31 0.34 15.68 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 124.172 0.989 . . . . 10.0 113.238 172.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 8.8 t -108.0 177.94 4.66 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 124.116 0.966 . . . . 10.0 111.046 174.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . 0.667 ' HD3' ' CD ' ' A' ' 166' ' ' GLU . 41.7 ttt180 -71.62 98.16 1.85 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.732 0.813 . . . . 10.0 110.973 170.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . 0.476 ' HB1' ' CD2' ' A' ' 42' ' ' PHE . . . -80.86 76.99 7.78 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.874 0.87 . . . . 10.0 112.08 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 40.21 102.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 128.831 2.852 . . . . 10.0 116.474 177.672 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . 0.482 0.3 OUTLIER 71.82 -55.43 0.66 Allowed 'General case' 0 C--O 1.241 0.647 0 C-N-CA 124.749 1.22 . . . . 10.0 110.656 -175.288 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -68.29 169.47 40.06 Favored Glycine 0 C--O 1.239 0.417 0 C-N-CA 129.73 3.538 . . . . 10.0 119.666 171.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.461 0 C-N-CA 128.491 2.716 . . . . 10.0 113.461 166.583 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 999' ' ' RET . . . . . 0.563 H183 ' HB3' ' A' ' 186' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1000 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A 1001 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A 1002 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A 1003 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 N--CA 1.477 0.893 0 CA-C-O 115.781 -2.057 . . . . 10.0 105.88 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 23.28 91.89 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 129.62 3.168 . . . . 10.0 117.262 160.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 28.6 65.12 0.11 Allowed 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 128.302 2.641 . . . . 10.0 114.479 155.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 86.7 mt -56.46 137.95 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 126.407 1.883 . . . . 10.0 113.34 -158.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.652 HG21 ' HB3' ' A' ' 77' ' ' PRO . 7.5 t -136.74 -165.21 1.7 Allowed 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 126.345 1.858 . . . . 10.0 114.01 -174.337 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 69.97 2.84 40.9 Favored Glycine 0 C--N 1.34 0.793 0 C-N-CA 127.49 2.471 . . . . 10.0 111.496 168.049 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.8 tpp180 -158.59 -51.27 0.01 OUTLIER Pre-proline 0 N--CA 1.443 -0.822 0 CA-C-O 114.301 -2.761 . . . . 10.0 116.694 -168.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -63.97 -60.7 0.14 Allowed 'Trans proline' 0 N--CA 1.465 -0.169 0 CA-C-N 123.559 2.307 . . . . 10.0 113.2 -175.372 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.41 ' H ' ' CD ' ' A' ' 9' ' ' GLU . 7.9 pm0 -67.16 4.27 0.96 Allowed 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 127.87 2.468 . . . . 10.0 115.787 179.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.422 ' CG ' ' N ' ' A' ' 11' ' ' ILE . 11.0 p-90 -51.31 -43.13 61.61 Favored 'General case' 0 C--O 1.222 -0.361 0 O-C-N 121.489 -0.757 . . . . 10.0 112.643 176.418 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.422 ' N ' ' CG ' ' A' ' 10' ' ' TRP . 8.9 tt -60.86 -49.61 83.92 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.338 0 C-N-CA 123.887 0.875 . . . . 10.0 109.316 179.416 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.535 ' CD2' HD23 ' A' ' 206' ' ' LEU . 2.6 m95 -55.38 -52.67 62.8 Favored 'General case' 0 C--O 1.223 -0.312 0 C-N-CA 123.455 0.702 . . . . 10.0 111.872 175.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 90.7 mt -57.35 -53.62 56.06 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.184 0.594 . . . . 10.0 112.213 177.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.86 -46.83 51.83 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.418 1.487 . . . . 10.0 113.288 173.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.575 ' HB3' ' HE2' ' A' ' 209' ' ' MET . 13.3 tp -65.62 -45.0 84.77 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.312 1.445 . . . . 10.0 113.045 179.122 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -49.79 -56.29 12.15 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 124.506 1.051 . . . . 10.0 111.622 166.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 22.5 m -49.46 -52.63 27.77 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.981 1.312 . . . . 10.0 112.408 174.254 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.45 -58.84 5.88 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.109 0.964 . . . . 10.0 112.196 177.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 95.0 mt -57.52 -48.51 79.09 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.566 0.746 . . . . 10.0 112.729 -179.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.549 ' SD ' ' HB1' ' A' ' 53' ' ' ALA . 56.4 mtt -58.7 -47.17 85.45 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.345 1.058 . . . . 10.0 111.403 177.497 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -58.45 -58.51 14.21 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 124.356 0.979 . . . . 10.0 113.901 173.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 81.0 mt -56.19 -45.96 79.59 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-N 118.691 1.246 . . . . 10.0 112.116 176.255 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.75 -41.86 76.46 Favored Glycine 0 CA--C 1.533 1.214 0 C-N-CA 124.752 1.167 . . . . 10.0 113.172 173.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 28.4 m -62.29 -58.54 7.35 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.778 0.831 . . . . 10.0 111.425 171.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -52.3 -40.92 62.46 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.99 0.916 . . . . 10.0 110.962 177.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -55.82 -58.01 9.63 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.586 1.154 . . . . 10.0 112.974 172.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 22.1 m-30 -59.62 -38.73 82.09 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 113.184 0.809 . . . . 10.0 113.184 178.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.401 ' C ' ' H ' ' A' ' 30' ' ' LYS . 11.8 mt -56.15 -67.44 0.3 Allowed 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 124.621 1.168 . . . . 10.0 113.585 169.171 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.7 t -76.38 40.97 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-O 123.79 1.757 . . . . 10.0 110.846 179.111 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.401 ' H ' ' C ' ' A' ' 28' ' ' LEU . 42.9 tttm -140.87 -44.87 0.39 Allowed 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 127.9 2.48 . . . . 10.0 109.32 171.173 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.91 23.07 0.87 Allowed Glycine 0 CA--C 1.528 0.898 0 N-CA-C 115.649 1.019 . . . . 10.0 115.649 173.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 37.3 mmm -59.47 -45.03 92.8 Favored 'General case' 0 C--O 1.225 -0.228 0 C-N-CA 127.188 2.195 . . . . 10.0 113.562 -179.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.71 -84.38 1.19 Allowed Glycine 0 CA--C 1.531 1.045 0 C-N-CA 123.743 0.687 . . . . 10.0 112.47 -170.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.8 t 32.99 88.76 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.242 0.706 0 C-N-CA 128.365 2.666 . . . . 10.0 116.96 166.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 28.5 m -79.6 -50.85 10.07 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 114.132 -1.394 . . . . 10.0 113.93 174.101 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -48.97 117.53 6.49 Favored Pre-proline 0 CA--C 1.536 0.418 0 O-C-N 124.815 1.322 . . . . 10.0 110.95 -172.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -58.53 -29.66 89.5 Favored 'Trans proline' 0 N--CA 1.459 -0.5 0 C-N-CA 123.695 2.93 . . . . 10.0 113.74 179.095 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -68.29 -60.64 2.31 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.142 0.577 . . . . 10.0 111.439 176.208 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.21 -40.08 23.19 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 125.065 1.346 . . . . 10.0 113.551 171.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.4 tttp -46.52 -47.39 19.5 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.241 1.416 . . . . 10.0 113.444 172.042 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.5 mttt -57.79 -53.05 62.58 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.507 0.723 . . . . 10.0 110.958 176.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.476 ' CD2' ' HB1' ' A' ' 228' ' ' ALA . 44.0 m-85 -57.03 -50.15 73.6 Favored 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 123.075 0.55 . . . . 10.0 112.348 -179.109 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -54.4 -51.29 65.35 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 118.921 -0.561 . . . . 10.0 112.377 173.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.38 -62.04 1.9 Allowed 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 113.38 0.881 . . . . 10.0 113.38 177.13 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 53.5 mt -48.42 -57.98 1.29 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 124.918 1.287 . . . . 10.0 110.323 178.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.2 m -68.42 -17.57 64.24 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.195 1.398 . . . . 10.0 113.819 -172.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 27.9 m -87.59 -40.3 14.35 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-N 119.511 1.05 . . . . 10.0 112.196 174.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 22.3 mt -58.76 -43.68 90.4 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 121.48 -0.762 . . . . 10.0 112.272 171.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 19.3 t -38.88 -66.13 0.34 Allowed Pre-proline 0 CA--C 1.552 1.032 0 C-N-CA 125.922 1.689 . . . . 10.0 112.861 175.367 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -69.76 -23.44 30.79 Favored 'Trans proline' 0 CA--C 1.546 1.082 0 C-N-CA 123.042 2.495 . . . . 10.0 114.66 176.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.27 -45.42 80.54 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 120.564 1.529 . . . . 10.0 113.357 175.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 32.6 mm -58.51 -46.1 89.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 O-C-N 121.072 -1.018 . . . . 10.0 109.569 169.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.549 ' HB1' ' SD ' ' A' ' 20' ' ' MET . . . -51.96 -51.28 58.18 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.642 1.177 . . . . 10.0 112.127 176.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -50.37 -58.3 6.0 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 126.045 1.738 . . . . 10.0 112.321 173.26 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.3 m -49.17 -52.88 23.84 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 125.139 1.376 . . . . 10.0 110.755 178.093 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.407 ' HG3' ' HB2' ' A' ' 85' ' ' ASP . 33.0 mmt -69.38 -48.59 60.7 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 124.165 0.986 . . . . 10.0 112.735 -176.362 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -57.18 -39.58 75.64 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-O 116.766 -1.588 . . . . 10.0 113.266 173.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 19.8 tp -53.29 -54.53 34.98 Favored 'General case' 0 C--O 1.224 -0.238 0 CA-C-N 120.482 1.492 . . . . 10.0 111.313 169.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 24.1 p -51.69 -41.11 61.19 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 115.178 1.547 . . . . 10.0 115.178 179.019 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 59.7 mtm -66.8 -50.88 61.23 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 123.56 0.744 . . . . 10.0 110.534 176.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 39.3 tp -48.58 -52.66 21.75 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.826 0.851 . . . . 10.0 112.94 172.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 22.4 mt -76.88 -5.62 49.15 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.349 1.06 . . . . 10.0 113.828 -177.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.35 -34.74 5.52 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 115.504 0.962 . . . . 10.0 115.504 174.128 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -49.24 -43.13 42.49 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 115.208 1.559 . . . . 10.0 115.208 -175.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.1 3.65 60.96 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 115.377 0.911 . . . . 10.0 115.377 -178.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.33 143.47 26.36 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 126.993 2.117 . . . . 10.0 108.992 172.018 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.0 t -145.54 171.09 15.18 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 124.046 0.938 . . . . 10.0 111.06 166.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.02 136.11 53.33 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 123.833 0.853 . . . . 10.0 109.728 179.556 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 58.6 t -129.59 129.62 23.18 Favored Pre-proline 0 C--N 1.329 -0.299 0 C-N-CA 125.034 1.333 . . . . 10.0 110.909 -176.018 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -80.78 116.23 3.15 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 N-CA-C 109.445 -1.021 . . . . 10.0 109.445 -178.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -156.68 164.44 38.15 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.858 0.688 . . . . 10.0 112.858 172.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 67.34 -82.01 0.14 Allowed Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.636 -0.986 . . . . 10.0 110.636 175.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -144.73 -3.29 0.7 Allowed Glycine 0 CA--C 1.527 0.818 0 N-CA-C 118.706 2.242 . . . . 10.0 118.706 170.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -151.64 -171.95 4.08 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 119.353 1.577 . . . . 10.0 112.247 -165.159 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -91.79 93.85 9.06 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 125.517 1.527 . . . . 10.0 111.137 -175.322 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.449 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 60.1 m-80 -89.41 120.8 69.69 Favored Pre-proline 0 N--CA 1.45 -0.427 0 N-CA-C 112.97 0.73 . . . . 10.0 112.97 -165.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.652 ' HB3' HG21 ' A' ' 5' ' ' THR . 76.0 Cg_exo -61.53 131.91 38.15 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 124.219 3.279 . . . . 10.0 112.137 171.554 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 43.4 mm -140.15 126.35 21.85 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 C-N-CA 125.971 1.708 . . . . 10.0 111.684 -179.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -93.67 85.11 4.76 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 123.338 1.542 . . . . 10.0 113.026 174.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 63.8 p-90 -59.41 -28.27 66.78 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 120.619 -1.301 . . . . 10.0 113.891 174.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -54.81 -36.33 64.86 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 114.976 1.473 . . . . 10.0 114.976 178.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -59.8 -35.87 75.57 Favored 'General case' 0 N--CA 1.476 0.835 0 O-C-N 120.543 -1.348 . . . . 10.0 112.168 172.103 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -66.75 -42.88 85.48 Favored 'General case' 0 CA--C 1.545 0.758 0 O-C-N 121.071 -1.018 . . . . 10.0 112.987 173.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -50.46 -48.88 56.41 Favored 'General case' 0 CA--C 1.558 1.252 0 C-N-CA 125.624 1.569 . . . . 10.0 111.513 167.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.407 ' HB2' ' HG3' ' A' ' 56' ' ' MET . 27.5 t70 -58.61 -63.11 1.4 Allowed 'General case' 0 N--CA 1.485 1.292 0 CA-C-N 119.54 1.064 . . . . 10.0 112.465 171.571 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' TRP . . . . . 0.427 ' HA ' HG22 ' A' ' 89' ' ' THR . 47.4 m0 -50.27 -39.42 45.09 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 126.87 2.068 . . . . 10.0 112.063 -175.075 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 32.4 tp -48.85 -48.59 41.81 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 126.434 1.893 . . . . 10.0 112.377 177.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -94.19 -46.48 7.07 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.904 0.881 . . . . 10.0 112.677 -176.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.427 HG22 ' HA ' ' A' ' 86' ' ' TRP . 4.7 t -62.2 -42.73 99.56 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 113.667 0.988 . . . . 10.0 113.667 -174.214 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . 0.308 74.5 p -63.49 -43.73 79.55 Favored Pre-proline 0 N--CA 1.473 0.697 0 O-C-N 120.977 -1.077 . . . . 10.0 112.935 -178.292 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -52.87 -44.63 46.8 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 122.912 2.408 . . . . 10.0 115.746 165.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 54.1 mt -59.84 -47.4 85.87 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 119.329 0.968 . . . . 10.0 111.714 176.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 6.1 tt -50.71 -48.95 58.6 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 126.302 1.841 . . . . 10.0 111.292 171.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.9 mp -57.46 -47.68 81.22 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.543 1.137 . . . . 10.0 113.19 169.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.77 -38.24 78.06 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 123.783 0.833 . . . . 10.0 112.925 178.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -52.32 -54.08 36.18 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 119.251 0.932 . . . . 10.0 111.15 169.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.36 -42.03 88.64 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.67 0.788 . . . . 10.0 112.094 -178.483 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -54.76 -54.75 37.88 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 124.0 0.92 . . . . 10.0 111.974 173.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.25 -41.16 79.11 Favored 'General case' 0 C--O 1.224 -0.237 0 C-N-CA 123.741 0.817 . . . . 10.0 112.731 174.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.9 tp -63.77 -38.58 91.65 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 114.445 1.276 . . . . 10.0 114.445 -179.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 58.2 t -94.85 1.49 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 124.998 1.319 . . . . 10.0 112.318 179.177 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 34.2 t70 48.63 53.41 12.26 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.811 1.644 . . . . 10.0 112.117 -174.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.28 145.89 47.58 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 120.017 -1.677 . . . . 10.0 112.458 -174.171 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -56.49 135.86 54.26 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 112.775 0.658 . . . . 10.0 112.775 175.149 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -42.82 -39.66 2.58 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.88 1.672 . . . . 10.0 113.474 175.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -47.34 -60.25 5.31 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 125.18 1.371 . . . . 10.0 115.245 169.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.0 p -61.96 -46.79 87.72 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-O 117.155 -1.402 . . . . 10.0 111.358 178.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 67.1 mt -48.49 -52.9 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 125.033 1.333 . . . . 10.0 111.115 178.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 36.2 tp -62.62 -51.27 67.93 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 112.549 0.574 . . . . 10.0 112.549 179.277 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -49.21 -44.84 43.62 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.465 0.706 . . . . 10.0 110.953 174.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.455 ' HA ' HD12 ' A' ' 111' ' ' LEU . 0.6 OUTLIER -59.6 -59.91 4.69 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 127.435 2.294 . . . . 10.0 114.794 174.944 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 51.7 t -61.02 -46.31 96.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 123.743 0.817 . . . . 10.0 111.393 -178.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -56.66 -50.31 64.09 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 123.686 0.66 . . . . 10.0 112.656 174.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -55.07 -46.27 75.39 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 113.427 0.899 . . . . 10.0 113.427 173.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 53.7 t0 -58.26 -45.38 87.93 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.68 0.792 . . . . 10.0 111.679 174.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -43.31 -56.12 4.84 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 125.332 1.444 . . . . 10.0 113.322 167.062 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 82.5 mt -57.08 -55.32 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 123.811 0.844 . . . . 10.0 110.367 173.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 16.1 tmm? -48.34 -58.09 5.09 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.09 1.356 . . . . 10.0 112.785 -176.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 48.7 mm -69.72 -44.93 78.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 O-C-N 121.662 -0.648 . . . . 10.0 112.594 177.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -54.14 -45.54 72.85 Favored Glycine 0 CA--C 1.532 1.138 0 CA-C-N 119.221 0.919 . . . . 10.0 112.992 176.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 28.3 m -60.54 -45.23 94.63 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.907 1.683 . . . . 10.0 111.209 173.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -47.08 -52.37 12.44 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 124.229 0.919 . . . . 10.0 113.219 165.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.4 tt -54.26 -46.83 72.73 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 127.936 2.494 . . . . 10.0 111.472 177.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 48.6 t -61.9 -49.28 84.82 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 125.433 1.493 . . . . 10.0 111.985 171.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -52.89 -59.21 9.63 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 125.875 1.702 . . . . 10.0 112.4 175.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -42.06 -43.07 3.1 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 128.439 2.696 . . . . 10.0 113.174 175.205 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 48.3 mt -101.34 -6.53 23.97 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 115.547 1.684 . . . . 10.0 115.547 -174.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 16.9 m -69.75 116.75 10.5 Favored 'General case' 0 N--CA 1.464 0.248 0 O-C-N 120.19 -1.569 . . . . 10.0 110.366 -178.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.621 ' H ' ' HD3' ' A' ' 129' ' ' LYS . 0.1 OUTLIER -55.41 -49.67 71.78 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 128.248 2.619 . . . . 10.0 113.288 177.734 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 60.8 t -69.66 106.39 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 C-N-CA 123.738 0.815 . . . . 10.0 110.087 179.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -46.95 -59.47 3.08 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 124.742 1.217 . . . . 10.0 114.065 -173.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.4 m -46.55 -42.08 15.3 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.489 1.516 . . . . 10.0 113.468 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -70.14 -24.6 63.19 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 114.959 1.466 . . . . 10.0 114.959 -178.149 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 69.0 mtp85 -53.94 -41.6 67.93 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 118.92 0.782 . . . . 10.0 110.787 176.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -70.11 -31.09 68.47 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 114.421 1.267 . . . . 10.0 114.421 176.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.8 t -55.49 -52.43 46.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 CA-C-N 118.989 0.813 . . . . 10.0 109.613 168.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 63.6 m95 -60.28 -44.16 95.6 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 113.914 1.079 . . . . 10.0 113.914 173.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' TRP . . . . . . . . . . . . . 88.8 t90 -52.02 -49.39 63.47 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 119.469 1.032 . . . . 10.0 112.909 171.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -57.47 -52.99 63.16 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.166 0.987 . . . . 10.0 111.76 178.228 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 97.7 mt -54.03 -50.62 52.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 125.173 1.389 . . . . 10.0 111.493 175.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 16.0 m -53.93 -48.43 70.22 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.65 1.18 . . . . 10.0 111.692 174.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 60.8 m -63.1 -44.16 96.46 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.293 1.437 . . . . 10.0 111.716 -179.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -56.94 -50.65 71.94 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.175 0.99 . . . . 10.0 112.242 170.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -56.14 -46.33 79.29 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.859 0.864 . . . . 10.0 112.452 174.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 40.3 ttp -57.0 -53.14 61.38 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.472 1.109 . . . . 10.0 111.966 172.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 63.4 tp -52.7 -47.14 67.48 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.225 1.41 . . . . 10.0 111.858 178.284 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 77.3 t80 -50.81 -54.75 21.01 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.972 0.909 . . . . 10.0 112.587 171.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 41.5 mm -52.26 -55.89 8.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 CA-C-N 118.884 0.765 . . . . 10.0 110.35 176.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 43.0 mt -58.8 -35.15 72.38 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 118.511 -0.757 . . . . 10.0 111.761 -177.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -57.21 -58.24 9.09 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 124.018 0.927 . . . . 10.0 113.046 173.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.41 -40.88 85.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 CA-C-O 118.304 -0.855 . . . . 10.0 111.461 177.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . . 45.3 mt -56.78 -49.39 75.45 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.895 1.225 . . . . 10.0 112.139 171.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.471 ' HA ' ' HD2' ' A' ' 175' ' ' ARG . 11.9 t80 -77.04 -70.28 0.47 Allowed 'General case' 0 C--N 1.326 -0.435 0 O-C-N 120.083 -1.636 . . . . 10.0 112.877 -175.236 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -73.73 -21.92 60.06 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.559 1.144 . . . . 10.0 113.459 -174.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -87.78 -79.15 1.26 Allowed Glycine 0 CA--C 1.526 0.747 0 C-N-CA 123.651 0.643 . . . . 10.0 113.502 171.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 5.5 m-30 -53.57 -32.44 50.92 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 126.301 1.841 . . . . 10.0 113.067 -166.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.4 m -52.15 -56.42 14.69 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 114.003 1.112 . . . . 10.0 114.003 172.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 91.3 p -53.69 -50.57 65.57 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 122.05 0.929 . . . . 10.0 112.269 -177.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 47.6 tttm -57.09 -46.06 82.85 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.136 0.975 . . . . 10.0 112.127 173.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -56.79 -47.52 80.01 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 114.513 1.301 . . . . 10.0 114.513 174.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -56.44 -11.33 1.21 Allowed 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.066 1.746 . . . . 10.0 114.235 177.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 15.2 m -107.08 6.69 29.15 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.382 1.873 . . . . 10.0 114.885 -179.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 93.2 mmm -91.89 -92.7 0.15 Allowed 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 123.509 1.623 . . . . 10.0 114.146 -170.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -138.69 153.91 72.66 Favored Pre-proline 0 C--O 1.236 0.367 0 C-N-CA 129.767 3.227 . . . . 10.0 105.541 170.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -52.77 -46.24 34.94 Favored 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 122.352 2.035 . . . . 10.0 113.082 179.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.667 ' CD ' ' HD3' ' A' ' 227' ' ' ARG . 0.1 OUTLIER -52.94 -46.12 68.0 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 129.04 2.936 . . . . 10.0 113.292 173.569 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 92.2 t -69.19 -53.01 27.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 C-N-CA 124.034 0.933 . . . . 10.0 109.765 -178.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.19 -46.76 75.85 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.274 0.63 . . . . 10.0 111.928 177.07 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 60.4 p -60.03 -56.22 24.4 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.933 0.893 . . . . 10.0 112.699 174.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 61.4 m -57.17 -53.2 60.78 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.169 0.988 . . . . 10.0 113.05 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -49.55 -49.49 46.05 Favored 'General case' 0 C--O 1.222 -0.386 0 C-N-CA 123.305 0.642 . . . . 10.0 111.131 174.024 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -57.17 -48.42 78.77 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 114.639 1.348 . . . . 10.0 114.639 -179.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 40.4 t -55.95 -49.61 74.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 CA-C-N 118.787 0.721 . . . . 10.0 110.506 176.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 94.0 mt -58.55 -51.61 69.17 Favored 'General case' 0 C--O 1.221 -0.397 0 N-CA-C 113.207 0.818 . . . . 10.0 113.207 175.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . 0.471 ' HD2' ' HA ' ' A' ' 153' ' ' PHE . 35.7 ttp180 -47.83 -47.74 31.15 Favored 'General case' 0 C--O 1.224 -0.246 0 C-N-CA 126.818 2.047 . . . . 10.0 111.047 174.456 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 63.7 m-20 -58.53 -58.3 9.16 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 122.785 0.434 . . . . 10.0 111.252 174.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 59.4 t -51.72 -49.79 34.04 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 C-N-CA 124.078 0.951 . . . . 10.0 111.193 179.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 30.3 m -57.01 -61.5 2.4 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 128.21 2.604 . . . . 10.0 112.435 178.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 55.2 t -52.15 -49.88 38.31 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 124.471 1.108 . . . . 10.0 110.944 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 80.4 t -59.71 -61.15 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 124.299 1.04 . . . . 10.0 112.007 177.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -57.35 -50.1 74.04 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 118.78 0.718 . . . . 10.0 112.388 -176.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' TRP . . . . . . . . . . . . . 10.2 m95 -55.26 -48.85 73.4 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.627 0.771 . . . . 10.0 111.935 177.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 51.1 m -54.32 -31.42 54.17 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 114.014 1.116 . . . . 10.0 114.014 179.101 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -63.19 -40.32 97.17 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 113.808 1.04 . . . . 10.0 113.808 176.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -49.74 -55.28 24.29 Favored Pre-proline 0 CA--C 1.546 0.79 0 N-CA-C 115.281 1.585 . . . . 10.0 115.281 -175.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 0.487 ' HB3' H183 ' A' ' 999' ' ' RET . 18.4 Cg_endo -57.5 -34.92 98.78 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 122.318 2.012 . . . . 10.0 113.286 176.175 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 21.7 t -64.74 -55.62 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 124.228 1.011 . . . . 10.0 110.554 176.067 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 93.2 t -53.09 -49.88 48.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 124.995 1.318 . . . . 10.0 111.558 177.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' TRP . . . . . . . . . . . . . 63.2 t90 -56.32 -52.69 63.62 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.403 1.081 . . . . 10.0 112.598 175.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 9.6 tt -57.83 -42.77 85.07 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 123.665 0.786 . . . . 10.0 112.369 -177.593 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 14.5 pt -83.74 -5.93 9.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 N-CA-C 115.085 1.513 . . . . 10.0 115.085 179.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -97.38 -169.32 33.02 Favored Glycine 0 N--CA 1.45 -0.404 0 CA-C-O 122.55 1.083 . . . . 10.0 113.925 -168.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' SER . . . . . . . . . . . . . 23.3 t -53.16 -41.43 65.16 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 114.17 -1.015 . . . . 10.0 111.854 177.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -67.98 -16.05 63.88 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 115.626 1.713 . . . . 10.0 115.626 -175.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -131.11 -106.04 1.08 Allowed Glycine 0 CA--C 1.533 1.157 0 CA-C-N 120.4 1.455 . . . . 10.0 113.908 -173.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -89.44 127.17 35.81 Favored 'General case' 0 C--N 1.328 -0.345 0 O-C-N 120.681 -1.482 . . . . 10.0 109.304 168.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . . . . . . . . . . . -72.56 65.37 1.39 Allowed Glycine 0 CA--C 1.532 1.141 0 N-CA-C 113.871 0.308 . . . . 10.0 113.871 173.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 60.6 mt -79.54 -42.76 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 126.078 1.751 . . . . 10.0 108.759 166.333 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 79.7 t -126.31 133.37 24.9 Favored Pre-proline 0 N--CA 1.454 -0.25 0 C-N-CA 126.436 1.894 . . . . 10.0 109.351 -174.176 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -68.71 153.81 72.49 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 123.745 2.963 . . . . 10.0 111.479 -176.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 12.2 tp -43.18 -39.79 3.04 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.341 1.056 . . . . 10.0 112.169 171.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -48.38 -52.39 22.04 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 114.653 1.353 . . . . 10.0 114.653 176.086 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 14.0 mm -75.9 -40.51 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 C-N-CA 124.453 1.101 . . . . 10.0 109.646 177.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -49.27 -49.78 41.98 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 118.592 0.633 . . . . 10.0 111.991 173.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 16.3 m -57.75 -47.03 83.65 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 126.015 1.726 . . . . 10.0 112.97 174.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.535 HD23 ' CD2' ' A' ' 12' ' ' TRP . 1.3 tm? -63.36 -52.28 62.39 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.923 0.889 . . . . 10.0 112.093 179.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 93.2 mt -52.57 -59.41 4.49 Favored 'General case' 0 C--N 1.335 -0.053 0 C-N-CA 124.362 1.065 . . . . 10.0 109.954 176.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -53.11 -47.06 68.91 Favored 'General case' 0 C--O 1.216 -0.66 0 CA-C-O 117.126 -1.416 . . . . 10.0 112.001 176.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 209' ' ' MET . . . . . 0.575 ' HE2' ' HB3' ' A' ' 15' ' ' LEU . 4.6 tmm? -50.99 -52.25 44.65 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 121.454 1.934 . . . . 10.0 113.168 174.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 79.4 t -60.14 -49.15 85.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 124.708 1.203 . . . . 10.0 111.263 178.37 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 4.3 mp -58.16 -51.61 68.99 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.631 1.573 . . . . 10.0 112.272 175.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 212' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -55.68 -58.27 8.51 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 127.824 2.45 . . . . 10.0 110.566 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 213' ' ' VAL . . . . . . . . . . . . . 78.7 t -56.24 -44.9 80.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 O-C-N 121.48 -0.762 . . . . 10.0 111.764 177.234 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 24.2 t -55.25 -55.2 34.03 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.502 0.721 . . . . 10.0 112.022 174.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -63.76 -20.35 65.69 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 115.093 1.516 . . . . 10.0 115.093 177.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 216' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.01 -75.76 0.49 Allowed 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.325 1.45 . . . . 10.0 110.137 175.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 21.7 t -77.78 -47.95 24.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 126.126 1.77 . . . . 10.0 111.297 -170.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -55.97 -55.98 26.35 Favored Glycine 0 CA--C 1.534 1.246 0 CA-C-N 119.042 0.837 . . . . 10.0 112.695 178.127 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 219' ' ' PHE . . . . . . . . . . . . . 61.1 t80 -44.3 -57.7 3.34 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.926 2.09 . . . . 10.0 112.166 166.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -55.17 -40.44 74.86 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 124.179 0.895 . . . . 10.0 114.265 177.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 24.2 mt -70.55 -27.33 64.06 Favored 'General case' 0 CA--C 1.512 -0.494 0 N-CA-C 115.528 1.677 . . . . 10.0 115.528 177.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 222' ' ' ILE . . . . . . . . . . . . . 74.4 mt -63.27 -57.53 11.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 108.616 -0.883 . . . . 10.0 108.616 165.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 32.1 tp -58.89 -64.68 0.85 Allowed 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.95 0.9 . . . . 10.0 113.126 -172.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 84.3 mt -71.55 5.23 2.5 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 115.333 1.605 . . . . 10.0 115.333 -171.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 225' ' ' ARG . . . . . . . . . . . . . 7.6 mtp-105 -112.35 0.39 15.66 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.168 0.987 . . . . 10.0 113.296 172.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 8.8 t -108.04 177.99 4.64 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 124.035 0.934 . . . . 10.0 111.002 174.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 227' ' ' ARG . . . . . 0.667 ' HD3' ' CD ' ' A' ' 166' ' ' GLU . 41.8 ttt180 -71.68 98.2 1.88 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.744 0.818 . . . . 10.0 110.953 170.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . 0.476 ' HB1' ' CD2' ' A' ' 42' ' ' PHE . . . -80.88 76.98 7.8 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.896 0.879 . . . . 10.0 112.111 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 40.08 102.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 128.837 2.855 . . . . 10.0 116.492 177.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . 0.483 0.3 OUTLIER 71.92 -55.46 0.66 Allowed 'General case' 0 C--O 1.241 0.647 0 C-N-CA 124.692 1.197 . . . . 10.0 110.632 -175.346 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -68.26 169.47 39.92 Favored Glycine 0 C--O 1.238 0.376 0 C-N-CA 129.782 3.563 . . . . 10.0 119.621 171.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.461 0 C-N-CA 128.473 2.709 . . . . 10.0 113.457 166.611 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 999' ' ' RET . . . . . 0.522 H181 ' H7 ' ' A' ' 999' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1000 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A 1001 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A 1002 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A 1003 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_